PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Traverse, JH; Henry, TD; Pepine, CJ; Willerson, JT; Zhao, DXM; Ellis, SG; Forder, JR; Anderson, RD; Hatzopoulos, AK; Penn, MS; Perin, EC; Chambers, J; Baran, KW; Raveendran, G; Lambert, C; Lerman, A; Simon, DI; Vaughan, DE; Lai, DJ; Gee, AP; Taylor, DA; Cogle, CR; Thomas, JD; Olson, RE; Bowman, S; Francescon, J; Geither, C; Handberg, E; Kappenman, C; Westbrook, L; Piller, LB; Simpson, LM; Baraniuk, S; Loghin, C; Aguilar, D; Richman, S; Zierold, C; Spoon, DB; Bettencourt, J; Sayre, SL; Vojvodic, RW; Skarlatos, SI; Gordon, DJ; Ebert, RF; Kwak, M; Moye, LA; Simari, RD				Traverse, Jay H.; Henry, Timothy D.; Pepine, Carl J.; Willerson, James T.; Zhao, David X. M.; Ellis, Stephen G.; Forder, John R.; Anderson, R. David; Hatzopoulos, Antonis K.; Penn, Marc S.; Perin, Emerson C.; Chambers, Jeffrey; Baran, Kenneth W.; Raveendran, Ganesh; Lambert, Charles; Lerman, Amir; Simon, Daniel I.; Vaughan, Douglas E.; Lai, Dejian; Gee, Adrian P.; Taylor, Doris A.; Cogle, Christopher R.; Thomas, James D.; Olson, Rachel E.; Bowman, Sherry; Francescon, Judy; Geither, Carrie; Handberg, Eileen; Kappenman, Casey; Westbrook, Lynette; Piller, Linda B.; Simpson, Lara M.; Baraniuk, Sarah; Loghin, Catalin; Aguilar, David; Richman, Sara; Zierold, Claudia; Spoon, Daniel B.; Bettencourt, Judy; Sayre, Shelly L.; Vojvodic, Rachel W.; Skarlatos, Sonia I.; Gordon, David J.; Ebert, Ray F.; Kwak, Minjung; Moye, Lemuel A.; Simari, Robert D.		CCTRN	Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial Infarction The TIME Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REDUCED NEOVASCULARIZATION CAPACITY; PROGENITOR CELLS; STEM-CELLS; INTRACORONARY INFUSION; DOUBLE-BLIND; REGENERATION; THERAPY; LATETIME; EFFICACY; IMPAIRS	Context While the delivery of cell therapy after ST-segment elevation myocardial infarction (STEMI) has been evaluated in previous clinical trials, the influence of the timing of cell delivery on the effect on left ventricular function has not been analyzed. Objectives To determine the effect of intracoronary autologous bone marrow mononuclear cell (BMC) delivery after STEMI on recovery of global and regional left ventricular function and whether timing of BMC delivery (3 days vs 7 days after reperfusion) influences this effect. Design, Setting, and Patients A randomized, 2 x 2 factorial, double-blind, placebo-controlled trial, Timing In Myocardial infarction Evaluation (TIME) enrolled 120 patients with left ventricular dysfunction (left ventricular ejection fraction [LVEF] <= 45%) after successful primary percutaneous coronary intervention (PCI) of anterior STEMI between July 17, 2008, and November 15, 2011, as part of the Cardiovascular Cell Therapy Research Network sponsored by the National Heart, Lung, and Blood Institute. Interventions Intracoronary infusion of 150 x 10(6) BMCs or placebo (randomized 2: 1) within 12 hours of aspiration and cell processing administered at day 3 or day 7 (randomized 1: 1) after treatment with PCI. Main Outcome Measures The primary end points were change in global (LVEF) and regional (wall motion) left ventricular function in infarct and border zones at 6 months measured by cardiac magnetic resonance imaging and change in left ventricular function as affected by timing of treatment on day 3 vs day 7. The secondary end points included major adverse cardiovascular events as well as changes in left ventricular volumes and infarct size. Results The mean (SD) patient age was 56.9 (10.9) years and 87.5% of participants were male. At 6 months, there was no significant increase in LVEF for the BMC group (45.2% [95% CI, 42.8% to 47.6%] to 48.3% [95% CI, 45.3% to 51.3%) vs the placebo group (44.5% [95% CI, 41.0% to 48.0%] to 47.8% [95% CI, 43.4% to 52.2%]) (P=.96). There was no significant treatment effect on regional left ventricular function observed in either infarct or border zones. There were no significant differences in change in global left ventricular function for patients treated at day 3 (-0.9% [95% CI, -6.6% to 4.9%], P=.76) or day 7 (1.1% [95% CI, -4.7% to 6.9%], P=.70). The timing of treatment had no significant effect on regional left ventricular function recovery. Major adverse events were rare among all treatment groups. Conclusion Among patients with STEMI treated with primary PCI, the administration of intracoronary BMCs at either 3 days or 7 days after the event had no significant effect on recovery of global or regional left ventricular function compared with placebo.	[Traverse, Jay H.; Henry, Timothy D.; Olson, Rachel E.] Abbott NW Hosp, Minneapolis Heart Inst, Minneapolis, MN 55407 USA; [Traverse, Jay H.; Henry, Timothy D.; Raveendran, Ganesh; Zierold, Claudia] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Pepine, Carl J.; Forder, John R.; Anderson, R. David; Lambert, Charles; Cogle, Christopher R.; Handberg, Eileen] Univ Florida, Coll Med, Gainesville, FL USA; [Willerson, James T.; Perin, Emerson C.; Taylor, Doris A.; Kappenman, Casey; Westbrook, Lynette] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX USA; [Zhao, David X. M.; Hatzopoulos, Antonis K.; Bowman, Sherry; Francescon, Judy] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Ellis, Stephen G.; Thomas, James D.; Geither, Carrie] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Penn, Marc S.] NE Ohio Med Univ, Rootstown, OH USA; [Chambers, Jeffrey] Mercy Hosp, Metropolitan Heart & Vasc Inst, Minneapolis, MN USA; [Baran, Kenneth W.] United Hosp, St Paul Heart Clin, St Paul, MN USA; [Lambert, Charles] Florida Hosp Pepin Heart Inst, Tampa, FL USA; [Lerman, Amir; Spoon, Daniel B.; Simari, Robert D.] Mayo Clin, Rochester, MN USA; [Simon, Daniel I.] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Vaughan, Douglas E.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Lai, Dejian; Piller, Linda B.; Simpson, Lara M.; Baraniuk, Sarah; Bettencourt, Judy; Sayre, Shelly L.; Vojvodic, Rachel W.; Moye, Lemuel A.] Univ Texas Houston, Sch Publ Hlth, Houston, TX 77030 USA; [Loghin, Catalin] Univ Texas Houston, Sch Med, Houston, TX 77030 USA; [Gee, Adrian P.; Aguilar, David; Richman, Sara] Baylor Coll Med, Houston, TX 77030 USA; [Skarlatos, Sonia I.; Gordon, David J.; Ebert, Ray F.; Kwak, Minjung] NHLBI, Bethesda, MD USA	Minneapolis Heart Institute Foundation; University of Minnesota System; University of Minnesota Twin Cities; State University System of Florida; University of Florida; Saint Lukes Episcopal Hospital; Texas Heart Institute; Vanderbilt University; Cleveland Clinic Foundation; Northeast Ohio Medical University (NEOMED); Adventist Health Services; AdventHealth; (AdventHealth) West Florida Division; West Florida Hospital; AdventHealth Pepin Heart Institute; Mayo Clinic; Case Western Reserve University; Case Western Reserve University Hospital; Northwestern University; Feinberg School of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Bettencourt, J (corresponding author), Univ Texas Houston, Sch Publ Hlth, 1200 Herman Pressler,Room W-838, Houston, TX 77030 USA.	judith.l.bettencourt@uth.tmc.edu	Aguilar, David/GZM-1928-2022; Hatzopoulos, Antonis/X-2043-2019; Cogle, Christopher/H-1746-2016; Hatzopoulos, Antonis/D-2049-2010; Raveendran, Ganesh/ABC-2669-2021; Loghin, Catalin/AAU-9519-2020	Aguilar, David/0000-0002-0916-2722; Hatzopoulos, Antonis/0000-0001-5610-0017; Cogle, Christopher/0000-0001-5422-6863; Anderson, R. David/0000-0003-3490-3286; Handberg, Eileen/0000-0002-7805-9577; Pepine, Carl/0000-0002-6011-681X	Capricor; Osiris; NHLBI; Athersys; Abbott Vascular; American Heart Association; National Space Biomedical Research Institute/National Aeronautics and Space Administration; Amorcyte; Baxter; BDI Pharma; National Heart, Lung, and Blood Institute [5 U01 HL087318-04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087318, UM1HL087318] Funding Source: NIH RePORTER	Capricor; Osiris; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Athersys; Abbott Vascular(Abbott Laboratories); American Heart Association(American Heart Association); National Space Biomedical Research Institute/National Aeronautics and Space Administration; Amorcyte; Baxter; BDI Pharma; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Henry reported serving as a consultant for Capricor; and receiving grant funding from Capricor and Osiris. Dr Pepine reported receiving funding for writing assistance, medicines, equipment, or administrative support from the National, Heart, Lung and Blood Institute (NHLBI) and Biosafe. Dr Willerson reported receiving funding from the NHLBI for participation in review activities. Dr Ellis reported receiving travel support from Abbott Vascular and Boston Scientific. Dr Hatzopoulos reported receiving funding from the NHLBI for writing and reviewing manuscripts, and participating in review activities. Dr Penn reported serving as a consultant to Aastrom and Juventas; receiving grant funding from Athersys; and having patents, receiving royalties, and owning stock/stock options in Juventas Therapeutics; and receiving reimbursement for travel expenses from Juventas Therapeutics. Dr Perin reported serving as a consultant to Cytori, Celgene, Biosense Webster, and Cephalon. Dr Simon reported serving as a consultant to Cordis/Johnson & Johnson, Medtronic Vascular, Merck, the Medicines Company, and Portola; serving as an expert witness for Cordis/Johnson & Johnson; and receiving payment for lectures from Abbott Vascular. Dr Taylor reported receiving payment for lectures from the American Heart Association. Dr Thomas reported that he served as president of the American Society of Echocardiography in 2011-2012; and received grant funding from the National Space Biomedical Research Institute/National Aeronautics and Space Administration. Dr Handberg reported receiving grant funding from Amorcyte, Baxter, and BDI Pharma. Ms Westbrook reported receiving travel reimbursement from Barnett International. All of the authors reported receiving research grant funding and support for travel expenses to meetings for the Cardiovascular Cell Therapy Research Network from the NHLBI.; Funding for this trial was provided by the National Heart, Lung, and Blood Institute under cooperative agreement 5 U01 HL087318-04.	Aktas M, 2008, CYTOTHERAPY, V10, P203, DOI 10.1080/14653240701851324; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Assmus B, 2010, J AM COLL CARDIOL, V55, P1385, DOI 10.1016/j.jacc.2009.10.059; Clifford DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub3; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Gee AP, 2010, CYTOTHERAPY, V12, P684, DOI 10.3109/14653249.2010.487900; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Hirsch A, 2011, EUR HEART J, V32, P1736, DOI 10.1093/eurheartj/ehq449; Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Miettinen JA, 2010, HEART, V96, P362, DOI 10.1136/hrt.2009.171694; Perin EC, 2012, JAMA-J AM MED ASSOC, V307, P1717, DOI 10.1001/jama.2012.418; Petersen JW, 2011, JACC-CARDIOVASC IMAG, V4, P671, DOI 10.1016/j.jcmg.2011.02.015; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Seeger FH, 2012, CIRC RES, V111, P854, DOI 10.1161/CIRCRESAHA.112.265678; Tendera M, 2009, EUR HEART J, V30, P1313, DOI 10.1093/eurheartj/ehp073; Traverse JH, 2011, JAMA-J AM MED ASSOC, V306, P2110, DOI 10.1001/jama.2011.1670; Traverse JH, 2010, TEX HEART I J, V37, P412; Traverse JH, 2009, AM HEART J, V158, P356, DOI 10.1016/j.ahj.2009.06.009; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Wang XY, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002814; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9	26	291	295	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2012	308	22					2380	2389		10.1001/jama.2012.28726	http://dx.doi.org/10.1001/jama.2012.28726			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051MW	23129008	Green Accepted, Bronze			2022-12-28	WOS:000312132400028
J	Pacheco, AR; Curtis, MM; Ritchie, JM; Munera, D; Waldor, MK; Moreira, CG; Sperandio, V				Pacheco, Alline R.; Curtis, Meredith M.; Ritchie, Jennifer M.; Munera, Diana; Waldor, Matthew K.; Moreira, Cristiano G.; Sperandio, Vanessa			Fucose sensing regulates bacterial intestinal colonization	NATURE			English	Article							PHOSPHATE-TRANSPORT SYSTEM; ESCHERICHIA-COLI; 2-COMPONENT SYSTEM; CARBON NUTRITION; MEMBRANE-PROTEIN; UHP GENES; GROWTH; INDUCTION; MG1655; MUCIN	The mammalian gastrointestinal tract provides a complex and competitive environment for the microbiota(1). Successful colonization by pathogens requires scavenging nutrients, sensing chemical signals, competing with the resident bacteria and precisely regulating the expression of virulence genes(2). The gastrointestinal pathogen enterohaemorrhagic Escherichia coli (EHEC) relies on inter-kingdom chemical sensing systems to regulate virulence gene expression(3,4). Here we show that these systems control the expression of a novel two-component signal transduction system, named FusKR, where FusK is the histidine sensor kinase and FusR the response regulator. FusK senses fucose and controls expression of virulence and metabolic genes. This fucose-sensing system is required for robust EHEC colonization of the mammalian intestine. Fucose is highly abundant in the intestine(5). Bacteroides theta-iotaomicron produces multiple fucosidases that cleave fucose from host glycans, resulting in high fucose availability in the gut lumen(6). During growth in mucin, B. thetaiotaomicron contributes to EHEC virulence by cleaving fucose from mucin, thereby activating the FusKR signalling cascade, modulating the virulence gene expression of EHEC. Our findings suggest that EHEC uses fucose, a host-derived signal made available by the microbiota, to modulate EHEC pathogenicity and metabolism.	[Pacheco, Alline R.; Curtis, Meredith M.; Moreira, Cristiano G.; Sperandio, Vanessa] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Pacheco, Alline R.; Curtis, Meredith M.; Moreira, Cristiano G.; Sperandio, Vanessa] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Ritchie, Jennifer M.; Munera, Diana; Waldor, Matthew K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sperandio, V (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	vanessa.sperandio@utsouthwestern.edu	Moreira, Cristiano/D-8694-2014; Moreira, Cristiano Gallina/AHB-1469-2022	Moreira, Cristiano/0000-0002-0689-4119; Moreira, Cristiano Gallina/0000-0002-0689-4119; Ritchie, Jennifer/0000-0002-1244-3082	National Institutes of Health (NIH) [AI053067, AI77853, AI077613]; Burroughs Wellcome Fund; NIH [AI42347, 5 T32 AI7520-14]; HHMI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042347, R37AI042347, U01AI077853, R01AI053067, T32AI007520, R01AI077613] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Kendall for comments. We thank the microarray core facility. This work was supported by the National Institutes of Health (NIH) Grants AI053067, AI77853 and AI077613, and the Burroughs Wellcome Fund (to V. S.) and NIH Grant AI42347 and HHMI (to M. K. W.). M. M. C. was supported through NIH Training Grant 5 T32 AI7520-14. The contents are solely the responsibility of the authors and do not represent the official views of the NIH NIAID.	Autieri SM, 2007, INFECT IMMUN, V75, P5465, DOI 10.1128/IAI.00822-07; Barrios H, 1999, NUCLEIC ACIDS RES, V27, P4305, DOI 10.1093/nar/27.22.4305; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; CHEN YM, 1987, J BACTERIOL, V169, P3712, DOI 10.1128/jb.169.8.3712-3719.1987; CHEN YM, 1987, MOL GEN GENET, V210, P331, DOI 10.1007/BF00325702; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002; Fox JT, 2009, J ANIM SCI, V87, P1304, DOI 10.2527/jas.2008-1166; Hughes DT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000553; ISLAND MD, 1992, J BACTERIOL, V174, P2754, DOI 10.1128/JB.174.9.2754-2762.1992; Janausch IG, 2004, MICROBIOL-SGM, V150, P877, DOI 10.1099/mic.0.26900-0; JASWAL VMS, 1988, BIOCHEM MED METAB B, V39, P105, DOI 10.1016/0885-4505(88)90064-3; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kendall MM, 2007, INFECT IMMUN, V75, P4875, DOI 10.1128/IAI.00550-07; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Miranda RL, 2004, INFECT IMMUN, V72, P1666, DOI 10.1128/IAI.72.3.1666-1676.2004; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Reading NC, 2010, MICROBIOL-SGM, V156, P1167, DOI 10.1099/mic.0.033027-0; Reading NC, 2009, P NATL ACAD SCI USA, V106, P5889, DOI 10.1073/pnas.0811409106; Ritchie K. M., 1989, INFECT IMMUN, V71, P7129; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sharp FC, 2007, INFECT IMMUN, V75, P2432, DOI 10.1128/IAI.02003-06; Snider TA, 2009, VET MICROBIOL, V136, P150, DOI 10.1016/j.vetmic.2008.10.033; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Sperandio V, 2000, TRENDS MICROBIOL, V8, P544, DOI 10.1016/S0966-842X(00)01896-5; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Walters M, 2006, INT J MED MICROBIOL, V296, P125, DOI 10.1016/j.ijmm.2006.01.041; WESTON LA, 1987, J BACTERIOL, V169, P3546, DOI 10.1128/jb.169.8.3546-3555.1987; WESTON LA, 1988, J BACTERIOL, V170, P3375, DOI 10.1128/jb.170.8.3375-3383.1988; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; ZHU Y, 1986, J MOL EVOL, V23, P259, DOI 10.1007/BF02115582	38	316	327	9	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					113	+		10.1038/nature11623	http://dx.doi.org/10.1038/nature11623			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23160491	Green Accepted, Green Submitted			2022-12-28	WOS:000311893400056
J	Brown, KS; Marean, CW; Jacobs, Z; Schoville, BJ; Oestmo, S; Fisher, EC; Bernatchez, J; Karkanas, P; Matthews, T				Brown, Kyle S.; Marean, Curtis W.; Jacobs, Zenobia; Schoville, Benjamin J.; Oestmo, Simen; Fisher, Erich C.; Bernatchez, Jocelyn; Karkanas, Panagiotis; Matthews, Thalassa			An early and enduring advanced technology originating 71,000 years ago in South Africa	NATURE			English	Article							MIDDLE STONE-AGE; QUATERNARY; EMERGENCE; SEDIMENTS; EVOLUTION; PROGRESS; QUARTZ	There is consensus that the modern human lineage appeared in Africa before 100,000 years ago(1,2). But there is debate as to when cultural and cognitive characteristics typical of modern humans first appeared, and the role that these had in the expansion of modern humans out of Africa(3). Scientists rely on symbolically specific proxies, such as artistic expression, to document the origins of complex cognition. Advanced technologies with elaborate chains of production are also proxies, as these often demand high-fidelity transmission and thus language. Some argue that advanced technologies in Africa appear and disappear and thus do not indicate complex cognition exclusive to early modern humans in Africa(3,4). The origins of composite tools and advanced projectile weapons figure prominently in modern human evolution research, and the latter have been argued to have been in the exclusive possession of modern humans(5,6). Here we describe a previously unrecognized advanced stone tool technology from Pinnacle Point Site 5-6 on the south coast of South Africa, originating approximately 71,000 years ago. This technology is dominated by the production of small bladelets (microliths) primarily from heat-treated stone. There is agreement that microlithic technology was used to create composite tool components aspart of advanced projectile weapons(7,8). Microliths were common worldwide by the mid-Holocene epoch, but have a patchy pattern of first appearance that is rarely earlier than 40,000 years ago(9,10), and were thought to appear briefly between 65,000 and 60,000 years ago in South Africa and then disappear. Our research extends this record to similar to 71,000 years, shows that microlithic technology originated early in South Africa, evolved over a vast time span (similar to 11,000 years), and was typically coupled to complex heat treatment that persisted for nearly 100,000 years. Advanced technologies in Africa were early and enduring; a small sample of excavated sites in Africa is the best explanation for any perceived 'flickering' pattern.	[Brown, Kyle S.; Marean, Curtis W.; Schoville, Benjamin J.; Oestmo, Simen; Fisher, Erich C.; Bernatchez, Jocelyn] Arizona State Univ, Sch Human Evolut & Social Change, Inst Human Origins, Tempe, AZ 85287 USA; [Brown, Kyle S.] Univ Cape Town, Dept Archaeol, ZA-7701 Rondebosch, South Africa; [Jacobs, Zenobia] Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia; [Karkanas, Panagiotis] Ephoreia Palaeoanthropol Speleol So Greece, Athens 11636, Greece; [Matthews, Thalassa] Iziko S African Museum, Dept Nat Hist, ZA-8000 Cape Town, South Africa	Arizona State University; Arizona State University-Tempe; University of Cape Town; University of Wollongong	Marean, CW (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Inst Human Origins, POB 872402, Tempe, AZ 85287 USA.	curtis.marean@asu.edu	Karkanas, Panagiotis/N-3168-2019; Jacobs, Zenobia/B-2721-2012; Fisher, Erich/ABA-9374-2020; Karkanas, Panagiotis/AAD-1227-2020; Karkanas, Panagiotis/F-7762-2011; Oestmo, Simen/D-6331-2013	Karkanas, Panagiotis/0000-0002-7156-671X; Jacobs, Zenobia/0000-0001-5424-5837; Fisher, Erich/0000-0002-9499-6093; Karkanas, Panagiotis/0000-0002-7156-671X; Oestmo, Simen/0000-0002-9662-4904; Schoville, Benjamin/0000-0002-0124-7959; Matthews, Thalassa/0000-0002-0176-5596	National Science Foundation [BCS-9912465, BCS-0130713, BCS-0524087, BCS-1138073]; Hyde Family Foundation; Institute of Human Origins (IHO); Australian Research Council [DP1092843]; Direct For Social, Behav & Economic Scie [1138073] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Hyde Family Foundation; Institute of Human Origins (IHO); Australian Research Council(Australian Research Council); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We thank the MAPCRM staff for their assistance, the Dias Museum for field facilities, and SAHRA and HWC for permits. This research was funded by the National Science Foundation (grants BCS-9912465, BCS-0130713, BCS-0524087 and BCS-1138073 to C.W.M.), the Hyde Family Foundation, the Institute of Human Origins (IHO), and the Australian Research Council (DP1092843 to Z.J.).	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Aitken M.J., 1998, INTRO OPTICAL DATING; Ambrose S.H., 2002, THINKING SMALL GLOBA, V12, P9; Bar-Yosef O, 1999, AM ANTHROPOL, V101, P322, DOI 10.1525/aa.1999.101.2.322; Barham L, 2002, J HUM EVOL, V43, P585, DOI 10.1006/jhev.2002.0597; Barham Lawrence, 2012, Int J Evol Biol, V2012, P230156, DOI 10.1155/2012/230156; Bernatchez J., 2011, SAA ARCHAEOL REC, V11, P16; Bingham PM, 2000, EVOL ANTHROPOL, V9, P248, DOI 10.1002/1520-6505(2000)9:6<248::AID-EVAN1003>3.0.CO;2-X; Blum MGB, 2011, MOL BIOL EVOL, V28, P889, DOI 10.1093/molbev/msq265; Bookstein F L, 1997, Med Image Anal, V1, P225; Brooks AS, 2006, INTERD CONTRIB ARCH, P233, DOI 10.1007/0-387-24661-4_13; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Churchill SE, 2009, J HUM EVOL, V57, P163, DOI 10.1016/j.jhevol.2009.05.010; Clark J.D., 1974, PALE ORIENT, V2, P323; Clark J.D., 1985, RECENT ADV INDOPACIF, P95; Clark JD., 1977, PALEORIENT, V3, P127, DOI [10.3406/paleo.1975.4193, DOI 10.3406/PALEO.1975.4193]; d'Errico F, 2011, PHILOS T R SOC B, V366, P1060, DOI 10.1098/rstb.2010.0340; Dibble H. L., 2005, SAA ARCHAEOL REC, V7, P33; Duller GAT, 2004, J QUATERNARY SCI, V19, P183, DOI 10.1002/jqs.809; Endicott P, 2010, J HUM EVOL, V59, P87, DOI 10.1016/j.jhevol.2010.04.005; Gliganic LA, 2012, J HUM EVOL, V62, P533, DOI 10.1016/j.jhevol.2012.02.004; Herries Andy I R, 2011, Int J Evol Biol, V2011, P961401, DOI 10.4061/2011/961401; HUNTLEY DJ, 1985, NATURE, V313, P105, DOI 10.1038/313105a0; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Jacobs Z, 2007, EVOL ANTHROPOL, V16, P210, DOI 10.1002/evan.20150; Kuhn S. L., 2002, THINKING SMALL GLOBA, V12, P83; Kuhn SL., 2002, ARCHEOLOGICAL PAPERS, V12, P1; Lian OB, 2006, QUATERNARY SCI REV, V25, P2449, DOI 10.1016/j.quascirev.2005.11.013; Manega P.C., 1993, THESIS U COLORADO; Marean C.W., 2004, PALEOANTHROPOL, P14; Marean CW, 2010, J HUM EVOL, V59, P234, DOI 10.1016/j.jhevol.2010.07.007; MELLARS P, 1989, CURR ANTHROPOL, V30, P349, DOI 10.1086/203755; Petillon JM, 2011, J ARCHAEOL SCI, V38, P1266, DOI 10.1016/j.jas.2011.01.002; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Rohlf FJ., 2006, TPSDIG VERSION 2 10; Shea JJ, 2006, J ARCHAEOL SCI, V33, P823, DOI 10.1016/j.jas.2005.10.015; Singer R., 1982, MIDDLE STONE AGE KLA; Sisk M. L., 2011, INT J EVOL BIOL, DOI DOI 10.4061/2011/968012; Skinner AR, 2003, QUATERNARY SCI REV, V22, P1361, DOI 10.1016/S0277-3791(03)00015-5; Wintle AG, 2008, ARCHAEOMETRY, V50, P276, DOI 10.1111/j.1475-4754.2008.00392; Wurz S, 1999, S AFR ARCHAEOL BULL, V54, P38, DOI 10.2307/3889138	41	214	221	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					590	+		10.1038/nature11660	http://dx.doi.org/10.1038/nature11660			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040RE	23135405				2022-12-28	WOS:000311339800051
J	Brandman, O; Stewart-Ornstein, J; Wong, D; Larson, A; Williams, CC; Li, GW; Zhou, S; King, D; Shen, PS; Weibezahn, J; Dunn, JG; Rouskin, S; Inada, T; Frost, A; Weissman, JS				Brandman, Onn; Stewart-Ornstein, Jacob; Wong, Daisy; Larson, Adam; Williams, Christopher C.; Li, Gene-Wei; Zhou, Sharleen; King, David; Shen, Peter S.; Weibezahn, Jimena; Dunn, Joshua G.; Rouskin, Silvi; Inada, Toshifumi; Frost, Adam; Weissman, Jonathan S.			A Ribosome-Bound Quality Control Complex Triggers Degradation of Nascent Peptides and Signals Translation Stress	CELL			English	Article							HEAT-SHOCK FACTOR-1; GENOME-WIDE ANALYSIS; PROTEIN-DEGRADATION; TRANSCRIPTION FACTOR; IN-VIVO; YEAST; KINASE; SYSTEM; SURVEILLANCE; ELONGATION	The conserved transcriptional regulator heat shock factor 1 (Hsf1) is a key sensor of proteotoxic and other stress in the eukaryotic cytosol. We surveyed Hsf1 activity in a genome-wide loss-of-function library in Saccaromyces cerevisiae as well as similar to 78,000 double mutants and found Hsf1 activity to be modulated by highly diverse stresses. These included disruption of a ribosome-bound complex we named the Ribosome Quality Control Complex (RQC) comprising the Ltn1 E3 ubiquitin ligase, two highly conserved but poorly characterized proteins (Tae2 and Rqc1), and Cdc48 and its cofactors. Electron microscopy and biochemical analyses revealed that the RQC forms a stable complex with 60S ribosomal subunits containing stalled polypeptides and triggers their degradation. A negative feedback loop regulates the RQC, and Hsf1 senses an RQC-mediated translation-stress signal distinctly from other stresses. Our work reveals the range of stresses Hsf1 monitors and elucidates a conserved cotranslational protein quality control mechanism.	[Shen, Peter S.; Frost, Adam] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Shen, Peter S.; Frost, Adam] Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Inada, Toshifumi] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Zhou, Sharleen; King, David] Univ Calif Berkeley, HHMI Mass Spectrometry Lab, Berkeley, CA 94720 USA; [Brandman, Onn; Stewart-Ornstein, Jacob; Wong, Daisy; Williams, Christopher C.; Li, Gene-Wei; Weibezahn, Jimena; Dunn, Joshua G.; Rouskin, Silvi; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Brandman, Onn; Stewart-Ornstein, Jacob; Wong, Daisy; Williams, Christopher C.; Li, Gene-Wei; Weibezahn, Jimena; Dunn, Joshua G.; Rouskin, Silvi; Weissman, Jonathan S.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Larson, Adam] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Brandman, Onn; Stewart-Ornstein, Jacob; Wong, Daisy; Williams, Christopher C.; Li, Gene-Wei; Weibezahn, Jimena; Dunn, Joshua G.; Rouskin, Silvi; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Tohoku University; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Frost, A (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	frost@biochem.utah.edu; weissman@cmp.ucsf.edu	Inada, Toshifumi/AAE-1517-2019	Frost, Adam/0000-0003-2231-2577; Shen, Peter/0000-0002-6256-6910; Dunn, Joshua/0000-0003-4476-7257; Li, Gene-Wei/0000-0001-7036-8511; Weissman, Jonathan/0000-0003-2445-670X; Rouskin, Silvi/0000-0003-2042-6642	Helen Hay Whitney postdoctoral fellowship; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM105913, T32GM064337] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [20112006] Funding Source: KAKEN	Helen Hay Whitney postdoctoral fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the members of the Weissman lab, M. Bassik, E. Boydston, L. Gilbert, A. Grenninger, C. Jan, M. Jonikas, M. Kampmann, Y. Liu, W. Luddington, M. McKeon, E. Oh, C. Reiger, M. Smith, N. Stern-Ginossar, and P. Walter for their valuable help with the manuscript and input on the project; T. Becker and R. Beckmann for help with EM; M. Larson and B. Toyama for help with graphic design; and M. Szeto for help in creating the fluorescent reporters. O.B. was supported by a Helen Hay Whitney postdoctoral fellowship. This work was funded by the Howard Hughes Medical Institute (to J.S.W.).	Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Alamgir Md, 2010, BMC Chemical Biology, V10, P6, DOI 10.1186/1472-6769-10-6; Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Ali A, 1998, MOL CELL BIOL, V18, P4949, DOI 10.1128/MCB.18.9.4949; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Christians ES, 2006, HANDB EXP PHARM, V172, P139; Craig EA, 2003, CURR OPIN MICROBIOL, V6, P157, DOI 10.1016/S1369-5274(03)00030-4; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Fritah S, 2009, MOL BIOL CELL, V20, P4976, DOI 10.1091/mbc.E09-04-0295; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; Jolly C, 1999, P NATL ACAD SCI USA, V96, P6769, DOI 10.1073/pnas.96.12.6769; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kremer SB, 2009, J BIOL CHEM, V284, P32914, DOI 10.1074/jbc.M109.058610; Kuroha K, 2010, EMBO REP, V11, P956, DOI 10.1038/embor.2010.169; Liu XD, 1997, EMBO J, V16, P6466, DOI 10.1093/emboj/16.21.6466; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Piatkov KI, 2012, P NATL ACAD SCI USA, V109, pE1839, DOI 10.1073/pnas.1207786109; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; SORGER PK, 1987, EMBO J, V6, P3035, DOI 10.1002/j.1460-2075.1987.tb02609.x; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Xavier IJ, 2000, J BIOL CHEM, V275, P29147, DOI 10.1074/jbc.M002169200; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yewdell JW, 1996, J IMMUNOL, V157, P1823; Zhao J, 2005, MOL CELL BIOL, V25, P8985, DOI 10.1128/MCB.25.20.8985-8999.2005	45	372	384	2	88	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 21	2012	151	5					1042	1054		10.1016/j.cell.2012.10.044	http://dx.doi.org/10.1016/j.cell.2012.10.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178123	Bronze, Green Accepted			2022-12-28	WOS:000311423500017
J	Guo, X; Wang, XF				Guo, Xing; Wang, Xiao-Fan			A Mediator Lost in the War on Cancer	CELL			English	Editorial Material								An unexpected role for a Mediator subunit, MED12, in resistance to multiple anticancer agents is revealed by Huang et al. Loss of MED12 confers drug resistance by activating transforming growth factor beta (TGF-beta) signaling. Inhibition of the TGF-beta pathway resensitizes cells to therapeutic drugs, suggesting a new combinatorial cancer treatment.	[Guo, Xing] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Wang, Xiao-Fan] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	University of California System; University of California San Diego; Duke University	Guo, X (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	x4guo@ucsd.edu; xiao.fan.wang@duke.edu						Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Bock C, 2012, NAT REV CANCER, V12, P494, DOI 10.1038/nrc3297; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Kummar S, 2010, NAT REV DRUG DISCOV, V9, P843, DOI 10.1038/nrd3216; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004	10	12	12	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					927	929		10.1016/j.cell.2012.11.003	http://dx.doi.org/10.1016/j.cell.2012.11.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178113	Bronze			2022-12-28	WOS:000311423500005
J	Lipchik, RJ				Lipchik, Randolph J.			Review: ACE inhibitors reduce risk for pneumonia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Med Coll Wisconsin, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Lipchik, RJ (corresponding author), Med Coll Wisconsin, Milwaukee, WI 53226 USA.							Arai T, 2005, NEUROLOGY, V64, P573, DOI 10.1212/01.WNL.0000150897.14961.0F; Ohkubo T, 2004, AM J RESP CRIT CARE, V169, P1041, DOI 10.1164/rccm.200309-1219OC	2	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10							JC5-2	10.7326/0003-4819-157-10-201211200-02002	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043VZ	23165678				2022-12-28	WOS:000311580000001
J	Simmons, A				Simmons, Alan			Mediterranean Island Voyages	SCIENCE			English	Editorial Material							CYPRUS		Univ Nevada, Dept Anthropol, Las Vegas, NV 89154 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Simmons, A (corresponding author), Univ Nevada, Dept Anthropol, Las Vegas, NV 89154 USA.	simmonsa@unlv.nevada.edu						Broodbank C, 2006, J MEDITERR ARCHAEOL, V19, P199, DOI DOI 10.1558//JMEA.2006.V19I2.199; Brumm A, 2010, NATURE, V464, P748, DOI 10.1038/nature08844; Cherry JF, 1990, J MEDITERR ARCHAEOL, V3, P145, DOI DOI 10.1558/JMEA.V3I1.145; Efstratiou N., 2011, ANASKAMMA, V5, P53; Ferentinos G, 2012, J ARCHAEOL SCI, V39, P2167, DOI 10.1016/j.jas.2012.01.032; Guilaine J., 2011, SHILLOUROKAMBOS ETAB; Hiscock P., 2008, ARCHAEOLOGY ANCIENT; Knapp AB, 2010, J WORLD PREHIST, V23, P79, DOI 10.1007/s10963-010-9034-2; Laskaris N, 2011, J ARCHAEOL SCI, V38, P2475, DOI 10.1016/j.jas.2011.05.019; Manning SW, 2010, ANTIQUITY, V84, P693, DOI 10.1017/S0003598X00100171; Peltenburg E, 2000, ANTIQUITY, V74, P844, DOI 10.1017/S0003598X0006049X; PERLES C, 1979, RECHERCHE, V10, P82; SIMMONS A, 1999, FAUNAL EXTINCTIONS I; Simmons A, 2007, WORLD ARCHAEOL, V39, P475, DOI 10.1080/00438240701676169; Simmons AH, 2012, J FIELD ARCHAEOL, V37, P86, DOI 10.1179/0093469012Z.0000000009; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Strasser T., 2012, NEWSLETTER AM SCH CL, V66, P11; Strasser TF, 2010, HESPERIA, V79, P145, DOI 10.2972/hesp.79.2.145; Vigne JD, 2012, P NATL ACAD SCI USA, V109, P8445, DOI 10.1073/pnas.1201693109	19	16	16	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					895	897		10.1126/science.1228880	http://dx.doi.org/10.1126/science.1228880			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	037DY	23161986				2022-12-28	WOS:000311083600030
J	De Greve, K; Yu, L; McMahon, PL; Pelc, JS; Natarajan, CM; Kim, NY; Abe, E; Maier, S; Schneider, C; Kamp, M; Hofling, S; Hadfield, RH; Forchel, A; Fejer, MM; Yamamoto, Y				De Greve, Kristiaan; Yu, Leo; McMahon, Peter L.; Pelc, Jason S.; Natarajan, Chandra M.; Kim, Na Young; Abe, Eisuke; Maier, Sebastian; Schneider, Christian; Kamp, Martin; Hoefling, Sven; Hadfield, Robert H.; Forchel, Alfred; Fejer, M. M.; Yamamoto, Yoshihisa			Quantum-dot spin-photon entanglement via frequency downconversion to telecom wavelength	NATURE			English	Article							SINGLE-PHOTON; ATOMIC ENSEMBLES; COMMUNICATION; EMISSION; DISTANCE; DEVICE; CAVITY	Long-distance quantum teleportation and quantum repeater technologies require entanglement between a single matter quantum bit (qubit) and a telecommunications (telecom)-wavelength photonic qubit(1-5). Electron spins in III-V semiconductor quantum dots are among the matter qubits that allow for the fastest spin manipulation(6,7) and photon emission(8,9), but entanglement between a single quantum-dot spin qubit and a flying (propagating) photonic qubit has yet to be demonstrated. Moreover, many quantum dots emit single photons at visible to near-infrared wavelengths, where silica fibre losses are so high that long-distance quantum communication protocols become difficult to implement(10). Here we demonstrate entanglement between an InAs quantum-dot electron spin qubit and a photonic qubit, by frequency downconversion of a spontaneously emitted photon from a singly charged quantum dot to a wavelength of 1,560 nanometres. The use of sub-10-picosecond pulses at a wavelength of 2.2 micrometres in the frequency downconversion process provides the necessary quantum erasure to eliminate which-path information in the photon energy. Together with previously demonstrated indistinguishable single-photon emission at high repetition rates(11,12), the present technique advances the III-V semiconductor quantum-dot spin system as a promising platform for long-distance quantum communication.	[De Greve, Kristiaan; Yu, Leo; McMahon, Peter L.; Pelc, Jason S.; Natarajan, Chandra M.; Kim, Na Young; Abe, Eisuke; Hoefling, Sven; Fejer, M. M.; Yamamoto, Yoshihisa] Stanford Univ, Edward L Ginzton Lab, Stanford, CA 94305 USA; [Natarajan, Chandra M.; Hadfield, Robert H.] Heriot Watt Univ, Scottish Univ Phys Alliance, Edinburgh EH14 4AS, Midlothian, Scotland; [Natarajan, Chandra M.; Hadfield, Robert H.] Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland; [Abe, Eisuke; Yamamoto, Yoshihisa] Natl Inst Informat, Chiyoda Ku, Tokyo 1018403, Japan; [Maier, Sebastian; Schneider, Christian; Kamp, Martin; Hoefling, Sven; Forchel, Alfred] Univ Wurzburg, Wilhelm Conrad Rontgen Res Ctr Complex Mat Syst, Inst Phys, D-97074 Wurzburg, Germany	Stanford University; Heriot Watt University; University of Edinburgh; Heriot Watt University; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; University of Wurzburg	De Greve, K (corresponding author), Harvard Univ, Dept Phys, 17 Oxford St, Cambridge, MA 02138 USA.	kdegreve@stanford.edu	Natarajan, Chandra M/C-3230-2014; Pelc, Jason/F-3258-2012; Hadfield, Robert H/L-8081-2013; Natarajan, Chandra Mouli/O-5521-2015; Hofling, Sven/C-3140-2013; Fejer, Martin/AAH-3883-2020; Kamp, Martin/G-9704-2011; McMahon, Peter/ABI-1817-2020; Yamamoto, Yoshihisa/A-2811-2012; De Greve, Kristiaan/N-1489-2013; Abe, Eisuke/C-1113-2009	Hadfield, Robert H/0000-0002-8084-4187; Hofling, Sven/0000-0003-0034-4682; Kamp, Martin/0000-0002-7219-2297; McMahon, Peter/0000-0002-1177-9887; Yamamoto, Yoshihisa/0000-0002-4150-6804; De Greve, Kristiaan/0000-0002-1314-9715; Forchel, Alfred/0000-0002-9377-9935; Abe, Eisuke/0000-0001-7993-3660	JSPS through its FIRST programme; NICT; NSF [CCR-08 29694]; NIST [60NANB9D9170]; Special Coordination Funds for Promoting Science and Technology; State of Bavaria; United States AFOSR [FA9550-12-1-0110]; Herb and Jane Dwight Stanford Graduate Fellowship; David Cheriton Stanford Graduate Fellowship; Robert N. Noyce Stanford Graduate Fellowship; SU2P Entrepreneurial Fellowship; Royal Society University Research Fellowship; EPSRC [EP/F009968/1, EP/G022151/1, EP/G042446/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F009968/1, EP/G042446/1, EP/G022151/1] Funding Source: researchfish	JSPS through its FIRST programme; NICT; NSF(National Science Foundation (NSF)); NIST(National Institute of Standards & Technology (NIST) - USA); Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); State of Bavaria; United States AFOSR; Herb and Jane Dwight Stanford Graduate Fellowship; David Cheriton Stanford Graduate Fellowship; Robert N. Noyce Stanford Graduate Fellowship; SU2P Entrepreneurial Fellowship; Royal Society University Research Fellowship(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank D. Press, T. Ladd, D. Sleiter, S. Tawfeeq, S. Rumley, D. Werthimer, A. Langman, C. Langrock, Q. Zhang, N. Namekata, S. Inoue, T. Inagaki and H. Kosaka for discussions, comments and technical assistance. We thank V. Zwiller and S. Dorenbos (TU Delft) for providing the superconducting detector samples used. This work was supported by the JSPS through its FIRST programme, NICT, NSF CCR-08 29694, NIST 60NANB9D9170, Special Coordination Funds for Promoting Science and Technology, and the State of Bavaria. J.S.P. and M.M.F. were supported by the United States AFOSR (grant FA9550-12-1-0110). Other authors were supported as follows: K.D.G. by a Herb and Jane Dwight Stanford Graduate Fellowship; P.L.M. by a David Cheriton Stanford Graduate Fellowship; J.S.P. by a Robert N. Noyce Stanford Graduate Fellowship; C.M.N. by a SU2P Entrepreneurial Fellowship; and R.H.H. by a Royal Society University Research Fellowship.	Bayer M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.195315; Blinov BB, 2004, NATURE, V428, P153, DOI 10.1038/nature02377; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Faraon A, 2011, NAT PHOTONICS, V5, P301, DOI [10.1038/nphoton.2011.52, 10.1038/NPHOTON.2011.52]; Kim D, 2011, NAT PHYS, V7, P223, DOI [10.1038/nphys1863, 10.1038/NPHYS1863]; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Michler P, 2000, SCIENCE, V290, P2282, DOI 10.1126/science.290.5500.2282; Moehring DL, 2007, NATURE, V449, P68, DOI 10.1038/nature06118; Moreau E, 2002, PHYSICA E, V13, P418, DOI 10.1016/S1386-9477(02)00157-1; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Patel RB, 2010, NAT PHOTONICS, V4, P632, DOI [10.1038/NPHOTON.2010.161, 10.1038/nphoton.2010.161]; Pelc JS, 2010, OPT LETT, V35, P2804, DOI 10.1364/OL.35.002804; Pelton M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.233602; Press D, 2008, NATURE, V456, P218, DOI 10.1038/nature07530; Press D, 2010, NAT PHOTONICS, V4, P367, DOI 10.1038/NPHOTON.2010.83; Ritter S, 2012, NATURE, V484, P195, DOI 10.1038/nature11023; Santori C, 2001, PHYS REV LETT, V86, P1502, DOI 10.1103/PhysRevLett.86.1502; SCULLY MO, 1982, PHYS REV A, V25, P2208, DOI 10.1103/PhysRevA.25.2208; Stute A, 2012, NATURE, V485, P482, DOI 10.1038/nature11120; Takesue H, 2007, NAT PHOTONICS, V1, P343, DOI 10.1038/nphoton.2007.75; Tanner MG, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3428960; Togan E, 2010, NATURE, V466, P730, DOI 10.1038/nature09256; Wilk T, 2007, SCIENCE, V317, P488, DOI 10.1126/science.1143835; Xu XD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.097401; Xu XD, 2009, NATURE, V459, P1105, DOI 10.1038/nature08120; Yuan ZS, 2008, NATURE, V454, P1098, DOI 10.1038/nature07241	29	357	359	11	203	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					421	+		10.1038/nature11577	http://dx.doi.org/10.1038/nature11577			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23151585				2022-12-28	WOS:000311031600041
J	Girotra, S; Nallamothu, BK; Spertus, JA; Li, Y; Krumholz, HM; Chan, PS				Girotra, Saket; Nallamothu, Brahmajee K.; Spertus, John A.; Li, Yan; Krumholz, Harlan M.; Chan, Paul S.		Amer Heart Assoc Get Guidelines	Trends in Survival after In-Hospital Cardiac Arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMERICAN-HEART-ASSOCIATION; AUSTRALIAN-RESUSCITATION-COUNCIL; HEALTH-CARE-PROFESSIONALS; CARDIOPULMONARY-RESUSCITATION; STROKE-FOUNDATION; NATIONAL-REGISTRY; DELAYED TIME; GUIDELINES; OUTCOMES; DEFIBRILLATION	BACKGROUND Despite advances in resuscitation care in recent years, it is not clear whether survival and neurologic function after in-hospital cardiac arrest have improved over time. METHODS We identified all adults who had an in-hospital cardiac arrest at 374 hospitals in the Get with the Guidelines-Resuscitation registry between 2000 and 2009. Using multivariable regression, we examined temporal trends in risk-adjusted rates of survival to discharge. Additional analyses explored whether trends were due to improved survival during acute resuscitation or postresuscitation care and whether they occurred at the expense of greater neurologic disability in survivors. RESULTS Among 84,625 hospitalized patients with cardiac arrest, 79.3% had an initial rhythm of asystole or pulseless electrical activity, and 20.7% had ventricular fibrillation or pulseless ventricular tachycardia. The proportion of cardiac arrests due to asystole or pulseless electrical activity increased over time (P<0.001 for trend). Risk-adjusted rates of survival to discharge increased from 13.7% in 2000 to 22.3% in 2009 (adjusted rate ratio per year, 1.04; 95% confidence interval [CI], 1.03 to 1.06; P<0.001 for trend). Survival improvement was similar in the two rhythm groups and was due to improvement in both acute resuscitation survival and postresuscitation survival. Rates of clinically significant neurologic disability among survivors decreased over time, with a risk- adjusted rate of 32.9% in 2000 and 28.1% in 2009 (adjusted rate ratio per year, 0.98; 95% CI, 0.97 to 1.00; P = 0.02 for trend). CONCLUSIONS Both survival and neurologic outcomes after in-hospital cardiac arrest have improved during the past decade at hospitals participating in a large national qualityimprovement registry. (Funded by the American Heart Association.)	[Girotra, Saket] Univ Iowa Hosp & Clin, Dept Internal Med, Div Cardiovasc Dis, Iowa City, IA 52242 USA; [Nallamothu, Brahmajee K.] Res & Dev Ctr Excellence, Vet Affairs Ann Arbor Hlth Serv, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Spertus, John A.; Chan, Paul S.] Univ Missouri, Kansas City, MO USA; [Spertus, John A.; Li, Yan; Chan, Paul S.] St Lukes Mid Amer Heart Inst, Kansas City, KS USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Missouri System; University of Missouri Kansas City; Saint Luke's Mid America Heart Institute; Yale University; Yale University; Yale University; Yale University	Girotra, S (corresponding author), Univ Iowa Hosp & Clin, Dept Internal Med, Div Cardiovasc Dis, 200 Hawkins Dr,Suite 4430 RCP, Iowa City, IA 52242 USA.	saket-girotra@uiowa.edu	Spertus, John/ABD-3075-2021; , Harlan/AAI-2875-2020	Girotra, Saket/0000-0002-4784-4513	American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102224] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the American Heart Association.	Abella BS, 2007, RESUSCITATION, V73, P54, DOI 10.1016/j.resuscitation.2006.10.027; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Aufderheide TP, 2010, HEART RHYTHM, V7, P1357, DOI 10.1016/j.hrthm.2010.04.022; Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; Chan PS, 2010, JAMA-J AM MED ASSOC, V304, P2129, DOI 10.1001/jama.2010.1576; Cummins RO, 1997, CIRCULATION, V95, P2213, DOI 10.1161/01.CIR.95.8.2213; Edelson DP, 2008, EMERG MED J, V168, P1063; Ehlenbach WJ, 2009, NEW ENGL J MED, V361, P22, DOI 10.1056/NEJMoa0810245; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Hinchey PR, 2010, ANN EMERG MED, V56, P348, DOI 10.1016/j.annemergmed.2010.01.036; Hunt EA, 2008, PEDIATRICS, V121, pE34, DOI 10.1542/peds.2007-0029; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; JENNETT B, 1975, LANCET, V1, P480; Kayser RG, 2008, RESUSCITATION, V78, P151, DOI 10.1016/j.resuscitation.2008.03.007; Meaney PA, 2010, CRIT CARE MED, V38, P101, DOI 10.1097/CCM.0b013e3181b43282; Merchant RM, 2011, CRIT CARE MED, V39, P2401, DOI 10.1097/CCM.0b013e3182257459; Mhyre JM, 2010, ANESTHESIOLOGY, V113, P782, DOI 10.1097/ALN.0b013e3181eaa74f; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Peberdy MA, 2008, JAMA-J AM MED ASSOC, V299, P785, DOI 10.1001/jama.299.7.785; Pell JP, 2006, EUR HEART J, V27, P406, DOI 10.1093/eurheartj/ehi604; Raghunathan T. E., 2002, IVEWARE IMPUTATION V; Rea TD, 2003, CIRCULATION, V108, P1196, DOI 10.1161/01.CIR.0000087403.24467.A4; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	25	554	575	1	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2012	367	20					1912	1920		10.1056/NEJMoa1109148	http://dx.doi.org/10.1056/NEJMoa1109148			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036MB	23150959	Green Accepted, Bronze			2022-12-28	WOS:000311029300007
J	Grantham, J				Grantham, Jeremy			Be persuasive. Be brave. Be arrested (if necessary)	NATURE			English	Editorial Material									[Grantham, Jeremy] GMO, Boston, MA USA; [Grantham, Jeremy] Grantham Fdn Protect Environm, Boston, MA USA		Grantham, J (corresponding author), GMO, Boston, MA USA.	jeremy@granthamfoundation.org							0	23	23	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					303	303		10.1038/491303a	http://dx.doi.org/10.1038/491303a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	036MY	23151541	Bronze			2022-12-28	WOS:000311031600004
J	Ponnuswamy, N; Cougnon, FBL; Clough, JM; Pantos, GD; Sanders, JKM				Ponnuswamy, Nandhini; Cougnon, Fabien B. L.; Clough, Jessica M.; Pantos, G. Dan; Sanders, Jeremy K. M.			Discovery of an Organic Trefoil Knot	SCIENCE			English	Article							TEMPLATES	Molecular knots remain difficult to produce using the current synthetic methods of chemistry because of their topological complexity. We report here the near-quantitative self-assembly of a trefoil knot from a naphthalenediimide-based aqueous disulfide dynamic combinatorial library. The formation of the knot appears to be driven by the hydrophobic effect and leads to a structure in which the aromatic components are buried while the hydrophilic carboxylate groups remain exposed to the solvent. Moreover, the building block chirality constrains the topological conformation of the knot and results in its stereoselective synthesis. This work demonstrates that the hydrophobic effect provides a powerful strategy to direct the synthesis of entwined architectures.	[Ponnuswamy, Nandhini; Cougnon, Fabien B. L.; Clough, Jessica M.; Sanders, Jeremy K. M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Pantos, G. Dan] Univ Bath, Dept Chem, Bath BA2 7AY, Avon, England	University of Cambridge; University of Bath	Sanders, JKM (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	jkms@cam.ac.uk	Pantoș, Dan/B-2352-2016	Pantoș, Dan/0000-0003-2200-550X; Clough, Jessica/0000-0003-3701-7829; Sanders, Jeremy Keith Morris/0000-0002-5143-5210	Gates Cambridge; Engineering and Physical Sciences Research Council; University of Bath; EPSRC [EP/F035888/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F035888/1] Funding Source: researchfish	Gates Cambridge; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University of Bath; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We are grateful to Gates Cambridge (N.P.), Engineering and Physical Sciences Research Council (F.B.L.C., J.K.M.S.), and the University of Bath (G.D.P.) for financial support. We thank S. Jackson for helpful discussions, N. Jenkins for his contribution in the early stage on the project, and A. Belenguer for maintaining the LC-MS facility.	ANDERSON S, 1993, ACCOUNTS CHEM RES, V26, P469, DOI 10.1021/ar00033a003; Arias KI, 2011, CHEM COMMUN, V47, P9588, DOI 10.1039/c1cc11209k; Ayme JF, 2012, NAT CHEM, V4, P15, DOI 10.1038/nchem.1193; Barran PE, 2011, ANGEW CHEM INT EDIT, V50, P12280, DOI 10.1002/anie.201105012; Corbett PT, 2006, CHEM REV, V106, P3652, DOI 10.1021/cr020452p; Cougnon FBL, 2012, ANGEW CHEM INT EDIT, V51, P1443, DOI 10.1002/anie.201106885; DIETRICHBUCHECKER CO, 1989, ANGEW CHEM INT EDIT, V28, P189, DOI 10.1002/anie.198901891; Feigel M, 2006, ANGEW CHEM INT EDIT, V45, P5698, DOI 10.1002/anie.200601111; Guo J, 2010, NAT CHEM, V2, P218, DOI [10.1038/NCHEM.544, 10.1038/nchem.544]; Klamt A., 1993, J CHEM SOC P2, V2, P799, DOI DOI 10.1039/P29930000799; Korth M, 2010, J CHEM THEORY COMPUT, V6, P3808, DOI 10.1021/ct100408b; LIANG CZ, 1994, J AM CHEM SOC, V116, P11189, DOI 10.1021/ja00103a057; LIU LF, 1981, P NATL ACAD SCI-BIOL, V78, P5498, DOI 10.1073/pnas.78.9.5498; Mallam AL, 2008, P NATL ACAD SCI USA, V105, P18740, DOI 10.1073/pnas.0806697105; Perret-Aebi LE, 2004, ANGEW CHEM INT EDIT, V43, P4482, DOI 10.1002/anie.200460250; Ponnuswamy N, 2012, J AM CHEM SOC, V134, P566, DOI 10.1021/ja2088647; Safarowsky O, 2000, ANGEW CHEM INT EDIT, V39, P1616, DOI 10.1002/(SICI)1521-3773(20000502)39:9<1616::AID-ANIE1616>3.0.CO;2-Y; Sauvage J.-P., 2012, SUPRAMOL CHEM; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Virnau P, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/3/033101; Wallin S, 2007, J MOL BIOL, V368, P884, DOI 10.1016/j.jmb.2007.02.035	21	225	227	1	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					783	785		10.1126/science.1227032	http://dx.doi.org/10.1126/science.1227032			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139329				2022-12-28	WOS:000310839500039
J	Kaiser, F; Coudreau, T; Milman, P; Ostrowsky, DB; Tanzilli, S				Kaiser, Florian; Coudreau, Thomas; Milman, Perola; Ostrowsky, Daniel B.; Tanzilli, Sebastien			Entanglement-Enabled Delayed-Choice Experiment	SCIENCE			English	Article								Wave-particle complementarity is one of the most intriguing features of quantum physics. To emphasize this measurement apparatus-dependent nature, experiments have been performed in which the output beam splitter of a Mach-Zehnder interferometer is inserted or removed after a photon has already entered the device. A recent extension suggested using a quantum beam splitter at the interferometer's output; we achieve this using pairs of polarization-entangled photons. One photon is tested in the interferometer and is detected, whereas the other allows us to determine whether wave, particle, or intermediate behaviors have been observed. Furthermore, this experiment allows us to continuously morph the tested photon's behavior from wavelike to particle-like, which illustrates the inadequacy of a naive wave or particle description of light.	[Kaiser, Florian; Ostrowsky, Daniel B.; Tanzilli, Sebastien] Univ Nice Sophia Antipolis, Lab Phys Mat Condensee, CNRS, UMR 7336, F-06108 Nice 2, France; [Coudreau, Thomas; Milman, Perola] Univ Paris Diderot, CNRS, Lab Mat & Phenomenes Quant, UMR 7162, F-75013 Paris, France; [Milman, Perola] Univ Paris 11, Inst Sci Mol Orsay CNRS, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay	Tanzilli, S (corresponding author), Univ Nice Sophia Antipolis, Lab Phys Mat Condensee, CNRS, UMR 7336, Parc Valrose, F-06108 Nice 2, France.	sebastien.tanzilli@unice.fr	Coudreau, Thomas/F-9529-2012	Coudreau, Thomas/0000-0002-5981-4418; Kaiser, Florian/0000-0002-5844-1779	CNRS; l'Universite de Nice-Sophia Antipolis; l'Agence Nationale de la Recherche [ANR-09-BLAN-0333-01]; "QUANTIP" project [ICT-2009.8.0 FET, 244026]; le Ministere de l'Enseignement Superieur et de la Recherche; la Fondation iXCore pour la Recherche; Conseil Regional PACA for the "QUANET" project	CNRS(Centre National de la Recherche Scientifique (CNRS)); l'Universite de Nice-Sophia Antipolis; l'Agence Nationale de la Recherche(French National Research Agency (ANR)); "QUANTIP" project; le Ministere de l'Enseignement Superieur et de la Recherche; la Fondation iXCore pour la Recherche; Conseil Regional PACA for the "QUANET" project(Region Provence-Alpes-Cote d'Azur)	We thank L. A. Ngah for his help on data acquisition and O. Alibart for fruitful discussions. This work was supported by the CNRS, l'Universite de Nice-Sophia Antipolis, l'Agence Nationale de la Recherche for the "e-QUANET" project (grant ANR-09-BLAN-0333-01), the European ICT-2009.8.0 FET open program for the "QUANTIP" project (grant 244026), le Ministere de l'Enseignement Superieur et de la Recherche, la Fondation iXCore pour la Recherche, and le Conseil Regional PACA for the "QUANET" project in the exploratory call.	ASPECT A, 1982, PHYS REV LETT, V49, P1804, DOI 10.1103/PhysRevLett.49.1804; Auccaise R, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.032121; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Bohr N., 1984, QUANTUM THEORY MEASU, P949; CLAUSER JF, 1974, PHYS REV D, V10, P526, DOI 10.1103/PhysRevD.10.526; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Englert BG, 1996, PHYS REV LETT, V77, P2154, DOI 10.1103/PhysRevLett.77.2154; GRANGIER P, 1986, EUROPHYS LETT, V1, P173, DOI 10.1209/0295-5075/1/4/004; Greenstein G., 2006, QUANTUM CHALLENGE MO; Ionicioiu R, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.230406; Jacques V, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.220402; Jacques V, 2007, SCIENCE, V315, P966, DOI 10.1126/science.1136303; Kaiser F., 1995, PHYS REV LETT, V75, P3034; Kim YH, 2000, PHYS REV LETT, V84, P1, DOI 10.1103/PhysRevLett.84.1; Ma XS, 2012, NAT PHYS, V8, P479, DOI [10.1038/nphys2294, 10.1038/NPHYS2294]; Peruzzo A, 2012, SCIENCE, V338, P634, DOI 10.1126/science.1226719; Roy SS, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.022109; Schirber M., 2011, PHYSICS, V4, P102; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P807, DOI 10.1007/BF01491891; Tang JS, 2012, NAT PHOTONICS, V6, P600, DOI [10.1038/NPHOTON.2012.179, 10.1038/nphoton.2012.179]; Walborn SP, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.033818; Weihs G, 1998, PHYS REV LETT, V81, P5039, DOI 10.1103/PhysRevLett.81.5039; Wheeler J. A., 1984, QUANTUM THEORY MEASU, P182; WOOTTERS WK, 1979, PHYS REV D, V19, P473, DOI 10.1103/PhysRevD.19.473	25	133	135	5	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107					637	640		10.1126/science.1226755	http://dx.doi.org/10.1126/science.1226755			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118184	Green Submitted			2022-12-28	WOS:000310516000045
J	Vecchi, GA; Msadek, R; Delworth, TL; Dixon, KW; Guilyardi, E; Hawkins, E; Karspeck, AR; Mignot, J; Robson, J; Rosati, A; Zhang, R				Vecchi, Gabriel A.; Msadek, Rym; Delworth, Thomas L.; Dixon, Keith W.; Guilyardi, Eric; Hawkins, Ed; Karspeck, Alicia R.; Mignot, Juliette; Robson, Jon; Rosati, Anthony; Zhang, Rong			Comment on "Multiyear Prediction of Monthly Mean Atlantic Meridional Overturning Circulation at 26.5 degrees N"	SCIENCE			English	Editorial Material							CLIMATE; PREDICTABILITY	Matei et al. (Reports, 6 January 2012, p. 76) claim to show skillful multiyear predictions of the Atlantic Meridional Overturning Circulation (AMOC). However, these claims are not justified, primarily because the predictions of AMOC transport do not outperform simple reference forecasts based on climatological annual cycles. Accordingly, there is no justification for the "confident" prediction of a stable AMOC through 2014.	[Vecchi, Gabriel A.; Msadek, Rym; Delworth, Thomas L.; Dixon, Keith W.; Rosati, Anthony; Zhang, Rong] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA; [Guilyardi, Eric; Mignot, Juliette] Univ Paris 06, CNRS, IRD, MNHN LOCEAN IPSL, Paris, France; [Guilyardi, Eric; Hawkins, Ed; Robson, Jon] Univ Reading, Dept Meteorol, Natl Ctr Atmospher Sci Climate, Reading, Berks, England; [Karspeck, Alicia R.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Atmospheric Science; University of Reading; National Center Atmospheric Research (NCAR) - USA	Vecchi, GA (corresponding author), NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA.	Gabriel.A.Vecchi@noaa.gov	Delworth, Thomas L/C-5191-2014; Robson, Jon/A-7677-2012; Hawkins, Ed/B-7921-2011; Kushnir, Yochanan/B-4472-2013; Zhang, Rong/D-9767-2014; Msadek, Rym/C-7752-2014; Guilyardi, Eric/D-4868-2011; Vecchi, Gabriel/A-2413-2008	Delworth, Thomas L/0000-0003-4865-5391; Robson, Jon/0000-0002-3467-018X; Hawkins, Ed/0000-0001-9477-3677; Zhang, Rong/0000-0002-8493-6556; Msadek, Rym/0000-0003-0450-4815; Guilyardi, Eric/0000-0002-2255-8625; Vecchi, Gabriel/0000-0002-5085-224X	NERC [NE/I020792/1, NE/G007845/1] Funding Source: UKRI; Natural Environment Research Council [ncas10009, NE/I020792/1, NE/G007845/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bickel P. J., 2015, MATH STAT BASIC IDEA, VI; Collins M, 2006, J CLIMATE, V19, P1195, DOI 10.1175/JCLI3654.1; Cunningham SA, 2007, SCIENCE, V317, P935, DOI 10.1126/science.1141304; Johnson NL, 1995, CONTINUOUS UNIVARIAT; Jungclaus JH, 2006, J CLIMATE, V19, P3952, DOI 10.1175/JCLI3827.1; Kanzow T, 2007, SCIENCE, V317, P938, DOI 10.1126/science.1141293; Knight JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024233; Matei D, 2012, SCIENCE, V335, P76, DOI 10.1126/science.1210299; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Msadek R, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044517; Pohlmann H, 2004, J CLIMATE, V17, P4463, DOI 10.1175/3209.1; Sutton RT, 2005, SCIENCE, V309, P115, DOI 10.1126/science.1109496; Zhang R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026267	13	8	8	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107								10.1126/science.1222566	http://dx.doi.org/10.1126/science.1222566			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118168				2022-12-28	WOS:000310516000028
J	Zwane, AP				Zwane, Alix Peterson			Implications of Scarcity	SCIENCE			English	Editorial Material							IMPACTS		Bill & Melinda Gates Fdn, Seattle, WA 98109 USA	Bill & Melinda Gates Foundation	Zwane, AP (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA 98109 USA.	alix.zwane@gatesfoundation.org						Ahuja A, 2010, ANNU REV RESOUR ECON, V2, P237, DOI 10.1146/annurev.resource.012809.103919; Banerjee A., 2011, POOR EC RADICAL RETH; Banerjee AV, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2220; Cohen J, 2010, Q J ECON, V125, P1, DOI 10.1162/qjec.2010.125.1.1; Duflo E., 2006, UNDERSTANDING POVERT; Dupas P, 2011, AM ECON J-APPL ECON, V3, P1, DOI 10.1257/app.3.1.1; Holla H., 2009, WHAT WORKS DEV THINK; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kremer M, 2007, Q J ECON, V122, P1007, DOI 10.1162/qjec.122.3.1007; Kremer M, 2011, Q J ECON, V126, P145, DOI 10.1093/qje/qjq010; Miguel E, 2004, ECONOMETRICA, V72, P159, DOI 10.1111/j.1468-0262.2004.00481.x; Schultz Theodore, 1964, TRANSFORMATION TRADI; Shah AK, 2012, SCIENCE, V338, P682, DOI 10.1126/science.1222426; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; World Bank, 2011, WORLD BANK WORLD DEV	15	11	12	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107					617	618		10.1126/science.1230292	http://dx.doi.org/10.1126/science.1230292			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	029SM	23118174				2022-12-28	WOS:000310516000035
J	Fu, TST; Lee, CS; Gunnell, D; Lee, WC; Cheng, ATA				Fu, Tiffany Szu-Ting; Lee, Chau-Shoun; Gunnell, David; Lee, Wen-Chung; Cheng, Andrew Tai-Ann			Changing trends in the prevalence of common mental disorders in Taiwan: a 20-year repeated cross-sectional survey	LANCET			English	Article							PSYCHIATRIC MORBIDITY; HEALTH-CARE; COMMUNITY; DEPRESSION; HAPPINESS; STRESS; LIFE	Background Macrosocial changes might affect mental health. We investigated whether the prevalence of common mental disorders (CMDs) changed over a 20-year period of industrialisation in Taiwan. Methods We used the 12-item Chinese Health Questionnaire to assess mental status of Taiwanese adults in 1990, 1995, 2000, 2005, and 2010. Respondents with scores of 3 or higher were classified as having probable CMDs. We assessed trends of probable CMDs with the Cochran-Armitage test and their risk factors (sex, age, marital status, educational level, employment status, and physical health) with multivariable logistic regression. The trends were compared with national rates of unemployment, divorce, and suicide. Findings Of 10 548 respondents, 9079 (86.1%) completed questionnaires. The prevalence of probable CMDs doubled from 11.5% in 1990 to 23.8% in 2010 (time trend p<0.001). Increases paralleled rises in national rates of unemployment, divorce, and suicide at all five timepoints. Significant risk factors for probable CMDs were female sex (adjusted odds ratio 1.6, 95% CI 1.4-1.8), 6 or fewer years of education (1.3, 1.1-1.5), unemployment (1.4, 1.1-1.7), and poor physical health that limited daily activities (6.5, 5.4-8.0). When we controlled for these factors in multivariable models, the time trends remained significant (p<0.0001). Interpretation National rates of unemployment, divorce, and suicide increased in parallel with prevalence of probable CMDs in Taiwan. Therefore, clinical and social preventive measures both seem important during times of change to the economy and labour market.	[Fu, Tiffany Szu-Ting; Cheng, Andrew Tai-Ann] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Fu, Tiffany Szu-Ting] Taipei Municipal Univ Educ, Taipei, Taiwan; [Lee, Chau-Shoun] Mackay Mem Hosp, Dept Psychiat, Taipei, Taiwan; [Lee, Chau-Shoun] Kainan Univ, Tao Yuan, Taiwan; [Lee, Chau-Shoun] Mackay Med Coll, New Taipei City, Taiwan; [Gunnell, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Lee, Wen-Chung] Natl Taiwan Univ, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan; [Lee, Wen-Chung] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan	Academia Sinica - Taiwan; University of Taipei; Mackay Memorial Hospital; Nan Kai University Technology; Mackay Medical College; University of Bristol; National Taiwan University; National Taiwan University	Cheng, ATA (corresponding author), Acad Sinica, Inst Biomed Sci, 128,Sect 2,Acad Rd, Taipei 11529, Taiwan.	bmandrew@gate.sinica.edu.tw	Cheng, Andrew/O-1159-2018; Gunnell, David/ABE-6653-2020	Cheng, Andrew/0000-0002-2698-0516; Gunnell, David/0000-0002-0829-6470; Lee, Wen-Chung/0000-0003-3171-7672	Taiwan National Science Council; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10068] Funding Source: researchfish; ESRC [ES/G007543/1] Funding Source: UKRI	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Taiwan National Science Council.	Abbott MW, 1999, AUST NZ J PSYCHIAT, V33, P13, DOI 10.1046/j.1440-1614.1999.00519.x; Aghaei A, 2010, INT J OCCUP ENV MED, V1, P75; Amoran O E, 2005, Ann Gen Psychiatry, V4, P19, DOI 10.1186/1744-859X-4-19; Araya R, 2001, BRIT J PSYCHIAT, V178, P228, DOI 10.1192/bjp.178.3.228; Barbato A, 2009, RIV PSICHIATR, V44, P249; Brockmann H, 2009, J HAPPINESS STUD, V10, P387, DOI 10.1007/s10902-008-9095-4; Cairney J, 2003, SOC PSYCH PSYCH EPID, V38, P442, DOI 10.1007/s00127-003-0661-0; Chang SS, 2009, SOC SCI MED, V68, P1322, DOI 10.1016/j.socscimed.2009.01.010; CHENG TA, 1990, ACTA PSYCHIAT SCAND, V82, P304, DOI 10.1111/j.1600-0447.1990.tb01389.x; CHENG TA, 1986, PSYCHOL MED, V16, P415, DOI 10.1017/S0033291700009247; CHENG TA, 1985, PSYCHOL MED, V15, P195, DOI 10.1017/S0033291700021061; CHENG TA, 1988, PSYCHOL MED, V18, P953, DOI 10.1017/S0033291700009880; Crompton R, 2008, WOMEN EMPLOYMENT CHA; Department of Health Executive Yuan ROC (Taiwan), 2010, 2010 STAT CAUS DEATH; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Goldberg DP., 1992, COMMON MENTAL DISORD; Green G, 2006, SOC SCI MED, V62, P1498, DOI 10.1016/j.socscimed.2005.08.014; Greenland S., 2008, MEASURES EFFECT MEAS, P51; Hawthorne G, 2008, AUST NZ J PSYCHIAT, V42, P606, DOI 10.1080/00048670802119788; Hodiamont PPG, 2005, J AFFECT DISORDERS, V84, P77, DOI 10.1016/j.jad.2004.09.001; Hou P.C., 2008, SURV RES METHOD APPL, V23, P7, DOI [10.7014/TCYCFFYYY.200804.0007, DOI 10.7014/TCYCFFYYY.200804.0007]; Jenkins GP, 2003, TAXATION EC DEV TAIW; Kearney C, 2012, EMERG MARK REV, V13, P159, DOI 10.1016/j.ememar.2012.01.003; Liu SI, 2002, PSYCHOL MED, V32, P629, DOI 10.1017/S0033291701005074; Ministry of Interior, STAT YB INT; Mirowsky J, 2003, SOCIAL CAUSES PSYCHO; Mukherjea A, 2010, ADV MED SOCIOL, V11, P1; Murray C.J.L., 1996, HARVARD SCH PUBLIC H; Nandi DN, 2000, BRIT J PSYCHIAT, V176, P351, DOI 10.1192/bjp.176.4.351; National Statistics Taiwan, 2011, LAB FORC; Osmond C, 1982, Stat Med, V1, P245, DOI 10.1002/sim.4780010306; Patel V, 2003, B WORLD HEALTH ORGAN, V81, P609; Pevalin DJ, 2003, PSYCHOL MED, V33, P299, DOI 10.1017/S0033291702006864; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Schoen R, 2002, SOC FORCES, V81, P643, DOI 10.1353/sof.2003.0019; Spiers N, 2012, PSYCHOL MED, V42, P2047, DOI 10.1017/S003329171200013X; Strine TW, 2008, J COMMUN HEALTH, V33, P40, DOI 10.1007/s10900-007-9066-4; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; UN Department of Economic and Social Affairs, 2007, IND DEV 21 CENT SUST; Wang WC, 2008, J CYBER CULTURE INFO, V14, P69; Wang YP, 2004, EUR ARCH PSY CLIN N, V254, P36, DOI 10.1007/s00406-004-0452-y; World Health Organization, 1992, ICD 10 ICD 10 CLASS	42	89	90	0	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2013	381	9862					235	241		10.1016/S0140-6736(12)61264-1	http://dx.doi.org/10.1016/S0140-6736(12)61264-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	075LL	23151370	Green Submitted			2022-12-28	WOS:000313887600035
J	Franz, DN; Belousova, E; Sparagana, S; Bebin, EM; Frost, M; Kuperman, R; Witt, O; Kohrman, MH; Flamini, JR; Wu, JY; Curatolo, P; de Vries, PJ; Whittemore, VH; Thiele, EA; Ford, JP; Shah, G; Cauwel, H; Lebwohl, D; Sahmoud, T; Jozwiak, S				Franz, David Neal; Belousova, Elena; Sparagana, Steven; Bebin, E. Martina; Frost, Michael; Kuperman, Rachel; Witt, Olaf; Kohrman, Michael H.; Flamini, J. Robert; Wu, Joyce Y.; Curatolo, Paolo; de Vries, Petrus J.; Whittemore, Vicky H.; Thiele, Elizabeth A.; Ford, James P.; Shah, Gaurav; Cauwel, Helene; Lebwohl, David; Sahmoud, Tarek; Jozwiak, Sergiusz			Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial	LANCET			English	Article							CONSENSUS CONFERENCE; MUTATIONAL ANALYSIS; RAPAMYCIN; TUMORS; REGRESSION; ANGIOMYOLIPOMA; SIROLIMUS; PATIENT; DISEASE; TSC2	Background Tuberous sclerosis complex is a genetic disorder leading to constitutive activation of mammalian target of rapamycin (mTOR) and growth of benign tumours in several organs. In the brain, growth of subependymal giant cell astrocytomas can cause life-threatening symptoms-eg, hydrocephalus, requiring surgery. In an open-label, phase 1/2 study, the mTOR inhibitor everolimus substantially and significantly reduced the volume of subependymal giant cell astrocytomas. We assessed the efficacy and safety of everolimus in patients with subependymal giant cell astrocytomas associated with tuberous sclerosis complex. Methods In this double-blind, placebo-controlled, phase 3 trial, patients (aged 0-65 years) in 24 centres in Australia, Belgium, Canada, Germany, the UK, Italy, the Netherlands, Poland, Russian Federation, and the USA were randomly assigned, with an interactive internet-response system, in a 2:1 ratio to oral everolimus 4.5 mg/m(2) per day (titrated to achieve blood trough concentrations of 5-15 ng/mL) or placebo. Eligible patients had a definite diagnosis of tuberous sclerosis complex and at least one lesion with a diameter of 1 cm or greater, and either serial growth of a subependymal giant cell astrocytoma, a new lesion of 1 cm or greater, or new or worsening hydrocephalus. The primary endpoint was the proportion of patients with confirmed response-ie, reduction in target volume of 50% or greater relative to baseline in subependymal giant cell astrocytomas. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00789828. Findings 117 patients were randomly assigned to everolimus (n=78) or placebo (n=39). 27 (35%) patients in the everolimus group had at least 50% reduction in the volume of subependymal giant cell astrocytomas versus none in the placebo group (difference 35%, 95% CI 15-52; one-sided exact Cochran-Mantel-Haenszel test, p<0.0001). Adverse events were mostly grade 1 or 2; no patients discontinued treatment because of adverse events. The most common adverse events were mouth ulceration (25 [32%] in the everolimus group vs two [5%] in the placebo group), stomatitis (24 [31%] vs eight [21%]), convulsion (18 [23%] vs ten [26%]), and pyrexia (17 [22%] vs six [15%]). Interpretation These results support the use of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis. Additionally, everolimus might represent a disease-modifying treatment for other aspects of tuberous sclerosis.	[Franz, David Neal] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Belousova, Elena] Moscow Res Inst Paediat & Paediat Surg, Moscow, Russia; [Sparagana, Steven] Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA; [Bebin, E. Martina] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Frost, Michael] Minnesota Epilepsy Grp, St Paul, MN USA; [Kuperman, Rachel] Childrens Hosp & Res Ctr, Oakland, CA USA; [Witt, Olaf] Heidelberg Univ, Med Ctr, Heidelberg, Germany; [Witt, Olaf] German Canc Res Ctr, Heidelberg, Germany; [Kohrman, Michael H.] Univ Chicago, Chicago, IL 60637 USA; [Flamini, J. Robert] Childrens Healthcare Atlanta, Atlanta, GA USA; [Wu, Joyce Y.] Univ Calif Los Angeles, Mattel Childrens Hosp, Los Angeles, CA USA; [Curatolo, Paolo] Univ Roma Tor Vergata, Rome, Italy; [de Vries, Petrus J.] Univ Cape Town, Div Child & Adolescent Psychiat, ZA-7925 Cape Town, South Africa; [Whittemore, Vicky H.] NINDS, NIH, Bethesda, MD 20892 USA; [Thiele, Elizabeth A.] Pediat Epilepsy Program, Boston, MA USA; [Ford, James P.; Shah, Gaurav; Cauwel, Helene; Lebwohl, David; Sahmoud, Tarek] Novartis Pharmaceut, Florham Pk, NJ USA; [Jozwiak, Sergiusz] Childrens Mem Hlth Inst Warsaw, Warsaw, Poland	Cincinnati Children's Hospital Medical Center; Texas Scottish Rite Hospital for Children; University of Alabama System; University of Alabama Birmingham; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Chicago; Children's Healthcare of Atlanta (CHOA); University of California System; University of California Los Angeles; University of Rome Tor Vergata; University of Cape Town; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Novartis; Children's Memorial Health Institute	Franz, DN (corresponding author), Cincinnati Childrens Hosp, Med Ctr, MLC 2015,3333 Burnet Ave, Cincinnati, OH 45229 USA.	tsclinic@cchmc.org	frost, michael/AAG-4031-2021	Belousova, Elena Dmitrievna/0000-0003-3594-6974; Jozwiak, Sergiusz/0000-0003-3350-6326; Sparagana, Steven/0000-0002-8439-4312	Novartis Pharmaceuticals; Novartis; Tuberous Sclerosis Alliance; Novartis Oncology	Novartis Pharmaceuticals(Novartis); Novartis(Novartis); Tuberous Sclerosis Alliance; Novartis Oncology	Novartis Pharmaceuticals.; JPF, GS, HC, DL, and TS are employees of Novartis. DNF, SS, EMB, MF, MHK, JYW, PJdV, and SJ are consultants for Novartis (including advisory boards), and have received travel payments, research funding, or speaker honoraria from Novartis. DNF has received compensation from various attorneys for legal work reviewing medical malpractice cases and occasionally gives expert testimony. SS and JYW have received honoraria from Lundbeck Pharmaceuticals. JYW serves on a professional advisory board for and receives research support from the Tuberous Sclerosis Alliance. PJdV has been a coprincipal investigator on research studies partly funded by Novartis Oncology. The other authors declare that they have no conflicts of interest.	Adriaensen MEAPM, 2009, EUR J NEUROL, V16, P691, DOI 10.1111/j.1468-1331.2009.02567.x; An KS, 2007, GENET MED, V9, P88, DOI 10.1097/GIM.0b013e31803068c7; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Borkowska J, 2011, INT J DERMATOL, V50, P13, DOI 10.1111/j.1365-4632.2010.04727.x; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; Dabora SL, 2001, AM J HUM GENET, V68, P64, DOI 10.1086/316951; de Ribaupierre S, 2007, NEUROSURGERY, V60, P83, DOI 10.1227/01.NEU.0000249216.19591.5D; Duvic M, 2001, ARCH DERMATOL, V137, P581; Fouladi M, 2007, J CLIN ONCOL, V25, P4806, DOI 10.1200/JCO.2007.11.4017; Franz DN, 2010, NEUROPEDIATRICS, V41, P199, DOI 10.1055/s-0030-1269906; Franz DN, 2006, ANN NEUROL, V59, P490, DOI 10.1002/ana.20784; Goh S, 2004, NEUROLOGY, V63, P1457, DOI 10.1212/01.wnl.0000142039.14522.1a; Heald P, 2003, J AM ACAD DERMATOL, V49, P801, DOI 10.1016/S0190-9622(03)01475-0; Hofbauer GFL, 2008, BRIT J DERMATOL, V159, P473, DOI 10.1111/j.1365-2133.2008.08677.x; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Hyman MH, 2000, ARCH NEUROL-CHICAGO, V57, P662, DOI 10.1001/archneur.57.5.662; Koenig MK, 2008, J CHILD NEUROL, V23, P1238, DOI 10.1177/0883073808321764; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Moavero R, 2011, CHILD NERV SYST, V27, P1203, DOI 10.1007/s00381-011-1406-0; Morton JM, 2008, J HEART LUNG TRANSPL, V27, P462, DOI 10.1016/j.healun.2008.01.005; NCI, 2006, CANC THER EV PROGR C; Perek-Polnik M, 2012, EUR J PAEDIATR NEURO, V16, P83, DOI 10.1016/j.ejpn.2011.09.006; Roa JA, 2010, TRENDS ENDOCRIN MET, V21, P519, DOI 10.1016/j.tem.2010.05.003; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; ROSZKOWSKI M, 1995, CHILD NERV SYST, V11, P335, DOI 10.1007/BF00301665; Sancak O, 2005, EUR J HUM GENET, V13, P731, DOI 10.1038/sj.ejhg.5201402; Stokes ME, 2000, CATEGORICAL DATA ANA; Sun P, 2012, CURR MED RES OPIN, V28, P1; Taille C, 2007, ANN INTERN MED, V146, P687, DOI 10.7326/0003-4819-146-9-200705010-00022; Torres OA, 1998, J CHILD NEUROL, V13, P173, DOI 10.1177/088307389801300405; Wienecke R, 2006, AM J KIDNEY DIS, V48, pE27, DOI 10.1053/j.ajkd.2006.05.018; Yalon M, 2011, CHILD NERV SYST, V27, P179, DOI 10.1007/s00381-010-1222-y	32	521	543	2	59	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2013	381	9861					125	132		10.1016/S0140-6736(12)61134-9	http://dx.doi.org/10.1016/S0140-6736(12)61134-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069FO	23158522				2022-12-28	WOS:000313420900028
J	Acquaviva, L; Szekvolgyi, L; Dichtl, B; Dichtl, BS; Saint Andre, CD; Nicolas, A; Geli, V				Acquaviva, Laurent; Szekvoelgyi, Lorant; Dichtl, Bernhard; Dichtl, Beatriz Solange; Saint Andre, Christophe de La Roche; Nicolas, Alain; Geli, Vincent			The COMPASS Subunit Spp1 Links Histone Methylation to Initiation of Meiotic Recombination	SCIENCE			English	Article							STRAND BREAK FORMATION; H3 TRIMETHYLATION; GENE-EXPRESSION; SITES; PROMOTER; FEATURES; HOTSPOTS; COMPLEX; PRDM9; ONSET	During meiosis, combinatorial associations of genetic traits arise from homologous recombination between parental chromosomes. Histone H3 lysine 4 trimethylation marks meiotic recombination hotspots in yeast and mammals, but how this ubiquitous chromatin modification relates to the initiation of double-strand breaks (DSBs) dependent on Spo11 remains unknown. Here, we show that the tethering of a PHD-containing protein, Spp1 (a component of the COMPASS complex), to recombinationally cold regions is sufficient to induce DSB formation. Furthermore, we found that Spp1 physically interacts with Mer2, a key protein of the differentiated chromosomal axis required for DSB formation. Thus, by interacting with H3K4me3 and Mer2, Spp1 promotes recruitment of potential meiotic DSB sites to the chromosomal axis, allowing Spo11 cleavage at nearby nucleosome-depleted regions.	[Acquaviva, Laurent; Saint Andre, Christophe de La Roche; Geli, Vincent] Aix Marseille Univ, Inst Paoli Calmettes, Marseille Canc Res Ctr CRCM, INSERM,CNRS,U1068,UMR7258, F-13009 Marseille, France; [Szekvoelgyi, Lorant; Nicolas, Alain] Univ Paris 06, CNRS, Inst Curie, Ctr Rech,UMR3244, F-75248 Paris, France; [Dichtl, Bernhard; Dichtl, Beatriz Solange] Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, Melbourne, Vic 3125, Australia; [Szekvoelgyi, Lorant] Univ Debrecen, Med & Hlth Sci Ctr, Dept Biophys & Cell Biol, H-4012 Debrecen, Hungary	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Deakin University; University of Debrecen	Dichtl, B (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, Melbourne, Vic 3125, Australia.	b.dichtl@deakin.edu.au; laroche@ifr88.cnrs-mrs.fr; alain.nicolas@curie.fr; geli@ifr88.cnrs-mrs.fr	Székvölgyi, Lóránt/AAC-1600-2021	Székvölgyi, Lóránt/0000-0002-7529-0319; Dichtl, Bernhard/0000-0001-5514-4982; Acquaviva, Laurent/0000-0001-5080-3619	"Ligue contre le Cancer" (Equipe Labelisees); Swiss National Science Foundation; Fondation ARC; European Union; Hungarian Research Fund	"Ligue contre le Cancer" (Equipe Labelisees); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation ARC; European Union(European Commission); Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	We thank F. Klein and V. Borde for materials, J. B. Boule for his help, and S. Kowalczykowski for reading of the manuscript. Work in the V. G. and A.N. laboratories is supported by the "Ligue contre le Cancer" (Equipe Labelisees). Work in the laboratory of B. D. was supported by the Swiss National Science Foundation. L. A. was supported by grants from the Fondation ARC and L.Sz. by the European Union and the Hungarian Research Fund.	Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Henderson KA, 2006, CELL, V125, P1321, DOI 10.1016/j.cell.2006.04.039; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Lardenois A, 2011, P NATL ACAD SCI USA, V108, P1058, DOI 10.1073/pnas.1016459108; Li J, 2006, GENETICS, V173, P1969, DOI 10.1534/genetics.106.058768; Lichten M, 2011, CELL, V147, P267, DOI 10.1016/j.cell.2011.09.038; Miyoshi T, 2012, MOL CELL, V47, P722, DOI 10.1016/j.molcel.2012.06.023; Murakami H, 2009, MOL CELL BIOL, V29, P3500, DOI 10.1128/MCB.00088-09; Murton BL, 2010, J MOL BIOL, V398, P481, DOI 10.1016/j.jmb.2010.03.036; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; Pecina A, 2002, CELL, V111, P173, DOI 10.1016/S0092-8674(02)01002-4; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Sasanuma H, 2008, GENE DEV, V22, P398, DOI 10.1101/gad.1626608; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Sollier J, 2004, EMBO J, V23, P1957, DOI 10.1038/sj.emboj.7600204; Tischfield SE, 2012, CELL CYCLE, V11, P1496, DOI 10.4161/cc.19733; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	24	132	134	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2013	339	6116					215	218		10.1126/science.1225739	http://dx.doi.org/10.1126/science.1225739			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23160953				2022-12-28	WOS:000313328200047
J	Jakobsen, L; Ratcliffe, JM; Surlykke, A				Jakobsen, Lasse; Ratcliffe, John M.; Surlykke, Annemarie			Convergent acoustic field of view in echolocating bats	NATURE			English	Article							SOUND BEAM; BROWN BAT; PREY; VESPERTILIONIDAE; PURSUIT; SIZE	Most echolocating bats exhibit a strong correlation between body size and the frequency of maximum energy in their echolocation calls (peak frequency), with smaller species using signals of higher frequency than larger ones(1,2). Size-signal allometry or acoustic detection constraints imposed on wavelength by preferred prey size have been used to explain this relationship(1,3). Here we propose the hypothesis that smaller bats emit higher frequencies to achieve directional sonar beams, and that variable beam width is critical for bats. Shorter wavelengths relative to the size of the emitter translate into more directional sound beams(4). Therefore, bats that emit their calls through their mouths should show a relationship between mouth size and wavelength, driving smaller bats to signals of higher frequency. We found that in a flight room mimicking a closed habitat, six aerial hawking vespertilionid species (ranging in size from 4 to 21 g, ref. 5) produced sonar beams of extraordinarily similar shape and volume. Each species had a directivity index of 11 +/- 1 dB (a half-amplitude angle of approximately 37 degrees) and an on-axis sound level of 108 +/- 4 dB sound pressure level referenced to 20 mu Pa root mean square at 10 cm. Thus all bats adapted their calls to achieve similar acoustic fields of view. We propose that the necessity for high directionality has been a key constraint on the evolution of echolocation, which explains the relationship between bat size and echolocation call frequency. Our results suggest that echolocation is a dynamic system that allows different species, regardless of their body size, to converge on optimal fields of view in response to habitat and task.	[Jakobsen, Lasse; Ratcliffe, John M.; Surlykke, Annemarie] Univ So Denmark, Sound Commun Grp, Inst Biol, DK-5230 Odense M, Denmark	University of Southern Denmark	Surlykke, A (corresponding author), Univ So Denmark, Sound Commun Grp, Inst Biol, DK-5230 Odense M, Denmark.	ams@biology.sdu.dk		Jakobsen, Lasse/0000-0002-8496-5576	Danish Council for Natural Sciences (FNU), Carlsberg, Oticon; European Commission via the Seventh Framework Programme project ChiRoPing, Information Society Technologies [215370]	Danish Council for Natural Sciences (FNU), Carlsberg, Oticon; European Commission via the Seventh Framework Programme project ChiRoPing, Information Society Technologies	We thank H. Baagoe and B. Fenton for access to the bat collections at the Natural History Museum of Denmark and the Royal Ontario Museum, respectively, and R. Fisher and J. Hallam for providing gape heights of bats in flight. S. Brinklov, C. Elemans, B. Falk, B. Fenton, J. Galef, P. Madsen, C. Moss, H.-U. Schnitzler and M. Wahlberg provided detailed comments that improved the manuscript. This study was funded by the Danish Council for Natural Sciences (FNU), Carlsberg, Oticon and the European Commission via the Seventh Framework Programme project ChiRoPing, Information Society Technologies Contract 215370. Animal capture and experimentation was approved by Skov-og Naturstyrelsen (Denmark).	ANSI standard S1, 1995, S1261995ASA1131995 A; BAAGOE HJ, 1987, RECENT ADV STUDY BAT, P57; BARCLAY RMR, 1991, AM NAT, V137, P693, DOI 10.1086/285188; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Bruel & Kj&AELIG;r, 1982, DAT HDB; Dietz C., 2007, HDB FLEDERMAUSE EURO; Ghose K, 2006, J NEUROSCI, V26, P1704, DOI 10.1523/JNEUROSCI.4315-05.2006; HERRING SW, 1974, AM NAT, V108, P561, DOI 10.1086/282934; Hoofer SR, 2003, ACTA CHIROPTEROL, V5, P1, DOI 10.3161/001.005.s101; Houston R. D., 2004, ECHOLOCATION BATS DO, P339, DOI DOI 10.1016/0370-1573(95)00083-6; Hulva P, 2004, MOL PHYLOGENET EVOL, V32, P1023, DOI 10.1016/j.ympev.2004.04.007; Jakobsen L, 2010, P NATL ACAD SCI USA, V107, P13930, DOI 10.1073/pnas.1006630107; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Jones G, 1999, J EXP BIOL, V202, P3359; KALLEN FC, 1972, J MORPHOL, V136, P385, DOI 10.1002/jmor.1051360402; Land MF, 2012, OXF ANIMAL BIOL SER, P1; LAWRENCE BD, 1982, J ACOUST SOC AM, V71, P585, DOI 10.1121/1.387529; MOGENSEN F, 1979, J COMP PHYSIOL, V134, P165, DOI 10.1007/BF00610475; Moss CF, 2011, CURR OPIN NEUROBIOL, V21, P645, DOI 10.1016/j.conb.2011.05.028; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Pye J. David, 1993, Bioacoustics, V4, P271; Ruedi M, 2001, MOL PHYLOGENET EVOL, V21, P436, DOI 10.1006/mpev.2001.1017; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SIMMONS JA, 1979, SCIENCE, V203, P16, DOI 10.1126/science.758674; Surlykke A, 2009, P ROY SOC B-BIOL SCI, V276, P853, DOI 10.1098/rspb.2008.1505; Suthers RA, 2004, AN ACAD BRAS CIENC, V76, P247, DOI 10.1590/S0001-37652004000200009; WATERS DA, 1995, BEHAV ECOL SOCIOBIOL, V37, P321, DOI 10.1007/BF00174136; Wotton JM, 1997, J ACOUST SOC AM, V101, P1723, DOI 10.1121/1.418271	29	82	85	2	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					93	96		10.1038/nature11664	http://dx.doi.org/10.1038/nature11664			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23172147				2022-12-28	WOS:000312933800037
J	Abyzov, A; Mariani, J; Palejev, D; Zhang, Y; Haney, MS; Tomasini, L; Ferrandino, AF; Belmaker, LAR; Szekely, A; Wilson, M; Kocabas, A; Calixto, NE; Grigorenko, EL; Huttner, A; Chawarska, K; Weissman, S; Urban, AE; Gerstein, M; Vaccarino, FM				Abyzov, Alexej; Mariani, Jessica; Palejev, Dean; Zhang, Ying; Haney, Michael Seamus; Tomasini, Livia; Ferrandino, Anthony F.; Belmaker, Lior A. Rosenberg; Szekely, Anna; Wilson, Michael; Kocabas, Arif; Calixto, Nathaniel E.; Grigorenko, Elena L.; Huttner, Anita; Chawarska, Katarzyna; Weissman, Sherman; Urban, Alexander Eckehart; Gerstein, Mark; Vaccarino, Flora M.			Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells	NATURE			English	Article							GENOMIC STRUCTURAL VARIANTS; NUCLEOTIDE-RESOLUTION; RETROTRANSPOSITION; FIBROBLASTS; FRAMEWORK; REGIONS; BRAIN; NANOG	Reprogramming somatic cells into induced pluripotent stem cells (iPSCs) has been suspected of causing de novo copy number variation(1-4). To explore this issue, here we performa whole-genome and transcriptome analysis of 20 human iPSC lines derived from the primary skin fibroblasts of seven individuals using next-generation sequencing. We find that, on average, an iPSC line manifests two copy number variants (CNVs) not apparent in the fibroblasts from which the iPSC was derived. Using PCR and digital droplet PCR, we show that at least 50% of those CNVs are present as low-frequency somatic genomic variants in parental fibroblasts (that is, the fibroblasts from which each corresponding human iPSC line is derived), and are manifested in iPSC lines owing to their clonal origin. Hence, reprogramming does not necessarily lead to de novo CNVs in iPSCs, because most of the line-manifested CNVs reflect somatic mosaicism in the human skin. Moreover, our findings demonstrate that clonal expansion, and iPSC lines in particular, can be used as a discovery tool to reliably detect low-frequency CNVs in the tissue of origin. Overall, we estimate that approximately 30% of the fibroblast cells have somatic CNVs in their genomes, suggesting widespread somatic mosaicism in the human body. Our study paves the way to understanding the fundamental question of the extent to which cells of the human body normally acquire structural alterations in their DNA post-zygotically.	[Abyzov, Alexej; Mariani, Jessica; Palejev, Dean; Zhang, Ying; Tomasini, Livia; Ferrandino, Anthony F.; Belmaker, Lior A. Rosenberg; Szekely, Anna; Wilson, Michael; Kocabas, Arif; Calixto, Nathaniel E.; Grigorenko, Elena L.; Huttner, Anita; Chawarska, Katarzyna; Weissman, Sherman; Urban, Alexander Eckehart; Gerstein, Mark; Vaccarino, Flora M.] Yale Univ, Program Neurodev & Regenerat, New Haven, CT 06520 USA; [Abyzov, Alexej; Wilson, Michael; Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Abyzov, Alexej; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Mariani, Jessica; Palejev, Dean; Tomasini, Livia; Ferrandino, Anthony F.; Belmaker, Lior A. Rosenberg; Wilson, Michael; Kocabas, Arif; Calixto, Nathaniel E.; Grigorenko, Elena L.; Chawarska, Katarzyna; Vaccarino, Flora M.] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; [Zhang, Ying; Szekely, Anna; Weissman, Sherman] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Haney, Michael Seamus; Urban, Alexander Eckehart] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Haney, Michael Seamus; Urban, Alexander Eckehart] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Szekely, Anna] Yale Univ, Dept Neurol, New Haven, CT 06520 USA; [Grigorenko, Elena L.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Grigorenko, Elena L.] Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; [Huttner, Anita] Yale Univ, Dept Pathol, New Haven, CT 06520 USA; [Gerstein, Mark] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Vaccarino, Flora M.] Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Stanford University; Stanford University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Vaccarino, FM (corresponding author), Yale Univ, Program Neurodev & Regenerat, New Haven, CT 06520 USA.	aeurban@stanford.edu; mark.gerstein@yale.edu; flora.vaccarino@yale.edu	Abyzov, Alexej/AAT-4615-2020; Abyzov, Alexej/M-4284-2013	Palejev, Dean/0000-0002-0563-6636; Vaccarino, Flora/0000-0003-2167-981X; Calixto, Nathaniel/0000-0002-0948-7607; Wilson, Michael/0000-0001-5892-6074; Abyzov, Alexej/0000-0001-5405-6729	National Institutes of Health (NIH); AL Williams Professorship fund; Harris Professorship fund; NIMH [MH089176, MH087879]; Simons Foundation [SFARI 137055]; State of Connecticut; NIH [RR19895]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH089176, R33MH087879, P50MH081756, R21MH087879] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AL Williams Professorship fund; Harris Professorship fund; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; State of Connecticut; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge support from the National Institutes of Health (NIH) and from the AL Williams Professorship fund and the Harris Professorship fund. We also acknowledge the Yale University Biomedical High Performance Computing Center and its support team(in particular, R. Bjornson and N. Carriero). We thank A. Klin for help with family recruitment. We thank M. V. Simonini for technical help, I.-H. Park for advice in the characterization of iPSC lines and the gift of the iPSC PGP1-1, and S. A. Duncan for the gift of the K3 iPSC line. We acknowledge the following grant support: NIMH MH089176 and MH087879, the Simons Foundation (SFARI 137055 F. V.) and the State of Connecticut, which funded the hiPSC generation and characterization; and NIH grant RR19895, which funded the instrumentation. We acknowledge the Yale Center for Clinical Investigation for clinical support in obtaining the biopsy specimens. We thank J. Overton for advice in carrying out DNA and RNA sequencing. Finally, we thank M. O'Huallachain and J. Li-Pook-Than for their advice on planning, carrying out and analysing the ddPCR experiments.	Abyzov A, 2011, BIOINFORMATICS, V27, P595, DOI 10.1093/bioinformatics/btq713; Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Arlt MF, 2011, P NATL ACAD SCI USA, V108, P17360, DOI 10.1073/pnas.1109272108; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Brennand KJ, 2011, STEM CELLS, V29, P1915, DOI 10.1002/stem.762; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; De S, 2011, TRENDS GENET, V27, P217, DOI 10.1016/j.tig.2011.03.002; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Elliott AM, 2010, MOL BIOTECHNOL, V46, P234, DOI 10.1007/s12033-010-9294-1; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Habegger L, 2011, BIOINFORMATICS, V27, P281, DOI 10.1093/bioinformatics/btq643; Haraksingh RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027859; Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kim JE, 2011, P NATL ACAD SCI USA, V108, P3005, DOI 10.1073/pnas.1007753108; Korbel JO, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r23; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang Q, 2008, P NATL ACAD SCI USA, V105, P17453, DOI 10.1073/pnas.0805638105; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Mkrtchyan H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009591; O'Huallachain M., 2012, P NATL ACAD SCI US; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Qin J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn518; Quinlan AR, 2011, CELL STEM CELL, V9, P366, DOI 10.1016/j.stem.2011.07.018; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vaccarino FM, 2011, J CHILD PSYCHOL PSYC, V52, P504, DOI 10.1111/j.1469-7610.2010.02348.x; Wang LY, 2009, GENOME RES, V19, P106, DOI 10.1101/gr.080069.108; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu H, 2008, STEM CELLS, V26, P1484, DOI 10.1634/stemcells.2007-0993; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	48	272	286	1	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					438	+		10.1038/nature11629	http://dx.doi.org/10.1038/nature11629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23160490	Green Accepted			2022-12-28	WOS:000312488200058
J	Brown, MTC; Tan, KR; O'Connor, EC; Nikonenko, I; Muller, D; Luscher, C				Brown, Matthew T. C.; Tan, Kelly R.; O'Connor, Eoin C.; Nikonenko, Irina; Muller, Dominique; Luescher, Christian			Ventral tegmental area GABA projections pause accumbal cholinergic interneurons to enhance associative learning	NATURE			English	Article							TONICALLY ACTIVE NEURONS; DOPAMINERGIC-NEURONS; NUCLEUS-ACCUMBENS; REWARD; ACTIVATION; STRIATUM; RELEASE; COCAINE	The ventral tegmental area (VTA) and nucleus accumbens (NAc) are essential for learning about environmental stimuli associated with motivationally relevant outcomes. The task of signalling such events, both rewarding and aversive, from the VTA to the NAc has largely been ascribed to dopamine neurons(1-3). The VTA also contains GABA (gamma-aminobutyric acid)-releasing neurons, which provide local inhibition(4,5) and also project to the NAc6,7. However, the cellular targets and functional importance of this long-range inhibitory projection have not been ascertained. Here we show that GABA-releasing neurons of the VTA that project to the NAc (VTA GABA projection neurons) inhibit accumbal cholinergic interneurons (CINs) to enhance stimulus-outcome learning. Combining optogenetics with structural imaging and electrophysiology, we found that VTA GABA projection neurons selectively target NAc CINs, forming multiple symmetrical synaptic contacts that generated inhibitory postsynaptic currents. This is remarkable considering that CINs represent a very small population of all accumbal neurons, and provide the primary source of cholinergic tone in the NAc. Brief activation of this projection was sufficient to halt the spontaneous activity of NAc CINs, resembling the pause recorded in animals learning stimulus-outcome associations(8-12). Indeed, we found that forcing CINs to pause in behaving mice enhanced discrimination of a motivationally important stimulus that had been associated with an aversive outcome. Our results demonstrate that VTA GABA projection neurons, through their selective targeting of accumbal CINs, provide a novel route through which the VTA communicates saliency to the NAc. VTA GABA projection neurons thus emerge as orchestrators of dopaminergic and cholinergic modulation in the NAc.	[Brown, Matthew T. C.; Tan, Kelly R.; O'Connor, Eoin C.; Nikonenko, Irina; Muller, Dominique; Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Luescher, Christian] Univ Hosp Geneva, Dept Clin Neurosci, Neurol Clin, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland.	christian.luscher@unige.ch	Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Brown, Matthew/0000-0001-6983-962X; O'Connor, Eoin/0000-0002-7810-1915	Swiss National Science Foundation; National Center of Competence in Research (NCCR) 'SYNAPSY - The Synaptic Bases of Mental Diseases' of the Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) 'SYNAPSY - The Synaptic Bases of Mental Diseases' of the Swiss National Science Foundation	We thank the members of the Luscher laboratory for discussion and comments on the manuscript. This work was funded by a grant of the Swiss National Science Foundation to C.L. and the National Center of Competence in Research (NCCR) 'SYNAPSY - The Synaptic Bases of Mental Diseases' of the Swiss National Science Foundation. fTom<SUP>PVALBcre</SUP> mice were provided by A. Holtmaat.	AOSAKI T, 1994, J NEUROSCI, V14, P3969; Apicella P, 2007, TRENDS NEUROSCI, V30, P299, DOI 10.1016/j.tins.2007.03.011; Apicella P, 2011, J NEUROSCI, V31, P1507, DOI 10.1523/JNEUROSCI.4880-10.2011; Cachope R, 2012, CELL REP, V2, P33, DOI 10.1016/j.celrep.2012.05.011; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cragg SJ, 2006, TRENDS NEUROSCI, V29, P125, DOI 10.1016/j.tins.2006.01.003; Ding JB, 2010, NEURON, V67, P294, DOI 10.1016/j.neuron.2010.06.017; English DF, 2012, NAT NEUROSCI, V15, P123, DOI 10.1038/nn.2984; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Goldberg JA, 2011, NEUROSCIENCE, V198, P27, DOI 10.1016/j.neuroscience.2011.08.067; Hikida T, 2001, P NATL ACAD SCI USA, V98, P13351, DOI 10.1073/pnas.231488998; Inokawa H, 2010, NEUROSCIENCE, V168, P395, DOI 10.1016/j.neuroscience.2010.03.062; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; Katzel D, 2011, NAT NEUROSCI, V14, P100, DOI 10.1038/nn.2687; KIMURA M, 1984, P NATL ACAD SCI-BIOL, V81, P4998, DOI 10.1073/pnas.81.15.4998; Ligorio M, 2009, J CHEM NEUROANAT, V37, P33, DOI 10.1016/j.jchemneu.2008.08.003; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Padgett CL, 2012, NEURON, V73, P978, DOI 10.1016/j.neuron.2011.12.031; Pratt WE, 2007, BEHAV NEUROSCI, V121, P1215, DOI 10.1037/0735-7044.121.6.1215; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; Schulz JM, 2011, J NEUROSCI, V31, P11133, DOI 10.1523/JNEUROSCI.0661-11.2011; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; VANBOCKSTAELE EJ, 1995, BRAIN RES, V682, P215, DOI 10.1016/0006-8993(95)00334-M; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771	30	224	225	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					452	456		10.1038/nature11657	http://dx.doi.org/10.1038/nature11657			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23178810				2022-12-28	WOS:000312488200061
J	Xu, NL; Harnett, MT; Williams, SR; Huber, D; O'Connor, DH; Svoboda, K; Magee, JC				Xu, Ning-long; Harnett, Mark T.; Williams, Stephen R.; Huber, Daniel; O'Connor, Daniel H.; Svoboda, Karel; Magee, Jeffrey C.			Nonlinear dendritic integration of sensory and motor input during an active sensing task	NATURE			English	Article							PRIMARY SOMATOSENSORY CORTEX; CORTICAL-NEURONS; OBJECT LOCALIZATION; PYRAMIDAL NEURONS; NEURAL ACTIVITY; CIRCUITS; ORGANIZATION; DYNAMICS; WHISKING; MOTION	Active dendrites provide neurons with powerful processing capabilities. However, little is known about the role of neuronal dendrites in behaviourally related circuit computations. Here we report that a novel global dendritic nonlinearity is involved in the integration of sensory and motor information within layer 5 pyramidal neurons during an active sensing behaviour. Layer 5 pyramidal neurons possess elaborate dendritic arborizations that receive functionally distinct inputs, each targeted to spatially separate regions(1,2). At the cellular level, coincident input from these segregated pathways initiates regenerative dendritic electrical events that produce bursts of action potential output(3,4) and circuits featuring this powerful dendritic nonlinearity can implement computations based on input correlation(5). To examine this in vivo we recorded dendritic activity in layer 5 pyramidal neurons in the barrel cortex using two-photon calcium imagingin mice performing an object-localization task. Large-amplitude, global calcium signals were observed throughout the apical tuft dendrites when active touch occurred at particular object locations or whisker angles. Such global calcium signals are produced by dendritic plateau potentials that require both vibrissal sensory input and primary motor cortex activity. These data provide direct evidence of nonlinear dendritic processing of correlated sensory and motor information in the mammalian neocortex during active sensation.	[Xu, Ning-long; Harnett, Mark T.; Huber, Daniel; O'Connor, Daniel H.; Svoboda, Karel; Magee, Jeffrey C.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Williams, Stephen R.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld 4072, Australia	Howard Hughes Medical Institute; University of Queensland	Magee, JC (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	mageej@janelia.hhmi.org	Xu, Ning-long/U-8665-2019; Huber, Daniel/C-2932-2013	Xu, Ning-long/0000-0002-1651-401X; Williams, Stephen/0000-0001-5352-7947; Huber, Daniel/0000-0002-0744-7679	Australian research council [FT100100502]; Australian National Health and Medical Research Council [APP1004575]	Australian research council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	We thank L. Tian and L. Looger for GCaMP3 constructs; J. Chandrashekar, N. Ryba and C. Zuker for GCaMP3 transgenic mice; W. Denk for comments on the manuscript; N. Clack, G. Myers, T. Zhao, V. Iyer, S. Peron and S. Drukmann for help with software and analysis; and L. Petreanu for help with experimental apparatus. S.R.W. is supported by the Australian research council (FT100100502) and Australian National Health and Medical Research Council (APP1004575).	Cauller LJ, 1998, J COMP NEUROL, V390, P297; Chen X., 2011, NATURE; Clack NG, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002591; Curtis JC, 2009, NAT NEUROSCI, V12, P492, DOI 10.1038/nn.2283; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Greenberg DS, 2009, J NEUROSCI METH, V176, P1, DOI 10.1016/j.jneumeth.2008.08.020; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Iyer V., 2009, 2009 NEUR M PLANN SO; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Petreanu L., 2012, NATURE; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Varga Z, 2011, P NATL ACAD SCI USA, V108, P15420, DOI 10.1073/pnas.1112355108; Williams SR, 2005, J NEUROSCI, V25, P5894, DOI 10.1523/JNEUROSCI.0502-05.2005; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Zhao T, 2011, NEUROINFORMATICS, V9, P247, DOI 10.1007/s12021-011-9120-3	38	308	311	6	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					247	+		10.1038/nature11601	http://dx.doi.org/10.1038/nature11601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23143335				2022-12-28	WOS:000312259300041
J	Zhu, WQ; London, NR; Gibson, CC; Davis, CT; Tong, ZZ; Sorensen, LK; Shi, DS; Guo, JP; Smith, MCP; Grossmann, AH; Thomas, KR; Li, DY				Zhu, Weiquan; London, Nyall R.; Gibson, Christopher C.; Davis, Chadwick T.; Tong, Zongzhong; Sorensen, Lise K.; Shi, Dallas S.; Guo, Jinping; Smith, Matthew C. P.; Grossmann, Allie H.; Thomas, Kirk R.; Li, Dean Y.			Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt vascular stability	NATURE			English	Article							NF-KAPPA-B; COLLAGEN-INDUCED ARTHRITIS; TUMOR-NECROSIS-FACTOR; ANTI-TNF-ALPHA; ENDOTHELIAL PERMEABILITY; INFLAMMATION; MECHANISMS; PROTEIN; GENE; MICE	The innate immune response is essential for combating infectious disease. Macrophages and other cells respond to infection by releasing cytokines, such as interleukin-1 beta (IL-1 beta), which in turn activate a well-described, myeloid-differentiation factor 88 (MYD88)-mediated, nuclear factor-kappa B (NF-kappa B)-dependent transcriptional pathway that results in inflammatory-cell activation and recruitment(1-4). Endothelial cells, which usually serve as a barrier to the movement of inflammatory cells out of the blood and into tissue, are also critical mediators of the inflammatory response(5,6). Paradoxically, the cytokines vital to a successful immune defence also have disruptive effects on endothelial cell-cell interactions and can trigger degradation of barrier function and dissociation of tissue architecture(7-9). The mechanism of this barrier dissolution and its relationship to the canonical NF-kappa B pathway remain poorly defined. Here we show that the direct, immediate and disruptive effects of IL-1 beta on endothelial stability in a human in vitro cell model are NF-kappa B independent and are instead the result of signalling through the small GTPase ADP-ribosylation factor 6 (ARF6) and its activator ARF nucleotide binding site opener (ARNO; also known as CYTH2). Moreover, we show that ARNO binds directly to the adaptor protein MYD88, and thus propose MYD88-ARNO-ARF6 as a proximal IL-1 beta signalling pathway distinct from that mediated by NF-kappa B. Finally, we show that SecinH3, an inhibitor of ARF guanine nucleotide-exchange factors such as ARNO, enhances vascular stability and significantly improves outcomes in animal models of inflammatory arthritis and acute inflammation.	[Zhu, Weiquan; London, Nyall R.; Guo, Jinping; Smith, Matthew C. P.; Thomas, Kirk R.; Li, Dean Y.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Zhu, Weiquan; London, Nyall R.; Gibson, Christopher C.; Davis, Chadwick T.; Sorensen, Lise K.; Shi, Dallas S.; Guo, Jinping; Smith, Matthew C. P.; Grossmann, Allie H.; Thomas, Kirk R.; Li, Dean Y.] Univ Utah, Program Mol Med, Salt Lake City, UT 84112 USA; [London, Nyall R.; Smith, Matthew C. P.; Li, Dean Y.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Gibson, Christopher C.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Davis, Chadwick T.; Shi, Dallas S.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Tong, Zongzhong] Navigen Inc, Salt Lake City, UT 84112 USA; [Guo, Jinping] Second Mil Med Univ, Dept Anat, Shanghai 200433, Peoples R China; [Grossmann, Allie H.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Li, Dean Y.] VA Salt Lake City Hlth Care Syst, Cardiol Sect, Salt Lake City, UT 84112 USA; [Li, Dean Y.] Sichuan Acad Med Sci, Inst Lab Med, Key Lab Human Dis Gene Study Sichuan Prov, Chengdu 610072, Sichuan, Peoples R China; [Li, Dean Y.] Sichuan Prov Peoples Hosp, Chengdu 610072, Sichuan, Peoples R China	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Naval Medical University; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Li, DY (corresponding author), Univ Utah, Dept Med, Salt Lake City, UT 84112 USA.	dean.li@u2m2.utah.edu		Sorensen, Lise K./0000-0003-3250-4564	National Heart, Lung, and Blood Institute; Burroughs Wellcome Fund; Juvenile Diabetes Research Foundation; NIAID Rocky Mountain Regional Center of Excellence in Biodefense and Emerging Infectious Disease; American Asthma Foundation; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA163970] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL112311, R01HL084516, R01HL065648] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIAID Rocky Mountain Regional Center of Excellence in Biodefense and Emerging Infectious Disease; American Asthma Foundation; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank D. Lim and T. Mleynek for graphical assistance, G. Zimmerman and J. Kaplan for reading the manuscript, S. Odelberg for reading the manuscript and statistical analysis, J. Ling for help with immunostaining, R. Campbell and A. Weyrich for providing primary human blood cells, C. Rodesch and the University of Utah Cell Imaging/Fluorescence Facility as well as the University of Utah Flow Cytometry Facility, and M. P. Revelo for help with pathology. D.Y.L. and his laboratory were funded by grants from the National Heart, Lung, and Blood Institute; Burroughs Wellcome Fund; Juvenile Diabetes Research Foundation; NIAID Rocky Mountain Regional Center of Excellence in Biodefense and Emerging Infectious Disease; the American Asthma Foundation; and the Department of Defense. D.Y.L. is the HA and Edna Benning Endowed Professor of Medicine and Cardiology.	Arend WP, 2001, SEMIN ARTHRITIS RHEU, V30, P1, DOI 10.1053/sarh.2001.23693; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Joosten LAB, 1996, ARTHRITIS RHEUM, V39, P797, DOI 10.1002/art.1780390513; Kaltschmidt B, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-16; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; London NR, 2009, ANGIOGENESIS, V12, P149, DOI 10.1007/s10456-009-9130-z; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Matthews JS, 1999, CYTOKINE, V11, P643, DOI 10.1006/cyto.1998.0478; Muller WA, 2002, LAB INVEST, V82, P521, DOI 10.1038/labinvest.3780446; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Riley KN, 2003, MOL BIOL CELL, V14, P4155, DOI 10.1091/mbc.e02-11-0726; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; ROYALL JA, 1989, AM J PHYSIOL, V257, pL399, DOI 10.1152/ajplung.1989.257.6.L399; Silva LCR, 2010, IMMUNOTHERAPY-UK, V2, P817, DOI [10.2217/imt.10.67, 10.2217/IMT.10.67]; Szekanecz Z, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2515; VANDENBERG WB, 1994, CLIN EXP IMMUNOL, V95, P237; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; WOOLEY PH, 1993, J IMMUNOL, V151, P6602; Zhang QS, 2007, P NATL ACAD SCI USA, V104, P7444, DOI 10.1073/pnas.0702136104; Zhu JK, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/781235	30	113	121	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					252	255		10.1038/nature11603	http://dx.doi.org/10.1038/nature11603			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23143332	Green Accepted			2022-12-28	WOS:000312259300042
J	Bayer, R; Gostin, L; Marcus-Toll, D				Bayer, Ronald; Gostin, Lawrence; Marcus-Toll, Daniel			Repackaging Cigarettes - Will the Courts Thwart the FDA?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bayer, Ronald; Marcus-Toll, Daniel] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, Ctr Hist & Eth Publ Hlth, New York, NY 10027 USA; [Gostin, Lawrence] Georgetown Univ, Dept Hlth Policy & Management, Ctr Law, Washington, DC USA	Columbia University; Georgetown University	Bayer, R (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, Ctr Hist & Eth Publ Hlth, New York, NY 10027 USA.			Gostin, Lawrence/0000-0001-5286-4044				Goodin R. E., 1989, NO SMOKING ETHICAL I; Gostin LO, 2000, PUBLIC HLTH LAW POWE; Institute of Medicine, 2007, GROW TOB FREE PREV N, P237	3	13	13	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2012	367	22					2065	2067		10.1056/NEJMp1211522	http://dx.doi.org/10.1056/NEJMp1211522			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	044MS	23151279				2022-12-28	WOS:000311624400001
J	Sokol, DK				Sokol, Daniel K.			How good a doctor do you need to be?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Sokol, DK (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	daniel.sokol@talk21.com						[Anonymous], 1990, TIMES; Woolf Harry, 2001, Med Law Rev, V9, P1	2	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 21	2012	345								e7858	10.1136/bmj.e7858	http://dx.doi.org/10.1136/bmj.e7858			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	044GW	23172943				2022-12-28	WOS:000311608500010
J	Zafonte, RD; Bagiella, E; Ansel, BM; Novack, TA; Friedewald, WT; Hesdorffer, DC; Timmons, SD; Jallo, J; Eisenberg, H; Hart, T; Ricker, JH; Diaz-Arrastia, R; Merchant, RE; Temkin, NR; Melton, S; Dikmen, SS				Zafonte, Ross D.; Bagiella, Emilia; Ansel, Beth M.; Novack, Thomas A.; Friedewald, William T.; Hesdorffer, Dale C.; Timmons, Shelly D.; Jallo, Jack; Eisenberg, Howard; Hart, Tessa; Ricker, Joseph H.; Diaz-Arrastia, Ramon; Merchant, Randall E.; Temkin, Nancy R.; Melton, Sherry; Dikmen, Sureyya S.			Effect of Citicoline on Functional and Cognitive Status Among Patients With Traumatic Brain Injury Citicoline Brain Injury Treatment Trial (COBRIT)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MILD HEAD-INJURY; CDP-CHOLINE; CLINICAL-TRIALS; MULTIPLE OUTCOMES; HIPPOCAMPAL; SYMPTOMS; RECOVERY; TBI	Context Traumatic brain injury (TBI) is a serious public health problem in the United States, yet no treatment is currently available to improve outcome after TBI. Approved for use in TBI in 59 countries, citicoline is an endogenous substance offering potential neuroprotective properties as well as facilitated neurorepair post injury. Objective To determine the ability of citicoline to positively affect functional and cognitive status in persons with complicated mild, moderate, and severe TBI. Design, Setting, and Patients The Citicoline Brain Injury Treatment Trial (COBRIT), a phase 3, double-blind randomized clinical trial conducted between July 20, 2007, and February 4, 2011, among 1213 patients at 8 US level 1 trauma centers to investigate effects of citicoline vs placebo in patients with TBI classified as complicated mild, moderate, or severe. Intervention Ninety-day regimen of daily enteral or oral citicoline (2000 mg) or placebo. Main Outcome Measures Functional and cognitive status, assessed at 90 days using the TBI-Clinical Trials Network Core Battery. A global statistical test was used to analyze the 9 scales of the core battery. Secondary outcomes were functional and cognitive improvement, assessed at 30, 90, and 180 days, and examination of the long-term maintenance of treatment effects. Results Rates of favorable improvement for the Glasgow Outcome Scale-Extended were 35.4% in the citicoline group and 35.6% in the placebo group. For all other scales the rate of improvement ranged from 37.3% to 86.5% in the citicoline group and from 42.7% to 84.0% in the placebo group. The citicoline and placebo groups did not differ significantly at the 90-day evaluation (global odds ratio [OR], 0.98 [95% CI, 0.83-1.15]); in addition, there was no significant treatment effect in the 2 severity subgroups (global OR, 1.14 [95% CI, 0.88-1.49] and 0.89 [95% CI, 0.72-1.49] for moderate/severe and complicated mild TBI, respectively). At the 180-day evaluation, the citicoline and placebo groups did not differ significantly with respect to the primary outcome (global OR, 0.87 [95% CI, 0.72-1.04]). Conclusion Among patients with traumatic brain injury, the use of citicoline compared with placebo for 90 days did not result in improvement in functional and cognitive status.	[Zafonte, Ross D.] Harvard Univ, Spaulding Rehabil Hosp Network, Sch Med, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Zafonte, Ross D.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Bagiella, Emilia] Mt Sinai Sch Med, Dept Hlth Evidence & Policy, New York, NY USA; [Ansel, Beth M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Novack, Thomas A.; Melton, Sherry] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Friedewald, William T.] Columbia Univ, Dept Biostat, New York, NY USA; [Hesdorffer, Dale C.] Columbia Univ, Dept Epidemiol, New York, NY USA; [Timmons, Shelly D.] Geisinger Med Ctr, Dept Neurosurg, Danville, PA 17822 USA; [Jallo, Jack] Thomas Jefferson Univ, Div Neurotrauma & Crit Care, Philadelphia, PA 19107 USA; [Eisenberg, Howard] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Hart, Tessa] Moss Rehabil Res Inst, Philadelphia, PA USA; [Ricker, Joseph H.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Rockville, MD USA; [Merchant, Randall E.] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23284 USA; [Temkin, Nancy R.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Dikmen, Sureyya S.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA	Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Alabama System; University of Alabama Birmingham; Columbia University; Columbia University; Geisinger Medical Center; Jefferson University; University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Uniformed Services University of the Health Sciences - USA; Virginia Commonwealth University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zafonte, RD (corresponding author), Harvard Univ, Spaulding Rehabil Hosp Network, Sch Med, Dept Phys Med & Rehabil, 125 Nashua St, Boston, MA 02114 USA.	rzafonte@partners.org		Jallo, Jack/0000-0002-5512-1729; Diaz-Arrastia, Ramon/0000-0001-6051-3594; Ricker, Joseph/0000-0003-3415-991X	National Institute of Child Health and Human Development at Temple University [U01HD042738]; National Institute of Child Health and Human Development at University of Alabama at Birmingham [U01HD042687]; National Institute of Child Health and Human Development at University of Maryland [U01HD042736]; National Institute of Child Health and Human Development at University of Pittsburgh [U01HD042678]; National Institute of Child Health and Human Development at University of Tennessee Health Sciences Center [U01HD042686]; National Institute of Child Health and Human Development at University of Texas Southwestern [U01HD042652]; National Institute of Child Health and Human Development grants at University of Washington [U01HD042653]; National Institute of Child Health and Human Development grants at Virginia Commonwealth University [U01HD042689]; National Institute of Child Health and Human Development grants at Columbia University [Columbia University (U01HD042823]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD042652] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD042687, U01HD042823, U01HD042738, U01HD042689, U01HD042686, U01HD042736, U01HD042653, U01HD042678] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development at Temple University; National Institute of Child Health and Human Development at University of Alabama at Birmingham; National Institute of Child Health and Human Development at University of Maryland; National Institute of Child Health and Human Development at University of Pittsburgh; National Institute of Child Health and Human Development at University of Tennessee Health Sciences Center; National Institute of Child Health and Human Development at University of Texas Southwestern; National Institute of Child Health and Human Development grants at University of Washington; National Institute of Child Health and Human Development grants at Virginia Commonwealth University; National Institute of Child Health and Human Development grants at Columbia University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by National Institute of Child Health and Human Development grants at the following institutions: Temple University (U01HD042738); University of Alabama at Birmingham (U01HD042687); University of Maryland (U01HD042736); University of Pittsburgh (U01HD042678); University of Tennessee Health Sciences Center (U01HD042686); University of Texas Southwestern (U01HD042652); University of Washington (U01HD042653); Virginia Commonwealth University (U01HD042689); and Columbia University (U01HD042823). Ferrer Grupo provided the citicoline and identical placebo used in the study.	Adibhatla RM, 2002, J NEUROSCI RES, V70, P133, DOI 10.1002/jnr.10403; Alexandrov A V, 2001, Curr Opin Investig Drugs, V2, P1757; [Anonymous], 1994, ASSESSMENT CLIN MANU; Arenth PM, 2011, PM&R, V3, pS123, DOI 10.1016/j.pmrj.2011.03.012; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; COHADON F, 1982, NEUROCHIRURGIE, V28, P287; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Dempsey RJ, 2003, J NEUROSURG, V98, P867, DOI 10.3171/jns.2003.98.4.0867; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; DODRILL CB, 1978, EPILEPSIA, V19, P611, DOI 10.1111/j.1528-1157.1978.tb05041.x; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hernandez AV, 2005, NEUROSURGERY, V57, P1244, DOI 10.1227/01.NEU.0000186039.57548.96; Kelso ML, 2011, PROG MOL BIOL TRANSL, V98, P85, DOI 10.1016/B978-0-12-385506-0.00003-X; KENNEDY EP, 1956, J BIOL CHEM, V222, P185; Langley J, 2010, BRAIN INJURY, V24, P939, DOI 10.3109/02699052.2010.491494; LEVIN HS, 1991, J NEUROL SCI, V103, pS39; Little R. J. A., 1987, STAT ANAL MISSING DA; LoBello S, 2003, ARCH PHYS MED REHAB, V84, pA9; LOZANO R, 1991, J NEUROL SCI, V103, pS43; MALDONADO VC, 1991, J NEUROL SCI, V103, pS15; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Pocock SJ, 1997, CONTROL CLIN TRIALS, V18, P530, DOI 10.1016/S0197-2456(97)00008-1; Reitan RM, 1992, TRAIL MAKING TEST MA; REITAN RM, 1993, HALSTEAD REITH NEURO; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rubin D., 1997, MULTIPLE IMPUTATION; Secades JJ, 2011, REV NEUROLOGIA, V52, pS1, DOI 10.33588/rn.52S02.2010787; Team RDC, 2019, R LANG ENV STAT COMP; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P457; Tilley BC, 1996, STROKE, V27, P2136, DOI 10.1161/01.STR.27.11.2136; Wechsler D, 1997, WECHSLER ADULT INTEL, VIII; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zafonte R, 2009, J NEUROTRAUM, V26, P2207, DOI 10.1089/neu.2009.1015	40	105	109	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2012	308	19					1993	2000		10.1001/jama.2012.13256	http://dx.doi.org/10.1001/jama.2012.13256			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040AQ	23168823	Bronze			2022-12-28	WOS:000311291400023
J	Corbett, EC				Corbett, Eugene C., Jr.			Review: Intensive glucose control reduces surrogate, but not clinical, renal outcomes in type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Virginia, Charlottesville, VA 22903 USA	University of Virginia	Corbett, EC (corresponding author), Univ Virginia, Charlottesville, VA 22903 USA.							Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10							JC5-6	10.7326/0003-4819-157-10-201211200-02006	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043VZ	23165682				2022-12-28	WOS:000311580000005
J	van Adel, B; Oczkowski, W				van Adel, Brian; Oczkowski, Wieslaw			rt-PA within 6 hours of acute ischemic stroke did not improve clinical outcomes at 6 months	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TISSUE-PLASMINOGEN ACTIVATOR; THROMBOLYSIS; ALTEPLASE; TIME		[van Adel, Brian; Oczkowski, Wieslaw] Hamilton Hlth Sci, Hamilton, ON, Canada	McMaster University	van Adel, B (corresponding author), Hamilton Hlth Sci, Hamilton, ON, Canada.							Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Meretoja A, 2010, STROKE, V41, P1450, DOI 10.1161/STROKEAHA.109.576140; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7	6	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10							JC5-7	10.7326/0003-4819-157-10-201211200-02007	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043VZ	23165683				2022-12-28	WOS:000311580000006
J	Jetz, W; Thomas, GH; Joy, JB; Hartmann, K; Mooers, AO				Jetz, W.; Thomas, G. H.; Joy, J. B.; Hartmann, K.; Mooers, A. O.			The global diversity of birds in space and time	NATURE			English	Article							MOLECULAR PHYLOGENIES; DIVERSIFICATION RATES; NORTH-AMERICAN; FOSSIL RECORD; EVOLUTION; RADIATIONS; PATTERNS; HISTORY; BIOGEOGRAPHY; EXTINCTION	Current global patterns of biodiversity result from processes that operate over both space and time and thus require an integrated macroecological and macroevolutionary perspective(1-4). Molecular time trees have advanced our understanding of the tempo and mode of diversification(5-7) and have identified remarkable adaptive radiations across the tree of life(8-10). However, incomplete joint phylogenetic and geographic sampling has limited broad-scale inference. Thus, the relative prevalence of rapid radiations and the importance of their geographic settings in shaping global biodiversity patterns remain unclear. Here we present, analyse and map the first complete dated phylogeny of all 9,993 extant species of birds, a widely studied group showing many unique adaptations. We find that birds have undergone a strong increase in diversification rate from about 50 million years ago to the near present. This acceleration is due to a number of significant rate increases, both within songbirds and within other young and mostly temperate radiations including the waterfowl, gulls and woodpeckers. Importantly, species characterized with very high past diversification rates are interspersed throughout the avian tree and across geographic space. Geographically, the major differences in diversification rates are hemispheric rather than latitudinal, with bird assemblages in Asia, North America and southern South America containing a disproportionate number of species from recent rapid radiations. The contribution of rapidly radiating lineages to both temporal diversification dynamics and spatial distributions of species diversity illustrates the benefits of an inclusive geographical and taxonomical perspective. Overall, whereas constituent clades may exhibit slowdowns(10,11), the adaptive zone into which modern birds have diversified since the Cretaceous may still offer opportunities for diversification.	[Jetz, W.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Thomas, G. H.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Joy, J. B.; Mooers, A. O.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Hartmann, K.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7001, Australia	Yale University; University of Sheffield; Simon Fraser University; University of Tasmania	Jetz, W (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, 165 Prospect St, New Haven, CT 06520 USA.	walter.jetz@yale.edu; amooers@sfu.ca	Thomas, Gavin/AAE-8959-2019; Jetz, Walter/ABF-1517-2020	Thomas, Gavin/0000-0002-1982-6051; Joy, Jeffrey/0000-0002-7013-1482; Jetz, Walter/0000-0002-1971-7277	NSF [DBI 0960550, DEB 1026764]; NASA [NNX11AP72G]; Natural Environment Research Council [NE/G012938/1]; NERC (Centre for Population Biology); NSERC Canada; Wissenschaftskolleg zu Berlin; Yale Institute for Biospheric Sciences; Simon Fraser University; NERC [NE/G012938/2, NE/G012938/1] Funding Source: UKRI; Natural Environment Research Council [NE/G012938/2] Funding Source: researchfish; Division Of Environmental Biology [1026764] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC (Centre for Population Biology)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Wissenschaftskolleg zu Berlin(Austrian Science Fund (FWF)); Yale Institute for Biospheric Sciences; Simon Fraser University; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank D. Redding for critical input in the early stages of this project; A. Mimoto, F. Ronqvist and M. Teslenko for help modifying MrBayes; I. Martyn for coding; R. Bowie, J. McGuire, A. Cooper, K. Burns and M. Sorenson among others, for unpublished phylogenetic material or information; M. Benton, T. Ezard, T. Price, M. Donoghue, J. Beaulieu, J. Belmaker, P. M. Hull, D. Field, N. Longrich, V. Saranathan, M. Steel, H. Morlon, J. Brown, A. Phillimore, R. Fitzjohn, R. Etienne, W. Stein and especially T. Stadler for data, important input and/or discussion; G. Smith, C. Schank, D. Thiele, T. M. Lee, F. La Sorte, C. Edwards, K. Ashton and J. Hazelhurst for help with spatial and phylogenetic data collection and management; C. Schank for help preparing the tree visualizations. This work was carried out using the BlueFern Supercomputing Facilities (http://www.bluefern.canterbury.ac.nz), University of Canterbury, the Advanced Computing Research Centre, University of Bristol (http://www.bris.ac.uk/acrc/) and the Interdisciplinary Research in Mathematics and Computer Sciences Centre, Simon Fraser University (http://www.irmacs.sfu.ca). This work was partly supported by NSF grants DBI 0960550 and DEB 1026764 and NASA Biodiversity Grant NNX11AP72G (W. J.); the Natural Environment Research Council (Postdoctoral Fellowship grant number NE/G012938/1 and the NERC Centre for Population Biology) (G.H.T.); and NSERC Canada, the Wissenschaftskolleg zu Berlin, the Yale Institute for Biospheric Sciences and Simon Fraser University (A.O.M.). Most importantly, we thank the many avian systematists and phylogeneticists who have contributed their data to public databases and so made our study possible.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Cardillo M, 2005, ECOLOGY, V86, P2278, DOI 10.1890/05-0112; Cusimano N, 2010, SYST BIOL, V59, P458, DOI 10.1093/sysbio/syq032; Derryberry EP, 2011, EVOLUTION, V65, P2973, DOI 10.1111/j.1558-5646.2011.01374.x; Ericson PGP, 2012, J BIOGEOGR, V39, P813, DOI 10.1111/j.1365-2699.2011.02650.x; Etienne RS, 2012, P ROY SOC B-BIOL SCI, V279, P1300, DOI 10.1098/rspb.2011.1439; Ezard THG, 2011, SCIENCE, V332, P349, DOI 10.1126/science.1203060; Grant PR, 2011, WHY SPECIES MULTIPLY; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Jetz W, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001292; Linder HP, 2008, PHILOS T R SOC B, V363, P3097, DOI 10.1098/rstb.2008.0075; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Morlon H, 2011, P NATL ACAD SCI USA, V108, P16327, DOI 10.1073/pnas.1102543108; Moyle RG, 2009, P NATL ACAD SCI USA, V106, P1863, DOI 10.1073/pnas.0809861105; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Price T, 2000, AM NAT, V156, P354, DOI 10.1086/303397; Price T, 2008, SPECIATION BIRDS; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Ricklefs RE, 2006, ECOLOGY, V87, P2468, DOI 10.1890/0012-9658(2006)87[2468:GVITDR]2.0.CO;2; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Smith SA, 2011, AM J BOT, V98, P404, DOI 10.3732/ajb.1000481; Stadler T, 2011, P NATL ACAD SCI USA, V108, P6187, DOI 10.1073/pnas.1016876108; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Weir JT, 2006, EVOLUTION, V60, P842	30	1994	2035	33	1102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					444	448		10.1038/nature11631	http://dx.doi.org/10.1038/nature11631			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23123857				2022-12-28	WOS:000311031600046
J	Myers, MG; Olson, DP				Myers, Martin G., Jr.; Olson, David P.			Central nervous system control of metabolism	NATURE			English	Review							REGULATES GLUCOSE-HOMEOSTASIS; CENTRAL MELANOCORTIN SYSTEM; ENERGY-BALANCE; LEPTIN ACTION; FOOD-INTAKE; INSULIN-RESISTANCE; VENTROMEDIAL HYPOTHALAMUS; POMC NEURONS; LOCOMOTOR-ACTIVITY; LIPID-METABOLISM	Although it is a widely held thought that direct hormone action on peripheral tissues is sufficient to mediate the control of nutrient handling, the role of the central nervous system in certain aspects of metabolism has long been recognized. Furthermore, recent findings have suggested a more general role for the central nervous system in metabolic control, and have revealed the importance of a number of cues and hypothalamic circuits. The brain's contributions to metabolic control are more readily revealed and play a crucial part in catabolic states or in hormone deficiencies that mimic starvation.	[Myers, Martin G., Jr.] Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA; [Myers, Martin G., Jr.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48105 USA; [Myers, Martin G., Jr.] Univ Michigan, Neurosci Program, Ann Arbor, MI 48105 USA; [Olson, David P.] Univ Michigan, Div Endocrinol, Dept Pediat, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Myers, MG (corresponding author), Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA.	mgmyers@umich.edu		Olson, David/0000-0001-9249-7760	Marilyn H. Vincent Foundation; National Institutes of Health; American Heart Association	Marilyn H. Vincent Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	The authors thank members of the Myers and Olson laboratories for discussions and scientific insight. M.G.M. is supported by the Marilyn H. Vincent Foundation and by grants from the National Institutes of Health and the American Heart Association.	Ahima RS, 2005, TRENDS ENDOCRIN MET, V16, P307, DOI 10.1016/j.tem.2005.07.010; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Barnes MB, 2011, AM J PHYSIOL-REG I, V301, pR1815, DOI 10.1152/ajpregu.00171.2011; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Begriche K, 2012, GENES BRAIN BEHAV, V11, P291, DOI 10.1111/j.1601-183X.2012.00766.x; Bergen HT, 1998, ENDOCRINOLOGY, V139, P4483, DOI 10.1210/en.139.11.4483; Berglund ED, 2012, J CLIN INVEST, V122, P1000, DOI 10.1172/JCI59816; Bingham NC, 2008, ENDOCRINOLOGY, V149, P2138, DOI 10.1210/en.2007-1200; Boghossian S, 2010, AM J PHYSIOL-REG I, V298, pR385, DOI 10.1152/ajpregu.00591.2009; Briggs DI, 2011, NEUROENDOCRINOLOGY, V93, P48, DOI 10.1159/000322589; Buettner C, 2006, CELL METAB, V4, P49, DOI 10.1016/j.cmet.2006.04.014; Burdakov D, 2005, J CELL MOL MED, V9, P795, DOI 10.1111/j.1582-4934.2005.tb00380.x; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; Butler AA, 2006, PEPTIDES, V27, P281, DOI 10.1016/j.peptides.2005.02.029; Chan O, 2007, DIABETES, V56, P1120, DOI 10.2337/db06-1102; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; Cherrington AD, 2005, J CLIN INVEST, V115, P1136, DOI 10.1172/JCI200525152; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; D'Alessio DA, 2005, J CLIN INVEST, V115, P3406, DOI 10.1172/JCI27207; de Backer MWA, 2011, INT J OBESITY, V35, P629, DOI 10.1038/ijo.2010.169; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Diano S, 2012, TRENDS MOL MED, V18, P52, DOI 10.1016/j.molmed.2011.08.003; Elias CF, 2000, J COMP NEUROL, V423, P261; Evans Mark L, 2002, Curr Diab Rep, V2, P101, DOI 10.1007/s11892-002-0065-7; German JP, 2010, DIABETES, V59, P1626, DOI 10.2337/db09-1918; Grill HJ, 2006, OBESITY, V14, P216, DOI 10.1038/oby.2006.312; Grill HJ, 1998, J NEUROSCI, V18, P10128; Gutierrez-Juarez R, 2004, J BIOL CHEM, V279, P49704, DOI 10.1074/jbc.M408665200; Haque MS, 1999, DIABETES, V48, P1706, DOI 10.2337/diabetes.48.9.1706; Heppner KM, 2011, CURR OPIN ENDOCRINOL, V18, P50, DOI 10.1097/MED.0b013e328341e1d3; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Hill JW, 2009, ENDOCRINOLOGY, V150, P4874, DOI 10.1210/en.2009-0454; Hribal ML, 2002, AM J PHYSIOL-ENDOC M, V282, pE977, DOI 10.1152/ajpendo.00561.2001; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jiang L, 2008, P NATL ACAD SCI USA, V105, P18619, DOI 10.1073/pnas.0804589105; Kang L, 2006, DIABETES, V55, P412, DOI 10.2337/diabetes.55.02.06.db05-1229; Kim KW, 2012, J CLIN INVEST, V122, P2578, DOI 10.1172/JCI62848; Kleinridders A, 2009, CURR OPIN PHARMACOL, V9, P794, DOI 10.1016/j.coph.2009.10.006; Klockener T, 2011, NAT NEUROSCI, V14, P911, DOI 10.1038/nn.2847; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Levin BE, 2007, CELL METAB, V6, P252, DOI 10.1016/j.cmet.2007.09.005; Levin BE, 2011, J CLIN INVEST, V121, P3392, DOI 10.1172/JCI59653; Levin BE, 2011, ENDOCRINOLOGY, V152, P2552, DOI 10.1210/en.2011-0194; Levin BE, 2004, DIABETES, V53, P2521, DOI 10.2337/diabetes.53.10.2521; Lin HV, 2010, DIABETES, V59, P337, DOI 10.2337/db09-1303; Liu LS, 1998, J BIOL CHEM, V273, P31160, DOI 10.1074/jbc.273.47.31160; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Morton GJ, 2003, ENDOCRINOLOGY, V144, P2016, DOI 10.1210/en.2002-0115; Myers MG, 2009, CELL METAB, V9, P117, DOI 10.1016/j.cmet.2008.12.001; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Patterson C. M., 2012, MOL METAB       0725; Perez-Tilve D, 2010, NAT NEUROSCI, V13, P877, DOI 10.1038/nn.2569; Pocai A, 2006, NAT MED, V12, P50, DOI 10.1038/nm0106-50; Pocai A, 2005, DIABETES, V54, P3182, DOI 10.2337/diabetes.54.11.3182; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Ritter S, 2011, ENDOCRINOLOGY, V152, P4019, DOI 10.1210/en.2010-1458; Robertson S, 2010, DIABETES, V59, P782, DOI 10.2337/db09-1556; Rossetti L, 1997, J BIOL CHEM, V272, P27758, DOI 10.1074/jbc.272.44.27758; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Sadagurski M, 2012, CELL METAB, V15, P703, DOI 10.1016/j.cmet.2012.04.011; Schwartz MW, 2006, OBESITY, V14, p1S, DOI 10.1038/oby.2006.275; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Shrestha YB, 2010, AM J PHYSIOL-REG I, V299, pR140, DOI 10.1152/ajpregu.00535.2009; STE ML, 2000, P NATL ACAD SCI USA, V97, P12339; Sutton GM, 2006, ENDOCRINOLOGY, V147, P2183, DOI 10.1210/en.2005-1209; Taborsky GJ, 2011, CELL METAB, V14, P5, DOI 10.1016/j.cmet.2011.06.004; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; VanPatten S, 2004, BIOCHEM J, V379, P229, DOI 10.1042/BJ20040134; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107; Wiesli P, 2005, DIABETES CARE, V28, P1910, DOI 10.2337/diacare.28.8.1910; Williams DL, 2000, ENDOCRINOLOGY, V141, P1332, DOI 10.1210/en.141.4.1332; Williams KW, 2011, EUR J PHARMACOL, V660, P2, DOI 10.1016/j.ejphar.2010.11.042; Xu Y, 2011, ANN NY ACAD SCI, V1243, P1, DOI 10.1111/j.1749-6632.2011.06248.x; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	83	229	233	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					357	363		10.1038/nature11705	http://dx.doi.org/10.1038/nature11705			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23151578				2022-12-28	WOS:000311031600032
J	Drakesmith, H; Prentice, AM				Drakesmith, Hal; Prentice, Andrew M.			Hepcidin and the Iron-Infection Axis	SCIENCE			English	Review							PATHOGEN INTERACTIONS; PEPTIDE HEPCIDIN; FERROPORTIN; GENE; MALARIA; ANEMIA; SUSCEPTIBILITY; SALMONELLA; OVERLOAD; HOST	Iron lies at the center of a battle for nutritional resource between higher organisms and their microbial pathogens. The iron status of the human host affects the pathogenicity of numerous infections including malaria, HIV-1, and tuberculosis. Hepcidin, an antimicrobial-like peptide hormone, has emerged as the master regulator of iron metabolism. Hepcidin controls the absorption of dietary iron and the distribution of iron among cell types in the body, and its synthesis is regulated by both iron and innate immunity. We describe how hepcidin integrates signals from diverse physiological inputs, forming a key molecular bridge between iron trafficking and response to infection.	[Drakesmith, Hal] Univ Oxford, John Radcliffe Hosp, Mol Immunol Grp, Oxford OX3 9DS, England; [Drakesmith, Hal] Univ Oxford, John Radcliffe Hosp, Med Res Council MRC, Human Immunol Unit,MRC Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Prentice, Andrew M.] Univ London London Sch Hyg & Trop Med, MRC Int Nutr Grp, London WC1E 7HT, England	University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Drakesmith, H (corresponding author), Univ Oxford, John Radcliffe Hosp, Mol Immunol Grp, Oxford OX3 9DS, England.	alexander.drakesmith@ndm.ox.ac.uk; andrew.prentice@lshtm.ac.uk	Girelli, Domenico/B-1183-2008; Prentice, Andrew/AAG-1961-2019	Girelli, Domenico/0000-0001-9684-1899; Drakesmith, Alexander/0000-0002-8503-6103	Medical Research Council UK [MC-A760-5QX00]; Beit Memorial Fellowship for Medical Research; Medical Research Council [G0700844, G0901149] Funding Source: researchfish; MRC [G0901149, G0700844] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Beit Memorial Fellowship for Medical Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by the Medical Research Council UK (MC-A760-5QX00) and the Beit Memorial Fellowship for Medical Research. We thank R. Moxon, L. Eddowes, and A. Armitage for critical reading of the manuscript.	Armitage AE, 2011, BLOOD, V118, P4129, DOI 10.1182/blood-2011-04-351957; Baker MA, 2012, J INFECT DIS, V205, P1043, DOI 10.1093/infdis/jis026; Bullen J J, 1978, Curr Top Microbiol Immunol, V80, P1; Carniel E, 1999, Int Microbiol, V2, P161; Chlosta S, 2006, INFECT IMMUN, V74, P3065, DOI 10.1128/IAI.74.5.3065-3067.2006; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; de Mast Q, 2009, J INFECT DIS, V199, P253, DOI 10.1086/595790; de Monye C, 1999, AIDS, V13, P375, DOI 10.1097/00002030-199902250-00010; Drakesmith H, 2005, BLOOD, V106, P1092, DOI 10.1182/blood-2005-02-0561; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Frank KM, 2011, NEW ENGL J MED, V364, P2563, DOI 10.1056/NEJMc1010939; Gangaidzo IT, 2001, J INFECT DIS, V184, P936, DOI 10.1086/323203; Gardenghi S, 2010, J CLIN INVEST, V120, P4466, DOI 10.1172/JCI41717; Girelli D, 2009, J HEPATOL, V51, P845, DOI 10.1016/j.jhep.2009.06.027; Gwamaka M, 2012, CLIN INFECT DIS, V54, P1137, DOI 10.1093/cid/cis010; Johnson EE, 2010, INFECT IMMUN, V78, P5099, DOI 10.1128/IAI.00498-10; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; McCance RA, 1937, LANCET, V2, P680; McDermid JM, 2006, CLIN SCI, V110, P503, DOI 10.1042/CS20050273; McDermid JM, 2009, AM J CLIN NUTR, V90, P225, DOI 10.3945/ajcn.2009.27709; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Motley ST, 2004, CELL MICROBIOL, V6, P849, DOI 10.1111/j.1462-5822.2004.00407.x; MURRAY MJ, 1978, BRIT MED J, V2, P1113, DOI 10.1136/bmj.2.6145.1113; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Peyssonnaux C, 2006, BLOOD, V107, P3727, DOI 10.1182/blood-2005-06-2259; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368; Prentice AM, 2012, BLOOD, V119, P1922, DOI 10.1182/blood-2011-11-391219; Preza GC, 2011, J CLIN INVEST, V121, P4880, DOI 10.1172/JCI57693; Rivera S, 2005, BLOOD, V106, P2196, DOI 10.1182/blood-2005-04-1766; Roux CM, 2010, INFECT IMMUN, V78, P1520, DOI 10.1128/IAI.00887-09; Ryan JD, 2012, HEPATOLOGY, V56, P492, DOI 10.1002/hep.25666; Sasu BJ, 2010, BLOOD, V115, P3616, DOI 10.1182/blood-2009-09-245977; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Schade AL, 1944, SCIENCE, V100, P14, DOI 10.1126/science.100.2584.14; Schaible UE, 2002, J EXP MED, V196, P1507, DOI 10.1084/jem.20020897; Shike H, 2002, EUR J BIOCHEM, V269, P2232, DOI 10.1046/j.1432-1033.2002.02881.x; Wang LJ, 2009, J CLIN INVEST, V119, P3322, DOI 10.1172/JCI39939; Xu M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-104; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	44	455	473	4	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2012	338	6108					768	772		10.1126/science.1224577	http://dx.doi.org/10.1126/science.1224577			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139325				2022-12-28	WOS:000310839500035
J	Kennett, DJ; Breitenbach, SFM; Aquino, VV; Asmerom, Y; Awe, J; Baldini, JUL; Bartlein, P; Culleton, BJ; Ebert, C; Jazwa, C; Macri, MJ; Marwan, N; Polyak, V; Prufer, KM; Ridley, HE; Sodemann, H; Winterhalder, B; Haug, GH				Kennett, Douglas J.; Breitenbach, Sebastian F. M.; Aquino, Valorie V.; Asmerom, Yemane; Awe, Jaime; Baldini, James U. L.; Bartlein, Patrick; Culleton, Brendan J.; Ebert, Claire; Jazwa, Christopher; Macri, Martha J.; Marwan, Norbert; Polyak, Victor; Prufer, Keith M.; Ridley, Harriet E.; Sodemann, Harald; Winterhalder, Bruce; Haug, Gerald H.			Development and Disintegration of Maya Political Systems in Response to Climate Change	SCIENCE			English	Article							YUCATAN PENINSULA; COLLAPSE; CIVILIZATION; VARIABILITY; ABANDONMENT; EVOLUTION; DROUGHTS; MEXICO	The role of climate change in the development and demise of Classic Maya civilization (300 to 1000 C.E.) remains controversial because of the absence of well-dated climate and archaeological sequences. We present a precisely dated subannual climate record for the past 2000 years from Yok Balum Cave, Belize. From comparison of this record with historical events compiled from well-dated stone monuments, we propose that anomalously high rainfall favored unprecedented population expansion and the proliferation of political centers between 440 and 660 C.E. This was followed by a drying trend between 660 and 1000 C.E. that triggered the balkanization of polities, increased warfare, and the asynchronous disintegration of polities, followed by population collapse in the context of an extended drought between 1020 and 1100 C.E.	[Kennett, Douglas J.; Culleton, Brendan J.; Ebert, Claire; Jazwa, Christopher] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Breitenbach, Sebastian F. M.; Haug, Gerald H.] ETH, Dept Earth Sci, CH-8092 Zurich, Switzerland; [Aquino, Valorie V.; Prufer, Keith M.] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Asmerom, Yemane; Polyak, Victor] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Awe, Jaime] Natl Inst Culture & Hist, Inst Archaeol, Belmopan, Belize; [Baldini, James U. L.; Ridley, Harriet E.] Univ Durham, Dept Earth Sci, Durham DH1 3LE, England; [Bartlein, Patrick] Univ Oregon, Dept Geog, Eugene, OR 97403 USA; [Macri, Martha J.] Univ Calif Davis, Dept Nat Amer Studies, Davis, CA 95616 USA; [Marwan, Norbert] Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany; [Sodemann, Harald] ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland; [Winterhalder, Bruce] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of New Mexico; University of New Mexico; Durham University; University of Oregon; University of California System; University of California Davis; Potsdam Institut fur Klimafolgenforschung; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Davis	Kennett, DJ (corresponding author), Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA.	djk23@psu.edu	Breitenbach, Sebastian/AAB-1420-2019; Bartlein, Patrick J./E-4643-2011; Breitenbach, Sebastian F.M./C-2529-2014; Kennett, Douglas J/I-7613-2015; Marwan, Norbert/D-9576-2011; Sodemann, Harald/ABG-5304-2021; Prufer, Keith/M-9877-2016	Bartlein, Patrick J./0000-0001-7657-5685; Kennett, Douglas J/0000-0001-5133-9010; Marwan, Norbert/0000-0003-1437-7039; Sodemann, Harald/0000-0002-8167-0860; Prufer, Keith/0000-0003-3173-1546; Ebert, Claire/0000-0002-8554-2727	NSF [HSD-0827305, BCS-0940744, EAR-0326902]; European Research Council [240167]; Swiss National Foundation [CRSI22-132646/1]; German Science Foundation [DFG FOR1380 "HIMPAC"]; Alphawood Foundation	NSF(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF)); German Science Foundation(German Research Foundation (DFG)); Alphawood Foundation	We thank D. Hodell, M. Brenner, J. Yaeger, J. Lohse, J. Kennett, D. Webster, and three anonymous reviewers for their useful comments. Thanks to H. Meyer (AWI Potsdam for isotope analysis of rain and drip water. This research was supported by NSF (HSD-0827305, BCS-0940744, and EAR-0326902), European Research Council (240167), Swiss National Foundation (CRSI22-132646/1), the German Science Foundation (DFG FOR1380 "HIMPAC"), and the Alphawood Foundation.	Aimers J, 2011, NATURE, V479, P44, DOI 10.1038/479044a; Beach T, 2009, QUATERNARY SCI REV, V28, P1710, DOI 10.1016/j.quascirev.2009.02.004; Culbert T.P., 1990, PRECOLUMBIAN POPULAT; Culleton BJ, 2012, J ARCHAEOL SCI, V39, P1572, DOI 10.1016/j.jas.2011.12.015; Curtis JH, 1996, QUATERNARY RES, V46, P37, DOI 10.1006/qres.1996.0042; Demarest Arthur A, 2004, ANCIENT MAYA RISE FA; Dunning NP, 2002, ANN ASSOC AM GEOGR, V92, P267, DOI 10.1111/1467-8306.00290; Estrada -Belli Francisco, 2011, 1 MAYA CIVILIZATION; Frappier AB, 2007, GEOLOGY, V35, P111, DOI 10.1130/G23145A.1; Garcia-Acosta V., 2003, DESASTRES AGRICOLAS, V1, P958; Haug GH, 2003, SCIENCE, V299, P1731, DOI 10.1126/science.1080444; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Hodell DA, 2005, QUATERNARY SCI REV, V24, P1413, DOI 10.1016/j.quascirev.2004.10.013; HODELL DA, 1995, NATURE, V375, P391, DOI 10.1038/375391a0; Lachniet MS, 2012, GEOLOGY, V40, P259, DOI 10.1130/G32471.1; Laporte Juan Pedro, 1995, ANCIENT MESOAM, V6, P41, DOI 10.1017/S0956536100002108; Luzzadder-Beach S, 2012, P NATL ACAD SCI USA, V109, P3646, DOI 10.1073/pnas.1114919109; Martin Simon, 2008, CHRONICLE MAYA KINGS, V2nd; Medina-Elizalde M, 2012, SCIENCE, V335, P956, DOI 10.1126/science.1216629; Mendoza B, 2007, CLIMATIC CHANGE, V83, P151, DOI [10.1007/s10584-006-9232-1, 10.1007/s 10584-006-9232-1]; Metcalfe SE, 2010, HOLOCENE, V20, P1195, DOI 10.1177/0959683610371994; Munson JL, 2009, J ANTHROPOL ARCHAEOL, V28, P424, DOI 10.1016/j.jaa.2009.08.002; Rice P.M., 2004, TERMINAL CLASSIC MAY, P125; Sabloff JA, 2007, P AM PHILOS SOC, V151, P11; Scarborough VL, 2012, P NATL ACAD SCI USA, V109, P12408, DOI 10.1073/pnas.1202881109; Schreiner Thomas, 2002, ANCIENT MESOAM, V13, P273, DOI DOI 10.1017/S0956536102132093; Stahle DW, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046472; Webster David, 2002, FALL ANCIENT MAYA SO; Webster JW, 2007, PALAEOGEOGR PALAEOCL, V250, P1, DOI 10.1016/j.palaeo.2007.02.022	29	342	351	12	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					788	791		10.1126/science.1226299	http://dx.doi.org/10.1126/science.1226299			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	033ZI	23139330	Green Published			2022-12-28	WOS:000310839500041
J	Manavella, PA; Hagmann, J; Ott, F; Laubinger, S; Franz, M; Macek, B; Weigel, D				Manavella, Pablo A.; Hagmann, Joerg; Ott, Felix; Laubinger, Sascha; Franz, Mirita; Macek, Boris; Weigel, Detlef			Fast-Forward Genetics Identifies Plant CPL Phosphatases as Regulators of miRNA Processing Factor HYL1	CELL			English	Article							RNA-POLYMERASE-II; SMALL INTERFERING RNA; CAP-BINDING COMPLEX; C-TERMINAL DOMAIN; ARABIDOPSIS-THALIANA; MICRORNA BIOGENESIS; ABSCISIC-ACID; POSTTRANSCRIPTIONAL REGULATION; PROTEIN-PHOSPHORYLATION; PRI-MIRNA	MicroRNAs (miRNAs) are processed from primary transcripts that contain partially self-complementary foldbacks. As in animals, the core microprocessor in plants is a Dicer protein, DICER-LIKE1 (DCL1). Processing accuracy and strand selection is greatly enhanced through the RNA binding protein HYPONASTIC LEAVES 1 (HYL1) and the zinc finger protein SERRATE (SE). We have combined a luciferase-based genetic screen with whole-genome sequencing for rapid identification of new regulators of miRNA biogenesis and action. Among the first six mutants analyzed were three alleles of C-TERMINAL DOMAIN PHOSPHATASE-LIKE 1 (CPL1)/FIERY2 (FRY2). In the miRNA processing complex, SE functions as a scaffold to mediate CPL1 interaction with HYL1, which needs to be dephosphorylated for optimal activity. In the absence of CPL1, HYL1 dephosphorylation and hence accurate processing and strand selection from miRNA duplexes are compromised. Our findings thus define a new regulatory step in plant miRNA biogenesis.	[Manavella, Pablo A.; Hagmann, Joerg; Ott, Felix; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Laubinger, Sascha] Univ Tubingen, Ctr Plant Mol Biol ZMBP, D-72076 Tubingen, Germany; [Franz, Mirita; Macek, Boris] Univ Tubingen, Interfac Inst Cell Biol, Proteome Ctr, D-72076 Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Weigel, D (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.	weigel@weigelworld.org	Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021; Macek, Boris/N-1442-2015; Weigel, Detlef/GSJ-0799-2022	Weigel, Detlef/0000-0002-2114-7963; Macek, Boris/0000-0002-1206-2458; Weigel, Detlef/0000-0002-2114-7963; Manavella, Pablo/0000-0003-3589-4414; Laubinger, Sascha/0000-0002-6682-0728	European Community IP SIROCCO [LSHG-CT-2006-037900]; Deutsche Forschungsgemeinschaft; Max Planck Society	European Community IP SIROCCO; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	We thank S. Grant and J. Dangl for cpl2 seeds, M. Christie, E. Izaurralde, I. Rubio-Somoza and R. Schwab for comments, C. Becker for help with RNA-seq analyses, and N. Camomilli for technical assistance. We are grateful to an anonymous reviewer for pointing out the miRNA* effects. Supported by a Human Frontier Science Program Long-Term Fellowship (P. A. M.), by European Community IP SIROCCO (contract LSHG-CT-2006-037900), a Gottfried Wilhelm Leibniz Award of the Deutsche Forschungsgemeinschaft and the Max Planck Society.	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Bezerra IC, 2004, PLANT J, V40, P112, DOI 10.1111/j.1365-313X.2004.02194.x; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Borchert N, 2010, GENOME RES, V20, P837, DOI 10.1101/gr.103119.109; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Brodersen P, 2012, P NATL ACAD SCI USA, V109, P1778, DOI 10.1073/pnas.1112500109; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; de Felippes FF, 2010, METHODS MOL BIOL, V592, P255, DOI 10.1007/978-1-60327-005-2_17; de Felippes FF, 2011, NUCLEIC ACIDS RES, V39, P2880, DOI 10.1093/nar/gkq1240; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Eamens AL, 2009, RNA, V15, P2219, DOI 10.1261/rna.1646909; Fujioka Y, 2007, PLANT CELL PHYSIOL, V48, P1243, DOI 10.1093/pcp/pcm099; Gregory BD, 2008, DEV CELL, V14, P854, DOI 10.1016/j.devcel.2008.04.005; Grigg SP, 2005, NATURE, V437, P1022, DOI 10.1038/nature04052; Gruber JJ, 2009, CELL, V138, P328, DOI 10.1016/j.cell.2009.04.046; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hugouvieux V, 2001, CELL, V106, P477, DOI 10.1016/S0092-8674(01)00460-3; Isono E, 2010, METHODS MOL BIOL, V655, P377, DOI 10.1007/978-1-60761-765-5_25; Jauvion V, 2010, PLANT CELL, V22, P2697, DOI 10.1105/tpc.110.076638; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kim S, 2008, PLANT CELL PHYSIOL, V49, P1634, DOI 10.1093/pcp/pcn146; Kinoshita E, 2004, DALTON T, P1189, DOI 10.1039/b400269e; Koch A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001588; Koiwa H, 2004, P NATL ACAD SCI USA, V101, P14539, DOI 10.1073/pnas.0403174101; Kurihara Y, 2006, RNA, V12, P206, DOI 10.1261/rna.2146906; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Laubinger S, 2008, P NATL ACAD SCI USA, V105, P8795, DOI 10.1073/pnas.0802493105; Laubinger S, 2010, P NATL ACAD SCI USA, V107, P17466, DOI 10.1073/pnas.1012891107; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lesicka-Gorecka J, 2008, ACTA BIOCHIM POL, V55, P517; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Liu CG, 2012, PLANT PHYSIOL, V159, P748, DOI 10.1104/pp.112.193508; Liu FQ, 2012, SCIENCE, V335, P1621, DOI 10.1126/science.1214402; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; Lu C, 2000, PLANT CELL, V12, P2351, DOI 10.1105/tpc.12.12.2351; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Matsuda O, 2009, PLANT J, V57, P96, DOI 10.1111/j.1365-313X.2008.03663.x; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Nogueira FTS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000320; Olsen Jesper V., 2009, V492, P131, DOI 10.1007/978-1-59745-493-3_7; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Sabin LR, 2009, CELL, V138, P340, DOI 10.1016/j.cell.2009.04.045; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Shen JQ, 2010, MOL GENET GENOMICS, V284, P477, DOI 10.1007/s00438-010-0581-0; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Song L, 2007, P NATL ACAD SCI USA, V104, P5437, DOI 10.1073/pnas.0701061104; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Tagami Y, 2009, RNA, V15, P450, DOI 10.1261/rna.1297109; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Ueda A, 2008, PLANT MOL BIOL, V67, P683, DOI 10.1007/s11103-008-9348-y; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang W, 2011, PLANT CELL, V23, P3565, DOI 10.1105/tpc.111.091058; Wu FJ, 2007, PLANT CELL, V19, P914, DOI 10.1105/tpc.106.048637; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x; Yang SW, 2010, STRUCTURE, V18, P594, DOI 10.1016/j.str.2010.02.006; Zhang JF, 2008, PLANT CELL ENVIRON, V31, P562, DOI 10.1111/j.1365-3040.2008.01786.x	70	153	159	2	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					859	870		10.1016/j.cell.2012.09.039	http://dx.doi.org/10.1016/j.cell.2012.09.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141542	Bronze			2022-12-28	WOS:000310921200016
J	Weinstock, JV				Weinstock, Joel V.			The worm returns	NATURE			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE; TRICHURIS-SUIS THERAPY; CROHNS-DISEASE; COLITIS		[Weinstock, Joel V.] Tufts Univ, Boston, MA 02111 USA; [Weinstock, Joel V.] Tufts Med Ctr, Div Gastroenterol & Hepatol, Boston, MA 02111 USA	Tufts University; Tufts Medical Center	Weinstock, JV (corresponding author), Tufts Univ, Boston, MA 02111 USA.	jweinstock2@tuftsmedicalcenter.org			NIDDK NIH HHS [R01 DK091987] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091987] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEER RJS, 1976, RES VET SCI, V20, P47, DOI 10.1016/S0034-5288(18)33478-7; Blum AM, 2012, J IMMUNOL, V189, P2512, DOI 10.4049/jimmunol.1102892; Elliott DE, 2003, AM J PHYSIOL-GASTR L, V284, pG385, DOI 10.1152/ajpgi.00049.2002; Elliott DE, 2000, FASEB J, V14, P1848, DOI 10.1096/fj.99-0885hyp; Shivananda S, 1996, GUT, V39, P690, DOI 10.1136/gut.39.5.690; SONNENBERG A, 1991, GASTROENTEROLOGY, V100, P143, DOI 10.1016/0016-5085(91)90594-B; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Weinstock JV, 2004, GUT, V53, P7, DOI 10.1136/gut.53.1.7; World Health Organization, 2007, ACT WORMS	10	60	69	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					183	185		10.1038/491183a	http://dx.doi.org/10.1038/491183a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23135449	Green Accepted, Bronze			2022-12-28	WOS:000310774300014
J	Kleinman, A				Kleinman, Arthur			The art of medicine Caregiving as moral experience	LANCET			English	Editorial Material									Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Kleinman, A (corresponding author), Harvard Univ, William James Hall,Room 330, Cambridge, MA 02138 USA.	kleinman@wjh.harvard.edu							0	99	101	4	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 3	2012	380	9853					1550	1551		10.1016/S0140-6736(12)61870-4	http://dx.doi.org/10.1016/S0140-6736(12)61870-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	030VR	23130363	Green Submitted			2022-12-28	WOS:000310598700017
J	Norris, DJ; Aydil, ES				Norris, David J.; Aydil, Eray S.			Getting Moore from Solar Cells	SCIENCE			English	Editorial Material							EFFICIENCY		[Norris, David J.] ETH, Opt Mat Engn Lab, CH-8092 Zurich, Switzerland; [Aydil, Eray S.] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Minnesota System; University of Minnesota Twin Cities	Norris, DJ (corresponding author), ETH, Opt Mat Engn Lab, CH-8092 Zurich, Switzerland.	dnorris@ethz.ch; aydil@umn.edu	Norris, David J/F-4022-2010; Aydil, Eray/M-5503-2019	Norris, David J/0000-0002-3765-0678; Aydil, Eray/0000-0002-8377-9480				Bach U, 1998, NATURE, V395, P583, DOI 10.1038/26936; Baxter JB, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1861510; CHAPIN DM, 1954, J APPL PHYS, V25, P676, DOI 10.1063/1.1721711; Earth Policy Institute, 2011, WORLD SOLAR PHOTOVOL; Graetzel M, 2012, NATURE, V488, P304, DOI 10.1038/nature11476; International Energy Agency, 2012, ELECTRICITY INFORMAT; Law M, 2005, NAT MATER, V4, P455, DOI 10.1038/nmat1387; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Leschkies KS, 2007, NANO LETT, V7, P1793, DOI 10.1021/nl070430o; Mitzi DB, 1999, PROG INORG CHEM, V48, P1, DOI 10.1002/9780470166499.ch1; Nozik AJ, 2002, PHYSICA E, V14, P115, DOI 10.1016/S1386-9477(02)00374-0; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Wolden CA, 2011, J VAC SCI TECHNOL A, V29, DOI 10.1116/1.3569757; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688	14	25	25	0	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					625	626		10.1126/science.1230283	http://dx.doi.org/10.1126/science.1230283			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118180				2022-12-28	WOS:000310516000041
J	Jonsson, T; Stefansson, H; Steinberg, S; Jonsdottir, I; Jonsson, PV; Snaedal, J; Bjornsson, S; Huttenlocher, J; Levey, AI; Lah, JJ; Rujescu, D; Hampel, H; Giegling, I; Andreassen, OA; Engedal, K; Ulstein, I; Djurovic, S; Ibrahim-Verbaas, C; Hofman, A; Ikram, MA; van Duijn, CM; Thorsteinsdottir, U; Kong, A; Stefansson, K				Jonsson, Thorlakur; Stefansson, Hreinn; Steinberg, Stacy; Jonsdottir, Ingileif; Jonsson, Palmi V.; Snaedal, Jon; Bjornsson, Sigurbjorn; Huttenlocher, Johanna; Levey, Allan I.; Lah, James J.; Rujescu, Dan; Hampel, Harald; Giegling, Ina; Andreassen, Ole A.; Engedal, Knut; Ulstein, Ingun; Djurovic, Srdjan; Ibrahim-Verbaas, Carla; Hofman, Albert; Ikram, M. Arfan; van Duijn, Cornelia M.; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari			Variant of TREM2 Associated with the Risk of Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; APOLIPOPROTEIN-E; CUTTING EDGE; MUTATIONS; RESPONSES; INFLAMMATION; EXPRESSION; FREQUENCY; DEMENTIA; SYSTEM	BACKGROUND Sequence variants, including the epsilon 4 allele of apolipoprotein E, have been associated with the risk of the common late-onset form of Alzheimer's disease. Few rare variants affecting the risk of late-onset Alzheimer's disease have been found. METHODS We obtained the genome sequences of 2261 Icelanders and identified sequence variants that were likely to affect protein function. We imputed these variants into the genomes of patients with Alzheimer's disease and control participants and then tested for an association with Alzheimer's disease. We performed replication tests using case-control series from the United States, Norway, the Netherlands, and Germany. We also tested for a genetic association with cognitive function in a population of unaffected elderly persons. RESULTS A rare missense mutation (rs75932628-T) in the gene encoding the triggering receptor expressed on myeloid cells 2 (TREM2), which was predicted to result in an R47H substitution, was found to confer a significant risk of Alzheimer's disease in Iceland (odds ratio, 2.92; 95% confidence interval [CI], 2.09 to 4.09; P=3.42x10(-10)). The mutation had a frequency of 0.46% in controls 85 years of age or older. We observed the association in additional sample sets (odds ratio, 2.90; 95% CI, 2.16 to 3.91; P=2.1x10(-12) in combined discovery and replication samples). We also found that carriers of rs75932628-T between the ages of 80 and 100 years without Alzheimer's disease had poorer cognitive function than noncarriers (P=0.003). CONCLUSIONS Our findings strongly implicate variant TREM2 in the pathogenesis of Alzheimer's disease. Given the reported antiinflammatory role of TREM2 in the brain, the R47H substitution may lead to an increased predisposition to Alzheimer's disease through impaired containment of inflammatory processes. (Funded by the National Institute on Aging and others.)	[Jonsson, Thorlakur; Stefansson, Hreinn; Steinberg, Stacy; Jonsdottir, Ingileif; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari] DeCODE Genet, IS-101 Reykjavik, Iceland; [Jonsdottir, Ingileif; Jonsson, Palmi V.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Jonsson, Palmi V.; Snaedal, Jon; Bjornsson, Sigurbjorn] Landspitali Univ Hosp, Reykjavik, Iceland; [Huttenlocher, Johanna] Inst Human Genet, Dept Med Genet, Tubingen, Germany; Univ Munich, Dept Psychiat, Div Mol & Clin Neurobiol, D-80539 Munich, Germany; [Rujescu, Dan; Giegling, Ina] Univ Halle Wittenberg, D-06108 Halle, Germany; [Hampel, Harald] Univ Frankfurt Main, Dept Psychiat, Frankfurt, Germany; [Levey, Allan I.; Lah, James J.] Emory Univ, Sch Med, Dept Neurol, Alzheimers Dis Ctr, Atlanta, GA 30322 USA; [Andreassen, Ole A.; Djurovic, Srdjan] Univ Oslo, Oslo Univ Hosp, KG Jebsen Ctr Psychosis Res, Div Mental Hlth & Addict, Oslo, Norway; [Engedal, Knut; Ulstein, Ingun] Univ Oslo, Oslo Univ Hosp, Norwegian Ctr Aging & Hlth, Dept Geriatr, Oslo, Norway; [Andreassen, Ole A.; Engedal, Knut; Djurovic, Srdjan] Univ Oslo, Inst Clin Med, Oslo, Norway; [Ibrahim-Verbaas, Carla; Hofman, Albert; Ikram, M. Arfan; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands	University of Iceland; Landspitali National University Hospital; Eberhard Karls University of Tubingen; University of Munich; Martin Luther University Halle Wittenberg; Goethe University Frankfurt; Emory University; University of Oslo; University of Oslo; University of Oslo; Erasmus University Rotterdam; Erasmus MC	Stefansson, K (corresponding author), DeCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	kstefans@decode.is	Andreassen, Ole A./AAY-7531-2020; Alexandrov, Boian/D-8815-2016; Rujescu, Dan/GRS-3875-2022; Stefansson, Kari/AAE-7187-2019; Levey, Allan/F-2104-2011; Giegling, Ina/ABA-3677-2021; Ikram, M. Arfan/AAM-5225-2021; Babu, Sudarsanam/D-1694-2010	Levey, Allan/0000-0002-3153-502X; Stefansson, Hreinn/0000-0002-9331-6666; Ikram, Mohammad Arfan/0000-0003-0372-8585; Andreassen, Ole A./0000-0002-4461-3568; Hampel, Harald/0000-0003-0894-8982; Babu, Sudarsanam/0000-0002-3531-2579; Van Duijn, Cornelia/0000-0002-2374-9204; Kong, Augustine/0000-0001-8193-5438; Ibrahim-verbaas, Carla/0000-0002-4325-0857; Djurovic, Srdjan/0000-0002-8140-8061	National Institute on Aging [P50-AG025688, U01AG006781]; Research Council of Norway; South-Eastern Norway Health Authority; National Institutes of Health [U01HG004438]; National Human Genome Research Institute [U01HG004610]; eMERGE Administrative Coordinating Center [U01HG004603]; National Center for Biotechnology Information; Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for Health Research and Development; Research Institute for Diseases in the Elderly; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission; Municipality of Rotterdam; Research Institute for Diseases in the Elderly [014-93-015]; Stichting Alzheimer Onder-zoek; Hersenstichting Nederland; Netherlands Genomics Initiative-Netherlands Organization for Scientific Research (Center for Medical Systems Biology and the Netherlands Consortium for Healthy Aging); Seventh Framework Program; ENGAGE project [HEALTH-F4-2007-201413]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004610, U01HG006375, U01HG004438, U01HG004603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG006781, U24AG021886, P50AG025688] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Research Council of Norway(Research Council of Norway); South-Eastern Norway Health Authority; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); eMERGE Administrative Coordinating Center; National Center for Biotechnology Information; Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Research Institute for Diseases in the Elderly; Stichting Alzheimer Onder-zoek; Hersenstichting Nederland; Netherlands Genomics Initiative-Netherlands Organization for Scientific Research (Center for Medical Systems Biology and the Netherlands Consortium for Healthy Aging); Seventh Framework Program(European Commission); ENGAGE project(General Electric); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the National Institute on Aging (P50-AG025688, to Dr. Levey, for samples from the Alzheimer's Disease Center at Emory University; U01AG006781 for the Alzheimer's Disease Patient Registry and Adult Changes in Thought study; and the Division of Neuroscience for the NIA-LOAD study); a grant from the Research Council of Norway and South-Eastern Norway Health Authority for samples from Norway; a gift from 3M to expand the Adult Changes in Thought cohort; a grant from the National Institutes of Health (U01HG004438) for genotyping at Johns Hopkins University; cooperative agreements with the National Human Genome Research Institute (U01HG004610 for genomewide association analyses); by the eMERGE Administrative Coordinating Center (U01HG004603) for assistance with phenotype harmonization and genotype data cleaning; and by the National Center for Biotechnology Information. The Rotterdam Study was funded by Erasmus Medical Center and Erasmus University, Rotterdam; the Netherlands Organization for Health Research and Development; the Research Institute for Diseases in the Elderly; the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the European Commission; and the Municipality of Rotterdam; by a grant (014-93-015; RIDE2) from the Research Institute for Diseases in the Elderly, Stichting Alzheimer Onder-zoek, Hersenstichting Nederland, the Netherlands Genomics Initiative-Netherlands Organization for Scientific Research (Center for Medical Systems Biology and the Netherlands Consortium for Healthy Aging), the Seventh Framework Program (FP7/2007-2013), and the ENGAGE project (grant agreement HEALTH-F4-2007-201413).	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Blalock EM, 2005, AGEING RES REV, V4, P481, DOI 10.1016/j.arr.2005.06.006; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Brakhus Anne, 2011, Tidsskr Nor Laegeforen, V131, P2254, DOI 10.4045/tidsskr.11.0786; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Castellani RJ, 2010, DM-DIS MON, V56, P484, DOI 10.1016/j.disamonth.2010.06.001; Chouery E, 2008, HUM MUTAT, V29, pE194, DOI 10.1002/humu.20836; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; EIKELENBOOM P, 1982, ACTA NEUROPATHOL, V57, P239, DOI 10.1007/BF00685397; Eikelenboom P, 2010, NEURODEGENER DIS, V7, P38, DOI 10.1159/000283480; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Guerreiro RJ, 2012, ARCH NEUROL; Hakola H P, 1972, Acta Psychiatr Scand Suppl, V232, P1; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; ISHII T, 1984, ACTA NEUROPATHOL, V63, P296, DOI 10.1007/BF00687336; Ito H, 2012, EUR J IMMUNOL, V42, P176, DOI 10.1002/eji.201141679; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Madry H, 2007, CLIN ORTHOP RELAT R, P262, DOI 10.1097/01.blo.0000229364.57985.df; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Melchior B, 2010, ASN NEURO, V2, P157, DOI 10.1042/AN20100010; Montalbetti L, 2005, FUNCT NEUROL, V20, P71; MORRIS JN, 1990, GERONTOLOGIST, V30, P293, DOI 10.1093/geront/30.3.293; Morris JN, 1997, J AM GERIATR SOC, V45, P1017, DOI 10.1111/j.1532-5415.1997.tb02975.x; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; NASU T, 1973, ACTA PATHOL JAPON, V23, P539; Paloneva, 2003, AM J HUM GENET, V72, P225; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4; ROZEMULLER JM, 1986, VIRCHOWS ARCH B, V51, P247, DOI 10.1007/BF02899034; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Sessa G, 2004, EUR J NEUROSCI, V20, P2617, DOI 10.1111/j.1460-9568.2004.03729.x; Stacey SN, 2011, NAT GENET, V43, P1098, DOI 10.1038/ng.926; Stefano L, 2009, J NEUROCHEM, V110, P284, DOI 10.1111/j.1471-4159.2009.06130.x; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sulem P, 2011, NAT GENET, V43, P1127, DOI 10.1038/ng.972; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Wunderlich P, 2010, GAMMA SECRETASE MEDI	51	1539	1574	6	205	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2013	368	2					107	116		10.1056/NEJMoa1211103	http://dx.doi.org/10.1056/NEJMoa1211103			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066RO	23150908	Green Accepted			2022-12-28	WOS:000313238100001
J	Sullivan, D; Olsson, AG; Scott, R; Kim, JB; Xue, A; Gebski, V; Wasserman, SM; Stein, EA				Sullivan, David; Olsson, Anders G.; Scott, Rob; Kim, Jae B.; Xue, Allen; Gebski, Val; Wasserman, Scott M.; Stein, Evan A.			Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients The GAUSS Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY HYPERCHOLESTEROLEMIA; HIGH-RISK; EFFICACY; SAFETY; EZETIMIBE; LDL; THERAPY	Context An estimated 10% to 20% of patients cannot tolerate statins or adequate doses to achieve treatment goals. Plasma proprotein convertase subtilisin/kexin type 9 (PCSK9) binds to low-density lipoprotein (LDL) receptors, promoting their degradation and increasing LDL cholesterol levels. In phase 1 studies, a human monoclonal antibody to PCSK9, AMG145, was well tolerated and reduced LDL cholesterol levels. Objective To assess the efficacy and tolerability of AMG145 in patients with statin intolerance due to muscle-related side effects. Design, Setting, and Patients A 12-week, randomized, double-blind, placebo- and ezetimibe-controlled, dose-ranging study conducted between July 2011 and May 2012 in statin-intolerant adult patients at 33 international sites. Intervention Patients were randomized equally to 1 of 5 groups: AMG145 alone at doses of 280 mg, 350 mg, or 420 mg; AMG145 at 420 mg plus 10 mg of ezetimibe; or 10 mg of ezetimibe plus placebo. AMG145 or placebo was administered subcutaneously every 4 weeks. Main Outcome Measures The primary end point was percentage change from baseline to week 12 in ultracentrifugation-measured LDL cholesterol. Other end points included measures of safety and tolerability of different doses of AMG145 and AMG145 plus ezetimibe. Results Of 236 patients screened, 160 were randomized (mean age, 62 years; 64% female; mean baseline LDL cholesterol, 193 mg/dL); all patients had intolerance to 1 or more statins because of muscle-related events. At week 12, mean changes in LDL cholesterol levels were -67 mg/dL (-41%; 95% CI, -49% to -33%) for the AMG145, 280-mg, group; -70 mg/dL (-43%; 95% CI, -51% to -35%) for the 350-mg group; -91 mg/dL (-51%; 95% CI, -59% to -43%) for the 420-mg group; and -110 mg/dL (-63%; 95% CI, -71% to -55%) for the 420-mg/ezetimibe group compared with -14 mg/dL (-15%; 95% CI, -23% to -7.0%) for the placebo/ezetimibe group (P<.001). Four serious adverse events were reported with AMG145 (coronary artery disease, acute pancreatitis, hip fracture, syncope). Myalgia was the most common treatment-emergent adverse event during the study, occurring in 5 patients (15.6%) in the 280-mg group (n=32); 1 patient (3.2%) in the 350-mg group (n=31), 1 patient (3.1%) in the 420-mg group (n=32), 6 patients (20.0%) receiving 420-mg AMG145/ezetimibe, and 1 patient (3.1%) receiving placebo/ezetimibe. Conclusion In this phase 2 study in statin-intolerant patients, subcutaneous administration of a monoclonal antibody to PCSK9 significantly reduced LDL cholesterol levels and was associated with short-term tolerability.	[Stein, Evan A.] Metab & Atherosclerosis Res Ctr, Cincinnati, OH 45227 USA; [Sullivan, David] Royal Prince Alfred Hosp, Dept Clin Biochem, Camperdown, NSW 2050, Australia; [Olsson, Anders G.] Linkoping Univ, Fac Hlth Sci, Stockholm, Sweden; [Olsson, Anders G.] Stockholm Heart Ctr, Stockholm, Sweden; [Scott, Rob; Kim, Jae B.; Xue, Allen; Wasserman, Scott M.] Amgen Inc, Thousand Oaks, CA USA; [Gebski, Val] Univ Sydney, Natl Hlth & Med Res Council Clin Trials Ctr, Sydney, NSW 2006, Australia	University of Sydney; Linkoping University; Amgen; University of Sydney	Stein, EA (corresponding author), Metab & Atherosclerosis Res Ctr, 4685 Forest Ave, Cincinnati, OH 45227 USA.	esteinmrl@aol.com		Gebski, Val/0000-0001-8748-1844; Scott, Robert/0000-0001-8266-1061	Amgen; Abbott Products; AstraZeneca; Merck Sharp and Dohme; sanofi-aventis; Pfizer Australia; Roche; Karobio; Pfizer; Merck; Adnexus Therapeutics; sanofi; Regeneron	Amgen(Amgen); Abbott Products; AstraZeneca(AstraZeneca); Merck Sharp and Dohme(Merck & Company); sanofi-aventis(Sanofi-Aventis); Pfizer Australia(PfizerPfizer Australia); Roche(Roche Holding); Karobio; Pfizer(Pfizer); Merck(Merck & Company); Adnexus Therapeutics; sanofi; Regeneron(Regeneron)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Sullivan reported having received research funding from Amgen, Abbott Products, AstraZeneca, Merck Sharp and Dohme, and sanofi-aventis and also having received funding for educational programs from Abbott Products, AstraZeneca, Merck Sharp and Dohme, Pfizer Australia, and Roche and travel support from Merck Sharp and Dohme. Dr Sullivan reported having served on advisory boards for Abbott Products, Merck Sharp and Dohme, and Pfizer Australia. Dr Olsson reported having received research support from Amgen, AstraZeneca, Karobio, Merck Sharp and Dohme, Pfizer, Roche, and sanofi-aventis and consultation fees from AstraZeneca, Karobio, Merck, Pfizer, and Roche. Mr Gebski is employed by the NHMRC Clinical Trials Centre, University of Sydney, which received compensation from Amgen for statistical analysis. Dr Stein reported having received consulting fees from Amgen, Adnexus Therapeutics, and sanofi related to PCSK9 inhibitors, and his institution has received research funding related to PCSK9 clinical trials from Amgen, sanofi, and Regeneron. Drs Scott, Kim, Xue, and Wasserman are employees of Amgen and have received Amgen stock/stock options.	Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Ballantyne CM, 2007, AM J CARDIOL, V99, P673, DOI 10.1016/j.amjcard.2006.10.022; Benjannet S, 2010, J BIOL CHEM, V285, P40965, DOI 10.1074/jbc.M110.154815; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Dias CS, 2012, J AM COLL CARDIOL, V60, P1888, DOI 10.1016/j.jacc.2012.08.986; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Knopp RH, 2003, INT J CLIN PRACT, V57, P363; McKenney JM, 2012, J AM COLL CARDIOL, V59, P2344, DOI 10.1016/j.jacc.2012.03.007; McPherson R, 2006, CAN J CARDIOL, V22, P913, DOI 10.1016/S0828-282X(06)70310-5; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Scharnagl H, 2001, CLIN CHEM LAB MED, V39, P426, DOI 10.1515/CCLM.2001.068; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Topol EJ, 2012, NY TIMES; Turner T, VALIDITY CALCULATED; Visser ME, 2012, EUR HEART J, V33, P1142, DOI 10.1093/eurheartj/ehs023	19	354	407	0	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2012	308	23					2497	2506		10.1001/jama.2012.25790	http://dx.doi.org/10.1001/jama.2012.25790			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055TU	23128163	Bronze			2022-12-28	WOS:000312441400026
J	Sur, IK; Hallikas, O; Vaharautio, A; Yan, J; Turunen, M; Enge, M; Taipale, M; Karhu, A; Aaltonen, LA; Taipale, J				Sur, Inderpreet Kaur; Hallikas, Outi; Vaharautio, Anna; Yan, Jian; Turunen, Mikko; Enge, Martin; Taipale, Minna; Karhu, Auli; Aaltonen, Lauri A.; Taipale, Jussi			Mice Lacking a Myc Enhancer That Includes Human SNP rs6983267 Are Resistant to Intestinal Tumors	SCIENCE			English	Article							LONG-RANGE INTERACTION; C-MYC; PROSTATE-CANCER; 8Q24 PROSTATE; BETA-CATENIN; COLON-CANCER; VARIANT; TARGET; SUSCEPTIBILITY; INHIBITION	Multiple cancer-associated single-nucleotide polymorphisms (SNPs) have been mapped to conserved sequences within a 500-kilobase region upstream of the MYC oncogene on human chromosome 8q24. These SNPs may affect cancer development through altered regulation of MYC expression, but this hypothesis has been difficult to confirm. We generated mice deficient in Myc-335, a putative MYC regulatory element that contains rs6983267, a SNP accounting for more human cancer-related morbidity than any other genetic variant or mutation. In Myc-335 null mice, Myc transcripts were expressed in the intestinal crypts in a pattern similar to that in wild-type mice but at modestly reduced levels. The mutant mice displayed no overt phenotype but were markedly resistant to intestinal tumorigenesis induced by the APCmin mutation. These results establish that a cancer-associated SNP identified in human genome-wide association studies has a functional effect in vivo.	[Sur, Inderpreet Kaur; Vaharautio, Anna; Yan, Jian; Enge, Martin; Taipale, Minna; Taipale, Jussi] Karolinska Inst, Sci Life Ctr, Dept Biosci & Nutr, Stockholm, Sweden; [Sur, Inderpreet Kaur] Karolinska Univ Hosp, Clin Res Ctr, Stockholm, Sweden; [Hallikas, Outi; Vaharautio, Anna; Turunen, Mikko; Taipale, Minna; Taipale, Jussi] Univ Helsinki, Biomedicum, Inst Biomed, Genome Scale Biol Program, FI-00014 Helsinki, Finland; [Karhu, Auli; Aaltonen, Lauri A.] Univ Helsinki, Biomedicum, Dept Med Genet, Genome Scale Biol Program, FI-00014 Helsinki, Finland	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Helsinki; University of Helsinki	Taipale, J (corresponding author), Karolinska Inst, Sci Life Ctr, Dept Biosci & Nutr, Stockholm, Sweden.	jussi.taipale@ki.se	Aaltonen, Lauri/A-5375-2010; Yan, Jian/B-2631-2018; Vähärautio, Anna/K-4279-2015; Enge, Martin/GYQ-5073-2022	Aaltonen, Lauri/0000-0001-6839-4286; Yan, Jian/0000-0002-1267-2870; Vähärautio, Anna/0000-0003-4721-3954; Karhu, Auli/0000-0002-7927-0796; Turunen, Mikko/0000-0001-5134-1559; Enge, Martin/0000-0001-8748-8931; Sur, Inderpreet Kaur/0000-0001-5787-1040; Taipale, Minna/0000-0002-1905-2551	Academy of Finland [140753]; Finnish Center of Excellence in Cancer Genetics Research [250345]; European Union Framework Program 7 project SYSCOL; European Research Council project GROWTHCONTROL; Sigrid Juselius Foundation; Finnish Cancer Society; Swedish Cancer Society; Center for Biosciences at Karolinska Institutet; Vetenskapsradet;  [134073]	Academy of Finland(Academy of Finland); Finnish Center of Excellence in Cancer Genetics Research; European Union Framework Program 7 project SYSCOL; European Research Council project GROWTHCONTROL; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Society; Swedish Cancer Society(Swedish Cancer Society); Center for Biosciences at Karolinska Institutet(Karolinska Institutet); Vetenskapsradet(Swedish Research Council); 	We thank S. Miettinen and A. Zetterlund for technical assistance. This work was supported by the Academy of Finland grant 140753, postdoctoral researcher's project 134073, Finnish Center of Excellence in Cancer Genetics Research 250345, European Union Framework Program 7 project SYSCOL, European Research Council project GROWTHCONTROL, the Sigrid Juselius Foundation, the Finnish Cancer Society, the Swedish Cancer Society, the Center for Biosciences at Karolinska Institutet, and Vetenskapsradet.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Athineos D, 2010, ONCOGENE, V29, P2585, DOI 10.1038/onc.2010.5; Bettess MD, 2005, MOL CELL BIOL, V25, P7868, DOI 10.1128/MCB.25.17.7868-7878.2005; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cohen J Craig, 2004, BMC Dev Biol, V4, P4; Dubois NC, 2008, DEVELOPMENT, V135, P2455, DOI 10.1242/dev.022707; Evan G, 2012, SCIENCE, V335, P293, DOI 10.1126/science.1217819; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ignatenko NA, 2006, CANCER BIOL THER, V5, P1658, DOI 10.4161/cbt.5.12.3376; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Pomerantz MM, 2009, CANCER RES, V69, P5568, DOI 10.1158/0008-5472.CAN-09-0387; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schumacher FR, 2007, CANCER RES, V67, P2951, DOI 10.1158/0008-5472.CAN-06-3591; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Yekkala K, 2007, MOL CANCER RES, V5, P1296, DOI 10.1158/1541-7786.MCR-07-0232; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	28	163	166	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1360	1363		10.1126/science.1228606	http://dx.doi.org/10.1126/science.1228606			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23118011				2022-12-28	WOS:000311991200072
J	Outterson, K				Outterson, Kevin			Regulating Compounding Pharmacies after NECC	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LOW-BACK-PAIN		Boston Univ, Sch Law, Boston, MA 02215 USA	Boston University	Outterson, K (corresponding author), Boston Univ, Sch Law, Boston, MA 02215 USA.			Outterson, Kevin/0000-0003-2513-3216				Boodoo JM, 2010, AM J LAW MED, V36, P220; CARETTE S, 1991, NEW ENGL J MED, V325, P1002, DOI 10.1056/NEJM199110033251405; Massachusetts Board of Registration in Pharmacy, 2012, NEW ENGL COMP CTR NE; Outterson Kevin, 2011, N Engl J Med, V365, pe13, DOI 10.1056/NEJMp1107614; Staal JB, 2009, SPINE, V34, P49, DOI 10.1097/BRS.0b013e3181909558	5	40	40	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2012	367	21					1969	1972		10.1056/NEJMp1212667	http://dx.doi.org/10.1056/NEJMp1212667			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040RI	23134357	Green Published			2022-12-28	WOS:000311340200001
J	Levy, BR; Slade, MD; Murphy, TE; Gill, TM				Levy, Becca R.; Slade, Martin D.; Murphy, Terrence E.; Gill, Thomas M.			Association Between Positive Age Stereotypes and Recovery From Disability in Older Persons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Levy, Becca R.] Yale Univ, Div Social & Behav Sci, Sch Publ Hlth, New Haven, CT 06520 USA; [Slade, Martin D.; Murphy, Terrence E.; Gill, Thomas M.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Yale University; Yale University	Levy, BR (corresponding author), Yale Univ, Div Social & Behav Sci, Sch Publ Hlth, New Haven, CT 06520 USA.	becca.levy@yale.edu	Gill, Thomas M./H-7043-2019	Gill, Thomas M./0000-0002-6450-0368	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG021507, R01AG032284, R37AG017560, P30AG021342] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL089314, R01HL089314] Funding Source: Medline; NIA NIH HHS [P30 AG021342, R01 AG032284, R01AG023993, P30AG21342, R43 AG023993, R37 AG017560, R01AG032284, K24 AG021507, K24AG021507, R37AG17560] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Gill TM, 2010, JAMA-J AM MED ASSOC, V304, P1919, DOI 10.1001/jama.2010.1568; Hardy SE, 2004, JAMA-J AM MED ASSOC, V291, P1596, DOI 10.1001/jama.291.13.1596; LEVY B, 1994, J PERS SOC PSYCHOL, V66, P989, DOI 10.1037/0022-3514.66.6.989; Levy B, 2009, CURR DIR PSYCHOL SCI, V18, P332, DOI 10.1111/j.1467-8721.2009.01662.x; Levy BR, 2009, PSYCHOL AGING, V24, P230, DOI 10.1037/a0014563; Levy BR, 2000, J GERONTOL B-PSYCHOL, V55, pP205, DOI 10.1093/geronb/55.4.P205	6	105	108	4	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2012	308	19					1972	1973		10.1001/jama.2012.14541	http://dx.doi.org/10.1001/jama.2012.14541			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040AQ	23168819	Green Accepted			2022-12-28	WOS:000311291400015
J	Jack, A				Jack, Andrew			Faking it	BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	andrew.jack@ft.com		Jack, Andrew/0000-0001-9679-2898				[Anonymous], IPHARMACIST ME; Bate R, 2012, RES REP TROP MED, V3, P57, DOI 10.2147/RRTM.S33108; Bate R, 2012, RES REP TROP MED, V3, P63, DOI 10.2147/RRTM.S33690; Efpia, 2012, EUR STAK MOD; European Commission, 2011, REP EU CUST ENF INT; Gathigah M, 2011, KEN CIV SOC DEF ACC; Jack A., 2012, FINANCIAL TIMES; Jack Andrew, 2011, FINANC TIMES; Jack Andrew., 2008, FINANCIAL TIMES; Organization W. H., 2012, MED SPUR FALS LAB FA; Pharmaceutical Security Institute, COUNT SIT; Tanne JH, 2008, BRIT MED J, V336, P412, DOI 10.1136/bmj.39496.419248.DB; WHO, 2006, COUNT MED FACTSH REV	13	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 20	2012	345								e7836	10.1136/bmj.e7836	http://dx.doi.org/10.1136/bmj.e7836			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	044GT	23169809				2022-12-28	WOS:000311608200012
J	Ortega, FB; Silventoinen, K; Tynelius, P; Rasmussen, F				Ortega, Francisco B.; Silventoinen, Karri; Tynelius, Per; Rasmussen, Finn			Muscular strength in male adolescents and premature death: cohort study of one million participants	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALL-CAUSE MORTALITY; BODY-MASS INDEX; ATTEMPTED-SUICIDE COHORT; CARDIORESPIRATORY FITNESS; MUSCLE STRENGTH; SELF-ESTEEM; DEPRESSIVE SYMPTOMS; PHYSICAL-ACTIVITY; EARLY ADULTHOOD; GRIP STRENGTH	Objectives To explore the extent to which muscular strength in adolescence is associated with all cause and cause specific premature mortality (<55 years). Design Prospective cohort study. Setting Sweden. Participants 1 142 599 Swedish male adolescents aged 16-19 years were followed over a period of 24 years. Main outcome measures Baseline examinations included knee extension, handgrip, and elbow flexion strength tests, as well as measures of diastolic and systolic blood pressure and body mass index. Cox regression was used to estimate hazard ratios for mortality according to muscular strength categories (tenths). Results During a median follow-up period of 24 years, 26 145 participants died. Suicide was a more frequent cause of death in young adulthood (22.3%) than was cardiovascular diseases (7.8%) or cancer (14.9%). High muscular strength in adolescence, as assessed by knee extension and handgrip tests, was associated with a 20-35% lower risk of premature mortality due to any cause or cardiovascular disease, independently of body mass index or blood pressure; no association was observed with mortality due to cancer. Stronger adolescents had a 20-30% lower risk of death from suicide and were 15-65% less likely to have any psychiatric diagnosis (such as schizophrenia and mood disorders). Adolescents in the lowest tenth of muscular strength showed by far the highest risk of mortality for different causes. All cause mortality rates (per 100 000 person years) ranged between 122.3 and 86.9 for the weakest and strongest adolescents; corresponding figures were 9.5 and 5.6 for mortality due to cardiovascular diseases and 24.6 and 16.9 for mortality due to suicide. Conclusions Low muscular strength in adolescents is an emerging risk factor for major causes of death in young adulthood, such as suicide and cardiovascular diseases. The effect size observed for all cause mortality was equivalent to that for well established risk factors such as elevated body mass index or blood pressure.	[Tynelius, Per; Rasmussen, Finn] Karolinska Inst, Dept Publ Hlth Sci, Child & Adolescent Publ Hlth Epidemiol Grp, Stockholm, Sweden; [Ortega, Francisco B.] Univ Granada, Sch Sport Sci, Dept Phys Educ & Sport, Granada, Spain; [Ortega, Francisco B.] Karolinska Inst, Novum, Dept Biosci & Nutr, Stockholm, Sweden; [Ortega, Francisco B.] Univ Granada, Sch Med, Dept Med Physiol, E-18071 Granada, Spain; [Silventoinen, Karri] Univ Helsinki, Dept Social Res, Populat Res Unit, Helsinki, Finland	Karolinska Institutet; University of Granada; Karolinska Institutet; University of Granada; University of Helsinki	Rasmussen, F (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Child & Adolescent Publ Hlth Epidemiol Grp, Stockholm, Sweden.	Finn.Rasmussen@ki.se	Ortega, Francisco B/B-4002-2010; Ortega, Francisco B./AAG-5195-2021	Ortega, Francisco B/0000-0003-2001-1121; Ortega, Francisco B./0000-0003-2001-1121; Tynelius, Per/0000-0001-8155-7406; Silventoinen, Karri/0000-0003-1759-3079; Rasmussen, Finn/0000-0001-7915-7809	Swedish Research Council [2007-5942]; Spanish Ministry of Science and Innovation [RYC-2011-09011]; Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was supported by a grant to FR from the Swedish Research Council (grant 2007-5942). FBO was supported by grants from the Spanish Ministry of Science and Innovation (RYC-2011-09011). The funding bodies had no role in the preparation of this manuscript.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: the study was supported by a grant to FR from the Swedish Research Council, and FBO was supported by grants from the Spanish Ministry of Science and Innovation; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Al Snih S, 2002, J AM GERIATR SOC, V50, P1250, DOI 10.1046/j.1532-5415.2002.50312.x; ANDREASSON S, 1988, BRIT MED J, V296, P1021, DOI 10.1136/bmj.296.6628.1021; Artero EG, 2011, J AM COLL CARDIOL, V57, P1831, DOI 10.1016/j.jacc.2010.12.025; Au ACY, 2009, ADOLESCENCE, V44, P851; Babiss LA, 2009, J DEV BEHAV PEDIATR, V30, P376, DOI 10.1097/DBP.0b013e3181b33659; Batty GD, 2010, AM J EPIDEMIOL, V172, P890, DOI 10.1093/aje/kwq274; Batty GD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2506; Batty GD, 2009, EPIDEMIOLOGY, V20, P100, DOI 10.1097/EDE.0b013e31818ba076; Beary M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1152; Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P685; De Leo D, 2004, INT SUICIDE RATES PR; Dishman RK, 2006, HEALTH PSYCHOL, V25, P396, DOI 10.1037/0278-6133.25.3.396; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; FUJITA Y, 1995, J CLIN EPIDEMIOL, V48, P1349, DOI 10.1016/0895-4356(95)00533-1; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Gale CR, 2012, ARCH GEN PSYCHIAT, V69, P823, DOI 10.1001/archgenpsychiatry.2011.2000; Galper DI, 2006, MED SCI SPORT EXER, V38, P173, DOI 10.1249/01.mss.0000180883.32116.28; Garaigordobil M, 2008, PSICOTHEMA, V20, P114; Greenleaf CA, 2010, RES Q EXERCISE SPORT, V81, pS65, DOI 10.1080/02701367.2010.10599695; Katzmarzyk PT, 2002, MED SCI SPORT EXER, V34, P740, DOI 10.1097/00005768-200205000-00002; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Koivukangas J, 2010, SCHIZOPHR RES, V116, P152, DOI 10.1016/j.schres.2009.10.022; Magnusson PKE, 2006, AM J EPIDEMIOL, V163, P1, DOI 10.1093/aje/kwj002; Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; National Board of Health and Welfare, 2010, CAUS DEATH HIST BACK; Neovius M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b496; Ortega FB, 2011, BRIT J SPORT MED, V45, P20, DOI 10.1136/bjsm.2009.062679; Ortega FB, 2005, REV ESP CARDIOL, V58, P898, DOI 10.1016/S1885-5857(06)60372-1; Ortega FB, 2010, AM J PREV MED, V39, P440, DOI 10.1016/j.amepre.2010.07.015; Rantanen T, 2000, J GERONTOL A-BIOL, V55, pM168, DOI 10.1093/gerona/55.3.M168; Rantanen T, 2012, AGE, V34, P563, DOI 10.1007/s11357-011-9256-y; Roberts JE, 1999, BRIT J CLIN PSYCHOL, V38, P425, DOI 10.1348/014466599162917; Romm KL, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-136; Ruiz JR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a439; Ruiz JR, 2011, BRIT J SPORT MED, V45, P518, DOI 10.1136/bjsm.2010.075341; Sasaki H, 2007, AM J MED, V120, P337, DOI 10.1016/j.amjmed.2006.04.018; Sato M, 2009, EPIDEMIOLOGY, V20, P463, DOI 10.1097/EDE.0b013e31819ed09f; Silventoinen K, 2009, INT J EPIDEMIOL, V38, P110, DOI 10.1093/ije/dyn231; Silventoinen K, 2008, GENET EPIDEMIOL, V32, P341, DOI 10.1002/gepi.20308; Smith GD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5043; Statistics Sweden. Multi-generation register, 2011, MULT REG 2010 DESCR; Sui XM, 2009, J PSYCHIATR RES, V43, P546, DOI 10.1016/j.jpsychires.2008.08.002; Sundstrom J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d643; VIITASALO JT, 1985, ERGONOMICS, V28, P1563, DOI 10.1080/00140138508963288; Wildgust HJ, 2010, J PSYCHOPHARMACOL, V24, P37, DOI 10.1177/1359786810384639	46	328	336	5	46	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2012	345								e7279	10.1136/bmj.e7279	http://dx.doi.org/10.1136/bmj.e7279			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	044GT	23169869	Green Published, hybrid			2022-12-28	WOS:000311608200003
J	Groenen, MAM; Archibald, AL; Uenishi, H; Tuggle, CK; Takeuchi, Y; Rothschild, MF; Rogel-Gaillard, C; Park, C; Milan, D; Megens, HJ; Li, ST; Larkin, DM; Kim, H; Frantz, LAF; Caccamo, M; Ahn, H; Aken, BL; Anselmo, A; Anthon, C; Auvil, L; Badaoui, B; Beattie, CW; Bendixen, C; Berman, D; Blecha, F; Blomberg, J; Bolund, L; Bosse, M; Botti, S; Zhan, BJ; Bystrom, M; Capitanu, B; Carvalho-Silva, D; Chardon, P; Chen, C; Cheng, R; Choi, SH; Chow, W; Clark, RC; Clee, C; Crooijmans, RPMA; Dawson, HD; Dehais, P; De Sapio, F; Dibbits, B; Drou, N; Du, ZQ; Eversole, K; Fadista, J; Fairley, S; Faraut, T; Faulkner, GJ; Fowler, KE; Fredholm, M; Fritz, E; Gilbert, JGR; Giuffra, E; Gorodkin, J; Griffin, DK; Harrow, JL; Hayward, A; Howe, K; Hu, ZL; Humphray, SJ; Hunt, T; Hornshoj, H; Jeon, JT; Jern, P; Jones, M; Jurka, J; Kanamori, H; Kapetanovic, R; Kim, J; Kim, JH; Kim, KW; Kim, TH; Larson, G; Lee, K; Lee, KT; Leggett, R; Lewin, HA; Li, YR; Liu, WS; Loveland, JE; Lu, Y; Lunney, JK; Ma, J; Madsen, O; Mann, K; Matthews, L; McLaren, S; Morozumi, T; Murtaugh, MP; Narayan, J; Nguyen, DT; Ni, PX; Oh, SJ; Onteru, S; Panitz, F; Park, EW; Park, HS; Pascal, G; Paudel, Y; Perez-Enciso, M; Ramirez-Gonzalez, R; Reecy, JM; Rodriguez-Zas, S; Rohrer, GA; Rund, L; Sang, YM; Schachtschneider, K; Schraiber, JG; Schwartz, J; Scobie, L; Scott, C; Searle, S; Servin, B; Southey, BR; Sperber, G; Stadler, P; Sweedler, JV; Tafer, H; Thomsen, B; Wali, R; Wang, J; Wang, J; White, S; Xu, X; Yerle, M; Zhang, GJ; Zhang, JG; Zhang, J; Zhao, SH; Rogers, J; Churcher, C; Schook, LB				Groenen, Martien A. M.; Archibald, Alan L.; Uenishi, Hirohide; Tuggle, Christopher K.; Takeuchi, Yasuhiro; Rothschild, Max F.; Rogel-Gaillard, Claire; Park, Chankyu; Milan, Denis; Megens, Hendrik-Jan; Li, Shengting; Larkin, Denis M.; Kim, Heebal; Frantz, Laurent A. F.; Caccamo, Mario; Ahn, Hyeonju; Aken, Bronwen L.; Anselmo, Anna; Anthon, Christian; Auvil, Loretta; Badaoui, Bouabid; Beattie, Craig W.; Bendixen, Christian; Berman, Daniel; Blecha, Frank; Blomberg, Jonas; Bolund, Lars; Bosse, Mirte; Botti, Sara; Zhan Bujie; Bystrom, Megan; Capitanu, Boris; Carvalho-Silva, Denise; Chardon, Patrick; Chen, Celine; Cheng, Ryan; Choi, Sang-Haeng; Chow, William; Clark, Richard C.; Clee, Christopher; Crooijmans, Richard P. M. A.; Dawson, Harry D.; Dehais, Patrice; De Sapio, Fioravante; Dibbits, Bert; Drou, Nizar; Du, Zhi-Qiang; Eversole, Kellye; Fadista, Joao; Fairley, Susan; Faraut, Thomas; Faulkner, Geoffrey J.; Fowler, Katie E.; Fredholm, Merete; Fritz, Eric; Gilbert, James G. R.; Giuffra, Elisabetta; Gorodkin, Jan; Griffin, Darren K.; Harrow, Jennifer L.; Hayward, Alexander; Howe, Kerstin; Hu, Zhi-Liang; Humphray, Sean J.; Hunt, Toby; Hornshoj, Henrik; Jeon, Jin-Tae; Jern, Patric; Jones, Matthew; Jurka, Jerzy; Kanamori, Hiroyuki; Kapetanovic, Ronan; Kim, Jaebum; Kim, Jae-Hwan; Kim, Kyu-Won; Kim, Tae-Hun; Larson, Greger; Lee, Kyooyeol; Lee, Kyung-Tai; Leggett, Richard; Lewin, Harris A.; Li, Yingrui; Liu, Wansheng; Loveland, Jane E.; Lu, Yao; Lunney, Joan K.; Ma, Jian; Madsen, Ole; Mann, Katherine; Matthews, Lucy; McLaren, Stuart; Morozumi, Takeya; Murtaugh, Michael P.; Narayan, Jitendra; Dinh Truong Nguyen; Ni, Peixiang; Oh, Song-Jung; Onteru, Suneel; Panitz, Frank; Park, Eung-Woo; Park, Hong-Seog; Pascal, Geraldine; Paudel, Yogesh; Perez-Enciso, Miguel; Ramirez-Gonzalez, Ricardo; Reecy, James M.; Rodriguez-Zas, Sandra; Rohrer, Gary A.; Rund, Lauretta; Sang, Yongming; Schachtschneider, Kyle; Schraiber, Joshua G.; Schwartz, John; Scobie, Linda; Scott, Carol; Searle, Stephen; Servin, Bertrand; Southey, Bruce R.; Sperber, Goran; Stadler, Peter; Sweedler, Jonathan V.; Tafer, Hakim; Thomsen, Bo; Wali, Rashmi; Wang, Jian; Wang, Jun; White, Simon; Xu, Xun; Yerle, Martine; Zhang, Guojie; Zhang, Jianguo; Zhang, Jie; Zhao, Shuhong; Rogers, Jane; Churcher, Carol; Schook, Lawrence B.			Analyses of pig genomes provide insight into porcine demography and evolution	NATURE			English	Article							SEQUENCE; GENE; RECEPTOR; TASTE	For 10,000 years pigs and humans have shared a close and complex relationship. From domestication to modern breeding practices, humans have shaped the genomes of domestic pigs. Here we present the assembly and analysis of the genome sequence of a female domestic Duroc pig (Sus scrofa) and a comparison with the genomes of wild and domestic pigs from Europe and Asia. Wild pigs emerged in South East Asia and subsequently spread across Eurasia. Our results reveal a deep phylogenetic split between European and Asian wild boars similar to 1 million years ago, and a selective sweep analysis indicates selection on genes involved in RNA processing and regulation. Genes associated with immune response and olfaction exhibit fast evolution. Pigs have the largest repertoire of functional olfactory receptor genes, reflecting the importance of smell in this scavenging animal. The pig genome sequence provides an important resource for further improvements of this important livestock species, and our identification of many putative disease-causing variants extends the potential of the pig as a biomedical model.	[Groenen, Martien A. M.; Megens, Hendrik-Jan; Frantz, Laurent A. F.; Bosse, Mirte; Crooijmans, Richard P. M. A.; Dibbits, Bert; Madsen, Ole; Paudel, Yogesh] Wageningen Univ, Anim Breeding & Genom Ctr, NL-6708 WD Wageningen, Netherlands; [Archibald, Alan L.; De Sapio, Fioravante; Faulkner, Geoffrey J.; Kapetanovic, Ronan] Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; [Archibald, Alan L.; De Sapio, Fioravante; Faulkner, Geoffrey J.; Kapetanovic, Ronan] Univ Edinburgh, R D SVS, Easter Bush EH25 9RG, Midlothian, Scotland; [Uenishi, Hirohide; Kanamori, Hiroyuki] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; [Tuggle, Christopher K.; Rothschild, Max F.; Bystrom, Megan; Cheng, Ryan; Du, Zhi-Qiang; Fritz, Eric; Hu, Zhi-Liang; Onteru, Suneel; Reecy, James M.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Tuggle, Christopher K.; Rothschild, Max F.; Bystrom, Megan; Cheng, Ryan; Du, Zhi-Qiang; Fritz, Eric; Hu, Zhi-Liang; Onteru, Suneel; Reecy, James M.] Iowa State Univ, Ctr Integrated Anim Genom, Ames, IA 50011 USA; [Takeuchi, Yasuhiro] UCL, Div Infect & Immun, MRC, UCL Ctr Med Mol Virol, London WC1E 6BT, England; [Takeuchi, Yasuhiro] UCL, Div Infect & Immun, Wohl Vir Ctr, London WC1E 6BT, England; [Rogel-Gaillard, Claire; Chardon, Patrick; Giuffra, Elisabetta] INRA, Lab Anim Genet & Integrat Biol, Lab Radiobiol & Etud Genome, AgroParisTech,CEA,DSV,IRCM, F-78350 Jouy En Josas, France; [Park, Chankyu; Kim, Jaebum; Lee, Kyooyeol; Dinh Truong Nguyen] Konkuk Univ, Dept Anim Biotechnol, Seoul 143701, South Korea; [Milan, Denis; Dehais, Patrice; Faraut, Thomas; Servin, Bertrand; Yerle, Martine] INRA, Lab Genet Cellulaire, F-31320 Castanet Tolosan, France; [Li, Shengting; Bolund, Lars; Li, Yingrui; Lu, Yao; Ni, Peixiang; Wang, Jian; Wang, Jun; Xu, Xun; Zhang, Guojie; Zhang, Jianguo] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Li, Shengting; Bolund, Lars] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Larkin, Denis M.; Narayan, Jitendra] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3DA, Ceredigion, Wales; [Kim, Heebal; Ahn, Hyeonju] Seoul Natl Univ, Dept Agr Biotechnol & C&K Genom, Seoul 151742, South Korea; [Caccamo, Mario; Drou, Nizar; Leggett, Richard; Ramirez-Gonzalez, Ricardo; Rogers, Jane] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Aken, Bronwen L.; Chow, William; Clark, Richard C.; Clee, Christopher; Fairley, Susan; Gilbert, James G. R.; Harrow, Jennifer L.; Howe, Kerstin; Humphray, Sean J.; Hunt, Toby; Jones, Matthew; Loveland, Jane E.; Matthews, Lucy; McLaren, Stuart; Scott, Carol; Searle, Stephen; White, Simon; Churcher, Carol] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Anselmo, Anna; Badaoui, Bouabid; Botti, Sara; Giuffra, Elisabetta] Parco Tecnol Padano, I-26900 Lodi, Italy; [Anthon, Christian; Fredholm, Merete; Gorodkin, Jan] IBHV Univ Copenhagen, Ctr Noncoding RNA Technol & Hlth, Frederiksberg, Denmark; [Auvil, Loretta; Capitanu, Boris] Univ Illinois, Illinois Informat Inst, Urbana, IL 61801 USA; [Beattie, Craig W.] Univ Illinois, Dept Surg, Chicago, IL 60612 USA; [Bendixen, Christian; Zhan Bujie; Fadista, Joao; Hornshoj, Henrik; Panitz, Frank; Thomsen, Bo] Aarhus Univ, Dept Mol Biol & Genet, DK-8830 Tjele, Denmark; [Berman, Daniel; Lunney, Joan K.; Mann, Katherine] USDA ARS, BARC Anim Parasit Dis Lab, Beltsville, MD 20705 USA; [Blecha, Frank; Sang, Yongming] Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Manhattan, KS 66506 USA; [Blomberg, Jonas] Uppsala Univ, Dept Med Sci, Acad Hosp, S-75185 Uppsala, Sweden; [Carvalho-Silva, Denise] European Bioinformat Inst, Hinxton CB10 1SD, Cambs, England; [Chen, Celine; Dawson, Harry D.] USDA, Immunol Lab, Beltsville Human Nutr Res Ctr, BARC E, Beltsville, MD 20705 USA; [Choi, Sang-Haeng; Park, Hong-Seog] Korean Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Eversole, Kellye] Eversole Associates, Bethesda, MD 20816 USA; [Eversole, Kellye] Alliance Anim Genome Res, Bethesda, MD 20816 USA; [Fowler, Katie E.; Griffin, Darren K.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Hayward, Alexander; Jern, Patric] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, BMC, SE-75123 Uppsala, Sweden; [Jeon, Jin-Tae] Gyeongsang Natl Univ, Coll Agr & Life Sci, Dept Anim Sci, Jinju 660701, South Korea; [Jurka, Jerzy] Genet Informat Res Inst, Mountain View, CA 94043 USA; [Kanamori, Hiroyuki; Morozumi, Takeya] Inst Japan Assoc Technoinnovat Agr Forestry & Fis, Tsukuba, Ibaraki 3050854, Japan; [Kim, Jaebum] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Kim, Jae-Hwan] Natl Inst Anim Sci, Anim Genet Resources Stn, RDA, Namwon 590832, South Korea; [Kim, Kyu-Won] C&K Genom, Seoul 151742, South Korea; [Kim, Tae-Hun; Lee, Kyung-Tai; Park, Eung-Woo] Natl Inst Anim Sci, Anim Genom & Bioinformat Div, RDA, Suwon 441706, South Korea; [Larson, Greger] Univ Durham, Dept Archaeol, Durham DH1 3LE, England; [Lewin, Harris A.] Univ Calif Davis, UC Davis Genome Ctr, Dept Ecol & Evolut, Davis, CA 95618 USA; [Liu, Wansheng] Penn State Univ, Coll Agr Sci, CRBH, Dept Dairy & Anim Sci, University Pk, PA 16802 USA; [Ma, Jian] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Ma, Jian] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Murtaugh, Michael P.; Schwartz, John] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Oh, Song-Jung] Jeju Natl Univ, Cheju 690756, South Korea; [Pascal, Geraldine] INRA, CNRS, UMR85, IFCE,Physiol Reprod & Comportements UMR7247, F-37380 Nouzilly, France; [Pascal, Geraldine] Univ Tours, F-37041 Tours, France; [Perez-Enciso, Miguel] CRAG, ICREA, E-08193 Bellaterra, Spain; [Perez-Enciso, Miguel] UAB, Fac Vet, E-08193 Bellaterra, Spain; [Rodriguez-Zas, Sandra; Rund, Lauretta; Schachtschneider, Kyle; Southey, Bruce R.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Rohrer, Gary A.] ARS, USDA, US Meat Anim Res Ctr, Clay Ctr, NE 68933 USA; [Schraiber, Joshua G.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Scobie, Linda; Wali, Rashmi] Glasgow Caledonian Univ, Dept Life Sci, Glasgow G4 0BA, Lanark, Scotland; [Sperber, Goran] Uppsala Univ, Biomed Ctr, Dept Neurosci, S-75124 Uppsala, Sweden; [Stadler, Peter; Tafer, Hakim] Univ Leipzig, Dept Comp Sci, Interdisciplinary Ctr Bioinformat, Bioinformat Grp, Leipzig, Germany; [Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Zhang, Guojie] BGI Europe, DK-2200 Copenhagen N, Denmark; [Zhang, Jie; Zhao, Shuhong] Huazhong Agr Univ, Minist Educ, Key Lab Anim Genet Breeding & Reprod, Wuhan 430070, Peoples R China; [Schook, Lawrence B.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Schook, Lawrence B.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	Wageningen University & Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; National Institute of Agrobiological Sciences - Japan; Iowa State University; Iowa State University; University of London; University College London; University of London; University College London; AgroParisTech; CEA; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Konkuk University; INRAE; Beijing Genomics Institute (BGI); Aarhus University; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Seoul National University (SNU); The Genome Analysis Centre (TGAC); Wellcome Trust Sanger Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Aarhus University; United States Department of Agriculture (USDA); Kansas State University; Uppsala University; European Molecular Biology Laboratory (EMBL); United States Department of Agriculture (USDA); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Kent; Uppsala University; Gyeongsang National University; University of Illinois System; University of Illinois Urbana-Champaign; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Durham University; University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Minnesota System; University of Minnesota Twin Cities; Jeju National University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Tours; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); ICREA; Autonomous University of Barcelona; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA); University of California System; University of California Berkeley; Glasgow Caledonian University; Uppsala University; Leipzig University; University of Illinois System; University of Illinois Urbana-Champaign; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Huazhong Agricultural University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Groenen, MAM (corresponding author), Wageningen Univ, Anim Breeding & Genom Ctr, Elst 1, NL-6708 WD Wageningen, Netherlands.	martien.groenen@wur.nl; alan.archibald@roslin.ed.ac.uk	Jensen, Betina W/J-2207-2015; Kim, Heebal/A-8889-2016; Pascal, Geraldine/P-8125-2019; Megens, Hendrik-Jan/M-5300-2019; kapetanovic, ronan/G-8322-2012; Park, Chankyu/D-8775-2011; Crooijmans, Richard PMA/E-2492-2012; Kim, Kyu Won/AAJ-7213-2020; Zhang, Guojie/J-7273-2019; Giuffra, Elisabetta/I-3201-2013; Larkin, Denis/AAB-2249-2022; Ramírez, Ricardo/H-4808-2019; Badaoui, Bouabid/AAV-8968-2021; Perez-Enciso, Miguel/H-6057-2015; Faulkner, Geoffrey J/M-3168-2014; Servin, Bertrand/B-2206-2008; Kapetanovic, Ronan/GRO-1748-2022; Xu, Xun/AAI-6763-2020; Li, Yingrui/K-1064-2015; Madsen, Ole/E-3730-2012; Jern, Patric/AAR-2133-2021; Giuffra, Elisabetta/J-8080-2014; Groenen, Martien/D-8408-2012; Larkin, Denis/AAB-1633-2022; PASCAL, Géraldine/L-4519-2013; Zhang, Guojie/B-6188-2014; Nguyen, Dinh-Truong/AAI-5062-2021; Dawson, Harry/H-8242-2013; Megens, Hendrik-Jan/E-9676-2010; Stadler, Peter F. F/L-7857-2015; Dawson, Harry/ABG-2734-2021; Ma, Jian/A-9838-2008; Panitz, Frank/A-3281-2017; PASCAL, Géraldine/A-7041-2008; Sweedler, Jonathan V/A-9405-2009; Schwartz, John/I-3002-2019; Eversole, Kellye/AAN-6141-2020; LEWIN, HARRIS/HGC-6543-2022; Fadista, Joao/AAM-4870-2020; Wang, Jun/A-7261-2013; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Kim, Heebal/0000-0003-3064-1303; Pascal, Geraldine/0000-0002-5250-6594; Megens, Hendrik-Jan/0000-0002-3619-7533; kapetanovic, ronan/0000-0002-2908-1014; Zhang, Guojie/0000-0001-6860-1521; Ramírez, Ricardo/0000-0001-5745-7085; Perez-Enciso, Miguel/0000-0003-3524-995X; Faulkner, Geoffrey J/0000-0001-5769-4494; Servin, Bertrand/0000-0001-5141-0913; Kapetanovic, Ronan/0000-0002-2908-1014; Xu, Xun/0000-0002-5338-5173; Madsen, Ole/0000-0001-8082-7881; Jern, Patric/0000-0003-3393-5825; Groenen, Martien/0000-0003-0484-4545; Larkin, Denis/0000-0001-7859-6201; PASCAL, Géraldine/0000-0002-5250-6594; Zhang, Guojie/0000-0001-6860-1521; Nguyen, Dinh-Truong/0000-0002-6452-5573; Megens, Hendrik-Jan/0000-0002-3619-7533; Stadler, Peter F. F/0000-0002-5016-5191; Dawson, Harry/0000-0002-7648-9952; Ma, Jian/0000-0002-4202-5834; Panitz, Frank/0000-0002-6909-5162; Sweedler, Jonathan V/0000-0003-3107-9922; Schwartz, John/0000-0003-2057-1831; Eversole, Kellye/0000-0002-8784-4913; LEWIN, HARRIS/0000-0002-1043-7287; Fadista, Joao/0000-0003-2539-634X; Frantz, Laurent/0000-0001-8030-3885; Mann, Katherine/0000-0001-8144-8170; Aken, Bronwen/0000-0002-3032-4095; Schachtschneider, Kyle/0000-0002-7293-8642; Harvey, Katie/0000-0003-0359-2390; Harrow, Jennifer/0000-0003-0338-3070; Wang, Jun/0000-0002-2113-5874; Hunt, Toby/0000-0001-8377-0841; Bosse, Mirte/0000-0003-2433-2483; Ahn, Hyeonju/0000-0002-8922-972X; Howe, Kerstin/0000-0003-2237-513X; Narayan, Jitendra/0000-0002-2065-2861; Wang, Jun/0000-0002-8540-8931; Gorodkin, Jan/0000-0001-5823-4000; White, Simon/0000-0001-6375-2363; Carvalho-Silva, Dr D/0000-0001-5662-1840; Southey, Bruce/0000-0002-8959-7709; Rohrer, Gary/0000-0002-8252-9308; Rodriguez-Zas, Sandra/0000-0003-1122-4758; Gilbert, James/0000-0001-8079-3159; Giuffra, Elisabetta/0000-0001-9568-2056; Reecy, James/0000-0003-4602-0990; fadista, joao/0000-0001-7558-7043; CHENG, RYAN PEI YEN/0000-0002-2119-6431; Loveland, Jane/0000-0002-7669-2934; Archibald, Alan/0000-0001-9213-1830; Tafer, Hakim/0000-0002-6252-9802; Fredholm, Merete/0000-0002-3563-7648; Park, Chankyu/0000-0003-4855-2210; rund, laurie/0000-0003-0761-7196; Anselmo, Anna/0000-0002-5279-8670; ROGEL-GAILLARD, Claire/0000-0002-2174-1962; Blomberg, Jonas/0000-0001-6492-2491; Schook, Lawrence/0000-0002-6580-8364; Fairley, Susan/0000-0001-9425-0788; Hayward, Alexander/0000-0001-7413-718X; Chow, William/0000-0002-9056-201X; Leggett, Richard/0000-0003-3044-4297; Zhang, Jianguo/0000-0003-0723-1701; Anthon, Christian/0000-0002-4336-1688; Thomsen, Bo/0000-0001-9622-0929	USDA CSREES/NIFA Swine Genome Coordination Program; College of Agricultural, Consumer and Environmental Sciences, University of Illinois; College of Agriculture and Life Sciences, Iowa State University; North Carolina Agricultural Research Service; USA National Pork Board; Iowa Pork Producers Association; North Carolina Pork Council; Danish government; TOPIGS Research Center IPG The Netherlands; INRA Genescope, France; Wellcome Trust Sanger Institute and BGI.; BBSRC [BB/E010520/1, BB/E010520/2, BB/I025328/1, BB/H005935/1, BB/G004013/1]; EC FP6 'Cutting edge genomics for sustainable animal breeding (SABRE)'; EC FP7 'Quantomics'; Australian NHMRC [575585]; Next-Generation BioGreen 21 Program [PJ009019, PJ0081162012, PJ0080892011]; RDA, Republic of Korea; Ministry of Research (Spain); NIH [R13 RR020283A, NIH R13 RR032267A, ILLU 535-314, ILLU 538-379, ILLU-538-312, ILLU-538-34, 5 P41LM006252, P20-RR017686, 5 P41 LM006252]; CSREES; NIFA; MAFF [IRPPIAUGT-AG 1101/1201]; USDA-NRSP8 Bioinformatics Coordination and Pig Genome Coordination funds; US-UK Fulbright Commission; USDA-ARS Project Plan [1235-51000-055-00D, 1265-32000-098-00D]; USDA AFRI NIFA/DHS [2010-39559-21860]; USDA ARS; USDA-NRSP8 Bioinformatics; NSFC [31025026]; Swedish Research Council FORMAS; Swedish Wenner-Gren Foundations; European Commission [LSHB-CT-2006-037377]; BioGreen21; RDA [PJ00622901, PJ00622902, PJ00622903, 20040301034467]; European Research Council under the European Community [249894]; NIH NIDA [P30 DA018310, R21 DA027548]; ANR [ANR07-GANI-001]; FTP/DFF [09-066598]; DSF/Strategic Growth Technologies [09-067036]; Lundbeck foundation [374/06]; DCSC (Scientific Computing); Funds for International Cooperation from the Ministry of Science and Technology of China [2002AA229061]; PL-Grid project: [POIG.02.03.00-00-007/08-00]; USDA-NIFA-CREES [AG 2006-35216-16668, AG 2002-34480-11828, AG 2003-34480-13172, AG 2004-34480-14417, AG 2005-34480-15939, AG 2006-34480-17150, AG 2008-34480-19328, AG 2009-34480-19875, AG 2002-35205-12712, AG 2008-35205-18769, AG 2009-65205-05642, AG 2004-3881-02193];  [USDA-NRI-2009-35205-05192];  [USDA-NRI-2006-35204-17337]; ICREA Funding Source: Custom; BBSRC [BB/E010768/1, BB/I025506/1, BB/I025360/1, BBS/E/D/20211550, BB/E011640/1, BBS/E/D/05191130, BBS/E/T/000PR5885] Funding Source: UKRI; MRC [G0900950] Funding Source: UKRI; NERC [NE/F003382/2, NE/F003382/1, NE/H005552/1, NE/H005269/1] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [R13RR020283, R13RR032267, P20RR017686] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI083196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310, R21DA027548] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [P41LM006252] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/E010768/1, BBS/E/D/05191130, BB/G004013/1, BB/E011640/1, BBS/E/D/20211550, BB/I025328/1, BB/E010520/1, BB/H005935/1, BB/E010520/2, BB/I025506/1, BB/I025360/1] Funding Source: researchfish; Medical Research Council [G0900950B, G0900950] Funding Source: researchfish; Natural Environment Research Council [NE/H005269/1, NE/F003382/2, NE/H005552/1, NE/F003382/1] Funding Source: researchfish; Chief Scientist Office [ETM/32] Funding Source: researchfish	USDA CSREES/NIFA Swine Genome Coordination Program; College of Agricultural, Consumer and Environmental Sciences, University of Illinois; College of Agriculture and Life Sciences, Iowa State University; North Carolina Agricultural Research Service; USA National Pork Board; Iowa Pork Producers Association; North Carolina Pork Council; Danish government; TOPIGS Research Center IPG The Netherlands; INRA Genescope, France; Wellcome Trust Sanger Institute and BGI.; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EC FP6 'Cutting edge genomics for sustainable animal breeding (SABRE)'; EC FP7 'Quantomics'; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); RDA, Republic of Korea; Ministry of Research (Spain); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NIFA(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); MAFF(Ministry of Agriculture Forestry & Fisheries - Japan); USDA-NRSP8 Bioinformatics Coordination and Pig Genome Coordination funds; US-UK Fulbright Commission; USDA-ARS Project Plan; USDA AFRI NIFA/DHS; USDA ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA-NRSP8 Bioinformatics; NSFC(National Natural Science Foundation of China (NSFC)); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish Wenner-Gren Foundations; European Commission(European CommissionEuropean Commission Joint Research Centre); BioGreen21(Rural Development Administration (RDA), Republic of Korea); RDA(Rural Development Administration (RDA), Republic of Korea); European Research Council under the European Community(European Research Council (ERC)); NIH NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); ANR(French National Research Agency (ANR)); FTP/DFF; DSF/Strategic Growth Technologies; Lundbeck foundation(Lundbeckfonden); DCSC (Scientific Computing); Funds for International Cooperation from the Ministry of Science and Technology of China; PL-Grid project:; USDA-NIFA-CREES; ; ; ICREA(ICREA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Chief Scientist Office	The authors recognize the contributions of the following individuals towards the establishment of the Swine Genome Sequencing Consortium and their leadership in realizing this effort: J. Jen, P. J. Burfening, D. Hamernik, R. A. Easter, N. Merchen, R. D. Green, J. Cassady, B. Harlizius, M. Boggess and M. Stratton. Also the authors acknowledge A. Hernandez, C. Wright at the University of Illinois Keck Center for Comparative and Functional Genomics; N. Bruneau and Prof. Ning Li for their contribution to PERV studies; D. Goodband and D. Berman for their efforts in genome annotation; D. Grafham of the Welcome Trust Sanger Institute for his efforts in the genome assembly and J. Hedegaard, M. Nielsen and R. O. Nielsen for their contribution on the miRNA analysis. We also recognize contributions from the National Institute of Agrobiological Sciences and the Institute of Japan Association for Techno-innovation in Agriculture, Forestry and Fisheries, Tsukuba, Japan, H. Shinkai, T. Eguchi-Ogawa, K. Suzuki, D. Toki, T. Matsumoto, N. Fujishima-Kanaya, A. Mikawa, N. Okumura, M. Tanaka-Matsuda, K. Kurita, H. Sasaki, K. Kamiya, A. Kikuta, T. Bito and N. Fujitsuka. We acknowledge support from the USDA CSREES/NIFA Swine Genome Coordination Program, College of Agricultural, Consumer and Environmental Sciences, University of Illinois; College of Agriculture and Life Sciences, Iowa State University; North Carolina Agricultural Research Service; USA National Pork Board; Iowa Pork Producers Association; North Carolina Pork Council; Danish government; TOPIGS Research Center IPG The Netherlands; INRA Genescope, France; Wellcome Trust Sanger Institute and BGI. We are grateful to the genome team at NCBI for their assistance in checking the Sscrofa 10.2 assembly and for their independent annotation of the sequence. This project was also partially supported by grants: BBSRC grants (Ensembl): BB/E010520/1, BB/E010520/2, BB/I025328/1; EC FP6 'Cutting edge genomics for sustainable animal breeding (SABRE)'; EC FP7 'Quantomics'; C. J. Martin Overseas Based Biomedical Fellowship from the Australian NHMRC (575585); BBSRC (BB/H005935/1); Next-Generation BioGreen 21 Program (PJ009019, PJ0081162012), RDA, Republic of Korea; Consolider programme from Ministry of Research (Spain); NIH R13 RR020283A; NIH R13 RR032267A; ILLU 535-314; ILLU 538-379; ILLU-538-312; ILLU-538-34; CSREES, NIFA for funding genome coordination activities; NIH grant 5 P41LM006252; MAFF grants (IRPPIAUGT-AG 1101/1201); USDA-NRI-2009-35205-05192; USDA-NRSP8 Bioinformatics Coordination and Pig Genome Coordination funds; US-UK Fulbright Commission; Next-Generation BioGreen 21 (no. PJ0080892011) Program, RDA, Republic of Korea; USDA-ARS Project Plan 1235-51000-055-00D; USDA-ARS Project Plan 1265-32000-098-00D; USDA-NRI-2006-35204-17337 USDA AFRI NIFA/DHS 2010-39559-21860; NIH P20-RR017686; USDA ARS; USDA-NRSP8 Bioinformatics; USDA ARS Beltsville Area Summer Undergraduate Fellowships; BBSRC grant BB/G004013/1; NSFC Outstanding Youth grant (31025026); The Swedish Research Council FORMAS; The Swedish Wenner-Gren Foundations; European Commission FP6 funded project LSHB-CT-2006-037377; BioGreen21, RDA grant PJ00622901; BioGreen21, RDA grant PJ00622902; BioGreen21, RDA grant PJ00622903; BioGreen21, RDA grant PJ00622903. The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no.; 249894 (SelSweep); NIH P20-RR017686; NIH NIDA P30 DA018310; NIH NIDA R21 DA027548; NIAS, RDA grant PJ001758; BioGreen21, RDA grant PJ006229; NIAS, RDA grant 20040301034467; ANR grant ANR07-GANI-001 DeliSus; Danish funding agencies: FTP/DFF (09-066598); DSF/Strategic Growth Technologies (09-067036); the Lundbeck foundation (374/06); DCSC (Scientific Computing); The Funds for International Cooperation from the Ministry of Science and Technology of China 2002AA229061; PL-Grid project: POIG.02.03.00-00-007/08-00 'Genome Assembly'; USDA-NIFA-CREES AG 2006-35216-16668; AG 2002-34480-11828; AG 2003-34480-13172; AG 2004-34480-14417; AG 2005-34480-15939; AG 2006-34480-17150; AG 2008-34480-19328; AG 2009-34480-19875; AG 2002-35205-12712; somatic cell genomics: Integrating QTL Discovery and Validation; AG 2008-35205-18769; AG 2009-65205-05642; AG 2004-3881-02193; AG 2011-67015-30229; AG 58-5438-2-313; AG 58-5438-7-317; and AG 58-0208-7-149; NIH grant 5 P41 LM006252.	Archibald AL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-438; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Barton NH, 2000, PHILOS T R SOC B, V355, P1553, DOI 10.1098/rstb.2000.0716; Bosse M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003100; Dong D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-12; Eguchi-Ogawa T, 2009, DEV COMP IMMUNOL, V33, P1111, DOI 10.1016/j.dci.2009.06.006; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fang X., GIGASCIENCE IN PRESS; Fischer A, 2005, MOL BIOL EVOL, V22, P432, DOI 10.1093/molbev/msi027; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hellekant G, 1999, J ANIM PHYSIOL AN N, V82, P8, DOI 10.1046/j.1439-0396.1999.00206.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Humphray SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r139; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kupsco JM, 2006, RNA, V12, P2103, DOI 10.1261/rna.186706; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; LYTTLE TW, 1993, TRENDS GENET, V9, P205, DOI 10.1016/0168-9525(93)90120-7; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Murgiano L., BMC GENOMIC IN PRESS; Nelson SL, 1997, CHEM SENSES, V22, P129, DOI 10.1093/chemse/22.2.129; Nguyen D. T., BMC GENOMIC IN PRESS; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Renard C, 2006, GENOMICS, V88, P96, DOI 10.1016/j.ygeno.2006.01.004; Rubin C. J., P NATL ACAD IN PRESS; Sambrook JG, 2006, IMMUNOGENETICS, V58, P481, DOI 10.1007/s00251-006-0110-9; Schook LB, 2005, COMP FUNCT GENOM, V6, P251, DOI 10.1002/cfg.479; Schwartz JC, 2012, IMMUNOGENETICS, V64, P399, DOI 10.1007/s00251-011-0594-9; Schwartz JC, 2012, IMMUNOGENETICS, V64, P303, DOI 10.1007/s00251-011-0589-6; Shimamura M, 1999, MOL BIOL EVOL, V16, P1046, DOI 10.1093/oxfordjournals.molbev.a026194; Tanaka-Matsuda M, 2009, GENOMICS, V93, P261, DOI 10.1016/j.ygeno.2008.10.004; Tortereau F., BMC GENOMIC IN PRESS; Uenishi H, 2003, IMMUNOLOGY, V109, P515, DOI 10.1046/j.1365-2567.2003.01695.x; Uenishi H, 2009, MOL IMMUNOL, V46, P1212, DOI 10.1016/j.molimm.2008.11.010; VANDENBROECK K, 1993, EUR J BIOCHEM, V217, P45, DOI 10.1111/j.1432-1033.1993.tb18216.x; Walters E. M., BMC MED GEN IN PRESS; White S, 2011, ENVIRON HIST-US, V16, P94, DOI 10.1093/envhis/emq143; Yokoyama Y, 2000, NATURE, V406, P713, DOI 10.1038/35021035	45	919	959	18	395	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					393	398		10.1038/nature11622	http://dx.doi.org/10.1038/nature11622			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23151582	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000311031600036
J	Vafai, SB; Mootha, VK				Vafai, Scott B.; Mootha, Vamsi K.			Mitochondrial disorders as windows into an ancient organelle	NATURE			English	Review							SKELETAL-MUSCLE MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION; MEMBRANE-PROTEIN; INNER MEMBRANE; MUTATION; DNA; DISEASE; CELLS; CA2+; COMPLEXES	Much of our current knowledge about mitochondria has come from studying patients who have respiratory chain disorders. These disorders comprise a large collection of individually rare syndromes, each presenting in a unique and often devastating way. In recent years, there has been great progress in defining their genetic basis, but we still know little about the cascade of events that gives rise to such diverse pathology. Here, we review these disorders and explore them in the context of a contemporary understanding of mitochondrial evolution, biochemistry and genetics. Fully deciphering their pathogenesis is a challenging next step that will inspire the development of drug treatments for rare and common diseases.	[Vafai, Scott B.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Ctr Human Genet Res, Boston, MA 02114 USA; [Vafai, Scott B.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Med, Ctr Human Genet Res, Boston, MA 02114 USA; [Vafai, Scott B.; Mootha, Vamsi K.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Mootha, VK (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Ctr Human Genet Res, Boston, MA 02114 USA.	vamsi@hms.harvard.edu			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We apologize to the many authors whose work we were unable to cite because of space limitations. We offer special thanks to D. Thorburn for careful review of the manuscript and his help with compiling an updated list of disease genes. We are grateful to S. Calvo, M. Jain, E. Rosen, V. Siegel and M. Gray for thoughtful feedback on the manuscript; J-.P. Mazat for providing a figure; M. Fleming, A. Sadun, M. Seidman, R. Mitchell, R. Saneto, D. McGuone and L. Rodriguez for providing clinical images; and G. Perkins and M. Ellisman for providing electron micrographs. We thank the National Institutes of Health for ongoing grant support.	Allen JF, 2003, PHILOS T R SOC B, V358, P19, DOI 10.1098/rstb.2002.1191; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Arnould T, 2002, EMBO J, V21, P53, DOI 10.1093/emboj/21.1.53; BALABAN RS, 1986, SCIENCE, V232, P1121, DOI 10.1126/science.3704638; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720; Chan D. C., 2012, ANN REV GENET; CHANCE B, 1955, NATURE, V176, P250, DOI 10.1038/176250a0; CHANCE B, 1955, J BIOL CHEM, V217, P409; COGSWELL AM, 1993, AM J PHYSIOL, V264, pC383, DOI 10.1152/ajpcell.1993.264.2.C383; Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016; Cote HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DIMAURO S, 1976, J NEUROL SCI, V27, P217, DOI 10.1016/0022-510X(76)90063-0; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; ERNSTER L, 1959, NATURE, V184, P1851, DOI 10.1038/1841851a0; Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; GROEN AK, 1982, J BIOL CHEM, V257, P2754; Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389; HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010; Hartwell L, 2004, SCIENCE, V303, P774, DOI 10.1126/science.1094731; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Hobbs AEA, 2001, J CELL BIOL, V152, P401, DOI 10.1083/jcb.152.2.401; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC698, DOI 10.1152/ajpcell.00109.2006; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Kaftan EJ, 2000, J BIOL CHEM, V275, P25465, DOI 10.1074/jbc.M000903200; Kirby DM, 2008, TWIN RES HUM GENET, V11, P395, DOI 10.1375/twin.11.4.395; Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lieber DS, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-3; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; MCKENZIE R, 1995, NEW ENGL J MED, V333, P1099, DOI 10.1056/NEJM199510263331702; Miceli Michael V., 2012, Frontiers in Genetics, V2, P102, DOI 10.3389/fgene.2011.00102; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; MORAIS R, 1982, CAN J BIOCHEM CELL B, V60, P290, DOI 10.1139/o82-035; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Munnich A., 2006, SCRIVERS ONLINE META; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3; Pierron D, 2012, BBA-BIOENERGETICS, V1817, P590, DOI 10.1016/j.bbabio.2011.07.007; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Reeves MB, 2007, SCIENCE, V316, P1345, DOI 10.1126/science.1142984; Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426; Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38; RUNSWICK MJ, 1991, FEBS LETT, V286, P121, DOI 10.1016/0014-5793(91)80955-3; Sadun A, 1998, Trans Am Ophthalmol Soc, V96, P881; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Schagger H, 2001, J BIOL CHEM, V276, P37861; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shaham O, 2010, P NATL ACAD SCI USA, V107, P1571, DOI 10.1073/pnas.0906039107; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Shoffner J., 2006, SCRIVERS ONLINE META; Shoubridge EA, 2012, CELL METAB, V15, P271, DOI 10.1016/j.cmet.2012.02.009; Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Spiegelman Bruce M, 2007, Novartis Found Symp, V287, P60; Stacpoole PW, 2011, MITOCHONDRION, V11, P679, DOI 10.1016/j.mito.2011.05.002; Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7; Szklarczyk R, 2010, PROTEOMICS, V10, P4012, DOI 10.1002/pmic.201000329; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Vasta V, 2012, PEDIATR INT, V54, P585, DOI 10.1111/j.1442-200X.2012.03644.x; Viscomi C, 2010, NAT MED, V16, P869, DOI 10.1038/nm.2188; Vockley J, 2000, MOL GENET METAB, V71, P10, DOI 10.1006/mgme.2000.3066; von Kleist-Retzow JC, 2007, EXP CELL RES, V313, P3076, DOI 10.1016/j.yexcr.2007.04.015; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Ward SM, 2000, J PHYSIOL-LONDON, V525, P355, DOI 10.1111/j.1469-7793.2000.t01-1-00355.x; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	98	465	473	2	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					374	383		10.1038/nature11707	http://dx.doi.org/10.1038/nature11707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23151580				2022-12-28	WOS:000311031600034
J	DeSantis, ME; Leung, EH; Sweeny, EA; Jackrel, ME; Cushman-Nick, M; Neuhaus-Follini, A; Vashist, S; Sochor, MA; Knight, MN; Shorter, J				DeSantis, Morgan E.; Leung, Eunice H.; Sweeny, Elizabeth A.; Jackrel, Meredith E.; Cushman-Nick, Mimi; Neuhaus-Follini, Alexandra; Vashist, Shilpa; Sochor, Matthew A.; Knight, M. Noelle; Shorter, James			Operational Plasticity Enables Hsp104 to Disaggregate Diverse Amyloid and Nonamyloid Clients	CELL			English	Article							PLUS CHAPERONE CLPB; PROTEIN DISAGGREGATION; AGGREGATED PROTEINS; COMMON MECHANISM; YEAST PRIONS; CENTRAL PORE; THERMOTOLERANCE; PROPAGATION; INHERITANCE; DISORDERS	It is not understood how Hsp104, a hexameric AAA+ ATPase from yeast, disaggregates diverse structures, including stress-induced aggregates, prions, and a-synuclein conformers connected to Parkinson disease. Here, we establish that Hsp104 hexamers adapt different mechanisms of intersubunit collaboration to disaggregate stress-induced aggregates versus amyloid. To resolve disordered aggregates, Hsp104 subunits collaborate noncooperatively via probabilistic substrate binding and ATP hydrolysis. To disaggregate amyloid, several subunits cooperatively engage substrate and hydrolyze ATP. Importantly, Hsp104 variants with impaired intersubunit communication dissolve disordered aggregates, but not amyloid. Unexpectedly, prokaryotic ClpB subunits collaborate differently than Hsp104 and couple probabilistic substrate binding to cooperative ATP hydrolysis, which enhances disordered aggregate dissolution but sensitizes ClpB to inhibition and diminishes amyloid disaggregation. Finally, we establish that Hsp104 hexamers deploy more subunits to disaggregate Sup35 prion strains with more stable "cross-beta" cores. Thus, operational plasticity enables Hsp104 to robustly dissolve amyloid and nonamyloid clients, which impose distinct mechanical demands.	[DeSantis, Morgan E.; Leung, Eunice H.; Sweeny, Elizabeth A.; Jackrel, Meredith E.; Cushman-Nick, Mimi; Neuhaus-Follini, Alexandra; Vashist, Shilpa; Sochor, Matthew A.; Knight, M. Noelle; Shorter, James] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [DeSantis, Morgan E.; Sweeny, Elizabeth A.; Sochor, Matthew A.; Knight, M. Noelle; Shorter, James] Univ Penn, Perelman Sch Med, Biochem & Mol Biophys Grad Grp, Philadelphia, PA 19104 USA; [Cushman-Nick, Mimi; Neuhaus-Follini, Alexandra; Shorter, James] Univ Penn, Perelman Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Shorter, J (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	jshorter@mail.med.upenn.edu	Shorter, James/ABE-7307-2020	Shorter, James/0000-0001-5269-8533; Jackrel, Meredith/0000-0003-4406-9504; Sweeny, Elizabeth/0000-0001-7818-9112	NIH [T32GM071339, T32GM008275, T32AG000255, DP2OD002177]; NRSA [F31NS079009, F31NS067890]; AHA; Ellison Medical Foundation New Scholar in Aging Award; Penn Institute of Aging; Alzheimer Disease Core Center; Diabetes Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071339, T32GM008275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS079009, F31NS067890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000255] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002177] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Ellison Medical Foundation New Scholar in Aging Award(Lawrence Ellison Foundation); Penn Institute of Aging; Alzheimer Disease Core Center; Diabetes Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Sue Lindquist, Sabine Kedzierska-Mieszkowska, and Virginia Lee for reagents. We thank Sandra Maday, Mark Lemmon, Aaron Gitler, Walter Englander, and Nancy Bonini for critiques and Lili Guo for artwork. Our work was funded by NIH training grant T32GM071339 and NRSA predoctoral fellowship F31NS079009 (M. E. D.); NIH training grant T32GM008275 (E. A. S. and M. A. S.); AHA predoctoral (E. A. S.) and postdoctoral fellowships (M.E.J.); NIH training grant T32AG000255 and NRSA predoctoral fellowship F31NS067890 (M.C.-N.); NIH Director's New Innovator Award (DP2OD002177), Ellison Medical Foundation New Scholar in Aging Award, Penn Institute of Aging, Alzheimer Disease Core Center, and Diabetes Research Center Awards (J.S.).	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; Dandoy-Dron F, 2006, NEUROSCI LETT, V405, P181, DOI 10.1016/j.neulet.2006.05.066; Doyle SM, 2007, P NATL ACAD SCI USA, V104, P11138, DOI 10.1073/pnas.0703980104; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Duennwald ML, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001346; Garrity SJ, 2010, P NATL ACAD SCI USA, V107, P10596, DOI 10.1073/pnas.0913280107; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Hoskins JR, 2009, P NATL ACAD SCI USA, V106, P22233, DOI 10.1073/pnas.0911937106; Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kurahashi H, 2007, MOL MICROBIOL, V63, P1669, DOI 10.1111/j.1365-2958.2007.05629.x; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Lindquist S, 1996, P NATL ACAD SCI USA, V93, P5301, DOI 10.1073/pnas.93.11.5301; Lo Bianco C, 2008, J CLIN INVEST, V118, P3087, DOI 10.1172/JCI35781; Lum R, 2008, J BIOL CHEM, V283, P30139, DOI 10.1074/jbc.M804849200; Lyubimov AY, 2011, CURR OPIN STRUC BIOL, V21, P240, DOI 10.1016/j.sbi.2011.01.002; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Reidy M, 2012, GENETICS, V192, P185, DOI 10.1534/genetics.112.142307; Schirmer EC, 2001, P NATL ACAD SCI USA, V98, P914, DOI 10.1073/pnas.031568098; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Vacher C, 2005, HUM MOL GENET, V14, P3425, DOI 10.1093/hmg/ddi372; Vashist S, 2010, BIOCHEM CELL BIOL, V88, P1, DOI [10.1139/O09-121, 10.1139/o09-121]; Wang L, 2010, ANGEW CHEM INT EDIT, V49, P3904, DOI 10.1002/anie.201000068; Wang L, 2008, PLOS BIOL, V6, P1791, DOI 10.1371/journal.pbio.0060195; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Weibezahn J, 2003, J BIOL CHEM, V278, P32608, DOI 10.1074/jbc.M303653200; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wendler P, 2009, MOL CELL, V34, P81, DOI 10.1016/j.molcel.2009.02.026; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; Wickner RB, 2011, PRION, V5, P258, DOI [10.4161/pri.5.4.17748, 10.4161/pri.17748]	45	128	129	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 9	2012	151	4					778	793		10.1016/j.cell.2012.09.038	http://dx.doi.org/10.1016/j.cell.2012.09.038			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141537	Green Accepted, Bronze			2022-12-28	WOS:000310921200010
J	Kuyken, W; Crane, R; Dalgleish, T				Kuyken, Willem; Crane, Rebecca; Dalgleish, Tim			Does mindfulness based cognitive therapy prevent relapse of depression?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIAL DESIGN; PROTOCOL		[Kuyken, Willem] Univ Exeter, Mood Disorders Ctr, Exeter EX4 4QG, Devon, England; [Crane, Rebecca] Bangor Univ, Sch Psychol, Ctr Mindfulness Res & Practice, Bangor LL57 1UT, Gwynedd, Wales; [Dalgleish, Tim] MRC, Cognit & Brain Sci Unit, Cambridge, England	University of Exeter; Bangor University	Kuyken, W (corresponding author), Univ Exeter, Mood Disorders Ctr, Exeter EX4 4QG, Devon, England.	w.kuyken@exeter.ac.uk	Dalgleish, Tim/E-8341-2010; Kuyken, Willem/ABC-5152-2021	Dalgleish, Tim/0000-0002-7304-2231; Kuyken, Willem/0000-0002-8596-5252	National Institute for Health Research [08/56/01] Funding Source: researchfish; MRC [G0401161] Funding Source: UKRI; Medical Research Council [G0401161, MC_U105579215] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Department of Health [08/56/01] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Department of Health		Crane RS, 2013, MINDFULNESS, V4, P246, DOI 10.1007/s12671-012-0121-6; Geddes JR, 2003, LANCET, V361, P653, DOI 10.1016/S0140-6736(03)12599-8; Huijbers MJ, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-125; Hunot Vivien M, 2007, Prim Care Companion J Clin Psychiatry, V9, P91; Kuyken W, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-99; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Munoz RF, 2010, ANNU REV CLIN PSYCHO, V6, P181, DOI 10.1146/annurev-clinpsy-033109-132040; National Institute for Health and Clinical Excellence, 2009, DEPR TREATM MAN DEPR; Piet J, 2011, CLIN PSYCHOL REV, V31, P1032, DOI 10.1016/j.cpr.2011.05.002; Segal Z. V., 2002, MINDFULNESS BASED CO; Shawyer F, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-3; Williams JMG, 2012, BRIT J PSYCHIAT, V200, P359, DOI 10.1192/bjp.bp.111.104745; Williams JMG, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-23	13	17	17	1	45	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 9	2012	345								e7194	10.1136/bmj.e7194	http://dx.doi.org/10.1136/bmj.e7194			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	036LZ	23144206	Green Submitted			2022-12-28	WOS:000311029100010
J	Creveling, JR; Mitrovica, JX; Chan, NH; Latychev, K; Matsuyama, I				Creveling, J. R.; Mitrovica, J. X.; Chan, N. -H.; Latychev, K.; Matsuyama, I.			Mechanisms for oscillatory true polar wander	NATURE			English	Article							ELASTIC LITHOSPHERES; ROTATIONAL STABILITY; MANTLE CONVECTION; EARTH; DYNAMICS; SUPERSWELLS; PLANETS; PLUMES; MODELS; TPW	Palaeomagnetic studies(1-5) of Palaeoproterozoic to Cretaceous rocks propose a suite of large and relatively rapid (tens of degrees over 10 to 100 million years) excursions of the rotation pole relative to the surface geography, or true polar wander (TPW). These excursions may be linked in an oscillatory, approximately coaxial succession about the centre of the contemporaneous supercontinent(5-7). Within the framework of a standard rotational theory(8,9), in which a delayed viscous adjustment of the rotational bulge acts to stabilize the rotation axis(10), geodynamic models for oscillatory TPW generally appeal to consecutive, opposite loading phases of comparable magnitude(6,11,12). Here we extend a nonlinear rotational stability theory(10) to incorporate the stabilizing effect of TPW-induced elastic stresses in the lithosphere(13,14). We demonstrate that convectively driven inertia perturbations acting on a nearly prolate, non-hydrostatic Earth(6,7) with an effective elastic lithospheric thickness of about 10 kilometres yield oscillatory TPW paths consistent with palaeomagnetic inferences. This estimate of elastic thickness can be reduced, even to zero, if the rotation axis is stabilized by long-term excess ellipticity in the plane of the TPW. We speculate that these sources of stabilization, acting on TPW driven by a time-varying mantle flow field(11,12,15-18), provide a mechanism for linking the distinct, oscillatory TPW events of the past few billion years.	[Creveling, J. R.; Mitrovica, J. X.; Chan, N. -H.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Latychev, K.] Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; [Matsuyama, I.] Univ Arizona, Dept Planetary Sci, Lunar & Planetary Lab, Tucson, AZ 85721 USA	Harvard University; University of Toronto; University of Arizona	Creveling, JR (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	jcrevel@gps.caltech.edu		Matsuyama, Isamu/0000-0002-2917-8633; Chan, Ngai-Ham/0000-0002-7212-5684	Canadian Institute for Advanced Research; Harvard University	Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Harvard University	We thank D. Evans, T. Torsvik and B. Steinberger for comprehensive and constructive reviews; A. Forte for providing us with geoid kernels; and C. Hay, N. Gomez, E. Morrow and A. Wickert for assistance with figures. We also thank A. Maloof, R. van der Voo, A. Watts, P. Hoffman, G. Spada, R. Mitchell, S. Stanley, S. Zhong, V. Tsai, D. Rowley and N. Swanson-Hysell for critical discussions; and D. Johnston and A. Knoll for reading of the manuscript. We acknowledge support from the Canadian Institute for Advanced Research and Harvard University.	Chambat F, 2010, GEOPHYS J INT, V183, P727, DOI 10.1111/j.1365-246X.2010.04771.x; Chan NH, 2011, GEOPHYS J INT, V187, P1319, DOI 10.1111/j.1365-246X.2011.05245.x; Crowley JW, 2011, EARTH PLANET SC LETT, V310, P380, DOI 10.1016/j.epsl.2011.08.035; Davaille A, 1999, NATURE, V402, P756, DOI 10.1038/45461; Dziewonski AM, 2010, EARTH PLANET SC LETT, V299, P69, DOI 10.1016/j.epsl.2010.08.013; Evans DA, 1998, EARTH PLANET SC LETT, V157, P1, DOI 10.1016/S0012-821X(98)00031-4; Evans DAD, 2003, TECTONOPHYSICS, V362, P303, DOI 10.1016/S0040-1951(02)000642-X; Forte A. M., 2007, TREATISE GEOPHYS, V1, P805, DOI DOI 10.1016/B978-044452748-6.00027-4; FORTE AM, 1991, J GEOPHYS RES-SOL EA, V96, P20131, DOI 10.1029/91JB01709; GOLD T, 1955, NATURE, V175, P526, DOI 10.1038/175526a0; GOLDREICH P, 1969, J GEOPHYS RES, V74, P2555, DOI 10.1029/JB074i010p02555; Greff-Lefftz M, 2004, GEOPHYS J INT, V159, P1125, DOI 10.1111/j.1365-246X.2004.02440.x; Maloof AC, 2006, GEOL SOC AM BULL, V118, P1099, DOI 10.1130/B25892.1; Matsuyama I, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002447; Milne-Thomson L. M., 1996, THEORETICAL HYDRODYN, P743; Mitchell RN, 2010, GEOLOGY, V38, P755, DOI 10.1130/G30910.1; Mitchell RN, 2010, PRECAMBRIAN RES, V179, P121, DOI 10.1016/j.precamres.2010.02.018; Mitrovica JX, 2004, EARTH PLANET SC LETT, V225, P177, DOI 10.1016/j.epsl.2004.06.005; Oldham D, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000603; RICARD Y, 1993, GEOPHYS J INT, V113, P284, DOI 10.1111/j.1365-246X.1993.tb00888.x; Richards MA, 1999, GEOPHYS RES LETT, V26, P1777, DOI 10.1029/1999GL900331; Ritsema J, 2000, Sci Prog, V83 ( Pt 3), P243; Rouby H, 2010, EARTH PLANET SC LETT, V292, P301, DOI 10.1016/j.epsl.2010.01.033; SPADA G, 1992, NATURE, V360, P452, DOI 10.1038/360452a0; SPADA G, 1994, GEOPHYS RES LETT, V21, P137, DOI 10.1029/93GL03465; Steinberger B, 2002, GEODYNAMICS, V29, P233; Steinberger B, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002889; Steinberger B, 2008, NATURE, V452, P620, DOI 10.1038/nature06824; Torsvik TH, 2012, EARTH-SCI REV, V114, P325, DOI 10.1016/j.earscirev.2012.06.007; Torsvik TH, 2010, NATURE, V466, P352, DOI 10.1038/nature09216; Tsai VC, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB003923; VANDERVOO R, 1994, EARTH PLANET SC LETT, V122, P239, DOI 10.1016/0012-821X(94)90063-9; Watts A.B., 2001, ISOSTASY FLEXURE LIT; WILLEMANN RJ, 1984, ICARUS, V60, P701, DOI 10.1016/0019-1035(84)90174-X; Zhang N, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006896; Zhong SJ, 2007, EARTH PLANET SC LETT, V261, P551, DOI 10.1016/j.epsl.2007.07.049	36	45	45	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					244	+		10.1038/nature11571	http://dx.doi.org/10.1038/nature11571			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23135471				2022-12-28	WOS:000310774300042
J	Trounson, A				Trounson, Alan			Keith H. Campbell (1954-2012) OBITUARY	NATURE			English	Biographical-Item									Calif Inst Regenerat Med, San Francisco, CA 94107 USA		Trounson, A (corresponding author), Calif Inst Regenerat Med, San Francisco, CA 94107 USA.	atrounson@cirm.ca.gov		Trounson, Alan/0000-0001-5469-0500				CAMPBELL K, PUBLICATION LIST	1	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					193	193		10.1038/491193a	http://dx.doi.org/10.1038/491193a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23135461	Bronze			2022-12-28	WOS:000310774300025
J	Peterson, ED; Gaziano, JM				Peterson, Eric D.; Gaziano, J. Michael			Viewing Cardiovascular Research Through the Eyes of Past, Present, and Future Generations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORONARY-HEART-DISEASE; CLOPIDOGREL; PRASUGREL; RISK; SEX		[Peterson, Eric D.] Duke Clin Res Inst, Durham, NC 27705 USA; [Gaziano, J. Michael] Brigham & Womens Hosp, Div Aging, Boston, MA 02115 USA	Duke University; Harvard University; Brigham & Women's Hospital	Peterson, ED (corresponding author), Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27705 USA.	eric.peterson016@mc.duke.edu	Peterson, Eric David/ABF-5033-2021					[Anonymous], 2012, JAMA-J AM MED ASSOC, V308, P1721; Cakulev I, 2009, CIRCULATION, V120, P1623, DOI 10.1161/CIRCULATIONAHA.109.865535; Chan PS, 2012, JAMA-J AM MED ASSOC, V307, P1917, DOI 10.1001/jama.2012.3504; Daviglus ML, 2012, JAMA-J AM MED ASSOC, V308, P1775, DOI 10.1001/jama.2012.14517; DAWBER TR, 1959, AM J PUBLIC HEALTH N, V49, P1349, DOI 10.2105/AJPH.49.10.1349; Dieleman JM, 2012, JAMA-J AM MED ASSOC, V308, P1761, DOI 10.1001/jama.2012.14144; Gurbel PA, 2012, JAMA-J AM MED ASSOC, V308, P1785, DOI 10.1001/jama.2012.17312; Hernandez AF, 2007, JAMA-J AM MED ASSOC, V298, P1525, DOI 10.1001/jama.298.13.1525; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Safford MM, 2012, JAMA-J AM MED ASSOC, V308, P1768, DOI 10.1001/jama.2012.14306; Sesso HD, 2012, JAMA-J AM MED ASSOC, V308, P1751, DOI 10.1001/jama.2012.14805; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wilkins JT, 2012, JAMA-J AM MED ASSOC, V308, P1795, DOI 10.1001/jama.2012.14312; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	14	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1809	1810		10.1001/jama.2012.28743	http://dx.doi.org/10.1001/jama.2012.28743			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117784				2022-12-28	WOS:000310726500030
J	Taber, S				Taber, Sally			Should all advertising of cosmetic surgery be banned? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Independent Healthcare Advisory Serv, London WC1A 1DU, England		Taber, S (corresponding author), Independent Healthcare Advisory Serv, London WC1A 1DU, England.	SallyTaber@independenthealthcare.org.uk						[Anonymous], 2012, GUARDIAN; [Anonymous], 2011, WHICH; Independent Healthcare Advisory Services, 2011, GOOD MEDICAL PRACTIC; Independent Healthcare Advisory Services, 2012, POLICY STATEMENT ON; Independent Healthcare Advisory Services, 2011, POLICY STATEMENT ON; Sweney M., 2011, GUARDIAN	6	5	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 7	2012	345								e7508	10.1136/bmj.e7508	http://dx.doi.org/10.1136/bmj.e7508			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	036LI	23135202				2022-12-28	WOS:000311027000002
J	Greenberg, ER; Chey, WD				Greenberg, E. Robert; Chey, William D.			Defining the role of sequential therapy for H pylori infection	LANCET			English	Editorial Material							GASTRIC-CANCER; TRIPLE THERAPY; ERADICATION; CONCOMITANT; MANAGEMENT; TRIAL		[Greenberg, E. Robert] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Chey, William D.] Univ Michigan, Sch Med, Div Gastroenterol, Ann Arbor, MI USA	Fred Hutchinson Cancer Center; University of Michigan System; University of Michigan	Greenberg, ER (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA.	e.r.greenberg@dartmouth.edu	Chey, William/AAY-7766-2021					Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; Choi HS, 2012, WORLD J GASTROENTERO, V18, P2377, DOI 10.3748/wjg.v18.i19.2377; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Gatta L, 2009, AM J GASTROENTEROL, V104, P3069, DOI 10.1038/ajg.2009.555; Graham DY, 2012, GASTROENTEROLOGY, V143, P10, DOI 10.1053/j.gastro.2012.05.012; Greenberg ER, 2011, LANCET, V378, P507, DOI 10.1016/S0140-6736(11)60825-8; Huang YK, 2012, J DIGEST DIS, V13, P232, DOI 10.1111/j.1751-2980.2012.00575.x; Kadayifci A, 2012, HELICOBACTER, V17, P121, DOI 10.1111/j.1523-5378.2011.00924.x; Liou JM, 2012, LANCET, V6736, P61579; Ma JL, 2012, J NATL CANCER I, V104, P488, DOI 10.1093/jnci/djs003; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; McNulty CAM, 2012, ALIMENT PHARM THER, V35, P1221, DOI 10.1111/j.1365-2036.2012.05083.x; Zullo A, 2003, ALIMENT PHARM THER, V17, P719, DOI 10.1046/j.1365-2036.2003.01461.x	13	2	2	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 19	2013	381	9862					180	182		10.1016/S0140-6736(12)61849-2	http://dx.doi.org/10.1016/S0140-6736(12)61849-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	075LL	23158881				2022-12-28	WOS:000313887600006
J	Teerlink, JR; Cotter, G; Davison, BA; Felker, GM; Filippatos, G; Greenberg, BH; Ponikowski, P; Unemori, E; Voors, AA; Adams, KF; Dorobantu, MI; Grinfeld, LR; Jondeau, G; Marmor, A; Masip, J; Pang, PS; Werdan, K; Teichman, SL; Trapani, A; Bush, CA; Saini, R; Schumacher, C; Severin, TM; Metra, M				Teerlink, John R.; Cotter, Gad; Davison, Beth A.; Felker, G. Michael; Filippatos, Gerasimos; Greenberg, Barry H.; Ponikowski, Piotr; Unemori, Elaine; Voors, Adriaan A.; Adams, Kirkwood F., Jr.; Dorobantu, Maria I.; Grinfeld, Liliana R.; Jondeau, Guillaume; Marmor, Alon; Masip, Josep; Pang, Peter S.; Werdan, Karl; Teichman, Sam L.; Trapani, Angelo; Bush, Christopher A.; Saini, Rajnish; Schumacher, Christoph; Severin, Thomas M.; Metra, Marco		RELAXin Acute Heart Failure RELAX-	Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial	LANCET			English	Article							RENAL-FUNCTION; DYSPNEA; ROLOFYLLINE; ANTAGONIST; OUTCOMES; HOSPITALIZATION; MORTALITY; LEVOSIMENDAN; READMISSION; ASSOCIATION	Background Serelaxin, recombinant human relaxin-2, is a vasoactive peptide hormone with many biological and haemodynamic effects. In a pilot study, serelaxin was safe and well tolerated with positive clinical outcome signals in patients with acute heart failure. The RELAX-AHF trial tested the hypothesis that serelaxin-treated patients would have greater dyspnoea relief compared with patients treated with standard care and placebo. Methods RELAX-AHF was an international, double-blind, placebo-controlled trial, enrolling patients admitted to hospital for acute heart failure who were randomly assigned (1:1) via a central randomisation scheme blocked by study centre to standard care plus 48-h intravenous infusions of placebo or serelaxin (30 mu g/kg per day) within 16 h from presentation. All patients had dyspnoea, congestion on chest radiograph, increased brain natriuretic peptide (BNP) or N-terminal prohormone of BNP, mild-to-moderate renal insufficiency, and systolic blood pressure greater than 125 mm Hg. Patients, personnel administering study drug, and those undertaking study-related assessments were masked to treatment assignment. The primary endpoints evaluating dyspnoea improvement were change from baseline in the visual analogue scale area under the curve (VAS AUC) to day 5 and the proportion of patients with moderate or marked dyspnoea improvement measured by Likert scale during the first 24 h, both analysed by intention to treat. This trial is registered at ClinicalTrials.gov, NCT00520806. Findings 1161 patients were randomly assigned to serelaxin (n=581) or placebo (n=580). Serelaxin improved the VAS AUC primary dyspnoea endpoint (448 mm x h, 95% CI 120-775; p=0.007) compared with placebo, but had no significant effect on the other primary endpoint (Likert scale; placebo, 150 patients [26%]; serelaxin, 156 [27%]; p=0.70). No significant effects were recorded for the secondary endpoints of cardiovascular death or readmission to hospital for heart failure or renal failure (placebo, 75 events [60-day Kaplan-Meier estimate, 13.0%]; serelaxin, 76 events [13.2%]; hazard ratio [HR] 1.02 [0.74-1.41], p=0.89] or days alive out of the hospital up to day 60 (placebo, 47.7 [SD 12.1] days; serelaxin, 48.3 [11.6]; p=0.37). Serelaxin treatment was associated with significant reductions of other prespecified additional endpoints, including fewer deaths at day 180 (placebo, 65 deaths; serelaxin, 42; HR 0.63, 95% CI 0.42-0.93; p=0.019). Interpretation Treatment of acute heart failure with serelaxin was associated with dyspnoea relief and improvement in other clinical outcomes, but had no effect on readmission to hospital. Serelaxin treatment was well tolerated and safe, supported by the reduced 180-day mortality.	[Teerlink, John R.] San Francisco VA Med Ctr, Div Cardiol, San Francisco, CA 94121 USA; [Teerlink, John R.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Cotter, Gad; Davison, Beth A.] Momentum Res, Durham, NC USA; [Felker, G. Michael] Duke Univ, Sch Med, Durham, NC USA; [Felker, G. Michael] Duke Univ, Med Ctr, Duke Heart Ctr, Durham, NC 27710 USA; [Filippatos, Gerasimos] Athens Univ Hosp, Athens, Greece; [Greenberg, Barry H.] Univ Calif San Diego, San Diego, CA 92103 USA; [Ponikowski, Piotr] Med Univ, Clin Mil Hosp, Wroclaw, Poland; [Unemori, Elaine; Teichman, Sam L.] Corthera, San Carlos, CA USA; [Voors, Adriaan A.] Univ Groningen, Univ Med Ctr Gronignen, Groningen, Netherlands; [Adams, Kirkwood F., Jr.] Univ N Carolina, Chapel Hill, NC USA; [Dorobantu, Maria I.] Floreasca Emergency Clin Hosp, Bucharest, Romania; [Grinfeld, Liliana R.] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Jondeau, Guillaume] Univ Paris 07, Hop Bichat, Paris, France; [Marmor, Alon] Ziv Med Ctr, Safed, Israel; [Masip, Josep] Univ Barcelona, Consorci Sanitari Integral, Barcelona, Spain; [Pang, Peter S.] Northwestern Univ, Chicago, IL 60611 USA; [Werdan, Karl] Univ Halle Wittenberg, Halle, Saale, Germany; [Trapani, Angelo; Bush, Christopher A.; Saini, Rajnish] Novartis Pharmaceut, E Hanover, NJ USA; [Schumacher, Christoph; Severin, Thomas M.] Novartis Pharmaceut, Basel, Switzerland; [Metra, Marco] Univ Brescia, Brescia, Italy	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Duke University; Duke University; University of California System; University of California San Diego; Wroclaw Medical University; University of Groningen; University of North Carolina; University of North Carolina Chapel Hill; University of Buenos Aires; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Ziv Medical Center; University of Barcelona; Northwestern University; Martin Luther University Halle Wittenberg; Novartis; Novartis; University of Brescia	Teerlink, JR (corresponding author), San Francisco VA Med Ctr, Div Cardiol, San Francisco, CA 94121 USA.	john.teerlink@ucsf.edu	Felker, Michael/AAX-2288-2021; Voors, Adriaan/ABE-6784-2020; Ponikowski, Piotr/O-6454-2015; Filippatos, Gerasimos/ABA-4656-2021; DOROBANTU, MARIA/AAS-2934-2020; Teerlink, John R/D-2986-2012; Metra, marco/E-7101-2010	Ponikowski, Piotr/0000-0002-3391-7064; Pang, Peter/0000-0003-3444-2811; Cotter, Gad/0000-0002-9613-3339; Metra, Marco/0000-0001-6691-8568; Felker, Gary/0000-0002-5931-1239; Davison, Beth/0000-0003-2374-6449	Corthera; Amgen; Bayer; Cardio3 Bioscience; Cytokinetics; Merck; Novartis; Takeda; Teva; Trevena; Otsuka; Roche Diagnostics; NHLBI; Nanosphere; European Union; Abbott; PDL BioPharma; Alere; Cardio3Biosciences; Celladon; Ceva; European Committee; Dutch Heart Foundation; Servier; Torrent; Vifor; Duke Clinical Research Institute; Momentum Research; Abbott Vascular	Corthera; Amgen(Amgen); Bayer(Bayer AG); Cardio3 Bioscience; Cytokinetics; Merck(Merck & Company); Novartis(Novartis); Takeda(Takeda Pharmaceutical Company Ltd); Teva(Teva Pharmaceutical Industries); Trevena; Otsuka(Otsuka Pharmaceutical); Roche Diagnostics; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Nanosphere; European Union(European Commission); Abbott(Abbott Laboratories); PDL BioPharma; Alere; Cardio3Biosciences; Celladon; Ceva; European Committee; Dutch Heart Foundation(Netherlands Heart Foundation); Servier(Servier); Torrent; Vifor; Duke Clinical Research Institute; Momentum Research; Abbott Vascular(Abbott Laboratories)	JRT has received research grants or consulting fees from Amgen, Bayer, Corthera, Cardio3 Bioscience, Cytokinetics, Merck, Novartis, Takeda, Teva, and Trevena. GC and BAD are employees of Momentum Research, which has provided consulting and trial management services to NovaCardia, Merck, Corthera, Novartis, Nile Therapeutics, Bioheart, Cardio3 Biosciences, Amgen, Celadon, Targegen, Trevena, Sorbent Therapeutics, and NIH. GMF reports consulting income from Novartis, Medpace, Amgen, Otsuka, Trevena, Roche Diagnostics, Merck, BG Medicine, Medtronic, and St Judes and grant fundings from Amgen, Otsuka, Roche Diagnostics, and NHLBI. GF is an executive committee member and consultant to Corthera (a Novartis company), Bayer, Cardiorentis, and has received research grants from Amgen, Nanosphere, European Union. BHG served as a consultant for Corthera and Novartis. PP was a consultant for Astellas, Bayer, EKR Therapeutics, J&J, the Medicines Company, Medtronic, Novartis, Otsuka, Palatin Technologies, PDL BioPharma, Pericor Therapeutics, SigmaTau, Solvay Pharmaceuticals, and Trevena; has received honoraria from Alere, Beckman-Coulter, BiogenIdec, Corthera, Ikaria, Nile Therapeutics, Momentum Research, and Overcome; has received research support from Abbott, Merck and PDL BioPharma; and has received travel support from MyLife and equipment support from Sonosite. EU is employed by the sponsor, Corthera (a Novartis company). AAV has received consultancy fees and/or research grants from Alere, Bayer, Cardio3Biosciences, Celladon, Ceva, European Committee, Dutch Heart Foundation, Novartis, Servier, Torrent, and Vifor. KFA has received research grants and consulting fees from Corthera, Merck, Roche Diagnostics, and Duke Clinical Research Institute; research grants from Novartis and Amgen; and consulting fees from Momentum Research. MID, LRG, JG, AM, JM, and KW have received research grants from Corthera (a Novartis affiliate company). KW received personal support for travel to meetings for the RELAX-AHF trial. KW's institution received honorarium for patient enrolment in the RELAX-AHF trial and honorarium for national coordinatorship of KW for the RELAX-AHF trial. PSP has been a consultant for Astellas, Bayer, EKR Therapeutics, J&J, the Medicines Company, Medtronic, Novartis, Otsuka, Palatin Technologies, PDL BioPharma, Pericor Therapeutics, SigmaTau, Solvay Pharmaceuticals, Trevena; received honoraria from Alere, Beckman-Coulter, BiogenIdec, Corthera, Ikaria, Nile Therapeutics, Momentum Research, and Overcome; received research support from Abbott, Merck, and PDL BioPharma; and received travel support from MyLife and equipment support from Sonosite. SLT was an employee of the sponsor, Corthera (a Novartis affiliate company). AT, CAB, RS, CS, and TMS are Novartis employees and receive salary, benefits, and stock options from Novartis Pharmaceuticals Corporation (CAB, RS, AT) or Novartis Pharma (CS, TS). MM has received consulting income from Abbott Vascular, Bayer, Corthera, and Novartis, as well as travel support and honoraria from Servier and Novartis.	ADHERE Scientific Advisory Committee, 2006, AC DEC HEART FAIL NA; Ander Douglas S, 2004, Congest Heart Fail, V10, P188, DOI 10.1111/j.1527-5299.2004.03475.x; Aronson D, 2010, J CARD FAIL, V16, P541, DOI 10.1016/j.cardfail.2010.02.001; Au AG, 2012, AM HEART J, V164, P365, DOI 10.1016/j.ahj.2012.06.010; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Conrad KP, 2011, AM J PHYSIOL-REG I, V301, pR267, DOI 10.1152/ajpregu.00156.2011; Cotter G, 2008, EUR J HEART FAIL, V10, P165, DOI 10.1016/j.ejheart.2008.01.007; Damasceno A, 2012, ARCH INTERN MED, V172, P1386, DOI 10.1001/archinternmed.2012.3310; Damman K, 2007, J CARD FAIL, V13, P599, DOI 10.1016/j.cardfail.2007.04.008; Dschietzig T, 2009, J CARD FAIL, V15, P182, DOI 10.1016/j.cardfail.2009.01.008; Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419; Felker GM, 2003, J AM COLL CARDIOL, V41, P997, DOI 10.1016/S0735-1097(02)02968-6; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Gheorghiade M, 2007, JAMA-J AM MED ASSOC, V297, P1332, DOI 10.1001/jama.297.12.1332; Gheorghiade M, 2009, J AM COLL CARDIOL, V53, P557, DOI 10.1016/j.jacc.2008.10.041; Heidenreich PA, 2010, J AM COLL CARDIOL, V56, P362, DOI 10.1016/j.jacc.2010.02.053; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Maggioni AP, 2010, EUR J HEART FAIL, V12, P1076, DOI 10.1093/eurjhf/hfq154; Massie BM, 2010, NEW ENGL J MED, V363, P1419, DOI 10.1056/NEJMoa0912613; McMurray JJV, 2007, JAMA-J AM MED ASSOC, V298, P2009, DOI 10.1001/jama.298.17.2009; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mebazaa A, 2007, JAMA-J AM MED ASSOC, V297, P1883, DOI 10.1001/jama.297.17.1883; Mebazaa A, 2011, INTENS CARE MED, V37, P290, DOI 10.1007/s00134-010-2073-4; Mebazaa A, 2010, EUR HEART J, V31, P832, DOI 10.1093/eurheartj/ehp458; Mebazaa A, 2009, EUR J HEART FAIL, V11, P304, DOI 10.1093/eurjhf/hfn045; Metra M, 2012, EUR HEART J, V33, P2135, DOI 10.1093/eurheartj/ehs205; Metra M, 2011, EUR HEART J, V32, P1519, DOI 10.1093/eurheartj/ehr042; Metra M, 2010, EUR J HEART FAIL, V12, P1130, DOI 10.1093/eurjhf/hfq132; Metra M, 2010, EUR J HEART FAIL, V12, P499, DOI [10.1093/eurjhf/hfq021, 10.1093/eurjhf/hfq186]; O'Connor CM, 2011, NEW ENGL J MED, V365, P32, DOI 10.1056/NEJMoa1100171; O'Connor CM, 2012, EUR J HEART FAIL, V14, P605, DOI 10.1093/eurjhf/hfs029; Ponikowski P, 2012, AM HEART J, V163, P149, DOI 10.1016/j.ahj.2011.10.009; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Solomon SD, 2007, CIRCULATION, V116, P1482, DOI 10.1161/CIRCULATIONAHA.107.696906; Teerlink JR, 2012, DRUG SAFETY, V35, P233, DOI 10.2165/11594680-000000000-00000; Teerlink JR, 2009, LANCET, V373, P1429, DOI 10.1016/S0140-6736(09)60622-X; Teichman Sam L, 2010, Curr Heart Fail Rep, V7, P75, DOI 10.1007/s11897-010-0010-z; Testani JM, 2010, CIRCULATION, V122, P265, DOI 10.1161/CIRCULATIONAHA.109.933275; Torre-Amione G, 2009, J CARD FAIL, V15, P639, DOI 10.1016/j.cardfail.2009.04.001; von Leupoldt A, 2009, NEUROIMAGE, V48, P200, DOI 10.1016/j.neuroimage.2009.06.015; Voors AA, 2011, J AM COLL CARDIOL, V57, P1899, DOI 10.1016/j.jacc.2010.11.057; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531, DOI 10.1001/jama.287.12.1531	43	660	699	2	76	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2013	381	9860					29	39		10.1016/S0140-6736(12)61855-8	http://dx.doi.org/10.1016/S0140-6736(12)61855-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064AW	23141816				2022-12-28	WOS:000313044300024
J	Warden, MR; Selimbeyoglu, A; Mirzabekov, JJ; Lo, M; Thompson, KR; Kim, SY; Adhikari, A; Tye, KM; Frank, LM; Deisseroth, K				Warden, Melissa R.; Selimbeyoglu, Aslihan; Mirzabekov, Julie J.; Lo, Maisie; Thompson, Kimberly R.; Kim, Sung-Yon; Adhikari, Avishek; Tye, Kay M.; Frank, Loren M.; Deisseroth, Karl			A prefrontal cortex-brainstem neuronal projection that controls response to behavioural challenge	NATURE			English	Article							COGNITIVE CONTROL; LATERAL HABENULA; DEPRESSION; RAT; DISORDERS; STIMULATION; MOOD	The prefrontal cortex (PFC) is thought to participate in high-level control of the generation of behaviours (including the decision to execute actions(1)); indeed, imaging and lesion studies in human beings have revealed that PFC dysfunction can lead to either impulsive states with increased tendency to initiate action(2), or to amotivational states characterized by symptoms such as reduced activity, hopelessness and depressed mood(3). Considering the opposite valence of these two phenotypes as well as the broad complexity of other tasks attributed to PFC, we sought to elucidate the PFC circuitry that favours effortful behavioural responses to challenging situations. Here we develop and use a quantitative method for the continuous assessment and control of active response to a behavioural challenge, synchronized with single-unit electrophysiology and optogenetics in freely moving rats. In recording from the medial PFC (mPFC), we observed that many neurons were not simply movement-related in their spike-firing patterns but instead were selectively modulated from moment to moment, according to the animal's decision to act in a challenging situation. Surprisingly, we next found that direct activation of principal neurons in the mPFC had no detectable causal effect on this behaviour. We tested whether this behaviour could be causally mediated by only a subclass of mPFC cells defined by specific downstream wiring. Indeed, by leveraging optogenetic projection-targeting to control cells with specific efferent wiring patterns, we found that selective activation of those mPFC cells projecting to the brainstem dorsal raphe nucleus (DRN), a serotonergic nucleus implicated in major depressive disorder(4), induced a profound, rapid and reversible effect on selection of the active behavioural state. These results may be of importance in understanding the neural circuitry underlying normal and pathological patterns of action selection and motivation in behaviour.	[Warden, Melissa R.; Selimbeyoglu, Aslihan; Mirzabekov, Julie J.; Thompson, Kimberly R.; Kim, Sung-Yon; Adhikari, Avishek; Tye, Kay M.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Selimbeyoglu, Aslihan; Kim, Sung-Yon; Deisseroth, Karl] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Lo, Maisie] Stanford Univ, Bio X Program, Stanford, CA 94305 USA; [Tye, Kay M.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Frank, Loren M.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Frank, Loren M.] Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Massachusetts Institute of Technology (MIT); Northwell Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Warden, MR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	mwarden@stanford.edu; deissero@stanford.edu	Tye, Kay/J-6158-2013; Adhikari, Avishek/A-3339-2012; Warden, Melissa R/M-9300-2016; Adhikari, Avishek/AAF-4444-2021; Kim, Sung-Yon/AAO-8405-2020; Adhikari, Avishek/N-1284-2015	Tye, Kay/0000-0002-2435-0182; Adhikari, Avishek/0000-0002-9187-9211; Warden, Melissa R/0000-0003-2240-3997; Adhikari, Avishek/0000-0002-9187-9211; Kim, Sung-Yon/0000-0003-0791-7308; Adhikari, Avishek/0000-0002-9187-9211; Frank, Loren/0000-0002-1752-5677	Wiegers Family Fund; NARSAD; Stanford Graduate Fellowship; Samsung Scholarship; Berry Foundation Fellowship; NIMH [1F32MH088010-01]; NIMH; NIDA; DARPA REPAIR Program; Keck Foundation; McKnight Foundation; Yu Foundation; Snyder Foundation; Tarlton Foundation; Alice Woo Foundation; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075957, F32MH088010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020794] Funding Source: NIH RePORTER	Wiegers Family Fund; NARSAD(NARSAD); Stanford Graduate Fellowship(Stanford University); Samsung Scholarship(Samsung); Berry Foundation Fellowship; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); DARPA REPAIR Program; Keck Foundation(W.M. Keck Foundation); McKnight Foundation; Yu Foundation; Snyder Foundation; Tarlton Foundation; Alice Woo Foundation; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank H. Mayberg, R. Malenka, L. Gunaydin, J. Mattis, I. Ellwood and I. Witten for helpful comments on the manuscript; I. Ellwood, I. Witten, R. Airan, L. Meltzer, M. Roy, V. Gradinaru, A. Andalman, T. Davidson, R. Durand, M. Bower and M. Carr for useful discussions; and all members of the K. D. laboratory for their support. We are grateful to S. Pak, C. Ramakrishnan and C. Perry for technical assistance. This work was supported by the Wiegers Family Fund (K.D.), NARSAD (M.R.W. and K.R.T.), Stanford Graduate Fellowship (A.S.), Samsung Scholarship (S.-Y.K.), Berry Foundation Fellowship (A.A.), NIMH (1F32MH088010-01, K.M.T.), and NIMH, NIDA, the DARPA REPAIR Program, the Keck Foundation, the McKnight Foundation, the Yu, Snyder, Tarlton and Alice Woo Foundations, and the Gatsby Charitable Foundation (K.D.).	Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Austin MP, 2001, BRIT J PSYCHIAT, V178, P200, DOI 10.1192/bjp.178.3.200; BAXTER LR, 1989, ARCH GEN PSYCHIAT, V46, P243; Celada P, 2001, J NEUROSCI, V21, P9917, DOI 10.1523/JNEUROSCI.21-24-09917.2001; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; DALGLEISH T, 1990, CLIN PSYCHOL REV, V10, P589, DOI 10.1016/0272-7358(90)90098-U; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Elliott R, 1997, PSYCHOL MED, V27, P931, DOI 10.1017/S0033291797005187; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Goncalves L, 2009, BRAIN RES BULL, V78, P240, DOI 10.1016/j.brainresbull.2008.11.012; Hamani C, 2010, BIOL PSYCHIAT, V67, P117, DOI 10.1016/j.biopsych.2009.08.025; INGRAM RE, 1994, COGNITIVE THER RES, V18, P317, DOI 10.1007/BF02357508; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Kim U, 2012, EUR J NEUROSCI, V35, P1253, DOI 10.1111/j.1460-9568.2012.08030.x; Maes Michael, 1995, P933; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; McGuire JT, 2010, P NATL ACAD SCI USA, V107, P7922, DOI 10.1073/pnas.0910662107; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097	27	400	409	4	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					428	432		10.1038/nature11617	http://dx.doi.org/10.1038/nature11617			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23160494	Green Accepted			2022-12-28	WOS:000312488200056
J	Ofri, D				Ofri, Danielle			The Storm and the Aftermath	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ofri, Danielle] NYU, Sch Med, New York, NY 10003 USA; [Ofri, Danielle] Bellevue Hosp, New York, NY USA	New York University; Bellevue Hospital Center	Ofri, D (corresponding author), NYU, Sch Med, New York, NY 10003 USA.			Ofri, Danielle/0000-0001-9865-7104					0	16	17	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24					2265	2267		10.1056/NEJMp1213843	http://dx.doi.org/10.1056/NEJMp1213843			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	052HF	23151281				2022-12-28	WOS:000312187700014
J	Han, ZJ; Qiu, F; Eisenberg, R; Holland, PL; Krauss, TD				Han, Zhiji; Qiu, Fen; Eisenberg, Richard; Holland, Patrick L.; Krauss, Todd D.			Robust Photogeneration of H-2 in Water Using Semiconductor Nanocrystals and a Nickel Catalyst	SCIENCE			English	Article							PHOTOCATALYTIC HYDROGEN-PRODUCTION; ARTIFICIAL PHOTOSYNTHESIS; REDUCTION; COMPLEX; LIGHT; LIGANDS	Homogeneous systems for light-driven reduction of protons to H-2 typically suffer from short lifetimes because of decomposition of the light-absorbing molecule. We report a robust and highly active system for solar hydrogen generation in water that uses CdSe nanocrystals capped with dihydrolipoic acid (DHLA) as the light absorber and a soluble Ni2+-DHLA catalyst for proton reduction with ascorbic acid as an electron donor at pH = 4.5, which gives >600,000 turnovers. Under appropriate conditions, the precious-metal-free system has undiminished activity for at least 360 hours under illumination at 520 nanometers and achieves quantum yields in water of over 36%.	[Han, Zhiji; Qiu, Fen; Eisenberg, Richard; Holland, Patrick L.; Krauss, Todd D.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA	University of Rochester	Eisenberg, R (corresponding author), Univ Rochester, Dept Chem, Rochester, NY 14627 USA.	eisenberg@chem.rochester.edu; holland@chem.rochester.edu; krauss@chem.rochester.edu	Krauss, Todd/GQA-6399-2022; Eisenberg, Robert/P-6070-2019; Qiu, Fen/H-9479-2016	Krauss, Todd/0000-0002-4860-874X; Eisenberg, Richard/0000-0003-1762-535X	Office of Basic Energy Sciences, U.S. Department of Energy [DE-FG02-09ER16121, DE-SC0002106]	Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE))	Z.H. led the effort for hydrogen generation and catalysis, and F. Q. for nanocrystal synthesis and characterization. This work was supported by the Office of Basic Energy Sciences, U.S. Department of Energy, grant DE-FG02-09ER16121 and DE-SC0002106. The authors acknowledge the University of Rochester Medical Center and the Department of Environmental Medicine for the analytical support and R. M. Gelein for the cadmium and nickel AAS measurements.	Alstrum-Acevedo JH, 2005, INORG CHEM, V44, P6802, DOI 10.1021/ic050904r; Amirav L, 2010, J PHYS CHEM LETT, V1, P1051, DOI 10.1021/jz100075c; BARD AJ, 1995, ACCOUNTS CHEM RES, V28, P141, DOI 10.1021/ar00051a007; BONOMI F, 1992, INORG CHIM ACTA, V192, P237, DOI 10.1016/S0020-1693(00)80765-3; BROWN GM, 1979, J AM CHEM SOC, V101, P1298, DOI 10.1021/ja00499a051; Brown KA, 2012, J AM CHEM SOC, V134, P5627, DOI 10.1021/ja2116348; Brown KA, 2010, J AM CHEM SOC, V132, P9672, DOI 10.1021/ja101031r; DiSalle BF, 2011, J AM CHEM SOC, V133, P11819, DOI 10.1021/ja201514e; Eckenhoff WT, 2012, DALTON T, V41, P13004, DOI 10.1039/c2dt30823a; Esswein AJ, 2007, CHEM REV, V107, P4022, DOI 10.1021/cr050193e; Fihri A, 2008, ANGEW CHEM INT EDIT, V47, P564, DOI 10.1002/anie.200702953; Han ZJ, 2012, ANGEW CHEM INT EDIT, V51, P1667, DOI 10.1002/anie.201107329; Jasieniak J, 2011, ACS NANO, V5, P5888, DOI 10.1021/nn201681s; Kockerling M, 2000, INORG CHEM COMMUN, V3, P117; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; McCormick TM, 2010, J AM CHEM SOC, V132, P15480, DOI 10.1021/ja1057357; McNamara WR, 2012, P NATL ACAD SCI USA, V109, P15594, DOI 10.1073/pnas.1120757109; Probst B, 2011, INORG CHEM, V50, P3404, DOI 10.1021/ic102317u; Shemesh Y, 2011, ANGEW CHEM INT EDIT, V50, P1185, DOI 10.1002/anie.201006407; SLETTEN J, 1994, ACTA CHEM SCAND, V48, P929, DOI 10.3891/acta.chem.scand.48-0929; Streich D, 2010, CHEM-EUR J, V16, P60, DOI 10.1002/chem.200902489; Talapin DV, 2004, J PHYS CHEM B, V108, P18826, DOI 10.1021/jp046481g; TREMEL W, 1988, INORG CHEM, V27, P3886, DOI 10.1021/ic00295a004; Wang F, 2011, ANGEW CHEM INT EDIT, V50, P3193, DOI 10.1002/anie.201006352; White TA, 2011, J AM CHEM SOC, V133, P15332, DOI 10.1021/ja206782k	27	633	644	32	928	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1321	1324		10.1126/science.1227775	http://dx.doi.org/10.1126/science.1227775			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23138979				2022-12-28	WOS:000311991200060
J	Cerreta, F; Eichler, HG; Rasi, G				Cerreta, Francesca; Eichler, Hans-Georg; Rasi, Guido			Drug Policy for an Aging Population - The European Medicines Agency's Geriatric Medicines Strategy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cerreta, Francesca; Eichler, Hans-Georg; Rasi, Guido] European Medicines Agcy, London, England; [Rasi, Guido] Univ Roma Tor Vergata, Rome, Italy	University of Rome Tor Vergata	Cerreta, F (corresponding author), European Medicines Agcy, London, England.		Rasi, Guido/AAC-8172-2021	Rasi, Guido/0000-0002-2191-1386				Cherubini A, 2010, J AM GERIATR SOC, V58, P1791, DOI 10.1111/j.1532-5415.2010.03032.x; European Medicines Agency, ICH HARM TRIP GUID E; European Medicines Agency, EMA GER MED STRAT; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923	4	99	104	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2012	367	21					1972	1974		10.1056/NEJMp1209034	http://dx.doi.org/10.1056/NEJMp1209034			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040RI	23171092				2022-12-28	WOS:000311340200002
J	Savage, KJ; Hawkeye, MM; Esteban, R; Borisov, AG; Aizpurua, J; Baumberg, JJ				Savage, Kevin J.; Hawkeye, Matthew M.; Esteban, Ruben; Borisov, Andrei G.; Aizpurua, Javier; Baumberg, Jeremy J.			Revealing the quantum regime in tunnelling plasmonics	NATURE			English	Article							METALLIC NANOPARTICLES; OPTICAL RECTIFICATION; FIELD ENHANCEMENT; LIGHT-EMISSION; MICROSCOPE; DIMERS; MODEL; PAIRS	When two metal nanostructures are placed nanometres apart, their optically driven free electrons couple electrically across the gap. The resulting plasmons have enhanced optical fields of a specific colour tightly confined inside the gap. Many emerging nanophotonic technologies depend on the careful control of this plasmonic coupling, including optical nanoantennas for high-sensitivity chemical and biological sensors(1), nanoscale control of active devices(2-4), and improved photovoltaic devices(5). But for subnanometre gaps, coherent quantum tunnelling becomes possible and the system enters a regime of extreme non-locality in which previous classical treatments(6-14) fail. Electron correlations across the gap that are driven by quantum tunnelling require a new description of non-local transport, which is crucial in nanoscale optoelectronics and single-molecule electronics. Here, by simultaneously measuring both the electrical and optical properties of two gold nanostructures with controllable subnanometre separation, we reveal the quantum regime of tunnelling plasmonics in unprecedented detail. All observed phenomena are in good agreement with recent quantum-based models of plasmonic systems(15), which eliminate the singularities predicted by classical theories. These findings imply that tunnelling establishes a quantum limit for plasmonic field confinement of about 10(-8) lambda(3) for visible light (of wavelength lambda). Our work thus prompts new theoretical and experimental investigations into quantum-domain plasmonic systems, and will affect the future of nanoplasmonic device engineering and nanoscale photochemistry.	[Savage, Kevin J.; Hawkeye, Matthew M.; Baumberg, Jeremy J.] Univ Cambridge, Cavendish Lab, Nanophoton Ctr, Cambridge CB3 0HE, England; [Esteban, Ruben; Borisov, Andrei G.; Aizpurua, Javier] Mat Phys Ctr CSIC UPV EHU, Donostia San Sebastian 20018, Spain; [Esteban, Ruben; Borisov, Andrei G.; Aizpurua, Javier] Donostia Int Phys Ctr DIPC, Donostia San Sebastian 20018, Spain; [Borisov, Andrei G.] Univ Paris 11, CNRS, UMR 8214, Inst Sci Mol Orsay, F-91405 Orsay, France	University of Cambridge; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay	Baumberg, JJ (corresponding author), Univ Cambridge, Cavendish Lab, Nanophoton Ctr, Cambridge CB3 0HE, England.	jjb12@cam.ac.uk	Borisov, Andrei/D-1554-2010; Esteban, Ruben/B-9669-2014; Baumberg, Jeremy J/C-1409-2009; Aizpurua, Javier/E-6889-2014	Borisov, Andrei/0000-0003-0819-5028; Esteban, Ruben/0000-0002-9175-2878; Baumberg, Jeremy J/0000-0002-9606-9488; Aizpurua, Javier/0000-0002-1444-7589	EPSRC [EP/G060649/1, EP/H007024/1]; EU grant CUBi-HOLE; Spanish Ministry of Science and Innovation [FIS2010-19609-C02-01, EUI200803816]; Ikerbasque Foundation; Jesus College Cambridge; University of Cambridge; Canadian NSERC post-doctoral fellowship; Engineering and Physical Sciences Research Council [EP/H007024/1, EP/G060649/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EU grant CUBi-HOLE; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ikerbasque Foundation; Jesus College Cambridge; University of Cambridge(University of Cambridge); Canadian NSERC post-doctoral fellowship; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by EPSRC grants EP/G060649/1 and EP/H007024/1, EU grant CUBi-HOLE, and projects FIS2010-19609-C02-01 and EUI200803816 from the Spanish Ministry of Science and Innovation. J.J.B. also acknowledges support from the Ikerbasque Foundation, Jesus College Cambridge and the University of Cambridge, and M. M. H. acknowledges support from a Canadian NSERC post-doctoral fellowship.	Atay T, 2004, NANO LETT, V4, P1627, DOI 10.1021/nl049215n; Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Aubry A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.233901; Bragas AV, 1998, APPL PHYS LETT, V72, P2075, DOI 10.1063/1.121280; Cappella B, 1999, SURF SCI REP, V34, P1, DOI 10.1016/S0167-5729(99)00003-5; Chen C, 2009, SCIENCE, V325, P981, DOI 10.1126/science.1174592; Ciraci C, 2012, SCIENCE, V337, P1072, DOI 10.1126/science.1224823; Cubukcu E, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2339286; Curto AG, 2010, SCIENCE, V329, P930, DOI 10.1126/science.1191922; Danckwerts M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.026104; Duan HG, 2012, NANO LETT, V12, P1683, DOI 10.1021/nl3001309; Esteban R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1806; Ittah N, 2011, NANO LETT, V11, P529, DOI 10.1021/nl103398z; Jain PK, 2007, NANO LETT, V7, P2080, DOI 10.1021/nl071008a; Johansson P, 1998, PHYS REV B, V58, P10823, DOI 10.1103/PhysRevB.58.10823; Kern J., 2012, NANO LETT; Lassiter JB, 2008, NANO LETT, V8, P1212, DOI 10.1021/nl080271o; Nordlander P, 2004, NANO LETT, V4, P899, DOI 10.1021/nl049681c; Novotny L, 2011, NAT PHOTONICS, V5, P83, DOI [10.1038/nphoton.2010.237, 10.1038/NPHOTON.2010.237]; Prodan E, 2003, SCIENCE, V302, P419, DOI 10.1126/science.1089171; Romero I, 2006, OPT EXPRESS, V14, P9988, DOI 10.1364/OE.14.009988; Savage KJ, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3623437; Schneider NL, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.026601; Scholl JA, 2012, NATURE, V483, P421, DOI 10.1038/nature10904; Schuck PJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.017402; Song P, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3554420; Taylor RW, 2011, ACS NANO, V5, P3878, DOI 10.1021/nn200250v; Ward DR, 2010, NAT NANOTECHNOL, V5, P732, DOI 10.1038/nnano.2010.176; Xu HX, 1999, PHYS REV LETT, V83, P4357, DOI 10.1103/PhysRevLett.83.4357; Zuloaga J, 2009, NANO LETT, V9, P887, DOI 10.1021/nl803811g	30	771	776	19	655	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					574	577		10.1038/nature11653	http://dx.doi.org/10.1038/nature11653			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23135399				2022-12-28	WOS:000311339800047
J	Zeppenfeld, M; Englert, BGU; Glockner, R; Prehn, A; Mielenz, M; Sommer, C; van Buuren, LD; Motsch, M; Rempe, G				Zeppenfeld, Martin; Englert, Barbara G. U.; Gloeckner, Rosa; Prehn, Alexander; Mielenz, Manuel; Sommer, Christian; van Buuren, Laurens D.; Motsch, Michael; Rempe, Gerhard			Sisyphus cooling of electrically trapped polyatomic molecules	NATURE			English	Article							POLAR-MOLECULES; SPECTROSCOPY; ATOMS; GAS	Polar molecules have a rich internal structure and long-range dipole-dipole interactions, making them useful for quantum-controlled applications and fundamental investigations. Their potential fully unfolds at ultracold temperatures, where various effects are predicted in many-body physics(1,2), quantum information science(3,4), ultracold chemistry(5,6) and physics beyond the standard model(7,8). Whereas a wide range of methods to produce cold molecular ensembles have been developed(9-13), the cooling of polyatomic molecules (that is, with three or more atoms) to ultracold temperatures has seemed intractable. Here we report the experimental realization of optoelectrical cooling(14), a recently proposed cooling and accumulation method for polar molecules. Its key attribute is the removal of a large fraction of a molecule's kinetic energy in each cycle of the cooling sequence via a Sisyphus effect, allowing cooling with only a few repetitions of the dissipative decay process. We demonstrate the potential of optoelectrical cooling by reducing the temperature of about one million CH3F molecules by a factor of 13.5, with the phase-space density increased by a factor of 29 (or a factor of 70 discounting trap losses). In contrast to other cooling mechanisms, our scheme proceeds in a trap, cools in all three dimensions and should work for a large variety of polar molecules. With no fundamental temperature limit anticipated down to the photon-recoil temperature in the nanokelvin range, we expect our method to be able to produce ultracold polyatomic molecules. The low temperatures, large molecule numbers and long trapping times of up to 27 seconds should allow an interaction-dominated regime to be attained, enabling collision studies and investigation of evaporative cooling towards a Bose-Einstein condensate of polyatomic molecules.	[Zeppenfeld, Martin; Englert, Barbara G. U.; Gloeckner, Rosa; Prehn, Alexander; Mielenz, Manuel; Sommer, Christian; van Buuren, Laurens D.; Motsch, Michael; Rempe, Gerhard] Max Planck Inst Quantum Opt, D-85748 Garching, Germany	Max Planck Society	Zeppenfeld, M (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	martin.zeppenfeld@mpq.mpg.de		Sommer, Christian/0000-0002-8900-2744	Deutsche Forschungsgemeinschaft via the excellence cluster "Munich Centre for Advanced Photonics"	Deutsche Forschungsgemeinschaft via the excellence cluster "Munich Centre for Advanced Photonics"	We thank P. W. H. Pinkse for help during the early stages of this experiment. Support by the Deutsche Forschungsgemeinschaft via the excellence cluster "Munich Centre for Advanced Photonics" is acknowledged.	Andre A, 2006, NAT PHYS, V2, P636, DOI 10.1038/nphys386; Bethlem HL, 1999, PHYS REV LETT, V83, P1558, DOI 10.1103/PhysRevLett.83.1558; Daussy C, 1999, PHYS REV LETT, V83, P1554, DOI 10.1103/PhysRevLett.83.1554; DeMille D, 2004, EUR PHYS J D, V31, P375, DOI 10.1140/epjd/e2004-00163-6; DeMille D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.067901; Englert BGU, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.263003; Fulton R, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.243004; Goral K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.170406; GRANER G, 1981, J MOL SPECTROSC, V89, P19, DOI 10.1016/0022-2852(81)90157-0; Gupta M, 1999, J PHYS CHEM A, V103, P10670, DOI 10.1021/jp993560x; Hinds EA, 1997, PHYS SCRIPTA, VT70, P34, DOI 10.1088/0031-8949/1997/T70/005; Hudson ER, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.063404; Junglen T, 2004, EUR PHYS J D, V31, P365, DOI 10.1140/epjd/e2004-00130-3; Krems RV, 2008, PHYS CHEM CHEM PHYS, V10, P4079, DOI 10.1039/b802322k; Lara M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.183201; Micheli A, 2006, NAT PHYS, V2, P341, DOI 10.1038/nphys287; Motsch M, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/063022; Nagy D, 2006, EUROPHYS LETT, V74, P254, DOI 10.1209/epl/i2005-10521-4; Narevicius E, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055046; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; PRITCHARD DE, 1983, PHYS REV LETT, V51, P1336, DOI 10.1103/PhysRevLett.51.1336; Riedel J, 2011, EUR PHYS J D, V65, P161, DOI 10.1140/epjd/e2011-20082-7; Shuman ES, 2010, NATURE, V467, P820, DOI 10.1038/nature09443; Vuletic V, 2000, PHYS REV LETT, V84, P3787, DOI 10.1103/PhysRevLett.84.3787; Weinstein JD, 1998, NATURE, V395, P148, DOI 10.1038/25949; Xuereb A, 2011, EUR PHYS J D, V65, P273, DOI 10.1140/epjd/e2011-20026-3; Zeppenfeld M, 2010, OPT EXPRESS, V18, P9580, DOI 10.1364/OE.18.009580; Zeppenfeld M, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.041401; Zuchowski PS, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.062708	30	145	145	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					570	573		10.1038/nature11595	http://dx.doi.org/10.1038/nature11595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23151480	Green Submitted			2022-12-28	WOS:000311339800046
J	Armstrong, K				Armstrong, Katrina			Genomics and Health Care Disparities The Role of Statistical Discrimination	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Penn, Ctr Comparat Effectiveness Genom Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Armstrong, K (corresponding author), Univ Penn, Ctr Comparat Effectiveness Genom Med, Perelman Sch Med, 1220 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	karmstro@mail.med.upenn.edu			NCI NIH HHS [UC2CA148310] Funding Source: Medline; NATIONAL CANCER INSTITUTE [UC2CA148310] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agency for Healthcare Research and Quality, 2010 NAT HEALTHC QUA; Bickell NA, 2006, J CLIN ONCOL, V24, P1357, DOI 10.1200/JCO.2005.04.5799; Collins FS, 2004, NAT GENET, V36, pS13, DOI 10.1038/ng1436; Harman JS, 2004, PSYCHIAT SERV, V55, P1379, DOI 10.1176/appi.ps.55.12.1379; *I MED, 2002, UN TREATM CONFR RAC; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lo SS, 2010, J CLIN ONCOL, V28, P1671, DOI 10.1200/JCO.2008.20.2119; Lohmueller KE, 2006, AM J HUM GENET, V78, P130, DOI 10.1086/499287; Valenzuela JM, 2011, PEDIATR DIABETES, V12, P696, DOI 10.1111/j.1399-5448.2011.00766.x	10	5	5	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2012	308	19					1979	1980		10.1001/2012.jama.10820	http://dx.doi.org/10.1001/2012.jama.10820			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040AQ	23138130				2022-12-28	WOS:000311291400019
J	Gruen, RL; Reade, MC				Gruen, Russell L.; Reade, Michael C.			Administer tranexamic acid early to injured patients at risk of substantial bleeding	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRAUMA PATIENTS; HEMORRHAGE; CRASH-2; MORTALITY		[Gruen, Russell L.] Natl Trauma Res Inst, Melbourne, Vic 3004, Australia; [Gruen, Russell L.] Monash Univ, Melbourne, Vic 3004, Australia; [Reade, Michael C.] Univ Queensland, Royal Brisbane & Womens Hosp, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld 4129, Australia; [Reade, Michael C.] Australian Def Force Joint Hlth Command, Canberra, ACT 2600, Australia; [Reade, Michael C.] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld 4129, Australia; [Gruen, Russell L.] The Alfred, Melbourne, Vic 3004, Australia	Monash University; Royal Brisbane & Women's Hospital; University of Queensland; Royal Brisbane & Women's Hospital	Gruen, RL (corresponding author), Natl Trauma Res Inst, Level 4,89 Commercial Rd, Melbourne, Vic 3004, Australia.	r.gruen@alfred.org.au	Reade, Michael/G-7035-2012	Reade, Michael/0000-0003-1570-0707				Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Gruen RL, 2012, LANCET, V380, P1099, DOI 10.1016/S0140-6736(12)61224-0; Guerriero C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018987; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Ker K, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-3; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Roberts I, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5839; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Roberts I, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004896.pub3; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5	14	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2012	345								e7133	10.1136/bmj.e7133	http://dx.doi.org/10.1136/bmj.e7133			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044GQ	23165649				2022-12-28	WOS:000311607800001
J	Huey, DJ; Hu, JC; Athanasiou, KA				Huey, Daniel J.; Hu, Jerry C.; Athanasiou, Kyriacos A.			Unlike Bone, Cartilage Regeneration Remains Elusive	SCIENCE			English	Review							AUTOLOGOUS CHONDROCYTE IMPLANTATION; MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE; IN-VITRO; FUNCTIONAL-PROPERTIES; TISSUE; REPAIR; DEFECTS; TRANSPLANTATION; CHONDROGENESIS	Articular cartilage was predicted to be one of the first tissues to successfully be regenerated, but this proved incorrect. In contrast, bone (but also vasculature and cardiac tissues) has seen numerous successful reparative approaches, despite consisting of multiple cell and tissue types and, thus, possessing more complex design requirements. Here, we use bone-regeneration successes to highlight cartilage-regeneration challenges: such as selecting appropriate cell sources and scaffolds, creating biomechanically suitable tissues, and integrating to native tissue. We also discuss technologies that can address the hurdles of engineering a tissue possessing mechanical properties that are unmatched in human-made materials and functioning in environments unfavorable to neotissue growth.	[Huey, Daniel J.; Hu, Jerry C.; Athanasiou, Kyriacos A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis	Athanasiou, KA (corresponding author), Univ Calif Davis, Dept Biomed Engn, 1 Shields Ave, Davis, CA 95616 USA.	athanasiou@ucdavis.edu	Hu, Jerry/E-7385-2013	Hu, Jerry/0000-0003-0651-1461	NIH [R01AR053286, R01DE015038, R01DE019666]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047839, R01AR053286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015038, R01DE019666] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We gratefully acknowledge support from the NIH (grants R01AR053286, R01DE015038, and R01DE019666). We declare no conflicts of interest.	Acharya C, 2012, J CELL PHYSIOL, V227, P88, DOI 10.1002/jcp.22706; Adkisson HD, 2010, AM J SPORT MED, V38, P1324, DOI 10.1177/0363546510361950; Allon AA, 2012, J BIOMED MATER RES A, V100A, P2168, DOI 10.1002/jbm.a.34144; Ando W, 2007, BIOMATERIALS, V28, P5462, DOI 10.1016/j.biomaterials.2007.08.030; Athanasiou K.A., 2009, SYNTH LECT TISSUE EN, V1, P1, DOI DOI 10.2200/S00212ED1V01Y200910TIS003; Aufderheide AC, 2007, TISSUE ENG, V13, P2195, DOI 10.1089/ten.2006.0291; Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905; Bian LM, 2010, TISSUE ENG PT A, V16, P1781, DOI [10.1089/ten.tea.2009.0482, 10.1089/ten.TEA.2009.0482]; Brand Richard A, 2005, Iowa Orthop J, V25, P82; Bravenboer JV, 2004, ARTHRITIS RES THER, V6, pR469, DOI 10.1186/ar1216; Chen FH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2514; Colnot C, 2011, TISSUE ENG PART B-RE, V17, P449, DOI [10.1089/ten.teb.2011.0243, 10.1089/ten.TEB.2011.0243]; Crawford DC, 2009, AM J SPORT MED, V37, P1334, DOI 10.1177/0363546509333011; Dehne T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2800; DuRaine G, 2009, J ORTHOP RES, V27, P249, DOI 10.1002/jor.20713; Elder BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002341; Englert C, 2005, ARTHRITIS RHEUM-US, V52, P1091, DOI 10.1002/art.20986; Gemmiti CV, 2006, TISSUE ENG, V12, P469, DOI 10.1089/ten.2006.12.469; Gilbert SJ, 2009, TISSUE ENG PT A, V15, P1739, DOI 10.1089/ten.tea.2008.0361; Gille J, 2010, CARTILAGE, V1, P29, DOI 10.1177/1947603509358721; Ha CW, 2012, CYTOTHERAPY, V14, P247, DOI 10.3109/14653249.2011.629645; He DM, 2010, J NEUROSURG, V112, P319, DOI 10.3171/2009.1.JNS08976; Khan IM, 2008, EUR CELLS MATER, V16, P26, DOI 10.22203/eCM.v016a04; Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X; Lewis Paul B, 2009, J Knee Surg, V22, P196; Lima EG, 2007, OSTEOARTHR CARTILAGE, V15, P1025, DOI 10.1016/j.joca.2007.03.008; Mavrogenis AF, 2009, J MUSCULOSKEL NEURON, V9, P61; McNary SM, 2012, TISSUE ENG PART B-RE, V18, P88, DOI [10.1089/ten.teb.2011.0394, 10.1089/ten.TEB.2011.0394]; Meyer U., 2006, BOND CARTILAGE ENG, P20; Mithoefer K, 2009, AM J SPORT MED, V37, P2053, DOI 10.1177/0363546508328414; Moore EE, 2005, OSTEOARTHR CARTILAGE, V13, P623, DOI 10.1016/j.joca.2005.03.003; Moutos FT, 2010, TISSUE ENG PT A, V16, P1291, DOI 10.1089/ten.TEA.2009.0480; Mouw JK, 2007, STEM CELLS, V25, P655, DOI 10.1634/stemcells.2006-0435; Natoli RM, 2009, TISSUE ENG PT A, V15, P3119, DOI 10.1089/ten.TEA.2008.0478; Niemeyer P, 2008, AM J SPORT MED, V36, P2091, DOI 10.1177/0363546508322131; Nuernberger S, 2011, BIOMATERIALS, V32, P1032, DOI 10.1016/j.biomaterials.2010.08.100; Ofek G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002795; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Roberts S, 2009, KNEE, V16, P398, DOI 10.1016/j.knee.2009.02.004; Schubert T, 2009, INT J MOL MED, V23, P455, DOI 10.3892/ijmm_00000151; Scotti C, 2010, BIOMATERIALS, V31, P2252, DOI 10.1016/j.biomaterials.2009.11.110; Steck E, 2009, STEM CELLS DEV, V18, P969, DOI 10.1089/scd.2008.0213; U.S. Department of Health and Human Services (HHS), 2011, GUID IND PREP IDES I; Vanlauwe J, 2011, AM J SPORT MED, V39, P2566, DOI 10.1177/0363546511422220; Vasara AI, 2005, CLIN ORTHOP RELAT R, P233, DOI 10.1097/01.blo.0000150567.00022.2e; VETTER U, 1993, J BONE MINER RES, V8, P133; Viola J., 2003, EMERGENCE TISSUE ENG; Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890; Williams R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013246; Yayon A, 2006, J BONE JOINT SURG BR, V88B, P344; Zheng MH, 2007, TISSUE ENG, V13, P737, DOI 10.1089/ten.2006.0246	53	701	729	33	496	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					917	921		10.1126/science.1222454	http://dx.doi.org/10.1126/science.1222454			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161992	Green Accepted			2022-12-28	WOS:000311083600036
J	Bockrath, MW				Bockrath, Marc W.			A Single-Molecule Engine	SCIENCE			English	Editorial Material									Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA	University of California System; University of California Riverside	Bockrath, MW (corresponding author), Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA.	marc.bockrath@ucr.edu						Cheng YC, 2009, ANNU REV PHYS CHEM, V60, P241, DOI 10.1146/annurev.physchem.040808.090259; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Lotze C, 2012, SCIENCE, V338, P779, DOI 10.1126/science.1227621	4	1	1	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					754	755		10.1126/science.1230530	http://dx.doi.org/10.1126/science.1230530			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139322				2022-12-28	WOS:000310839500031
J	Cohen, JM; Woolsey, AM; Sabot, OJ; Gething, PW; Tatem, AJ; Moonen, B				Cohen, Justin M.; Woolsey, Aaron M.; Sabot, Oliver J.; Gething, Peter W.; Tatem, Andrew J.; Moonen, Bruno			Optimizing Investments in Malaria Treatment and Diagnosis	SCIENCE			English	Editorial Material							SUB-SAHARAN AFRICA; COUNTRIES; FEVERS; POLICY		[Cohen, Justin M.; Woolsey, Aaron M.; Sabot, Oliver J.; Moonen, Bruno] Clinton Hlth Access Initiat, Boston, MA 02127 USA; [Gething, Peter W.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Tatem, Andrew J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA; [Tatem, Andrew J.] Univ Florida, Dept Geog, Gainesville, FL 32610 USA	University of Oxford; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Cohen, JM (corresponding author), Clinton Hlth Access Initiat, Boston, MA 02127 USA.	jcohen@clinton-healthaccess.org	Gething, Peter/ABD-2110-2020; Gething, Peter/GQR-1884-2022	Gething, Peter/0000-0001-6759-5449; Cohen, Justin/0000-0003-4481-6784; Tatem, Andrew/0000-0002-7270-941X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Arnold F., 2012, PRELIMINARY REP IND; Bastiaens GJH, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-76; Clinton Health Access Initiative, 2011, MAINT GAINS GLOB MAL; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Fairhurst RM, 2012, AM J TROP MED HYG, V87, P231, DOI 10.4269/ajtmh.2012.12-0025; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Johnston G., 1996, REPEATED MEASURES AN; Kunene S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-313; Larson BA, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-314; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; O'Connell KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-326; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-99; Pigott DM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-246; Roll Back Malaria Partnership, 2008, GLOB MAL ACT PLAN MA; Shewchuk T, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-325; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2010, GUID TREATM MAL, V2nd; Zanzibar Malaria Control Program, 2009, MAL EL ZANZ FEAS ASS	24	38	38	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107					612	614		10.1126/science.1229045	http://dx.doi.org/10.1126/science.1229045			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	029SM	23118172				2022-12-28	WOS:000310516000033
J	McLaskey, GC; Thomas, AM; Glaser, SD; Nadeau, RM				McLaskey, Gregory C.; Thomas, Amanda M.; Glaser, Steven D.; Nadeau, Robert M.			Fault healing promotes high-frequency earthquakes in laboratory experiments and on natural faults	NATURE			English	Article							RECURRENCE INTERVAL; DEPENDENT FRICTION; STICK-SLIP; STATE; ASPERITIES; VELOCITY; MOMENT; ROCKS; CREEP; MODEL	Faults strengthen or heal with time in stationary contact(1,2), and this healing may be an essential ingredient for the generation of earthquakes(1-3). In the laboratory, healing is thought to be the result of thermally activated mechanisms that weld together micrometre-sized asperity contacts on the fault surface, but the relationship between laboratory measures of fault healing and the seismically observable properties of earthquakes is at present not well defined. Here we report on laboratory experiments and seismological observations that show how the spectral properties of earthquakes vary as a function of fault healing time. In the laboratory, we find that increased healing causes a disproportionately large amount of high-frequency seismic radiation to be produced during fault rupture. We observe a similar connection between earthquake spectra and recurrence time for repeating earthquake sequences on natural faults. Healing rates depend on pressure, temperature(4) and mineralogy(1), so the connection between seismicity and healing may help to explain recent observations of large megathrust earthquakes which indicate that energetic, high-frequency seismic radiation originates from locations that are distinct from the geodetically inferred locations of large-amplitude fault slip(5-7).	[McLaskey, Gregory C.; Glaser, Steven D.] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA; [Thomas, Amanda M.; Nadeau, Robert M.] Univ Calif Berkeley, Berkeley Seismol Lab, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	McLaskey, GC (corresponding author), US Geol Survey, 345 Middlefield Rd,MS 977, Menlo Pk, CA 94025 USA.	gmclaskey@usgs.gov	Nadeau, Robert/G-1884-2017	Nadeau, Robert/0000-0003-1255-0643	US NSF GRF; NSF [CMMI-1131582, EAR-0738342, EAR-0910322]; Div Of Civil, Mechanical, & Manufact Inn [1131582] Funding Source: National Science Foundation	US NSF GRF; NSF(National Science Foundation (NSF)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This paper was improved by suggestions from R. Burgmann and constructive reviews by T. Tullis, C. Marone, W. Ellsworth and N. Beeler. High-Resolution Seismic Network data was provided by the Berkeley Seismological Laboratory and NCEDC. Research was supported by the US NSF GRF and NSF grants CMMI-1131582, EAR-0738342 and EAR-0910322. This is BSL contribution #11-12.	Beeler NM, 2001, J GEOPHYS RES-SOL EA, V106, P30701, DOI 10.1029/2000JB900242; Berthoud P, 1999, PHYS REV B, V59, P14313, DOI 10.1103/PhysRevB.59.14313; Carpenter BM, 2011, NAT GEOSCI, V4, P251, DOI [10.1038/ngeo1089, 10.1038/NGEO1089]; Chen KH, 2010, EARTH PLANET SC LETT, V299, P118, DOI 10.1016/j.epsl.2010.08.027; Chen T, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005749; COX SF, 1991, GEOPHYS RES LETT, V18, P1401, DOI 10.1029/91GL01802; DIETERICH JH, 1984, J GEOPHYS RES, V89, P4196, DOI 10.1029/JB089iB06p04196; DIETERICH JH, 1994, PURE APPL GEOPHYS, V143, P283, DOI 10.1007/BF00874332; DIETERICH JH, 1972, J GEOPHYS RES, V77, P3690, DOI 10.1029/JB077i020p03690; Dreger D, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031353; HESLOT F, 1994, PHYS REV E, V49, P4973, DOI 10.1103/PhysRevE.49.4973; Johnson LR, 2010, GEOPHYS J INT, V182, P1339, DOI 10.1111/j.1365-246X.2010.04680.x; Karner S. L., 2000, GEOPHYS MONOGR SER, V120, P187; Kiser E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047140; Lay T, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009133; Li QY, 2011, NATURE, V480, P233, DOI 10.1038/nature10589; McLaskey GC, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047507; Meng LS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048118; Nadeau RM, 1999, SCIENCE, V285, P718, DOI 10.1126/science.285.5428.718; Nadeau RM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019409; Page MT, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003736; Peng ZG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022626; Rabinowitz E, 1965, FRICTION WEAR MAT; Rice J. R., 2007, TECTONIC FAULTS AGEN, P99; Rubinstein JL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023189; Saffer DM, 2003, EARTH PLANET SC LETT, V215, P219, DOI 10.1016/S0012-821X(03)00424-2; Scholz C.H., 2002, MECH EARTHQUAKES FAU, P81; VIDALE JE, 1994, NATURE, V368, P624, DOI 10.1038/368624a0; WU FT, 1972, B SEISMOL SOC AM, V62, P1621	29	60	61	4	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2012	491	7422					101	U114		10.1038/nature11512	http://dx.doi.org/10.1038/nature11512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23128232				2022-12-28	WOS:000310434500038
J	Shoham, S; Marr, KA				Shoham, Shmuel; Marr, Kieren A.			Treatment of Iatrogenic Fungal Infections: A Black Mold Defines a New Gray Zone in Medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VORICONAZOLE		[Shoham, Shmuel; Marr, Kieren A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21212 USA	Johns Hopkins University	Marr, KA (corresponding author), Johns Hopkins Univ, Sch Med, Div Infect Dis, 720 Rutland Ave,Ross 1064, Baltimore, MD 21212 USA.	Kmarr4@jhmi.edu			NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA006973] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Centers for Disease Control and Prevention, MULTISTATE FUNGAL ME; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P842; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Kainer Marion, 2012, Morbidity and Mortality Weekly Report, V61, P839; Kauffman CA, 2012, N ENGL J MED; Klont RR, 2004, CLIN INFECT DIS, V39, P1467, DOI 10.1086/425317; Lyons JL, 2012, ANN INTERN MED, V157, P835, DOI 10.7326/0003-4819-158-1-201212040-00557; Marr KA, 2012, PRESENTED AT 22ND EU; Pascual A, 2008, CLIN INFECT DIS, V46, P201, DOI 10.1086/524669; U.S. Food and Drug Administration, MULTISTATE OUTBREAK; U.S. Food and Drug Administration Antiviral Drugs Advisory Committee, 2001, BRIEFING DOCUMENT FO	11	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2013	158	3					208	+		10.7326/0003-4819-158-3-201302050-00572	http://dx.doi.org/10.7326/0003-4819-158-3-201302050-00572			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087JP	23147215	Green Accepted			2022-12-28	WOS:000314757900008
J	Waddell, T; Cunningham, D				Waddell, Tom; Cunningham, David			Evaluation of regorafenib in colorectal cancer and GIST	LANCET			English	Editorial Material							GASTROINTESTINAL STROMAL TUMORS; IMATINIB; TRIAL; FLUOROURACIL; LEUCOVORIN; MUTATIONS		[Waddell, Tom; Cunningham, David] Royal Marsden Hosp, Sutton SM2 5PT, Surrey, England	Royal Marsden NHS Foundation Trust	Cunningham, D (corresponding author), Royal Marsden Hosp, Downs Rd, Sutton SM2 5PT, Surrey, England.	david.cunningham@rmh.nhs.uk		Cunningham, David/0000-0001-5158-1069				Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Demetri GD, 2012, LANCET; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; George S, 2012, J CLIN ONCOL, V30, P2401, DOI 10.1200/JCO.2011.39.9394; Grothey A, 2012, LANCET; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Heinrich MC, 2008, J CLIN ONCOL, V26, P5352, DOI 10.1200/JCO.2007.15.7461; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; National Cancer Institute, SURV EP END RES; Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302; Strumberg D, 2012, BRIT J CANCER, V106, P1722, DOI 10.1038/bjc.2012.153; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0; Wardelmann E, 2006, CLIN CANCER RES, V12, P1743, DOI 10.1158/1078-0432.CCR-05-1211; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864	15	20	20	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 26	2013	381	9863					273	275		10.1016/S0140-6736(12)62006-6	http://dx.doi.org/10.1016/S0140-6736(12)62006-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077IT	23177516				2022-12-28	WOS:000314021800009
J	Thethi, T; Fonseca, V				Thethi, Tina; Fonseca, Vivian			Comparing diabetes drugs-helping clinical decisions?	LANCET			English	Editorial Material							OPEN-LABEL; LIRAGLUTIDE; EXENATIDE; TWICE; SAFETY		[Fonseca, Vivian] SE Louisiana Vet Hlth Care Syst, New Orleans, LA USA; Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70112 USA	Tulane University	Fonseca, V (corresponding author), SE Louisiana Vet Hlth Care Syst, New Orleans, LA USA.	vfonseca@tulane.edu						Aroda VR, 2011, DIABETES-METAB RES, V27, P528, DOI 10.1002/dmrr.1202; Blevins T, 2011, J CLIN ENDOCR METAB, V96, P1301, DOI 10.1210/jc.2010-2081; Buse JB, 2012, LANCET; Buse JB, 2011, J CLIN ENDOCR METAB, V96, P1695, DOI 10.1210/jc.2010-2822; Buse JB, 2010, DIABETES CARE, V33, P1300, DOI 10.2337/dc09-2260; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Fineman MS, 2012, DIABETES OBES METAB, V14, P546, DOI 10.1111/j.1463-1326.2012.01561.x; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Zinman B, 2012, DIABETES OBES METAB, V14, P77, DOI 10.1111/j.1463-1326.2011.01493.x	11	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 12	2013	381	9861					93	94		10.1016/S0140-6736(12)61576-1	http://dx.doi.org/10.1016/S0140-6736(12)61576-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	069FO	23141811				2022-12-28	WOS:000313420900005
J	Bart, BA; Goldsmith, SR; Lee, KL; Givertz, MM; O'Connor, CM; Bull, DA; Redfield, MM; Deswal, A; Rouleau, JL; LeWinter, MM; Ofili, EO; Stevenson, LW; Semigran, MJ; Felker, GM; Chen, HH; Hernandez, AF; Anstrom, KJ; McNulty, SE; Velazquez, EJ; Ibarra, JC; Mascette, AM; Braunwald, E				Bart, Bradley A.; Goldsmith, Steven R.; Lee, Kerry L.; Givertz, Michael M.; O'Connor, Christopher M.; Bull, David A.; Redfield, Margaret M.; Deswal, Anita; Rouleau, Jean L.; LeWinter, Martin M.; Ofili, Elizabeth O.; Stevenson, Lynne W.; Semigran, Marc J.; Felker, G. Michael; Chen, Horng H.; Hernandez, Adrian F.; Anstrom, Kevin J.; McNulty, Steven E.; Velazquez, Eric J.; Ibarra, Jenny C.; Mascette, Alice M.; Braunwald, Eugene		Heart Failure Clinical Res Network	Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WORSENING RENAL-FUNCTION; CONGESTION; DIURETICS; OVERLOAD	BACKGROUND Ultrafiltration is an alternative strategy to diuretic therapy for the treatment of patients with acute decompensated heart failure. Little is known about the efficacy and safety of ultrafiltration in patients with acute decompensated heart failure complicated by persistent congestion and worsened renal function. METHODS We randomly assigned a total of 188 patients with acute decompensated heart failure, worsened renal function, and persistent congestion to a strategy of stepped pharmacologic therapy (94 patients) or ultrafiltration (94 patients). The primary end point was the bivariate change from baseline in the serum creatinine level and body weight, as assessed 96 hours after random assignment. Patients were followed for 60 days. RESULTS Ultrafiltration was inferior to pharmacologic therapy with respect to the bivariate end point of the change in the serum creatinine level and body weight 96 hours after enrollment (P = 0.003), owing primarily to an increase in the creatinine level in the ultrafiltration group. At 96 hours, the mean change in the creatinine level was -0.04 +/- 0.53 mg per deciliter (-3.5 +/- 46.9 mu mol per liter) in the pharmacologictherapy group, as compared with +0.23 +/- 0.70 mg per deciliter (20.3 +/- 61.9 mu mol per liter) in the ultrafiltration group (P = 0.003). There was no significant difference in weight loss 96 hours after enrollment between patients in the pharmacologic-therapy group and those in the ultrafiltration group (a loss of 5.5 +/- 5.1 kg [12.1 +/- 11.3 lb] and 5.7 +/- 3.9 kg [12.6 +/- 8.5 lb], respectively; P = 0.58). A higher percentage of patients in the ultrafiltration group than in the pharmacologic-therapy group had a serious adverse event (72% vs. 57%, P = 0.03). CONCLUSIONS In a randomized trial involving patients hospitalized for acute decompensated heart failure, worsened renal function, and persistent congestion, the use of a stepped pharmacologic-therapy algorithm was superior to a strategy of ultrafiltration for the preservation of renal function at 96 hours, with a similar amount of weight loss with the two approaches. Ultrafiltration was associated with a higher rate of adverse events. (Funded by the National Heart, Lung, and Blood Institute; ClinicalTrials.gov number, NCT00608491.)	[Bart, Bradley A.; Goldsmith, Steven R.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Redfield, Margaret M.; Chen, Horng H.] Mayo Clin, Rochester, MN USA; [Lee, Kerry L.; Hernandez, Adrian F.; Anstrom, Kevin J.; McNulty, Steven E.; Velazquez, Eric J.; Ibarra, Jenny C.] Duke Clin Res Inst, Durham, NC USA; [O'Connor, Christopher M.; Felker, G. Michael] Duke Univ, Med Ctr, Durham, NC USA; [O'Connor, Christopher M.; Felker, G. Michael] Duke Univ, Med Ctr, Duke Heart Ctr, Durham, NC 27710 USA; [Givertz, Michael M.; Stevenson, Lynne W.; Braunwald, Eugene] Brigham & Womens Hosp, Boston, MA 02115 USA; [Semigran, Marc J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Bull, David A.] Univ Utah, Salt Lake City, UT USA; [Deswal, Anita] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Deswal, Anita] Baylor Coll Med, Houston, TX 77030 USA; [Rouleau, Jean L.] Univ Montreal, Montreal, PQ, Canada; [Rouleau, Jean L.] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [LeWinter, Martin M.] Univ Vermont, Burlington, VT 05405 USA; [Ofili, Elizabeth O.] Morehouse Sch Med, Atlanta, GA 30310 USA; [Mascette, Alice M.] NHLBI, Bethesda, MD 20892 USA	Hennepin County Medical Center; Mayo Clinic; Duke University; Duke University; Duke University; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Utah System of Higher Education; University of Utah; Baylor College of Medicine; Baylor College of Medicine; Universite de Montreal; Universite de Montreal; University of Vermont; Morehouse School of Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Bart, BA (corresponding author), O5 HCMC,701 Pk Ave S, Minneapolis, MN 55410 USA.	bartx006@umn.edu	Hernandez, Adrian F/A-7818-2016	Hernandez, Adrian F/0000-0003-3387-9616; Felker, Gary/0000-0002-5931-1239; NOIRI, Eisei/0000-0002-9515-7582; Bozkurt, Biykem/0000-0002-6362-0253	National Heart, Lung, and Blood Institute [U10HL084904, U10HL084861, U10HL084875, U10HL084877, U10HL084889, U10HL084890, U10HL084891, U10HL084899, U10HL084907, U10HL084931]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL084889, U01HL084931, U01HL084907, U10HL084904, U01HL084899, U01HL084891, U01HL084877, U01HL084861, U01HL084875, U01HL084890] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Supported by grants from the National Heart, Lung, and Blood Institute (U10HL084904 [for the data coordinating center], U10HL084861, U10HL084875, U10HL084877, U10HL084889, U10HL084890, U10HL084891, U10HL084899, U10HL084907, and U10HL084931 [for the clinical centers]).	Bart BA, 2005, J AM COLL CARDIOL, V46, P2043, DOI 10.1016/j.jacc.2005.05.098; Bart BA, 2008, J CARD FAIL, V14, P531, DOI 10.1016/j.cardfail.2008.03.002; Bart BA, 2012, J CARD FAIL, V18, P176, DOI 10.1016/j.cardfail.2011.12.009; Bart BA, 2009, CIRC-HEART FAIL, V2, P499, DOI 10.1161/CIRCHEARTFAILURE.109.863381; Butler J, 2004, AM HEART J, V147, P331, DOI 10.1016/j.ahj.2003.08.012; Costanzo MR, 2007, J AM COLL CARDIOL, V49, P675, DOI 10.1016/j.jacc.2006.07.073; COX DR, 1972, J R STAT SOC B, V34, P187; Felker GM, 2012, J AM COLL CARDIOL, V59, P2145, DOI 10.1016/j.jacc.2011.10.910; Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419; Forman DE, 2004, J AM COLL CARDIOL, V43, P61, DOI 10.1016/j.jacc.2003.07.031; Freda BJ, 2011, AM J KIDNEY DIS, V58, P1005, DOI 10.1053/j.ajkd.2011.07.023; Grant S, 1999, CHEST, V116, P1208, DOI 10.1378/chest.116.5.1208; Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979; Hunt, 2010, CIRCULATION, V121, pE258, DOI 10.1161/CIR.0b013e3181d7a6b3; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Johnson RA, 2007, APPL MULTIVARIATE ST, P331; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Marenzi G, 2001, J AM COLL CARDIOL, V38, P963, DOI 10.1016/S0735-1097(01)01479-6; Massie BM, 2010, NEW ENGL J MED, V363, P1419, DOI 10.1056/NEJMoa0912613; Metra M, 2012, CIRC-HEART FAIL, V5, P54, DOI 10.1161/CIRCHEARTFAILURE.111.963413; O'Connor CM, 2011, NEW ENGL J MED, V365, P32, DOI 10.1056/NEJMoa1100171; Owan TE, 2006, J CARD FAIL, V12, P257, DOI 10.1016/j.cardfail.2006.02.007; Ronco C, 2012, J AM COLL CARDIOL, V60, P1031, DOI 10.1016/j.jacc.2012.01.077; Testani JM, 2010, CIRCULATION, V122, P265, DOI 10.1161/CIRCULATIONAHA.109.933275	24	542	602	2	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24					2296	2304		10.1056/NEJMoa1210357	http://dx.doi.org/10.1056/NEJMoa1210357			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HF	23131078	Green Accepted			2022-12-28	WOS:000312187700003
J	Redlener, I; Reilly, MJ				Redlener, Irwin; Reilly, Michael J.			Lessons from Sandy - Preparing Health Systems for Future Disasters	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Redlener, Irwin; Reilly, Michael J.] Columbia Univ, Mailman Sch Publ Hlth, Natl Ctr Disaster Preparedness, New York, NY 10027 USA	Columbia University	Redlener, I (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Natl Ctr Disaster Preparedness, New York, NY 10027 USA.							Clements BW, 2009, DISASTERS AND PUBLIC HEALTH: PLANNING AND RESPONSE, P1; Hartocollis A, 2012, NY TIMES, pA1; Hupert N, 2011, HLTH CARE EMERGENCY, P223; Redlener I, 2006, AM RISK; U.S. Environmental Protection Agency, 2012, GOW CAN HURR SAND SA	5	66	67	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24					2269	2271		10.1056/NEJMp1213486	http://dx.doi.org/10.1056/NEJMp1213486			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	052HF	23171063	Green Published			2022-12-28	WOS:000312187700016
J	Parving, HH; Brenner, BM; McMurray, JJV; de Zeeuw, D; Haffner, SM; Solomon, SD; Chaturvedi, N; Persson, F; Desai, AS; Nicolaides, M; Richard, A; Xiang, ZH; Brunel, P; Pfeffer, MA; Juncos, L; Orias, M; Kuschnir, E; Rusculleda, M; Garcia, S; Farias, E; Lema, L; Hominal, M; Montana, O; Sala, J; Diaz, M; Piskorz, D; Vita, N; Litwak, L; Sinay, I; Marin, M; Massari, P; Majul, C; Aizemberg, D; Azize, GM; Bartolacci, I; Reboredo, A; Vico, M; Milesi, R; Sessa, H; Wassermann, A; Margulis, F; Zangroniz, P; Watschinger, B; Prager, R; Toplak, H; Paulweber, B; Drexel, H; Francesconi, C; Foeger, B; Mayer, G; Braun, RK; Brath, H; Gaal, LV; Niepen, PVD; Persu, A; Vercammen, C; Vriese, AD; Coucke, F; Mathieu, C; Fery, F; Treille, S; Meeus, G; Acker, KV; Scheen, A; Tits, J; Ruige, J; Krzesinski, JM; Hollanders, G; Lienart, F; Dendale, P; Quinonez, M; Arnouts, P; Vanuytsel, J; Zanella, M; Mion, D; Forti, A; Almeida, F; Cunha, R; de Paula, RB; Brandao, A; Rocha, J; Krieger, E; Feitosa, G; Saraiva, J; Martin, J; Hissa, MN; Schmid, H; Felicio, J; Sgarbi, J; Oigman, W; Bowering, K; Garceau, C; Berlingieri, JC; Weisnagel, SJ; Hardin, P; Powell, C; Turcot, R; Muirhead, N; Aronson, R; Barima, YT; Steele, AW; Pandey, S; Woo, V; Cha, J; Dattani, D; Godin, C; Gupta, M; Leiter, L; Saunders, K; Tellier, G; Ting, G; Tobe, S; Chouinard, G; Schlosser, R; Khandwala, H; Ekoe, JM; Harris, SB; Pichette, V; Lachance, P; Ooi, TC; Tildesley, H; Barrett, B; Cournoyer, S; Lu, J; Zhang, H; Liu, X; Yan, S; Qi, X; Li, Q; Li, H; Lv, X; Yang, J; Sun, N; Xia, W; Wang, N; Tong, N; Mei, C; Gu, S; Zhang, J; Chen, X; Li, L; Su, B; Wang, L; Qiu, M; Wu, X; Liu, Z; Jia, W; Xu, G; Dong, J; Zhu, D; Mei, C; Gu, S; Zhang, J; Chen, X; Li, L; Su, B; Wang, L; Qiu, M; Wu, X; Liu, Z; Jia, W; Xu, G; Dong, J; Zhu, D; Zhang, M; Yan, J; Liu, B; Chen, J; Fu, J; Yan, L; Zhan, X; Zhong, L; Yang, T; Ma, J; Xu, M; Xu, X; Shi, B; Ji, Q; Zhong, H; He, R; Yuan, Z; Zhou, Z; Lin, H; Yang, W; Ke, Y; Li, Q; Hong, T; Franco, C; Casas, L; Triana, A; Botero, R; Jaramillo, C; Hernandez, E; Barrera, C; Blanco, D; Stipal, R; Widimsky, P; Dohnalova, L; Komroskova, M; Kvapil, M; Belobradkova, J; Tesar, V; Cifkova, R; Vodnansky, P; Kocourkova, B; Christiansen, JS; Lervang, H; Perrild, H; Rossing, P; Oestergaard, O; Juhl, H; Thorsteinsson, B; Snorgaard, O; Urhammer, S; Egstrup, K; Tikkanen, T; Helin, K; Rinne, J; Lahtela, J; Strand, J; Valtonen, E; Saari, M; Kananen, K; Savela, K; Marre, M; Blacher, J; Aldigier, JC; Zaoui, P; Fauvel, JP; Gouet, D; Valensi, PE; Charpentier, G; Marechaud, R; Penfornis, A; Ovize, M; Kovalchuck, AA; Haller, H; Dellanna, F; Schoen, N; Groeschel, W; Eickhoff, F; Hanefeld, M; Merke, J; Rambausek, M; Zimmermann, U; Stuetz, W; Vosskuehler, A; Hevendehl, G; Schax, U; Lehmann, G; Haack, A; Hilgenberg, J; Klausmann, G; Adelberger, V; Gessner, S; Fiesselmann, A; Oerter, E; Hohenstatt, T; Groeschel, A; Behnke, T; Sisting, RT; Schoch, D; Bieler, T; Schleyer, S; Altes, U; Klepzig, G; Rudofsky, G; Mueller, G; Burkhardt, F; Reschke, K; Senftleber, I; Wiesweg, CK; Herrmann, HJ; Brandstetter, R; Segner, A; Nickenig, G; Schmitt, H; Rippert, R; Goebel, R; Schreibmueller, F; Pencz, I; Ott, P; Siamopoulos, K; Migdalis, I; Pappas, S; Pagkalos, E; Yalouris, A; Tsapas, A; Maltezos, E; Tentolouris, N; Papadakis, I; Ioannidis, G; Goumenos Guatemala, D; Corona, V; Gonzalez, R; Haase, F; Monterroso, V; Sanchez, V; Turcios, E; Wyss, F; Arango, JL; Bako, B; Deak, L; Domotor, E; Dudas, M; Fulop, T; Kiss, I; Koranyi, L; Lengyel, Z; Nyirati, G; Oroszlan, T; Aniko, S; Voros, P; Kapocsi, J; Wittmann, I; Paragh, G; Abraham, G; Tandon, N; Thomas, N; Mohan, V; Sahay, R; Sethi, B; Rao, V; Kumar, S; Chowdhury, S; Dharmalingam, M; Seshiah, V; Bantwal, G; Viswanathan, V; Yajnik, C; Adhikari, P; Hiremath, J; Bha Ittacharyya, A; Dani, S; Modi, KK; Glorioso, N; Morosetti, M; Veglio, F; Perticone, F; Dotta, F; Quarello, F; Sesti, G; Aiello, A; D'Ospina, A; Giordano, C; Novo, S; Ferri, C; Capuano, V; Trimarco, B; Tonolo, G; Villa, G; De Pellegrin, A; Zanette, G; Federici, M; Aucello, G; Piatti, P; Vinciguerra, A; Mannarino, E; Taddei, S; Filetti, S; Grandaliano, G; Marchionni, N; Lambiase, C; Locatelli, F; Scanferla, F; Lembo, G; Leotta, S; Mos, L; Calatola, P; Fogari, R; David, S; Pedrinelli, R; Pignone, AM; Cozzolino, D; Bevilacqua, MT; Catena, C; Del Prato, S; Cerasola, G; Frontoni, S; Falcone, C; Porta, A; Bonora, E; Cocchi, R; Fucili, A; Frisinghelli, A; Volpe, M; Carugo, S; Gambardella, S; Spagnuolo, V; Maglia, G; D'Angelo, AR; Corsi, A; Limone, PP; Guarnieri, A; Ghigo, E; Ronchi, E; Ravera, M; Scioli, GA; Sekiguchi, M; Aoki, S; Ogawa, Y; Seino, H; Onishi, Y; Tojo, A; Narimiya, M; Iwaita, Y; Takeda, H; Shimizu, H; Yamada, T; Kojima, S; Zushi, S; Kaneko, S; Matsumoto, A; Kajiyama, S; Fujita, H; Shikata, K; Tone, A; Matsubayashi, S; Tanaka, S; Sekigami, T; Tatsukawa, Y; Abe, N; Kawahara, K; Kasahara, H; Maeda, Y; Suzuki, Y; Okamoto, H; Tachi, K; Yamada, K; Uzu, T; Itou, T; Fukui, T; Kim, S; Kim, Y; Cho, W; Kwak, I; Chae, D; Oh, H; Ha, S; Shin, Y; Cha, D; Kim, Y; Kim, S; Kang, S; Lim, C; Song, J; Lim, C; Song, J; Kwon, Y; Badariene, J; Labutiniene, IP; Zabuliene, L; Poteliuniene, V; Miglinas, M; Kooy, A; van den Meiracker, AH; Smak Gregoor, PJH; Luik, AJ; Potter van Loon, BJ; Feenstra, HJ; Kaasjager, HAH; Viergever, PP; Woittiez, AJJ; van Bemmel, T; Lieverse, AG; Simsek, S; Gaillard, CAJM; van der Zwaan, C; Lok, DJA; Spiering, W; Nierop, PR; Baggen, MGA; Leendert, RJM; de Jong, A; Leurs, PB; Vincent, HH; Wins, EHR; Voors, AA; Ronner, E; Heeg, JE; van Hal, JMC; Boermans, T; Feis, WL; Mostard, G; Bakker, RC; Dunselman, PHJM; Jorde, R; Skeie, S; Istad, H; Skjelvan, G; Gronert, J; Tomala, T; Gudnason, S; Tarje Torvik, D; Risberg, K; Abedini, S; Cabrera, W; Medina, B; Medina, F; Herrada, B; Saavedra, A; Jorge Polonia, D; Luis Providencia, D; Carvalho, D; Vasconcelos, MP; da Silva, GF; Branco, P; Gil, DV; da Costa, AG; da Silva, PM; Arez, L; Martins, L; Birne, R; Dzuponova, J; Surovcikova, M; Culak, J; Dukat, A; Filipova, S; Andre, I; Stevlik, J; Uhliar, R; Fabryova, L; Benacka, J; Koleny, D; Szentivanyi, M; Spisak, V; Pella, D; Pastrnakova, E; Martinka, E; Chua, T; Wong, KS; Lau, T; Ng, TG; Yeoh, LY; Bhana, SA; Rayner, B; Wellmann, H; Amod, A; Ranjith, N; Ahmed, F; Rheeder, P; Makan, H; Naicker, P; Podgorski, G; De Teresa, E; Olivan, J; Fernandez, VL; Povedano, ST; Terns, M; Ricart, W; Gonzalez, JM; Fernandez, P; de Teresa Parreno, L; Redon, J; Parra, J; Calvo, C; Lopez, I; Puig, JG; Calle, A; Garcia, JCF; Lopez, JM; Jimenez, ML; Fraile, B; Perez, JS; Nadal, JJ; Guija, E; Calvino, J; Barrios, V; Iglesias, JN; Armario, P; Garcia, M; Aranda, P; Brotons, C; Ruilope, L; Gomez, P; Catelao, AM; Cusachs, AR; Sarro, M; Martinez, V; dell Valle, MH; Trias, F; Comas, A; Salvador, N; Martinez, F; Hernandez, F; Martinez, J; Mateos, C; Peral, JL; Tolosana, J; Sobrino, J; Isart, J; Vizcaino, J; Fernandez Vega, F; Zamorano, JL; Bacariza, M; Soubriet, A; Fernandez-Cruz, A; Querejeta, R; Munoz Leira, V; Calvo Iglesias, FE; Ibrik, O; Martin, D; Nanclares, MS; Mediavilla, JD; Galceran, JM; Lopez, A; Muros, T; Pascual, J; Casalla, F; Tornero, F; Fernandez, G; Weiss, L; Pettersson, P; Olsen, H; Franke, F; Stroembom, U; Furuland, H; Larnefelt, H; Allemann, Y; Krapf, R; Wuethrich, R; Gerber, P; Munger, R; Hayoz, D; Graf, HJ; Burnier, M; Petrillo, A; Batt, R; Constam, EN; Moccetti, T; Bianda, T; Rickli, H; Builliard, C; Wu, KD; Lin, SH; Wu, CJ; Huey-Herng Sheu, W; Su, SL; Chen, SC; Chou, CW; Lee, CT; Yang, TC; Chen, HC; Sritara, P; Sukonthasarn, A; Sriratanasathavorn, C; Eiam-Ong, S; Supasyndh, O; Chanchairujira, T; Kitiyakara, C; Comlekci, A; Arici, M; Usalan, C; Guneri, S; Koc, M; Kalender, B; Ates, K; Gurgun, C; Araz, M; Demirbas, B; Biernacki, W; Calvert, J; Eavis, P; Kerrane, J; Litchfield, J; Middleton, A; Roberts, J; Simpson, H; Charles, H; Jardine, A; Fisher, M; Banerjee, D; Gallen, I; Gnudi, L; Harvey, J; O'Hare, P; Vora, J; Winocour, P; Soran, H; Browne, D; Darko, D; Mancebo, JG; de Roa, ER; Antepara, N; Carrillo, E; Berrizbeitia, M; Guevara, L; Pernalete, N; Ontiveros, C; Zigrang, W; Blakney, E; Rosenblit, P; Weinstein, R; Klaff, L; Lipetz, R; Busick, E; Tung, P; Cooperman, M; Michael, S; Sun, CH; Hart, T; Maddux, A; Bowden, R; East, C; Arakaki, R; Villafuerte, B; Mamish, Z; Mendez, R; Connery, L; Nour, K; Wynne, A; Busch, R; Zamora, B; Sachson, R; Prasad, J; Lasala, G; Smith, M; Fitz-Patrick, D; Ruiz-Rivera, L; Barranco, E; Solomon, R; Woolley, A; Brown, C; Freedman, Z; Schmidt, S; Pollock, J; Ruddy, M; Toto, R; Kopyt, NP; Bazzi, A; Horowitz, B; Feng, W; Wahl, T; Duprez, D; Gilbert, J; Steigerwalt, S; Jacqmein, J; Gorton, S; Allison, J; Pino, J; Lock, J; Leimbach, W; Anderson, J; Beacom, M; Craig, W; Gorson, D; Kerstein, H; Lerman, S; Minehart, C; Agarwal, N; Verma, SI; Valitutto, M; Demetry, K; Mersey, J; Koeper, D; Fanti, P; Eng, G; Jamerson, K; Grimm, R; Fagan, T; Bajaj, M; Katz, L; Portnay, G; Altschuller, A; Desai, V; Bilazari, S; Ipp, E; Rodelas, R; Burstein, D; Berg, J; Velez, J; Lund, R; Rekhi, A; Martin, E; Martin, J; Robertson, D; Singh, N; Narayan, P; Moustafa, M; Lanier, D; Seidner, M; Phillips, A; Vaughters, B; Sprague, A; Swartz, S; Lopez, R; Kumar, J; Bressler, P; Sadler, L; Wise, J; Kilbane, A				Parving, Hans-Henrik; Brenner, Barry M.; McMurray, John J. V.; de Zeeuw, Dick; Haffner, Steven M.; Solomon, Scott D.; Chaturvedi, Nish; Persson, Frederik; Desai, Akshay S.; Nicolaides, Maria; Richard, Alexia; Xiang, Zhihua; Brunel, Patrick; Pfeffer, Marc A.; Juncos, Luis; Orias, Marcelo; Kuschnir, Emilio; Rusculleda, Marcelo; Garcia, Sergio; Farias, Eduardo; Lema, Luis; Hominal, Miguel; Montana, Oscar; Sala, Jorgelina; Diaz, Monica; Piskorz, Daniel; Vita, Nestor; Litwak, Leon; Sinay, Isaac; Marin, Marcos; Massari, Pablo; Majul, Claudio; Aizemberg, D.; Azize, Guillermo Moises; Bartolacci, Ines; Reboredo, Ana; Vico, Marisa; Milesi, Ricardo; Sessa, Horacio; Wassermann, Alfredo; Margulis, Fernando; Zangroniz, Pedro; Watschinger, B.; Prager, R.; Toplak, H.; Paulweber, B.; Drexel, H.; Francesconi, C.; Foeger, B.; Mayer, G.; Braun, R. K.; Brath, H.; Gaal, L.V.; Niepen, P.V.D.; Persu, A.; Vercammen, C.; Vriese, A.D.; Coucke, F.; Mathieu, C.; Fery, F.; Treille, S.; Meeus, G.; Acker, K.V.; Scheen, A.; Tits, J.; Ruige, J.; Krzesinski, J.M.; Hollanders, G.; Lienart, F.; Dendale, P.; Quinonez, M.; Arnouts, P.; Vanuytsel, J.; Zanella, M.; Mion, D; Forti, A.; Almeida, F.; Cunha, R.; de Paula, R.B.; Brandao, A.; Rocha, J.; Krieger, E.; Feitosa, G.; Saraiva, J.; Martin, J.; Hissa, M.N.; Schmid, H.; Felicio, J.; Sgarbi, J.; Oigman, W.; Bowering, K.; Garceau, C.; Berlingieri, J.C.; Weisnagel, S.J.; Hardin, P.; Powell, C.; Turcot, R.; Muirhead, N.; Aronson, R.; Barima, Y.T.; Steele, A.W.; Pandey, S.; Woo, V.; Cha, J.; Dattani, D.; Godin, C.; Gupta, M.; Leiter, L.; Saunders, K.; Tellier, G.; Ting, R; Tobe, S.; Chouinard, G.; Schlosser, R.; Khandwala, H.; Ekoe, J. M.; Harris, S. B.; Pichette, V.; Lachance, P.; Ooi, TC; Tildesley, H.; Barrett, B.; Cournoyer, S.; Lu, J; Zhang, J.; Liu, X.; Yan, S.; Qi, X.; Li, Q.; Li, H.; Lv, X.; Yang, J.; Sun, N.; Xia, W.; Wang, N.; Tong, N.; Mei, C.; Gu, S.; Zhang, J.; Chen, X.; Li, L.; Su, B.; Wang, L.; Qiu, M.; Wu, X.; Liu, Z.; Jia, W.; Xu, G.; Dong, J.; Zhu, D.; Mei, C.; Gu, S.; Zhang, J.; Chen, X.; Li, L.; Su, B.; Wang, L.; Qiu, M.; Wu, X.; Liu, Z.; Jia, W.; Xu, G.; Dong, J.; Zhu, D.; Zhang, M.; Yan, J.; Liu, B.; Chen, J.; Fu, J.; Yan, L.; Zhan, X.; Zhong, L.; Yang, T.; Ma, J.; Xu, M.; Xu, X.; Shi, B.; Ji, Q.; Zhong, H.; He, R.; Yuan, Z.; Zhou, Z.; Lin, H.; Yang, W.; Ke, Y.; Li, Q.; Hong, T.; Franco, C.; Casas, L.; Triana, A.; Botero, R.; Jaramillo, C.; Hernandez, E.; Barrera, C.; Blanco, D.; Stipal, R.; Widimsky, P.; Dohnalova, L.; Komroskova, M.; Kvapil, M.; Belobradkova, J.; Tesar, V.; Cifkova, R.; Vodnansky, P.; Kocourkova, B.; Christiansen, J.S.; Lervang, H.; Perrild, H.; Rossing, P.; Oestergaard, O.; Juhl, H.; Thorsteinsson, B.; Snorgaard, O.; Urhammer, S.; Egstrup, K.; Tikkanen, T; Helin, K.; Rinne, J.; Lahtela, J.; Strand, J.; Valtonen, E.; Saari, M.; Kananen, K.; Savela, K.; Marre, M.; Blacher, J.; Aldigier, J-C; Zaoui, P.; Fauvel, J-P; Gouet, D.; Valensi, P-E; Charpentier, G.; Marechaud, R.; Penfornis, A.; Ovize, M; Kovalchuck, A.A.; Haller, H.; Dellanna, F.; Schoen, N.; Groeschel, W.; Eickhoff, F.; Hanefeld, M.; Merke, J.; Rambausek, M.; Zimmermann, U.; Stuetz, W.; Vosskuehler, A.; Hevendehl, G.; Schax, U.; Lehmann, G.; Haack, A.; Hilgenberg, J.; Klausmann, G.; Adelberger, V.; Gessner, S.; Fiesselmann, A.; Oerter, E.; Hohenstatt, T.; Groeschel, A.; Behnke, T.; Sisting, R.T.; Schoch, D.; Bieler, T.; Schleyer, S.; Altes, U; Klepzig, G.; Rudofsky, G.; Mueller, G.; Burkhardt, F.; Reschke, K.; Senftleber, I.; Wiesweg, C.K.; Herrmann, HJ; Brandstetter, R.; Segner, A.; Nickenig, G.; Schmitt, H.; Rippert, R.; Goebel, R.; Schreibmueller, F.; Pencz, I.; Ott, P; Siamopoulos, K.; Migdalis, I.; Pappas, S; Pagkalos, E.; Yalouris, A.; Tsapas, A; Maltezos, E.; Tentolouris, N.; Papadakis, I; Ioannidis, G.; Goumenos Guatemala, D.; Corona, V.; Gonzalez, R.; Haase, F.; Monterroso, V.; Sanchez, V.; Turcios, E.; Wyss, F.; Arango, JL; Bako, B.; Deak, L.; Domotor, E.; Dudas, M; Fulop, T.; Kiss, I.; Koranyi, L.; Lengyel, Z.; Nyirati, G.; Oroszlan, T.; Aniko, S.; Voros, P.; Kapocsi, J.; Wittmann, I.; Paragh, G.; Abraham, G.; Tandon, N.; Thomas, N.; Mohan, V.; Sahay, R.; Sethi, B.; Rao, V.; Kumar, S; Chowdhury, S.; Dharmalingam, M.; Seshiah, V.; Bantwal, G.; Viswanathan, V.; Yajnik, C.; Adhikari, P.; Hiremath, J.; Bha Ittacharyya, A.; Dani, S.; Modi, KK; Glorioso, N.; Morosetti, M.; Veglio, F.; Perticone, F.; Dotta, F.; Quarello, F.; Sesti, G.; Aiello, A; D'Ospina, A; Giordano, C; Novo, S; Ferri, C; Capuano, V.; Trimarco, B.; Tonolo, G.; Villa, G.; De Pellegrin, A.; Zanette, G.; Federici, M.; Aucello, G.; Piatti, P.; Vinciguerra, A.; Mannarino, E.; Taddei, S; Filetti, S; Grandaliano, G.; Marchionni, N.; Lambiase, C.; Locatelli, F.; Scanferla, F.; Lembo, G.; Leotta, S.; Mos, L.; Calatola, P.; Fogari, R.; David, S.; Pedrinelli, R.; Pignone, A. M.; Cozzolino, D.; Bevilacqua, M.T.; Catena, C.; Del Prato, S.; Cerasola, G.; Frontoni, S.; Falcone, C.; Porta, A.; Bonora, E.; Cocchi, R.; Fucili, A.; Frisinghelli, A.; Volpe, M.; Carugo, S.; Gambardella, S.; Spagnuolo, V.; Maglia, G.; D'Angelo, A.R.; Corsi, A.; Limone, P.P.; Guarnieri, A.; Ghigo, E.; Ronchi, E.; Ravera, M.; Scioli, G.A.; Sekiguchi, M.; Aoki, S.; Ogawa, Y.; Seino, H.; Onishi, Y.; Tojo, A; Narimiya, M.; Iwaita, Y.; Takeda, H.; Shimizu, H.; Yamada, T.; Kojima, S.; Zushi, S.; Kaneko, S.; Matsumoto, A.; Kajiyama, S.; Fujita, H.; Shikata, K.; Tone, A.; Matsubayashi, S.; Tanaka, S.; Sekigami, T.; Tatsukawa, Y.; Abe, N.; Kawahara, K.; Kasahara, H.; Maeda, Y.; Suzuki, Y.; Okamoto, H.; Tachi, K.; Yamada, K.; Uzu, T.; Itou, T.; Fukui, T.; Kim, S.; Kim, Y.; Cho, W.; Kwak, I.; Chae, D.; Oh, H.; Ha, S.; Shin, Y; Cha, D.; Kim, Y.; Kim, S.; Kang, S.; Lim, C.; Song, J.; Lim, C.; Song, J.; Kwon, Y.; Badariene, J.; Labutiniene, I.P.; Zabuliene, L.; Poteliuniene, V.; Miglinas, M.; Kooy, A; van den Meiracker, A.H.; Smak Gregoor, P.J.H.; Luik, A.J.; Potter van Loon, B.J.; Feenstra, H.J.; Kaasjager, H.A.H.; Viergever, P. P.; Woittiez, A.J.J.; van Bemmel, T.; Lieverse, A.G.; Simsek, S.; Gaillard, C.A.J.M.; van der Zwaan, C.; Lok, Dirk J.A.; Spiering, Wilco; Nierop, P. R.; Baggen, M.G.A.; Leendert, R.J.M.; de Jong, A; Leurs, P.B.; Vincent, H.H.; Wins, E.H.R.; Voors, A.A.; Ronner, E.; Heeg, J.E.; van Hal, J.M.C.; Boermans, Ton; Feis, W.L.; Mostard, G.; Bakker, R.C.; Dunselman, P.H.J.M.; Jorde, R.; Skeie, S.; Istad, H.; Skjelvan, G.; Gronert, J.; Tomala, T.; Gudnason, S; Tarje Torvik, D.; Risberg, K.; Abedini, S.; Cabrera, W.; Medina, B.; Medina, F.; Herrada, B.; Saavedra, A; Jorge Polonia, D.; Luis Providencia, D.; Carvalho, D.; Vasconcelos, M.P.; da Silva, G.F.; Branco, P.; Gil, D.V.; da Costa, A.G.; da Silva, P.M.; Arez, L.; Martins, L.; Birne, R.; Dzuponova, J.; Surovcikova, M.; Culak, J.; Dukat, A.; Filipova, S.; Andre, I.; Stevlik, J.; Uhliar, R.; Fabryova, L.; Benacka, J.; Koleny, D.; Szentivanyi, M.; Spisak, V.; Pella, D.; Pastrnakova, E.; Martinka, E.; Chua, T.; Wong, K.S.; Lau, T.; Ng, T.G.; Yeoh, L.Y.; Bhana, S.A.; Rayner, B.; Wellmann, H.; Amod, A.; Ranjith, N.; Ahmed, F.; Rheeder, P.; Makan, H.; Naicker, P.; Podgorski, G.; De Teresa, E.; Olivan, J.; Fernandez, V.L.; Povedano, S.T.; Terns, M.; Ricart, W.; Gonzalez, J.M.; Fernandez, P.; de Teresa Parreno, L.; Redon, J.; Parra, J.; Calvo, C.; Lopez, I.; Puig, J.G.; Calle, A.; Garcia, JCF; Lopez, J.M.; Jimenez, M.L.; Fraile, B.; Perez, J.S.; Nadal, J.J.; Guija, E.; Calvino, J.; Barrios, V.; Iglesias, J.N.; Armario, P.; Garcia, M.; Aranda, P.; Brotons, C.; Ruilope, L.; Gomez, P.; Catelao, A.M.; Cusachs, A.R.; Sarro, M.; Martinez, V.; dell Valle, M.H.; Trias, F.; Comas, A.; Salvador, N.; Martinez, F.; Hernandez, F.; Martinez, J.; Mateos, C.; Peral, J.L.; Tolosana, J.; Sobrino, J.; Isart, J.; Vizcaino, J.; Fernandez Vega, F.; Zamorano, J.L.; Bacariza, M.; Soubriet, A.; Fernandez-Cruz, A.; Querejeta, R.; Munoz Leira, V.; Calvo Iglesias, F.E.; Ibrik, O.; Martin, D.; Nanclares, M.S.; Mediavilla, J.D.; Galceran, J.M.; Lopez, A.; Muros, T.; Pascual, J.; Casalla, F.; Tornero, F.; Fernandez, G.; Weiss, L.; Pettersson, P.; Olsen, H.; Franke, F.; Stroembom, U.; Furuland, H.; Larnefelt, H.; Allemann, Y.; Krapf, R.; Wuethrich, R.; Gerber, P.; Munger, R.; Hayoz, D.; Graf, H.J.; Burnier, M.; Petrillo, A.; Batt, R; Constam, E.N.; Moccetti, T.; Bianda, T.; Rickli, H.; Builliard, C.; Wu, Kwan Du; Lin, Shih Hua; Wu, Chih Jen; Huey-Herng Sheu, W.; Su, Shih Li; Chen, Shih-Chueh; Chou, Chien-Wen; Lee, Chien-Te; Yang, Te-Cheng; Chen, Hung-Chun; Sritara, P.; Sukonthasarn, A.; Sriratanasathavorn, C.; Eiam-Ong, S.; Supasyndh, O.; Chanchairujira, T.; Kitiyakara, C.; Comlekci, A.; Arici, M.; Usalan, C.; Guneri, S.; Koc, M.; Kalender, B.; Ates, K.; Gurgun, C.; Araz, M.; Demirbas, B.; Biernacki, W.; Calvert, J.; Eavis, P.; Kerrane, J.; Litchfield, J.; Middleton, A; Roberts, J.; Simpson, H.; Charles, H.; Jardine, A.; Fisher, M.; Banerjee, D.; Gallen, I.; Gnudi, L.; Harvey, J.; O'Hare, P.; Vora, J.; Winocour, P.; Soran, H.; Browne, D.; Darko, D.; Mancebo, J.G.; de Roa, E.R.; Antepara, N.; Carrillo, E.; Berrizbeitia, M.; Guevara, L.; Pernalete, N.; Ontiveros, C.; Zigrang, W.; Blakney, E.; Rosenblit, P; Weinstein, R.; Klaff, L.; Lipetz, R.; Busick, E.; Tung, P.; Cooperman, M.; Michael, S.; Sun, C.-Huan; Hart, T.; Maddux, A.; Bowden, R.; East, C.; Arakaki, R.; Villafuerte, B.; Mamish, Z; Mendez, R.; Connery, L.; Nour, K.; Wynne, A.; Busch, R.; Zamora, B.; Sachson, R.; Prasad, J.; Lasala, G.; Smith, M.; Fitz-Patrick, D.; Ruiz-Rivera, L.; Barranco, E.; Solomon, R.; Woolley, A; Brown, C.; Freedman, Z.; Schmidt, S; Pollock, J.; Ruddy, M.; Toto, R.; Kopyt, N.P.; Bazzi, A; Horowitz, B.; Feng, W.; Wahl, T.; Duprez, D.; Gilbert, J.; Steigerwalt, S; Jacqmein, J.; Gorton, S.; Allison, J.; Pino, J.; Lock, J.; Leimbach, W.; Anderson, J; Beacom, M.; Craig, W.; Gorson, D.; Kerstein, H.; Lerman, S.; Minehart, C.; Agarwal, N.; Verma, S.I.; Valitutto, M; Demetry, K.; Mersey, J.; Koeper, D; Fanti, P.; Eng, G; Jamerson, K.; Grimm, R.; Fagan, T; Bajaj, M.; Katz, L.; Portnay, G.; Altschuller, A; Desai, V.; Bilazari, S.; Ipp, E; Rodelas, R.; Burstein, D.; Berg, J.; Velez, J.; Lund, R.; Rekhi, A; Martin, E; Martin, J.; Robertson, D.; Singh, N.; Narayan, P.; Moustafa, M.; Lanier, D; Seidner, M; Phillips, A; Vaughters, B.; Sprague, A.; Swartz, S; Lopez, R.; Kumar, J.; Bressler, P.; Sadler, L.; Wise, J.; Kilbane, A		ALTITUDE Investigators	Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLOMERULAR-FILTRATION-RATE; CONVERTING-ENZYME INHIBITORS; LEFT-VENTRICULAR DYSFUNCTION; CHRONIC HEART-FAILURE; MYOCARDIAL-INFARCTION; DOUBLE-BLIND; CARDIOVASCULAR MORTALITY; SYSTOLIC DYSFUNCTION; BLOOD-PRESSURE; FOLLOW-UP	BACKGROUND This study was undertaken to determine whether use of the direct renin inhibitor aliskiren would reduce cardiovascular and renal events in patients with type 2 diabetes and chronic kidney disease, cardiovascular disease, or both. METHODS In a double-blind fashion, we randomly assigned 8561 patients to aliskiren (300 mg daily) or placebo as an adjunct to an angiotensin-converting-enzyme inhibitor or an angiotensin-receptor blocker. The primary end point was a composite of the time to cardiovascular death or a first occurrence of cardiac arrest with resuscitation; nonfatal myocardial infarction; nonfatal stroke; unplanned hospitalization for heart failure; end-stage renal disease, death attributable to kidney failure, or the need for renal-replacement therapy with no dialysis or transplantation available or initiated; or doubling of the baseline serum creatinine level. RESULTS The trial was stopped prematurely after the second interim efficacy analysis. After a median follow-up of 32.9 months, the primary end point had occurred in 783 patients (18.3%) assigned to aliskiren as compared with 732 (17.1%) assigned to placebo (hazard ratio, 1.08; 95% confidence interval [CI], 0.98 to 1.20; P = 0.12). Effects on secondary renal end points were similar. Systolic and diastolic blood pressures were lower with aliskiren (between-group differences, 1.3 and 0.6 mm Hg, respectively) and the mean reduction in the urinary albumin-to-creatinine ratio was greater (between-group difference, 14 percentage points; 95% CI, 11 to 17). The proportion of patients with hyperkalemia (serum potassium level, = 6 mmol per liter) was significantly higher in the aliskiren group than in the placebo group (11.2% vs. 7.2%), as was the proportion with reported hypotension (12.1% vs. 8.3%) (P < 0.001 for both comparisons). CONCLUSIONS The addition of aliskiren to standard therapy with renin-angiotensin system blockade in patients with type 2 diabetes who are at high risk for cardiovascular and renal events is not supported by these data and may even be harmful. (Funded by Novartis; ALTITUDE ClinicalTrials.gov number, NCT00549757.)	[Parving, Hans-Henrik] Univ Copenhagen, Rigshosp, Dept Med Endocrinol, DK-2100 Copenhagen, Denmark; [Parving, Hans-Henrik] Aarhus Univ, Fac Hlth Sci, Aarhus, Denmark; [Persson, Frederik] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Brenner, Barry M.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Solomon, Scott D.; Desai, Akshay S.; Pfeffer, Marc A.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; [McMurray, John J. V.] Univ Glasgow, Cardiovasc Res Ctr, British Heart Fdn, Glasgow, Lanark, Scotland; [Chaturvedi, Nish] Univ London Imperial Coll Sci Technol & Med, London, England; [de Zeeuw, Dick] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands; [Haffner, Steven M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med & Clin Epidemiol, San Antonio, TX 78229 USA; [Nicolaides, Maria; Richard, Alexia; Xiang, Zhihua; Brunel, Patrick] Novartis Pharmaceut, Basel, Switzerland	Rigshospitalet; University of Copenhagen; Aarhus University; Steno Diabetes Center; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Glasgow; Imperial College London; University of Groningen; University of Texas System; University of Texas Health San Antonio; Novartis	Parving, HH (corresponding author), Univ Copenhagen, Rigshosp, Dept Med Endocrinol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	hhparving@dadlnet.dk	Redon, Josep/L-5997-2019; De Jong, Audrey/N-6406-2018; de Paula, Rogério B/K-5973-2012; Tesar, Vladimir/O-2312-2017; Sesti, Giorgio/B-1509-2012; Cífková, Renata/O-5731-2017; Bonora, Enzo/AAA-5300-2022; Koya, Daisuke/J-3257-2014; de Zeeuw, Dick/E-9080-2014; Del Prato, Stefano/K-3405-2016; Leiter, Lawrence/AAG-4059-2020; Toto, Robert/AAQ-3336-2021; REDON, JOSEP/E-1719-2019; rossing, peter/AAZ-3415-2021; KITIYAKARA, CHAGRIYA/AAD-7975-2021; Dotta, Francesco/H-3788-2012; Desai, Akshay/ABE-7250-2020; Jardine, Alan/L-5770-2019; Grandaliano, Giuseppe/J-7822-2016; POLONIA, JORGE/J-8288-2013; Piskorz, Daniel/AAJ-8751-2020; Aldigier, Jean/O-8551-2016; Persson, Frederik/E-6973-2015; Carugo, Stefano/Z-2205-2019; Ibrik, Omar Ibrik/R-6411-2019; rossing, peter/AAH-7879-2021; Toplak, Hermann/ABG-3269-2020; Blacher, Jacques/F-2685-2017; Solomon, Scott/I-5789-2013; Persson, Frederik/AAE-6572-2020; Trimarco, Bruno BT/K-7851-2016; TENTOLOURIS, NIKOLAOS/AAH-6231-2019; Helin, Kristian/K-2526-2019; Usalan, Celalettin/AAH-7497-2020; Arici, Mustafa/I-9265-2013; Tsapas, Apostolos/P-5593-2019; Sahay, Rakesh Kumar/I-1336-2013; FRONTONI, SIMONA/J-4893-2012; KOC, Mehmet/U-5525-2019; Piatti, Piermarco/AAN-3115-2020; Marchionni, Niccolò/ABE-3977-2020; Widimsky, Petr/P-8088-2016; Del+Prato, Stefano/AAC-9197-2021; De Jong, Audrey/AAA-8553-2020; Volpe, Massimo/K-5240-2016; Onishi, Yukiko/AAU-9057-2021; Gaillard, Carlo/AAC-6729-2022; mcmurray, John/B-2467-2013; Ovize, michel/AAL-9247-2020; Wyss, Fernando/AAV-4651-2021; Voors, Adriaan/ABE-6784-2020; Rayner, Brian/AAA-3174-2021; Ferri, Claudio/AAB-5070-2022; Miglinas, Marius/AAU-2533-2020; Dotta, Francesco/AAF-1123-2019; Remuzzi, Giuseppe/V-9766-2017; , CINTESIS/C-6631-2014; GIORDANO, Carla/R-4296-2017	Redon, Josep/0000-0001-8777-6773; De Jong, Audrey/0000-0002-3413-2752; Tesar, Vladimir/0000-0001-6982-0689; Cífková, Renata/0000-0003-2765-3821; de Zeeuw, Dick/0000-0003-3434-7777; Del Prato, Stefano/0000-0002-5388-0270; rossing, peter/0000-0002-1531-4294; Grandaliano, Giuseppe/0000-0003-1213-2177; Piskorz, Daniel/0000-0002-8615-5446; Aldigier, Jean/0000-0002-1804-981X; Persson, Frederik/0000-0001-6242-6638; Toplak, Hermann/0000-0002-7513-5167; Blacher, Jacques/0000-0003-4860-4279; Persson, Frederik/0000-0001-6242-6638; Trimarco, Bruno BT/0000-0002-0701-6449; TENTOLOURIS, NIKOLAOS/0000-0003-0615-2534; Usalan, Celalettin/0000-0002-9967-1925; Tsapas, Apostolos/0000-0003-0221-4072; Sahay, Rakesh Kumar/0000-0002-5471-0695; FRONTONI, SIMONA/0000-0001-8241-7552; Marchionni, Niccolò/0000-0002-8101-4695; Widimsky, Petr/0000-0001-5686-7752; Volpe, Massimo/0000-0002-9642-8380; Onishi, Yukiko/0000-0003-1180-5982; Gaillard, Carlo/0000-0002-8964-0236; mcmurray, John/0000-0002-6317-3975; Ferri, Claudio/0000-0002-3594-2503; Remuzzi, Giuseppe/0000-0002-6194-3446; De Vriese, An/0000-0002-9596-8529; Koranyi, Laszlo/0000-0002-5733-9350; Sgarbi, Jose/0000-0001-7187-984X; Polonia, Jorge/0000-0002-0133-7217; , CINTESIS/0000-0001-7248-2086; GIORDANO, Carla/0000-0003-1731-9395; Ruilope, Luis M/0000-0001-6278-7951; Persu, Alexandre/0000-0002-4007-9695				Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; Desai AS, 2011, AM J KIDNEY DIS, V58, P717, DOI 10.1053/j.ajkd.2011.05.020; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gerstein HC, 2000, LANCET, V355, P253; Gheorghiade M, 2011, EUR J HEART FAIL, V13, P100, DOI 10.1093/eurjhf/hfq209; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; *HEART OUTC PREV E, 2000, LANCET, V356, P860; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Holtkamp FA, 2011, EUR HEART J, V32, P1493, DOI 10.1093/eurheartj/ehr017; Krum H, 2011, EUR J HEART FAIL, V13, P107, DOI 10.1093/eurjhf/hfq212; Levey AS, 2008, ANN INTERN MED, V149, P519, DOI 10.7326/0003-4819-149-7-200810070-00023; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Masson S, 2010, J CARD FAIL, V16, P964, DOI 10.1016/j.cardfail.2010.06.417; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McMurray JJV, 2008, CIRC-HEART FAIL, V1, P17, DOI 10.1161/CIRCHEARTFAILURE.107.740704; Miao Y, 2011, DIABETOLOGIA, V54, P44, DOI 10.1007/s00125-010-1922-6; Oparil S, 2007, LANCET, V370, P221, DOI 10.1016/S0140-6736(07)61124-6; Parving HH, 2008, NEW ENGL J MED, V358, P2433, DOI 10.1056/NEJMoa0708379; Parving HH, 2009, NEPHROL DIAL TRANSPL, V24, P1663, DOI 10.1093/ndt/gfn721; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Pfeffer MA, 2010, DIAL CARDIOVASC MED, V15, P130; Pfeffer MA, 2008, CIRCULATION, V118, P2491, DOI 10.1161/CIRCULATIONAHA.108.821512; Ruggenenti P, 1998, LANCET, V352, P1252, DOI 10.1016/S0140-6736(98)04433-X; Sampson UK, 2007, EUR HEART J, V28, P685, DOI 10.1093/eurheartj/ehl197; Schjoedt KJ, 2004, DIABETOLOGIA, V47, P1936, DOI 10.1007/s00125-004-1542-0; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Solomon SD, 2011, EUR HEART J, V32, P1227, DOI 10.1093/eurheartj/ehq522; Staessen JA, 2006, LANCET, V368, P1449, DOI 10.1016/S0140-6736(06)69442-7; The Emerging Risk Factors Collaboration, 2011, NEW ENGL J MED, V364, P1281; Verma S, 2011, EUR HEART J, V32, P2135, DOI 10.1093/eurheartj/ehr066; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	39	885	919	3	166	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2012	367	23					2204	2213		10.1056/NEJMoa1208799	http://dx.doi.org/10.1056/NEJMoa1208799			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048DO	23121378	Green Published			2022-12-28	WOS:000311890600007
J	Grant, KM; Rohling, EJ; Bar-Matthews, M; Ayalon, A; Medina-Elizalde, M; Ramsey, CB; Satow, C; Roberts, AP				Grant, K. M.; Rohling, E. J.; Bar-Matthews, M.; Ayalon, A.; Medina-Elizalde, M.; Ramsey, C. Bronk; Satow, C.; Roberts, A. P.			Rapid coupling between ice volume and polar temperature over the past 150,000 years	NATURE			English	Article							SEA-LEVEL; CLIMATE; FORAMINIFERA; CONSTRAINTS; CHRONOLOGY	Current global warming necessitates a detailed understanding of the relationships between climate and global ice volume. Highly resolved and continuous sea-level records are essential for quantifying ice-volume changes. However, an unbiased study of the timing of past ice-volume changes, relative to polar climate change, has so far been impossible because available sea-level records either were dated by using orbital tuning or ice-core timescales, or were discontinuous in time. Here we present an independent dating of a continuous, high-resolution sea-level record(1,2) in millennial-scale detail throughout the past 150,000 years. We find that the timing of ice-volume fluctuations agrees well with that of variations in Antarctic climate and especially Greenland climate. Amplitudes of ice-volume fluctuations more closely match Antarctic (rather than Greenland) climate changes. Polar climate and ice-volume changes, and their rates of change, are found to covary within centennial response times. Finally, rates of sea-level rise reached at least 1.2 m per century during all major episodes of ice-volume reduction.	[Grant, K. M.; Rohling, E. J.; Medina-Elizalde, M.] Univ Southampton, Sch Ocean & Earth Sci, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; [Rohling, E. J.; Roberts, A. P.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Bar-Matthews, M.; Ayalon, A.] Geol Survey Israel, IL-95501 Jerusalem, Israel; [Ramsey, C. Bronk] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford OX1 3QY, England; [Satow, C.] Royal Holloway Univ London, Dept Geog, Egham TW20 0EX, Surrey, England	NERC National Oceanography Centre; University of Southampton; Australian National University; Geological Survey Israel; University of Oxford; University of London; Royal Holloway University London	Grant, KM (corresponding author), Univ Southampton, Sch Ocean & Earth Sci, Natl Oceanog Ctr, European Way, Southampton SO14 3ZH, Hants, England.	kxg@noc.soton.ac.uk	Rohling, Eelco J/B-9736-2008; Ramsey, Christopher Bronk/A-3277-2012; Ramsey, Christopher Bronk/AAQ-2227-2021; Roberts, Andrew P/E-6422-2010	Rohling, Eelco J/0000-0001-5349-2158; Ramsey, Christopher Bronk/0000-0002-8641-9309; Ramsey, Christopher Bronk/0000-0002-8641-9309; Roberts, Andrew P/0000-0003-0566-8117; Grant, Katharine/0000-0003-4299-5504	UK Natural Environment Research Council (NERC) [NE/H004424/1, NE/E01531X/1, NE/I009906/1]; Royal Society Wolfson Research Merit Award; Australian Laureate Fellowship [FL120100050]; Natural Environment Research Council [NE/E01531X/1, NE/E015670/1, NE/I009906/1, NRCF010002, bosc01001, NE/H004424/1] Funding Source: researchfish; NERC [NE/H004424/1, NE/E015670/1, NE/I009906/1, NRCF010002, bosc01001, NE/E01531X/1] Funding Source: UKRI	UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society Wolfson Research Merit Award(Royal Society of London); Australian Laureate Fellowship; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank A. Dutton for comments that improved the manuscript. S. Lee helped with the use of OxCal. This study contributes to UK Natural Environment Research Council (NERC) projects NE/H004424/1, NE/E01531X/1 and NE/I009906/1, to a Royal Society Wolfson Research Merit Award (E.J.R.), and to a 2012 Australian Laureate Fellowship FL120100050 (E.J.R.).	Almogi-Labin A, 2009, QUATERNARY SCI REV, V28, P2882, DOI 10.1016/j.quascirev.2009.07.017; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Bar-Matthews M, 2003, GEOCHIM COSMOCHIM AC, V67, P3181, DOI 10.1016/S0016-7037(02)01031-1; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Bintanja R, 2005, NATURE, V437, P125, DOI 10.1038/nature03975; Chappell J, 2002, QUATERNARY SCI REV, V21, P1229, DOI 10.1016/S0277-3791(01)00141-X; Cuffey KM, 2000, NATURE, V404, P591, DOI 10.1038/35007053; Cutler KB, 2003, EARTH PLANET SC LETT, V206, P253, DOI 10.1016/S0012-821X(02)01107-X; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; De Vivo B, 2001, MINER PETROL, V73, P47, DOI 10.1007/s007100170010; Dutton A, 2012, SCIENCE, V337, P216, DOI 10.1126/science.1205749; Gregory JM, 2004, NATURE, V428, P616, DOI 10.1038/428616a; Hansen J, 2007, PHILOS T R SOC A, V365, P1925, DOI 10.1098/rsta.2007.2052; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kohler P, 2010, QUATERNARY SCI REV, V29, P129, DOI 10.1016/j.quascirev.2009.09.026; Kopp RE, 2009, NATURE, V462, P863, DOI 10.1038/nature08686; Lambeck K, 2011, QUATERNARY SCI REV, V30, P3542, DOI 10.1016/j.quascirev.2011.08.008; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Manning SW, 2006, SCIENCE, V312, P565, DOI 10.1126/science.1125682; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Parrenin F, 2007, CLIM PAST, V3, P485, DOI 10.5194/cp-3-485-2007; Ramsey CB, 2008, QUATERNARY SCI REV, V27, P42, DOI 10.1016/j.quascirev.2007.01.019; Rohling EJ, 2009, NAT GEOSCI, V2, P500, DOI 10.1038/ngeo557; Rohling EJ, 1999, PALEOCEANOGRAPHY, V14, P706, DOI 10.1029/1999PA900042; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Stanford JD, 2011, GLOBAL PLANET CHANGE, V79, P193, DOI 10.1016/j.gloplacha.2010.11.002; Svensson A, 2008, CLIM PAST, V4, P47, DOI 10.5194/cp-4-47-2008; Thompson WG, 2005, SCIENCE, V308, P401, DOI 10.1126/science.1104035; Thompson WG, 2011, NAT GEOSCI, V4, P684, DOI [10.1038/ngeo1253, 10.1038/NGEO1253]; Trommer G, 2011, CLIM PAST, V7, P941, DOI 10.5194/cp-7-941-2011; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9	32	371	375	8	222	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					744	747		10.1038/nature11593	http://dx.doi.org/10.1038/nature11593			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23151478				2022-12-28	WOS:000311606000042
J	van Ginneken, E; Habicht, J; Murauskiene, L; Behmane, D; Mladovsky, P				van Ginneken, Ewout; Habicht, Jarno; Murauskiene, Liubove; Behmane, Daiga; Mladovsky, Philipa			HEALTH SYSTEMS PERSPECTIVES The Baltic states: building on 20 years of health reforms	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POLICY; CARE		[van Ginneken, Ewout] Berlin Univ Technol, Dept Hlth Care Management, D-10623 Berlin, Germany; [van Ginneken, Ewout; Mladovsky, Philipa] European Observ Hlth Syst & Policies, B-1070 Brussels, Belgium; [Habicht, Jarno] WHO, WHO Country Off Republ Moldova, MD-2029 Kishinev, Moldova; [Murauskiene, Liubove] MTVC Training Res & Dev Ctr, LT-10305 Vilnius, Lithuania; [Behmane, Daiga] Latvian Assoc Hlth Econ, LV-1001 Riga, Latvia; [Mladovsky, Philipa] Univ London London Sch Econ & Polit Sci, LSE Hlth, London WC2A 2AE, England	Technical University of Berlin; European Observatory on Health Systems & Policies; World Health Organization; University of London; London School Economics & Political Science	van Ginneken, E (corresponding author), Berlin Univ Technol, Dept Hlth Care Management, Str 17 Juni 135, D-10623 Berlin, Germany.	ewout.vanginneken@tu-berlin.de	Mladovsky, Philipa/AAN-2264-2020; Murauskiene, Liubove/AGL-5510-2022	Murauskiene, Liubove/0000-0002-6625-8843				Atun RA, 2005, REV EXPERIENCE FAMIL, V1; Atun RA, 2006, HEALTH POLICY, V79, P79, DOI 10.1016/j.healthpol.2005.12.005; Bankauskaite V, 2008, HEALTH POLICY, V88, P155, DOI 10.1016/j.healthpol.2007.10.017; Behmane D., 2011, Eurohealth, V17, P8; Cerniauskas G, 2000, HLTH CARE SYSTEMS TR; Charlemagne, 2012, ECONOMIST; Cockcroft A, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-15; European Commission Directorate General Health & Consumers, 2007, COUNTR SHEETS HLTH S; European Monitoring Drug Centre, 2012, JOINT EMCDDA ECDC RA; Eurostat, 2012, EU LAB FORC SURV; EUROSTAT, 2012, REAL GDP GROWTH RAT; Eurostat, 2012, SELF REP UNM NEED ME; Garuoliene K., 2011, Eurohealth, V17, P1; Gemmill MC, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-12; Gili M, 2013, EUR J PUBLIC HEALTH, V23, P103, DOI 10.1093/eurpub/cks035; Habicht J, 2010, EUROHEALTH, V16, P19; Habicht J, 2009, INT J PUBLIC HEALTH, V54, P250, DOI 10.1007/s00038-009-8012-x; Habicht T, 2008, GOVERNING MANDATORY; Karanikolos M, 2012, J EPIDEMIOL COMMUN H, V66, P1043, DOI 10.1136/jech-2011-200879; Koppel A, 2008, HLTH SYST T, V10, P1; Lai T, 2011, ALCOHOL ALCOHOLISM, V46, P200, DOI 10.1093/alcalc/agr001; Lohr K, 1986, MED CARE S, V24, pS31; MANNING WG, 1987, AM ECON REV, V77, P251; McDaid D, 2012, HLTH SYSTEMS HLTH WE; McKee M, 2004, HLTH POLICY EUROPEAN; Mittenbergs U, HLTH SYSTEM IN PRESS; Mladovsky P, EUROHEALTH, V18, P3; Mladovsky Philipa, 2012, HLTH POLICY RESPONSE; Newhouse JP, 1993, FREE ALL LESSONS RAN; Padaiga Z, 2011, HLTH PROFESSIONAL MO, P395; Rechel B, 2009, LANCET, V374, P1186, DOI 10.1016/S0140-6736(09)61334-9; Ruutel D., 2011, Eurohealth, V17, P5; Saar P, 2011, HLTH PROFESSIONAL MO; Tragakes E, 2008, HLTH SYST TRANSIT, V10, P1; WHO Regional Office for Europe, 2012, EUR HLTH ALL DAT HFA; Wismar M., 2011, HLTH PROFESSIONAL MO	36	13	13	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2012	345								e7348	10.1136/bmj.e7348	http://dx.doi.org/10.1136/bmj.e7348			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	044HI	23179867				2022-12-28	WOS:000311609800001
J	Logothetis, NK; Eschenko, O; Murayama, Y; Augath, M; Steudel, T; Evrard, HC; Besserve, M; Oeltermann, A				Logothetis, N. K.; Eschenko, O.; Murayama, Y.; Augath, M.; Steudel, T.; Evrard, H. C.; Besserve, M.; Oeltermann, A.			Hippocampal-cortical interaction during periods of subcortical silence	NATURE			English	Article							SLOW-WAVE SLEEP; TRAINING REVERSIBLE INACTIVATION; MEMORY-SYSTEMS; DECLARATIVE MEMORY; SHARP WAVES; RIPPLES; OSCILLATION; CONSOLIDATION; REACTIVATION; STATE	Hippocampal ripples, episodic high-frequency field-potential oscillations primarily occurring during sleep and calmness, have been described in mice, rats, rabbits, monkeys and humans, and so far they have been associated with retention of previously acquired awake experience. Although hippocampal ripples have been studied in detail using neurophysiological methods, the global effects of ripples on the entire brain remain elusive, primarily owing to a lack of methodologies permitting concurrent hippocampal recordings and whole-brain activity mapping. By combining electrophysiological recordings in hippocampus with ripple-triggered functional magnetic resonance imaging, here we show that most of the cerebral cortex is selectively activated during the ripples, whereas most diencephalic, midbrain and brainstem regions are strongly and consistently inhibited. Analysis of regional temporal response patterns indicates that thalamic activity suppression precedes the hippocampal population burst, which itself is temporally bounded by massive activations of association and primary cortical areas. These findings suggest that during off-line memory consolidation, synergistic thalamocortical activity may be orchestrating a privileged interaction state between hippocampus and cortex by silencing the output of subcortical centres involved in sensory processing or potentially mediating procedural learning. Such a mechanism would cause minimal interference, enabling consolidation of hippocampus-dependent memory.	[Logothetis, N. K.; Eschenko, O.; Murayama, Y.; Augath, M.; Steudel, T.; Evrard, H. C.; Besserve, M.; Oeltermann, A.] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Logothetis, N. K.] Univ Manchester, Biomed Imaging Inst, Ctr Imaging Sci, Manchester M13 9PT, Lancs, England; [Besserve, M.] Max Planck Inst Intelligent Syst, D-72076 Tubingen, Germany	Max Planck Society; University of Manchester; Max Planck Society	Logothetis, NK (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	Nikos.Logothetis@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019; Eschenko, Oxana/N-7335-2013	Eschenko, Oxana/0000-0001-7482-5628; Evrard, Henry/0000-0001-8429-4699	Max Planck Society	Max Planck Society(Max Planck Society)	We thank D. Omer and M. Munk for reading the manuscript and for useful suggestions, D. Blaurock for English language corrections and editing, and P. Douay for help with the alert monkey experiments. This research was supported by the Max Planck Society. We apologize to those whose work we have not been able to cite for reasons of space.	Amzica F, 1997, NEUROLOGY, V49, P952, DOI 10.1212/WNL.49.4.952; Axmacher N, 2008, BRAIN, V131, P1806, DOI 10.1093/brain/awn103; Axmacher N, 2008, BEHAV BRAIN RES, V189, P1, DOI 10.1016/j.bbr.2007.12.018; Axmacher N, 2006, BRAIN RES REV, V52, P170, DOI 10.1016/j.brainresrev.2006.01.007; Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; Born J, 2010, WORLD J BIOL PSYCHIA, V11, P16, DOI 10.3109/15622971003637637; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Clemens Z, 2007, BRAIN, V130, P2868, DOI 10.1093/brain/awm146; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Eichenbaum H, 1997, ANNU REV PSYCHOL, V48, P547, DOI 10.1146/annurev.psych.48.1.547; Eschenko O, 2008, LEARN MEMORY, V15, P222, DOI 10.1101/lm.726008; Girardeau G, 2011, CURR OPIN NEUROBIOL, V21, P452, DOI 10.1016/j.conb.2011.02.005; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Hasselmo M E, 1999, Prog Brain Res, V121, P3; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2010, NAT NEUROSCI, V13, P1283, DOI 10.1038/nn.2631; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; Molle M, 2002, J NEUROSCI, V22, P10941; MOURET J, 1963, J PHYSIOLOGY PARIS, V55, P305; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nadel L, 2011, NEUROPSYCHOPHARMACOL, V36, P251, DOI 10.1038/npp.2010.169; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV, P114; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; Oliveira AMM, 2010, LEARN MEMORY, V17, P155, DOI 10.1101/lm.1625310; Paxinos G., 2008, RHESUS MONKEY BRAIN, V2nd ed; Pennartz CMA, 2002, PROG BRAIN RES, V138, P143, DOI 10.1016/S0079-6123(02)38076-2; Poldrack RA, 2004, NEUROBIOL LEARN MEM, V82, P324, DOI 10.1016/j.nlm.2004.05.003; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Ramadan W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006697; Schroeder JP, 2002, HIPPOCAMPUS, V12, P280, DOI 10.1002/hipo.10024; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 2007, J NEUROPHYSIOL, V98, P898, DOI 10.1152/jn.00401.2007; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Steriade M, 2003, FRONT BIOSCI-LANDMRK, V8, pD878, DOI 10.2741/1043; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Sullivan D, 2011, J NEUROSCI, V31, P8605, DOI 10.1523/JNEUROSCI.0294-11.2011; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wierzynski CM, 2009, NEURON, V61, P587, DOI 10.1016/j.neuron.2009.01.011; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; YLINEN A, 1995, J NEUROSCI, V15, P30	50	238	239	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					547	553		10.1038/nature11618	http://dx.doi.org/10.1038/nature11618			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23172213				2022-12-28	WOS:000311339800042
J	Clark, ME				Clark, Megan Elizabeth			No More Apologies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Clark, Megan Elizabeth] Univ Missouri, Univ Hosp, Columbia, MO 65211 USA; [Clark, Megan Elizabeth] Univ Missouri, Rusk Rehabil Ctr, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Clark, ME (corresponding author), Univ Missouri, Univ Hosp, Columbia, MO 65211 USA.	meca8f@mizzou.edu							0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2012	308	19					1983	1984		10.1001/2012.jama.10596	http://dx.doi.org/10.1001/2012.jama.10596			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040AQ	23168822				2022-12-28	WOS:000311291400021
J	Bass, J				Bass, Joseph			Circadian topology of metabolism	NATURE			English	Review							REV-ERB-ALPHA; HYPOCRETIN OREXIN; MAMMALIAN CLOCK; BLOOD-PRESSURE; TRANSCRIPTION; RECEPTOR; RHYTHMS; MELANOPSIN; EXPRESSION; BEHAVIOR	Biological clocks are genetically encoded oscillators that allow organisms to anticipate changes in the light-dark environment that are tied to the rotation of Earth. Clocks enhance fitness and growth in prokaryotes, and they are expressed throughout the central nervous system and peripheral tissues of multicelled organisms in which they influence sleep, arousal, feeding and metabolism. Biological clocks capture the imagination because of their tie to geophysical time, and tools are now in hand to analyse their function in health and disease at the cellular and molecular level.	[Bass, Joseph] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Bass, Joseph] Northwestern Univ, Dept Neurobiol, Weinberg Coll Arts & Sci, Evanston, IL 60208 USA	Northwestern University; Feinberg School of Medicine; Northwestern University	Bass, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA.	j-bass@northwestern.edu			NIH Diabetes and Digestive and Kidney Diseases Institute [R01DK090625]; National Institute on Aging [P01AG011412]; Chicago Biomedical Consortium Searle Funds; American Diabetes Association [1-09-RA-07]; Juvenile Diabetes Research Foundation [1-2008-114]; University of Chicago Diabetes Research and Training Center [P60 DK020595]; NIH Heart, Lung and Blood Institute [R01HL097817]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595, R01DK090625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011412] Funding Source: NIH RePORTER	NIH Diabetes and Digestive and Kidney Diseases Institute; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Chicago Biomedical Consortium Searle Funds; American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); University of Chicago Diabetes Research and Training Center(University of Chicago); NIH Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	I wish to thank G. Barish, K. Moynihan Ramsey and the anonymous reviewers for comments on the manuscript, as well as D. Levine and B. Marcheva for their help with the figures. I also thank my fellow time travellers, R. Allada, J. Takahashi and F. Turek, for their collegiality and discussions. Work towards this manuscript was supported by grants from the NIH Diabetes and Digestive and Kidney Diseases (R01DK090625), and Heart, Lung and Blood (R01HL097817) Institutes, National Institute on Aging (P01AG011412), the Chicago Biomedical Consortium Searle Funds, the American Diabetes Association (1-09-RA-07), the Juvenile Diabetes Research Foundation (1-2008-114) and the University of Chicago Diabetes Research and Training Center (P60 DK020595).	Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Brown SA, 2005, SCIENCE, V308, P693, DOI 10.1126/science.1107373; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; Cheng B, 2011, P NATL ACAD SCI USA, V108, P17147, DOI 10.1073/pnas.1112998108; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Chou TC, 2003, J NEUROSCI, V23, P10691; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; DiTacchio L, 2011, SCIENCE, V333, P1881, DOI 10.1126/science.1206022; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Douris N, 2011, CURR BIOL, V21, P1347, DOI 10.1016/j.cub.2011.07.018; Dubrovsky YV, 2010, AGING-US, V2, P936, DOI 10.18632/aging.100241; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Dufour CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002143; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Etchegaray JP, 2006, J BIOL CHEM, V281, P21209, DOI 10.1074/jbc.M603722200; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Funato H, 2009, CELL METAB, V9, P64, DOI 10.1016/j.cmet.2008.10.010; Gilles-Gonzalez MA, 2004, J APPL PHYSIOL, V96, P774, DOI 10.1152/japplphysiol.00941.2003; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hsu DS, 1996, BIOCHEMISTRY-US, V35, P13871, DOI 10.1021/bi962209o; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Jones MA, 2010, P NATL ACAD SCI USA, V107, P21623, DOI 10.1073/pnas.1014204108; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Kitayama Y, 2008, GENE DEV, V22, P1513, DOI 10.1101/gad.1661808; Knutson KL, 2011, DIABETES CARE, V34, P1171, DOI 10.2337/dc10-1962; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Landry GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024187; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Libert S, 2012, AGING CELL, V11, P794, DOI 10.1111/j.1474-9726.2012.00846.x; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; LOROS JJ, 1991, MOL CELL BIOL, V11, P558, DOI 10.1128/MCB.11.1.558; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Marvin KA, 2009, BIOCHEMISTRY-US, V48, P7056, DOI 10.1021/bi900697c; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishino S, 2001, ANN NEUROL, V50, P381, DOI 10.1002/ana.1130; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Pan XY, 2010, CELL METAB, V12, P174, DOI 10.1016/j.cmet.2010.05.014; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Picinato MC, 2002, J PINEAL RES, V33, P172, DOI 10.1034/j.1600-079X.2002.02925.x; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rust MJ, 2011, SCIENCE, V331, P220, DOI 10.1126/science.1197243; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Schoenhard JA, 2003, J MOL CELL CARDIOL, V35, P473, DOI 10.1016/S0022-2828(03)00051-8; Shea SA, 2011, CIRC RES, V108, P980, DOI 10.1161/CIRCRESAHA.110.233668; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Sutton GM, 2008, J NEUROSCI, V28, P12946, DOI 10.1523/JNEUROSCI.3615-08.2008; Torra IP, 2000, ENDOCRINOLOGY, V141, P3799, DOI 10.1210/en.141.10.3799; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; Williams SR, 2012, AM J HUM GENET, V90, P941, DOI 10.1016/j.ajhg.2012.04.013; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Yamazaki S, 2002, P NATL ACAD SCI USA, V99, P10801, DOI 10.1073/pnas.152318499; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhang QH, 2002, SCIENCE, V295, P1895	100	437	452	2	161	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					348	356		10.1038/nature11704	http://dx.doi.org/10.1038/nature11704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23151577				2022-12-28	WOS:000311031600031
J	Brown, DJA; Brugger, H; Boyd, J; Paal, P				Brown, Douglas J. A.; Brugger, Hermann; Boyd, Jeff; Paal, Peter			Accidental Hypothermia	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							EXTRACORPOREAL MEMBRANE-OXYGENATION; OF-THE-LITERATURE; CARDIAC-ARREST; PROFOUND HYPOTHERMIA; CARDIOCIRCULATORY ARREST; CEREBRAL OXYGENATION; CIRCULATORY ARREST; AVALANCHE VICTIM; RESUSCITATION; TRAUMA		[Brown, Douglas J. A.] Univ British Columbia, Dept Emergency Med, Vancouver, BC V5Z 1M9, Canada; [Boyd, Jeff] Mineral Springs Hosp, Dept Emergency Med, Banff, AB, Canada; [Brugger, Hermann] European Acad Bolzano, Inst Mt Emergency Med, Bolzano, Italy; [Paal, Peter] Innsbruck Med Univ, Dept Anesthesiol & Crit Care Med, Innsbruck, Austria	University of British Columbia; European Academy of Bozen-Bolzano; Medical University of Innsbruck	Brown, DJA (corresponding author), Univ British Columbia, Dept Emergency Med, Vancouver Gen Hosp, 855 W 12th Ave, Vancouver, BC V5Z 1M9, Canada.	dbhypothermia@gmail.com		Paal, Peter/0000-0002-2939-4782				ALTHAUS U, 1982, ANN SURG, V195, P492, DOI 10.1097/00000658-198204000-00018; Baumgartner EA, 2008, WILD ENVIRON MED, V19, P233, DOI 10.1580/07-WEME-OR-104.1; BOLTE RG, 1988, JAMA-J AM MED ASSOC, V260, P377, DOI 10.1001/jama.260.3.377; Boyd J, 2010, RESUSCITATION, V81, P645, DOI 10.1016/j.resuscitation.2010.01.037; Brandstrom H, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18502; Brugger H, 2001, RESUSCITATION, V51, P7, DOI 10.1016/S0300-9572(01)00383-5; Brugger H, 2011, HIGH ALT MED BIOL, V12, P199, DOI 10.1089/ham.2011.1025; DANZL DF, 1989, CRIT CARE MED, V17, P227, DOI 10.1097/00003246-198903000-00005; DANZL DF, 1987, ANN EMERG MED, V16, P1042, DOI 10.1016/S0196-0644(87)80757-6; Danzl DF, 2012, WILDERNESS MED, P116; Dobson JAR, 1996, J TRAUMA, V40, P483, DOI 10.1097/00005373-199603000-00032; Durrer B, 2003, HIGH ALT MED BIOL, V4, P99, DOI 10.1089/152702903321489031; Eich C, 2005, RESUSCITATION, V67, P145, DOI 10.1016/j.resuscitation.2005.05.002; Farstad M, 2001, EUR J CARDIO-THORAC, V20, P58, DOI 10.1016/S1010-7940(01)00713-8; Giesbrecht GG, 2012, WILDERNESS MED, P143; Gilbert M, 2000, LANCET, V355, P375, DOI 10.1016/S0140-6736(00)01021-7; Hultzer Michele V, 2005, CJEM, V7, P378; HUSBY P, 1990, INTENS CARE MED, V16, P69, DOI 10.1007/BF01706328; Kamarainen A, 2012, RESUSCITATION, V83, P138, DOI 10.1016/j.resuscitation.2011.09.011; Kornberger E, 1999, RESUSCITATION, V41, P105, DOI 10.1016/S0300-9572(99)00069-6; LARACH MG, 1995, LANCET, V345, P493, DOI 10.1016/S0140-6736(95)90587-1; Lexow K, 1991, Arctic Med Res, V50 Suppl 6, P112; Locher T, 1996, Praxis (Bern 1994), V85, P1275; Lundgren P, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-59; MAIR P, 1994, RESUSCITATION, V27, P47, DOI 10.1016/0300-9572(94)90021-3; MILLER JW, 1980, ANN EMERG MED, V9, P456, DOI 10.1016/S0196-0644(80)80304-0; Monika BM, 2011, INJURY, V42, P539, DOI 10.1016/j.injury.2010.11.037; Morita S, 2011, CRIT CARE MED, V39, P1064, DOI 10.1097/CCM.0b013e31820edd04; NIAZI SA, 1958, ANN SURG, V147, P264, DOI 10.1097/00000658-195802000-00019; Oberhammer R, 2008, RESUSCITATION, V76, P474, DOI 10.1016/j.resuscitation.2007.09.004; Paal R, 2006, ANAESTHESIST, V55, P314, DOI 10.1007/s00101-006-0997-4; Perkins GD, 2010, CURR OPIN CRIT CARE, V16, P203, DOI 10.1097/MCC.0b013e328339cf59; Plaisier BR, 2005, RESUSCITATION, V66, P99, DOI 10.1016/j.resuscitation.2004.12.024; Putzer G, 2010, RESUSCITATION, V81, P1043, DOI 10.1016/j.resuscitation.2010.04.019; Rajagopalan S, 2008, ANESTHESIOLOGY, V108, P71, DOI 10.1097/01.anes.0000296719.73450.52; Roggla M, 2002, WIEN KLIN WOCHENSCHR, V114, P315; Rubio A, 2008, J CARDIAC SURG, V23, P474, DOI 10.1111/j.1540-8191.2008.00644.x; Ruttmann E, 2007, J THORAC CARDIOV SUR, V134, P594, DOI 10.1016/j.jtcvs.2007.03.049; SCHALLER MD, 1990, JAMA-J AM MED ASSOC, V264, P1842, DOI 10.1001/jama.264.14.1842; Schwarz B, 2002, CRIT CARE MED, V30, P1311, DOI 10.1097/00003246-200206000-00027; Silfvast T, 2003, RESUSCITATION, V59, P285, DOI 10.1016/S0300-9572(03)00237-5; Soar J, 2010, RESUSCITATION, V81, P1400, DOI 10.1016/j.resuscitation.2010.08.015; Steele MT, 1996, ANN EMERG MED, V27, P479, DOI 10.1016/S0196-0644(96)70237-8; Strapazzon G, 2012, ANN EMERG MED, V60, P193, DOI 10.1016/j.annemergmed.2011.11.015; Sultan N, 2009, CAN J EMERG MED, V11, P174; Taylor Edward E, 2008, Proc (Bayl Univ Med Cent), V21, P120; Tipton MJ, 2011, RESUSCITATION, V82, P819, DOI 10.1016/j.resuscitation.2011.02.021; Tiruvoipati R, 2005, ASAIO J, V51, P474, DOI 10.1097/01.mat.0000169124.32865.d6; van der Ploeg GJ, 2010, RESUSCITATION, V81, P1550, DOI 10.1016/j.resuscitation.2010.05.023; Vanden HTL, 2011, CIRCULATION, V124, pE405, DOI 10.1161/CIR.0b013e318235cf3f; Vella J, 1996, IRISH J MED SCI, V165, P113, DOI 10.1007/BF02943796; VONSEGESSER LK, 1991, ANN THORAC SURG, V52, P560, DOI 10.1016/0003-4975(91)90929-K; Walpoth BH, 1997, NEW ENGL J MED, V337, P1500, DOI 10.1056/NEJM199711203372103; WALPOTH BH, 1994, J CLIN MONITOR, V10, P91, DOI 10.1007/BF02886820; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80; Watts DD, 1998, J TRAUMA, V44, P846, DOI 10.1097/00005373-199805000-00017; Wira CR, 2008, RESUSCITATION, V78, P21, DOI 10.1016/j.resuscitation.2008.01.025	57	326	347	4	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2012	367	20					1930	1938		10.1056/NEJMra1114208	http://dx.doi.org/10.1056/NEJMra1114208			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036MB	23150960				2022-12-28	WOS:000311029300009
J	Cook-Deegan, R				Cook-Deegan, Robert			Law and Science Collide Over Human Gene Patents	SCIENCE			English	Editorial Material							CANCER SUSCEPTIBILITY; ASCO STATEMENT		Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Duke University	Cook-Deegan, R (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA.	bob.cd@duke.edu		Cook-Deegan, Robert/0000-0002-8251-4237	NHGRI NIH HHS [P50 HG003391] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Collins FS, 1996, J CLIN ONCOL, V14, P1738; Conley J., 2012, GENOMIC LAW REP 0817; Holman CM, 2008, SCIENCE, V322, P198, DOI 10.1126/science.1160687; Holman Christopher M., 2009, KAN JL PUB POLY, V18, P215; Rai Arti K., 2011, YALE LAW J ONLINE, V121, P335; Skolnick M, 1996, J CLIN ONCOL, V14, P1737; Visco FM, 1996, J CLIN ONCOL, V14, P1737, DOI 10.1200/JCO.1996.14.5.1737	7	13	13	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					745	747		10.1126/science.1229854	http://dx.doi.org/10.1126/science.1229854			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	033ZI	23139317				2022-12-28	WOS:000310839500026
J	Woodworth, MB; Greig, LC; Kriegstein, AR; Macklis, JD				Woodworth, Mollie B.; Greig, Luciano Custo; Kriegstein, Arnold R.; Macklis, Jeffrey D.			SnapShot: Cortical Development	CELL			English	Editorial Material							CEREBRAL-CORTEX; SPECIFICATION; NEURONS		[Woodworth, Mollie B.; Greig, Luciano Custo; Macklis, Jeffrey D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Woodworth, Mollie B.; Greig, Luciano Custo; Macklis, Jeffrey D.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Woodworth, Mollie B.; Greig, Luciano Custo; Macklis, Jeffrey D.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	Harvard University; Harvard University; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Woodworth, MB (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.			Greig, Luciano/0000-0002-0020-9379; Woodworth, Mollie/0000-0003-2130-2289	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS080343, R01NS041590, R37NS041590, R01NS075672, F31NS064730, R01NS075998, R01NS072630, R01NS045523, R37NS035710, R01NS049553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000222] Funding Source: NIH RePORTER; NIA NIH HHS [T32 AG000222] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; NINDS NIH HHS [F31 NS080343, R01 NS072630, R01 NS075998, R01 NS049553, R01 NS041590, R37 NS035710, R01 NS075672, F31 NS064730, R01 NS045523, R37 NS041590] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Hansen DV, 2011, NEURON, V70, P645, DOI 10.1016/j.neuron.2011.05.006; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; MACDONALD JL, 2012, DEV NEUROSCIENCE COM, V1; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Shoemaker LD, 2010, BIOESSAYS, V32, P197, DOI 10.1002/bies.200900114	6	44	44	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					918	+		10.1016/j.cell.2012.10.004	http://dx.doi.org/10.1016/j.cell.2012.10.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141546	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000310921200023
J	Coenraads, PJ				Coenraads, Pieter-Jan			Hand Eczema	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONTACT-DERMATITIS; DOUBLE-BLIND; LONG-TERM; SKIN; CLASSIFICATION; PUVA; ALITRETINOIN; CYCLOSPORINE; MULTICENTER; POPULATION	A 33-year-old woman presents with redness of the hands and reports the intermittent occurrence of tiny vesicles, scaling, and fissuring, accompanied by itching on the palms, fingers, and dorsal sides of the hands. She has two young children and works as a nurse in a nearby hospital. She has a history of childhood eczema and a contact allergy to nickel. How should this case be managed?	Univ Groningen, Dept Dermatol, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands	University of Groningen	Coenraads, PJ (corresponding author), Univ Groningen, Dept Dermatol, Univ Med Ctr Groningen, POB 30-001, NL-9700 RB Groningen, Netherlands.	p.j.coenraads@med.umcg.nl			HEAP Research; Astellas Pharma; Basilea Pharmaceutica; Procter Gamble; GlaxoSmithKline	HEAP Research; Astellas Pharma(Astellas Pharmaceuticals); Basilea Pharmaceutica; Procter Gamble(Procter & Gamble); GlaxoSmithKline(GlaxoSmithKline)	Dr. Coenraads reports receiving consulting fees from HEAP Research, Astellas Pharma, Basilea Pharmaceutica, and Procter & Gamble, grant support to his institution from Basilea Pharmaceutica, and lecture fees from GlaxoSmithKline. No other potential conflict of interest relevant to this article was reported.	Alikhan A, 2011, DERMATITIS, V22, P121, DOI 10.2310/6620.2011.10122; [Anonymous], 2010, WORK HLTH ASTHM ECZ; Bauer A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004414.pub2; Belsito Donald V, 2004, Dermatol Ther, V17, P231, DOI 10.1111/j.1396-0296.2004.04033.x; Belsito DV, 2004, CUTIS, V73, P31; Bissonnette R, 2010, BRIT J DERMATOL, V162, P420, DOI 10.1111/j.1365-2133.2009.09572.x; Diepgen TL, 2009, BRIT J DERMATOL, V160, P353, DOI 10.1111/j.1365-2133.2008.08907.x; Diepgen Thomas L, 2009, J Dtsch Dermatol Ges, V7 Suppl 3, pS1, DOI 10.1111/j.1610-0387.2009.07061.x; Diepgen TL, 2003, INT ARCH OCC ENV HEA, V76, P331, DOI 10.1007/s00420-002-0418-1; Drake LA, 1996, J AM ACAD DERMATOL, V35, P615; Egan CA, 1999, J AM ACAD DERMATOL, V40, P612, DOI 10.1016/S0190-9622(99)70446-9; English J, 2009, CLIN EXP DERMATOL, V34, P761, DOI 10.1111/j.1365-2230.2009.03649.x; Flohr C, 2004, J ALLERGY CLIN IMMUN, V114, P150, DOI 10.1016/j.jaci.2004.04.027; Granlund H, 1996, ACTA DERM-VENEREOL, V76, P371; Hald M, 2009, BRIT J DERMATOL, V160, P1229, DOI 10.1111/j.1365-2133.2009.09139.x; Halpern SM, 2000, BRIT J DERMATOL, V142, P22, DOI 10.1046/j.1365-2133.2000.03237.x; HERSLE K, 1982, BRIT J DERMATOL, V107, P195, DOI 10.1111/j.1365-2133.1982.tb00338.x; HOLNESS DL, 1995, AM J IND MED, V27, P807, DOI 10.1002/ajim.4700270605; Hordinsky M, 2010, DERMATOLOGY, V221, P71, DOI 10.1159/000297524; Hughes R, 2008, CLIN EXP DERMATOL, V33, P710, DOI 10.1111/j.1365-2230.2008.02832.x; Ibler KS, 2010, BMC DERMATOL, V10, DOI 10.1186/1471-5945-10-8; Jensen CS, 2006, CONTACT DERMATITIS, V54, P79, DOI 10.1111/j.0105-1873.2006.00773.x; Johansen JD, 2011, CONTACT DERMATITIS, V65, P13, DOI 10.1111/j.1600-0536.2011.01911.x; Kaae J, 2012, CONTACT DERMATITIS, V67, P119, DOI 10.1111/j.1600-0536.2012.02130.x; Krejci-Manwaring J, 2008, J DRUGS DERMATOL, V7, P643; Kucharekova M, 2003, CONTACT DERMATITIS, V48, P293, DOI 10.1034/j.1600-0536.2003.00119.x; Kwon S, 2006, J AM ACAD DERMATOL, V55, P891, DOI 10.1016/j.jaad.2006.05.037; Loden M, 2012, J EUR ACAD DERMATOL, V26, P597, DOI 10.1111/j.1468-3083.2011.04128.x; Lynde C, 2011, J CUTAN MED SURG, V15, P360; Menne T, 2011, CONTACT DERMATITIS, V65, P3, DOI 10.1111/j.1600-0536.2011.01915.x; Moberg C, 2009, BRIT J DERMATOL, V161, P397, DOI 10.1111/j.1365-2133.2009.09099.x; Molin S, 2011, CLIN EXP DERMATOL, V36, P595, DOI 10.1111/j.1365-2230.2010.04001.x; Murray ML, 2007, CLIN EXP DERMATOL, V32, P23, DOI 10.1111/j.1365-2230.2006.02290.x; NILSSON E, 1985, CONTACT DERMATITIS, V13, P216, DOI 10.1111/j.1600-0536.1985.tb02553.x; Ramsing DW, 1996, CONTACT DERMATITIS, V34, P258, DOI 10.1111/j.1600-0536.1996.tb02196.x; ROSEN K, 1987, ACTA DERM-VENEREOL, V67, P48; Ruzicka T, 2008, BRIT J DERMATOL, V158, P808, DOI 10.1111/j.1365-2133.2008.08487.x; Saripalli YV, 2003, J AM ACAD DERMATOL, V49, P65, DOI 10.1067/mjd.2003.489; Schmitt J, 2007, J EUR ACAD DERMATOL, V21, P606, DOI 10.1111/j.1468-3083.2006.02023.x; Schnopp C, 2002, J AM ACAD DERMATOL, V46, P73, DOI 10.1067/mjd.2002.117856; Sezer E, 2007, PHOTODERMATOL PHOTO, V23, P10, DOI 10.1111/j.1600-0781.2007.00258.x; Thestrup-Pedersen K, 2001, ACTA DERM-VENEREOL, V81, P353, DOI 10.1080/000155501317140089; Thyssen JP, 2010, CONTACT DERMATITIS, V62, P75, DOI 10.1111/j.1600-0536.2009.01669.x; Tzaneva S, 2009, PHOTODERMATOL PHOTO, V25, P101, DOI 10.1111/j.1600-0781.2009.00419.x; Van Coevorden AM, 2004, BRIT J DERMATOL, V151, P446, DOI 10.1111/j.1365-2133.2004.06040.x; van Coevorden AM, 2004, ARCH DERMATOL, V140, P1463, DOI 10.1001/archderm.140.12.1463; Veien NK, 2008, CONTACT DERMATITIS, V58, P335, DOI 10.1111/j.1600-0536.2008.01346.x; Veien NK, 1999, BRIT J DERMATOL, V140, P882, DOI 10.1046/j.1365-2133.1999.02819.x; Weistenhofer W, 2010, BRIT J DERMATOL, V162, P239, DOI 10.1111/j.1365-2133.2009.09463.x	49	87	90	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2012	367	19					1829	1837		10.1056/NEJMcp1104084	http://dx.doi.org/10.1056/NEJMcp1104084			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033DG	23134383	Green Published			2022-12-28	WOS:000310773200010
J	Rasmussen, LH; Larsen, TB; Graungaard, T; Skjoth, F; Lip, GYH				Rasmussen, Lars Hvilsted; Larsen, Torben Bjerregaard; Graungaard, Tina; Skjoth, Flemming; Lip, Gregory Y. H.			Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRANSIENT ISCHEMIC ATTACK; SUBGROUP ANALYSIS; WARFARIN; DABIGATRAN; APIXABAN; METAANALYSIS; EFFICACY; EVENTS; SAFETY	Objective To do an indirect comparison analysis of apixaban against dabigatran etexilate (2 doses) and rivaroxaban (1 dose), as well as of rivaroxaban against dabigatranetexilate (2 doses), for their relative efficacy and safety against each other, with particular focus on the secondary prevention population for stroke prevention in atrial fibrillation. A secondary objective was to do the same analysis in the primary prevention cohort. Design Indirect treatment comparisons of phase III clinical trials of stroke prevention in atrial fibrillation, with a focus on the secondary prevention cohorts. A secondary analysis was done on the primary prevention cohort. Data sources Medline and Central (up to June 2012), clinical trials registers, conference proceedings, and websites of regulatory agencies. Study selection Randomised controlled trials of rivaroxaban, dabigatran, or apixaban compared with warfarin for stroke prevention in atrial fibrillation. Results In the secondary prevention (previous stroke) subgroup, when apixaban was compared with dabigatran (110 mg and 150 mg twice daily) for efficacy and safety endpoints, the only significant difference seen was less myocardial infarction (hazard ratio 0.39, 95% confidence interval 0.16 to 0.95) with apixaban compared with dabigatran 150 mg twice daily. No significant differences were seen in efficacy and most safety endpoints between apixaban or dabigatran 150 mg twice daily versus rivaroxaban. Less haemorrhagic stroke (hazard ratio 0.15, 0.03 to 0.66), vascular death (0.64, 0.42 to 0.99), major bleeding (0.68, 0.47 to 0.99), and intracranial bleeding (0.27, 0.10 to 0.73) were seen with dabigatran 110 mg twice daily versus rivaroxaban. In the primary prevention (no previous stroke) subgroup, apixaban was superior to dabigatran 110 mg twice daily for disabling or fatal stroke (hazard ratio 0.59, 0.36 to 0.97). Compared with dabigatran 150 mg twice daily, apixaban was associated with more stroke (hazard ratio 1.45, 1.01 to 2.08) and with less major bleeding (0.75, 0.60 to 0.94), gastrointestinal bleeding (0.61, 0.42 to 0.89), and other location bleeding (0.74, 0.58 to 0.94). Compared with rivaroxaban, dabigatran 110 mg twice daily was associated with more myocardial infarction events. No significant differences were seen for the main efficacy and safety endpoints between dabigatran 150 mg twice daily and rivaroxaban, or in efficacy endpoints between apixaban and rivaroxaban. Apixaban was associated with less major bleeding (hazard ratio 0.61, 0.48 to 0.78) than rivaroxaban. Conclusions For secondary prevention, apixaban, rivaroxaban, and dabigatran had broadly similar efficacy for the main endpoints, although the endpoints of haemorrhagic stroke, vascular death, major bleeding, and intracranial bleeding were less common with dabigatran 110 mg twice daily than with rivaroxaban. For primary prevention, the three drugs showed some differences in relation to efficacy and bleeding. These results are hypothesis generating and should be confirmed in a head to head randomised trial.	[Rasmussen, Lars Hvilsted; Larsen, Torben Bjerregaard; Graungaard, Tina; Skjoth, Flemming; Lip, Gregory Y. H.] Aalborg Univ, Thrombosis Res Unit, Aalborg, Denmark; [Rasmussen, Lars Hvilsted; Larsen, Torben Bjerregaard; Graungaard, Tina; Skjoth, Flemming] Aalborg Hosp, Dept Cardiol, Aalborg AF Study Grp, Cardiovasc Res Ctr, Aalborg, Denmark; [Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England	Aalborg University; Aalborg University; Aalborg University Hospital; University of Birmingham	Lip, GYH (corresponding author), Aalborg Univ, Thrombosis Res Unit, Aalborg, Denmark.	g.y.h.lip@bham.ac.uk	Skjøth, Flemming/AAI-9954-2020; Larsen, Torben Bjerregaard/I-5081-2012	Skjoth, Flemming/0000-0003-2975-647X; Larsen, Torben Bjerregaard/0000-0002-8485-8674				Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Connolly SJ, 2010, NEW ENGL J MED, V363, P1875, DOI 10.1056/NEJMc1007378; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Diener HC, 2010, LANCET NEUROL, V9, P1157, DOI 10.1016/S1474-4422(10)70274-X; Easton JD, 2012, LANCET NEUROL, V11, P503, DOI 10.1016/S1474-4422(12)70092-3; Gallagher AM, 2011, THROMB HAEMOSTASIS, V106, P968, DOI 10.1160/TH11-05-0353; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hankey GJ, 2012, LANCET NEUROL, V11, P315, DOI 10.1016/S1474-4422(12)70042-X; Heneghan C, 2012, LANCET, V379, P322, DOI 10.1016/S0140-6736(11)61294-4; Hohnloser SH, 2012, CIRCULATION, V125, P669, DOI 10.1161/CIRCULATIONAHA.111.055970; Lip GYH, 2012, J AM COLL CARDIOL, V60, P738, DOI 10.1016/j.jacc.2012.03.019; Mantha S, 2012, THROMB HAEMOSTASIS, V108, P476, DOI 10.1160/TH12-02-0093; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Potpara TS, 2012, HEART, V98, P1341, DOI 10.1136/heartjnl-2012-301841; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4; Wan Y, 2008, CIRC-CARDIOVASC QUAL, V1, P84, DOI 10.1161/CIRCOUTCOMES.108.796185	17	91	92	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 5	2012	345								e7097	10.1136/bmj.e7097	http://dx.doi.org/10.1136/bmj.e7097			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036KY	23129490	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000311026000002
J	Hampsey, M				Hampsey, Michael			A New Direction for Gene Loops	SCIENCE			English	Editorial Material							TRANSCRIPTION TERMINATION; POLYMERASE; COMPLEX; PHOSPHATASE		Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Hampsey, M (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA.	michael.hampsey@umdnj.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039484] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM039484] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Bataille AR, 2012, MOL CELL, V45, P158, DOI 10.1016/j.molcel.2011.11.024; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Hampsey M, 2011, ADV ENZYME REGUL, V51, P118, DOI 10.1016/j.advenzreg.2010.10.001; Kuehner JN, 2011, NAT REV MOL CELL BIO, V12, P283, DOI 10.1038/nrm3098; Laine JP, 2009, GENE DEV, V23, P2604, DOI 10.1101/gad.1823609; Mapendano CK, 2010, MOL CELL, V40, P410, DOI 10.1016/j.molcel.2010.10.012; Medler S, 2011, J BIOL CHEM, V286, P33709, DOI 10.1074/jbc.M110.193870; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Perkins KJ, 2008, MOL CELL, V29, P56, DOI 10.1016/j.molcel.2007.11.030; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zhang DW, 2012, J BIOL CHEM, V287, P8541, DOI 10.1074/jbc.M111.335687	15	4	4	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					624	625		10.1126/science.1230576	http://dx.doi.org/10.1126/science.1230576			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118179				2022-12-28	WOS:000310516000040
J	Foreman, BZ; Heller, PL; Clementz, MT				Foreman, Brady Z.; Heller, Paul L.; Clementz, Mark T.			Fluvial response to abrupt global warming at the Palaeocene/Eocene boundary	NATURE			English	Article							EOCENE THERMAL MAXIMUM; CLIMATE; BASIN; MODEL; COLORADO; PETM	Climate strongly affects the production of sediment from mountain catchments as well as its transport and deposition within adjacent sedimentary basins(1-3). However, identifying climatic influences on basin stratigraphy is complicated by nonlinearities, feedback loops, lag times, buffering and convergence among processes within the sediment routeing system(3,4). The Palaeocene/Eocene thermal maximum (PETM) arguably represents the most abrupt and dramatic instance of global warming in the Cenozoic era and has been proposed to be a geologic analogue for anthropogenic climate change(5). Here we evaluate the fluvial response in western Colorado to the PETM. Concomitant with the carbon isotope excursion marking the PETM we document a basin-wide shift to thick, multistoried, sheets of sandstone characterized by variable channel dimensions, dominance of upper flow regime sedimentary structures, and prevalent crevasse splay deposits. This progradation of coarse-grained lithofacies matches model predictions for rapid increases in sediment flux and discharge(1,3), instigated by regional vegetation overturn(5,6) and enhanced monsoon precipitation(7,8). Yet the change in fluvial deposition persisted long after the approximately 200,000-year-long PETM9 with its increased carbon dioxide levels in the atmosphere, emphasizing the strong role the protracted transmission of catchment responses to distant depositional systems has in constructing large-scale basin stratigraphy. Our results, combined with evidence for increased dissolved loads(10) and terrestrial clay export(5,11,12) to world oceans, indicate that the transient hyper-greenhouse climate of the PETM may represent a major geomorphic 'system-clearing event'(13), involving a global mobilization of dissolved and solid sediment loads on Earth's surface.	[Foreman, Brady Z.; Heller, Paul L.; Clementz, Mark T.] Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA	University of Wyoming	Foreman, BZ (corresponding author), Univ Wyoming, Dept Geol & Geophys, 1000 E Univ Ave, Laramie, WY 82071 USA.	bforema1@uwyo.edu			International Association of Sedimentologists; Tobacco Root Geological Society; Colorado Scientific Society; Chevron Energy Technology Company; NSF Graduate Research Fellowship; Wyoming NASA Space Grant Consortium Fellowship	International Association of Sedimentologists; Tobacco Root Geological Society; Colorado Scientific Society; Chevron Energy Technology Company; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Wyoming NASA Space Grant Consortium Fellowship	We thank personnel at the University of Arizona LaserChron Facility and University of Wyoming Stable Isotope Facility for assistance in analysing detrital zircon and carbon isotope samples. The International Association of Sedimentologists, the Tobacco Root Geological Society, the Colorado Scientific Society, and the Chevron Energy Technology Company provided funding for analyses and fieldwork. The research was completed while on a NSF Graduate Research Fellowship and Wyoming NASA Space Grant Consortium Fellowship to B.Z.F.	Allen PA, 2008, GEOL SOC SPEC PUBL, V296, P7, DOI 10.1144/SP296.2; Armitage JJ, 2011, NAT GEOSCI, V4, P231, DOI [10.1038/ngeo1087, 10.1038/NGEO1087]; Blecha A. M., 2004, GSA ABSTR PROGR, V36, P307; Bowen GJ, 2004, NATURE, V432, P495, DOI 10.1038/nature03115; Burger BJ, 2008, J VERTEBR PALEONTOL, V28, P816, DOI 10.1671/0272-4634(2008)28[816:PMPFTL]2.0.CO;2; Dickinson WR, 2003, SEDIMENT GEOL, V163, P29, DOI 10.1016/S0037-0738(03)00158-1; DICKINSON WR, 1988, GEOL SOC AM BULL, V100, P1023, DOI 10.1130/0016-7606(1988)100<1023:PAPSOL>2.3.CO;2; Ethridge F.G., 1978, CANADIAN SOC PETROLE, P703; Fielding CR, 2006, SEDIMENT GEOL, V190, P227, DOI 10.1016/j.sedgeo.2006.05.009; Gehrels GE, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001805; Gibson TG, 2000, SEDIMENT GEOL, V134, P65, DOI 10.1016/S0037-0738(00)00014-2; HELLER PL, 1988, GEOLOGY, V16, P501, DOI 10.1130/0091-7613(1988)016<0501:TPSMOF>2.3.CO;2; Jerolmack DJ, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044638; Johnson R. C., 1978, PRELIMINARY STRATIGR; Johnson RC., 2003, PICEANCE BASIN GUIDE, P21; Johnson S. Y., 1992, USGS B, V1787-FF, pFF1; Kraus MJ, 2007, PALAEOGEOGR PALAEOCL, V245, P444, DOI 10.1016/j.palaeo.2006.09.011; Lillegraven J. A., 1990, DAWN AGE MAMMALS NO, V243, P1; Lorenz JC, 2002, J SEDIMENT RES, V72, P376, DOI 10.1306/100801720376; McInerney FA, 2011, ANNU REV EARTH PL SC, V39, P489, DOI 10.1146/annurev-earth-040610-133431; Murphy BH, 2010, GEOCHIM COSMOCHIM AC, V74, P5098, DOI 10.1016/j.gca.2010.03.039; Paola C., 1992, BASIN RES, V4, P73, DOI [10.1111/j.1365-2117.1992.tb00145.x, DOI 10.1111/J.1365-2117.1992.TB00145.X]; Ravizza G, 2001, PALEOCEANOGRAPHY, V16, P155, DOI 10.1029/2000PA000541; ROBERT C, 1994, GEOLOGY, V22, P211, DOI 10.1130/0091-7613(1994)022<0211:ASHEAT>2.3.CO;2; Schmitz B, 2003, GEOLOGY, V31, P689, DOI 10.1130/G19527.1; Schmitz B, 2007, GEOLOGY, V35, P215, DOI 10.1130/G23261A.1; Shellito CJ, 2003, PALAEOGEOGR PALAEOCL, V193, P113, DOI 10.1016/S0031-0182(02)00718-6; Tucker GE, 1997, WATER RESOUR RES, V33, P2031, DOI 10.1029/97WR00409; Wing SL, 2005, SCIENCE, V310, P993, DOI 10.1126/science.1116913; Winguth A, 2010, J CLIMATE, V23, P2562, DOI 10.1175/2009JCLI3113.1	30	137	140	5	119	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 1	2012	491	7422					92	95		10.1038/nature11513	http://dx.doi.org/10.1038/nature11513			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23128230				2022-12-28	WOS:000310434500036
J	Gkogkas, CG; Khoutorsky, A; Ran, I; Rampakakis, E; Nevarko, T; Weatherill, DB; Vasuta, C; Yee, S; Truitt, M; Dallaire, P; Major, F; Lasko, P; Ruggero, D; Nader, K; Lacaille, JC; Sonenberg, N				Gkogkas, Christos G.; Khoutorsky, Arkady; Ran, Israeli; Rampakakis, Emmanouil; Nevarko, Tatiana; Weatherill, Daniel B.; Vasuta, Cristina; Yee, Stephanie; Truitt, Morgan; Dallaire, Paul; Major, Francois; Lasko, Paul; Ruggero, Davide; Nader, Karim; Lacaille, Jean-Claude; Sonenberg, Nahum			Autism-related deficits via dysregulated eIF4E-dependent translational control	NATURE			English	Article							FRAGILE-X-SYNDROME; COPY-NUMBER VARIATION; TUBEROUS-SCLEROSIS; ULTRASONIC VOCALIZATIONS; INHIBITORY SYNAPSES; SYNAPTIC PLASTICITY; SPECTRUM DISORDERS; LEARNING-DEFICITS; REPRESSOR 4E-BP2; MOUSE MODELS	Hyperconnectivity of neuronal circuits due to increased synaptic protein synthesis is thought to cause autism spectrum disorders (ASDs). The mammalian target of rapamycin (mTOR) is strongly implicated in ASDs by means of upstream signalling; however, downstream regulatory mechanisms are ill-defined. Here we show that knockout of the eukaryotic translation initiation factor 4E-binding protein 2 (4E-BP2)-an eIF4E repressor downstream of mTOR-or eIF4E overexpression leads to increased translation of neuroligins, which are postsynaptic proteins that are causally linked to ASDs. Mice that have the gene encoding 4E-BP2 (Eif4ebp2) knocked out exhibit an increased ratio of excitatory to inhibitory synaptic inputs and autistic-like behaviours (that is, social interaction deficits, altered communication and repetitive/stereotyped behaviours). Pharmacological inhibition of eIF4E activity or normalization of neuroligin 1, but not neuroligin 2, protein levels restores the normal excitation/inhibition ratio and rectifies the social behaviour deficits. Thus, translational control by eIF4E regulates the synthesis of neuroligins, maintaining the excitation-to-inhibition balance, and its dysregulation engenders ASD-like phenotypes.	[Gkogkas, Christos G.; Khoutorsky, Arkady; Rampakakis, Emmanouil; Nevarko, Tatiana; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Gkogkas, Christos G.; Khoutorsky, Arkady; Rampakakis, Emmanouil; Nevarko, Tatiana; Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Ran, Israeli; Weatherill, Daniel B.; Vasuta, Cristina; Lacaille, Jean-Claude] Univ Montreal, GRSNC, Montreal, PQ H3C 3J7, Canada; [Ran, Israeli; Weatherill, Daniel B.; Vasuta, Cristina; Lacaille, Jean-Claude] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Rampakakis, Emmanouil] JSS Med Res Inc, Montreal, PQ H4S 1N8, Canada; [Yee, Stephanie; Lasko, Paul] McGill Univ, Dept Biol, Montreal, PQ H3G 0B1, Canada; [Truitt, Morgan; Ruggero, Davide] Univ Calif San Francisco, Sch Med, San Francisco, CA 94158 USA; [Truitt, Morgan; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Urol, San Francisco, CA 94158 USA; [Dallaire, Paul; Major, Francois] Univ Montreal, Dept Comp Sci, Montreal, PQ H3C 3J7, Canada; [Dallaire, Paul; Major, Francois] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Nader, Karim] McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada	McGill University; McGill University; Universite de Montreal; Universite de Montreal; McGill University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Universite de Montreal; Universite de Montreal; McGill University	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada.	jean-claude.lacaille@umontreal.ca; nahum.sonenberg@mcgill.ca	Gkogkas, Christos/GQH-2659-2022; Gkogkas, Christos/GLR-5348-2022; Lasko, Paul/C-6761-2014; Ran, Israeli/B-2432-2009	Gkogkas, Christos/0000-0001-6281-3419; Lasko, Paul/0000-0002-4037-3501; Ran, Israeli/0000-0003-4824-6416; Rampakakis, Emmanouil/0000-0002-7427-8246; Khoutorsky, Arkady/0000-0003-3846-8728	Canadian Institutes of Health Research [MOP-114994, MOP-10848, MOP-93679, MOP-44050]; Autism Speaks [7109]; Fonds de la Recherche en Sante du Quebec (FRSQ; Groupe de Recherche sur le Systeme Nerveux Central); National Institutes of Health [NIH RO1 CA154916, NIH RO1 CA140456]; Canada Research Chair in Cellular and Molecular Neurophysiology; Savoy Foundation; NATIONAL CANCER INSTITUTE [R01CA154916, R01CA140456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088813] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Autism Speaks; Fonds de la Recherche en Sante du Quebec (FRSQ; Groupe de Recherche sur le Systeme Nerveux Central); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chair in Cellular and Molecular Neurophysiology(Canada Research Chairs); Savoy Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Canadian Institutes of Health Research (N.S., MOP-114994; J.-C.L., MOP-10848; P.D. and F.M., MOP-93679; and P.L. and N.S., MOP-44050), Autism Speaks (Grant 7109 to N.S.), and the Fonds de la Recherche en Sante du Quebec (J.-C.L. FRSQ; Groupe de Recherche sur le Systeme Nerveux Central), and the National Institutes of Health (D.R.; NIH RO1 CA154916 and NIH RO1 CA140456). D.R. is a Leukemia & Lymphoma Society Scholar. J.-C.L. is the recipient of the Canada Research Chair in Cellular and Molecular Neurophysiology. I.R. was supported by a Fellowship of the Savoy Foundation. We thank Y. Svitkin, A. Parsyan, E. Petroulakis, R. Karni and V. Polunovski for advice; K. Gamache, A. Sylvestre, S. Perreault, C. Lister and I. Harvey for technical assistance; T. Alain for assistance with lentiviral titration; S. Hamdani for assistance with USVs; and W. Sossin and P. Skehel for critical reading of the manuscript.	Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Banko JL, 2007, NEUROBIOL LEARN MEM, V87, P248, DOI 10.1016/j.nlm.2006.08.012; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Bateup HS, 2011, J NEUROSCI, V31, P8862, DOI 10.1523/JNEUROSCI.1617-11.2011; Bidinosti M, 2010, MOL CELL, V37, P797, DOI 10.1016/j.molcel.2010.02.022; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Cornew L, 2012, J AUTISM DEV DISORD, V42, P1884, DOI 10.1007/s10803-011-1431-6; Dahlhaus R, 2010, HIPPOCAMPUS, V20, P305, DOI 10.1002/hipo.20630; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Graff JR, 2007, J CLIN INVEST, V117, P2638, DOI 10.1172/JCI32044; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hoeffer CA, 2012, GENES BRAIN BEHAV, V11, P332, DOI 10.1111/j.1601-183X.2012.00768.x; Hoeffer CA, 2011, P NATL ACAD SCI USA, V108, P3383, DOI 10.1073/pnas.1013063108; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Jeste SS, 2008, J CHILD NEUROL, V23, P520, DOI 10.1177/0883073807309788; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Larsson O, 2012, P NATL ACAD SCI USA, V109, P8977, DOI 10.1073/pnas.1201689109; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Luikart BW, 2011, J NEUROSCI, V31, P4345, DOI 10.1523/JNEUROSCI.0061-11.2011; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Neves-Pereira M, 2009, J MED GENET, V46, P759, DOI 10.1136/jmg.2009.066852; Nowicki ST, 2007, J DEV BEHAV PEDIATR, V28, P133, DOI 10.1097/01.DBP.0000267563.18952.c9; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Parada LF, 2012, CURR OPIN NEUROBIOL; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Petroulakis E, 2009, CANCER CELL, V16, P439, DOI 10.1016/j.ccr.2009.09.025; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Schmeisser MJ, 2012, NATURE, V486, P256, DOI 10.1038/nature11015; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Uhlhaas PJ, 2012, NEURON, V75, P963, DOI 10.1016/j.neuron.2012.09.004; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Young DM, 2010, P NATL ACAD SCI USA, V107, P11074, DOI 10.1073/pnas.1005620107; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009	46	348	355	1	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2013	493	7432					371	U113		10.1038/nature11628	http://dx.doi.org/10.1038/nature11628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23172145	Green Accepted, Green Published			2022-12-28	WOS:000313615900044
J	Haider, B; Hausser, M; Carandini, M				Haider, Bilal; Haeusser, Michael; Carandini, Matteo			Inhibition dominates sensory responses in the awake cortex	NATURE			English	Article							LOCAL CORTICAL NETWORKS; PRIMARY VISUAL-CORTEX; NEURONS IN-VIVO; ORIENTATION SELECTIVITY; NEOCORTICAL NEURONS; HZ OSCILLATION; BARREL CORTEX; MECHANISMS; INTERNEURONS; SPARSE	The activity of the cerebral cortex is thought to depend on the precise relationship between synaptic excitation and inhibition(1-4). In the visual cortex, in particular, intracellular measurements have related response selectivity to coordinated increases in excitation and inhibition(5-9). These measurements, however, have all been made during anaesthesia, which strongly influences cortical state(10) and therefore sensory processing(7,11-15). The synaptic activity that is evoked by visual stimulation during wakefulness is unknown. Here we measured visually evoked responses-and the underlying synaptic conductances-in the visual cortex of anaesthetized and awake mice. Under anaesthesia, responses could be elicited from a large region of visual space(16) and were prolonged. During wakefulness, responses were more spatially selective and much briefer. Whole-cell patch-clamp recordings of synaptic conductances(5,17) showed a difference in synaptic inhibition between the two conditions. Under anaesthesia, inhibition tracked excitation in amplitude and spatial selectivity. By contrast, during wakefulness, inhibition was much stronger than excitation and had extremely broad spatial selectivity. We conclude that during wakefulness, cortical responses to visual stimulation are dominated by synaptic inhibition, restricting the spatial spread and temporal persistence of neural activity. These results provide a direct glimpse of synaptic mechanisms that control sensory responses in the awake cortex.	[Haider, Bilal; Carandini, Matteo] UCL, UCL Inst Ophthalmol, London EC1V 9EL, England; [Haeusser, Michael] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Haeusser, Michael] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Haider, B (corresponding author), UCL, UCL Inst Ophthalmol, 11-43 Bath St, London EC1V 9EL, England.	b.haider@ucl.ac.uk	Carandini, Matteo/ABD-8296-2021; Hausser, Michael/AAW-6827-2020	Carandini, Matteo/0000-0003-4880-7682; Hausser, Michael/0000-0002-2673-8957; Haider, Bilal/0000-0002-6382-1426	National Science Foundation; European Research Council; Wellcome Trust; Medical Research Council; Gatsby Charitable Foundation; MRC [G0800791] Funding Source: UKRI; Medical Research Council [G0800791] Funding Source: researchfish	National Science Foundation(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Gatsby Charitable Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank T. Sato, A. Saleem and A. Ayaz for help with procedures; S. L. Smith, C. Schmidt-Hieber and K. Powell for advice on recordings, and A. Roth, M. Scanziani and D. McCormick for comments. We are grateful to the National Science Foundation, the European Research Council, the Wellcome Trust, the Medical Research Council and the Gatsby Charitable Foundation for financial support. M. C. holds the GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience.	Arroyo S, 2012, J NEUROSCI, V32, P3859, DOI 10.1523/JNEUROSCI.0115-12.2012; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Cafaro J, 2010, NATURE, V468, P964, DOI 10.1038/nature09570; Cardin JA, 2010, J NEUROSCI, V30, P3652, DOI 10.1523/JNEUROSCI.5279-09.2010; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Haider B, 2007, J NEUROPHYSIOL, V97, P4186, DOI 10.1152/jn.01114.2006; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Liu BH, 2011, NEURON, V71, P542, DOI 10.1016/j.neuron.2011.06.017; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; SIMONS DJ, 1992, EXP BRAIN RES, V91, P259; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Swadlow HA, 2002, PHILOS T R SOC B, V357, P1717, DOI 10.1098/rstb.2002.1156; Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Worgotter F, 1998, NATURE, V396, P165, DOI 10.1038/24157	36	347	349	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					97	+		10.1038/nature11665	http://dx.doi.org/10.1038/nature11665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23172139	Green Accepted			2022-12-28	WOS:000312933800038
J	Huang, GN; Thatcher, JE; McAnally, J; Kong, YL; Qi, XX; Tan, W; DiMaio, JM; Amatruda, JF; Gerard, RD; Hill, JA; Bassel-Duby, R; Olson, EN				Huang, Guo N.; Thatcher, Jeffrey E.; McAnally, John; Kong, Yongli; Qi, Xiaoxia; Tan, Wei; DiMaio, J. Michael; Amatruda, James F.; Gerard, Robert D.; Hill, Joseph A.; Bassel-Duby, Rhonda; Olson, Eric N.			C/EBP Transcription Factors Mediate Epicardial Activation During Heart Development and Injury	SCIENCE			English	Article							RETINOIC ACID; BINDING PROTEIN; GRAINY-HEAD; MOUSE HEART; REGENERATION; ZEBRAFISH; CELLS; DROSOPHILA; INTEGRITY; IMMUNITY	The epicardium encapsulates the heart and functions as a source of multipotent progenitor cells and paracrine factors essential for cardiac development and repair. Injury of the adult heart results in reactivation of a developmental gene program in the epicardium, but the transcriptional basis of epicardial gene expression has not been delineated. We established a mouse embryonic heart organ culture and gene expression system that facilitated the identification of epicardial enhancers activated during heart development and injury. Epicardial activation of these enhancers depends on a combinatorial transcriptional code centered on CCAAT/enhancer binding protein (C/EBP) transcription factors. Disruption of C/EBP signaling in the adult epicardium reduced injury-induced neutrophil infiltration and improved cardiac function. These findings reveal a transcriptional basis for epicardial activation and heart injury, providing a platform for enhancing cardiac regeneration.	[Huang, Guo N.; McAnally, John; Qi, Xiaoxia; Amatruda, James F.; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Thatcher, Jeffrey E.; DiMaio, J. Michael] Univ Texas SW Med Ctr Dallas, Dept Cardiovasc & Thorac Surg, Dallas, TX 75390 USA; [Kong, Yongli; Tan, Wei; Amatruda, James F.; Gerard, Robert D.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu	Tan, Weihong/AAA-4536-2020; Tan, Weihong/A-5412-2008	Tan, Weihong/0000-0002-8066-1524; Huang, Guo/0000-0002-4335-9123	O'Donnell Foundation Fellow of the Life Sciences Research Foundation; NIH Pathway [1K99HL114738]; NIH [HL100401-01]; Donald W. Reynolds Center for Clinical Cardiovascular Research; American Heart Association; Jon Holden DeHaan Foundation; Leducq Foundation; Robert A. Welch Foundation [1-0025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093039, K99HL114738, R01HL077439, R00HL114738, R01HL111665, U01HL100401] Funding Source: NIH RePORTER	O'Donnell Foundation Fellow of the Life Sciences Research Foundation; NIH Pathway; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Center for Clinical Cardiovascular Research; American Heart Association(American Heart Association); Jon Holden DeHaan Foundation; Leducq Foundation(Leducq Foundation); Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Cabrera for graphical assistance; J. Shelton and J. A. Richardson for histology; A. Mobley for assistance with fluorescence-activated cell sorting; the UT Southwestern microarray core facility; and K. Kangasniemi, K. Sagiyama, and M. Takahashi for cardiac magnetic resonance imaging. We are grateful to G. Begemann, S. Jane, P. Johnson, C. Lagman, R. MacDonald, R. Roeder, J. Rosen, G. Stark, C. Vinson, M. Wolfgang, and C. Zahnow for plasmids and reagents. We thank J. Chen, N. Munshi, P. Yi, and members of the Olson laboratory for scientific discussion and critical reading of the manuscript. G. N. H. is an O'Donnell Foundation Fellow of the Life Sciences Research Foundation and a recipient of the NIH Pathway to Independence Award (1K99HL114738). Supported by NIH grant HL100401-01, the Donald W. Reynolds Center for Clinical Cardiovascular Research, the American Heart Association, the Jon Holden DeHaan Foundation, the Leducq Foundation, and the Robert A. Welch Foundation (grant 1-0025) (E.N.O.). Microarray data have been deposited in Gene Expession Omnibus (accession no. GSE41959).	Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Chen THP, 2002, DEV BIOL, V250, P198, DOI 10.1006/dbio.2002.0796; Didon L, 2011, AM J RESP CRIT CARE, V184, P233, DOI 10.1164/rccm.201007-1113OC; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Kikuchi K, 2011, DEVELOPMENT, V138, P2895, DOI 10.1242/dev.067041; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; Kim CH, 2011, VITAM HORM, V86, P83, DOI 10.1016/B978-0-12-386960-9.00004-6; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Limana F, 2010, J MOL CELL CARDIOL, V48, P609, DOI 10.1016/j.yjmcc.2009.11.008; Lu JR, 2000, P NATL ACAD SCI USA, V97, P9525, DOI 10.1073/pnas.97.17.9525; Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Moss JB, 1998, DEV BIOL, V199, P55, DOI 10.1006/dbio.1998.8911; Osada S, 1996, J BIOL CHEM, V271, P3891; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Serluca FC, 2008, DEV BIOL, V315, P18, DOI 10.1016/j.ydbio.2007.10.007; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Sucov HM, 2009, PEDIATR CARDIOL, V30, P617, DOI 10.1007/s00246-009-9391-8; Timmers L, 2012, CARDIOVASC RES, V94, P276, DOI 10.1093/cvr/cvs018; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; von Gise A, 2011, DEV BIOL, V356, P421, DOI 10.1016/j.ydbio.2011.05.668; Winter EM, 2007, CIRCULATION, V116, P917, DOI 10.1161/CIRCULATIONAHA.106.668178; Winter EM, 2007, CELL MOL LIFE SCI, V64, P692, DOI 10.1007/s00018-007-6522-3; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	28	150	156	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1599	1603		10.1126/science.1229765	http://dx.doi.org/10.1126/science.1229765			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23160954	Green Accepted			2022-12-28	WOS:000312533100047
J	Koren, MJ; Scott, R; Kim, JB; Knusel, B; Liu, T; Lei, L; Bolognese, M; Wasserman, SM				Koren, Michael J.; Scott, Rob; Kim, Jae B.; Knusel, Beat; Liu, Thomas; Lei, Lei; Bolognese, Michael; Wasserman, Scott M.			Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study	LANCET			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; PCSK9; EZETIMIBE; RECEPTOR; THERAPY; LDL	Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) increases serum LDL-cholesterol (LDL-C) concentrations. We assessed the effects of AMG 145, a human monoclonal antibody against PCSK9, in patients with hypercholesterolaemia in the absence of concurrent lipid-lowering treatment. Methods In a phase 2 trial done at 52 centres in Europe, the USA, Canada, and Australia, patients (aged 18-75 years) with serum LDL-C concentrations of 2.6 mmol/L or greater but less than 4.9 mmol/L were randomly assigned equally through an interactive voice response system to subcutaneous injections of AMG 145 70 mg, 105 mg, or 140 mg, or placebo every 2 weeks; subcutaneous AMG 145 280 mg, 350 mg, or 420 mg or placebo every 4 weeks; or oral ezetimibe 10 mg/day. The primary endpoint was percentage change from baseline in LDL-C concentration at week 12. Analysis was by modified intention to treat. Study personnel and patients were masked to treatment assignment of AMG 145 or placebo. Ezetimibe assignment was open label. This trial is registered with ClinicalTrials.gov, number NCT01375777. Findings 406 patients were assigned to AMG 145 70 mg (n=45), 105 mg (n=46), or 140 mg (n=45) every 2 weeks; AMG 145 280 mg (n=45), 350 mg (n=45), or 420 mg (n=45) every 4 weeks; placebo every 2 weeks (n=45) or every 4 weeks (n=45); or ezetimibe (n=45). AMG 145 significantly reduced LDL-C concentrations in all dose groups (mean baseline LDL-C concentration 3.7 mmol/L [SD 0.6]; changes from baseline with every 2 weeks AMG 145 70 mg -41.0% [95% CI -46.2 to -35.8]; 105 mg -43.9% [-49.0 to -38.7]; 140 mg -50.9% [-56.2 to -45.7]; every 4 weeks AMG 145 280 mg -39.0% [-44.1 to -34.0]; 350 mg -43.2% [-48.3 to -38.1]; 420 mg -48.0% [-53.1 to -42.9]; placebo every 2 weeks -3.7% [-9.0 to 1.6]; placebo every 4 weeks 4.5% [-0.7 to 9.8]; and ezetimibe -14.7% [-18.6 to -10.8]; p<0.0001 for all doses vs placebo or ezetimibe). Treatment-emergent adverse events occurred in 136 (50%) of 271 patients in the AMG 145 groups, 41 (46%) of 90 patients in the placebo groups, and 26 (58%) of 45 patients in the ezetimibe group; no deaths or serious treatment-related adverse events were reported. Interpretation The results of our study support the further assessment of AMG 145 in long-term studies with larger and more diverse populations including patients with documented statin intolerance.	[Koren, Michael J.] Jacksonville Ctr Clin Res, Jacksonville, FL 32216 USA; [Scott, Rob; Kim, Jae B.; Knusel, Beat; Liu, Thomas; Lei, Lei; Wasserman, Scott M.] Amgen Inc, Thousand Oaks, CA USA; [Bolognese, Michael] Bethesda Hlth Res Ctr, Bethesda, MD USA	Amgen	Koren, MJ (corresponding author), Jacksonville Ctr Clin Res, 4085 Univ Blvd S,Suite 1, Jacksonville, FL 32216 USA.	mkoren@encoredocs.com			Amgen	Amgen(Amgen)	Amgen.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; [Anonymous], 2007, PREVENTION OF CARDIO; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Bruckert E, 1999, J CLIN EPIDEMIOL, V52, P589, DOI 10.1016/S0895-4356(99)00019-0; Cohen DE, 2006, AM J CARDIOL, V97, p77C, DOI 10.1016/j.amjcard.2005.12.014; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Dias CS, 2012, J AM COLL CARDIOL; Elam M, 2011, CURR OPIN LIPIDOL, V22, P55, DOI 10.1097/MOL.0b013e328341a5a8; Gazi IF, 2007, CURR MED RES OPIN, V23, P2183, DOI 10.1185/030079907X226267; Giugliano RP, 2012, LANCET; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hansen KE, 2005, ARCH INTERN MED, V165, P2671, DOI 10.1001/archinte.165.22.2671; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Joy TR, 2009, ANN INTERN MED, V150, P858, DOI 10.7326/0003-4819-150-12-200906160-00009; Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141; McKenney JM, 2012, J AM COLL CARDIOL, V59, P2344, DOI 10.1016/j.jacc.2012.03.007; McKenney JM, 2006, J AM COLL CARDIOL, V47, P1584, DOI 10.1016/j.jacc.2005.11.072; McPherson R, 2006, CAN J CARDIOL, V22, P913, DOI 10.1016/S0828-282X(06)70310-5; Pasternak RC, 2002, CIRCULATION, V106, P1024, DOI 10.1161/01.CIR.0000032466.44170.44; Qian YW, 2007, J LIPID RES, V48, P1488, DOI 10.1194/jlr.M700071-JLR200; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Silva MA, 2006, CLIN THER, V28, P26, DOI 10.1016/j.clinthera.2006.01.005; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Topol EJ, 2012, NY TIMES; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	27	283	307	0	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	2012	380	9858					1995	2006		10.1016/S0140-6736(12)61771-1	http://dx.doi.org/10.1016/S0140-6736(12)61771-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051KI	23141812				2022-12-28	WOS:000312124900030
J	Abitua, PB; Wagner, E; Navarrete, IA; Levine, M				Abitua, Philip Barron; Wagner, Eileen; Navarrete, Ignacio A.; Levine, Michael			Identification of a rudimentary neural crest in a non-vertebrate chordate	NATURE			English	Article							MESODERMAL TISSUES; CELL FATE; LINEAGE; GENE; PLASTICITY; INDUCTION; EVOLUTION; INSIGHTS; ORIGIN; GENOME	Neural crest arises at the neural plate border, expresses a core set of regulatory genes and produces a diverse array of cell types, including ectomesenchyme derivatives that elaborate the vertebrate head(1,2). The evolution of neural crest has been proposed to be a key event leading to the appearance of new cell types that fostered the transition from filter feeding to active predation in ancestral vertebrates(3). However, the origin of neural crest remains controversial, as homologous cell types have not been unambiguously identified in non-vertebrate chordates(1,4). Here we show that the tunicate Ciona intestinalis possesses a cephalic melanocyte lineage (a9.49) similar to neural crest that can be reprogrammed into migrating 'ectomesenchyme' by the targeted misexpression of Twist (also known as twist-like 2). Our results suggest that the neural crest melanocyte regulatory network pre-dated the divergence of tunicates and vertebrates. We propose that the co-option of mesenchyme determinants, such as Twist, into the neural plate ectoderm was crucial to the emergence of the vertebrate 'new head'(3).	[Abitua, Philip Barron; Wagner, Eileen; Navarrete, Ignacio A.; Levine, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr Integrat Genom, Div Genet Genom & Dev, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Levine, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr Integrat Genom, Div Genet Genom & Dev, 229 Stanley Hall, Berkeley, CA 94720 USA.	mlevine@berkeley.edu		Abitua, Philip/0000-0002-8264-0807; Levine, Michael/0000-0001-7629-0081; Navarrete, Ignacio/0000-0001-6644-1616	US National Science Foundation; US National Institutes of Health [NS 076542]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076542] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Stolfi for his continued support and guidance, Y. Satou for isolating the Twist enhancer, N. Ellis for cloning Dmbx > Twist and B. Gainous for critical reading of the manuscript. P. B. A is supported by a graduate fellowship from the US National Science Foundation. This work was supported by a grant from the US National Institutes of Health (NS 076542).	Bildsoe H, 2009, DEV BIOL, V331, P176, DOI 10.1016/j.ydbio.2009.04.034; Bronner ME, 2012, DEV BIOL, V366, P2, DOI 10.1016/j.ydbio.2011.12.042; Curran K, 2010, DEV BIOL, V344, P107, DOI 10.1016/j.ydbio.2010.04.023; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; HOPWOOD ND, 1989, CELL, V59, P893, DOI 10.1016/0092-8674(89)90612-0; Horie T, 2011, NATURE, V469, P525, DOI 10.1038/nature09631; Imai KS, 2006, SCIENCE, V312, P1183, DOI 10.1126/science.1123404; Imai KS, 2002, DEVELOPMENT, V129, P3441; Jeffery WR, 2006, J EXP ZOOL PART B, V306B, P470, DOI 10.1002/jez.b.21109; Jeffery WR, 2008, DEV BIOL, V324, P152, DOI 10.1016/j.ydbio.2008.08.022; Jeffery WR, 2004, NATURE, V431, P696, DOI 10.1038/nature02975; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; NISHIDA H, 1989, DEV BIOL, V132, P355, DOI 10.1016/0012-1606(89)90232-7; Russo MT, 2004, DEV BIOL, V267, P517, DOI 10.1016/j.ydbio.2003.11.005; Shi W, 2008, DEVELOPMENT, V135, P931, DOI 10.1242/dev.011940; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Soo K, 2002, DEV BIOL, V247, P251, DOI 10.1006/dbio.2002.0699; Squarzoni P, 2011, DEVELOPMENT, V138, P1421, DOI 10.1242/dev.057323; Stolfi A, 2011, DEVELOPMENT, V138, P995, DOI 10.1242/dev.061507; Tassy O, 2010, GENOME RES, V20, P1459, DOI 10.1101/gr.108175.110; Thomas AJ, 2009, DEVELOPMENT, V136, P1849, DOI 10.1242/dev.031989; Tokuoka M, 2005, DEV BIOL, V288, P387, DOI 10.1016/j.ydbio.2005.09.018; Vincentz JW, 2008, DEV BIOL, V320, P131, DOI 10.1016/j.ydbio.2008.04.037; Vlaeminck-Guillem V, 2000, MECH DEVELOP, V91, P331, DOI 10.1016/S0925-4773(99)00272-5; Wada H, 2006, INT J BIOL SCI, V2, P133; Yajima I, 2003, MECH DEVELOP, V120, P1489, DOI 10.1016/j.mod.2003.08.009; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007; Yu JK, 2008, GENOME RES, V18, P1127, DOI 10.1101/gr.076208.108	30	147	148	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					104	+		10.1038/nature11589	http://dx.doi.org/10.1038/nature11589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23135395	Green Accepted			2022-12-28	WOS:000311893400054
J	Mozaffarian, D; Marchioli, R; Macchia, A; Silletta, MG; Ferrazzi, P; Gardner, TJ; Latini, R; Libby, P; Lombardi, F; O'Gara, PT; Page, RL; Tavazzi, L; Tognoni, G				Mozaffarian, Dariush; Marchioli, Roberto; Macchia, Alejandro; Silletta, Maria G.; Ferrazzi, Paolo; Gardner, Timothy J.; Latini, Roberto; Libby, Peter; Lombardi, Federico; O'Gara, Patrick T.; Page, Richard L.; Tavazzi, Luigi; Tognoni, Gianni		OPERA Investigators	Fish Oil and Postoperative Atrial Fibrillation The Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLYUNSATURATED FATTY-ACIDS; ARTERY-BYPASS SURGERY; ELECTRICAL CARDIOVERSION; DOUBLE-BLIND; RISK; SUPPLEMENTATION; ASSOCIATION; RECURRENCE; DEATH; GUIDELINES	Context Postoperative atrial fibrillation or flutter (AF) is one of the most common complications of cardiac surgery and significantly increases morbidity and health care utilization. A few small trials have evaluated whether long-chain n-3-polyunsaturated fatty acids (PUFAs) reduce postoperative AF, with mixed results. Objective To determine whether perioperative n-3-PUFA supplementation reduces postoperative AF. Design, Setting, and Patients The Omega-3 Fatty Acids for Prevention of Postoperative Atrial Fibrillation (OPERA) double-blind, placebo-controlled, randomized clinical trial. A total of 1516 patients scheduled for cardiac surgery in 28 centers in the United States, Italy, and Argentina were enrolled between August 2010 and June 2012. Inclusion criteria were broad; the main exclusions were regular use of fish oil or absence of sinus rhythm at enrollment. Intervention Patients were randomized to receive fish oil (1-g capsules containing >= 840 mg n-3-PUFAs as ethyl esters) or placebo, with preoperative loading of 10 g over 3 to 5 days (or 8 g over 2 days) followed postoperatively by 2 g/d until hospital discharge or postoperative day 10, whichever came first. Main Outcome Measure Occurrence of postoperative AF lasting longer than 30 seconds. Secondary end points were postoperative AF lasting longer than 1 hour, resulting in symptoms, or treated with cardioversion; postoperative AF excluding atrial flutter; time to first postoperative AF; number of AF episodes per patient; hospital utilization; and major adverse cardiovascular events, 30-day mortality, bleeding, and other adverse events. Results At enrollment, mean age was 64 (SD, 13) years; 72.2% of patients were men, and 51.8% had planned valvular surgery. The primary end point occurred in 233 (30.7%) patients assigned to placebo and 227 (30.0%) assigned to n-3-PUFAs (odds ratio, 0.96 [95% CI, 0.77-1.20]; P=.74). None of the secondary end points were significantly different between the placebo and fish oil groups, including postoperative AF that was sustained, symptomatic, or treated (231 [30.5%] vs 224 [29.6%], P=.70) or number of postoperative AF episodes per patient (1 episode: 156 [20.6%] vs 157 [20.7%]; 2 episodes: 59 [7.8%] vs 49 [6.5%]; >3 episodes: 18 [2.4%] vs 21 [2.8%]) (P=.73). Supplementation with n-3-PUFAs was generally well tolerated, with no evidence for increased risk of bleeding or serious adverse events. Conclusion In this large multinational trial among patients undergoing cardiac surgery, perioperative supplementation with n-3-PUFAs, compared with placebo, did not reduce the risk of postoperative AF.	[Mozaffarian, Dariush] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Mozaffarian, Dariush] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Mozaffarian, Dariush; Libby, Peter; O'Gara, Patrick T.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Mozaffarian, Dariush] Brigham & Womens Hosp, Channing Div Network Med, Dept Med, Boston, MA 02115 USA; [Mozaffarian, Dariush] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Marchioli, Roberto; Silletta, Maria G.; Tognoni, Gianni] Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, Santa Maria Imbaro, Italy; [Macchia, Alejandro] GESICA Fdn, Buenos Aires, DF, Argentina; [Ferrazzi, Paolo] Ospedali Riuniti Bergamo, Bergamo, Italy; [Gardner, Timothy J.] Christiana Care Hlth Syst, Ctr Heart & Vasc Hlth, Newark, DE USA; [Latini, Roberto] Ist Ric Farmacol Mario Negri, Milan, Italy; [Lombardi, Federico] Univ Milan, Dept Hlth Sci, Milan, Italy; [Tavazzi, Luigi] Villa Maria Cecilia Hosp, GVM Hosp Care & Res, Cotignola, Italy	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Consorzio Mario Negri Sud; Ospedali Riuniti di Bergamo; Christiana Care Health System; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan; Maria Cecilia Hospital	Mozaffarian, D (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 665 Huntington Ave,Bldg 2-319, Boston, MA 02115 USA.	dmozaffa@hsph.harvard.edu; marchioli@negrisud.it	Latini, Roberto/AAB-1410-2020; De Caterina, Raffaele/K-3857-2016; Tavazzi, Luigi/ABD-5119-2020; Page, Richard L./L-5501-2014; Cavallotti, Laura/K-3347-2018; Giroli, Monica/D-4323-2019; pezzoli, Laura/AAA-4479-2019; Iascone, Maria/AAA-4599-2019; lombardi, federico/L-1023-2016; Macchia, Alejandro/AAV-9665-2020; Libby, Peter/AAY-6404-2021; Wu, Jason/J-2936-2019; Raffa, Giuseppe Maria/J-8612-2016; Myasoedova, Veronika A/K-1024-2016; Milne, Ginger/D-7648-2014	Latini, Roberto/0000-0002-3729-4650; De Caterina, Raffaele/0000-0003-1637-574X; Tavazzi, Luigi/0000-0003-0336-8356; Page, Richard L./0000-0001-5603-1330; Cavallotti, Laura/0000-0002-1341-2552; Giroli, Monica/0000-0002-9200-8821; pezzoli, Laura/0000-0002-8111-563X; Iascone, Maria/0000-0002-4707-212X; lombardi, federico/0000-0003-2424-2509; Macchia, Alejandro/0000-0002-5424-5009; Libby, Peter/0000-0002-1502-502X; Wu, Jason/0000-0003-2073-3562; Raffa, Giuseppe Maria/0000-0001-7141-2561; Myasoedova, Veronika A/0000-0001-8414-5300; LIVI, Ugolino/0000-0003-1394-736X; Marchetto, Giovanni/0000-0002-4480-4700; Fortunato, Guglielmo/0000-0001-5322-2668; Gennari, Marco/0000-0001-9079-3275; Aleksova, Aneta/0000-0001-7711-9905; Milne, Ginger/0000-0003-3890-151X; Laguzzi, Federica/0000-0003-3551-1348; Daprati, Andrea/0000-0003-1974-757X; Brambilla, Marta/0000-0002-7251-9106; DOZZA, LUCA/0000-0002-6116-0580; Brooks, Maria/0000-0002-2030-7873; Salizzoni, Stefano/0000-0002-1032-9155	OPERA; National Heart, Lung, and Blood Institute, National Institutes of Health [RC2-HL101816]; GlaxoSmithKline; Sigma Tau; Pronova BioPharma; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096844, RC2HL101816] Funding Source: NIH RePORTER	OPERA; National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); GlaxoSmithKline(GlaxoSmithKline); Sigma Tau; Pronova BioPharma; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The OPERA trial was an investigator-initiated, not-for-profit trial sponsored by the OPERA Investigators, who had full responsibility for study planning and conduct, curation of the study database, and discretion on data utilization, analysis, and publication. Financial support was provided by the National Heart, Lung, and Blood Institute, National Institutes of Health (RC2-HL101816), GlaxoSmithKline, Sigma Tau, and Pronova BioPharma, which also provided the study drug.	Auer J, 2005, J CARDIOVASC SURG, V46, P583; Bianconi L, 2011, EUROPACE, V13, P174, DOI 10.1093/europace/euq386; Brouwer IA, 2009, EUR HEART J, V30, P820, DOI 10.1093/eurheartj/ehp003; Burgess DC, 2006, EUR HEART J, V27, P2846, DOI 10.1093/eurheartj/ehl272; BURR ML, 1989, LANCET, V2, P757; Calo L, 2005, J AM COLL CARDIOL, V45, P1723, DOI 10.1016/j.jacc.2005.02.079; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; ERITSLAND J, 1995, BLOOD COAGUL FIBRIN, V6, P17, DOI 10.1097/00001721-199502000-00003; Farquharson AL, 2011, AM J CARDIOL, V108, P851, DOI 10.1016/j.amjcard.2011.04.036; Finzi AA, 2011, AM HEART J, V161, P338, DOI 10.1016/j.ahj.2010.10.032; Harris WS, 1992, FISH FISH OIL HUMAN, P88; Heidarsdottir R, 2010, EUROPACE, V12, P356, DOI 10.1093/europace/eup429; Heidt MC, 2009, THORAC CARDIOV SURG, V57, P276, DOI 10.1055/s-0029-1185301; Hogue CW, 2005, CHEST, V128, p9S, DOI 10.1378/chest.128.2_suppl.9S; Hravnak M, 2002, AM J CRIT CARE, V11, P228, DOI 10.4037/ajcc2002.11.3.228; Jahangiri A, 2000, MOL CELL BIOCHEM, V206, P33, DOI 10.1023/A:1007025007403; Khawaja O, 2012, J AM COLL NUTR, V31, P4, DOI 10.1080/07315724.2012.10720003; Kowey PR, 2010, JAMA-J AM MED ASSOC, V304, P2363, DOI 10.1001/jama.2010.1735; Kumar S, 2012, HEART RHYTHM, V9, P483, DOI 10.1016/j.hrthm.2011.11.034; Kumar S, 2011, AM J CARDIOL, V108, P531, DOI 10.1016/j.amjcard.2011.03.082; Kumar S, 2011, HEART RHYTHM, V8, P562, DOI 10.1016/j.hrthm.2010.12.017; Leaf A, 2003, CIRCULATION, V107, P2646, DOI 10.1161/01.CIR.0000069566.78305.33; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; Mariscalco G, 2008, CIRCULATION, V118, P1612, DOI 10.1161/CIRCULATIONAHA.108.777789; Mathew JP, 1996, JAMA-J AM MED ASSOC, V276, P300, DOI 10.1001/jama.276.4.300; McLennan PL, 2001, LIPIDS, V36, pS111, DOI 10.1007/s11745-001-0692-x; Mitchell LB, 2011, CAN J CARDIOL, V27, P91, DOI 10.1016/j.cjca.2010.11.005; Mozaffarian D, 2004, CIRCULATION, V110, P368, DOI 10.1161/01.CIR.0000138154.00779.A5; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Mozaffarian D, 2011, AM HEART J, V162, P56, DOI 10.1016/j.ahj.2011.03.035; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Nodari S, 2011, CIRCULATION, V124, P1100, DOI 10.1161/CIRCULATIONAHA.111.022194; Ozaydin M, 2011, ANATOL J CARDIOL, V11, P305, DOI 10.5152/akd.2011.080; RAPP JH, 1991, ARTERIOSCLER THROMB, V11, P903, DOI 10.1161/01.ATV.11.4.903; REIS GJ, 1989, LANCET, V2, P177; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Roques F, 2003, EUR HEART J, V24, P881, DOI 10.1016/S0195-668X(02)00799-6; Sandesara CM, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000547; Saravanan P, 2010, CIRC-ARRHYTHMIA ELEC, V3, P46, DOI 10.1161/CIRCEP.109.899633; Sorice Mario, 2011, Monaldi Arch Chest Dis, V76, P93; Thies F, 2003, LANCET, V361, P477, DOI 10.1016/S0140-6736(03)12468-3; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Wu JHY, 2012, CIRCULATION, V125, P1084, DOI 10.1161/CIRCULATIONAHA.111.062653	44	165	202	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2012	308	19					2001	2011		10.1001/jama.2012.28733	http://dx.doi.org/10.1001/jama.2012.28733			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040AQ	23128104	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000311291400024
J	Hsu, CY				Hsu, Chi-yuan			CKD-EPI eGFR categories were better than MDRD categories for predicting mortality in a range of populations	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							GLOMERULAR-FILTRATION-RATE		Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Hsu, CY (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.							Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006	2	9	9	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10							JC5-12	10.7326/0003-4819-157-10-201211200-02012	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043VZ	23165688				2022-12-28	WOS:000311580000011
J	Gonzalez-Rodriguez, D; Guevorkian, K; Douezan, S; Brochard-Wyart, F				Gonzalez-Rodriguez, David; Guevorkian, Karine; Douezan, Stephane; Brochard-Wyart, Francoise			Soft Matter Models of Developing Tissues and Tumors	SCIENCE			English	Review							CELL-CELL; EMBRYONIC-TISSUES; DIFFERENTIAL ADHESION; SURFACE-TENSION; MECHANICS; FORCES; REARRANGEMENT; MORPHOGENESIS; ORGANIZATION; COMPRESSION	Analogies with inert soft condensed matter-such as viscoelastic liquids, pastes, foams, emulsions, colloids, and polymers-can be used to investigate the mechanical response of soft biological tissues to forces. A variety of experimental techniques and biophysical models have exploited these analogies allowing the quantitative characterization of the mechanical properties of model tissues, such as surface tension, elasticity, and viscosity. The framework of soft matter has been successful in explaining a number of dynamical tissue behaviors observed in physiology and development, such as cell sorting, tissue spreading, or the escape of individual cells from a tumor. However, living tissues also exhibit active responses, such as rigidity sensing or cell pulsation, that are absent in inert soft materials. The soft matter models reviewed here have provided valuable insight in understanding morphogenesis and cancer invasion and have set bases for using tissue engineering within medicine.	[Douezan, Stephane; Brochard-Wyart, Francoise] Univ Paris 06, Inst Curie, F-75005 Paris, France; [Douezan, Stephane; Brochard-Wyart, Francoise] CNRS, UMR 168, F-75005 Paris, France; [Gonzalez-Rodriguez, David] Ecole Polytech, CNRS, Lab Hydrodynam LadHyX, UMR 7646, F-91128 Palaiseau, France; [Guevorkian, Karine] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire IGBMC, CNRS, UMR 7104, F-67400 Illkirch Graffenstaden, France; [Guevorkian, Karine] Univ Strasbourg, INSERM, U964, F-67400 Illkirch Graffenstaden, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Brochard-Wyart, F (corresponding author), Univ Paris 06, Inst Curie, 26 Rue Ulm, F-75005 Paris, France.	brochard@curie.fr	Gonzalez-Rodriguez, David/AAY-7037-2021	Guevorkian, Karine/0000-0001-8243-4248				Ambrosi D, 2009, BIOMECH MODEL MECHAN, V8, P397, DOI 10.1007/s10237-008-0145-y; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Basan M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.158101; BELOUSSOV LV, 1994, INT REV CYTOL, V150, P1; Beloussov LV, 1995, BIOCHEM CELL BIOL, V73, P555, DOI 10.1139/o95-061; Brodland GW, 2002, J BIOMECH ENG-T ASME, V124, P188, DOI 10.1115/1.1449491; Butcher JT, 2007, CIRC RES, V100, P1503, DOI 10.1161/CIRCRESAHA.107.148684; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Douezan S, 2012, EUR PHYS J E, V35, DOI 10.1140/epje/i2012-12034-9; Douezan S, 2012, SOFT MATTER, V8, P4578, DOI 10.1039/c2sm07418d; Douezan S, 2012, SOFT MATTER, V8, P784, DOI 10.1039/c1sm06399e; Douezan S, 2011, P NATL ACAD SCI USA, V108, P7315, DOI 10.1073/pnas.1018057108; Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7; Durth M., 2012, THESIS U SEVILLE SPA; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Fleming PA, 2010, DEV DYNAM, V239, P398, DOI 10.1002/dvdy.22161; Forgacs G, 1998, BIOPHYS J, V74, P2227, DOI 10.1016/S0006-3495(98)77932-9; Forgacs G., 2010, PHYSICS, V3, P43; Foty RA, 2004, INT J DEV BIOL, V48, P397, DOI 10.1387/ijdb.041810rf; Foty RA, 1996, DEVELOPMENT, V122, P1611; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; FOTY RA, 1994, PHYS REV LETT, V72, P2298, DOI 10.1103/PhysRevLett.72.2298; Giverso C, 2012, MATH MED BIOL, V29, P181, DOI 10.1093/imammb/dqr008; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Gonzalez-Rodriguez D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.218105; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Guevorkian K, 2011, P NATL ACAD SCI USA, V108, P13387, DOI 10.1073/pnas.1105741108; Guevorkian K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218101; Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144; HARRIS AK, 1976, J THEOR BIOL, V61, P267, DOI 10.1016/0022-5193(76)90019-9; Hayashi T, 2004, NATURE, V431, P647, DOI 10.1038/nature02952; Hegedus B, 2006, BIOPHYS J, V91, P2708, DOI 10.1529/biophysj.105.077834; Holftreter J., 1943, J EXP ZOOL, V94, P261; Jakab K, 2004, P NATL ACAD SCI USA, V101, P2864, DOI 10.1073/pnas.0400164101; Jakab K, 2008, DEV DYNAM, V237, P2438, DOI 10.1002/dvdy.21684; Jakab K, 2008, TISSUE ENG PT A, V14, P413, DOI 10.1089/tea.2007.0173; Jia D, 2007, DEV DYNAM, V236, P2039, DOI 10.1002/dvdy.21207; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; Kalantarian A, 2009, BIOPHYS J, V96, P1606, DOI 10.1016/j.bpj.2008.10.064; Krens SFG, 2011, CURR TOP DEV BIOL, V95, P189, DOI 10.1016/B978-0-12-385065-2.00006-2; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Luu O, 2011, P NATL ACAD SCI USA, V108, P4000, DOI 10.1073/pnas.1010331108; Maitre JL, 2012, SCIENCE, V338, P253, DOI 10.1126/science.1225399; Manning ML, 2010, P NATL ACAD SCI USA, V107, P12517, DOI 10.1073/pnas.1003743107; Mansurov AN, 2011, RUSS J DEV BIOL+, V42, P101, DOI 10.1134/S1062360411010073; Marmottant P, 2009, P NATL ACAD SCI USA, V106, P17271, DOI 10.1073/pnas.0902085106; Martin AC, 2010, DEV BIOL, V341, P114, DOI 10.1016/j.ydbio.2009.10.031; Mgharbel A, 2009, HFSP J, V3, P213, DOI 10.2976/1.3116822; Micoulet A, 2005, CHEMPHYSCHEM, V6, P663, DOI 10.1002/cphc.200400417; Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084; Mombach JCM, 2005, PHYSICA A, V352, P525, DOI 10.1016/j.physa.2005.02.008; Montel F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.188102; Nicolas A, 2008, BIOPHYS J, V95, P527, DOI 10.1529/biophysj.107.127399; Ninomiya H, 2008, NAT CELL BIOL, V10, P61, DOI 10.1038/ncb1669; Ninomiya H, 2012, J CELL SCI, V125, P1877, DOI 10.1242/jcs.095315; Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; PHILLIPS HM, 1978, J CELL SCI, V30, P1; PHILLIPS HM, 1969, P NATL ACAD SCI USA, V64, P121, DOI 10.1073/pnas.64.1.121; Pontani LL, 2012, P NATL ACAD SCI USA, V109, P9839, DOI 10.1073/pnas.1201499109; Preziosi L, 2010, J THEOR BIOL, V262, P35, DOI 10.1016/j.jtbi.2009.08.023; Ranft J, 2010, P NATL ACAD SCI USA, V107, P20863, DOI 10.1073/pnas.1011086107; Rieu JP, 2002, EUR PHYS J B, V27, P167, DOI 10.1140/epjb/e20020142; Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398; Sabari J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024810; Schotz EM, 2008, HFSP J, V2, P42, DOI 10.2976/1.2834817; SHANAHAN MER, 1987, J PHYS D APPL PHYS, V20, P945, DOI 10.1088/0022-3727/20/7/018; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; Steinberg MS, 1996, DEV BIOL, V180, P377, DOI 10.1006/dbio.1996.0312; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109; von Dassow M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015359; von Dassow M, 2009, DEV DYNAM, V238, P2, DOI 10.1002/dvdy.21809; Wiebe C, 2005, J BIOMECH, V38, P2087, DOI 10.1016/j.jbiomech.2004.09.005; Winters BS, 2005, INT J CANCER, V114, P371, DOI 10.1002/ijc.20722	77	174	174	4	308	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					910	917		10.1126/science.1226418	http://dx.doi.org/10.1126/science.1226418			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161991				2022-12-28	WOS:000311083600035
J	Spano, S; Galan, JE				Spano, Stefania; Galan, Jorge E.			A Rab32-Dependent Pathway Contributes to Salmonella Typhi Host Restriction	SCIENCE			English	Article							LYSOSOME-RELATED ORGANELLES; HERMANSKY-PUDLAK-SYNDROME; SECRETORY LYSOSOMES; BACTERIAL SURVIVAL; PUDIAK-SYNDROME; SYNDROME GENES; III SECRETION; MURINE; PATHOGENESIS; TYPHIMURIUM	Unlike other Salmonellae, the intracellular bacterial human pathogen Salmonella Typhi exhibits strict host specificity. The molecular bases for this restriction are unknown. Here we found that the expression of a single type III secretion system effector protein from broad-host Salmonella Typhimurium allowed Salmonella Typhi to survive and replicate within macrophages and tissues from mice, a nonpermissive host. This effector proteolytically targeted Rab32, which controls traffic to lysosome-related organelles in conjunction with components of the biogenesis of lysosome-related organelle complexes (BLOCs). RNA interference-mediated depletion of Rab32 or of an essential component of a BLOC complex was sufficient to allow S. Typhi to survive within mouse macrophages. Furthermore, S. Typhi was able to survive in macrophages from mice defective in BLOC components.	[Spano, Stefania; Galan, Jorge E.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, 295 Congress Ave, New Haven, CT 06536 USA.	jorge.galan@yale.edu	Spanò, Stefania/F-4951-2011	Spanò, Stefania/0000-0001-9154-7463	National Institute of Allergy and Infectious Diseases [AI079022, AI055472]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079022, R01AI055472, R56AI079022] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank W. Mothes for providing primary bone-marrow-derived macrophages from pa/co/le mice, which had been provided to him by R. Swank. We also thank C. Roy's laboratory for providing various Rab GTPase constructs and members of the Galan laboratory for critical reading of the manuscript. This work was supported by National Institute of Allergy and Infectious Diseases grants AI079022 and AI055472 (to J.E.G.).	Aspengren S, 2009, INT REV CEL MOL BIO, V272, P245, DOI 10.1016/S1937-6448(08)01606-7; Bakowski MA, 2008, TRAFFIC, V9, P2022, DOI 10.1111/j.1600-0854.2008.00827.x; Benado A, 2009, IMMUNOBIOLOGY, V214, P507, DOI 10.1016/j.imbio.2008.11.011; Brighouse A, 2010, CELL MOL LIFE SCI, V67, P3449, DOI 10.1007/s00018-010-0436-1; Bultema JJ, 2012, J BIOL CHEM, V287, P19550, DOI 10.1074/jbc.M112.351908; Chan WT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002713; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Di Pietro SM, 2005, TRAFFIC, V6, P525, DOI 10.1111/j.1600-0854.2005.00299.x; EDSALL G, 1960, J EXP MED, V112, P143, DOI 10.1084/jem.112.1.143; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Gautam R, 2006, TRAFFIC, V7, P779, DOI 10.1111/j.1600-0854.2006.00431.x; Grassl GA, 2008, CURR OPIN GASTROEN, V24, P22, DOI 10.1097/MOG.0b013e3282f21388; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Holt OJ, 2006, J BIOCHEM, V140, P7, DOI 10.1093/jb/mvj126; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; Li W, 2004, BIOESSAYS, V26, P616, DOI 10.1002/bies.20042; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Raffatellu M, 2008, J INFECT DEV COUNTR, V2, P260; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Sabbagh SC, 2010, FEMS MICROBIOL LETT, V305, P1, DOI 10.1111/j.1574-6968.2010.01904.x; Schwan WR, 2000, INFECT IMMUN, V68, P1005, DOI 10.1128/IAI.68.3.1005-1013.2000; Seto S, 2011, TRAFFIC, V12, P407, DOI 10.1111/j.1600-0854.2011.01165.x; Spano S, 2011, P NATL ACAD SCI USA, V108, P18418, DOI 10.1073/pnas.1111959108; Srikanth CV, 2011, CELL MOL LIFE SCI, V68, P3687, DOI 10.1007/s00018-011-0841-0; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; VLADOIANU IR, 1990, MICROB PATHOGENESIS, V8, P83, DOI 10.1016/0882-4010(90)90072-X; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Zhang FR, 2011, NAT GENET, V43, P1247, DOI 10.1038/ng.973	36	100	100	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					960	963		10.1126/science.1229224	http://dx.doi.org/10.1126/science.1229224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23162001	Green Accepted			2022-12-28	WOS:000311083600047
J	Storb, R				Storb, Rainer			Edward Donnall Thomas (1920-2012)	NATURE			English	Biographical-Item									[Storb, Rainer] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Storb, Rainer] Univ Washington, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Storb, R (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	rstorb@fhcrc.org						THOMAS ED, PUBLICATION LIST, P51246	1	3	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					334	334		10.1038/491334a	http://dx.doi.org/10.1038/491334a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23151572	Bronze			2022-12-28	WOS:000311031600021
J	Tong, L; Tan, J; Thumboo, J; Seow, G				Tong, Louis; Tan, Jeremy; Thumboo, Julian; Seow, Gabriel			Dry eye	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Tong, Louis] Singapore Natl Eye Ctr, Dept Cornea & External Eye Dis, Singapore 168751, Singapore; [Tong, Louis] Duke NUS Grad Med Sch, Off Clin Sci, Singapore, Singapore; [Tan, Jeremy] Faith Med Grp, Singapore, Singapore; [Tan, Jeremy; Thumboo, Julian] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Thumboo, Julian] Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore 0316, Singapore; [Seow, Gabriel] Woodlands Clin, Singapore, Singapore	Singapore National Eye Center; National University of Singapore; National University of Singapore; Singapore General Hospital	Tong, L (corresponding author), Singapore Natl Eye Ctr, Dept Cornea & External Eye Dis, 11 3rd Hosp Ave, Singapore 168751, Singapore.	Louis.tong.h.t@snec.com.sg		Tong, Louis/0000-0002-3986-6552					0	4	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 15	2012	345								e7533	10.1136/bmj.e7533	http://dx.doi.org/10.1136/bmj.e7533			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040QE	23153839				2022-12-28	WOS:000311337000006
J	Dieleman, JM; Nierich, AP; Rosseel, PM; van der Maaten, JM; Hofland, J; Diephuis, JC; Schepp, RM; Boer, C; Moons, KG; van Herwerden, LA; Tijssen, JG; Numan, SC; Kalkman, CJ; van Dijk, D				Dieleman, Jan M.; Nierich, Arno P.; Rosseel, Peter M.; van der Maaten, Joost M.; Hofland, Jan; Diephuis, Jan C.; Schepp, Ronald M.; Boer, Christa; Moons, Karel G.; van Herwerden, Lex A.; Tijssen, Jan G.; Numan, Sandra C.; Kalkman, Cor J.; van Dijk, Diederik		Dexamethasone Cardiac Surg DECS St	Intraoperative High-Dose Dexamethasone for Cardiac Surgery A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOPULMONARY BYPASS; CORTICOSTEROIDS; DEFINITION; INJURY; SYSTEM	Context Prophylactic corticosteroids are often administered during cardiac surgery to attenuate the inflammatory response to cardiopulmonary bypass and surgical trauma; however, evidence that routine corticosteroid use can prevent major adverse events is lacking. Objective To quantify the effect of intraoperative high-dose dexamethasone on the incidence of major adverse events in patients undergoing cardiac surgery. Design, Setting, and Participants A multicenter, randomized, double-blind, placebo-controlled trial of 4494 patients aged 18 years or older undergoing cardiac surgery with cardiopulmonary bypass at 8 cardiac surgical centers in the Netherlands enrolled between April 13, 2006, and November 23, 2011. Intervention Patients were randomly assigned to receive a single intraoperative dose of 1 mg/kg dexamethasone (n=2239) or placebo (n=2255). Main Outcome Measures A composite of death, myocardial infarction, stroke, renal failure, or respiratory failure, within 30 days of randomization. Results Of the 4494 patients who underwent randomization, 4482 (99.7%) could be evaluated for the primary outcome. A total of 157 patients (7.0%) in the dexamethasone group and 191 patients (8.5%) in the placebo group reached the primary study end point (relative risk, 0.83; 95% CI, 0.67-1.01; absolute risk reduction, -1.5%; 95% CI, -3.0% to 0.1%; P=.07). Dexamethasone was associated with reductions in postoperative infection, duration of postoperative mechanical ventilation, and lengths of intensive care unit and hospital stays. In contrast, dexamethasone was associated with higher postoperative glucose levels. Conclusion In our trial of adults undergoing cardiac surgery, the use of intraoperative dexamethasone did not reduce the 30-day incidence of major adverse events compared with placebo.	[Dieleman, Jan M.; Moons, Karel G.; van Herwerden, Lex A.; Numan, Sandra C.; Kalkman, Cor J.; van Dijk, Diederik] Univ Med Ctr Utrecht, Div Anesthesiol Intens Care & Emergency Med, NL-3508 GA Utrecht, Netherlands; [Nierich, Arno P.] Isala Klin, Zwolle, Netherlands; [Rosseel, Peter M.] Amphia Ziekenhuis, Breda, Netherlands; [van der Maaten, Joost M.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Hofland, Jan] Erasmus MC, Rotterdam, Netherlands; [Diephuis, Jan C.] Med Spectrum Twente, Enschede, Netherlands; [Schepp, Ronald M.] Med Ctr, Leeuwarden, Netherlands; [Boer, Christa] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Tijssen, Jan G.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Isala Clinics; Amphia Hospital; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Medical Spectrum Twente; Medical Center Leeuwarden; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Dieleman, JM (corresponding author), Univ Med Ctr Utrecht, Div Anesthesiol Intens Care & Emergency Med, POB 85500, NL-3508 GA Utrecht, Netherlands.	s.dieleman@umcutrecht.nl	Ottens, Thomas/AAF-5128-2019; Hofland, Jan/Q-3542-2016; Kalkman, Cor/O-3215-2019	Ottens, Thomas/0000-0001-6861-5755; Hofland, Jan/0000-0001-8241-7069; Kalkman, Cor/0000-0002-8372-6960; van der Maaten, Joost/0000-0001-8796-4977; Buhre, Wolfgang/0000-0002-8296-9426; Dieleman, Jan/0000-0001-5867-9341; Boer, Christa/0000-0002-7781-6951; van Herwerden, Lex A./0000-0003-1087-1275	Netherlands Organization for Health Research and Development (ZonMw) [80-82310-98-08607]; Dutch Heart Foundation [2007B125]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Dutch Heart Foundation(Netherlands Heart Foundation)	This work was supported by grants 80-82310-98-08607 from the Netherlands Organization for Health Research and Development (ZonMw) and 2007B125 from the Dutch Heart Foundation.	Asimakopoulos G, 2001, PERFUSION-UK, V16, P353, DOI 10.1177/026765910101600505; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Chaney MA, 2002, CHEST, V121, P921, DOI 10.1378/chest.121.3.921; Dieleman JM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005566.pub3; Duncan AE, 2010, ANESTHESIOLOGY, V112, P860, DOI 10.1097/ALN.0b013e3181d3d4b4; Halonen J, 2007, JAMA-J AM MED ASSOC, V297, P1562, DOI 10.1001/jama.297.14.1562; Ho KM, 2009, CIRCULATION, V119, P1853, DOI 10.1161/CIRCULATIONAHA.108.848218; Mariscalco G, 2011, ANN THORAC SURG, V92, P1539, DOI 10.1016/j.athoracsur.2011.04.123; MOAT NE, 1993, EUR J CARDIO-THORAC, V7, P563, DOI 10.1016/1010-7940(93)90241-3; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Newman MF, 2006, LANCET, V368, P694, DOI 10.1016/S0140-6736(06)69254-4; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sulzer CF, 2005, J CARDIOTHOR VASC AN, V19, P255, DOI 10.1053/j.jvca.2005.02.008; Thygesen K, 2007, EUR HEART J, V28, P2525; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vogelzang M, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-39; Wan S, 1997, CHEST, V112, P676, DOI 10.1378/chest.112.3.676; Whitlock RP, 2008, EUR HEART J, V29, P2592, DOI 10.1093/eurheartj/ehn333; Whitlock RP, 2005, J CARDIOTHOR VASC AN, V19, P250, DOI 10.1053/j.jvca.2005.02.010	20	281	292	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1761	1767		10.1001/jama.2012.14144	http://dx.doi.org/10.1001/jama.2012.14144			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117776	Bronze			2022-12-28	WOS:000310726500022
J	Weinberg, DS; Schoen, RE				Weinberg, David S.; Schoen, Robert E.			Colorectal Cancer Screening: America's Next Top Model?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TASK-FORCE; COLONOSCOPY; POLYPS		[Weinberg, David S.] Fox Chase Canc Ctr, Dept Med, Philadelphia, PA 19111 USA; [Schoen, Robert E.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA	Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Weinberg, DS (corresponding author), Fox Chase Canc Ctr, Dept Med, 333 Cottman Ave, Philadelphia, PA 19111 USA.	david.weinberg@fccc.edu						Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Inadomi JM, 2012, ARCH INTERN MED, V172, P575, DOI 10.1001/archinternmed.2012.332; Knudsen AB, 2012, ANN INTERN MED, V157, P611, DOI 10.7326/0003-4819-157-9-201211060-00005; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Penn E, 2010, ARCH INTERN MED, V170, P1127, DOI 10.1001/archinternmed.2010.152; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245	9	2	2	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2012	157	9					673	+		10.7326/0003-4819-157-9-201211060-00017	http://dx.doi.org/10.7326/0003-4819-157-9-201211060-00017			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033GX	23128867				2022-12-28	WOS:000310783300012
J	Kessler, F				Kessler, Felix			Chloroplast Delivery by UPS	SCIENCE			English	Editorial Material							IMPORT RECEPTOR; PROTEIN; MACHINERY; PLASTIDS; FAMILY		Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland	University of Neuchatel	Kessler, F (corresponding author), Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland.	felix.kessler@unine.ch	Kessler, Felix Henrique/AAO-1722-2020	Kessler, Felix/0000-0001-6409-5043				Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Bauer J, 2000, NATURE, V403, P203, DOI 10.1038/35003214; HIRSCH S, 1994, SCIENCE, V266, P1989, DOI 10.1126/science.7801125; Ivanova Y, 2004, MOL BIOL CELL, V15, P3379, DOI 10.1091/mbc.E03-12-0923; Jarvis P, 1998, SCIENCE, V282, P100, DOI 10.1126/science.282.5386.100; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Kessler F, 2009, CURR OPIN CELL BIOL, V21, P494, DOI 10.1016/j.ceb.2009.03.004; Kubis S, 2004, PLANT CELL, V16, P2059, DOI 10.1105/tpc.104.023309; Ling QH, 2012, SCIENCE, V338, P655, DOI 10.1126/science.1225053; PERRY SE, 1994, PLANT CELL, V6, P93, DOI 10.1105/tpc.6.1.93; SCHNELL DJ, 1994, SCIENCE, V266, P1007, DOI 10.1126/science.7973649; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	14	8	9	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					622	623		10.1126/science.1230658	http://dx.doi.org/10.1126/science.1230658			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118178	Green Submitted			2022-12-28	WOS:000310516000039
J	Demetri, GD; Reichardt, P; Kang, YK; Blay, JY; Rutkowski, P; Gelderblom, H; Hohenberger, P; Leahy, M; von Mehren, M; Joensuu, H; Badalamenti, G; Blackstein, M; Le Cesne, A; Schoffski, P; Maki, RG; Bauer, S; Nguyen, BB; Xu, JM; Nishida, T; Chung, J; Kappeler, C; Kuss, I; Laurent, D; Casali, PG				Demetri, George D.; Reichardt, Peter; Kang, Yoon-Koo; Blay, Jean-Yves; Rutkowski, Piotr; Gelderblom, Hans; Hohenberger, Peter; Leahy, Michael; von Mehren, Margaret; Joensuu, Heikki; Badalamenti, Giuseppe; Blackstein, Martin; Le Cesne, Axel; Schoffski, Patrick; Maki, Robert G.; Bauer, Sebastian; Binh Bui Nguyen; Xu, Jianming; Nishida, Toshirou; Chung, John; Kappeler, Christian; Kuss, Iris; Laurent, Dirk; Casali, Paolo G.		GRID Study Investigators	Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial	LANCET			English	Article							TYROSINE KINASE INHIBITOR; ADJUVANT IMATINIB; GROWTH-FACTOR; RESISTANCE; KIT; MUTATIONS; MECHANISMS; MESYLATE; SU11248; MANAGEMENT	Background Until now, only imatinib and sunitinib have proven clinical benefit in patients with gastrointestinal stromal tumours (GIST), but almost all metastatic GIST eventually develop resistance to these agents, resulting in fatal disease progression. We aimed to assess efficacy and safety of regorafenib in patients with metastatic or unresectable GIST progressing after failure of at least imatinib and sunitinib. Methods We did this phase 3 trial at 57 hospitals in 17 countries. Patients with histologically confirmed, metastatic or unresectable GIST, with failure of at least previous imatinib and sunitinib were randomised in a 2:1 ratio (by computer-generated randomisation list and interactive voice response system; preallocated block design (block size 12); stratified by treatment line and geographical region) to receive either oral regorafenib 160 mg daily or placebo, plus best supportive care in both groups, for the first 3 weeks of each 4 week cycle. The study sponsor, participants, and investigators were masked to treatment assignment. The primary endpoint was progression-free survival (PFS). At disease progression, patients assigned placebo could crossover to open-label regorafenib. Analyses were by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT01271712. Results From Jan 4, to Aug 18, 2011, 240 patients were screened and 199 were randomised to receive regorafenib (n=133) or matching placebo (n=66). Data cutoff was Jan 26, 2012. Median PFS per independent blinded central review was 4.8 months (IQR 1.4-9.2) for regorafenib and 0.9 months (0.9-1.8) for placebo (hazard ratio [HR] 0.27, 95% CI 0.19-0.39; p<0.0001). After progression, 56 patients (85%) assigned placebo crossed over to regorafenib. Drug-related adverse events were reported in 130 (98%) patients assigned regorafenib and 45 (68%) patients assigned placebo. The most common regorafenib-related adverse events of grade 3 or higher were hypertension (31 of 132, 23%), hand-foot skin reaction (26 of 132, 20%), and diarrhoea (seven of 132, 5%). Interpretation The results of this study show that oral regorafenib can provide a significant improvement in progression-free survival compared with placebo in patients with metastatic GIST after progression on standard treatments. As far as we are aware, this is the first clinical trial to show benefit from a kinase inhibitor in this highly refractory population of patients.	[Demetri, George D.] Dana Farber Canc Inst, Ludwig Ctr, Boston, MA 02215 USA; [Demetri, George D.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Reichardt, Peter] HELIOS Klinikum Bad Saarow, Dept Hematol Oncol & Palliat Med, Bad Saarow Pieskow, Germany; [Kang, Yoon-Koo] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; [Blay, Jean-Yves] Ctr Leon Berard, F-69373 Lyon, France; [Blay, Jean-Yves] Univ Lyon 1, F-69365 Lyon, France; [Rutkowski, Piotr] Maria Sklodowska Curie Mem Canc Ctr, Dept Soft Tissue Bone Sarcoma & Melanoma, Warsaw, Poland; [Rutkowski, Piotr] Inst Oncol, Warsaw, Poland; [Gelderblom, Hans] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands; [Hohenberger, Peter] Univ Hosp Mannheim, Div Surg Oncol & Thorac Surg, Mannheim, Germany; [Leahy, Michael] Christie NHS Fdn Trust, Manchester, Lancs, England; [von Mehren, Margaret] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Joensuu, Heikki] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland; [Badalamenti, Giuseppe] Univ Palermo, Dept Oncol, Palermo, Italy; [Blackstein, Martin] Mt Sinai Hosp, Med Oncol Unit, Toronto, ON M5G 1X5, Canada; [Le Cesne, Axel] Inst Gustave Roussy, Dept Med, Paris, France; [Schoffski, Patrick] Katholieke Univ Leuven Hosp, Dept Gen Med Oncol, Louvain, Belgium; [Maki, Robert G.] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Bauer, Sebastian] Univ Duisburg Essen, Sarcoma Ctr, W German Canc Ctr, Essen, Germany; [Binh Bui Nguyen] Bergonie Inst, Bordeaux, France; [Xu, Jianming] Acad Mil Med Sci, Affiliated Hosp Canc Ctr, Beijing, Peoples R China; [Nishida, Toshirou] Osaka Police Hosp, Dept Surg, Osaka, Japan; [Chung, John] Bayer Healthcare Pharmaceut, Wayne, NJ USA; [Kappeler, Christian; Kuss, Iris; Laurent, Dirk] Bayer Pharma AG, Berlin, Germany; [Casali, Paolo G.] Fdn IRCCS Ist Nazl Tumori, Milan, Italy	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Helios Kliniken; University of Ulsan; Asan Medical Center; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Ruprecht Karls University Heidelberg; Christie NHS Foundation Trust; Fox Chase Cancer Center; University of Helsinki; Helsinki University Central Hospital; University of Palermo; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Sanofi-Aventis; Sanofi France; UNICANCER; Gustave Roussy; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Icahn School of Medicine at Mount Sinai; University of Duisburg Essen; UNICANCER; Institut Bergonie; Academy of Military Medical Sciences - China; Osaka Police Hospital; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Fondazione IRCCS Istituto Nazionale Tumori Milan	Demetri, GD (corresponding author), Dana Farber Canc Inst, Ludwig Ctr, Boston, MA 02215 USA.	gdemetri@partners.org	Maki, Robert G/J-9145-2019; Rutkowski, Piotr/B-3907-2013; Maki, Robert G./AAI-2793-2020; adenis, antoine/N-1536-2014; casali, Paolo Giovanni/D-1524-2017; Bauer, Sebastian/D-8120-2012; Jones, Robin L/AAO-3738-2020; van der Graaf, Winette T/A-5006-2014; Leahy, Michael G/K-8697-2015; Bauer, Sebastian/HHR-9319-2022; Blay, Jean-Yves/N-3966-2016; ravegnini, gloria/K-1330-2016	Maki, Robert G/0000-0002-9853-2528; Rutkowski, Piotr/0000-0002-8920-5429; adenis, antoine/0000-0003-0585-5078; casali, Paolo Giovanni/0000-0003-4056-8023; Bauer, Sebastian/0000-0001-5949-8120; Jones, Robin L/0000-0003-4173-3844; van der Graaf, Winette T/0000-0001-7549-3338; Leahy, Michael G/0000-0002-9936-0537; Blay, Jean-Yves/0000-0001-7190-120X; ravegnini, gloria/0000-0002-7774-402X; Joensuu, Heikki/0000-0003-0281-2507; Gelderblom, Hans/0000-0001-9270-8636	Bayer HealthCare Pharmaceuticals; Virginia and Daniel K Ludwig Trust for Cancer Research; Team Russo; Paul's Posse; Pan Mass Challenge; US National Cancer Institute [1P50CA127003-05]; Cancer Foundation Finland sr [120084, 130093, 110071] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P50CA127003] Funding Source: NIH RePORTER	Bayer HealthCare Pharmaceuticals(Bayer AGBayer Healthcare Pharmaceuticals); Virginia and Daniel K Ludwig Trust for Cancer Research; Team Russo; Paul's Posse; Pan Mass Challenge; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Foundation Finland sr; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the participating patients and staff at each of the study centres. The trial was supported by Bayer HealthCare Pharmaceuticals. Administrative and minor editorial assistance in the preparation of this report was provided by Succinct Healthcare Communications, with financial support from Bayer HealthCare Pharmaceuticals; the authors retained complete editorial control over the content. Additional support for this work has been provided to GDD from the following sources: The Virginia and Daniel K Ludwig Trust for Cancer Research, Team Russo, Paul's Posse and the Pan Mass Challenge, and Gastrointestinal Cancer SPORE Grant 1P50CA127003-05 from the US National Cancer Institute.	Abrams TJ, 2003, MOL CANCER THER, V2, P1011; Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Broutin S, 2011, CLIN CANCER RES, V17, P2044, DOI 10.1158/1078-0432.CCR-10-2041; Caram MV, 2011, J SURG ONCOL, V104, P888, DOI 10.1002/jso.21930; Chen LL, 2004, CANCER RES, V64, P5913, DOI 10.1158/0008-5472.CAN-04-0085; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Debiec-Rychter M, 2005, GASTROENTEROLOGY, V128, P270, DOI 10.1053/j.gastro.2004.11.020; Debiec-Rychter M, 2006, EUR J CANCER, V42, P1093, DOI 10.1016/j.ejca.2006.01.030; DeMatteo RP, 2009, LANCET, V373, P1097, DOI 10.1016/S0140-6736(09)60500-6; DeMatteo RP, 2002, HUM PATHOL, V33, P466, DOI 10.1053/hupa.2002.124122; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Demetri GD, 2011, SEMIN ONCOL, V38, pS10, DOI 10.1053/j.seminoncol.2011.01.018; Demetri GD, 2010, J NATL COMPR CANC NE, V8, pS1; Ducimetiere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020294; Edmonson JH, 2002, CANCER INVEST, V20, P605, DOI 10.1081/CNV-120002485; Gajiwala KS, 2009, P NATL ACAD SCI USA, V106, P1542, DOI 10.1073/pnas.0812413106; George S, 2012, J CLIN ONCOL, V30, P2401, DOI 10.1200/JCO.2011.39.9394; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Heinrich MC, 2008, J CLIN ONCOL, V26, P5360, DOI 10.1200/JCO.2008.17.4284; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Joensuu H, 2012, NAT REV CLIN ONCOL, V9, P351, DOI 10.1038/nrclinonc.2012.74; Joensuu H, 2012, JAMA-J AM MED ASSOC, V307, P1265, DOI 10.1001/jama.2012.347; Liegl B, 2008, J PATHOL, V216, P64, DOI 10.1002/path.2382; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Mross K, 2012, CLIN CANCER RES, V18, P2658, DOI 10.1158/1078-0432.CCR-11-1900; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Osusky Katherine L., 2004, Angiogenesis, V7, P225, DOI 10.1007/s10456-004-3149-y; Reichardt P, 2012, ANN ONCOL, V23, P1680, DOI 10.1093/annonc/mdr598; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864	33	863	919	1	140	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 26	2013	381	9863					295	302		10.1016/S0140-6736(12)61857-1	http://dx.doi.org/10.1016/S0140-6736(12)61857-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077IT	23177515	Green Accepted, Green Submitted			2022-12-28	WOS:000314021800026
J	Hughes, AL; Gottschling, DE				Hughes, Adam L.; Gottschling, Daniel E.			An early age increase in vacuolar pH limits mitochondrial function and lifespan in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; H+-ATPASE; PROTEINS; MECHANISMS; MEMBRANE; INHERITANCE; MORPHOLOGY; EXCHANGER; INSIGHTS	Mitochondria have a central role in ageing. They are considered to be both a target of the ageing process and a contributor to it(1). Alterations in mitochondrial structure and function are evident during ageing in most eukaryotes(2), but how this occurs is poorly understood. Here we identify a functional link between the lysosome-like vacuole and mitochondria in Saccharomyces cerevisiae, and show that mitochondrial dysfunction in replicatively aged yeast arises from altered vacuolar pH. We found that vacuolar acidity declines during the early asymmetric divisions of a mother cell, and that preventing this decline suppresses mitochondrial dysfunction and extends lifespan. Surprisingly, changes in vacuolar pH do not limit mitochondrial function by disrupting vacuolar protein degradation, but rather by reducing pH-dependent amino acid storage in the vacuolar lumen. We also found that calorie restriction promotes lifespan extension at least in part by increasing vacuolar acidity via conserved nutrient-sensing pathways(3). Interestingly, although vacuolar acidity is reduced in aged mother cells, acidic vacuoles are regenerated in newborn daughters, coinciding with daughter cells having a renewed lifespan potential(4). Overall, our results identify vacuolar pH as a critical regulator of ageing and mitochondrial function, and outline a potentially conserved mechanism by which calorie restriction delays the ageing process. Because the functions of the vacuole are highly conserved throughout evolution(5), we propose that lysosomal pH may modulate mitochondrial function and lifespan in other eukaryotic cells.	[Hughes, Adam L.; Gottschling, Daniel E.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Gottschling, DE (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	dgottsch@fhcrc.org		Hughes, Adam/0000-0002-7095-3793	National Institutes of Health [AG037512, AG023779]; Glenn Award for Research in Biological Mechanisms of Aging; Helen Hay Whitney Foundation; Genetic Approaches to Aging Training Grant [T32 AG000057]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057, R01AG037512, R01AG023779, R37AG023779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Award for Research in Biological Mechanisms of Aging; Helen Hay Whitney Foundation; Genetic Approaches to Aging Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank L. Pallanck and members of the Gottschling laboratory for reviewing the manuscript; K. Henderson for helpful discussions; G. Miesenbock, D. Lindstromand J. Hsu for reagents; and L. Dimitrov for technical assistance. This work was supported by National Institutes of Health grants AG037512 and AG023779, and a Glenn Award for Research in Biological Mechanisms of Aging to D.E.G., and by fellowships from the Helen Hay Whitney Foundation and Genetic Approaches to Aging Training Grant (T32 AG000057) to A.L.H.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Altmann K, 2005, MOL BIOL CELL, V16, P5410, DOI 10.1091/mbc.E05-07-0678; Baker B, 1998, INTERNET WORLD, V9, P14; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; HIRATA R, 1990, J BIOL CHEM, V265, P6726; Hu YH, 2007, GENOME RES, V17, P536, DOI 10.1101/gr.6037607; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jackson DD, 1997, J BIOL CHEM, V272, P25928, DOI 10.1074/jbc.272.41.25928; Jones GM, 2008, NAT METHODS, V5, P239, DOI 10.1038/NMETH.1181; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Lam YT, 2011, FREE RADICAL BIO MED, V50, P963, DOI 10.1016/j.freeradbiomed.2011.01.013; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lindstrom DL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002015; Lindstrom DL, 2009, GENETICS, V183, P413, DOI 10.1534/genetics.109.106229; McFaline-Figueroa JR, 2011, AGING CELL, V10, P885, DOI 10.1111/j.1474-9726.2011.00731.x; Miseta A, 1999, FEBS LETT, V451, P132, DOI 10.1016/S0014-5793(99)00519-0; MORANO KA, 1994, J CELL SCI, V107, P2813; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; Parr CL, 2007, YEAST, V24, P467, DOI 10.1002/yea.1485; Piper MDW, 2011, CELL METAB, V14, P154, DOI 10.1016/j.cmet.2011.06.013; Plant PJ, 1999, J BIOL CHEM, V274, P37270, DOI 10.1074/jbc.274.52.37270; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Russnak R, 2001, J BIOL CHEM, V276, P23849, DOI 10.1074/jbc.M008028200; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Shimazu M, 2005, J BIOL CHEM, V280, P4851, DOI 10.1074/jbc.M412617200; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; TANAKA K, 1990, CELL, V60, P803, DOI 10.1016/0092-8674(90)90094-U; Van Leeuwen F, 2002, METHOD ENZYMOL, V350, P165, DOI 10.1016/S0076-6879(02)50962-9; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; WEISMAN LS, 1987, J CELL BIOL, V105, P1539, DOI 10.1083/jcb.105.4.1539	41	329	333	1	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					261	+		10.1038/nature11654	http://dx.doi.org/10.1038/nature11654			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23172144	Green Accepted			2022-12-28	WOS:000312259300044
J	Jangi, S				Jangi, Sushrut			Facing Uncertainty - Dispatch from Beth Israel Medical Center, Manhattan	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Jangi, S (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.								0	16	16	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24					2267	2269		10.1056/NEJMp1213844	http://dx.doi.org/10.1056/NEJMp1213844			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	052HF	23151280				2022-12-28	WOS:000312187700015
J	Hernandez, AR; Klein, AM; Kirschner, MW				Hernandez, Ana R.; Klein, Allon M.; Kirschner, Marc W.			Kinetic Responses of beta-Catenin Specify the Sites of Wnt Control	SCIENCE			English	Article							AXIN; PHOSPHORYLATION	Despite more than 30 years of work on the Wnt signaling pathway, the basic mechanism of how the extracellular Wnt signal increases the intracellular concentration of beta-catenin is still contentious. Circumventing much of the detailed biochemistry, we used basic principles of chemical kinetics coupled with quantitative measurements to define the reactions on beta-catenin directly affected by the Wnt signal. We conclude that the core signal transduction mechanism is relatively simple, with only two regulated phosphorylation steps. Their partial inhibition gives rise to the full dynamics of the response and subsequently maintains a steady state in which the concentration of beta-catenin is increased.	[Hernandez, Ana R.; Klein, Allon M.; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	marc@hms.harvard.edu			Novartis Institutes for Biomedical Research; Career Award at the Scientific Interface from the Burroughs Welcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125603] Funding Source: NIH RePORTER	Novartis Institutes for Biomedical Research; Career Award at the Scientific Interface from the Burroughs Welcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Gerhart, M. Springer, X. He, W. Fontana, J. Gunawardena, J. Gray, F. Cong, and R. Deibler for discussions and comments on the manuscript; Y. Ben-Neriah for plasmids; and the Novartis Institutes for Biomedical Research for support of this work. A. M. K. holds a Career Award at the Scientific Interface from the Burroughs Welcome Fund. M. W. K. serves as a paid consultant on the scientific review board of Novartis.	Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI DOI 10.1074/MCP.M111.011429; CHANCE B, 1958, NATURE, V182, P1190, DOI 10.1038/1821190a0; HEINRICH R, 1974, EUR J BIOCHEM, V42, P97, DOI 10.1111/j.1432-1033.1974.tb03319.x; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Maher MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010184; Peacocke AR, 1996, J THEOR BIOL, V182, P219, DOI 10.1006/jtbi.1996.0158; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; Schilling CH, 1999, BIOTECHNOL PROGR, V15, P296, DOI 10.1021/bp990048k; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200	16	89	89	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1337	1340		10.1126/science.1228734	http://dx.doi.org/10.1126/science.1228734			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23138978				2022-12-28	WOS:000311991200065
J	Maisel, SB; Hofler, M; Muller, S				Maisel, Sascha B.; Hoefler, Michaela; Mueller, Stefan			A canonical stability-elasticity relationship verified for one million face-centred-cubic structures	NATURE			English	Article							TOTAL-ENERGY CALCULATIONS; ROMAN CIVILIZATIONS; 1ST-PRINCIPLES; ALLOYS; ETRUSCAN; GREEK	Any thermodynamically stable or metastable phase corresponds to a local minimum of a potentially very complicated energy landscape. But however complex the crystal might be, this energy landscape is of parabolic shape near its minima. Roughly speaking, the depth of this energy well with respect to some reference level determines the thermodynamic stability of the system, and the steepness of the parabola near its minimum determines the system's elastic properties. Although changing alloying elements and their concentrations in a given material to enhance certain properties dates back to the Bronze Age(1,2), the systematic search for desirable properties in metastable atomic configurations at a fixed stoichiometry is a very recent tool in materials design(3). Here we demonstrate, using first-principles studies of four binary alloy systems, that the elastic properties of face-centred-cubic intermetallic compounds obey certain rules. We reach two conclusions based on calculations on a huge subset of the face-centred-cubic configuration space. First, the stiffness and the heat of formation are negatively correlated with a nearly constant Spearman correlation(4) for all concentrations. Second, the averaged stiffness of metastable configurations at a fixed concentration decays linearly with their distance to the ground-state line (the phase diagram of an alloy at zero Kelvin). We hope that our methods will help to simplify the quest for new materials with optimal properties from the vast configuration space available.	[Maisel, Sascha B.; Hoefler, Michaela; Mueller, Stefan] Hamburg Univ Technol, Inst Adv Ceram, D-21073 Hamburg, Germany	Hamburg University of Technology	Maisel, SB (corresponding author), Hamburg Univ Technol, Inst Adv Ceram, Denickestr 15, D-21073 Hamburg, Germany.	stefan.mueller@tuhh.de	Maisel, Sascha/I-3559-2015	Maisel, Sascha/0000-0002-7603-371X	DFG (Deutsche Forschungsgemeinschaft) [Mu1648/5]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	Funding by the DFG (Deutsche Forschungsgemeinschaft) grant Mu1648/5 is acknowledged. We also thank the RRZ-Hamburg super-computing site for a generous amount of computational time and E. Kahnert and her team for support and advice related to the computing facilities. Additional computing resources from the German super-computing alliance HLRN are acknowledged.	BLOCHL PE, 1994, PHYS REV B, V49, P16223, DOI 10.1103/PhysRevB.49.16223; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Blum V, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.165113; CRADDOCK PT, 1976, J ARCHAEOL SCI, V3, P93, DOI 10.1016/0305-4403(76)90079-0; CRADDOCK PT, 1977, J ARCHAEOL SCI, V4, P103, DOI 10.1016/0305-4403(77)90058-9; Duan G, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2360203; Hart GLW, 2005, NAT MATER, V4, P391, DOI 10.1038/nmat1374; Hart GLW, 2007, NAT MATER, V6, P941, DOI 10.1038/nmat2057; Hart GLW, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.224115; Holec D., 2012, PHYS REV B, V84; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Lerch D, 2009, MODEL SIMUL MATER SC, V17, DOI 10.1088/0965-0393/17/5/055003; Liu JZ, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.144109; METHFESSEL M, 1989, PHYS REV B, V40, P3616, DOI 10.1103/PhysRevB.40.3616; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Raabe D, 2007, ACTA MATER, V55, P4475, DOI 10.1016/j.actamat.2007.04.024; Saito T, 2003, SCIENCE, V300, P464, DOI 10.1126/science.1081957; SANCHEZ JM, 1984, PHYSICA A, V128, P334, DOI 10.1016/0378-4371(84)90096-7; Sanchez JM, 1981, STRUCTURE BONDING CR, V2, P117; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; WERTIME TA, 1973, SCIENCE, V182, P875, DOI 10.1126/science.182.4115.875; Yuge K, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/41/415403; Zhou Y, 2012, J SOLID STATE CHEM, V187, P211, DOI 10.1016/j.jssc.2012.01.001; Zhu LF, 2012, ACTA MATER, V60, P1594, DOI 10.1016/j.actamat.2011.11.046	25	19	19	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					740	+		10.1038/nature11609	http://dx.doi.org/10.1038/nature11609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23172142				2022-12-28	WOS:000311606000041
J	Salazar, RF; Dotson, NM; Bressler, SL; Gray, CM				Salazar, R. F.; Dotson, N. M.; Bressler, S. L.; Gray, C. M.			Content-Specific Fronto-Parietal Synchronization During Visual Working Memory	SCIENCE			English	Article							SHORT-TERM-MEMORY; PRIMATE PREFRONTAL CORTEX; POSTERIOR PARIETAL CORTICES; NEURAL MECHANISMS; RHESUS-MONKEY; TOP-DOWN; OSCILLATIONS; ATTENTION; NEURONS; NETWORKS	Lateral prefrontal and posterior parietal cortical areas exhibit task-dependent activation during working memory tasks in humans and monkeys. Neurons in these regions become synchronized during attention-demanding tasks, but the contribution of these interactions to working memory is largely unknown. Using simultaneous recordings of neural activity from multiple areas in both regions, we find widespread, task-dependent, and content-specific synchronization of activity across the fronto-parietal network during visual working memory. The patterns of synchronization are prevalent among stimulus-selective neurons and are governed by influences arising in parietal cortex. These results indicate that short-term memories are represented by large-scale patterns of synchronized activity across the fronto-parietal network.	[Salazar, R. F.; Dotson, N. M.; Gray, C. M.] Montana State Univ, Bozeman, MT 59717 USA; [Bressler, S. L.] Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA	Montana State University System; Montana State University Bozeman; State University System of Florida; Florida Atlantic University	Gray, CM (corresponding author), Montana State Univ, Bozeman, MT 59717 USA.	cmgray@cns.montana.edu		Dotson, Nicholas/0000-0002-0885-2182; Salazar, Rodrigo/0000-0003-3530-666X	National Institute of Mental Health [MH069374, MH081162]; National Institute of Neurological Disorders and Stroke [NS059312]; Swiss National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH069374, R01MH081162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059312] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institute of Mental Health (MH069374, MH081162), the National Institute of Neurological Disorders and Stroke (NS059312), and the Swiss National Science Foundation. We thank B. Goodell for the design and development of the microdrive systems used in this study and U. Koster for technical support in the computational procedures. We also thank two anonymous reviewers for helpful comments on an earlier version of the manuscript.	ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; BRESSLER SL, 1995, BRAIN RES REV, V20, P288, DOI 10.1016/0165-0173(94)00016-I; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Chafee MV, 2000, J NEUROPHYSIOL, V83, P1550, DOI 10.1152/jn.2000.83.3.1550; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Deiber MP, 2007, J COGNITIVE NEUROSCI, V19, P158, DOI 10.1162/jocn.2007.19.1.158; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Hebb Donald O., 1949, ORG BEHAV; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Liebe S, 2012, NAT NEUROSCI, V15, P456, DOI 10.1038/nn.3038; Miller EK, 1996, J NEUROSCI, V16, P5154; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; QUINTANA J, 1989, BRAIN RES, V503, P100, DOI 10.1016/0006-8993(89)91709-5; Rainer G, 1998, P NATL ACAD SCI USA, V95, P15008, DOI 10.1073/pnas.95.25.15008; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Rottschy C, 2012, NEUROIMAGE, V60, P830, DOI 10.1016/j.neuroimage.2011.11.050; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; Verhoef BE, 2011, J NEUROPHYSIOL, V105, P2030, DOI 10.1152/jn.00924.2010; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836	31	237	240	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1097	1100		10.1126/science.1224000	http://dx.doi.org/10.1126/science.1224000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23118014	Green Accepted			2022-12-28	WOS:000311390600048
J	Gelfand, EW				Gelfand, Erwin W.			Mechanisms of Disease Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							IVIG-MEDIATED AMELIORATION; ANTIINFLAMMATORY ACTIVITY; THROMBOCYTOPENIC PURPURA; GAMMA-GLOBULIN; FC-RECEPTOR; RHEUMATOID-ARTHRITIS; ALZHEIMERS-DISEASE; THERAPEUTIC-USE; COPY NUMBER; MOUSE MODEL		Natl Jewish Hlth, Dept Pediat, Div Cell Biol, Denver, CO 80206 USA	National Jewish Health	Gelfand, EW (corresponding author), Natl Jewish Hlth, Dept Pediat, Div Cell Biol, 1400 Jackson St, Denver, CO 80206 USA.	gelfande@njhealth.org						Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Akilesh S, 2004, J CLIN INVEST, V113, P1328, DOI 10.1172/JCI200418838; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; AUKRUST P, 1994, BLOOD, V84, P2136; Basta M, 2008, MOL IMMUNOL, V45, P4073, DOI 10.1016/j.molimm.2008.07.012; BOND A, 1990, EUR J IMMUNOL, V20, P2229, DOI 10.1002/eji.1830201011; Bruhns P, 2003, IMMUNITY, V18, P573, DOI 10.1016/S1074-7613(03)00080-3; BUSSEL JB, 1991, BLOOD, V77, P1884; Caminschi I, 2006, INT IMMUNOL, V18, P741, DOI 10.1093/intimm/dxl011; Charmandari E, 2005, MOL ENDOCRINOL, V19, P52, DOI 10.1210/me.2004-0112; Chua I, 2011, J ALLERGY CLIN IMMUN, V127, P1410, DOI 10.1016/j.jaci.2011.01.035; Crow AR, 2003, BLOOD, V102, P558, DOI 10.1182/blood-2003-01-0023; DEBRE M, 1993, LANCET, V342, P945, DOI 10.1016/0140-6736(93)92000-J; Frank MM, 2000, IMMUNOL RES, V22, P137, DOI 10.1385/IR:22:2-3:137; GELFAND EW, 1993, CLIN INFECT DIS, V17, pS250; Gross KL, 2009, MOL CELL ENDOCRINOL, V300, P7, DOI 10.1016/j.mce.2008.10.001; Gupta M, 2001, J CLIN IMMUNOL, V21, P193, DOI 10.1023/A:1011039216251; Gutierrez-Roelens I, 2008, CURR MOL MED, V8, P551, DOI 10.2174/156652408785747906; Hansen RJ, 2002, THROMB HAEMOSTASIS, V88, P898, DOI 10.1055/s-0037-1613331; Hartung HP, 2009, CLIN EXP IMMUNOL, V158, P23, DOI [10.1111/j.1365-2249.2009.04024.X, 10.1111/j.1365-2249.2009.04024.x]; Hughes RAC, 2008, LANCET NEUROL, V7, P136, DOI 10.1016/S1474-4422(07)70329-0; HUIZINGA TWJ, 1990, BLOOD, V76, P1927; HULETT MD, 1994, ADV IMMUNOL, V57, P1, DOI 10.1016/S0065-2776(08)60671-9; Hurez V, 1994, Ther Immunol, V1, P269; IMBACH P, 1981, LANCET, V1, P1228; Jordan SC, 2009, CONTRIB NEPHROL, V162, P13, DOI 10.1159/000170864; Junghans RP, 1996, P NATL ACAD SCI USA, V93, P5512, DOI 10.1073/pnas.93.11.5512; KAM JC, 1993, J IMMUNOL, V151, P3460; Kaneko Y, 2006, J EXP MED, V203, P789, DOI 10.1084/jem.20051900; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kaveri S, 1996, J CLIN INVEST, V97, P865, DOI 10.1172/JCI118488; KAZATCHKINE MD, 1994, IMMUNOL REV, V139, P79, DOI 10.1111/j.1600-065X.1994.tb00858.x; Koene HR, 1998, BLOOD, V91, P673, DOI 10.1182/blood.V91.2.673.673_673_679; Laxer R M, 1987, Prog Clin Biol Res, V250, P175; Leontyev D, 2012, TRANSFUSION, V52, P1799, DOI 10.1111/j.1537-2995.2011.03517.x; Magga J, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-90; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; MARCHALONIS JJ, 1992, P NATL ACAD SCI USA, V89, P3325, DOI 10.1073/pnas.89.8.3325; Matsumoto A, 2000, J BIOCHEM-TOKYO, V128, P621, DOI 10.1093/oxfordjournals.jbchem.a022794; MIZUOCHI T, 1990, J IMMUNOL, V145, P1794; Modiano JF, 1997, CLIN IMMUNOL IMMUNOP, V83, P77, DOI 10.1006/clin.1997.4329; Negi VS, 2007, J CLIN IMMUNOL, V27, P233, DOI 10.1007/s10875-007-9088-9; NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601; Nimmerjahn F, 2008, ANNU REV IMMUNOL, V26, P513, DOI 10.1146/annurev.immunol.26.021607.090232; Oakley RH, 2011, J BIOL CHEM, V286, P3177, DOI 10.1074/jbc.R110.179325; Orange JS, 2006, J ALLERGY CLIN IMMUN, V117, pS525, DOI 10.1016/j.jaci.2006.01.015; Prasad NKA, 1998, J IMMUNOL, V161, P3781; Prins C, 2007, ACTA DERM-VENEREOL, V87, P206, DOI 10.2340/00015555-0249; RADEMACHER TW, 1994, P NATL ACAD SCI USA, V91, P6123, DOI 10.1073/pnas.91.13.6123; RAVETCH JV, 2003, FUNDAMENTAL IMMUNOLO, P685; Relkin N, 2010, NEUROLOGY, V75, P380; ROSSI F, 1989, J IMMUNOL, V143, P4104; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Scallon BJ, 2007, MOL IMMUNOL, V44, P1524, DOI 10.1016/j.molimm.2006.09.005; Schwab I, 2012, EUR J IMMUNOL, V42, P826, DOI 10.1002/eji.201142260; Siragam V, 2005, J CLIN INVEST, V115, P155, DOI 10.1172/JCI200522753; Spahn JD, 1999, J ALLERGY CLIN IMMUN, V103, P421, DOI 10.1016/S0091-6749(99)70466-5; Sylvestre D, 1996, J EXP MED, V184, P2385, DOI 10.1084/jem.184.6.2385; Tackenberg B, 2009, P NATL ACAD SCI USA, V106, P4788, DOI 10.1073/pnas.0807319106; TAKEI S, 1993, J CLIN INVEST, V91, P602, DOI 10.1172/JCI116240; Teeling JL, 2001, BLOOD, V98, P1095, DOI 10.1182/blood.V98.4.1095; VASSILEV T, 1993, CLIN EXP IMMUNOL, V92, P369; Viard I, 1998, SCIENCE, V282, P490, DOI 10.1126/science.282.5388.490; Willcocks LC, 2008, J EXP MED, V205, P1573, DOI 10.1084/jem.20072413; Yu ZY, 1999, NEW ENGL J MED, V340, P227, DOI 10.1056/NEJM199901213400311	66	312	328	4	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2012	367	21					2015	2025		10.1056/NEJMra1009433	http://dx.doi.org/10.1056/NEJMra1009433			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040RI	23171098				2022-12-28	WOS:000311340200009
J	Heath, I				Heath, Iona			Falling through the gaps in care	BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath22@yahoo.co.uk						Royal College of Physicians, HOSPITALS ON THE EDG	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 21	2012	345								e7863	10.1136/bmj.e7863	http://dx.doi.org/10.1136/bmj.e7863			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	044GW	23172944				2022-12-28	WOS:000311608500011
J	Greenwald, JL; McDermott, S; Dighe, AS				Greenwald, Jeffrey L.; McDermott, Shaunagh; Dighe, Anand S.			Case 35-2012: A 69-Year-Old Chronically Ill Man with Weakness, Anorexia, and Diffuse Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RENAL-TRANSPLANTATION; ADRENAL INSUFFICIENCY; DISEASE		[Greenwald, Jeffrey L.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Dighe, Anand S.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [McDermott, Shaunagh] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Greenwald, Jeffrey L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Dighe, Anand S.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [McDermott, Shaunagh] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Greenwald, JL (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Dighe, Anand/AAP-9640-2020	Dighe, Anand/0000-0003-4130-0758	Society of Hospital Medicine	Society of Hospital Medicine	Dr. Greenwald reports receiving grant support to his institution from the Society of Hospital Medicine. No other potential conflict of interest relevant to this article was reported.	Ardalan M, 2009, TRANSPL P, V41, P2915, DOI 10.1016/j.transproceed.2009.07.024; Boots JMM, 2002, TRANSPLANT P, V34, P1696, DOI 10.1016/S0041-1345(02)02987-1; Buell JF, 2005, TRANSPLANTATION, V80, pS254, DOI 10.1097/01.tp.0000186382.81130.ba; Committee on a National Research Agenda on Aging, 1991, EXT LIF ENH LIF NAT; Crowder CD, 2005, AM J TRANSPLANT, V5, P1151, DOI 10.1111/j.1600-6143.2005.00800.x; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; KENDALLTAYLOR P, 1983, BRIT MED J, V287, P705, DOI 10.1136/bmj.287.6394.705; Newstead CG, 2000, NEPHROL DIAL TRANSPL, V15, P1913, DOI 10.1093/ndt/15.12.1913; Silva DR, 2009, J BRAS PNEUMOL, V35, P179, DOI 10.1590/S1806-37132009000200012; Thomas MC, 2002, AM J KIDNEY DIS, V39, P354, DOI 10.1053/ajkd.2002.30556	10	0	0	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2012	367	20					1940	1948		10.1056/NEJMcpc1209437	http://dx.doi.org/10.1056/NEJMcpc1209437			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036MB	23150962				2022-12-28	WOS:000311029300012
J	Puwanant, S; Lohawijarn, W				Puwanant, Sarinya; Lohawijarn, Watchara			Hemolytic Anemia after Mitral-Valve Repair	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Puwanant, Sarinya; Lohawijarn, Watchara] Chulalongkorn Univ, Bangkok, Thailand	Chulalongkorn University	Puwanant, S (corresponding author), Chulalongkorn Univ, Bangkok, Thailand.	spuwanant@gmail.com							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2012	367	20					E29	E29		10.1056/NEJMicm1201695	http://dx.doi.org/10.1056/NEJMicm1201695			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036MB	23150979				2022-12-28	WOS:000311029300011
J	Palm-Meinders, IH; Koppen, H; Terwindt, GM; Launer, LJ; Konishi, J; Moonen, JME; Bakkers, JTN; Hofman, PAM; van Lew, B; Middelkoop, HAM; van Buchem, MA; Ferrari, MD; Kruit, MC				Palm-Meinders, Inge H.; Koppen, Hille; Terwindt, Gisela M.; Launer, Lenore J.; Konishi, Junya; Moonen, Juliette M. E.; Bakkers, Jacobus T. N.; Hofman, Paul A. M.; van Lew, Baldur; Middelkoop, Huub A. M.; van Buchem, Mark A.; Ferrari, Michel D.; Kruit, Mark C.			Structural Brain Changes in Migraine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WHITE-MATTER HYPERINTENSITIES; SMALL-VESSEL DISEASE; CARDIOVASCULAR-DISEASE; COGNITIVE FUNCTION; VERBAL FLUENCY; POPULATION; LESIONS; RISK; HEADACHE; INFARCTS	Context A previous cross-sectional study showed an association of migraine with a higher prevalence of magnetic resonance imaging (MRI)-measured ischemic lesions in the brain. Objective To determine whether women or men with migraine (with and without aura) have a higher incidence of brain lesions 9 years after initial MRI, whether migraine frequency was associated with progression of brain lesions, and whether progression of brain lesions was associated with cognitive decline. Design, Setting, and Participants In a follow-up of the 2000 Cerebral Abnormalities in Migraine, an Epidemiological Risk Analysis cohort, a prospective population-based observational study of Dutch participants with migraine and an age-and sex-matched control group, 203 of the 295 baseline participants in the migraine group and 83 of 140 in the control group underwent MRI scan in 2009 to identify progression of MRI-measured brain lesions. Comparisons were adjusted for age, sex, hypertension, diabetes, and educational level. The participants in the migraine group were a mean 57 years (range, 43-72 years), and 71% were women. Those in the control group were a mean 55 years (range, 44-71 years), and 69% were women. Main Outcome Measures Progression of MRI-measured cerebral deep white matter hyperintensities, infratentorial hyperintensities, and posterior circulation territory infarctlike lesions. Change in cognition was also measured. Results Of the 145 women in the migraine group, 112 (77%) vs 33 of 55 women (60%) in the control group had progression of deep white matter hyperintensities (adjusted odds ratio [OR], 2.1; 95% CI, 1.0-4.1; P = .04). There were no significant associations of migraine with progression of infratentorial hyperintensities: 21 participants (15%) in the migraine group and 1 of 57 participants (2%) in the control group showed progression (adjusted OR, 7.7; 95% CI, 1.0-59.5; P = .05) or new posterior circulation territory infarctlike lesions: 10 of 203 participants (5%) in the migraine group but none of 83 in the control group (P = .07). There was no association of number or frequency of migraine headaches with progression of lesions. There was no significant association of high vs nonhigh deep white matter hyperintensity load with change in cognitive scores (-3.7 in the migraine group vs 1.4 in the control group; 95% CI, -4.4 to 0.2; adjusted P = .07). Conclusions In a community-based cohort followed up after 9 years, women with migraine had a higher incidence of deep white matter hyperintensities but did not have significantly higher progression of other MRI-measured brain changes. There was no association of migraine with progression of any MRI-measured brain lesions in men. JAMA. 2012;308(18):1889-1897 www.jama.com	[Palm-Meinders, Inge H.; Konishi, Junya; Moonen, Juliette M. E.; van Buchem, Mark A.; Kruit, Mark C.] Leiden Univ, Med Ctr, Dept Radiol, NL-2300 RC Leiden, Netherlands; [van Lew, Baldur] Leiden Univ, Med Ctr, Div Image Proc, NL-2300 RC Leiden, Netherlands; [Koppen, Hille; Terwindt, Gisela M.; Ferrari, Michel D.] Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RC Leiden, Netherlands; [Middelkoop, Huub A. M.] Leiden Univ, Med Ctr, Dept Neuropsychol, NL-2300 RC Leiden, Netherlands; [Koppen, Hille] Haga Hosp, Dept Neurol, The Hague, Netherlands; [Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Bakkers, Jacobus T. N.] Slingeland Hosp, Dept Radiol, Doetinchem, Netherlands; [Hofman, Paul A. M.] Acad Hosp Maastricht, Dept Radiol, Maastricht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haga Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Maastricht University; Maastricht University Medical Centre (MUMC)	Kruit, MC (corresponding author), Leiden Univ, Med Ctr, Dept Radiol, POB 9600, NL-2300 RC Leiden, Netherlands.	m.c.kruit@lumc.nl	van Buchem, Mark/AAC-9843-2022; Ferrari, Michel D./ABE-3758-2021; Kruit, Mark C/K-2431-2012	van Buchem, Mark/0000-0003-1881-1998; Ferrari, Michel D./0000-0001-9691-9449; Kruit, Mark C/0000-0002-4319-834X; Dichgans, Martin/0000-0002-0654-387X	Almirall; Coherex; Colucid; Eisai; GlaxoSmithKline; Linde; MAP; Medtronic; Menarini; Merck; Minster; Pfizer; St Jude; National Institutes of Health [1R01NS061382-01]; Netherlands Heart Foundation [2007B016]; Netherlands Organisation for Scientific Research [903-52-291, VICI 918-56-602]; National Institute on Aging [907-00-217, Vidi 917-11-319]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061382] Funding Source: NIH RePORTER	Almirall(Almirall); Coherex; Colucid; Eisai(Eisai Co Ltd); GlaxoSmithKline(GlaxoSmithKline); Linde; MAP; Medtronic(Medtronic); Menarini(Menarini Group); Merck(Merck & Company); Minster; Pfizer(Pfizer); St Jude(St. Jude Medical); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Ferrari reported receiving grants and consultancy or industry support from Almirall, Coherex, Colucid, Eisai, GlaxoSmithKline, Linde, MAP, Medtronic, Menarini, Merck, Minster, Pfizer, and St Jude, and independent support from the Netherlands Organisation for Scientific Research (NOW). Dr Terwindt reported receiving consultancy support from Merck, Janssen-Cilag, Almirall, and Menarini. Dr Koppen reported consultancy or industry support from Allergan, Benecke congres, Pfizer, and In circulation website. The other authors reported no financial disclosures.; This work was supported by grants 1R01NS061382-01 from the National Institutes of Health, 2007B016 from the Netherlands Heart Foundation, and 903-52-291, VICI 918-56-602, and Spinoza 2009 from the Netherlands Organisation for Scientific Research, and 907-00-217 and Vidi 917-11-319 from the Intramural Research Program at the National Institute on Aging.	Bigal ME, 2010, NEUROLOGY, V74, P628, DOI 10.1212/WNL.0b013e3181d0cc8b; Buyck JF, 2009, STROKE, V40, P2327, DOI 10.1161/STROKEAHA.109.548222; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Dufouil C, 2001, NEUROLOGY, V56, P921, DOI 10.1212/WNL.56.7.921; Ferrari MD, 1998, LANCET, V351, P1043, DOI 10.1016/S0140-6736(97)11370-8; Kruit MC, 2006, STROKE, V37, P1109, DOI 10.1161/01.STR.0000206446.26702.e9; Kruit MC, 2005, BRAIN, V128, P2068, DOI 10.1093/brain/awh542; Kruit MC, 2004, JAMA-J AM MED ASSOC, V291, P427, DOI 10.1001/jama.291.4.427; Kurth T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7357; Kurth Tobias, 2006, Curr Pain Headache Rep, V10, P214, DOI 10.1007/s11916-006-0048-5; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Le Pira F, 2004, FUNCT NEUROL, V19, P101; Lee ST, 2008, NEUROLOGY, V70, P1510, DOI 10.1212/01.wnl.0000294329.93565.94; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Meyer JS, 2000, HEADACHE, V40, P638, DOI 10.1046/j.1526-4610.2000.040008638.x; MILLER E, 1984, BRIT J CLIN PSYCHOL, V23, P53, DOI 10.1111/j.2044-8260.1984.tb00626.x; Mulder EJCM, 1999, CEPHALALGIA, V19, P557, DOI 10.1046/j.1468-2982.1999.019006557.x; O'Bryant SE, 2006, HEADACHE, V46, P1364, DOI 10.1111/j.1526-4610.2006.00579.x; Prins ND, 2005, BRAIN, V128, P2034, DOI 10.1093/brain/awh553; Rey A, 1985, EXAMIN CLIN PSYCHOL; Scher AI, 2006, ANN NEUROL, V59, P372, DOI 10.1002/ana.20755; Scher AI, 2009, JAMA-J AM MED ASSOC, V301, P2563, DOI 10.1001/jama.2009.932; Schurks M, 2010, HEADACHE, V50, P588, DOI 10.1111/j.1526-4610.2009.01570.x; Schurks M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3914; Schwedt TJ, 2008, CEPHALALGIA, V28, P531, DOI 10.1111/j.1468-2982.2008.01554.x; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tietjen GE, 2009, STROKE, V40, P2977, DOI 10.1161/STROKEAHA.109.547901; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Van der Elst W, 2006, J INT NEUROPSYCH SOC, V12, P80, DOI 10.1017/S1355617706060115; van der Flier WM, 2005, STROKE, V36, P2116, DOI 10.1161/01.STR.0000179092.59909.42; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2; Waldie KE, 2002, NEUROLOGY, V59, P904, DOI 10.1212/WNL.59.6.904; Wechsler D., 2010, WAIS R MANUAL, VUK 4th Edn; Wolf ME, 2011, NEUROLOGY, V76, P1911, DOI 10.1212/WNL.0b013e31821d74d5	35	137	144	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1889	1897		10.1001/jama.2012.14276	http://dx.doi.org/10.1001/jama.2012.14276			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23150008	Green Accepted			2022-12-28	WOS:000310952700025
J	Downs, J				Downs, Jim			The art of medicine Emancipation, sickness, and death in the American Civil War	LANCET			English	Editorial Material									Connecticut Coll, Dept Hist, New London, CT 06320 USA	Connecticut College	Downs, J (corresponding author), Connecticut Coll, Dept Hist, New London, CT 06320 USA.	jdowns@conncoll.edu						David W, 2001, BLIGHT RACE AND REUN; Downs Jim, 2012, SICK FROM FREEDOM AF; Fabian Ann, 2010, THE SKULL COLLECTORS; Faust D., 2008, THIS REPUBLIC OF SUF; Nelson Megan Kate, 2012, RUIN NATION DESTRUCT	5	1	1	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 10	2012	380	9854					1640	1641		10.1016/S0140-6736(12)61937-0	http://dx.doi.org/10.1016/S0140-6736(12)61937-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	035MN	23162826	Bronze			2022-12-28	WOS:000310951400013
J	Fasullo, JT; Trenberth, KE				Fasullo, John T.; Trenberth, Kevin E.			A Less Cloudy Future: The Role of Subtropical Subsidence in Climate Sensitivity	SCIENCE			English	Article							TEMPERATURE; FEEDBACKS	An observable constraint on climate sensitivity, based on variations in mid-tropospheric relative humidity (RH) and their impact on clouds, is proposed. We show that the tropics and subtropics are linked by teleconnections that induce seasonal RH variations that relate strongly to albedo (via clouds), and that this covariability is mimicked in a warming climate. A present-day analog for future trends is thus identified whereby the intensity of subtropical dry zones in models associated with the boreal monsoon is strongly linked to projected cloud trends, reflected solar radiation, and model sensitivity. Many models, particularly those with low climate sensitivity, fail to adequately resolve these teleconnections and hence are identifiably biased. Improving model fidelity in matching observed variations provides a viable path forward for better predicting future climate.	[Fasullo, John T.; Trenberth, Kevin E.] Natl Ctr Atmospher Res, Boulder, CO 80305 USA	National Center Atmospheric Research (NCAR) - USA	Fasullo, JT (corresponding author), Natl Ctr Atmospher Res, Boulder, CO 80305 USA.	fasullo@ucar.edu	Trenberth, Kevin Edward/A-5683-2012; Keyes, Dennis/AAZ-9285-2021; Fasullo, John/H-4552-2019	Trenberth, Kevin Edward/0000-0002-1445-1000; Fasullo, John/0000-0003-1216-892X	National Science Foundation; NASA [NNX09AH89G]	National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	NCAR is sponsored by the National Science Foundation. This work was supported by NASA award NNX09AH89G. Support of the CMIP data sets is provided by the Office of Science, U.S. Department of Energy. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modeling groups for producing and making available their model output.	Bender FAM, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/1/014001; Bony S, 2004, CLIM DYNAM, V22, P71, DOI 10.1007/s00382-003-0369-6; Clement AC, 2009, SCIENCE, V325, P460, DOI 10.1126/science.1171255; Dessler AE, 2010, SCIENCE, V330, P1523, DOI 10.1126/science.1192546; Dufresne JL, 2008, J CLIMATE, V21, P5135, DOI 10.1175/2008JCLI2239.1; Knutti R, 2008, NAT GEOSCI, V1, P735, DOI 10.1038/ngeo337; Lu J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028443; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Posselt DJ, 2012, J CLIMATE, V25, P557, DOI 10.1175/2011JCLI4167.1; Richter I, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010561; Scheff J, 2012, J CLIMATE, V25, P4330, DOI 10.1175/JCLI-D-11-00393.1; Soden BJ, 2006, J CLIMATE, V19, P3354, DOI 10.1175/JCLI3799.1; Trenberth Kevin E, 2002, Science, V296, P2095; Trenberth KE, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037527; Volodin EM, 2008, IZV ATMOS OCEAN PHY+, V44, P288, DOI 10.1134/S0001433808030043; Zelinka MD, 2012, J CLIMATE, V25, P3736, DOI 10.1175/JCLI-D-11-00249.1	16	122	123	1	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2012	338	6108					792	794		10.1126/science.1227465	http://dx.doi.org/10.1126/science.1227465			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139331				2022-12-28	WOS:000310839500042
J	Sittig, DF; Singh, H				Sittig, Dean F.; Singh, Hardeep			Electronic Health Records and National Patient-Safety Goals	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ORDER ENTRY SYSTEMS; INFORMATION-TECHNOLOGY; ADVERSE EVENTS; FOLLOW-UP; ERRORS; CARE; IMPLEMENTATION; LESSONS; ALERTS; ISSUES		[Sittig, Dean F.] Univ Texas Hlth Sci Ctr, Sch Biomed Informat, Univ Texas Mem Hermann Ctr Healthcare Qual & Safe, Houston, TX 77225 USA; [Singh, Hardeep] Michael E DeBakey VA Med Ctr, Houston VA Hlth Serv Res & Dev Ctr Excellence, Houston, TX USA; [Singh, Hardeep] Michael E DeBakey VA Med Ctr, Houston VA Patient Safety Ctr Inquiry, Houston, TX USA; [Singh, Hardeep] Baylor Coll Med, Dept Med, Sect Hlth Serv Res, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Sittig, DF (corresponding author), Univ Texas Hlth Sci Ctr, Sch Biomed Informat, Univ Texas Mem Hermann Ctr Healthcare Qual & Safe, Houston, TX 77225 USA.		Sittig, Dean F./D-2471-2009	Sittig, Dean F./0000-0001-5811-8915	AHRQ HHS [R18HS017820, R18 HS017820] Funding Source: Medline; NCI NIH HHS [K23CA125585, K23 CA125585] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS017820] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K23CA125585] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adelman J.S., 2012, J AM MED INFORM ASS; [Anonymous], 2007, CCHIT CERT AMB EHR 2; [Anonymous], CERT HTLH IT PROD LI; [Anonymous], 2011, MENLO REPORT ETHICAL; [Anonymous], 2012, CERT HLTH IT PROD LI; ASHP Section of Pharmacy Informatics and Technology, 2011, Am J Health Syst Pharm, V68, pe9, DOI 10.2146/sp100011e; Blumenthal D, 2007, NEW ENGL J MED, V356, P2527, DOI 10.1056/NEJMhpr066212; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Blumenthal D, 2009, NEW ENGL J MED, V360, P1477, DOI 10.1056/NEJMp0901592; Classen DC, 2008, J PATIENT SAF, V4, P169, DOI [DOI 10.1097/PTS.0B013E318183A475, 10.1097/pts.0b013e318183a475]; Department of Health and Human Services, 2012, FED REGISTER, V77, P54163; Gandhi TK, 2011, NEW ENGL J MED, V365, P486, DOI 10.1056/NEJMp1106313; Gardner RM, 2009, J AM MED INFORM ASSN, V16, P153, DOI 10.1197/jamia.M3045; Griffin FA, 2008, QUAL SAF HEALTH CARE, V17, P253, DOI 10.1136/qshc.2007.025080; Hamblin JF, 2010, ELECT J HLTH INFORM, V5, P2010; Hamblin JF, 2010, ELECTRON J HEALTH IN, V5; Harrington L, 2011, J HEALTHC MANAG, V56, P31, DOI 10.1097/00115514-201101000-00006; Haynes K, 2011, J AM MED INFORM ASSN, V18, P164, DOI 10.1136/jamia.2009.002998; HealthCare.gov, PARTN PAT BETT CAR L; Institute of Medicine, 2012, HLTH IT PAT SAF BUIL; Jha AK, 2011, NEW ENGL J MED, V365, P1756, DOI 10.1056/NEJMp1109398; Kahn J, 2012, MEDICARE MEDICAID EH; Kilbridge P, 2003, NEW ENGL J MED, V348, P881, DOI 10.1056/NEJMp030010; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Kulikowski CA, 2012, J AM MED INFORM ASS; Kuperman GJ, 1999, J AM MED INFORM ASSN, V6, P512, DOI 10.1136/jamia.1999.0060512; Kuperman GJ, 2003, J BIOMED INFORM, V36, P70, DOI 10.1016/S1532-0464(03)00063-7; Lin CP, 2008, J AM MED INFORM ASSN, V15, P620, DOI 10.1197/jamia.M2453; Magrabi F, 2012, J AM MED INFORM ASSN, V19, P45, DOI 10.1136/amiajnl-2011-000369; McCoy AB, 2012, J AM MED INFORM ASSN, V19, P346, DOI 10.1136/amiajnl-2011-000185; Myers RB, 2011, APPL CLIN INFORM, V2, P63, DOI 10.4338/ACI-2010-11-RA-0064; National Public radio, 2010, ANT PROGR UPD WREAKS; Nwulu U, 2012, EUR J CLIN PHARM; Osheroff JA, 2012, IMPROVING OUTCOMES C, DOI 10.4324/9781498757461; Patel N, 2010, BOTCHED MCAFEE UPDAT; Paterno MD, 2009, J AM MED INFORM ASSN, V16, P40, DOI 10.1197/jamia.M2808; Perrow C., 1999, NORMAL ACCIDENTS LIV; Phansalkar S, 2012, J AM MED INFORM ASS; Powsner SM, 1998, LANCET, V352, P1617, DOI 10.1016/S0140-6736(98)08309-3; Radecki RP, 2011, JAMA-J AM MED ASSOC, V306, P92, DOI 10.1001/jama.2011.937; Shojania KG, 2010, JT COMM J QUAL PATIE, V36, P399, DOI 10.1016/S1553-7250(10)36058-2; Singh H, 2011, J PATIENT SAF, V7, P169, DOI 10.1097/PTS.0b013e31823d8df0; Singh H, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-49; Singh H, 2009, ARCH INTERN MED, V169, P1578, DOI 10.1001/archinternmed.2009.263; Singh H, 2009, ARCH INTERN MED, V169, P982, DOI 10.1001/archinternmed.2009.102; Sittig DF, 2006, PEDIATRICS, V118, P797, DOI 10.1542/peds.2005-3132; Sittig Dean F, 2007, AMIA Annu Symp Proc, P671; Sittig DF, 2012, CAN MED ASSOC J, V184, P1479, DOI 10.1503/cmaj.111599; Sittig DF, 2011, ARCH INTERN MED, V171, P1281, DOI 10.1001/archinternmed.2011.327; Sittig DF, 2010, QUAL SAF HEALTH CARE, V19, pI68, DOI 10.1136/qshc.2010.042085; Sittig DF, 2009, PEDIATRICS, V124, P375, DOI 10.1542/peds.2009-0339; Warm D, 2012, APPL CLIN INFORM, V3, P248, DOI 10.4338/ACI-2012-03-RA-0010; Wetterneck TB, 2011, J AM MED INFORM ASSN, V18, P774, DOI 10.1136/amiajnl-2011-000255; WRIGHT A, 2011, COMMUN ACM, V54, P18; Wright A, 2007, J AM MED INFORM ASSN, V14, P489, DOI 10.1197/jamia.M2364; Wright A, 2012, INT J MED INFORM, V81, P733, DOI 10.1016/j.ijmedinf.2012.04.003	56	119	121	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2012	367	19					1854	1860		10.1056/NEJMsb1205420	http://dx.doi.org/10.1056/NEJMsb1205420			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033DG	23134389	Green Accepted			2022-12-28	WOS:000310773200019
J	Sesso, HD; Christen, WG; Bubes, V; Smith, JP; MacFadyen, J; Schvartz, M; Manson, JE; Glynn, RJ; Buring, JE; Gaziano, JM				Sesso, Howard D.; Christen, William G.; Bubes, Vadim; Smith, Joanne P.; MacFadyen, Jean; Schvartz, Miriam; Manson, JoAnn E.; Glynn, Robert J.; Buring, Julie E.; Gaziano, J. Michael			Multivitamins in the Prevention of Cardiovascular Disease in Men The Physicians' Health Study II Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-TERM SUPPLEMENTATION; CORONARY-HEART-DISEASE; BETA-CAROTENE; VITAMIN-E; B-VITAMINS; MYOCARDIAL-INFARCTION; ALPHA-TOCOPHEROL; VEGETABLE INTAKE; WOMENS HEALTH; FOLIC-ACID	Context Although multivitamins are used to prevent vitamin and mineral deficiency, there is a perception that multivitamins may prevent cardiovascular disease (CVD). Observational studies have shown inconsistent associations between regular multivitamin use and CVD, with no long-term clinical trials of multivitamin use. Objective To determine whether long-term multivitamin supplementation decreases the risk of major cardiovascular events among men. Design, Setting, and Participants The Physicians' Health Study II, a randomized, double-blind, placebo-controlled trial of a common daily multivitamin, began in 1997 with continued treatment and follow-up through June 1, 2011. A total of 14 641 male US physicians initially aged 50 years or older (mean, 64.3 [SD, 9.2] years), including 754 men with a history of CVD at randomization, were enrolled. Intervention Daily multivitamin or placebo. Main Outcome Measures Composite end point of major cardiovascular events, including nonfatal myocardial infarction (MI), nonfatal stroke, and CVD mortality. Secondary outcomes included MI and stroke individually. Results During a median follow-up of 11.2 (interquartile range, 10.7-13.3) years, there were 1732 confirmed major cardiovascular events. Compared with placebo, there was no significant effect of a daily multivitamin on major cardiovascular events (11.0 and 10.8 events per 1000 person-years for multivitamin vs placebo, respectively; hazard ratio [HR], 1.01; 95% CI, 0.91-1.10; P=.91). Further, a daily multivitamin had no effect on total MI (3.9 and 4.2 events per 1000 person-years; HR, 0.93; 95% CI, 0.80-1.09; P=.39), total stroke (4.1 and 3.9 events per 1000 person-years; HR, 1.06; 95% CI, 0.91-1.23; P=.48), or CVD mortality (5.0 and 5.1 events per 1000 person-years; HR, 0.95; 95% CI, 0.83-1.09; P=.47). A daily multivitamin was also not significantly associated with total mortality (HR, 0.94; 95% CI, 0.88-1.02; P=.13). The effect of a daily multivitamin on major cardiovascular events did not differ between men with or without a baseline history of CVD (P=.62 for interaction). Conclusion Among this population of US male physicians, taking a daily multivitamin did not reduce major cardiovascular events, MI, stroke, and CVD mortality after more than a decade of treatment and follow-up.	[Sesso, Howard D.; Christen, William G.; Bubes, Vadim; Smith, Joanne P.; MacFadyen, Jean; Schvartz, Miriam; Manson, JoAnn E.; Glynn, Robert J.; Buring, Julie E.; Gaziano, J. Michael] Brigham & Womens Hosp, Div Prevent Med, Dept Med, Boston, MA 02215 USA; [Sesso, Howard D.; Buring, Julie E.; Gaziano, J. Michael] Brigham & Womens Hosp, Div Aging, Dept Med, Boston, MA 02215 USA; [Gaziano, J. Michael] Brigham & Womens Hosp, Div Cardiovasc Dis, Dept Med, Boston, MA 02215 USA; [Buring, Julie E.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; [Sesso, Howard D.; Manson, JoAnn E.; Buring, Julie E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Glynn, Robert J.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Gaziano, J. Michael] VA Boston Healthcare Ctr, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Sesso, HD (corresponding author), Brigham & Womens Hosp, Div Prevent Med, Dept Med, 900 Commonwealth Ave E,3rd Floor, Boston, MA 02215 USA.	hsesso@hsph.harvard.edu			NIH (Bethesda, Maryland) [CA 097193, CA 34944, CA 40360, HL 26490, HL 34595]; BASF Corporation (Florham Park, New Jersey); Tomato Products Wellness Council; National Institutes of Health (NIH); Cambridge Theranostics Ltd.; Harvard University (Clinical Nutrition Research Center); DSM Nutritional Products Inc; nonprofit Aurora Foundation; Bristol-Meyers Squibb; AstraZeneca; Novartis; Veterans Administration; BASF Corporation; NATIONAL CANCER INSTITUTE [R01CA040360, R01CA097193] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595] Funding Source: NIH RePORTER	NIH (Bethesda, Maryland)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BASF Corporation (Florham Park, New Jersey)(BASF); Tomato Products Wellness Council; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cambridge Theranostics Ltd.; Harvard University (Clinical Nutrition Research Center); DSM Nutritional Products Inc; nonprofit Aurora Foundation; Bristol-Meyers Squibb(Bristol-Myers Squibb); AstraZeneca(AstraZeneca); Novartis(Novartis); Veterans Administration(US Department of Veterans Affairs); BASF Corporation(BASF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Sesso reported receiving investigator-initiated research funding from the National Institutes of Health (NIH), the Tomato Products Wellness Council, and Cambridge Theranostics Ltd. Dr Christen reported receiving research funding support from the NIH, Harvard University (Clinical Nutrition Research Center), and DSM Nutritional Products Inc (formerly Roche Vitamins). Dr Manson reported receiving investigator-initiated research funding from the NIH; assistance with study pills and packaging from BASF and Cognis Corporations for the Women's Antioxidant and Folic Acid Cardiovascular Study and from Pronova BioPharma and Pharmavite for the VITamin D and OmegA-3 TriaL; and funding from the nonprofit Aurora Foundation. Dr Glynn reported receiving investigator-initiated research funding from the NIH, Bristol-Meyers Squibb, AstraZeneca, and Novartis, and signing a consulting agreement with Merck to give an invited talk. Dr Buring reported receiving investigator-initiated research funding from the NIH and assistance with study pills and packaging from Natural Source Vitamin E Association and Bayer Healthcare for the Women's Health Study. Dr Gaziano reported receiving investigator-initiated research funding from the NIH, the Veterans Administration, and BASF Corporation to assist in the establishment of this trial cohort; assistance with study agents and packaging from BASF Corporation and Pfizer (formerly Wyeth, American Home Products, and Lederle); and assistance with study packaging provided by DSM Nutritional Products Inc (formerly Roche Vitamins). No other authors reported disclosures.; This study was supported by grants CA 097193, CA 34944, CA 40360, HL 26490, and HL 34595 from the NIH (Bethesda, Maryland) and an investigator-initiated grant from BASF Corporation (Florham Park, New Jersey). Study agents and packaging were provided by BASF Corporation and Pfizer (formerly Wyeth, American Home Products, and Lederle) (New York, New York), and study packaging was provided by DSM Nutritional Products Inc (formerly Roche Vitamins) (Parsippany, New Jersey).	Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; Bailey RL, 2011, J NUTR, V141, P261, DOI 10.3945/jn.110.133025; Berger K, 1996, STROKE, V27, P238, DOI 10.1161/01.STR.27.2.238; Blendon RJ, 2001, ARCH INTERN MED, V161, P805, DOI 10.1001/archinte.161.6.805; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Clarke R, 2010, ARCH INTERN MED, V170, P1622, DOI 10.1001/archinternmed.2010.348; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Cook NR, 2007, ARCH INTERN MED, V167, P1610, DOI 10.1001/archinte.167.15.1610; Ervin RB, 1999, VITAL HLTH STAT, V11, p[i, 1]; ESTERBAUER H, 1992, FREE RADICAL BIO MED, V13, P341, DOI 10.1016/0891-5849(92)90181-F; Gahche Jamie, 2011, NCHS Data Brief, P1; Gaziano JM, 2012, JAMA-J AM MED ASSOC, V308, P1871, DOI 10.1001/jama.2012.14641; Gaziano JM, 2009, JAMA-J AM MED ASSOC, V301, P52, DOI 10.1001/jama.2008.862; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Holmquist C, 2003, J NUTR, V133, P2650, DOI 10.1093/jn/133.8.2650; Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; Joshipura KJ, 2009, PUBLIC HEALTH NUTR, V12, P115, DOI 10.1017/S1368980008002036; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; Joshipura KJ, 2001, ANN INTERN MED, V134, P1106, DOI 10.7326/0003-4819-134-12-200106190-00010; KEANEY JF, 1993, P NATL ACAD SCI USA, V90, P11880, DOI 10.1073/pnas.90.24.11880; Lee IM, 1999, J NATL CANCER I, V91, P2102, DOI 10.1093/jnci/91.24.2102; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Leppala JM, 2000, ARTERIOSCL THROM VAS, V20, P230, DOI 10.1161/01.ATV.20.1.230; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; Mabile L, 1999, ATHEROSCLEROSIS, V147, P177, DOI 10.1016/S0021-9150(99)00169-0; McGinnis JM, 2006, ANN INTERN MED, V145, P364, DOI 10.7326/0003-4819-145-5-200609050-00136; Mehta J, 1999, J NUTR, V129, P109, DOI 10.1093/jn/129.1.109; Morris MC, 2011, JAMA-J AM MED ASSOC, V305, P1348, DOI 10.1001/jama.2011.383; Muntwyler J, 2002, ARCH INTERN MED, V162, P1472, DOI 10.1001/archinte.162.13.1472; Muth M.K., 1999, EC CHARACTERIZATION; Neuhouser ML, 2009, ARCH INTERN MED, V169, P294, DOI 10.1001/archinternmed.2008.540; Osganian SK, 2003, J AM COLL CARDIOL, V42, P246, DOI 10.1016/S0735-1097(03)00575-8; Paolisso G, 2000, J CLIN ENDOCR METAB, V85, P109, DOI 10.1210/jc.85.1.109; Park SY, 2011, AM J EPIDEMIOL, V173, P906, DOI 10.1093/aje/kwq447; Rautiainen S, 2010, AM J CLIN NUTR, V92, P1251, DOI 10.3945/ajcn.2010.29371; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; SATTERFIELD S, 1990, AM J PREV MED, V6, P290, DOI 10.1016/S0749-3797(18)30997-8; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Timbo BB, 2006, J AM DIET ASSOC, V106, P1966, DOI 10.1016/j.jada.2006.09.002; U.S. Department of Agriculture U.S. Department of Health and Human Services, 2010, REP DIET GUID ADV CO; Walker AE, 1981, STROKE S1, V12, P13; Watkins ML, 2000, AM J EPIDEMIOL, V152, P149, DOI 10.1093/aje/152.2.149	48	114	120	0	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1751	1760		10.1001/jama.2012.14805	http://dx.doi.org/10.1001/jama.2012.14805			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117775	Bronze, Green Accepted			2022-12-28	WOS:000310726500021
J	Navaratnam, AV; Ball, S; Emerson, C; Eckersley, R				Navaratnam, Annakan V.; Ball, Simon; Emerson, Claire; Eckersley, Rupert			Perilunate dislocation	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Navaratnam, Annakan V.; Ball, Simon; Emerson, Claire; Eckersley, Rupert] Chelsea & Westminster Hosp, London SW10 9NH, England	Imperial College London	Navaratnam, AV (corresponding author), Chelsea & Westminster Hosp, London SW10 9NH, England.	annakan.navaratnam04@imperial.ac.uk	Therattil, Paul/AAT-3797-2020	Therattil, Paul/0000-0002-3106-7246				Dhillon MS, 2011, INDIAN J ORTHOP, V45, P427, DOI 10.4103/0019-5413.83138; Divecha HM, 2011, J ORTHOP TRAUMATOL, V12, P159, DOI 10.1007/s10195-011-0143-1; GILULA LA, 1984, CLIN ORTHOP RELAT R, P52; Grabow RJ, 2006, HAND CLIN, V22, P485, DOI 10.1016/j.hcl.2006.07.004; Komurcu M, 2008, J ORTHOP TRAUMA, V22, P535, DOI 10.1097/BOT.0b013e318183eb23; Lal H, 2012, INDIAN J ORTHOP, V46, P351, DOI 10.4103/0019-5413.90427; Ramamoorthy EN, 2011, SURG-J R COLL SURG E, V9, P356, DOI 10.1016/j.surge.2010.11.026; Shinohara T, 2011, ACTA ORTHOP BELG, V77, P765; Weil WM, 2006, CLIN ORTHOP RELAT R, P120, DOI 10.1097/01.blo.0000205889.11824.03; WITVOET J, 1973, REV CHIR ORTHOP, V59, P98	10	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 6	2012	345								e7026	10.1136/bmj.e7026	http://dx.doi.org/10.1136/bmj.e7026			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	036LE	23131669				2022-12-28	WOS:000311026600016
J	Bollyky, TJ; Bollyky, PL				Bollyky, Thomas J.; Bollyky, Paul L.			Obama and the Promotion of International Science	SCIENCE			English	Editorial Material									[Bollyky, Thomas J.] Council Foreign Relat, Washington, DC 20006 USA; [Bollyky, Paul L.] Univ Washington, Div Allergy & Infect Dis, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Bollyky, TJ (corresponding author), Council Foreign Relat, Washington, DC 20006 USA.	tbollyky@cfr.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI101984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096087] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL113294] Funding Source: Medline; NIAID NIH HHS [U01 AI101984] Funding Source: Medline; NIDDK NIH HHS [R01 DK096087] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bollyky T. J., 2009, INTELLECTUAL PROPERT; Bollyky T. J., 2011, SAFER FASTER CHEAPER; Collins FS, 2010, SCIENCE, V330, P1324, DOI 10.1126/science.1199930; Frehill L. M., 2010, INT WORKSH INT SCI C; Global Attitudes Project Pew Research Center, 2012, GLOB OP OB SLIPS INT; Hormats R. D., 2012, SCI DIPLOMACY    MAR; Johnson V.C., 2009, VISA IMMIGRATION POL; Levine O, 2011, WASHINGTON POST; National Institute of Food and Agriculture, 2012, GLOB ENG NIFA FEED F; National Science Board, 2012, NAT SCI ENG IND 2012; OBAMA B, 2009, PRES NAT AC SCI ANN; Obama B, 2009, COMMUNICATION   0604; Shah R., 2012, COMMUNICATION   0928; Shah R., 2010, C SCI TECHN INN DEV; Stine D, 2009, SCI TECHNOLOGY AM DI; Suresh S, 2012, SCIENCE, V336, P959, DOI 10.1126/science.1224580; The Royal Society, 2011, KNOWL NETW NAT GLOB; U.S. Citizenship and Immigration Services, 2012, H 1B SPEC OCC DOD CO; USAID, 2012, USAID NAT SCI FDN EX; USAID, 2012, GRAND CHALL DEV; USDA, 2011, GRANTS INT SCI ED IS; Wagner CS, 2008, NEW INVISIBLE COLLEGE: SCIENCE FOR DEVELOPMENT, P1	22	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					610	612		10.1126/science.1230970	http://dx.doi.org/10.1126/science.1230970			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	029SM	23118171	Green Accepted			2022-12-28	WOS:000310516000032
J	Kainer, MA; Reagan, DR; Nguyen, DB; Wiese, AD; Wise, ME; Ward, J; Park, BJ; Kanago, ML; Baumblatt, J; Schaefer, MK; Berger, BE; Marder, EP; Min, JY; Dunn, JR; Smith, RM; Dreyzehner, J; Jones, TF				Kainer, Marion A.; Reagan, David R.; Nguyen, Duc B.; Wiese, Andrew D.; Wise, Matthew E.; Ward, Jennifer; Park, Benjamin J.; Kanago, Meredith L.; Baumblatt, Jane; Schaefer, Melissa K.; Berger, Brynn E.; Marder, Ellyn P.; Min, Jea-Young; Dunn, John R.; Smith, Rachel M.; Dreyzehner, John; Jones, Timothy F.		Tennessee Fungal Meningitis Invest	Fungal Infections Associated with Contaminated Methylprednisolone in Tennessee	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASPERGILLUS MENINGITIS; EPIDURAL ABSCESS; SRI-LANKA; OUTBREAK; EXSEROHILUM; PHEOHYPHOMYCOSIS; VORICONAZOLE; MANAGEMENT; INJECTION	Background We investigated an outbreak of fungal infections of the central nervous system that occurred among patients who received epidural or paraspinal glucocorticoid injections of preservative-free methylprednisolone acetate prepared by a single compounding pharmacy. Methods Case patients were defined as patients with fungal meningitis, posterior circulation stroke, spinal osteomyelitis, or epidural abscess that developed after epidural or paraspinal glucocorticoid injections. Clinical and procedure data were abstracted. A cohort analysis was performed. Results The median age of the 66 case patients was 69 years (range, 23 to 91). The median time from the last epidural glucocorticoid injection to symptom onset was 18 days (range, 0 to 56). Patients presented with meningitis alone (73%), the cauda equina syndrome or focal infection (15%), or posterior circulation stroke with or without meningitis (12%). Symptoms and signs included headache (in 73% of the patients), new or worsening back pain (in 50%), neurologic symptoms (in 48%), nausea (in 39%), and stiff neck (in 29%). The median cerebrospinal fluid white-cell count on the first lumbar puncture among patients who presented with meningitis, with or without stroke or focal infection, was 648 per cubic millimeter (range, 6 to 10,140), with 78% granulocytes (range, 0 to 97); the protein level was 114 mg per deciliter (range, 29 to 440); and the glucose concentration was 44 mg per deciliter (range, 12 to 121) (2.5 mmol per liter [range, 0.7 to 6.7]). A total of 22 patients had laboratory confirmation of Exserohilum rostratum infection (21 patients) or Aspergillus fumigatus infection (1 patient). The risk of infection increased with exposure to lot 06292012@26, older vials, higher doses, multiple procedures, and translaminar approach to epidural glucocorticoid injection. Voriconazole was used to treat 61 patients (92%); 35 patients (53%) were also treated with liposomal amphotericin B. Eight patients (12%) died, seven of whom had stroke. Conclusions We describe an outbreak of fungal meningitis after epidural or paraspinal glucocorticoid injection with methylprednisolone from a single compounding pharmacy. Rapid recognition of illness and prompt initiation of therapy are important to prevent complications. (Funded by the Tennessee Department of Health and the Centers for Disease Control and Prevention.)	[Kainer, Marion A.] Tennessee Dept Hlth, Div Communicable & Environm Dis & Emergency Prepa, Nashville, TN 37243 USA; [Nguyen, Duc B.; Wise, Matthew E.; Schaefer, Melissa K.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA USA; [Nguyen, Duc B.; Baumblatt, Jane; Smith, Rachel M.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Sci Educ & Profess Dev Program Off, Atlanta, GA USA; [Park, Benjamin J.; Smith, Rachel M.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA	Tennessee Department Health; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Kainer, MA (corresponding author), Tennessee Dept Hlth, Div Communicable & Environm Dis & Emergency Prepa, 1st Fl,Cordell Hull Bldg,425 5th Ave N, Nashville, TN 37243 USA.	marion.kainer@tn.gov	Wiese, Andrew D/U-9745-2017; Wiese, Andrew/D-2200-2019	Wiese, Andrew D/0000-0002-0699-4224; Wiese, Andrew/0000-0002-0699-4224; Kainer, Marion/0000-0001-7678-8744; Marder, Ellyn/0000-0003-3331-7920; Pepe, Dana/0000-0002-5519-4506	Tennessee Department of Health; Centers for Disease Control and Prevention [5U38HM000414-5]; Prevention and Public Health Fund: Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Building and Strengthening Epidemiology; Laboratory and Health Information Systems Capacity in State and Local Health Departments [3U5OCI000929-02S5]; Epidemiology and Laboratory Capacity for Infectious Diseases-Program Components [1U5OCK000211-01]; Emerging Infections Program [1U5OCK000198-01]; National Center for Preparedness, Detection, and Control of Infectious Diseases [U50CI000929] Funding Source: NIH RePORTER	Tennessee Department of Health; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Prevention and Public Health Fund: Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Building and Strengthening Epidemiology; Laboratory and Health Information Systems Capacity in State and Local Health Departments; Epidemiology and Laboratory Capacity for Infectious Diseases-Program Components; Emerging Infections Program; National Center for Preparedness, Detection, and Control of Infectious Diseases(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Supported by the Tennessee Department of Health, by an appointment to the Applied Epidemiology Fellowship Program administered by the Council of State and Territorial Epidemiologists and funded by the Centers for Disease Control and Prevention Cooperative Agreement 5U38HM000414-5, and by the Prevention and Public Health Fund 2012: Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Building and Strengthening Epidemiology, Laboratory and Health Information Systems Capacity in State and Local Health Departments Cooperative Agreement 3U5OCI000929-02S5; the Epidemiology and Laboratory Capacity for Infectious Diseases-Program Components Cooperative Agreement 1U5OCK000211-01; and the Emerging Infections Program Cooperative Agreement 1U5OCK000198-01 (all, Centers for Disease Control and Prevention).	Adler A, 2006, EUR J CLIN MICROBIOL, V25, P247, DOI 10.1007/s10096-006-0093-3; AGARWAL A, 1995, MYCOPATHOLOGIA, V131, P9, DOI 10.1007/BF01103898; Anderson Shoana, 2012, Morbidity and Mortality Weekly Report, V61, P501; Carrino JA, 2002, RADIOLOGY, V225, P723, DOI 10.1148/radiol.2253011401; Centers for Disease Control and Prevention, INT TREATM GUID CENT; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1109; Civen R, 2006, CLIN INFECT DIS, V43, P831, DOI 10.1086/507336; CLSI, 2008, MM18A CLSI; Food and Drug Administration, 2012, FDA FUNG MEN UPD 10; Frost BA, 2011, NEW ENGL J MED, V365, P2238, DOI 10.1056/NEJMc1105759; Gunaratne P. S., 2006, Ceylon Medical Journal, V51, P137; Gunaratne PS, 2007, NEW ENGL J MED, V356, P754, DOI 10.1056/NEJMc062547; Hooten WM, 2004, MAYO CLIN PROC, V79, P682, DOI 10.4065/79.5.682; Huang RC, 2004, SPINE, V29, pE7, DOI 10.1097/01.BRS.0000106764.40001.84; Jacobs F, 2012, EUR J CLIN MICROBIOL, V31, P1173, DOI 10.1007/s10096-011-1425-5; Jones TF, 2002, AM J MED, V112, P31, DOI 10.1016/S0002-9343(01)01032-4; Kainer Marion, 2012, Morbidity and Mortality Weekly Report, V61, P839; Kolbe ABL, 2007, ACTA RADIOL, V48, P687, DOI 10.1080/02841850701342153; Lai Chih-Cheng, 2008, Journal of Infection and Chemotherapy, V14, P77, DOI 10.1007/s10156-007-0595-7; LaSala PR, 2005, PEDIATR INFECT DIS J, V24, P939, DOI 10.1097/01.inf.0000180988.96528.5c; MCGINNIS MR, 1986, J CLIN MICROBIOL, V24, P250, DOI 10.1128/JCM.24.2.250-259.1986; McPherson TB, 2006, J AM PHARM ASSOC, V46, P568, DOI 10.1331/1544-3191.46.5.568.McPherson; Muijsers RBR, 2002, DRUGS, V62, P2655, DOI 10.2165/00003495-200262180-00010; NG TTC, 1994, MICROBIOL-UK, V140, P2475, DOI 10.1099/13500872-140-9-2475; Pettit AC, 2012, NEW ENGL J MED, V367, P2119, DOI 10.1056/NEJMoa1212292; Poluzzi E, 2010, DRUG SAFETY, V33, P303, DOI 10.2165/11531850-000000000-00000; Scott LJ, 2007, DRUGS, V67, P269, DOI 10.2165/00003495-200767020-00009; Sunenshine RH, 2007, CLIN INFECT DIS, V45, P527, DOI 10.1086/520664	28	119	120	1	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2012	367	23					2194	2203		10.1056/NEJMoa1212972	http://dx.doi.org/10.1056/NEJMoa1212972			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048DO	23131029	Green Accepted			2022-12-28	WOS:000311890600006
J	Choat, B; Jansen, S; Brodribb, TJ; Cochard, H; Delzon, S; Bhaskar, R; Bucci, SJ; Feild, TS; Gleason, SM; Hacke, UG; Jacobsen, AL; Lens, F; Maherali, H; Martinez-Vilalta, J; Mayr, S; Mencuccini, M; Mitchell, PJ; Nardini, A; Pittermann, J; Pratt, RB; Sperry, JS; Westoby, M; Wright, IJ; Zanne, AE				Choat, Brendan; Jansen, Steven; Brodribb, Tim J.; Cochard, Herve; Delzon, Sylvain; Bhaskar, Radika; Bucci, Sandra J.; Feild, Taylor S.; Gleason, Sean M.; Hacke, Uwe G.; Jacobsen, Anna L.; Lens, Frederic; Maherali, Hafiz; Martinez-Vilalta, Jordi; Mayr, Stefan; Mencuccini, Maurizio; Mitchell, Patrick J.; Nardini, Andrea; Pittermann, Jarmila; Pratt, R. Brandon; Sperry, John S.; Westoby, Mark; Wright, Ian J.; Zanne, Amy E.			Global convergence in the vulnerability of forests to drought	NATURE			English	Article							HYDRAULIC ARCHITECTURE; TROPICAL FORESTS; XYLEM CAVITATION; WOODY-PLANTS; RAIN-FOREST; DIE-OFF; WATER; VEGETATION; MORTALITY; EMBOLISM	Shifts in rainfall patterns and increasing temperatures associated with climate change are likely to cause widespread forest decline in regions where droughts are predicted to increase in duration and severity(1). One primary cause of productivity loss and plant mortality during drought is hydraulic failure(2-4). Drought stress creates trapped gas emboli in the water transport system, which reduces the ability of plants to supply water to leaves for photosynthetic gas exchange and can ultimately result in desiccation and mortality. At present we lack a clear picture of how thresholds to hydraulic failure vary across a broad range of species and environments, despite many individual experiments. Here we draw together published and unpublished data on the vulnerability of the transport system to drought-induced embolism for a large number of woody species, with a view to examining the likely consequences of climate change for forest biomes. We show that 70% of 226 forest species from 81 sites worldwide operate with narrow (<1 megapascal) hydraulic safety margins against injurious levels of drought stress and therefore potentially face long-term reductions in productivity and survival if temperature and aridity increase as predicted for many regions across the globe(5,6). Safety margins are largely independent of mean annual precipitation, showing that there is global convergence in the vulnerability of forests to drought, with all forest biomes equally vulnerable to hydraulic failure regardless of their current rainfall environment. These findings provide insight into why drought-induced forest decline is occurring not only in arid regions but also in wet forests not normally considered at drought risk(7,8).	[Jansen, Steven] Ulm Univ, Inst Systemat Bot & Ecol, D-89081 Ulm, Germany; [Choat, Brendan] Univ Western Sydney, Hawkesbury Inst Environm, Richmond, NSW 2753, Australia; [Brodribb, Tim J.] Univ Tasmania, Sch Plant Sci, Hobart, Tas 7001, Australia; [Cochard, Herve] INRA, PIAF UMR547, F-63100 Clermont Ferrand, France; [Delzon, Sylvain] Univ Bordeaux, INRA, UMR BIOGECO, F-33450 Talence, France; [Bhaskar, Radika] Brown Univ, Environm Change Initiat, Providence, RI 02912 USA; [Bucci, Sandra J.] Univ Nacl Patagonia San Juan Bosco, Dept Biol, Fac Ciencias Nat, RA-9000 Comodoro Rivadavia, Argentina; [Feild, Taylor S.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Gleason, Sean M.; Westoby, Mark; Wright, Ian J.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; [Hacke, Uwe G.] Univ Alberta, Dept Renewable Resources, Edmonton, AB T6G 2E3, Canada; [Jacobsen, Anna L.; Pratt, R. Brandon] Calif State Univ, Dept Biol, Bakersfield, CA 93311 USA; [Lens, Frederic] Leiden Univ, Nat Biodivers Ctr, NL-2300 RA Leiden, Netherlands; [Maherali, Hafiz] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Martinez-Vilalta, Jordi] CREAF, Cerdanyola Del Valles 08193, Spain; [Mencuccini, Maurizio] Univ Autonoma Barcelona, ICREA, CREAF, Cerdanyola Del Valles 08193, Spain; [Mayr, Stefan] Univ Innsbruck, Inst Bot, A-6020 Innsbruck, Austria; [Mencuccini, Maurizio] Univ Edinburgh, Sch GeoSci, Edinburgh EH9 3JN, Midlothian, Scotland; [Mitchell, Patrick J.] CSIRO, Sandy Bay, Tas 7005, Australia; [Nardini, Andrea] Univ Trieste, Dipartimento Sci Vita, I-34127 Trieste, Italy; [Pittermann, Jarmila] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Sperry, John S.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Zanne, Amy E.] Ctr Conservat & Sustainable Dev, Missouri Bot Garden, St Louis, MO 63166 USA; [Zanne, Amy E.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA	Ulm University; Western Sydney University; University of Tasmania; INRAE; INRAE; UDICE-French Research Universities; Universite de Bordeaux; Brown University; Universidad Nacional de la Patagonia San Juan Bosco; James Cook University; Macquarie University; University of Alberta; California State University System; California State University Bakersfield; Leiden University; Leiden University - Excl LUMC; Naturalis Biodiversity Center; University of Guelph; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); ICREA; University of Innsbruck; University of Edinburgh; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Trieste; University of California System; University of California Santa Cruz; Utah System of Higher Education; University of Utah; Missouri Botanical Gardens; George Washington University	Jansen, S (corresponding author), Ulm Univ, Inst Systemat Bot & Ecol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	steven.jansen@uni-ulm.de	Cochard, Hervé/P-7406-2015; Mitchell, Patrick/D-7454-2011; Wright, Ian J/G-4979-2012; Hacke, Uwe/M-7719-2015; Lens, Frederic/B-8482-2011; Martínez-Vilalta, Jordi/D-3385-2014; Dorman, Michael/F-7389-2010; Gleason, Sean M/AAZ-7685-2020; Mencuccini, Maurizio/B-9052-2011; Camarero, J. Julio/A-8602-2013; Jansen, Steven/A-9868-2012; Choat, Brendan/C-8445-2009; Brodribb, Timothy John/C-6797-2013; Nardini, Andrea/C-6525-2009; Delzon, Sylvain/R-9538-2018	Cochard, Hervé/0000-0002-2727-7072; Mitchell, Patrick/0000-0002-5016-7031; Wright, Ian J/0000-0001-8338-9143; Hacke, Uwe/0000-0001-5983-3582; Lens, Frederic/0000-0002-5001-0149; Martínez-Vilalta, Jordi/0000-0002-2332-7298; Mencuccini, Maurizio/0000-0003-0840-1477; Camarero, J. Julio/0000-0003-2436-2922; Jansen, Steven/0000-0002-4476-5334; Choat, Brendan/0000-0002-9105-640X; Brodribb, Timothy John/0000-0002-4964-6107; Delzon, Sylvain/0000-0003-3442-1711; Westoby, Mark/0000-0001-7690-4530; Bucci, Sandra Janet/0000-0003-1079-9277; Gleason, Sean/0000-0002-5607-4741; Jacobsen, Anna/0000-0001-7830-5590; Bhaskar, Radika/0000-0002-9191-3555; Mayr, Stefan/0000-0002-3319-4396	Alexander von Humboldt Foundation; NERC [NE/I011749/1] Funding Source: UKRI; ICREA Funding Source: Custom; Austrian Science Fund (FWF) [P 20852] Funding Source: researchfish; Natural Environment Research Council [NE/I011749/1] Funding Source: researchfish	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ICREA(ICREA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the ARC-NZ Vegetation Function Network for hosting the original working group from which the data set was compiled. We are grateful to the Alexander von Humboldt Foundation for supporting B.C. during preparation of the manuscript.	Alder NN, 1996, OECOLOGIA, V105, P293, DOI 10.1007/BF00328731; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Allison I, 2009, COPENHAGEN DIAGNOSIS; Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Brodersen CR, 2010, PLANT PHYSIOL, V154, P1088, DOI 10.1104/pp.110.162396; Brodribb TJ, 2010, NEW PHYTOL, V188, P533, DOI 10.1111/j.1469-8137.2010.03393.x; Brodribb TJ, 2009, PLANT PHYSIOL, V149, P575, DOI 10.1104/pp.108.129783; Choat B, 2005, TREES-STRUCT FUNCT, V19, P305, DOI 10.1007/s00468-004-0392-1; Delzon S, 2010, PLANT CELL ENVIRON, V33, P2101, DOI 10.1111/j.1365-3040.2010.02208.x; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Kursar TA, 2009, FUNCT ECOL, V23, P93, DOI 10.1111/j.1365-2435.2008.01483.x; Lamy JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023476; Lewis SL, 2006, PHILOS T R SOC B, V361, P195, DOI 10.1098/rstb.2005.1711; Maherali H, 2004, ECOLOGY, V85, P2184, DOI 10.1890/02-0538; Martinez-Vilalta J, 2004, PLANT ECOL, V171, P3, DOI 10.1023/B:VEGE.0000029378.87169.b1; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; Meinzer FC, 2009, FUNCT ECOL, V23, P922, DOI 10.1111/j.1365-2435.2009.01577.x; Meir P, 2010, NEW PHYTOL, V187, P553, DOI 10.1111/j.1469-8137.2010.03390.x; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Pockman WT, 2000, AM J BOT, V87, P1287, DOI 10.2307/2656722; POCKMAN WT, 1995, NATURE, V378, P715, DOI 10.1038/378715a0; Scholz FG, 2011, TREE PHYSIOL-NETH, V4, P341, DOI 10.1007/978-94-007-1242-3_13; Sperry JS, 2006, AM J BOT, V93, P1490, DOI 10.3732/ajb.93.10.1490; Sperry JS, 1998, PLANT CELL ENVIRON, V21, P347, DOI 10.1046/j.1365-3040.1998.00287.x; TYREE MT, 1989, ANNU REV PLANT PHYS, V40, P19, DOI 10.1146/annurev.pp.40.060189.000315; Wortemann R, 2011, TREE PHYSIOL, V31, P1175, DOI 10.1093/treephys/tpr101; Zhang XB, 2007, NATURE, V448, P461, DOI 10.1038/nature06025; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]	30	1502	1589	76	1638	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					752	+		10.1038/nature11688	http://dx.doi.org/10.1038/nature11688			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23172141	Green Published			2022-12-28	WOS:000311606000044
J	Ortiz, JL; Sicardy, B; Braga-Ribas, F; Alvarez-Candal, A; Lellouch, E; Duffard, R; Pinilla-Alonso, N; Ivanov, VD; Littlefair, SP; Camargo, JIB; Assafin, M; Unda-Sanzana, E; Jehin, E; Morales, N; Tancredi, G; Gil-Hutton, R; De la Cueva, I; Colque, JP; Neto, DND; Manfroid, J; Thirouin, A; Gutierrez, PJ; Lecacheux, J; Gillon, M; Maury, A; Colas, F; Licandro, J; Mueller, T; Jacques, C; Weaver, D; Milone, A; Salvo, R; Bruzzone, S; Organero, F; Behrend, R; Roland, S; Vieira-Martins, R; Widemann, T; Roques, F; Santos-Sanz, P; Hestroffer, D; Dhillon, VS; Marsh, TR; Harlingten, C; Bagatin, AC; Alonso, ML; Ortiz, M; Colazo, C; Lima, HJF; Oliveira, AS; Kerber, LO; Smiljanic, R; Pimentel, E; Giacchini, B; Cacella, P; Emilio, M				Ortiz, J. L.; Sicardy, B.; Braga-Ribas, F.; Alvarez-Candal, A.; Lellouch, E.; Duffard, R.; Pinilla-Alonso, N.; Ivanov, V. D.; Littlefair, S. P.; Camargo, J. I. B.; Assafin, M.; Unda-Sanzana, E.; Jehin, E.; Morales, N.; Tancredi, G.; Gil-Hutton, R.; De la Cueva, I.; Colque, J. P.; Da Silva Neto, D. N.; Manfroid, J.; Thirouin, A.; Gutierrez, P. J.; Lecacheux, J.; Gillon, M.; Maury, A.; Colas, F.; Licandro, J.; Mueller, T.; Jacques, C.; Weaver, D.; Milone, A.; Salvo, R.; Bruzzone, S.; Organero, F.; Behrend, R.; Roland, S.; Vieira-Martins, R.; Widemann, T.; Roques, F.; Santos-Sanz, P.; Hestroffer, D.; Dhillon, V. S.; Marsh, T. R.; Harlingten, C.; Campo Bagatin, A.; Alonso, M. L.; Ortiz, M.; Colazo, C.; Lima, H. J. F.; Oliveira, A. S.; Kerber, L. O.; Smiljanic, R.; Pimentel, E.; Giacchini, B.; Cacella, P.; Emilio, M.			Albedo and atmospheric constraints of dwarf planet Makemake from a stellar occultation	NATURE			English	Article							TRANS-NEPTUNIAN OBJECTS; PHOTOMETRIC-OBSERVATIONS; PLUTO; SIZE; ICE; VARIABILITY; SURFACE; ERIS	Pluto and Eris are icy dwarf planets with nearly identical sizes, comparable densities and similar surface compositions as revealed by spectroscopic studies(1,2). Pluto possesses an atmosphere whereas Eris does not; the difference probably arises from their differing distances from the Sun, and explains their different albedos(3). Makemake is another icy dwarf planet with a spectrum similar to Eris and Pluto(4), and is currently at a distance to the Sun intermediate between the two. Although Makemake's size (1,420 +/- 60 km) and albedo are roughly known(5,6), there has been no constraint on its density and there were expectations that it could have a Pluto-like atmosphere(4,7,8). Here we report the results from a stellar occultation by Makemake on 2011 April 23. Our preferred solution that fits the occultation chords corresponds to a body with projected axes of 1,430 +/- 9 km (1 sigma) and 1,502 +/- 45 km, implying a V-band geometric albedo p(V) = 0.77 +/- 0.03. This albedo is larger than that of Pluto, but smaller than that of Eris. The disappearances and reappearances of the star were abrupt, showing that Makemake has no global Pluto-like atmosphere at an upper limit of 4-12 nano-bar (1 sigma) for the surface pressure, although a localized atmosphere is possible. A density of 1.7 +/- 0.3 g cm(-3) is inferred from the data.	[Ortiz, J. L.; Alvarez-Candal, A.; Duffard, R.; Pinilla-Alonso, N.; Morales, N.; Thirouin, A.; Gutierrez, P. J.; Santos-Sanz, P.] CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; [Sicardy, B.; Braga-Ribas, F.; Lellouch, E.; Lecacheux, J.; Widemann, T.; Roques, F.; Santos-Sanz, P.] Univ Paris Diderot, Univ Paris 06, CNRS, Observ Paris,LESIA, F-92195 Meudon, France; [Sicardy, B.] Univ Paris 06, F-75252 Paris 5, France; [Sicardy, B.] Inst Univ France, F-75005 Paris, France; [Braga-Ribas, F.; Camargo, J. I. B.; Da Silva Neto, D. N.; Vieira-Martins, R.] Observ Nacl MCTI, BR-20921400 Rio De Janeiro, Brazil; [Alvarez-Candal, A.; Ivanov, V. D.] European So Observ, Santiago 19, Chile; [Pinilla-Alonso, N.] SETI Inst, Mountain View, CA 94043 USA; [Littlefair, S. P.; Dhillon, V. S.] Univ Sheffield, Dept Phys & Astron, Sheffield S3 7RH, S Yorkshire, England; [Assafin, M.; Vieira-Martins, R.] Univ Fed Rio de Janeiro, Observ Valongo, BR-20080090 Rio De Janeiro, Brazil; [Unda-Sanzana, E.; Colque, J. P.] Univ Antofagasta, Fac Ciencias Basicas, Unidad Astron, Antofagasta, Chile; [Jehin, E.; Manfroid, J.; Gillon, M.] Univ Liege, Inst Astrophys, B-4000 Liege, Belgium; [Tancredi, G.; Salvo, R.; Bruzzone, S.; Roland, S.] Observ Astron Los Molinos DICYT MEC, Montevideo 12400, Uruguay; [Gil-Hutton, R.] Complejo Astron El Leoncito CASLEO, San Juan, Argentina; [Gil-Hutton, R.] San Juan Natl Univ, San Juan, Argentina; [De la Cueva, I.] Astroimagen, Ibiza 07800, Spain; [Maury, A.] San Pedro Atacama Celestial Explorat, San Pedro De Atacama, Chile; [Colas, F.; Vieira-Martins, R.; Hestroffer, D.] Univ Lille 1, UPMC, Observ Paris, CNRS,IMCCE, F-75014 Paris, France; [Licandro, J.] Inst Astrofis Canarias, Tenerife 38250, Spain; [Mueller, T.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Jacques, C.; Pimentel, E.; Giacchini, B.] Observ CEAMIG REA, BR-31545120 Belo Horizonte, MG, Brazil; [Weaver, D.] Univ Fortaleza, Observ Astron Christus, Fortaleza, Ceara, Brazil; [Milone, A.] Inst Nacl Pesquisas Espaciais MCTI, Div Astrofis, BR-12227010 Sao Jose Dos Campos, SP, Brazil; [Organero, F.] Observ Astron La Hita, Toledo 45840, Spain; [Behrend, R.] Observ Geneva, CH-1290 Sauverny, Switzerland; [Marsh, T. R.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Harlingten, C.] Caisey Harlingten Observ, Erpingham NR11 7QX, Norfolk, England; [Campo Bagatin, A.] Univ Alcala de Henares, Dept Fis Ingn Sistemas & Teoria Senal, Alicante 03080, Spain; [Campo Bagatin, A.] Univ Alcala de Henares, Inst Fis Aplicada Ciencias & Tecnol, Alicante 03080, Spain; [Alonso, M. L.] Katholieke Univ Leuven, Inst Sterrenkunde, B-3001 Heverlee, Belgium; [Ortiz, M.] Pontificia Univ Catolica Chile, Santiago 7820436, Chile; [Colazo, C.] Observ Astron Gato Gris, Cordoba, Argentina; [Lima, H. J. F.; Oliveira, A. S.] Univ Vale Paraiba, IP&D, BR-12244000 Sao Jose Dos Campos, Brazil; [Kerber, L. O.] Univ Estadual Santa Cruz, Dept Ciencias Exatas & Tecnol, Lab Astrofis Teor & Observ, Santa Cruz, RJ, Brazil; [Smiljanic, R.] European So Observ, D-85748 Garching, Germany; [Cacella, P.] Rede Astron Observ, BR-71745501 Brasilia, DF, Brazil; [Emilio, M.] Univ Estadual Ponta Grossa, OA DEGEO, BR-84030900 Ponta Grossa, Brazil	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Institut Universitaire de France; European Southern Observatory; University of Sheffield; Universidade Federal do Rio de Janeiro; Universidad de Antofagasta; University of Liege; Universidad Nacional de San Juan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite de Lille - ISITE; Universite de Lille; Instituto de Astrofisica de Canarias; Max Planck Society; Universidade Fortaleza; University of Geneva; University of Warwick; Universidad de Alcala; Universidad de Alcala; KU Leuven; Pontificia Universidad Catolica de Chile; Universidade do Vale do Paraiba; Universidade Estadual de Santa Cruz; European Southern Observatory; Universidade Estadual de Ponta Grossa	Ortiz, JL (corresponding author), CSIC, Inst Astrofis Andalucia, Apartado 3004, E-18080 Granada, Spain.	ortiz@iaa.es	Assafin, Marcelo/C-3188-2013; Cacella, Paulo/J-4728-2014; Emilio, Marcelo/C-4118-2011; Ortiz, Jose L./L-3192-2014; Licandro, Javier/L-7667-2014; Santos-Sanz, Pablo/O-1308-2019; Pinilla-Alonso, Noemi/K-4361-2017; de Oliveira, Alexandre Soares/D-1719-2013; Duffard, Rene/A-2233-2009; Unda-Sanzana, Eduardo/K-3592-2012; Dhillon, Vikram/AAB-5180-2019; Ribas, Felipe Braga/H-4727-2012; Bueno de Camargo, Julio Ignacio/C-3145-2013; Alvarez-Candal, Alvaro/M-4834-2013; de Castro Milone, Andre/B-8489-2012; Bagatin, Adriano Campo/L-2809-2014; Smiljanic, Rodolfo/A-1789-2008; Giacchini, Breno/I-3158-2016; de Oliveira Kerber, Leandro/O-1002-2014; Gutiérrez, Pedro J/AAJ-6177-2020	Cacella, Paulo/0000-0002-3546-3190; Emilio, Marcelo/0000-0001-5589-9015; Ortiz, Jose L./0000-0002-8690-2413; Licandro, Javier/0000-0002-9214-337X; Santos-Sanz, Pablo/0000-0002-1123-983X; Pinilla-Alonso, Noemi/0000-0002-2770-7896; de Oliveira, Alexandre Soares/0000-0001-6422-9486; Duffard, Rene/0000-0001-5963-5850; Unda-Sanzana, Eduardo/0000-0002-7514-8312; Dhillon, Vikram/0000-0003-4236-9642; Ribas, Felipe Braga/0000-0003-2311-2438; Bueno de Camargo, Julio Ignacio/0000-0002-1642-4065; Alvarez-Candal, Alvaro/0000-0002-5045-9675; de Castro Milone, Andre/0000-0002-6725-1109; Bagatin, Adriano Campo/0000-0001-9840-2216; Smiljanic, Rodolfo/0000-0003-0942-7855; Giacchini, Breno/0000-0002-6449-7189; de Oliveira Kerber, Leandro/0000-0002-7435-8748; Gutiérrez, Pedro J/0000-0002-7332-6269; Ivanov, Valentin/0000-0002-5963-1283; Bruzzone, Sebastian/0000-0002-2731-0397; Thirouin, Audrey/0000-0002-1506-4248; Alonso Tagle, Maria Luisa/0000-0003-2439-1993; HESTROFFER, Daniel/0000-0003-0472-9459; Morales Palomino, Nicolas F./0000-0003-0419-1599; Littlefair, Stuart/0000-0001-7221-855X; Assafin, Marcelo/0000-0002-8211-0777; Gillon, Michael/0000-0003-1462-7739	European Southern Observatory Telescopes at the La Silla and Paranal Observatories under programme [287C-5013]; European Regional Development Fund (FEDER); French National Research Agency (ANR); Institut Universitaire de France; Chilean National Commission for Scientific and Technical Research (Gemini-CONICYT funds); North Catholic University of Chile Vicerectorate of Research and Technology Development (UCN-VRIDT); Belgian Fund for Scientific Research (FRS-FNRS); Brazilian National Council for the Development of Science and Technology (CNPq); Foundation for Research Support of the State of Rio de Janeiro (FAPERJ); Centre National de la Recherche Scientifique (CNRS); Argentinian National Scientific and Technical Research Council (CONICET); French-Brazilian Doctoral College Coordination of Improvement of Graduated Personnel programme (CDFB/CAPES); Marie Curie Actions of the European Commission (FP7-COFUND); ULTRACAM from the UK Science and Technology Facilities Council; Spanish Ministry of Economics and Competitiveness; STFC [ST/H008500/1, ST/K002783/1, ST/J001589/1, ST/G003092/1, ST/I001719/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J001589/1, ST/G003092/1, ST/H008500/1, ST/K002783/1, ST/I001719/1] Funding Source: researchfish	European Southern Observatory Telescopes at the La Silla and Paranal Observatories under programme; European Regional Development Fund (FEDER)(European Commission); French National Research Agency (ANR)(French National Research Agency (ANR)); Institut Universitaire de France; Chilean National Commission for Scientific and Technical Research (Gemini-CONICYT funds); North Catholic University of Chile Vicerectorate of Research and Technology Development (UCN-VRIDT); Belgian Fund for Scientific Research (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Brazilian National Council for the Development of Science and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Argentinian National Scientific and Technical Research Council (CONICET); French-Brazilian Doctoral College Coordination of Improvement of Graduated Personnel programme (CDFB/CAPES); Marie Curie Actions of the European Commission (FP7-COFUND); ULTRACAM from the UK Science and Technology Facilities Council; Spanish Ministry of Economics and Competitiveness(Spanish Government); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	These results were based partially on observations made with European Southern Observatory Telescopes at the La Silla and Paranal Observatories under programme 287C-5013. J.L.O. acknowledges funding from Spanish and Andalusian grants and the European Regional Development Fund (FEDER). B. S. acknowledges support from French National Research Agency (ANR) grant 'Beyond Neptune', and from the Institut Universitaire de France. E.U.-S. acknowledges the support from the Chilean National Commission for Scientific and Technical Research (Gemini-CONICYT funds), and from the North Catholic University of Chile Vicerectorate of Research and Technology Development (UCN-VRIDT). TRAPPIST is a project funded by the Belgian Fund for Scientific Research (FRS-FNRS) with the participation of the Swiss National Science Foundation (SNF). J.I.B.C. acknowledges grants by the Brazilian National Council for the Development of Science and Technology (CNPq), and the Foundation for Research Support of the State of Rio de Janeiro (FAPERJ). P.S.-S. acknowledges financial support by the Centre National de la Recherche Scientifique (CNRS). R. G.-H. acknowledges partial financial support by the Argentinian National Scientific and Technical Research Council (CONICET). F.B.-R. acknowledges the support of the French-Brazilian Doctoral College Coordination of Improvement of Graduated Personnel programme (CDFB/CAPES). A. A.-C. acknowledges support from the Marie Curie Actions of the European Commission (FP7-COFUND). S. P. L., V. S. D. and T. R. M. acknowledge funding for ULTRACAM from the UK Science and Technology Facilities Council. R. D. acknowledges support from Spanish Ministry of Economics and Competitiveness through a Ramon y Cajal contract.	Alvarez-Candal A, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201117069; Assafin M, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201118349; Brown ME, 2006, ASTROPHYS J, V639, pL43, DOI 10.1086/501524; Buratti BJ, 2003, ICARUS, V162, P171, DOI 10.1016/S0019-1035(02)00068-4; Elliot JL, 2010, NATURE, V465, P897, DOI 10.1038/nature09109; ELLIOT JL, 1977, ASTROPHYS J, V217, P661, DOI 10.1086/155612; Fray N, 2009, PLANET SPACE SCI, V57, P2053, DOI 10.1016/j.pss.2009.09.011; Heinze AN, 2009, ASTRON J, V138, P428, DOI 10.1088/0004-6256/138/2/428; HUBBARD WB, 1988, NATURE, V336, P452, DOI 10.1038/336452a0; Licandro J, 2006, ASTRON ASTROPHYS, V458, pL5, DOI 10.1051/0004-6361:20066028; Licandro J, 2006, ASTRON ASTROPHYS, V445, pL35, DOI 10.1051/0004-6361:200500219; Lim TL, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014701; MOORWOOD A, 1999, MESSENGER, V95, P1; Muller T., 2011, EPSC DPS JOINT M 201, P1416; Ortiz JL, 2007, ASTRON ASTROPHYS, V468, pL13, DOI 10.1051/0004-6361:20077355; Rabinowitz DL, 2007, ASTRON J, V133, P26, DOI 10.1086/508931; Rabinowitz DL, 2006, ASTROPHYS J, V639, P1238, DOI 10.1086/499575; Schaller EL, 2007, ASTROPHYS J, V659, pL61, DOI 10.1086/516709; Sicardy B, 2006, NATURE, V439, P52, DOI 10.1038/nature04351; Sicardy B, 2011, NATURE, V478, P493, DOI 10.1038/nature10550; Stansberry J., 2008, SOLAR SYSTEM NEPTUNE, V161; Stern S. A., 2008, SOLAR SYSTEM NEPTUNE, P365; Tancredi G, 2008, ICARUS, V195, P851, DOI 10.1016/j.icarus.2007.12.020; Tegler SC, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/1/76; Thirouin A, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/200912340; Young EF, 2008, ASTRON J, V136, P1757, DOI 10.1088/0004-6256/136/5/1757	27	78	78	0	35	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					566	569		10.1038/nature11597	http://dx.doi.org/10.1038/nature11597			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23172214	Green Published			2022-12-28	WOS:000311339800045
J	Rosenbaum, L; Lamas, D				Rosenbaum, Lisa; Lamas, Daniela			Residents' Duty Hours - Toward an Empirical Narrative	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERNS WORK HOURS; MORTALITY; REFORM; SLEEP		[Rosenbaum, Lisa] Univ Penn, Philadelphia VA Med Ctr, Philadelphia, PA 19104 USA; [Rosenbaum, Lisa] Univ Penn, Robert Wood Johnson Fdn, Clin Scholars Program, Philadelphia, PA 19104 USA; [Lamas, Daniela] Massachusetts Gen Hosp, Div Pulm & Crit Care Med, Boston, MA 02114 USA	University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Robert Wood Johnson Foundation (RWJF); University of Pennsylvania; Harvard University; Massachusetts General Hospital	Rosenbaum, L (corresponding author), Univ Penn, Philadelphia VA Med Ctr, Philadelphia, PA 19104 USA.							Accreditation Council for Graduate Medical Education, ACGME 2011 DUT HOUR; Arora Vineet M, 2011, J Grad Med Educ, V3, P281, DOI 10.4300/JGME-D-11-00146.1; Blum AB, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-33; Gurjala A, 2001, PUBLIC CITIZEN  0430; Keslar L, 2011, PROTOMAG         SPR, P21; Kihss P, 1975, NY TIMES; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Lerner B.H., 2006, WASHINGTON POST; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Pennell NA, 2005, NEW ENGL J MED, V352, P726; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Williamson AM, 2000, OCCUP ENVIRON MED, V57, P649, DOI 10.1136/oem.57.10.649	13	44	45	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2012	367	21					2044	2049		10.1056/NEJMsr1210160	http://dx.doi.org/10.1056/NEJMsr1210160			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040RI	23171102				2022-12-28	WOS:000311340200016
J	Sheridan, RL; Schaefer, PW; Whalen, M; Fagan, S; Stoddard, FJ; Schneider, JC; McConkey, B; Cancio, LC				Sheridan, Robert L.; Schaefer, Pamela W.; Whalen, Michael; Fagan, Shawn; Stoddard, Frederick J., Jr.; Schneider, Jeffrey C.; McConkey, Brock; Cancio, Leopoldo C.			Case 36-2012: Recovery of a 16-Year-Old Girl from Trauma and Burns after a Car Accident	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; BRAIN-INJURY; CHILDREN; SOLDIERS; MORPHINE; RETURN; DUTY		[Sheridan, Robert L.; Fagan, Shawn] Massachusetts Gen Hosp, Burn Unit, Boston, MA 02114 USA; [Schaefer, Pamela W.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Whalen, Michael] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Sheridan, Robert L.; Fagan, Shawn] Shriners Hosp Children, Burn Unit, Sacramento, CA USA; [Stoddard, Frederick J., Jr.] Shriners Hosp Children, Dept Psychiat, Sacramento, CA USA; [Stoddard, Frederick J., Jr.] Shriners Hosp Children, Dept Prosthet, Sacramento, CA USA; [Schneider, Jeffrey C.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Cambridge, MA USA; [Sheridan, Robert L.] VA Boston Healthcare Syst, Dept Surg, Boston, MA USA; [Sheridan, Robert L.; Fagan, Shawn] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Schaefer, Pamela W.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Whalen, Michael] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Stoddard, Frederick J., Jr.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Schneider, Jeffrey C.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Cancio, Leopoldo C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Surg, San Antonio, TX 78229 USA; [Cancio, Leopoldo C.] USA, Inst Surg Res, San Antonio, TX USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Spaulding Rehabilitation Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Texas System; University of Texas Health San Antonio	Sheridan, RL (corresponding author), Massachusetts Gen Hosp, Burn Unit, Boston, MA 02114 USA.		Schaefer, Pamela/AAA-1323-2019; Schneider, Jeffrey/AAO-2126-2020					BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cohen SP, 2010, LANCET, V375, P301, DOI 10.1016/S0140-6736(09)61797-9; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dillingham TR, 2001, AM J PHYS MED REHAB, V80, P563, DOI 10.1097/00002060-200108000-00003; Holbrook TL, 2010, NEW ENGL J MED, V362, P110, DOI 10.1056/NEJMoa0903326; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Klein MB, 2007, ANN SURG, V245, P622, DOI 10.1097/01.sla.0000252572.50684.49; Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116; Lansdowne R, 1997, VISIBLY DIFFERENT CO; Lemaire CM, 2011, DISASTER PSYCHIAT RE, P179; Nugent N., 2007, TOTAL BURN CARE, V3, P262; Petruzzo P, 2011, AM J TRANSPLANT, V11, P808, DOI 10.1111/j.1600-6143.2011.03469.x; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Quigley MJ, 1992, PROSTHETIC REHABILIT, P67; Rosenkranz KM, 2002, BURNS, V28, P665, DOI 10.1016/S0305-4179(02)00109-2; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Saxe G, 2001, J AM ACAD CHILD PSY, V40, P915, DOI 10.1097/00004583-200108000-00013; Sheridan RL, 2000, JAMA-J AM MED ASSOC, V283, P69, DOI 10.1001/jama.283.1.69; Sheridan RL, 2003, JAMA-J AM MED ASSOC, V290, P719, DOI 10.1001/jama.290.6.719; Sheridan RL, 2012, J TRAUMA ACUTE CARE, V73, pS205, DOI 10.1097/TA.0b013e318265c81f; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Stinner DJ, 2010, J TRAUMA, V68, P1476, DOI 10.1097/TA.0b013e3181bb9a6c; Stoddard FJ, 2011, TXB MILITARY MED, P339; Stoddard FJ, 2006, CHILD ADOL PSYCH CL, V15, P611, DOI 10.1016/j.chc.2006.02.005; Stoddard FJ, 2011, J CHILD ADOL PSYCHOP, V21, P469, DOI 10.1089/cap.2010.0133; Stoddard FJ, 2011, J BURN CARE RES, V32, P519, DOI 10.1097/BCR.0b013e31822bef92; Tien MHC, 2008, J AM COLL SURGEONS, V207, P174, DOI 10.1016/j.jamcollsurg.2008.01.065; Traber DL, 2007, TOTAL BURN CARE, P248; van der Linde H, 2004, J REHABIL RES DEV, V41, P555, DOI 10.1682/JRRD.2003.06.0102; Waters R L, 2004, ATLAS AMPUTATIONS LI, P395; Winthrop AL, 2005, J TRAUMA, V58, P468, DOI 10.1097/01.TA.0000153940.23471.B7	34	4	4	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2012	367	21					2027	2037		10.1056/NEJMcpc1200088	http://dx.doi.org/10.1056/NEJMcpc1200088			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040RI	23171100				2022-12-28	WOS:000311340200012
J	Calabrese, JM; Sun, W; Song, LY; Mugford, JW; Williams, L; Yee, D; Starmer, J; Mieczkowski, P; Crawford, GE; Magnuson, T				Calabrese, J. Mauro; Sun, Wei; Song, Lingyun; Mugford, Joshua W.; Williams, Lucy; Yee, Della; Starmer, Joshua; Mieczkowski, Piotr; Crawford, Gregory E.; Magnuson, Terry			Site-Specific Silencing of Regulatory Elements as a Mechanism of X Inactivation	CELL			English	Article							TROPHOBLAST STEM-CELLS; CHROMOSOME INACTIVATION; XIST RNA; MOUSE; METHYLATION; SEQUENCES; GENOME; GENE; RECRUITMENT; INITIATION	The inactive X chromosome's (Xi) physical territory is microscopically devoid of transcriptional hallmarks and enriched in silencing-associated modifications. How these microscopic signatures relate to specific Xi sequences is unknown. Therefore, we profiled Xi gene expression and chromatin states at high resolution via allele-specific sequencing in mouse trophoblast stem cells. Most notably, X-inactivated transcription start sites harbored distinct epigenetic signatures relative to surrounding Xi DNA. These sites displayed H3-lysine27-trimethylation enrichment and DNaseI hypersensitivity, similar to autosomal Polycomb targets, yet excluded Pol II and other transcriptional hallmarks, similar to nontranscribed genes. CTCF bound X-inactivated and escaping genes, irrespective of measured chromatin boundaries. Escape from X inactivation occurred within, and X inactivation was maintained exterior to, the area encompassed by Xist in cells subject to imprinted and random X inactivation. The data support a model whereby inactivation of specific regulatory elements, rather than a simple chromosome-wide separation from transcription machinery, governs gene silencing over the Xi.	[Calabrese, J. Mauro; Sun, Wei; Mugford, Joshua W.; Williams, Lucy; Yee, Della; Starmer, Joshua; Mieczkowski, Piotr; Magnuson, Terry] Univ N Carolina, Carolina Ctr Genome Sci, Dept Genet, Chapel Hill, NC 27599 USA; [Calabrese, J. Mauro; Sun, Wei; Mugford, Joshua W.; Williams, Lucy; Yee, Della; Starmer, Joshua; Mieczkowski, Piotr; Magnuson, Terry] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Sun, Wei] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Song, Lingyun; Crawford, Gregory E.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Song, Lingyun; Crawford, Gregory E.] Duke Univ, Dept Pediat, Div Med Genet, Durham, NC 27708 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University	Magnuson, T (corresponding author), Univ N Carolina, Carolina Ctr Genome Sci, Dept Genet, Chapel Hill, NC 27599 USA.	trm4@med.unc.edu		Mieczkowski, Piotr/0000-0003-2418-0096	NIH [R01-GM101974]; UNC Cancer Research Fund; American Cancer Society postdoctoral fellowship [117571-PF-09-124-01-DDC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101974, R01GM074175] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC Cancer Research Fund; American Cancer Society postdoctoral fellowship(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Thanks to Magnuson lab members for critical comments, to Terry Furey and Darin London for DNase-Seq help, and to Victor Lobanenkov for kindly providing the CTCF antibody mixture. This work was supported by the NIH grant R01-GM101974 and UNC Cancer Research Fund. JMC was supported by the American Cancer Society postdoctoral fellowship 117571-PF-09-124-01-DDC.	Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chadwick BP, 2007, CHROMOSOMA, V116, P147, DOI 10.1007/s00412-006-0085-1; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chow JC, 2010, CELL, V141, P956, DOI 10.1016/j.cell.2010.04.042; Ciavatta D, 2006, P NATL ACAD SCI USA, V103, P9958, DOI 10.1073/pnas.0603754103; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Duthie SM, 1999, HUM MOL GENET, V8, P195, DOI 10.1093/hmg/8.2.195; Escamilla-Del-Arenal M, 2011, HUM GENET, V130, P307, DOI 10.1007/s00439-011-1029-2; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kalantry S, 2006, NAT CELL BIOL, V8, P195, DOI 10.1038/ncb1351; Kalantry S, 2009, NATURE, V460, P647, DOI 10.1038/nature08161; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Namekawa SH, 2010, MOL CELL BIOL, V30, P3187, DOI 10.1128/MCB.00227-10; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Pugacheva EM, 2005, HUM MOL GENET, V14, P953, DOI 10.1093/hmg/ddi089; Quinn J, 2006, METH MOLEC MED, V121, P125; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Song L, 2010, COLD SPRING HARB PRO, V2; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Tattermusch A, 2011, HUM GENET, V130, P247, DOI 10.1007/s00439-011-1027-4; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574; Williams LH, 2011, DEVELOPMENT, V138, P2049, DOI 10.1242/dev.061176; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109	35	135	140	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					951	963		10.1016/j.cell.2012.10.037	http://dx.doi.org/10.1016/j.cell.2012.10.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178118	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000311423500010
J	Pencheva, N; Tran, H; Buss, C; Huh, D; Drobnjak, M; Busam, K; Tavazoie, SF				Pencheva, Nora; Tran, Hien; Buss, Colin; Huh, Doowon; Drobnjak, Marija; Busam, Klaus; Tavazoie, Sohail F.			Convergent Multi-miRNA Targeting of ApoE Drives LRP1/LRP8-Dependent Melanoma Metastasis and Angiogenesis	CELL			English	Article							CANCER METASTASIS; TUMOR INVASION; MICRORNAS; GENE; SIGNATURES; SURVIVAL	Through in vivo selection of human cancer cell populations, we uncover a convergent and cooperative miRNA network that drives melanoma metastasis. We identify miR-1908, miR-199a-5p, and miR-199a-3p as endogenous promoters of metastatic invasion, angiogenesis, and colonization in melanoma. These miRNAs convergently target apolipoprotein E (ApoE) and the heat shock factor DNAJA4. Cancer-secreted ApoE suppresses invasion and metastatic endothelial recruitment (MER) by engaging melanoma cell LRP1 and endothelial cell LRP8 receptors, respectively, while DNAJA4 promotes ApoE expression. Expression levels of these miRNAs and ApoE correlate with human metastatic progression outcomes. Treatment of cells with locked nucleic acids (LNAs) targeting these miRNAs inhibits metastasis to multiple organs, and therapeutic delivery of these LNAs strongly suppresses melanoma metastasis. We thus identify miRNAs with dual cell-intrinsic/cell-extrinsic roles in cancer, reveal convergent cooperativity in a metastatic miRNA network, identify ApoE as an anti-angiogenic and metastasis-suppressive factor, and uncover multiple prognostic miRNAs with synergistic combinatorial therapeutic potential in melanoma.	[Pencheva, Nora; Tran, Hien; Buss, Colin; Huh, Doowon; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA; [Drobnjak, Marija; Busam, Klaus] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center	Tavazoie, SF (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA.	stavazoie@mail.rockefeller.edu	Buss, Colin/I-5326-2014	Buss, Colin/0000-0001-7771-1685; Huh, Doowon/0000-0003-2722-0217; Drobnjak, Marija/0000-0003-0676-4709	Rita Allen foundation; Elizabeth foundation; Vincent Mayer foundation; DOD Era of Hope Scholar award; CTSA [5KL2 RR024142-04]; Melanoma Research Alliance; Melanoma Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024142] Funding Source: NIH RePORTER	Rita Allen foundation; Elizabeth foundation; Vincent Mayer foundation; DOD Era of Hope Scholar award; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Melanoma Research Alliance; Melanoma Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the members of our laboratory for thoughtful comments on previous versions of this manuscript and Masoud Tavazoie for insightful discussions regarding melanoma. ApoE null mice were generously provided by Jan Breslow. We thank Jordana Ray-Kirton for tremendous help with clinical sample procurement and Yves Marcel for kindly providing ApoE neutralization antibody. S.F.T. was supported by the Rita Allen and the Elizabeth and Vincent Mayer foundations and a DOD Era of Hope Scholar award. H.T. was partially supported by an NIH/NCRR clinical scholar and CTSA awards 5KL2 RR024142-04. This work was also generously supported by the Melanoma Research Alliance and the Melanoma Research Foundation. S.F.T. is a cofounder and shareholder of Rgenix and a member of its scientific advisory board.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Garbe C, 2011, ONCOLOGIST, V16, P5, DOI 10.1634/theoncologist.2010-0190; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Lucas R., 2006, ENV BURDEN DIS SERIE, V13; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; POLLACK VA, 1982, J NATL CANCER I, V69, P137; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Worley LA, 2008, MELANOMA RES, V18, P184, DOI 10.1097/CMR.0b013e3282feeac6	28	259	277	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					1068	1082		10.1016/j.cell.2012.10.028	http://dx.doi.org/10.1016/j.cell.2012.10.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23142051	Green Accepted, Bronze			2022-12-28	WOS:000311423500019
J	Ferner, R				Ferner, Robin			A short history of pharmaceutical marketing	BRITISH MEDICAL JOURNAL			English	Editorial Material									City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England	University of Birmingham	Ferner, R (corresponding author), City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	R.E.Ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				British Medical Association, 1912, MOR SECR REM WHAT TH; Dalrymple T., 2012, POLICEMAN BROTHEL VI; Fleming N, 2006, DAILY TELEGRAPH; Gagnon MA, 2008, PLOS MED, V5, P29, DOI 10.1371/journal.pmed.0050001; Tanne JH, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c7360	5	0	0	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 20	2012	345								e7801	10.1136/bmj.e7801	http://dx.doi.org/10.1136/bmj.e7801			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	044GT	23169805				2022-12-28	WOS:000311608200009
J	Dixson, DL; Hay, ME				Dixson, Danielle L.; Hay, Mark E.			Corals Chemically Cue Mutualistic Fishes to Remove Competing Seaweeds	SCIENCE			English	Article							REGION-WIDE DECLINES; OCEAN ACIDIFICATION; DWELLING GOBIES; GENUS GOBIODON; CLIMATE-CHANGE; BENTHIC ALGAE; REEFS; SPECIALIZATION; BIODIVERSITY; HERBIVORES	Corals in the genus Acropora generate much of the structural complexity upon which coral reefs depend, but they are susceptible to damage from toxic seaweeds. Acropora nasuta minimizes this damage by chemically cuing symbiotic goby fishes (Gobidon histrio or Paragobidon enchinocephalus) to remove the toxic seaweed Chlorodesmis fastigiata. Within minutes of seaweed contact, or contact from only seaweed chemical extract, the coral releases an odor that recruits gobies to trim the seaweed and dramatically reduce coral damage that would otherwise occur. In turn, chemically defended gobies become more toxic after consumption of this noxious alga. Mutualistic gobies and corals appear to represent a marine parallel to terrestrial ant-plants, in that the host provides shelter and food in return for protection from natural enemies.	[Hay, Mark E.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; Georgia Inst Technol, Aquat Chem Ecol Ctr, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Hay, ME (corresponding author), Georgia Inst Technol, Sch Biol, 310 Ferst Dr, Atlanta, GA 30332 USA.	mark.hay@biology.gatech.edu	Hay, Mark E/D-9752-2011; Dixson, Danielle L/B-9253-2018	Hay, Mark E/0000-0002-6130-9349; Dixson, Danielle L/0000-0003-1493-1482	NSF [OCE-0929119]; NIH [U01-TW007401]; Teasley Endowment; Division Of Ocean Sciences [0929119] Funding Source: National Science Foundation; FOGARTY INTERNATIONAL CENTER [U19TW007401, U01TW007401] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Teasley Endowment; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Support provided by NSF grant OCE-0929119, NIH grant U01-TW007401, and the Teasley Endowment to the Georgia Institute of Technology. We thank the Fijian government and the Korolevu-i-wai district elders for collection and research permissions; B. Devine, J. White, G. Longo, R. Bonaldo, and D. Rasher for field, lab, or statistical assistance; J. Kubanek, D. Rasher, P. Munday, J. P. Hobbs, and anonymous reviewers for comments on the manuscript; and V. Bonito for assisting scientifically and culturally. The data reported in this manuscript are presented in the main paper and supplementary materials.	Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barott KL, 2012, P ROY SOC B-BIOL SCI, V279, P1655, DOI 10.1098/rspb.2011.2155; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Brooker RM, 2010, J FISH BIOL, V76, P2578, DOI 10.1111/j.1095-8649.2010.02644.x; Cowman PF, 2011, J EVOLUTION BIOL, V24, P2543, DOI 10.1111/j.1420-9101.2011.02391.x; Dicke M, 2009, PLANT CELL ENVIRON, V32, P654, DOI 10.1111/j.1365-3040.2008.01913.x; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; HASHIMOTO Y, 1974, TOXICON, V12, P523, DOI 10.1016/0041-0101(74)90043-9; HAY ME, 1989, OECOLOGIA, V81, P418, DOI 10.1007/BF00377093; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; MEYER KD, 1994, CORAL REEFS, V13, P105, DOI 10.1007/BF00300770; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Munday PL, 1997, MAR ECOL PROG SER, V152, P227, DOI 10.3354/meps152227; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Rasher DB, 2011, P NATL ACAD SCI USA, V108, P17726, DOI 10.1073/pnas.1108628108; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Riedlecker E, 2009, J ZOOL SYST EVOL RES, V47, P160, DOI 10.1111/j.1439-0469.2008.00497.x; Schubert M, 2003, ENVIRON BIOL FISH, V67, P359, DOI 10.1023/A:1025826829548; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Williams DE, 2012, CORAL REEFS, V31, P369, DOI 10.1007/s00338-011-0847-y	29	48	49	4	230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2012	338	6108					804	807		10.1126/science.1225748	http://dx.doi.org/10.1126/science.1225748			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139333	Green Accepted			2022-12-28	WOS:000310839500046
J	Murray, AN; Kelly, JW				Murray, Amber N.; Kelly, Jeffery W.			Hsp104 Gives Clients the Individual Attention They Need	CELL			English	Editorial Material							AMYLOIDOSIS	Yeast heat shock protein 104 (Hsp104), the only known eukaryotic disaggregase, remodels both disordered protein aggregates and cross-beta sheet amyloids. To handle this diverse clientele, DeSantis et al. report that Hsp104 hexamers use distinct mechanisms-individual subunits are able to dissolve disordered aggregates, but global subunit cooperativity is required to untangle amyloids.	[Murray, Amber N.; Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Chem, La Jolla, CA 92037 USA; [Murray, Amber N.; Kelly, Jeffery W.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Murray, AN (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	amurray@scripps.edu; jkelly@scripps.edu						Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Johan K, 1998, P NATL ACAD SCI USA, V95, P2558, DOI 10.1073/pnas.95.5.2558; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Winkler J, 2012, J STRUCT BIOL, V179, P152, DOI 10.1016/j.jsb.2012.05.002	8	6	6	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					695	697		10.1016/j.cell.2012.10.033	http://dx.doi.org/10.1016/j.cell.2012.10.033			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141530	Bronze			2022-12-28	WOS:000310921200001
J	Cardemil, CV; Cortese, MM; Medina-Marino, A; Jasuja, S; Desai, R; Leung, J; Rodriguez-Hart, C; Villarruel, G; Howland, J; Quaye, O; Tam, KI; Bowen, MD; Parashar, UD; Gerber, SI				Cardemil, Cristina V.; Cortese, Margaret M.; Medina-Marino, Andrew; Jasuja, Supriya; Desai, Rishi; Leung, Jessica; Rodriguez-Hart, Cristina; Villarruel, Gissela; Howland, Julia; Quaye, Osbourne; Tam, Ka Ian; Bowen, Michael D.; Parashar, Umesh D.; Gerber, Susan I.		Rotavirus Invest Team	Two Rotavirus Outbreaks Caused by Genotype G2P[4] at Large Retirement Communities Cohort Studies	ANNALS OF INTERNAL MEDICINE			English	Article							NURSING-HOME; GASTROENTERITIS; INFECTION; VACCINE; SEVERITY; CHILDREN; DIARRHEA; ADULTS; EPIDEMIOLOGY; SURVEILLANCE	Background: Outbreaks of rotavirus gastroenteritis in elderly adults are reported infrequently but are often caused by G2P[4] strains. In 2011, outbreaks were reported in 2 Illinois retirement facilities. Objective: To implement control measures, determine the extent and severity of illness, and assess risk factors for disease among residents and employees. Design: Cohort studies using surveys and medical chart abstraction. Setting: Two large retirement facilities in Cook County, Illinois. Patients: Residents and employees at both facilities and community residents with rotavirus disease. Measurements: Attack rates, hospitalization rates, and rotavirus genotype. Results: At facility A, 84 of 324 residents (26%) were identified with clinical or laboratory-confirmed rotavirus gastroenteritis (median age, 84 years) and 11 (13%) were hospitalized. The outbreak lasted 7 weeks. At facility B, 90 case patients among 855 residents (11%) were identified (median age, 88 years) and 19 (21%) were hospitalized. The facility B outbreak lasted 9.3 weeks. Ill employees were identified at both locations. In each facility, attack rates seemed to differ by residential setting, with the lowest rates among those in more separated settings or with high baseline level of infection control measures. The causative genotype for both outbreaks was G2P[4]. Some individuals shed virus detected by enzyme immunoassay or genotyping reverse transcription polymerase chain reaction for at least 35 days. G2P[4] was also identified in 17 of 19 (89%) samples from the older adult community but only 15 of 40 (38%) pediatric samples. Limitation: Medical or cognitive impairment among residents limited the success of some interviews. Conclusion: Rotavirus outbreaks can occur among elderly adults in residential facilities and can result in considerable morbidity. Among older adults, G2P[4] may be of unique importance. Health professionals should consider rotavirus as a cause of acute gastroenteritis in adults.	[Cortese, Margaret M.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Cook Cty Dept Publ Hlth, Oak Forest, IL USA; Illinois Dept Publ Hlth, Chicago, IL USA	Centers for Disease Control & Prevention - USA	Cortese, MM (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd, Atlanta, GA 30333 USA.	mcortese@cdc.gov	Desai, Rishi/AAH-8988-2021	Quaye, Osbourne/0000-0002-0621-876X; , Andrew/0000-0002-0095-4141				ABBAS AMA, 1987, J HOSP INFECT, V9, P76, DOI 10.1016/0195-6701(87)90099-5; Anderson EJ, 2004, LANCET INFECT DIS, V4, P91, DOI 10.1016/S1473-3099(04)00928-4; Anderson EJ, 2012, J INFECTION, V64, P89, DOI 10.1016/j.jinf.2011.09.003; Banyai Krisztian, 2002, Orv Hetil, V143, P1347; Barnes GL, 2003, J PEDIATR-US, V142, P722, DOI 10.1067/mpd.2003.240; BARNES GL, 1992, J PAEDIATR CHILD H, V28, P54, DOI 10.1111/j.1440-1754.1992.tb02618.x; BERN C, 1992, J CLIN MICROBIOL, V30, P3234, DOI 10.1128/JCM.30.12.3234-3238.1992; Bishop RF, 1996, ARCH VIROL, P119; Sanz JC, 2009, ENFERM INFEC MICR CL, V27, P219, DOI 10.1016/j.eimc.2008.06.005; Cascio A, 2001, CLIN INFECT DIS, V32, P1126, DOI 10.1086/319744; Chimura Yuri, 2002, Kansenshogaku Zasshi, V76, P450; Clark HF, 2011, HUM VACCINES, V7, P1118, DOI 10.4161/hv.7.11.17820; Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843; CUBITT WD, 1980, J CLIN PATHOL, V33, P306, DOI 10.1136/jcp.33.3.306; de Rougemont A, 2011, PEDIATR INFECT DIS J, V30, P118, DOI 10.1097/INF.0b013e3181ef034e; Edmonson L M, 2000, J Am Med Dir Assoc, V1, P175; Fauvel M, 1980, CAN DIS WEEKLY REP, V6, P205; Feeney SA, 2006, J MED VIROL, V78, P1119, DOI 10.1002/jmv.20671; Fletcher M., 2000, Morbidity and Mortality Weekly Report, V49, P1131; Freeman MM, 2008, J MED VIROL, V80, P1489, DOI 10.1002/jmv.21228; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; GOUVEA V, 1990, J INFECT DIS, V162, P362, DOI 10.1093/infdis/162.2.362; GREEN KY, 1990, J INFECT DIS, V161, P667, DOI 10.1093/infdis/161.4.667; Griffin DD, 2002, J INFECT DIS, V185, P1502, DOI 10.1086/340218; HALVORSRUD J, 1980, SCAND J INFECT DIS, V12, P161, DOI 10.3109/inf.1980.12.issue-3.01; HOLZEL H, 1980, J INFECTION, V2, P33, DOI 10.1016/S0163-4453(80)91750-8; Hull JJ, 2011, PEDIATR INFECT DIS J, V30, pS42, DOI 10.1097/INF.0b013e3181fefd78; Iijima Y, 2006, SCAND J INFECT DIS, V38, P490, DOI 10.1080/00365540500532134; Justino MCA, 2011, PEDIATR INFECT DIS J, V30, P396, DOI 10.1097/INF.0b013e3182055cc2; Kapikian A.Z., 1996, FIELDS VIROLOGY, P1657; Kirk MD, 2010, CLIN INFECT DIS, V51, P907, DOI 10.1086/656406; LAMBERT M, 1991, CAN J PUBLIC HEALTH, V82, P351; Lederer P, 1995, Gesundheitswesen, V57, P326; LEWIS DC, 1989, J HOSP INFECT, V14, P9, DOI 10.1016/0195-6701(89)90128-X; Lopman BA, 2004, EMERG INFECT DIS, V10, P1827, DOI 10.3201/eid1010.030941; MARRIE TJ, 1982, ARCH INTERN MED, V142, P313, DOI 10.1001/archinte.142.2.313; Marshall J, 2003, J CLIN VIROL, V28, P331, DOI 10.1016/S1386-6532(03)00081-7; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Mori I, 2002, J MED VIROL, V67, P613, DOI 10.1002/jmv.10147; National Institute of Infectious Diseases, 2000, OUTBR GROUP A ROT GA; Piednoir E, 2010, J HOSP INFECT, V75, P295, DOI 10.1016/j.jhin.2010.03.024; RAO GG, 1995, J HOSP INFECT, V30, P1, DOI 10.1016/0195-6701(95)90244-9; Ryan MJ, 1997, J INFECTION, V34, P49, DOI 10.1016/S0163-4453(97)80009-6; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Skaza A Trop, 2011, EURO SURVEILL, V16; SPRINGTHORPE VS, 1986, J HYG-CAMBRIDGE, V97, P139, DOI 10.1017/S0022172400064433; STEEL HM, 1992, J MED VIROL, V37, P132, DOI 10.1002/jmv.1890370211; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; WANDLESS I, 1981, AGE AGEING, V10, P36, DOI 10.1093/ageing/10.1.36; Yamagami Takaya, 2007, Kansenshogaku Zasshi, V81, P256; YOLKEN RH, 1978, NEW ENGL J MED, V299, P1156, DOI 10.1056/NEJM197811232992103	53	24	25	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2012	157	9					621	+		10.7326/0003-4819-157-9-201211060-00006	http://dx.doi.org/10.7326/0003-4819-157-9-201211060-00006			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033GX	23128862				2022-12-28	WOS:000310783300003
J	Peruzzo, A; Shadbolt, P; Brunner, N; Popescu, S; O'Brien, JL				Peruzzo, Alberto; Shadbolt, Peter; Brunner, Nicolas; Popescu, Sandu; O'Brien, Jeremy L.			A Quantum Delayed-Choice Experiment	SCIENCE			English	Article								Quantum systems exhibit particle-or wavelike behavior depending on the experimental apparatus they are confronted by. This wave-particle duality is at the heart of quantum mechanics. Its paradoxical nature is best captured in the delayed-choice thought experiment, in which a photon is forced to choose a behavior before the observer decides what to measure. Here, we report on a quantum delayed-choice experiment in which both particle and wave behaviors are investigated simultaneously. The genuinely quantum nature of the photon's behavior is certified via nonlocality, which here replaces the delayed choice of the observer in the original experiment. We observed strong nonlocal correlations, which show that the photon must simultaneously behave both as a particle and as a wave.	[Peruzzo, Alberto; Shadbolt, Peter; O'Brien, Jeremy L.] Univ Bristol, Ctr Quantum Photon, HH Wills Phys Lab, Bristol BS8 1UB, Avon, England; [Peruzzo, Alberto; Shadbolt, Peter; O'Brien, Jeremy L.] Univ Bristol, Dept Elect & Elect Engn, Bristol BS8 1UB, Avon, England; [Brunner, Nicolas; Popescu, Sandu] Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England	University of Bristol; University of Bristol; University of Bristol	O'Brien, JL (corresponding author), Univ Bristol, Ctr Quantum Photon, HH Wills Phys Lab, Bristol BS8 1UB, Avon, England.	jeremy.obrien@bristol.ac.uk	Peruzzo, Alberto/E-2113-2011; Popescu, Sandu/N-2455-2017	Peruzzo, Alberto/0000-0002-7953-3875; O'Brien, Jeremy/0000-0002-3576-8285; Popescu, Sandu/0000-0003-1142-7694	UK Engineering and Physical Sciences Research Council (EPSRC); European Research Council (ERC); Quantum Integrated Photonics (QUANTIP) project; Toolbox for Photon Orbital Angular Momentum Technology (PHORBITECH) project; Quantum InterfacES; SENsors; Communication based on Entanglement (Q-ESSENCE) integrating project; Nokia; Centre for Nanoscience and Quantum Information (NSQI); Templeton Foundation; European Union Union Device-Independent Quantum Information Processing (DIQIP) project; Royal Society Wolfson Merit Award; Royal Academy of Engineering Research Fellowship; EPSRC [EP/J017175/1, EP/F010524/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J017175/1, EP/F010524/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council (ERC)(European Research Council (ERC)European Commission); Quantum Integrated Photonics (QUANTIP) project; Toolbox for Photon Orbital Angular Momentum Technology (PHORBITECH) project; Quantum InterfacES; SENsors; Communication based on Entanglement (Q-ESSENCE) integrating project; Nokia(Nokia Corporation); Centre for Nanoscience and Quantum Information (NSQI); Templeton Foundation; European Union Union Device-Independent Quantum Information Processing (DIQIP) project; Royal Society Wolfson Merit Award(Royal Society of London); Royal Academy of Engineering Research Fellowship(Royal Academy of Engineering - UK); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank R. Ionicioiu, S. Pironio, T. Rudolph, N. Sangouard, and D. R. Terno for useful discussions, and acknowledge financial support from the UK Engineering and Physical Sciences Research Council (EPSRC), European Research Council (ERC), the Quantum Integrated Photonics (QUANTIP) project, A Toolbox for Photon Orbital Angular Momentum Technology (PHORBITECH) project, the Quantum InterfacES, SENsors, the Communication based on Entanglement (Q-ESSENCE) integrating project, Nokia, the Centre for Nanoscience and Quantum Information (NSQI), the Templeton Foundation, and the European Union Union Device-Independent Quantum Information Processing (DIQIP) project. J.L.O. and S. P. acknowledge a Royal Society Wolfson Merit Award. A. P. holds a Royal Academy of Engineering Research Fellowship.	[Anonymous], [No title captured]; Arkin, 2019, SCIENCE, DOI [10.1126/science.364.6438.320, 10.1126/science.abe9728]; ASPECT A, 1982, PHYS REV LETT, V49, P1804, DOI 10.1103/PhysRevLett.49.1804; Auccaise R, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.032121; Bell J.S., 2004, SPEAKABLE UNSPEAKABL, P14; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; CIRELSON BS, 1980, LETT MATH PHYS, V4, P93, DOI 10.1007/BF00417500; Englert BG, 1996, PHYS REV LETT, V77, P2154, DOI 10.1103/PhysRevLett.77.2154; Feynman R. P., 1965, LECT NOTES PHYS; HELLMUTH T, 1987, PHYS REV A, V35, P2532, DOI 10.1103/PhysRevA.35.2532; Hofmann HF, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.024308; Ionicioiu R, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.230406; Jacques V, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.220402; Jacques V, 2007, SCIENCE, V315, P966, DOI 10.1126/science.1136303; Kaiser F, 2012, SCIENCE, V338, P637, DOI 10.1126/science.1226755; Kim YH, 2000, PHYS REV LETT, V84, P1, DOI 10.1103/PhysRevLett.84.1; LawsonDaku BJ, 1996, PHYS REV A, V54, P5042, DOI 10.1103/PhysRevA.54.5042; Leggett A. J., 2009, COMPENDIUM QUANTUM P, P161; Ma X.-s., 1978, QUANTUM PHYS; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Qureshi T., 2007, QUANTUM PHYS; Ralph TC, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.062324; Roy SS, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.022109; SCULLY MO, 1991, NATURE, V351, P111, DOI 10.1038/351111a0; Shadbolt PJ, 2012, NAT PHOTONICS, V6, P45, DOI [10.1038/nphoton.2011.283, 10.1038/NPHOTON.2011.283]; Tang JS, 2012, NAT PHOTONICS, V6, P600, DOI [10.1038/NPHOTON.2012.179, 10.1038/nphoton.2012.179]; Weihs G, 1998, PHYS REV LETT, V81, P5039, DOI 10.1103/PhysRevLett.81.5039; Wheeler J. A., 1978, MATH FDN QUANTUM THE, P9, DOI DOI 10.1016/B978-0-12-473250-6.50006-6; Wheeler J. A., 1984, QUANTUM THEORY MEASU, P182; WOOTTERS WK, 1979, PHYS REV D, V19, P473, DOI 10.1103/PhysRevD.19.473; Zeilinger A, 2005, NATURE, V433, P230, DOI 10.1038/nature03280; Zeilinger A, 2007, NATURE, V446, P342, DOI 10.1038/nature05274	33	153	157	6	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107					634	637		10.1126/science.1226719	http://dx.doi.org/10.1126/science.1226719			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118183	Green Submitted			2022-12-28	WOS:000310516000044
J	Grothey, A; Van Cutsem, E; Sobrero, A; Siena, S; Falcone, A; Ychou, M; Humblet, Y; Bouche, O; Mineur, L; Barone, C; Adenis, A; Tabernero, J; Yoshino, T; Lenz, HJ; Goldberg, RM; Sargent, DJ; Cihon, F; Cupit, L; Wagner, A; Laurent, D				Grothey, Axel; Van Cutsem, Eric; Sobrero, Alberto; Siena, Salvatore; Falcone, Alfredo; Ychou, Marc; Humblet, Yves; Bouche, Olivier; Mineur, Laurent; Barone, Carlo; Adenis, Antoine; Tabernero, Josep; Yoshino, Takayuki; Lenz, Heinz-Josef; Goldberg, Richard M.; Sargent, Daniel J.; Cihon, Frank; Cupit, Lisa; Wagner, Andrea; Laurent, Dirk		CORRECT Study Grp	Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial	LANCET			English	Article							PTK787/ZK 222584; DOUBLE-BLIND; PLUS; OXALIPLATIN; CEDIRANIB	Background No treatment options are available for patients with metastatic colorectal cancer that progresses after all approved standard therapies, but many patients maintain a good performance status and could be candidates for further therapy. An international phase 3 trial was done to assess the multikinase inhibitor regorafenib in these patients. Methods We did this trial at 114 centres in 16 countries. Patients with documented metastatic colorectal cancer and progression during or within 3 months after the last standard therapy were randomised (in a 2: 1 ratio; by computer-generated randomisation list and interactive voice response system; preallocated block design (block size six); stratified by previous treatment with VEGF-targeting drugs, time from diagnosis of metastatic disease, and geographical region) to receive best supportive care plus oral regorafenib 160 mg or placebo once daily, for the first 3 weeks of each 4 week cycle. The primary endpoint was overall survival. The study sponsor, participants, and investigators were masked to treatment assignment. Efficacy analyses were by intention to treat. This trial is registered at ClinicalTrials.gov, number NCT01103323. Findings Between April 30, 2010, and March 22, 2011, 1052 patients were screened, 760 patients were randomised to receive regorafenib (n=505) or placebo (n=255), and 753 patients initiated treatment (regorafenib n=500; placebo n=253; population for safety analyses). The primary endpoint of overall survival was met at a preplanned interim analysis; data cutoff was on July 21, 2011. Median overall survival was 6.4 months in the regorafenib group versus 5.0 months in the placebo group (hazard ratio 0.77; 95% CI 0.64-0.94; one-sided p=0.0052). Treatment-related adverse events occurred in 465 (93%) patients assigned regorafenib and in 154 (61%) of those assigned placebo. The most common adverse events of grade three or higher related to regorafenib were hand-foot skin reaction (83 patients, 17%), fatigue (48, 10%), diarrhoea (36, 7%), hypertension (36, 7%), and rash or desquamation (29, 6%). Interpretation Regorafenib is the first small-molecule multikinase inhibitor with survival benefits in metastatic colorectal cancer which has progressed after all standard therapies. The present study provides evidence for a continuing role of targeted treatment after disease progression, with regorafenib offering a potential new line of therapy in this treatment-refractory population.	[Grothey, Axel] Mayo Clin, Div Med Oncol, Rochester, MN USA; [Van Cutsem, Eric] Katholieke Univ Leuven Hosp, Leuven Canc Inst, Louvain, Belgium; [Van Cutsem, Eric] Katholieke Univ Leuven, Dept Oncol, Louvain, Belgium; [Sobrero, Alberto] San Martino Hosp, Genoa, Italy; [Siena, Salvatore] Osped Niguarda Ca Granda, Falck Div Med Oncol, Milan, Italy; [Falcone, Alfredo] Univ Hosp, Dept Med Oncol, Pisa, Italy; [Ychou, Marc] CRLC Val dAurelle, Digest Oncol Unit, Montpellier, France; [Humblet, Yves] St Luc Univ Hosp, Dept Med Oncol, Brussels, Belgium; [Bouche, Olivier] Robert Debre Univ Hosp, Reims, France; [Mineur, Laurent] Inst St Catherine, Gastrointestinal & Liver Oncol Radiotherapy Unit, Avignon, France; [Barone, Carlo] Univ Cattolica Sacro Cuore, Div Med Oncol, I-00168 Rome, Italy; [Adenis, Antoine] Ctr Oscar Lambret, Dept Gastrointestinal Oncol, F-59020 Lille, France; [Tabernero, Josep] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Med Oncol, E-08193 Barcelona, Spain; [Yoshino, Takayuki] Natl Canc Ctr Hosp E, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan; [Lenz, Heinz-Josef] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Div Med Oncol, Los Angeles, CA 90033 USA; [Goldberg, Richard M.] Ohio State Univ, Sch Med, James Canc Hosp, Div Med Oncol, Columbus, OH 43210 USA; [Goldberg, Richard M.] Solove Res Inst, Columbus, OH USA; [Cihon, Frank; Cupit, Lisa] Bayer HealthCare Pharmaceut, Montville, NJ USA; [Wagner, Andrea; Laurent, Dirk] Bayer Pharma AG, Berlin, Germany	Mayo Clinic; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; KU Leuven; University of Genoa; IRCCS AOU San Martino IST; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Pisa; Azienda Ospedaliero Universitaria Pisana; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; CHU de Reims; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; UNICANCER; Centre Oscar Lambret; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); National Cancer Center - Japan; University of Southern California; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals	Van Cutsem, E (corresponding author), Univ Hosp Gasthuisberg Leuven, Digest Oncol Unit, B-3000 Louvain, Belgium.	eric.vancutsem@uzleuven.be	Sobrero, Alberto/AAF-9742-2019; Van+Cutsem, Eric/ABE-1762-2021; Tabernero, Josep/AAG-5026-2019; SIENA, SALVATORE/AAC-5806-2019; Goldberg, Richard/O-1871-2017; Goldberg, Richard M/M-1311-2013; adenis, antoine/N-1536-2014; Falcone, Alfredo/G-5217-2013; Folprecht, Gunnar/F-8638-2011	Sobrero, Alberto/0000-0001-7764-673X; Tabernero, Josep/0000-0002-2495-8139; SIENA, SALVATORE/0000-0002-2681-2846; Goldberg, Richard/0000-0003-3713-6895; adenis, antoine/0000-0003-0585-5078; Gibbs, Peter/0000-0003-1423-4484; Andre, Thierry/0000-0002-5103-7095; Prenen, Hans/0000-0001-8802-7352; Borel, Christian/0000-0002-7710-2086; Falcone, Alfredo/0000-0001-5840-2529; Garcia-Carbonero, Rocio/0000-0002-3342-397X; Ychou, Marc/0000-0001-7378-9469; Folprecht, Gunnar/0000-0002-9321-9911; Sargent, Daniel/0000-0002-2684-4741	Bayer HealthCare Pharmaceuticals; Genentech; Sanofi; Bayer; Daiichi; Imclone; Amgen; Merck Serono; Roche; Takeda; Daiichi Sankyo; Taiho; Myriad; Jennerex; Lilly; CORRECT steering committee	Bayer HealthCare Pharmaceuticals(Bayer AGBayer Healthcare Pharmaceuticals); Genentech(Roche HoldingGenentech); Sanofi; Bayer(Bayer AG); Daiichi(Daiichi Sankyo Company Limited); Imclone; Amgen(Amgen); Merck Serono(Merck & Company); Roche(Roche Holding); Takeda(Takeda Pharmaceutical Company Ltd); Daiichi Sankyo(Daiichi Sankyo Company Limited); Taiho; Myriad; Jennerex; Lilly(Eli Lilly); CORRECT steering committee	Bayer HealthCare Pharmaceuticals.; The Mayo Foundation has received research funding for clinical studies done by AG from Genentech, Sanofi, Bayer, Daiichi, and Imclone and has received honoraria for consulting activities of AG for Genentech, Roche, Onyx, Bayer, Imclone, Bristol-Myers Squibb, and Sanofi. EVC has received research funding from Bayer. AS has been an advisory board member and has spoken at symposia for Roche, Merck, Bayer, Amgen, and Sanofi. SS has been an advisory board member for Amgen, AstraZeneca, Bayer, Genentech, Merck Serono, Roche, and Sanofi. AF has received honoraria from Amgen, Bayer, Merck Serono, Roche, and Sanofi for speaking, consultancy, and advisory board membership, and has received research support from Amgen, Bayer, Merck Serono, Roche, and Sanofi. MY has received honoraria from Bayer for advisory board membership. YH has received honoraria from Bayer to act as a consultant and has received research funding from Bayer. OB has received honoraria from Roche, Merck Serono, and Amgen. LM declares that he has no conflicts of interest. CB has received honoraria for lecturing and advisory board membership from Bayer, Merck, Roche, and Novartis, and has received honoraria for lecturing from GlaxoSmithKline and Amgen. AA has received honoraria from Bayer (conference and research funding). JT has been a consultant and advisory board member for Amgen, Bristol-Myers Squibb, Genentech, Merck KGaA, Millennium, Novartis, Onyx, Pfizer, Roche, Sanofi, and Bayer and has received honoraria from Amgen, Merck KGaA, Novartis, Roche, and Sanofi. TY has received consulting fees from Takeda, honoraria from Chugai, Takeda, Yakult, Bristol-Myers Squibb, and Merck Serono, and research funding from Daiichi Sankyo, Taiho, Bayer, and Imclone. H-JL has been an advisory board member for Bayer. RMG has received research support to Ohio State University from Sanofi, Bayer, Myriad, and Jennerex, has provided unpaid consultancy for Bayer and Sanofi, and has received payment from Lilly for participation in a data safety monitoring board. DJS has received consulting fees from the CORRECT steering committee (less than $5000/year). FC, LC, AW, and DL are employees of Bayer. FC and DL have Bayer stock ownership.	Bendell JC, 2012, J CLIN ONCOL S4, V30; Chu E, 2012, CLIN COLORECTAL CANC, V11, P1, DOI 10.1016/j.clcc.2011.05.005; European Organisation for Research and Treatment of Cancer, 2001, EORTC QLQ C30 SCOR M; Globocan, 2008, COL CANC FACT SHEET; Hecht JR, 2011, J CLIN ONCOL, V29, P1997, DOI 10.1200/JCO.2010.29.4496; Hoff PM, 2012, J CLIN ONCOL, V30, P3596, DOI 10.1200/JCO.2012.42.6031; National Comprehensive Cancer Network, 2012, NCCN CLIN PRACT GUID; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Pickard AS, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-70; Schmieder R, 2012, AM ASS CANC RES 103, P2337; Schmoll HJ, 2012, J CLIN ONCOL, V30, P3588, DOI 10.1200/JCO.2012.42.5355; Siu LL, 2012, J CLIN ONCOL, V30, DOI 10.1200/jco.2012.30.4_suppl.386; Strumberg D, 2012, BRIT J CANCER, V106, P1722, DOI 10.1038/bjc.2012.153; Tabernero J, 2011, EUR MULT CANC C STOC, p19LBA; Van Cutsem E, 2010, ANN ONCOL, V21, pv93, DOI 10.1093/annonc/mdq222; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2004, DOI 10.1200/JCO.2010.29.5436; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Zopf D, 2011, AM ASS CANC RES 102, P4262	18	1818	1873	4	167	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 26	2013	381	9863					303	312		10.1016/S0140-6736(12)61900-X	http://dx.doi.org/10.1016/S0140-6736(12)61900-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077IT	23177514				2022-12-28	WOS:000314021800027
J	Abbati, S				Abbati, Santiago			Idiopathic Aqueductal Stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hosp Clin Buenos Aires, Buenos Aires, DF, Argentina	University of Buenos Aires	Abbati, S (corresponding author), Hosp Clin Buenos Aires, Buenos Aires, DF, Argentina.	sgabbati@gmail.com							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2012	367	21					E30	E30		10.1056/NEJMicm1200835	http://dx.doi.org/10.1056/NEJMicm1200835			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040RI	23171120				2022-12-28	WOS:000311340200011
J	Shorr, RI; Chandler, AM; Mion, LC; Waters, TM; Liu, MZ; Daniels, MJ; Kessler, LA; Miller, ST				Shorr, Ronald I.; Chandler, A. Michelle; Mion, Lorraine C.; Waters, Teresa M.; Liu, Minzhao; Daniels, Michael J.; Kessler, Lori A.; Miller, Stephen T.			Effects of an Intervention to Increase Bed Alarm Use to Prevent Falls in Hospitalized Patients A Cluster Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE-CARE; INPATIENT FALLS; SYSTEM; INJURIES	Background: Bed alarm systems intended to prevent hospital falls have not been formally evaluated. Objective: To investigate whether an intervention aimed at increasing bed alarm use decreases hospital falls and related events. Design: Pair-matched, cluster randomized trial over 18 months. Nursing units were allocated by computer-generated randomization on the basis of baseline fall rates. Patients and outcome assessors were blinded to unit assignment; outcome assessors may have become unblinded. (ClinicalTrials.gov registration number: NCT00183053) Setting: 16 nursing units in an urban community hospital. Patients: 27 672 inpatients in general medical, surgical, and specialty units. Intervention: Education, training, and technical support to promote use of a standard bed alarm system (intervention units); bed alarms available but not formally promoted or supported (control units). Measurements: Pre-post difference in change in falls per 1000 patient-days (primary end point); number of patients who fell, fall-related injuries, and number of patients restrained (secondary end points). Results: Prevalence of alarm use was 64.41 days per 1000 patient-days on intervention units and 1.79 days per 1000 patient-days on control units (P = 0.004). There was no difference in change in fall rates per 1000 patient-days (risk ratio, 1.09 [ 95% CI, 0.85 to 1.53]; difference, 0.41 [CI, -1.05 to 2.47], which corresponds to a greater difference in falls in control vs. intervention units) or in the number of patients who fell, injurious fall rates, or the number of patients physically restrained on intervention units compared with control units. Limitation: The study was conducted at a single site and was slightly underpowered compared with the initial design. Conclusion: An intervention designed to increase bed alarm use in an urban hospital increased alarm use but had no statistically or clinically significant effect on fall-related events or physical restraint use. Primary Funding Source: National Institute on Aging.	Malcom Randall Vet Affairs Med Ctr, GRECC, Gainesville, FL 32608 USA; Univ Florida, Gainesville, FL 32611 USA; Methodist Healthcare, Memphis, TN 38104 USA; Univ Tennessee, Hlth Sci Ctr, Memphis, TN 38104 USA; Vanderbilt Univ, Sch Nursing, Nashville, TN 37240 USA	Geriatric Research Education & Clinical Center; State University System of Florida; University of Florida; University of Tennessee System; University of Tennessee Health Science Center; Vanderbilt University	Shorr, RI (corresponding author), Malcom Randall Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr 182, 1601 SW Archer Rd, Gainesville, FL 32608 USA.	rshorr@ufl.edu		Waters, Teresa/0000-0002-3823-5177	National Institute on Aging [R01-AG025285, R01-AG033005]; NATIONAL INSTITUTE ON AGING [R01AG025285, P30AG028740, R01AG033005] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Aging (R01-AG025285 and R01-AG033005).	Agostini JV, 2001, MAKING HLTH CARE SAF, V01-E058, P281; [Anonymous], 2007, FED REGISTER, V72, P47; BATES DW, 1995, AM J MED, V99, P137, DOI 10.1016/S0002-9343(99)80133-8; Cameron ID, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub2; Capezuti E, 2009, ARCH GERONTOL GERIAT, V49, P27, DOI 10.1016/j.archger.2008.04.007; Coussement J, 2008, J AM GERIATR SOC, V56, P29, DOI 10.1111/j.1532-5415.2007.01508.x; Cumming RG, 2008, BMJ-BRIT MED J, V336, P758, DOI 10.1136/bmj.39499.546030.BE; Dunton N, 2007, ONLINE J ISSUES NURS, P12, DOI DOI 10.3912/OJIN.VOL12NO03MAN03; Dykes PC, 2010, JAMA-J AM MED ASSOC, V304, P1912, DOI 10.1001/jama.2010.1567; Efron B., 1994, MONOGRAPHS STAT APPL; Geffre S, 2001, BED ALARMS INVESTIGA; Graham KC, 2010, AM J CRIT CARE, V19, P28, DOI 10.4037/ajcc2010651; Haines TP, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-254; Haines TP, 2009, J AM GERIATR SOC, V57, P517, DOI 10.1111/j.1532-5415.2008.02142.x; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Inouye SK, 2000, J AM GERIATR SOC, V48, P1697; Krauss MJ, 2007, INFECT CONT HOSP EP, V28, P544, DOI 10.1086/513725; Morse JM, 2002, AM J INFECT CONTROL, V30, P376, DOI 10.1067/mic.2002.125808; Morse JM, 2009, PREVENTING PATIENT F; National Quality Forum, 2009, 0203 NQF; Oliver D, 2008, AGE AGEING, V37, P248, DOI 10.1093/ageing/afn088; Oliver D, 2007, BRIT MED J, V334, P82, DOI 10.1136/bmj.39049.706493.55; Oliver D, 2010, CLIN GERIATR MED, V26, P645, DOI 10.1016/j.cger.2010.06.005; Perell KL, 2001, J GERONTOL A-BIOL, V56, pM761, DOI 10.1093/gerona/56.12.M761; Rosenthal MB, 2007, NEW ENGL J MED, V357, P1573, DOI 10.1056/NEJMp078184; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Sahota O, 2009, AGE AGEING, V38, P339, DOI 10.1093/ageing/afp012; Shorr RI, 2008, J AM GERIATR SOC, V56, P701, DOI 10.1111/j.1532-5415.2007.01605.x; Shuto H, 2010, BRIT J CLIN PHARMACO, V69, P535, DOI 10.1111/j.1365-2125.2010.03613.x; TIDEIKSAAR R, 1993, MT SINAI J MED, V60, P522; TINETTI ME, 1989, NEW ENGL J MED, V320, P1055; Vassallo M, 2000, INT J CLIN PRACT, V54, P654; Widder B, 1985, Geriatr Nurs, V6, P287, DOI 10.1016/S0197-4572(85)80068-9	34	109	108	1	42	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10					692	+		10.7326/0003-4819-157-10-201211200-00005	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	043VZ	23165660	Green Accepted			2022-12-28	WOS:000311580000014
J	Cheng, ZL; Al Zaki, A; Hui, JZ; Muzykantov, VR; Tsourkas, A				Cheng, Zhiliang; Al Zaki, Ajlan; Hui, James Z.; Muzykantov, Vladimir R.; Tsourkas, Andrew			Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities	SCIENCE			English	Review							SUPERPARAMAGNETIC IRON-OXIDE; TUMOR-ASSOCIATED MACROPHAGES; AMINOPEPTIDASE-A EXPRESSION; METASTATIC BREAST-CANCER; IN-VIVO; DRUG-DELIVERY; SOLID TUMORS; POLYMERIC NANOPARTICLES; MAGNETIC NANOPARTICLES; GOLD NANORODS	Nanoparticle-based drug delivery systems have been developed to improve the efficacy and reduce the systemic toxicity of a wide range of drugs. Although clinically approved nanoparticles have consistently shown value in reducing drug toxicity, their use has not always translated into improved clinical outcomes. This has led to the development of "multifunctional" nanoparticles, where additional capabilities like targeting and image contrast enhancement are added to the nanoparticles. However, additional functionality means additional synthetic steps and costs, more convoluted behavior and effects in vivo, and also greater regulatory hurdles. The trade-off between additional functionality and complexity is the subject of ongoing debate and the focus of this Review.	[Cheng, Zhiliang; Al Zaki, Ajlan; Hui, James Z.; Tsourkas, Andrew] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Muzykantov, Vladimir R.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Muzykantov, Vladimir R.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Tsourkas, A (corresponding author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.	atsourk@seas.upenn.edu	Tsourkas, Andrew/AAM-8252-2020; Tsourkas, Andrew/A-1074-2007	Tsourkas, Andrew/0000-0001-7758-1753; Tsourkas, Andrew/0000-0001-7758-1753; Cheng, Zhiliang/0000-0003-3351-6874	NIH National Institute of Biomedical Imaging and Bioengineering (NIBIB) [R01-EB012065]; National Cancer Institute [R01-CA157766]; NIBIB [R21-EB013226, R21-EB013754]; National Heart, Lung, and Blood Institute [RO1 HL087036]; NATIONAL CANCER INSTITUTE [R01CA157766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB013226, R01EB012065, R21EB013754] Funding Source: NIH RePORTER	NIH National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported in part by the NIH National Institute of Biomedical Imaging and Bioengineering (NIBIB) grant R01-EB012065, National Cancer Institute R01-CA157766, NIBIB R21-EB013226, NIBIB R21-EB013754, and National Heart, Lung, and Blood Institute RO1 HL087036.	Adiseshaiah PP, 2010, WIRES NANOMED NANOBI, V2, P99, DOI 10.1002/wnan.66; Alexiou C, 2006, EUR BIOPHYS J BIOPHY, V35, P446, DOI 10.1007/s00249-006-0042-1; Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Bhattacharyya S, 2010, P NATL ACAD SCI USA, V107, P14541, DOI 10.1073/pnas.1006507107; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Blackwell KL, 2012, J CLIN ONCOL, V30, P2585, DOI 10.1200/JCO.2011.35.6725; Bogenrieder T, 1997, PROSTATE, V33, P225; Briley-Saebo KC, 2006, MAGN RESON MED, V56, P1336, DOI 10.1002/mrm.21094; Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]; Chatterjee DK, 2008, ADV DRUG DELIVER REV, V60, P1627, DOI 10.1016/j.addr.2008.08.003; Chauhan VP, 2011, ANNU REV CHEM BIOMOL, V2, P281, DOI 10.1146/annurev-chembioeng-061010-114300; Chen B, 2006, CLIN CANCER RES, V12, P917, DOI 10.1158/1078-0432.CCR-05-1673; Cheng ZL, 2010, ANGEW CHEM INT EDIT, V49, P346, DOI 10.1002/anie.200905133; Cho RW, 2008, CURR OPIN GENET DEV, V18, P48, DOI 10.1016/j.gde.2008.01.017; Chrastina A, 2011, WIRES NANOMED NANOBI, V3, P421, DOI 10.1002/wnan.143; COLE WC, 1987, J NUCL MED, V28, P83; Crayton SH, 2011, ACS NANO, V5, P9592, DOI 10.1021/nn202863x; Danhier F, 2010, J CONTROL RELEASE, V148, P135, DOI 10.1016/j.jconrel.2010.08.027; Davies A, 2012, P NATL ACAD SCI USA, V109, P1862, DOI 10.1073/pnas.1112132109; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dutta T, 2007, BBA-GEN SUBJECTS, V1770, P681, DOI 10.1016/j.bbagen.2006.12.007; Elbayoumi TA, 2006, EUR J NUCL MED MOL I, V33, P1196, DOI 10.1007/s00259-006-0139-x; Elias D. R., NANOMED-NANOTECHNOL, DOI [10.1016/j.nano.2012.05.015, DOI 10.1016/J.NANO.2012.05.015)]; Fleck LM, 2006, HASTINGS CENT REP, V36, P13, DOI 10.1353/hcr.2006.0040; Fujimura H, 2000, ONCOLOGY-BASEL, V58, P342, DOI 10.1159/000012122; GATTER KC, 1983, J CLIN PATHOL, V36, P539, DOI 10.1136/jcp.36.5.539; Gendler SJ, 2001, J MAMMARY GLAND BIOL, V6, P339, DOI 10.1023/A:1011379725811; Goodman TT, 2008, BIOTECHNOL BIOENG, V101, P388, DOI 10.1002/bit.21910; Goodman TT, 2007, INT J NANOMED, V2, P265; Haun JB, 2008, LANGMUIR, V24, P8821, DOI 10.1021/la8005844; Herbst RS, 2002, CANCER-AM CANCER SOC, V94, P1593, DOI 10.1002/cncr.10372; Hong S, 2007, CHEM BIOL, V14, P107, DOI 10.1016/j.chembiol.2006.11.015; Huang P, 2011, BIOMATERIALS, V32, P9796, DOI 10.1016/j.biomaterials.2011.08.086; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Jordan A, 2006, J NEURO-ONCOL, V78, P7, DOI 10.1007/s11060-005-9059-z; Kale AA, 2010, METHODS MOL BIOL, V605, P213, DOI 10.1007/978-1-60327-360-2_15; Kano MR, 2007, P NATL ACAD SCI USA, V104, P3460, DOI 10.1073/pnas.0611660104; Kim JO, 2009, J CONTROL RELEASE, V138, P197, DOI 10.1016/j.jconrel.2009.04.019; Kluza E, 2010, NANO LETT, V10, P52, DOI 10.1021/nl902659g; Krishnan S, 2010, INT J HYPERTHER, V26, P775, DOI 10.3109/02656736.2010.485593; Lacunza E, 2010, CANCER GENET CYTOGEN, V201, P102, DOI 10.1016/j.cancergencyto.2010.05.015; Lallana E, 2012, PHARM RES-DORDR, V29, P1, DOI 10.1007/s11095-011-0568-5; Lankveld DPK, 2011, NANOMEDICINE-UK, V6, P339, DOI 10.2217/NNM.10.122; Lee H, 2010, MOL PHARMACEUT, V7, P1195, DOI 10.1021/mp100038h; Lewis CE, 2007, CANCER RES, V67, P8429, DOI 10.1158/0008-5472.CAN-07-1684; Li C, 2000, CLIN CANCER RES, V6, P2829; Li YP, 2010, J CONTROL RELEASE, V144, P314, DOI 10.1016/j.jconrel.2010.02.027; Lipinski C., 2002, AM PHARM REV, V5, P82; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Lovell JF, 2011, NAT MATER, V10, P324, DOI [10.1038/NMAT2986, 10.1038/nmat2986]; Luo YL, 2011, ACS NANO, V5, P7796, DOI 10.1021/nn201592s; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Marchal C, 2004, HISTOL HISTOPATHOL, V19, P715, DOI 10.14670/HH-19.715; McNeeley KM, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/38/385101; Morawski AM, 2004, MAGN RESON MED, V51, P480, DOI 10.1002/mrm.20010; Murphy EJ, 2008, LIPIDS, V43, P105, DOI 10.1007/s11745-008-3156-7; Muzykantov VR, 1999, P NATL ACAD SCI USA, V96, P2379, DOI 10.1073/pnas.96.5.2379; Nair P, 2005, CURR SCI INDIA, V88, P890; Nanda A, 2004, CURR OPIN ONCOL, V16, P44, DOI 10.1097/00001622-200401000-00009; Nanus DM, 1998, INT J ONCOL, V13, P261; Nie SM, 2007, ANNU REV BIOMED ENG, V9, P257, DOI 10.1146/annurev.bioeng.9.060906.152025; Nishiyama N, 2003, CANCER RES, V63, P8977; O'Brien MER, 2004, ANN ONCOL, V15, P440, DOI 10.1093/annonc/mdh097; Olson ES, 2010, P NATL ACAD SCI USA, V107, P4311, DOI 10.1073/pnas.0910283107; Opavsky R, 2001, J BIOL CHEM, V276, P38795, DOI 10.1074/jbc.M105241200; Parker N, 2005, ANAL BIOCHEM, V338, P284, DOI 10.1016/j.ab.2004.12.026; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Poon Z, 2011, NANOMED-NANOTECHNOL, V7, P201, DOI 10.1016/j.nano.2010.07.008; PRESS MF, 1990, ONCOGENE, V5, P953; Prutki M, 2006, CANCER LETT, V238, P188, DOI 10.1016/j.canlet.2005.07.001; Reddy GR, 2006, CLIN CANCER RES, V12, P6677, DOI 10.1158/1078-0432.CCR-06-0946; Reshetnyak YK, 2008, P NATL ACAD SCI USA, V105, P15340, DOI 10.1073/pnas.0804746105; Reshetnyak YK, 2011, MOL IMAGING BIOL, V13, P1146, DOI 10.1007/s11307-010-0457-z; Romberg B, 2008, PHARM RES, V25, P55, DOI 10.1007/s11095-007-9348-7; Sanson C, 2010, J CONTROL RELEASE, V147, P428, DOI 10.1016/j.jconrel.2010.07.123; Santra S, 2005, ADV MATER, V17, P2165, DOI 10.1002/adma.200500018; Schlingemann RO, 1996, J PATHOL, V179, P436; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Shokeen M, 2011, ACS NANO, V5, P738, DOI 10.1021/nn102278w; Simone EA, 2012, BIOMATERIALS, V33, P5406, DOI 10.1016/j.biomaterials.2012.04.036; Simone EA, 2008, EXPERT OPIN DRUG DEL, V5, P1283, DOI 10.1517/17425240802567846 ; Stefanou D, 2004, HISTOL HISTOPATHOL, V19, P37, DOI 10.14670/HH-19.37; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Sweat SD, 1998, UROLOGY, V52, P637, DOI 10.1016/S0090-4295(98)00278-7; Thorek DLJ, 2009, MOL IMAGING, V8, P221, DOI 10.2310/7290.2009.00021; Torchilin VP, 2000, EUR J PHARM SCI, V11, pS81, DOI 10.1016/S0928-0987(00)00166-4; van Waarde A, 2007, J NUCL MED, V48, P1320, DOI 10.2967/jnumed.107.042085; Wang J, 2010, J AM CHEM SOC, V132, P11306, DOI 10.1021/ja1043177; Yang J, 2007, ANGEW CHEM INT EDIT, V46, P8836, DOI 10.1002/anie.200703554; Yang JY, 2012, CELL BIOCHEM BIOPHYS, V62, P221, DOI 10.1007/s12013-011-9286-1; YATVIN MB, 1980, SCIENCE, V210, P1253, DOI 10.1126/science.7434025; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230; Zhang G, 2010, P NATL ACAD SCI USA, V107, P732, DOI 10.1073/pnas.0911397107; Zou P, 2010, MOL PHARMACEUT, V7, P1974, DOI 10.1021/mp100273t	97	1000	1019	14	939	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					903	910		10.1126/science.1226338	http://dx.doi.org/10.1126/science.1226338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161990	Green Accepted			2022-12-28	WOS:000311083600034
J	Lavine, M; Frisk, M; Pennisi, E				Lavine, Marc; Frisk, Megan; Pennisi, Elizabeth			Biomaterials INTRODUCTION	SCIENCE			English	Editorial Material																			0	5	5	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2012	338	6109					899	899		10.1126/science.338.6109.899	http://dx.doi.org/10.1126/science.338.6109.899			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161988				2022-12-28	WOS:000311083600032
J	Schulz, M				Schulz, Mark			Speeding Up Artificial Muscles	SCIENCE			English	Editorial Material									Univ Cincinnati, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Schulz, M (corresponding author), Univ Cincinnati, Cincinnati, OH 45221 USA.	mark.schulz@uc.edu						Lima MD, 2012, SCIENCE, V338, P928, DOI 10.1126/science.1226762; Mirfakhrai T, 2009, ADV SCI TECH, V61, P65; Pinto F., 2012, 48 AIAA ASME SAE ASE, P1, DOI [10.2514/6.2012-3713, DOI 10.2514/6.2012-3713]; Wen Q, 2010, ADV MATER, V22, P1867, DOI 10.1002/adma.200902746; Yuan QH, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.245505	5	13	14	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					893	894		10.1126/science.1230428	http://dx.doi.org/10.1126/science.1230428			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161984				2022-12-28	WOS:000311083600028
J	Spencer, FA; Iorio, A; You, J; Murad, MH; Schunemann, HJ; Vandvik, PO; Crowther, MA; Pottie, K; Lang, ES; Meerpohl, JJ; Falck-Ytter, Y; Alonso-Coello, P; Guyatt, GH				Spencer, Frederick A.; Iorio, Alfonso; You, John; Murad, M. Hassad; Schuenemann, Holger J.; Vandvik, Per O.; Crowther, Mark A.; Pottie, Kevin; Lang, Eddy S.; Meerpohl, Joerg J.; Falck-Ytter, Yngve; Alonso-Coello, Pablo; Guyatt, Gordon H.			Uncertainties in baseline risk estimates and confidence in treatment effects	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ATRIAL-FIBRILLATION; GRADE; QUALITY; RECOMMENDATIONS; ANTICOAGULATION; PUBLICATION		[Spencer, Frederick A.; Iorio, Alfonso; You, John; Schuenemann, Holger J.; Crowther, Mark A.] McMaster Univ, Dept Med, Hamilton, ON L8N 4A6, Canada; [Iorio, Alfonso; You, John; Schuenemann, Holger J.; Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 4A6, Canada; [Murad, M. Hassad] Mayo Clin, Div Prevent Med, Rochester, MN USA; [Vandvik, Per O.] Inlandet Hosp Trust, Dept Med, Gjovik, Norway; [Vandvik, Per O.] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway; [Crowther, Mark A.] McMaster Univ, Dept Mol Med, Hamilton, ON L8N 4A6, Canada; [Pottie, Kevin] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Pottie, Kevin] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Lang, Eddy S.] Univ Calgary, Div Emergency Med, Calgary, AB, Canada; [Meerpohl, Joerg J.] Univ Med Ctr, Inst Med Biometry & Med Informat, German Cochrane Ctr, Freiburg, Germany; [Falck-Ytter, Yngve] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Alonso-Coello, Pablo] CIBERESP IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain	McMaster University; McMaster University; Mayo Clinic; Innlandet Hospital Trust; Norwegian Knowledge Centre for Health Services; McMaster University; University of Ottawa; University of Ottawa; University of Calgary; University of Freiburg; Case Western Reserve University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Spencer, FA (corresponding author), McMaster Univ, Dept Med, Hamilton, ON L8N 4A6, Canada.	fspence@mcmaster.ca	Lang, Eddy/AAS-2080-2020; Murad, M. Hassan/AAW-4367-2020; Iorio, Alfonso/B-9478-2013; Falck-Ytter, Yngve/GZH-0993-2022; Meerpohl, Joerg J/J-4224-2013; Yngve Falck-Ytter, AGAF/AAC-5362-2019; Pottie, Kevin/ABC-4385-2020; Lang, Eddy/I-4759-2014	Iorio, Alfonso/0000-0002-3331-8766; Meerpohl, Joerg J/0000-0002-1333-5403; Yngve Falck-Ytter, AGAF/0000-0002-4688-3211; Schunemann, Holger/0000-0003-3211-8479; Crowther, Mark/0000-0003-4986-4873; Murad, Mohammad Hassan/0000-0001-5502-5975; Lang, Eddy/0000-0003-0850-4337; Alonso-Coello, Pablo/0000-0002-8001-8504				Bates SM, 2012, CHEST, V141, pE691S, DOI 10.1378/chest.11-2300; Danish SF, 2005, NEUROSURGERY, V56, P1286, DOI 10.1227/01.NEU.0000159882.11635.EA; Danish SF, 2005, NEUROSURGERY, V56, P92; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Guyatt GH, 2008, BRIT MED J, V336, P1170, DOI 10.1136/bmj.39504.506319.80; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1303, DOI 10.1016/j.jclinepi.2011.04.014; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1277, DOI 10.1016/j.jclinepi.2011.01.011; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Mara M, 2004, Ceska Gynekol, V69, P312; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003; You JJ, 2012, CHEST, V141, pE531S, DOI 10.1378/chest.11-2304	20	36	40	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 14	2012	345								e7401	10.1136/bmj.e7401	http://dx.doi.org/10.1136/bmj.e7401			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040PZ	23152569	Green Submitted, Bronze			2022-12-28	WOS:000311336400019
J	Attaran, A; Barry, D; Basheer, S; Bate, R; Benton, D; Chauvin, J; Garrett, L; Kickbusch, I; Kohler, JC; Midha, K; Newton, PN; Nishtar, S; Orhii, P; McKee, M				Attaran, Amir; Barry, Donna; Basheer, Shamnad; Bate, Roger; Benton, David; Chauvin, James; Garrett, Laurie; Kickbusch, Ilona; Kohler, Jillian Clare; Midha, Kamal; Newton, Paul N.; Nishtar, Sania; Orhii, Paul; McKee, Martin			How to achieve international action on falsified and substandard medicines	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DRUG QUALITY		[Attaran, Amir] Univ Ottawa, Ottawa, ON K1N 6N5, Canada; [Barry, Donna] Partners Hlth, Boston, MA USA; [Basheer, Shamnad] Natl Univ Jurid Sci, Kolkata, India; [Bate, Roger] Amer Enterprise Inst Publ Policy Res, Washington, DC USA; [Benton, David] Int Council Nurses, Geneva, Switzerland; [Chauvin, James] World Federat Publ Hlth Assoc, Geneva, Switzerland; [Garrett, Laurie] Council Foreign Relat, New York, NY USA; [Kickbusch, Ilona] Grad Inst, Global Hlth Programme, Geneva, Switzerland; [Kohler, Jillian Clare] Univ Toronto, Toronto, ON, Canada; [Midha, Kamal] Int Pharmaceut Federat, The Hague, Netherlands; [Newton, Paul N.] Univ Oxford, Oxford, England; [Nishtar, Sania] Heartfile, Islamabad, Pakistan; [Orhii, Paul] Natl Agcy Food & Drug Adm & Control, Abuja, Nigeria; [McKee, Martin] London Sch Hyg & Trop Med, London WC1, England	University of Ottawa; Partners Healthcare System; American Enterprise Institute for Public Policy Research; University of Toronto; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Attaran, A (corresponding author), Univ Ottawa, 1 Stewart St, Ottawa, ON K1N 6N5, Canada.	aattaran@uottawa.ca	benton, david/AAC-5298-2020; McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	benton, david/0000-0001-8418-8618; McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Benton, David/0000-0002-4068-8124; Newton, Paul/0000-0002-4608-6431	Wellcome Trust [089275] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ahmad K, 2004, LANCET, V363, P713, DOI 10.1016/S0140-6736(04)15670-5; [Anonymous], 2011, LANCET, V377, P1626, DOI 10.1016/S0140-6736(11)60656-9; [Anonymous], 2010, BERKELEY DECLARATION; [Anonymous], 2011, HIV AIDS KENYA MAJOR; Attaran A, 2011, J INT CRIM JUSTICE, V9, P325, DOI 10.1093/jicj/mqr005; Bate R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002132; Bate R, 2010, LANCET, V376, P1446, DOI 10.1016/S0140-6736(10)61416-X; Beni S, 2011, ANAL BIOANAL CHEM, V399, P527, DOI 10.1007/s00216-010-4121-x; Callard C, 2010, TOB CONTROL, V19, P285, DOI 10.1136/tc.2009.035071; China State Council, 2012, NAT 12 5 YEAR PLAN D; Choudary A., 2012, POLICE BODY RECOMMEN; Cockburn R, 2005, PLOS MED, V2, P302, DOI 10.1371/journal.pmed.0020100; Council of Europe, 2011, CONV COUNT MED PROD; Erhun WO., 2001, J HLTH POPULATION DE, V4, P23; European Commission, 2011, REP EU CUST ENF INT; Fitz-Maurice E, 1932, AM J INT LAW, V26, P533, DOI 10.2307/2190203; Garrett L, ENSURING SAFETY INTE; India Parliamentary Standing Committee on Health and Family Welfare, 2012, 59 IND PARL STAND CO; Kubic TT, 2010, J BIOLAW BUS, V13, P38; Molzon JA, 2011, CLIN PHARMACOL THER, V89, P503, DOI 10.1038/clpt.2011.10; Mullard A, 2010, LANCET, V375, P1335, DOI 10.1016/S0140-6736(10)60560-0; Newton PN, 2006, PLOS MED, V3, P752, DOI 10.1371/journal.pmed.0030197; Newton PN, 2006, LANCET INFECT DIS, V6, P602, DOI 10.1016/S1473-3099(06)70581-3; Newton PN, 2002, BRIT MED J, V324, P800, DOI 10.1136/bmj.324.7341.800; Nordt SP, 2010, AM J CARDIOVASC DRUG, V10, P261, DOI 10.2165/11537640-000000000-00000; Okie S, 2009, NEW ENGL J MED, V361, P737, DOI 10.1056/NEJMp0903870; Oxfam, 2011, EYE BALL MED REG NOT; People's Health Movement, 2011, IT CONS 64 WHA; Pew Charitable Trusts, 2011, HEP PROT CONS RISKS; Schep LJ, 2009, CLIN TOXICOL, V47, P525, DOI 10.1080/15563650903086444; Third World Network, 2010, WHOS COUNT PROGR LEG; United Nations Office on Drugs and Crime, 2010, GLOBALIZATION CRIME; Von Braun J, 2010, AFR J INT COMP LAW, V18, P238, DOI 10.3366/ajicl.2010.0007; Weaver CM, 2012, WALL STREET J; WHO, 2011, WHOS ROL PREV CONTR; WHO, 2011, WHO PREQ MED PROGR F; WHO, 2011, FALS LAM ZID NEV TAB; WHO and IMPACT, 2006, COUNT MED UPD EST; World Health Organization, 2010, COUNT MED PROD REP S; World Health Organization, 2011, REP WORK GROUP MEMB; World Health Organization, INT PHARM; World Trade Organization, 1994, TRAD REL ASP INT PRO; [No title captured]	43	65	65	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 13	2012	345								e7381	10.1136/bmj.e7381	http://dx.doi.org/10.1136/bmj.e7381			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040PU	23149211	Bronze, Green Submitted			2022-12-28	WOS:000311335800015
J	Auth, MKH; Vora, R; Farrelly, P; Baillie, C				Auth, Marcus K. H.; Vora, Rakesh; Farrelly, Paul; Baillie, Colin			Childhood constipation	BRITISH MEDICAL JOURNAL			English	Review							SLOW-TRANSIT CONSTIPATION; TERM-FOLLOW-UP; IDIOPATHIC CONSTIPATION; RANDOMIZED-TRIAL; FECAL IMPACTION; COLONIC TRANSIT; CHILDREN; EPIDEMIOLOGY; DISEASE; ENEMA		[Auth, Marcus K. H.] Alder Hey Childrens NHS Fdn Trust, Dept Paediat Gastroenterol, Liverpool L12 2AP, Merseyside, England; Alder Hey Childrens NHS Fdn Trust, Dept Gen Surg, Liverpool L12 2AP, Merseyside, England	Alder Hey Children's NHS Foundation Trust; Alder Hey Children's NHS Foundation Trust	Auth, MKH (corresponding author), Alder Hey Childrens NHS Fdn Trust, Dept Paediat Gastroenterol, Liverpool L12 2AP, Merseyside, England.	marcus.auth@alderhey.nhs.uk						[Anonymous], 2010, CONST CHILDR YOUNG P; [Anonymous], 2006, J PEDIAT GASTROENTER, V43, P405; [Anonymous], 2012, BMJ GROUP, P64; Asipu D, 2010, ARCH DIS CHILD, V95, P867, DOI 10.1136/adc.2009.172973; Bekkali NLH, 2010, J PEDIATR-US, V156, P461, DOI 10.1016/j.jpeds.2009.09.048; Bekkali NLH, 2009, PEDIATRICS, V124, pE1108, DOI 10.1542/peds.2009-0022; Bennett WE, 2012, J PEDIATR GASTR NUTR, V54, P285, DOI 10.1097/MPG.0b013e318239714f; Benninga M, 2005, J PEDIATR GASTR NUTR, V40, P273, DOI 10.1097/01.MPG.0000158071.24327.88; Benninga MA, 1996, J PEDIATR GASTR NUTR, V23, P241, DOI 10.1097/00005176-199610000-00007; Benninga MA, 2004, J PEDIATR GASTR NUTR, V39, P448, DOI 10.1097/00005176-200411000-00002; Berger MY, 2012, J PEDIAT, V161, P44; Blum NJ, 2004, PEDIATRICS, V113, pE520, DOI 10.1542/peds.113.6.e520; Boccia G, 2007, J PEDIATR-US, V151, P394, DOI 10.1016/j.jpeds.2007.04.011; Castillejo G, 2006, PEDIATRICS, V118, pE641, DOI 10.1542/peds.2006-0090; FREEMAN NV, 1984, J ROY SOC MED, V77, P6; Godbole PP, 2001, EUR J PEDIATR SURG, V11, P48, DOI 10.1055/s-2001-12203; Gordon M, 2011, COCHRANE DB SYST REV, V5; Jaffray B, 2009, J PEDIATR SURG, V44, P404, DOI 10.1016/j.jpedsurg.2008.10.097; Kenny SE, 2001, ARCH DIS CHILD, V85, P404, DOI 10.1136/adc.85.5.404; Keshtgar AS, 2007, J PEDIATR SURG, V42, P672, DOI 10.1016/j.jpedsurg.2006.12.045; Keshtgar AS, 2005, PEDIATR SURG INT, V21, P100, DOI 10.1007/s00383-004-1336-y; KeuzenkampJansen CW, 1996, ARCH DIS CHILD, V75, P36, DOI 10.1136/adc.75.1.36; King SK, 2005, J PEDIATR SURG, V40, P1935, DOI 10.1016/j.jpedsurg.2005.08.011; Lewis NA, 2003, J PEDIATR SURG, V38, P412, DOI 10.1053/jpsu.2003.50070; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Loening-Baucke V, 2002, PRACTICAL GASTRO NOV, P13; Mugie SM, 2011, BEST PRACT RES CL GA, V25, P3, DOI 10.1016/j.bpg.2010.12.010; Pang KH, 2011, PEDIATR SURG INT, V27, P353, DOI 10.1007/s00383-010-2680-8; Pelleboer RAA, 2012, J PEDIAT-BRAZIL, V88, P173, DOI 10.2223/JPED.2155; Tabbers MM, 2011, PEDIATRICS, V128, P753, DOI 10.1542/peds.2011-0179; Tabbers MM, 2010, CLIN EVIDENCE BMJ OV; TOLIA V, 1993, ALIMENT PHARM THERAP, V7, P523; van den Berg MM, 2006, AM J GASTROENTEROL, V101, P2401, DOI 10.1111/j.1572-0241.2006.00771.x; van Ginkel R, 2003, GASTROENTEROLOGY, V125, P357, DOI 10.1016/S0016-5085(03)00888-6; vanderPlas RN, 1996, ARCH DIS CHILD, V75, P367, DOI 10.1136/adc.75.5.367	35	16	16	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 13	2012	345								e7309	10.1136/bmj.e7309	http://dx.doi.org/10.1136/bmj.e7309			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040PU	23150472				2022-12-28	WOS:000311335800016
J	van de Beek, D; Brouwer, MC; Thwaites, GE; Tunkel, AR				van de Beek, Diederik; Brouwer, Matthijs C.; Thwaites, Guy E.; Tunkel, Allan R.			Advances in treatment of bacterial meningitis	LANCET			English	Article							NEISSERIA-MENINGITIDIS; CEREBROSPINAL-FLUID; DEXAMETHASONE THERAPY; ADJUNCTIVE DEXAMETHASONE; PNEUMOCOCCAL MENINGITIS; LISTERIA-MONOCYTOGENES; ANTIBIOTIC-THERAPY; UNITED-STATES; DOUBLE-BLIND; ADULTS	Bacterial meningitis kills or maims about a fifth of people with the disease. Early antibiotic treatment improves outcomes, but the effectiveness of widely available antibiotics is threatened by global emergence of multidrug-resistant bacteria. New antibiotics, such as fluoroquinolones, could have a role in these circumstances, but clinical data to support this notion are scarce. Additionally, whether or not adjunctive anti-inflammatory therapies (eg, dexamethasone) improve outcomes in patients with bacterial meningitis remains controversial; in resource-poor regions, where the disease burden is highest, dexamethasone is ineffective. Other adjunctive therapeutic strategies, such as glycerol, paracetamol, and induction of hypothermia, are being tested further. Therefore, bacterial meningitis is a substantial and evolving therapeutic challenge. We review this challenge, with a focus on strategies to optimise antibiotic efficacy in view of increasingly drug-resistant bacteria, and discuss the role of current and future adjunctive therapies.	[van de Beek, Diederik; Brouwer, Matthijs C.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, Ctr Infect & Immun Amsterdam CINIMA, NL-1100 DD Amsterdam, Netherlands; [Thwaites, Guy E.] Kings Coll London, Dept Infect Dis, Ctr Clin Infect & Diagnost Res, London WC2R 2LS, England; [Thwaites, Guy E.] Guys & St Thomas NHS Fdn Trust, London, England; [Tunkel, Allan R.] Monmouth Med Ctr, Dept Med, Long Branch, NJ USA	University of Amsterdam; Academic Medical Center Amsterdam; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	van de Beek, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurol, Ctr Infect & Immun Amsterdam CINIMA, POB 22660, NL-1100 DD Amsterdam, Netherlands.	d.vandebeek@amc.uva.nl	Thwaites, Guy E/R-4993-2019; van de Beek, Diederik/Y-2713-2019	Thwaites, Guy E/0000-0002-2858-2087; van de Beek, Diederik/0000-0002-4571-044X				Ajdukiewicz KMB, 2011, LANCET INFECT DIS, V11, P293, DOI 10.1016/S1473-3099(10)70317-0; Andes DR, 1999, INFECT DIS CLIN N AM, V13, P595, DOI 10.1016/S0891-5520(05)70096-9; Appelbaum PC, 2002, CLIN INFECT DIS, V34, P1613, DOI 10.1086/340400; Auburtin M, 2006, CRIT CARE MED, V34, P2758, DOI 10.1097/01.CCM.0000239434.26669.65; Brouwer MC, 2010, NEUROLOGY, V75, P1533, DOI 10.1212/WNL.0b013e3181f96297; Brouwer MC, 2006, CLIN INFECT DIS, V43, P1233, DOI 10.1086/508462; Brouwer MC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004405.pub3; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Cubells CL, 1997, ACTA PAEDIATR, V86, P26, DOI 10.1111/j.1651-2227.1997.tb08826.x; Daoud AS, 1999, EUR J PEDIATR, V158, P230, DOI 10.1007/s004310051056; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; EAGLE H, 1953, NEW ENGL J MED, V248, P481, DOI 10.1056/NEJM195303192481201; Egermann U, 2009, ANTIMICROB AGENTS CH, V53, P3030, DOI 10.1128/AAC.00952-08; Galimand M, 1998, NEW ENGL J MED, V339, P868, DOI 10.1056/NEJM199809243391302; Guardado AR, 2008, J ANTIMICROB CHEMOTH, V61, P908, DOI 10.1093/jac/dkn018; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Heckenberg SGB, 2012, NEUROLOGY, V79, P1563, DOI 10.1212/WNL.0b013e31826e2684; Hedberg ST, 2009, ANTIMICROB AGENTS CH, V53, P1561, DOI 10.1128/AAC.00994-08; Hirakata Y, 2009, ANTIMICROB AGENTS CH, V53, P4225, DOI 10.1128/AAC.00192-09; Hoogman M, 2007, J NEUROL NEUROSUR PS, V78, P1092, DOI 10.1136/jnnp.2006.110023; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Karageorgopoulos DE, 2009, ARCH DIS CHILD, V94, P607, DOI 10.1136/adc.2008.151563; KILPI T, 1995, PEDIATR INFECT DIS J, V14, P270, DOI 10.1097/00006454-199504000-00005; Kim BN, 2009, LANCET INFECT DIS, V9, P245, DOI 10.1016/S1473-3099(09)70055-6; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Klugman KP, 2008, PEDIATR INFECT DIS J, V27, P671, DOI 10.1097/INF.0b013e31817709cf; Latorre C, 2000, ACTA PAEDIATR, V89, P661, DOI 10.1080/080352500750043954; Le J, 2010, ANN PHARMACOTHER, V44, P2001, DOI 10.1345/aph.1P333; Lee DH, 2008, CLIN INFECT DIS, V47, P588, DOI 10.1086/590257; Lindvall P, 2004, CLIN INFECT DIS, V38, P384, DOI 10.1086/380970; Lodise TP, 2007, DIAGN MICR INFEC DIS, V58, P445, DOI 10.1016/j.diagmicrobio.2007.03.015; Lutsar I, 2003, J ANTIMICROB CHEMOTH, V52, P651, DOI 10.1093/jac/dkg417; Lutsar I, 1998, ANTIMICROB AGENTS CH, V42, P2650, DOI 10.1128/AAC.42.10.2650; Mai NTH, 2007, NEW ENGL J MED, V357, P2431, DOI 10.1056/NEJMoa070852; MCCRACKEN GH, 1980, LANCET, V1, P787; MCCRACKEN GH, 1976, J PEDIATR-US, V89, P66, DOI 10.1016/S0022-3476(76)80929-8; MerleMelet M, 1996, J INFECTION, V33, P79, DOI 10.1016/S0163-4453(96)92929-1; Miranda J, 2009, INFECT DIS CLIN N AM, V23, P925, DOI 10.1016/j.idc.2009.06.014; Mitja O, 2009, J ANTIMICROB CHEMOTH, V64, P416, DOI 10.1093/jac/dkp180; Moissenet D, 2010, J CLIN MICROBIOL, V48, P2459, DOI 10.1128/JCM.00529-10; Molyneux E, 2011, LANCET, V377, P1837, DOI 10.1016/S0140-6736(11)60580-1; Molyneux EM, 2002, LANCET, V360, P211, DOI 10.1016/S0140-6736(02)09458-8; Mook-Kanamori BB, 2011, CLIN MICROBIOL REV, V24, P557, DOI 10.1128/CMR.00008-11; Moran JL, 2010, CRIT CARE, V14, DOI 10.1186/cc9182; Mylonakis E, 1998, MEDICINE, V77, P313, DOI 10.1097/00005792-199809000-00002; Nalda-Molina R, 2012, J ANTIMICROB CHEMOTH, V67, P1722, DOI 10.1093/jac/dks106; Nathan N, 2005, LANCET, V366, P308, DOI 10.1016/S0140-6736(05)66792-X; Nau R, 2010, CLIN MICROBIOL REV, V23, P858, DOI 10.1128/CMR.00007-10; Ntziora F, 2007, ANN PHARMACOTHER, V41, P296, DOI 10.1345/aph.1H307; Ostergaard C, 1998, ANTIMICROB AGENTS CH, V42, P1706; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Pelkonen T, 2011, LANCET INFECT DIS, V11, P613, DOI 10.1016/S1473-3099(11)70055-X; PELTOLA H, 1989, LANCET, V1, P1281; Peltola H, 2007, CLIN INFECT DIS, V45, P1277, DOI 10.1086/522534; RAHAL JJ, 1974, NEW ENGL J MED, V290, P1394, DOI 10.1056/NEJM197406202902502; Ray L, 2010, ANN PHARMACOTHER, V44, P582, DOI 10.1345/aph.1M480; Reingold A., 2008, Morbidity and Mortality Weekly Report, V57, P1353; Ricard JD, 2007, CLIN INFECT DIS, V44, P250, DOI 10.1086/510390; Roberts JA, 2009, CRIT CARE MED, V37, P2071, DOI 10.1097/CCM.0b013e3181a0054d; Rosenstein NE, 2000, CLIN INFECT DIS, V30, P212, DOI 10.1086/313599; Saez-Llorens X, 2002, PEDIATR INFECT DIS J, V21, P14, DOI 10.1097/00006454-200201000-00004; Scarborough M, 2008, LANCET NEUROL, V7, P637, DOI 10.1016/S1474-4422(08)70139-X; Scarborough M, 2007, NEW ENGL J MED, V357, P2441, DOI 10.1056/NEJMoa065711; SCHAAD UB, 1990, NEW ENGL J MED, V322, P141, DOI 10.1056/NEJM199001183220301; Schut ES, 2009, NEUROLOGY, V73, P1988, DOI 10.1212/WNL.0b013e3181c55d2e; Schut ES, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-57; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; SYROGIANNOPOULOS GA, 1994, J INFECT DIS, V169, P853, DOI 10.1093/infdis/169.4.853; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van de Beek D, 2006, NAT CLIN PRACT NEURO, V2, P504, DOI 10.1038/ncpneuro0265; van de Beek D, 2010, LANCET NEUROL, V9, P254, DOI 10.1016/S1474-4422(10)70023-5; van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573; Visintin Cristina, 2010, BMJ, V340, pc3209, DOI 10.1136/bmj.c3209; Weisfelt M, 2006, ANN NEUROL, V60, P456, DOI 10.1002/ana.20944; Woehrl B, 2011, J CLIN INVEST, V121, P3943, DOI 10.1172/JCI57522; World Health Organization, 2007, STAND TREATM BACT ME; Wu HM, 2009, NEW ENGL J MED, V360, P886, DOI 10.1056/NEJMoa0806414; Yogev R, 2010, PEDIATR INFECT DIS J, V29, P827, DOI 10.1097/INF.0b013e3181df4b9a; Zoons E, 2008, NEUROLOGY, V70, P2109, DOI 10.1212/01.wnl.0000288178.91614.5d	83	168	172	3	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2012	380	9854					1693	1702		10.1016/S0140-6736(12)61186-6	http://dx.doi.org/10.1016/S0140-6736(12)61186-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035MN	23141618				2022-12-28	WOS:000310951400032
J	Gu, S; Jin, L; Zhang, Y; Huang, Y; Zhang, FJ; Valdmanis, PN; Kay, MA				Gu, Shuo; Jin, Lan; Zhang, Yue; Huang, Yong; Zhang, Feijie; Valdmanis, Paul N.; Kay, Mark A.			The Loop Position of shRNAs and Pre-miRNAs Is Critical for the Accuracy of Dicer Processing In Vivo	CELL			English	Article							RNA-INTERFERENCE; STRUCTURAL BASIS; HELICASE DOMAIN; MESSENGER-RNAS; RECOGNITION; EXPRESSION; MICRORNAS; BIOGENESIS; EFFICIENT; TERMINI	Short hairpin RNA (shRNA)-induced RNAi is used for biological discovery and therapeutics. Dicer, whose normal role is to liberate endogenous miRNAs from their precursors, processes shRNAs into different biologically active siRNAs, affecting their efficacy and potential for off-targeting. We found that, in cells, Dicer induced imprecise cleavage events around the expected sites based on the previously described 50/30 counting rules. These promiscuous noncanonical cleavages were abrogated when the cleavage site was positioned 2 nt from a bulge or loop. Interestingly, we observed that the similar to 1/3 of mammalian endogenous pre-miRNAs that contained such structures were more precisely processed by Dicer. Implementing a "loop-counting rule," we designed potent anti-HCV shRNAs with substantially reduced off-target effects. Our results suggest that Dicer recognizes the loop/bulge structure in addition to the ends of shRNAs/pre-miRNAs for accurate processing. This has important implications for both miRNA processing and future design of shRNAs for RNAi-based genetic screens and therapies.	[Gu, Shuo; Jin, Lan; Zhang, Yue; Huang, Yong; Zhang, Feijie; Valdmanis, Paul N.; Kay, Mark A.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Gu, Shuo; Jin, Lan; Zhang, Yue; Huang, Yong; Zhang, Feijie; Valdmanis, Paul N.; Kay, Mark A.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Kay, MA (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.	markay@stanford.edu	Gu, Shuo/K-5404-2016	Valdmanis, Paul/0000-0001-8840-6969; Gu, Shuo/0000-0002-7924-5363; Kay, Mark/0000-0002-2799-2615	NIH [DK 078424, AI071068]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078424] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH DK 078424 (M. A. K.) and NIH AI071068 (M. A. K.). We thank Dr. Grace Zheng for the Dicer KO ES cells and Dr. George Mias for helpful discussions on statistical methods.	Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gu S, 2011, P NATL ACAD SCI USA, V108, P9208, DOI 10.1073/pnas.1018023108; Gurtan AM, 2012, RNA, V18, P1116, DOI 10.1261/rna.032680.112; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lau PW, 2012, NAT STRUCT MOL BIOL, V19, P436, DOI 10.1038/nsmb.2268; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; Mcintyre GJ, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-34; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Pan QW, 2012, TRENDS BIOTECHNOL, V30, P206, DOI 10.1016/j.tibtech.2012.01.002; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Sawh AN, 2012, NAT STRUCT MOL BIOL, V19, P365, DOI 10.1038/nsmb.2275; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Seitz Herve, 2011, Silence, V2, P4, DOI 10.1186/1758-907X-2-4; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Soifer HS, 2008, NUCLEIC ACIDS RES, V36, P6511, DOI 10.1093/nar/gkn687; Starega-Roslan J, 2011, NUCLEIC ACIDS RES, V39, P257, DOI 10.1093/nar/gkq727; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; Welker NC, 2011, MOL CELL, V41, P589, DOI 10.1016/j.molcel.2011.02.005; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	48	194	206	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 9	2012	151	4					900	911		10.1016/j.cell.2012.09.042	http://dx.doi.org/10.1016/j.cell.2012.09.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141545	Green Accepted, Bronze			2022-12-28	WOS:000310921200019
J	Zhou, XX; Chung, HK; Lam, AJ; Lin, MZ				Zhou, Xin X.; Chung, Hokyung K.; Lam, Amy J.; Lin, Michael Z.			Optical Control of Protein Activity by Fluorescent Protein Domains	SCIENCE			English	Article							SPATIOTEMPORAL CONTROL; LIGHT; ACTIVATION; INDUCTION; GTPASES; CELLS	Fluorescent proteins (FPs) are widely used as optical sensors, whereas other light-absorbing domains have been used for optical control of protein localization or activity. Here, we describe light-dependent dissociation and association in a mutant of the photochromic FP Dronpa, and we used it to control protein activities with light. We created a fluorescent light-inducible protein design in which Dronpa domains are fused to both termini of an enzyme domain. In the dark, the Dronpa domains associate and cage the protein, but light induces Dronpa dissociation and activates the protein. This method enabled optical control over guanine nucleotide exchange factor and protease domains without extensive screening. Our findings extend the applications of FPs from exclusively sensing functions to also encompass optogenetic control.	[Zhou, Xin X.; Chung, Hokyung K.; Lam, Amy J.; Lin, Michael Z.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Lin, Michael Z.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	Stanford University; Stanford University	Lin, MZ (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	mzlin@stanford.edu		Lin, Michael/0000-0002-0492-1961; Zhou, Xin/0000-0002-8198-2856; Chung, H. Kay/0000-0002-7028-2432	Stanford School of Engineering; Stanford Graduate Fellowship; Siebel Foundation Scholarship; Lucille Packard Children's Health Initiative; Burroughs Wellcome Career Award for Medical Scientists; NIH [R01NS076860]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076860] Funding Source: NIH RePORTER	Stanford School of Engineering; Stanford Graduate Fellowship(Stanford University); Siebel Foundation Scholarship; Lucille Packard Children's Health Initiative; Burroughs Wellcome Career Award for Medical Scientists(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Davidson (Florida State University) for pcDNA3-mNeptune-Fascin, N. Shaner and R. Tsien (University of California San Diego) for pBAD-tdTomato, M. Yazawa and R. Dolmetsch (Stanford University) for cell lines and advice, Y. Geng in the Lin laboratory for assistance with plasmid design, and other members of the Lin laboratory. This work was funded by the Stanford School of Engineering and a Stanford Graduate Fellowship (X.X.Z.); a Siebel Foundation Scholarship (A.J.L.); and the Lucille Packard Children's Health Initiative, a Burroughs Wellcome Career Award for Medical Scientists, and NIH grant R01NS076860 (M.Z.L.). M.Z.L. is a Rita Allen Foundation Scholar. X.X.Z. and M.Z.L. are inventors on a patent application filed by Stanford University covering the construct design described in the paper. X.X.Z. designed, executed, and analyzed experiments and cowrote the manuscript. H.K.C. designed, executed, and analyzed experiments. A.J.L. assisted with experimental design. M.Z.L. conceived of the study, directed the project, provided advice, analyzed experiments, and cowrote the manuscript.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Block J, 2012, CURR BIOL, V22, P1005, DOI 10.1016/j.cub.2012.03.064; Faix J, 2009, INT J BIOCHEM CELL B, V41, P1656, DOI 10.1016/j.biocel.2009.02.012; Fan HY, 2011, BIOCHEMISTRY-US, V50, P1226, DOI 10.1021/bi101432p; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Krauss U, 2011, CHEM-EUR J, V17, P2552, DOI 10.1002/chem.201002716; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Leonard TA, 2007, CELL, V129, P1037, DOI 10.1016/j.cell.2007.06.001; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Lin MZ, 2008, P NATL ACAD SCI USA, V105, P7744, DOI 10.1073/pnas.0803060105; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Mizuno H, 2008, P NATL ACAD SCI USA, V105, P9227, DOI 10.1073/pnas.0709599105; Mizuno H, 2010, PHOTOCH PHOTOBIO SCI, V9, P239, DOI 10.1039/b9pp00124g; Moglich A, 2010, PHOTOCH PHOTOBIO SCI, V9, P1286, DOI 10.1039/c0pp00167h; Muller J, 2008, CHEMBIOCHEM, V9, P2029, DOI 10.1002/cbic.200800190; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Powers Hilary J, 2012, Subcell Biochem, V56, P229, DOI 10.1007/978-94-007-2199-9_12; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Riggsbee CW, 2010, TRENDS BIOTECHNOL, V28, P468, DOI 10.1016/j.tibtech.2010.06.001; Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Strickland D, 2008, P NATL ACAD SCI USA, V105, P10709, DOI 10.1073/pnas.0709610105; Strickland D, 2010, NAT METHODS, V7, P623, DOI [10.1038/NMETH.1473, 10.1038/nmeth.1473]; Tyszkiewicz AB, 2008, NAT METHODS, V5, P303, DOI [10.1038/nmeth.1189, 10.1038/NMETH.1189]; Wu YI, 2011, METHOD ENZYMOL, V497, P393, DOI 10.1016/B978-0-12-385075-1.00016-0; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569; Yeh BJ, 2007, NATURE, V447, P596, DOI 10.1038/nature05851; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033	31	204	210	2	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2012	338	6108					810	814		10.1126/science.1226854	http://dx.doi.org/10.1126/science.1226854			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139335	Green Accepted			2022-12-28	WOS:000310839500048
J	Gurbel, PA; Erlinge, D; Ohman, EM; Neely, B; Neely, M; Goodman, SG; Huber, K; Chan, MY; Cornel, JH; Brown, E; Zhou, CM; Jakubowski, JA; White, HD; Fox, KAA; Prabhakaran, D; Armstrong, PW; Tantry, US; Roe, MT				Gurbel, Paul A.; Erlinge, David; Ohman, E. Magnus; Neely, Benjamin; Neely, Megan; Goodman, Shaun G.; Huber, Kurt; Chan, Mark Y.; Cornel, Jan H.; Brown, Eileen; Zhou, Chunmei; Jakubowski, Joseph A.; White, Harvey D.; Fox, Keith A. A.; Prabhakaran, Dorairaj; Armstrong, Paul W.; Tantry, Udaya S.; Roe, Matthew T.		TRILOGY ACS Platelet Function Subs	Platelet Function During Extended Prasugrel and Clopidogrel Therapy for Patients With ACS Treated Without Revascularization The TRILOGY ACS Platelet Function Substudy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS CORONARY INTERVENTION; DOSE CLOPIDOGREL; REACTIVITY; TRIAL	Context The relationship of platelet function testing measurements with outcomes in patients with acute coronary syndromes (ACS) initially managed medically without revascularization is unknown. Objective To characterize the differences and evaluate clinical outcomes associated with platelet reactivity among patients with ACS treated with clopidogrel or prasugrel. Design, Setting, and Patients Patients with medically managed unstable angina or non-ST-segment elevation myocardial infarction were enrolled in the TRILOGY ACS trial (2008 to 2011) comparing clopidogrel vs prasugrel. Of 9326 participants, 27.5% were included in a platelet function substudy: 1286 treated with prasugrel and 1278 treated with clopidogrel. Interventions Aspirin with either prasugrel (10 or 5 mg/d) or clopidogrel (75 mg/d); those 75 years or older and younger than 75 years but who weighed less than 60 kg received a 5-mg prasugrel maintenance dose. Main Outcome Measures Platelet reactivity, measured in P2Y(12) reaction units (PRUs), was performed at baseline, at 2 hours, and at 1, 3, 6, 12, 18, 24, and 30 months after randomization. The primary efficacy end point was a composite of cardiovascular death, myocardial infarction, or stroke through 30 months. Results Among participants younger than 75 years and weighing 60 kg or more, the median PRU values at 30 days were 64 (interquartile range [IQR], 33-128) in the prasugrel group vs 200 (IQR, 141-260) in the clopidogrel group (P<.001), a difference that persisted through all subsequent time points. For participants younger than 75 years and weighing less than 60 kg, the median 30-day PRU values were 139 (IQR, 86-203) for the prasugrel group vs 209 (IQR, 148-283) for the clopidogrel group (P<.001), and for participants 75 years or older, the median PRU values were 164 (IQR, 105-216) for the prasugrel group vs 222 (IQR, 148-268) for the clopidogrel group (P<.001). At 30 months the rate of the primary efficacy end point was 17.2% (160 events) in the prasugrel group vs 18.9% (180 events) in the clopidogrel group (P=.29). There were no significant differences in the continuous distributions of 30-day PRU values for participants with a primary efficacy end point event after 30 days (n=214) compared with participants without an event (n=1794; P=.07) and no significant relationship between the occurence of the primary efficacy end point and continuous PRU values (adjusted hazard ratio [HR] for increase of 60 PRUs, 1.03; 95% CI, 0.96-1.11; P=.44). Similar findings were observed with 30-day PRU cut points used to define high on-treatment platelet reactivity-PRU more than 208 (adjusted HR, 1.16; 95% CI, 0.89-1.52, P=.28) and PRU more than 230 (adjusted HR, 1.20; 95% CI, 0.90-1.61; P=.21). Conclusions Among patients with ACS without ST-segment elevation and initially managed without revascularization, prasugrel was associated with lower platelet reactivity than clopidogrel, irrespective of age, weight, and dose. Among those in the platelet substudy, no significant differences existed between prasugrel vs clopidogrel in the occurence of the primary efficacy end point through 30 months and no significant association existed between platelet reactivity and occurrence of ischemic outcomes.	[Neely, Benjamin; Neely, Megan; Roe, Matthew T.] Duke Clin Res Inst, Durham, NC 27705 USA; [Gurbel, Paul A.; Tantry, Udaya S.] Sinai Ctr Thrombosis Res, Baltimore, MD USA; [Erlinge, David] Lund Univ, Dept Cardiol, Lund, Sweden; [Ohman, E. Magnus; Roe, Matthew T.] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Goodman, Shaun G.] Univ Toronto, St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Huber, Kurt] Wilhelminenhosp, Dept Internal Med Cardiol & Emergency Med 3, Med Abt Kardiol, Vienna, Austria; [Chan, Mark Y.] Natl Univ Heart Ctr, Singapore, Singapore; [Cornel, Jan H.] Med Ctr Alkmaar, Alkmaar, Netherlands; [Brown, Eileen; Zhou, Chunmei; Jakubowski, Joseph A.] Eli Lilly & Co, Indianapolis, IN 46285 USA; [White, Harvey D.] Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New Zealand; [Fox, Keith A. A.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Armstrong, Paul W.] Univ Alberta, Div Cardiol, Edmonton, AB, Canada	Duke University; Sinai Center Thrombosis Research; Sinai Hospital of Baltimore; Lund University; Duke University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Wilhelminenspital; National University of Singapore; Medical Center Of Alkmaar; Eli Lilly; Auckland City Hospital; University of Edinburgh; University of Alberta	Roe, MT (corresponding author), Duke Clin Res Inst, 2400 Pratt St,Room 7035, Durham, NC 27705 USA.	matthew.roe@duke.edu	Fox, keith A A/I-3742-2013; Chan, Mark/K-4988-2013; cornel, jan hein/Y-7065-2019; Chan, Yan Yee Mark/ABE-1929-2021; Prabhakaran, Dorairaj/B-4147-2011	cornel, jan hein/0000-0002-1006-2112; Chan, Yan Yee Mark/0000-0003-0389-7450; Prabhakaran, Dorairaj/0000-0002-3172-834X; Armstrong, Paul/0000-0002-0460-3445	National Institutes of Health; Daiichi Sankyo; Lilly; Pozen; CSL; AstraZeneca; sanofi-aventis; Haemoscope; Medtronic; Harvard Clinical Research Institute; Duke Clinical Research Institute; Eli Lilly Co; Boehringer Ingelheim; Bristol-Myers Squibb; Gilead Sciences; Janssen Pharmaceuticals; Liposcience; Liposcience, Merck; Hoffmann-LaRoche; Medicines Company; WebMD; Bayer Healthcare; NIH; Pfizer; Roche; Johnson Johnson; Schering-Plough; Merck Sharp Dohme; Axio Research; Orexigen; Scios Inc; Ortho Biotech; Amylin Pharmaceuticals Inc; Merck; Novartis; KAI Pharmaceuticals; Helsinn Pharmaceuticals; Regeneron; Eli Lilly	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Daiichi Sankyo(Daiichi Sankyo Company Limited); Lilly(Eli Lilly); Pozen; CSL; AstraZeneca(AstraZeneca); sanofi-aventis(Sanofi-Aventis); Haemoscope; Medtronic(Medtronic); Harvard Clinical Research Institute; Duke Clinical Research Institute; Eli Lilly Co(Eli Lilly); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Liposcience; Liposcience, Merck; Hoffmann-LaRoche(Hoffmann-La Roche); Medicines Company; WebMD; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); Roche(Roche Holding); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Schering-Plough(Merck & CompanySchering Plough Corporation); Merck Sharp Dohme(Merck & Company); Axio Research; Orexigen; Scios Inc; Ortho Biotech; Amylin Pharmaceuticals Inc(Bristol-Myers Squibb); Merck(Merck & Company); Novartis(Novartis); KAI Pharmaceuticals; Helsinn Pharmaceuticals; Regeneron(Regeneron); Eli Lilly(Eli Lilly)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Gurbel reports serving as a consultant for Daiichi Sankyo, Lilly, Pozen, Novartis, Bayer, AstraZeneca, Accumetrics, Nanosphere, sanofi-aventis, Boehringer Ingelheim, Merck, Medtronic, Iverson Genetics, CSL, and Haemonetics; receiving grants from the National Institutes of Health, Daiichi Sankyo, Lilly, Pozen, CSL, AstraZeneca, sanofi-aventis, Haemoscope, Medtronic, Harvard Clinical Research Institute, and Duke Clinical Research Institute; receiving payment for lectures, including service on speakers' bureaus, from Lilly, Daiichi Sankyo, Nanosphere, sanofi-aventis, Merck, and Iverson Genetics; receiving payment for development of educational presentations from Schering-Plough, the Discovery Channel, and Pri-Med; holding stock or stock options in Merck, Medtronic, and Pfizer; and holding patents in the area of personalized antiplatelet therapy and interventional cardiology. Dr Erlinge reports serving on advisory boards for AstraZeneca, Lilly, and Boehringer Ingelheim and receiving speaking fees from AstraZeneca and Lilly. Dr E. Magnus Ohman reports receiving grant funding and travel expenses from Daiichi Sankyo and Eli Lilly & Co; consulting fees from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Liposcience, Merck, Pozen, Hoffmann-LaRoche, sanofi-aventis, The Medicines Company, and WebMD; grant funding from Gilead Sciences; and lecture fees from Gilead Sciences, Boehringer Ingelheim, and The Medicines Company. Dr Goodman reports receiving grant funding from the Duke Clinical Research Institute, Eli Lilly & Co, sanofi-aventis, Bristol-Myers Squibb, and AstraZeneca; travel expenses from the Duke Clinical Research Institute; consulting fees from Eli Lilly & Co, sanofi-aventis, Bristol-Myers Squibb, and AstraZeneca; and payment for developing presentations and lecture fees from Eli Lilly & Co, sanofi-aventis, Bristol-Myers Squibb, and AstraZeneca. Disclosure information for Dr Chan reports receiving institutional grants and consulting fees from Eli Lilly & Co, Bayer Healthcare, and AstraZeneca and travel support from Eli Lilly & Co. Dr Cornel reports serving as a board member for Eli Lilly & Co, Daiichi Sankyo, and AstraZeneca and receiving consulting fees from Merck. Drs Brown and Jakubowski and Ms Zhou are employees of Eli Lilly & Co and all three report that they own Lilly stock. Dr White reports receiving grant funding from sanofi-aventis, Eli Lilly & Co, The Medicines Company, NIH, Pfizer, Roche, Johnson & Johnson, Schering-Plough, Merck Sharp& Dohme, AstraZeneca, GlaxoSmithKline, Daiichi Sankyo, and Bristol-Myers Squibb; serving as a board member for Merck Sharp & Dohme and Regado Biosciences. Dr Fox reports receiving grant funding from Eli Lilly & Co, Bayer, Johnson & Johnson, and AstraZeneca; travel expenses from Eli Lilly & Co; consulting fees from Eli Lilly & Co, Bayer, Johnson & Johnson, AstraZeneca, sanofi-aventis, and Boehringer Ingelheim; and lecture fees from Bayer, Johnson & Johnson, AstraZeneca, and sanofi-aventis. Dr Prabhakaran reports receiving consulting fees from Eli Lilly & Co.; Dr Armstrong reports receiving consulting fees from Eli Lilly & Co, Hoffmann-La Roche, Merck, Axio Research, and Orexigen; grant funding from Boehringer Ingelheim, Hoffmann-LaRoche, sanofi-aventis, Scios Inc, Ortho Biotech, Johnson & Johnson, Janssen Pharmaceuticals, GlaxoSmithKline, Amylin Pharmaceuticals Inc, and Merck; and payment for developing educational presentations from AstraZeneca and Eli Lilly & Co. Dr Tantry reports receiving payment for lectures and receiving travel support from Accumetrics. Dr Roe reports receiving grant funding from Eli Lilly & Co, Bristol-Myers Squibb, Hoffmann-La Roche, Novartis, Schering-Plough, and KAI Pharmaceuticals; consulting fees from Eli Lilly & Co and Daiichi Sankyo, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Janssen Pharmaceuticals, KAI Pharmaceuticals, sanofi-aventis, Helsinn Pharmaceuticals, Regeneron, Novartis, AstraZeneca, and Orexigen and lecture fees from AstraZeneca and Janssen Pharmaceuticals. Mr B. Neely and Drs M. Neely and Huber report no conflicts of interest.; The TRILOGY ACS study was funded by Eli Lilly and Daiichi Sankyo.	Aradi D, 2010, AM HEART J, V160, P543, DOI 10.1016/j.ahj.2010.06.004; Campo G, 2011, J AM COLL CARDIOL, V57, P2474, DOI 10.1016/j.jacc.2010.12.047; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Erlinge D, 2012, EUR HEART J, V33, P675; Erlinge D, 2012, J AM COLL CARDIOL, V60, P2032, DOI 10.1016/j.jacc.2012.08.964; Gurbel Paul A, 2004, Expert Rev Cardiovasc Ther, V2, P535, DOI 10.1586/14779072.2.4.535; Gurbel PA, 2012, THROMB HAEMOSTASIS, V108, P12, DOI 10.1160/TH12-01-0039; Gurbel PA, 2012, CIRCULATION, V125, P1276, DOI 10.1161/CIRCULATIONAHA.111.031195; Jakubowski JA, 2007, CARDIOVASC DRUG REV, V25, P357, DOI 10.1111/j.1527-3466.2007.00027.x; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Silvain J, 2012, EUR HEART J, V33, P1241, DOI 10.1093/eurheartj/ehr407; Stone GW, 2011, TRANSC CARD THER 23; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026; Wiviott SD, 2007, CIRCULATION, V116, P2923, DOI 10.1161/CIRCULATIONAHA.107.740324	15	182	196	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1785	1794		10.1001/jama.2012.17312	http://dx.doi.org/10.1001/jama.2012.17312			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117779				2022-12-28	WOS:000310726500025
J	Shaughnessy, AF				Shaughnessy, Allen F.			Meningitis outbreak shines light on compounding pharmacies	BRITISH MEDICAL JOURNAL			English	Editorial Material									Tufts Univ, Sch Med, Boston, MA 02111 USA	Tufts University	Shaughnessy, AF (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.	Allen.Shaughnessy@Tufts.edu						Ballentine Carol, 1981, FDA CONSUMER MAG JUN; Centers for Disease Control and Prevention, MULT FUNG MEN OUTBR; EMLab P& K, 2011, USP 797 STAND GUID U; Lam Carol, PHARM COMPOUNDING RE; Lamb E, EARN PHARM COMPOUNDI; Pharmaceutical Commerce, 2012, DRUG SHORT 2012 WORS; Silverman E., 2012, PHARMALOT       1005; US Food and Drug Administration, 2012, QUEST ANSW FUNG MEN	8	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 5	2012	345								e7432	10.1136/bmj.e7432	http://dx.doi.org/10.1136/bmj.e7432			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	036KY	23129491				2022-12-28	WOS:000311026000005
J	Ling, QH; Huang, WH; Baldwin, A; Jarvis, P				Ling, Qihua; Huang, Weihua; Baldwin, Amy; Jarvis, Paul			Chloroplast Biogenesis Is Regulated by Direct Action of the Ubiquitin-Proteasome System	SCIENCE			English	Article							MITOCHONDRIAL E3; IMPORT RECEPTOR; ARABIDOPSIS; LIGASE; PROTEINS; PLASTIDS; DEGRADATION; PATHWAYS; DYNAMICS; NUCLEUS	Development of chloroplasts and other plastids depends on the import of thousands of nucleus-encoded proteins from the cytosol. Import is initiated by TOC (translocon at the outer envelope of chloroplasts) complexes in the plastid outer membrane that incorporate multiple, client-specific receptors. Modulation of import is thought to control the plastid's proteome, developmental fate, and functions. Using forward genetics, we identified Arabidopsis SP1, which encodes a RING-type ubiquitin E3 ligase of the chloroplast outer membrane. The SP1 protein associated with TOC complexes and mediated ubiquitination of TOC components, promoting their degradation. Mutant sp1 plants performed developmental transitions that involve plastid proteome changes inefficiently, indicating a requirement for reorganization of the TOC machinery. Thus, the ubiquitin-proteasome system acts on plastids to control their development.	[Ling, Qihua; Huang, Weihua; Baldwin, Amy; Jarvis, Paul] Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England	University of Leicester	Jarvis, P (corresponding author), Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England.	rpj3@le.ac.uk	Huang, Weihua/GVS-4853-2022	Ling, Qihua/0000-0002-6984-9921; Baldwin, Amy/0000-0002-2162-3771; Jarvis, Paul/0000-0003-2127-5671	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D016541/1, BB/H008039/1]; Royal Society Rosenheim Research Fellowship; Royal Society International Incoming Fellowship; Biotechnology and Biological Sciences Research Council [BB/H008039/1, BB/D016541/1] Funding Source: researchfish; BBSRC [BB/H008039/1, BB/D016541/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society Rosenheim Research Fellowship; Royal Society International Incoming Fellowship(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank M. Rashbrooke for assistance with initial phenotype analyses and rough mapping of sp1; U. Ranganathan for her contribution to the analysis of SPL1; R. Patel and R. Berkeley for excellent technical assistance; N. Allcock and S. Hyman for electron microscopy (EM) carried out within the EM Laboratory, University of Leicester; C. Dean and R. Trosch for helpful comments on the manuscript; U. Flores-Perez for antigen preparation (atToc132 and atToc34); M. Boutry (PMA2), N. E. Hoffman (LHCP), K. Inoue (OEP80), F. Kessler (atToc159), and G. Thorlby (SFR2) for antibodies; C. E. Stebbins for the AtUBC8 clone; and the Salk Institute Genomic Analysis Laboratory (SIGnAL) and the Nottingham Arabidopsis Stock Centre (NASC) for the sp1-2 and sp1-3 alleles. This study was supported by grants from the Biotechnology and Biological Sciences Research Council (BBSRC; BB/D016541/1 and BB/H008039/1) to P.J., by the Royal Society Rosenheim Research Fellowship to P.J., and by a Royal Society International Incoming Fellowship to W. H. This work is the subject of patent application number GB 1216090.9, which covers the role of the ubiquitin-proteasome system in the control of plastid development. The data are presented in the manuscript and in the supplementary materials.	Barsan C, 2010, J EXP BOT, V61, P2413, DOI 10.1093/jxb/erq070; Basnayake BMVS, 2011, PLANT CELL REP, V30, P37, DOI 10.1007/s00299-010-0941-6; Bauer J, 2000, NATURE, V403, P203, DOI 10.1038/35003214; Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Huang WH, 2006, PLANT CELL, V18, P2479, DOI 10.1105/tpc.106.045013; Huang WH, 2011, PLANT PHYSIOL, V157, P147, DOI 10.1104/pp.111.181891; Ivanova Y, 2004, MOL BIOL CELL, V15, P3379, DOI 10.1091/mbc.E03-12-0923; Jarvis P, 1998, SCIENCE, V282, P100, DOI 10.1126/science.282.5386.100; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kessler F, 2006, TRAFFIC, V7, P248, DOI 10.1111/j.1600-0854.2005.00382.x; Kleffmann T, 2007, PLANT PHYSIOL, V143, P912, DOI 10.1104/pp.106.090738; Kubis S, 2003, PLANT CELL, V15, P1859, DOI 10.1105/tpc.012955; Lee S, 2009, PLANT CELL, V21, P3984, DOI 10.1105/tpc.109.071548; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; Lu DP, 2011, SCIENCE, V332, P1439, DOI 10.1126/science.1204903; Mochizuki N, 1996, PLANT PHYSIOL, V112, P1465, DOI 10.1104/pp.112.4.1465; Myung J, 2001, MED RES REV, V21, P245, DOI 10.1002/med.1009.abs; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Shen GX, 2007, PLANT J, V52, P309, DOI 10.1111/j.1365-313X.2007.03239.x; Stanga JP, 2009, PLANT PHYSIOL, V149, P1896, DOI 10.1104/pp.109.135301; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748; Zhang BC, 2008, CELL RES, V18, P900, DOI 10.1038/cr.2008.75	29	165	177	10	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107					655	659		10.1126/science.1225053	http://dx.doi.org/10.1126/science.1225053			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118188				2022-12-28	WOS:000310516000050
J	Lloyd, S				Lloyd, Seth			Quantum Procrastination	SCIENCE			English	Editorial Material									MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Lloyd, S (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	slloyd@mit.edu						Bell J. S., 1964, PHYS REV LETT, V1, P3; Jacques V, 2007, SCIENCE, V315, P966, DOI 10.1126/science.1136303; Kaiser F, 2012, SCIENCE, V338, P637, DOI 10.1126/science.1226755; Kim YH, 2000, PHYS REV LETT, V84, P1, DOI 10.1103/PhysRevLett.84.1; Mach L., 1891, Z INSTRUMENTENKD, V12, P89; Nielsen M. A., 2011, QUANTUM COMPUTATION, DOI DOI 10.1017/CBO9780511976667; Peruzzo A, 2012, SCIENCE, V338, P634, DOI 10.1126/science.1226719; Wheeler J. A., 1984, QUANTUM THEORY MEASU, P182; Zehnder L, 1891, Z INSTRUMENTENKD, V11, P275	9	2	2	3	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107					621	622		10.1126/science.1229825	http://dx.doi.org/10.1126/science.1229825			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118177				2022-12-28	WOS:000310516000038
J	Roehr, B				Roehr, Bob			MEDICAL RESEARCH Creating credibility and value in comparative effectiveness research	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												BobRoehr@aol.com						Roehr B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7019; Roehr B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6658; Roehr B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5336	3	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2012	345								e7302	10.1136/bmj.e7302	http://dx.doi.org/10.1136/bmj.e7302			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033FG	23118306				2022-12-28	WOS:000310779000008
J	Liou, JM; Chen, CC; Chen, MJ; Chen, CC; Chang, CY; Fang, YJ; Lee, JY; Hsu, SJ; Luo, JC; Chang, WH; Hsu, YC; Tseng, CH; Tseng, PH; Wang, HP; Yang, UC; Shun, CT; Lin, JT; Lee, YC; Wu, MS				Liou, Jyh-Ming; Chen, Chieh-Chang; Chen, Mei-Jyh; Chen, Chien-Chuan; Chang, Chi-Yang; Fang, Yu-Jen; Lee, Ji-Yuh; Hsu, Shih-Jer; Luo, Jiing-Chyuan; Chang, Wen-Hsiung; Hsu, Yao-Chun; Tseng, Cheng-Hao; Tseng, Ping-Huei; Wang, Hsiu-Po; Yang, Ueng-Cheng; Shun, Chia-Tung; Lin, Jaw-Town; Lee, Yi-Chia; Wu, Ming-Shiang		Taiwan Helicobacter Consortium	Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial	LANCET			English	Article							ERADICATION THERAPY; CLINICAL-TRIAL; INFECTION; METAANALYSIS; LEVOFLOXACIN; RESISTANCE; MANAGEMENT; DIAGNOSIS; GENOTYPES; CHILDREN	Background Whether sequential treatment can replace triple therapy as the standard treatment for Helicobacter pylori infection is unknown. We compared the efficacy of sequential treatment for 10 days and 14 days with triple therapy for 14 days in first-line treatment. Methods For this multicentre, open-label, randomised trial, we recruited patients (>= 20 years of age) with H pylori infection from six centres in Taiwan. Using a computer-generated randomisation sequence, we randomly allocated patients (1:1:1; block sizes of six) to either sequential treatment (lansoprazole 30 mg and amoxicillin 1 g for the first 7 days, followed by lansoprazole 30 mg, clarithromycin 500 mg, and metronidazole 500 mg for another 7 days; with all drugs given twice daily) for either 10 days (S-10) or 14 days (S-14), of 14 days of triple therapy (T-14; lansoprazole 30 mg, amoxicillin 1 g, and clarithromycin 500 mg for 14 days; with all drugs given twice daily). Investigators were masked to treatment allocation. Our primary outcome was the eradication rate in first-line treatment by intention-to-treat (ITT) and per-protocol (PP) analyses. This trial is registered with ClinicalTrials.gov, number NCT01042184. Findings Between Dec 28, 2009, and Sept 24, 2011, we enrolled 900 patients:300 to each group. The eradication rate was 90.7% (95% CI 87.4-94.0; 272 of 300 patients) in the S-14 group, 87.0% (83.2-90.8; 261 of 300 patients) in the S-10 group, and 82.3% (78.0-86.6; 247 of 300 patients) in the T-14 group. Treatment efficacy was better in the S-14 group than it was in the T-14 group in both the ITT analysis (number needed to treat of 12.0 [95% CI 7.2-34.5]; p=0.003) and PP analyses (13.7 [8.3-40], p=0.003). We recorded no significant difference in the occurrence of adverse effects or in compliance between the three groups. Interpretation Our findings lend support to the use of sequential treatment as the standard first-line treatment for H pylori infection.	[Liou, Jyh-Ming; Chen, Chieh-Chang; Chen, Mei-Jyh; Tseng, Ping-Huei; Wang, Hsiu-Po; Lin, Jaw-Town; Lee, Yi-Chia; Wu, Ming-Shiang] Natl Taiwan Univ, Coll Med, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Liou, Jyh-Ming; Lee, Yi-Chia] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chang, Chi-Yang; Hsu, Yao-Chun; Tseng, Cheng-Hao] E DA Hosp, Dept Internal Med, Kaohsiung, Kaohsiung Count, Taiwan; [Chang, Chi-Yang; Hsu, Yao-Chun; Tseng, Cheng-Hao] I Shou Univ, Kaohsiung, Kaohsiung Count, Taiwan; [Luo, Jiing-Chyuan] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei 112, Taiwan; [Luo, Jiing-Chyuan; Yang, Ueng-Cheng] Taipei Vet Gen Hosp, Taipei, Taiwan; [Chang, Wen-Hsiung] Mackay Mem Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Yang, Ueng-Cheng] Natl Yang Ming Univ, Sch Med, Inst Biomed Informat, Taipei 112, Taiwan; [Shun, Chia-Tung] Natl Taiwan Univ, Coll Med, Dept Pathol, Natl Taiwan Univ Hosp, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; E-Da Hospital; I Shou University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Mackay Memorial Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital	Lee, YC (corresponding author), 7 Chung Shan S Rd, Taipei 10002, Taiwan.	yichialee@ntu.edu.tw; mingshiang@ntu.edu.tw	Shun, Chia-Tung/M-1400-2019; Chen, Chieh-Chang/ABD-3228-2021; Tseng, Ping-Huei/GZA-8772-2022	SHUN, CHIA-TUNG/0000-0002-0468-4468; Chen, Mei-Jyh/0000-0003-3284-004X; Wu, Ming-Shiang/0000-0002-1940-6428; TSENG, PING-HUEI/0000-0002-7483-7538; LIOU, JYH-MING/0000-0002-7945-5408	National Taiwan University Hospital; National Science Council; National Clinical Trial Centre of National Taiwan University Hospital; National Science Council, Executive Yuan, ROC, Taiwan [NSC 100-2325-B-002-063]; Bioinformatics Consortium of Taiwan, National Core Facility Program for Biotechnology [NSC 100-2319-B-010-002]	National Taiwan University Hospital(National Taiwan University); National Science Council(Ministry of Science and Technology, Taiwan); National Clinical Trial Centre of National Taiwan University Hospital; National Science Council, Executive Yuan, ROC, Taiwan(Ministry of Science and Technology, Taiwan); Bioinformatics Consortium of Taiwan, National Core Facility Program for Biotechnology	National Taiwan University Hospital and National Science Council.; A list of the Taiwan Helicobacter Consortium investigators is given in the appendix. The study was funded by the National Clinical Trial Centre of National Taiwan University Hospital and the National Science Council, Executive Yuan, ROC, Taiwan (grant number, NSC 100-2325-B-002-063). The lansoprazole used in this study was provided for free by the Takeda Company (Taipei City, Taiwan), which had no role in the analyses and interpretation of data in the present study. We would like to thank the staff of the Eighth Core Lab, Department of Medical Research, National Taiwan University Hospital, and the Bioinformatics Consortium of Taiwan, National Core Facility Program for Biotechnology (NSC 100-2319-B-010-002) for technical support in this study.	Alvarez A, 2009, ANTIMICROB AGENTS CH, V53, P4022, DOI 10.1128/AAC.00145-09; Chen TS, 2003, J GASTROEN HEPATOL, V18, P1237, DOI 10.1046/j.1440-1746.2003.03139.x; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; De Francesco V, 2006, ANN INTERN MED, V144, P94, DOI 10.7326/0003-4819-144-2-200601170-00006; De Francesco V, 2004, ALIMENT PHARM THER, V19, P407, DOI 10.1046/j.1365-2036.2004.01818.x; Fuccio L, 2007, ANN INTERN MED, V147, P553, DOI 10.7326/0003-4819-147-8-200710160-00008; Gatta L, 2009, AM J GASTROENTEROL, V104, P3069, DOI 10.1038/ajg.2009.555; Graham DY, 2008, NAT CLIN PRACT GASTR, V5, P321, DOI 10.1038/ncpgasthep1138; Greenberg ER, 2011, LANCET, V378, P507, DOI 10.1016/S0140-6736(11)60825-8; Jafri NS, 2008, ANN INTERN MED, V148, P923, DOI 10.7326/0003-4819-148-12-200806170-00226; Kim YS, 2011, ALIMENT PHARM THER, V34, P1098, DOI 10.1111/j.1365-2036.2011.04843.x; Lee MTM, 2009, PHARMACOGENOMICS, V10, P1905, DOI [10.2217/pgs.09.106, 10.2217/PGS.09.106]; Lee YC, 2013, GUT, V62, P676, DOI 10.1136/gutjnl-2012-302240; Liou JM, 2011, J ANTIMICROB CHEMOTH, V66, P1847, DOI 10.1093/jac/dkr217; Liou JM, 2011, ANTIMICROB AGENTS CH, V55, P1123, DOI 10.1128/AAC.01131-10; Liou JM, 2010, GUT, V59, P572, DOI 10.1136/gut.2009.198309; Maconi G, 2001, AM J GASTROENTEROL, V96, P359; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Malfertheiner P, 2011, LANCET, V377, P905, DOI 10.1016/S0140-6736(11)60020-2; Moayyedi P, 2007, LANCET, V370, P1010, DOI 10.1016/S0140-6736(07)61455-X; Nista EC, 2006, AM J GASTROENTEROL, V101, P1985, DOI 10.1111/j.1572-0241.2006.00716.x; Padol S, 2006, AM J GASTROENTEROL, V101, P1467, DOI 10.1111/j.1572-0241.2006.00717.x; Ricci C, 2007, BEST PRACT RES CL GA, V21, P299, DOI 10.1016/j.bpg.2006.11.002; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Sugimoto M, 2009, ARCH IMMUNOL THER EX, V57, P45, DOI 10.1007/s00005-009-0007-z; Talley NJ, 2008, AM J GASTROENTEROL, V103, P510, DOI 10.1111/j.1572-0241.2008.01819.x; Torres J, 2001, J CLIN MICROBIOL, V39, P2677, DOI 10.1128/JCM.39.7.2677-2680.2001; Vaira D, 2007, ANN INTERN MED, V146, P556, DOI 10.7326/0003-4819-146-8-200704170-00006; Vakil N, 2008, JAMA-J AM MED ASSOC, V300, P1346, DOI 10.1001/jama.300.11.1346; Vakil N, 2007, GASTROENTEROLOGY, V133, P985, DOI 10.1053/j.gastro.2007.07.008; Wu MS, 2007, J INFECT DIS, V196, P1386, DOI 10.1086/522520; Zullo A, 2007, GUT, V56, P1353, DOI 10.1136/gut.2007.125658; Zullo A, 2010, J CLIN GASTROENTEROL, V44, P459, DOI 10.1097/MCG.0b013e3181d06b41	33	187	198	2	36	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 19	2013	381	9862					205	213		10.1016/S0140-6736(12)61579-7	http://dx.doi.org/10.1016/S0140-6736(12)61579-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075LL	23158886	Green Submitted			2022-12-28	WOS:000313887600032
J	Chakraborty, S; Gruber, T; Barry, CE; Boshoff, HI; Rhee, KY				Chakraborty, Sumit; Gruber, Todd; Barry, Clifton E., III; Boshoff, Helena I.; Rhee, Kyu Y.			Para-Aminosalicylic Acid Acts as an Alternative Substrate of Folate Metabolism in Mycobacterium tuberculosis	SCIENCE			English	Article							DIHYDROPTEROATE SYNTHASE; THYMIDYLATE SYNTHASE; ESCHERICHIA-COLI; LIGAND-BINDING; RESISTANCE; METHOTREXATE; INHIBITION; DEPLETION; THYX	Folate biosynthesis is an established anti-infective target, and the antifolate para-aminosalicylic acid (PAS) was one of the first anti-infectives introduced into clinical practice on the basis of target-based drug discovery. Fifty years later, PAS continues to be used to treat tuberculosis. PAS is assumed to inhibit dihydropteroate synthase (DHPS) in Mycobacterium tuberculosis by mimicking the substrate p-aminobenzoate (PABA). However, we found that sulfonamide inhibitors of DHPS inhibited growth of M. tuberculosis only weakly because of their intracellular metabolism. In contrast, PAS served as a replacement substrate for DHPS. Products of PAS metabolism at this and subsequent steps in folate metabolism inhibited those enzymes, competing with their substrates. PAS is thus a prodrug that blocks growth of M. tuberculosis when its active forms are generated by enzymes in the pathway they poison.	[Chakraborty, Sumit; Rhee, Kyu Y.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Chakraborty, Sumit; Rhee, Kyu Y.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Gruber, Todd; Barry, Clifton E., III; Boshoff, Helena I.] NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	Cornell University; Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Rhee, KY (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.	kyr9001@med.cornell.edu	Barry, Clifton E/ABE-7992-2020; Barry, III, Clifton/H-3839-2012	Barry, Clifton E/0000-0002-2927-270X; Barry, III, Clifton/0000-0002-2927-270X	Burroughs Wellcome Career Award in the Biomedical Sciences; William Randolph Hearst Foundation; Bill and Melinda Gates TB Drug Accelerator Program [OPP1024050]; NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000783] Funding Source: NIH RePORTER	Burroughs Wellcome Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); William Randolph Hearst Foundation; Bill and Melinda Gates TB Drug Accelerator Program; NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Nathan for critical discussions and reading of the manuscript, D. Garboczi for assistance in preparing purified FolP1 and FolC, R. Lee and M. Serono for the generous gifts of pure folate intermediates and pteroate analogs, S. Fischer for expert mass spectrometric support, a Burroughs Wellcome Career Award in the Biomedical Sciences to K.Y.R., the William Randolph Hearst Foundation, and the Bill and Melinda Gates TB Drug Accelerator Program (OPP1024050) for support. This work was supported in part by the Intramural Research Program of NIAID, NIH. Primary data are deposited in Dryad; the provisional doi is 10.5061/dryad.vh36n.	ALLEGRA CJ, 1985, P NATL ACAD SCI USA, V82, P4881, DOI 10.1073/pnas.82.15.4881; ALLEGRA CJ, 1986, J BIOL CHEM, V261, P6478; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Carvalho LPS, 2010, CHEM BIOL, V17, P1122, DOI 10.1016/j.chembiol.2010.08.009; ELION GERTRUDE B., 1965, ADVANCE CHEMOTHERAP, V2, P91; Fivian-Hughes AS, 2012, MICROBIOL-SGM, V158, P308, DOI 10.1099/mic.0.053983-0; Gengenbacher M, 2008, FEMS MICROBIOL LETT, V287, P128, DOI 10.1111/j.1574-6968.2008.01302.x; Huang TS, 2012, J ANTIMICROB CHEMOTH, V67, P633, DOI 10.1093/jac/dkr501; Hunter JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002237; Kwon YK, 2010, ACS CHEM BIOL, V5, P787, DOI 10.1021/cb100096f; Long E. R, 1958, CHEM CHEMOTHERAPY TU, P347; Lu WY, 2007, J AM SOC MASS SPECTR, V18, P898, DOI 10.1016/j.jasms.2007.01.017; Mathys V, 2009, ANTIMICROB AGENTS CH, V53, P2100, DOI 10.1128/AAC.01197-08; Nathan C, 2009, CELL HOST MICROBE, V5, P220, DOI 10.1016/j.chom.2009.02.004; Nopponpunth V, 1999, J BACTERIOL, V181, P6814, DOI 10.1128/JB.181.21.6814-6821.1999; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Rengarajan J, 2004, MOL MICROBIOL, V53, P275, DOI 10.1111/j.1365-2958.2004.04120.x; ROSDAHL K. -G, 1948, SVENSK KEMISK TIDSKR, V60, P12; Schuessler DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034471; Spencer HT, 1997, BIOCHEMISTRY-US, V36, P4212, DOI 10.1021/bi961794q; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108	22	139	142	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					88	91		10.1126/science.1228980	http://dx.doi.org/10.1126/science.1228980			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23118010	Green Accepted			2022-12-28	WOS:000312985800058
J	Neria, Y; Shultz, JM				Neria, Yuval; Shultz, James M.			Mental Health Effects of Hurricane Sandy Characteristics, Potential Aftermath, and Response	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSTTRAUMATIC-STRESS-DISORDER; TERRORIST ATTACKS		[Neria, Yuval] New York State Psychiat Inst & Hosp, Unit 69, New York, NY 10032 USA; [Neria, Yuval] Columbia Univ, Dept Psychiat, New York, NY USA; [Neria, Yuval] Columbia Univ, Dept Epidemiol, New York, NY USA; [Shultz, James M.] Univ Miami, Miller Sch Med, Ctr Disaster & Extreme Event Preparedness DEEP Ct, Miami, FL 33136 USA	New York State Psychiatry Institute; Columbia University; Columbia University; University of Miami	Neria, Y (corresponding author), New York State Psychiat Inst & Hosp, Unit 69, 1051 Riverside Dr, New York, NY 10032 USA.	ny126@columbia.edu			NIMH NIH HHS [R01 MH072833] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072833] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 2007, PSYCHIATRY, V70, P283, DOI 10.1521/psyc.2007.70.4.283; [Anonymous], NY TIMES; Foa EB, 2005, NEUROPSYCHOPHARMACOL, V30, P1806, DOI 10.1038/sj.npp.1300815; Galea S, 2003, AM J EPIDEMIOL, V158, P514, DOI 10.1093/aje/kwg187; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Sandy Hurricane, 2012, HURR SAND; van Griensven F, 2006, JAMA-J AM MED ASSOC, V296, P537, DOI 10.1001/jama.296.5.537; Walsh MW, NY TIMES	9	98	99	0	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2571	2572		10.1001/jama.2012.110700	http://dx.doi.org/10.1001/jama.2012.110700			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23160987	Green Accepted			2022-12-28	WOS:000312916600020
J	Michel-Kerjan, E				Michel-Kerjan, Erwann			How resilient is your country?	NATURE			English	Editorial Material									[Michel-Kerjan, Erwann] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Michel-Kerjan, Erwann] Univ Penn, Wharton Risk Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Michel-Kerjan, E (corresponding author), Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA.	erwannmk@wharton.upenn.edu							0	14	15	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					497	497		10.1038/491497a	http://dx.doi.org/10.1038/491497a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040RE	23172178	Bronze			2022-12-28	WOS:000311339800014
J	Sienski, G; Donertas, D; Brennecke, J				Sienski, Grzegorz; Doenertas, Derya; Brennecke, Julius			Transcriptional Silencing of Transposons by Piwi and Maelstrom and Its Impact on Chromatin State and Gene Expression	CELL			English	Article							PRIMARY PIRNA BIOGENESIS; SMALL RNAS; EPIGENETIC MEMORY; DROSOPHILA; HETEROCHROMATIN; PROTEIN; METHYLATION; GERMLINE; PATHWAY; ROLES	Eukaryotic genomes are colonized by transposons whose uncontrolled activity causes genomic instability. The piRNA pathway silences transposons in animal gonads, yet how this is achieved molecularly remains controversial. Here, we show that the HMG protein Maelstrom is essential for Piwi-mediated silencing in Drosophila. Genome-wide assays revealed highly correlated changes in RNA polymerase II recruitment, nascent RNA output, and steady-state RNA levels of transposons upon loss of Piwi or Maelstrom. Our data demonstrate piRNA-mediated trans-silencing of hundreds of transposon copies at the transcriptional level. We show that Piwi is required to establish heterochromatic H3K9me3 marks on transposons and their genomic surroundings. In contrast, loss of Maelstrom affects transposon H3K9me3 patterns only mildly yet leads to increased heterochromatin spreading, suggesting that Maelstrom acts downstream of or in parallel to H3K9me3. Our work illustrates the widespread influence of transposons and the piRNA pathway on chromatin patterns and gene expression.	[Sienski, Grzegorz; Doenertas, Derya; Brennecke, Julius] Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Brennecke, J (corresponding author), Austrian Acad Sci, IMBA, Inst Mol Biotechnol, Dr Bohrgasse 3, A-1030 Vienna, Austria.	julius.brennecke@imba.oeaw.ac.at	Brennecke, Julius/C-1626-2015; Brennecke, Julius/T-5883-2019	Brennecke, Julius/0000-0002-5141-0814; Brennecke, Julius/0000-0002-5141-0814	Austrian Academy of Sciences; European Community's 7th Framework Programme [FP7/2007-2013]; ERC grant [260711EU]; Austrian Science Fund (FWF) [Y 510-B12]; Boehringer Ingelheim Fonds; Austrian Science Fund (FWF) [Y 510] Funding Source: researchfish	Austrian Academy of Sciences; European Community's 7th Framework Programme; ERC grant; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank K. Adelman for alpha-Rbp3; M. Siomi for OSCs and alpha-Armi; M. Madalinski for antibody purifications; S. Lopez for fly injections; the VDRC; A. Pelisson and H. Ruohola-Baker for fly strains; D. Jurczak, A. Stark, D. Gerlach, R. Maier and R. Sachidanandam for help with bioinformatics; and the CSF NGS unit for deep sequencing. We thank S. Grewal and D. Moazed for inspiring discussions and comments on the manuscript. The Brennecke laboratory is supported by the Austrian Academy of Sciences, the European Community's 7th Framework Programme (FP7/2007-2013; ERC grant # 260711EU), and the Austrian Science Fund (FWF; Y 510-B12). G.S. is supported by the Boehringer Ingelheim Fonds. G.S., D.D., and J.B. designed the experiments. G.S. and D.D. performed the experiments. G.S. performed the computational analysis. G.S., D.D., and JB analyzed the data and wrote the paper.	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000764; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Burton NO, 2011, P NATL ACAD SCI USA, V108, P19683, DOI 10.1073/pnas.1113310108; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dufourt J, 2011, DNA RES, V18, P451, DOI 10.1093/dnares/dsr031; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Klenov MS, 2011, P NATL ACAD SCI USA, V108, P18760, DOI 10.1073/pnas.1106676108; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Luteijn MJ, 2012, EMBO J, V31, P3422, DOI 10.1038/emboj.2012.213; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Moshkovich N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000880; Niki Y, 2006, P NATL ACAD SCI USA, V103, P16325, DOI 10.1073/pnas.0607435103; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Patil VS, 2010, CURR BIOL, V20, P724, DOI 10.1016/j.cub.2010.02.046; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; Reyes-Turcu FE, 2012, CURR OPIN GENET DEV, V22, P156, DOI 10.1016/j.gde.2011.12.004; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Shpiz S, 2011, NUCLEIC ACIDS RES, V39, P8703, DOI 10.1093/nar/gkr552; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Vermaak D, 2009, ANNU REV GENET, V43, P467, DOI 10.1146/annurev-genet-102108-134802; Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109; Zhang DP, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-48; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406	39	407	423	3	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					964	980		10.1016/j.cell.2012.10.040	http://dx.doi.org/10.1016/j.cell.2012.10.040			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23159368	Green Published, hybrid			2022-12-28	WOS:000311423500011
J	Holmes, D				Holmes, David			Fred Sai: the godfather of family planning	LANCET			English	Biographical-Item																		SAI F, PUBLICATION LIST	1	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 17	2012	380	9855					1731	1731		10.1016/S0140-6736(12)61977-1	http://dx.doi.org/10.1016/S0140-6736(12)61977-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CV	23158240	Bronze			2022-12-28	WOS:000311153700015
J	Alexander, GC; Kruszewski, SP; Webster, DW				Alexander, G. Caleb; Kruszewski, Stefan P.; Webster, Daniel W.			Rethinking Opioid Prescribing to Protect Patient Safety and Public Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ASSOCIATION; PAIN		[Alexander, G. Caleb] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Webster, Daniel W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; [Webster, Daniel W.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Gun Policy & Res, Baltimore, MD 21205 USA; [Alexander, G. Caleb] Johns Hopkins Med, Dept Med, Sect Gen Internal Med, Baltimore, MD USA; [Alexander, G. Caleb] Univ Illinois, Sch Pharm, Dept Pharm Practice, Chicago, IL USA; [Kruszewski, Stefan P.] Stefan P Kruszewski MD & Associates, Harrisburg, PA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Alexander, GC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St,W6035, Baltimore, MD 21205 USA.	galexand@jhsph.edu			AHRQ HHS [R01 HS0189960] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		American College of Emergency Physicians Opioid Guideline Writing Panel, CLIN POL CRIT ISS PR; Baucus, 2012, GRASSLEY SEEK ANSWER; Centers for Disease Control and Prevention (CDC), 2011, CDC VIT SIGNS PRESCR; Chou R, 2009, J PAIN, V10, P147, DOI 10.1016/j.jpain.2008.10.007; Dasgupta N, 2006, DRUG ALCOHOL DEPEN, V82, P135, DOI 10.1016/j.drugalcdep.2005.08.019; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; National Center for Injury Prevention and Control Division of Unintentional Injury Centers for Disease Control and Prevention, 2011, POL IMP PRESCR PAIN; University of Wisconsin Pain and Policy Group, CENTR PRINC BAL	8	70	70	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1865	1866		10.1001/jama.2012.14282	http://dx.doi.org/10.1001/jama.2012.14282			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23150006				2022-12-28	WOS:000310952700020
J	Deane, L; Giele, H; Johnson, K				Deane, Lauren; Giele, Henk; Johnson, Karen			Thoracic outlet syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Deane, Lauren; Johnson, Karen] Poplar Grove Practice, Aylesbury HP20 1XB, Bucks, England; [Giele, Henk] Nuffield Orthopaed Ctr, Oxford OX3 7LD, England	Nuffield Orthopaedic Centre	Deane, L (corresponding author), Poplar Grove Practice, Aylesbury HP20 1XB, Bucks, England.	lauren85@live.co.uk; karenjohnson@nhs.net		Giele, Henk/0000-0003-2017-5193					0	3	3	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 9	2012	345								e7373	10.1136/bmj.e7373	http://dx.doi.org/10.1136/bmj.e7373			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036LZ	23144208	Green Submitted, Bronze			2022-12-28	WOS:000311029100009
J	Lauer, MS				Lauer, Michael S.			Time for a Creative Transformation of Epidemiology in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORONARY-HEART-DISEASE; NATIONAL HEART; RISK; LUNG; RACE		NHLBI, Off Director, Div Cardiovasc Sci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lauer, MS (corresponding author), NHLBI, Off Director, Div Cardiovasc Sci, 6701 Rockledge Dr,Room 8128, Bethesda, MD 20892 USA.	lauerm@nhlbi.nih.gov	Lauer, Michael S/L-9656-2013	Lauer, Michael S/0000-0002-9217-8177				[Anonymous], 2012, MILL HEARTS PARTN; Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; Daviglus ML, 2012, JAMA-J AM MED ASSOC, V308, P1775, DOI 10.1001/jama.2012.14517; Ferguson TB, 2003, JAMA-J AM MED ASSOC, V290, P49, DOI 10.1001/jama.290.1.49; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Lauer MS, 2011, JAMA-J AM MED ASSOC, V306, P2145, DOI 10.1001/jama.2011.1669; Lauer MS, 2011, CIRC RES, V108, P405, DOI 10.1161/RES.0b013e3182125662; Manolio TA, 2012, AM J EPIDEMIOL, V175, P859, DOI 10.1093/aje/kwr453; Manolio TA, 2010, JAMA-J AM MED ASSOC, V304, P2290, DOI 10.1001/jama.2010.1686; Marshall E, 2011, SCIENCE, V334, P28, DOI 10.1126/science.334.6052.28; MATTHEWS C, 1988, HARDBALL POLITICS IS; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; Rosbash M, 2011, SCIENCE, V333, P136, DOI 10.1126/science.1210374; Safford MM, 2012, JAMA-J AM MED ASSOC, V308, P1768, DOI 10.1001/jama.2012.14306; Sorlie PD, 2012, AM J EPIDEMIOL, V175, P597, DOI 10.1093/aje/kws138; Topol EJ, 2012, CREATIVE DESTRUCTION	16	39	39	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1804	1805		10.1001/jama.2012.14838	http://dx.doi.org/10.1001/jama.2012.14838			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117782				2022-12-28	WOS:000310726500028
J	Fhogartaigh, CN; Sanford, C; Behrens, RH				Fhogartaigh, Caoimhe Nic; Sanford, Christopher; Behrens, Ron H.			Preparing young travellers for low resource destinations	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HEALTH-PROBLEMS; RISK; MALARIA; EPIDEMIOLOGY; PREVENTION; INJURIES; SPECTRUM; DISEASES		[Fhogartaigh, Caoimhe Nic] Hosp Trop Dis, Mortimer Market Ctr, London WC1E 6JB, England; [Sanford, Christopher] Univ Washington, Dept Family Med, Seattle, WA 98195 USA; [Behrens, Ron H.] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1E 7HT, England	University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University of Washington; University of Washington Seattle; University of London; London School of Hygiene & Tropical Medicine	Behrens, RH (corresponding author), Hosp Trop Dis, Travel Clin, London WC1E 6JB, England.	ron.behrens@lshtm.ac.uk		Behrens, Ron/0000-0002-8166-2633	UCL Hospitals Comprehensive Biomedical Research Centre Infection Theme	UCL Hospitals Comprehensive Biomedical Research Centre Infection Theme	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; RHB is supported by the UCL Hospitals Comprehensive Biomedical Research Centre Infection Theme, he is on the clinical advisory board for Sigma Tau and Norgine Pharmaceutical, and he has received support for producing an educational course from Norgine; RHB's employer has received a contract research grant from Intercell; no other relationships or activities that could appear to have influenced the submitted work.	Alon D, 2010, J TRAVEL MED, V17, P250, DOI 10.1111/j.1708-8305.2010.00425.x; Behrens RH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-266; Behrens RH, 2010, J TRAVEL MED, V17, P153, DOI 10.1111/j.1708-8305.2010.00398.x; Behrens RH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-235; Carey MJ, 1996, ANN EMERG MED, V28, P424, DOI 10.1016/S0196-0644(96)70009-4; *CDCP, MAL TRAV; Centres for Disease Control and Prevention, TRAV HLTH DEST; Chiodini P, 2007, GUIDELINES MALARIA P; De Bruyn G, 2000, COCHRANE DB SYST REV, DOI 10.1002/; DuPont HL, 2009, J TRAVEL MED, V16, P149, DOI 10.1111/j.1708-8305.2008.00299.x; Ekdahl K, 2005, J TRAVEL MED, V12, P197, DOI 10.2310/7060.2005.12405; Ericsson CD, 2007, J TRAVEL MED, V14, P312, DOI 10.1111/j.1708-8305.2007.00144.x; Guse CE, 2007, J TRAVEL MED, V14, P279, DOI 10.1111/j.1708-8305.2007.00133.x; Hagmann S, 2009, J TRAVEL MED, V16, P407, DOI 10.1111/j.1708-8305.2009.00357.x; Hargarten S W, 1993, Air Med J, V12, P398, DOI 10.1016/S1067-991X(05)80171-3; HARGARTEN SW, 1991, ANN EMERG MED, V20, P622, DOI 10.1016/S0196-0644(05)82379-0; Hatz CF, 2008, MALARIASCHUTZ KUR S1, V2006; Hill DR, 2010, CURR OPIN INFECT DIS, V23, P481, DOI 10.1097/QCO.0b013e32833dfca5; Hill DR, 2000, J TRAVEL MED, V7, P259, DOI 10.2310/7060.2000.00075; Laver SM, 2001, J TRAVEL MED, V8, P298, DOI 10.2310/7060.2001.23975; Leggat PA, 2001, J TRAVEL MED, V8, P46; MacPherson DW, 2007, J TRAVEL MED, V14, P77, DOI 10.1111/j.1708-8305.2007.00107.x; Mutsch M, 2005, CLIN INFECT DIS, V40, P1282, DOI 10.1086/429243; National Travel Health Network and Centre, COUNTR INF; Nielsen US, 2009, J INFECTION, V58, P47, DOI 10.1016/j.jinf.2008.10.010; Petridou E, 1997, ACCIDENT ANAL PREV, V29, P687, DOI 10.1016/S0001-4575(97)00038-9; Piyaphanee W, 2010, AM J TROP MED HYG, V82, P1168, DOI 10.4269/ajtmh.2010.09-0699; Rack J, 2005, J TRAVEL MED, V12, P248, DOI 10.2310/7060.2005.12502; Shlim DR, 2005, CLIN INFECT DIS, V41, pS531, DOI 10.1086/432947; Sonder GJB, 2009, J TRAVEL MED, V16, P18, DOI 10.1111/j.1708-8305.2008.00268.x; Steffen R, 2005, CLIN INFECT DIS, V41, pS536, DOI 10.1086/432948; STEFFEN R, 1991, T ROY SOC TROP MED H, V85, P156, DOI 10.1016/0035-9203(91)90005-J; STEFFEN R, 1987, J INFECT DIS, V156, P84, DOI 10.1093/infdis/156.1.84; Thompson DT, 2003, J TRAVEL MED, V10, P79, DOI 10.2310/7060.2003.31628	34	7	8	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2012	345								e7179	10.1136/bmj.e7179	http://dx.doi.org/10.1136/bmj.e7179			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036LE	23131670	Green Accepted			2022-12-28	WOS:000311026600015
J	Santos, ME; Salzburger, W				Santos, M. Emilia; Salzburger, Walter			How Cichlids Diversify	SCIENCE			English	Editorial Material							ADAPTIVE RADIATION; EVOLUTION; SPECIATION; SELECTION; FISHES		[Santos, M. Emilia; Salzburger, Walter] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland	University of Basel	Santos, ME (corresponding author), Univ Basel, Inst Zool, Vesalgasse 1, CH-4051 Basel, Switzerland.	emilia.santos@unibas.ch; walter.salzburger@unibas.ch	Salzburger, Walter/G-1598-2011	Salzburger, Walter/0000-0002-9988-1674; Santos, M. Emilia/0000-0003-3158-7935				Albertson RC, 2005, P NATL ACAD SCI USA, V102, P16287, DOI 10.1073/pnas.0506649102; Baldo L, 2011, GENOME BIOL EVOL, V3, P443, DOI 10.1093/gbe/evr047; Barlow GW., 2000, CICHLID FISHES NATUR; Colombo M, 2013, MOL ECOL, V22, P670, DOI 10.1111/mec.12029; Fraser GJ, 2009, PLOS BIOL, V7, P233, DOI 10.1371/journal.pbio.1000031; Fryer G, 1972, CICHLID FISHES GREAT; Fujimura K, 2011, AQUACULTURE, V319, P342, DOI 10.1016/j.aquaculture.2011.07.021; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Kidd MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031236; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Loh YHE, 2011, GENOME BIOL EVOL, V3, P55, DOI 10.1093/gbe/evq085; Manousaki T, 2013, MOL ECOL, V22, P650, DOI 10.1111/mec.12034; Miyagi R, 2012, MOL BIOL EVOL, V29, P3281, DOI 10.1093/molbev/mss139; Roberts RB, 2009, SCIENCE, V326, P998, DOI 10.1126/science.1174705; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Wagner CE, 2012, NATURE, V487, P366, DOI 10.1038/nature11144	17	42	43	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					619	621		10.1126/science.1224818	http://dx.doi.org/10.1126/science.1224818			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118176				2022-12-28	WOS:000310516000037
J	Bolker, J				Bolker, Jessica			There's more to life than rats and flies	NATURE			English	Editorial Material							MODEL; MICE; BIOLOGY		Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	Bolker, J (corresponding author), Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA.	jessica.bolker@unh.edu						Beckers J, 2009, NAT REV GENET, V10, P371, DOI 10.1038/nrg2578; BOLKER JA, 1995, BIOESSAYS, V17, P451, DOI 10.1002/bies.950170513; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Geerts H, 2009, CNS DRUGS, V23, P915, DOI 10.2165/11310890-000000000-00000; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/NMETH.1500, 10.1038/nmeth.1500]; Kohler R.E., 1994, LORDS FLY DROSOPHILA; Maher B, 2009, NATURE, V458, P695, DOI 10.1038/458695a; NELSON RJ, 1995, NATURE, V378, P383, DOI 10.1038/378383a0; Schnabel J, 2008, NATURE, V454, P682, DOI 10.1038/454682a; von Herrath MG, 2005, J EXP MED, V202, P1159, DOI 10.1084/jem.20051224	10	114	117	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					31	33		10.1038/491031a	http://dx.doi.org/10.1038/491031a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23128209	Bronze			2022-12-28	WOS:000310434500013
J	Farkas, H; Csuka, D				Farkas, Henriette; Csuka, Dorottya			An abdominal attack of hereditary angio-oedema	LANCET			English	Editorial Material									[Farkas, Henriette; Csuka, Dorottya] Semmelweis Univ, Dept Internal Med 3, H-1125 Budapest, Hungary	Semmelweis University	Farkas, H (corresponding author), Semmelweis Univ, Dept Internal Med 3, Kutvolgyi Ut 4, H-1125 Budapest, Hungary.	farkash@kut.sote.hu	Csuka, Dorottya/F-2224-2010	Csuka, Dorottya/0000-0003-3610-9852; Farkas, Henriette/0000-0003-2929-1721					0	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2013	381	9875					1404	1404		10.1016/S0140-6736(12)61146-5	http://dx.doi.org/10.1016/S0140-6736(12)61146-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130EF	23158885	Bronze			2022-12-28	WOS:000317894800037
J	Collet, JP; Cuisset, T; Range, G; Cayla, G; Elhadad, S; Pouillot, C; Henry, P; Motreff, P; Carrie, D; Boueri, Z; Belle, L; Van Belle, E; Rousseau, H; Aubry, P; Monsegu, J; Sabouret, P; O'Connor, SA; Abtan, J; Kerneis, M; Saint-Etienne, C; Barthelemy, O; Beygui, F; Silvain, J; Vicaut, E; Montalescot, G				Collet, Jean-Philippe; Cuisset, Thomas; Range, Gregoire; Cayla, Guillaume; Elhadad, Simon; Pouillot, Christophe; Henry, Patrick; Motreff, Pascal; Carrie, Didier; Boueri, Ziad; Belle, Loic; Van Belle, Eric; Rousseau, Helene; Aubry, Pierre; Monsegu, Jacques; Sabouret, Pierre; O'Connor, Stephen A.; Abtan, Jeremie; Kerneis, Mathieu; Saint-Etienne, Christophe; Barthelemy, Olivier; Beygui, Farzin; Silvain, Johanne; Vicaut, Eric; Montalescot, Gilles		ARCTIC Investigators	Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLATELET REACTIVITY; DOSE CLOPIDOGREL; DOUBLE-BLIND; INTERVENTION; IMPACT; PRASUGREL; METAANALYSIS; INHIBITION; TICAGRELOR; OUTCOMES	BACKGROUND Patients' responses to oral antiplatelet therapy are subject to variation. Bedside monitoring offers the opportunity to improve outcomes after coronary stenting by individualizing therapy. METHODS We randomly assigned 2440 patients scheduled for coronary stenting at 38 centers to a strategy of platelet-function monitoring, with drug adjustment in patients who had a poor response to antiplatelet therapy, or to a conventional strategy without monitoring and drug adjustment. The primary end point was the composite of death, myocardial infarction, stent thrombosis, stroke, or urgent revascularization 1 year after stent implantation. For patients in the monitoring group, the VerifyNow P2Y12 and aspirin point-of-care assays were used in the catheterization laboratory before stent implantation and in the outpatient clinic 2 to 4 weeks later. RESULTS In the monitoring group, high platelet reactivity in patients taking clopidogrel (34.5% of patients) or aspirin (7.6%) led to the administration of an additional bolus of clopidogrel, prasugrel, or aspirin along with glycoprotein IIb/IIIa inhibitors during the procedure. The primary end point occurred in 34.6% of the patients in the monitoring group, as compared with 31.1% of those in the conventional-treatment group (hazard ratio, 1.13; 95% confidence interval [CI], 0.98 to 1.29; P=0.10). The main secondary end point, stent thrombosis or any urgent revascularization, occurred in 4.9% of the patients in the monitoring group and 4.6% of those in the conventional-treatment group (hazard ratio, 1.06; 95% CI, 0.74 to 1.52; P=0.77). The rate of major bleeding events did not differ significantly between groups. CONCLUSIONS This study showed no significant improvements in clinical outcomes with platelet-function monitoring and treatment adjustment for coronary stenting, as compared with standard antiplatelet therapy without monitoring. (Funded by Allies in Cardiovascular Trials Initiatives and Organized Networks and others; ARCTIC ClinicalTrials.gov number, NCT00827411.)	[Montalescot, Gilles] CHU Pitie Salpetriere, Inst Cardiol, Bur 2 236, Hop La Pitie Salpetriere, 47 Blvd Hop, F-75013 Paris, France; [Collet, Jean-Philippe; Sabouret, Pierre; O'Connor, Stephen A.; Abtan, Jeremie; Kerneis, Mathieu; Barthelemy, Olivier; Beygui, Farzin; Silvain, Johanne; Montalescot, Gilles] Univ Paris 06, Paris, France; [Henry, Patrick] Hop Lariboisiere, Dept Cardiol, Paris, France; [Rousseau, Helene; Vicaut, Eric] Hop Lariboisiere, Unite Rech Clin, Paris, France; [Aubry, Pierre] Univ Paris 07, Ctr Hosp Bichat, Paris, France; [Monsegu, Jacques] Hop Instruct Armees Val de Grace, Paris, France; [Cuisset, Thomas] CHU Timone, Dept Cardiol, Marseille, France; [Range, Gregoire] Hop Chartres, Le Coudray, France; [Cayla, Guillaume] CHU Caremeau, Dept Cardiol, Nimes, France; [Elhadad, Simon] Ctr Hosp Lagny Marne la Vallee, Dept Cardiol, Lagny Sur Marne, France; [Pouillot, Christophe] Clin Ste Clotilde, St Denis De La Reunion, France; [Motreff, Pascal] CHU Clermont Ferrand, Clermont Ferrand, France; [Carrie, Didier] CHU Rangueil, F-31054 Toulouse, France; [Boueri, Ziad] Ctr Hosp Bastia, Bastia, France; [Belle, Loic] Ctr Hosp Annecy, Annecy, France; [Van Belle, Eric] Ctr Hosp Reg Univ Lille, Lille, France; [Saint-Etienne, Christophe] CHU Trousseau, Tours, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Val-de-Grace Hospital; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montpellier; CHU de Nimes; CHU Clermont Ferrand; CHU de Toulouse; Centre Hospitalier Annecy Genevois; Universite de Lille - ISITE; CHU Lille; CHU Tours	Montalescot, G (corresponding author), CHU Pitie Salpetriere, Inst Cardiol, Bur 2 236, Hop La Pitie Salpetriere, 47 Blvd Hop, F-75013 Paris, France.	gilles.montalescot@psl.aphp.fr	Carrie, Didier/M-5781-2014; Sabouret, Pierre/AAE-3459-2020; Aubry, Pierre/ABF-1167-2021; SILVAIN, Johanne/C-7521-2016	Sabouret, Pierre/0000-0002-0243-3673; O'Connor, Stephen/0000-0002-6539-0375; CARRIE, didier/0000-0003-2479-8144; SILVAIN, Johanne/0000-0002-1901-2808; VAN BELLE, ERIC/0000-0001-6509-443X; Kerneis, Mathieu/0000-0002-7141-5209	Allies in Cardiovascular Trials Initiatives and Organized Networks; Assistance Publique-Hopitaux de Paris; Fondation de France; Sanofi-Aventis; Cordis; Medtronic; Boston Scientific; Fondation Societe Generale Asset Management	Allies in Cardiovascular Trials Initiatives and Organized Networks; Assistance Publique-Hopitaux de Paris; Fondation de France(Fondation de France); Sanofi-Aventis(Sanofi-Aventis); Cordis; Medtronic(Medtronic); Boston Scientific(Boston Scientific); Fondation Societe Generale Asset Management	Funded by Allies in Cardiovascular Trials Initiatives and Organized Networks and othersr Supported by Allies in Cardiovascular Trials Initiatives and Organized Networks, Assistance Publique-Hopitaux de Paris, Fondation de France, Sanofi-Aventis, Cordis, Medtronic, Boston Scientific, and Fondation Societe Generale Asset Management.	Aradi D, 2012, INT J CARDIOL; Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047; Brar SS, 2011, J AM COLL CARDIOL, V58, P1945, DOI 10.1016/j.jacc.2011.06.059; Breet NJ, 2011, JAMA-J AM MED ASSOC, V305, P2174, DOI 10.1001/jama.2011.712; Buonamici P, 2007, J AM COLL CARDIOL, V49, P2312, DOI 10.1016/j.jacc.2007.01.094; Cannon CP, 2010, LANCET, V375, P283, DOI 10.1016/S0140-6736(09)62191-7; Collet JP, 2008, CIRCULATION, V118, P1225, DOI [10.1161/CIRCULATIONAHA.108.776757, 10.1161/CIRCULATIONAHA.108.191108]; Collet JP, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.029; Cuisset T, 2008, JACC-CARDIOVASC INTE, V1, P649, DOI 10.1016/j.jcin.2008.08.018; Hochholzer W, 2006, J AM COLL CARDIOL, V48, P1742, DOI 10.1016/j.jacc.2006.06.065; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; LINCOFF AM, 2003, JAMA-J AM MED ASSOC, V289, P1638; Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4; Montalescot G, 2006, NEW ENGL J MED, V355, P1006, DOI 10.1056/NEJMoa052711; Price MJ, 2008, EUR HEART J, V29, P992, DOI 10.1093/eurheartj/ehn046; Price MJ, 2011, CIRCULATION, V124, P1132, DOI 10.1161/CIRCULATIONAHA.111.029165; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Roberts JD, 2012, LANCET, V379, P1705, DOI 10.1016/S0140-6736(12)60161-5; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Valgimigli M, 2009, CIRCULATION, V119, P3215, DOI 10.1161/CIRCULATIONAHA.108.833236; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	26	686	728	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2012	367	22					2100	2109		10.1056/NEJMoa1209979	http://dx.doi.org/10.1056/NEJMoa1209979			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044MS	23121439				2022-12-28	WOS:000311624400007
J	Sprenger, T; Kappos, L				Sprenger, Till; Kappos, Ludwig			Alemtuzumab for multiple sclerosis: who and when to treat?	LANCET			English	Editorial Material							INTERFERON BETA-1A; NATALIZUMAB		[Sprenger, Till; Kappos, Ludwig] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Sprenger, Till] Univ Basel Hosp, Dept Radiol, Div Neuroradiol, CH-4031 Basel, Switzerland	University of Basel; University of Basel	Kappos, L (corresponding author), Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland.	lkappos@uhbs.ch		Sprenger, Till/0000-0002-5390-819X				Cohen JA, 2012, LANCET; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Coles AJ, 2012, NEUROLOGY, V78, P1069, DOI 10.1212/WNL.0b013e31824e8ee7; Coles AJ, 2012, LANCET; Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670; Cossburn M, 2011, NEUROLOGY, V77, P573, DOI 10.1212/WNL.0b013e318228bec5; Hill-Cawthorne GA, 2012, J NEUROL NEUROSUR PS, V83, P298, DOI 10.1136/jnnp-2011-300826; Isaacs JD, 1996, CLIN EXP IMMUNOL, V106, P427, DOI 10.1046/j.1365-2249.1996.d01-876.x; Jones JL, 2009, J CLIN INVEST, V119, P2052, DOI 10.1172/JCI37878; Kappos L, 2004, NEUROLOGY, V63, P1779, DOI 10.1212/01.WNL.0000145561.08973.4F; Kappos L, 2011, LANCET NEUROL, V10, P745, DOI 10.1016/S1474-4422(11)70149-1; Killestein J, 2011, LANCET NEUROL, V10, P1026, DOI 10.1016/S1474-4422(11)70228-9; Moreau T, 1996, Mult Scler, V1, P357; Ontaneda D, 2012, ANNU REV MED, V63, P389, DOI 10.1146/annurev-med-042910-135833; Ropper AH, 2012, NEW ENGL J MED, V366, P1938, DOI 10.1056/NEJMe1201395; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396	16	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 24	2012	380	9856					1795	1797		10.1016/S0140-6736(12)61859-5	http://dx.doi.org/10.1016/S0140-6736(12)61859-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	041XK	23128041				2022-12-28	WOS:000311435000006
J	Logan, RF				Logan, Richard F.			A single FIT (>= 50 ng Hb/mL) detected 38% of screen-detected advanced colorectal neoplasia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OCCULT BLOOD-TESTS; CANCER		Univ Nottingham Hosp, Nottingham NG7 2UH, England	University of Nottingham	Logan, RF (corresponding author), Univ Nottingham Hosp, Nottingham NG7 2UH, England.							Levi Z, 2007, ANN INTERN MED, V146, P244, DOI 10.7326/0003-4819-146-4-200702200-00003; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040; van Rossum LGM, 2009, INT J CANCER, V125, P746, DOI 10.1002/ijc.24458	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10							JC5-10	10.7326/0003-4819-157-10-201211200-02010	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043VZ	23165686				2022-12-28	WOS:000311580000009
J	Spitzer, M; Basaria, S; Travison, TG; Davda, MN; Paley, A; Cohen, B; Mazer, NA; Knapp, PE; Hanka, S; Lakshman, KM; Ulloor, J; Zhang, AQ; Orwoll, K; Eder, R; Collins, L; Mohammed, N; Rosen, RC; DeRogatis, L; Bhasin, S				Spitzer, Matthew; Basaria, Shehzad; Travison, Thomas G.; Davda, Maithili N.; Paley, Amanda; Cohen, Beth; Mazer, Norman A.; Knapp, Philip E.; Hanka, Samson; Lakshman, Kishore M.; Ulloor, Jagadish; Zhang, Anqi; Orwoll, Katie; Eder, Richard; Collins, Lauren; Mohammed, Nurahmed; Rosen, Raymond C.; DeRogatis, Leonard; Bhasin, Shalender			Effect of Testosterone Replacement on Response to Sildenafil Citrate in Men With Erectile Dysfunction A Parallel, Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL-PRACTICE GUIDELINE; MULTIPLY-IMPUTED DATA; VIRUS-INFECTED WOMEN; HYPOGONADAL MEN; INTERNATIONAL INDEX; SEXUAL DYSFUNCTION; ANDROGENIC MAINTENANCE; ORAL SILDENAFIL; UNITED-STATES; FUNCTION IIEF	Background: Erectile dysfunction and low testosterone levels frequently occur together. Objective: To determine whether addition of testosterone to sildenafil therapy improves erectile response in men with erectile dysfunction and low testosterone levels. Design: Randomized, double-blind, parallel, placebo-controlled trial. (ClinicalTrials.gov registration number: NCT00512707) Setting: Outpatient academic research center. Participants: Men aged 40 to 70 years with scores of 25 or less for the erectile function domain (EFD) of the International Index of Erectile Function, total testosterone levels less than 11.45 nmol/L (<330 ng/dL), or free testosterone levels less than 173.35 pmol/L (<50 pg/mL). Intervention: Sildenafil dose was optimized, and 140 participants were then randomly assigned to 14 weeks of daily transdermal gel that contained 10-g testosterone for 70 participants and placebo for the remaining 70 participants. All participants were included in the primary analysis, although 10 in the testosterone group and 12 in the placebo group did not complete the study. Results: At baseline, the 2 groups had similar EFD scores. Administration of sildenafil alone was associated with a substantial increase in EFD score (mean, 7.7 [95% CI, 6.5 to 8.8]), but change in EFD score after randomization did not differ between the groups (difference, 2.2 [CI, -0.8 to 5.1]; P = 0.150). The findings were similar for other domains of sexual function in younger men, more obese men, and men with lower baseline testosterone levels or an inadequate response to sildenafil alone. Frequency of adverse events was similar for testosterone and placebo groups. Limitation: Whether testosterone could improve erectile function without sildenafil was not studied. Conclusion: Sildenafil plus testosterone was not superior to sildenafil plus placebo in improving erectile function in men with erectile dysfunction and low testosterone levels. Primary Funding Source: National Institute of Child Health and Human Development.	[Spitzer, Matthew] Boston Univ, Sch Med, Med Ctr, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA; New England Res Inst, Watertown, MA 02472 USA; F Hoffmann La Roche, Basel, Switzerland; Johns Hopkins Univ, Baltimore, MD USA	Boston University; Boston University; HealthCore, Inc; Roche Holding; Johns Hopkins University	Spitzer, M (corresponding author), Boston Univ, Sch Med, Med Ctr, 670 Albany St, Boston, MA 02118 USA.	matthew.spitzer@bmc.org	Mazer, Norman A/HGU-8266-2022	Zhang, Anqi/0000-0003-3723-8293; Knapp, Philip/0000-0002-5290-6125; Basaria, Shehzad/0000-0002-8533-2383	National Institute of Child Health and Human Development [5R01HD047722]; Boston University Clinical and Translational Science Institute [1UL1RR025771]; Boston Claude D. Pepper Older Americans Independence Center (National Institute on Aging) [5P30AG031679]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047722] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG031679] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Boston University Clinical and Translational Science Institute; Boston Claude D. Pepper Older Americans Independence Center (National Institute on Aging); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the National Institute of Child Health and Human Development (5R01HD047722). Additional support was provided by the Boston University Clinical and Translational Science Institute (1UL1RR025771) and Boston Claude D. Pepper Older Americans Independence Center (grant 5P30AG031679 from the National Institute on Aging).	ALEXANDER GM, 1991, HORM BEHAV, V25, P367, DOI 10.1016/0018-506X(91)90008-6; Andric SA, 2010, AM J PHYSIOL-ENDOC M, V299, pE544, DOI 10.1152/ajpendo.00337.2010; Aversa A, 2003, CLIN ENDOCRINOL, V58, P632, DOI 10.1046/j.1365-2265.2003.01764.x; Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Bhasin S, 2007, LANCET, V369, P597, DOI 10.1016/S0140-6736(07)60280-3; Bhasin S, 2012, JAMA-J AM MED ASSOC, V307, P931, DOI 10.1001/jama.2012.227; Bhasin S, 2011, J CLIN ENDOCR METAB, V96, P2430, DOI 10.1210/jc.2010-3012; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; BUENA F, 1993, FERTIL STERIL, V59, P1118; BURRIS AS, 1992, J ANDROL, V13, P297; Buvat J, 2011, J SEX MED, V8, P284, DOI 10.1111/j.1743-6109.2010.01956.x; Carosa E, 2004, CLIN ENDOCRINOL, V61, P382, DOI 10.1111/j.1365-2265.2004.02108.x; Cavallini G, 2004, UROLOGY, V63, P641, DOI 10.1016/j.urology.2003.11.009; Choi HH, 2005, J CLIN ENDOCR METAB, V90, P1531, DOI 10.1210/jc.2004-1677; DEROGATIS LR, 1998, EVALUATING STRESS BO, V2, P89; Dong JY, 2011, J AM COLL CARDIOL, V58, P1378, DOI 10.1016/j.jacc.2011.06.024; Dupuy H.J., 1984, ASSESSMENT QUALITY L, P170; Fisher WA, 2009, J SEX MED, V6, P2746, DOI 10.1111/j.1743-6109.2009.01457.x; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Guay Andre T, 2003, Endocr Pract, V9, P77; Hatzimouratidis K, 2010, EUR UROL, V57, P804, DOI 10.1016/j.eururo.2010.02.020; Janjic MM, 2012, J SEX MED; Khera M, 2011, J SEX MED, V8, P3204, DOI 10.1111/j.1743-6109.2011.02436.x; LI KH, 1991, STAT SINICA, V1, P65; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; MENG XL, 1992, BIOMETRIKA, V79, P103, DOI 10.1093/biomet/79.1.103; Mills TM, 1999, STEROIDS, V64, P605, DOI 10.1016/S0039-128X(99)00040-9; Mills TM, 1998, BIOL REPROD, V59, P1413, DOI 10.1095/biolreprod59.6.1413; Montorsi F, 1999, UROLOGY, V53, P1011, DOI 10.1016/S0090-4295(98)00643-8; Montorsi F, 2010, J SEX MED, V7, P3572, DOI 10.1111/j.1743-6109.2010.02062.x; Padma-Nathan H, 2001, INT J IMPOT RES, V13, P2, DOI 10.1038/sj.ijir.3900631; Paige NM, 2001, J UROLOGY, V166, P1774, DOI 10.1016/S0022-5347(05)65673-X; Qaseem A, 2009, ANN INTERN MED, V151, P639, DOI 10.7326/0003-4819-151-9-200911030-00151; Reilly CM, 1997, J ANDROL, V18, P110; Rosen RC, 2011, EUR UROL, V60, P1010, DOI 10.1016/j.eururo.2011.07.053; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Rosen RC, 2004, UROLOGY, V64, P777, DOI 10.1016/j.urology.2004.04.056; Rosen RC, 2002, INT J IMPOT RES, V14, P226, DOI 10.1038/sj.ijir.3900857; SCHAG CAC, 1991, CANCER, V68, P1406, DOI 10.1002/1097-0142(19910915)68:6<1406::AID-CNCR2820680638>3.0.CO;2-2; Seftel AD, 2004, J UROLOGY, V171, P2341, DOI 10.1097/01.ju.0000125198.32936.38; Shabsigh R, 2004, J UROLOGY, V172, P658, DOI 10.1097/01.ju.0000132389.97804.d7; Sinha-Hikim I, 1998, J CLIN ENDOCR METAB, V83, P1312, DOI 10.1210/jc.83.4.1312; Steidle C, 2003, J CLIN ENDOCR METAB, V88, P2673, DOI 10.1210/jc.2002-021058; Traish AM, 2009, J ANDROL, V30, P363, DOI 10.2164/jandrol.108.006007; Traish AM, 1999, ENDOCRINOLOGY, V140, P1861, DOI 10.1210/en.140.4.1861; Tsertsvadze A, 2009, ANN INTERN MED, V151, P650, DOI 10.7326/0003-4819-151-9-200911030-00150; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Wagner TH, 1996, QUAL LIFE RES, V5, P443, DOI 10.1007/BF00449919; Wang C, 2009, J ANDROL, V30, P1, DOI 10.2164/jandrol.108.006486; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	51	106	109	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10					681	+		10.7326/0003-4819-157-10-201211200-00004	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-00004			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043VZ	23165659				2022-12-28	WOS:000311580000013
J	Jones, JL; Esber, GR; McDannald, MA; Gruber, AJ; Hernandez, A; Mirenzi, A; Schoenbaum, G				Jones, Joshua L.; Esber, Guillem R.; McDannald, Michael A.; Gruber, Aaron J.; Hernandez, Alex; Mirenzi, Aaron; Schoenbaum, Geoffrey			Orbitofrontal Cortex Supports Behavior and Learning Using Inferred But Not Cached Values	SCIENCE			English	Article							PREFRONTAL CORTEX; VENTRAL STRIATUM; REWARD VALUE; LESIONS; AMYGDALA; INACTIVATION; DEVALUATION; RESPONSES; REVERSAL; NEURONS	Computational and learning theory models propose that behavioral control reflects value that is both cached (computed and stored during previous experience) and inferred (estimated on the fly on the basis of knowledge of the causal structure of the environment). The latter is thought to depend on the orbitofrontal cortex. Yet some accounts propose that the orbitofrontal cortex contributes to behavior by signaling "economic" value, regardless of the associative basis of the information. We found that the orbitofrontal cortex is critical for both value-based behavior and learning when value must be inferred but not when a cached value is sufficient. The orbitofrontal cortex is thus fundamental for accessing model-based representations of the environment to compute value rather than for signaling value per se.	[Jones, Joshua L.; Hernandez, Alex; Schoenbaum, Geoffrey] Univ Maryland, Dept Anat & Neurobiol, Sch Med, Baltimore, MD 21201 USA; [Esber, Guillem R.; McDannald, Michael A.; Mirenzi, Aaron; Schoenbaum, Geoffrey] NIDA, Behav Neurophysiol Res Sect, Cellular Neurobiol Res Branch, Intramural Res Program, Baltimore, MD 21201 USA; [Gruber, Aaron J.] Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Lethbridge	Jones, JL (corresponding author), Univ Maryland, Dept Anat & Neurobiol, Sch Med, 20 Penn St, Baltimore, MD 21201 USA.	josh.jones@nih.gov; geoffrey.schoenbaum@nih.gov	Esber, Guillem/AAL-9246-2020	Esber, Guillem/0000-0001-8874-4255; Gruber, Aaron/0000-0003-2700-5429; Hernandez, Alex/0000-0002-2267-4781	National Institute on Drug Abuse (NIDA), NIH [F32-031517]; NIDA [R01-DA015718]; Natural Sciences and Engineering Research Council of Canada; Intramural Research Program at NIDA; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000587, F32DA031517, R01DA015718] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Intramural Research Program at NIDA; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute on Drug Abuse (NIDA), NIH, F32-031517 to J.L.J., NIDA R01-DA015718 to G. S., funding from Natural Sciences and Engineering Research Council of Canada to A.J.G., and by the Intramural Research Program at NIDA. The opinions expressed in this article are the authors' own and do not reflect the view of the NIH or U.S. Department of Health and Human Services. The authors declare that they have no conflicts of interest related to the data presented in this manuscript.	Balleine BW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P367, DOI 10.1016/B978-0-12-374176-9.00024-5; Brogden WJ, 1939, J EXP PSYCHOL, V25, P323, DOI 10.1037/h0058944; Burke KA, 2008, NATURE, V454, P340, DOI 10.1038/nature06993; Burke KA, 2009, EUR J NEUROSCI, V30, P1941, DOI 10.1111/j.1460-9568.2009.06992.x; Camille N, 2011, J NEUROSCI, V31, P7527, DOI 10.1523/JNEUROSCI.6527-10.2011; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1673, DOI 10.1152/jn.1996.75.4.1673; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Gallagher M, 1999, J NEUROSCI, V19, P6610; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Hall, 1982, QUANTITATIVE ANAL BE, V3, P241; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Hornak J, 2004, J COGNITIVE NEUROSCI, V16, P463, DOI 10.1162/089892904322926791; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; Kamin LJ, 1969, PUNISHMENT AVERSIVE, P242; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Kim H, 2011, CEREB CORTEX, V21, P769, DOI 10.1093/cercor/bhq145; Machado CJ, 2007, EUR J NEUROSCI, V25, P2885, DOI 10.1111/j.1460-9568.2007.05525.x; McDannald MA, 2011, J NEUROSCI, V31, P2700, DOI 10.1523/JNEUROSCI.5499-10.2011; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Ostlund SB, 2007, J NEUROSCI, V27, P4819, DOI 10.1523/JNEUROSCI.5443-06.2007; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Pickens CL, 2005, BEHAV NEUROSCI, V119, P317, DOI 10.1037/0735-7044.119.1.317; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; West EA, 2011, J NEUROSCI, V31, P15128, DOI 10.1523/JNEUROSCI.3295-11.2011	30	185	186	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					953	956		10.1126/science.1227489	http://dx.doi.org/10.1126/science.1227489			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23162000	Green Accepted			2022-12-28	WOS:000311083600045
J	Koren, I; Kimchi, A				Koren, Itay; Kimchi, Adi			Promoting Tumorigenesis by Suppressing Autophagy	SCIENCE			English	Editorial Material							TUMOR-SUPPRESSOR; BECLIN 1; GENE; INDUCTION; CANCER		[Koren, Itay; Kimchi, Adi] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Koren, I (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	itay.koren@weizmann.ac.il; adi.kimchi@weizmann.ac.il	Koren, Itay/AAI-1936-2021	Koren, Itay/0000-0002-5693-1651				Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Gozuacik D, 2006, AUTOPHAGY, V2, P74, DOI 10.4161/auto.2.2.2459; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Luo SQ, 2012, MOL CELL, V47, P359, DOI 10.1016/j.molcel.2012.05.040; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246	12	31	37	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2012	338	6109					889	890		10.1126/science.1230577	http://dx.doi.org/10.1126/science.1230577			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161981				2022-12-28	WOS:000311083600025
J	Nicholson, JK; Holmes, E; Kinross, JM; Darzi, AW; Takats, Z; Lindon, JC				Nicholson, Jeremy K.; Holmes, Elaine; Kinross, James M.; Darzi, Ara W.; Takats, Zoltan; Lindon, John C.			Metabolic phenotyping in clinical and surgical environments	NATURE			English	Review							NUCLEAR-MAGNETIC-RESONANCE; CHROMATOGRAPHY MASS-SPECTROMETRY; GUT MICROBIOTA; NMR-SPECTROSCOPY; BREAST-CANCER; BIOCHEMICAL PROCESSES; ACID-METABOLISM; SYSTEMS BIOLOGY; METABONOMICS; PROFILES	Metabolic phenotyping involves the comprehensive analysis of biological fluids or tissue samples. This analysis allows biochemical classification of a person's physiological or pathological states that relate to disease diagnosis or prognosis at the individual level and to disease risk factors at the population level. These approaches are currently being implemented in hospital environments and in regional phenotyping centres worldwide. The ultimate aim of such work is to generate information on patient biology using techniques such as patient stratification to better inform clinicians on factors that will enhance diagnosis or the choice of therapy. There have been many reports of direct applications of metabolic phenotyping in a clinical setting.	[Nicholson, Jeremy K.; Holmes, Elaine; Kinross, James M.; Darzi, Ara W.; Takats, Zoltan; Lindon, John C.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Fac Med, London SW7 2AZ, England	Imperial College London	Nicholson, JK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Fac Med, London SW7 2AZ, England.	j.nicholson@imperial.ac.uk	Holmes, Elaine/A-2189-2015; Nicholson, Jeremy K/B-3395-2012; Holmes, Elaine/ABE-6606-2020; Cockshutt, Naomi/AAJ-2721-2020	Nicholson, Jeremy K/0000-0002-8123-8349; Holmes, Elaine/0000-0002-0556-8389; Lindon, John/0000-0002-0916-6360; Kinross, James/0000-0002-0427-7643	National Institute of Health Research Biomedical Research Centre; MRC; NIHR; MRC-NIHR Phenome Centre (joint with Kings College London, Bruker Spectrospin and the Waters Corporation); Imperial NIHR Clinical Phenome Centre; Medical Research Council [G0801056B] Funding Source: researchfish	National Institute of Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); MRC-NIHR Phenome Centre (joint with Kings College London, Bruker Spectrospin and the Waters Corporation); Imperial NIHR Clinical Phenome Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors would like to acknowledge the National Institute of Health Research Biomedical Research Centre for funding clinical and surgical metabonomic projects in real-time diagnostics and chemical imaging at Imperial College London. We also wish to thank the MRC and NIHR for funding major programmes that relate to these studies, including the MRC-NIHR Phenome Centre (joint with Kings College London, Bruker Spectrospin and the Waters Corporation) and the Imperial NIHR Clinical Phenome Centre.	Alverdy JC, 2003, CRIT CARE MED, V31, P598, DOI 10.1097/01.CCM.0000045576.55937.67; Backshall A, 2011, CLIN CANCER RES, V17, P3019, DOI 10.1158/1078-0432.CCR-10-2474; Balog J, 2010, ANAL CHEM, V82, P7343, DOI 10.1021/ac101283x; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bertilsson H, 2012, CLIN CANCER RES, V18, P3261, DOI 10.1158/1078-0432.CCR-11-2929; Biagi E, 2012, AGE, V34, P247, DOI 10.1007/s11357-011-9217-5; Caldeira M, 2011, J CHROMATOGR A, V1218, P3771, DOI 10.1016/j.chroma.2011.04.026; Carrola J, 2011, J PROTEOME RES, V10, P221, DOI 10.1021/pr100899x; Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232; Chen JH, 2012, MOL BIOSYST, V8, P871, DOI 10.1039/c2mb05454j; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Cohen MJ, 2010, J TRAUMA, V69, P31, DOI 10.1097/TA.0b013e3181e043fe; Crockford DJ, 2006, ANAL CHEM, V78, P363, DOI 10.1021/ac051444m; Evans C, 2008, NUTR NEUROSCI, V11, P9, DOI 10.1179/147683008X301360; Fan LJ, 2012, ACTA ONCOL, V51, P473, DOI 10.3109/0284186X.2011.648338; Fens N., 2009, EUR RESPIR J, V38, P1301; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fitzgerald SP, 2010, J AM MED DIR ASSOC, V11, P475, DOI 10.1016/j.jamda.2010.05.008; Fonville JM, 2012, ANAL CHEM, V84, P1310, DOI 10.1021/ac201767g; Friedrich N, 2012, J ENDOCRINOL, V215, P29, DOI 10.1530/JOE-12-0120; Ganti S, 2012, INT J CANCER, V130, P2791, DOI 10.1002/ijc.26274; Garcia E, 2011, J PROTEOME RES, V10, P1765, DOI 10.1021/pr101050d; Gaudet MM, 2012, J CLIN ENDOCR METAB, V97, P3216, DOI 10.1210/jc.2012-1490; Gavaghan CL, 2000, FEBS LETT, V484, P169, DOI 10.1016/S0014-5793(00)02147-5; Gerbig S, 2012, ANAL BIOANAL CHEM, V403, P2315, DOI 10.1007/s00216-012-5841-x; Girlanda R., 2012, AM J TRANSPLANT; Gletsu-Miller N, 2012, NEW ENGL J MED, V367, P473, DOI 10.1056/NEJMc1206633; Gordon JI, 2012, SCIENCE, V336, P1251, DOI 10.1126/science.1224686; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Griffin JL, 2011, NAT REV CARDIOL, V8, P630, DOI 10.1038/nrcardio.2011.138; Guenther S, 2011, J AM SOC MASS SPECTR, V22, P2082, DOI 10.1007/s13361-011-0230-9; HOLMES E, 1992, MOL PHARMACOL, V42, P922; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Holmes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004244; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; HOWELLS SI, 1992, NMR BIOMED, V5, P59, DOI 10.1002/nbm.1940050203; ILES RA, 1984, LANCET, V2, P1221; Jeevan R, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4505; JELLUM E, 1976, J CHROMATOGR, V126, P487, DOI 10.1016/S0021-9673(01)84095-4; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Kim CD, 2010, TRANSPLANTATION, V90, P748, DOI 10.1097/TP.0b013e3181edd69a; Kinross JM, 2011, LANCET, V377, P1817, DOI 10.1016/S0140-6736(11)60171-2; Legido-Quigley C, 2011, ELECTROPHORESIS, V32, P2063, DOI 10.1002/elps.201000512; Li JV, 2011, GUT, V60, P1214, DOI 10.1136/gut.2010.234708; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Lin L, 2011, J PROTEOME RES, V10, P1396, DOI 10.1021/pr101161u; Lindon JC, 2008, ANNU REV ANAL CHEM, V1, P45, DOI 10.1146/annurev.anchem.1.031207.113026; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Makinen VP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100205; Mao HL, 2009, J PROTEOME RES, V8, P5423, DOI 10.1021/pr900576y; Marchesi JR, 2007, J PROTEOME RES, V6, P546, DOI 10.1021/pr060470d; McDonnell LA, 2007, MASS SPECTROM REV, V26, P606, DOI 10.1002/mas.20124; Mirnezami R, 2012, NEW ENGL J MED, V366, P489, DOI 10.1056/NEJMp1114866; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; Mutch DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007905; Nevedomskaya E, 2011, MOL BIOSYST, V7, P3214, DOI 10.1039/c1mb05280b; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; NICHOLSON JK, 1984, BIOCHEM J, V217, P365, DOI 10.1042/bj2170365; Nishiumi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040459; Oakman C, 2011, ANN ONCOL, V22, P1295, DOI 10.1093/annonc/mdq606; Ooi M, 2011, INFLAMM RES, V60, P831, DOI 10.1007/s00011-011-0340-7; Opstad KS, 2008, NMR BIOMED, V21, P677, DOI 10.1002/nbm.1239; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Patterson AD, 2011, J BIOL CHEM, V286, P19511, DOI 10.1074/jbc.M111.221739; Polinder S, 2012, BRIT J SURG, V99, P114, DOI 10.1002/bjs.7708; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ramautar R, 2011, ELECTROPHORESIS, V32, P52, DOI 10.1002/elps.201000378; Robertson DG, 2007, J PROTEOME RES, V6, P526, DOI 10.1021/pr060535c; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Saude EJ, 2011, J ALLERGY CLIN IMMUN, V127, P757, DOI 10.1016/j.jaci.2010.12.1077; Schafer KC, 2011, ANAL CHEM, V83, P7729, DOI 10.1021/ac201251s; Schmerler D, 2012, J LIPID RES, V53, P1369, DOI 10.1194/jlr.P023309; Shah AA, 2012, J THORAC CARDIOV SUR, V143, P873, DOI 10.1016/j.jtcvs.2011.09.070; Shah SH, 2012, AM HEART J, V163, P844, DOI 10.1016/j.ahj.2012.02.005; Slupsky CM, 2010, CLIN CANCER RES, V16, P5835, DOI 10.1158/1078-0432.CCR-10-1434; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Tenori L, 2012, MOL ONCOL, V6, P437, DOI 10.1016/j.molonc.2012.05.003; Thomas EL, 2011, PEDIATR RES, V70, P507, DOI 10.1203/PDR.0b013e31822d7860; Tomlins AM, 1998, BBA-GEN SUBJECTS, V1379, P367, DOI 10.1016/S0304-4165(97)00116-5; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Ubhi BK, 2012, EUR RESPIR J, V40, P345, DOI 10.1183/09031936.00112411; Volkert D, 2010, J NUTR HEALTH AGING, V14, P387, DOI 10.1007/s12603-010-0085-y; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Williams HRT, 2009, AM J GASTROENTEROL, V104, P1435, DOI 10.1038/ajg.2009.175; Wong A, 2012, ANAL CHEM, V84, P3843, DOI 10.1021/ac300153k; Wright AJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-66; Wu CL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000513; Yap IKS, 2010, J PROTEOME RES, V9, P2996, DOI 10.1021/pr901188e; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	100	345	378	9	341	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					384	392		10.1038/nature11708	http://dx.doi.org/10.1038/nature11708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23151581				2022-12-28	WOS:000311031600035
J	Brown, JL				Brown, Jeffrey L.			The Unasked Question	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brown, Jeffrey L.] New York Med Coll, Dept Pediat, New York, NY USA; [Brown, Jeffrey L.] Weill Cornell Med Coll, Dept Psychiat, New York, NY USA	New York Medical College; Cornell University	Brown, JL (corresponding author), New York Med Coll, Dept Pediat, New York, NY USA.	jlbrown100@msn.com						[U.S. Department of Veterans Affairs Veterans' diseases associated with Agent Orange], VET DIS ASS AG OR; US Census Bureau American Fact Finder, TABL B21001 SEX AG V; US Dept of Veterans Affairs Veterans Health Administration, 2012, VET HLTH ADM 2011 SU	3	28	28	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1869	1870		10.1001/jama.2012.14254	http://dx.doi.org/10.1001/jama.2012.14254			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23150007				2022-12-28	WOS:000310952700022
J	Gaziano, JM; Sesso, HD; Christen, WG; Bubes, V; Smith, JP; MacFadyen, J; Schvartz, M; Manson, JE; Glynn, RJ; Buring, JE				Gaziano, J. Michael; Sesso, Howard D.; Christen, William G.; Bubes, Vadim; Smith, Joanne P.; MacFadyen, Jean; Schvartz, Miriam; Manson, JoAnn E.; Glynn, Robert J.; Buring, Julie E.			Multivitamins in the Prevention of Cancer in Men The Physicians' Health Study II Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-TERM SUPPLEMENTATION; CARDIOVASCULAR-DISEASE; PROSTATE-CANCER; BREAST-CANCER; BETA-CAROTENE; VITAMINS E; VEGETABLE INTAKE; WOMENS HEALTH; COLON-CANCER; MORTALITY	Context Multivitamin preparations are the most common dietary supplement, taken by at least one-third of all US adults. Observational studies have not provided evidence regarding associations of multivitamin use with total and site-specific cancer incidence or mortality. Objective To determine whether long-term multivitamin supplementation decreases the risk of total and site-specific cancer events among men. Design, Setting, and Participants A large-scale, randomized, double-blind, placebo-controlled trial (Physicians' Health Study II) of 14 641 male US physicians initially aged 50 years or older (mean [SD] age, 64.3 [9.2] years), including 1312 men with a history of cancer at randomization, enrolled in a common multivitamin study that began in 1997 with treatment and follow-up through June 1, 2011. Intervention Daily multivitamin or placebo. Main Outcome Measures Total cancer (excluding nonmelanoma skin cancer), with prostate, colorectal, and other site-specific cancers among the secondary end points. Results During a median (interquartile range) follow-up of 11.2 (10.7-13.3) years, there were 2669 men with confirmed cancer, including 1373 cases of prostate cancer and 210 cases of colorectal cancer. Compared with placebo, men taking a daily multivitamin had a statistically significant reduction in the incidence of total cancer (multivitamin and placebo groups, 17.0 and 18.3 events, respectively, per 1000 person-years; hazard ratio [HR], 0.92; 95% CI, 0.86-0.998; P = .04). There was no significant effect of a daily multivitamin on prostate cancer (multivitamin and placebo groups, 9.1 and 9.2 events, respectively, per 1000 person-years; HR, 0.98; 95% CI, 0.88-1.09; P = .76), colorectal cancer (multivitamin and placebo groups, 1.2 and 1.4 events, respectively, per 1000 person-years; HR, 0.89; 95% CI, 0.68-1.17; P = .39), or other site-specific cancers. There was no significant difference in the risk of cancer mortality (multivitamin and placebo groups, 4.9 and 5.6 events, respectively, per 1000 person-years; HR, 0.88; 95% CI, 0.77-1.01; P = .07). Daily multivitamin use was associated with a reduction in total cancer among 1312 men with a baseline history of cancer (HR, 0.73; 95% CI, 0.56-0.96; P = .02), but this did not differ significantly from that among 13 329 men initially without cancer (HR, 0.94; 95% CI, 0.87-1.02; P = .15; P for interaction = .07). Conclusion In this large prevention trial of male physicians, daily multivitamin supplementation modestly but significantly reduced the risk of total cancer.	[Gaziano, J. Michael; Sesso, Howard D.; Christen, William G.; Bubes, Vadim; Smith, Joanne P.; MacFadyen, Jean; Schvartz, Miriam; Manson, JoAnn E.; Glynn, Robert J.; Buring, Julie E.] Brigham & Womens Hosp, Dept Med, Boston, MA 02120 USA; [Gaziano, J. Michael; Sesso, Howard D.; Christen, William G.; Bubes, Vadim; Smith, Joanne P.; MacFadyen, Jean; Schvartz, Miriam; Manson, JoAnn E.; Glynn, Robert J.; Buring, Julie E.] Harvard Univ, Sch Med, Boston, MA USA; [Gaziano, J. Michael] VA Boston Healthcare Syst, Boston, MA USA; [Sesso, Howard D.; Manson, JoAnn E.; Buring, Julie E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Glynn, Robert J.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Gaziano, JM (corresponding author), Brigham & Womens Hosp, Dept Med, 1620 Tremont St, Boston, MA 02120 USA.	jmgaziano@partners.org		Hanna, Jasmah/0000-0001-5157-5136	National Institutes of Health (NIH) [CA 097193, CA 34944, CA 40360, HL 26490, HL 34595]; Veterans Administration; BASF Corporation; Tomato Products Wellness Council; Cambridge Theranostics Ltd.; Harvard University (Clinical Nutrition Research Center); DSM Nutritional Products Inc; Aurora Foundation; Bristol-Meyers Squibb; AstraZeneca; Novartis; NATIONAL CANCER INSTITUTE [R01CA097193, R01CA040360] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); BASF Corporation(BASF); Tomato Products Wellness Council; Cambridge Theranostics Ltd.; Harvard University (Clinical Nutrition Research Center); DSM Nutritional Products Inc; Aurora Foundation; Bristol-Meyers Squibb(Bristol-Myers Squibb); AstraZeneca(AstraZeneca); Novartis(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Gaziano reported receiving investigator-initiated research funding from the National Institutes of Health (NIH), the Veterans Administration, and the BASF Corporation; assistance with study agents and packaging from BASF Corporation and Pfizer (formerly Wyeth, American Home Products, and Lederle); and assistance with study packaging provided by DSM Nutritional Products Inc (formerly Roche Vitamins). Dr Sesso reported receiving investigator-initiated research funding from the NIH, the Tomato Products Wellness Council, and Cambridge Theranostics Ltd. Dr Christen reported receiving research funding support from the NIH, Harvard University (Clinical Nutrition Research Center), and DSM Nutritional Products Inc (formerly Roche Vitamins). Dr Manson reported receiving investigator-initiated research funding from the NIH, and assistance with study pills and packaging from BASF and Cognis Corporations for the Women's Antioxidant and Folic Acid Cardiovascular Study and from Pronova Bio-Pharma and Pharmavite for the VITamin D and OmegA-3 TriaL, and funding from the nonprofit Aurora Foundation. Dr Glynn reported receiving investigator-initiated research funding from the NIH, Bristol-Meyers Squibb, AstraZeneca, and Novartis; and signed a consulting agreement with Merck to give an invited talk. Dr Buring reported receiving investigator-initiated research funding from the NIH, and assistance with study pills and packaging from Natural Source Vitamin E Association and Bayer Healthcare for the Women's Health Study. No other authors reported any financial disclosures.; This work was supported by grants CA 097193, CA 34944, CA 40360, HL 26490, and HL 34595 from the NIH and an investigator-initiated grant from BASF Corporation. Study agents and packaging were provided by BASF Corporation and Pfizer (formerly Wyeth, American Home Products, and Lederle) and study packaging was provided by DSM Nutritional Products Inc (formerly Roche Vitamins).	Asgari MM, 2011, J AM ACAD DERMATOL, V65, P1145, DOI 10.1016/j.jaad.2010.09.009; Bailey RL, 2011, J NUTR, V141, P261, DOI 10.3945/jn.110.133025; Block G, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-30; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y; Boffetta P, 2010, JNCI-J NATL CANCER I, V102, P529, DOI 10.1093/jnci/djq072; Cauley JA, 2012, J BONE MINER RES S1, V27; Chan ALF, 2011, ANN PHARMACOTHER, V45, P476, DOI 10.1345/aph.1P445; Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Clarke R, 2010, ARCH INTERN MED, V170, P1622, DOI 10.1001/archinternmed.2010.348; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Ervin R.B., 1999, VITAL HLTH STAT, V11, P1; Gahche Jamie, 2011, NCHS Data Brief, P1; Gaziano JM, 2009, JAMA-J AM MED ASSOC, V301, P52, DOI 10.1001/jama.2008.862; Giovannucci E, 1998, ANN INTERN MED, V129, P517, DOI 10.7326/0003-4819-129-7-199810010-00002; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Hung HC, 2004, JNCI-J NATL CANCER I, V96, P1577, DOI 10.1093/jnci/djh296; Jacobs EJ, 2003, AM J EPIDEMIOL, V158, P621, DOI 10.1093/aje/kwg190; Jacobs EJ, 2001, CANCER CAUSE CONTROL, V12, P927, DOI 10.1023/A:1013716323466; Kwan ML, 2011, BREAST CANCER RES TR, V130, P195, DOI 10.1007/s10549-011-1557-4; LANG JM, 1991, STAT MED, V10, P1585, DOI 10.1002/sim.4780101010; Larsson SC, 2010, AM J CLIN NUTR, V91, P1268, DOI 10.3945/ajcn.2009.28837; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Li KR, 2012, EUR J NUTR, V51, P407, DOI 10.1007/s00394-011-0224-1; Lin J, 2009, JNCI-J NATL CANCER I, V101, P14, DOI 10.1093/jnci/djn438; Lof M, 2011, CANCER CAUSE CONTROL, V22, P283, DOI 10.1007/s10552-010-9696-1; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; McGinnis JM, 2006, ANN INTERN MED, V145, P364, DOI 10.7326/0003-4819-145-5-200609050-00136; Morris MC, 2011, JAMA-J AM MED ASSOC, V305, P1348, DOI 10.1001/jama.2011.383; Neppl-Huber C, 2012, ANN ONCOL, V23, P1325, DOI 10.1093/annonc/mdr414; Neuhouser ML, 2009, ARCH INTERN MED, V169, P294, DOI 10.1001/archinternmed.2008.540; Park K, 2009, AM J EPIDEMIOL, V169, P887, DOI 10.1093/aje/kwn410; Park SY, 2011, AM J EPIDEMIOL, V173, P906, DOI 10.1093/aje/kwq447; Pocobelli G, 2009, AM J EPIDEMIOL, V170, P472, DOI 10.1093/aje/kwp167; Qiao YL, 2009, JNCI-J NATL CANCER I, V101, P507, DOI 10.1093/jnci/djp037; Riboli E, 2003, AM J CLIN NUTR, V78, p559S, DOI 10.1093/ajcn/78.3.559S; Sebastian RS, 2007, J AM DIET ASSOC, V107, P1322, DOI 10.1016/j.jada.2007.05.010; Sesso HD, 2002, CONTROL CLIN TRIALS, V23, P686, DOI 10.1016/S0197-2456(02)00235-0; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Stevens VL, 2005, CANCER CAUSE CONTROL, V16, P643, DOI 10.1007/s10552-005-0384-5; U.S. Department of Agriculture U.S. Department of Health and Human Services, 2010, REP DIET GUID ADV CO; Watkins ML, 2000, AM J EPIDEMIOL, V152, P149, DOI 10.1093/aje/152.2.149; White E, 1997, CANCER EPIDEM BIOMAR, V6, P769; Zhang YQ, 2009, CANCER CAUSE CONTROL, V20, P691, DOI 10.1007/s10552-008-9282-y	47	169	175	0	65	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1871	1880		10.1001/jama.2012.14641	http://dx.doi.org/10.1001/jama.2012.14641			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23162860	Green Accepted			2022-12-28	WOS:000310952700023
J	Bertolotti, J; van Putten, EG; Blum, C; Lagendijk, A; Vos, WL; Mosk, AP				Bertolotti, Jacopo; van Putten, Elbert G.; Blum, Christian; Lagendijk, Ad; Vos, Willem L.; Mosk, Allard P.			Non-invasive imaging through opaque scattering layers	NATURE			English	Article							PHASE RETRIEVAL; TOMOGRAPHY; MICROSCOPY; WAVES; TIME	Non-invasive optical imaging techniques, such as optical coherence tomography(1-3), are essential diagnostic tools in many disciplines, from the life sciences to nanotechnology. However, present methods are not able to image through opaque layers that scatter all the incident light(4,5). Even a very thin layer of a scattering material can appear opaque and hide any objects behind it(6). Although great progress has been made recently with methods such as ghost imaging(7,8) and wavefront shaping(9-11), present procedures are still invasive because they require either a detector(12) or a nonlinear material(13) to be placed behind the scattering layer. Here we report an optical method that allows non-invasive imaging of a fluorescent object that is completely hidden behind an opaque scattering layer. We illuminate the object with laser light that has passed through the scattering layer. We scan the angle of incidence of the laser beam and detect the total fluorescence of the object from the front. From the detected signal, we obtain the image of the hidden object using an iterative algorithm(14,15). As a proof of concept, we retrieve a detailed image of a fluorescent object, comparable in size (50 micrometres) to a typical human cell, hidden 6 millimetres behind an opaque optical diffuser, and an image of a complex biological sample enclosed between two opaque screens. This approach to non-invasive imaging through strongly scattering media can be generalized to other contrast mechanisms and geometries.	[Bertolotti, Jacopo; van Putten, Elbert G.; Lagendijk, Ad; Vos, Willem L.; Mosk, Allard P.] Univ Twente, MESA Inst Nanotechnol, Complex Photon Syst COPS, NL-7500 AE Enschede, Netherlands; [Bertolotti, Jacopo] Univ Florence, Dipartimento Fis, I-50019 Sesto Fiorentino, Italy; [Blum, Christian] Univ Twente, MESA Inst Nanotechnol, Nanobiophys NBP, NL-7500 AE Enschede, Netherlands; [Lagendijk, Ad] FOM Inst Atom & Mol Phys, NL-1098 XG Amsterdam, Netherlands	University of Twente; University of Florence; University of Twente; AMOLF	Bertolotti, J (corresponding author), Univ Twente, MESA Inst Nanotechnol, Complex Photon Syst COPS, POB 217, NL-7500 AE Enschede, Netherlands.	j.bertolotti@utwente.nl	Vos, Willem L./B-7489-2012; Lagendijk, Ad/I-5409-2013; Mosk, Allard P./B-2401-2008; Bertolotti, Jacopo/A-4314-2009	Vos, Willem L./0000-0003-3066-859X; Mosk, Allard P./0000-0002-1140-6626; Bertolotti, Jacopo/0000-0002-7163-6343; Blum, Christian/0000-0002-6524-2495	Stichting Technische Wetenschappen; Stichting voor Fundamenteel Onderzoek der Materie; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO); FIRB-MIUR 'Futuro in Ricerca' [RBFR08UH60]; NWO; European Research Council [279248]	Stichting Technische Wetenschappen; Stichting voor Fundamenteel Onderzoek der Materie(FOM (The Netherlands)); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); FIRB-MIUR 'Futuro in Ricerca'(Ministry of Education, Universities and Research (MIUR)); NWO(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission)	We thank W. L. Barnes for discussions and for reading the manuscript, and M. Claessens, V. Subramaniam and J. Schleipen for discussions and for help with samples and equipment. This work is supported by the Stichting Technische Wetenschappen and the Stichting voor Fundamenteel Onderzoek der Materie, which are financially supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO). J. B. acknowledges a grant by FIRB-MIUR 'Futuro in Ricerca' (project RBFR08UH60). A. P. M. acknowledges a 'Vidi' grant from NWO and European Research Council grant no. 279248.	Abbey B, 2011, NAT PHOTONICS, V5, P420, DOI [10.1038/nphoton.2011.125, 10.1038/NPHOTON.2011.125]; ABRAMSON N, 1978, OPT LETT, V3, P121, DOI 10.1364/OL.3.000121; Akkermans E, 2007, MESOSCOPIC PHYSICS OF ELECTRONS AND PHOTONS, P427, DOI 10.1017/CBO9780511618833.014; Bennink RS, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.113601; Culver JP, 2001, OPT LETT, V26, P701, DOI 10.1364/OL.26.000701; Dainty J. C., 1984, LASER SPECKLE RELATE; FENG SC, 1988, PHYS REV LETT, V61, P834, DOI 10.1103/PhysRevLett.61.834; FIENUP JR, 1978, OPT LETT, V3, P27, DOI 10.1364/OL.3.000027; FIENUP JR, 1982, APPL OPTICS, V21, P2758, DOI 10.1364/AO.21.002758; Fink M, 1997, PHYS TODAY, V50, P34, DOI 10.1063/1.881692; FREUND I, 1988, PHYS REV LETT, V61, P2328, DOI 10.1103/PhysRevLett.61.2328; FREUND I, 1990, PHYSICA A, V168, P49, DOI 10.1016/0378-4371(90)90357-X; Gibson AP, 2005, PHYS MED BIOL, V50, pR1, DOI 10.1088/0031-9155/50/4/R01; Hsieh CL, 2010, OPT EXPRESS, V18, P20723, DOI 10.1364/OE.18.020723; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Ishimaru A, 2012, WAVE RANDOM COMPLEX, V22, P24, DOI 10.1080/17455030.2010.528065; Katz O, 2012, NAT PHOTONICS, V6, P549, DOI 10.1038/nphoton.2012.150; Katz O, 2011, NAT PHOTONICS, V5, P372, DOI [10.1038/NPHOTON.2011.72, 10.1038/nphoton.2011.72]; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Mosk AP, 2012, NAT PHOTONICS, V6, P283, DOI [10.1038/NPHOTON.2012.88, 10.1038/nphoton.2012.88]; Nasr MB, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.083601; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/nmeth.1483, 10.1038/NMETH.1483]; Popoff SM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.100601; Sheng P., 1995, INTRO WAVE SCATTERIN, Vsecond; STREKALOV DV, 1995, PHYS REV LETT, V74, P3600, DOI 10.1103/PhysRevLett.74.3600; Thurman ST, 2009, J OPT SOC AM A, V26, P1008, DOI 10.1364/JOSAA.26.001008; van Putten EG, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.193905; Vellekoop IM, 2010, OPT LETT, V35, P1245, DOI 10.1364/OL.35.001245; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Yaqoob Z, 2008, NAT PHOTONICS, V2, P110, DOI 10.1038/nphoton.2007.297	30	699	722	34	460	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2012	491	7423					232	234		10.1038/nature11578	http://dx.doi.org/10.1038/nature11578			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23135468	Green Published			2022-12-28	WOS:000310774300039
J	Modi, N; Clark, H; Wolfe, I; Costello, A; Budge, H				Modi, Neena; Clark, Howard; Wolfe, Ingrid; Costello, Anthony; Budge, Helen		Royal Coll Paediat Child Hlth Comm	A healthy nation: strengthening child health research in the UK	LANCET			English	Review							RANDOMIZED CONTROLLED-TRIALS; INFANT-DEATH-SYNDROME; SLEEPING POSITION; POLICY; CONSENT; ADULTS	Despite a general acknowledgment that research in children is necessary and ethical, the evidence base for child-specific treatments is still sparse. We investigated children's biomedical and health services research in the UK in relation to training, infrastructure and activity, research evidence, and visibility. We show that excellent opportunities for career researchers exist through a competitive, national integrated academic training programme, but that the number of academic paediatricians has decreased by 18% between 2000 and 2011, falling from 11.3% to 5.9% of the consultant workforce. The potential for rapid delivery of studies in children through the National Health Service (NHS) is not being realised: clinical trainees are poorly equipped with core research skills; most newly appointed consultant paediatricians have little or no research experience; less than 5% of contracted consultant time supports research; less than 2.5% of the 2 million children seen in the NHS every year are recruited to studies; and ten of the 20 UK children's hospitals do not have a clinical research facility. Support through National Institute for Health Research networks is good for studies into drugs, but inconsistent for non-drug research; less than 5% of registered studies involve children and only one children's biomedical research centre has been allocated funding from 2012. Of the UK annual public and charitable biomedical research expenditure of roughly 2.2 pound billion, about 5% is directed at child health research. The scant evidence base is impeding the development of clinical guidance and policy-less than 20% of the outputs of the National Institute for Health and Clinical Excellence are applicable to children. Paediatric representation on major research boards is weak. Parent and young people's advocacy is fragmented, and their views are insufficiently heeded by regulatory bodies. The strong UK Government commitment to biomedical research has not been translated fully to research for children. The power of research in children to turn the tide of the growing burden of non-communicable, chronic, adult diseases that have their origins in early life, to benefit the health of an ageing population and future generations, and to reduce health-care costs is inadequately recognised. On the basis of our findings, we make several recommendations to improve early-years research, including the formation of multidisciplinary, cross-institutional groups of clinical and non-clinical child health researchers and their access to diagnostic and laboratory facilities suitable for children; a unified Children's Research Network for drug studies and non-drug studies; regulatory assessment of research that is proportionate and based on consistent national criteria; an expansion of research posts; support for parents' and young people's advocacy; collaboration between children's research charities; improved research training for paediatric trainees; and closer integration of child health research with core NHS activities.	[Modi, Neena] Univ London Imperial Coll Sci Technol & Med, London SW10 9NH, England; [Clark, Howard] Univ Southampton, Univ Hosp, Southampton, Hants, England; [Wolfe, Ingrid] London Sch Hyg & Trop Med, London WC1, England; [Costello, Anthony] UCL, UCL Inst Global Hlth, London, England; [Budge, Helen] Univ Nottingham, Univ Hosp, Nottingham NG7 2RD, England	Imperial College London; University of Southampton; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Nottingham University Hospital NHS Trust; University of Nottingham	Modi, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp Campus,369 Fulham Rd, London SW10 9NH, England.	n.modi@imperial.ac.uk	Harding, Richard/G-9729-2012; Roland, Damian/D-9553-2018	Roland, Damian/0000-0001-9334-5144; Hyde, Matthew/0000-0002-4489-7003; Lumsden, Daniel/0000-0002-5524-6177; Prayle, Andrew/0000-0002-1514-2840; Wolfe, Ingrid/0000-0002-4717-7634	National Institute for Health Research; National Institute for Health Research [DRF-2010-03-119, DRF-2009-02-112] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	NM, HC, AC, and HB hold tenured academic appointments. NM is vice president of the Royal College of Paediatrics and Child Health (RCPCH) with responsibility for Science and Research; HC is chair of the RCPCH Academic Training Committee; other members of the writing group-Damian Roland and Daniel Lumsden-are immediate past and present chairs of the RCPCH Trainee's Committee, respectively. Damian Roland is doing a full-time doctoral research fellowship funded by the National Institute for Health Research. All authors (including all writing group members) declare that they have no other conflicts of interest. IW is married to Richard Horton, Editor of The Lancet. Richard Horton had no involvement in the peer review and acceptance process for this Review.	Abramson H, 1944, J PEDIATR-US, V25, P404, DOI 10.1016/S0022-3476(44)80005-1; *AC MED SCI, 2003, STRENGTH CLIN RES; Academy of Medical Sciences, 2011, NEW PATHW REG GOV HL; [Anonymous], 1997, Arch Dis Child, V76, P1; [Anonymous], 1980, ARCH DIS CHILD, V55, P75; [Anonymous], 2005, MED DENT QUAL AC STA; [Anonymous], CHILD POV PERSP OV C; [Anonymous], 2012, FDN FACT SHEET; [Anonymous], 2012, SURV RAIS QUEST NHS; [Anonymous], 2011, CHILD HLTH DAT 2000; Barrington K J, 2001, BMC Pediatr, V1, P1, DOI 10.1186/1471-2431-1-1; Bartlett D, W MIDL RES COLL TRAI; Baur LA, 2010, J PAEDIATR CHILD H, V46, P696, DOI 10.1111/j.1440-1754.2010.01905.x; Bloor C, 2011, STRAT UK LIF SCI; Boat TF, 2007, J PEDIATR-US, V151, pS21, DOI 10.1016/j.jpeds.2007.08.016; Boots I, 2007, EUR J PEDIATR, V166, P849, DOI 10.1007/s00431-006-0381-z; Bourgeois FT, 2012, PEDIATRICS, V130, P285, DOI 10.1542/peds.2012-0139; Cooksey D., 2006, REV UK HLTH RES FUND; DEJONGE GA, 1993, ARCH DIS CHILD, V69, P660, DOI 10.1136/adc.69.6.660; Department of Health, 2006, BEST RES BEST HLTH N; Department of Health, 2009, HLTH CHILD PROGR PRE; Department of Health, 2010, EQ EXC LIB NHS; DWORKIN G, 1978, ARCH DIS CHILD, V53, P443, DOI 10.1136/adc.53.6.443; Evans I, 2011, TESTING TREATMENTS B; Fern Lorna A, 2010, Semin Oncol, V37, pe1, DOI 10.1053/j.seminoncol.2010.04.002; Fitzpatrick S, 2012, SURVEY STAFFING LEVE; Fitzpatrick S., 2011, SURVEY STAFFING LEVE; FLEMING PJ, 1990, BRIT MED J, V301, P85, DOI 10.1136/bmj.301.6743.85; Foundation for the Study of Infant Deaths, 2009, FACTFILE 2 RES BACKG; Freer Y, 2009, PEDIATRICS, V123, P1301, DOI 10.1542/peds.2007-3860; Garralda ME, 2012, PSYCHIATR BULL, V36, P32, DOI 10.1192/pb.bp.111.034447; Gilbert R, 2005, INT J EPIDEMIOL, V34, P874, DOI 10.1093/ije/dyi088; Gitterman DP, 2008, PEDIATR RES, V64, P462, DOI 10.1203/PDR.0b013e31818912fd; Gitterman DP, 2004, HEALTH AFFAIR, V23, P113, DOI 10.1377/hlthaff.23.5.113; GMC, 2006, GOOD MED PRACT; Gompels LL, 2011, CLIN MED, V11, P434, DOI 10.7861/clinmedicine.11-5-434; Hay WW, 2010, PEDIATRICS, V125, P1259, DOI 10.1542/peds.2009-2635; Hospital Episode Statistics, INP DAT; Innvaer Simon, 2002, J Health Serv Res Policy, V7, P239, DOI 10.1258/135581902320432778; Kelly Frank, 2011, Res Rep Health Eff Inst, P3; Kirby P., 2004, GUIDE ACTIVELY INVOL; Lavis JN, 2009, HEALTH RES POLICY SY, V7, DOI [10.1186/1478-4505-7-S1-S1, 10.1186/1478-4505-7-S1-11, 10.1186/1478-4505-7-S1-S15, 10.1186/1478-4505-7-S1-I1]; Law C, 2010, CLIN MED, V10, P595, DOI 10.7861/clinmedicine.10-6-595; Levene M, 2005, ARCH DIS CHILD, V90, P450, DOI 10.1136/adc.2004.050286; Mason SA, 2000, LANCET, V356, P2045, DOI 10.1016/S0140-6736(00)03401-2; McKee M, 1996, HEALTH POLICY, V37, P117, DOI 10.1016/0168-8510(95)00829-2; Medical Research Council, 2009, RES CHANG LIV MRC ST; Modi N, 2011, ARCH DIS CHILD, V96, P500, DOI 10.1136/adc.2010.188243; National Research Ethics Service, WHO WE AR; Pandolfini C, 2009, EUR J CLIN PHARMACOL, V65, P873, DOI 10.1007/s00228-009-0687-7; RCPCH, 2010, CURR PAED TRAIN GEN; Shamliyan T, 2012, PEDIATRICS, V129, pE1291, DOI 10.1542/peds.2010-2847; Shilling V, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15150; SKEGG PDG, 1977, LANCET, V2, P754; Snowdon C., 2007, CLIN ETHICS, V2, P193, DOI [DOI 10.1258/147775007783560193, 10.1258/147775007783560193]; Spencer A, 2012, ARCH DIS CHILD-FETAL, DOI [10.1136/archdischild-2011-300872, DOI 10.1136/ARCHDISCHID-2011-300872]; Stock W, 2008, BLOOD, V112, P1646, DOI 10.1182/blood-2008-01-130237; Sun GH, 2012, NEW ENGL J MED, V367, P687, DOI 10.1056/NEJMp1206643; The Academy of Medical Sciences, 2010, REAP  REW VIS UK MED; The Federation of the Royal Colleges of Physicians of the UK, 2011, CENS CONS PHYS MED R; Wellcome Trust, 2010, STRAT PLAN 2010 20 E; Western Australia Commissioner for Children and Young People, 2020, NAT SERV FRAM CHILDR; Wolfe I, 2013, SUCCESSES FAILURES H; Wolfe I, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1277; World Health Organization, 2008, GLOB BURD DIS 2004 U	66	38	38	0	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2013	381	9860					73	87		10.1016/S0140-6736(12)61818-2	http://dx.doi.org/10.1016/S0140-6736(12)61818-2			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064AW	23176802				2022-12-28	WOS:000313044300029
J	Barry, ER; Morikawa, T; Butler, BL; Shrestha, K; de la Rosa, R; Yan, KS; Fuchs, CS; Magness, ST; Smits, R; Ogino, S; Kuo, CJ; Camargo, FD				Barry, Evan R.; Morikawa, Teppei; Butler, Brian L.; Shrestha, Kriti; de la Rosa, Rosemarie; Yan, Kelley S.; Fuchs, Charles S.; Magness, Scott T.; Smits, Ron; Ogino, Shuji; Kuo, Calvin J.; Camargo, Fernando D.			Restriction of intestinal stem cell expansion and the regenerative response by YAP	NATURE			English	Article							HIPPO SIGNALING PATHWAY; WNT/BETA-CATENIN; COLORECTAL-CANCER; IN-VITRO; MOUSE MODEL; EXPRESSION; HOMEOSTASIS; EPITHELIUM; CRYPT; LGR5	A remarkable feature of regenerative processes is their ability to halt proliferation once an organ's structure has been restored. The Wnt signalling pathway is the major driving force for homeostatic self-renewal and regeneration in the mammalian intestine. However, the mechanisms that counterbalance Wnt-driven proliferation are poorly understood. Here we demonstrate in mice and humans that yes-associated protein 1 (YAP; also known as YAP1)-a protein known for its powerful growth-inducing and oncogenic properties(1,2)-has an unexpected growth-suppressive function, restricting Wnt signals during intestinal regeneration. Transgenic expression of YAP reduces Wnt target gene expression and results in the rapid loss of intestinal crypts. In addition, loss of YAP results in Wnt hypersensitivity during regeneration, leading to hyperplasia, expansion of intestinal stem cells and niche cells, and formation of ectopic crypts and microadenomas. We find that cytoplasmic YAP restricts elevated Wnt signalling independently of the AXIN-APC-GSK-3 beta complex partly by limiting the activity of dishevelled (DVL). DVL signals in the nucleus of intestinal stem cells, and its forced expression leads to enhanced Wnt signalling in crypts. YAP dampens Wnt signals by restricting DVL nuclear translocation during regenerative growth. Finally, we provide evidence that YAP is silenced in a subset of highly aggressive and undifferentiated human colorectal carcinomas, and that its expression can restrict the growth of colorectal carcinoma xenografts. Collectively, our work describes a novel mechanistic paradigm for how proliferative signals are counterbalanced in regenerating tissues. Additionally, our findings have important implications for the targeting of YAP in human malignancies.	[Barry, Evan R.; Butler, Brian L.; Shrestha, Kriti; de la Rosa, Rosemarie; Camargo, Fernando D.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Barry, Evan R.; Butler, Brian L.; Shrestha, Kriti; de la Rosa, Rosemarie; Camargo, Fernando D.] Childrens Hosp, Dept Hematol Oncol, Boston, MA 02115 USA; [Barry, Evan R.; Butler, Brian L.; Camargo, Fernando D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Barry, Evan R.; Camargo, Fernando D.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Morikawa, Teppei; Fuchs, Charles S.; Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Morikawa, Teppei; Fuchs, Charles S.; Ogino, Shuji] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Yan, Kelley S.; Kuo, Calvin J.] Stanford Univ, Dept Med, Div Hematol, Stanford, CA 94305 USA; [Fuchs, Charles S.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Fuchs, Charles S.; Ogino, Shuji] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Magness, Scott T.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Magness, Scott T.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Smits, Ron] Erasmus MC, Dept Gastroenterol & Hepatol, NL-3000 CA Rotterdam, Netherlands; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Stanford University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Erasmus University Rotterdam; Erasmus MC; Harvard University; Brigham & Women's Hospital	Camargo, FD (corresponding author), Childrens Hosp, Stem Cell Program, 300 Longwood Ave, Boston, MA 02115 USA.	Fernando.camargo@childrens.harvard.edu		camargo, fernando/0000-0002-5630-5909; Ogino, Shuji/0000-0002-3909-2323; Kuo, Calvin/0000-0002-7427-5985; Magness, Scott/0000-0002-2746-1224	Stand Up to Cancer-AACR initiative; National Institutes of Health [R01 CA131426, AR064036]; Harvard Stem Cell Institute; American Cancer Society Illinois Division [PF-12-245-01-CCG]; CIRM [1K08DK096048];  [1U01DK085527];  [R01 CA151993];  [R01 DK091427];  [P01CA87969];  [P50CA127003]; NATIONAL CANCER INSTITUTE [P01CA087969, R01CA131426, R01CA151993, P50CA127003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085527, P30DK049216, K08DK096048, R01DK091427] Funding Source: NIH RePORTER	Stand Up to Cancer-AACR initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; American Cancer Society Illinois Division(American Cancer Society); CIRM(California Institute for Regenerative Medicine); ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank L. Zon and Camargo laboratory members for critical review of this manuscript and X. He for Myc-DVL2 constructs. This work was supported by grants from the Stand Up to Cancer-AACR initiative (F. D. C.), National Institutes of Health R01 CA131426 and AR064036 (F. D. C.) and the Harvard Stem Cell Institute (F. D. C.). F. D. C. is a Pew Scholar in the Biomedical Sciences. E. R. B. is supported by a postdoctoral fellowship from the American Cancer Society Illinois Division (PF-12-245-01-CCG). This work has also benefited from support to K.S.Y. (CIRM, and 1K08DK096048), C.J.K. (1U01DK085527), S.O. (R01 CA151993 and R01 DK091427), S. T. M. (P01CA87969) and C. S. F. (P50CA127003).	Andreu P, 2008, DEV BIOL, V324, P288, DOI 10.1016/j.ydbio.2008.09.027; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Avruch J, 2012, CELL CYCLE, V11, P1090, DOI 10.4161/cc.11.6.19453; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Cheung AF, 2010, ONCOGENE, V29, P1857, DOI 10.1038/onc.2009.457; Colnot S, 2004, LAB INVEST, V84, P1619, DOI 10.1038/labinvest.3700180; Davies PS, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-57; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Metcalfe C, 2010, CANCER RES, V70, P6629, DOI 10.1158/0008-5472.CAN-10-1616; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Ogino S, 2006, NEOPLASIA, V8, P458, DOI 10.1593/neo.06247; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Roth S, 2009, GENESIS, V47, P7, DOI 10.1002/dvg.20446; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	39	388	399	3	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					106	+		10.1038/nature11693	http://dx.doi.org/10.1038/nature11693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23178811	Green Submitted, Green Accepted			2022-12-28	WOS:000312933800040
J	Ohouo, PY; de Oliveira, FMB; Liu, Y; Ma, CJ; Smolka, MB				Ohouo, Patrice Y.; de Oliveira, Francisco M. Bastos; Liu, Yi; Ma, Chu Jian; Smolka, Marcus B.			DNA-repair scaffolds dampen checkpoint signalling by counteracting the adaptor Rad9	NATURE			English	Article							HOLLIDAY JUNCTION RESOLVASE; DAMAGE CHECKPOINT; PROTEIN-INTERACTION; REPLICATION STRESS; PHOSPHORYLATION; DPB11; SLX4; ACTIVATION; KINASE; DOMAIN	In response to genotoxic stress, a transient arrest in cell-cycle progression enforced by the DNA-damage checkpoint (DDC) signalling pathway positively contributes to genome maintenance(1). Because hyperactivated DDC signalling can lead to a persistent and detrimental cell-cycle arrest(2,3), cells must tightly regulate the activity of the kinases involved in this pathway. Despite their importance, the mechanisms for monitoring and modulating DDC signalling are not fully understood. Here we show that the DNA-repair scaffolding proteins Slx4 and Rtt107 prevent the aberrant hyperactivation of DDC signalling by lesions that are generated during DNA replication in Saccharomyces cerevisiae. On replication stress, cells lacking Slx4 or Rtt107 show hyperactivation of the downstream DDC kinase Rad53, whereas activation of the upstream DDC kinase Mec1 remains normal. An Slx4-Rtt107 complex counteracts the checkpoint adaptor Rad9 by physically interacting with Dpb11 and phosphorylated histone H2A, two positive regulators of Rad9-dependent Rad53 activation. A decrease in DDC signalling results from hypomorphic mutations in RAD53 and H2A and rescues the hypersensitivity to replication stress of cells lacking Slx4 or Rtt107. We propose that the Slx4-Rtt107 complex modulates Rad53 activation by a competition-based mechanism that balances the engagement of Rad9 at replication-induced lesions. Our findings show that DDC signalling is monitored and modulated through the direct action of DNA-repair factors.	[Ohouo, Patrice Y.; de Oliveira, Francisco M. Bastos; Liu, Yi; Ma, Chu Jian; Smolka, Marcus B.] Cornell Univ, Dept Mol Biol & Genet, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA	Cornell University	Smolka, MB (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA.	mbs266@cornell.edu	Bastos de Oliveira, Francisco/C-2349-2008; de Oliveira, Francisco Bastos/I-3540-2013	de Oliveira, Francisco Bastos/0000-0003-3314-3940	National Institutes of Health [RO1-GM097272, F31-GM093588]; Cornell Fleming Research Fellowship; HHMI Institutional Undergraduate Education Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097272, F31GM093588] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell Fleming Research Fellowship; HHMI Institutional Undergraduate Education Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (RO1-GM097272 to M. B. S. and F31-GM093588 to P.Y.O.). F.M.B.O. was supported by a Cornell Fleming Research Fellowship. C.J.M. was supported by an HHMI Institutional Undergraduate Education Grant to Cornell. The authors thank B. Almeida for technical assistance and R. Weiss, S. Emr, A. Bretscher, G. Balmus and P. Russell for comments on the manuscript.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Chen SH, 2010, J BIOL CHEM, V285, P12803, DOI 10.1074/jbc.M110.106989; Clerici M, 2001, EMBO J, V20, P6485, DOI 10.1093/emboj/20.22.6485; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Fricke WM, 2003, GENE DEV, V17, P1768, DOI 10.1101/gad.1105203; Granata M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001047; Javaheri A, 2006, P NATL ACAD SCI USA, V103, P13771, DOI 10.1073/pnas.0511192103; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Li XX, 2012, J BIOL CHEM, V287, P9137, DOI 10.1074/jbc.M111.311860; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; Ohouo PY, 2010, MOL CELL, V39, P300, DOI 10.1016/j.molcel.2010.06.019; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Pfander B, 2011, EMBO J, V30, P4897, DOI 10.1038/emboj.2011.345; Puddu F, 2008, MOL CELL BIOL, V28, P4782, DOI 10.1128/MCB.00330-08; Roberts TM, 2006, MOL BIOL CELL, V17, P539, DOI 10.1091/mbc.E05-08-0785; Schwartz MF, 2003, CELL CYCLE, V2, P384, DOI 10.4161/cc.2.4.457; Schwartz MF, 2002, MOL CELL, V9, P1055, DOI 10.1016/S1097-2765(02)00532-4; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Smolka MB, 2006, J CELL BIOL, V175, P743, DOI 10.1083/jcb.200605081; Smolka MB, 2005, MOL CELL PROTEOMICS, V4, P1358, DOI 10.1074/mcp.M500115-MCP200; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	30	73	73	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					120	+		10.1038/nature11658	http://dx.doi.org/10.1038/nature11658			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23160493	Green Accepted			2022-12-28	WOS:000312933800043
J	Weis, P; Driesner, T; Heinrich, CA				Weis, P.; Driesner, T.; Heinrich, C. A.			Porphyry-Copper Ore Shells Form at Stable Pressure-Temperature Fronts Within Dynamic Fluid Plumes	SCIENCE			English	Article							HYDROTHERMAL SYSTEMS; BINGHAM PORPHYRY; GOLD DEPOSIT; PERMEABILITY; VEINS; DEFORMATION; MODEL; ROCK; FLOW	Porphyry-type ore deposits are major resources of copper and gold, precipitated from fluids expelled by crustal magma chambers. The metals are typically concentrated in confined ore shells within vertically extensive vein networks, formed through hydraulic fracturing of rock by ascending fluids. Numerical modeling shows that dynamic permeability responses to magmatic fluid expulsion can stabilize a front of metal precipitation at the boundary between lithostatically pressured up-flow of hot magmatic fluids and hydrostatically pressured convection of cooler meteoric fluids. The balance between focused heat advection and lateral cooling controls the most important economic characteristics, including size, shape, and ore grade. This self-sustaining process may extend to epithermal gold deposits, venting at active volcanoes, and regions with the potential for geothermal energy production.	[Weis, P.; Driesner, T.; Heinrich, C. A.] ETH, Dept Earth Sci, CH-8092 Zurich, Switzerland; [Heinrich, C. A.] Univ Zurich, Fac Math & Nat Sci, CH-8006 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Weis, P (corresponding author), ETH, Dept Earth Sci, CH-8092 Zurich, Switzerland.	weis@erdw.ethz.ch	Weis, Philipp/B-8553-2016; Heinrich, Christoph A/D-3921-2014; Driesner, Thomas/N-6361-2016	Weis, Philipp/0000-0001-8912-0735; Heinrich, Christoph A/0000-0001-5838-4607; 	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation. We thank the reviewers for inspiring thoughts on the manuscript. This study benefited from discussions with D. Coumou, S. Cox, J. Dilles, S. Geiger, S. Matthai, and many others. Selected data and code are provided as supplementary materials.	Arif J, 2004, MINER DEPOSITA, V39, P523, DOI 10.1007/s00126-004-0433-0; Bodnar RJ, 2007, GEOLOGY, V35, P791, DOI 10.1130/G23653A.1; Cathles LM, 2007, EARTH PLANET SC LETT, V262, P92, DOI 10.1016/j.epsl.2007.07.029; CATHLES LM, 1993, ECON GEOL BULL SOC, V88, P1977, DOI 10.2113/gsecongeo.88.8.1977; CLOKE PL, 1979, ECON GEOL, V74, P1823, DOI 10.2113/gsecongeo.74.8.1823; Coumou D, 2008, SCIENCE, V321, P1825, DOI 10.1126/science.1159582; Cox SF, 2010, GEOFLUIDS, V10, P217, DOI 10.1111/j.1468-8123.2010.00281.x; DILLES JH, 1987, ECON GEOL, V82, P1750, DOI 10.2113/gsecongeo.82.7.1750; Evans KF, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003169; Fournier RO, 1999, ECON GEOL BULL SOC, V94, P1193, DOI 10.2113/gsecongeo.94.8.1193; Gruen G, 2010, ECON GEOL, V105, P69, DOI 10.2113/gsecongeo.105.1.69; Hayba DO, 1997, J GEOPHYS RES-SOL EA, V102, P12235, DOI 10.1029/97JB00552; HEDENQUIST JW, 1994, NATURE, V370, P519, DOI 10.1038/370519a0; HEDENQUIST JW, 1994, GEOLOGY, V22, P585, DOI 10.1130/0091-7613(1994)022<0585:FOVAOF>2.3.CO;2; HENLEY RW, 1978, ECON GEOL, V73, P1, DOI 10.2113/gsecongeo.73.1.1; HENLEY RW, 1983, EARTH-SCI REV, V19, P1, DOI 10.1016/0012-8252(83)90075-2; Hezarkhani A., 1999, MINER DEPOSITA, V34, P770, DOI DOI 10.1007/S001260050237; Ingebritsen SE, 2010, GEOFLUIDS, V10, P193, DOI 10.1111/j.1468-8123.2010.00278.x; IZAWA E, 1990, J GEOCHEM EXPLOR, V36, P1, DOI 10.1016/0375-6742(90)90050-K; Jupp T, 2000, NATURE, V403, P880, DOI 10.1038/35002552; Landtwing MR, 2005, EARTH PLANET SC LETT, V235, P229, DOI 10.1016/j.epsl.2005.02.046; Proffett JM, 2003, ECON GEOL BULL SOC, V98, P1535, DOI 10.2113/98.8.1535; Redmond PB, 2004, GEOLOGY, V32, P217, DOI 10.1130/G19986.1; Rojstaczer SA, 2008, GEOFLUIDS, V8, P128, DOI 10.1111/j.1468-8123.2008.00211.x; Rusk B, 2002, GEOLOGY, V30, P727, DOI 10.1130/0091-7613(2002)030<0727:SEMCAO>2.0.CO;2; Shinohara H, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000244; Sillitoe RH, 2010, ECON GEOL, V105, P3, DOI 10.2113/gsecongeo.105.1.3; von Quadt A, 2011, GEOLOGY, V39, P731, DOI 10.1130/G31966.1; Zoback MD, 2002, INT GEOL REV, V44, P383, DOI 10.2747/0020-6814.44.5.383	29	181	195	1	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1613	1616		10.1126/science.1225009	http://dx.doi.org/10.1126/science.1225009			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23160957	Green Accepted			2022-12-28	WOS:000312533100051
J	Clapier, CR; Cairns, BR				Clapier, Cedric R.; Cairns, Bradley R.			Regulation of ISWI involves inhibitory modules antagonized by nucleosomal epitopes	NATURE			English	Article							DNA TRANSLOCATION; CHROMATIN; MECHANISM; BINDING; RSC; IDENTIFICATION; RECOGNITION; DOMAIN	Chromatin-remodelling complexes (CRCs) mobilize nucleosomes to mediate the access of DNA-binding factors to their sites in vivo. These CRCs contain a catalytic subunit that bears an ATPase/DNA-translocase domain and flanking regions that bind nucleosomal epitopes(1). A central question is whether and how these flanking regions regulate ATP hydrolysis or the coupling of hydrolysis to DNA translocation, to affect nucleosome-sliding efficiency. ISWI-family CRCs contain the protein ISWI2, which uses its ATPase/DNA-translocase domain to pump DNA around the histone octamer to enable sliding(3-7). ISWI is positively regulated by two 'activating' nucleosomal epitopes: the 'basic patch' on the histone H4 tail, and extranucleosomal (linker) DNA(8-13). Previous work defined the HAND-SANT-SLIDE (HSS) domain at the ISWI carboxy terminus that binds linker DNA, needed for ISWI activity(14,15). Here we define two new, conserved and separate regulatory regions on Drosophila ISWI, termed AutoN and NegC, which negatively regulate ATP hydrolysis (AutoN) or the coupling of ATP hydrolysis to productive DNA translocation (NegC). The two aforementioned nucleosomal epitopes promote remodelling indirectly by preventing the negative regulation of AutoN and NegC. Notably, mutation or removal of AutoN and NegC enables marked nucleosome sliding without the H4 basic patch or extranucleosomal DNA, or the HSS domain, conferring on ISWI the biochemical attributes normally associated with SWI/SNF-family ATPases. Thus, the ISWI ATPase catalytic core is an intrinsically active DNA translocase that conducts nucleosome sliding, onto which selective 'inhibition-of-inhibition' modules are placed, to help ensure that remodelling occurs only in the presence of proper nucleosomal epitopes. This supports a general concept for the specialization of chromatin-remodelling ATPases, in which specific regulatory modules adapt an ancient active DNA translocase to conduct particular tasks only on the appropriate chromatin landscape.	[Clapier, Cedric R.; Cairns, Bradley R.] Univ Utah, Howard Hughes Med Inst, Sch Med, Salt Lake City, UT 84112 USA; [Clapier, Cedric R.; Cairns, Bradley R.] Univ Utah, Sch Med, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Cairns, BR (corresponding author), Univ Utah, Howard Hughes Med Inst, Sch Med, 2000 Circle Hope, Salt Lake City, UT 84112 USA.	cedric.clapier@hci.utah.edu; brad.cairns@hci.utah.edu			National Institutes of Health [GM60415, CA042014]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Tan for pST55-16 x NCP601a and G. Langst for pUC12 x 601. We thank C. Muller for experience gained by C. Clapier on structural aspects of ISWI protein. We thank T. Owen-Hughes for the S. cerevisiae strain TOH1358, T. Tsukiyama for the initial ISW1-containing plasmid, P. Gawu for technical assistance and B. Schackmann for DNA sequencing and peptide synthesis. This work was supported by National Institutes of Health grant GM60415 (supplies), Howard Hughes Medical Institute (support of C.R.C. and B.R.C.), and CA042014 (University of Utah core facilities).	Blosser TR, 2009, NATURE, V462, P1022, DOI 10.1038/nature08627; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Clapier CR, 2002, NUCLEIC ACIDS RES, V30, P649, DOI 10.1093/nar/30.3.649; Corona DFV, 2004, BBA-GENE STRUCT EXPR, V1677, P113, DOI 10.1016/j.bbaexp.2003.09.018; Dang WW, 2006, MOL CELL BIOL, V26, P7388, DOI 10.1128/MCB.01159-06; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Fazzio TG, 2005, MOL CELL BIOL, V25, P9165, DOI 10.1128/MCB.25.21.9165-9174.2005; Fitzgerald DJ, 2004, EMBO J, V23, P3836, DOI 10.1038/sj.emboj.7600364; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Forne I, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012088; Fyodorov DV, 2002, NATURE, V418, P897, DOI 10.1038/nature00929; Gkikopoulos T, 2011, SCIENCE, V333, P1758, DOI 10.1126/science.1206097; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; Hauk G, 2010, MOL CELL, V39, P711, DOI 10.1016/j.molcel.2010.08.012; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lorch Y, 2010, P NATL ACAD SCI USA, V107, P3458, DOI 10.1073/pnas.1000398107; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Patel A, 2011, J BIOL CHEM, V286, P43984, DOI 10.1074/jbc.M111.282970; Ryan DP, 2011, EMBO J, V30, P2596, DOI 10.1038/emboj.2011.166; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Schrodinger L. L. C., 2010, PYMOL MOL GRAPH SYST; Schwanbeck R, 2004, J BIOL CHEM, V279, P39933, DOI 10.1074/jbc.M406060200; Sen P, 2011, NUCLEIC ACIDS RES, V39, P9155, DOI 10.1093/nar/gkr622; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sirinakis G, 2011, EMBO J, V30, P2364, DOI 10.1038/emboj.2011.141; Strohner R, 2005, NAT STRUCT MOL BIOL, V12, P683, DOI 10.1038/nsmb966; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Wilson B, 2006, GENETICS, V172, P795, DOI 10.1534/genetics.105.047589; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	34	107	107	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					280	+		10.1038/nature11625	http://dx.doi.org/10.1038/nature11625			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23143334	Green Accepted			2022-12-28	WOS:000312259300048
J	Giugliano, RP; Desai, NR; Kohli, P; Rogers, WJ; Somaratne, R; Huang, F; Liu, T; Mohanavelu, S; Hoffman, EB; McDonald, ST; Abrahamsen, TE; Wasserman, SM; Scott, R; Sabatine, MS				Giugliano, Robert P.; Desai, Nihar R.; Kohli, Payal; Rogers, William J.; Somaratne, Ransi; Huang, Fannie; Liu, Thomas; Mohanavelu, Satishkumar; Hoffman, Elaine B.; McDonald, Shannon T.; Abrahamsen, Timothy E.; Wasserman, Scott M.; Scott, Robert; Sabatine, Marc S.		LAPLACE-TIMI 57 Investigators	Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study	LANCET			English	Article							LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; LDL CHOLESTEROL; PCSK9; THERAPY; GUIDELINES; TRIAL	Background LDL cholesterol (LDL-C) is a well established risk factor for cardiovascular disease. Proprotein convertase subtilisin/kexin type 9 (PCSK9) binds LDL receptors, targeting them for degradation. We therefore assessed the efficacy, safety, and tolerability of AMG 145, a human monoclonal IgG2 antibody against PCSK9, in stable patients with hypercholesterolemia on a statin. Methods In a phase 2, dose-ranging study done in 78 centres in the USA, Canada, Denmark, Hungary, and Czech Republic, patients (aged 18-80 years) with LDL-C greater than 2.2 mmol/L on a stable dose of statin (with or without ezetimibe), were randomly assigned equally, through an interactive voice response system, to subcutaneous injections of AMG 145 70 mg, 105 mg, or 140 mg, or matching placebo every 2 weeks; or subcutaneous injections of AMG 145 280 mg, 350 mg, or 420 mg, or matching placebo every 4 weeks. Everyone was masked to treatment assignment within the every 2 weeks and every 4 weeks schedules. The primary endpoint was the percentage change in LDL-C concentration from baseline after 12 weeks. Analysis was by modified intention to treat. This study is registered with ClinicalTrials.gov, number NCT01380730. Findings 631 patients with hypercholesterolaemia were randomly assigned to AMG 145 70 mg (n=79), 105 mg (n=79), or 140 mg (n=78), or matching placebo (n=78) every 2 weeks; or AMG 145 280 mg (n=79), 350 mg (n=79), and 420 mg (n=80), and matching placebo (n=79) every 4 weeks. At the end of the dosing interval at week 12, the mean LDL-C concentrations were reduced generally dose dependently by AMG 145 every 2 weeks (ranging from 41.8% to 66.1%; p<0.0001 for each dose vs placebo) and AMG 145 every 4 weeks (ranging from 41.8% to 50.3%; p<0.0001). No treatment-related serious adverse events occurred. The frequencies of treatment-related adverse events were similar in the AMG 145 and placebo groups (39 [8%] of 474 vs 11 [7%] of 155); none of these events were severe or life-threatening. Interpretation The results suggest that PCSK9 inhibition could be a new model in lipid management. Inhibition of PCSK9 warrants assessment in phase 3 clinical trials.	[Giugliano, Robert P.; Desai, Nihar R.; Kohli, Payal; Mohanavelu, Satishkumar; Hoffman, Elaine B.; McDonald, Shannon T.; Abrahamsen, Timothy E.; Sabatine, Marc S.] Brigham & Womens Hosp, TIMI Study Grp, Boston, MA 02115 USA; [Rogers, William J.] Univ Alabama Birmingham, Birmingham, AL USA; [Somaratne, Ransi; Huang, Fannie; Liu, Thomas; Wasserman, Scott M.; Scott, Robert] Amgen Inc, Thousand Oaks, CA USA	Harvard University; Brigham & Women's Hospital; University of Alabama System; University of Alabama Birmingham; Amgen	Giugliano, RP (corresponding author), Brigham & Womens Hosp, TIMI Study Grp, 350 Longwood Ave,1st Floor Off, Boston, MA 02115 USA.	rgiugliano@partners.org	Sabatine, Marc/AAJ-6751-2020; Giugliano, Robert/N-7233-2017	Sabatine, Marc/0000-0002-0691-3359; Kohli, Payal/0000-0002-1049-5233; Scott, Robert/0000-0001-8266-1061; Giugliano, Robert/0000-0003-4110-7675	Amgen; Amgen through Brigham and Women's Hospital; AstraZeneca throught Brigham and Women's Hospital; AstraZeneca/Bristol-Myers Squibb Alliance; Bristol-Myers Squibb/Sanofi-Aventis Joint Venture; Daiichi-Sankyo; Genzyme; Sanofi-Aventis; Sanofi-Aventis, Merck; Pfizer; Amgen, Thousand Oaks, CA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007604] Funding Source: NIH RePORTER	Amgen(Amgen); Amgen through Brigham and Women's Hospital; AstraZeneca throught Brigham and Women's Hospital; AstraZeneca/Bristol-Myers Squibb Alliance; Bristol-Myers Squibb/Sanofi-Aventis Joint Venture(Bristol-Myers Squibb); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Genzyme(Sanofi-AventisGenzyme Corporation); Sanofi-Aventis(Sanofi-Aventis); Sanofi-Aventis, Merck; Pfizer(Pfizer); Amgen, Thousand Oaks, CA(Amgen); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Amgen.; RPG, NRD, PK, SM, EBH, STM, TEA, and MSS received research grant support through Brigham and Women's Hospital for this trial from Amgen. RPG and MSS also have served as consultants for Amgen. WJR received research grant support for participation in this trial from Amgen. RSo, FH, TL, SMW, and RSc are employees of Amgen and own Amgen stock. MSS also received research grant support through Brigham and Women's Hospital from AstraZeneca, AstraZeneca/Bristol-Myers Squibb Alliance, Bristol-Myers Squibb/Sanofi-Aventis Joint Venture, Daiichi-Sankyo, Genzyme, Sanofi-Aventis, Merck, and Pfizer, and received honoraria for consulting from Aegerion, Sanofi-Aventis, GlazoSmithKline, Merck, and Pfizer.; LAPLACE-TIMI 57 was supported by a research grant from Amgen, Thousand Oaks, CA. We thank all the investigators, Data Monitoring and Clinical Endpoint Committee members, and Meera Kodukulla, Amgen, for her editorial support in formatting the report.	Artenstein AW, 2011, NEW ENGL J MED, V365, P2507, DOI 10.1056/NEJMra1106700; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; CHEN ZM, 1991, BRIT MED J, V303, P276, DOI 10.1136/bmj.303.6797.276; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Dias CS, 2012, J AM COLL CARDIOL; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Kohli P, 2012, CLIN CARDIOL, V35, P385, DOI 10.1002/clc.22014; Mabuchi H, 1998, AM J CARDIOL, V82, P1489, DOI 10.1016/S0002-9149(98)00692-4; McKenney JM, 2012, J AM COLL CARDIOL, V59, P2344, DOI 10.1016/j.jacc.2012.03.007; Murphy SA, 2009, J AM COLL CARDIOL, V54, P2358, DOI 10.1016/j.jacc.2009.10.005; O'Keefe JH, 2004, J AM COLL CARDIOL, V43, P2142, DOI 10.1016/j.jacc.2004.03.046; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Waters DD, 2009, CIRCULATION, V120, P28, DOI 10.1161/CIRCULATIONAHA.108.838466	17	344	373	1	42	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 8	2012	380	9858					2007	2017		10.1016/S0140-6736(12)61770-X	http://dx.doi.org/10.1016/S0140-6736(12)61770-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051KI	23141813	Green Accepted			2022-12-28	WOS:000312124900031
J	Cohn, JN				Cohn, Jay N.			Fractional flow reserve-guided PCI reduced urgent revascularization at 7 months in coronary artery disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Cohn, JN (corresponding author), Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA.							Pursnani S, 2012, CIRC-CARDIOVASC INTE, V5, P476, DOI 10.1161/CIRCINTERVENTIONS.112.970954; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611	2	2	2	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10							JC5-9	10.7326/0003-4819-157-10-201211200-02009	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043VZ	23165685				2022-12-28	WOS:000311580000008
J	Rathi, V; Dzara, K; Gross, CP; Hrynaszkiewicz, I; Joffe, S; Krumholz, HM; Strait, KM; Ross, JS				Rathi, Vinay; Dzara, Kristina; Gross, Cary P.; Hrynaszkiewicz, Iain; Joffe, Steven; Krumholz, Harlan M.; Strait, Kelly M.; Ross, Joseph S.			Sharing of clinical trial data among trialists: a cross sectional survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACCESS; TRANSPARENCY; GENETICS; IMPROVE; SCIENCE; AUTHORS	Objective To investigate clinical trialists' opinions and experiences of sharing of clinical trial data with investigators who are not directly collaborating with the research team. Design and setting Cross sectional, web based survey. Participants Clinical trialists who were corresponding authors of clinical trials published in 2010 or 2011 in one of six general medical journals with the highest impact factor in 2011. Main outcome measures Support for and prevalence of data sharing through data repositories and in response to individual requests, concerns with data sharing through repositories, and reasons for granting or denying requests. Results Of 683 potential respondents, 317 completed the survey (response rate 46%). In principle, 236 (74%) thought that sharing de-identified data through data repositories should be required, and 229 (72%) thought that investigators should be required to share de-identified data in response to individual requests. In practice, only 56 (18%) indicated that they were required by the trial funder to deposit the trial data in a repository; of these 32 (57%) had done so. In all, 149 respondents (47%) had received an individual request to share their clinical trial data; of these, 115 (77%) had granted and 56 (38%) had denied at least one request. Respondents' most common concerns about data sharing were related to appropriate data use, investigator or funder interests, and protection of research subjects. Conclusions We found strong support for sharing clinical trial data among corresponding authors of recently published trials in high impact general medical journals who responded to our survey, including a willingness to share data, although several practical concerns were identified.	[Dzara, Kristina; Gross, Cary P.; Ross, Joseph S.] Yale Univ, Sch Med, Gen Internal Med Sect, Dept Med, New Haven, CT 06520 USA; [Gross, Cary P.; Krumholz, Harlan M.; Ross, Joseph S.] Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Fdn Clin Scholars Program, New Haven, CT 06510 USA; [Hrynaszkiewicz, Iain] BioMed Cent, London, England; [Joffe, Steven] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Joffe, Steven] Boston Childrens Hosp, Dept Med, Boston, MA USA; [Krumholz, Harlan M.; Strait, Kelly M.; Ross, Joseph S.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Epidemiol & Publ Hlth, New Haven, CT USA	Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Yale University; Yale University; Yale University	Ross, JS (corresponding author), Yale Univ, Sch Med, Gen Internal Med Sect, Dept Med, POB 208093, New Haven, CT 06520 USA.	joseph.ross@yale.edu	, Harlan/AAI-2875-2020; Joffe, Steven/H-3941-2019	Joffe, Steven/0000-0002-0667-7384; Hrynaszkiewicz, Iain/0000-0002-9673-5559; Ross, Joseph/0000-0002-9218-3320; Dzara, Kristina/0000-0001-9425-2679	Yale University School of Medicine Medical Student Research Fellowship; Centers of Medicare and Medicaid Services (CMS); National Heart Lung Blood Institute Cardiovascular Outcomes Center Award [1U01HL105270-02]; National Institute on Aging [K08 AG032886]; American Federation for Aging Research through the Paul B Beeson Career Development Award Program; Medtronic; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	Yale University School of Medicine Medical Student Research Fellowship; Centers of Medicare and Medicaid Services (CMS); National Heart Lung Blood Institute Cardiovascular Outcomes Center Award; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research through the Paul B Beeson Career Development Award Program; Medtronic(Medtronic); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was not supported by any external grants or funds. VR received support from the Yale University School of Medicine Medical Student Research Fellowship. The five $100 Amazon gift certificates were paid for from JSR's institutional discretionary funds. HMK and JSR receive support from the Centers of Medicare and Medicaid Services (CMS) to develop and maintain hospital performance measures that are used for public reporting. HMK is supported by a National Heart Lung Blood Institute Cardiovascular Outcomes Center Award (1U01HL105270-02). JSR is supported by the National Institute on Aging (K08 AG032886) and by the American Federation for Aging Research through the Paul B Beeson Career Development Award Program.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; CPG, HMK, and JSR receive research support from Medtronic to develop methods to promote data sharing; CPG and JSR are on a scientific advisory board for FAIR Health, a not-for-profit organisation with the mission to achieve fairness and transparency in healthcare reimbursement; HMK chairs a scientific advisory board for UnitedHealthcare, a health insurance company; SJ is a paid member of a data monitoring committee for Genzyme/Sanofi; no other relationships or activities that could appear to have influenced the submitted work.	Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357; Altman DG, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-248; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Bill and Melinda Gates Foundation, OUR COMMITMENT TO SH; Blumenthal D, 2006, ACAD MED, V81, P137, DOI 10.1097/00001888-200602000-00008; Blumenthal D, 1997, JAMA-J AM MED ASSOC, V277, P1224, DOI 10.1001/jama.277.15.1224; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Chan AW, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d80; Fowler FJ., 2013, SURV RES METHODS-GER, V5; Godlee F, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5641; Gotzsche PC, 2006, JAMA-J AM MED ASSOC, V295, P1645, DOI 10.1001/jama.295.14.1645; Gotzsche PC, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-249; Gotzsche PC, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2686; Groves T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c564; Haahr MT, 2006, CLIN TRIALS, V3, P360, DOI 10.1177/1740774506069153; Hampton T, 2012, JAMA-J AM MED ASSOC, V308, P850, DOI 10.1001/2012.jama.10451; Hrynaszkiewicz I, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c181; Hrynaszkiewicz I, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-17; Keyhani S, 2009, NEW ENGL J MED, V361, DOI 10.1056/NEJMp0908239; Kirwan JR, 1997, J RHEUMATOL, V24, P822; Krumholz HM, 2012, CIRC-CARDIOVASC QUAL, V5, P418, DOI 10.1161/CIRCOUTCOMES.112.967646; Krumholz HM, 2012, CIRC-CARDIOVASC QUAL, V5, P141, DOI 10.1161/CIRCOUTCOMES.112.965848; Krumholz HM, 2011, JAMA-J AM MED ASSOC, V306, P1593, DOI 10.1001/jama.2011.1459; Laine C, 2007, ANN INTERN MED, V146, P450, DOI 10.7326/0003-4819-146-6-200703200-00154; Loder E., 2012, LIBERATING CLINICAL; Lundh A, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-146; Lundh A, 2011, LANCET, V378, P1995, DOI 10.1016/S0140-6736(11)61871-0; Medical Research Council (MRC), MRC POLICY ON RESEAR; National Institutes of Health, 2003, FINAL NIH STATEMENT; Nature Publishing Group, AUTHORS AND REFERENC; Piwowar HA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000308; Piwowar HA, 2008, PLOS MED, V5, P1315, DOI 10.1371/journal.pmed.0050183; Reidpath DD, 2001, BIOETHICS, V15, P125, DOI 10.1111/1467-8519.00220; Rochon PA, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-9; Rodwin MA, 2012, JAMA-J AM MED ASSOC, V308, P871, DOI 10.1001/jama.2012.9661; Ross JS, 2012, CIRC-CARDIOVASC QUAL, V5, P238, DOI 10.1161/CIRCOUTCOMES.112.965798; Ross JS, 2012, AM J PUBLIC HEALTH, V102, P72, DOI 10.2105/AJPH.2011.300187; Savage CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007078; Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199; Sudman S, 1982, ASKING QUESTIONS A P; Thomas K., 2012, NY TIMES; Trials, ABOUT TRIALS EDITORI; Vickers AJ, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-15; Walport M, 2011, LANCET, V377, P537, DOI 10.1016/S0140-6736(10)62234-9; Wieseler B, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3834	45	67	67	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2012	345								e7570	10.1136/bmj.e7570	http://dx.doi.org/10.1136/bmj.e7570			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044GT	23169870	Green Published, hybrid			2022-12-28	WOS:000311608200005
J	Tarduno, JA; Cottrell, RD; Nimmo, F; Hopkins, J; Voronov, J; Erickson, A; Blackman, E; Scott, ERD; McKinley, R				Tarduno, John A.; Cottrell, Rory D.; Nimmo, Francis; Hopkins, Julianna; Voronov, Julia; Erickson, Austen; Blackman, Eric; Scott, Edward R. D.; McKinley, Robert			Evidence for a Dynamo in the Main Group Pallasite Parent Body	SCIENCE			English	Article							IRON-METEORITES; SOLAR-SYSTEM; MAGNETIC-FIELD; ORIGIN; DIFFERENTIATION; PLANETESIMALS; OLIVINE	Understanding the origin of pallasites, stony-iron meteorites made mainly of olivine crystals and FeNi metal, has been a vexing problem since their discovery. Here, we show that pallasite olivines host minute magnetic inclusions that have favorable magnetic recording properties. Our paleointensity measurements indicate strong paleomagnetic fields, suggesting dynamo action in the pallasite parent body. We use these data and thermal modeling to suggest that some pallasites formed when liquid FeNi from the core of an impactor was injected as dikes into the shallow mantle of a similar to 200-kilometer-radius protoplanet. The protoplanet remained intact for at least several tens of millions of years after the olivine-metal mixing event.	[Tarduno, John A.; Cottrell, Rory D.; Voronov, Julia; Erickson, Austen; McKinley, Robert] Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA; [Tarduno, John A.; Hopkins, Julianna; Erickson, Austen; Blackman, Eric] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA; [Nimmo, Francis] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Scott, Edward R. D.] Univ Hawaii, Hawaii Inst Geophys & Planetol, Manoa, HI 96822 USA	University of Rochester; University of Rochester; University of California System; University of California Santa Cruz; University of Hawaii System; University of Hawaii Manoa	Tarduno, JA (corresponding author), Univ Rochester, Dept Earth & Environm Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	john.tarduno@rochester.edu		Tarduno, John/0000-0002-0490-0124; Blackman, Eric/0000-0002-9405-8435; Cottrell, Rory/0000-0003-4174-6389; Scott, Edward/0000-0002-5137-3830	NASA [NNX11AG66G]; NSF [EAR0619467, EAR1015269]	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	We thank J. Hunt for assistance with microprobe analyses. This work was supported by NASA grant NNX11AG66G and NSF grants EAR0619467 and EAR1015269 (to J. A. T.) Paleomagnetic data are included in the supplementary materials.	Bondar YV, 2003, RADIAT MEAS, V36, P367, DOI 10.1016/S1350-4487(03)00153-7; Bottke WF, 2006, NATURE, V439, P821, DOI 10.1038/nature04536; BRECHER A, 1977, J GEOMAGN GEOELECTR, V29, P379, DOI 10.5636/jgg.29.379; BUSECK PR, 1977, GEOCHIM COSMOCHIM AC, V41, P711, DOI 10.1016/0016-7037(77)90044-8; CHUANG YY, 1986, METALL TRANS A, V17, P1361, DOI 10.1007/BF02650117; CISOWSKI SM, 1987, GEOMAGN AERON, V2, P525; Clayton RN, 2003, SPACE SCI REV, V106, P19, DOI 10.1023/A:1024669116828; COE RS, 1967, J GEOMAGN GEOELECTR, V19, P157, DOI 10.5636/jgg.19.157; DAVIS AM, 1991, NATURE, V353, P637, DOI 10.1038/353637a0; Dunlop D. J., 1997, ROCK MAGNETISM FUNDA; Ghosh A, 1998, ICARUS, V134, P187, DOI 10.1006/icar.1998.5956; Jackson A, 2000, PHILOS T ROY SOC A, V358, P957, DOI 10.1098/rsta.2000.0569; Le Bars M, 2011, NATURE, V479, P215, DOI 10.1038/nature10565; LOVERING JF, 1960, GEOCHIM COSMOCHIM AC, V19, P156, DOI 10.1016/0016-7037(60)90002-8; Lugmair GW, 1998, GEOCHIM COSMOCHIM AC, V62, P2863, DOI 10.1016/S0016-7037(98)00189-6; MATSUI T, 1980, GEOPHYS RES LETT, V7, P1007, DOI 10.1029/GL007i011p01007; MITTLEFEHLDT DW, 1980, EARTH PLANET SC LETT, V51, P29, DOI 10.1016/0012-821X(80)90254-X; NAGATA T, 1979, PHYS EARTH PLANET IN, V20, P324, DOI 10.1016/0031-9201(79)90055-4; Nagata T., 1978, MEM NATL INST POLAR, V8, P240; Nimmo F, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037997; RAYLEIGH L, 1942, P ROY SOC LOND A MAT, V179, P386; Reimold WU, 2006, CHEM ERDE-GEOCHEM, V66, P1, DOI 10.1016/j.chemer.2005.07.003; Roberts AP, 2000, J GEOPHYS RES-SOL EA, V105, P28461, DOI 10.1029/2000JB900326; SCOTT ERD, 1977, GEOCHIM COSMOCHIM AC, V41, P349, DOI 10.1016/0016-7037(77)90262-9; Tarduno JA, 2006, REV GEOPHYS, V44, DOI 10.1029/2005RG000189; Tarduno JA, 2007, NATURE, V446, P657, DOI 10.1038/nature05667; Urey H. C., 1966, MON NOT R ASTRON SOC, V131, P199; Wasson JT, 2003, GEOCHIM COSMOCHIM AC, V67, P3079, DOI 10.1016/S0016-7037(03)00306-5; Weiss B. P., 1952, SPACE SCI REV, V152; Weiss BP, 2008, SCIENCE, V322, P713, DOI 10.1126/science.1162459; Yang JJ, 2010, GEOCHIM COSMOCHIM AC, V74, P4471, DOI 10.1016/j.gca.2010.04.016	31	77	77	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					939	942		10.1126/science.1223932	http://dx.doi.org/10.1126/science.1223932			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161997				2022-12-28	WOS:000311083600041
J	Cutler, D; Wikler, E; Basch, P				Cutler, David; Wikler, Elizabeth; Basch, Peter			Reducing Administrative Costs and Improving the Health Care System	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cutler, David] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Wikler, Elizabeth] Harvard Univ, PhD Program Hlth Policy, Cambridge, MA 02138 USA; [Basch, Peter] MedStar Hlth, Washington, DC USA	Harvard University; Harvard University	Cutler, D (corresponding author), Harvard Univ, Dept Econ, Cambridge, MA 02138 USA.			Cutler, David/0000-0002-4949-8917				[Anonymous], 2010, US HEALTHC EFF IND N; [Anonymous], 2009, HLTH CAR COST CONT T; Casalino LP, 2009, HEALTH AFFAIR, V28, pW533, DOI 10.1377/hlthaff.28.4.w533; Pope Christina, 2004, MGMA Connex, V4, P36; Yong PL, 2010, HEALTHCARE IMPERATIV	5	45	45	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2012	367	20					1875	1878		10.1056/NEJMp1209711	http://dx.doi.org/10.1056/NEJMp1209711			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	036MB	23150956	Green Published			2022-12-28	WOS:000311029300002
J	Sanchez, T; Chen, DTN; DeCamp, SJ; Heymann, M; Dogic, Z				Sanchez, Tim; Chen, Daniel T. N.; DeCamp, Stephen J.; Heymann, Michael; Dogic, Zvonimir			Spontaneous motion in hierarchically assembled active matter	NATURE			English	Article							SELF-ORGANIZATION; MICROTUBULES; FILAMENTS; BUNDLES; MOTORS; DRIVEN; CELLS; PURIFICATION; NETWORKS	With remarkable precision and reproducibility, cells orchestrate the cooperative action of thousands of nanometre-sized molecular motors to carry out mechanical tasks at much larger length scales, such as cell motility, division and replication(1). Besides their biological importance, such inherently non-equilibrium processes suggest approaches for developing biomimetic active materials from microscopic components that consume energy to generate continuous motion(2-4). Being actively driven, these materials are not constrained by the laws of equilibrium statistical mechanics and can thus exhibit sought-after properties such as autonomous motility, internally generated flows and self-organized beating(5-7). Here, starting from extensile microtubule bundles, we hierarchically assemble far-from-equilibrium analogues of conventional polymer gels, liquid crystals and emulsions. At high enough concentration, the microtubules form a percolating active network characterized by internally driven chaotic flows, hydrodynamic instabilities, enhanced transport and fluid mixing. When confined to emulsion droplets, three-dimensional networks spontaneously adsorb onto the droplet surfaces to produce highly active two-dimensional nematic liquid crystals whose streaming flows are controlled by internally generated fractures and self-healing, as well as unbinding and annihilation of oppositely charged disclination defects. The resulting active emulsions exhibit unexpected properties, such as autonomous motility, which are not observed in their passive analogues. Taken together, these observations exemplify how assemblages of animate microscopic objects exhibit collective biomimetic properties that are very different from those found in materials assembled from inanimate building blocks, challenging us to develop a theoretical framework that would allow for a systematic engineering of their far-from-equilibrium material properties.	[Sanchez, Tim; Chen, Daniel T. N.; DeCamp, Stephen J.; Heymann, Michael; Dogic, Zvonimir] Brandeis Univ, Martin Fisher Sch Phys, Waltham, MA 02454 USA; [Heymann, Michael] Brandeis Univ, Grad Program Biophys & Struct Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Dogic, Z (corresponding author), Brandeis Univ, Martin Fisher Sch Phys, 415 South St, Waltham, MA 02454 USA.	zdogic@brandeis.edu	Heymann, Michael/J-6134-2015; Sanchez, Tim/H-6339-2013	Heymann, Michael/0000-0002-9278-8207; DeCamp, Stephen/0000-0001-7002-7370	W. M. Keck Foundation; National Institute of Health [5K25GM85613]; National Science Foundation [NSF-MRSEC-0820492, NSF-MRI 0923057]; Pioneer Research Center Program through the National Research Foundation of Korea [2012-0001255]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K25GM085613, T35GM008561] Funding Source: NIH RePORTER	W. M. Keck Foundation(W.M. Keck Foundation); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Pioneer Research Center Program through the National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge discussions with R. Meyer, R. Bruinsma and E. Frey about the nature of liquid crystalline defects. Biotin-labelled kinesin 401 (K401) was a gift from J. Gelles. This work was supported by the W. M. Keck Foundation, the National Institute of Health (5K25GM85613), the National Science Foundation (NSF-MRSEC-0820492, NSF-MRI 0923057) and the Pioneer Research Center Program through the National Research Foundation of Korea (2012-0001255). We acknowledge use of the MRSEC Optical Microscopy and Microfluidics facilities.	Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Bray D., 2000, CELL MOVEMENTS MOL M; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chate H, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.180602; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Dombrowski C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098103; Fletcher DA, 2009, ANNU REV PHYS CHEM, V60, P469, DOI 10.1146/annurev.physchem.040808.090304; Giomi L, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.218101; Giomi L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.198101; Henkes S, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.040301; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; Holtze C, 2008, LAB CHIP, V8, P1632, DOI 10.1039/b806706f; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Hyman A., 1991, METHODS ENZYMOL, V196, P478; Kemkemer R, 2000, EUR PHYS J E, V1, P215, DOI 10.1007/s101890050024; Kohler S, 2011, NAT MATER, V10, P462, DOI [10.1038/NMAT3009, 10.1038/nmat3009]; Kruse K, 2000, PHYS REV LETT, V85, P1778, DOI 10.1103/PhysRevLett.85.1778; Kruse K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.078101; Lau AWC, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/48006; Liverpool TB, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.138102; MacKintosh FC, 2010, CURR OPIN CELL BIOL, V22, P29, DOI 10.1016/j.ceb.2010.01.002; Marchetti M. C., 2012, SOFT ACTIVE MATTER; Muller M, 2003, J BIOMED MATER RES A, V66A, P55, DOI 10.1002/jbm.a.10502; Narayan V, 2007, SCIENCE, V317, P105, DOI 10.1126/science.1140414; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Nelson DR, 2002, NANO LETT, V2, P1125, DOI [10.1021/nl0202096, 10.1021/n10202096]; Pinot M, 2009, CURR BIOL, V19, P954, DOI 10.1016/j.cub.2009.04.027; Riedel IH, 2005, SCIENCE, V309, P300, DOI 10.1126/science.1110329; Saintillan D, 2012, J R SOC INTERFACE, V9, P571, DOI 10.1098/rsif.2011.0355; Sanchez T, 2011, SCIENCE, V333, P456, DOI 10.1126/science.1203963; Schaller V, 2010, NATURE, V467, P73, DOI 10.1038/nature09312; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Serbus LR, 2005, DEVELOPMENT, V132, P3743, DOI 10.1242/dev.01956; Simha RA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.058101; Sumino Y, 2012, NATURE, V483, P448, DOI 10.1038/nature10874; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; Thoresen T, 2011, BIOPHYS J, V100, P2698, DOI 10.1016/j.bpj.2011.04.031; Woodhouse FG, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.168105; Wu XL, 2000, PHYS REV LETT, V84, P3017, DOI 10.1103/PhysRevLett.84.3017; YOUNG EC, 1995, J BIOL CHEM, V270, P3926, DOI 10.1074/jbc.270.8.3926	41	867	868	32	741	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					431	+		10.1038/nature11591	http://dx.doi.org/10.1038/nature11591			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23135402	Green Accepted, Green Submitted			2022-12-28	WOS:000311031600043
J	O'Dowd, A				O'Dowd, Adrian			Liverpool care pathway: doctors speak out	BRITISH MEDICAL JOURNAL			English	Editorial Material												adrianodowd@aol.com						[Anonymous], 2012, DAILY TELEGRAPH; Kmietowicz Z, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7511; McCartney M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7316	3	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 14	2012	345								e7644	10.1136/bmj.e7644	http://dx.doi.org/10.1136/bmj.e7644			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040PZ	23152572				2022-12-28	WOS:000311336400012
J	Pak, J; Maniar, JM; Mello, CC; Fire, A				Pak, Julia; Maniar, Jay Mahesh; Mello, Cecilia Cabral; Fire, Andrew			Protection from Feed-Forward Amplification in an Amplified RNAi Mechanism	CELL			English	Article							GERM-LINE DEVELOPMENT; C-ELEGANS; CAENORHABDITIS-ELEGANS; POLYMERASE-II; INTERFERENCE; SIRNAS; ARGONAUTE; ROLES; RDE-1; DCR-1	The effectiveness of RNA interference (RNAi) in many organisms is potentiated through the signal-amplifying activity of a targeted RNA-directed RNA polymerase (RdRP) system that can convert a small population of exogenously-encountered dsRNA fragments into an abundant internal pool of small interfering RNA (siRNA). As for any biological amplification system, we expect an underlying architecture that will limit the ability of a randomly encountered trigger to produce an uncontrolled and self-escalating response. Investigating such limits in Caenorhabditis elegans, we find that feed-forward amplification is limited by biosynthetic and structural distinctions at the RNA level between (1) triggers that can produce amplification and (2) siRNA products of the amplification reaction. By assuring that initial (primary) siRNAs can act as triggers but not templates for activation, and that the resulting (secondary) siRNAs can enforce gene silencing on additional targets without unbridled trigger amplification, the system achieves substantial but fundamentally limited signal amplification.	[Pak, Julia; Mello, Cecilia Cabral; Fire, Andrew] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Maniar, Jay Mahesh; Fire, Andrew] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Fire, A (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	afire@stanford.edu		Fire, Andrew/0000-0001-6217-8312	NIGMS [R01GM37706]; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037706] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Liu, L. Zhang, M. Stadler, A. Lamm, H. Zhang, D. Wu, L. Gracey, R. Li, I. Gabdank, K. Artiles, S. Gu, J. Gent, C. Kumsta, M. Hansen, P. Parameswaran, C. Smith, Z. Weng, R. Alcazar, W. Lui, P. Lacroute, A. Sidow, A. Jheon, O. Klein, anonymous reviewers and NIGMS (R01GM37706) for help and support.	Alder MN, 2003, RNA, V9, P25, DOI 10.1261/rna.2650903; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Bergstrom CT, 2003, P NATL ACAD SCI USA, V100, P11511, DOI 10.1073/pnas.1931639100; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blanchard D, 2006, MOL CELL PROTEOMICS, V5, P2175, DOI 10.1074/mcp.T600025-MCP200; Boisvert MEL, 2008, CURR TOP MICROBIOL, V320, P21; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; FILES JG, 1983, J MOL BIOL, V164, P355, DOI 10.1016/0022-2836(83)90056-6; Fischer SEJ, 2010, INT J BIOCHEM CELL B, V42, P1306, DOI 10.1016/j.biocel.2010.03.006; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Gent JI, 2009, GENETICS, V183, P1297, DOI 10.1534/genetics.109.109686; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Habig JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004052; Han T, 2009, P NATL ACAD SCI USA, V106, P18674, DOI 10.1073/pnas.0906378106; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Kumsta C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035428; LANDEL CP, 1984, J MOL BIOL, V180, P497, DOI 10.1016/0022-2836(84)90024-X; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lehmann E, 2007, NATURE, V450, P445, DOI 10.1038/nature06290; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; MacQueen AJ, 2005, MOL BIOL CELL, V16, P3247, DOI 10.1091/mbc.E04-12-1061; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Maniar JM, 2011, CURR BIOL, V21, P449, DOI 10.1016/j.cub.2011.02.019; Marques JT, 2010, NAT STRUCT MOL BIOL, V17, P24, DOI 10.1038/nsmb.1735; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nowotny M, 2009, CURR OPIN STRUC BIOL, V19, P286, DOI 10.1016/j.sbi.2009.04.006; Okamura K, 2011, MOL CELL BIOL, V31, P884, DOI 10.1128/MCB.01141-10; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Parrish S, 2001, RNA, V7, P1397; Pavelec DM, 2009, GENETICS, V183, P1283, DOI 10.1534/genetics.109.108134; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Steiner FA, 2009, NAT STRUCT MOL BIOL, V16, P207, DOI 10.1038/nsmb.1541; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Vasale JJ, 2010, P NATL ACAD SCI USA, V107, P3582, DOI 10.1073/pnas.0911908107; Willis JH, 2006, MOL BIOL CELL, V17, P1051, DOI 10.1091/mbc.E05-09-0886; Wu D, 2011, NAT STRUCT MOL BIOL, V18, P1094, DOI 10.1038/nsmb.2129; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	55	53	55	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 9	2012	151	4					885	899		10.1016/j.cell.2012.10.022	http://dx.doi.org/10.1016/j.cell.2012.10.022			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141544	Green Accepted, Bronze			2022-12-28	WOS:000310921200018
J	Psakhye, I; Jentsch, S				Psakhye, Ivan; Jentsch, Stefan			Protein Group Modification and Synergy in the SUMO Pathway as Exemplified in DNA Repair	CELL			English	Article							UBIQUITIN E3 LIGASE; HOMOLOGOUS RECOMBINATION; RAD52 SUMOYLATION; DAMAGE-TOLERANCE; S-PHASE; REPLICATION; CHECKPOINT; COMPLEX; PCNA; EXO1	Protein modification by SUMO affects a wide range of protein substrates. Surprisingly, although SUMO pathway mutants display strong phenotypes, the function of individual SUMO modifications is often enigmatic, and SUMOylation-defective mutants commonly lack notable phenotypes. Here, we use DNA double-strand break repair as an example and show that DNA damage triggers a SUMOylation wave, leading to simultaneous multisite modifications of several repair proteins of the same pathway. Catalyzed by a DNA-bound SUMO ligase and triggered by single-stranded DNA, SUMOylation stabilizes physical interactions between the proteins. Notably, only wholesale elimination of SUMOylation of several repair proteins significantly affects the homologous recombination pathway by considerably slowing down DNA repair. Thus, SUMO acts synergistically on several proteins, and individual modifications only add up to efficient repair. We propose that SUMOylation may thus often target a protein group rather than individual proteins, whereas localized modification enzymes and highly specific triggers ensure specificity.	[Psakhye, Ivan; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	jentsch@biochem.mpg.de		Psakhye, Ivan/0000-0003-3877-133X	Max Planck Society; Deutsche Forschungsgemeinschaft; Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence; Louis-Jeantet Foundation; EU Marie Curie Training Network	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence; Louis-Jeantet Foundation; EU Marie Curie Training Network(European Commission)	We thank S. Bergink, G. I. Karras, M. Kern, C. Lademann, B. Pfander, J. Renkawitz, and Z. Storchova for comments on the manuscript; C. Boulegue for mass spectrometry analysis; J. Rech for help with peptide array synthesis; K. Hofmann for help with bioinformatic analysis; and A. Strasser for technical assistance. I. P. was supported by a stipend from EU Marie Curie Training Network, and research by S. J. was supported by the Max Planck Society, Deutsche Forschungsgemeinschaft, Center for Integrated Protein Science Munich, RUBICON EU Network of Excellence, and Louis-Jeantet Foundation.	Altmannova V, 2010, NUCLEIC ACIDS RES, V38, P4708, DOI 10.1093/nar/gkq195; Armstrong AA, 2012, NATURE, V483, P59, DOI 10.1038/nature10883; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Dantuma NP, 2012, TRENDS CELL BIOL, V22, P483, DOI 10.1016/j.tcb.2012.06.003; Davis AP, 2003, DNA REPAIR, V2, P1127, DOI 10.1016/S1568-7864(03)00121-6; Dou H, 2011, FEBS LETT, V585, P2891, DOI 10.1016/j.febslet.2011.04.002; Dou H, 2010, MOL CELL, V39, P333, DOI 10.1016/j.molcel.2010.07.021; Finkbeiner E, 2011, NUCLEUS-PHILA, V2, P527, DOI 10.4161/nucl.2.6.17604; Finkbeiner E, 2011, EMBO J, V30, P1067, DOI 10.1038/emboj.2011.33; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Giannattasio M, 2010, MOL CELL, V40, P50, DOI 10.1016/j.molcel.2010.09.004; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Karras GI, 2010, CELL, V141, P255, DOI 10.1016/j.cell.2010.02.028; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Maeda D, 2004, DNA REPAIR, V3, P335, DOI 10.1016/j.dnarep.2003.11.011; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2011, DNA REPAIR, V10, P344, DOI 10.1016/j.dnarep.2010.12.004; Morin I, 2008, EMBO J, V27, P2400, DOI 10.1038/emboj.2008.171; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Ohuchi T, 2008, DNA REPAIR, V7, P879, DOI 10.1016/j.dnarep.2008.02.005; Ohuchi T, 2009, DNA REPAIR, V8, P690, DOI 10.1016/j.dnarep.2009.01.018; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Panse VG, 2006, TRAFFIC, V7, P1311, DOI 10.1111/j.1600-0854.2006.00471.x; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Silver HR, 2011, DNA REPAIR, V10, P1243, DOI 10.1016/j.dnarep.2011.09.013; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Takahashi Y, 2001, J BIOL CHEM, V276, P48973, DOI 10.1074/jbc.M109295200; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Ullmann R, 2012, MOL CELL, V46, P759, DOI 10.1016/j.molcel.2012.04.006; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; Westman BJ, 2011, NUCLEUS-AUSTIN, V2, P30, DOI 10.4161/nucl.2.1.14437; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	51	330	338	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					807	820		10.1016/j.cell.2012.10.021	http://dx.doi.org/10.1016/j.cell.2012.10.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23122649	Bronze			2022-12-28	WOS:000310921200012
J	Anbarasan, P; Baer, ZC; Sreekumar, S; Gross, E; Binder, JB; Blanch, HW; Clark, DS; Toste, FD				Anbarasan, Pazhamalai; Baer, Zachary C.; Sreekumar, Sanil; Gross, Elad; Binder, Joseph B.; Blanch, Harvey W.; Clark, Douglas S.; Toste, F. Dean			Integration of chemical catalysis with extractive fermentation to produce fuels	NATURE			English	Article							MICROBIAL-PRODUCTION; BUTANOL; RECOVERY; BIOMASS; HYDROCARBONS; CONVERSION; SUBSTRATE; BIOFUELS; ALKANES; ACETONE	Nearly one hundred years ago, the fermentative production of acetone by Clostridium acetobutylicum provided a crucial alternative source of this solvent for manufacture of the explosive cordite. Today there is a resurgence of interest in solventogenic Clostridium species to produce n-butanol and ethanol for use as renewable alternative transportation fuels(1-3). Acetone, a product of acetone-n-butanol-ethanol (ABE) fermentation, harbours a nucleophilic alpha-carbon, which is amenable to C-C bond formation with the electrophilic alcohols produced in ABE fermentation. This functionality can be used to form higher-molecular-mass hydrocarbons similar to those found in current jet and diesel fuels. Here we describe the integration of biological and chemocatalytic routes to convert ABE fermentation products efficiently into ketones by a palladium-catalysed alkylation. Tuning of the reaction conditions permits the production of either petrol or jet and diesel precursors. Glyceryl tributyrate was used for the in situ selective extraction of both acetone and alcohols to enable the simple integration of ABE fermentation and chemical catalysis, while reducing the energy demand of the overall process. This process provides a means to selectively produce petrol, jet and diesel blend stocks from lignocellulosic and cane sugars at yields near their theoretical maxima.	[Anbarasan, Pazhamalai; Sreekumar, Sanil; Gross, Elad; Toste, F. Dean] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Anbarasan, Pazhamalai; Baer, Zachary C.; Sreekumar, Sanil; Binder, Joseph B.; Blanch, Harvey W.; Clark, Douglas S.; Toste, F. Dean] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Baer, Zachary C.; Blanch, Harvey W.; Clark, Douglas S.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Gross, Elad; Toste, F. Dean] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Toste, FD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	fdtoste@berkeley.edu	Toste, F. Dean/Y-2556-2019; Anbarasan, Pazhamalai/E-7054-2011	Toste, F. Dean/0000-0001-8018-2198; Anbarasan, Pazhamalai/0000-0001-6049-5023	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Energy Biosciences Institute	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Energy Biosciences Institute	We are grateful to H.-J. Song for performing initial experiments on the catalytic alkylation of acetone, and V. Mitchell for analysing acid pretreatment hydrolysate inhibitors present in Miscanthus giganteus. F. D. T. and E. G. acknowledge funding from the Director, Office of Science of the US Department of Energy, under contract no. DE-AC02-05CH11231. This work was funded by the Energy Biosciences Institute.	Alsaker KV, 2010, BIOTECHNOL BIOENG, V105, P1131, DOI 10.1002/bit.22628; Blommel PG, 2008, INT SUGAR J, V110, P672; Carlini C, 2004, J MOL CATAL A-CHEM, V212, P65, DOI 10.1016/j.molcata.2003.10.045; Corma A, 2011, ANGEW CHEM INT EDIT, V50, P2375, DOI 10.1002/anie.201007508; Dobereiner GE, 2010, CHEM REV, V110, P681, DOI 10.1021/cr900202j; Dugar D, 2011, NAT BIOTECHNOL, V29, P1074, DOI 10.1038/nbt.2055; Green EM, 2011, CURR OPIN BIOTECH, V22, P337, DOI 10.1016/j.copbio.2011.02.004; Guillena G, 2007, ANGEW CHEM INT EDIT, V46, P2358, DOI 10.1002/anie.200603794; Guillena G, 2010, CHEM REV, V110, P1611, DOI 10.1021/cr9002159; Gurbuz EI, 2010, GREEN CHEM, V12, P223, DOI 10.1039/b920369a; Hamid MHSA, 2007, ADV SYNTH CATAL, V349, P1555, DOI 10.1002/adsc.200600638; Huber GW, 2005, SCIENCE, V308, P1446, DOI 10.1126/science.1111166; JEON YJ, 1987, ANN NY ACAD SCI, V506, P536, DOI 10.1111/j.1749-6632.1987.tb23848.x; Kraemer K, 2011, COMPUT CHEM ENG, V35, P949, DOI 10.1016/j.compchemeng.2011.01.028; Kunkes EL, 2008, SCIENCE, V322, P417, DOI 10.1126/science.1159210; Kwon MS, 2005, ANGEW CHEM INT EDIT, V44, P6913, DOI 10.1002/anie.200502422; Peralta-Yahya PP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1494; Ren C, 2010, METAB ENG, V12, P446, DOI 10.1016/j.ymben.2010.05.002; ROFFLER SR, 1987, BIOPROCESS ENG, V2, P181, DOI 10.1007/BF00387326; ROFFLER SR, 1988, BIOTECHNOL BIOENG, V31, P135, DOI 10.1002/bit.260310207; SALVAPATI GS, 1989, J MOL CATAL, V54, P9, DOI 10.1016/0304-5102(89)80134-8; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Tracy BP, 2012, CURR OPIN BIOTECH, V23, P364, DOI 10.1016/j.copbio.2011.10.008; Vane LM, 2008, BIOFUEL BIOPROD BIOR, V2, P553, DOI 10.1002/bbb.108; Wang C, 2011, METAB ENG, V13, P648, DOI 10.1016/j.ymben.2011.08.001; WAYMAN M, 1987, J FERMENT BIOENG, V65, P295, DOI 10.1016/0385-6380(87)90091-4; Xing R, 2010, GREEN CHEM, V12, P1933, DOI 10.1039/c0gc00263a	27	282	289	10	391	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2012	491	7423					235	239		10.1038/nature11594	http://dx.doi.org/10.1038/nature11594			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23135469				2022-12-28	WOS:000310774300040
J	Safford, MM; Brown, TM; Muntner, PM; Durant, RW; Glasser, S; Halanych, JH; Shikany, JM; Prineas, RJ; Samdarshi, T; Bittner, VA; Lewis, CE; Gamboa, C; Cushman, M; Howard, V; Howard, G				Safford, Monika M.; Brown, Todd M.; Muntner, Paul M.; Durant, Raegan W.; Glasser, Stephen; Halanych, Jewell H.; Shikany, James M.; Prineas, Ronald J.; Samdarshi, Tandaw; Bittner, Vera A.; Lewis, Cora E.; Gamboa, Christopher; Cushman, Mary; Howard, Virginia; Howard, George		REGARDS Investigators	Association of Race and Sex With Risk of Incident Acute Coronary Heart Disease Events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYOCARDIAL-INFARCTION; UNIVERSAL DEFINITION; UNITED-STATES; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS RISK; MULTIPLE IMPUTATION; TRENDS; REVASCULARIZATION; STROKE; HEALTH	Context It is unknown whether long-standing disparities in incidence of coronary heart disease (CHD) among US blacks and whites persist. Objective To examine incident CHD by black and white race and by sex. Design, Setting, and Participants Prospective cohort study of 24 443 participants without CHD at baseline from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort, who resided in the continental United States and were enrolled between 2003 and 2007 with follow-up through December 31, 2009. Main Outcome Measure Expert-adjudicated total (fatal and nonfatal) CHD, fatal CHD, and nonfatal CHD (definite or probable myocardial infarction [MI]; very small non-ST-elevation MI [NSTEMI] had peak troponin level <0.5 mu g/L). Results Over a mean (SD) of 4.2 (1.5) years of follow-up, 659 incident CHD events occurred (153 in black men, 138 in black women, 254 in white men, and 114 in white women). Among men, the age-standardized incidence rate per 1000 person-years for total CHD was 9.0 (95% CI, 7.5-10.8) for blacks vs 8.1 (95% CI, 6.9-9.4) for whites; fatal CHD: 4.0 (95% CI, 2.9-5.3) vs 1.9 (95% CI, 1.4-2.6), respectively; and nonfatal CHD: 4.9 (95% CI, 3.8-6.2) vs 6.2 (95% CI, 5.2-7.4). Among women, the age-standardized incidence rate per 1000 person-years for total CHD was 5.0 (95% CI, 4.2-6.1) for blacks vs 3.4 (95% CI, 2.8-4.2) for whites; fatal CHD: 2.0 (95% CI, 1.5-2.7) vs 1.0 (95% CI, 0.7-1.5), respectively; and nonfatal CHD: 2.8 (95% CI, 2.2-3.7) vs 2.2 (95% CI, 1.7-2.9). Age-and region-adjusted hazard ratios for fatal CHD among blacks vs whites was near 2.0 for both men and women and became statistically nonsignificant after multivariable adjustment. The multivariable-adjusted hazard ratio for incident nonfatal CHD for blacks vs whites was 0.68 (95% CI, 0.51-0.91) for men and 0.81 (95% CI, 0.58-1.15) for women. Of the 444 nonfatal CHD events, 139 participants (31.3%) had very small NSTEMIs. Conclusions The higher risk of fatal CHD among blacks compared with whites was associated with cardiovascular disease risk factor burden. These relationships may differ by sex.	[Safford, Monika M.; Brown, Todd M.; Durant, Raegan W.; Glasser, Stephen; Halanych, Jewell H.; Shikany, James M.; Bittner, Vera A.; Lewis, Cora E.] Univ Alabama Birmingham, Sch Med, Birmingham, AL 35294 USA; [Muntner, Paul M.; Gamboa, Christopher; Howard, Virginia; Howard, George] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA; [Prineas, Ronald J.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Samdarshi, Tandaw] Univ Mississippi, Sch Med, Oxford, MS USA; [Cushman, Mary] Univ Vermont, Sch Med, Burlington, VT 05405 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Wake Forest University; Wake Forest Baptist Medical Center; University of Mississippi; University of Vermont	Safford, MM (corresponding author), Univ Alabama Birmingham, Sch Med, 1717 11th Ave S,MT643, Birmingham, AL 35294 USA.	msafford@uab.edu	Cushman, Mary/K-1157-2019	Cushman, Mary/0000-0002-7871-6143; Howard, George/0000-0002-3068-5720; Brown, Todd/0000-0002-9820-5738; Bittner, Vera/0000-0001-9456-850X	National Heart, Lung, and Blood Institute [R01 HL080477]; National Center for Research Resources [KL2 RR025776-04]; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services [U01 NS041588]; Amgen Corporation; Amgen; NovoNordisk; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025776] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL111154, R01HL080477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Amgen Corporation(Amgen); Amgen(Amgen); NovoNordisk(Novo Nordisk); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Brown reported receiving grants from Amgen Pharmaceuticals not related to this article. Dr Muntner reported serving on an Amgen advisory board in 2011; serving as a consultant to Amgen; and receiving grants from Amgen. Dr Lewis reported receiving a grant from NovoNordisk for an obesity study. No other authors reported any disclosures.; This research project was supported by grant R01 HL080477 from the National Heart, Lung, and Blood Institute (Dr Safford); grant KL2 RR025776-04 from the National Center for Research Resources (Dr Brown); and cooperative agreement U01 NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services (Dr G Howard). Additional funding was provided by an investigator-initiated grant-in-aid from Amgen Corporation (Dr Safford).	Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Centers for Disease Control and Prevention, CDC WOND COMPR MORT; Chen J, 2010, CIRCULATION, V121, P1322, DOI 10.1161/CIRCULATIONAHA.109.862094; Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551; Halim SA, 2009, CIRC-CARDIOVASC QUAL, V2, P199, DOI 10.1161/CIRCOUTCOMES.108.810127; Hemingway H, 2001, NEW ENGL J MED, V344, P645, DOI 10.1056/NEJM200103013440906; Hochholzer W, 2008, AM J MED, V121, P399, DOI 10.1016/j.amjmed.2008.01.033; Howard VJ, 2010, J AM SOC HYPERTENS, V4, P32, DOI 10.1016/j.jash.2010.02.001; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Hozawa A, 2007, ARCH INTERN MED, V167, P573, DOI 10.1001/archinte.167.6.573; Jha AK, 2005, NEW ENGL J MED, V353, P683, DOI 10.1056/NEJMsa050672; Jones DW, 2002, ARCH INTERN MED, V162, P2565, DOI 10.1001/archinte.162.22.2565; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin GA, 2008, JAMA-J AM MED ASSOC, V300, P1765, DOI 10.1001/jama.300.15.1765; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Lucas FL, 2006, CIRCULATION, V113, P374, DOI 10.1161/CIRCULATIONAHA.105.560433; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Mann D, 2008, ANN PHARMACOTHER, V42, P1208, DOI 10.1345/aph.1L181; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Mills NL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1533; Mills NL, 2011, JAMA-J AM MED ASSOC, V305, P1210, DOI 10.1001/jama.2011.338; Nallamothu BK, 2007, JAMA-J AM MED ASSOC, V297, P962, DOI 10.1001/jama.297.9.962; Peterson ED, 1997, NEW ENGL J MED, V336, P480, DOI 10.1056/NEJM199702133360706; Prineas R., 1982, MINNESOTA CODE MANUA; Prineas RJ, 2010, MINNESOTA CODE MANUA; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rosamond WD, 2012, CIRCULATION, V125, P1848, DOI 10.1161/CIRCULATIONAHA.111.047480; Ross JS, 2007, CIRCULATION, V115, P1012, DOI 10.1161/CIRCULATIONAHA.106.658377; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Soliman EZ, 2011, HEART, V97, P1597, DOI 10.1136/hrt.2010.215871; Spertus JA, 2004, CIRCULATION, V110, P3789, DOI 10.1161/01.CIR.0000150392.70749.C7; Tate J, ANAL CHARACTERISTICS; Thygesen K, 2012, EUR HEART J; Thygesen K, 2008, CURR OPIN CRIT CARE, V14, P543, DOI 10.1097/MCC.0b013e32830d34b9; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Urban P, 2008, AM J MED, V121, P1065, DOI 10.1016/j.amjmed.2008.08.020; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	40	226	228	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1768	1774		10.1001/jama.2012.14306	http://dx.doi.org/10.1001/jama.2012.14306			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117777	Green Accepted, Bronze			2022-12-28	WOS:000310726500023
J	Cuchel, M; Meagher, EA; Theron, HD; Blom, DJ; Marais, AD; Hegele, RA; Averna, MR; Sirtori, CR; Shah, PK; Gaudet, D; Stefanutti, C; Vigna, GB; Du Plessis, AME; Propert, KJ; Sasiela, WJ; Bloedon, LT; Rader, DJ				Cuchel, Marina; Meagher, Emma A.; Theron, Hendrik du Toit; Blom, Dirk J.; Marais, A. David; Hegele, Robert A.; Averna, Maurizio R.; Sirtori, Cesare R.; Shah, Prediman K.; Gaudet, Daniel; Stefanutti, Claudia; Vigna, Giovanni B.; Du Plessis, Anna M. E.; Propert, Kathleen J.; Sasiela, William J.; Bloedon, LeAnne T.; Rader, Daniel J.		Phase 3 HoFH Lomitapide Study Inve	Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study	LANCET			English	Article							LDL-APHERESIS; LIVER-TRANSPLANTATION; ATORVASTATIN; SIMVASTATIN; EZETIMIBE	Background Patients with homozygous familial hypercholesterolaemia respond inadequately to existing drugs. We aimed to assess the efficacy and safety of the microsomal triglyceride transfer protein inhibitor lomitapide in adults with this disease. Methods We did a single-arm, open-label, phase 3 study of lomitapide for treatment of patients with homozygous familial hypercholesterolemia. Current lipid lowering therapy was maintained from 6 weeks before baseline through to at least week 26. Lomitapide dose was escalated on the basis of safety and tolerability from 5 mg to a maximum of 60 mg a day. The primary endpoint was mean percent change in levels of LDL cholesterol from baseline to week 26, after which patients remained on lomitapide through to week 78 for safety assessment. Percent change from baseline to week 26 was assessed with a mixed linear model. Findings 29 men and women with homozygous familial hypercholesterolaemia, aged 18 years or older, were recruited from 11 centres in four countries (USA, Canada, South Africa, and Italy). 23 of 29 enrolled patients completed both the efficacy phase (26 weeks) and the full study (78 weeks). The median dose of lomitapide was 40 mg a day. LDL cholesterol was reduced by 50% (95% CI -62 to -39) from baseline (mean 8.7 mmol/L [SD 2.9]) to week 26 (4.3 mmol/L [2.5]; p<0.0001). Levels of LDL cholesterol were lower than 2.6 mmol/L in eight patients at 26 weeks. Concentrations of LDL cholesterol remained reduced by 44% (95% CI -57 to -31; p<0.0001) at week 56 and 38% (-52 to -24; p<0.0001) at week 78. Gastrointestinal symptoms were the most common adverse event. Four patients had aminotransaminase levels of more than five times the upper limit of normal, which resolved after dose reduction or temporary interruption of lomitapide. No patient permanently discontinued treatment because of liver abnormalities. Interpretation Our study suggests that treatment with lomitapide could be a valuable drug in the management of homozygous familial hypercholesterolaemia.	[Cuchel, Marina] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Cuchel, Marina; Meagher, Emma A.; Propert, Kathleen J.; Bloedon, LeAnne T.; Rader, Daniel J.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Theron, Hendrik du Toit] Netcare Private Hosp, Bloemfontein, South Africa; [Blom, Dirk J.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Marais, A. David] Univ Cape Town, Dept Chem Pathol, ZA-7925 Cape Town, South Africa; [Blom, Dirk J.; Marais, A. David] Cape Heart Grp, Med Res Council S Africa, Cape Town, South Africa; [Hegele, Robert A.] Univ Western Ontario, Robarts Res Inst, London, ON, Canada; [Hegele, Robert A.] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada; [Averna, Maurizio R.] Univ Palermo, Palermo, Italy; [Sirtori, Cesare R.] Osped Maggiore Niguarda, Milan, Italy; [Shah, Prediman K.] Cedars Sinai Heart Inst, Div Cardiol, Los Angeles, CA USA; [Shah, Prediman K.] Cedars Sinai Heart Inst, Atherosclerosis Res Ctr, Los Angeles, CA USA; [Gaudet, Daniel] Univ Montreal, Dept Med, Chicoutimi, PQ, Canada; [Stefanutti, Claudia] Univ Roma La Sapienza, Extracorporeal Therapeut Tech Unit, Dept Mol Med, Rome, Italy; [Vigna, Giovanni B.] Univ Ferrara, Dept Clin & Expt Med, I-44100 Ferrara, Italy; [Du Plessis, Anna M. E.] Univ Pretoria, Clin Res Unit, ZA-0002 Pretoria, South Africa; [Sasiela, William J.; Bloedon, LeAnne T.] Aeger Pharmaceut, Cambridge, MA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Cape Town; University of Cape Town; South African Medical Research Council; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Palermo; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Universite de Montreal; Sapienza University Rome; University of Ferrara; University of Pretoria	Cuchel, M (corresponding author), Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Cardiovasc Inst, 3600 Spruce St,Maloney Bldg,Room 8039, Philadelphia, PA 19104 USA.	mcuchel@mail.med.upenn.edu	Vigna, Giovanni/H-2826-2015; STEFANUTTI, Claudia/AAI-4716-2020; Hegele, Robert/G-3301-2011; Stefanutti, Claudia/I-2355-2012; Averna, Maurizio/U-9527-2017; Sirtori, Cesare/F-4658-2012; Hegele, Robert/AAF-6482-2020	Vigna, Giovanni/0000-0001-8640-7052; Stefanutti, Claudia/0000-0003-3448-2426; Hegele, Robert/0000-0003-2861-5325; Noto, Davide/0000-0002-5346-2829; Blom, Dirk/0000-0003-3965-5912; Meagher, Emma/0000-0003-1841-4570; Averna, Maurizio/0000-0003-3558-9209	Doris Duke Charitable Foundation; Medical Research Council of South Africa (Cape Heart Group); US Food and Drug Administration Office of the Orphan Product Development [FR-R-003098]; NIH National Center for Research Resources [UL1-RR-024134]; Aegerion Pharmaceuticals; FDA Office of the Orphan Product Development, Aegerion Pharmaceuticals; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Medical Research Council of South Africa (Cape Heart Group); US Food and Drug Administration Office of the Orphan Product Development; NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Aegerion Pharmaceuticals; FDA Office of the Orphan Product Development, Aegerion Pharmaceuticals; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	FDA Office of the Orphan Product Development, Aegerion Pharmaceuticals.; The phase 2 study, on which this study was based, was funded by a grant from the Doris Duke Charitable Foundation. Diagnostic work-up for patients in South Africa was supported by the Medical Research Council of South Africa (Cape Heart Group). This study was supported by a grant from the US Food and Drug Administration Office of the Orphan Product Development (FR-R-003098) to MC, by a grant for the NIH National Center for Research Resources (UL1-RR-024134) to the University of Pennsylvania, and by Aegerion Pharmaceuticals. We thank all of the staff at the clinical sites as well as the study participants for their participation in this study.	Cuchel M, 2007, NEW ENGL J MED, V356, P148, DOI 10.1056/NEJMoa061189; Gagne C, 2002, CIRCULATION, V105, P2469, DOI 10.1161/01.CIR.0000018744.58460.62; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; Hovland A, 2012, TRANSFUS APHER SCI, V46, P73, DOI 10.1016/j.transci.2011.11.016; Hudgins LC, 2002, CARDIOVASC DRUG REV, V20, P271; Hudgins LC, 2008, AM J CARDIOL, V102, P1199, DOI 10.1016/j.amjcard.2008.06.049; Kolansky DM, 2008, AM J CARDIOL, V102, P1438, DOI 10.1016/j.amjcard.2008.07.035; Macchiaiolo M, 2012, LANCET, V379, P1330, DOI 10.1016/S0140-6736(11)61476-1; Maiorana A, 2011, PEDIATR TRANSPLANT, V15, pE25, DOI 10.1111/j.1399-3046.2010.01383.x; Marais AD, 2008, ATHEROSCLEROSIS, V197, P400, DOI 10.1016/j.atherosclerosis.2007.06.028; Marais Adrian David, 2004, Semin Vasc Med, V4, P43; Raal FJ, 2000, ATHEROSCLEROSIS, V150, P421, DOI 10.1016/S0021-9150(99)00435-9; Raal FJ, 1997, ATHEROSCLEROSIS, V135, P249, DOI 10.1016/S0021-9150(97)00168-8; Raal FJ, 2011, CIRCULATION, V124, P2202, DOI 10.1161/CIRCULATIONAHA.111.042523; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; Sachais BS, 2005, J CLIN APHERESIS, V20, P252, DOI 10.1002/jca.20036; Samaha FF, 2008, NAT CLIN PRACT CARD, V5, P497, DOI 10.1038/ncpcardio1250; STARZL TE, 1984, LANCET, V1, P1382; Stefanutti C, 2009, ATHEROSCLEROSIS SUPP, V10, P89, DOI 10.1016/S1567-5688(09)71819-7; Thompson GR, 2010, CURR OPIN LIPIDOL, V21, P492, DOI 10.1097/MOL.0b013e3283402f53; Thompson GR, 2010, ATHEROSCLEROSIS, V208, P317, DOI 10.1016/j.atherosclerosis.2009.06.010; Wetterau JR, 1998, SCIENCE, V282, P751, DOI 10.1126/science.282.5389.751; Wetterau JR, 1997, BBA-LIPID LIPID MET, V1345, P136, DOI 10.1016/S0005-2760(96)00168-3	24	491	508	1	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2013	381	9860					40	46		10.1016/S0140-6736(12)61731-0	http://dx.doi.org/10.1016/S0140-6736(12)61731-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064AW	23122768	Green Accepted, Green Submitted			2022-12-28	WOS:000313044300025
J	Langecker, M; Arnaut, V; Martin, TG; List, J; Renner, S; Mayer, M; Dietz, H; Simmel, FC				Langecker, Martin; Arnaut, Vera; Martin, Thomas G.; List, Jonathan; Renner, Stephan; Mayer, Michael; Dietz, Hendrik; Simmel, Friedrich C.			Synthetic Lipid Membrane Channels Formed by Designed DNA Nanostructures	SCIENCE			English	Article							SOLID-STATE NANOPORES; SINGLE-NUCLEOTIDE RESOLUTION; HAIRPIN MOLECULES; NANOSCALE SHAPES; ALPHA-HEMOLYSIN; FOLDING DNA; ORIGAMI; PORE	We created nanometer-scale transmembrane channels in lipid bilayers by means of self-assembled DNA-based nanostructures. Scaffolded DNA origami was used to create a stem that penetrated and spanned a lipid membrane, as well as a barrel-shaped cap that adhered to the membrane, in part via 26 cholesterol moieties. In single-channel electrophysiological measurements, we found similarities to the response of natural ion channels, such as conductances on the order of 1 nanosiemens and channel gating. More pronounced gating was seen for mutations in which a single DNA strand of the stem protruded into the channel. Single-molecule translocation experiments show that the synthetic channels can be used to discriminate single DNA molecules.	[Martin, Thomas G.; Dietz, Hendrik] Tech Univ Munich, Dept Phys, Walter Schottky Inst, D-85748 Garching, Germany; [Langecker, Martin; Arnaut, Vera; List, Jonathan; Renner, Stephan; Simmel, Friedrich C.] Tech Univ Munich, Dept Phys, Lehrstuhl Bioelekt, D-85748 Garching, Germany; [Langecker, Martin; Arnaut, Vera; List, Jonathan; Renner, Stephan; Simmel, Friedrich C.] Tech Univ Munich, ZNN WSI, D-85748 Garching, Germany; [Mayer, Michael] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Michigan System; University of Michigan	Dietz, H (corresponding author), Tech Univ Munich, Dept Phys, Walter Schottky Inst, D-85748 Garching, Germany.	dietz@tum.de; simmel@tum.de	Simmel, Friedrich/G-3281-2010; Mayer, Michael/C-1299-2010; Mayer, Michael/AAS-1777-2020	Simmel, Friedrich/0000-0003-3829-3446; Mayer, Michael/0000-0002-6148-5756; Dietz, Hendrik/0000-0003-1270-3662; List, Jonathan/0000-0001-8408-0877	Deutsche Forschungsgemeinschaft [SFB 863]; Bundesministerium fur Bildung und Forschung [13N10970]; European Research Council [GA 256270]; Technische Universitat Munchen Institute for Advanced Study; NIH [1R01GM081705]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081705] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Research Council(European Research Council (ERC)European Commission); Technische Universitat Munchen Institute for Advanced Study; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the Deutsche Forschungsgemeinschaft [grant SFB 863 and Excellence Clusters NIM (Nanosystems Initiative Munich) and CIPSM (Center for Integrated Protein Science Munich)], the Bundesministerium fur Bildung und Forschung (grant 13N10970), the European Research Council (starting grant GA 256270, H. D.), the Technische Universitat Munchen Institute for Advanced Study, and NIH grant 1R01GM081705 (M. M.). We thank M. Hiller and A. Bessonov for preliminary work, G. Baaken and J. Behrends for kindly providing the MECA chips, and A. Seifert, M. Beckler, and N. Fertig for technical support with the Orbit setup. M. M., H. D., and F. C. S. designed the research; M. L., V. A., and S. R. performed electrophysiological experiments; T. G. M. prepared the synthetic DNA channels and performed TEM; J. L., V. A., and T. G. M. performed experiments with lipid vesicles; and H. D. and F. C. S. wrote the paper. All authors discussed the results and commented on the manuscript.	Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Baaken G, 2008, LAB CHIP, V8, P938, DOI 10.1039/b800431e; Bayley H, 2001, NATURE, V413, P226, DOI 10.1038/35093038; Bell NAW, 2012, NANO LETT, V12, P512, DOI 10.1021/nl204098n; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; Danelon C, 2006, BIOPHYS J, V90, P1617, DOI 10.1529/biophysj.105.075192; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Hall AR, 2010, NAT NANOTECHNOL, V5, P874, DOI [10.1038/nnano.2010.237, 10.1038/NNANO.2010.237]; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Howorka S, 2009, CHEM SOC REV, V38, P2360, DOI 10.1039/b813796j; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Majd S, 2010, CURR OPIN BIOTECH, V21, P439, DOI 10.1016/j.copbio.2010.05.002; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Mathe J, 2004, BIOPHYS J, V87, P3205, DOI 10.1529/biophysj.104.047274; Renner S, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3558902; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Sakmann B., 1995, SINGLE CHANNEL RECOR; Sauer-Budge AF, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.238101; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Vercoutere W, 2001, NAT BIOTECHNOL, V19, P248, DOI 10.1038/85696; Wei RS, 2012, ANGEW CHEM INT EDIT, V51, P4864, DOI 10.1002/anie.201200688	27	508	572	25	465	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2012	338	6109					932	936		10.1126/science.1225624	http://dx.doi.org/10.1126/science.1225624			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161995	Green Accepted			2022-12-28	WOS:000311083600039
J	Sherr, CJ				Sherr, Charles J.			How politics trumped peer review at Texas cancer institute	BRITISH MEDICAL JOURNAL			English	Editorial Material									St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Sherr, CJ (corresponding author), St Jude Childrens Res Hosp, Dept Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.		Sherr, Charles J/N-8074-2018	Sherr, Charles J/0000-0002-5516-6206				Berger E, 2012, CRITICISM MOUNTS PER; Berger E, 2012, CANC CHIEFS EMAIL IN; Gilman AG, 2012, CANC I CAN REGAIN SC	3	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 15	2012	345								e7334	10.1136/bmj.e7334	http://dx.doi.org/10.1136/bmj.e7334			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040QE	23153837				2022-12-28	WOS:000311337000007
J	Sutton, M; Nikolova, S; Boaden, R; Lester, H; McDonald, R; Roland, M				Sutton, Matt; Nikolova, Silviya; Boaden, Ruth; Lester, Helen; McDonald, Ruth; Roland, Martin			Reduced Mortality with Hospital Pay for Performance in England	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-CARE; FOR-PERFORMANCE; IMPROVEMENT	BACKGROUND Pay-for-performance programs are being adopted internationally despite little evidence that they improve patient outcomes. In 2008, a program called Advancing Quality, based on the Hospital Quality Incentive Demonstration in the United States, was introduced in all National Health Service (NHS) hospitals in the northwest region of England (population, 6.8 million). METHODS We analyzed 30-day in-hospital mortality among 134,435 patients admitted for pneumonia, heart failure, or acute myocardial infarction to 24 hospitals covered by the pay-for-performance program. We used difference-in-differences regression analysis to compare mortality 18 months before and 18 months after the introduction of the program with mortality in two comparators: 722,139 patients admitted for the same three conditions to the 132 other hospitals in England and 241,009 patients admitted for six other conditions to both groups of hospitals. RESULTS Risk-adjusted, absolute mortality for the conditions included in the pay-for-performance program decreased significantly, with an absolute reduction of 1.3 percentage points (95% confidence interval [CI], 0.4 to 2.1; P = 0.006) and a relative reduction of 6%, equivalent to 890 fewer deaths (95% CI, 260 to 1500) during the 18-month period. The largest reduction, for pneumonia, was significant (1.9 percentage points; 95% CI, 0.9 to 3.0; P<0.001), with nonsignificant reductions for acute myocardial infarction (0.6 percentage points; 95% CI, -0.4 to 1.7; P = 0.23) and heart failure (0.6 percentage points; 95% CI, -0.6 to 1.8; P = 0.30). CONCLUSIONS The introduction of pay for performance in all NHS hospitals in one region of England was associated with a clinically significant reduction in mortality. As compared with a similar U. S. program, the U. K. program had larger bonuses and a greater investment by hospitals in quality-improvement activities. Further research is needed on how implementation of pay-for-performance programs influences their effects. (Funded by the NHS National Institute for Health Research.)	[Sutton, Matt; Nikolova, Silviya] Univ Manchester, Ctr Hlth Econ, Inst Populat Hlth, Manchester M13 9PL, Lancs, England; [Boaden, Ruth] Univ Manchester, Manchester Business Sch, Manchester M13 9PL, Lancs, England; [Lester, Helen] Univ Birmingham, Birmingham, W Midlands, England; [McDonald, Ruth] Univ Nottingham, Sch Business, Nottingham NG7 2RD, England; [Roland, Martin] Univ Cambridge, Cambridge Ctr Hlth Serv Res, Cambridge, England	University of Manchester; University of Manchester; University of Birmingham; University of Nottingham; University of Cambridge	Sutton, M (corresponding author), Univ Manchester, Ctr Hlth Econ, Inst Populat Hlth, Rm 1-304,Jean McFarlane Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.	matt.sutton@manchester.ac.uk	McDonald, Ruth/C-3547-2013; Boaden, Ruth/L-3443-2016	Boaden, Ruth/0000-0003-1927-6405; Sutton, Matt/0000-0002-6635-2127; McDonald, Ruth/0000-0002-3488-4209; Roland, Martin/0000-0002-8533-3060; Nikolova, Silviya/0000-0002-6922-5115	NHS National Institute for Health Research; National Health Service National Institute for Health Research; National Institute for Health Research [08/1809/250] Funding Source: researchfish	NHS National Institute for Health Research(National Institute for Health Research (NIHR)); National Health Service National Institute for Health Research; National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by the NHS National Institute for Health Research.; Supported by the National Health Service National Institute for Health Research.	Bhattacharyya T, 2009, HEALTH AFFAIR, V28, P526, DOI 10.1377/hlthaff.28.2.526; Centers for Medicare & Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P26490; Damberg CL, 2009, HEALTH AFFAIR, V28, P517, DOI 10.1377/hlthaff.28.2.517; Flodgren G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009255; Glickman SW, 2007, JAMA-J AM MED ASSOC, V297, P2373, DOI 10.1001/jama.297.21.2373; Grossbart SR, 2006, MED CARE RES REV, V63, p29S, DOI 10.1177/1077558705283643; Healthcare Commission, ANN HLTH CHECK 2007; Jha AK, 2007, HEALTH AFFAIR, V26, P1104, DOI 10.1377/hlthaff.26.4.1104; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Marini G, 2008, HEALTH ECON, V17, P751, DOI 10.1002/hec.1292; Mehrotra A, 2009, AM J MED QUAL, V24, P19, DOI 10.1177/1062860608326634; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ryan AM, 2011, HEALTH SERV RES, V46, P712, DOI 10.1111/j.1475-6773.2010.01224.x; Ryan AM, 2009, INQUIRY-J HEALTH CAR, V46, P274, DOI 10.5034/inquiryjrnl_46.03.274; Ryan AM, 2009, HEALTH SERV RES, V44, P821, DOI 10.1111/j.1475-6773.2009.00956.x; Van Herck P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-247; Werner RM, 2011, HEALTH AFFAIR, V30, P690, DOI 10.1377/hlthaff.2010.1277; Werner RM, 2007, JAMA-J AM MED ASSOC, V297, P700	19	146	151	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2012	367	19					1821	1828		10.1056/NEJMsa1114951	http://dx.doi.org/10.1056/NEJMsa1114951			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033DG	23134382	Green Published			2022-12-28	WOS:000310773200009
J	Chang, HH; Larson, J; Blencowe, H; Spong, CY; Howson, CP; Cairns-Smith, S; Lackritz, EM; Lee, SK; Mason, E; Serazin, AC; Walani, S; Simpson, JL; Lawn, JE				Chang, Hannah H.; Larson, Jim; Blencowe, Hannah; Spong, Catherine Y.; Howson, Christopher P.; Cairns-Smith, Sarah; Lackritz, Eve M.; Lee, Shoo K.; Mason, Elizabeth; Serazin, Andrew C.; Walani, Salimah; Simpson, Joe Leigh; Lawn, Joy E.		Born Too Soon Preterm Prevention A	Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index	LANCET			English	Article							PREGNANT-WOMEN; SYSTEMATIC ANALYSIS; CERVICAL PESSARY; TIME TRENDS; SMOKING; RATES; RISK; PROGESTERONE; OUTCOMES; METAANALYSIS	Background Every year, 1.1 million babies die from prematurity, and many survivors are disabled. Worldwide, 15 million babies are born preterm (<37 weeks' gestation), with two decades of increasing rates in almost all countries with reliable data. The understanding of drivers and potential benefit of preventive interventions for preterm births is poor. We examined trends and estimate the potential reduction in preterm births for countries with very high human development index (VHHDI) if present evidence-based interventions were widely implemented. This analysis is to inform a rate reduction target for Born Too Soon. Methods Countries were assessed for inclusion based on availability and quality of preterm prevalence data (2000-10), and trend analyses with projections undertaken. We analysed drivers of rate increases in the USA, 1989-2004. For 39 countries with VHHDI with more than 10 000 births, we did country-by-country analyses based on target population, incremental coverage increase, and intervention efficacy. We estimated cost savings on the basis of reported costs for preterm care in the USA adjusted using World Bank purchasing power parity. Findings From 2010, even if all countries with VHHDI achieved annual preterm birth rate reductions of the best performers for 1990-2010 (Estonia and Croatia), 2000-10 (Sweden and Netherlands), or 2005-10 (Lithuania, Estonia), rates would experience a relative reduction of less than 5% by 2015 on average across the 39 countries. Our analysis of preterm birth rise 1989-2004 in USA suggests half the change is unexplained, but important drivers include non-medically indicated labour induction and caesarean delivery and assisted reproductive technologies. For all 39 countries with VHHDI, five interventions modelling at high coverage predicted a 5% relative reduction of preterm birth rate from 9.59% to 9.07% of livebirths: smoking cessation (0.01 rate reduction), decreasing multiple embryo transfers during assisted reproductive technologies (0.06), cervical cerclage (0.15), progesterone supplementation (0.01), and reduction of non-medically indicated labour induction or caesarean delivery (0.29). These findings translate to roughly 58 000 preterm births averted and total annual economic cost savings of about US$3 billion. Interpretation We recommend a conservative target of a relative reduction in preterm birth rates of 5% by 2015. Our findings highlight the urgent need for research into underlying mechanisms of preterm births, and development of innovative interventions. Furthermore, the highest preterm birth rates occur in low-income settings where the causes of prematurity might differ and have simpler solutions such as birth spacing and treatment of infections in pregnancy than in high-income countries. Urgent focus on these settings is also crucial to reduce preterm births worldwide.	[Chang, Hannah H.; Larson, Jim; Cairns-Smith, Sarah] Boston Consulting Grp Inc, Boston, MA USA; [Blencowe, Hannah] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Spong, Catherine Y.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA; [Howson, Christopher P.; Walani, Salimah; Simpson, Joe Leigh] March Dimes Fdn, White Plains, NY USA; [Lackritz, Eve M.] Alliance Prevent Prematur & Stillbirth, Seattle, WA USA; [Lee, Shoo K.] Canadian Inst Hlth Res, Inst Human Dev Child & Youth Hlth, Toronto, ON, Canada; [Mason, Elizabeth] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland; [Serazin, Andrew C.] Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA USA; [Lawn, Joy E.] Save Children, Saving Newborn Lives, London, England	Boston Consulting Group (BCG); University of London; London School of Hygiene & Tropical Medicine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Institute for Work & Health; World Health Organization; Bill & Melinda Gates Foundation; Save the Children	Lawn, JE (corresponding author), Save Children, Saving Newborn Lives, London, England.	joylawn@yahoo.co.uk	Lawn, Joy/ABE-6382-2020; Lee, Shoo K/P-3016-2015	Lawn, Joy/0000-0002-4573-1443; Lackritz, Eve/0000-0002-5397-7291; Blencowe, Hannah/0000-0003-1556-3159	March of Dimes, USA; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health, USA; March of Dimes; Bill & Melinda Gates Foundation	March of Dimes, USA(March of Dimes); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	March of Dimes, USA, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and National Institutes of Health, USA.; The time of HHC, JL, and SC-S was funded by the March of Dimes and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. JEL's time was funded by a grant from the Bill & Melinda Gates Foundation to Save the Children's Saving Newborn Lives programme. HB's time was funded by a grant from the Bill & Melinda Gates Foundation to the Child Health Epidemiology Reference Group. We thank Simon Cousens of the London School of Hygiene and Tropical Medicine and Craig Rubens of the Global Alliance to Prevent Prematurity and Stillbirth for technical review. We are grateful to Lori McDougall of the Partnership for Maternal Newborn and Child Health, Lily Kak of USAID, Tola Ladejobi of Boston Consulting Group, Judith Palais, and Rachel Diamond of the March of Dimes for support.	Aly H, 2010, J PERINATOL, V30, P447, DOI 10.1038/jp.2009.117; Barros FC, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S3; Behrman RE, 2007, PRETERM BIRTH CAUSES, V6; Berghella V, 2012, AM J OBSTET GYNECOL, V206, P376, DOI 10.1016/j.ajog.2012.03.010; Berghella V, 2011, OBSTET GYNECOL, V117, P663, DOI 10.1097/AOG.0b013e31820ca847; Bhattacharya S, 2010, OBSTET GYNECOL, V115, P1125, DOI 10.1097/AOG.0b013e3181dffcdb; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Brose LS, 2011, THORAX, V66, P924, DOI 10.1136/thoraxjnl-2011-200251; Centers for Disease Control and Prevention American Society for Reproductive Medicine and Society for Assisted Reproductive Technology, 2009, 2009 ASS REPR TECHN; Centers for Disease Control and Prevention ASfRM Society for Assisted Reproductive Technology, 2011, 2009 ASS REPR TECHN; Chaudhari BP, 2008, CLIN GENET, V74, P493, DOI 10.1111/j.1399-0004.2008.01124.x; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cobb NK, 2005, NICOTINE TOB RES, V7, P207, DOI 10.1080/14622200500055319; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Declercq E, 2006, AM J PUBLIC HEALTH, V96, P867, DOI 10.2105/AJPH.2004.052381; Dodd JM, 2006, COCHRANE DB SYST REV, V1; Dodd JM, 2008, OBSTET GYNECOL, V112, P127, DOI 10.1097/AOG.0b013e31817d0262; Donovan EF, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.044; Ferraretti AP, 2012, HUM REPROD, V27, P2571, DOI 10.1093/humrep/des255; Filion KB, 2011, BJOG-INT J OBSTET GY, V118, P1422, DOI 10.1111/j.1471-0528.2011.03065.x; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Fritz MA, 2009, FERTIL STERIL, V92, P1518, DOI 10.1016/j.fertnstert.2009.08.059; Gibbons L, 2010, WORLD HEALTH REPORT; Goldenberg RL, 2012, AM J OBSTET GYNECOL, V206, P113, DOI 10.1016/j.ajog.2011.10.865; Goya M, 2012, LANCET, V379, P1800, DOI 10.1016/S0140-6736(12)60030-0; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Houda M, 2012, LANCET, V380, P886, DOI 10.1016/S0140-6736(12)61503-7; Howson CP, 2012, MARCH DIMES PMNCH SA; Hui ASY, 2012, LANCET, V380, P887, DOI 10.1016/S0140-6736(12)61504-9; Kim SY, 2009, AM J PUBLIC HEALTH, V99, P893, DOI 10.2105/AJPH.2008.144485; Kramer MS, 2012, AM J OBSTET GYNECOL, V206, P108, DOI 10.1016/j.ajog.2011.10.864; Lanting CI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008363; Laughon SK, 2010, OBSTET GYNECOL, V116, P1047, DOI 10.1097/AOG.0b013e3181f73f97; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mangham LJ, 2009, PEDIATRICS, V123, pE312, DOI 10.1542/peds.2008-1827; Martin JA., 2009, NATL VITAL STAT REP, V57, P1; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Melendez J, 2012, LANCET, V380, P886, DOI 10.1016/S0140-6736(12)61502-5; Mugo M, 2005, CURR HYPERTENS REP, V7, P348, DOI 10.1007/s11906-005-0068-2; Murphy HR, 2011, DIABETIC MED, V28, P1060, DOI 10.1111/j.1464-5491.2011.03333.x; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Norman JE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-79; Norman JE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000153; Norman JE, 2009, LANCET, V373, P2034, DOI 10.1016/S0140-6736(09)60947-8; Osterman Michelle J K, 2011, Natl Vital Stat Rep, V59, P1; Owen J, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.08.015; Reddy UM, 2009, PEDIATRICS, V124, P234, DOI 10.1542/peds.2008-3232; Shah NR, 2000, AM J OBSTET GYNECOL, V182, P465, DOI 10.1016/S0002-9378(00)70240-7; TESTART J, 1992, HUM REPROD, V7, P362, DOI 10.1093/oxfordjournals.humrep.a137651; U.S. Census Bureau, 2011, STAT ABSTR US 2012; van der Klis KAM, 2002, AUST NZ J PUBL HEAL, V26, P125, DOI 10.1111/j.1467-842X.2002.tb00904.x; VanderWeele TJ, 2012, SOC SCI MED, V74, P196, DOI 10.1016/j.socscimed.2011.10.031; Zhang X, 2012, BJOG-INT J OBSTET GY, V119, P1309, DOI 10.1111/j.1471-0528.2012.03453.x	54	352	375	3	116	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2013	381	9862					223	234		10.1016/S0140-6736(12)61856-X	http://dx.doi.org/10.1016/S0140-6736(12)61856-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	075LL	23158883	Green Accepted			2022-12-28	WOS:000313887600034
J	Stuckler, D; McKee, M				Stuckler, David; McKee, Martin			The progress of nations: what we can learn from Taiwan	LANCET			English	Editorial Material							HEALTH		[Stuckler, David] Univ Cambridge, Dept Sociol, Cambridge CB3 3RQ, England; [Stuckler, David; McKee, Martin] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England	University of Cambridge; University of London; London School of Hygiene & Tropical Medicine	Stuckler, D (corresponding author), Univ Cambridge, Dept Sociol, Free Sch Lane, Cambridge CB3 3RQ, England.	ds450@cam.ac.uk	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Stuckler, David/0000-0002-1288-8401				Berger S., 2005, GLOBAL TAIWAN BUILDI; Brockmann H, 2009, J HAPPINESS STUD, V10, P387, DOI 10.1007/s10902-008-9095-4; CHENG TA, 1986, PSYCHOL MED, V16, P415, DOI 10.1017/S0033291700009247; Fu T.S., 2012, LANCET; Kennedy Robert F., 1968, COMMUNICATION   0318; Kwarteng K, 2012, BRITANNIA UNCHAINED: GLOBAL LESSONS FOR GROWTH AND PROSPERITY, P1; Lawn PA, 2003, ECOL ECON, V44, P105, DOI 10.1016/S0921-8009(02)00258-6; Lee YC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-225; McKee M, 2012, CLIN MED, V12, P346, DOI 10.7861/clinmedicine.12-4-346; Perlman F, 2009, AM J PUBLIC HEALTH, V99, P1818, DOI 10.2105/AJPH.2008.154815; Stratton A., 2010, GUARDIAN; Stuckler D, 2011, LANCET, V378, P124, DOI 10.1016/S0140-6736(11)61079-9	12	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 19	2013	381	9862					185	187		10.1016/S0140-6736(12)61602-X	http://dx.doi.org/10.1016/S0140-6736(12)61602-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	075LL	23151369				2022-12-28	WOS:000313887600009
J	O'Roak, BJ; Vives, L; Fu, WQ; Egertson, JD; Stanaway, IB; Phelps, IG; Carvill, G; Kumar, A; Lee, C; Ankenman, K; Munson, J; Hiatt, JB; Turner, EH; Levy, R; O'Day, DR; Krumm, N; Coe, BP; Martin, BK; Borenstein, E; Nickerson, DA; Mefford, HC; Doherty, D; Akey, JM; Bernier, R; Eichler, EE; Shendure, J				O'Roak, Brian J.; Vives, Laura; Fu, Wenqing; Egertson, Jarrett D.; Stanaway, Ian B.; Phelps, Ian G.; Carvill, Gemma; Kumar, Akash; Lee, Choli; Ankenman, Katy; Munson, Jeff; Hiatt, Joseph B.; Turner, Emily H.; Levy, Roie; O'Day, Diana R.; Krumm, Niklas; Coe, Bradley P.; Martin, Beth K.; Borenstein, Elhanan; Nickerson, Deborah A.; Mefford, Heather C.; Doherty, Dan; Akey, Joshua M.; Bernier, Raphael; Eichler, Evan E.; Shendure, Jay			Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders	SCIENCE			English	Article							DE-NOVO MUTATIONS; DYRK1A; AMPLIFICATION; RISK	Exome sequencing studies of autism spectrum disorders (ASDs) have identified many de novo mutations but few recurrently disrupted genes. We therefore developed a modified molecular inversion probe method enabling ultra-low-cost candidate gene resequencing in very large cohorts. To demonstrate the power of this approach, we captured and sequenced 44 candidate genes in 2446 ASD probands. We discovered 27 de novo events in 16 genes, 59% of which are predicted to truncate proteins or disrupt splicing. We estimate that recurrent disruptive mutations in six genes-CHD8, DYRK1A, GRIN2B, TBR1, PTEN, and TBL1XR1-may contribute to 1% of sporadic ASDs. Our data support associations between specific genes and reciprocal subphenotypes (CHD8-macrocephaly and DYRK1A-microcephaly) and replicate the importance of a beta-catenin-chromatin-remodeling network to ASD etiology.	[O'Roak, Brian J.; Vives, Laura; Fu, Wenqing; Egertson, Jarrett D.; Stanaway, Ian B.; Kumar, Akash; Lee, Choli; Hiatt, Joseph B.; Turner, Emily H.; Levy, Roie; Krumm, Niklas; Coe, Bradley P.; Martin, Beth K.; Borenstein, Elhanan; Nickerson, Deborah A.; Akey, Joshua M.; Eichler, Evan E.; Shendure, Jay] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Phelps, Ian G.; Carvill, Gemma; O'Day, Diana R.; Mefford, Heather C.; Doherty, Dan] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Phelps, Ian G.; Carvill, Gemma; Mefford, Heather C.; Doherty, Dan] Seattle Childrens Hosp, Seattle, WA 98105 USA; [Ankenman, Katy; Munson, Jeff; Bernier, Raphael] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Borenstein, Elhanan] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Borenstein, Elhanan] Santa Fe Inst, Santa Fe, NM 87501 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; The Santa Fe Institute; Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu; shendure@uw.edu	Shendure, Jay/AAU-3684-2021; Coe, Bradley/A-2878-2009	O'Roak, Brian/0000-0002-4141-0095; Martin, Beth/0000-0002-9661-014X; Akey, Joshua/0000-0002-4411-1330; Shendure, Jay/0000-0002-1516-1865; Coe, Bradley/0000-0001-8471-4016; Kumar, Akash/0000-0001-9442-3597; Turner, Emily/0000-0001-9040-9229	National Heart, Lung, and Blood Institute, NIH Grand Opportunity (GO) Exome Sequencing Project; Lung GO Sequencing Project [HL-102923]; Women's Health Initiative Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; Simons Foundation [SFARI 137578, 191889]; NIH [HD065285, NS069605, R01 NS064077]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD065285] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL102926, UC2HL103010, UC2HL102924, RC2HL102924, RC2HL102923, RC2HL102926, RC2HL103010, UC2HL102923, UC2HL102925, RC2HL102925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069605, R56NS069605, R01NS064077] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, NIH Grand Opportunity (GO) Exome Sequencing Project; Lung GO Sequencing Project; Women's Health Initiative Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; Simons Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the National Heart, Lung, and Blood Institute, NIH Grand Opportunity (GO) Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926), and the Heart GO Sequencing Project (HL-103010); we also thank B. Vernot, M. Dennis, T. Brown, and other members of the Eichler and Shendure labs for helpful discussions. We are grateful to all of the families at the participating Simons Simplex Collection (SSC) sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, R. Goin-Kochel, E. Hanson, D. Grice, A. Klin, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren, E. Wijsman). We appreciate obtaining access to phenotypic data on the Simons Foundation Autism Research Initiative (SFARI) Base. Approved researchers can obtain the SSC population dataset described in this study (https://ordering.base.sfari.org/similar to browse_collection/archive[ssc_v13]/ui:view) by applying at https://base.sfari.org. This work was supported by grants from the Simons Foundation (SFARI 137578, 191889 to E. E. E., J.S., and R. B.), NIH HD065285 (E. E. E. and J.S.), NIH NS069605 (H. C. M.), and R01 NS064077 (D. D.). E. B. is an Alfred P. Sloan Research Fellow. E. E. E. is an Investigator of the Howard Hughes Medical Institute. Scientific advisory boards or consulting affiliations: Ariosa Diagnostics (J.S.), Stratos Genomics (J.S.), Good Start Genetics (J.S.), Adaptive Biotechnologies (J. S.), Pacific Biosciences (E. E. E.), SynapDx (E. E. E.), DNAnexus (E. E. E.), and SFARI GENE (H. C. M.). B.J.O. is an inventor on patent PCT/US2009/30620: Mutations in contactin associated protein 2 are associated with increased risk for idiopathic autism. Raw sequencing data available at the National Database for Autism Research, NDARCOL1878.	Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Guedj F, 2012, NEUROBIOL DIS, V46, P190, DOI 10.1016/j.nbd.2012.01.007; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Krishnakumar S, 2008, P NATL ACAD SCI USA, V105, P9296, DOI 10.1073/pnas.0803240105; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248; van Bon BWM, 2011, CLIN GENET, V79, P296, DOI 10.1111/j.1399-0004.2010.01544.x; Williams CA, 2008, AM J MED GENET A, V146A, P2023, DOI 10.1002/ajmg.a.32434; Zhou J, 2012, CURR OPIN NEUROBIOL, V22, P873, DOI 10.1016/j.conb.2012.05.004	21	863	901	6	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1619	1622		10.1126/science.1227764	http://dx.doi.org/10.1126/science.1227764			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23160955	Green Accepted			2022-12-28	WOS:000312533100053
J	Rincon-Arano, H; Halow, J; Delrow, JJ; Parkhurst, SM; Groudine, M				Rincon-Arano, Hector; Halow, Jessica; Delrow, Jeffrey J.; Parkhurst, Susan M.; Groudine, Mark			UpSET Recruits HDAC Complexes and Restricts Chromatin Accessibility and Acetylation at Promoter Regions	CELL			English	Article							SET-DOMAIN PROTEIN; RNA-POLYMERASE-II; NUCLEOSOME ORGANIZATION; DROSOPHILA GENOME; INACTIVE GENES; IN-VIVO; MLL5; METHYLTRANSFERASE; METHYLATION; H3K4	Developmental gene expression results from the orchestrated interplay between genetic and epigenetic mechanisms. Here, we describe upSET, a transcriptional regulator encoding a SET domain-containing protein recruited to active and inducible genes in Drosophila. However, unlike other Drosophila SET proteins associated with gene transcription, UpSET is part of an Rpd3/Sin3-containing complex that restricts chromatin accessibility and histone acetylation to promoter regions. In the absence of UpSET, active chromatin marks and chromatin accessibility increase and spread to genic and flanking regions due to destabilization of the histone deacetylase complex. Consistent with this, transcriptional noise increases, as manifest by activation of repetitive elements and off-target genes. Interestingly, upSET mutant flies are female sterile due to upregulation of key components of Notch signaling during oogenesis. Thus UpSET defines a class of metazoan transcriptional regulators required to fine tune transcription by preventing the spread of active chromatin.	[Rincon-Arano, Hector; Halow, Jessica; Parkhurst, Susan M.; Groudine, Mark] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Groudine, Mark] Univ Washington, Sch Med, Dept Radiat Oncol, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Groudine, M (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	markg@fhcrc.org	Halow, Jessica/GQO-7562-2022	Parkhurst, Susan/0000-0001-5806-9930	NIH [GM073021, GM097083, DK44746, HL65440]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044746, R37DK044746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097083, R01GM073021] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jorja Henikoff, Steve Henikoff, and Galina Filippova for their interest, advice and comments on the manuscript. We thank Jorja Henikoff, Ryan Basom and Janet Young for bioinformatic help. We also thank Erika Bach, Al Courey, Barry Honda, Steven Hou, Lori Pile, Liz Wayner, the Harvard Exelixis Collection, the Bloomington/Kyoto Stock Centers, and the Developmental Studies Hybridoma Bank for antibodies, flies and other reagents used in this study. This work was supported by NIH grants GM073021 and GM097083 (to SMP) and DK44746 and HL65440 (to MG).	Abed M, 2009, METHODS MOL BIOL, V567, P155, DOI 10.1007/978-1-60327-414-2_11; Ardehali MB, 2011, EMBO J, V30, P2817, DOI 10.1038/emboj.2011.194; Assa-Kunik E, 2007, DEVELOPMENT, V134, P1161, DOI 10.1242/dev.02800; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Bartkuhn M, 2009, EMBO J, V28, P877, DOI 10.1038/emboj.2009.34; Bastock R, 2008, CURR BIOL, V18, pR1082, DOI 10.1016/j.cub.2008.09.011; Bell O, 2010, NAT STRUCT MOL BIOL, V17, P894, DOI 10.1038/nsmb.1825; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Buratowski S, 2010, COLD SH Q B, V75, P95, DOI 10.1101/sqb.2010.75.036; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Castaneda J, 2011, MUTAT RES-FUND MOL M, V714, P95, DOI 10.1016/j.mrfmmm.2011.05.002; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Greil F, 2006, METHOD ENZYMOL, V410, P342, DOI 10.1016/S0076-6879(06)10016-6; Hallson G, 2012, GENETICS, V190, P91, DOI 10.1534/genetics.111.135863; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Heuser M, 2009, BLOOD, V113, P1432, DOI [10.1182/blood-2008-02-162263, 10.1182/blood-2008-06-162263]; KAMINKER JS, 2002, GENOME BIOL, V0003; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Mohan M, 2011, MOL CELL BIOL, V31, P4310, DOI 10.1128/MCB.06092-11; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Sims RJ, 2011, SCIENCE, V332, P99, DOI 10.1126/science.1202663; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Yap DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027127; Zhang Y, 2009, BLOOD, V113, P1455, DOI 10.1182/blood-2008-05-159905; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	46	38	40	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1214	1228		10.1016/j.cell.2012.11.009	http://dx.doi.org/10.1016/j.cell.2012.11.009			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23177352	Green Accepted, Bronze			2022-12-28	WOS:000311999900012
J	Okuda, S; Freinkman, E; Kahne, D				Okuda, Suguru; Freinkman, Elizaveta; Kahne, Daniel			Cytoplasmic ATP Hydrolysis Powers Transport of Lipopolysaccharide Across the Periplasm in E-coli	SCIENCE			English	Article							OUTER-MEMBRANE; INNER-MEMBRANE; GENETIC-CODE; FUNCTIONAL-ANALYSIS; PROTEIN COMPLEX; CELL-ENVELOPE; IDENTIFICATION; MECHANISM; SURFACE; EXPORT	Millions of molecules of lipopolysaccharide (LPS) must be assembled on the Escherichia coli cell surface each time the cell divides. The biogenesis of LPS requires seven essential lipopolysaccharide transport (Lpt) proteins to move LPS from the inner membrane through the periplasm to the cell surface. However, no intermediate transport states have been observed. We developed methods to observe intermediate LPS molecules bound to Lpt proteins in the process of being transported in vivo. Movement of individual LPS molecules along these binding sites required multiple rounds of adenosine triphosphate (ATP) hydrolysis in vitro, which suggests that ATP is used to push a continuous stream of LPS through a transenvelope bridge in discrete steps against a concentration gradient.	[Okuda, Suguru; Freinkman, Elizaveta; Kahne, Daniel] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Kahne, Daniel] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School	Kahne, D (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	kahne@chemistry.harvard.edu	Okuda, Suguru/K-6571-2017	Okuda, Suguru/0000-0002-9184-5601	NIH [AI081059, GM066174]; Fannie and John Hertz Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066174] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fannie and John Hertz Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The plasmid pSup-BpaRS-6TRN was a gift from P. G. Schultz (Scripps Research Institute). We thank C. Hagan for valuable discussion. Supported by NIH grants AI081059 and GM066174 (D.K.) and a Fannie and John Hertz Foundation graduate fellowship (E.F.).	Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chng SS, 2010, BIOCHEMISTRY-US, V49, P4565, DOI 10.1021/bi100493e; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Freinkman E, 2012, BIOCHEMISTRY-US, V51, P4800, DOI 10.1021/bi300592c; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; KABACK HR, 1966, P NATL ACAD SCI USA, V55, P920, DOI 10.1073/pnas.55.4.920; KIM YJ, 1994, CELL, V78, P845; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Narita S, 2009, FEBS LETT, V583, P2160, DOI 10.1016/j.febslet.2009.05.051; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Sperandeo P, 2011, J BACTERIOL, V193, P1042, DOI 10.1128/JB.01037-10; Suits MDL, 2008, J MOL BIOL, V380, P476, DOI 10.1016/j.jmb.2008.04.045; Tran AX, 2010, J BIOL CHEM, V285, P33529, DOI 10.1074/jbc.M110.144709; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Yakushi T, 1998, J BIOL CHEM, V273, P32576, DOI 10.1074/jbc.273.49.32576	27	139	141	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1214	1217		10.1126/science.1228984	http://dx.doi.org/10.1126/science.1228984			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23138981	Green Accepted			2022-12-28	WOS:000311666200047
J	Lederle, FA; Freischlag, JA; Kyriakides, TC; Matsumura, JS; Padberg, FT; Kohler, TR; Kougias, P; Jean-Claude, JM; Cikrit, DF; Swanson, KM				Lederle, Frank A.; Freischlag, Julie A.; Kyriakides, Tassos C.; Matsumura, Jon S.; Padberg, Frank T., Jr.; Kohler, Ted R.; Kougias, Panagiotis; Jean-Claude, Jessie M.; Cikrit, Dolores F.; Swanson, Kathleen M.		OVER Vet Affairs Cooperative Study	Long-Term Comparison of Endovascular and Open Repair of Abdominal Aortic Aneurysm	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MORTALITY; OUTCOMES; STATES	Background Whether elective endovascular repair of abdominal aortic aneurysm reduces long-term morbidity and mortality, as compared with traditional open repair, remains uncertain. Methods We randomly assigned 881 patients with asymptomatic abdominal aortic aneurysms who were candidates for both procedures to either endovascular repair (444) or open repair (437) and followed them for up to 9 years (mean, 5.2). Patients were selected from 42 Veterans Affairs medical centers and were 49 years of age or older at the time of registration. Results More than 95% of the patients underwent the assigned repair. For the primary outcome of all-cause mortality, 146 deaths occurred in each group (hazard ratio with endovascular repair versus open repair, 0.97; 95% confidence interval [CI], 0.77 to 1.22; P = 0.81). The previously reported reduction in perioperative mortality with endovascular repair was sustained at 2 years (hazard ratio, 0.63; 95% CI, 0.40 to 0.98; P = 0.04) and at 3 years (hazard ratio, 0.72; 95% CI, 0.51 to 1.00; P = 0.05) but not thereafter. There were 10 aneurysm-related deaths in the endovascular-repair group (2.3%) versus 16 in the open-repair group (3.7%) (P = 0.22). Six aneurysm ruptures were confirmed in the endovascular-repair group versus none in the open-repair group (P = 0.03). A significant interaction was observed between age and type of treatment (P = 0.006); survival was increased among patients under 70 years of age in the endovascular-repair group but tended to be better among those 70 years of age or older in the open-repair group. Conclusions Endovascular repair and open repair resulted in similar long-term survival. The perioperative survival advantage with endovascular repair was sustained for several years, but rupture after repair remained a concern. Endovascular repair led to increased long-term survival among younger patients but not among older patients, for whom a greater benefit from the endovascular approach had been expected. (Funded by the Department of Veterans Affairs Office of Research and Development; OVER ClinicalTrials.gov number, NCT00094575.)	[Lederle, Frank A.] Vet Affairs Med Ctr, Dept Med III 0, Minneapolis, MN 55417 USA; [Freischlag, Julie A.] Vet Affairs Med Ctr, Baltimore, MD USA; [Kyriakides, Tassos C.] Vet Affairs Med Ctr, West Haven, CT USA; [Matsumura, Jon S.] Vet Affairs Med Ctr, Madison, WI USA; [Kougias, Panagiotis] Vet Affairs Med Ctr, Houston, TX 77030 USA; [Jean-Claude, Jessie M.] Vet Affairs Med Ctr, Cleveland, OH USA; [Cikrit, Dolores F.] Vet Affairs Med Ctr, Indianapolis, IN USA; [Swanson, Kathleen M.] Vet Affairs Med Ctr, Albuquerque, NM USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA)	Lederle, FA (corresponding author), Vet Affairs Med Ctr, Dept Med III 0, 1 Vet Dr, Minneapolis, MN 55417 USA.	frank.lederle@va.gov	Kyriakides, Tassos/E-4980-2013	Kyriakides, Tassos/0000-0001-8913-108X; Pipinos, Iraklis/0000-0001-6873-6346; Jacobowitz, Glenn/0000-0002-8136-2518; Padberg, Frank/0000-0001-5067-4247	Department of Veterans Affairs Office of Research and Development [NCT00094575]; Veterans Affairs [I01BX001318] Funding Source: NIH RePORTER	Department of Veterans Affairs Office of Research and Development(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	Funded by the Department of Veterans Affairs Office of Research and Development; OVER ClinicalTrials.gov number, NCT00094575.	[Anonymous], SF 36 HLTH SURVEY UP; Blankensteijn JD, 2005, NEW ENGL J MED, V352, P2398, DOI 10.1056/NEJMoa051255; Brown LC, 2007, BRIT J SURG, V94, P709, DOI 10.1002/bjs.5776; Brown LC, 2011, BRIT J SURG, V98, P162, DOI 10.1002/bjs.7391; Brown LC, 2010, BRIT J SURG, V97, P1207, DOI 10.1002/bjs.7104; De Bruin JL, 2010, NEW ENGL J MED, V362, P1881, DOI 10.1056/NEJMoa0909499; Diehr P, 2003, MED CARE, V41, P1065, DOI 10.1097/01.MLR.0000083748.86769.A9; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Kalbfleish J., 1980, STAT ANAL FAILURE TI; Klein JP, 2008, COMPUT METH PROG BIO, V89, P289, DOI 10.1016/j.cmpb.2007.11.017; Lederle FA, 2009, JAMA-J AM MED ASSOC, V302, P1535, DOI 10.1001/jama.2009.1426; Levey AS, 2008, ANN INTERN MED, V149, P519, DOI 10.7326/0003-4819-149-7-200810070-00023; McPhee JT, 2007, J VASC SURG, V45, P891, DOI 10.1016/j.jvs.2007.01.043; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003	16	454	476	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2012	367	21					1988	1997		10.1056/NEJMoa1207481	http://dx.doi.org/10.1056/NEJMoa1207481			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040RI	23171095	Bronze			2022-12-28	WOS:000311340200006
J	LeGates, TA; Altimus, CM; Wang, H; Lee, HK; Yang, SG; Zhao, HQ; Kirkwood, A; Weber, ET; Hattar, S				LeGates, Tara A.; Altimus, Cara M.; Wang, Hui; Lee, Hey-Kyoung; Yang, Sunggu; Zhao, Haiqing; Kirkwood, Alfredo; Weber, E. Todd; Hattar, Samer			Aberrant light directly impairs mood and learning through melanopsin-expressing neurons	NATURE			English	Article							RETINAL GANGLION-CELLS; LONG-TERM DEPRESSION; MORRIS WATER MAZE; BEHAVIORAL DESPAIR; MEMORY; CLOCK; RATS; PROJECTIONS; FLUOXETINE; ANXIETY	The daily solar cycle allows organisms to synchronize their circadian rhythms and sleep-wake cycles to the correct temporal niche(1). Changes in day-length, shift-work, and transmeridian travel lead to mood alterations and cognitive function deficits(2). Sleep deprivation and circadian disruption underlie mood and cognitive disorders associated with irregular light schedules(2). Whether irregular light schedules directly affect mood and cognitive functions in the context of normal sleep and circadian rhythms remains unclear. Here we show, using an aberrant light cycle that neither changes the amount and architecture of sleep nor causes changes in the circadian timing system, that light directly regulates mood-related behaviours and cognitive functions in mice. Animals exposed to the aberrant light cycle maintain daily corticosterone rhythms, but the overall levels of corticosterone are increased. Despite normal circadian and sleep structures, these animals show increased depression-like behaviours and impaired hippocampal long-term potentiation and learning. Administration of the antidepressant drugs fluoxetine or desipramine restores learning in mice exposed to the aberrant light cycle, suggesting that the mood deficit precedes the learning impairments. To determine the retinal circuits underlying this impairment of mood and learning, we examined the behavioural consequences of this light cycle in animals that lack intrinsically photosensitive retinal ganglion cells. In these animals, the aberrant light cycle does not impair mood and learning, despite the presence of the conventional retinal ganglion cells and the ability of these animals to detect light for image formation. These findings demonstrate the ability of light to influence cognitive and mood functions directly through intrinsically photosensitive retinal ganglion cells.	[LeGates, Tara A.; Altimus, Cara M.; Zhao, Haiqing; Hattar, Samer] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Wang, Hui; Lee, Hey-Kyoung; Yang, Sunggu; Kirkwood, Alfredo; Hattar, Samer] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA; [Weber, E. Todd] Rider Univ, Dept Biol, Lawrenceville, NJ 08648 USA	Johns Hopkins University; Johns Hopkins University; Rider University	Hattar, S (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	shattar@jhu.edu	Hattar, Samer/W-6927-2019	Yang, Sunggu/0000-0002-7567-9949; LeGates, Tara/0000-0002-6005-4786; Lee, Hey-Kyoung/0000-0002-5554-983X	David and Lucile Packard Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034606] Funding Source: NIH RePORTER	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank T. Gould, G. Ball and A. Sawa for their expert advice on the behavioural tests. We would like to thank R. Kuruvilla for her critical reading and advice on this manuscript. We would also like to thank the mouse tri-laboratory for suggestions and advice. This work was supported by the David and Lucile Packard Foundation grant to S.H.	Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; Baldi E, 2003, PHYSIOL BEHAV, V78, P785, DOI 10.1016/S0031-9384(03)00064-7; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Fonken LK, 2009, BEHAV BRAIN RES, V205, P349, DOI 10.1016/j.bbr.2009.07.001; Foster RG, 2005, NAT REV NEUROSCI, V6, P407, DOI 10.1038/nrn1670; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Honey RC, 1998, J NEUROSCI, V18, P2226; Iyilikci O, 2009, BEHAV BRAIN RES, V203, P65, DOI 10.1016/j.bbr.2009.04.013; Lam RW, 2000, J PSYCHIATR NEUROSCI, V25, P469; Lee HK, 2005, NAT NEUROSCI, V8, P1657, DOI 10.1038/nn1586; Lockley SW, 2006, SLEEP, V29, P161; Ma WP, 2007, NEUROSCI RES, V59, P224, DOI 10.1016/j.neures.2007.06.1474; McDermott CM, 2003, J NEUROSCI, V23, P9687; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Sprouse J, 2006, BIOL PSYCHIAT, V60, P896, DOI 10.1016/j.biopsych.2006.03.003; Tataroglu O, 2004, BRAIN RES, V1001, P118, DOI 10.1016/j.brainres.2003.11.063; Vandewalle G, 2010, P NATL ACAD SCI USA, V107, P19549, DOI 10.1073/pnas.1010180107; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Warthen DM, 2011, P NATL ACAD SCI USA, V108, P13788, DOI 10.1073/pnas.1103214108	27	316	327	8	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					594	+		10.1038/nature11673	http://dx.doi.org/10.1038/nature11673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23151476	Green Accepted			2022-12-28	WOS:000311339800052
J	Milucka, J; Ferdelman, TG; Polerecky, L; Franzke, D; Wegener, G; Schmid, M; Lieberwirth, I; Wagner, M; Widdel, F; Kuypers, MMM				Milucka, Jana; Ferdelman, Timothy G.; Polerecky, Lubos; Franzke, Daniela; Wegener, Gunter; Schmid, Markus; Lieberwirth, Ingo; Wagner, Michael; Widdel, Friedrich; Kuypers, Marcel M. M.			Zero-valent sulphur is a key intermediate in marine methane oxidation	NATURE			English	Article							MEDIATING ANAEROBIC OXIDATION; IN-SITU HYBRIDIZATION; MOSBY MUD VOLCANO; SULFATE REDUCTION; ELEMENTAL SULFUR; EQUILIBRIUM DISTRIBUTION; OLIGONUCLEOTIDE PROBES; MICROBIAL COMMUNITIES; AQUEOUS-SOLUTIONS; POLYSULFIDE IONS	Emissions of methane, a potent greenhouse gas, from marine sediments are controlled by anaerobic oxidation of methane coupled primarily to sulphate reduction (AOM). Sulphate-coupled AOM is believed to be mediated by a consortium of methanotrophic archaea (ANME) and sulphate-reducing Deltaproteobacteria but the underlying mechanism has not yet been resolved. Here we show that zero-valent sulphur compounds (S-0) are formed during AOM through a new pathway for dissimilatory sulphate reduction performed by the methanotrophic archaea. Hence, AOM might not be an obligate syntrophic process but may be carried out by the ANME alone. Furthermore, we show that the produced S-0-in the form of disulphide-is disproportionated by the Deltaproteobacteria associated with the ANME. Our observations expand the diversity of known microbially mediated sulphur transformations and have significant implications for our understanding of the biogeochemical carbon and sulphur cycles.	[Milucka, Jana; Ferdelman, Timothy G.; Polerecky, Lubos; Franzke, Daniela; Wegener, Gunter; Widdel, Friedrich; Kuypers, Marcel M. M.] Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; [Wegener, Gunter] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Schmid, Markus; Wagner, Michael] Univ Vienna, A-1090 Vienna, Austria; [Lieberwirth, Ingo] Max Planck Inst Polymer Res, D-55128 Mainz, Germany	Max Planck Society; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Vienna; Max Planck Society	Milucka, J (corresponding author), Max Planck Inst Marine Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	jmilucka@mpi-bremen.de	Schmid, Markus C/D-2669-2012; Lieberwirth, Ingo/Q-5862-2017; Wagner, Michael/A-7801-2011; Polerecky, Lubos/E-1134-2014; Ferdelman, Timothy G/A-3758-2013	Wagner, Michael/0000-0002-9778-7684; Polerecky, Lubos/0000-0003-4425-585X; Ferdelman, Timothy G/0000-0002-9701-3793; Wegener, Gunter/0000-0002-6819-373X	Max Planck Society; ERC [294343]	Max Planck Society(Max Planck SocietyFoundation CELLEX); ERC(European Research Council (ERC)European Commission)	We want to thank G. Klockgether, K. Imhoff, S. Littmann and T. Vagner for technical support, G. Lavik and M. Formolo for analytical support and discussions, M. Schuler and T. Keil for assistance with cryosectioning, A. Boetius for providing samples, and T. Holler for the initial enrichment and maintenance of the Isis culture. This work was financially supported by the Max Planck Society and the ERC Advanced Grant 294343 (to M.W.).	Alperin M, 2010, SCIENCE, V329, P288, DOI 10.1126/science.1189966; Alperin MJ, 2009, AM J SCI, V309, P869, DOI 10.2475/10.2009.01; Balows A., 1992, PROKARYOTES, P3352, DOI [10.1007/978-1-4757-2191-1_21, DOI 10.1007/978-1-4757-2191-1_]; Basen M, 2011, ENVIRON MICROBIOL, V13, P1370, DOI 10.1111/j.1462-2920.2011.02443.x; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; CORDRUWISCH R, 1985, J MICROBIOL METH, V4, P33, DOI 10.1016/0167-7012(85)90005-3; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; FUSELER K, 1995, ARCH MICROBIOL, V164, P104, DOI 10.1007/BF02525315; Hansen LB, 1998, AQUAT MICROB ECOL, V14, P195, DOI 10.3354/ame014195; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Holler T, 2011, P NATL ACAD SCI USA, V108, pE1484, DOI 10.1073/pnas.1106032108; Holmkvist L, 2011, GEOCHIM COSMOCHIM AC, V75, P3581, DOI 10.1016/j.gca.2011.03.033; Holmkvist L, 2011, DEEP-SEA RES PT I, V58, P493, DOI 10.1016/j.dsr.2011.02.009; House Christopher H., 2011, Life-Basel, V1, P19, DOI 10.3390/life1010019; Huang WE, 2007, ENVIRON MICROBIOL, V9, P1878, DOI 10.1111/j.1462-2920.2007.01352.x; Johnson EF, 2008, MICROBIAL SULFUR METABOLISM, P202, DOI 10.1007/978-3-540-72682-1_16; JORGENSEN BB, 1974, MAR BIOL, V24, P189, DOI 10.1007/BF00391893; Joye SB, 2004, CHEM GEOL, V205, P219, DOI 10.1016/j.chemgeo.2003.12.019; Kallmeyer J, 2004, LIMNOL OCEANOGR-METH, V2, P171, DOI 10.4319/lom.2004.2.171; Kamyshny A, 2006, ANAL CHEM, V78, P2631, DOI 10.1021/ac051854a; Kamyshny A, 2004, ENVIRON SCI TECHNOL, V38, P6633, DOI 10.1021/es049514e; Kamyshny A, 2009, GEOCHIM COSMOCHIM AC, V73, P6022, DOI 10.1016/j.gca.2009.07.003; Kamyshny A, 2007, ENVIRON SCI TECHNOL, V41, P2395, DOI 10.1021/es062637+; Kamyshny A, 2009, GEOSTAND GEOANAL RES, V33, P415, DOI 10.1111/j.1751-908X.2009.00907.x; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; KRAMER M, 1989, ARCH MICROBIOL, V151, P232, DOI 10.1007/BF00413135; Kubo K, 2012, ISME J, V6, P1949, DOI 10.1038/ismej.2012.37; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Losekann T, 2007, APPL ENVIRON MICROB, V73, P3348, DOI 10.1128/AEM.00016-07; LOVLEY DR, 1994, APPL ENVIRON MICROB, V60, P2394, DOI 10.1128/AEM.60.7.2394-2399.1994; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Mastalerz V, 2007, CHEM GEOL, V246, P87, DOI 10.1016/j.chemgeo.2007.09.005; Meulepas RJW, 2010, APPL MICROBIOL BIOT, V87, P1499, DOI 10.1007/s00253-010-2597-0; Meyerdierks A, 2010, ENVIRON MICROBIOL, V12, P422, DOI 10.1111/j.1462-2920.2009.02083.x; Meysman FJR, 2005, MAR CHEM, V97, P206, DOI 10.1016/j.marchem.2005.08.005; Milucka J., 2012, ENV MICROBIOL; Moran JJ, 2008, ENVIRON MICROBIOL, V10, P162, DOI 10.1111/j.1462-2920.2007.01441.x; Musat N, 2008, P NATL ACAD SCI USA, V105, P17861, DOI 10.1073/pnas.0809329105; Nauhaus K, 2002, ENVIRON MICROBIOL, V4, P296, DOI 10.1046/j.1462-2920.2002.00299.x; Nauhaus K, 2007, ENVIRON MICROBIOL, V9, P187, DOI 10.1111/j.1462-2920.2006.01127.x; Niemann H, 2006, NATURE, V443, P854, DOI 10.1038/nature05227; Orcutt B, 2008, BIOGEOSCIENCES, V5, P1587, DOI 10.5194/bg-5-1587-2008; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; Pasteris JD, 2001, CHEM GEOL, V180, P3, DOI 10.1016/S0009-2541(01)00302-3; Pernthaler A, 2008, P NATL ACAD SCI USA, V105, P7052, DOI 10.1073/pnas.0711303105; Philippot P, 2007, SCIENCE, V317, P1534, DOI 10.1126/science.1145861; Ploug H, 2010, ISME J, V4, P1215, DOI 10.1038/ismej.2010.53; Polerecky L, 2012, ENVIRON MICROBIOL, V14, P1009, DOI 10.1111/j.1462-2920.2011.02681.x; Rickard D, 2007, CHEM REV, V107, P514, DOI 10.1021/cr0503658; SALEH AM, 1964, J APPL BACTERIOL, V27, P281, DOI 10.1111/j.1365-2672.1964.tb04914.x; Schreiber L, 2010, ENVIRON MICROBIOL, V12, P2327, DOI 10.1111/j.1462-2920.2010.02275.x; Shima S, 2005, CURR OPIN MICROBIOL, V8, P643, DOI 10.1016/j.mib.2005.10.002; Sorensen KB, 2001, MICROBIAL ECOL, V42, P1; Stahl D.A., 1991, NUCL ACID TECHNIQUES, P205; STEUDEL R, 1988, Z NATURFORSCH B, V43, P203; Stoecker K, 2010, APPL ENVIRON MICROB, V76, P922, DOI 10.1128/AEM.02456-09; Stumm W., 1996, AQUAT CHEM, P990; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; Thauer RK, 2008, ANN NY ACAD SCI, V1125, P158, DOI 10.1196/annals.1419.000; Thauer RK, 2011, CURR OPIN MICROBIOL, V14, P292, DOI 10.1016/j.mib.2011.03.003; THODE HG, 1961, GEOCHIM COSMOCHIM AC, V25, P159, DOI 10.1016/0016-7037(61)90074-6; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Treude T, 2003, MAR ECOL PROG SER, V264, P1, DOI 10.3354/meps264001; Treude T, 2007, APPL ENVIRON MICROB, V73, P2271, DOI 10.1128/AEM.02685-06; Trofimov BA, 2009, J SULFUR CHEM, V30, P518, DOI 10.1080/17415990902998579; TRUPER HG, 1982, PHILOS T ROY SOC B, V298, P529, DOI 10.1098/rstb.1982.0095; Wegener G, 2008, ENVIRON MICROBIOL, V10, P2287, DOI 10.1111/j.1462-2920.2008.01653.x; Widdel F, 2007, SULPHATE-REDUCING BACTERIA: ENVIRONMENTAL AND ENGINEERED SYSTEMS, P265, DOI 10.1017/CBO9780511541490.010; Zopfi J, 2004, GEOLOGICAL SOC AM SP, V379, P97, DOI DOI 10.1130/0-8137-2379-5.97	73	375	398	16	477	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					541	+		10.1038/nature11656	http://dx.doi.org/10.1038/nature11656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23135396				2022-12-28	WOS:000311339800041
J	del Monte, G; Harvey, RP				del Monte, Gonzalo; Harvey, Richard Paul			An Endothelial Contribution to Coronary Vessels	CELL			English	Editorial Material							CELLS; ORIGIN	Despite the profound impact of coronary artery disease on human health, the origins of the coronary blood vessels are poorly understood. Wu et al. use imaging and genetic techniques to show that the endocardium contributes to the coronary vessels and that the coronary arteries and veins have multilineage origins.	[del Monte, Gonzalo; Harvey, Richard Paul] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia; [Harvey, Richard Paul] Univ New S Wales, St Vincents Clin Sch, Kensington, NSW 2052, Australia	Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Harvey, RP (corresponding author), Victor Chang Cardiac Res Inst, Lowy Packer Bldg,405 Liverpool St, Darlinghurst, NSW 2010, Australia.	r.harvey@victorchang.edu.au	del Monte-Nieto, Gonzalo/R-2831-2019	del Monte-Nieto, Gonzalo/0000-0003-3830-2226; Harvey, Richard/0000-0002-9950-9792				Chong JJH, 2011, CELL STEM CELL, V9, P527, DOI 10.1016/j.stem.2011.10.002; Katz TC, 2012, DEV CELL, V22, P639, DOI 10.1016/j.devcel.2012.01.012; Lavine KJ, 2008, DEVELOPMENT, V135, P3161, DOI 10.1242/dev.019919; Lewis FT, 1904, ANAT ANZEIGER, V25, P261; POELMANN RE, 1993, CIRC RES, V73, P559, DOI 10.1161/01.RES.73.3.559; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Rudat C, 2012, CIRC RES, V111, P165, DOI 10.1161/CIRCRESAHA.112.273946; VIRAGH S, 1981, ANAT REC, V201, P157, DOI 10.1002/ar.1092010117; Wu BR, 2012, CELL, V151, P1083, DOI 10.1016/j.cell.2012.10.023	9	15	15	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 21	2012	151	5					932	934		10.1016/j.cell.2012.11.004	http://dx.doi.org/10.1016/j.cell.2012.11.004			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178115	Bronze			2022-12-28	WOS:000311423500007
J	Mechanic, R; Tompkins, C				Mechanic, Robert; Tompkins, Christopher			Lessons Learned Preparing for Medicare Bundled Payments	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mechanic, Robert; Tompkins, Christopher] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02454 USA	Brandeis University	Mechanic, R (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02454 USA.							Mechanic RE, 2009, HEALTH AFFAIR, V28, pW262, DOI 10.1377/hlthaff.28.2.w262; RTI International, 2011, POST CAR EP EXP AN F; Tompkins C, 2012, ANAL FINANCIAL RISK; Welch WP, 1998, HEALTH AFFAIR, V17, P69, DOI 10.1377/hlthaff.17.6.69	4	40	42	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2012	367	20					1873	1875		10.1056/NEJMp1210823	http://dx.doi.org/10.1056/NEJMp1210823			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	036MB	23150955				2022-12-28	WOS:000311029300001
J	Sheffield, J; Wood, EF; Roderick, ML				Sheffield, Justin; Wood, Eric F.; Roderick, Michael L.			Little change in global drought over the past 60 years	NATURE			English	Article							PAN EVAPORATION; SEVERITY INDEX; SOIL-MOISTURE; CLIMATE; PRECIPITATION; DATASET; WATER	Drought is expected to increase in frequency and severity in the future as a result of climate change, mainly as a consequence of decreases in regional precipitation but also because of increasing evaporation driven by global warming(1-3). Previous assessments of historic changes in drought over the late twentieth and early twenty-first centuries indicate that this may already be happening globally. In particular, calculations of the Palmer Drought Severity Index (PDSI) show a decrease in moisture globally since the 1970s with a commensurate increase in the area in drought that is attributed, in part, to global warming(4,5). The simplicity of the PDSI, which is calculated from a simple water-balance model forced by monthly precipitation and temperature data, makes it an attractive tool in large-scale drought assessments, but may give biased results in the context of climate change(6). Here we show that the previously reported increase in global drought is overestimated because the PDSI uses a simplified model of potential evaporation(7) that responds only to changes in temperature and thus responds incorrectly to global warming in recent decades. More realistic calculations, based on the underlying physical principles(8) that take into account changes in available energy, humidity and wind speed, suggest that there has been little change in drought over the past 60 years. The results have implications for how we interpret the impact of global warming on the hydrological cycle and its extremes, and may help to explain why palaeoclimate drought reconstructions based on tree-ring data diverge from the PDSI-based drought record in recent years(9,10).	[Sheffield, Justin; Wood, Eric F.] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA; [Roderick, Michael L.] Australian Natl Univ, Res Sch Earth Sci, Australian Res Council Ctr Excellence Climate Sys, Canberra, ACT 0200, Australia; [Roderick, Michael L.] Australian Natl Univ, Res Sch Biol, Australian Res Council Ctr Excellence Climate Sys, Canberra, ACT 0200, Australia	Princeton University; Australian National University; Australian National University	Sheffield, J (corresponding author), Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA.	justin@princeton.edu	Roderick, Michael/C-9621-2009	Roderick, Michael/0000-0002-3630-7739; Wood, Eric/0000-0001-7037-9675; Sheffield, Justin/0000-0003-2400-0630	US National Oceanic and Atmospheric Agency [NA10OAR4310130, NA11OAR4310097]; NASA [NNX08AN40A]; Australian Research Council [DP0879763, DP110105376, CE11E0098]	US National Oceanic and Atmospheric Agency; NASA(National Aeronautics & Space Administration (NASA)); Australian Research Council(Australian Research Council)	J.S. acknowledges support from the US National Oceanic and Atmospheric Agency (NA10OAR4310130, NA11OAR4310097) and NASA (NNX08AN40A). M.L.R. acknowledges the support of the Australian Research Council (DP0879763, DP110105376, CE11E0098).	ALLEY WM, 1984, J CLIM APPL METEOROL, V23, P1100, DOI 10.1175/1520-0450(1984)023<1100:TPDSIL>2.0.CO;2; [Anonymous], 1993, HDB HYDROLOGY; Briffa KR, 2009, INT J CLIMATOL, V29, P1894, DOI 10.1002/joc.1836; Cai W, 2009, GEOPHYS RES LETT, V36, DOI [10.1029/2009GL037604, 10.1029/2009GL039902]; Chen MY, 2002, J HYDROMETEOROL, V3, P249, DOI 10.1175/1525-7541(2002)003<0249:GLPAYM>2.0.CO;2; Cleugh HA, 2007, REMOTE SENS ENVIRON, V106, P285, DOI 10.1016/j.rse.2006.07.007; Cook ER, 1999, J CLIMATE, V12, P1145, DOI 10.1175/1520-0442(1999)012<1145:DRFTCU>2.0.CO;2; D'Arrigo R, 2008, GLOBAL PLANET CHANGE, V60, P289, DOI 10.1016/j.gloplacha.2007.03.004; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; DAI AG, 2011, WILEY INTERDISCIP RE, V2, P45, DOI [DOI 10.1002/WCC.81, 10.1002/wcc.81]; Dai AG, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015541; De Grandpre L, 2011, CAN J FOREST RES, V41, P1242, DOI [10.1139/x11-051, 10.1139/X11-051]; Donohue RJ, 2010, J HYDROL, V386, P186, DOI 10.1016/j.jhydrol.2010.03.020; Fang KY, 2009, CLIM RES, V38, P129, DOI 10.3354/cr00781; Gupta SK, 2006, GEWEX NEWS, V16, P12; Hirschi M, 2011, NAT GEOSCI, V4, P17, DOI 10.1038/NGEO1032; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Jensen M.E., 1973, CONSUMPTIVE USE WATE, P215; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Lockart N, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040598; McCabe GJ, 2006, INT J CLIMATOL, V26, P849, DOI 10.1002/joc.1289; Milly PCD, 2011, EARTH INTERACT, V15, DOI 10.1175/2010EI363.1; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Monteith J. L., 1964, S SOC EXP BIOL, V19, P205; Mu QZ, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000179; Palmer W.C., 1965, 45 US DEP COMM WEATH, P45; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; Roderick ML, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031166; Roderick ML, 2009, GEOGR COMPASS, V3, P761, DOI 10.1111/j.1749-8198.2008.00214.x; Roderick ML, 2004, INT J CLIMATOL, V24, P1077, DOI 10.1002/joc.1061; Schneider U., 2008, WEATHER CLIMATE DTSC; Seneviratne SI, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P109; Shaw SB, 2011, HYDROL PROCESS, V25, P1466, DOI 10.1002/hyp.7913; Sheffield J, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008288; Sheffield J, 2008, CLIM DYNAM, V31, P79, DOI 10.1007/s00382-007-0340-z; Sheffield J, 2006, J CLIMATE, V19, P3088, DOI 10.1175/JCLI3790.1; Sheffield J, 2010, J HYDROMETEOROL, V11, P253, DOI 10.1175/2009JHM1176.1; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sternberg T, 2011, NATURE, V472, P169, DOI 10.1038/472169d; Svoboda M, 2002, B AM METEOROL SOC, V83, P1181, DOI 10.1175/1520-0477(2002)083&lt;1181:TDM&gt;2.3.CO;2; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; van der Schrier G, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006745; van der Schrier G, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015001; Wang JS, 2010, CLIM RES, V41, P51, DOI 10.3354/cr00837; Wells N, 2004, J CLIMATE, V17, P2335, DOI 10.1175/1520-0442(2004)017&lt;2335:ASPDSI&gt;2.0.CO;2; Willmott C. J., 2010, GLOBAL AIR TEMPERATU; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]	47	1215	1268	67	779	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					435	+		10.1038/nature11575	http://dx.doi.org/10.1038/nature11575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23151587				2022-12-28	WOS:000311031600044
J	Straub, AC; Lohman, AW; Billaud, M; Johnstone, SR; Dwyer, ST; Lee, MY; Bortz, PS; Best, AK; Columbus, L; Gaston, B; Isakson, BE				Straub, Adam C.; Lohman, Alexander W.; Billaud, Marie; Johnstone, Scott R.; Dwyer, Scott T.; Lee, Monica Y.; Bortz, Pamela Schoppee; Best, Angela K.; Columbus, Linda; Gaston, Benjamin; Isakson, Brant E.			Endothelial cell expression of haemoglobin alpha regulates nitric oxide signalling	NATURE			English	Article							RELAXING FACTOR; SMOOTH-MUSCLE; NO; PROPYLTHIOURACIL; NITROSYLATION; HEMOPROTEINS; MYOGLOBIN; OXIDATION; REDUCTASE; PROTEINS	Models of unregulated nitric oxide (NO) diffusion do not consistently account for the biochemistry of NO synthase (NOS)-dependent signalling in many cell systems(1-3). For example, endothelial NOS controls blood pressure, blood flow and oxygen delivery through its effect on vascular smooth muscle tone(4), but the regulation of these processes is not adequately explained by simple NO diffusion from endothelium to smooth muscle(3,5). Here we report a new model for the regulation of NO signalling by demonstrating that haemoglobin (Hb) alpha (encoded by the HBA1 and HBA2 genes in humans) is expressed in human and mouse arterial endothelial cells and enriched at the myoendothelial junction, where it regulates the effects of NO on vascular reactivity. Notably, this function is unique to Hb alpha and is abrogated by its genetic depletion. Mechanistically, endothelial Hb alpha haem iron in the Fe3+ state permits NO signalling, and this signalling is shut off when Hb alpha is reduced to the Fe2+ state by endothelial cytochrome b5 reductase 3 (CYB5R3, also known as diaphorase 1)(6). Genetic and pharmacological inhibition of CYB5R3 increases NO bioactivity in small arteries. These data reveal a new mechanism by which the regulation of the intracellular Hb alpha oxidation state controls NOS signalling in non-erythroid cells. This model may be relevant to haem-containing globins in a broad range of NOS-containing somatic cells(7-13).	[Straub, Adam C.; Lohman, Alexander W.; Billaud, Marie; Johnstone, Scott R.; Lee, Monica Y.; Bortz, Pamela Schoppee; Best, Angela K.; Isakson, Brant E.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Lohman, Alexander W.; Billaud, Marie; Isakson, Brant E.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Dwyer, Scott T.; Gaston, Benjamin] Univ Virginia, Dept Pediat, Charlottesville, VA 22908 USA; [Columbus, Linda] Univ Virginia, Dept Chem, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Isakson, BE (corresponding author), Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA.	brant@virginia.edu	Billaud, Marie/N-7609-2017; Johnstone, Scott R/E-5032-2013; Columbus, Linda/F-5877-2010	Billaud, Marie/0000-0002-7591-0362; Johnstone, Scott R/0000-0003-1920-5033; Columbus, Linda/0000-0002-2574-0561; Straub, Adam/0000-0003-0542-9466	American Heart Association; National Institutes of Health [HL088554, HL107963, HL059337, HL101871, HL112904, HL007284]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059337, T32HL007284, R00HL112904, K99HL112904, P01HL101871, R56HL059337, R21HL107963, R01HL088554] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the Advanced Microscopy and Histology core at the University of Virginia and the Yale Proteomic Facility. We acknowledge V. Balasubramaniam, S. Lewis and D. Singel for discussions of the data and B. Duling for critical evaluation of experiments and the manuscript. We also thank M. Weiss for the Hb alpha-stabilizing protein antibody and for discussions. This work was supported by an American Heart Association Scientist Development Grant (B. E. I.), National Institutes of Health grants HL088554 (B. E. I.), HL107963 (B. E. I.) HL059337 (B. G.), HL101871 (B. G.), HL112904 (A. C. S.) and HL007284 (A. W. L. and A. C. S.). M. B. and S.R.J. were supported by American Heart Association postdoctoral fellowships, and A. W. L. and M.Y.L. were supported by American Heart Association predoctoral fellowships.	Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; Angelo M, 2008, METHOD ENZYMOL, V436, P131, DOI 10.1016/S0076-6879(08)36008-X; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; CASSOLY R, 1975, J MOL BIOL, V91, P301, DOI 10.1016/0022-2836(75)90382-4; Davalos A, 2010, MOL CELL PROTEOMICS, V9, P2109, DOI 10.1074/mcp.M110.001289; Dora KA, 1997, P NATL ACAD SCI USA, V94, P6529, DOI 10.1073/pnas.94.12.6529; DOYLE MP, 1981, J INORG BIOCHEM, V14, P351, DOI 10.1016/S0162-0134(00)80291-3; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; FREGLY MJ, 1959, CIRC RES, V7, P486, DOI 10.1161/01.RES.7.3.486; Gladwin MT, 2003, NAT MED, V9, P496, DOI 10.1038/nm0503-496; Halligan KE, 2009, J BIOL CHEM, V284, P8539, DOI 10.1074/jbc.M808231200; Heberlein KR, 2010, CIRC RES, V106, P1092, DOI 10.1161/CIRCRESAHA.109.215723; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HULTQUIST DE, 1971, NATURE-NEW BIOL, V229, P252, DOI 10.1038/newbio229252a0; IGNARRO LJ, 1986, J BIOL CHEM, V261, P4997; IGNARRO LJ, 1987, CIRC RES, V61, P866, DOI 10.1161/01.RES.61.6.866; Lam YH, 2002, PRENATAL DIAG, V22, P56; LEE E, 1986, FEBS LETT, V209, P49, DOI 10.1016/0014-5793(86)81082-1; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Liu LM, 1999, P NATL ACAD SCI USA, V96, P6643, DOI 10.1073/pnas.96.12.6643; Newton DA, 2006, J BIOL CHEM, V281, P5668, DOI 10.1074/jbc.M509314200; Nishi H, 2008, J AM SOC NEPHROL, V19, P1500, DOI 10.1681/ASN.2007101085; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Schelshorn DW, 2009, J CEREBR BLOOD F MET, V29, P585, DOI 10.1038/jcbfm.2008.152; SHARMA VS, 1987, BIOCHEMISTRY-US, V26, P3837, DOI 10.1021/bi00387a015; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Straub AC, 2011, ARTERIOSCL THROM VAS, V31, P399, DOI 10.1161/ATVBAHA.110.215939; Tejero J, 2012, J BIOL CHEM, V287, P18262, DOI 10.1074/jbc.M111.298927	30	206	212	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					473	477		10.1038/nature11626	http://dx.doi.org/10.1038/nature11626			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23123858	Green Accepted			2022-12-28	WOS:000311031600052
J	Levin, GP; Robinson-Cohen, C; de Boer, IH; Houston, DK; Lohman, K; Liu, YM; Kritchevsky, SB; Cauley, JA; Tanaka, T; Ferrucci, L; Bandinelli, S; Patel, KV; Hagstrom, E; Michaelsson, K; Melhus, H; Wang, T; Wolf, M; Psaty, BM; Siscovick, D; Kestenbaum, B				Levin, Gregory P.; Robinson-Cohen, Cassianne; de Boer, Ian H.; Houston, Denise K.; Lohman, Kurt; Liu, Yongmei; Kritchevsky, Stephen B.; Cauley, Jane A.; Tanaka, Toshiko; Ferrucci, Luigi; Bandinelli, Stefania; Patel, Kushang V.; Hagstrom, Emil; Michaelsson, Karl; Melhus, Hakan; Wang, Thomas; Wolf, Myles; Psaty, Bruce M.; Siscovick, David; Kestenbaum, Bryan			Genetic Variants and Associations of 25-Hydroxyvitamin D Concentrations With Major Clinical Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							D-RECEPTOR GENE; VITAMIN-D; SERUM 25-HYDROXYVITAMIN-D; 1,25-DIHYDROXYVITAMIN D-3; SEASONAL-VARIATION; FRACTURE RISK; HIP FRACTURE; OLDER-ADULTS; POLYMORPHISMS; CANCER	Context Lower serum 25-hydroxyvitamin D concentrations are associated with greater risks of many chronic diseases across large, prospective community-based studies. Substrate 25-hydroxyvitamin D must be converted to 1,25-dihydroxyvitamin D for full biological activity, and complex metabolic pathways suggest that interindividual variability in vitamin D metabolism may alter the clinical consequences of measured serum 25-hydroxyvitamin D. Objective To investigate whether common variation within genes encoding the vitamin D-binding protein, megalin, cubilin, CYP27B1, CYP24A1, and the vitamin D receptor (VDR) modify associations of low 25-hydroxyvitamin D with major clinical outcomes. Design, Setting, and Participants Examination of 141 single-nucleotide polymorphisms in a discovery cohort of 1514 white participants (who were recruited from 4 US regions) from the community-based Cardiovascular Health Study. Participants had serum 25-hydroxyvitamin D measurements in 1992-1993 and were followed up for a median of 11 years (through 2006). Replication meta-analyses were conducted across the independent, community-based US Health, Aging, and Body Composition (n=922; follow-up: 1998-1999 through 2005), Italian Invecchiare in Chianti (n=835; follow-up: 1998-2000 through 2006), and Swedish Uppsala Longitudinal Study of Adult Men (n=970; follow-up: 1991-1995 through 2008) cohort studies. Main Outcome Measure Composite outcome of incident hip facture, myocardial infarction, cancer, and mortality over long-term follow-up. Results Interactions between 5 single-nucleotide polymorphisms and low 25-hydroxyvitamin D concentration were identified in the discovery phase and 1 involving a variant in the VDR gene replicated in independent meta-analysis. Among Cardiovascular Health Study participants, low 25-hydroxyvitamin D concentration was associated with hazard ratios for risk of the composite outcome of 1.40 (95% CI, 1.12-1.74) for those who had 1 minor allele at rs7968585 and 1.82 (95% CI, 1.31-2.54) for those with 2 minor alleles at rs7968585. In contrast, there was no evidence of an association (estimated hazard ratio, 0.93 [95% CI, 0.70-1.24]) among participants who had 0 minor alleles at this single-nucleotide polymorphism. Conclusion Known associations of low 25-hydroxyvitamin D with major health outcomes may vary according to common genetic differences in the vitamin D receptor. JAMA. 2012;308(18):1898-1905 www.jama.com	[Levin, Gregory P.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Robinson-Cohen, Cassianne; de Boer, Ian H.; Psaty, Bruce M.; Siscovick, David; Kestenbaum, Bryan] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [de Boer, Ian H.; Psaty, Bruce M.; Siscovick, David; Kestenbaum, Bryan] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Patel, Kushang V.] Univ Washington, Dept Anasthesiol & Pain Med, Seattle, WA 98195 USA; [de Boer, Ian H.; Kestenbaum, Bryan] Univ Washington, Div Nephrol, Seattle, WA 98195 USA; [de Boer, Ian H.; Kestenbaum, Bryan] Univ Washington, Kidney Res Inst, Seattle, WA 98195 USA; [Patel, Kushang V.] Univ Washington, Ctr Pain Res Impact Measurement & Effectiveness, Seattle, WA 98195 USA; [Psaty, Bruce M.; Siscovick, David] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Grp Hlth Res Inst & Cooperat, Seattle, WA 98195 USA; [Houston, Denise K.; Kritchevsky, Stephen B.] Wake Forest Univ, Dept Internal Med, Winston Salem, NC 27109 USA; [Lohman, Kurt] Wake Forest Univ, Dept Biostat Sci, Winston Salem, NC 27109 USA; [Liu, Yongmei] Wake Forest Univ, Dept Epidemiol & Prevent, Winston Salem, NC 27109 USA; [Lohman, Kurt; Liu, Yongmei] Wake Forest Univ, Div Publ Hlth Sci, Winston Salem, NC 27109 USA; [Houston, Denise K.; Lohman, Kurt; Kritchevsky, Stephen B.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Cauley, Jane A.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Tanaka, Toshiko; Ferrucci, Luigi] NIA, Clin Res Branch, Baltimore, MD 21224 USA; [Bandinelli, Stefania] Azienda Sanit Firenze, Geriatr Unit, Florence, Italy; [Hagstrom, Emil; Melhus, Hakan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Michaelsson, Karl] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Wang, Thomas] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol,Dept Med, Boston, MA USA; [Wolf, Myles] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest Baptist Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Azienda Sanitaria di Firenze; Uppsala University; Uppsala University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Miami	Levin, GP (corresponding author), Univ Washington, Dept Biostat, Box 357232, Seattle, WA 98195 USA.	glevin11@uw.edu	Michaelsson, Karl/AAM-9094-2021; de Boer, Ian/GYJ-3282-2022; Robinson-Cohen, Cassianne/ABB-4985-2021; bandinelli, stefania/AAL-4570-2020; Hagstrom, Emil/AAE-8361-2021	Robinson-Cohen, Cassianne/0000-0003-4783-7046; Michaelsson, Karl/0000-0003-2815-1217; Kritchevsky, Stephen/0000-0003-3336-6781; Wang, Thomas/0000-0003-4063-6508; Cauley, Jane A/0000-0003-0752-4408; Houston, Denise/0000-0002-3355-4304	Abbott Laboratories; National Institute on Aging, National Institutes of Health; American Society for Nutrition; Department of Veteran Affairs; Abbott Nutrition Health Institute; National Institutes of Health; Shire; Amgen; Abbott; Genzyme; Medtronic; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC075150, N01HC085079, N01HC035129, N01HC045133, N01HC085086, N01HC015103, N01HC055222] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000069] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087652, R01HL096875, R01HL105756, R01HL084443, U01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029364, N01AG012111, N01AG062106, P30AG021332, R01AG032098, K01AG030506, R01AG027002, N01AG062103, N01AG062101] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD009164] Funding Source: NIH RePORTER	Abbott Laboratories(Abbott Laboratories); National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Society for Nutrition; Department of Veteran Affairs(US Department of Veterans Affairs); Abbott Nutrition Health Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shire; Amgen(Amgen); Abbott(Abbott Laboratories); Genzyme(Sanofi-AventisGenzyme Corporation); Medtronic(Medtronic); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr de Boer reported receiving research grant funding from Abbott Laboratories. Dr Houston reported pending institutional grant support from the National Institute on Aging, National Institutes of Health; and receiving payment for lectures from the American Society for Nutrition, the Department of Veteran Affairs, and Abbott Nutrition Health Institute. Dr Wang reported serving as a consultant to Diasorin; receiving an investigatorinitiated grant from Diasorin; and receiving payment for lectures from Diasorin. Dr Wolf reported serving as a consultant to Abbott, Genzyme, Luitpold, Mitsubishi, Cytochroma, Astellas, and Kai; receiving institutional grants from the National Institutes of Health, Shire, and Amgen; receiving payment for lectures from Abbott, Genzyme, and Shire; and having a pending patent. Dr Psaty reported serving on a data and safety monitoring board for a clinical trial of a device funded by Zoll ZifeCor; and serving on a steering committee for the Yale Open Data Access Project funded by Medtronic. Dr Kestenbaum reported receiving institutional grant support from Amgen. No other authors reported disclosures.	Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolland MJ, 2007, AM J CLIN NUTR, V86, P959, DOI 10.1093/ajcn/86.4.959; Cauley JA, 2008, ANN INTERN MED, V149, P242, DOI 10.7326/0003-4819-149-4-200808190-00005; CHESKIS B, 1994, MOL CELL BIOL, V14, P3329, DOI 10.1128/MCB.14.5.3329; de Boer IH, 2012, ANN INTERN MED, V156, P627, DOI 10.7326/0003-4819-156-9-201205010-00004; de Boer IH, 2009, J AM SOC NEPHROL, V20, P1805, DOI 10.1681/ASN.2008111157; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Gong G, 1999, OSTEOPOROSIS INT, V9, P55, DOI 10.1007/s001980050116; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 2008, AM J CLIN NUTR, V88, p507S, DOI 10.1093/ajcn/88.2.507S; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Ji GR, 2010, BONE, V47, P681, DOI 10.1016/j.bone.2010.06.024; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Karami S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007013; Kestenbaum B, 2011, J AM COLL CARDIOL, V58, P1433, DOI 10.1016/j.jacc.2011.03.069; Liu CK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S10; Looker AC, 2008, J BONE MINER RES, V23, P143, DOI 10.1359/JBMR.071003; Lurie G, 2007, CANCER EPIDEM BIOMAR, V16, P2566, DOI 10.1158/1055-9965.EPI-07-0753; Manson JE, 2012, CONTEMP CLIN TRIALS, V33, P159, DOI 10.1016/j.cct.2011.09.009; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Melhus H, 2010, J CLIN ENDOCR METAB, V95, P2637, DOI 10.1210/jc.2009-2699; Morrison NA, 2005, PHARMACOGENET GENOM, V15, P127, DOI 10.1097/01213011-200502000-00008; Onen IH, 2008, EXP BIOL MED, V233, P1608, DOI 10.3181/0803-RM-110; Penna-Martinez M, 2009, THYROID, V19, P623, DOI 10.1089/thy.2008.0388; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Raimondi S, 2009, CARCINOGENESIS, V30, P1170, DOI 10.1093/carcin/bgp103; Robinson-Cohen C, 2011, J CLIN ENDOCR METAB, V96, P2186, DOI 10.1210/jc.2010-2878; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; SHERMAN SS, 1990, J CLIN ENDOCR METAB, V71, P405, DOI 10.1210/jcem-71-2-405; Shoben AB, 2011, AM J EPIDEMIOL, V174, P1363, DOI 10.1093/aje/kwr258; Simonsick EM, 2001, J GERONTOL A-BIOL, V56, pM644, DOI 10.1093/gerona/56.10.M644; Smith NL, 2009, THROMB RES, V123, pS25, DOI 10.1016/S0049-3848(09)70139-2; Thakkinstian A, 2004, J BONE MINER RES, V19, P419, DOI 10.1359/JBMR.0301265; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wang YT, 2009, AM J EPIDEMIOL, V170, P88, DOI 10.1093/aje/kwp086; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Xiang W, 2005, AM J PHYSIOL-ENDOC M, V288, pE125, DOI 10.1152/ajpendo.00224.2004; Xiao R, 2009, GENET EPIDEMIOL, V33, P453, DOI 10.1002/gepi.20398	46	132	139	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1898	1905		10.1001/jama.2012.17304	http://dx.doi.org/10.1001/jama.2012.17304			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23150009	Green Accepted, Bronze			2022-12-28	WOS:000310952700026
J	Byers, J; Dunn, S				Byers, John; Dunn, Stacey			Bateman in Nature: Predation on Offspring Reduces the Potential for Sexual Selection	SCIENCE			English	Article							MATE CHOICE; MATING SUCCESS; VARIANCE	Sexual selection is driven by competition for mates, and the advantage of a competitor is determined by the number of offspring it produces. Early experiments by Angus Bateman characterized this interaction, and the quantitative relationship between a male's number of mates and number of offspring is known as the Bateman slope. Sexual dimorphism, one of the most obvious results of sexual selection, largely requires a positive Bateman relationship, and the slope provides an estimate of the potential for sexual selection. However, natural selection from the environment can also influence male success, as can random effects, and some have argued for inclusion of the latter in calculations of mate success. Data from pronghorn (Antilocapra americana) reveal the presence of a positive Bateman slope in each year of a 10-year study. We found no evidence that random effects skewed male mating success; however, substantial yearly variation in the Bateman slope due to predation on fawns was evident. These results support the validity of the Bateman relationship, yet they also demonstrate that environmental or extrinsic influences can limit the potential for sexual selection.	[Byers, John; Dunn, Stacey] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA	Idaho; University of Idaho	Byers, J (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA.	jbyers@uidaho.edu			U.S. Fish and Wildlife Service; NSF [9808377, 0097115, 0738012]	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); NSF(National Science Foundation (NSF))	We thank the dozens of field volunteers who helped build our data set, L. Waits for laboratory guidance, S. Nuismer for statistical consultation, and the U.S. Fish and Wildlife Service for access permits and support. Supported by NSF grants 9808377, 0097115, and 0738012 to J.B. Data location: Dryad Digital Repository (http://datadryad.org/handle/10255/dryad.34974).	ARNOLD SJ, 1994, AM NAT, V144, pS126, DOI 10.1086/285656; Barnowe-Meyer KK, 2010, J MAMMAL, V91, P712, DOI 10.1644/09-MAMM-A-057.1; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Byers J.A., 1997, AM PRONGHORN SOCIAL; Byers J. A., 2006, P 22 BIENN PRONGH WO, V22, P27; Byers JA, 1997, J MAMMAL, V78, P894, DOI 10.2307/1382948; BYERS JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P147, DOI 10.1007/BF00293804; Chaine AS, 2008, SCIENCE, V319, P459, DOI 10.1126/science.1149167; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; HUBBELL SP, 1987, AM NAT, V130, P91, DOI 10.1086/284700; Jones AG, 2009, P NATL ACAD SCI USA, V106, P10001, DOI 10.1073/pnas.0901129106; Jones AG, 2009, EVOLUTION, V63, P1673, DOI 10.1111/j.1558-5646.2009.00664.x; SUTHERLAND WJ, 1985, ANIM BEHAV, V33, P1349, DOI 10.1016/S0003-3472(85)80197-4; Wade MJ, 2010, HEREDITY, V105, P507, DOI 10.1038/hdy.2010.8	14	23	23	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					802	804		10.1126/science.1224660	http://dx.doi.org/10.1126/science.1224660			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139332				2022-12-28	WOS:000310839500045
J	Clement, JP; Aceti, M; Creson, TK; Ozkan, ED; Shi, YL; Reish, NJ; Almonte, AG; Miller, BH; Wiltgen, BJ; Miller, CA; Xu, XM; Rumbaugh, G				Clement, James P.; Aceti, Massimiliano; Creson, Thomas K.; Ozkan, Emin D.; Shi, Yulin; Reish, Nicholas J.; Almonte, Antoine G.; Miller, Brooke H.; Wiltgen, Brian J.; Miller, Courtney A.; Xu, Xiangmin; Rumbaugh, Gavin			Pathogenic SYNGAP1 Mutations Impair Cognitive Development by Disrupting Maturation of Dendritic Spine Synapses	CELL			English	Article							GTPASE-ACTIVATING PROTEIN; NMDA RECEPTOR; SYNAPTIC PLASTICITY; MENTAL-RETARDATION; SILENT SYNAPSES; IN-VIVO; CRITICAL PERIOD; VISUAL-CORTEX; ANIMAL-MODEL; AUTISM	Mutations that cause intellectual disability (ID) and autism spectrum disorder (ASD) are commonly found in genes that encode for synaptic proteins. However, it remains unclear how mutations that disrupt synapse function impact intellectual ability. In the SYNGAP1 mouse model of ID/ASD, we found that dendritic spine synapses develop prematurely during the early postnatal period. Premature spine maturation dramatically enhanced excitability in the developing hippocampus, which corresponded with the emergence of behavioral abnormalities. Inducing SYNGAP1 mutations after critical developmental windows closed had minimal impact on spine synapse function, whereas repairing these pathogenic mutations in adulthood did not improve behavior and cognition. These data demonstrate that SynGAP protein acts as a critical developmental repressor of neural excitability that promotes the development of life-long cognitive abilities. We propose that the pace of dendritic spine synapse maturation in early life is a critical determinant of normal intellectual development.	[Clement, James P.; Aceti, Massimiliano; Creson, Thomas K.; Ozkan, Emin D.; Miller, Brooke H.; Miller, Courtney A.; Rumbaugh, Gavin] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Miller, Courtney A.] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA; [Shi, Yulin; Xu, Xiangmin] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Reish, Nicholas J.; Almonte, Antoine G.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Wiltgen, Brian J.] Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California Irvine; University of Alabama System; University of Alabama Birmingham; University of Virginia	Rumbaugh, G (corresponding author), Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA.	grumbaug@scripps.edu	Ozkan, Emin Deniz/A-5752-2009; Miller, Courtney A/E-8651-2010; Reish, Nicholas/ACC-7587-2022; Clement, James/Q-5628-2019; Wiltgen, Brian/D-2947-2013	Ozkan, Emin Deniz/0000-0002-1073-6703; Miller, Courtney A/0000-0001-8628-4902; Clement, James/0000-0001-7625-6430; Reish, Nicholas/0000-0001-5677-3895; Aceti, Massimiliano/0000-0002-6632-1398; Almonte, Antoine/0000-0002-8778-2724	National Institute for Neurological Disorders and Stroke [R01NS064079]; Eunice Kennedy Shriver National Institute for Child Health and Human Development [R03HD060672]; National Alliance for Research on Schizophrenia and Depression (NARSAD); National Institute for Drug Abuse [DA023700-04S1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD060672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA023700, R00DA023700] Funding Source: NIH RePORTER	National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Eunice Kennedy Shriver National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); National Institute for Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Drs. Ronald Davis, Damon Page, and Fadi Hamdan, as well as members of the Rumbaugh Laboratory, for their helpful comments on this manuscript. We also thank Zachary Collier, Samuel Bacharach, Bryce Grier, and Gopi Patel for assistance in context discrimination studies. This work was supported by grants to G. R. from the National Institute for Neurological Disorders and Stroke (R01NS064079), The Eunice Kennedy Shriver National Institute for Child Health and Human Development (R03HD060672), and the National Alliance for Research on Schizophrenia and Depression (NARSAD). The laser photostimulation and voltage-sensitive dye imaging part of this work was performed in X.X.'s laboratory, supported by a grant from the National Institute for Drug Abuse (DA023700-04S1). J.P.C. and E.D.O. performed electrophysiological recordings; M. A. performed multiphoton imaging studies and spine analysis; T. K. C., N.J.R., A. G. A., and B.J.W. performed behavioral studies; Y.S. and X. X. performed laser photo-stimulation and imaging studies; G. R., C. A. M., T. K. C., J.P.C., M. A., B.J.W., X. X. designed experiments; B. M. and T. K. C. performed protein/mRNA studies; G. R. conceived the study and wrote the manuscript; G. R., C. A. M., J.P.C., and T. K. C. edited the manuscript.	Ashby MC, 2011, NEURON, V70, P510, DOI 10.1016/j.neuron.2011.02.057; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bender RA, 2004, ADV EXP MED BIOL, V548, P213; Carlisle HJ, 2008, J NEUROSCI, V28, P13673, DOI 10.1523/JNEUROSCI.4695-08.2008; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Daenen EWPM, 2002, BEHAV BRAIN RES, V131, P67, DOI 10.1016/S0166-4328(01)00350-3; Danglot L, 2006, HIPPOCAMPUS, V16, P1032, DOI 10.1002/hipo.20225; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Dvorkin A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000027; Gauthier J, 2011, HUM GENET, V130, P563, DOI 10.1007/s00439-011-0975-z; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Guo XC, 2009, NEUROPSYCHOPHARMACOL, V34, P1659, DOI 10.1038/npp.2008.223; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Hamdan FF, 2011, BIOL PSYCHIAT, V69, P898, DOI 10.1016/j.biopsych.2010.11.015; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kesner RP, 2007, PROG BRAIN RES, V163, P567, DOI 10.1016/S0079-6123(07)63030-1; Kim JH, 2003, J NEUROSCI, V23, P1119; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Konur S, 2004, J NEUROBIOL, V59, P236, DOI 10.1002/neu.10306; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Krepischi ACV, 2010, AM J MED GENET A, V152A, P2376, DOI 10.1002/ajmg.a.33554; Lau CG, 2012, J NEUROSCI, V32, P8521, DOI 10.1523/JNEUROSCI.1245-12.2012; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; McMahon AC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1900; Muhia M, 2010, EUR J NEUROSCI, V31, P529, DOI 10.1111/j.1460-9568.2010.07079.x; Musumeci SA, 2000, EPILEPSIA, V41, P19, DOI 10.1111/j.1528-1157.2000.tb01499.x; Noguchi J, 2011, J PHYSIOL-LONDON, V589, P2447, DOI 10.1113/jphysiol.2011.207100; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Pilpel N, 2009, J NEUROSCI METH, V182, P55, DOI 10.1016/j.jneumeth.2009.05.020; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Porter K, 2005, EUR J NEUROSCI, V21, P351, DOI 10.1111/j.1460-9568.2005.03874.x; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Saitoh O, 2001, BRAIN, V124, P1317, DOI 10.1093/brain/124.7.1317; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Vazquez LE, 2004, J NEUROSCI, V24, P8862, DOI 10.1523/JNEUROSCI.3213-04.2004; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024; Zhang WD, 1999, J NEUROSCI, V19, P96, DOI 10.1523/JNEUROSCI.19-01-00096.1999	56	216	223	1	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					709	723		10.1016/j.cell.2012.08.045	http://dx.doi.org/10.1016/j.cell.2012.08.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141534	Green Accepted, Bronze			2022-12-28	WOS:000310921200005
J	Herzog, RW; Ostrov, DA				Herzog, Roland W.; Ostrov, David A.			A Decorated Virus Cannot Hide	SCIENCE			English	Editorial Material							IN-VIVO; HEXON; MODEL		[Herzog, Roland W.] Univ Florida, Dept Pediat, Gainesville, FL 32610 USA; [Ostrov, David A.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Herzog, RW (corresponding author), Univ Florida, Dept Pediat, Gainesville, FL 32610 USA.	rherzog@ufl.edu; ostroda@pathology.ufl.edu			NIAID NIH HHS [R01 AI051390] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051390] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aldhamen YA, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00040; Barrera V, 2011, BLOOD, V117, P5674, DOI 10.1182/blood-2010-10-312413; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; Delvaeye M, 2009, BLOOD, V114, P2367, DOI 10.1182/blood-2009-05-199208; Di Paolo NC, 2009, IMMUNITY, V31, P110, DOI 10.1016/j.immuni.2009.04.015; Doronin K, 2012, SCIENCE, V338, P795, DOI 10.1126/science.1226625; Kaiser J, 2011, SCIENCE, V334, P29, DOI 10.1126/science.334.6052.29; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Nayak S, 2010, GENE THER, V17, P295, DOI 10.1038/gt.2009.148; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Tai SJ, 2008, J THROMB HAEMOST, V6, P339, DOI 10.1111/j.1538-7836.2007.02849.x; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016	15	4	4	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					748	749		10.1126/science.1230342	http://dx.doi.org/10.1126/science.1230342			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139318				2022-12-28	WOS:000310839500027
J	Getahun, BS; Yeshi, MM; Roberts, DJ				Getahun, Birhanu Sendek; Yeshi, Melisachew M.; Roberts, Drucilla J.			Case 34-2012: A 27-Year-Old Woman in Ethiopia with Severe Pain, Bleeding, and Shock during Labor	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MATERNAL MORTALITY; RUPTURED UTERUS; UTERINE RUPTURE; ABDOMINAL-PAIN; TERM LABOR; 3 DELAYS; MANAGEMENT; PREGNANCY; WOMEN		[Getahun, Birhanu Sendek] Univ Gondar, Dept Obstet & Gynecol, Gondar Coll Med & Hlth Sci, Gondar, Ethiopia; [Yeshi, Melisachew M.] Mekelle Univ, Ayder Referral Hosp, Dept Pathol, Mekelle, Ethiopia; [Roberts, Drucilla J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Roberts, Drucilla J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	University of Gondar; Mekelle University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Getahun, BS (corresponding author), Univ Gondar, Dept Obstet & Gynecol, Gondar Coll Med & Hlth Sci, Gondar, Ethiopia.		Roberts, Drucilla/AAB-6379-2022					Archie JG, 2006, AM J CLIN PATHOL, V126, P256, DOI 10.1309/FK9D5WBA1UEPT5BB; Barkat A, 1997, J Health Popul Dev Ctries, V1, P57; Barnes-Josiah D, 1998, SOC SCI MED, V46, P981, DOI 10.1016/S0277-9536(97)10018-1; Buhimschi CS, 2005, BJOG-INT J OBSTET GY, V112, P38, DOI 10.1111/j.1471-0528.2004.00300.x; Castro R, 2000, J WOMEN HEALTH GEN-B, V9, P679, DOI 10.1089/15246090050118206; Chen FP, 2007, J REPROD MED, V52, P981; Cichowski S, 2006, OBSTET GYNECOL, V108, P1229, DOI 10.1097/01.AOG.0000244100.48449.d8; Ebeigbe PN, 2005, ACTA OBSTET GYN SCAN, V84, P1172, DOI 10.1111/j.0001-6349.2005.00778.x; Ganatra B R, 1995, J Indian Med Assoc, V93, P47; Gessessew Amanuel, 2007, Ethiop Med J, V45, P47; Gilo NB, 2009, CLIN OBSTET GYNECOL, V52, P586, DOI 10.1097/GRF.0b013e3181c11d10; Gray J, 2004, EMERG MED J, V21, P606, DOI 10.1136/emj.2004.017830; Guise JM, 2010, OBSTET GYNECOL, V115, P1267, DOI 10.1097/AOG.0b013e3181df925f; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Henrich W, 2008, J PERINAT MED, V36, P467, DOI 10.1515/JPM.2008.093; Kadowa I, 2010, SINGAP MED J, V51, P35; Kapoor DS, 2003, J PERINAT MED, V31, P337, DOI 10.1515/JPM.2003.048; Kennedy A, 2000, SEMIN ULTRASOUND CT, V21, P64, DOI 10.1016/S0887-2171(00)90014-3; Landon MB, 2010, SEMIN PERINATOL, V34, P267, DOI 10.1053/j.semperi.2010.03.005; Lawrence LL, 2003, EMERG MED CLIN N AM, V21, P649, DOI 10.1016/S0733-8627(03)00040-3; Mittelmark Maurice B, 2009, Glob Health Promot, V16, P3, DOI 10.1177/1757975909348140; Mittelmark MB, 2009, GLOB HLTH PROMOT, V16, P88; Mittelmark MB, 2009, GLOB HLTH PROMOT, V16, P73; Muleta M, 2007, East Afr Med J, V84, P525; Nour Nawal N, 2010, Rev Obstet Gynecol, V3, P180; Ojenuwah SA, 2007, TROP DOCT, V37, P219, DOI 10.1258/004947507782332892; Ozumba BC, 2004, INT J GYNECOL OBSTET, V84, P114, DOI 10.1016/S0020-7292(03)00210-8; Paul John, 2008, World Health Popul, V10, P3; Romero R, 2006, SEMIN FETAL NEONAT M, V11, P317, DOI 10.1016/j.siny.2006.05.001; Shah N, 2009, JCPSP-J COLL PHYSICI, V19, P95, DOI 02.2009/JCPSP.9598; Supratikto G, 2002, B WORLD HEALTH ORGAN, V80, P228; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Tikkanen M, 2006, ACTA OBSTET GYN SCAN, V85, P700, DOI 10.1080/00016340500449915	33	4	5	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2012	367	19					1839	1845		10.1056/NEJMcpc1209508	http://dx.doi.org/10.1056/NEJMcpc1209508			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033DG	23134385				2022-12-28	WOS:000310773200014
J	Knudsen, AB; Hur, C; Gazelle, GS; Schrag, D; McFarland, EG; Kuntz, KM				Knudsen, Amy B.; Hur, Chin; Gazelle, G. Scott; Schrag, Deborah; McFarland, Elizabeth G.; Kuntz, Karen M.			Rescreening of Persons With a Negative Colonoscopy Result: Results From a Microsimulation Model	ANNALS OF INTERNAL MEDICINE			English	Article							FECAL OCCULT-BLOOD; AMERICAN-CANCER-SOCIETY; RANDOMIZED CONTROLLED-TRIAL; ON-COLORECTAL-CANCER; SERVICES TASK-FORCE; CT COLONOGRAPHY; SCREENING COLONOSCOPY; MEDICARE POPULATION; LARGE-INTESTINE; LARGE-BOWEL	Background: Persons with a negative result on screening colonoscopy are recommended to repeat the procedure in 10 years. Objective: To assess the effectiveness and costs of colonoscopy versus other rescreening strategies after an initial negative colonoscopy result. Design: Microsimulation model. Data Sources: Literature and data from the Surveillance, Epidemiology, and End Results program. Target Population: Persons aged 50 years who had no adenomas or cancer detected on screening colonoscopy. Time Horizon: Lifetime. Perspective: Societal. Intervention: No further screening or rescreening starting at age 60 years with colonoscopy every 10 years, annual highly sensitive guaiac fecal occult blood testing (HSFOBT), annual fecal immuno-chemical testing (FIT), or computed tomographic colonography (CTC) every 5 years. Outcome Measures: Lifetime cases of colorectal cancer, life expectancy, and lifetime costs per 1000 persons, assuming either perfect or imperfect adherence. Results of Base-Case Analysis: Rescreening with any method substantially reduced the risk for colorectal cancer compared with no further screening (range, 7.7 to 12.6 lifetime cases per 1000 persons [perfect adherence] and 17.7 to 20.9 lifetime cases per 1000 persons [imperfect adherence] vs. 31.3 lifetime cases per 1000 persons with no further screening). In both adherence scenarios, the differences in life-years across rescreening strategies were small (range, 30 893 to 30 902 life-years per 1000 persons [perfect adherence] vs. 30 865 to 30 869 life-years per 1000 persons [imperfect adherence]). Rescreening with HSFOBT, FIT, or CTC had fewer complications and was less costly than continuing colonoscopy. Results of Sensitivity Analysis: Results were sensitive to test-specific adherence rates. Limitation: Data on adherence to rescreening were limited. Conclusion: Compared with the currently recommended strategy of continuing colonoscopy every 10 years after an initial negative examination, rescreening at age 60 years with annual HSFOBT, annual FIT, or CTC every 5 years provides approximately the same benefit in life-years with fewer complications at a lower cost. Therefore, it is reasonable to use other methods to rescreen persons with negative colonoscopy results.	[Knudsen, Amy B.] Harvard Univ, Massachusetts Gen Hosp, Sch Publ Hlth, Inst Technol Assessment, Boston, MA 02114 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; SSM St Joseph Hosp, St Charles, MO USA; Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA	Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; University of Minnesota System; University of Minnesota Twin Cities	Knudsen, AB (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Publ Hlth, Inst Technol Assessment, 101 Merrimac St,10th Floor, Boston, MA 02114 USA.	aknudsen@mgh-ita.org		Hur, Chin/0000-0002-2819-7576	National Cancer Institute, National Institutes of Health [RC1CA147256, U01CA088204, U01CA152959]; National Cancer Institute; NATIONAL CANCER INSTITUTE [U01CA088204, RC1CA147256, U01CA152959] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By award RC1CA147256 and grants U01CA088204 and U01CA152959 from the National Cancer Institute, National Institutes of Health.; Primary Funding Source: National Cancer Institute.	Arias Elizabeth, 2007, Natl Vital Stat Rep, V56, P1; ARMINSKI T. C., 1964, DIS COLON RECTUM, V7, P249, DOI 10.1007/BF02630528; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Blatt LJ., 1961, DIS COLON RECTUM, V4, P277; BOMBI JA, 1988, CANCER-AM CANCER SOC, V61, P1472, DOI 10.1002/1097-0142(19880401)61:7<1472::AID-CNCR2820610734>3.0.CO;2-E; Brenner H, 2006, GUT, V55, P1145, DOI [10.1136/gut.2005.087130, 10.1136/gut.2005087130]; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Centers for Medicare & Medicaid Services (CMS) HHS, 2006, FED REG, V71, P69623; CHAPMAN I, 1963, ANN SURG, V157, P223, DOI 10.1097/00000658-196302000-00007; CLARK JC, 1985, INT J CANCER, V36, P179, DOI 10.1002/ijc.2910360209; de Gonzalez AB, 2011, AM J ROENTGENOL, V196, P816, DOI 10.2214/AJR.10.4907; Ding A, 2011, RADIOL CLIN N AM, V49, P257, DOI 10.1016/j.rcl.2010.11.004; Gatto NM, 2003, J NATL CANCER I, V95, P230, DOI 10.1093/jnci/95.3.230; Gellad ZF, 2011, AM J GASTROENTEROL, V106, P1125, DOI 10.1038/ajg.2011.11; Ho W, 2010, AM J ROENTGENOL, V195, P393, DOI 10.2214/AJR.09.3500; Hol L, 2009, BRIT J CANCER, V100, P1103, DOI 10.1038/sj.bjc.6604961; Imperiale TF, 2008, NEW ENGL J MED, V359, P1218, DOI 10.1056/NEJMoa0803597; JASS JR, 1992, GUT, V33, P1508, DOI 10.1136/gut.33.11.1508; JOHANNSEN LGK, 1989, SCAND J GASTROENTERO, V24, P799, DOI 10.3109/00365528909089217; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Jonas DE, 2007, AM J GASTROENTEROL, V102, P2401, DOI 10.1111/j.1572-0241.2007.01387.x; Klabunde CN, 2011, CANCER EPIDEM BIOMAR, V20, P1611, DOI 10.1158/1055-9965.EPI-11-0220; Knudsen AB, 2010, JNCI-J NATL CANCER I, V102, P1238, DOI 10.1093/jnci/djq242; Kronborg O, 2004, SCAND J GASTROENTERO, V39, P846, DOI 10.1080/00365520410003182; Kuntz KM, 2011, MED DECIS MAKING, V31, P530, DOI 10.1177/0272989X11408730; Lansdorp-Vogelaar I, 2010, ANN INTERN MED, V153, P368, DOI 10.7326/0003-4819-153-6-201009210-00004; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Moawad FJ, 2010, AM J ROENTGENOL, V195, P1118, DOI 10.2214/AJR.10.4921; National Center for Health Statistics, 2009, 2008 NAT HLTH INT SU; Pickhardt PJ, 2011, RADIOLOGY, V259, P393, DOI 10.1148/radiol.11101887; Pickhardt PJ, 2006, RADIOLOGY, V239, P313, DOI 10.1148/radiol.2392052002; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Population Division U.S. Census Bureau, 2009, NCEST200801 US CENS; Rabeneck L, 2008, GASTROENTEROLOGY, V135, P1899, DOI 10.1053/j.gastro.2008.08.058; RICKERT RR, 1979, CANCER-AM CANCER SOC, V43, P1847, DOI 10.1002/1097-0142(197905)43:5<1847::AID-CNCR2820430538>3.0.CO;2-L; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Scholefield JH, 2002, GUT, V50, P840, DOI 10.1136/gut.50.6.840; Schwartz DC, 2008, AM J GASTROENTEROL, V103, P346, DOI 10.1111/j.1572-0241.2007.01586.x; Shapiro JA, 2012, CANCER EPIDEM BIOMAR, V21, P895, DOI 10.1158/1055-9965.EPI-12-0192; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; Stoop EM, 2012, LANCET ONCOL, V13, P55, DOI 10.1016/S1470-2045(11)70283-2; Surveillance Epidemiology and End Results (SEER) Program, SEER STAT DAT INC SE; Thomson PDR, 2010, RED BOOK PHARM FUNDA; U.S. Bureau of Labor Statistics, 2011, NAT COMP SURV OCC EA; U.S. Census Bureau, 2011, STAT ABSTR US 2012; van Ballegooijen M, 2011, MED DECIS MAKING, V31, P540, DOI 10.1177/0272989X11408915; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; Yabroff KR, 2005, MED CARE, V43, P640, DOI 10.1097/01.mlr.0000167177.45020.4a; Zauber AG, 2007, COST EFFECTIVENESS D; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	64	23	23	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2012	157	9					611	+		10.7326/0003-4819-157-9-201211060-00005	http://dx.doi.org/10.7326/0003-4819-157-9-201211060-00005			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033GX	23128861	Green Accepted			2022-12-28	WOS:000310783300002
J	Hawkes, N				Hawkes, Nigel			Revalidation seems to add little to the current appraisal process	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 2	2012	345								e7375	10.1136/bmj.e7375	http://dx.doi.org/10.1136/bmj.e7375			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033FL	23125127				2022-12-28	WOS:000310779500003
J	Rizo, H; Boyet, M; Blichert-Toft, J; O'Neil, J; Rosing, MT; Paquette, JL				Rizo, Hanika; Boyet, Maud; Blichert-Toft, Janne; O'Neil, Jonathan; Rosing, Minik T.; Paquette, Jean-Louis			The elusive Hadean enriched reservoir revealed by Nd-142 deficits in Isua Archaean rocks	NATURE			English	Article							U-TH-PB; EARLY DIFFERENTIATION; ISOTOPIC EVIDENCE; WEST GREENLAND; LU-HF; MANTLE; ND; CONSTRAINTS; SYSTEMATICS; EARTH	The first indisputable evidence for very early differentiation of the silicate Earth came from the extinct Sm-146-Nd-142 chronometer. Nd-142 excesses measured in 3.7-billion-year (Gyr)-old rocks from Isua(1,2) (southwest Greenland) relative to modern terrestrial samples imply their derivation from a depleted mantle formed in the Hadean eon (about 4,570-4,000 Gyr ago). As dictated by mass balance, the differentiation event responsible for the formation of the Isua early-depleted reservoir must also have formed a complementary enriched component. However, considerable efforts to find early-enriched mantle components in Isua have so far been unsuccessful(3-7). Here we show that the signature of the Hadean enriched reservoir, complementary to the depleted reservoir in Isua, is recorded in 3.4-Gyr-old mafic dykes intruding into the Early Archaean rocks. Five out of seven dykes carry Nd-142 deficits compared to the terrestrial Nd standard, with three samples yielding resolvable deficits down to -10.6 parts per million. The enriched component that we report here could have been a mantle reservoir that differentiated owing to the crystallization of a magma ocean, or could represent a mafic proto-crust that separated from the mantle more than 4.47 Gyr ago. Our results testify to the existence of an enriched component in the Hadean, and may suggest that the southwest Greenland mantle preserved early-formed heterogeneities until at least 3.4 Gyr ago.	[Rizo, Hanika; Boyet, Maud; O'Neil, Jonathan; Paquette, Jean-Louis] Univ Blaise Pascal, Clermont Univ, Lab Magmas & Volcans, CNRS,UMR 6524,IRDR 163, F-63000 Clermont Ferrand, France; [Blichert-Toft, Janne] Ecole Normale Super Lyon, Lab Geol Lyon, F-69007 Lyon, France; [Blichert-Toft, Janne] Univ Lyon 1, CNRS, UMR 5276, F-69007 Lyon, France; [Rosing, Minik T.] Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark; [Rosing, Minik T.] Univ Copenhagen, Nord Ctr Earth Evolut, DK-1350 Copenhagen, Denmark	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); Universite Clermont Auvergne (UCA); Universite Jean Monnet; Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Copenhagen	Rizo, H (corresponding author), Univ Blaise Pascal, Clermont Univ, Lab Magmas & Volcans, CNRS,UMR 6524,IRDR 163, BP 10448, F-63000 Clermont Ferrand, France.	h.rizo@opgc.univ-bpclermont.fr	Blichert-Toft, Janne/C-8280-2012; Rosing, Minik/A-9977-2013	Blichert-Toft, Janne/0000-0002-4932-4079; Rosing, Minik/0000-0001-7559-661X	European Research Council under the European Community's Seventh Framework Programme; French Programme National de Planetologie of the Institut National des Sciences de l'Univers and Centre National d'Etudes Spatiales; French Agence Nationale de la Recherche; French embassy in Denmark	European Research Council under the European Community's Seventh Framework Programme; French Programme National de Planetologie of the Institut National des Sciences de l'Univers and Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales); French Agence Nationale de la Recherche(French National Research Agency (ANR)); French embassy in Denmark	We thank C. Bosq for providing clean-laboratory facilities, D. Auclair for assistance with the TIMS, P. Telouk for assistance with the MC-ICP-MS, and J. L. Devidal for assistance with the Microprobe and the LA-ICP-MS. M. Benbakkar carried out the major element analyses. We thank A. Brandon and M. Jackson for comments that helped clarify the manuscript. We thank the Geological Survey of Japan for providing the isotopic standard JNdi-1. The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Programme (to M. B.), the French Programme National de Planetologie of the Institut National des Sciences de l'Univers and Centre National d'Etudes Spatiales, and the French Agence Nationale de la Recherche (grants BEGDy and M&Ms) (to J. B. T.), and the French embassy in Denmark (to M. R.). This is Laboratory of Excellence ClerVolc contribution no. 30.	Andreasen R, 2008, EARTH PLANET SC LETT, V266, P14, DOI 10.1016/j.epsl.2007.10.009; Andreasen R, 2009, INT J MASS SPECTROM, V285, P49, DOI 10.1016/j.ijms.2009.04.004; BENNETT VC, 1993, EARTH PLANET SC LETT, V119, P299, DOI 10.1016/0012-821X(93)90140-5; Bennett VC, 2007, SCIENCE, V318, P1907, DOI 10.1126/science.1145928; Blichert-Toft J, 2002, EARTH PLANET SC LETT, V204, P167, DOI 10.1016/S0012-821X(02)00976-7; Blichert-Toft J, 2008, EARTH PLANET SC LETT, V265, P686, DOI 10.1016/j.epsl.2007.10.054; BlichertToft J, 1997, CONTRIB MINERAL PETR, V127, P248, DOI 10.1007/s004100050278; BLICHERTTOFT J, 1994, SCIENCE, V263, P1593, DOI 10.1126/science.263.5153.1593; Bouvier A, 2008, EARTH PLANET SC LETT, V273, P48, DOI 10.1016/j.epsl.2008.06.010; Boyet M, 2003, EARTH PLANET SC LETT, V214, P427, DOI 10.1016/S0012-821X(03)00423-0; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Boyet M, 2006, EARTH PLANET SC LETT, V250, P254, DOI 10.1016/j.epsl.2006.07.046; Carlson RW, 2008, PHILOS T R SOC A, V366, P4077, DOI 10.1098/rsta.2008.0166; Caro G, 2006, GEOCHIM COSMOCHIM AC, V70, P164, DOI 10.1016/j.gca.2005.08.015; Caro G, 2003, NATURE, V423, P428, DOI 10.1038/nature01668; Caro G, 2010, GEOCHIM COSMOCHIM AC, V74, P3333, DOI 10.1016/j.gca.2010.02.025; Cipriani A, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003415; Coltice N, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027707; DePaolo D. J., 1988, MINERALS ROCKS SERIE; GILL RCO, 1976, EARTH PLANET SC LETT, V29, P276, DOI 10.1016/0012-821X(76)90131-X; HARPER CL, 1992, NATURE, V360, P728, DOI 10.1038/360728a0; HEAMAN LM, 1993, CHEM GEOL, V110, P95, DOI 10.1016/0009-2541(93)90249-I; Horn I, 2000, CHEM GEOL, V164, P281, DOI 10.1016/S0009-2541(99)00168-0; Horn I, 2007, SPECTROCHIM ACTA B, V62, P410, DOI 10.1016/j.sab.2007.03.034; JACKSON MG, 2012, GEOCHEM GEOPHY GEOSY, V13, P1, DOI DOI 10.1029/2011GC003955; Jackson SE, 2004, CHEM GEOL, V211, P47, DOI 10.1016/j.chemgeo.2004.06.017; Kamber BS, 2003, CONTRIB MINERAL PETR, V145, P25, DOI 10.1007/s00410-002-0429-7; Kemp AIS, 2010, EARTH PLANET SC LETT, V296, P45, DOI 10.1016/j.epsl.2010.04.043; Kinoshita N, 2012, SCIENCE, V335, P1614, DOI 10.1126/science.1215510; Ludwig K. R., 2001, USERS MANUAL ISOPLOT; Muller W, 2009, J ANAL ATOM SPECTROM, V24, P209, DOI 10.1039/b805995k; Murphy DT, 2010, GEOCHIM COSMOCHIM AC, V74, P738, DOI 10.1016/j.gca.2009.10.005; Nielsen SG, 2002, PRECAMBRIAN RES, V118, P133, DOI 10.1016/S0301-9268(02)00108-0; Nutman AP, 2004, J GEOL SOC LONDON, V161, P421, DOI 10.1144/0016-764903-043; O'Neil J, 2008, SCIENCE, V321, P1828, DOI 10.1126/science.1161925; Paquette JL, 2007, CHEM GEOL, V240, P222, DOI 10.1016/j.chemgeo.2007.02.014; Pin C, 1997, ANAL CHIM ACTA, V339, P79, DOI 10.1016/S0003-2670(96)00499-0; Rizo H, 2011, EARTH PLANET SC LETT, V312, P267, DOI 10.1016/j.epsl.2011.10.014; Tanaka T, 2000, CHEM GEOL, V168, P279, DOI 10.1016/S0009-2541(00)00198-4; Tiepolo M., 2003, CHEM GEOL, V141, P1; Touboul M, 2012, SCIENCE, V335, P1065, DOI 10.1126/science.1216351; Upadhyay D, 2009, NATURE, V459, P1118, DOI 10.1038/nature08089; Van Actherbergh E., 2001, LASER ABLATION ICP M, P239, DOI DOI 10.1016/S0277-3791(02)00016-1; WIEDENBECK M, 1995, GEOSTANDARD NEWSLETT, V19, P1, DOI 10.1111/j.1751-908X.1995.tb00147.x	44	84	88	1	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2012	491	7422					96	U109		10.1038/nature11565	http://dx.doi.org/10.1038/nature11565			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23128231				2022-12-28	WOS:000310434500037
J	Whitney, CG				Whitney, Cynthia G.			More evidence for use of pneumococcal conjugate vaccines	LANCET			English	Editorial Material							DOUBLE-BLIND; EFFICACY; CHILDREN; SAFETY		Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Whitney, CG (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	cwhitney@cdc.gov						[Anonymous], 2012, Wkly Epidemiol Rec, V87, P129; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Johns Hopkins Bloomberg School of Public Health International Vaccine Access Center (IVAC), 2012, VIMS REP GLOB VACC I; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; Palmu AA, 2012, LANCET; Prymula R, 2006, LANCET, V367, P740, DOI 10.1016/S0140-6736(06)68304-9; Scott P, 2011, VACCINE, V29, P9711, DOI 10.1016/j.vaccine.2011.07.042; Tregnaghi MW, 2011, ESPID 2011 JUN 7 11; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P435; World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P12	15	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2013	381	9862					182	183		10.1016/S0140-6736(12)61957-6	http://dx.doi.org/10.1016/S0140-6736(12)61957-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	075LL	23158884				2022-12-28	WOS:000313887600007
J	McAleenan, A; Clemente-Blanco, A; Cordon-Preciado, V; Sen, N; Esteras, M; Jarmuz, A; Aragon, L				McAleenan, Alexandra; Clemente-Blanco, Andres; Cordon-Preciado, Violeta; Sen, Nicholas; Esteras, Miguel; Jarmuz, Adam; Aragon, Luis			Post-replicative repair involves separase-dependent removal of the kleisin subunit of cohesin	NATURE			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; DNA-REPAIR; CLEAVAGE; PATHWAY; DAMAGE; EXO1; HELICASE	DNA double-strand break repair is critical for cell viability and involves highly coordinated pathways to restore DNA integrity at the lesion. An early event during homology-dependent repair is resection of the break to generate progressively longer 3' single-strand tails that are used to identify suitable templates for repair(1). Sister chromatids provide near-perfect sequence homology and are therefore the preferred templates during homologous recombination(2,3). To provide a bias for the use of sisters as donors, cohesin-the complex that tethers sister chromatids together(4)-is recruited to the break(5,6) to enforce physical proximity. Here we show that DNA breaks promote dissociation of cohesin loaded during the previous S phase in budding yeast, and that damage-induced dissociation of cohesin requires separase, the protease that dissolves cohesion in anaphase(7). Moreover, a separase-resistant allele of the gene coding for the alpha-kleisin subunit of cohesin, Mcd1 (also known as Scc1), reduces double-strand break resection and compromises the efficiency of repair even when loaded during DNA damage. We conclude that post-replicative DNA repair involves cohesin dissociation by separase to promote accessibility to repair factors during the coordinated cellular response to restore DNA integrity.	[McAleenan, Alexandra; Clemente-Blanco, Andres; Cordon-Preciado, Violeta; Sen, Nicholas; Esteras, Miguel; Jarmuz, Adam; Aragon, Luis] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Cell Cycle Grp, London W12 0NN, England	Imperial College London	Aragon, L (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Cell Cycle Grp, Du Cane Rd, London W12 0NN, England.	luis.aragon@csc.mrc.ac.uk	Blanco, Andrés Clemente/D-4255-2014	Blanco, Andrés Clemente/0000-0002-3674-0671; Esteras Bejar, Miguel/0000-0001-6697-3890	Intramural Research Program of the Medical Research Council UK; MRC [MC_U120074328] Funding Source: UKRI; Medical Research Council [MC_U120074328] Funding Source: researchfish	Intramural Research Program of the Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank D. Koshland, E. Unal, J. Haber, G. Ira and K. Nasmyth for providing valuable strains. We thank members of the Aragon laboratory, P. Ullal, S. Farmer, K. Pegram, J. Torres-Rosell and M. Merkenschlager for discussions and reading of the manuscript. This work was funded by the Intramural Research Program of the Medical Research Council UK.	Baskerville C, 2008, GENETICS, V178, P2361, DOI 10.1534/genetics.107.085308; Heidinger-Pauli JM, 2008, MOL CELL, V31, P47, DOI 10.1016/j.molcel.2008.06.005; Heidinger-Pauli JM, 2010, CURR BIOL, V20, P957, DOI 10.1016/j.cub.2010.04.018; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; Jain S, 2009, GENE DEV, V23, P291, DOI 10.1101/gad.1751209; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; KADYK LC, 1992, GENETICS, V132, P387; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Nagao K, 2004, NATURE, V430, P1044, DOI 10.1038/nature02803; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	19	38	38	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2013	493	7431					250	U270		10.1038/nature11630	http://dx.doi.org/10.1038/nature11630			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23178808				2022-12-28	WOS:000313259600045
J	Geu-Flores, F; Sherden, NH; Courdavault, V; Burlat, V; Glenn, WS; Wu, C; Nims, E; Cui, YH; O'Connor, SE				Geu-Flores, Fernando; Sherden, Nathaniel H.; Courdavault, Vincent; Burlat, Vincent; Glenn, Weslee S.; Wu, Cen; Nims, Ezekiel; Cui, Yuehua; O'Connor, Sarah E.			An alternative route to cyclic terpenes by reductive cyclization in iridoid biosynthesis	NATURE			English	Article							IRIDANE SKELETON FORMATION; PROGESTERONE 5-BETA-REDUCTASE; CATHARANTHUS-ROSEUS; ALKALOID BIOSYNTHESIS; METABOLISM; MECHANISM; GENES; SECOIRIDOIDS; VINDOLINE; P5-BETA-R	The iridoids comprise a large family of distinctive bicyclic monoterpenes that possess a wide range of pharmacological activities, including anticancer, anti-inflammatory, antifungal and antibacterial activities(1-4). Additionally, certain iridoids are used as sex pheromones in agriculturally important species of aphids, a fact that has underpinned innovative and integrated pest management strategies(5). To harness the biotechnological potential of this natural product class, the enzymes involved in the biosynthetic pathway must be elucidated. Here we report the discovery of iridoid synthase, a plant-derived enzyme that generates the iridoid ring scaffold, as evidenced by biochemical assays, gene silencing, co-expression analysis and localization studies. In contrast to all known monoterpene cyclases, which use geranyl diphosphate as substrate and invoke a cationic intermediate, iridoid synthase uses the linear monoterpene 10-oxogeranial as substrate and probably couples an initial NAD(P) H-dependent reduction step with a subsequent cyclization step via a Diels-Alder cycloaddition or a Michael addition. Our results illustrate how a short-chain reductase was recruited as cyclase for the production of iridoids in medicinal plants. Furthermore, we highlight the prospects of using unrelated reductases to generate artificial cyclic scaffolds. Beyond the recognition of an alternative biochemical mechanism for the biosynthesis of cyclic terpenes, we anticipate that our work will enable the large-scale heterologous production of iridoids in plants and microorganisms for agricultural(5-8) and pharmaceutical(1-4,9) applications.	[Geu-Flores, Fernando; Sherden, Nathaniel H.; Glenn, Weslee S.; O'Connor, Sarah E.] John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Courdavault, Vincent] Univ Tours, Biomol & Biotechnol Vegetales EA2106, F-37200 Tours, France; [Burlat, Vincent] Univ Toulouse, UPS, UMR 5546, Lab Rech Sci Vegetales, F-31326 Castanet Tolosan, France; [Burlat, Vincent] CNRS, UMR 5546, F-31326 Castanet Tolosan, France; [Glenn, Weslee S.; Nims, Ezekiel] MIT, Dept Chem, Cambridge, MA 02139 USA; [Wu, Cen; Cui, Yuehua] Michigan State Univ, Dept Stat & Probabil, E Lansing, MI 48824 USA; [O'Connor, Sarah E.] Univ E Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Universite de Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Massachusetts Institute of Technology (MIT); Michigan State University; University of East Anglia	O'Connor, SE (corresponding author), John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England.	sarah.o'connor@jic.ac.uk	Cui, Yuehua/A-3529-2008; burlat, vincent/ABB-1802-2021; Cui, Yuehua/E-8004-2010; O'Connor, Sarah Ellen/X-2893-2019; Courdavault, Vincent/AAK-1117-2020; Geu-Flores, Fernando/B-2737-2015; burlat, vincent/J-6831-2015; O'Connor, Sarah/O-5850-2016	Cui, Yuehua/0000-0001-8099-1753; burlat, vincent/0000-0002-0897-6011; Cui, Yuehua/0000-0001-8099-1753; Geu-Flores, Fernando/0000-0002-5735-9810; burlat, vincent/0000-0002-0897-6011; O'Connor, Sarah/0000-0003-0356-6213; Courdavault, Vincent/0000-0001-8902-4532	Danish Council for Independent Research (Natural Sciences) [10-082858]; NIH [GM074820]; John Innes Foundation; National Science Foundation; NSF [DMS-1209112]; John Innes Centre; University of East Anglia;  [j004561SRC (BB/J004561/1)];  [BB/J009091/1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074820] Funding Source: NIH RePORTER; BBSRC [BB/J009091/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J009091/1] Funding Source: researchfish	Danish Council for Independent Research (Natural Sciences)(Det Frie Forskningsrad (DFF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Innes Foundation; National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); John Innes Centre; University of East Anglia; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The present study was funded by the Danish Council for Independent Research (Natural Sciences) through Postdoctoral Fellowship 10-082858 granted to F.G.-F. Additional funding was received from the NIH (GM074820), the j004561SRC (BB/J004561/1 and BB/J009091/1) and the John Innes Foundation. This work was conducted under Defra Plant Health Licence PHSI 449/6612(07/2011). W. S. G. gratefully acknowledges a National Science Foundation Predoctoral Fellowship. Y.C. would like to thank the NSF for grant DMS-1209112. K. R. Chauhan is acknowledged for providing initial nepetalactol samples. We thank S. Fairhurst, L. Hill and A. Jones for NMR, LC-MS and GC-MS assistance, respectively. J. Ward and N. Hawkins are acknowledged for the GC-MS-based high-resolution mass spectra (HRMS) of synthesized compounds. R. Buell and E. Gongora-Castillo provided many helpful discussions on the transcriptome data. The purified EasA protein was provided J. Z. Cheng, to whom we are deeply indebted. S.E.O. receives salary support through a synergy initiative between the John Innes Centre and the University of East Anglia.	Bauer P, 2010, PHYTOCHEMISTRY, V71, P1495, DOI 10.1016/j.phytochem.2010.06.004; Burlat V, 2004, PLANT J, V38, P131, DOI 10.1111/j.1365-313X.2004.02030.x; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Cheng JZ, 2010, J AM CHEM SOC, V132, P1776, DOI 10.1021/ja910193p; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Dewhirst SY, 2010, VITAM HORM, V83, P551, DOI 10.1016/S0083-6729(10)83022-5; Dinda B, 2007, CHEM PHARM BULL, V55, P689, DOI 10.1248/cpb.55.689; Dinda B, 2011, CHEM PHARM BULL, V59, P803, DOI 10.1248/cpb.59.803; Dinda B, 2009, CHEM PHARM BULL, V57, P765, DOI 10.1248/cpb.57.765; Dobler S, 2011, PHYTOCHEMISTRY, V72, P1593, DOI 10.1016/j.phytochem.2011.04.015; Gavidia I, 2007, PHYTOCHEMISTRY, V68, P853, DOI 10.1016/j.phytochem.2006.11.019; Giddings LA, 2011, J BIOL CHEM, V286, P16751, DOI 10.1074/jbc.M111.225383; Gongora-Castillo E, 2012, METHOD ENZYMOL, V517, P139, DOI 10.1016/B978-0-12-404634-4.00007-3; Guirimand G, 2011, J PLANT PHYSIOL, V168, P549, DOI 10.1016/j.jplph.2010.08.018; Guirimand G, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-182; Guirimand G, 2009, PLANT CELL REP, V28, P1215, DOI 10.1007/s00299-009-0722-2; INOUYE H, 1978, PLANTA MED, V33, P193, DOI 10.1055/s-0028-1097377; Kim HJ, 2012, CURR OPIN CHEM BIOL, V16, P124, DOI 10.1016/j.cbpa.2011.12.017; Liblikas I, 2005, J NAT PROD, V68, P886, DOI 10.1021/np049647d; Liscombe DK, 2011, PHYTOCHEMISTRY, V72, P1969, DOI 10.1016/j.phytochem.2011.07.001; Mahroug S, 2006, PLANTA, V223, P1191, DOI 10.1007/s00425-005-0167-y; McElvain SM, 1942, J AM CHEM SOC, V64, P1828, DOI 10.1021/ja01260a025; Nour-Eldin HH, 2010, METHODS MOL BIOL, V643, P185, DOI 10.1007/978-1-60761-723-5_13; Oudin A, 2007, PLANT MOL BIOL, V65, P13, DOI 10.1007/s11103-007-9190-7; Soe ARB, 2004, ISOT ENVIRON HEALT S, V40, P175, DOI 10.1080/10256010410001674994; Thorn A, 2008, J BIOL CHEM, V283, P17260, DOI 10.1074/jbc.M706185200; Tundis R, 2008, MINI-REV MED CHEM, V8, P399, DOI 10.2174/138955708783955926; UESATO S, 1987, TETRAHEDRON LETT, V28, P4431, DOI 10.1016/S0040-4039(00)96530-4; UESATO S, 1984, CHEM PHARM BULL, V32, P3764, DOI 10.1248/cpb.32.3764; UESATO S, 1984, CHEM PHARM BULL, V32, P1671; UESATO S, 1983, CHEM PHARM BULL, V31, P4185; van der Heijden R, 2004, CURR MED CHEM, V11, P607; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730	33	226	239	6	299	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					138	+		10.1038/nature11692	http://dx.doi.org/10.1038/nature11692			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23172143				2022-12-28	WOS:000311893400061
J	Lee, GS; Subramanian, N; Kim, AI; Aksentijevich, I; Goldbach-Mansky, R; Sacks, DB; Germain, RN; Kastner, DL; Chae, JJ				Lee, Geun-Shik; Subramanian, Naeha; Kim, Andrew I.; Aksentijevich, Ivona; Goldbach-Mansky, Raphaela; Sacks, David B.; Germain, Ronald N.; Kastner, Daniel L.; Chae, Jae Jin			The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP	NATURE			English	Article							NALP3 INFLAMMASOME; ACTIVATION; ATP; LIPOPOLYSACCHARIDE; SECRETION; CRYSTALS	Mutations in the gene encoding NLRP3 cause a spectrum of auto-inflammatory diseases known as cryopyrin-associated periodic syndromes (CAPS)(1). NLRP3 is a key component of one of several distinct cytoplasmic multiprotein complexes (inflammasomes) that mediate the maturation of the proinflammatory cytokine interleukin-1 beta (IL-1 beta) by activating caspase-1. Although several models for inflammasome activation, such as K+ efflux(2), generation of reactive oxygen species(3) and lysosomal destabilization(4), have been proposed, the precise molecular mechanism of NLRP3 inflammasome activation, as well as the mechanism by which CAPS-associated mutations activate NLRP3, remain to be elucidated. Here we show that the murine calcium-sensing receptor (CASR) activates the NLRP3 inflammasome, mediated by increased intracellular Ca2+ and decreased cellular cyclic AMP(cAMP). Ca2+ or other CASR agonists activate the NLRP3 inflammasome in the absence of exogenous ATP, whereas knockdown of CASR reduces inflammasome activation in response to known NLRP3 activators. CASR activates the NLRP3 inflammasome through phospholipase C, which catalyses inositol-1,4,5-trisphosphate production and thereby induces release of Ca2+ from endoplasmic reticulum stores. The increased cytoplasmic Ca2+ promotes the assembly of inflammasome components, and intracellular Ca2+ is required for spontaneous inflammasome activity in cells from patients with CAPS. CASR stimulation also results in reduced intracellular cAMP, which independently activates the NLRP3 inflammasome. cAMP binds to NLRP3 directly to inhibit inflammasome assembly, and downregulation of cAMP relieves this inhibition. The binding affinity of cAMP for CAPS-associated mutant NLRP3 is substantially lower than for wild-type NLRP3, and the uncontrolled mature IL-1 beta production from CAPS patients' peripheral blood mononuclear cells is attenuated by increasing cAMP. Taken together, these findings indicate that Ca2+ and cAMP are two key molecular regulators of the NLRP3 inflammasome that have critical roles in the molecular pathogenesis of CAPS.	[Lee, Geun-Shik; Kim, Andrew I.; Aksentijevich, Ivona; Kastner, Daniel L.; Chae, Jae Jin] NHGRI, Inflammatory Dis Sect, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Lee, Geun-Shik] Kangwon Natl Univ, Coll Vet Med, Chunchon 200701, Gangwon, South Korea; [Subramanian, Naeha; Germain, Ronald N.] NIAID, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Goldbach-Mansky, Raphaela] NIAMSD, Translat Autoinflammatory Dis Sect, NIH, Bethesda, MD 20892 USA; [Sacks, David B.] NIH, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Kangwon National University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Kastner, DL (corresponding author), NHGRI, Inflammatory Dis Sect, Med Genet Branch, NIH, Bethesda, MD 20892 USA.	kastnerd@mail.nih.gov; chaej@mail.nih.gov	Aksentijevich, Ivona/AAF-1335-2019; Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019; Goldbach-Mansky, Raphaela/N-5917-2017	Chae, Jae Jin/0000-0003-0719-4349; Subramanian, Naeha/0000-0003-3754-0521; Sacks, David/0000-0003-3100-0735	NIAMS; NHGRI; NIAID, NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200372, ZIAHG200373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIEAR041176, ZIAAR041138] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); CLINICAL CENTER	This work was supported by the Intramural Research Programs of the NIAMS, NHGRI, and NIAID, NIH. We thank E. Remmers for discussion and a thorough review of this manuscript.	Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Brough D, 2003, J IMMUNOL, V170, P3029, DOI 10.4049/jimmunol.170.6.3029; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; COCKCROFT S, 1979, J PHYSIOL-LONDON, V296, P229, DOI 10.1113/jphysiol.1979.sp013002; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Menkin V., 1981, BIOCH MECH INFLAMMAT; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Osawa Y, 2006, AM J PHYSIOL-CELL PH, V290, pC143, DOI 10.1152/ajpcell.00171.2005; Peters-Golden M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275pe37; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Ross PE, 1997, J CELL BIOL, V138, P987, DOI 10.1083/jcb.138.5.987; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351, DOI 10.1164/ajrccm.157.2.9708012; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Xi YH, 2010, MOL CELL BIOCHEM, V342, P233, DOI 10.1007/s11010-010-0489-3; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	24	614	641	12	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					123	+		10.1038/nature11588	http://dx.doi.org/10.1038/nature11588			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23143333	Green Accepted			2022-12-28	WOS:000311893400058
J	Sotomayor, M; Weihofen, WA; Gaudet, R; Corey, DP				Sotomayor, Marcos; Weihofen, Wilhelm A.; Gaudet, Rachelle; Corey, David P.			Structure of a force-conveying cadherin bond essential for inner-ear mechanotransduction	NATURE			English	Article							USHER-SYNDROME; HAIR-CELLS; MOLECULAR-DYNAMICS; SENSORY TRANSDUCTION; HEARING-LOSS; ADHESION; MUTATIONS; PCDH15; CDH23; STEREOCILIA	Hearing and balance use hair cells in the inner ear to transform mechanical stimuli into electrical signals(1). Mechanical force from sound waves or head movements is conveyed to hair-cell transduction channels by tip links(2,3), fine filaments formed by two atypical cadherins known as protocadherin 15 and cadherin 23 (refs 4, 5). These two proteins are involved in inherited deafness(6-10) and feature long extracellular domains that interact tip-to-tip(5,11) in a Ca2+-dependent manner. However, the molecular architecture of this complex is unknown. Here we combine crystallography, molecular dynamics simulations and binding experiments to characterize the protocadherin 15-cadherin 23 bond. We find a unique cadherin interaction mechanism, in which the two most amino-terminal cadherin repeats (extracellular cadherin repeats 1 and 2) of each protein interact to form an overlapped, antiparallel heterodimer. Simulations predict that this tip-link bond is mechanically strong enough to resist forces in hair cells. In addition, the complex is shown to become unstable in response to Ca2+ removal owing to increased flexure of Ca2+-free cadherin repeats. Finally, we use structures and biochemical measurements to study the molecular mechanisms by which deafness mutations disrupt tip-link function. Overall, our results shed light on the molecular mechanics of hair-cell sensory transduction and on new interaction mechanisms for cadherins, a large protein family implicated in tissue and organ morphogenesis(12,13), neural connectivity(14) and cancer(15).	[Sotomayor, Marcos; Corey, David P.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Sotomayor, Marcos; Corey, David P.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Weihofen, Wilhelm A.; Gaudet, Rachelle] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University	Corey, DP (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.	gaudet@mcb.harvard.edu; dcorey@hms.harvard.edu	Gaudet, Rachelle/I-4133-2014; Sotomayor, Marcos/J-4898-2012; Sotomayor, Marcos/T-2411-2019; Gaudet, Rachelle/Y-3985-2019	Gaudet, Rachelle/0000-0002-9177-054X; Sotomayor, Marcos/0000-0002-3333-1805; Sotomayor, Marcos/0000-0002-3333-1805; Gaudet, Rachelle/0000-0002-9177-054X; Corey, David/0000-0003-4497-6016	NIH [R01 DC02281, RC2GM093307, RR-15301]; National Science Foundation through TeraGrid/XSEDE [TRAC MCB080015]; Department of Energy (DOE) [DE-AC02-06CH11357]; DOE [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM093307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002281] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation through TeraGrid/XSEDE; Department of Energy (DOE)(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank B. Derfler for assistance with mutagenesis, V. D'Souza and her laboratory for advice on calorimetry, and the Corey and Gaudet laboratories for discussions. Full-length complementary DNAs of Cdh23 and Pcdh15 used as template for some of our constructs were provided by U. Muller (The Scripps Research Institute) and T. B. Friedman (National Institutes of Health (NIH)). This work was supported by the NIH (R01 DC02281 to D. P. C.; RC2GM093307 to National Resource for Biomedical Supercomputing/Pittsburgh Supercomputing Center) and the National Science Foundation through TeraGrid/XSEDE (TRAC MCB080015). Simulations were performed at the NCSA-Abe, NICS-Kraken, TACC-Ranger and PSC-Anton supercomputers. Use of Advanced Photon Source beamlines was supported by NIH award RR-15301 and Department of Energy (DOE) contract no. DE-AC02-06CH11357. Use of Advanced Light Source beamline 4.2.2 was supported by DOE contract no. DE-AC02-05CH11231. M. S. was a Howard Hughes Medical Institute (HHMI) Fellow of the Helen Hay Whitney Foundation and D. P. C. is an HHMI Investigator.	Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Ahmed ZM, 2008, HUM GENET, V124, P215, DOI 10.1007/s00439-008-0543-3; Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Astuto LM, 2002, AM J HUM GENET, V71, P262, DOI 10.1086/341558; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; de Brouwer APM, 2003, HUM GENET, V112, P156, DOI 10.1007/s00439-002-0833-0; Deans MR, 2011, NEURON, V71, P820, DOI 10.1016/j.neuron.2011.06.026; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Elledge HM, 2010, P NATL ACAD SCI USA, V107, P10708, DOI 10.1073/pnas.1006284107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Han F, 2012, PHARMACOGENOMICS J, V12, P30, DOI 10.1038/tpj.2010.60; Haussinger D, 2002, J MOL BIOL, V324, P823, DOI 10.1016/S0022-2836(02)01137-3; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753; Lelli A, 2010, J NEUROSCI, V30, P11259, DOI 10.1523/JNEUROSCI.1949-10.2010; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marchand S, 1998, PROTEINS, V33, P265, DOI 10.1002/(SICI)1097-0134(19981101)33:2<265::AID-PROT10>3.3.CO;2-G; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Rouget-Quermalet V, 2006, ONCOGENE, V25, P2807, DOI 10.1038/sj.onc.1209301; Shapiro L, 2007, ANNU REV NEUROSCI, V30, P451, DOI 10.1146/annurev.neuro.29.051605.113034; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Sotomayor M, 2008, BIOPHYS J, V94, P4621, DOI 10.1529/biophysj.107.125591; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Sotomayor M, 2010, NEURON, V66, P85, DOI 10.1016/j.neuron.2010.03.028; Stauffer EA, 2007, J NEUROPHYSIOL, V98, P3360, DOI 10.1152/jn.00914.2007; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Thomson J.A., 2004, BIOCALORIMETRY, P37; Tsumoto K, 1998, J IMMUNOL METHODS, V219, P119, DOI 10.1016/S0022-1759(98)00127-6	46	102	108	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					128	+		10.1038/nature11590	http://dx.doi.org/10.1038/nature11590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23135401	Green Accepted, Green Submitted			2022-12-28	WOS:000311893400059
J	Arrow, KJ; Danzon, PM; Gelband, H; Jamison, D; Laxminarayan, R; Mills, A; Mwabu, G; Panosian, C; Peto, R; White, NJ				Arrow, Kenneth J.; Danzon, Patricia M.; Gelband, Hellen; Jamison, Dean; Laxminarayan, Ramanan; Mills, Anne; Mwabu, Germano; Panosian, Claire; Peto, Richard; White, Nicholas J.			The Affordable Medicines Facility-malaria: killing it slowly	LANCET			English	Editorial Material									[Gelband, Hellen; Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC 20036 USA; [Arrow, Kenneth J.] Stanford Univ, Dept Econ, Stanford, CA 94305 USA; [Danzon, Patricia M.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Jamison, Dean] Univ Washington, Seattle, WA 98195 USA; [Mills, Anne] London Sch Hyg & Trop Med, London WC1, England; [Mwabu, Germano] Univ Nairobi, Dept Econ, Nairobi, Kenya; [Panosian, Claire] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Peto, Richard] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [White, Nicholas J.] Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand	Stanford University; University of Pennsylvania; University of Washington; University of Washington Seattle; University of London; London School of Hygiene & Tropical Medicine; University of Nairobi; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU)	Laxminarayan, R (corresponding author), Ctr Dis Dynam Econ & Policy, Washington, DC 20036 USA.	ramanan@cddep.org	Laxminarayan, Ramanan/ABD-5050-2021; White, Nick/AAC-6527-2019	White, Nick/0000-0002-1897-1978; Mills, Anne/0000-0001-9863-9950	MRC [MC_U137686857] Funding Source: UKRI; Medical Research Council [MC_U137686857] Funding Source: Medline; Wellcome Trust [093956, 089275] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		[Anonymous], 2009, NY TIMES; Arnold F, 2012, INDEPENDENT EVALUATI; Bloom B, 2012, EXPERT ADVISORY GROU; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; President's Malaria Initiative, 2012, AMFM PMIS COMM GLOB; Simon J, 2011, EXTERNAL EVALUATION; Tougher S, 2012, LANCET; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; WHO, 2006, GUID TREATM MAL; WHO, 2010, STOP MARK OR ART BAS; Yamey G, 2012, B WORLD HEALTH ORGAN, V90, P452, DOI 10.2471/BLT.11.091199	13	7	7	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 1	2012	380	9857					1889	1890		10.1016/S0140-6736(12)61843-1	http://dx.doi.org/10.1016/S0140-6736(12)61843-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	046IK	23122218				2022-12-28	WOS:000311758500007
J	Lichtenstein, P; Halldner, L; Zetterqvist, J; Sjolander, A; Serlachius, E; Fazel, S; Langstrom, N; Larsson, H				Lichtenstein, Paul; Halldner, Linda; Zetterqvist, Johan; Sjolander, Arvid; Serlachius, Eva; Fazel, Seena; Langstrom, Niklas; Larsson, Henrik			Medication for Attention Deficit-Hyperactivity Disorder and Criminality	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RELEASE METHYLPHENIDATE TREATMENT; FOLLOW-UP; DEFICIT/HYPERACTIVITY DISORDER; ADHD; CHILDREN; SAFETY; MTA; PREVALENCE; EFFICACY; ADULTS	Background Attention deficit-hyperactivity disorder (ADHD) is a common disorder that has been associated with criminal behavior in some studies. Pharmacologic treatment is available for ADHD and may reduce the risk of criminality. Methods Using Swedish national registers, we gathered information on 25,656 patients with a diagnosis of ADHD, their pharmacologic treatment, and subsequent criminal convictions in Sweden from 2006 through 2009. We used stratified Cox regression analyses to compare the rate of criminality while the patients were receiving ADHD medication, as compared with the rate for the same patients while not receiving medication. Results As compared with nonmedication periods, among patients receiving ADHD medication, there was a significant reduction of 32% in the criminality rate for men (adjusted hazard ratio, 0.68; 95% confidence interval [CI], 0.63 to 0.73) and 41% for women (hazard ratio, 0.59; 95% CI, 0.50 to 0.70). The rate reduction remained between 17% and 46% in sensitivity analyses among men, with factors that included different types of drugs (e.g., stimulant vs. nonstimulant) and outcomes (e.g., type of crime). Conclusions Among patients with ADHD, rates of criminality were lower during periods when they were receiving ADHD medication. These findings raise the possibility that the use of medication reduces the risk of criminality among patients with ADHD. (Funded by the Swedish Research Council and others.)	[Lichtenstein, Paul; Halldner, Linda; Zetterqvist, Johan; Sjolander, Arvid; Langstrom, Niklas; Larsson, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Serlachius, Eva] Karolinska Inst, Dept Clin Neurosci, S-17177 Stockholm, Sweden; [Fazel, Seena] Univ Oxford, Dept Psychiat, Oxford, England	Karolinska Institutet; Karolinska Institutet; University of Oxford	Lichtenstein, P (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, S-17177 Stockholm, Sweden.	paul.lichtenstein@ki.se	Sjölander, Arvid/AAR-2993-2021; Fazel, Seena/B-5307-2008; Larsson, Henrik/GYD-5161-2022; Langstrom, Niklas/C-5615-2009; Serlachius, Eva/E-8956-2013	Fazel, Seena/0000-0002-5383-5365; Langstrom, Niklas/0000-0002-2686-6799; Serlachius, Eva/0000-0001-7115-6422; Halldner Henriksson, Linda/0000-0003-0561-5998; Larsson, Henrik/0000-0002-6851-3297; lichtenstein, paul/0000-0003-3037-5287	Swedish Research Council; Swedish Council for Working Life and Social Research; Swedish Prison and Probation Services; National Institute of Child Health and Human Development [HD061817]; Wellcome Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061817] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Prison and Probation Services; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funded by the Swedish Research Council and others.; Supported in part by grants from the Swedish Research Council, the Swedish Council for Working Life and Social Research, the Swedish Prison and Probation Services, the National Institute of Child Health and Human Development (HD061817), and the Wellcome Trust (to Dr. Fazel).	Adler LA, 2009, J CLIN PSYCHOPHARM, V29, P239, DOI 10.1097/JCP.0b013e3181a390ce; Adler LD, 2010, POSTGRAD MED, V122, P184, DOI 10.3810/pgm.2010.01.2112; Alison P., 2009, FIXED EFFECTS REGRES; Angold A, 1999, J CHILD PSYCHOL PSYC, V40, P57, DOI 10.1017/S0021963098003448; [Anonymous], 2011, KRIM 2010 CRIM STAT; Arnold LE, 2004, J ABNORM CHILD PSYCH, V32, P39, DOI 10.1023/B:JACP.0000007579.61289.31; Banaschewski T, 2006, EUR CHILD ADOLES PSY, V15, P476, DOI 10.1007/s00787-006-0549-0; Barkley RA, 2004, J CHILD PSYCHOL PSYC, V45, P195, DOI 10.1111/j.1469-7610.2004.00214.x; Biederman J, 2010, PSYCHIAT RES, V177, P299, DOI 10.1016/j.psychres.2009.12.010; Chamberlain SR, 2007, BIOL PSYCHIAT, V61, P1317, DOI 10.1016/j.biopsych.2007.04.009; Cole SR, 2010, INT J EPIDEMIOL, V39, P417, DOI 10.1093/ije/dyp334; DOLMEN L, 2001, BROTTSLIGHETEN OLIKA; FARRINGTON D, 2004, CROSS NATL STUDIES C; Fazel S, 2006, AM J PSYCHIAT, V163, P1397, DOI 10.1176/appi.ajp.163.8.1397; Findling RL, 2008, CLIN THER, V30, P942, DOI 10.1016/j.clinthera.2008.05.006; Gibbons RD, 2010, ANNU REV PUBL HEALTH, V31, P419, DOI 10.1146/annurev.publhealth.012809.103649; Graham J, 2008, CNS DRUGS, V22, P213, DOI 10.2165/00023210-200822030-00003; Greenhill, 2007, J AM ACAD CHILD PSY, V46, P141; Greenhill L, 2006, J AM ACAD CHILD PSY, V45, P1284, DOI 10.1097/01.chi.0000235077.32661.61; Jensen PS, 2007, J AM ACAD CHILD PSY, V46, P989, DOI 10.1097/chi.0b013e3180686d48; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Koesters M, 2009, J PSYCHOPHARMACOL, V23, P733, DOI 10.1177/0269881108092338; Kooij SJJ, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-67; Lee E. W., 1992, SURVIVAL ANAL STATE, P237, DOI [DOI 10.1007/978-94-015-7983-4_14, 10.1007/978-94-015-7983-4_14]; Lindevall O., 2009, PASTILL COMPREHENSIV; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; McCarthy S, 2009, BRIT J PSYCHIAT, V194, P273, DOI 10.1192/bjp.bp.107.045245; Molina BSG, 2007, J AM ACAD CHILD PSY, V46, P1028, DOI 10.1097/chi.0b013e3180686d96; Pastor Patricia N, 2008, Vital Health Stat 10, P1; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Satterfield JH, 2007, J AM ACAD CHILD PSY, V46, P601, DOI 10.1097/chi.0b013e318033ff59; Scheffler RM, 2007, HEALTH AFFAIR, V26, P450, DOI 10.1377/hlthaff.26.2.450; Singh I, 2008, NAT REV NEUROSCI, V9, P957, DOI 10.1038/nrn2514; Snapinn SM, 2005, AM STAT, V59, P301, DOI 10.1198/000313005X70371; Swanson J, 2008, J ATTEN DISORD, V12, P4, DOI 10.1177/1087054708319345; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Winhusen TM, 2011, J CHILD ADOL PSYCHOP, V21, P455, DOI 10.1089/cap.2011.0014; Zetterqvist J, 2012, ACTA PSYCHIAT SCAND; Zoega H, 2011, ACTA PSYCHIAT SCAND, V123, P360, DOI 10.1111/j.1600-0447.2010.01607.x	40	318	326	1	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2012	367	21					2006	2014		10.1056/NEJMoa1203241	http://dx.doi.org/10.1056/NEJMoa1203241			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040RI	23171097	Green Accepted, Bronze			2022-12-28	WOS:000311340200008
J	Spence, D				Spence, Des			The peeved middle	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Baker D, 2003, J EPIDEMIOL COMMUN H, V57, P417, DOI 10.1136/jech.57.6.417; Edwards NI, 2000, AGE AGEING, V29, P131, DOI 10.1093/ageing/29.2.131; Macleod J, 2005, BRIT MED J, V330, P940, DOI 10.1136/bmj.38413.663137.8F	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 16	2012	345								e7799	10.1136/bmj.e7799	http://dx.doi.org/10.1136/bmj.e7799			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040QI	23160786				2022-12-28	WOS:000311337500008
J	Tokinaga, H; Xie, SP; Deser, C; Kosaka, Y; Okumura, YM				Tokinaga, Hiroki; Xie, Shang-Ping; Deser, Clara; Kosaka, Yu; Okumura, Yuko M.			Slowdown of the Walker circulation driven by tropical Indo-Pacific warming	NATURE			English	Article							ASIAN CLIMATE; PRECIPITATION; SENSITIVITY; SIMULATION; SHIFT	Global mean sea surface temperature (SST) has risen steadily over the past century(1,2), but the overall pattern contains extensive and often uncertain spatial variations, with potentially important effects on regional precipitation(3,4). Observations suggest a slowdown of the zonal atmospheric overturning circulation above the tropical Pacific Ocean (the Walker circulation) over the twentieth century(1,5). Although this change has been attributed to a muted hydrological cycle forced by global warming(5,6), the effect of SST warming patterns has not been explored and quantified(1,7,8). Here we perform experiments using an atmospheric model, and find that SST warming patterns are the main cause of the weakened Walker circulation over the past six decades (1950-2009). The SST trend reconstructed from bucket-sampled SST and night-time marine surface air temperature features a reduced zonal gradient in the tropical Indo-Pacific Ocean, a change consistent with subsurface temperature observations(8). Model experiments with this trend pattern robustly simulate the observed changes, including the Walker circulation slowdown and the eastward shift of atmospheric convection from the Indonesian maritime continent to the central tropical Pacific. Our results cannot establish whether the observed changes are due to natural variability or anthropogenic global warming, but they do show that the observed slowdown in the Walker circulation is presumably driven by oceanic rather than atmospheric processes.	[Tokinaga, Hiroki; Xie, Shang-Ping] Univ Hawaii Manoa, SOEST, Dept Meteorol, Int Pacific Res Ctr, 1680 EW Rd, Honolulu, HI 96822 USA; [Xie, Shang-Ping] Ocean Univ China, Phys Oceanog Lab, Qingdao 266003, Peoples R China; [Deser, Clara] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Okumura, Yuko M.] Univ Texas Austin, Inst Geophys, Austin, TX 78758 USA	University of Hawaii System; University of Hawaii Manoa; Ocean University of China; National Center Atmospheric Research (NCAR) - USA; University of Texas System; University of Texas Austin	Tokinaga, H (corresponding author), Univ Hawaii Manoa, SOEST, Dept Meteorol, Int Pacific Res Ctr, 1680 EW Rd, Honolulu, HI 96822 USA.	tokinaga@hawaii.edu; xie@hawaii.edu	Okumura, Yuko/A-9742-2012; Kosaka, Yu/C-2792-2009; Xie, Shang-Ping/C-1254-2009; Tokinaga, Hiroki/K-6813-2012	Kosaka, Yu/0000-0001-5575-4668; Xie, Shang-Ping/0000-0002-3676-1325; Tokinaga, Hiroki/0000-0002-2734-1820; Okumura, Yuko/0000-0002-1874-3465	JAMSTEC; National Basic Research Program of China [2012CB955600]; NASA; NSF; NOAA	JAMSTEC; National Basic Research Program of China(National Basic Research Program of China); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	We thank A. Timmermann for discussions, and X. T. Zheng and J. Ma for data processing. The work was supported by JAMSTEC, the National Basic Research Program of China (2012CB955600), NASA, NSF and NOAA. NCAR is sponsored by NSF.	Allan R, 2006, J CLIMATE, V19, P5816, DOI 10.1175/JCLI3937.1; Anderson JL, 2004, J CLIMATE, V17, P4641, DOI 10.1175/JCLI-3223.1; Bunge L, 2009, J CLIMATE, V22, P3979, DOI 10.1175/2009JCLI2724.1; Chen MY, 2002, J HYDROMETEOROL, V3, P249, DOI 10.1175/1525-7541(2002)003<0249:GLPAYM>2.0.CO;2; Clement A, 2011, J CLIMATE, V24, P4056, DOI 10.1175/2011JCLI3973.1; Compo GP, 2011, Q J ROY METEOR SOC, V137, P1, DOI 10.1002/qj.776; Deser C, 2006, J CLIMATE, V19, P6170, DOI 10.1175/JCLI3963.1; Deser C, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043321; DiNezio P. N., 2010, EOS T AM GEOPHYS UN, V91, P141, DOI DOI 10.1029/2010EO160001; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Hulme M, 1998, GEOPHYS RES LETT, V25, P3379, DOI 10.1029/98GL02562; Johnson NC, 2010, NAT GEOSCI, V3, P842, DOI [10.1038/ngeo1008, 10.1038/NGEO1008]; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kendall M. G., 1975, RANK CORRELATION MET; Kennedy JJ, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015218; KENNEDY JJ, 2011, J GEOPHYS RES-ATMOS, V116, DOI DOI 10.1029/2010JD015220; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Meehl GA, 2009, J CLIMATE, V22, P780, DOI 10.1175/2008JCLI2552.1; Meng QJ, 2012, CLIM DYNAM, V38, P1757, DOI 10.1007/s00382-011-1047-8; Neale R. B., J CLIM UNPUB; Power SB, 2011, J CLIMATE, V24, P6501, DOI 10.1175/2011JCLI4101.1; Ramanathan V, 2005, P NATL ACAD SCI USA, V102, P5326, DOI 10.1073/pnas.0500656102; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Roeckner E., 2003, 349 MPI; Schneider U., 2008, GLOBAL PRECIPITATION; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Shin SI, 2011, CLIM DYNAM, V36, P1577, DOI 10.1007/s00382-009-0732-3; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Tokinaga H, 2012, J CLIMATE, V25, P1689, DOI 10.1175/JCLI-D-11-00263.1; Tokinaga H, 2011, J CLIMATE, V24, P267, DOI 10.1175/2010JCLI3789.1; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Vecchi GA, 2006, NATURE, V441, P73, DOI 10.1038/nature04744; Vecchi GA, 2007, J CLIMATE, V20, P4316, DOI 10.1175/JCLI4258.1; WILLMOTT CJ, 1995, INT J CLIMATOL, V15, P221, DOI 10.1002/joc.3370150207; Woodruff SD, 2011, INT J CLIMATOL, V31, P951, DOI 10.1002/joc.2103; Xie SP, 2010, J CLIMATE, V23, P3352, DOI 10.1175/2010JCLI3429.1; Xie SP, 2010, J CLIMATE, V23, P966, DOI 10.1175/2009JCLI3329.1	38	246	261	4	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					439	443		10.1038/nature11576	http://dx.doi.org/10.1038/nature11576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23151588				2022-12-28	WOS:000311031600045
J	Wade, MJ				Wade, Michael J.			Constraints on Sexual Selection	SCIENCE			English	Editorial Material							BATEMAN; OPPORTUNITY; PRINCIPLES		Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Wade, MJ (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	mjwade@indiana.edu						ARNOLD SJ, 1994, AM NAT, V144, pS126, DOI 10.1086/285656; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Byers J, 2012, SCIENCE, V338, P802, DOI 10.1126/science.1224660; CROW JF, 1958, AM ANTHROPOL, V60, P1; Darwin C., 1964, ORIGIN SPECIES; Fisher, 1958, GENETICAL THEORY NAT; Jennions MD, 2012, J EVOLUTION BIOL, V25, P591, DOI 10.1111/j.1420-9101.2011.02451.x; Jones AG, 2009, EVOLUTION, V63, P1673, DOI 10.1111/j.1558-5646.2009.00664.x; Jones AG, 2005, INTEGR COMP BIOL, V45, P874, DOI 10.1093/icb/45.5.874; SHUSTER SM, 2003, MG BEH ECOL, pR7; WADE MJ, 1979, AM NAT, V114, P742, DOI 10.1086/283520	11	1	1	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2012	338	6108					749	750		10.1126/science.1230395	http://dx.doi.org/10.1126/science.1230395			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139319				2022-12-28	WOS:000310839500028
J	Antman, EM; Harrington, RA				Antman, Elliott M.; Harrington, Robert A.			Transforming Clinical Trials in Cardiovascular Disease Mission Critical for Health and Economic Well-being	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DESIGN		[Antman, Elliott M.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Harrington, Robert A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA	Harvard University; Brigham & Women's Hospital; Stanford University	Antman, EM (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	eantman@rics.bwh.harvard.edu						Antman E, 2012, WIRES SYST BIOL MED, V4, P367, DOI 10.1002/wsbm.1173; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Iglehart JK, 2009, NEW ENGL J MED, V361, P325, DOI 10.1056/NEJMp0904133; Mehta C, 2009, CIRCULATION, V119, P597, DOI 10.1161/CIRCULATIONAHA.108.809707; Meurer WJ, 2012, JAMA-J AM MED ASSOC, V307, P2377, DOI 10.1001/jama.2012.4174; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; US Food and Drug Administration Center for Drug Evaluation and Research, 2011, CDER SCI PRIOR REV C	8	33	33	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1743	1744		10.1001/jama.2012.14841	http://dx.doi.org/10.1001/jama.2012.14841			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117771				2022-12-28	WOS:000310726500017
J	Arnett, DK; Claas, SA				Arnett, Donna K.; Claas, Steven A.			Preventing and Controlling Hypertension in the Era of Genomic Innovation and Environmental Transformation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Arnett, Donna K.; Claas, Steven A.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham	Arnett, DK (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, RPHB 220E,1530 3rd Ave S, Birmingham, AL USA.	arnett@ms.soph.uab.edu		Claas, Steven/0000-0001-9789-8395				Bloom DE, 2011, GLOBAL EC BURDEN NON; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Cogswell ME, 2012, AM J CLIN NUTR, V96, P647, DOI 10.3945/ajcn.112.034413; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Konner M, 2010, NUTR CLIN PRACT, V25, P594, DOI 10.1177/0884533610385702; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; World Health Organization, 2012, CARD DIS CVDS FACT S	10	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1745	1746		10.1001/jama.2012.28747	http://dx.doi.org/10.1001/jama.2012.28747			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117772				2022-12-28	WOS:000310726500018
J	Califf, RM; Sanderson, I; Miranda, ML				Califf, Robert M.; Sanderson, Iain; Miranda, Marie Lynn			The Future of Cardiovascular Clinical Research Informatics, Clinical Investigators, and Community Engagement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Califf, Robert M.] Duke Univ, Med Ctr, Duke Translat Med Inst, Durham, NC 27710 USA; [Miranda, Marie Lynn] Univ Michigan, Dept Pediat, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Califf, Robert M.] Duke Translat Med Inst, Durham, England; [Sanderson, Iain] Duke Hlth Technol Solut, Durham, England	Duke University; University of Michigan System; University of Michigan	Califf, RM (corresponding author), Duke Univ, Med Ctr, Duke Translat Med Inst, 200 Trent Dr,1117 Davison Bldg, Durham, NC 27710 USA.	robert.califf@duke.edu		Miranda, Marie Lynn/0000-0002-5670-0837				CALIFF RM, 1981, WESTERN J MED, V135, P321; Califf RM, 2012, JAMA-J AM MED ASSOC, V307, P1838, DOI 10.1001/jama.2012.3424; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; Grossman C, 2011, I MED NAT AC ENG WOR; Health Care Systems (HCS) Research Collaboratory, NIH COMM FUND OFF ST; Jha AK, 2010, HEALTH AFFAIR, V29, P1951, DOI 10.1377/hlthaff.2010.0502; Miranda Marie Lynn, 2011, N C Med J, V72, P132; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867	9	20	20	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1747	1748		10.1001/jama.2012.28745	http://dx.doi.org/10.1001/jama.2012.28745			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117773				2022-12-28	WOS:000310726500019
J	Spence, D				Spence, Des			Medicine's dystopian future	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 2	2012	345								e7413	10.1136/bmj.e7413	http://dx.doi.org/10.1136/bmj.e7413			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033FL	23125129				2022-12-28	WOS:000310779500005
J	Mizuno, K; Miyabe, I; Schalbetter, SA; Carr, AM; Murray, JM				Mizuno, Ken'Ichi; Miyabe, Izumi; Schalbetter, Stephanie A.; Carr, Antony M.; Murray, Johanne M.			Recombination-restarted replication makes inverted chromosome fusions at inverted repeats	NATURE			English	Article							BREAK-INDUCED REPLICATION; GENOMIC REARRANGEMENTS; TEMPLATE EXCHANGE; RIBOSOMAL DNA; FRAGILE SITE; MECHANISMS; DISORDERS; REPAIR	Impediments to DNA replication are known to induce gross chromosomal rearrangements (GCRs) and copy-number variations (CNVs). GCRs and CNVs underlie human genomic disorders(1) and are a feature of cancer(2). During cancer development, environmental factors and oncogene-driven proliferation promote replication stress. Resulting GCRs and CNVs are proposed to contribute to cancer development and therapy resistance(3). When stress arrests replication, the replisome remains associated with the fork DNA(stalled fork) and is protected by the inter-S-phase checkpoint. Stalled forks efficiently resume when the stress is relieved. However, if the polymerases dissociate from the fork (fork collapse) or the fork structure breaks (broken fork), replication restart can proceed either by homologous recombination or microhomology-primed re-initiation(4,5). Here we ascertain the consequences of replication with a fork restarted by homologous recombination in fission yeast. We identify a new mechanism of chromosomal rearrangement through the observation that recombination-restarted forks have a considerably high propensity to execute a U-turn at small inverted repeats (up to 1 in 40 replication events). We propose that the error-prone nature of restarted forks contributes to the generation of GCRs and gene amplification in cancer, and to non-recurrent CNVs in genomic disorders.	[Mizuno, Ken'Ichi; Miyabe, Izumi; Schalbetter, Stephanie A.; Carr, Antony M.; Murray, Johanne M.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Sussex	Carr, AM (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	a.m.carr@sussex.ac.uk	Miyabe, Izumi/K-7536-2017; Mizuno, Ken'Ichi/P-7350-2015	Miyabe, Izumi/0000-0002-4546-2837; Carr, Antony Michael/0000-0002-2028-2389; Mizuno, Ken'Ichi/0000-0001-8115-7808	Cancer Research UK (CRUK) [C9601/A9484]; Medical Research Council (MRC) [G0600233]; Biotechnology and Biological Sciences Research Council [BB/C510291/1] Funding Source: researchfish; Medical Research Council [G1100074, G0600233, G0500308] Funding Source: researchfish; Worldwide Cancer Research [10-0273] Funding Source: researchfish; MRC [G0600233, G1100074, G0500308] Funding Source: UKRI	Cancer Research UK (CRUK)(Cancer Research UK); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank E. Hoffman, J. Baxter, M. Neale and members of the Carr and Murray laboratories for discussions. J. M. M. acknowledges Cancer Research UK (CRUK) grant C9601/A9484: A. M. C. acknowledges Medical Research Council (MRC) grant G0600233.	Arlt MF, 2012, CURR OPIN GENET DEV, V22, P204, DOI 10.1016/j.gde.2012.01.009; Blow JJ, 2011, TRENDS BIOCHEM SCI, V36, P405, DOI 10.1016/j.tibs.2011.05.002; Blumrich A, 2011, HUM MOL GENET, V20, P1488, DOI 10.1093/hmg/ddr027; Carvalho CMB, 2011, NAT GENET, V43, P1074, DOI 10.1038/ng.944; Deem A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000594; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Iraqui I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002976; Kloosterman WP, 2012, CELL REP, V1, P648, DOI 10.1016/j.celrep.2012.05.009; Krings G, 2004, P NATL ACAD SCI USA, V101, P14085, DOI 10.1073/pnas.0406037101; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Lambert S, 2010, MOL CELL, V39, P346, DOI 10.1016/j.molcel.2010.07.015; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; Liu PF, 2012, CURR OPIN GENET DEV, V22, P211, DOI 10.1016/j.gde.2012.02.012; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Lydeard JR, 2010, GENE DEV, V24, P1133, DOI 10.1101/gad.1922610; Mizuno K, 2009, GENE DEV, V23, P2876, DOI 10.1101/gad.1863009; Mondello C, 2010, MUTAT RES-REV MUTAT, V704, P29, DOI 10.1016/j.mrrev.2010.01.008; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Ozeri-Galai E, 2011, MOL CELL, V43, P122, DOI 10.1016/j.molcel.2011.05.019; Pelliccia F, 2010, CANCER LETT, V299, P37, DOI 10.1016/j.canlet.2010.08.001; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Sanchez-Gorostiaga A, 2004, MOL CELL BIOL, V24, P398, DOI 10.1128/MCB.24.1.398-406.2004; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105; WILLIAMS WL, 1987, J MOL BIOL, V196, P743; Zuffardi O, 2009, CLIN GENET, V75, P505, DOI 10.1111/j.1399-0004.2009.01187.x	30	109	110	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					246	249		10.1038/nature11676	http://dx.doi.org/10.1038/nature11676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23178809	Green Accepted			2022-12-28	WOS:000313259600044
J	Pickard, R; Lam, T; MacLennan, G; Starr, K; Kilonzo, M; McPherson, G; Gillies, K; McDonald, A; Walton, K; Buckley, B; Glazener, C; Boachie, C; Burr, J; Norrie, J; Vale, L; Grant, A; N'Dow, J				Pickard, Robert; Lam, Thomas; MacLennan, Graeme; Starr, Kath; Kilonzo, Mary; McPherson, Gladys; Gillies, Katie; McDonald, Alison; Walton, Katherine; Buckley, Brian; Glazener, Cathryn; Boachie, Charles; Burr, Jennifer; Norrie, John; Vale, Luke; Grant, Adrian; N'Dow, James			Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial	LANCET			English	Article							COST; RISK	Background Catheter-associated urinary tract infection (CAUTI) is a major preventable cause of harm for patients in hospital. We aimed to establish whether short-term routine use of antimicrobial catheters reduced risk of CAUTI compared with standard polytetrafl uoroethylene (PTFE) catheterisation. Methods In our parallel, three group, multicentre, randomised controlled superiority trial, we enrolled adults (aged >= 16 years) requiring short-term (<= 14 days) catheterisation at 24 hospitals in the UK. Participants were randomly allocated 1:1:1 with a remote computer allocation to receive a silver alloy-coated catheter, a nitrofural-impregnated catheter, or a PTFE-coated catheter (control group). Patients undergoing unplanned catheterisation were also included and consent for participation was obtained retrospectively. Participants and trial staff were unmasked to treatment assignment. Data were collected by trial staff and by patient-reported questionnaires for 6 weeks after randomisation. The primary outcome was incidence of symptomatic urinary tract infection for which an antibiotic was prescribed by 6 weeks. We postulated that a 3.3% absolute reduction in CAUTI would represent sufficient benefit to recommend routine use of antimicrobial catheters. This study is registered, number ISRCTN75198618. Findings 708 (10%) of 7102 randomly allocated participants were not catheterised, did not confirm consent, or withdrew, and were not included in the primary analyses. Compared with 271 (12.6%) of 2144 participants in the control group, 263 (12.5%) of 2097 participants allocated a silver alloy catheter had the primary outcome (difference -0.1% [95% CI -2.4 to 2.2]), as did 228 (10.6%) of 2153 participants allocated a nitrofural catheter (-2.1% [-4.2 to 0.1]). Rates of catheter-related discomfort were higher in the nitrofural group than they were in the other groups. Interpretation Silver alloy-coated catheters were not effective for reduction of incidence of symptomatic CAUTI. The reduction we noted in CAUTI associated with nitrofural-impregnated catheters was less than that regarded as clinically important. Routine use of antimicrobial-impregnated catheters is not supported by this trial.	[Pickard, Robert] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Lam, Thomas; Starr, Kath; N'Dow, James] Univ Aberdeen, Acad Urol Unit, Aberdeen, Scotland; [Starr, Kath; McPherson, Gladys; McDonald, Alison; Burr, Jennifer; Norrie, John] Univ Aberdeen, Hlth Serv Res Unit, Ctr Healthcare Randomised Trials, Aberdeen, Scotland; [Kilonzo, Mary] Univ Aberdeen, Hlth Econ Res Unit, Aberdeen, Scotland; [Walton, Katherine] Newcastle Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Buckley, Brian] Natl Univ Ireland, Dept Gen Practice, Galway, Ireland; [Buckley, Brian] Univ Philippines, Coll Med, Manila, Philippines; [Vale, Luke] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Grant, Adrian] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen, Scotland	Newcastle University - UK; University of Aberdeen; University of Aberdeen; University of Aberdeen; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Ollscoil na Gaillimhe-University of Galway; University of the Philippines System; University of the Philippines Manila; Newcastle University - UK; University of Aberdeen	Pickard, R (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	robert.pickard@newcastle.ac.uk		MacLennan, Graeme/0000-0002-1039-5646; Burr, Jennifer/0000-0002-9478-738X; Gillies, Katie/0000-0001-7890-2854; Kilonzo, Mary/0000-0002-3450-4536; Buckley, Brian/0000-0002-6007-9238; Vale, Luke/0000-0001-8574-8429	UK National Institute for Health Research Health Technology Assessment Programme; UK National Institute for Health Research; UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme [05/46/01]; Chief Scientist Office of the Scottish Government Health Directorates; National Institute for Health Research [05/46/01] Funding Source: researchfish; Chief Scientist Office [HSRU1] Funding Source: researchfish	UK National Institute for Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR)); UK National Institute for Health Research(National Institute for Health Research (NIHR)); UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme; Chief Scientist Office of the Scottish Government Health Directorates; National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	UK National Institute for Health Research Health Technology Assessment Programme.; AG receives salary support from the UK National Institute for Health Research for his role as Director of their Programme Grants for Applied Research Programme. TL and KG authored the Cochrane Review on antimicrobial catheters. RP, GM, KS, MK, GMc, AM, KW, BB, CG, CB, JB, JN, LV, and JN'D declare that they have no conflicts of interest.; This project was funded by the UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme (project number 05/46/01) and will be published in full in Health Technology Assessment. The views and opinions expressed in this report are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, National Health Service or the UK Department of Health. HSRU and HERU are funded by the Chief Scientist Office of the Scottish Government Health Directorates. The authors accept full responsibility for the research. The Catheter Study group would like to thank all patients who willingly participated in the study and completed their questionnaires and diaries. We also thank all Principal Investigators, Research Nurses/Fellows and other staff at each of our centres. We particularly thank Rashmi Bhardwaj, for leading and motivating the excellent team of Research Nurses in the North East of England. We thank all members of the Trial Steering Committee and Data Monitoring Committee. Thanks to the Catheter Study office staff (Karen McIntosh and Anne Duncan) for administration of the trial. We thank the Comprehensive Local Research Networks and Primary Care Research Networks of the UK National Institute for Health Research and all the participating English NHS Trusts and Scottish Health Boards who facilitated recruitment of their patients.	[Anonymous], 2011, BURD END HLTH CAR AS; Billote-Domingo K., 1999, PHIL J MICROBIAL INF, V28, P133; Burton DC, 2011, INFECT CONT HOSP EP, V32, P748, DOI 10.1086/660872; Centers for disease control and prevention, NAT HOSP DISCH SURV; Centers for Disease Control and Prevention, PREV HEALTHC ASS INF; Centers for Disease Control and Prevention, 2012, NHSN ANN REP; Curtis J, CEP06001 EVIDENCE RE; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI DOI 10.1007/s00134-012-2769-8; Gould CV, 2010, INFECT CONT HOSP EP, V31, P319, DOI 10.1086/651091; Guay DR, 2001, DRUGS, V61, P353, DOI 10.2165/00003495-200161030-00004; HCAI Technology Innovation Programme, 2011, 1 HCAI TECHN INN PRO; Healthcare Infection Control Practices Advisory Committee, CAUTI APP; Johnson JR, 1999, ANTIMICROB AGENTS CH, V43, P2990, DOI 10.1128/AAC.43.12.2990; Karchmer TB, 2000, ARCH INTERN MED, V160, P3294, DOI 10.1001/archinte.160.21.3294; Kind P, 2011, UK POPULATION NORMS; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; N'Dow J., 2012, 75198618 ISCRTN; Plowman R, 2001, J HOSP INFECT, V48, P33, DOI 10.1053/jhin.2001.0938; Pratt RJ, 2007, J HOSP INFECT, V65, pS1, DOI 10.1016/S0195-6701(07)60002-4; Rupp ME, 2004, AM J INFECT CONTROL, V32, P445, DOI 10.1016/j.ajic.2004.05.002; Schumm K, 2008, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD004013.pub1, DOI 10.1002/14651858.CD004013.PUB1]; Seymour Coral, 2006, Br J Nurs, V15, P598; Stensballe J, 2007, ANN INTERN MED, V147, P285, DOI 10.7326/0003-4819-147-5-200709040-00002; Tiwari MM, 2012, AM J INFECT CONTROL, V40, P51, DOI 10.1016/j.ajic.2011.03.032; Umscheid CA, 2011, INFECT CONT HOSP EP, V32, P101, DOI 10.1086/657912; US Department of Health and Human Services (HHS), 2011, ACT PLAN PREV HEALTH; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	27	154	164	2	72	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2012	380	9857					1927	1935		10.1016/S0140-6736(12)61380-4	http://dx.doi.org/10.1016/S0140-6736(12)61380-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	046IK	23134837	Green Submitted			2022-12-28	WOS:000311758500029
J	Shah, DI; Takahashi-Makise, N; Cooney, JD; Li, LT; Schultz, IJ; Pierce, EL; Narla, A; Seguin, A; Hattangadi, SM; Medlock, AE; Langer, NB; Dailey, TA; Hurst, SN; Faccenda, D; Wiwczar, JM; Heggers, SK; Vogin, G; Chen, W; Chen, CY; Campagna, DR; Brugnara, C; Zhou, Y; Ebert, BL; Danial, NN; Fleming, MD; Ward, DM; Campanella, M; Dailey, HA; Kaplan, J; Paw, BH				Shah, Dhvanit I.; Takahashi-Makise, Naoko; Cooney, Jeffrey D.; Li, Liangtao; Schultz, Iman J.; Pierce, Eric L.; Narla, Anupama; Seguin, Alexandra; Hattangadi, Shilpa M.; Medlock, Amy E.; Langer, Nathaniel B.; Dailey, Tamara A.; Hurst, Slater N.; Faccenda, Danilo; Wiwczar, Jessica M.; Heggers, Spencer K.; Vogin, Guillaume; Chen, Wen; Chen, Caiyong; Campagna, Dean R.; Brugnara, Carlo; Zhou, Yi; Ebert, Benjamin L.; Danial, Nika N.; Fleming, Mark D.; Ward, Diane M.; Campanella, Michelangelo; Dailey, Harry A.; Kaplan, Jerry; Paw, Barry H.			Mitochondrial Atpif1 regulates haem synthesis in developing erythroblasts	NATURE			English	Article							IRON-METABOLISM; ZEBRAFISH; YEAST; FERROCHELATASE; INHIBITOR; TRANSPORT; DEFECTS; PROTEIN; CYTOSOL; ANEMIA	Defects in the availability of haem substrates or the catalytic activity of the terminal enzyme in haem biosynthesis, ferrochelatase (Fech), impair haem synthesis and thus cause human congenital anaemias(1,2). The interdependent functions of regulators of mitochondrial homeostasis and enzymes responsible for haem synthesis are largely unknown. To investigate this we used zebrafish genetic screens and cloned mitochondrial ATPase inhibitory factor 1 (atpif1) from a zebrafish mutant with profound anaemia, pinotage (pnt (tq209)). Here we describe a direct mechanism establishing that Atpif1 regulates the catalytic efficiency of vertebrate Fech to synthesize haem. The loss of Atpif1 impairs haemoglobin synthesis in zebrafish, mouse and human haematopoietic models as a consequence of diminished Fech activity and elevated mitochondrial pH. To understand the relationship between mitochondrial pH, redox potential, [2Fe-2S] clusters and Fech activity, we used genetic complementation studies of Fech constructs with or without [2Fe-2S] clusters in pnt, as well as pharmacological agents modulating mitochondrial pH and redox potential. The presence of [2Fe-2S] cluster renders vertebrate Fech vulnerable to perturbations in Atpif1-regulated mitochondrial pH and redox potential. Therefore, Atpif1 deficiency reduces the efficiency of vertebrate Fech to synthesize haem, resulting in anaemia. The identification of mitochondrial Atpif1 as a regulator of haem synthesis advances our understanding of the mechanisms regulating mitochondrial haem homeostasis and red blood cell development. An ATPIF1 deficiency may contribute to important human diseases, such as congenital sideroblastic anaemias and mitochondriopathies.	[Shah, Dhvanit I.; Cooney, Jeffrey D.; Schultz, Iman J.; Pierce, Eric L.; Narla, Anupama; Langer, Nathaniel B.; Hurst, Slater N.; Heggers, Spencer K.; Vogin, Guillaume; Chen, Wen; Chen, Caiyong; Ebert, Benjamin L.; Paw, Barry H.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Hematol, Boston, MA 02115 USA; [Takahashi-Makise, Naoko; Li, Liangtao; Seguin, Alexandra; Ward, Diane M.; Kaplan, Jerry] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84312 USA; [Narla, Anupama; Hattangadi, Shilpa M.; Paw, Barry H.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Med,Div Hematol Oncol, Boston, MA 02115 USA; [Hattangadi, Shilpa M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Hattangadi, Shilpa M.] MIT, Cambridge, MA 02142 USA; [Medlock, Amy E.; Dailey, Tamara A.; Dailey, Harry A.] Univ Georgia, Dept Microbiol, Biomed & Hlth Sci Inst, Athens, GA 30602 USA; [Medlock, Amy E.; Dailey, Tamara A.; Dailey, Harry A.] Univ Georgia, Dept Biochem, Biomed & Hlth Sci Inst, Athens, GA 30602 USA; [Medlock, Amy E.; Dailey, Tamara A.; Dailey, Harry A.] Univ Georgia, Dept Mol Biol, Biomed & Hlth Sci Inst, Athens, GA 30602 USA; [Faccenda, Danilo; Campanella, Michelangelo] Univ London Royal Vet Coll, London NW1 0TU, England; [Faccenda, Danilo; Campanella, Michelangelo] UCL, Consortium Mitochondrial Res, London NW1 0TU, England; [Wiwczar, Jessica M.; Danial, Nika N.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Campagna, Dean R.; Fleming, Mark D.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Brugnara, Carlo] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Utah System of Higher Education; University of Utah; Harvard University; Boston Children's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of London; University of London Royal Veterinary College; University of London; University College London; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Paw, BH (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Hematol, Boston, MA 02115 USA.	hdailey@uga.edu; jerry.kaplan@path.utah.edu; bpaw@rics.bwh.harvard.edu	; Campanella, Michelangelo/K-8172-2016	Vogin, Guillaume/0000-0002-8114-5900; Faccenda, Danilo/0000-0003-2827-2529; Paw, Barry/0000-0002-0492-1419; Shah, Dhvanit/0000-0002-3173-2402; Campanella, Michelangelo/0000-0002-6948-4184; Fleming, Mark/0000-0003-0948-4024; Medlock, Amy/0000-0001-9402-3593	Cooley's Anemia Foundation; March of Dimes Foundation; American Heart Association; Dutch National Science Fund; Fondation Soldati pour la Recherche en Cancerologie; Burroughs Welcome Fund; NIDDK; NHLBI; Biotechnology and Biological Sciences Research Council [BB/I013695/1] Funding Source: researchfish; BBSRC [BB/I013695/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082945, P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK032303, K01DK085217, R01DK070838, R01DK087992, R01DK096051, R01DK052380, P30DK072437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	Cooley's Anemia Foundation; March of Dimes Foundation(March of Dimes); American Heart Association(American Heart Association); Dutch National Science Fund; Fondation Soldati pour la Recherche en Cancerologie; Burroughs Welcome Fund(Burroughs Wellcome Fund); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of our laboratory (M. Cassim, A. Kaplan, G. Hildick-Smith and H. Anderson) and colleagues (S. L. Alper, K. Pepper and N. S. Trede) for critical review of the manuscript, T. C. Law for pnt adult blood characterization, H. Mulhern for help with the electron microscopy, and Christopher Lawrence and his team for the zebrafish husbandry. This research was supported in part by the Cooley's Anemia Foundation (D.I.S. and C.C.), the March of Dimes Foundation (B.H.P.), the American Heart Association (J.D.C. and A.E.M.), the Dutch National Science Fund (I.J.S.), the Fondation Soldati pour la Recherche en Cancerologie (G.V.), the Burroughs Welcome Fund (N.N.D.), the NIDDK (D.I.S., B.H.P., A.N., J.K., H.A.D. and S.M.H.) and the NHLBI (D.I.S. and B.H.P).	Anderson K. E., 2011, ONLINE METABOLIC MOL, P1; Ando C, 2008, J BIOCHEM, V144, P547, DOI 10.1093/jb/mvn100; Camaschella C, 2009, SEMIN HEMATOL, V46, P371, DOI 10.1053/j.seminhematol.2009.07.001; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Campanella M, 2009, TRENDS BIOCHEM SCI, V34, P343, DOI 10.1016/j.tibs.2009.03.006; Cao YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020634; Childs S, 2000, CURR BIOL, V10, P1001, DOI 10.1016/S0960-9822(00)00653-9; Crooks DR, 2010, BLOOD, V115, P860, DOI 10.1182/blood-2009-09-243105; Formentini L, 2012, MOL CELL, V45, P731, DOI 10.1016/j.molcel.2012.01.008; Froschauer EM, 2009, BBA-BIOMEMBRANES, V1788, P1044, DOI 10.1016/j.bbamem.2009.03.004; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Iolascon A, 2009, HAEMATOL-HEMATOL J, V94, P395, DOI 10.3324/haematol.13619; Lange H, 1999, J BIOL CHEM, V274, P18989, DOI 10.1074/jbc.274.27.18989; Lanzilotta W.N., 2011, HDB METALLOPROTEINS, V4, P138; Li LT, 2004, J BIOL CHEM, V279, P33653, DOI 10.1074/jbc.M403146200; Medlock AE, 2000, BIOCHEMISTRY-US, V39, P7461, DOI 10.1021/bi000134p; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; North TE, 2010, P NATL ACAD SCI USA, V107, P17315, DOI 10.1073/pnas.1008209107; Park D, 2011, NATURE, V477, P220, DOI 10.1038/nature10340; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Ransom DG, 1996, DEVELOPMENT, V123, P311; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Sheftel AD, 2009, ACTA HAEMATOL-BASEL, V122, P120, DOI 10.1159/000243796; Shin JT, 2002, ANNU REV GENOM HUM G, V3, P311, DOI 10.1146/annurev.genom.3.031402.131506; WALKER JE, 1994, CURR OPIN STRUC BIOL, V4, P912, DOI 10.1016/0959-440X(94)90274-7; Yu DN, 2010, GENE DEV, V24, P1620, DOI 10.1101/gad.1942110	30	67	74	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					608	612		10.1038/nature11536	http://dx.doi.org/10.1038/nature11536			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23135403	Green Accepted, Green Submitted			2022-12-28	WOS:000311339800055
J	Knight, ZA; Tan, K; Birsoy, K; Schmidt, S; Garrison, JL; Wysocki, RW; Emiliano, A; Ekstrand, MI; Friedman, JM				Knight, Zachary A.; Tan, Keith; Birsoy, Kivanc; Schmidt, Sarah; Garrison, Jennifer L.; Wysocki, Robert W.; Emiliano, Ana; Ekstrand, Mats I.; Friedman, Jeffrey M.			Molecular Profiling of Activated Neurons by Phosphorylated Ribosome Capture	CELL			English	Article							CELL-TYPES; GENE-EXPRESSION; NERVOUS-SYSTEM; GLUCOSE-HOMEOSTASIS; OSMOTIC STIMULATION; SIGNALING PATHWAY; ARCUATE NUCLEUS; NEUROPEPTIDE-Y; MESSENGER-RNA; BODY-WEIGHT	The mammalian brain is composed of thousands of interacting neural cell types. Systematic approaches to establish the molecular identity of functional populations of neurons would advance our understanding of neural mechanisms controlling behavior. Here, we show that ribosomal protein S6, a structural component of the ribosome, becomes phosphorylated in neurons activated by a wide range of stimuli. We show that these phosphorylated ribosomes can be captured from mouse brain homogenates, thereby enriching directly for the mRNAs expressed in discrete subpopulations of activated cells. We use this approach to identify neurons in the hypothalamus regulated by changes in salt balance or food availability. We show that galanin neurons are activated by fasting and that prodynorphin neurons restrain food intake during scheduled feeding. These studies identify elements of the neural circuit that controls food intake and illustrate how the activity-dependent capture of cell-type-specific transcripts can elucidate the functional organization of a complex tissue.	[Knight, Zachary A.; Tan, Keith; Birsoy, Kivanc; Schmidt, Sarah; Garrison, Jennifer L.; Wysocki, Robert W.; Emiliano, Ana; Ekstrand, Mats I.; Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Genet, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Knight, ZA (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Genet, 1230 York Ave, New York, NY 10021 USA.	zachary.knight@ucsf.edu; friedj@rockefeller.edu		Knight, Zachary/0000-0001-7621-1478; Ekstrand, Mats/0000-0003-0019-9462; Wysocki, Robert/0000-0001-9812-6071	JPB Foundation; NIH [DK083531]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK083531, R00DK083531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095654] Funding Source: NIH RePORTER	JPB Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by funding from the JPB Foundation (J.M.F.) and NIH grant DK083531 (Z.A.K.). The authors have filed a patent related to this work. Dr. Friedman is a Founder of Envoy Therapeutics and holds equity in it and receives a retainer from the company. Envoy holds an option to license this technology from the Rockefeller University.	Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; BROWN MR, 1988, BRAIN RES, V452, P212, DOI 10.1016/0006-8993(88)90025-X; Bruchas MR, 2007, J BIOL CHEM, V282, P29803, DOI 10.1074/jbc.M705540200; Cao RF, 2008, MOL CELL NEUROSCI, V38, P312, DOI 10.1016/j.mcn.2008.03.005; Carroll I, 2004, EUR J PHARMACOL, V501, P111, DOI 10.1016/j.ejphar.2004.08.028; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; de Mateos-Verchere JG, 2001, EUR J PHARMACOL, V414, P225; Dielenberg RA, 2001, NEUROSCIENCE, V104, P1085, DOI 10.1016/S0306-4522(01)00150-6; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; GAI WP, 1990, J COMP NEUROL, V298, P265, DOI 10.1002/cne.902980302; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hahm S, 2002, J NEUROSCI, V22, P6929; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; Ivanova EA, 2008, AM J PHYSIOL-ENDOC M, V294, pE176, DOI 10.1152/ajpendo.00199.2007; Koch C., 2001, INT ENCY SOCIAL BEHA, P2600; Koch C, 2012, NATURE, V483, P397, DOI 10.1038/483397a; Koike K, 1997, MOL BRAIN RES, V52, P326, DOI 10.1016/S0169-328X(97)00300-8; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; Porter JP, 2004, AM J PHYSIOL-REG I, V287, pR422, DOI 10.1152/ajpregu.00537.2003; Reaux-Le Goazigo A, 2011, AM J PHYSIOL-ENDOC M, V301, pE955, DOI 10.1152/ajpendo.00090.2011; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; SCHWARTZ MW, 1993, BRAIN RES BULL, V31, P361, DOI 10.1016/0361-9230(93)90228-4; SHERMAN TG, 1986, NEUROENDOCRINOLOGY, V44, P222, DOI 10.1159/000124649; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Stevens CF, 1998, CURR BIOL, V8, pR708, DOI 10.1016/S0960-9822(98)70454-3; Sunn N, 2002, P NATL ACAD SCI USA, V99, P1701, DOI 10.1073/pnas.022647699; THORNTON SN, 1995, J NEUROENDOCRINOL, V7, P165, DOI 10.1111/j.1365-2826.1995.tb00743.x; Valjent E, 2011, NEUROPSYCHOPHARMACOL, V36, P2561, DOI 10.1038/npp.2011.144; Verhagen LAW, 2011, EUR NEUROPSYCHOPHARM, V21, P384, DOI 10.1016/j.euroneuro.2010.06.005; Villanueva EC, 2009, ENDOCRINOLOGY, V150, P4541, DOI 10.1210/en.2009-0642; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhou D, 2005, REGUL PEPTIDES, V124, P53, DOI 10.1016/j.regpep.2004.06.026	49	187	190	0	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 21	2012	151	5					1126	1137		10.1016/j.cell.2012.10.039	http://dx.doi.org/10.1016/j.cell.2012.10.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178128	Green Accepted, Bronze			2022-12-28	WOS:000311423500023
J	Soufi, A; Donahue, G; Zaret, KS				Soufi, Abdenour; Donahue, Greg; Zaret, Kenneth S.			Facilitators and Impediments of the Pluripotency Reprogramming Factors' Initial Engagement with the Genome	CELL			English	Article							EMBRYONIC STEM-CELLS; HUMAN SOMATIC-CELLS; TRANSCRIPTION FACTORS; CRYSTAL-STRUCTURE; HUMAN FIBROBLASTS; IN-VITRO; GENERATION; CHROMATIN; DNA; EXPRESSION	The ectopic expression of transcription factors can reprogram cell fate, yet it is unknown how the initial binding of factors to the genome relates functionally to the binding seen in the minority of cells that become reprogrammed. We report a map of Oct4, Sox2, Klf4, and c-Myc (O, S, K, and M) on the human genome during the first 48 hr of reprogramming fibroblasts to pluripotency. Three striking aspects of the initial chromatin binding events include an unexpected role for c-Myc in facilitating OSK chromatin engagement, the primacy of O, S, and K as pioneer factors at enhancers of genes that promote reprogramming, and megabase-scale chromatin domains spanned by H3K9me3, including many genes required for pluripotency, that prevent initial OSKM binding and impede the efficiency of reprogramming. We find diverse aspects of initial factor binding that must be overcome in the minority of cells that become reprogrammed.	[Soufi, Abdenour; Donahue, Greg; Zaret, Kenneth S.] Univ Penn, Dept Cell & Dev Biol, Smilow Ctr Translat Res, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Zaret, KS (corresponding author), Univ Penn, Dept Cell & Dev Biol, Smilow Ctr Translat Res, Perelman Sch Med, Bldg 421,Rooms 131-132,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	zaret@upenn.edu		Soufi, Abdenour/0000-0002-3666-3266	NIH [R37GM36477, P01GM099134]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099134, R01GM036477, R37GM036477] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Kim for iPS reagents; G. Blobel, K. Blahnik, J. Caravaca, M. Iwafuchi-Doi, and J. Kim for comments on the manuscript; and K. Kaestner and J. Schug for sequencing by the UPenn Diabetes Research Center Functional Genomics Gore (P30-DK19525). The work was supported by NIH grants R37GM36477 and P01GM099134 to K.S.Z.	ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chandra T, 2012, MOL CELL, V47, P203, DOI 10.1016/j.molcel.2012.06.010; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Knoepfler PS, 2008, CELL STEM CELL, V2, P18, DOI 10.1016/j.stem.2007.12.004; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Lerou PH, 2008, NAT PROTOC, V3, P923, DOI 10.1038/nprot.2008.60; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Mah N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024351; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Taberlay PC, 2011, CELL, V147, P1283, DOI 10.1016/j.cell.2011.10.040; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	55	568	585	4	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					994	1004		10.1016/j.cell.2012.09.045	http://dx.doi.org/10.1016/j.cell.2012.09.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23159369	Green Accepted, Bronze			2022-12-28	WOS:000311423500013
J	Kepros, J				Kepros, John			Refusal of transfusions for cardiac surgery was not associated with shorter long-term survival	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							REQUIREMENTS; TRIAL		Michigan State Univ, Sparrow Hlth Syst, Lansing, MI 48824 USA	Michigan State University	Kepros, J (corresponding author), Michigan State Univ, Sparrow Hlth Syst, Lansing, MI 48824 USA.							Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10							JC5-11	10.7326/0003-4819-157-10-201211200-02011	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043VZ	23165687				2022-12-28	WOS:000311580000010
J	Martinez, GJ; Rao, A				Martinez, Gustavo J.; Rao, Anjana			Cooperative Transcription Factor Complexes in Control	SCIENCE			English	Editorial Material							CRYSTAL-STRUCTURE; TERNARY COMPLEX; T-CELLS; JUN; STAT3; NFAT; IRF		[Martinez, Gustavo J.; Rao, Anjana] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Martinez, GJ (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.	arao@liai.org		Martinez, Gustavo/0000-0003-0178-3329	NCI NIH HHS [R01 CA42471, R01 CA042471] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042471] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Escalante CR, 2002, MOL CELL, V10, P1097, DOI 10.1016/S1097-2765(02)00703-7; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Martinez GJ, 2008, ANN NY ACAD SCI, V1143, P188, DOI 10.1196/annals.1443.021; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Zhang XK, 1999, MOL CELL BIOL, V19, P7138	15	29	29	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2012	338	6109					891	892		10.1126/science.1231310	http://dx.doi.org/10.1126/science.1231310			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161983	Green Accepted			2022-12-28	WOS:000311083600027
J	Montealegre-Z, F; Jonsson, T; Robson-Brown, KA; Postles, M; Robert, D				Montealegre-Z, Fernando; Jonsson, Thorin; Robson-Brown, Kate A.; Postles, Matthew; Robert, Daniel			Convergent Evolution Between Insect and Mammalian Audition	SCIENCE			English	Article							AUDITORY RECEPTOR ORGANS; BUSH-CRICKETS; MORPHOLOGY; PHYSIOLOGY; EAR	In mammals, hearing is dependent on three canonical processing stages: (i) an eardrum collecting sound, (ii) a middle ear impedance converter, and (iii) a cochlear frequency analyzer. Here, we show that some insects, such as rainforest katydids, possess equivalent biophysical mechanisms for auditory processing. Although katydid ears are among the smallest in all organisms, these ears perform the crucial stage of air-to-liquid impedance conversion and signal amplification, with the use of a distinct tympanal lever system. Further along the chain of hearing, spectral sound analysis is achieved through dispersive wave propagation across a fluid substrate, as in the mammalian cochlea. Thus, two phylogenetically remote organisms, katydids and mammals, have evolved a series of convergent solutions to common biophysical problems, despite their reliance on very different morphological substrates.	[Montealegre-Z, Fernando; Jonsson, Thorin; Postles, Matthew; Robert, Daniel] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [Robson-Brown, Kate A.] Univ Bristol, Dept Archaeol & Anthropol, Imaging Lab, Bristol BS8 1UG, Avon, England	University of Bristol; University of Bristol	Montealegre-Z, F (corresponding author), Lincoln Univ, Sch Life Sci, Riseholme Campus, Lincoln LN2 2LG, England.	fmontealegrez@lincoln.ac.uk; d.robert@bristol.ac.uk	Jonsson, Thorin/AAH-3490-2019	Jonsson, Thorin/0000-0002-5049-7612	Human Frontier Science Program (Cross Disciplinary Fellowship) [LT00024/2008-C]; Royal Society of London; UK-India Education and Research Initiative [SA06-169E]; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/C518522/1, BB/I009671/1] Funding Source: researchfish; BBSRC [BB/I009671/1] Funding Source: UKRI	Human Frontier Science Program (Cross Disciplinary Fellowship)(Human Frontier Science Program); Royal Society of London(Royal Society of London); UK-India Education and Research Initiative; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was sponsored by the Human Frontier Science Program (Cross Disciplinary Fellowship LT00024/2008-C to F.M.-Z.). D. R. is supported by the Royal Society of London. This research was also partially supported by the UK-India Education and Research Initiative (grant no. SA06-169E) and the Biotechnology and Biological Sciences Research Council. We declare no conflict of interest. The Colombian Ministry of Environment granted a permit for fieldwork at Gorgona National Park (decree DTS0-G-31 11/07). All additional information regarding data generation is given in the text and the supplementary materials.	Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; Bangert M, 1998, HEARING RES, V115, P27, DOI 10.1016/S0378-5955(97)00177-9; BELWOOD JJ, 1987, SCIENCE, V238, P64, DOI 10.1126/science.238.4823.64; BIALEK W, 1987, ANNU REV BIOPHYS BIO, V16, P455; Boistel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022080; Hoy RR, 1996, ANNU REV ENTOMOL, V41, P433, DOI 10.1146/annurev.en.41.010196.002245; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; KALMRING K, 1993, ZOOL JAHRB ALLG ZOOL, V97, P75; LEWIS DB, 1974, J EXP BIOL, V60, P839; Montealegre-Z Fernando, 2010, Journal of Orthoptera Research, V19, P347, DOI 10.1665/034.019.0223; Muller J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000889; Nowotny M, 2010, J COMP PHYSIOL A, V196, P939, DOI 10.1007/s00359-010-0577-6; OLDFIELD BP, 1982, J COMP PHYSIOL, V147, P461, DOI 10.1007/BF00612011; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Thomassen HA, 2007, HEARING RES, V225, P25, DOI 10.1016/j.heares.2006.11.013; Udayashankar AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031008; vonBekesy G., 1960, EXPT HEARING; Windmill JFC, 2005, J EXP BIOL, V208, P157, DOI 10.1242/jeb.01332; Yack JE, 2004, MICROSC RES TECHNIQ, V63, P315, DOI 10.1002/jemt.20051	19	57	60	4	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					968	971		10.1126/science.1225271	http://dx.doi.org/10.1126/science.1225271			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23162003				2022-12-28	WOS:000311083600049
J	Loscalzo, J				Loscalzo, Joseph			From Clinical Observation to Mechanism - Heyde's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VON-WILLEBRAND-FACTOR; AORTIC-STENOSIS; GASTROINTESTINAL ANGIODYSPLASIA; MONOCLONAL GAMMOPATHY; FACTOR MULTIMERS; DISEASE; AGGREGATION; ASSOCIATION; DIAGNOSIS; PLASMA		[Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Loscalzo, Joseph] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Loscalzo, J (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.		Loscalzo, Joseph/ABD-8980-2021					BHUTANI MS, 1995, GASTROINTEST ENDOSC, V42, P398, DOI 10.1016/S0016-5107(95)70038-2; CHOW TW, 1992, BLOOD, V80, P113; COOPERMAN M, 1979, ANN SURG, V190, P24, DOI 10.1097/00000658-197907000-00005; Crawley JTB, 2011, BLOOD, V118, P3212, DOI 10.1182/blood-2011-02-306597; GILL JC, 1986, BLOOD, V67, P758; GREENSTEIN RJ, 1986, AM J SURG, V151, P347, DOI 10.1016/0002-9610(86)90465-4; Gupta PK, 2006, HAEMOPHILIA, V12, P452, DOI 10.1111/j.1365-2516.2006.01301.x; HEYDE EC, 1958, NEW ENGL J MED, V259, P196; Ho-Tin-Noe B, 2011, J THROMB HAEMOST, V9, P56, DOI 10.1111/j.1538-7836.2011.04317.x; JASPERSEN D, 1994, GASTROINTEST ENDOSC, V40, P40, DOI 10.1016/S0016-5107(94)70007-9; KING RM, 1987, ANN THORAC SURG, V44, P514, DOI 10.1016/S0003-4975(10)62112-1; Koscielny JK, 2000, THROMB HAEMOSTASIS, V84, P981; Lamboley V, 2002, JOINT BONE SPINE, V69, P62, DOI 10.1016/S1297-319X(01)00343-8; Panzer S, 2010, THROMB HAEMOSTASIS, V103, P408, DOI 10.1160/TH09-06-0391; SALZMAN EW, 1986, NEW ENGL J MED, V314, P1402, DOI 10.1056/NEJM198605293142202; Schodel J, 2007, INT J CARDIOL, V120, P286, DOI 10.1016/j.ijcard.2006.08.078; Shimizu M, 2007, INTERNAL MED, V46, P481, DOI 10.2169/internalmedicine.46.6026; STEWART AK, 1990, POSTGRAD MED J, V66, P560, DOI 10.1136/pgmj.66.777.560; TSAI HM, 1994, BLOOD, V83, P2171; Veyradier A, 2001, GASTROENTEROLOGY, V120, P346, DOI 10.1053/gast.2001.21204; Vincentelli A, 2003, NEW ENGL J MED, V349, P343, DOI 10.1056/NEJMoa022831; WARKENTIN TE, 1992, LANCET, V340, P35, DOI 10.1016/0140-6736(92)92434-H	22	96	99	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2012	367	20					1954	1956		10.1056/NEJMcibr1205363	http://dx.doi.org/10.1056/NEJMcibr1205363			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036MB	23150964				2022-12-28	WOS:000311029300015
J	Montano, SP; Pigli, YZ; Rice, PA				Montano, Sherwin P.; Pigli, Ying Z.; Rice, Phoebe A.			The Mu transpososome structure sheds light on DDE recombinase evolution	NATURE			English	Article							IN-VITRO TRANSPOSITION; DNA-BINDING DOMAIN; BACTERIOPHAGE-MU; PHAGE-MU; STRAND TRANSFER; CRYSTAL-STRUCTURE; COMPLEX; PROTEIN; CLPX; INTEGRATION	Studies of bacteriophage Mu transposition paved the way for understanding retroviral integration and V(D)J recombination as well as many other DNA transposition reactions. Here we report the structure of the Mu transpososome-Mu transposase (MuA) in complex with bacteriophage DNA ends and target DNA-determined from data that extend anisotropically to 5.2 angstrom, 5.2 angstrom and 3.7 angstrom resolution, in conjunction with previously determined structures of individual domains. The highly intertwined structure illustrates why chemical activity depends on formation of the synaptic complex, and reveals that individual domains have different roles when bound to different sites. The structure also provides explanations for the increased stability of the final product complex and for its preferential recognition by the ATP-dependent unfoldase ClpX. Although MuA and many other recombinases share a structurally conserved 'DDE' catalytic domain, comparisons among the limited set of available complex structures indicate that some conserved features, such as catalysis in trans and target DNA bending, arose through convergent evolution because they are important for function.	[Montano, Sherwin P.; Pigli, Ying Z.; Rice, Phoebe A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago	Rice, PA (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.	PRice@uchicago.edu			NIH [GM086826]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086826] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Mizuuchi for initiating this project, K. K. Swinger and B. Vertessy for early crystallization efforts, and X. Yang and the staff of APS beamlines 14, 19 and 21 for assistance with data collection. This work was funded in part by NIH grant GM086826 (to P.A.R.).	Abdelhakim AH, 2008, MOL CELL, V30, P39, DOI 10.1016/j.molcel.2008.02.013; Abdelhakim AH, 2010, P NATL ACAD SCI USA, V107, P2437, DOI 10.1073/pnas.0910905106; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aldaz H, 1996, CELL, V85, P257, DOI 10.1016/S0092-8674(00)81102-2; ALLISON RG, 1992, J BIOL CHEM, V267, P19963; Au TK, 2004, EMBO J, V23, P3408, DOI 10.1038/sj.emboj.7600344; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER TA, 1992, GENE DEV, V6, P2221, DOI 10.1101/gad.6.11.2221; BAKER TA, 1993, CELL, V74, P723, DOI 10.1016/0092-8674(93)90519-V; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burton BM, 2003, CHEM BIOL, V10, P463, DOI 10.1016/S1074-5521(03)00102-9; CHACONAS G, 1983, VIROLOGY, V128, P48, DOI 10.1016/0042-6822(83)90317-3; Choi W, 2010, P NATL ACAD SCI USA, V107, P10014, DOI 10.1073/pnas.0912615107; Clubb RT, 1997, J MOL BIOL, V273, P19, DOI 10.1006/jmbi.1997.1312; CRAIG NL, 2002, MOBILE DNA, V2; CRAIGIE R, 1986, CELL, V45, P793, DOI 10.1016/0092-8674(86)90554-4; CRAIGIE R, 1984, CELL, V39, P387, DOI 10.1016/0092-8674(84)90017-5; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Ducruix A., 1992, PREPARATION SELENOME; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Haapa S, 1999, NUCLEIC ACIDS RES, V27, P2777, DOI 10.1093/nar/27.13.2777; Harshey RM, 2006, CRIT REV BIOCHEM MOL, V41, P387, DOI 10.1080/10409230600946015; Jiang H, 1999, EMBO J, V18, P3845, DOI 10.1093/emboj/18.13.3845; Krementsova E, 1998, J BIOL CHEM, V273, P31358, DOI 10.1074/jbc.273.47.31358; Kruklitis R, 1996, EMBO J, V15, P935, DOI 10.1002/j.1460-2075.1996.tb00428.x; KUO CF, 1991, EMBO J, V10, P1585, DOI 10.1002/j.1460-2075.1991.tb07679.x; LAVOIE BD, 1993, GENE DEV, V7, P2510, DOI 10.1101/gad.7.12b.2510; LAVOIE BD, 1991, EMBO J, V10, P3051, DOI 10.1002/j.1460-2075.1991.tb07856.x; LEVCHENKO I, 1995, GENE DEV, V9, P2399, DOI 10.1101/gad.9.19.2399; Levchenko I, 1997, GENE DEV, V11, P1561, DOI 10.1101/gad.11.12.1561; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; MHAMMEDIALAOUI A, 1994, MOL MICROBIOL, V11, P1109, DOI 10.1111/j.1365-2958.1994.tb00387.x; MIZUUCHI K, 1983, CELL, V35, P785, DOI 10.1016/0092-8674(83)90111-3; Mizuuchi M, 2001, EMBO J, V20, P6927, DOI 10.1093/emboj/20.23.6927; MIZUUCHI M, 1991, P NATL ACAD SCI USA, V88, P9031, DOI 10.1073/pnas.88.20.9031; Mizuuchi M, 2007, P NATL ACAD SCI USA, V104, P14622, DOI 10.1073/pnas.0706556104; Montano SP, 2011, CURR OPIN STRUC BIOL, V21, P370, DOI 10.1016/j.sbi.2011.03.004; Naigamwalla DZ, 1998, J MOL BIOL, V282, P265, DOI 10.1006/jmbi.1998.2011; Namgoong SY, 1998, NUCLEIC ACIDS RES, V26, P3521, DOI 10.1093/nar/26.15.3521; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pribil PA, 2003, J MOL BIOL, V330, P247, DOI 10.1016/S0022-2836(03)00588-6; RICE P, 1995, CELL, V82, P209, DOI 10.1016/0092-8674(95)90308-9; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Savilahti H, 1996, CELL, V85, P271, DOI 10.1016/S0092-8674(00)81103-4; SAVILAHTI H, 1995, EMBO J, V14, P4893, DOI 10.1002/j.1460-2075.1995.tb00170.x; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Schumacher S, 1997, EMBO J, V16, P7532, DOI 10.1093/emboj/16.24.7532; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; SURETTE MG, 1989, J BIOL CHEM, V264, P3028; SURETTE MG, 1992, CELL, V68, P1101, DOI 10.1016/0092-8674(92)90081-M; SURETTE MG, 1987, CELL, V49, P253, DOI 10.1016/0092-8674(87)90566-6; Swinger KK, 2007, J MOL BIOL, V365, P1005, DOI 10.1016/j.jmb.2006.10.024; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; Tanaka Y, 2001, EMBO J, V20, P6612, DOI 10.1093/emboj/20.23.6612; Watkins S, 2004, NUCLEIC ACIDS RES, V32, P4306, DOI 10.1093/nar/gkh770; WU ZG, 1995, EMBO J, V14, P3835, DOI 10.1002/j.1460-2075.1995.tb00053.x; Yanagihara K, 2002, P NATL ACAD SCI USA, V99, P11317, DOI 10.1073/pnas.132403399; YANG JY, 1995, EMBO J, V14, P2374, DOI 10.1002/j.1460-2075.1995.tb07232.x; Yuan JF, 2005, GENE DEV, V19, P840, DOI 10.1101/gad.1291405; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X; Zheng GH, 2009, NUCLEIC ACIDS RES, V37, pW240, DOI 10.1093/nar/gkp358; ZOU A, 1991, J BIOL CHEM, V266, P20476	63	83	86	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					413	+		10.1038/nature11602	http://dx.doi.org/10.1038/nature11602			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23135398	Green Accepted			2022-12-28	WOS:000311031600039
J	Wu, CY; Chen, YJ; Ho, HJ; Hsu, YC; Kuo, KN; Wu, MS; Lin, JT				Wu, Chun-Ying; Chen, Yi-Ju; Ho, Hsiu J.; Hsu, Yao-Chun; Kuo, Ken N.; Wu, Ming-Shiang; Lin, Jaw-Town			Association Between Nucleoside Analogues and Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma Recurrence Following Liver Resection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMORTAL TIME BIAS; ANTIVIRAL THERAPY; VIRAL LOAD; LAMIVUDINE; SURVIVAL; REPLICATION; APOPTOSIS; IMPACT	Context Tumor recurrence is a major issue for patients with hepatocellular carcinoma (HCC) following curative liver resection. Objective To investigate the association between nucleoside analogue use and risk of tumor recurrence in patients with hepatitis B virus (HBV)-related HCC after curative surgery. Design, Setting, and Participants A nationwide cohort study between October 2003 and September 2010. Data from the Taiwan National Health Insurance Research Database. Among 100 938 newly diagnosed HCC patients, we identified 4569 HBV-related HCC patients who received curative liver resection for HCC between October 2003 and September 2010. Main Outcome Measures The risk of first tumor recurrence was compared between patients not taking nucleoside analogues (untreated cohort, n=4051) and patients taking nucleoside analogues (treated cohort, n=518). Cumulative incidences and hazard ratios (HRs) were calculated after adjusting for competing mortality. Results The treated cohort had a higher prevalence of liver cirrhosis when compared with the untreated cohort (48.6% vs 38.7%; P<.001), but lower risk of HCC recurrence (n=106 [20.5%] vs n=1765 [43.6%]; P<.001), and lower overall death (n=55 [10.6%] vs n=1145 [28.3%]; P<.001). After adjusting for competing mortality, the treated cohort had a significantly lower 6-year HCC recurrence rate (45.6%; 95% CI, 36.5%-54.6% vs untreated, 54.6%; 95% CI, 52.5%-56.6%; P<.001). Six-year overall mortalities for treated cohorts were 29.0% (95% CI, 20.0%-38.0%) and for untreated 42.4% (95% CI, 40.0%-44.7%; P<.001). On modified Cox regression analysis, nucleoside analogue use (HR, 0.67; 95% CI, 0.55-0.81; P<.001), statin use (HR, 0.68; 95% CI, 0.53-0.87; P=.002), and nonsteroidal anti-inflammatory drugs or aspirin use (HR, 0.80; 95% CI, 0.73-0.88; P<.001) were independently associated with a reduced risk of HCC recurrence. Multivariable stratified analyses verified the association in all subgroups of patients, including those who were noncirrhotic (HR, 0.56; 95% CI, 0.42-0.76) and diabetic (HR, 0.52; 95% CI, 0.31-0.89). Conclusion Nucleoside analogue use was associated with a lower risk of HCC recurrence among patients with HBV-related HCC after liver resection. JAMA. 2012; 308(18): 1906-1913 Published online November 12, 2012. doi: 10.1001/2012.jama.11975 www.jama.com	[Wu, Chun-Ying; Chen, Yi-Ju] Natl Yang Ming Univ, Sch Med, Taipei 11221, Taiwan; [Wu, Chun-Ying] Taichung Vet Gen Hosp, Div Gastroenterol, Taichung, Taiwan; [Chen, Yi-Ju] Taichung Vet Gen Hosp, Dept Dermatol, Taichung, Taiwan; [Wu, Chun-Ying; Hsu, Yao-Chun] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Wu, Chun-Ying; Hsu, Yao-Chun] China Med Univ, Grad Inst Clin Med, Taichung, Taiwan; [Wu, Chun-Ying] Natl Yang Ming Univ, Dept Life Sci, Taipei 11221, Taiwan; [Ho, Hsiu J.; Wu, Ming-Shiang; Lin, Jaw-Town] Natl Taiwan Univ Hosp, Div Gastroenterol, Taipei, Taiwan; [Hsu, Yao-Chun; Lin, Jaw-Town] I Shou Univ, Dept Internal Med, E Da Hosp, Kaohsiung, Taiwan; [Kuo, Ken N.] Taipei Med Coll, Coll Med, Taipei, Taiwan; [Kuo, Ken N.; Lin, Jaw-Town] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan; [Lin, Jaw-Town] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; E-Da Hospital; I Shou University; Taipei Medical University; National Health Research Institutes - Taiwan; Fu Jen Catholic University	Wu, CY (corresponding author), Natl Yang Ming Univ, Sch Med, 155,Sect 2,Linong St, Taipei 11221, Taiwan.	chun@vghtc.gov.tw	Wu, Chun-Ying/AAX-5077-2021	Wu, Chun-Ying/0000-0001-5053-1801; Wu, Ming-Shiang/0000-0002-1940-6428	National Health Research Institutes; Taiwan's National Health Research Institute [PH-101-PP-23]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan); Taiwan's National Health Research Institute	The National Health Research Institutes provided access to the National Health Insurance Research Database (NHIRD) and financial support for the hiring of a research assistant. This work was supported by Taiwan's National Health Research Institute (PH-101-PP-23). This study is based on data from the NHIRD provided by the Bureau of National Health Insurance, Department of Health, and managed by the NHIRD, Taiwan.	Chan ACY, 2011, ARCH SURG-CHICAGO, V146, P675, DOI 10.1001/archsurg.2011.125; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cho YK, 2011, J GASTROEN HEPATOL, V26, P1354, DOI 10.1111/j.1440-1746.2011.06812.x; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Grazi GL, 2003, ALIMENT PHARM THER, V17, P119, DOI 10.1046/j.1365-2036.17.s2.9.x; Hossain MA, 2012, INT J ONCOL, V40, P1298, DOI 10.3892/ijo.2011.1304; Hung IFN, 2008, AM J GASTROENTEROL, V103, P1663, DOI 10.1111/j.1572-0241.2008.01872.x; Jang JW, 2007, CANCER, V110, P1760, DOI 10.1002/cncr.22984; Kim BK, 2008, LIVER INT, V28, P393, DOI 10.1111/j.1478-3231.2007.01625.x; Kubo S, 2000, CANCER-AM CANCER SOC, V88, P1016, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1016::AID-CNCR10>3.0.CO;2-V; Kubo S, 2007, HEPATOL RES, V37, P94, DOI 10.1111/j.1872-034X.2007.00013.x; Kuzuya T, 2007, J GASTROEN HEPATOL, V22, P1929, DOI 10.1111/j.1440-1746.2006.04707.x; Kwon H, 2011, NAT REV GASTRO HEPAT, V8, P275, DOI 10.1038/nrgastro.2011.33; Li N, 2010, ANN SURG ONCOL, V17, P179, DOI 10.1245/s10434-009-0694-z; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2009, J HEPATOL, V51, P403, DOI 10.1016/j.jhep.2009.04.003; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Poon RTP, 2000, J CLIN ONCOL, V18, P1094, DOI 10.1200/JCO.2000.18.5.1094; Raza H, 2011, EUR J PHARMACOL, V668, P15, DOI 10.1016/j.ejphar.2011.06.016; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Sitia G, 2012, P NATL ACAD SCI USA, V109, pE2165, DOI 10.1073/pnas.1209182109; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Suissa S, 2007, PHARMACOEPIDEM DR S, V16, P241, DOI 10.1002/pds.1357; TONG MJ, 1971, ANN INTERN MED, V75, P687, DOI 10.7326/0003-4819-75-5-687; Tsan YT, 2012, J CLIN ONCOL, V30, P623, DOI 10.1200/JCO.2011.36.0917; Wu CY, 2011, GUT, V60, P1038, DOI 10.1136/gut.2010.224329; Wu CY, 2010, GASTROENTEROLOGY, V139, P1165, DOI 10.1053/j.gastro.2010.06.067; Wu CY, 2010, J CLIN ONCOL, V28, P2952, DOI 10.1200/JCO.2009.26.0695; Wu CY, 2009, GASTROENTEROLOGY, V137, P1641, DOI 10.1053/j.gastro.2009.07.060; Wu JC, 2009, J HEPATOL, V51, P890, DOI 10.1016/j.jhep.2009.07.009; Yang PM, 2010, CANCER RES, V70, P7699, DOI 10.1158/0008-5472.CAN-10-1626; Yuen MF, 2011, J GASTROEN HEPATOL, V26, P138, DOI 10.1111/j.1440-1746.2010.06545.x	35	670	694	5	74	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1906	1913		10.1001/2012.jama.11975	http://dx.doi.org/10.1001/2012.jama.11975			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23162861	Green Submitted, Bronze			2022-12-28	WOS:000310952700027
J	Rando, OJ				Rando, Oliver J.			Daddy Issues: Paternal Effects on Phenotype	CELL			English	Article							TRANSGENERATIONAL EPIGENETIC INHERITANCE; DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; MOUSE; TRANSMISSION; ARABIDOPSIS; METHYLATION; MECHANISMS; RESPONSES; DYNAMICS	The once popular and then heretical idea that ancestral environment can affect the phenotype of future generations is coming back into vogue due to advances in the field of epigenetic inheritance. How paternal environmental conditions influence the phenotype of progeny is now a tractable question, and researchers are exploring potential mechanisms underlying such effects.	Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Rando, OJ (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	oliver.rando@umassmed.edu		Rando, Oliver/0000-0003-1516-9397	NIGMS; G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033664] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Thanks to N. Francis, M. Walhout, J. Shea, M. Vallaster, M. Garber, H. Florman, and B. Carone for critical reading of early drafts of this manuscript. I apologize to the many authors of relevant work left uncited due to space constraints. This work was supported by NIGMS and by the G. Harold and Leila Y. Mathers Foundation.	Alcazar RM, 2008, GENETICS, V180, P1275, DOI 10.1534/genetics.108.089433; Anderson LM, 2006, NUTRITION, V22, P327, DOI 10.1016/j.nut.2005.09.006; Arteaga-Vazquez MA, 2010, CURR OPIN GENET DEV, V20, P156, DOI 10.1016/j.gde.2010.01.008; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Avital Eytan, 2000, ANIMAL TRADITIONS BE, DOI 10-1017/CBO9780511542251; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; BENDER J, 1995, CELL, V83, P725, DOI 10.1016/0092-8674(95)90185-X; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chason RJ, 2011, TRENDS ENDOCRIN MET, V22, P412, DOI 10.1016/j.tem.2011.05.005; Chong SY, 2007, NAT GENET, V39, P614, DOI 10.1038/ng2031; Curley JP, 2011, HORM BEHAV, V59, P306, DOI 10.1016/j.yhbeh.2010.06.018; Dietz DM, 2011, BIOL PSYCHIAT, V70, P408, DOI 10.1016/j.biopsych.2011.05.005; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fish EW, 2004, ANN NY ACAD SCI, V1036, P167, DOI 10.1196/annals.1330.011; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Guyonnet B, 2012, MOL CELL PROTEOMICS, V11, P758, DOI 10.1074/mcp.M112.020339; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hauser MT, 2011, BBA-GENE REGUL MECH, V1809, P459, DOI 10.1016/j.bbagrm.2011.03.007; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Katz DJ, 2009, CELL, V137, P308, DOI 10.1016/j.cell.2009.02.015; Li M, 2011, EXP DIABETES RES, DOI [10.1155/2011/592408, 10.4061/2011/179819]; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Nelson VR, 2010, EPIGENOMICS-UK, V2, P513, DOI 10.2217/EPI.10.26; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Ooi SL, 2007, CURR OPIN CELL BIOL, V19, P257, DOI 10.1016/j.ceb.2007.04.015; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pryke SR, 2009, SCIENCE, V323, P1605, DOI 10.1126/science.1168928; Radford EJ, 2012, PLOS GENET, V8, P41, DOI 10.1371/journal.pgen.1002605; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Rassoulzadegan M, 2010, ORGANOGENESIS, V6, P33, DOI 10.4161/org.6.1.11094; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Suh N, 2011, DEVELOPMENT, V138, P1653, DOI 10.1242/dev.056234; van Montfoort APA, 2012, HUM REPROD UPDATE, V18, P171, DOI 10.1093/humupd/dmr047; von Horsten HH, 2007, J BIOL CHEM, V282, P32912, DOI 10.1074/jbc.M703956200; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445	48	192	198	1	64	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					702	708		10.1016/j.cell.2012.10.020	http://dx.doi.org/10.1016/j.cell.2012.10.020			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141533	Bronze, Green Accepted			2022-12-28	WOS:000310921200004
J	Siegel, JS				Siegel, Jay S.			Driving the Formation of Molecular Knots	SCIENCE			English	Editorial Material							CHEMICAL TOPOLOGY; LINKS		Univ Zurich, Inst Organ Chem, CH-8057 Zurich, Switzerland	University of Zurich	Siegel, JS (corresponding author), Univ Zurich, Inst Organ Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	jss@oci.uzh.ch	Siegel, Jay/E-6415-2011	Siegel, Jay/0000-0002-3226-3521				Arias KI, 2011, CHEM COMMUN, V47, P9588, DOI 10.1039/c1cc11209k; Ayme JF, 2012, NAT CHEM, V4, P15, DOI 10.1038/nchem.1193; Bao XR, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.265506; Barran PE, 2011, ANGEW CHEM INT EDIT, V50, P12280, DOI 10.1002/anie.201105012; Chichak KS, 2004, SCIENCE, V304, P1308, DOI 10.1126/science.1096914; Cougnon FBL, 2012, ANGEW CHEM INT EDIT, V51, P1443, DOI 10.1002/anie.201106885; Flammini A, 2007, P R SOC A, V463, P569, DOI 10.1098/rspa.2006.1782; Forgan RS, 2011, CHEM REV, V111, P5434, DOI 10.1021/cr200034u; FRISCH HL, 1961, J AM CHEM SOC, V83, P3789, DOI 10.1021/ja01479a015; LIANG CZ, 1994, J MATH CHEM, V16, P27, DOI 10.1007/BF01169193; Mallam AL, 2008, P NATL ACAD SCI USA, V105, P18740, DOI 10.1073/pnas.0806697105; Piaget J., 1956, CHILDS CONCEPTION SP; Ponnuswamy N, 2012, SCIENCE, V338, P783, DOI 10.1126/science.1227032; Sauvage, 1999, MOL CATENANES ROTAXA; SEEMAN N, 2007, SCI AM REPORTS, V17, P30; WALBA DM, 1985, TETRAHEDRON, V41, P3161, DOI 10.1016/S0040-4020(01)96671-2; WANG JC, 1982, SCI AM, V247, P94, DOI 10.1038/scientificamerican0782-94; Yan LZ, 2001, ANGEW CHEM INT EDIT, V40, P3625, DOI 10.1002/1521-3773(20011001)40:19<3625::AID-ANIE3625>3.0.CO;2-Q	18	6	6	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					752	753		10.1126/science.1230319	http://dx.doi.org/10.1126/science.1230319			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139321				2022-12-28	WOS:000310839500030
J	Raiten, JM; Neuman, MD				Raiten, Jesse M.; Neuman, Mark D.			"If I Had Only Known" - On Choice and Uncertainty in the ICU	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Raiten, Jesse M.; Neuman, Mark D.] Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA; [Neuman, Mark D.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Raiten, JM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA.							Mol A, 2009, LANCET, V373, P1756, DOI 10.1016/S0140-6736(09)60971-5; Mol Annemarie, 2008, LOGIC CARE HLTH PROB, DOI DOI 10.4324/9780203927076; Nelson JE, 2010, AM J RESP CRIT CARE, V182, P446, DOI 10.1164/rccm.201002-0210CI; Neuman MD, 2012, MILBANK Q, V90, P135, DOI 10.1111/j.1468-0009.2011.00657.x; Schwarze ML, 2010, CRIT CARE MED, V38, P843, DOI 10.1097/CCM.0b013e3181cc466b	5	10	10	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2012	367	19					1779	1781		10.1056/NEJMp1209698	http://dx.doi.org/10.1056/NEJMp1209698			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033DG	23134380				2022-12-28	WOS:000310773200004
J	Fatah, F				Fatah, Fazel			Should all advertising of cosmetic surgery be banned? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DEFINITION		Westbourne Ctr, Birmingham B15 3SJ, W Midlands, England		Fatah, F (corresponding author), Westbourne Ctr, Birmingham B15 3SJ, W Midlands, England.	ffatah@aol.com						All Party Parliamentary Group on Body Image, 2012, REFLECTIONS ON BODY; [Anonymous], 2011, DAILY MAIL; Awofeso N, 2005, B WHO; Bircher Johannes, 2005, Med Health Care Philos, V8, P335, DOI 10.1007/s11019-005-0538-y; Boseley Sara, 2012, GUARDIAN; Department of Health, 2012, VIEWS SOUGHT FOR REV; DYER AR, 1985, J MED ETHICS, V11, P72, DOI 10.1136/jme.11.2.72; Fogli A., 2009, CLIN RISK, V15, P224; Hall Sarah, 2006, GUARDIAN; Miller FG, 2000, CAMB Q HEALTHC ETHIC, V9, P353, DOI 10.1017/S0963180100903074; Saracci R, 1997, BRIT MED J, V314, P1409; Spilson SV, 2002, PLAST RECONSTR SURG, V109, P1181, DOI 10.1097/00006534-200203000-00064; World Health Organization, 1946, WHO DEFINITION OF HE	13	7	7	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 7	2012	345								e7489	10.1136/bmj.e7489	http://dx.doi.org/10.1136/bmj.e7489			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	036LI	23135201				2022-12-28	WOS:000311027000001
J	Weinstein, E				Weinstein, Eleanor			On Caring for Those Who Will Remain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Weinstein, Eleanor] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Weinstein, Eleanor] Jacobi Med Ctr, Bronx, NY USA	Yeshiva University; Albert Einstein College of Medicine; Jacobi Medical Center	Weinstein, E (corresponding author), Albert Einstein Coll Med, Bronx, NY 10467 USA.	eleanor.weinstein@nbhn.net							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1749	1750		10.1001/jama.2012.13254	http://dx.doi.org/10.1001/jama.2012.13254			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117774				2022-12-28	WOS:000310726500020
J	Jostins, L; Ripke, S; Weersma, RK; Duerr, RH; McGovern, DP; Hui, KY; Lee, JC; Schumm, LP; Sharma, Y; Anderson, CA; Essers, J; Mitrovic, M; Ning, K; Cleynen, I; Theatre, E; Spain, SL; Raychaudhuri, S; Goyette, P; Wei, Z; Abraham, C; Achkar, JP; Ahmad, T; Amininejad, L; Ananthakrishnan, AN; Andersen, V; Andrews, JM; Baidoo, L; Balschun, T; Bampton, PA; Bitton, A; Boucher, G; Brand, S; Buning, C; Cohain, A; Cichon, S; D'Amato, M; De Jong, D; Devaney, KL; Dubinsky, M; Edwards, C; Ellinghaus, D; Ferguson, LR; Franchimont, D; Fransen, K; Gearry, R; Georges, M; Gieger, C; Glas, J; Haritunians, T; Hart, A; Hawkey, C; Hedl, M; Hu, XL; Karlsen, TH; Kupcinskas, L; Kugathasan, S; Latiano, A; Laukens, D; Lawrance, IC; Lees, CW; Louis, E; Mahy, G; Mansfield, J; Morgan, AR; Mowat, C; Newman, W; Palmieri, O; Ponsioen, CY; Potocnik, U; Prescott, NJ; Regueiro, M; Rotter, JI; Russell, RK; Sanderson, JD; Sans, M; Satsangi, J; Schreiber, S; Simms, LA; Sventoraityte, J; Targan, SR; Taylor, KD; Tremelling, M; Verspaget, HW; De Vos, M; Wijmenga, C; Wilson, DC; Winkelmann, J; Xavier, RJ; Zeissig, S; Zhang, B; Zhang, CK; Zhao, HY; Silverberg, MS; Annese, V; Hakonarson, H; Brant, SR; Radford-Smith, G; Mathew, CG; Rioux, JD; Schadt, EE; Daly, MJ; Franke, A; Parkes, M; Vermeire, S; Barrett, JC; Cho, JH				Jostins, Luke; Ripke, Stephan; Weersma, Rinse K.; Duerr, Richard H.; McGovern, Dermot P.; Hui, Ken Y.; Lee, James C.; Schumm, L. Philip; Sharma, Yashoda; Anderson, Carl A.; Essers, Jonah; Mitrovic, Mitja; Ning, Kaida; Cleynen, Isabelle; Theatre, Emilie; Spain, Sarah L.; Raychaudhuri, Soumya; Goyette, Philippe; Wei, Zhi; Abraham, Clara; Achkar, Jean-Paul; Ahmad, Tariq; Amininejad, Leila; Ananthakrishnan, Ashwin N.; Andersen, Vibeke; Andrews, Jane M.; Baidoo, Leonard; Balschun, Tobias; Bampton, Peter A.; Bitton, Alain; Boucher, Gabrielle; Brand, Stephan; Buening, Carsten; Cohain, Ariella; Cichon, Sven; D'Amato, Mauro; De Jong, Dirk; Devaney, Kathy L.; Dubinsky, Marla; Edwards, Cathryn; Ellinghaus, David; Ferguson, Lynnette R.; Franchimont, Denis; Fransen, Karin; Gearry, Richard; Georges, Michel; Gieger, Christian; Glas, Juergen; Haritunians, Talin; Hart, Ailsa; Hawkey, Chris; Hedl, Matija; Hu, Xinli; Karlsen, Tom H.; Kupcinskas, Limas; Kugathasan, Subra; Latiano, Anna; Laukens, Debby; Lawrance, Ian C.; Lees, Charlie W.; Louis, Edouard; Mahy, Gillian; Mansfield, John; Morgan, Angharad R.; Mowat, Craig; Newman, William; Palmieri, Orazio; Ponsioen, Cyriel Y.; Potocnik, Uros; Prescott, Natalie J.; Regueiro, Miguel; Rotter, Jerome I.; Russell, Richard K.; Sanderson, Jeremy D.; Sans, Miquel; Satsangi, Jack; Schreiber, Stefan; Simms, Lisa A.; Sventoraityte, Jurgita; Targan, Stephan R.; Taylor, Kent D.; Tremelling, Mark; Verspaget, Hein W.; De Vos, Martine; Wijmenga, Cisca; Wilson, David C.; Winkelmann, Juliane; Xavier, Ramnik J.; Zeissig, Sebastian; Zhang, Bin; Zhang, Clarence K.; Zhao, Hongyu; Silverberg, Mark S.; Annese, Vito; Hakonarson, Hakon; Brant, Steven R.; Radford-Smith, Graham; Mathew, Christopher G.; Rioux, John D.; Schadt, Eric E.; Daly, Mark J.; Franke, Andre; Parkes, Miles; Vermeire, Severine; Barrett, Jeffrey C.; Cho, Judy H.		Int IBD Genetics Consortium IIBDGC	Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease	NATURE			English	Article							HYPER-IGE SYNDROME; RISK LOCI; SUSCEPTIBILITY; EXPRESSION; METAANALYSIS; TUBERCULOSIS; MUTATIONS; NETWORK; NUMBER	Crohn's disease and ulcerative colitis, the two common forms of inflammatory bowel disease (IBD), affect over 2.5 million people of European ancestry, with rising prevalence in other populations(1). Genome-wide association studies and subsequent meta-analyses of these two diseases(2,3) as separate phenotypes have implicated previously unsuspected mechanisms, such as autophagy(4), in their pathogenesis and showed that some IBD loci are shared with other inflammatory diseases(5). Here we expand on the knowledge of relevant pathways by undertaking a meta-analysis of Crohn's disease and ulcerative colitis genome-wide association scans, followed by extensive validation of significant findings, with a combined total of more than 75,000 cases and controls. We identify 71 new associations, for a total of 163 IBD loci, that meet genome-wide significance thresholds. Most loci contribute to both phenotypes, and both directional (consistently favouring one allele over the course of human history) and balancing (favouring the retention of both alleles within populations) selection effects are evident. Many IBD loci are also implicated in other immune-mediated disorders, most notably with ankylosing spondylitis and psoriasis. We also observe considerable overlap between susceptibility loci for IBD and mycobacterial infection. Gene co-expression network analysis emphasizes this relationship, with pathways shared between host responses to mycobacteria and those predisposing to IBD.	[Hui, Ken Y.; Cho, Judy H.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Jostins, Luke; Anderson, Carl A.; Barrett, Jeffrey C.] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Ripke, Stephan; Daly, Mark J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ripke, Stephan; Daly, Mark J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Weersma, Rinse K.; De Jong, Dirk] Univ Groningen, Dept Gastroenterol & Hepatol, NL-9700 RB Groningen, Netherlands; [Mitrovic, Mitja] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Duerr, Richard H.; Baidoo, Leonard; Fransen, Karin; Regueiro, Miguel] Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15261 USA; [Duerr, Richard H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [McGovern, Dermot P.; Targan, Stephan R.; Taylor, Kent D.] F Widjaja Fdn Inflammatory Bowel, Los Angeles, CA 90048 USA; [McGovern, Dermot P.; Targan, Stephan R.; Taylor, Kent D.] Immunobiol Res Inst, Los Angeles, CA 90048 USA; [McGovern, Dermot P.; Haritunians, Talin; Rotter, Jerome I.; Taylor, Kent D.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Lee, James C.; Parkes, Miles] Univ Cambridge, Addenbrookes Hosp, Inflammatory Bowel Dis Res Grp, Cambridge CB2 0QQ, England; [Schumm, L. Philip] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Sharma, Yashoda; Ning, Kaida; Abraham, Clara; Hedl, Matija; Cho, Judy H.] Yale Univ, Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT 06520 USA; [Essers, Jonah] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Mitrovic, Mitja; Potocnik, Uros] Univ Maribor, Fac Med, Ctr Human Mol Genet & Pharmacogen, SLO-2000 Maribor, Slovenia; [Cleynen, Isabelle; Vermeire, Severine] Katholieke Univ Leuven, Gastroenterol Sect, Dept Clin & Expt Med, B-3000 Louvain, Belgium; [Theatre, Emilie; Georges, Michel] Univ Liege, Grp Interdisciplinaire Genoprote Appl GIGA R, Unit Anim Genom, B-4000 Liege, Belgium; [Theatre, Emilie; Georges, Michel] Univ Liege, Fac Vet Med, B-4000 Liege, Belgium; [Theatre, Emilie; Louis, Edouard] Univ Liege, Ctr Hosp Univ, Div Gastroenterol, B-4000 Liege, Belgium; [Spain, Sarah L.; Prescott, Natalie J.; Mathew, Christopher G.] Kings Coll London, Dept Med & Mol Genet, Div Genet & Mol Med, Sch Med,Guys Hosp, London SE1 9RT, England; [Raychaudhuri, Soumya; Hu, Xinli] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Raychaudhuri, Soumya] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Goyette, Philippe; Boucher, Gabrielle; Rioux, John D.] Univ Montreal, Montreal, PQ H1T 1C8, Canada; [Goyette, Philippe; Boucher, Gabrielle; Rioux, John D.] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Wei, Zhi] New Jersey Inst Technol, Dept Comp Sci, Newark, NJ 07102 USA; [Achkar, Jean-Paul] Cleveland Clin, Dept Gastroenterol & Hepatol, Inst Digest Dis, Cleveland, OH 44195 USA; [Achkar, Jean-Paul] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Ahmad, Tariq] Peninsula Coll Med & Dent, Exeter EX1 2LU, Devon, England; [Amininejad, Leila; Franchimont, Denis] Free Univ Brussels, Erasmus Hosp, Dept Gastroenterol, B-1070 Brussels, Belgium; [Ananthakrishnan, Ashwin N.; Devaney, Kathy L.; Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastroenterol Unit, Boston, MA 02114 USA; [Andersen, Vibeke] Viborg Reg Hosp, Dept Med, DK-8800 Viborg, Denmark; [Andrews, Jane M.] Royal Adelaide Hosp, Dept Gastroenterol & Hepatol, Inflammatory Bowel Dis Serv, Adelaide, SA 5000, Australia; [Andrews, Jane M.] Univ Adelaide, Sch Med, Adelaide, SA 5000, Australia; [Balschun, Tobias; Ellinghaus, David; Schreiber, Stefan; Franke, Andre] Univ Kiel, Inst Clin Chem, D-24105 Kiel, Germany; [Bampton, Peter A.] Flinders Med Ctr, Dept Gastroenterol & Hepatol, Adelaide, SA 5000, Australia; [Bampton, Peter A.] Flinders Univ S Australia, Sch Med, Adelaide, SA 5000, Australia; [Bitton, Alain; Glas, Juergen] McGill Univ, Ctr Hlth, Div Gastroenterol, Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada; [Brand, Stephan] Univ Munich, Univ Hosp Munich Grosshadern, Dept Med 2, D-80336 Munich, Germany; [Buening, Carsten] Univ Med Berlin, Charite, Dept Gastroenterol, D-10117 Berlin, Germany; [Cohain, Ariella; Zhang, Bin; Schadt, Eric E.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Cichon, Sven] Univ Hosp Bonn, Life & Brain Ctr, Dept Genom, D-53012 Bonn, Germany; [D'Amato, Mauro] Karolinska Inst, Dept Biosci & Nutr, S-14183 Stockholm, Sweden; [Dubinsky, Marla] Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA; [Edwards, Cathryn] Torbay Hosp, Dept Gastroenterol, Torquay TQ2 7AA, Devon, England; [Ferguson, Lynnette R.; Morgan, Angharad R.] Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Auckland 1142, New Zealand; [Fransen, Karin; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen T, Netherlands; [Gearry, Richard] Univ Otago, Dept Med, Christchurch 8140, New Zealand; [Gearry, Richard] Christchurch Hosp, Dept Gastroenterol, Christchurch 8011, New Zealand; [Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Hart, Ailsa] St Marks Hosp, Harrow HA1 3UJ, Middx, England; [Hawkey, Chris] QueensMed Ctr, Nottingham Digest Dis Ctr, Nottingham NG7 1AW, England; [Karlsen, Tom H.] Natl Hosp Norway, Oslo Univ Hosp, Internal Med Res Inst, N-0424 Oslo, Norway; [Kupcinskas, Limas; Sventoraityte, Jurgita] Kaunas Univ Med, Dept Gastroenterol, LT-44307 Kaunas, Lithuania; [Kugathasan, Subra] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Latiano, Anna; Palmieri, Orazio; Annese, Vito] Ist Ricovero & Cura Carattere Sci Casa Sollievo S, Gastroenterol Unit, I-71013 San Giovanni Rotondo, Italy; [Laukens, Debby; De Vos, Martine] Ghent Univ Hosp, Dept Gastroenterol & Hepatol, B-9000 Ghent, Belgium; [Lawrance, Ian C.] Univ Western Australia, Sch Med & Pharmacol, Fremantle, WA 6009, Australia; [Lees, Charlie W.; Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Gastrointestinal Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Mahy, Gillian] Townsville Hosp, Dept Gastroenterol, Townsville, Qld 4810, Australia; [Mansfield, John] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Mowat, Craig] Univ Dundee, Ninewells Hosp & Med Sch, Dept Med, Dundee DD1 9SY, Scotland; [Newman, William] Univ Manchester, MAHSC, Manchester M13 9PL, Lancs, England; [Ponsioen, Cyriel Y.] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol, NL-1105 AZ Amsterdam, Netherlands; [Potocnik, Uros] Univ Maribor, Fac Chem & Chem Engn, SLO-2000 Maribor, Slovenia; [Russell, Richard K.; Wilson, David C.] Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland; [Sanderson, Jeremy D.] Guys & St Thomas NHS Fdn Trust, St Thomas Hosp, Dept Gastroenterol, London SE1 7EH, England; [Sans, Miquel] Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Dept Gastroenterol, Barcelona, Spain; [Sans, Miquel] CIBER EHD, Barcelona 08036, Spain; [Schreiber, Stefan; Zeissig, Sebastian] Univ Kiel, Dept Gen Internal Med, D-24118 Kiel, Germany; [Simms, Lisa A.; Radford-Smith, Graham] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Tremelling, Mark] Norfolk & Norwich Univ Hosp, Norwich NR4 7UY, Norfolk, England; [Verspaget, Hein W.] Leiden Univ, Med Ctr, Dept Gastroenterol, NL-2333 ZA Leiden, Netherlands; [Wilson, David C.] Univ Edinburgh, Edinburgh EH9 1UW, Midlothian, Scotland; [Winkelmann, Juliane] Tech Univ Munich, Inst Human Genet, D-80336 Munich, Germany; [Winkelmann, Juliane] Tech Univ Munich, Dept Neurol, D-80336 Munich, Germany; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Zhang, Clarence K.; Zhao, Hongyu] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT 06520 USA; [Silverberg, Mark S.] Univ Toronto, Mt Sinai Hosp, Ctr Inflammatory Bowel Dis, Toronto, ON M5G 1X5, Canada; [Annese, Vito] Azienda Osped Univ AOU Careggi, Unit Gastroenterol SOD2, I-50134 Florence, Italy; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Pediat Inflammatory Bowel Dis, Dept Pediat, Philadelphia, PA 19104 USA; [Brant, Steven R.] Johns Hopkins Univ, Sch Med, Dept Med, Meyerhoff Inflammatory Bowel Dis Ctr, Baltimore, MD 21205 USA; [Brant, Steven R.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Radford-Smith, Graham] Royal Brisbane & Womens Hosp, Dept Gastroenterol, Brisbane, Qld 4029, Australia; [Radford-Smith, Graham] Univ Queensland, Sch Med, Brisbane, Qld 4029, Australia; [Vermeire, Severine] Univ Hosp Leuven, Dept Gastroenterol, B-3000 Louvain, Belgium	Yale University; Wellcome Trust Sanger Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Groningen; University of Groningen; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cedars Sinai Medical Center; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Chicago; Yale University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Maribor; KU Leuven; University of Liege; University of Liege; University of Liege; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Universite de Montreal; Universite de Montreal; New Jersey Institute of Technology; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Exeter; University of Plymouth; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Harvard University; Harvard Medical School; Massachusetts General Hospital; Aarhus University; Royal Adelaide Hospital; University of Adelaide; University of Kiel; Flinders Medical Centre; Flinders University South Australia; McGill University; Royal Victoria Hospital; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Icahn School of Medicine at Mount Sinai; University of Bonn; Karolinska Institutet; Cedars Sinai Medical Center; University of Auckland; University of Groningen; University of Otago; Christchurch Hospital New Zealand; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Imperial College London; University of Nottingham; University of Oslo; National Hospital Norway; Lithuanian University of Health Sciences; Emory University; Ghent University; Ghent University Hospital; University of Western Australia; University of Edinburgh; Newcastle University - UK; University of Dundee; University of Manchester; University of Amsterdam; Academic Medical Center Amsterdam; University of Maribor; University of Glasgow; Guy's & St Thomas' NHS Foundation Trust; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Kiel; QIMR Berghofer Medical Research Institute; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Edinburgh; Technical University of Munich; Technical University of Munich; Harvard University; Massachusetts General Hospital; Yale University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Royal Brisbane & Women's Hospital; University of Queensland; KU Leuven; University Hospital Leuven	Cho, JH (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA.	judy.cho@yale.edu	Radford-Smith, Graham/H-2792-2013; Weersma, Rinse/ABE-3807-2021; Duerr, Richard H/B-4188-2009; Baidoo, Leonard/GMW-4607-2022; Wijmenga, Cisca/AAE-7719-2019; Silverberg, Mark/B-4183-2008; Jankowski, Janusz/H-2706-2012; Breen, Gerome/Y-2706-2019; Palmieri, Orazio/J-7697-2012; Kennedy, Nicholas Alexander/AET-5648-2022; Henderson, Paul/F-5106-2012; , AndyWei/H-4415-2012; Wijmenga, Cisca/D-2173-2009; Cichon, Sven/B-9618-2014; D'Amato, Mauro/B-5050-2019; Dominiczak, Anna F/P-9390-2017; Lawrance, Ian C/H-5252-2014; Franke, Andre/B-2151-2010; hart, ailsa/AFO-1919-2022; Andersen, Vibeke/I-7932-2012; D'Amato, Mauro/F-2450-2010; Bellenguez, Céline/X-4004-2019; Prescott, Natalie J/F-6490-2011; Ripke, Stephan/AAK-5486-2021; Barclay, Murray Lindsay/D-9000-2012; Rioux, John D/A-9599-2015; Cichon, Sven/H-8803-2013; Mowat, Craig/AAD-1851-2019; Zeissig, Sebastian/B-6297-2012; Radford-Smith, Graham L/G-5749-2017; Bramon, Elvira/HHC-3809-2022; eyre, stephen/K-3776-2017; Lee, James/ABD-5920-2020; Rotter, Jerome/AAY-6598-2021; O'Donovan, Michael C/P-7005-2018; Daly, Mark J/B-2453-2017; Gearry, Richard B/H-3959-2019; Van Limbergen, Johan/L-1855-2019; Ellinghaus, David/ABC-3610-2020; Blackwell, Jenefer M/H-3015-2015; Latiano, Anna/R-1965-2016; Belllenguez, Céline/Y-3183-2018; Baidoo, Leonard/AAK-2405-2020; Annese, Vito/AGW-4200-2022; Croitoru, Kenneth/C-4604-2015; Ellinghaus, David/G-4467-2012; Brown, Matthew A/E-5749-2010; Mathew, Christopher G/G-3434-2015; Anderson, Carl A/B-8327-2013; McCarthy, Mark/M-3763-2015; Wood, Nicholas/C-2505-2009; Spain, Sarah/G-1968-2010; Myers, Simon/A-6792-2015	Radford-Smith, Graham/0000-0002-2047-6239; Duerr, Richard H/0000-0001-6586-3905; Wijmenga, Cisca/0000-0002-5635-1614; Jankowski, Janusz/0000-0003-2130-9181; Breen, Gerome/0000-0003-2053-1792; Palmieri, Orazio/0000-0002-0019-7929; Kennedy, Nicholas Alexander/0000-0003-4368-1961; Henderson, Paul/0000-0003-3634-6428; Cichon, Sven/0000-0002-9475-086X; D'Amato, Mauro/0000-0003-2743-5197; Dominiczak, Anna F/0000-0003-4913-3608; Franke, Andre/0000-0003-1530-5811; Andersen, Vibeke/0000-0002-0127-2863; D'Amato, Mauro/0000-0003-2743-5197; Bellenguez, Céline/0000-0002-1240-7874; Prescott, Natalie J/0000-0002-5901-7371; Barclay, Murray Lindsay/0000-0003-2944-8338; Rioux, John D/0000-0001-7560-8326; Cichon, Sven/0000-0002-9475-086X; Mowat, Craig/0000-0002-5021-415X; Zeissig, Sebastian/0000-0001-5124-0897; Radford-Smith, Graham L/0000-0002-2047-6239; Bramon, Elvira/0000-0003-1369-5983; eyre, stephen/0000-0002-1251-6974; Lee, James/0000-0001-5711-9385; O'Donovan, Michael C/0000-0001-7073-2379; Daly, Mark J/0000-0002-0949-8752; Gearry, Richard B/0000-0002-2298-5141; Van Limbergen, Johan/0000-0001-5822-4371; Ellinghaus, David/0000-0002-4332-6110; Latiano, Anna/0000-0003-3719-2061; Belllenguez, Céline/0000-0002-1240-7874; Annese, Vito/0000-0002-0082-892X; Croitoru, Kenneth/0000-0003-1231-0180; Brown, Matthew A/0000-0003-0538-8211; Mathew, Christopher G/0000-0003-4178-1838; Anderson, Carl A/0000-0003-1719-7009; Ouwehand, Willem/0000-0002-7744-1790; Wain, Louise/0000-0003-4951-1867; ripke, stephan/0000-0003-3622-835X; Martin, Paul/0000-0002-1016-6851; Bruce, Ian/0000-0003-3047-500X; McCarthy, Mark/0000-0002-4393-0510; Mitrovic, Mitja/0000-0002-7648-7674; Howson, Joanna/0000-0001-7618-0050; Morgan, Ann/0000-0003-1109-624X; Hugot, Jean-Pierre/0000-0002-8446-6056; Wood, Nicholas/0000-0002-9500-3348; Young, Allan/0000-0003-2291-6952; Turnbull, Clare/0000-0002-1734-5772; peyrin-biroulet, laurent/0000-0003-2536-6618; Gillman, Matthew S./0000-0002-2340-6930; Jones, Lisa/0000-0002-5122-8334; Barrett, Jeffrey/0000-0002-1152-370X; Newman, William/0000-0002-6382-4678; Walters, James/0000-0002-6980-4053; Harrison, Pille/0000-0003-4117-6910; ZHANG, HU/0000-0002-3281-4661; Simms, Lisa/0000-0002-5387-7397; Aerts, Jan/0000-0002-6416-2717; Simms, Lisa/0000-0001-8358-1426; Parkes, Miles/0000-0002-6467-0631; Wallace, Chris/0000-0001-9755-1703; Lango Allen, Hana/0000-0002-7803-8688; Giannoulatou, Eleni/0000-0002-7084-6736; Tobin, Martin/0000-0002-3596-7874; Plomin, Robert/0000-0002-0756-3629; Evans, Gareth/0000-0002-8482-5784; Plagnol, Vincent/0000-0002-5597-9215; Raychaudhuri, Soumya/0000-0002-1901-8265; Zeggini, Eleftheria/0000-0003-4238-659X; Vermeire, Severine/0000-0001-9942-3019; Grozeva, Detelina/0000-0003-3239-8415; Forbes, Alastair/0000-0001-7416-9843; Eccles, Diana M/0000-0002-9935-3169; Spain, Sarah/0000-0002-7591-8364; Caulfield, Mark/0000-0001-9295-3594; Wei, Zhi/0000-0001-6059-4267; Georges, Michel/0000-0003-4124-2375; Schumm, Phil/0000-0002-3050-2429; Mentzer, Alexander/0000-0002-4502-2209; Laukens, Debby/0000-0002-1984-5850; Lees, Charlie/0000-0002-0732-8215; Munroe, Patricia/0000-0002-4176-2947; Myers, Simon/0000-0002-2585-9626; Burren, Oliver/0000-0002-3388-5760; Hocking, Lynne J/0000-0002-2414-2826; Potocnik, Uros/0000-0003-1624-9428; Halfvarson, Jonas/0000-0003-0122-7234; Lindgren, Cecilia/0000-0002-4903-9374; Hattersley, Andrew/0000-0001-5620-473X; Edwards, Cathryn/0000-0002-5550-9184; Massey, Dunecan/0000-0002-7144-4579; Winkelmann, Juliane/0000-0003-2667-9691; Weedon, Michael/0000-0002-6174-6135; Isaacs, John/0000-0002-6103-7056; Gieger, Christian/0000-0001-6986-9554	National Association for Colitis and Crohn's disease; Wellcome Trust [098051, 083948/Z/07/Z, 085475/B/08/Z, 085475/Z/08/Z]; Medical Research Council UK; Catherine McEwan Foundation; NHS Research Scotland career fellowship; Peninsula College of Medicine and Dentistry, Exeter; National Institute for Health Research, through the Comprehensive Local Research Network; Biomedical ResearchCentre; Saint Thomas' NationalHealth Service Trust; King's College London; Addenbrooke's Hospital, University of Cambridge School of Clinical Medicine; University of Manchester; Central Manchester Foundation Trust; Medical Research Council [G0000934]; Wellcome Trust grant [068545/Z/02]; UK National Blood Service; National Institute of Diabetes, Digestive and Kidney diseases (NIDDK) IBD Genetics Consortium; National Institutes of Health (NIH) [MSTP TG T32GM07205]; USPHS [PO1DK046763]; Cedars-Sinai F. Widjaja Inflammatory Bowel and Immunobiology Research Institute Research Funds; National Center for Research Resources (NCRR) [M01-RR00425]; UCLA/Cedars-Sinai/Harbor/Drew Clinical and Translational Science Institute (CTSI) [UL1 TR000124-01]; Southern California Diabetes and Endocrinology Research Grant (DERC) [DK063491]; Helmsley Foundation; Crohn's and Colitis Foundation of America; Netherlands Organization for Scientific Research [90.700.281, 918.66.620]; Celiac Disease Consortium [BSIK03009]; German Ministry of Education and Research through the National Genome Research Network; Popgen biobank, through the Deutsche Forschungsgemeinschaft (DFG) cluster of excellence ` Inflammation at Interfaces'; DFG [FR 2821/2-1, BR 1912/6-1]; Else Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium); Italian Society for Paediatric Gastroenterology, Hepatology and Nutrition; Italian Ministry of Health [GR-2008-1144485]; Swedish Society of Medicine; Ihre Foundation; Orebro University Hospital Research Foundation; Karolinska Institutet; Swedish National Program for IBD Genetics; Swedish Organization for IBD; Swedish Medical Research Council; Royal Brisbane and Women's Hospital Foundation; National Health and Medical Research Council, Australia; European Community (5th PCRDT); NIDDK, National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute (NHGRI); National Institute of Child Health and Human Development (NICHD); Juvenile Diabetes Research Foundation (JDRF); Helmholtz Zentrum Munchen-German Research Center for Environmental Health; German Federal Ministry of Education and Research (BMBF); State of Bavaria;  [DK062431];  [DK062422];  [DK062420];  [DK062432];  [DK062423];  [DK062413];  [DK076984];  [DK084554];  [DK062429];  [DK062429-S1];  [CA141743];  [DK83756];  [AI062773];  [DK043351];  [U01 DK062418]; MRC [G0800759, G1002033, G0600329, G0800675] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA141743] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005, UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK097142, P30DK043351, U01DK062422, P01DK046763, U01DK062413, U01DK062432, U01DK062431, U01DK062429, R01DK055731, U01DK062420, U01DK062418, R01DK083756, R03DK076984, U01DK062423, P30DK063491, R21DK084554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; Medical Research Council [G1002033, G0800759, G0800675, G0600329] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10299, NF-SI-0611-10219] Funding Source: researchfish; Versus Arthritis [18475] Funding Source: researchfish; Chief Scientist Office [CZB/4/540, ETM/75, ETM/137] Funding Source: researchfish; Crohn&quot;s and Colitis UK [M11-1] Funding Source: researchfish	National Association for Colitis and Crohn's disease; Wellcome Trust(Wellcome Trust); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Catherine McEwan Foundation; NHS Research Scotland career fellowship; Peninsula College of Medicine and Dentistry, Exeter; National Institute for Health Research, through the Comprehensive Local Research Network; Biomedical ResearchCentre; Saint Thomas' NationalHealth Service Trust; King's College London(General Electric); Addenbrooke's Hospital, University of Cambridge School of Clinical Medicine; University of Manchester; Central Manchester Foundation Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust grant(Wellcome Trust); UK National Blood Service; National Institute of Diabetes, Digestive and Kidney diseases (NIDDK) IBD Genetics Consortium; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Cedars-Sinai F. Widjaja Inflammatory Bowel and Immunobiology Research Institute Research Funds; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); UCLA/Cedars-Sinai/Harbor/Drew Clinical and Translational Science Institute (CTSI); Southern California Diabetes and Endocrinology Research Grant (DERC); Helmsley Foundation; Crohn's and Colitis Foundation of America; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Celiac Disease Consortium; German Ministry of Education and Research through the National Genome Research Network; Popgen biobank, through the Deutsche Forschungsgemeinschaft (DFG) cluster of excellence ` Inflammation at Interfaces'(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium); Italian Society for Paediatric Gastroenterology, Hepatology and Nutrition; Italian Ministry of Health(Ministry of Health, Italy); Swedish Society of Medicine; Ihre Foundation; Orebro University Hospital Research Foundation; Karolinska Institutet(Karolinska Institutet); Swedish National Program for IBD Genetics; Swedish Organization for IBD; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Royal Brisbane and Women's Hospital Foundation; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); European Community (5th PCRDT); NIDDK, National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Helmholtz Zentrum Munchen-German Research Center for Environmental Health(Helmholtz Association); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis); Chief Scientist Office; Crohn&quot;s and Colitis UK	We thank all the subjects who contributed samples and the physicians and nursing staff who helped with recruitment globally. UK case collections were supported by the National Association for Colitis and Crohn's disease; Wellcome Trust grant 098051 (L. J., C. A. A., J. C. B.); Medical Research Council UK; the Catherine McEwan Foundation; an NHS Research Scotland career fellowship (R. K. R.); Peninsula College of Medicine and Dentistry, Exeter; the National Institute for Health Research, through the Comprehensive Local Research Network, and through Biomedical ResearchCentreawards toGuy's& Saint Thomas' NationalHealth Service Trust, King's College London, Addenbrooke's Hospital, University of Cambridge School of Clinical Medicine and to the University of Manchester and Central Manchester Foundation Trust. The British 1958 Birth Cohort DNA collection was funded by Medical Research Council grant G0000934 and Wellcome Trust grant 068545/Z/02, and the UK National Blood Service controls by the Wellcome Trust. The Wellcome Trust Case Control Consortiumprojects were supported by Wellcome Trust grants 083948/Z/07/Z, 085475/B/08/Z and 085475/Z/08/Z. North American collections and data processing were supported by funds to the National Institute of Diabetes, Digestive and Kidney diseases (NIDDK) IBD Genetics Consortium, which is funded by the following grants: DK062431 (S. R. B.), DK062422 (J. H. C.), DK062420 (R. H. D.), DK062432 (J. D. R.), DK062423 (M. S. S.), DK062413 (D. P. M.), DK076984 (M. J. D.), DK084554 (M. J. D. and D. P. M.) and DK062429 (J. H. C.). Additional funds were provided by funding to J. H. C. (DK062429-S1 and Crohn's & Colitis Foundation of America, Senior Investigator Award (5-2229)) and R.H.D. (CA141743). K. Y. H. is supported by the National Institutes of Health (NIH) MSTP TG T32GM07205 training award. Cedars-Sinai is supported by USPHS grant PO1DK046763 and the Cedars-Sinai F. Widjaja Inflammatory Bowel and Immunobiology Research Institute Research Funds, National Center for Research Resources (NCRR) grant M01-RR00425, UCLA/Cedars-Sinai/Harbor/Drew Clinical and Translational Science Institute (CTSI) Grant (UL1 TR000124-01), the Southern California Diabetes and Endocrinology Research Grant (DERC) (DK063491), The Helmsley Foundation (D. P. M.) and the Crohn's and Colitis Foundation of America (D. P. M.). R. J. X. and A. N. A. are funded by DK83756, AI062773, DK043351 and the Helmsley Foundation. The Netherlands Organization for Scientific Research supported R. K. W. with a clinical fellowship grant (90.700.281) and C. W. (VICI grant 918.66.620). C. W. is also supported by the Celiac Disease Consortium (BSIK03009). This study was also supported by the German Ministry of Education and Research through the National Genome Research Network, the Popgen biobank, through the Deutsche Forschungsgemeinschaft (DFG) cluster of excellence ` Inflammation at Interfaces' and DFG grant no. FR 2821/2-1. S. B. was supported by DFG BR 1912/6-1 and the Else Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium 2010_EKES.32). Italian case collections were supported by the Italian Group for IBD and the Italian Society for Paediatric Gastroenterology, Hepatology and Nutrition and funded by the Italian Ministry of Health GR-2008-1144485. Activities in Sweden were supported by the Swedish Society of Medicine, Ihre Foundation, Orebro University Hospital Research Foundation, Karolinska Institutet, the Swedish National Program for IBD Genetics, the Swedish Organization for IBD, and the Swedish Medical Research Council. D. F. and S. V.; rare senior clinical investigators for the Funds for Scientific Research (FWO/FNRS) Belgium. We acknowledge a grant from Viborg Regional Hospital, Denmark. V. Andersen was supported by SHS Aabenraa, Denmark. We acknowledge funding provided by the Royal Brisbane and Women's Hospital Foundation, National Health and Medical Research Council, Australia and by the European Community (5th PCRDT). We acknowledge the following groups that provided biological samples or data for this study: the Inflammatory Bowel in South Eastern Norway (IBSEN) study group, the Norwegian Bone Marrow Donor Registry (NMBDR), the Avon Longitudinal Study of Parents and Children, the Human Biological Data Interchange and Diabetes UK, and Banco Nacional de ADN, Salamanca. This research also uses resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the NIDDK, National Institute of Allergy and Infectious Diseases (NIAID), National Human Genome Research Institute (NHGRI), National Institute of Child Health and Human Development (NICHD), and Juvenile Diabetes Research Foundation (JDRF) and supported by U01 DK062418. The KORA study was initiated and financed by the Helmholtz Zentrum Munchen-German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. KORAresearch was supported within the Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Bhattacharjee A, 2011, J BIOL CHEM, V286, P36709, DOI 10.1074/jbc.M111.291492; Bustamante J, 2011, ANN NY ACAD SCI, V1246, P92, DOI 10.1111/j.1749-6632.2011.06273.x; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Glocker EO, 2010, LANCET, V376, P1272, DOI 10.1016/S0140-6736(10)61008-2; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Hu XL, 2011, AM J HUM GENET, V89, P496, DOI 10.1016/j.ajhg.2011.09.002; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Lewis SJ, 2005, INT J TUBERC LUNG D, V9, P1174; Li XK, 2011, NANOSCALE RES LETT, V6, P1, DOI 10.1186/1556-276X-6-625; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Notarangelo LD, 2009, J ALLERGY CLIN IMMUN, V124, P1161, DOI 10.1016/j.jaci.2009.10.013; Patel SY, 2008, J CLIN PATHOL, V61, P1006, DOI 10.1136/jcp.2007.051201; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang FR, 2011, NAT GENET, V43, P1247, DOI 10.1038/ng.973; Zhong H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000932; Zhu J, 2007, PLOS COMPUT BIOL, V3, P692, DOI 10.1371/journal.pcbi.0030069; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	30	3056	3132	31	789	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2012	491	7422					119	124		10.1038/nature11582	http://dx.doi.org/10.1038/nature11582			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23128233	Green Submitted, Green Accepted			2022-12-28	WOS:000310434500042
J	King, JS				King, Jaime S.			Politics and fetal diagnostics collide	NATURE			English	Editorial Material									Univ Calif San Francisco, Hastings Coll Law, San Francisco, CA 94102 USA	University of California System; University of California San Francisco	King, JS (corresponding author), Univ Calif San Francisco, Hastings Coll Law, San Francisco, CA 94102 USA.	kingja@uchastings.edu						Americans United for Life, 2012, DEF LIF 2012; Fan HC, 2012, NATURE, V487, P320, DOI 10.1038/nature11251; Greely HT, 2011, NATURE, V469, P289, DOI 10.1038/469289a; Hvistendahl, 2011, UNNATURAL SELECTION; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; McGovern C., 2012, NATL CATHOLIC R 0625; Sen B, 2012, SOC SCI MED, V75, P156, DOI 10.1016/j.socscimed.2012.01.037	7	14	14	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					33	34		10.1038/491033a	http://dx.doi.org/10.1038/491033a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	028PM	23128210	Bronze			2022-12-28	WOS:000310434500014
J	Wang, YF; Wang, Y; Breed, DR; Manoharan, VN; Feng, L; Hollingsworth, AD; Weck, M; Pine, DJ				Wang, Yufeng; Wang, Yu; Breed, Dana R.; Manoharan, Vinothan N.; Feng, Lang; Hollingsworth, Andrew D.; Weck, Marcus; Pine, David J.			Colloids with valence and specific directional bonding	NATURE			English	Article							ASYMMETRIC FUNCTIONALIZATION; CLUSTERS; NANOPARTICLES; PARTICLES; ANISOTROPY	The ability to design and assemble three-dimensional structures from colloidal particles is limited by the absence of specific directional bonds. As a result, complex or low-coordination structures, common in atomic and molecular systems, are rare in the colloidal domain. Here we demonstrate a general method for creating the colloidal analogues of atoms with valence: colloidal particles with chemically distinct surface patches that imitate hybridized atomic orbitals, including sp, sp(2), sp(3), sp(3)d, sp(3)d(2) and sp(3)d(3). Functionalized with DNA with single-stranded sticky ends, patches on different particles can form highly directional bonds through programmable, specific and reversible DNA hybridization. These features allow the particles to self-assemble into 'colloidal molecules' with triangular, tetrahedral and other bonding symmetries, and should also give access to a rich variety of new microstructured colloidal materials.	[Feng, Lang; Hollingsworth, Andrew D.; Pine, David J.] NYU, Ctr Soft Matter Res, New York, NY 10003 USA; [Feng, Lang; Hollingsworth, Andrew D.; Pine, David J.] NYU, Dept Phys, New York, NY 10003 USA; [Wang, Yufeng; Wang, Yu; Weck, Marcus] NYU, Inst Mol Design, New York, NY 10003 USA; [Wang, Yufeng; Wang, Yu; Weck, Marcus] NYU, Dept Chem, New York, NY 10003 USA; [Breed, Dana R.] Dow Chem Co USA, Freeport, TX 77541 USA; [Manoharan, Vinothan N.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Manoharan, Vinothan N.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	New York University; New York University; New York University; New York University; Dow Chemical Company; Harvard University; Harvard University	Pine, DJ (corresponding author), NYU, Ctr Soft Matter Res, New York, NY 10003 USA.	marcus.weck@nyu.edu; pine@nyu.edu	Manoharan, Vinothan N/C-1292-2008; Wang, Yu/E-7358-2015; Pine, David J/B-7740-2016; Feng, Lang/P-7891-2014	Manoharan, Vinothan N/0000-0003-0370-6095; Wang, Yu/0000-0003-1286-2401; Pine, David J/0000-0002-3304-6684; Wang, Yufeng/0000-0001-9409-7250; Weck, Marcus/0000-0002-6486-4268	MRSEC Program of the National Science Foundation [DMR-0820341]; National Science Foundation [ChE-0911460]; MRI programme of the National Science Foundation [DMR-0923251]	MRSEC Program of the National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); National Science Foundation(National Science Foundation (NSF)); MRI programme of the National Science Foundation	We thank M. T. Elsesser, D. Kraft, and G.-R. Yi for discussions. This work was supported partially by the MRSEC Program of the National Science Foundation under award number DMR-0820341. Additional financial support was provided by the National Science Foundation (ChE-0911460). We acknowledge support from the MRI programme of the National Science Foundation under award number DMR-0923251 for the purchase of a Zeiss field emission scanning electron microscope.	Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Bianchi E, 2011, PHYS CHEM CHEM PHYS, V13, P6397, DOI 10.1039/c0cp02296a; Breed D. R., 2007, THESIS U CALIFORNIA; Chen Q, 2011, NATURE, V469, P381, DOI 10.1038/nature09713; Chen Q, 2011, SCIENCE, V331, P199, DOI 10.1126/science.1197451; Cho YS, 2007, CHEM MATER, V19, P3183, DOI 10.1021/cm070051w; Dreyfus R, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041404; Frenkel D, 2002, SCIENCE, V296, P65, DOI 10.1126/science.1070865; Glotzer SC, 2004, SCIENCE, V306, P419, DOI 10.1126/science.1099988; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; HO KM, 1990, PHYS REV LETT, V65, P3152, DOI 10.1103/PhysRevLett.65.3152; Hong L, 2008, LANGMUIR, V24, P621, DOI 10.1021/la7030818; Huo FW, 2006, ADV MATER, V18, P2304, DOI 10.1002/adma.200601178; Johnson PM, 2005, LANGMUIR, V21, P11510, DOI 10.1021/la0518750; Jones MR, 2011, J AM CHEM SOC, V133, P18865, DOI 10.1021/ja206777k; Khan A., 1985, MAKROMOL CHEM, V10, P215; Kraft DJ, 2009, SOFT MATTER, V5, P3823, DOI 10.1039/b910593j; Kraft DJ, 2009, J AM CHEM SOC, V131, P1182, DOI 10.1021/ja8079803; Leunissen ME, 2005, NATURE, V437, P235, DOI 10.1038/nature03946; Leunissen ME, 2009, NAT MATER, V8, P590, DOI [10.1038/nmat2471, 10.1038/NMAT2471]; Li F, 2011, ANGEW CHEM INT EDIT, V50, P360, DOI 10.1002/anie.201001451; Macfarlane RJ, 2011, SCIENCE, V334, P204, DOI 10.1126/science.1210493; Manoharan V. N., 2004, THESIS U CALIFORNIA; Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189; Meng GN, 2010, SCIENCE, V327, P560, DOI 10.1126/science.1181263; Miller MA, 2005, J PHYS CHEM B, V109, P23109, DOI 10.1021/jp0549632; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Nelson DR, 2002, NANO LETT, V2, P1125, DOI [10.1021/nl0202096, 10.1021/n10202096]; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; OTTEWILL RH, 1967, KOLLOID Z Z POLYM, V215, P161, DOI 10.1007/BF01520398; Pawar AB, 2010, MACROMOL RAPID COMM, V31, P150, DOI 10.1002/marc.200900614; Pawar AB, 2009, LANGMUIR, V25, P9057, DOI 10.1021/la900809b; Perro A, 2009, ANGEW CHEM INT EDIT, V48, P361, DOI 10.1002/anie.200802562; Romano F, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3578182; Rossi L, 2011, SOFT MATTER, V7, P4139, DOI 10.1039/c0sm01246g; Sacanna S, 2010, NATURE, V464, P575, DOI 10.1038/nature08906; Sacanna S, 2011, CURR OPIN COLLOID IN, V16, P96, DOI 10.1016/j.cocis.2011.01.003; UGELSTAD J, 1979, MAKROMOL CHEM, V180, P737; van Kampen NG, 2007, NORTH-HOLL PERS LIBR, P292; Velikov KP, 2002, SCIENCE, V296, P106, DOI 10.1126/science.1067141; Walther A, 2008, SOFT MATTER, V4, P663, DOI 10.1039/b718131k; Xu XY, 2006, J AM CHEM SOC, V128, P9286, DOI 10.1021/ja061980b; Zerrouki D, 2006, LANGMUIR, V22, P57, DOI 10.1021/la051765t; Zhang G, 2005, NANO LETT, V5, P143, DOI 10.1012/nl048121a; Zhang ZL, 2005, LANGMUIR, V21, P11547, DOI 10.1021/la0513611; Zhang ZL, 2004, NANO LETT, V4, P1407, DOI 10.1021/nl0493500; Zoldesi CI, 2006, LANGMUIR, V22, P4343, DOI 10.1021/la060101w	47	785	794	15	676	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2012	491	7422					51	U61		10.1038/nature11564	http://dx.doi.org/10.1038/nature11564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23128225	Green Submitted			2022-12-28	WOS:000310434500029
J	Ghaffar, A; Tran, NT; Reddy, KS; Kasonde, J; Bajwa, T; Ammar, W; Ren, MH; Rottingen, JA; Mills, A				Ghaffar, Abdul; Tran, Nhan T.; Reddy, K. Srinath; Kasonde, Joseph; Bajwa, Tariq; Ammar, Walid; Ren, Minghui; Rottingen, John-Arne; Mills, Anne			Changing mindsets in health policy and systems research	LANCET			English	Editorial Material									[Ghaffar, Abdul; Tran, Nhan T.] WHO, Alliance Hlth Policy & Syst Res Hlth Syst & Serv, CH-1211 Geneva 27, Switzerland; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India; [Kasonde, Joseph] Govt Zambia, Minist Hlth, Lusaka, Zambia; [Bajwa, Tariq] Govt Punjab, Civil Secretariat, Lahore, Pakistan; [Ammar, Walid] Minist Publ Hlth, Beruit, Lebanon; [Ren, Minghui] Minist Hlth, Int Cooperat Dept, Beijing, Peoples R China; [Rottingen, John-Arne] Univ Oslo, Inst Hlth & Soc, Dept Hlth Management & Hlth Econ, Oslo, Norway; [Mills, Anne] Univ London London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1E 7HT, England	World Health Organization; Public Health Foundation of India; University of Oslo; University of London; London School of Hygiene & Tropical Medicine	Ghaffar, A (corresponding author), WHO, Alliance Hlth Policy & Syst Res Hlth Syst & Serv, CH-1211 Geneva 27, Switzerland.	ghaffara@who.int		Reddy, K Srinath/0000-0003-3416-3548; Mills, Anne/0000-0001-9863-9950				Alliance for Health Policy and Systems Research, 2011, STRATEGIC PLAN 2011; Gilson L, 2012, HEALTH POLICY AND SY; Gilson L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001079; Mills A, 2012, HEALTH POLICY PLANN, V27, P1, DOI 10.1093/heapol/czr006; Reich MR, 2008, LANCET, V371, P865, DOI 10.1016/S0140-6736(08)60384-0; UN System Task Team on the Post-2015 UN Development Agenda, 2012, REPORT TO THE SECRET; [No title captured]	7	13	13	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 9	2013	381	9865					436	437		10.1016/S0140-6736(12)61858-3	http://dx.doi.org/10.1016/S0140-6736(12)61858-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088CH	23122651				2022-12-28	WOS:000314810900012
J	Palmu, AA; Jokinen, J; Borys, D; Nieminen, H; Ruokokoski, E; Siira, L; Puumalainen, T; Lommel, P; Hezareh, M; Moreira, M; Schuerman, L; Kilpi, TM				Palmu, Arto A.; Jokinen, Jukka; Borys, Dorota; Nieminen, Heta; Ruokokoski, Esa; Siira, Lotta; Puumalainen, Taneli; Lommel, Patricia; Hezareh, Marjan; Moreira, Marta; Schuerman, Lode; Kilpi, Terhi M.			Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial	LANCET			English	Article							PHID-CV; DOUBLE-BLIND; CHILDREN; EFFICACY; SAFETY; IMMUNOGENICITY; PROGRAM; ENGLAND; TRENDS	Background The Finnish Invasive Pneumococcal disease (FinIP) vaccine trial was designed to assess the effectiveness of a pneumococcal vaccine containing ten serotype-specific polysaccharides conjugated to Haemophilus influenzae protein D, tetanus toxoid, and diphtheria toxoid as the carrier proteins (PHiD-CV10) against invasive pneumococcal disease. Methods In this cluster-randomised, double-blind trial, children aged younger than 19 months received PHiD-CV10 in 52 clusters or hepatitis vaccines as control in 26 clusters. Infants aged younger than 7 months at the first vaccination received either a 3+1 or a 2+1 vaccination schedule, children aged 7-11 months received a 2+1 schedule, and those 12-18 months of age received a two-dose schedule. The primary and secondary objectives were to assess vaccine effectiveness against culture-confirmed invasive pneumococcal disease due to any of the ten vaccine serotypes for the 3+1 and 2+1 schedules, respectively, in children who received at least one PHiD-CV10 dose before 7 months of age. Masked follow-up of pneumococcal disease lasted from the first vaccination (from February, 2009, to October, 2010) to January 31, 2012. Invasive disease data were retrieved from data accumulated in the national infectious diseases register. This trial and the nested acute otitis media trial are registered with ClinicalTrials.gov, numbers NCT00861380 and NCT00839254, respectively. Findings 47 369 children were enrolled from February, 2009, to October, 2010. 30 528 participants were assessed for the primary objective. 13 culture-confirmed vaccine-type cases of invasive pneumococcal disease were detected: none in the PHiD-CV10 3+1 group, one in the PHiD-CV10 2+1 group, and 12 in the control groups. The estimates for vaccine effectiveness were 100% (95% CI 83-100) for PHiD-CV10 3+1 and 92% (58-100) for PHiD-CV10 2+1 groups. Two cases of any culture-confirmed invasive disease irrespective of serotype were detected in combined PHiD-CV10 infant cohorts compared with 14 in the corresponding control cohorts (vaccine effectiveness 93%, 75-99). In catch-up cohorts, seven cases of invasive disease were reported, all in the control group: two cases in the children enrolled at 7-11 months of age; and five cases in children enrolled at 12-18 months of age (vaccine effectiveness 100%, 79-100). Non-fatal serious adverse events suspected to be vaccine-related were reported via routine post-immunisation safety surveillance in 18 children. Interpretation This nationwide trial showed high PHiD-CV10 effectiveness against invasive pneumococcal disease when given in different schedules. For the first time, effectiveness of a 2+1 schedule in infants was confirmed in a clinical trial.	[Palmu, Arto A.; Nieminen, Heta] Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Tampere, Finland; [Jokinen, Jukka; Ruokokoski, Esa; Kilpi, Terhi M.] Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Helsinki, Finland; [Borys, Dorota; Lommel, Patricia; Hezareh, Marjan; Moreira, Marta; Schuerman, Lode] GlaxoSmithKline Vaccines, Global Vaccine Dev, Wavre, Belgium; [Siira, Lotta] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Helsinki, Finland; [Puumalainen, Taneli] GlaxoSmithKline Vaccines, Espoo, Finland; [Puumalainen, Taneli] Minist Social Affairs & Hlth, Helsinki, Finland	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; GlaxoSmithKline; Finland National Institute for Health & Welfare; GlaxoSmithKline	Palmu, AA (corresponding author), Natl Inst Hlth & Welf THL, Biokatu 6, Tampere 33520, Finland.	arto.palmu@thl.fi		Palmu, Arto A./0000-0001-8071-8896; Siira, Lotta/0000-0002-0330-7396	GlaxoSmithKline Biologicals SA; National Institute for Health and Welfare, Finland; GlaxoSmithKline; Sanofi Pasteur MSD	GlaxoSmithKline Biologicals SA(GlaxoSmithKline); National Institute for Health and Welfare, Finland; GlaxoSmithKline(GlaxoSmithKline); Sanofi Pasteur MSD	GlaxoSmithKline Biologicals SA and National Institute for Health and Welfare, Finland.; AAP has had travel paid for and honoraria from GlaxoSmithKline to attend expert group meetings, has had travel paid by Merck to attend expert group meetings and has received a travel grant from Sanofi Pasteur MSD; and is the head of Clinical Research Unit at the National Institute for Health and Welfare, which has received research funding from GlaxoSmithKline. JJ is the head of Vaccine Research Unit at the National Institute for Health and Welfare, which has received research funding from GlaxoSmithKline. DB is an employee of GlaxoSmithKline Vaccines and has stocks and shares ownership of GlaxoSmithKline. HN is an employee of the Department of Vaccination and Immune Protection at the National Institute for Health and Welfare, which has received research funding from GlaxoSmithKline. ER is an employee of the Department of Vaccination and Immune Protection at the National Institute for Health and Welfare, which has received research funding from GlaxoSmithKline. TP was an employee of GlaxoSmithKline Vaccines during the study. PL is an employee of GlaxoSmithKline Vaccines and has stock ownership of GlaxoSmithKline. MH works as a consultant from Chiltern International for GlaxoSmithKline Vaccines. MM is an employee of GlaxoSmithKline Vaccines and has stock ownership of GlaxoSmithKline. LSc is an employee of GlaxoSmithKline Vaccines and has stock ownership of GlaxoSmithKline. TMK is director of the Department of Vaccination and Immune Protection at the National Institute for Health and Welfare, which has received research funding from GlaxoSmithKline. LSi declares no confl icts of interest. Synflorix, Engerix B and Havrix 720 Junior are trademarks of the GlaxoSmithKline group of companies. Prevenar/Prevnar is a trademark of Pfizer.	Barndorff-Nielsen OE, 1994, INFERENCE SYMPTOTICS; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Chevallier B, 2009, PEDIATR INFECT DIS J, V28, pS109, DOI 10.1097/INF.0b013e318199f62d; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; De Wals P, 2012, VACCINE, V30, P6416, DOI 10.1016/j.vaccine.2012.08.017; Expert Committee on Biological Standardization, 2009, REC ASS QUAL SAF EFF; Harboe ZB, 2010, VACCINE, V28, P2642, DOI 10.1016/j.vaccine.2010.01.017; Harnden A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1514; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Ihekweazu CA, 2008, EPIDEMIOL INFECT, V136, P1096, DOI 10.1017/S0950268807009715; Johnson DR, 2012, VACCINE, V30, P2206, DOI 10.1016/j.vaccine.2011.12.119; Jokinen J, 2012, ISPPD 8 IG FALLS BRA, P196; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Klemets P, 2008, SCAND J INFECT DIS, V40, P621, DOI 10.1080/00365540801938931; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Leal J, 2012, PEDIATR INFECT DIS J, V31, pE169, DOI 10.1097/INF.0b013e3182624a40; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Prymula R, 2006, LANCET, V367, P740, DOI 10.1016/S0140-6736(06)68304-9; Salo E, 2012, PEDIATR INT, V54, P770, DOI 10.1111/j.1442-200X.2012.03692.x; Siira L, 2012, J CLIN MICROBIOL, V50, P2727, DOI 10.1128/JCM.00689-12; Silfverdal Sven Arne, 2009, Pediatr Infect Dis J, V28, pe276, DOI 10.1097/INF.0b013e3181b48ca3; Tregnaghi MW, 2011, ESPID 2011 HAG NETH; Vesikari T, 2012, ICAAC 2012 SAN FRANC; Vesikari T, 2009, PEDIATR INFECT DIS J, V28, pS66, DOI 10.1097/INF.0b013e318199f8ef; Vestrheim DF, 2008, VACCINE, V26, P3277, DOI 10.1016/j.vaccine.2008.03.087; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	29	156	160	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2013	381	9862					214	222		10.1016/S0140-6736(12)61854-6	http://dx.doi.org/10.1016/S0140-6736(12)61854-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075LL	23158882	Green Submitted			2022-12-28	WOS:000313887600033
J	Duch, A; Felipe-Abrio, I; Barroso, S; Yaakov, G; Garcia-Rubio, M; Aguilera, A; de Nadal, E; Posas, F				Duch, Alba; Felipe-Abrio, Irene; Barroso, Sonia; Yaakov, Gilad; Garcia-Rubio, Maria; Aguilera, Andres; de Nadal, Eulalia; Posas, Francesc			Coordinated control of replication and transcription by a SAPK protects genomic integrity	NATURE			English	Article							DOUBLE-STRAND BREAKS; GENE-EXPRESSION; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; FORK PROGRESSION; CELL-CYCLE; STRESS; MRC1; PHASE; KINASE	Upon environmental changes or extracellular signals, cells are subjected to marked changes in gene expression (1,2). Dealing with high levels of transcription during replication is critical to prevent collisions between the transcription and replication pathways and avoid recombination events(3-5). In response to osmostress, hundreds of stress-responsive genes are rapidly induced by the stress-activated protein kinase (SAPK) Hog1 (ref.6), even during S phase(7). Here we show in Saccharomyces cerevisae that a single signalling molecule, Hog1, coordinates both replication and transcription upon osmostress. Hog1 interacts with and phosphorylates Mrc1, a component of the replication complex(8-11). Phosphorylation occurs at different sites to those targeted by Mec1 upon DNA damage(8,9). Mrc1 phosphorylation by Hog1 delays early and late origin firing by preventing Cdc45 loading, as well as slowing down replication-complex progression. Regulation of Mrc1 by Hog1 is completely independent of Mec1 and Rad53. Cells carrying a non-phosphorylatable allele of MRC1 (mrc1(3A)) do not delay replication upon stress and show a marked increase in transcription-associated recombination, genomic instability and Rad52 foci. In contrast, mrc1(3A) induces Rad53 and survival in the presence of hydroxyurea or methyl methanesulphonate. Therefore, Hog1 and Mrc1 define a novel S-phase checkpoint independent of the DNA-damage checkpoint that permits eukaryotic cells to prevent conflicts between DNA replication and transcription, which would otherwise lead to genomic instability when both phenomena are temporally coincident.	[Duch, Alba; Yaakov, Gilad; de Nadal, Eulalia; Posas, Francesc] Univ Pompeu Fabra, Cell Signaling Unit, Dept Ciencies Expt & Salut, E-08003 Barcelona, Spain; [Felipe-Abrio, Irene; Barroso, Sonia; Garcia-Rubio, Maria; Aguilera, Andres] Univ Seville, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville 41092, Spain	Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Posas, F (corresponding author), Univ Pompeu Fabra, Cell Signaling Unit, Dept Ciencies Expt & Salut, E-08003 Barcelona, Spain.	francesc.posas@upf.edu	de Nadal, Eulàlia/J-8178-2014; Posas, Francesc/K-1364-2013; Garcia-Rubio, Maria/C-2061-2017; Duch, Alba/AGI-1035-2022; Aguilera, Andres/L-1825-2014; Barroso, Sonia/F-2288-2016; FELIPE, IRENE/ABF-9743-2021	de Nadal, Eulàlia/0000-0003-0039-5607; Posas, Francesc/0000-0002-4164-7076; Garcia-Rubio, Maria/0000-0003-0981-0555; Duch, Alba/0000-0001-6041-1360; Aguilera, Andres/0000-0003-4782-1714; Barroso, Sonia/0000-0002-0062-2016; FELIPE, IRENE/0000-0001-7781-1459	Spanish Government [BIO2009-07762, BFU2012-33503, BFU2011-26722, BFU2010-16372, CSD2007-0015]; FP7 UNICELLSYS grant [201142]; Fundacion Marcelino Botin; ICREA Academia (Generalitat de Catalunya)	Spanish Government(Spanish GovernmentEuropean Commission); FP7 UNICELLSYS grant; Fundacion Marcelino Botin; ICREA Academia (Generalitat de Catalunya)(ICREAGeneralitat de Catalunya)	We thank L. Subirana, S. Ovejas and A. Fernandez for technical support. This work was supported by grants from the Spanish Government (BIO2009-07762 and BFU2012-33503 to F. P., BFU2011-26722 to E.d.N., BFU2010-16372 to A. A., and Consolider Ingenio 2010 programme CSD2007-0015 to F. P. and A. A.) and FP7 UNICELLSYS grant (no. 201142) and the Fundacion Marcelino Botin to F. P. F. P. and E.d.N. are recipients of an ICREA Academia (Generalitat de Catalunya).	Aguilera A, 2005, NAT STRUCT MOL BIOL, V12, P737, DOI 10.1038/nsmb0905-737; Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bianco JN, 2012, METHODS, V57, P149, DOI 10.1016/j.ymeth.2012.04.007; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Clotet J, 2007, METHOD ENZYMOL, V428, P63, DOI 10.1016/S0076-6879(07)28004-8; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; Garcia-Rubio M, 2008, MOL GENET GENOMICS, V279, P123, DOI 10.1007/s00438-007-0301-6; Gonzalez-Barrera S, 2002, GENETICS, V162, P603; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Jacobson MD, 2000, MOL CELL BIOL, V20, P4483, DOI 10.1128/MCB.20.13.4483-4493.2000; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Moriel-Carretero M, 2010, MOL CELL, V37, P690, DOI 10.1016/j.molcel.2010.02.008; Muers M, 2011, NAT REV GENET, V12, P156, DOI 10.1038/nrg2960; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Pomerantz RT, 2010, SCIENCE, V327, P590, DOI 10.1126/science.1179595; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; SPENCER F, 1990, GENETICS, V124, P237; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Yaakov G, 2009, MOL BIOL CELL, V20, P3572, DOI 10.1091/mbc.E09-02-0129	32	61	62	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					116	+		10.1038/nature11675	http://dx.doi.org/10.1038/nature11675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23178807				2022-12-28	WOS:000312933800042
J	Torres, VE; Chapman, AB; Devuyst, O; Gansevoort, RT; Grantham, JJ; Higashihara, E; Perrone, RD; Krasa, HB; Ouyang, J; Czerwiec, FS				Torres, Vicente E.; Chapman, Arlene B.; Devuyst, Olivier; Gansevoort, Ron T.; Grantham, Jared J.; Higashihara, Eiji; Perrone, Ronald D.; Krasa, Holly B.; Ouyang, John; Czerwiec, Frank S.		TEMPO 3 4 Trial Investigators	Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VASOPRESSIN V-2-RECEPTOR ANTAGONIST; LONG-ACTING SOMATOSTATIN; VOLUME PROGRESSION; ORAL TOLVAPTAN; RENAL-FUNCTION; CYST GROWTH; SIROLIMUS; OPC-41061; MODEL	BACKGROUND The course of autosomal dominant polycystic kidney disease (ADPKD) is often associated with pain, hypertension, and kidney failure. Preclinical studies indicated that vasopressin V-2-receptor antagonists inhibit cyst growth and slow the decline of kidney function. METHODS In this phase 3, multicenter, double-blind, placebo-controlled, 3-year trial, we randomly assigned 1445 patients, 18 to 50 years of age, who had ADPKD with a total kidney volume of 750 ml or more and an estimated creatinine clearance of 60 ml per minute or more, in a 2: 1 ratio to receive tolvaptan, a V-2-receptor antagonist, at the highest of three twice-daily dose regimens that the patient found tolerable, or placebo. The primary outcome was the annual rate of change in the total kidney volume. Sequential secondary end points included a composite of time to clinical progression (defined as worsening kidney function, kidney pain, hypertension, and albuminuria) and rate of kidney-function decline. RESULTS Over a 3-year period, the increase in total kidney volume in the tolvaptan group was 2.8% per year (95% confidence interval [CI], 2.5 to 3.1), versus 5.5% per year in the placebo group (95% CI, 5.1 to 6.0; P<0.001). The composite end point favored tolvaptan over placebo (44 vs. 50 events per 100 follow-up-years, P = 0.01), with lower rates of worsening kidney function (2 vs. 5 events per 100 person-years of follow-up, P<0.001) and kidney pain (5 vs. 7 events per 100 person-years of follow-up, P = 0.007). Tolvaptan was associated with a slower decline in kidney function (reciprocal of the serum creatinine level, -2.61 [mg per milliliter](-1) per year vs. -3.81 [mg per milliliter](-1) per year; P<0.001). There were fewer ADPKD-related adverse events in the tolvaptan group but more events related to aquaresis (excretion of electrolyte-free water) and hepatic adverse events unrelated to ADPKD, contributing to a higher discontinuation rate (23%, vs. 14% in the placebo group). CONCLUSIONS Tolvaptan, as compared with placebo, slowed the increase in total kidney volume and the decline in kidney function over a 3-year period in patients with ADPKD but was associated with a higher discontinuation rate, owing to adverse events. (Funded by Otsuka Pharmaceuticals and Otsuka Pharmaceutical Development and Commercialization; TEMPO 3: 4 ClinicalTrials.gov number, NCT00428948.)	[Torres, Vicente E.] Mayo Clin, Div Nephrol & Hypertens, Dept Internal Med, Rochester, MN 55905 USA; [Chapman, Arlene B.] Emory Univ, Sch Med, Div Nephrol, Atlanta, GA USA; [Devuyst, Olivier] Catholic Univ Louvain, Sch Med, Div Nephrol, Clin Univ St Luc, B-1200 Brussels, Belgium; [Devuyst, Olivier] Univ Zurich, Inst Physiol, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Gansevoort, Ron T.] Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Internal Med, Groningen, Netherlands; [Grantham, Jared J.] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS USA; [Grantham, Jared J.] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS USA; [Higashihara, Eiji] Kyorin Univ, Sch Med, Dept Urol, Mitaka, Tokyo 181, Japan; [Perrone, Ronald D.] Tufts Univ, Sch Med, Tufts Med Ctr, Dept Med,Div Nephrol, Boston, MA 02111 USA; [Krasa, Holly B.; Ouyang, John; Czerwiec, Frank S.] Otsuka Pharmaceut Dev & Commercializat, Rockville, MD USA	Mayo Clinic; Emory University; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Groningen; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Kyorin University; Tufts Medical Center; Tufts University; Otsuka Pharmaceutical	Torres, VE (corresponding author), Mayo Clin, Div Nephrol & Hypertens, Dept Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	torres.vicente@mayo.edu	Magistroni, Riccardo/AAL-8753-2020; Ciechanowski, Kazimierz -/A-5675-2016; Maxwell, Patrick H/C-5557-2008; Manunta, Paolo/ABH-5476-2020; Combe, Christian/N-3726-2015; Remuzzi, Giuseppe/V-9766-2017; Torra, Roser/A-9983-2008; Volovat, Constantin/N-6580-2013	Magistroni, Riccardo/0000-0002-3319-0248; Maxwell, Patrick H/0000-0002-0338-2679; Manunta, Paolo/0000-0003-3976-9696; Combe, Christian/0000-0002-0360-573X; Fukagawa, Masafumi/0000-0002-7832-2339; BICHET, DANIEL-G/0000-0003-2856-6850; Remuzzi, Giuseppe/0000-0002-6194-3446; Krajewska, Magdalena/0000-0002-2632-2409; Torra, Roser/0000-0001-8714-2332; Capasso, Giovambattista/0000-0003-3469-8614; Volovat, Constantin/0000-0003-1582-0135; Torres, Vicente/0000-0003-2008-1576; Mottl, Amy/0000-0002-4258-1726; Ruilope, Luis M/0000-0001-6278-7951; Devuyst, Olivier/0000-0003-3744-4767; Van der Niepen, Patricia/0000-0002-6401-1580; Maxwell, Alexander P./0000-0002-6110-7253; Holt, Steve/0000-0001-6936-9736	Otsuka Pharmaceuticals; Otsuka Pharmaceutical Development and Commercialization; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER	Otsuka Pharmaceuticals(Otsuka Pharmaceutical); Otsuka Pharmaceutical Development and Commercialization(Otsuka Pharmaceutical); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by Otsuka Pharmaceuticals and Otsuka Pharmaceutical Development and Commercialization.	Berl T, 2010, J AM SOC NEPHROL, V21, P705, DOI 10.1681/ASN.2009080857; Boertien WE, 2012, J AM SOC NEPHROL, V23, p243A; Chapman AB, 2012, CLIN J AM SOC NEPHRO, V7, P479, DOI 10.2215/CJN.09500911; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Grantham JJ, 2008, NEW ENGL J MED, V359, P1477, DOI 10.1056/NEJMcp0804458; Grantham JJ, 2006, CLIN J AM SOC NEPHRO, V1, P148, DOI 10.2215/CJN.00330705; Grantham JJ, 2006, NEW ENGL J MED, V354, P2122, DOI 10.1056/NEJMoa054341; Higashihara E, 2011, CLIN J AM SOC NEPHRO, V6, P2499, DOI 10.2215/CJN.03530411; Hogan MC, 2010, J AM SOC NEPHROL, V21, P1052, DOI 10.1681/ASN.2009121291; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Irazabal MV, 2011, KIDNEY INT, V80, P295, DOI 10.1038/ki.2011.119; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; LEFANTE JJ, 1990, STAT MED, V9, P437, DOI 10.1002/sim.4780090414; Levey AS, 2008, ANN INTERN MED, V149, P519, DOI 10.7326/0003-4819-149-7-200810070-00023; Matsuzaki Masunori, 2011, Cardiovasc Drugs Ther, V25 Suppl 1, pS33, DOI 10.1007/s10557-011-6304-x; Meijer E, 2011, NEPHROL DIAL TRANSPL, V26, P2445, DOI 10.1093/ndt/gfr069; Nagao S, 2006, J AM SOC NEPHROL, V17, P2220, DOI 10.1681/ASN.2006030251; Perico N, 2010, J AM SOC NEPHROL, V21, P1031, DOI 10.1681/ASN.2009121302; RAVINE D, 1994, LANCET, V343, P824, DOI 10.1016/S0140-6736(94)92026-5; Reif GA, 2011, AM J PHYSIOL-RENAL, V301, pF1005, DOI 10.1152/ajprenal.00243.2011; Ruggenenti P, 2005, KIDNEY INT, V68, P206, DOI 10.1111/j.1523-1755.2005.00395.x; Rule AD, 2006, J AM SOC NEPHROL, V17, P854, DOI 10.1681/ASN.2005070697; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Therneau TM, 2000, MODELING SURVIVAL DA; Torres VE, 2004, NAT MED, V10, P363, DOI 10.1038/nm1004; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2011, AM J KIDNEY DIS, V57, P692, DOI 10.1053/j.ajkd.2010.11.029; Van Keimpema L, 2009, GASTROENTEROLOGY, V137, P1661, DOI 10.1053/j.gastro.2009.07.052; Walz G, 2010, NEW ENGL J MED, V363, P1977; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; Wang XF, 2005, J AM SOC NEPHROL, V16, P846, DOI 10.1681/ASN.2004121090; Wang XF, 2008, J AM SOC NEPHROL, V19, P102, DOI 10.1681/ASN.2007060688; Yamamura Y, 1998, J PHARMACOL EXP THER, V287, P860	36	939	969	4	114	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2012	367	25					2407	2418		10.1056/NEJMoa1205511	http://dx.doi.org/10.1056/NEJMoa1205511			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056ZP	23121377	Green Accepted, Green Published			2022-12-28	WOS:000312531600008
J	Ouyang, WM; Liao, W; Luo, CT; Yin, N; Huse, M; Kim, MV; Peng, M; Chan, P; Ma, Q; Mo, YF; Meijer, D; Zhao, KJ; Rudensky, AY; Atwal, G; Zhang, MQ; Li, MO				Ouyang, Weiming; Liao, Will; Luo, Chong T.; Yin, Na; Huse, Morgan; Kim, Myoungjoo V.; Peng, Min; Chan, Pamela; Ma, Qian; Mo, Yifan; Meijer, Dies; Zhao, Keji; Rudensky, Alexander Y.; Atwal, Gurinder; Zhang, Michael Q.; Li, Ming O.			Novel Foxo1-dependent transcriptional programs control T-reg cell function	NATURE			English	Article							FOXP3 EXPRESSION; GENE-EXPRESSION; TARGET GENES; DIFFERENTIATION; FOXO1; TOOL; AKT; MECHANISMS; INDUCTION; PROFILES	Regulatory T (T-reg) cells, characterized by expression of the transcription factor forkhead box P3 (Foxp3), maintain immune homeostasis by suppressing self-destructive immune responses(1-4). Foxp3 operates as a late-acting differentiation factor controlling T-reg cell homeostasis and function(5), whereas the early T-reg-cell-lineage commitment is regulated by the Akt kinase and the forkhead box O (Foxo) family of transcription factors(6-10). However, whether Foxo proteins act beyond the T-reg-cell-commitment stage to control T-reg cell homeostasis and function remains largely unexplored. Here we show that Foxo1 is a pivotal regulator of T-reg cell function. T-reg cells express high amounts of Foxo1 and display reduced T-cell-receptor-induced Akt activation, Foxo1 phosphorylation and Foxo1 nuclear exclusion. Mice with T-reg-cell-specific deletion of Foxo1 develop a fatal inflammatory disorder similar in severity to that seen in Foxp3-deficient mice, but without the loss of T-reg cells. Genome-wide analysis of Foxo1 binding sites reveals similar to 300 Foxo1-bound target genes, including the pro-inflammatory cytokine Ifng, that do not seem to be directly regulated by Foxp3. These findings show that the evolutionarily ancient Akt-Foxo1 signalling module controls a novel genetic program indispensable for T-reg cell function.	[Ouyang, Weiming; Luo, Chong T.; Yin, Na; Huse, Morgan; Kim, Myoungjoo V.; Peng, Min; Chan, Pamela; Ma, Qian; Rudensky, Alexander Y.; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Liao, Will; Mo, Yifan; Atwal, Gurinder] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Liao, Will; Mo, Yifan] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Luo, Chong T.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA; [Meijer, Dies] Erasmus Univ, Med Ctr, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; [Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Zhang, Michael Q.] Univ Texas Dallas, Ctr Syst Biol, Dept Mol & Cell Biol, Richardson, TX 75080 USA; [Zhang, Michael Q.] Tsinghua Univ, TNLIST, Ctr Synthet & Syst Biol, Bioinformat Div, Beijing 100084, Peoples R China	Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Memorial Sloan Kettering Cancer Center; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; University of Texas System; University of Texas Dallas; Tsinghua University	Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.	mzhang@cshl.edu; lim@mskcc.org	Meijer, Dies/C-7786-2012; Peng, Min/O-3770-2017	Meijer, Dies/0000-0002-8461-6341; Peng, Min/0000-0002-5885-0660; li, ming/0000-0002-1383-0535; Luo, Chong/0000-0002-3477-5969	Starr Cancer Consortium [13-A123]; Rita Allen Foundation; National Bio Resource Project (NBRPC) [2012CB316503]; National Institutes of Health [HG001696]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006030, ZIAHL005801] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001696] Funding Source: NIH RePORTER	Starr Cancer Consortium; Rita Allen Foundation; National Bio Resource Project (NBRPC); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank R. Flavell for the Foxp3-IRES-RFP mouse strain, K. Rajewsky and C. Xiao for the Rosa26 targeting vector and T. Unterman for the HA-hFoxo1(AAA) construct. This work was supported by the Starr Cancer Consortium (13-A123 to M.O.L., M.Q.Z. and G. A.), the Rita Allen Foundation (M.O.L.), National Bio Resource Project (NBRPC) (2012CB316503 to M.Q.Z.) and National Institutes of Health (HG001696 to M.Q.Z.).	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Driegen S, 2005, TRANSGENIC RES, V14, P477, DOI 10.1007/s11248-005-7220-2; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li LP, 2009, J COMPUT BIOL, V16, P317, DOI 10.1089/cmb.2008.16TT; Lopez-Romero P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-64; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Patterson SJ, 2011, J IMMUNOL, V186, P5533, DOI 10.4049/jimmunol.1002126; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith AD, 2006, P NATL ACAD SCI USA, V103, P6275, DOI 10.1073/pnas.0508169103; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	44	278	286	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					554	+		10.1038/nature11581	http://dx.doi.org/10.1038/nature11581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23135404	Green Accepted			2022-12-28	WOS:000311339800043
J	Derby, B				Derby, Brian			Printing and Prototyping of Tissues and Scaffolds	SCIENCE			English	Review							CELL; MICROENVIRONMENTS; BIOMATERIALS; PROTEINS; DESIGN; BONE	New manufacturing technologies under the banner of rapid prototyping enable the fabrication of structures close in architecture to biological tissue. In their simplest form, these technologies allow the manufacture of scaffolds upon which cells can grow for later implantation into the body. A more exciting prospect is the printing and patterning in three dimensions of all the components that make up a tissue (cells and matrix materials) to generate structures analogous to tissues; this has been termed bioprinting. Such techniques have opened new areas of research in tissue engineering and regenerative medicine.	Univ Manchester, Sch Mat, Manchester M13 9PL, Lancs, England	University of Manchester	Derby, B (corresponding author), Univ Manchester, Sch Mat, Oxford Rd, Manchester M13 9PL, Lancs, England.	brian.derby@manchester.ac.uk	Derby, Brian/E-3529-2010	Derby, Brian/0000-0001-5753-0166	Engineering and Physical Sciences Research Council [EP/C01328X/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Barron JA, 2004, BIOMED MICRODEVICES, V6, P139, DOI 10.1023/B:BMMD.0000031751.67267.9f; Boland T, 2003, ANAT REC PART A, V272A, P497, DOI 10.1002/ar.a.10059; Campbell PG, 2005, BIOMATERIALS, V26, P6762, DOI 10.1016/j.biomaterials.2005.04.032; Catros S, 2011, APPL SURF SCI, V257, P5142, DOI 10.1016/j.apsusc.2010.11.049; Chang R, 2008, TISSUE ENG PART C-ME, V14, P157, DOI 10.1089/ten.tec.2007.0392; Chang R, 2008, TISSUE ENG PT A, V14, P41, DOI 10.1089/ten.a.2007.0004; Cohen D. L., 2006, TISSUE ENG, V12, P1325; Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.tea.2011.0543, 10.1089/ten.TEA.2011.0543]; Cui XF, 2010, BIOTECHNOL BIOENG, V106, P963, DOI 10.1002/bit.22762; Derby B, 2010, ANNU REV MATER RES, V40, P395, DOI 10.1146/annurev-matsci-070909-104502; Derby B, 2008, J MATER CHEM, V18, P5717, DOI 10.1039/b807560c; Di Biase M, 2011, SOFT MATTER, V7, P2639, DOI 10.1039/c0sm00996b; Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Jayasinghe SN, 2006, SMALL, V2, P216, DOI 10.1002/sm11.200500291; Jones R, 2011, ROBOTICA, V29, P177, DOI 10.1017/S026357471000069X; Kelm JM, 2006, TISSUE ENG, V12, P2151, DOI 10.1089/ten.2006.12.2151; Kelm JM, 2004, TRENDS BIOTECHNOL, V22, P195, DOI 10.1016/j.tibtech.2004.02.002; Ker EDF, 2011, BIOMATERIALS, V32, P8097, DOI 10.1016/j.biomaterials.2011.07.025; KLEBE RJ, 1988, EXP CELL RES, V179, P362, DOI 10.1016/0014-4827(88)90275-3; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Malone E, 2007, RAPID PROTOTYPING J, V13, P245, DOI 10.1108/13552540710776197; Melchels FPW, 2010, BIOMATERIALS, V31, P6909, DOI 10.1016/j.biomaterials.2010.05.068; Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]; Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084; Mott M, 1999, J AM CERAM SOC, V82, P1653, DOI 10.1111/j.1151-2916.1999.tb01982.x; Nakamura M, 2005, TISSUE ENG, V11, P1658, DOI 10.1089/ten.2005.11.1658; Nelson CM, 2003, J CELL SCI, V116, P3571, DOI 10.1242/jcs.00680; Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h; Phillippi JA, 2008, STEM CELLS, V26, P127, DOI 10.1634/stemcells.2007-0520; Probst FA, 2010, HANDCHIR MIKROCHIR P, V42, P369, DOI 10.1055/s-0030-1248310; Reichert JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003720; Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270; Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052; Sachlos E., 2003, European Cells & Materials, V5, P29; Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8; Saunders RE, 2008, BIOMATERIALS, V29, P193, DOI 10.1016/j.biomaterials.2007.09.032; Sekitani T, 2008, P NATL ACAD SCI USA, V105, P4976, DOI 10.1073/pnas.0708340105; Sekula S, 2008, SMALL, V4, P1785, DOI 10.1002/smll.200800949; Stringer J, 2010, LANGMUIR, V26, P10365, DOI 10.1021/la101296e; Stroock AD, 2010, TISSUE ENG PT A, V16, P2143, DOI [10.1089/ten.tea.2009.0689, 10.1089/ten.TEA.2009.0689]; Symes MD, 2012, NAT CHEM, V4, P349, DOI [10.1038/NCHEM.1313, 10.1038/nchem.1313]; Wang XH, 2007, TRENDS BIOTECHNOL, V25, P505, DOI 10.1016/j.tibtech.2007.08.010; Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024; Windle J, 1999, J MATER SCI LETT, V18, P87, DOI 10.1023/A:1006689713205; Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011; Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061	50	738	822	19	936	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					921	926		10.1126/science.1226340	http://dx.doi.org/10.1126/science.1226340			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161993	Green Submitted			2022-12-28	WOS:000311083600037
J	Luckyanova, MN; Garg, J; Esfarjani, K; Jandl, A; Bulsara, MT; Schmidt, AJ; Minnich, AJ; Chen, S; Dresselhaus, MS; Ren, ZF; Fitzgerald, EA; Chen, G				Luckyanova, Maria N.; Garg, Jivtesh; Esfarjani, Keivan; Jandl, Adam; Bulsara, Mayank T.; Schmidt, Aaron J.; Minnich, Austin J.; Chen, Shuo; Dresselhaus, Mildred S.; Ren, Zhifeng; Fitzgerald, Eugene A.; Chen, Gang			Coherent Phonon Heat Conduction in Superlattices	SCIENCE			English	Article							THERMAL-CONDUCTIVITY; TRANSPORT; PROPAGATION; SCATTERING; NANOSCALE	The control of heat conduction through the manipulation of phonons as coherent waves in solids is of fundamental interest and could also be exploited in applications, but coherent heat conduction has not been experimentally confirmed. We report the experimental observation of coherent heat conduction through the use of finite-thickness superlattices with varying numbers of periods. The measured thermal conductivity increased linearly with increasing total superlattice thickness over a temperature range from 30 to 150 kelvin, which is consistent with a coherent phonon heat conduction process. First-principles and Green's function-based simulations further support this coherent transport model. Accessing the coherent heat conduction regime opens a new venue for phonon engineering for an array of applications.	[Luckyanova, Maria N.; Garg, Jivtesh; Esfarjani, Keivan; Chen, Gang] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Jandl, Adam; Bulsara, Mayank T.; Fitzgerald, Eugene A.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Schmidt, Aaron J.] Boston Univ, Dept Mech Engn, Boston, MA 02215 USA; [Minnich, Austin J.] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; [Chen, Shuo; Ren, Zhifeng] Boston Coll, Dept Phys, Chestnut Hill, MA 02467 USA; [Dresselhaus, Mildred S.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Dresselhaus, Mildred S.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Boston University; California Institute of Technology; Boston College; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Chen, G (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	gchen2@mit.edu	Esfarjani, Keivan/D-4828-2016; Chen, Gang/J-1325-2014; Garg, Jivtesh/D-2125-2013; Garg, Jivtesh/T-5494-2018; Chen, Shuo/HCH-3354-2022; Esfarjani, Keivan/AAR-1828-2021; Ren, Zhifeng/B-4275-2014; Chen, Shuo/H-2491-2011; Esfarjani, Keivan/L-4017-2019	Esfarjani, Keivan/0000-0003-1969-0956; Chen, Gang/0000-0002-3968-8530; Garg, Jivtesh/0000-0001-8436-0537; Esfarjani, Keivan/0000-0003-1969-0956; Chen, Shuo/0000-0002-7145-1269; /0000-0001-9676-8783; Minnich, Austin J./0000-0002-9671-9540	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001299/DE-FG02-09ER46577]; National Science Foundation Graduate Research Fellowship [1122374]	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	We thank A. A. Maznev, K. A. Nelson, K. C. Collins, and J. Johnson for helpful discussions. This material is based on work supported as part of the Solid State Solar-Thermal Energy Conversion Center (S<SUP>3</SUP>TEC), an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award DE-SC0001299/DE-FG02-09ER46577. M.N.L. was partially supported by the National Science Foundation Graduate Research Fellowship under grant 1122374.	AFROMOWITZ MA, 1973, J APPL PHYS, V44, P1292, DOI 10.1063/1.1662342; BARONI S, 1987, PHYS REV LETT, V58, P1861, DOI 10.1103/PhysRevLett.58.1861; Broido DA, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2822891; Cahill DG, 2003, J APPL PHYS, V93, P793, DOI 10.1063/1.1524305; Cahill DG, 2004, REV SCI INSTRUM, V75, P5119, DOI 10.1063/1.1819431; Capinski WS, 1999, PHYS REV B, V59, P8105, DOI 10.1103/PhysRevB.59.8105; CAROLI C, 1971, J PHYS PART C SOLID, V4, P916, DOI 10.1088/0022-3719/4/8/018; Casimir HBG, 1938, PHYSICA, V5, P495, DOI 10.1016/S0031-8914(38)80162-2; Chang CW, 2006, SCIENCE, V314, P1121, DOI 10.1126/science.1132898; Chen G, 1998, PHYS REV B, V57, P14958, DOI 10.1103/PhysRevB.57.14958; Chiritescu C, 2007, SCIENCE, V315, P351, DOI 10.1126/science.1136494; COLVARD C, 1980, PHYS REV LETT, V45, P298, DOI 10.1103/PhysRevLett.45.298; Costescu RM, 2004, SCIENCE, V303, P989, DOI 10.1126/science.1093711; Daly BC, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.024301; Esfarjani K, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.085204; Garg J, 2011, NANO LETT, V11, P5135, DOI 10.1021/nl202186y; Garg J, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.045901; Hyldgaard P, 1997, PHYS REV B, V56, P10754, DOI 10.1103/PhysRevB.56.10754; Koh YK, 2009, ADV FUNCT MATER, V19, P610, DOI 10.1002/adfm.200800984; LANDAUER R, 1970, PHILOS MAG, V21, P863, DOI 10.1080/14786437008238472; Landry ES, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.075316; LEE PA, 1981, PHYS REV LETT, V47, P882, DOI 10.1103/PhysRevLett.47.882; Lee SM, 1997, APPL PHYS LETT, V70, P2957, DOI 10.1063/1.118755; Li DY, 2003, APPL PHYS LETT, V83, P2934, DOI 10.1063/1.1616981; Lim JW, 2012, NANO LETT, V12, P2475, DOI 10.1021/nl3005868; MEIR Y, 1992, PHYS REV LETT, V68, P2512, DOI 10.1103/PhysRevLett.68.2512; NARAYANAMURTI V, 1979, PHYS REV LETT, V43, P2012, DOI 10.1103/PhysRevLett.43.2012; NARAYANAMURTI V, 1981, SCIENCE, V213, P717, DOI 10.1126/science.213.4509.717; PADDOCK CA, 1986, J APPL PHYS, V60, P285, DOI 10.1063/1.337642; Pernot G, 2010, NAT MATER, V9, P491, DOI [10.1038/nmat2752, 10.1038/NMAT2752]; Robb PD, 2008, ULTRAMICROSCOPY, V109, P61, DOI 10.1016/j.ultramic.2008.08.001; Schmidt AJ, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.3006335; SWARTZ ET, 1989, REV MOD PHYS, V61, P605, DOI 10.1103/RevModPhys.61.605; Tamura S, 1999, PHYS REV B, V60, P2627, DOI 10.1103/PhysRevB.60.2627; TAMURA S, 1988, PHYS REV B, V38, P1427, DOI 10.1103/PhysRevB.38.1427; TAMURA S, 1983, PHYS REV B, V27, P858, DOI 10.1103/PhysRevB.27.858; Volz S, 2000, MICROELECTRON J, V31, P815, DOI 10.1016/S0026-2692(00)00064-1; Wang J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.153311; YAO T, 1987, APPL PHYS LETT, V51, P1798, DOI 10.1063/1.98526; Yu JK, 2010, NAT NANOTECHNOL, V5, P718, DOI 10.1038/nnano.2010.149; YU XY, 1995, APPL PHYS LETT, V67, P3554, DOI 10.1063/1.114919	41	423	427	12	359	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					936	939		10.1126/science.1225549	http://dx.doi.org/10.1126/science.1225549			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161996				2022-12-28	WOS:000311083600040
J	Mulla, O; Charaklias, N; Nix, PA				Mulla, O.; Charaklias, N.; Nix, P. A.			A man with a blocked nose	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NASAL POLYPOSIS; MANAGEMENT; THERAPY		[Mulla, O.; Charaklias, N.; Nix, P. A.] Leeds Gen Infirm, Dept Ear Nose & Throat, Leeds LS1 3EX, W Yorkshire, England	Leeds General Infirmary; University of Leeds	Mulla, O (corresponding author), Leeds Gen Infirm, Dept Ear Nose & Throat, Leeds LS1 3EX, W Yorkshire, England.	omarmulla22@gmail.com		Nix, Paul/0000-0002-7284-710X				Alobid I, 2012, CURR ALLERGY ASTHM R, V12, P144, DOI 10.1007/s11882-012-0247-6; Arslan HH, 2011, J CRANIOFAC SURG, V22, P751, DOI 10.1097/SCS.0b013e3182085598; Casale Manuele, 2011, Inflammation & Allergy Drug Targets, V10, P158; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Hopkins C, 2009, LARYNGOSCOPE, V119, P2459, DOI 10.1002/lary.20653; Martinez-devesa P, 2011, COCHRANE DB SYST REV, V7; Mullol J, 2011, ANN INTERN MED, V154, P365, DOI 10.7326/0003-4819-154-5-201103010-00011; Snidvongs K, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009274.pub2, 10.1002/14651858.CD009274]; Wise SK, 2009, CURR OPIN OTOLARYNGO, V17, P216, DOI 10.1097/MOO.0b013e32832ad23d	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 16	2012	345								e7567	10.1136/bmj.e7567	http://dx.doi.org/10.1136/bmj.e7567			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040QI	23160968				2022-12-28	WOS:000311337500009
J	Andrews, J; Teo, I				Andrews, Jack; Teo, Isabel			Multiple enlarging nodules on the lower limb	BRITISH MEDICAL JOURNAL			English	Editorial Material							SQUAMOUS-CELL CARCINOMA; SKIN; LIP		[Andrews, Jack; Teo, Isabel] Ninewells Hosp, Plast Surg Unit, Dundee DD1 9SY, Scotland	University of Dundee	Andrews, J (corresponding author), Ninewells Hosp, Plast Surg Unit, Dundee DD1 9SY, Scotland.	jackandrews88@gmail.com						*AM JOINT COMM CAN, 2010, CANC STAG MAN; Australian Cancer Network Management of Non-Melanoma Skin Cancer Working Party, 2002, CLIN PRACT GUID NONM; Broders AC, 1920, J AMER MED ASSOC, V74, P656, DOI 10.1001/jama.1920.02620100016007; FITZPATRICK TB, 1975, J MED ESTHET, V2, P330; Heal Clare, 2006, Aust Fam Physician, V35, P825; Lomas A, 2012, BRIT J DERMATOL, V166, P1069, DOI 10.1111/j.1365-2133.2012.10830.x; Miller Stanley J, 2007, J Natl Compr Canc Netw, V5, P506; Motley R, 2002, BRIT J DERMATOL, V146, P18, DOI 10.1046/j.0007-0963.2001.04615.x; ROWE DE, 1992, J AM ACAD DERMATOL, V26, P976, DOI 10.1016/0190-9622(92)70144-5	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 15	2012	345								e7409	10.1136/bmj.e7409	http://dx.doi.org/10.1136/bmj.e7409			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040QE	23153838				2022-12-28	WOS:000311337000008
J	Batygin, K				Batygin, Konstantin			A primordial origin for misalignments between stellar spin axes and planetary orbits	NATURE			English	Article							MULTIPLE-STAR-FORMATION; HOT JUPITERS; DYNAMICS; BINARY; ENVIRONMENT; SCATTERING; MIGRATION; EVOLUTION; ROTATION; SYSTEMS	The existence of gaseous giant planets whose orbits lie close to their host stars ('hot Jupiters') can largely be accounted for by planetary migration associated with viscous evolution of proto-planetary nebulae(1). Recently, observations of the Rossiter-McLaughlin effect(2) during planetary transits have revealed that a considerable fraction of hot Jupiters are on orbits that are misaligned with respect to the spin axes of their host stars(3). This observation has cast doubt on the importance of disk-driven migration as a mechanism for producing hot Jupiters. Here I show that misaligned orbits can be a natural consequence of disk migration in binary systems whose orbital plane is uncorrelated with the spin axes of the individual stars(4-6). The gravitational torques arising from the dynamical evolution of idealized proto-planetary disks under perturbations from massive distant bodies act to misalign the orbital planes of the disks relative to the spin poles of their host stars. As a result, I suggest that in the absence of strong coupling between the angular momentum of the disk and that of the host star, or of sufficient dissipation that acts to realign the stellar spin axis and the planetary orbits, the fraction of planetary systems (including systems of 'hot Neptunes' and 'super-Earths') whose angular momentum vectors are misaligned with respect to their host stars will be commensurate with the rate of primordial stellar multiplicity.	[Batygin, Konstantin] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Batygin, Konstantin] Harvard Smithsonian Ctr Astrophys, Inst Theory & Computat, Cambridge, MA 02138 USA	California Institute of Technology; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Batygin, K (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	kbatygin@gps.caltech.edu		Batygin, Konstantin/0000-0002-7094-7908				Bate MR, 2010, MON NOT R ASTRON SOC, V401, P1505, DOI 10.1111/j.1365-2966.2009.15773.x; Batygin K, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117193; Calvet N, 2005, ASTRON J, V129, P935, DOI 10.1086/426910; Fabrycky D, 2007, ASTROPHYS J, V669, P1298, DOI 10.1086/521702; Ford EB, 2008, ASTROPHYS J, V686, P621, DOI 10.1086/590926; Gauss C.F., 1866, WERKE, V3, P331; GHEZ AM, 1993, ASTRON J, V106, P2005, DOI 10.1086/116782; Guillochon J, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/2/74; Hebrard G, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/201016331; Herbst W, 2002, ASTRON ASTROPHYS, V396, P513, DOI 10.1051/0004-6361:20021362; Kaib NA, 2011, ASTROPHYS J LETT, V742, DOI 10.1088/2041-8205/742/2/L24; Kraus AL, 2007, ASTROPHYS J, V662, P413, DOI 10.1086/516835; Kraus AL, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/1/8; Lissauer JJ, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/8; Marks M, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201118231; Marquis de Laplace P.-S., 1799, TRAITE MECANIQUE CEL, V1, P569; McLaughlin DB, 1924, ASTROPHYS J, V60, P22, DOI 10.1086/142826; Morbidelli A., 2002, MODERN CELESTIAL MEC; Morbidelli A, 2007, ICARUS, V191, P158, DOI 10.1016/j.icarus.2007.04.001; Murray C. D., 1999, SOLAR SYSTEM DYNAMIC; Nagasawa M, 2008, ASTROPHYS J, V678, P498, DOI 10.1086/529369; Naoz S, 2011, NATURE, V473, P187, DOI 10.1038/nature10076; Terquem C, 2007, ASTROPHYS J, V654, P1110, DOI 10.1086/509497; Touma JR, 2009, MON NOT R ASTRON SOC, V394, P1085, DOI 10.1111/j.1365-2966.2009.14409.x; Winn JN, 2010, ASTROPHYS J LETT, V718, pL145, DOI 10.1088/2041-8205/718/2/L145; Wu Y, 2003, ASTROPHYS J, V589, P605, DOI 10.1086/374598; Wu YQ, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/2/109	29	198	198	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					418	420		10.1038/nature11560	http://dx.doi.org/10.1038/nature11560			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23151584	Green Submitted, Green Accepted			2022-12-28	WOS:000311031600040
J	Huang, JH; Ofek, G; Laub, L; Louder, MK; Doria-Rose, NA; Longo, NS; Imamichi, H; Bailer, RT; Chakrabarti, B; Sharma, SK; Alam, SM; Wang, T; Yang, YP; Zhang, BS; Migueles, SA; Wyatt, R; Haynes, BF; Kwong, PD; Mascola, JR; Connors, M				Huang, Jinghe; Ofek, Gilad; Laub, Leo; Louder, Mark K.; Doria-Rose, Nicole A.; Longo, Nancy S.; Imamichi, Hiromi; Bailer, Robert T.; Chakrabarti, Bimal; Sharma, Shailendra K.; Alam, S. Munir; Wang, Tao; Yang, Yongping; Zhang, Baoshan; Migueles, Stephen A.; Wyatt, Richard; Haynes, Barton F.; Kwong, Peter D.; Mascola, John R.; Connors, Mark			Broad and potent neutralization of HIV-1 by a gp41-specific human antibody	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROXIMAL EXTERNAL REGION; MONOCLONAL-ANTIBODIES; GLYCOPROTEIN GP41; T-CELLS; EPITOPE; MEMBRANE; BINDING; 4E10; SPECIFICITIES	Characterization of human monoclonal antibodies is providing considerable insight into mechanisms of broad HIV-1 neutralization. Here we report an HIV-1 gp41 membrane-proximal external region (MPER)-specific antibody, named 10E8, which neutralizes similar to 98% of tested viruses. An analysis of sera from 78 healthy HIV-1-infected donors demonstrated that 27% contained MPER-specific antibodies and 8% contained 10E8-like specificities. In contrast to other neutralizing MPER antibodies, 10E8 did not bind phospholipids, was not autoreactive, and bound cell-surface envelope. The structure of 10E8 in complex with the complete MPER revealed a site of vulnerability comprising a narrow stretch of highly conserved gp41-hydrophobic residues and a critical arginine or lysine just before the transmembrane region. Analysis of resistant HIV-1 variants confirmed the importance of these residues for neutralization. The highly conserved MPER is a target of potent, non-self-reactive neutralizing antibodies, suggesting that HIV-1 vaccines should aim to induce antibodies to this region of HIV-1 envelope glycoprotein.	[Huang, Jinghe; Laub, Leo; Imamichi, Hiromi; Migueles, Stephen A.; Connors, Mark] NIAID, HIV Specif Immun Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Ofek, Gilad; Louder, Mark K.; Doria-Rose, Nicole A.; Longo, Nancy S.; Bailer, Robert T.; Wang, Tao; Yang, Yongping; Zhang, Baoshan; Kwong, Peter D.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Chakrabarti, Bimal; Sharma, Shailendra K.; Wyatt, Richard] Scripps Res Inst, Dept Immunol & Microbial Sci, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Alam, S. Munir; Haynes, Barton F.] Duke Univ, Duke Human Vaccine Inst, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); International AIDS Vaccine Initiative; Scripps Research Institute; Duke University	Connors, M (corresponding author), NIAID, HIV Specif Immun Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA.	mconnors@nih.gov	Mascola, John/AAI-7193-2021; Huang, Jinghe/P-8068-2019; Huang, Jinghe/O-1986-2015; Alam, S. Munir/AAC-6711-2019	Huang, Jinghe/0000-0002-1968-871X	NIAID; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001090, ZIAAI000855, ZIAAI005022, ZIAAI005095] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. W. Hallahan for statistical analyses. We thank K. Lloyd. R. Parks, J. Eudailey and J. Blinn for performing autoantibody assays. We also thank M. Zwick for providing us with the HIV-1 JR2 MPER alanine mutant pseudovirus plasmids. HIV-2/HIV-1 chimaeras were provided by G. Shaw and L. Morris. We thank J. Stuckey for assistance with figures, and members of the Structural Biology Section and Structural Bioinformatics Core, Vaccine Research Center, for discussions and comments on the manuscript. This project has been funded in part with federal funds from the Intramural Research Programs of NIAID and the National Cancer Institute, National Institutes of Health, under Contract no. HHSN261200800001E. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Binley J, 2009, CURR OPIN HIV AIDS, V4, P364, DOI 10.1097/COH.0b013e32832e06fe; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Brunel FM, 2006, J VIROL, V80, P1680, DOI 10.1128/JVI.80.4.1680-1687.2006; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Cardoso RMF, 2007, J MOL BIOL, V365, P1533, DOI 10.1016/j.jmb.2006.10.088; Chakrabarti BK, 2011, J VIROL, V85, P8217, DOI 10.1128/JVI.00756-11; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2009, J VIROL, V83, P11265, DOI 10.1128/JVI.01359-09; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Imamichi H, 2001, J INFECT DIS, V183, P36, DOI 10.1086/317641; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Kabat EA, 1991, SEQUENCES PROTEINS I; Kershaw MH, 2001, CANCER RES, V61, P7920; Koch M, 2003, VIROLOGY, V313, P387, DOI 10.1016/S0042-6822(03)00294-0; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Mascola JR, 2002, J VIROL, V76, P4810, DOI 10.1128/JVI.76.10.4810-4821.2002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Rathinakumar R, 2012, J VIROL, V86, P1820, DOI 10.1128/JVI.05489-11; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu XL, 2012, J VIROL, V86, P5844, DOI 10.1128/JVI.07139-11; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	56	610	653	2	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					406	+		10.1038/nature11544	http://dx.doi.org/10.1038/nature11544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23151583	Green Accepted			2022-12-28	WOS:000311031600038
J	Moeinoddini, SA; Parikh, RJ; Moore, SR; Moore, DJ				Moeinoddini, Seyed Ali; Parikh, Rajkumar James; Moore, Sarah Ruth; Moore, David James			Sequential bilateral femoral fractures	BRITISH MEDICAL JOURNAL			English	Editorial Material							BISPHOSPHONATES; THERAPY; BONE		[Moeinoddini, Seyed Ali; Parikh, Rajkumar James] Pennine Acute Hosp NHS Trust, Royal Oldham Hosp, Oldham OL1 2JH, England; [Moore, Sarah Ruth] Sheffield Teaching Hosp NHS Trust, No Gen Hosp, Sheffield, S Yorkshire, England; [Moore, David James] E Cheshire NHS Trust, Macclesfield Dist Gen Hosp, Macclesfield, Cheshire, England	Northern General Hospital; University of Sheffield	Parikh, RJ (corresponding author), Pennine Acute Hosp NHS Trust, Royal Oldham Hosp, Oldham OL1 2JH, England.	raj.parikh@pat.nhs.uk						Abrahamsen Bo, 2011, Evid Based Med, V16, P168, DOI 10.1136/ebm.2011.000013; Black DM, 2010, NEW ENGL J MED, V362, P1761, DOI 10.1056/NEJMoa1001086; Medicines and Healthcare Products Regulatory Agency, 2011, DRUG SAF UPD BISPH A; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Ott SM, 2011, CLEV CLIN J MED, V78, P619, DOI 10.3949/ccjm.78a.11022; Park-Wyllie LY, 2011, JAMA-J AM MED ASSOC, V305, P783, DOI 10.1001/jama.2011.190; Perret MC, 2011, J SURG RAD, V2, P294; Poole KE, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3211; Rizzoli R, 2011, OSTEOPOROSIS INT, V22, P373, DOI 10.1007/s00198-010-1453-5; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253; Yoon RS, 2011, J BONE JOINT SURG BR, V93B, P1289, DOI 10.1302/0301-620X.93B10.26924; YOON RS, 2010, ORTHOPEDICS, P267, DOI DOI 10.3928/01477447-20100225-21	12	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 14	2012	345								e7361	10.1136/bmj.e7361	http://dx.doi.org/10.1136/bmj.e7361			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040PZ	23152568				2022-12-28	WOS:000311336400009
J	Birks, HH; Giesecke, T; Hewitt, GM; Tzedakis, PC; Bakke, J; Birks, HJB				Birks, Hilary H.; Giesecke, Thomas; Hewitt, Godfrey M.; Tzedakis, Polychronis C.; Bakke, Jostein; Birks, H. John B.			Comment on "Glacial Survival of Boreal Trees in Northern Scandinavia"	SCIENCE			English	Editorial Material							PICEA-ABIES; NORWAY; DNA; BP	Parducci et al. (Reports, 2 March 2012, p. 1083) fail to present convincing evidence for glacial survival of Pinus and Picea in northern Scandinavia. Their methodology does not exclude contamination. Additionally, they should consider the lack of suitable habitats, the apparent extinction of both taxa after deglacial warming, and alternative hypotheses for the distribution of the Picea genetic marker haplotype A.	[Birks, Hilary H.; Birks, H. John B.] Univ Bergen, Dept Biol, NO-5020 Bergen, Norway; [Giesecke, Thomas] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Palynol & Climate Dynam, D-37073 Gottingen, Germany; [Hewitt, Godfrey M.] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; [Tzedakis, Polychronis C.; Birks, H. John B.] UCL, Dept Geog, Environm Change Res Ctr, London WC1E 6BT, England; [Bakke, Jostein] Univ Bergen, Dept Earth Sci, NO-5007 Bergen, Norway; [Birks, H. John B.] Univ Oxford, Dept Geog & Environm, Oxford OX1 3QY, England	University of Bergen; University of Gottingen; University of East Anglia; University of London; University College London; University of Bergen; University of Oxford	Birks, HH (corresponding author), Univ Bergen, Dept Biol, NO-5020 Bergen, Norway.	hilary.birks@bio.uib.no	AL, Ramanathan -/E-7217-2012; Giesecke, Thomas/N-6395-2019; Bakke, Jostein/AAI-1145-2020; Giesecke, Thomas/A-2450-2013; Tzedakis, Polychronis/J-1894-2012; Birks, John B/C-3103-2008	AL, Ramanathan -/0000-0002-3491-2273; Giesecke, Thomas/0000-0002-5132-1061; Giesecke, Thomas/0000-0002-5132-1061; Birks, John B/0000-0002-5891-9859; Tzedakis, Polychronis/0000-0001-6072-1166; Bakke, Jostein/0000-0001-6114-0400				ALM T, 1993, BOREAS, V22, P171, DOI 10.1111/j.1502-3885.1993.tb00178.x; [Anonymous], 1999, NATL ATLAS NORWAY VE; Feek DT, 2011, J PALEOLIMNOL, V45, P115, DOI 10.1007/s10933-010-9474-9; Giesecke T, 2004, J BIOGEOGR, V31, P1523, DOI 10.1111/j.1365-2699.2004.01095.x; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Hofreiter M, 2012, QUATERNARY SCI REV, V33, P1, DOI 10.1016/j.quascirev.2011.11.018; Kullman L, 2002, J BIOGEOGR, V29, P1117, DOI 10.1046/j.1365-2699.2002.00743.x; Parducci L, 2012, SCIENCE, V335, P1083, DOI 10.1126/science.1216043; Tollefsrud MM, 2009, HEREDITY, V102, P549, DOI 10.1038/hdy.2009.16; Velichko A. A., 2001, SER GEOGRAPHIHESKAYA, V3, P42; Vorren KD, 2009, BOREAS, V38, P401, DOI 10.1111/j.1502-3885.2008.00081.x; Vorren TO, 2002, BOREAS, V31, P97, DOI 10.1080/030094802320129926; Waters JM, 2011, MOL ECOL, V20, P4388, DOI 10.1111/j.1365-294X.2011.05286.x; Willerslev E, 1999, P NATL ACAD SCI USA, V96, P8017, DOI 10.1073/pnas.96.14.8017	14	38	42	0	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108								10.1126/science.1225345	http://dx.doi.org/10.1126/science.1225345			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139314				2022-12-28	WOS:000310839500022
J	Boffin, HMJ; Miszalski, B; Rauch, T; Jones, D; Corradi, RLM; Napiwotzki, R; Day-Jones, AC; Koppen, J				Boffin, Henri M. J.; Miszalski, Brent; Rauch, Thomas; Jones, David; Corradi, Romano L. M.; Napiwotzki, Ralf; Day-Jones, Avril C.; Koeppen, Joachim			An Interacting Binary System Powers Precessing Outflows of an Evolved Star	SCIENCE			English	Article							PLANETARY-NEBULAE; JETS	Stars are generally spherical, yet their gaseous envelopes often appear nonspherical when ejected near the end of their lives. This quirk is most notable during the planetary nebula phase, when these envelopes become ionized. Interactions among stars in a binary system are suspected to cause the asymmetry. In particular, a precessing accretion disk around a companion is believed to launch point-symmetric jets, as seen in the prototype Fleming 1. Our finding of a post-common-envelope binary nucleus in Fleming 1 confirms that this scenario is highly favorable. Similar binary interactions are therefore likely to explain these kinds of outflows in a large variety of systems.	[Boffin, Henri M. J.; Jones, David] European So Observ ESO, Santiago 3107, Chile; [Miszalski, Brent] S African Astron Observ SAAO, ZA-7935 Observatory, South Africa; [Miszalski, Brent] So African Large Telescope Fdn, ZA-7935 Observatory, South Africa; [Rauch, Thomas] Univ Tubingen, Kepler Ctr Astro & Particle Phys, Inst Astron & Astrophys, D-72076 Tubingen, Germany; [Corradi, Romano L. M.] Inst Astrofis Canarias, E-38200 Tenerife, Spain; [Corradi, Romano L. M.] Univ La Laguna, Dept Astrofis, E-38206 Tenerife, Spain; [Napiwotzki, Ralf] Univ Hertfordshire, Hatfield AL10 9AB, Herts, England; [Day-Jones, Avril C.] Univ Chile, Santiago, Chile; [Koeppen, Joachim] Observ Strasbourg, F-67000 Strasbourg, France	European Southern Observatory; National Research Foundation - South Africa; South African Astronomical Observatory; National Research Foundation - South Africa; South African Astronomical Observatory; Eberhard Karls University of Tubingen; Instituto de Astrofisica de Canarias; Universidad de la Laguna; University of Hertfordshire; Universidad de Chile	Boffin, HMJ (corresponding author), European So Observ ESO, Casilla 19001, Santiago 3107, Chile.	hboffin@eso.org	Jones, David/G-8109-2014	Jones, David/0000-0003-3947-5946; Rauch, Thomas/0000-0003-1081-0720	German Aerospace Center (DLR) [05 OR 0806]; Marie Curie Actions of the European Commission (FP7-COFUND); Spanish Ministry of Science and Innovation (MICINN) [AYA2007-66804]; FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico) [3100098]; Joint Committee ESO-Government of Chile	German Aerospace Center (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); Marie Curie Actions of the European Commission (FP7-COFUND); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Joint Committee ESO-Government of Chile	This paper uses data from ESO programs 084.C-0508(A), 085.D-0629(A), and 087.D-0446(B) and includes observations made at the SAAO. The measured radial velocities and observed spectrum are provided in the supplementary materials. Observations obtained with ESO telescopes can also be obtained from the ESO science archive at http://archive.eso.org, using the above-mentioned program numbers. The SAAO photometric data are available from www.eso.org/~hboffin/Fg1/. B.M. thanks ESO for its hospitality and the opportunity to participate in its visitor program during January 2012. T.R. is supported by the German Aerospace Center (DLR) grant 05 OR 0806. This work was cofunded under the Marie Curie Actions of the European Commission (FP7-COFUND). The work of R.L.M.C. has been supported by the Spanish Ministry of Science and Innovation (MICINN) under grant AYA2007-66804. A.C.D.-J. is supported by a FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico) "postdoctorado" fellowship under project number 3100098 and partially supported by the Joint Committee ESO-Government of Chile.	Balick B, 2002, ANNU REV ASTRON ASTR, V40, P439, DOI 10.1146/annurev.astro.40.060401.093849; Blind N, 2011, ASTRON ASTROPHYS, V536, DOI 10.1051/0004-6361/201118036; CLIFFE JA, 1995, ASTROPHYS J, V447, pL49, DOI 10.1086/309559; De Marco O, 2008, ASTRON J, V136, P323, DOI 10.1088/0004-6256/136/1/323; De Marco O, 2009, PUBL ASTRON SOC PAC, V121, P316, DOI 10.1086/597765; Jones D, 2011, ASTR SOC P, V447, P165; LOPEZ JA, 1993, ASTROPHYS J, V415, pL135, DOI 10.1086/187051; LOPEZ JA, 1993, ASTRON ASTROPHYS, V267, P194; Maciel W. J., 1984, Astronomy & Astrophysics Supplement Series, V55, P253; Mattila S, 2010, ASTROPHYS J, V717, P1140, DOI 10.1088/0004-637X/717/2/1140; Mikolajewska J, 2012, BALT ASTRON, V21, P5; Miranda LF, 2001, MON NOT R ASTRON SOC, V321, P487, DOI 10.1046/j.1365-8711.2001.04040.x; Miszalski B, 2011, MON NOT R ASTRON SOC, V413, P1264, DOI 10.1111/j.1365-2966.2011.18212.x; Miszalski B, 2009, ASTRON ASTROPHYS, V505, P249, DOI 10.1051/0004-6361/200912176; Miszalski B, 2009, ASTRON ASTROPHYS, V496, P813, DOI 10.1051/0004-6361/200811380; Mohamed S, 2010, AIP CONF PROC, V1314, P51, DOI 10.1063/1.3536409; Nordhaus J, 2006, MON NOT R ASTRON SOC, V370, P2004, DOI 10.1111/j.1365-2966.2006.10625.x; Palmer JW, 1996, ASTRON ASTROPHYS, V307, P225; PHILLIPS JP, 1983, ASTRON ASTROPHYS, V117, P33; Pudritz R. E., 2007, PROTOSTARS PLANETS, P277; Raga AC, 2008, ASTRON ASTROPHYS, V489, P1141, DOI 10.1051/0004-6361:20079157; Raga AC, 2009, ASTROPHYS J LETT, V707, pL6, DOI 10.1088/0004-637X/707/1/L6; Sandquist EL, 1998, ASTROPHYS J, V500, P909, DOI 10.1086/305778; Santander-Garcia M, 2007, ASTRON ASTROPHYS, V465, P481, DOI 10.1051/0004-6361:20065875; SCHONBERNER D, 1983, ASTROPHYS J, V272, P708, DOI 10.1086/161333; Smith N, 2007, ASTRON J, V134, P846, DOI 10.1086/518563; Soker N, 2006, PUBL ASTRON SOC PAC, V118, P260, DOI 10.1086/498829; SOKER N, 1994, ASTROPHYS J, V421, P219, DOI 10.1086/173639; Theuns T, 1996, MON NOT R ASTRON SOC, V280, P1264, DOI 10.1093/mnras/280.4.1264	32	75	75	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2012	338	6108					773	775		10.1126/science.1225386	http://dx.doi.org/10.1126/science.1225386			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139326	Green Submitted			2022-12-28	WOS:000310839500036
J	Gong, P				Gong, Peng			China's new leaders must keep science in focus	NATURE			English	Editorial Material									[Gong, Peng] Tsinghua Univ, Ctr Earth Syst Sci, Beijing, Peoples R China; [Gong, Peng] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Tsinghua University; University of California System; University of California Berkeley	Gong, P (corresponding author), Tsinghua Univ, Ctr Earth Syst Sci, Beijing, Peoples R China.	penggong@tsinghua.edu.cn	Gong, Peng/AAM-1516-2021	Gong, Peng/0000-0003-1513-3765					0	1	1	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					161	161		10.1038/491161a	http://dx.doi.org/10.1038/491161a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	033DP	23135429	Bronze			2022-12-28	WOS:000310774300004
J	Lederle, FA; Bloomfield, HE				Lederle, Frank A.; Bloomfield, Hanna E.			Drug Treatment of Asymptomatic Hypertriglyceridemia to Prevent Pancreatitis: Where Is the Evidence?	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIOVASCULAR-DISEASE; TRIGLYCERIDES; CHOLESTEROL; THERAPY		[Lederle, Frank A.; Bloomfield, Hanna E.] Vet Affairs Med Ctr, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Lederle, FA (corresponding author), Vet Affairs Med Ctr 111O, Minneapolis, MN 55417 USA.	frank.lederle@va.gov		bloomfield, hanna/0000-0002-0756-7064				[Anonymous], 1984, JAMA, V251, P1196; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Briel M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b92; CHAIT A, 1992, ADV INTERNAL MED, V37, P249; Christian JB, 2011, AM J CARDIOL, V107, P891, DOI 10.1016/j.amjcard.2010.11.008; DOMINGUEZMUNOZ JE, 1995, INT J PANCREATOL, V18, P101; FORTSON MR, 1995, AM J GASTROENTEROL, V90, P2134; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Goldberg IJ, 2011, ARTERIOSCL THROM VAS, V31, P1716, DOI 10.1161/ATVBAHA.111.226100; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hall M F, 2010, NATL HLTH STAT REPOR, V29; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Linares CL, 2008, PANCREAS, V37, P13, DOI 10.1097/MPA.0b013e31816074a1; MILLER A, 1979, ANN SURG, V190, P401, DOI 10.1097/00000658-197909000-00016; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Nichols GA, 2011, AM J CARDIOL, V107, P225, DOI 10.1016/j.amjcard.2010.09.010; Sandhu S, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-157; Veterans Health Administration Pharmacy Benefits Management Services Medical Advisory Panel Center for Medication Safety, 2009, NAT PBM B SAF HIGH D	18	14	16	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2012	157	9					662	+		10.7326/0003-4819-157-9-201211060-00011	http://dx.doi.org/10.7326/0003-4819-157-9-201211060-00011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033GX	23128864				2022-12-28	WOS:000310783300007
J	Wang, SY; Olson-Kellogg, B; Shamliyan, TA; Choi, JY; Ramakrishnan, R; Kane, RL				Wang, Shi-Yi; Olson-Kellogg, Becky; Shamliyan, Tatyana A.; Choi, Jae-Young; Ramakrishnan, Rema; Kane, Robert L.			Physical Therapy Interventions for Knee Pain Secondary to Osteoarthritis A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							ELECTRICAL NERVE-STIMULATION; MEDIAL COMPARTMENT OSTEOARTHRITIS; PULSED ELECTROMAGNETIC-FIELDS; SHORT-WAVE DIATHERMY; QUALITY-OF-LIFE; VARUS DEFORMITY OSTEOARTHRITIS; RANDOMIZED CONTROLLED-TRIAL; SUPERVISED FITNESS WALKING; LATERALLY WEDGED INSOLES; LAND-BASED EXERCISE	Background: Osteoarthritis is a leading cause of disability. Nonsurgical treatment is a key first step. Purpose: Systematic literature review of physical therapy (PT) interventions for community-dwelling adults with knee osteoarthritis. Data Sources: MEDLINE, the Cochrane Library, the Physiotherapy Evidence Database, Scirus, Allied and Complementary Medicine, and the Health and Psychosocial Instruments bibliography database. Study Selection: 193 randomized, controlled trials (RCTs) published in English from 1970 to 29 February 2012. Data Extraction: Means of outcomes, PT interventions, and risk of bias were extracted to pool standardized mean differences. Disagreements between reviewers abstracting and checking data were resolved through discussion. Data Synthesis: Meta-analyses of 84 RCTs provided evidence for 13 PT interventions on pain (58 RCTs), physical function (36 RCTs), and disability (29 RCTs). Meta-analyses provided low-strength evidence that aerobic (11 RCTs) and aquatic (3 RCTs) exercise improved disability and that aerobic exercise (19 RCTs), strengthening exercise (17 RCTs), and ultrasonography (6 RCTs) reduced pain and improved function. Several individual RCTs demonstrated clinically important improvements in pain and disability with aerobic exercise. Other PT interventions demonstrated no sustained benefit. Individual RCTs showed similar benefits with aerobic, aquatic, and strengthening exercise. Adverse events were uncommon and did not deter participants from continuing treatment. Limitation: Variability in PT interventions and outcomes measures hampered synthesis of evidence. Conclusion: Low-strength evidence suggested that only a few PT interventions were effective. Future studies should compare combined PT interventions (which is how PT is generally administered for pain associated with knee osteoarthritis).	[Shamliyan, Tatyana A.] Univ Minnesota, Div Hlth Policy & Management, Sch Publ Hlth, Sch Med, Minneapolis, MN 55455 USA; Minnesota Evidence Based Practice Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Shamliyan, TA (corresponding author), Univ Minnesota, Div Hlth Policy & Management, Sch Publ Hlth, Sch Med, D330-5 Mayo,MMC 729,420 Delaware St SE, Minneapolis, MN 55455 USA.	shaml005@umn.edu	Shamliyan, Tatyana/AAU-8323-2020; Ramakrishnan, Rema/AAM-7811-2020; Ramakrishnan, Rema/AAE-1742-2022	Ramakrishnan, Rema/0000-0002-6784-8319; Shamliyan, Tatyana/0000-0003-3584-2008; Wang, Shi-Yi/0000-0002-3294-5784	AHRQ [290-2007-10064-I]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Grant Support: By AHRQ (under contract 290-2007-10064-I).	Agency for Healthcare Research and Quality, 2011, EV BAS PRACT CTR SYS; Aglamis B, 2008, J BACK MUSCULOSKELET, V21, P121; Akyol Y, 2010, EUR J PHYS REHAB MED, V46, P325; Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; American Academy of Orthopaedic Surgeons, 2008, TREATM OST KNEE NON; An BC, 2008, J ALTERN COMPLEM MED, V14, P167, DOI 10.1089/acm.2007.0600; Angst F, 2001, ARTHRIT RHEUM-ARTHR, V45, P384, DOI 10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0; Angst F, 2002, J RHEUMATOL, V29, P131; Ay S, 2009, RHEUMATOL INT, V29, P663, DOI 10.1007/s00296-008-0754-x; Baker KR, 2001, J RHEUMATOL, V28, P1655; Baker K, 2007, ARTHRITIS RHEUM, V56, P1198, DOI 10.1002/art.22516; Bar-Ziv Y, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-179; Bautch JC, 1997, ARTHRIT CARE RES, V10, P48, DOI 10.1002/art.1790100108; Bennell KL, 2010, OSTEOARTHR CARTILAGE, V18, P621, DOI 10.1016/j.joca.2010.01.010; Bennell KL, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2912; Bennell KL, 2005, ANN RHEUM DIS, V64, P906, DOI 10.1136/ard.2004.026526; Bernstein AB, 2003, DHHS PUBLICATION, V2004-1031; Borenstein DM, 2009, INTRO METAANALYSIS S; Borjesson M, 1996, Physiother Res Int, V1, P89; Brand C, 2009, GUIDELINE NONSURGICA; Brismee JM, 2007, CLIN REHABIL, V21, P99, DOI 10.1177/0269215506070505; Brouwer RW, 2006, OSTEOARTHR CARTILAGE, V14, P777, DOI 10.1016/j.joca.2006.02.004; Bruckenthal Patricia, 2007, ANS Adv Nurs Sci, V30, pE72; Burch FX, 2008, OSTEOARTHR CARTILAGE, V16, P865, DOI 10.1016/j.joca.2007.11.013; Callaghan MJ, 2005, JOINT BONE SPINE, V72, P150, DOI 10.1016/j.jbspin.2004.03.010; Cetin N, 2008, AM J PHYS MED REHAB, V87, P443, DOI 10.1097/PHM.0b013e318174e467; Cheing GLY, 2004, CLIN REHABIL, V18, P487, DOI 10.1191/0269215504cr760oa; Cheing GLY, 2002, CLIN REHABIL, V16, P749, DOI 10.1191/0269215502cr549oa; Chou R, 2006, AHRQ PUBLICATION; Chou R, 2010, J CLIN EPIDEMIOL, V63, P502, DOI 10.1016/j.jclinepi.2008.06.007; Christensen R, 2007, ANN RHEUM DIS, V66, P433, DOI 10.1136/ard.2006.065904; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; CUSHNAGHAN J, 1994, BRIT MED J, V308, P753, DOI 10.1136/bmj.308.6931.753; Denegar CR, 2010, CLIN INTERV AGING, V5, P199; Deyle GD, 2000, ANN INTERN MED, V132, P173, DOI 10.7326/0003-4819-132-3-200002010-00002; Deyle GD, 2005, PHYS THER, V85, P1301, DOI 10.1093/ptj/85.12.1301; Dickersin K, 1993, ONLINE J CURRENT CLI, V50, P4967; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Doherty M, 1998, OSTEOARTHR CARTILAGE, V6, P371, DOI 10.1053/joca.1998.0139; Doi T, 2008, AM J PHYS MED REHAB, V87, P258, DOI 10.1097/PHM.0b013e318168c02d; Durmus D, 2007, CLIN RHEUMATOL, V26, P674, DOI 10.1007/s10067-006-0358-3; Eberle E, 1999, OSTEOARTHR CARTILAGE, V7, P502, DOI 10.1053/joca.1999.0246; Egger M., 2001, SYSTEMATIC REV HLTH; Ehrich EW, 2000, J RHEUMATOL, V27, P2635; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; Farr JN, 2010, PHYS THER, V90, P356, DOI 10.2522/ptj.20090041; Fe RW, 2011, J CLIN EPIDEMIOL, V64, P1187, DOI 10.1016/j.jclinepi.2010.08.010; FISHER NM, 1993, ARCH PHYS MED REHAB, V74, P1319, DOI 10.1016/0003-9993(93)90087-Q; Fitzgerald GK, 2001, PHYS THER, V81, P1446, DOI 10.1093/ptj/81.8.1446; Focht BC, 2005, ARTHRIT RHEUM-ARTHR, V53, P659, DOI 10.1002/art.21466; Fukuda TY, 2011, PHYS THER, V91, P1009, DOI 10.2522/ptj.20100306; Gaines JM, 2004, APPL NURS RES, V17, P201, DOI 10.1016/j.apnr.2004.06.004; Garland D, 2007, OSTEOARTHR CARTILAGE, V15, P630, DOI 10.1016/j.joca.2007.01.004; Grimmer K, 1992, Aust J Physiother, V38, P49, DOI 10.1016/S0004-9514(14)60551-1; Gur H, 2002, ARCH PHYS MED REHAB, V83, P308, DOI 10.1053/apmr.2002.30620; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Hay EM, 2006, BRIT MED J, V333, P995, DOI 10.1136/BMJ.38977.590752.0B; Herbison P, 2006, J CLIN EPIDEMIOL, V59, P1249, DOI 10.1016/j.jclinepi.2006.03.008; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hinman RS, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-146; Hinman RS, 2003, RHEUMATOLOGY, V42, P865, DOI 10.1093/rheumatology/keg233; Hinman RS, 2003, BRIT MED J, V327, P135, DOI 10.1136/bmj.327.7407.135; Huang MH, 2005, ARTHRIT RHEUM-ARTHR, V53, P812, DOI 10.1002/art.21590; Huang MH, 2005, ARCH PHYS MED REHAB, V86, P1545, DOI 10.1016/j.apmr.2005.02.007; Huang MH, 2000, ARTHRIT CARE RES, V13, P398, DOI 10.1002/1529-0131(200012)13:6<398::AID-ART10>3.0.CO;2-E; Imboden J, 2007, CURRENT RHEUMATOLOGY; Itoh Kazunori, 2008, Chin Med, V3, P2, DOI 10.1186/1749-8546-3-2; Jan MH, 2008, PHYS THER, V88, P427, DOI 10.2522/ptj.20060300; Jan MH, 2008, J ORTHOP SPORT PHYS, V38, P19, DOI 10.2519/jospt.2008.2512; Jan MH, 2009, ARCH PHYS MED REHAB, V90, P897, DOI 10.1016/j.apmr.2008.11.018; Jordan JM, 2007, J RHEUMATOL, V34, P172; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Kang RW, 2007, ORTHOPEDICS, V30, P439, DOI 10.3928/01477447-20070601-11; Keefe FJ, 2004, PAIN, V110, P539, DOI 10.1016/j.pain.2004.03.022; Keller C, 2009, WESTERN J NURS RES, V31, P289, DOI 10.1177/0193945908326067; Kennedy DM, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-3; Kerrigan DC, 2002, ARCH PHYS MED REHAB, V83, P889, DOI 10.1053/apmr.2002.33225; Khanna D, 2011, QUAL LIFE RES, V20, P1131, DOI 10.1007/s11136-011-9849-z; Knapp G, 2006, BIOMETRICAL J, V48, P271, DOI 10.1002/bimj.200510175; Ko T, 2009, J PHYS THER SCI, V21, P293, DOI 10.1589/jpts.21.293; KOVAR PA, 1992, ANN INTERN MED, V116, P529, DOI 10.7326/0003-4819-116-7-529; Kuptniratsaikul Vilai, 2002, J Med Assoc Thai, V85, P33; Kuroyanagi Y, 2007, OSTEOARTHR CARTILAGE, V15, P932, DOI 10.1016/j.joca.2007.02.004; Laufer Y, 2005, CLIN REHABIL, V19, P255, DOI 10.1191/0269215505cr864oa; Law PPW, 2004, JCR-J CLIN RHEUMATOL, V10, P295, DOI 10.1097/01.rhu.0000147047.77460.b0; Law PPW, 2004, J REHABIL MED, V36, P220, DOI 10.1080/16501970410029834; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lee HJ, 2009, CLIN REHABIL, V23, P504, DOI 10.1177/0269215508101746; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lim BW, 2008, ARTHRIT RHEUM-ARTHR, V59, P943, DOI 10.1002/art.23823; Lin DH, 2009, J ORTHOP SPORT PHYS, V39, P450, DOI 10.2519/jospt.2009.2923; Lingard EA, 2001, J BONE JOINT SURG AM, V83A, P1856, DOI 10.2106/00004623-200112000-00014; Loyola-Sanchez A, 2012, ARCH PHYS MED REHAB, V93, P35, DOI 10.1016/j.apmr.2011.07.196; Lund H, 2008, J REHABIL MED, V40, P137, DOI 10.2340/16501977-0134; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Maillefert JF, 2001, OSTEOARTHR CARTILAGE, V9, P738, DOI 10.1053/joca.2001.0470; Maly MR, 2002, CLIN BIOMECH, V17, P603, DOI 10.1016/S0268-0033(02)00073-6; Mangani I, 2006, AGING CLIN EXP RES, V18, P374; Mangione KK, 2010, PHYS THER, V90, P921, DOI 10.2522/ptj.20090363; Massey B, 2001, PHYS THER, V81, P9; Mazieres B, 2001, JOINT BONE SPINE, V68, P231, DOI 10.1016/S1297-319X(01)00271-8; Mazzuca SA, 2004, ARTHRIT RHEUM-ARTHR, V51, P716, DOI 10.1002/art.20683; Messier SP, 2004, ARTHRITIS RHEUM-US, V50, P1501, DOI 10.1002/art.20256; Messier SP, 1997, J APPL BIOMECH, V13, P205, DOI 10.1123/jab.13.2.205; Mikesky AE, 2006, ARTHRIT RHEUM-ARTHR, V55, P690, DOI 10.1002/art.22245; Moss P, 2007, MANUAL THER, V12, P109, DOI 10.1016/j.math.2006.02.009; National Collaborating Centre for Chronic Conditions, 2008, OST NAT CLIN GUID CA; Nicolakis P, 2002, WIEN KLIN WOCHENSCHR, V114, P678; Nigg BM, 2006, MED SCI SPORT EXER, V38, P1701, DOI 10.1249/01.mss.0000228364.93703.53; Ozgonenel L, 2009, ULTRASOUND MED BIOL, V35, P44, DOI 10.1016/j.ultrasmedbio.2008.07.009; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Patrick DL, 2001, MED CARE, V39, P413, DOI 10.1097/00005650-200105000-00002; Peloquin L, 1999, JCR-J CLIN RHEUMATOL, V5, P126, DOI 10.1097/00124743-199906000-00004; Penninx BWJH, 2002, J GERONTOL B-PSYCHOL, V57, pP124, DOI 10.1093/geronb/57.2.P124; Penninx BWJH, 2001, ARCH INTERN MED, V161, P2309, DOI 10.1001/archinte.161.19.2309; Perlman AI, 2006, ARCH INTERN MED, V166, P2533, DOI 10.1001/archinte.166.22.2533; Peterson M G, 1993, Arthritis Care Res, V6, P11, DOI 10.1002/art.1790060104; Petrella RJ, 2000, J RHEUMATOL, V27, P2215; Pham T, 2003, J RHEUMATOL, V30, P1648; Pham T, 2004, OSTEOARTHR CARTILAGE, V12, P389, DOI 10.1016/j.joca.2004.02.001; Pietrosimone BG, 2010, CLIN REHABIL, V24, P1091, DOI 10.1177/0269215510375903; Pietrosimone BG, 2009, MED SCI SPORT EXER, V41, P1175, DOI 10.1249/MSS.0b013e3181982557; Pollard Henry, 2008, J Can Chiropr Assoc, V52, P229; Rattanachaiyanont M, 2008, OSTEOARTHR CARTILAGE, V16, P823, DOI 10.1016/j.joca.2007.10.013; REDELMEIER DA, 1993, ARCH INTERN MED, V153, P1337, DOI 10.1001/archinte.153.11.1337; Rejeski WJ, 1997, MED SCI SPORT EXER, V29, P977, DOI 10.1097/00005768-199708000-00001; Rejeski WJ, 2002, HEALTH PSYCHOL, V21, P419, DOI 10.1037/0278-6133.21.5.419; Richmond J, 2010, J BONE JOINT SURG AM, V92A, P990, DOI 10.2106/JBJS.I.00982; Rooks DS, 2006, ARTHRIT RHEUM-ARTHR, V55, P700, DOI 10.1002/art.22223; Rutjes AWS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003132.pub2; Rutjes AWS, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002823.pub2, 10.1002/14651858.CD007321.pub2]; Salaffi F, 2004, EUR J PAIN, V8, P283, DOI 10.1016/j.ejpain.2003.09.004; Sayers SP, 2012, ARTHRIT CARE RES, V64, P46, DOI 10.1002/acr.20675; Schilke JM, 1996, NURS RES, V45, P68, DOI 10.1097/00006199-199603000-00002; Selfe TK, 2008, J ALTERN COMPLEM MED, V14, P1075, DOI 10.1089/acm.2008.0305; Shakoor M A, 2007, Bangladesh Med Res Counc Bull, V33, P55; Shamliyan T, 2012, COMP EFFECTIVENSS RE; Shamliyan TA, 2012, COMP EFFECTIVENESS P; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003; Silva LE, 2008, PHYS THER, V88, P12, DOI 10.2522/ptj.20060040; Song R, 2010, J ALTERN COMPLEM MED, V16, P227, DOI 10.1089/acm.2009.0165; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stratford PW, 2007, OSTEOARTHR CARTILAGE, V15, P266, DOI 10.1016/j.joca.2006.09.005; Sullivan T, 1998, ARTHRIT CARE RES, V11, P228, DOI 10.1002/art.1790110403; Swank AM, 2011, J STRENGTH COND RES, V25, P318, DOI 10.1519/JSC.0b013e318202e431; Talbot LA, 2003, J AM GERIATR SOC, V51, P387, DOI 10.1046/j.1532-5415.2003.51113.x; Talbot LA, 2003, J RHEUMATOL, V30, P1571; Tascioglu F, 2010, J INT MED RES, V38, P1233, DOI 10.1177/147323001003800404; TAYLOR P, 1981, PAIN, V11, P233, DOI 10.1016/0304-3959(81)90008-7; Thamsborg G, 2005, OSTEOARTHR CARTILAGE, V13, P575, DOI 10.1016/j.joca.2005.02.012; Thomas KS, 2002, BMJ-BRIT MED J, V325, P752, DOI 10.1136/bmj.325.7367.752; Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4; Thorstensson CA, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-27; Toda Y, 2008, OSTEOARTHR CARTILAGE, V16, P244, DOI 10.1016/j.joca.2007.06.010; Toda Y, 2005, OSTEOARTHR CARTILAGE, V13, P353, DOI 10.1016/j.joca.2004.12.012; Toda Y, 2004, ARTHRITIS RHEUM-US, V50, P3129, DOI 10.1002/art.20569; Toda Y, 2004, ARCH PHYS MED REHAB, V85, P673, DOI 10.1016/j.apmr.2003.06.011; Toda Y, 2001, J RHEUMATOL, V28, P2705; Topp R, 2002, ARCH PHYS MED REHAB, V83, P1187, DOI 10.1053/apmr.2002.33988; TROCK DH, 1994, J RHEUMATOL, V21, P1903; Tsauo JY, 2008, CLIN REHABIL, V22, P448, DOI 10.1177/0269215507084597; Tubach F, 2005, J RHEUMATOL, V32, P2025; Tubach F, 2005, ANN RHEUM DIS, V64, P29, DOI 10.1136/ard.2004.022905; van Gool CH, 2005, ARTHRIT RHEUM-ARTHR, V53, P24, DOI 10.1002/art.20902; Viechtbauer W, 2007, STAT MED, V26, P37, DOI 10.1002/sim.2514; Viswanathan M, 2012, ASSESSING RISK BIAS; Wang CC, 2009, ARTHRIT RHEUM-ARTHR, V61, P1545, DOI 10.1002/art.24832; WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005; Weng MC, 2009, KAOHSIUNG J MED SCI, V25, P306, DOI 10.1016/S1607-551X(09)70521-2; White DK, 2010, J RHEUMATOL, V37, P1244, DOI 10.3899/jrheum.090989; Wyatt FB, 2001, J STRENGTH COND RES, V15, P337; Yip YB, 2007, PATIENT EDUC COUNS, V65, P113, DOI 10.1016/j.pec.2006.06.019; Yip YB, 2008, COMPLEMENT THER MED, V16, P131, DOI 10.1016/j.ctim.2007.12.003; Yip Yin-Bing, 2008, Psychol Health Med, V13, P402, DOI 10.1080/13548500701584030; Yurtkuran M, 1999, Am J Acupunct, V27, P133; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013; ZIZIC TM, 1995, J RHEUMATOL, V22, P1757	177	62	62	0	48	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2012	157	9					632	+		10.7326/0003-4819-157-9-201211060-00007	http://dx.doi.org/10.7326/0003-4819-157-9-201211060-00007			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033GX	23128863				2022-12-28	WOS:000310783300004
J	Carlsson, G; Nordstrom, A				Carlsson, Gunilla; Nordstrom, Anders			Global engagement for health could achieve better results now and after 2015	LANCET			English	Editorial Material									[Carlsson, Gunilla; Nordstrom, Anders] Minist Foreign Affairs, S-10339 Stockholm, Sweden		Carlsson, G (corresponding author), Minist Foreign Affairs, S-10339 Stockholm, Sweden.	anders.nordstrom@foreign.ministry.se							0	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 3	2012	380	9853					1533	1534		10.1016/S0140-6736(12)61809-1	http://dx.doi.org/10.1016/S0140-6736(12)61809-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	030VR	23122236				2022-12-28	WOS:000310598700006
J	Charidimou, A; Law, R; Werring, DJ				Charidimou, Andreas; Law, Ruth; Werring, David J.			Amyloid "spells" trouble	LANCET			English	Editorial Material							CLINICAL SPECTRUM; ANGIOPATHY		[Charidimou, Andreas; Law, Ruth; Werring, David J.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; [Charidimou, Andreas; Law, Ruth; Werring, David J.] UCL Inst Neurol, Dept Brain Repair & Rehabil, Stroke Res Grp, London, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London	Werring, DJ (corresponding author), Natl Hosp Neurol & Neurosurg, Box 6,Queen Sq, London WC1N 3BG, England.	d.werring@ucl.ac.uk	Werring, David/Q-8435-2019; Demchuk, Andrew M/E-1103-2012	Werring, David/0000-0003-2074-1861; Demchuk, Andrew M/0000-0002-4930-7789	Stroke Association [TSABHF2009/01] Funding Source: researchfish	Stroke Association		Charidimou A, 2012, STROKE, V43, P2324, DOI 10.1161/STROKEAHA.112.657759; Charidimou A, 2012, J NEUROL NEUROSUR PS, V83, P124, DOI 10.1136/jnnp-2011-301308; GREENBERG SM, 1993, NEUROLOGY, V43, P2073, DOI 10.1212/WNL.43.10.2073; Knudsen KA, 2001, NEUROLOGY, V56, P537, DOI 10.1212/WNL.56.4.537	4	27	30	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 3	2012	380	9853					1620	1620		10.1016/S0140-6736(12)61333-6	http://dx.doi.org/10.1016/S0140-6736(12)61333-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030VR	23122250				2022-12-28	WOS:000310598700037
J	Kressler, D; Bange, G; Ogawa, Y; Stjepanovic, G; Bradatsch, B; Pratte, D; Amlacher, S; Strauss, D; Yoneda, Y; Katahira, J; Sinning, I; Hurt, E				Kressler, Dieter; Bange, Gert; Ogawa, Yutaka; Stjepanovic, Goran; Bradatsch, Bettina; Pratte, Dagmar; Amlacher, Stefan; Strauss, Daniela; Yoneda, Yoshihiro; Katahira, Jun; Sinning, Irmgard; Hurt, Ed			Synchronizing Nuclear Import of Ribosomal Proteins with Ribosome Assembly	SCIENCE			English	Article							EUKARYOTIC RIBOSOME; TRANSPORT; COMPLEX; RNA; BIOGENESIS; RESOLUTION; NUCLEOLUS; CYTOPLASM; SUBUNIT; PATHWAY	Ribosomal proteins are synthesized in the cytoplasm, before nuclear import and assembly with ribosomal RNA (rRNA). Little is known about coordination of nucleocytoplasmic transport with ribosome assembly. Here, we identify a transport adaptor, symportin 1 (Syo1), that facilitates synchronized coimport of the two 5S-rRNA binding proteins Rpl5 and Rpl11. In vitro studies revealed that Syo1 concomitantly binds Rpl5-Rpl11 and furthermore recruits the import receptor Kap104. The Syo1-Rpl5-Rpl11 import complex is released from Kap104 by RanGTP and can be directly transferred onto the 5S rRNA. Syo1 can shuttle back to the cytoplasm by interaction with phenylalanine-glycine nucleoporins. X-ray crystallography uncovered how the a-solenoid symportin accommodates the Rpl5 amino terminus, normally bound to 5S rRNA, in an extended groove. Symportin-mediated coimport of Rpl5-Rpl11 could ensure coordinated and stoichiometric incorporation of these proteins into pre-60S ribosomes.	[Kressler, Dieter; Bange, Gert; Stjepanovic, Goran; Bradatsch, Bettina; Amlacher, Stefan; Strauss, Daniela; Sinning, Irmgard; Hurt, Ed] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; [Kressler, Dieter; Pratte, Dagmar] Univ Fribourg, Dept Biol, Unit Biochem, CH-1700 Fribourg, Switzerland; [Ogawa, Yutaka; Yoneda, Yoshihiro; Katahira, Jun] Osaka Univ, Grad Sch Frontier Biosci, Biomol Networks Labs, Suita, Osaka 5650871, Japan	Ruprecht Karls University Heidelberg; University of Fribourg; Osaka University	Kressler, D (corresponding author), Heidelberg Univ, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	dieter.kressler@unifr.ch; irmi.sinning@bzh.uni-heidelberg.de; ed.hurt@bzh.uni-heidelberg.de	Stjepanovic, Goran/A-7902-2010; Bange, Gert/AAB-3734-2021; Ed Hurt, Dr./AAE-8874-2019; Kressler, Dieter/C-2218-2012	Stjepanovic, Goran/0000-0002-4841-9949; Ed Hurt, Dr./0000-0002-4535-8255; Bange, Gert/0000-0002-7826-0932; Kressler, Dieter/0000-0003-4855-3563; Katahira, Jun/0000-0001-5188-0368	German Research Council [Hu363/9-4, SFB 638]; Swiss National Science Foundation [PP00P3_123341]; Japan Society for the Promotion of Science [21570195, 21247032]	German Research Council(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank A. Hendricks and C. Deforel for technical assistance, J. Kopp and C. Siegmann from the BZH Cluster of Excellence:CellNetworks crystallization platform, J. Lechner and his team for mass spectrometry, T. Ruppert and M. Mayer (Zentrum fur Molekulare Biologie Heidelberg) for access to the core facility for mass spectrometry for the HX-MS experiments, J. Woolford for sharing published rpl5 mutant plasmids, and L. Dimitrova (Hurt laboratory) for providing the full-length ctKAP104 clone. Data collection was performed at the European Synchrotron Radiation Facility, Grenoble. This work was funded by the German Research Council (Hu363/9-4 to E. H. and SFB 638 to I. S.), the Swiss National Science Foundation (PP00P3_123341 to D. K.), and the Japan Society for the Promotion of Science (no. 21570195 and no. 21247032 to J.K. and Y.Y., respectively). I. S. and E. H. are investigators of the Cluster of Excellence:CellNetworks, and G. B. is a fellow of the Peter and Traudl Engelhorn Foundation. D. K., G. B., I. S., and E. H. conceived the experiments. D. K., G. B., J.K., I. S., and E. H. analyzed the data. D. K., G. B., I. S., and E. H. wrote the paper. D. K. and D. S. constructed yeast strains and carried out all yeast genetic experiments. D. K., G. B., and S. A. constructed plasmids. D. K. carried out tandem-affinity purifications of yeast proteins. G. B. and D. K. performed binding assays. G. B. determined crystal structures. G. S. carried out the HX-MS experiments. D. P. and D. S. performed fluorescence microscopy of live yeast cells. B. B. performed in vitro FG-repeat binding assays. Y.O. performed in vitro import assays with permeabilized HeLa cells under the supervision of J.K. in the laboratory of Y.Y. J.K. measured binding constants by BIAcore. D. K. and G. B. contributed equally to this study. All authors commented on the manuscript. Atomic coordinates and structure factors for the reported crystal structures have been deposited with the Protein Data Bank (PDB) under accession codes 4GMNO (ctSyo1) and 4GMN (ctSyo1/ctL5-N). The authors declare no competing financial interests. Correspondence and requests for materials should be addressed to D. K. (dieter. kressler@unifr.ch), I.S. (irmi.sinning@bzh.uni-heidelberg.de), or E.H. (ed.hurt@bzh.uni-heidelberg.de).	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bradatsch B, 2007, MOL CELL, V27, P767, DOI 10.1016/j.molcel.2007.06.034; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Ciganda M, 2011, WIRES RNA, V2, P523, DOI 10.1002/wrna.74; Claussen M, 1999, J BIOL CHEM, V274, P33951, DOI 10.1074/jbc.274.48.33951; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Lafontaine DLJ, 2001, NAT REV MOL CELL BIO, V2, P514, DOI 10.1038/35080045; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Pederson T, 2009, J CELL BIOL, V184, P771, DOI 10.1083/jcb.200812014; Poll G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008249; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Staley JP, 2009, CURR OPIN CELL BIOL, V21, P109, DOI 10.1016/j.ceb.2009.01.003; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Suel KE, 2006, METHODS, V39, P342, DOI 10.1016/j.ymeth.2006.06.015; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307	31	77	82	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107					666	671		10.1126/science.1226960	http://dx.doi.org/10.1126/science.1226960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118189	Green Submitted			2022-12-28	WOS:000310516000053
J	Appleby, J				Appleby, John			DATA BRIEFING Rises in healthcare spending: where will it end?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						[Anonymous], LONG TERM OUTL HLTH; Baumol W., 1966, PERFORMING ARTS EC D; Centers for Medicare and Medicaid, 2012, MED TRUST REP; Cutler D.M., 1995, TECHNOLOGY HLTH COST; NEWHOUSE JP, 1992, J ECON PERSPECT, V6, P3, DOI 10.1257/jep.6.3.3; Office of Budget Responsibility, 2012, FISC SUST REP; Oliveira M J, 2006, 477 OECD EC DEP; Organisation for Economic Cooperation and Development, HLTH DAT 2012 FREQ R; Smith S, 2009, HEALTH AFFAIR, V28, P1276, DOI 10.1377/hlthaff.28.5.1276; Stein H, 2003, NY TIMES	10	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 1	2012	345								e7127	10.1136/bmj.e7127	http://dx.doi.org/10.1136/bmj.e7127			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033FG	23118304				2022-12-28	WOS:000310779000005
J	Wee, LM; Flores-Jasso, CF; Salomon, WE; Zamore, PD				Wee, Liang Meng; Flores-Jasso, C. Fabian; Salomon, William E.; Zamore, Phillip D.			Argonaute Divides Its RNA Guide into Domains with Distinct Functions and RNA-Binding Properties	CELL			English	Article							DOUBLE-STRANDED-RNA; MESSENGER-RNA; CRYSTAL-STRUCTURE; GENETIC INTERFERENCE; SITE ACCESSIBILITY; CODING REGION; NUCLEIC-ACID; MICRO RNAS; TARGET; RISC	MicroRNAs (miRNAs) and small interfering RNAs (siRNAs) guide Argonaute proteins to silence mRNA expression. Argonaute binding alters the properties of an RNA guide, creating functional domains. We show that the domains established by Argonaute-the anchor, seed, central, 30 supplementary, and tail regions-have distinct biochemical properties that explain the differences between how animal miRNAs and siRNAs bind their targets. Extensive complementarity between an siRNA and its target slows the rate at which fly Argonaute2 (Ago2) binds to and dissociates from the target. Highlighting its role in antiviral defense, fly Ago2 dissociates so slowly from extensively complementary target RNAs that essentially every fully paired target is cleaved. Conversely, mouse AGO2, which mainly mediates miRNA directed repression, dissociates rapidly and with similar rates for fully paired and seed-matched targets. Our data narrow the range of biochemically reasonable models for how Argonaute-bound siRNAs and miRNAs find, bind, and regulate their targets.	[Wee, Liang Meng; Flores-Jasso, C. Fabian; Salomon, William E.; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Wee, Liang Meng; Flores-Jasso, C. Fabian; Salomon, William E.; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013; Wee, Liang Meng/U-2188-2017	Wee, Liang Meng/0000-0003-3870-8568; Flores-Jasso, C. Fabian/0000-0002-3745-495X; Zamore, Phillip/0000-0002-4505-9618; Flores-Jasso, Carlos Fabian/0000-0001-9096-0264	National Institutes of Health [GM62862, GM65236]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062862, R01GM065236, R01GM062862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Turner, J. Chen, A. Carruthers, R. Gilmore, S. Ryder, B. Farley, O. Bilsel, S. Kathuria, and P. Gandhi for help and discussions; the Turner lab for use of equipment; A. Boucher, T. Covello, and G. Farley for technical support; and members of the Zamore lab for critical comments on the manuscript. This work was supported in part by National Institutes of Health grants GM62862 and GM65236. Phillip D. Zamore is a cofounder and scientific advisor to Alnylam Pharmaceuticals.	Amarzguioui M, 2003, NUCLEIC ACIDS RES, V31, P589, DOI 10.1093/nar/gkg147; Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Boland A, 2011, P NATL ACAD SCI USA, V108, P10466, DOI 10.1073/pnas.1103946108; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Broderick JA, 2011, RNA, V17, P1858, DOI 10.1261/rna.2778911; Brown KM, 2005, NAT STRUCT MOL BIOL, V12, P469, DOI 10.1038/nsmb931; COHEN LS, 1967, J CELL PHYSIOL, V69, P331, DOI 10.1002/jcp.1040690309; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Ding HL, 2003, AGING CELL, V2, P209, DOI 10.1046/j.1474-9728.2003.00054.x; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Goswami S, 2010, J BIOL CHEM, V285, P20532, DOI 10.1074/jbc.M110.109298; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Haley B, 2003, METHODS, V30, P330, DOI 10.1016/S1046-2023(03)00052-5; HALL KB, 1992, NUCLEIC ACIDS RES, V20, P4283, DOI 10.1093/nar/20.16.4283; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammes G.G., 1970, ENZYMES, V2, P67; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Huang J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705116200; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jafarifar F, 2011, EMBO J, V30, P1324, DOI 10.1038/emboj.2011.38; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Lai EC, 1998, CELL, V93, P1103, DOI 10.1016/S0092-8674(00)81454-3; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Loya CM, 2009, NAT METHODS, V6, P897, DOI 10.1038/nmeth.1402; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/NMETH.2078, 10.1038/nmeth.2078]; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Schroeder SJ, 2009, METHOD ENZYMOL, V468, P371, DOI 10.1016/S0076-6879(09)68017-4; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Takeda Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007513; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Toledano H, 2012, NATURE, V485, P605, DOI 10.1038/nature11061; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957; Wright JE, 2011, EMBO J, V30, P533, DOI 10.1038/emboj.2010.334; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Xie J, 2012, NAT METHODS, V9, P403, DOI [10.1038/NMETH.1903, 10.1038/nmeth.1903]; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yoda M, 2010, NAT STRUCT MOL BIOL, V17, P17, DOI 10.1038/nsmb.1733; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011; Zamore PD, 1999, BIOCHEMISTRY-US, V38, P596, DOI 10.1021/bi982264s; Zearfoss NR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001269; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	87	246	250	0	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					1055	1067		10.1016/j.cell.2012.10.036	http://dx.doi.org/10.1016/j.cell.2012.10.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178124	Green Accepted, Bronze			2022-12-28	WOS:000311423500018
J	Mitra, D; Luo, X; Morgan, A; Wang, J; Hoang, MP; Lo, J; Guerrero, CR; Lennerz, JK; Mihm, MC; Wargo, JA; Robinson, KC; Devi, SP; Vanover, JC; D'Orazio, JA; McMahon, M; Bosenberg, MW; Haigis, KM; Haber, DA; Wang, YS; Fisher, DE				Mitra, Devarati; Luo, Xi; Morgan, Ann; Wang, Jin; Hoang, Mai P.; Lo, Jennifer; Guerrero, Candace R.; Lennerz, Jochen K.; Mihm, Martin C.; Wargo, Jennifer A.; Robinson, Kathleen C.; Devi, Suprabha P.; Vanover, Jillian C.; D'Orazio, John A.; McMahon, Martin; Bosenberg, Marcus W.; Haigis, Kevin M.; Haber, Daniel A.; Wang, Yinsheng; Fisher, David E.			An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background	NATURE			English	Article							STEM-CELL FACTOR; DNA LESIONS; MELANOCYTES; MICE; MUTATIONS; RISK; PIGMENTATION; SENESCENCE; EXPRESSION; DAMAGE	People with pale skin, red hair, freckles and an inability to tan-the 'red hair/fair skin' phenotype-are at highest risk of developing melanoma, compared to all other pigmentation types(1). Genetically, this phenotype is frequently the product of inactivating polymorphisms in the melanocortin 1 receptor (MC1R) gene. MC1R encodes a cyclic AMP-stimulating G-protein-coupled receptor that controls pigment production. Minimal receptor activity, as in red hair/fair skin polymorphisms, produces the red/yellow pheomelanin pigment, whereas increasing MC1R activity stimulates the production of black/brown eumelanin(2). Pheomelanin has weak shielding capacity against ultraviolet radiation relative to eumelanin, and has been shown to amplify ultraviolet-A-induced reactive oxygen species(3-5). Several observations, however, complicate the assumption that melanoma risk is completely ultraviolet-radiation-dependent. For example, unlike non-melanoma skin cancers, melanoma is not restricted to sun-exposed skin and ultraviolet radiation signature mutations are infrequently oncogenic drivers(6). Although linkage of melanoma risk to ultraviolet radiation exposure is beyond doubt, ultraviolet-radiation-independent events are likely to have a significant role(1,7). Here we introduce a conditional, melanocyte-targeted allele of the most common melanoma oncoprotein, BRAF(V600E), into mice carrying an inactivating mutation in the Mc1r gene (these mice have a phenotype analogous to red hair/fair skin humans). We observed a high incidence of invasive melanomas without providing additional gene aberrations or ultraviolet radiation exposure. To investigate the mechanism of ultraviolet-radiation-independent carcinogenesis, we introduced an albino allele, which ablates all pigment production on the Mc1r(e/e) background. Selective absence of pheomelanin synthesis was protective against melanoma development. In addition, normal Mc1r(e/e) mouse skin was found to have significantly greater oxidative DNA and lipid damage than albino Mc1r(e/e) mouse skin. These data suggest that the pheomelanin pigment pathway produces ultraviolet-radiation-independent carcinogenic contributions to melanomagenesis by a mechanism of oxidative damage. Although protection from ultraviolet radiation remains important, additional strategies may be required for optimal melanoma prevention.	[Mitra, Devarati; Morgan, Ann; Lo, Jennifer; Robinson, Kathleen C.; Devi, Suprabha P.; Fisher, David E.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Luo, Xi; Haigis, Kevin M.; Haber, Daniel A.] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Wang, Jin; Guerrero, Candace R.; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Hoang, Mai P.; Mihm, Martin C.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Lennerz, Jochen K.] Univ Ulm, Inst Pathol, D-89070 Ulm, Germany; [Wargo, Jennifer A.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Vanover, Jillian C.; D'Orazio, John A.] Univ Kentucky, Sch Med, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; [McMahon, Martin] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Bosenberg, Marcus W.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of California System; University of California Riverside; Harvard University; Massachusetts General Hospital; Ulm University; Harvard University; Massachusetts General Hospital; University of Kentucky; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Yale University	Fisher, DE (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA.	dfisher3@partners.org	Wang, Jin/AAE-3809-2022; Fisher, David/AAH-2878-2019	Wang, Jin/0000-0001-5511-3983; Hoang, Mai/0000-0002-1406-7981; /0000-0002-9520-6874	National Institutes of Health [5R01 AR043369-16, R01-CA101864, F30 ES020663-01]; Dr Miriam and Sheldon G. Adelson Medical Research Foundation; US-Israel Binational Science Foundation; Melanoma Research Alliance; NATIONAL CANCER INSTITUTE [R01CA176839, R01CA131075, R01CA129933, R01CA101864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES020663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr Miriam and Sheldon G. Adelson Medical Research Foundation; US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Melanoma Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Kunisada for generously sharing K14-SCF mice and C. L. Evans for help with mouse skin irradiation. We also thank A. P. Codgill for help with primary tumour cell culture and A. Piris for pathology consultation as well as M. Haigis and Z. Abdel-Malik for discussions. This work was supported by the following grants from the National Institutes of Health 5R01 AR043369-16 (D.E.F.), R01-CA101864 (Y.W.) and F30 ES020663-01 (D.M.), as well as support from the Dr Miriam and Sheldon G. Adelson Medical Research Foundation, the US-Israel Binational Science Foundation, and the Melanoma Research Alliance (D.E.F.).	Boni A, 2010, CANCER RES, V70, P5213, DOI 10.1158/0008-5472.CAN-10-0118; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Elwood JM, 1997, INT J CANCER, V73, P198, DOI 10.1002/(SICI)1097-0215(19971009)73:2<198::AID-IJC6>3.0.CO;2-R; Goel VK, 2009, ONCOGENE, V28, P2289, DOI 10.1038/onc.2009.95; Green AC, 2011, J CLIN ONCOL, V29, P257, DOI 10.1200/JCO.2010.28.7078; HALABAN R, 1988, P NATL ACAD SCI USA, V85, P7241, DOI 10.1073/pnas.85.19.7241; Hill HZ, 2000, PIGM CELL RES, V13, P140, DOI 10.1034/j.1600-0749.13.s8.25.x; Huncharek M, 2002, AM J PUBLIC HEALTH, V92, P1173, DOI 10.2105/AJPH.92.7.1173; Jaruga P, 2008, DNA REPAIR, V7, P1413, DOI 10.1016/j.dnarep.2008.06.005; Kadekaro AL, 2010, FASEB J, V24, P3850, DOI 10.1096/fj.10-158485; Kovacs D, 2012, J INVEST DERMATOL, V132, P1196, DOI 10.1038/jid.2011.457; Kunisada T, 1998, J EXP MED, V187, P1565, DOI 10.1084/jem.187.10.1565; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; NEUGUT AI, 1994, AM J PUBLIC HEALTH, V84, P1828, DOI 10.2105/AJPH.84.11.1828; Nofsinger JB, 2002, FREE RADICAL BIO MED, V32, P720, DOI 10.1016/S0891-5849(02)00763-3; Noonan FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1893; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Rae J, 2012, J INVEST DERMATOL, V132, P488, DOI 10.1038/jid.2011.341; RHODES AR, 1987, JAMA-J AM MED ASSOC, V258, P3146, DOI 10.1001/jama.258.21.3146; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Rouzaud F, 2005, MUTAT RES-FUND MOL M, V571, P133, DOI 10.1016/j.mrfmmm.2004.09.014; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Vanover JC, 2009, PIGM CELL MELANOMA R, V22, P827, DOI 10.1111/j.1755-148X.2009.00617.x; Wang J, 2011, ANAL CHEM, V83, P2201, DOI 10.1021/ac103099s; Wang YS, 2008, CHEM RES TOXICOL, V21, P276, DOI 10.1021/tx700411g; Wenczl E, 1998, J INVEST DERMATOL, V111, P678, DOI 10.1046/j.1523-1747.1998.00357.x; Yuan BF, 2011, NUCLEIC ACIDS RES, V39, P5945, DOI 10.1093/nar/gkr159	30	310	316	3	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					449	+		10.1038/nature11624	http://dx.doi.org/10.1038/nature11624			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23123854	Green Accepted, Green Submitted			2022-12-28	WOS:000311031600047
J	Lin, HF				Lin, Haifan			Capturing the Cloud: UAP56 in Nuage Assembly and Function	CELL			English	Editorial Material							PROTEIN; COMPONENT; TUDOR	The nuage is a hazy electron-dense structure unique to germ cells and is enriched in components of the piRNA pathway. Although the nuage is cytoplasmic, Zhang et al. now show that it is organized by an intranuclear protein, UAP56.	[Lin, Haifan] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06520 USA; [Lin, Haifan] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Lin, Haifan] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Lin, HF (corresponding author), Yale Univ, Sch Med, Yale Stem Cell Ctr, 333 Cedar St, New Haven, CT 06520 USA.	haifan.lin@yale.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042012] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [DP1CA174418] Funding Source: NIH RePORTER; NCI NIH HHS [DP1 CA174418, DP1CA174418] Funding Source: Medline; NICHD NIH HHS [R01 HD042012, R01HD42012] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2; Grimaldi MR, 2007, GENETICS, V175, P1751, DOI 10.1534/genetics.106.062844; Harris AN, 2001, DEVELOPMENT, V128, P2823; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Liu L, 2011, DEVELOPMENT, V138, P1863, DOI 10.1242/dev.059287; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Nishida KM, 2009, EMBO J, V28, P3820, DOI 10.1038/emboj.2009.365; Voronina E, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002774; Wilhelm JE, 2005, DEV CELL, V9, P675, DOI 10.1016/j.devcel.2005.09.015; Zhang F, 2012, CELL, V151, P871, DOI 10.1016/j.cell.2012.09.040	10	2	2	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 9	2012	151	4					699	701		10.1016/j.cell.2012.10.026	http://dx.doi.org/10.1016/j.cell.2012.10.026			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141532	Green Accepted, Bronze			2022-12-28	WOS:000310921200003
J	Lotze, C; Corso, M; Franke, KJ; von Oppen, F; Pascual, JI				Lotze, Christian; Corso, Martina; Franke, Katharina J.; von Oppen, Felix; Ignacio Pascual, Jose			Driving a Macroscopic Oscillator with the Stochastic Motion of a Hydrogen Molecule	SCIENCE			English	Article							ATOMIC-FORCE MICROSCOPY; SINGLE-MOLECULE; RESONANCE; CRAYFISH; DRIVEN; NOISE; MOTOR	Energy harvesting from noise is a paradigm proposed by the theory of stochastic resonances. We demonstrate that the random switching of a hydrogen (H-2) molecule can drive the oscillation of a macroscopic mechanical resonator. The H-2 motion was activated by tunneling electrons and caused fluctuations of the forces sensed by the tip of a noncontact atomic force microscope. The stochastic molecular noise and the periodic oscillation of the tip were coupled in a concerted dynamic that drives the system into self-oscillation. This phenomenon could be a way for enhancing the transfer of energy from incoherent sources into coherent dynamics of a molecular engine.	[Lotze, Christian; Corso, Martina; Franke, Katharina J.; von Oppen, Felix; Ignacio Pascual, Jose] Free Univ Berlin, Fachbereich Phys, D-14195 Berlin, Germany; [von Oppen, Felix] Free Univ Berlin, Dahlem Ctr Complex Quantum Syst, D-14195 Berlin, Germany; [Ignacio Pascual, Jose] CIC NanoGUNE, Donostia San Sebastian 20018, Spain; [Ignacio Pascual, Jose] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Spain	Free University of Berlin; Free University of Berlin; Basque Foundation for Science	Pascual, JI (corresponding author), Free Univ Berlin, Fachbereich Phys, D-14195 Berlin, Germany.	ji.pascual@nanogune.eu	Franke, Katharina J/G-4470-2011; Pascual, Jose Ignacio/N-3102-2016; Lotze, Christian/J-1730-2012; von Oppen, Felix/O-6730-2016; Corso, Martina/B-7768-2014; Pascual, Jose I/F-3489-2011	Franke, Katharina J/0000-0001-9416-023X; Pascual, Jose Ignacio/0000-0002-7152-4747; Lotze, Christian/0000-0001-6847-5676; Corso, Martina/0000-0002-8592-1284; nanoGUNE, CIC/0000-0001-7874-5254	Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft [Sfb 658, SPP 1243]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We gratefully acknowledge the Alexander von Humboldt Foundation for the research grant of M.C. and the Deutsche Forschungsgemeinschaft for financial support through the collaborative projects Sfb 658 and SPP 1243.	Astumian RD, 1996, BIOPHYS J, V70, P637, DOI 10.1016/S0006-3495(96)79605-4; BRUMME T, 2011, PHYS REV B, V84, DOI DOI 10.1103/PHYSREVB.71.161402; Djukic D, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.161402; DOUGLASS JK, 1993, NATURE, V365, P337, DOI 10.1038/365337a0; Fletcher SP, 2005, SCIENCE, V310, P80, DOI 10.1126/science.1117090; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Giessibl FJ, 2000, APPL PHYS LETT, V76, P1470, DOI 10.1063/1.126067; Giessibl FJ, 2003, REV MOD PHYS, V75, P949, DOI 10.1103/RevModPhys.75.949; Gupta JA, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.115416; Halbritter A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075402; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Kiselev SI, 2003, NATURE, V425, P380, DOI 10.1038/nature01967; Kudernac T, 2011, NATURE, V479, P208, DOI 10.1038/nature10587; Lassagne B, 2009, SCIENCE, V325, P1107, DOI 10.1126/science.1174290; Smit RHM, 2002, NATURE, V419, P906, DOI 10.1038/nature01103; Steele GA, 2009, SCIENCE, V325, P1103, DOI 10.1126/science.1176076; Stipe BC, 1998, SCIENCE, V279, P1907, DOI 10.1126/science.279.5358.1907; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; TEMIROV R, 2008, NEW J PHYS, V10, DOI DOI 10.1103/PHYSREVB.80.081407; Thijssen WHA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.226806; Tierney HL, 2011, NAT NANOTECHNOL, V6, P625, DOI [10.1038/nnano.2011.142, 10.1038/NNANO.2011.142]; TROUWBORST ML, 2009, PHYS REV B, V80, DOI DOI 10.1103/PHYSREVB.77.075402; WEISS C, 2010, PHYS REV LETT, V105, DOI DOI 10.1088/1367-2630/10/5/053012; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0	24	36	36	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					779	782		10.1126/science.1227621	http://dx.doi.org/10.1126/science.1227621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139328				2022-12-28	WOS:000310839500038
J	Shyh-Chang, N; Locasale, JW; Lyssiotis, CA; Zheng, YX; Teo, RY; Ratanasirintrawoot, S; Zhang, J; Onder, T; Unternaehrer, JJ; Zhu, H; Asara, JM; Daley, GQ; Cantley, LC				Ng Shyh-Chang; Locasale, Jason W.; Lyssiotis, Costas A.; Zheng, Yuxiang; Teo, Ren Yi; Ratanasirintrawoot, Sutheera; Zhang, Jin; Onder, Tamer; Unternaehrer, Juli J.; Zhu, Hao; Asara, John M.; Daley, George Q.; Cantley, Lewis C.			Influence of Threonine Metabolism on S-Adenosylmethionine and Histone Methylation	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; MOUSE; GLYCINE; CANCER; CHROMATIN	Threonine is the only amino acid critically required for the pluripotency of mouse embryonic stem cells (mESCs), but the detailed mechanism remains unclear. We found that threonine and S-adenosylmethionine (SAM) metabolism are coupled in pluripotent stem cells, resulting in regulation of histone methylation. Isotope labeling of mESCs revealed that threonine provides a substantial fraction of both the cellular glycine and the acetyl-coenzyme A (CoA) needed for SAM synthesis. Depletion of threonine from the culture medium or threonine dehydrogenase (Tdh) from mESCs decreased accumulation of SAM and decreased trimethylation of histone H3 lysine 4 (H3K4me3), leading to slowed growth and increased differentiation. Thus, abundance of SAM appears to influence H3K4me3, providing a possible mechanism by which modulation of a metabolic pathway might influence stem cell fate.	[Ng Shyh-Chang; Teo, Ren Yi; Ratanasirintrawoot, Sutheera; Zhang, Jin; Onder, Tamer; Unternaehrer, Juli J.; Zhu, Hao; Daley, George Q.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Pediat Hematol & Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA; [Ng Shyh-Chang; Teo, Ren Yi; Ratanasirintrawoot, Sutheera; Zhang, Jin; Onder, Tamer; Unternaehrer, Juli J.; Zhu, Hao; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Ng Shyh-Chang; Ratanasirintrawoot, Sutheera; Zhang, Jin; Onder, Tamer; Unternaehrer, Juli J.; Zhu, Hao; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ng Shyh-Chang; Ratanasirintrawoot, Sutheera; Zhang, Jin; Onder, Tamer; Unternaehrer, Juli J.; Zhu, Hao; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ng Shyh-Chang; Daley, George Q.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Ng Shyh-Chang; Locasale, Jason W.; Lyssiotis, Costas A.; Zheng, Yuxiang; Asara, John M.; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Dept Med, Boston, MA 02215 USA; [Ng Shyh-Chang; Locasale, Jason W.; Lyssiotis, Costas A.; Zheng, Yuxiang; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Daley, GQ (corresponding author), Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Pediat Hematol & Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu; lewis_cantley@hms.harvard.edu	Lyssiotis, Costas A/AAI-1923-2019; Onder, Tamer T/H-3330-2013; ZHANG, JIN/D-1435-2013; Locasale, Jason W/ABE-6505-2020; Cantley, Lewis C/D-1800-2014; Zhu, Hao/L-5114-2013; Onder, Tamer/O-3669-2019	Lyssiotis, Costas A/0000-0001-9309-6141; Onder, Tamer T/0000-0002-2372-9158; Locasale, Jason W/0000-0002-7766-3502; Cantley, Lewis C/0000-0002-1298-7653; Zhu, Hao/0000-0002-8417-9698; Onder, Tamer/0000-0002-2372-9158; Shyh-Chang, Ng/0000-0003-3138-9525; Unternaehrer-Hamm, Julia/0000-0001-5864-4704; Ratanasirintrawoot, Sutheera/0000-0002-0641-5106	NSS Scholarship from the Agency for Science, Technology and Research, Singapore; American Cancer Society; NIH [4R00CA168997-02, RC2HL102815, U01 HL100001, R01 GM56203]; Damon Runyon Cancer Research Foundation Amgen fellowship; iPierian Inc.; NATIONAL CANCER INSTITUTE [R00CA168997, K08CA157727] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001, RC2HL102815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER	NSS Scholarship from the Agency for Science, Technology and Research, Singapore; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation Amgen fellowship; iPierian Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Daley and Cantley labs for helpful discussions. Supported by the NSS Scholarship from the Agency for Science, Technology and Research, Singapore (N.S.-C.), the American Cancer Society and NIH grant 4R00CA168997-02 (J.W.L.), a Damon Runyon Cancer Research Foundation Amgen fellowship (C. A. L.), NIH grants RC2HL102815 and U01 HL100001 (G. Q. D.), and NIH grant R01 GM56203 (L. C. C.). G. Q. D. is an investigator of the HHMI. G. Q. D., as a co-founder and scientific advisory board member, holds stock options and receives consulting fees from iPierian Inc., a biopharmaceutical company that uses iPS cells in drug discovery against neurologic disease. L. C. C. is the founder and a member of the board of directors of Agios Pharmaceuticals, a company that targets metabolic enzymes for cancer treatment.	Alexander PB, 2011, P NATL ACAD SCI USA, V108, P15828, DOI 10.1073/pnas.1111312108; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; BACKLUND PS, 1986, EUR J BIOCHEM, V160, P245, DOI 10.1111/j.1432-1033.1986.tb09963.x; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; EAGLE H, 1961, J BIOL CHEM, V236, P2039; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Iwabata H, 2005, PROTEOMICS, V5, P4653, DOI 10.1002/pmic.200500042; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Luka Z, 2009, J BIOL CHEM, V284, P22507, DOI 10.1074/jbc.R109.019273; McMillan JM, 2005, J PHARM PHARMACOL, V57, P599, DOI 10.1211/0022357056082; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; VALANCIUS V, 1991, MOL CELL BIOL, V11, P1402, DOI 10.1128/MCB.11.3.1402; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784; Zhang DW, 2012, GENE DEV, V26, P461, DOI 10.1101/gad.182998.111; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	24	425	432	1	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					222	226		10.1126/science.1226603	http://dx.doi.org/10.1126/science.1226603			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23118012	Green Accepted			2022-12-28	WOS:000313328200049
J	Farkouh, ME; Domanski, M; Sleeper, LA; Siami, FS; Dangas, G; Mack, M; Yang, M; Cohen, DJ; Rosenberg, Y; Solomon, SD; Desai, AS; Gersh, BJ; Magnuson, EA; Lansky, A; Boineau, R; Weinberger, J; Ramanathan, K; Sousa, JE; Rankin, J; Bhargava, B; Buse, J; Hueb, W; Smith, CR; Muratov, V; Bansilal, S; King, S; Bertrand, M; Fuster, V				Farkouh, Michael E.; Domanski, Michael; Sleeper, Lynn A.; Siami, Flora S.; Dangas, George; Mack, Michael; Yang, May; Cohen, David J.; Rosenberg, Yves; Solomon, Scott D.; Desai, Akshay S.; Gersh, Bernard J.; Magnuson, Elizabeth A.; Lansky, Alexandra; Boineau, Robin; Weinberger, Jesse; Ramanathan, Krishnan; Sousa, J. Eduardo; Rankin, Jamie; Bhargava, Balram; Buse, John; Hueb, Whady; Smith, Craig R.; Muratov, Victoria; Bansilal, Sameer; King, Spencer, III; Bertrand, Michel; Fuster, Valentin		FREEDOM Trial Investigators	Strategies for Multivessel Revascularization in Patients with Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; HEART-ASSOCIATION; RANDOMIZED-TRIAL; BYPASS-SURGERY; DISEASE; ANGIOPLASTY; STROKE; BARI; MELLITUS; OUTCOMES	BACKGROUND In some randomized trials comparing revascularization strategies for patients with diabetes, coronary-artery bypass grafting (CABG) has had a better outcome than percutaneous coronary intervention (PCI). We sought to discover whether aggressive medical therapy and the use of drug-eluting stents could alter the revascularization approach for patients with diabetes and multivessel coronary artery disease. METHODS In this randomized trial, we assigned patients with diabetes and multivessel coronary artery disease to undergo either PCI with drug-eluting stents or CABG. The patients were followed for a minimum of 2 years (median among survivors, 3.8 years). All patients were prescribed currently recommended medical therapies for the control of low-density lipoprotein cholesterol, systolic blood pressure, and glycated hemoglobin. The primary outcome measure was a composite of death from any cause, nonfatal myocardial infarction, or nonfatal stroke. RESULTS From 2005 through 2010, we enrolled 1900 patients at 140 international centers. The patients' mean age was 63.1 +/- 9.1 years, 29% were women, and 83% had three-vessel disease. The primary outcome occurred more frequently in the PCI group (P=0.005), with 5-year rates of 26.6% in the PCI group and 18.7% in the CABG group. The benefit of CABG was driven by differences in rates of both myocardial infarction (P<0.001) and death from any cause (P=0.049). Stroke was more frequent in the CABG group, with 5-year rates of 2.4% in the PCI group and 5.2% in the CABG group (P=0.03). CONCLUSIONS For patients with diabetes and advanced coronary artery disease, CABG was superior to PCI in that it significantly reduced rates of death and myocardial infarction, with a higher rate of stroke. (Funded by the National Heart, Lung, and Blood Institute and others; FREEDOM ClinicalTrials.gov number, NCT00086450.)	[Fuster, Valentin] Mt Sinai Sch Med, Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA; [Dangas, George] Cardiovasc Res Fdn, New York, NY USA; [Smith, Craig R.] New York Presbyterian Med Ctr, New York, NY USA; [Farkouh, Michael E.] Univ Toronto, Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Farkouh, Michael E.] Univ Toronto, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Ramanathan, Krishnan] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Sleeper, Lynn A.; Siami, Flora S.; Yang, May; Muratov, Victoria] New England Res Inst, Watertown, MA 02172 USA; [Solomon, Scott D.; Desai, Akshay S.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Mack, Michael] Baylor Univ, Med Ctr, Dallas, TX USA; [Cohen, David J.; Magnuson, Elizabeth A.] Univ Missouri Kansas City, St Lukes Midamer Heart Inst, Kansas City, MO USA; [Rosenberg, Yves; Boineau, Robin] NHLBI, Bethesda, MD 20892 USA; [Gersh, Bernard J.] Mayo Clin, Rochester, MN USA; [Lansky, Alexandra] Yale Univ, New Haven, CT USA; [Sousa, J. Eduardo] Univ Sao Paulo, Sch Med, Dante Pazzanese Hosp, Sao Paulo, Brazil; [Hueb, Whady] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil; [Rankin, Jamie] Royal Perth Hosp, Perth, WA, Australia; [Bhargava, Balram] All India Inst Med Sci, New Delhi, India; [Buse, John] Univ N Carolina, Chapel Hill, NC USA; [King, Spencer, III] St Josephs Hosp, Atlanta, GA USA; [Bertrand, Michel] Univ Lille, Lille, France; [Fuster, Valentin] Ctr Nacl Invest Cardiovasc, Madrid, Spain	Icahn School of Medicine at Mount Sinai; Cardiovascular Research Foundation (CRF); University of Toronto; Peter Munk Cardiac Centre; University of Toronto; Li Ka Shing Knowledge Institute; University of British Columbia; HealthCore, Inc; Harvard University; Brigham & Women's Hospital; Baylor University; Baylor University Medical Center; University of Missouri System; University of Missouri Kansas City; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Mayo Clinic; Yale University; Instituto Dante Pazzanese de Cardiologia; Universidade de Sao Paulo; Universidade de Sao Paulo; Royal Perth Hospital; University of Western Australia; All India Institute of Medical Sciences (AIIMS) New Delhi; University of North Carolina; University of North Carolina Chapel Hill; Universite de Lille - ISITE; Universite de Lille; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Fuster, V (corresponding author), Mt Sinai Sch Med, Michael A Wiener Cardiovasc Inst, 1 Gustave L Levy Pl,Box 1030, New York, NY 10029 USA.	valentin.fuster@mssm.edu	Genovese, Stefano/F-9706-2017; Hueb, Whady/A-7919-2013; Solomon, Scott/I-5789-2013; Assmus, Birgit/L-3274-2017; Hueb, Alexandre/E-6804-2013; Desai, Akshay/ABE-7250-2020; Buse, John Bernard/J-9742-2019; Fuster, Valentin/H-4319-2015; Deplanque, Dominique/E-4901-2015; Caramori, Paulo/I-1370-2012; Ponikowski, Piotr/O-6454-2015; Wijesekera, Vishva/G-3259-2014; Boineau, Robin/AAR-4452-2021; Frey, Norbert/A-9695-2010; Cohen, David/AAF-1648-2019; Lemos, Pedro A./G-5758-2013; Hankey, Graeme J/H-4968-2014; Hamilton-Craig, Christian/E-8225-2010	Genovese, Stefano/0000-0002-6085-437X; Hueb, Whady/0000-0002-3166-6054; Assmus, Birgit/0000-0003-2658-6444; Buse, John Bernard/0000-0002-9723-3876; Fuster, Valentin/0000-0002-9043-9986; Deplanque, Dominique/0000-0002-4995-584X; Ponikowski, Piotr/0000-0002-3391-7064; Wijesekera, Vishva/0000-0002-3722-3377; Lemos, Pedro A./0000-0002-6782-750X; Hankey, Graeme J/0000-0002-6044-7328; Felix, Ana Cristina Goncalves/0000-0002-3690-1156; Ung, Kjell-Arne/0000-0002-2346-8031; Bauters, christophe/0000-0001-8268-8467; Cisowski, Marek/0000-0002-0971-2528; Bochenek, Andrzej/0000-0002-3046-3001; VAN BELLE, ERIC/0000-0001-6509-443X; CARRIE, didier/0000-0003-2479-8144; Hamilton-Craig, Christian/0000-0001-7702-7234; Oteo Dominguez, Juan Francisco/0000-0002-2641-4135; Vincentelli, Andre/0000-0003-4081-786X; Kruithof-de Julio, Marianna/0000-0002-6085-7706; Chew, Derek/0000-0003-3593-296X; Mendiz, Oscar/0000-0002-5268-0429; TEIGER, emmanuel/0000-0001-7515-4344; krishnan, prakash/0000-0003-2871-3689; Anderson, R. David/0000-0003-3490-3286	NHLBI [U01 01HL071988, 01HL092989]; Cordis; Johnson Johnson; Boston Scientific; Sanofi-Aventis; Bristol-Myers Squibb; Eli Lilly; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092989, U01HL071988] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cordis; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Boston Scientific(Boston Scientific); Sanofi-Aventis(Sanofi-Aventis); Bristol-Myers Squibb(Bristol-Myers Squibb); Eli Lilly(Eli Lilly); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants (U01 01HL071988 and 01HL092989) from the NHLBI. Cordis, Johnson & Johnson, and Boston Scientific provided the stents; Eli Lilly provided abciximab and an unrestricted research grant; and Sanofi-Aventis and Bristol-Myers Squibb provided clopidogrel.	Alderman E, 1997, CIRCULATION, V96, P1761, DOI 10.1161/01.CIR.96.6.1761; Alderman EL, 1996, NEW ENGL J MED, V335, P217; Bonow RO, 2002, CIRCULATION, V106, P1602, DOI 10.1161/01.CIR.0000035036.22612.2B; CHESEBRO JH, 1982, NEW ENGL J MED, V307, P1453; CHESEBRO JH, 1984, NEW ENGL J MED, V310, P209, DOI 10.1056/NEJM198401263100401; Farkouh ME, 2008, AM HEART J, V155, P215, DOI 10.1016/j.ahj.2007.10.012; FERGUSON JJ, 1995, CIRCULATION, V92, P3371, DOI 10.1161/01.CIR.92.12.3371; Fuster V, 2010, CIRCULATION, V121, P2450, DOI 10.1161/CIRCULATIONAHA.109.925867; Groot MW, 2012, HERZ, V37, P281, DOI 10.1007/s00059-012-3602-4; Hillis LD, 2011, CIRCULATION, V124, P2610, DOI 10.1161/CIR.0b013e31823b5fee; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014; Lyden P, 1999, STROKE, V30, P2347, DOI 10.1161/01.STR.30.11.2347; Palmerini T, 2012, J AM COLL CARDIOL, V60, P798, DOI 10.1016/j.jacc.2011.10.912; RANKIN J, 1957, Scott Med J, V2, P200; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Serruys PW, 2005, J AM COLL CARDIOL, V46, P575, DOI 10.1016/j.jacc.2004.12.082; Sianos Georgios, 2005, EuroIntervention, V1, P219; The Bypass Angioplasty Revascularization Investigation (BARI) Investigators, 1997, NEW ENGL J MED, V336, P147; Thygesen K, 2012, NAT REV CARDIOL	21	1238	1306	0	181	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2012	367	25					2375	2384		10.1056/NEJMoa1211585	http://dx.doi.org/10.1056/NEJMoa1211585			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056ZP	23121323	Green Published			2022-12-28	WOS:000312531600005
J	Oberlander, J				Oberlander, Jonathan			The Future of Obamacare	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ N Carolina, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Oberlander, J (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.							Alonso-Zaldivar R, 2012, OBAMAS HLTH CARE LAW; Kaiser Family Foundation, 2012, KAIS HLTH TRACK POLL; Kaiser Henry J., HLTH REF SOURC; Oberlander J, 2010, NEW YORK REV BOOKS; Oberlander J, 2011, J HEALTH POLIT POLIC, V36, P477, DOI 10.1215/03616878-1271126	5	25	26	0	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2012	367	23					2165	2167		10.1056/NEJMp1213674	http://dx.doi.org/10.1056/NEJMp1213674			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048DO	23171062				2022-12-28	WOS:000311890600001
J	Schwartz, GG; Olsson, AG; Abt, M; Ballantyne, CM; Barter, PJ; Brumm, J; Chaitman, BR; Holme, IM; Kallend, D; Leiter, LA; Leitersdorf, E; McMurray, JJV; Mundl, H; Nicholls, SJ; Shah, PK; Tardif, JC; Wright, RS				Schwartz, Gregory G.; Olsson, Anders G.; Abt, Markus; Ballantyne, Christie M.; Barter, Philip J.; Brumm, Jochen; Chaitman, Bernard R.; Holme, Ingar M.; Kallend, David; Leiter, Lawrence A.; Leitersdorf, Eran; McMurray, John J. V.; Mundl, Hardi; Nicholls, Stephen J.; Shah, Prediman K.; Tardif, Jean-Claude; Wright, R. Scott		dal-OUTCOMES Investigators	Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-DENSITY-LIPOPROTEIN; HEART-DISEASE; CARDIOVASCULAR EVENTS; CHOLESTEROL EFFLUX; HDL CHOLESTEROL; STATIN THERAPY; HIGH-RISK; SAFETY; PREVENTION; TRIAL	BACKGROUND In observational analyses, higher levels of high-density lipoprotein (HDL) cholesterol have been associated with a lower risk of coronary heart disease events. However, whether raising HDL cholesterol levels therapeutically reduces cardiovascular risk remains uncertain. Inhibition of cholesteryl ester transfer protein (CETP) raises HDL cholesterol levels and might therefore improve cardiovascular outcomes. METHODS We randomly assigned 15,871 patients who had had a recent acute coronary syndrome to receive the CETP inhibitor dalcetrapib, at a dose of 600 mg daily, or placebo, in addition to the best available evidence-based care. The primary efficacy end point was a composite of death from coronary heart disease, nonfatal myocardial infarction, ischemic stroke, unstable angina, or cardiac arrest with resuscitation. RESULTS At the time of randomization, the mean HDL cholesterol level was 42 mg per deciliter (1.1 mmol per liter), and the mean low-density lipoprotein (LDL) cholesterol level was 76 mg per deciliter (2.0 mmol per liter). Over the course of the trial, HDL cholesterol levels increased from baseline by 4 to 11% in the placebo group and by 31 to 40% in the dalcetrapib group. Dalcetrapib had a minimal effect on LDL cholesterol levels. Patients were followed for a median of 31 months. At a prespecified interim analysis that included 1135 primary end-point events (71% of the projected total number), the independent data and safety monitoring board recommended termination of the trial for futility. As compared with placebo, dalcetrapib did not alter the risk of the primary end point (cumulative event rate, 8.0% and 8.3%, respectively; hazard ratio with dalcetrapib, 1.04; 95% confidence interval, 0.93 to 1.16; P = 0.52) and did not have a significant effect on any component of the primary end point or total mortality. The median C-reactive protein level was 0.2 mg per liter higher and the mean systolic blood pressure was 0.6 mm Hg higher with dalcetrapib as compared with placebo (P<0.001 for both comparisons). CONCLUSIONS In patients who had had a recent acute coronary syndrome, dalcetrapib increased HDL cholesterol levels but did not reduce the risk of recurrent cardiovascular events. (Funded by F. Hoffmann-La Roche; dal-OUTCOMES ClinicalTrials.gov number, NCT00658515.)	[Schwartz, Gregory G.] Univ Colorado, Sch Med, Denver, CO USA; [Olsson, Anders G.] Stockholm & Linkoping Univ, Stockholm Heart Ctr, Linkoping, Sweden; [Abt, Markus; Brumm, Jochen; Kallend, David; Mundl, Hardi] F Hoffmann La Roche, Basel, Switzerland; [Ballantyne, Christie M.] Baylor Coll Med, Houston, TX 77030 USA; [Ballantyne, Christie M.] Methodist DeBakey Heart & Vasc Ctr, Houston, TX 77030 USA; [Barter, Philip J.] Heart Res Inst, Sydney, NSW, Australia; [Chaitman, Bernard R.] St Louis Univ, St Louis, MO 63103 USA; [Holme, Ingar M.] Oslo Univ Hosp, Oslo, Norway; [Leiter, Lawrence A.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Leitersdorf, Eran] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel; [McMurray, John J. V.] Univ Glasgow, British Heart Fdn Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Nicholls, Stephen J.] Univ Adelaide, S Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Shah, Prediman K.] Cedars Sinai Heart Inst, Los Angeles, CA USA; [Tardif, Jean-Claude] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Wright, R. Scott] Mayo Clin, Rochester, MN USA; [Schwartz, Gregory G.] Vet Affairs Med Ctr, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Linkoping University; Roche Holding; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; University of Sydney; Heart Research Institute; Saint Louis University; University of Oslo; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Glasgow; South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide; Cedars Sinai Medical Center; Universite de Montreal; Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Schwartz, GG (corresponding author), VA Med Ctr, Cardiol Sect 111B, 1055 Clermont St, Denver, CO 80220 USA.	gregory.schwartz@va.gov	mcmurray, John/B-2467-2013; Antonio Carlos SOUSA, A. C. S Sobral Sousa/D-7494-2013; Aroney, Con/A-7672-2013; Ponikowski, Piotr/O-6454-2015; Leiter, Lawrence/AAG-4059-2020; Prunier, Fabrice/A-5210-2011; Kubica, Jacek/D-6906-2014; De Caterina, Raffaele/K-3857-2016; Colquhoun, David M/F-9078-2013; Ballantyne, Christie/A-6599-2008; Esposito, Giovanni/F-2880-2010; Schmidt, André/G-1569-2011; Braile-Sternieri, Maria Christiane Valeria Braga/P-9461-2018	mcmurray, John/0000-0002-6317-3975; Aroney, Con/0000-0002-0908-7179; Ponikowski, Piotr/0000-0002-3391-7064; Kubica, Jacek/0000-0001-8250-754X; De Caterina, Raffaele/0000-0003-1637-574X; Esposito, Giovanni/0000-0003-0565-7127; Schmidt, André/0000-0002-1090-8165; Brumm, Jochen/0000-0001-9518-038X; Gupta, Milan/0000-0002-7385-9006; Ballantyne, Christie/0000-0002-6432-1730; A. Samad, Bassem/0000-0001-9440-5073; Braile-Sternieri, Maria Christiane Valeria Braga/0000-0003-2704-2481; Brilakis, Emmanouil/0000-0001-9416-9701; Kim, Sang-Hyun/0000-0001-8026-1582; GALINIER, Michel/0000-0003-1735-3390; MAthur, Anthony/0000-0001-7941-9653; Maurer, Gerald/0000-0002-9043-7657; Nicholls, Stephen/0000-0002-9668-4368; Sobral Sousa, Antonio Carlos/0000-0002-4158-9726	F. Hoffmann-La Roche; Anthera Pharmaceuticals; Resverlogix; Roche; Sanofi; AstraZeneca; Abbott; Adnexus; Amarin; Amylin; Bristol-Myers Squibb; Esperion Therapeutics; Genentech; GlaxoSmithKline; Idera Pharmaceuticals; Kowa Pharmaceuticals; Merck; Novartis; Omthera Pharmaceuticals; Pfizer; Takeda Pharmaceuticals; CSL Behring; Eli Lilly; Boehringer Ingelheim; Servier; Cerenis Therapeutics	F. Hoffmann-La Roche(Hoffmann-La Roche); Anthera Pharmaceuticals; Resverlogix; Roche(Roche Holding); Sanofi; AstraZeneca(AstraZeneca); Abbott(Abbott Laboratories); Adnexus; Amarin; Amylin; Bristol-Myers Squibb(Bristol-Myers Squibb); Esperion Therapeutics; Genentech(Roche HoldingGenentech); GlaxoSmithKline(GlaxoSmithKline); Idera Pharmaceuticals; Kowa Pharmaceuticals; Merck(Merck & Company); Novartis(Novartis); Omthera Pharmaceuticals; Pfizer(Pfizer); Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); CSL Behring; Eli Lilly(Eli Lilly); Boehringer Ingelheim(Boehringer Ingelheim); Servier(Servier); Cerenis Therapeutics	Funded by F. Hoffmann-La Roche; Supported by F. Hoffmann-La Roche.; Dr. Schwartz reports receiving grant support on behalf of his institution from Anthera Pharmaceuticals, Resverlogix, Roche, and Sanofi; Dr. Olsson, receiving lecture fees from AstraZeneca and serving on an advisory board for Karo Bio and Merck; Drs. Abt, Kallend, Brumm, and Mundl, being employees of Roche; Dr. Ballantyne, receiving consulting fees from Abbott, Adnexus, Amarin, Amylin, AstraZeneca, Bristol-Myers Squibb, Esperion Therapeutics, Genentech, GlaxoSmithKline, Idera Pharmaceuticals, Kowa Pharmaceuticals, Merck, Novartis, Omthera Pharmaceuticals, Pfizer, Resverlogix, Roche, Sanofi, and Takeda Pharmaceuticals, lecture fees from Abbott, GlaxoSmithKline, and Merck, and grant support on behalf of his institution from Abbott, Amarin, AstraZeneca, Bristol-Myers Squibb, Genentech, GlaxoSmithKline, Kowa Pharmaceuticals, Merck, Novartis, Sanofi, and Takeda Pharmaceuticals; Dr. Barter, receiving consulting fees from CSL Behring and Merck, lecture fees from AstraZeneca, Kowa Pharmaceuticals, Merck, Pfizer, and Roche, and reimbursement for travel expenses from AstraZeneca, CSL Behring, Merck, and Pfizer; Dr. Chaitman, receiving consulting fees from Merck, Pfizer, and Abbott; Dr. Leiter, receiving consulting fees from Abbott, Amgen, AstraZeneca, Eli Lilly, Merck, Roche, and Sanofi, lecture fees from AstraZeneca, Eli Lilly, Merck, and Roche, fees for development of educational materials from Merck, and grant support on behalf of his institution from Amgen, AstraZeneca, Eli Lilly, Merck, Roche, and Sanofi; Dr. Leitersdorf, serving on a board for and receiving consulting fees from Novartis and Merck, receiving lecture fees from Merck, and receiving grant support on behalf of his institution from Merck; Dr. McMurray, receiving reimbursement for travel expenses from Roche and consulting fees on behalf of his institution from Roche; Dr. Nicholls, receiving consulting fees from Boehringer Ingelheim, CSL Behring, Merck, Omthera Pharmaceuticals, Roche, and Takeda Pharmaceuticals and grant support on behalf of his institution from Anthera Pharmaceuticals, AstraZeneca, Eli Lilly, Novartis, Resverlogix, and Roche; Dr. Shah, receiving consulting fees from Roche; Dr. Tardif, receiving lecture fees from Roche and Servier and grant support on behalf of his institution from Cerenis Therapeutics, Merck, Roche, and Servier; and Dr. Wright, receiving fees for the development of educational presentations from Vindico Medical Education and consulting fees from Roche for himself and on behalf of his institution. No other potential conflict of interest relevant to this article was reported.	ACCORD Stud Group, 2010, NEW ENGL J MED, V1362, P1748; AIM- HIGH Investigators, 2012, NEW ENGL J MED, V367, P189; ASSMANN G, 1992, AM J CARDIOL, V70, P733, DOI 10.1016/0002-9149(92)90550-I; Baigent C, 2008, LANCET, V371, P2084; Bangalore S, 2010, CIRCULATION, V122, P2142, DOI 10.1161/CIRCULATIONAHA.109.905687; Barter P, 2004, ENDOCRIN METAB CLIN, V33, P393, DOI 10.1016/j.ecl.2004.03.006; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Cannon CP, 2010, NEW ENGL J MED, V363, P2406, DOI 10.1056/NEJMoa1009744; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Keech A, 2006, LANCET, V367, P1142, DOI 10.1016/S0140-6736(06)68501-2; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Keech A, 2006, LANCET, V368, P1415, DOI 10.1016/S0140-6736(06)69594-9; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Luscher TF, 2012, EUR HEART J, V33, P857, DOI 10.1093/eurheartj/ehs019; Mora S, 2012, J AM COLL CARDIOL, V59, P1521, DOI 10.1016/j.jacc.2011.12.035; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Nicholls SJ, 2011, JAMA-J AM MED ASSOC, V306, P2099, DOI 10.1001/jama.2011.1649; Olsson AG, 2005, EUR HEART J, V26, P890, DOI 10.1093/eurheartj/ehi186; PEDERSEN TR, 1995, LANCET, V345, P1274; Ray KK, 2009, ARTERIOSCL THROM VAS, V29, P424, DOI 10.1161/ATVBAHA.108.181735; Ridker PM, 2009, CIRC-CARDIOVASC GENE, V2, P26, DOI 10.1161/CIRCGENETICS.108.817304; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; ROSENSON RS, 1993, J AM COLL CARDIOL, V22, P933; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; Schwartz GG, 2012, CURR ATHEROSCLER REP, V14, P41, DOI 10.1007/s11883-011-0217-9; Schwartz GG, 2009, AM HEART J, V158, P896, DOI 10.1016/j.ahj.2009.09.017; Stein EA, 2009, AM J CARDIOL, V104, P82, DOI 10.1016/j.amjcard.2009.02.061; Thompson A, 2008, JAMA-J AM MED ASSOC, V299, P2777, DOI 10.1001/jama.299.23.2777; Voight BF, 2012, LANCET, V380, P564; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wolfram RM, 2006, AM J CARDIOL, V98, P711, DOI 10.1016/j.amjcard.2006.04.006; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751	38	1430	1474	1	104	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2012	367	22					2089	2099		10.1056/NEJMoa1206797	http://dx.doi.org/10.1056/NEJMoa1206797			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044MS	23126252	Green Accepted			2022-12-28	WOS:000311624400006
J	Davis, JG; Gierszal, KP; Wang, P; Ben-Amotz, D				Davis, Joel G.; Gierszal, Kamil P.; Wang, Ping; Ben-Amotz, Dor			Water structural transformation at molecular hydrophobic interfaces	NATURE			English	Article							HYDRATION; METHANE	Hydrophobic hydration is considered to have a key role in biological processes ranging from membrane formation to protein folding and ligand binding(1). Historically, hydrophobic hydration shells were thought to resemble solid clathrate hydrates(2-4), with solutes surrounded by polyhedral cages composed of tetrahedrally hydrogen-bonded water molecules. But more recent experimental(5-8) and theoretical(9-16) studies have challenged this view and emphasized the importance of the length scales involved. Here we report combined polarized, isotopic and temperature-dependent Raman scattering measurements with multivariate curve resolution (Raman-MCR)(17-19) that explore hydrophobic hydration by mapping the vibrational spectroscopic features arising from the hydrophobic hydration shells of linear alcohols ranging from methanol to heptanol. Our data, covering the entire 0-100 degrees C temperature range, show clear evidence that at low temperatures the hydration shells have a hydrophobically enhanced water structure with greater tetrahedral order and fewer weak hydrogen bonds than the surrounding bulk water. This structure disappears with increasing temperature and is then, for hydrophobic chains longer than similar to 1 nm, replaced by a more disordered structure with weaker hydrogen bonds than bulk water. These observations support our current understanding of hydrophobic hydration, including the thermally induced water structural transformation that is suggestive of the hydrophobic crossover predicted to occur at lengths of similar to 1 nm (refs 5, 9, 10, 14).	[Davis, Joel G.; Gierszal, Kamil P.; Wang, Ping; Ben-Amotz, Dor] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ben-Amotz, D (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	bendor@purdue.edu			National Science Foundation [CHE-0847928]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (CHE-0847928). We thank B. Widom, D. Chandler, M. Fayer and S. Granick for comments and suggestions; D. Wilcox for writing the SMCR code used in this work; B. Rankin for performing molecular dynamics simulations to determine the number of water molecules in the first hydration shells of n-alcohols (as further described in Supplementary Methods); and D. L. McCaffrey, S. Zukowski and C. DeShaw (undergraduate research students) for assistance in collecting experimental results relevant to this work.	Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; Ben-Amotz D, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2121648; Buchanan P, 2005, CHEM PHYS LETT, V415, P89, DOI 10.1016/j.cplett.2005.08.064; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Cheng YK, 1998, NATURE, V392, P696, DOI 10.1038/33653; FRANK HS, 1945, J CHEM PHYS, V13, P507, DOI 10.1063/1.1723985; Friesen AD, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3633478; Garde S, 1996, PHYS REV LETT, V77, P4966, DOI 10.1103/PhysRevLett.77.4966; Garde S, 2011, P NATL ACAD SCI USA, V108, P16491, DOI 10.1073/pnas.1113256108; Gierszal KP, 2011, J PHYS CHEM LETT, V2, P2930, DOI 10.1021/jz201373e; GILL SJ, 1985, J PHYS CHEM-US, V89, P3758, DOI 10.1021/j100263a034; GLEW DN, 1962, J PHYS CHEM-US, V66, P605, DOI 10.1021/j100810a008; Laage D, 2009, J PHYS CHEM B, V113, P2428, DOI 10.1021/jp809521t; LAWTON WH, 1971, TECHNOMETRICS, V13, P617, DOI 10.2307/1267173; Li F, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3516460; Li ITS, 2011, P NATL ACAD SCI USA, V108, P16527, DOI 10.1073/pnas.1105450108; Liu CL, 2011, SPECTROSC SPECT ANAL, V31, P1524, DOI 10.3964/j.issn.1000-0593(2011)06-1524-05; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Matysiak S, 2011, J PHYS CHEM B, V115, P14859, DOI 10.1021/jp2079633; Perera PN, 2009, P NATL ACAD SCI USA, V106, P12230, DOI 10.1073/pnas.0903675106; Perera P, 2008, J AM CHEM SOC, V130, P4576, DOI 10.1021/ja077333h; Petersen C, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3142861; Raschke TM, 2005, P NATL ACAD SCI USA, V102, P6777, DOI 10.1073/pnas.0500225102; ROSSKY PJ, 1982, FARADAY SYMP CHEM S, P69, DOI 10.1039/fs9821700069; Smith JD, 2005, P NATL ACAD SCI USA, V102, P14171, DOI 10.1073/pnas.0506899102; Stiopkin IV, 2011, NATURE, V474, P192, DOI 10.1038/nature10173; Tomlinson-Phillips J, 2011, J PHYS CHEM A, V115, P6177, DOI 10.1021/jp111346s; Torii H, 2006, J PHYS CHEM A, V110, P9469, DOI 10.1021/jp062033s; Yang M, 2010, PHYS CHEM CHEM PHYS, V12, P982, DOI 10.1039/b918314k; Zhang XY, 2002, SCIENCE, V295, P663, DOI 10.1126/science.1066854	30	379	380	21	657	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					582	585		10.1038/nature11570	http://dx.doi.org/10.1038/nature11570			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23172216				2022-12-28	WOS:000311339800049
J	Pearce, JM				Pearce, Joshua M.			Make nanotechnology research open-source	NATURE			English	Editorial Material									[Pearce, Joshua M.] Michigan Technol Univ, Dept Mat Sci & Engn, Open Sustainabil Technol Lab, Houghton, MI 49931 USA; [Pearce, Joshua M.] Michigan Technol Univ, Dept Elect & Comp Engn, Open Sustainabil Technol Lab, Houghton, MI 49931 USA	Michigan Technological University; Michigan Technological University	Pearce, JM (corresponding author), Michigan Technol Univ, Dept Mat Sci & Engn, Open Sustainabil Technol Lab, Houghton, MI 49931 USA.	pearce@mtu.edu	Pearce, Joshua M/D-2052-2010; Pearce, J.M/C-9240-2013	Pearce, Joshua M/0000-0001-9802-3056; Pearce, J.M/0000-0001-9802-3056				Harris DL, 2008, NANOTECHNOLOGY & SOCIETY: CURRENT AND EMERGING ETHICAL ISSUES, P163; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Lemley MA, 2005, STANFORD LAW REV, V58, P601; Makker A, 2011, SOUTH CALIF LAW REV, V84, P1163; Miller J. C., 2005, HDB NANOTECHNOLOGY B; Mushtaq U., 2011, NANOTECHNOLOGY GLOBA, P191; Pearce JM, 2012, SCIENCE, V337, P1303, DOI 10.1126/science.1228183; Stiles A.R., 2012, DREXEL LAW REV, V4, P555; Toumey C, 2009, NAT NANOTECHNOL, V4, P136, DOI 10.1038/nnano.2009.16; Tullis TK, 2012, NANOTECHNOL REV, V1, P189, DOI 10.1515/ntrev-2012-0501	10	45	45	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					519	521		10.1038/491519a	http://dx.doi.org/10.1038/491519a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23172198	Green Submitted, hybrid			2022-12-28	WOS:000311339800024
J	Berman, AJ; Cech, TR				Berman, Andrea J.; Cech, Thomas R.			SnapShot: Telomeres and Telomerase	CELL			English	Editorial Material									[Berman, Andrea J.; Cech, Thomas R.] Univ Colorado, HHMI, BioFrontiers Inst, Boulder, CO 80309 USA; [Berman, Andrea J.; Cech, Thomas R.] Univ Colorado, Dept Chem & Biochem, BioFrontiers Inst, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Berman, AJ (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.							Du H.-Y., 2008, TELOMERES TELOMERASE; Egan ED, 2012, RNA, V18, P1747, DOI 10.1261/rna.034629.112; Podlevsky JD, 2008, NUCLEIC ACIDS RES, V36, pD339, DOI 10.1093/nar/gkm700	3	6	6	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 21	2012	151	5								10.1016/j.cell.2012.11.008	http://dx.doi.org/10.1016/j.cell.2012.11.008			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178129	Bronze			2022-12-28	WOS:000311423500024
J	Chou, R; Cantor, AG; Zakher, B; Bougatsos, C				Chou, Roger; Cantor, Amy G.; Zakher, Bernadette; Bougatsos, Christina			Screening for HIV in Pregnant Women: Systematic Review to Update the 2005 US Preventive Services Task Force Recommendation	ANNALS OF INTERNAL MEDICINE			English	Review							ACTIVE ANTIRETROVIRAL THERAPY; SINGLE-DOSE NEVIRAPINE; TO-CHILD TRANSMISSION; LOW-BIRTH-WEIGHT; INFECTED WOMEN; UNINFECTED CHILDREN; IN-UTERO; INFANTS BORN; CONGENITAL-ABNORMALITIES; PERINATAL TRANSMISSION	Background: A 2005 U.S. Preventive Services Task Force (USPSTF) review found good evidence that prenatal HIV screening is accurate and can lead to interventions that reduce the risk for mother-to-child transmission. Purpose: To update the 2005 USPSTF review, focusing on previously identified research gaps and new evidence on treatments. Data Sources: MEDLINE (2004 to June 2012) and the Cochrane Library (2005 to the second quarter of 2012). Study Selection: Randomized trials and cohort studies of pregnant women on risk for mother-to-child transmission or harms associated with prenatal HIV screening or antiretroviral therapy during pregnancy. Data Extraction: 2 reviewers abstracted and confirmed study details and quality by using predefined criteria. Data Synthesis: No studies directly evaluated effects of prenatal HIV screening on risk for mother-to-child transmission or maternal or infant clinical outcomes. One fair-quality, large cohort study (HIV prevalence, 0.7%) found that rapid testing during labor was associated with a positive predictive value of 90%. New cohort studies of nonbreastfeeding women in the United States and Europe con-firm that full-course combination antiretroviral therapy reduces rates of mother-to-child transmission (<1% to 2.4% vs. 9% to 22% with no antiretroviral therapy). New cohort studies found antiretroviral therapy during pregnancy to be associated with increased risk for preterm delivery (<37 weeks' gestation); there were no clear associations with low birthweight, congenital abnormalities, or infant neurodevelopment. Evidence on long-term maternal harms after short-term antiretroviral therapy exposure during pregnancy remains sparse. Limitations: Only English-language articles were included. Studies conducted in resource-poor settings may be of limited applicability to screening in the United States. Conclusion: Antiretroviral therapy in combination with avoidance of breastfeeding and elective cesarean section in women with viremia reduces risk for mother-to-child transmission. Use of certain antiretroviral therapy regimens during pregnancy may increase risk for preterm delivery. Primary Funding Source: Agency for Healthcare Research and Quality. Ann Intern Med. 2012; 157: 719-728.	[Chou, Roger] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; Oregon Evidence Based Practice Ctr, Portland, OR USA	Oregon Health & Science University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610; Cantor, Amy/0000-0002-4467-8484	Agency for Healthcare Research and Quality [290-02-0024]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By contract 290-02-0024 from the Agency for Healthcare Research and Quality.	Aldrovandi GM, 2009, PEDIATRICS, V124, pE1189, DOI 10.1542/peds.2008-2771; Alimenti A, 2006, PEDIATRICS, V118, pE1139, DOI 10.1542/peds.2006-0525; American College of Obstetricians and Gynecologists, 2010, COMM OP SCHED CES DE; Bardeguez AD, 2003, JAIDS-J ACQ IMM DEF, V32, P170, DOI 10.1097/00126334-200302010-00009; Benhammou V, 2008, AIDS, V22, P2165, DOI 10.1097/QAD.0b013e328311d18b; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Briand N, 2009, AIDS, V23, P1235, DOI 10.1097/QAD.0b013e32832be0df; Brogly SB, 2007, AIDS, V21, P929, DOI 10.1097/QAD.0b013e3280d5a786; Bulterys M, 2004, JAMA-J AM MED ASSOC, V292, P219, DOI 10.1001/jama.292.2.219; Bunders MJ, 2005, ACTA PAEDIATR, V94, P1571, DOI 10.1080/08035250510042951; Carceller A, 2009, PHARMACOTHERAPY, V29, P1289, DOI 10.1592/phco.29.11.1289; Cdcp enters for Disease Control and Prevention, 2009, HIV SURV REP 2009, V21; Centers for Disease Control and Prevention, 2011, SEX TRANSM DIS STDS; Centers for Disease Control and Prevention, 2010, HIV SURV SUPPL REP C, V16; Chi BH, 2008, JAIDS-J ACQ IMM DEF, V48, P220, DOI 10.1097/QAI.0b013e3181743969; Chou R, 2005, ANN INTERN MED, V143, P38, DOI 10.7326/0003-4819-143-1-200507050-00009; Chou R, SCREENING HIV PREGNA; Chou R, 2005, SCREENING HUMAN IMMU; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Cote HCF, 2008, J INFECT DIS, V198, P851, DOI 10.1086/591253; Cotter AM, 2006, J INFECT DIS, V193, P1195, DOI 10.1086/503045; El Beitune Patrícia, 2005, Clinics, V60, P207, DOI 10.1590/S1807-59322005000300005; Fowler MG, 2010, CLIN PERINATOL, V37, P699, DOI 10.1016/j.clp.2010.09.002; Garcia-Tejedor A, 2009, ACTA OBSTET GYN SCAN, V88, P882, DOI 10.1080/00016340903062836; Gray G, 2006, JAIDS-J ACQ IMM DEF, V42, P169, DOI 10.1097/01.qai.0000219772.74432.20; Grosch-Woerner I, 2008, HIV MED, V9, P6, DOI 10.1111/j.1468-1293.2008.00520.x; Harris NS, 2007, AM J OBSTET GYNECOL, V197, pS33, DOI 10.1016/j.ajog.2007.03.081; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Jamieson DJ, 2007, AM J OBSTET GYNECOL, V197, pS72, DOI 10.1016/j.ajog.2007.03.067; Lipshultz SE, 2011, J AM COLL CARDIOL, V57, P76, DOI 10.1016/j.jacc.2010.08.620; Marti C, 2007, ACTA OBSTET GYN SCAN, V86, P409, DOI 10.1080/00016340601148531; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Mofenson L., 2006, Morbidity and Mortality Weekly Report, V55, P592; Morris AB, 2005, JAIDS-J ACQ IMM DEF, V40, P30, DOI 10.1097/01.qai.0000174651.40782.95; Mussi-Pinhata MM, 2007, PEDIATR INFECT DIS J, V26, P1032, DOI 10.1097/INF.0b013e31812f56ed; Pacheco SE, 2006, J INFECT DIS, V194, P1089, DOI 10.1086/507645; Panel on treatment of HIV-infected pregnant women and prevention of perinatal transmission, 2011, REC US ANT DRUGS PRE; Patel D, 2005, JAIDS-J ACQ IMM DEF, V40, P116, DOI 10.1097/01.qai.0000156854.99769.a5; Paul ME, 2005, PEDIATR INFECT DIS J, V24, P46, DOI 10.1097/01.inf.0000148879.83854.7e; Powis KM, 2011, J INFECT DIS, V204, P506, DOI 10.1093/infdis/jir307; Rudin C, 2011, HIV MED, V12, P228, DOI 10.1111/j.1468-1293.2010.00876.x; Schulte J, 2007, PEDIATRICS, V119, pE900, DOI 10.1542/peds.2006-1123; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Shapiro RL, 2006, AIDS, V20, P1281, DOI 10.1097/01.aids.0000232236.26630.35; Tariq S, 2011, JAIDS-J ACQ IMM DEF, V57, P326, DOI 10.1097/QAI.0b013e31821d34d0; Thistle P, 2007, CLIN INFECT DIS, V44, P111, DOI 10.1086/508869; Townsend CL, 2008, AIDS, V22, P973, DOI 10.1097/QAD.0b013e3282f9b67a; Townsend CL, 2007, AIDS, V21, P1019, DOI 10.1097/QAD.0b013e328133884b; Townsend CL, 2009, AIDS, V23, P519, DOI 10.1097/QAD.0b013e328326ca8e; Tung CS, 2010, J PERINATOL, V30, P30, DOI 10.1038/jp.2009.122; Tuomala RK, 2005, JAIDS-J ACQ IMM DEF, V38, P449, DOI 10.1097/01.qai.0000139398.38236.4d; U.S. Preventive Services Task Force, 2007, SCREEN HIV REC STAT; Watts DH, 2011, J PERINAT MED, V39, P163, DOI [10.1515/JPM.2010.139, 10.1515/jpm.2010.139]; Watts DH, 2003, JAIDS-J ACQ IMM DEF, V33, P585, DOI 10.1097/00126334-200308150-00006; Williams PL, 2010, PEDIATRICS, V125, pE250, DOI 10.1542/peds.2009-1112	55	16	16	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10					719	+		10.7326/0003-4819-157-10-201211200-00009	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-00009			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043VZ	23165663				2022-12-28	WOS:000311580000017
J	Qaseem, A; Fihn, SD; Williams, S; Dallas, P; Owens, DK; Shekelle, P				Qaseem, Amir; Fihn, Stephan D.; Williams, Sankey; Dallas, Paul; Owens, Douglas K.; Shekelle, Paul		Amer Coll Phys	Diagnosis of Stable Ischemic Heart Disease: Summary of a Clinical Practice Guideline From the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; EMISSION COMPUTED-TOMOGRAPHY; INCREMENTAL PROGNOSTIC VALUE; LEFT-VENTRICULAR MASS; SUPINE EXERCISE ELECTROCARDIOGRAPHY; MYOCARDIAL-PERFUSION SCINTIGRAPHY; ADENOSINE STRESS PERFUSION; MEDICALLY TREATED PATIENTS; MAJOR CARDIAC EVENTS; BUNDLE-BRANCH BLOCK	Description: The American College of Physicians (ACP) developed this guideline in collaboration with the American College of Cardiology Foundation (ACCF), American Heart Association (AHA), American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, and Society of Thoracic Surgeons to help clinicians diagnose known or suspected stable ischemic heart disease. Methods: Literature on this topic published before November 2011 was identified by using MEDLINE, Embase, Cochrane CENTRAL, PsychINFO, AMED, and SCOPUS. Searches were limited to human studies published in English. This guideline grades the evidence and recommendations according to a translation of the ACCF/AHA grading system into ACP's clinical practice guidelines grading system. Recommendations: This guideline includes 28 recommendations that address the following issues: the initial diagnosis of the patient who might have stable ischemic heart disease, cardiac stress testing to assess the risk for death or myocardial infarction in patients diagnosed with stable ischemic heart disease, and coronary angiography for risk assessment. Ann Intern Med. 2012; 157: 729-734.	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Univ Penn, Philadelphia, PA 19104 USA; Dept Vet Affairs, Seattle, WA USA; Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA USA; Stanford Univ, Stanford, CA 94305 USA; Virginia Tech, Caril Sch Med, Roanoke, VA USA; W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA	American College of Physicians; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Virginia Polytechnic Institute & State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org	Fihn, Stephan/ABA-1040-2020		ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Akram K, 2009, ATHEROSCLEROSIS, V203, P533, DOI 10.1016/j.atherosclerosis.2008.07.008; [Anonymous], 1980, Lancet, V2, P491; Badran HM, 2007, J AM SOC ECHOCARDIOG, V20, P820, DOI 10.1016/j.echo.2007.01.007; Bello D, 2003, CIRCULATION, V108, P1945, DOI 10.1161/01.CIR.0000095029.57483.60; Bingham SE, 2011, CIRCULATION, V123, P1509, DOI 10.1161/CIRCULATIONAHA.109.907659; BLOCK WJ, 1952, JAMA-J AM MED ASSOC, V150, P259, DOI 10.1001/jama.1952.03680040001001; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bodi V, 2007, J AM COLL CARDIOL, V50, P1174, DOI 10.1016/j.jacc.2007.06.016; Bouzas-Mosquera A, 2009, J AM COLL CARDIOL, V53, P1981, DOI 10.1016/j.jacc.2009.01.067; BRAAT SH, 1985, AM J CARDIOL, V55, P224, DOI 10.1016/0002-9149(85)90335-2; Braunwald E, 1994, UNSTABLE ANGINA DIAG; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; BURNS RJ, 1991, AM J CARDIOL, V68, P504, DOI 10.1016/0002-9149(91)90786-K; Cademartiri F, 2010, EUR RADIOL, V20, P81, DOI 10.1007/s00330-009-1529-9; CALIFF RM, 1989, JAMA-J AM MED ASSOC, V261, P2077, DOI 10.1001/jama.261.14.2077; CAMPEAU L, 1976, CIRCULATION, V54, P522, DOI 10.1161/circ.54.3.947585; Centers for Medicare & Medicaid Services, 2008, MED MED STAT SUPPL; CHAITMAN BR, 1981, CIRCULATION, V64, P360, DOI 10.1161/01.CIR.64.2.360; CHRISTIAN TF, 1994, ANN INTERN MED, V121, P825, DOI 10.7326/0003-4819-121-11-199412010-00001; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; d'Othee BJ, 2008, EUR J RADIOL, V65, P449, DOI 10.1016/j.ejrad.2007.05.003; Daly C, 2003, EUR HEART J, V24, P534, DOI 10.1016/S0195-668X(02)00820-5; Daly CA, 2006, BMJ-BRIT MED J, V332, P262, DOI 10.1136/bmj.38695.605440.AE; DEPUEY EG, 1988, J NUCL MED, V29, P1479; DETRE K, 1981, CIRCULATION, V63, P1329, DOI 10.1161/01.CIR.63.6.1329; DIAMOND GA, 1980, J CLIN INVEST, V65, P1210, DOI 10.1172/JCI109776; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; EGSTRUP K, 1988, AM J CARDIOL, V61, P1219, DOI 10.1016/0002-9149(88)91158-7; Elhendy A, 2002, J AM COLL CARDIOL, V40, P1623, DOI 10.1016/S0735-1097(02)02338-0; Epstein FH, 2007, J NUCL CARDIOL, V14, P729, DOI 10.1016/j.nuclcard.2007.07.006; EVERY NR, 1992, J AM COLL CARDIOL, V19, P1435, DOI 10.1016/0735-1097(92)90599-I; Fihn SD, 2012, J AM COLL C IN PRESS; FRANK CW, 1973, CIRCULATION, V47, P509, DOI 10.1161/01.CIR.47.3.509; Froelicher VF, 1998, ANN INTERN MED, V128, P965, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00001; Garber AM, 1999, ANN INTERN MED, V130, P719, DOI 10.7326/0003-4819-130-9-199905040-00003; Gehi AK, 2008, ARCH INTERN MED, V168, P1423, DOI 10.1001/archinte.168.13.1423; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Gibbons RJ, 1999, CIRCULATION, V100, P2140, DOI 10.1161/01.CIR.100.21.2140; GIBBONS RJ, 1990, ANN INTERN MED, V112, P743, DOI 10.7326/0003-4819-112-10-743; GOLDMAN L, 1982, CIRCULATION, V66, P945, DOI 10.1161/01.CIR.66.5.945; Gulati M, 2005, NEW ENGL J MED, V353, P468, DOI 10.1056/NEJMoa044154; Haberl R, 2005, AM HEART J, V149, P1112, DOI 10.1016/j.ahj.2005.02.048; Hachamovitch R, 2004, J AM COLL CARDIOL, V43, P200, DOI 10.1016/j.jacc.2003.07.043; Hachamovitch R, 1998, CIRCULATION, V97, P535; Hachamovitch R, 2002, CIRCULATION, V105, P823, DOI 10.1161/hc0702.103973; Hachamovitch R, 1996, CIRCULATION, V93, P905, DOI 10.1161/01.CIR.93.5.905; Hachamovitch R, 1997, AM J CARDIOL, V80, P426, DOI 10.1016/S0002-9149(97)00390-1; Hachamovitch R, 2003, J AM COLL CARDIOL, V41, P1329, DOI 10.1016/S0735-1097(03)00125-6; Hachamovitch R, 2012, J AM COLL CARDIOL, V59, P462, DOI 10.1016/j.jacc.2011.09.066; HAMMERMEISTER KE, 1979, CIRCULATION, V59, P421, DOI 10.1161/01.CIR.59.3.421; Hamon M, 2006, J AM COLL CARDIOL, V48, P1896, DOI 10.1016/j.jacc.2006.08.028; Hemingway H, 1998, EUR HEART J, V19, P859, DOI 10.1053/euhj.1997.0862; Henneman MM, 2008, J AM COLL CARDIOL, V52, P216, DOI 10.1016/j.jacc.2008.04.012; HIRZEL HO, 1984, AM J CARDIOL, V53, P764, DOI 10.1016/0002-9149(84)90400-4; HUBBARD BL, 1992, ARCH INTERN MED, V152, P309, DOI 10.1001/archinte.152.2.309; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Jahnke C, 2007, CIRCULATION, V115, P1769, DOI 10.1161/CIRCULATIONAHA.106.652016; Johansen A, 2006, CLIN PHYSIOL FUNCT I, V26, P288, DOI 10.1111/j.1475-097X.2006.00690.x; JUKEMA JW, 1993, EUR HEART J, V14, P53, DOI 10.1093/eurheartj/14.1.53; Kamalesh M, 2002, AM HEART J, V143, P163, DOI 10.1067/mhj.2002.119377; Keim RG, 2002, J CLIN ORTHOD, V36, P637; Keim Robert G, 2002, J Clin Orthod, V36, P627; Kelle S, 2011, JACC-CARDIOVASC IMAG, V4, P161, DOI 10.1016/j.jcmg.2010.11.012; KNOCHEL JP, 1961, AM J MED, V30, P299, DOI 10.1016/0002-9343(61)90101-2; KOREN MJ, 1991, ANN INTERN MED, V114, P345, DOI 10.7326/0003-4819-114-5-345; Korosoglou G, 2010, J AM COLL CARDIOL, V56, P1225, DOI 10.1016/j.jacc.2010.06.020; Kuntz KM, 1999, ANN INTERN MED, V130, P709, DOI 10.7326/0003-4819-130-9-199905040-00002; LADENHEIM ML, 1987, AM J CARDIOL, V59, P270, DOI 10.1016/0002-9149(87)90798-3; LARCOS G, 1991, AM J CARDIOL, V68, P1097, DOI 10.1016/0002-9149(91)90504-E; Lauer MS, 2007, ANN INTERN MED, V147, P821, DOI 10.7326/0003-4819-147-12-200712180-00001; Leape LL, 2000, AM HEART J, V139, P106, DOI 10.1016/S0002-8703(00)90316-8; Lebtahi NE, 1997, J NUCL CARDIOL, V4, P266, DOI 10.1016/S1071-3581(97)90103-3; Leischik R, 2007, INT J CARDIOL, V119, P297, DOI 10.1016/j.ijcard.2006.07.190; LEVY D, 1990, NEW ENGL J MED, V0322; LEVY D, 1989, ANN INTERN MED, V110, P101, DOI 10.7326/0003-4819-110-2-101; Lorenzoni R, 2003, J AM SOC ECHOCARDIOG, V16, P1287, DOI 10.1067/j.echo.2003.07.007; MARK DB, 1987, ANN INTERN MED, V106, P793, DOI 10.7326/0003-4819-106-6-793; MARK DB, 1991, NEW ENGL J MED, V325, P849, DOI 10.1056/NEJM199109193251204; Marwick TH, 2001, J AM COLL CARDIOL, V37, P754, DOI 10.1016/S0735-1097(00)01191-8; Mattera JA, 1998, J NUCL CARDIOL, V5, P498, DOI 10.1016/S1071-3581(98)90181-7; McCully RB, 2002, J AM COLL CARDIOL, V39, P1345, DOI 10.1016/S0735-1097(02)01778-3; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; MELIN JA, 1985, CIRCULATION, V71, P535, DOI 10.1161/01.CIR.71.3.535; Mensah GA, 2007, HEALTH AFFAIR, V26, P38, DOI 10.1377/hlthaff.26.1.38; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Min JK, 2011, J AM COLL CARDIOL, V58, P849, DOI 10.1016/j.jacc.2011.02.074; Min JK, 2010, J AM COLL CARDIOL, V55, P957, DOI 10.1016/j.jacc.2009.08.087; MOCK MB, 1982, CIRCULATION, V66, P562, DOI 10.1161/01.CIR.66.3.562; MORAIS J, 1990, CAN J CARDIOL, V6, P5; MORISE AP, 1995, AM HEART J, V130, P741, DOI 10.1016/0002-8703(95)90072-1; Mowatt G, 2004, HEALTH TECHNOL ASSES, V8, P1; MURPHY ML, 1977, NEW ENGL J MED, V297, P621, DOI 10.1056/NEJM197709222971201; Murphy S. L., 2012, NATL VITAL STAT REP, V60, P4; MYERS WO, 1989, J THORAC CARDIOV SUR, V97, P487; MYERS WO, 1987, ANN THORAC SURG, V44, P471, DOI 10.1016/S0003-4975(10)62104-2; Nagao T, 2007, CIRC J, V71, P1029, DOI 10.1253/circj.71.1029; NALLAMOTHU N, 1995, J AM COLL CARDIOL, V25, P830, DOI 10.1016/0735-1097(94)00471-2; Navare SM, 2004, J NUCL CARDIOL, V11, P551, DOI 10.1016/j.nuclcard.2004.06.128; O'Rourke RA, 2000, CIRCULATION, V102, P126, DOI 10.1161/01.CIR.102.1.126; OKEEFE JH, 1993, J AM COLL CARDIOL, V21, P1332, DOI 10.1016/0735-1097(93)90305-K; PATEL R, 1995, NUCL MED COMMUN, V16, P137, DOI 10.1097/00006231-199516030-00004; Poldermans D, 1999, CIRCULATION, V99, P757, DOI 10.1161/01.CIR.99.6.757; Priori SG, 1997, CIRCULATION, V95, P265; PROUDFIT WJ, 1983, CIRCULATION, V68, P986, DOI 10.1161/01.CIR.68.5.986; PRYOR DB, 1991, AM J MED, V90, P553; PRYOR DB, 1993, ANN INTERN MED, V118, P81, DOI 10.7326/0003-4819-118-2-199301150-00001; PSATY BM, 1990, JAMA-J AM MED ASSOC, V263, P1653, DOI 10.1001/jama.263.12.1653; Qaseem A, 2012, ANN INTERN MED, V157, P735, DOI 10.7326/0003-4819-157-10-201211200-00011; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; ROCKETT JF, 1990, CLIN NUCL MED, V15, P401, DOI 10.1097/00003072-199006000-00008; Rozanski A, 2010, J NUCL CARDIOL, V17, P999, DOI 10.1007/s12350-010-9300-9; RUBERMAN W, 1980, CIRCULATION, V61, P1172, DOI 10.1161/01.CIR.61.6.1172; Rubinshtein R, 2007, AM J CARDIOL, V99, P472, DOI 10.1016/j.amjcard.2006.08.060; Sabharwal NK, 2007, J NUCL CARDIOL, V14, P174, DOI 10.1016/j.nuclcard.2006.12.324; Schillinger M, 2002, WIEN KLIN WOCHENSCHR, V114, P917; Schuetz GM, 2010, ANN INTERN MED, V152, P167, DOI 10.7326/0003-4819-152-3-201002020-00008; Schuijf JD, 2006, AM HEART J, V151, P404, DOI 10.1016/j.ahj.2005.03.022; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Shaw LJ, 2004, J NUCL CARDIOL, V11, P171, DOI 10.1016/j.nuclcard.2003.12.004; SIMARI RD, 1991, AM J CARDIOL, V67, P573, DOI 10.1016/0002-9149(91)90894-Q; Smith SC, 2006, CIRCULATION, V113, pE166, DOI 10.1161/CIRCULATIONAHA.106.173220; Spaulding CM, 1997, NEW ENGL J MED, V336, P1629, DOI 10.1056/NEJM199706053362302; Stein PD, 2006, AM J MED, V119, P203, DOI 10.1016/j.amjmed.2005.06.071; Sun ZH, 2006, EUR J RADIOL, V60, P279, DOI 10.1016/j.ejrad.2006.06.009; Vaduganathan P, 1996, J AM COLL CARDIOL, V28, P543, DOI 10.1016/0735-1097(96)00224-0; WEINER DA, 1984, J AM COLL CARDIOL, V3, P772, DOI 10.1016/S0735-1097(84)80254-5	127	37	45	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10					729	+		10.7326/0003-4819-157-10-201211200-00010	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-00010			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043VZ	23165664				2022-12-28	WOS:000311580000018
J	Stewart, S; Carrington, MJ; Swemmer, CH; Anderson, C; Kurstjens, NP; Amerena, J; Brown, A; Burrell, LM; de Looze, FJ; Harris, M; Hung, J; Krum, H; Nelson, M; Schlaich, M; Stocks, NP; Jennings, GL				Stewart, Simon; Carrington, Melinda J.; Swemmer, Carla H.; Anderson, Craig; Kurstjens, Nicol P.; Amerena, John; Brown, Alex; Burrell, Louise M.; de Looze, Ferdinandus J.; Harris, Mark; Hung, Joseph; Krum, Henry; Nelson, Mark; Schlaich, Markus; Stocks, Nigel P.; Jennings, Garry L.		VIPER-BP Study Investigators	Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTIHYPERTENSIVE TREATMENT; ALL-CAUSE; HYPERTENSION; OUTCOMES; MORTALITY; PEOPLE; HOME	Objective To determine the effectiveness of intensive structured care to optimise blood pressure control based on individual absolute risk targets in primary care. Design Pragmatic multicentre randomised controlled trial. Setting General practices throughout Australia, except Northern Territory, 2009-11. Participants Of 2185 patients from 119 general practices who were eligible for drug treatment for hypertension according to national guidelines 416 (19.0%) achieved their individual blood pressure target during a 28 day run-in period of monotherapy. After exclusions, 1562 participants not at target blood pressure (systolic 150 (SD 17) mm Hg, diastolic 88 (SD 11) mm Hg) were randomised (1: 2 ratio) to usual care (n=524) or the intervention (n=1038). Intervention Computer assisted clinical profiling and risk target setting (all participants) with intensified follow-up and stepwise drug titration (initial angiotensin receptor blocker monotherapy or two forms of combination therapy using angiotensin receptor blockers) for those randomised to the intervention. The control group received usual care. Main outcome measures The primary outcome was individual blood pressure target achieved at 26 weeks. Secondary outcomes were change in mean sitting systolic and diastolic blood pressure, absolute risk for cardiovascular disease within five years based on the Framingham risk score, and proportion and rate of adverse events. Results On an intention to treat basis, there was an 8.8% absolute difference in individual blood pressure target achieved at 26 weeks in favour of the intervention group compared with usual care group (358/988 (36.2%) v 138/504 (27.4%)): adjusted relative risk 1.28 (95% confidence interval 1.10 to 1.49, P=0.0013). There was also a 9.5% absolute difference in favour of the intervention group for achieving the classic blood pressure target of <= 140/90 mm Hg (627/988 (63.5%) v 272/504 (54.0%)): adjusted relative risk 1.18 (1.07 to 1.29, P<0.001). The intervention group achieved a mean adjusted reduction in systolic blood pressure of 13.2 mm Hg (95% confidence interval -12.3 to -14.2 mm Hg) and diastolic blood pressure of 7.7 mm Hg (-7.1 to -8.3 mm Hg) v 10.1 mm Hg (-8.8 to 11.3 mm Hg) and 5.5 mm Hg (-4.7 to -6.2 mm Hg) in the usual care group (P<0.001). Among 1141 participants in whom five year absolute cardiovascular risk scores were calculated from baseline to the 26 week follow-up, the reduction in risk scores was greater in the intervention group than usual care group (14.7% (SD 9.3%) to 10.9% (SD 8.0%); difference -3.7% (SD 4.5%) and 15.0% (SD 10.1%) to 12.4% (SD 9.4%); -2.6% (SD 4.5%): adjusted mean difference -1.13% (95% confidence interval -0.69% to -1.63%; P<0.001). Owing to adverse events 82 (7.9%) participants in the intervention group and 10 (1.9%) in the usual care group had their drug treatment modified. Conclusions In a primary care setting intensive structured care resulted in higher levels of blood pressure control, with clinically lower blood pressure and absolute risk of future cardiovascular events overall and with more people achieving their target blood pressure. An important gap in treatment remains though and applying intensive management and achieving currently advocated risk based blood pressure targets is challenging.	[Stewart, Simon] Baker IDI Heart & Diabet Inst, Preventat Hlth Grp, Melbourne, Vic 8008, Australia; [Schlaich, Markus] Baker IDI Heart & Diabet Inst, Hypertens & Kidney Dis Lab, Melbourne, Vic 8008, Australia; [Swemmer, Carla H.] Novartis Pharmaceut Australia, Med Operat, Sydney, NSW, Australia; [Anderson, Craig] Univ Sydney, George Inst, Neurol & Mental Hlth Div, Sydney, NSW 2006, Australia; [Amerena, John] Deakin Univ, Geelong Cardiol Res Dept, Geelong, Vic 3217, Australia; [Brown, Alex] Baker IDI Heart & Diabet Inst, Alice Springs, NT, Australia; [Burrell, Louise M.] Univ Melbourne, Austin Hlth, Dept Med, Melbourne, Vic 3010, Australia; [Burrell, Louise M.] Univ Melbourne, Austin Hlth, Dept Cardiol, Melbourne, Vic 3010, Australia; [de Looze, Ferdinandus J.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Harris, Mark] Univ New S Wales, Ctr Primary Hlth Care & Equ, Sydney, NSW, Australia; [Hung, Joseph] Univ Western Australia, Sir Charles Gairdner Hosp Unit, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Krum, Henry] Monash Univ, Sch Publ Hlth & Prevent Med, Monash Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia; [Nelson, Mark] Univ Tasmania, Menzies Res Inst Tasmania, Discipline Gen Practice, Hobart, Tas, Australia; [Stocks, Nigel P.] Univ Adelaide, Discipline Gen Practice, Adelaide, SA, Australia	Baker Heart and Diabetes Institute; Baker Heart and Diabetes Institute; Novartis; University of Sydney; Deakin University; Baker Heart and Diabetes Institute; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Queensland; University of New South Wales Sydney; University of Western Australia; Monash University; University of Tasmania; Menzies Institute for Medical Research; University of Adelaide	Stewart, S (corresponding author), Baker IDI Heart & Diabet Inst, Preventat Hlth Grp, POB 6492,St Kilda Rd Cent, Melbourne, Vic 8008, Australia.	simon.stewart@bakeridi.edu.au	Harris, Mark F/I-2793-2019; Stocks, Nigel P/I-1083-2012; Stewart, Simon/M-3316-2016; Jennings, Garry/B-3914-2009	Harris, Mark F/0000-0002-0705-8913; Stewart, Simon/0000-0001-9032-8998; Carrington, Melinda J/0000-0003-3865-1645; Schlaich, Markus/0000-0002-1765-0195; Anderson, Craig/0000-0002-7248-4863; Jennings, Garry/0000-0002-7865-5483; Brown, Alex/0000-0003-2112-3918; Stocks, Nigel/0000-0002-9018-0361	Novartis Pharmaceuticals Australia; National Health and Medical Research Council of Australia; Victoria government's operational infrastructure support program	Novartis Pharmaceuticals Australia; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victoria government's operational infrastructure support program	The VIPER-BP study was sponsored by Novartis Pharmaceuticals Australia. The sponsors participated in discussions on the design and conduct of the study and provided logistical support during the trial. The study statistician (Adrian Esterman, University of South Australia) independently generated analyses on behalf of the other members of the clinical safety and efficacy committee (Colin Johnston, MN, Richard Gerraty) who received remuneration from Novartis Pharmaceuticals Australia as study consultants. The study investigators and sponsor jointly assessed study data. All the investigators received remuneration from Baker IDI for the research component of clinical study activities.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that all authors had a form of support (as described above) and specific relationships (as described above) with Novartis Pharmaceuticals Australia for the submitted work. SS, GLJ, and MJC are supported by the National Health and Medical Research Council of Australia. VIPER-BP study was supported by the Victoria government's operational infrastructure support program.	Carrington MJ, 2010, INT J CARDIOL, V145, P461, DOI 10.1016/j.ijcard.2009.06.003; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clark CE, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3995; Ernst ME, 2011, HYPERTENSION, V58, P987, DOI 10.1161/HYPERTENSIONAHA.111.183459; Fahey T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182.pub3; Feldman RD, 2009, HYPERTENSION, V53, P646, DOI 10.1161/HYPERTENSIONAHA.108.123455; Franklin SS, 2012, HYPERTENSION, V59, P564, DOI 10.1161/HYPERTENSIONAHA.111.180653; Julius S, 2006, HYPERTENSION, V48, P385, DOI 10.1161/01.HYP.0000236119.96301.f2; Kjeldsen SE, 2008, BLOOD PRESSURE, V17, P7, DOI 10.1080/08037050801972857; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; National Blood Pressure and Vascular Disease Advisory Committee, 2008, GUIDE TO MANAGEMENT; National Institute for Health and Clinical Excellence, 2011, HYPERTENSION CLINICA; National Vascular Disease Prevention Alliance, 2009, GUIDELINES FOR THE A; Sliwa K, 2011, CIRCULATION, V123, P2892, DOI 10.1161/CIRCULATIONAHA.110.992362; Staessen JA, 2004, JAMA-J AM MED ASSOC, V291, P955, DOI 10.1001/jama.291.8.955; Stewart S, 2012, J AM COLL CARDIOL, V60, P1239, DOI 10.1016/j.jacc.2012.06.025; Stewart S, 2011, INT J CARDIOL, V153, P317, DOI 10.1016/j.ijcard.2010.12.055; Vamos EP, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5567; Weber MA, 2004, LANCET, V363, P2049, DOI 10.1016/S0140-6736(04)16456-8; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; World Health Organization, 2008, 2008 2013 ACTION PLA; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339	22	22	23	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2012	345								e7156	10.1136/bmj.e7156	http://dx.doi.org/10.1136/bmj.e7156			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044GT	23169801	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000311608200001
J	Nadelman, RB; Hanincova, K; Mukherjee, P; Liveris, D; Nowakowski, J; McKenna, D; Brisson, D; Cooper, D; Bittker, S; Madison, G; Holmgren, D; Schwartz, I; Wormser, GP				Nadelman, Robert B.; Hanincova, Klara; Mukherjee, Priyanka; Liveris, Dionysios; Nowakowski, John; McKenna, Donna; Brisson, Dustin; Cooper, Denise; Bittker, Susan; Madison, Gul; Holmgren, Diane; Schwartz, Ira; Wormser, Gary P.			Differentiation of Reinfection from Relapse in Recurrent Lyme Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BURGDORFERI SENSU-STRICTO; BORRELIA-BURGDORFERI; ERYTHEMA MIGRANS; IXODES-SCAPULARIS; HEMATOGENOUS DISSEMINATION; GENETIC DIVERSITY; CULTURE; INFECTION; FAILURE; OSPC	BACKGROUND Erythema migrans is the most common manifestation of Lyme disease. Recurrences are not uncommon, and although they are usually attributed to reinfection rather than relapse of the original infection, this remains somewhat controversial. We used molecular typing of Borrelia burgdorferi isolates obtained from patients with culture-confirmed episodes of erythema migrans to distinguish between relapse and reinfection. Methods We determined the genotype of the gene encoding outer-surface protein C (ospC) of B. burgdorferi strains detected in cultures of skin or blood specimens obtained from patients with consecutive episodes of erythema migrans. After polymerase-chain-reaction amplification, ospC genotyping was performed by means of reverse line-blot analysis or DNA sequencing of the nearly full-length gene. Most strains were further analyzed by determining the genotype according to the 16S-23S ribosomal RNA intergenic spacer type, multilocus sequence typing, or both. Patients received standard courses of antibiotics for erythema migrans. RESULTS B. burgdorferi isolates obtained from 17 patients who received a diagnosis of erythema migrans between 1991 and 2011 and who had 22 paired episodes of this lesion (initial and second episodes) were available for testing. The ospC genotype was found to be different at each initial and second episode. Apparently identical genotypes were identified on more than one occasion in only one patient, at the first and third episodes, 5 years apart, but different genotypes were identified at the second and fourth episodes. CONCLUSIONS None of the 22 paired consecutive episodes of erythema migrans were associated with the same strain of B. burgdorferi on culture. Our data show that repeat episodes of erythema migrans in appropriately treated patients were due to reinfection and not relapse. (Funded by the National Institutes of Health and the William and Sylvia Silberstein Foundation.)	[Nadelman, Robert B.; Nowakowski, John; McKenna, Donna; Cooper, Denise; Bittker, Susan; Madison, Gul; Holmgren, Diane; Wormser, Gary P.] New York Med Coll, Div Infect Dis, Dept Med, Valhalla, NY 10595 USA; [Hanincova, Klara; Mukherjee, Priyanka; Liveris, Dionysios; Schwartz, Ira] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Brisson, Dustin] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	New York Medical College; New York Medical College; University of Pennsylvania	Nadelman, RB (corresponding author), New York Med Coll, Div Infect Dis, Dept Med, Rm 245, Valhalla, NY 10595 USA.	robert_nadelman@nymc.edu	Brisson, Dustin/B-2428-2008	Brisson, Dustin/0000-0002-9493-7579; Madison, Guy/0000-0001-5366-1169	National Institutes of Health; William and Sylvia Silberstein Foundation; Guide-point Global and Decision Resources; Baxter; Bio-Rad; DiaSorin; Immunetics; bioMerieux; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William and Sylvia Silberstein Foundation; Guide-point Global and Decision Resources; Baxter; Bio-Rad; DiaSorin; Immunetics; bioMerieux; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funded by the National Institutes of Health and the William and Sylvia Silberstein Foundation.; Supported in part by grants from the National Institutes of Health (AR41511 and AI45801) and the William and Sylvia Silberstein Foundation, to Dr. Schwartz.; Dr. Nadelman reports receiving consulting fees from Guide-point Global and Decision Resources and serving as an expert witness in medical malpractice cases regarding Lyme disease. Dr. Wormser reports receiving consulting fees from Baxter, serving as an expert witness in medical malpractice cases regarding Lyme disease, holding stock in Abbott, and receiving grant support to his institution from Bio-Rad, DiaSorin, Immunetics, and bioMerieux. No other potential conflict of interest relevant to this article was reported.	BERGER BW, 1992, J AM ACAD DERMATOL, V27, P34, DOI 10.1016/0190-9622(92)70152-6; Brisson D, 2006, AM J TROP MED HYG, V74, P615, DOI 10.4269/ajtmh.2006.74.615; Brisson D, 2004, GENETICS, V168, P713, DOI 10.1534/genetics.104.028738; Brisson D, 2010, EMERG INFECT DIS, V16, P911, DOI 10.3201/eid1606.090329; Crowder CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010650; Dandache P, 2008, INFECT DIS CLIN N AM, V22, P235, DOI 10.1016/j.idc.2007.12.012; Dykhuizen DE, 2008, AM J TROP MED HYG, V78, P806, DOI 10.4269/ajtmh.2008.78.806; Falco RC, 1999, AM J EPIDEMIOL, V149, P771, DOI 10.1093/oxfordjournals.aje.a009886; Golde WT, 1998, J CLIN MICROBIOL, V36, P1015, DOI 10.1128/JCM.36.4.1015-1019.1998; Guttman DS, 1996, J CLIN MICROBIOL, V34, P652, DOI 10.1128/JCM.34.3.652-656.1996; Hanincova K, 2008, APPL ENVIRON MICROB, V74, P5008, DOI 10.1128/AEM.00479-08; Jones KL, 2006, J CLIN MICROBIOL, V44, P4407, DOI 10.1128/JCM.01077-06; Krause PJ, 2006, AM J TROP MED HYG, V75, P1090, DOI 10.4269/ajtmh.2006.75.1090; Liveris D, 2002, J CLIN MICROBIOL, V40, P1249, DOI 10.1128/JCM.40.4.1249-1253.2002; Liveris D, 1999, J CLIN MICROBIOL, V37, P565, DOI 10.1128/JCM.37.3.565-569.1999; MALANE MS, 1991, ANN INTERN MED, V114, P490, DOI 10.7326/0003-4819-114-6-490; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; MELSKI JW, 1993, ARCH DERMATOL, V129, P709, DOI 10.1001/archderm.129.6.709; NADELMAN RB, 1993, AM J MED, V94, P583, DOI 10.1016/0002-9343(93)90208-7; Nadelman RB, 2008, CLIN INFECT DIS, V46, P950, DOI 10.1086/528872; Nadelman RB, 2007, CLIN INFECT DIS, V45, P1032, DOI 10.1086/521256; Nowakowski J, 1997, ANN INTERN MED, V127, P130, DOI 10.7326/0003-4819-127-2-199707150-00006; Nowakowski J, 2000, ARCH FAM MED, V9, P563, DOI 10.1001/archfami.9.6.563; Nowakowski J, 2003, AM J MED, V115, P91, DOI 10.1016/S0002-9343(03)00308-5; Nowakowski J, 2001, CLIN INFECT DIS, V33, P2023, DOI 10.1086/324490; Probert WS, 1997, J INFECT DIS, V175, P400, DOI 10.1093/infdis/175.2.400; Qiu WG, 2002, GENETICS, V160, P833; SCHWARTZ I, 1992, J CLIN MICROBIOL, V30, P3082, DOI 10.1128/JCM.30.12.3082-3088.1992; Seinost G, 1999, ARCH DERMATOL, V135, P1329, DOI 10.1001/archderm.135.11.1329; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; STEERE AC, 1983, ANN INTERN MED, V99, P76, DOI 10.7326/0003-4819-99-1-76; Vaz A, 2001, INFECT IMMUN, V69, P7437, DOI 10.1128/IAI.69.12.7437-7444.2001; Wang GQ, 1999, J CLIN MICROBIOL, V37, P3025, DOI 10.1128/JCM.37.9.3025-3028.1999; Wang IN, 1999, GENETICS, V151, P15; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 2009, CLIN MICROBIOL REV, V22, P387, DOI 10.1128/CMR.00004-09; Wormser GP, 1999, J INFECT DIS, V180, P720, DOI 10.1086/314922	38	63	64	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2012	367	20					1883	1890		10.1056/NEJMoa1114362	http://dx.doi.org/10.1056/NEJMoa1114362			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036MB	23150958	Green Accepted, Bronze			2022-12-28	WOS:000311029300004
J	Drucker, E				Drucker, Ernest			Drugs: the third rail of US politics	LANCET			English	Editorial Material									[Drucker, Ernest] Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Drucker, Ernest] CUNY, John Jay Coll Criminal Justice, New York, NY 10021 USA	Columbia University; City University of New York (CUNY) System	Drucker, E (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA.	emdrucker@earthlink.net						[Anonymous], 2010, BARS 2 SUBST AB AM P; Baker P., 2012, NY TIMES; Drucker E., 2011, PLAGUE PRISONS EPIDE; Drucker E, 2012, J PUBLIC HEALTH POL, V33, P309, DOI 10.1057/jphp.2012.16; Drug Policy Alliance, 2012, REF MAR LAWS; European Commission Eurostat, 1998, EU27 EUR COMM EUR; Guillermoprieto A., 2012, NEW YORK REV BOOKS; Kain E., 2012, FORBES; OECD, 2012, HLTH GLANC EUR 2010; Onishi N, 2012, NY TIMES; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; The Disaster Center, 2011, 2011 US CRIM RAT 196; Thoumi FE, 2005, J DRUG ISSUES, V35, P185, DOI 10.1177/002204260503500109; UN Office on Drugs and Crime, 2011, GLOB STUD HOM 2011; US Centers for Disease Control and Prevention, 2012, HOM RECR SAF UN POIS	15	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2012	380	9854					1626	1628		10.1016/S0140-6736(12)61889-3	http://dx.doi.org/10.1016/S0140-6736(12)61889-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	035MN	23138110				2022-12-28	WOS:000310951400006
J	Johns, C; Zuromskis, T				Johns, Christopher; Zuromskis, Tadas			The sound of silence	LANCET			English	Editorial Material									[Johns, Christopher; Zuromskis, Tadas] Scarborough Gen Hosp, Dept Neurol, Scarborough, N Yorkshire, England		Johns, C (corresponding author), No Gen Hosp, Dept Radiol, Herries Rd, Sheffield S5 7AU, S Yorkshire, England.	chrisjohns@doctors.org.uk		Johns, Christopher/0000-0003-3724-0430				de Morsier G, 1967, ANN MED-PSYCHOL, V128, P677; Griffiths TD, 2000, BRAIN, V123, P2065, DOI 10.1093/brain/123.10.2065; Jacob A, 2004, BMJ-BRIT MED J, V328, P1552, DOI 10.1136/bmj.328.7455.1552; Lagoudis A, 2011, Psychiatriki, V22, P68; Menon GJ, 2003, SURV OPHTHALMOL, V48, P58, DOI 10.1016/S0039-6257(02)00414-9	5	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2012	380	9854					1712	1712		10.1016/S0140-6736(12)61331-2	http://dx.doi.org/10.1016/S0140-6736(12)61331-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035MN	23141620				2022-12-28	WOS:000310951400034
J	Clowney, EJ; LeGros, MA; Mosley, CP; Clowney, FG; Markenskoff-Papadimitriou, EC; Myllys, M; Barnea, G; Larabell, CA; Lomvardas, S				Clowney, E. Josephine; LeGros, Mark A.; Mosley, Colleen P.; Clowney, Fiona G.; Markenskoff-Papadimitriou, Eirene C.; Myllys, Markko; Barnea, Gilad; Larabell, Carolyn A.; Lomvardas, Stavros			Nuclear Aggregation of Olfactory Receptor Genes Governs Their Monogenic Expression	CELL			English	Article							ORGANIZATION; CHROMATIN; CHOICE; MORPHOLOGY; PROMOTER; LAMINA; GENOME; MICE	Gene positioning and regulation of nuclear architecture are thought to influence gene expression. Here, we show that, in mouse olfactory neurons, silent olfactory receptor (OR) genes from different chromosomes converge in a small number of heterochromatic foci. These foci are OR exclusive and form in a cell-type-specific and differentiation-dependent manner. The aggregation of OR genes is developmentally synchronous with the downregulation of lamin b receptor (LBR) and can be reversed by ectopic expression of LBR in mature olfactory neurons. LBR-induced reorganization of nuclear architecture and disruption of OR aggregates perturbs the singularity of OR transcription and disrupts the targeting specificity of the olfactory neurons. Our observations propose spatial sequestering of heterochromatinized OR family members as a basis of monogenic and monoallelic gene expression.	[Clowney, E. Josephine; Lomvardas, Stavros] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94158 USA; [LeGros, Mark A.; Mosley, Colleen P.; Clowney, Fiona G.; Larabell, Carolyn A.; Lomvardas, Stavros] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Markenskoff-Papadimitriou, Eirene C.; Lomvardas, Stavros] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94158 USA; [LeGros, Mark A.; Larabell, Carolyn A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Myllys, Markko] Univ Jyvaskyla, Dept Phys, FI-40014 Jyvaskyla, Finland; [Barnea, Gilad] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Jyvaskyla; Brown University	Lomvardas, S (corresponding author), Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94158 USA.	stavros.lomvardas@ucsf.edu		Clowney, Eleanor/0000-0002-9150-9464; Lomvardas, Stavros/0000-0002-7668-3026	National Science Foundation (NSF GRFP); Roadmap for Epigenomics grant [5R01DA030320-02]; McKnight Endowment for Neurosciences; National Center for Research Resources [5P41RR019664-08]; National Institute of General Medical Sciences from the National Institutes of Health [8 P41 GM103445-08]; US Department of Energy, Office of Biological and Environmental Research [DE-AC02-05CH11231]; NIH [5R01MH086920]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR019664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030320] Funding Source: NIH RePORTER	National Science Foundation (NSF GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD)); Roadmap for Epigenomics grant; McKnight Endowment for Neurosciences; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank Dr. Nicholas Ryba for the G gamma 8 tTA transgenic mice; Drs. Monica Zwerger and Harald Herrmann for the anti-LBR antibody; David Lyons and Drs. Richard Axel, Keith Yamamoto, and David Agard for input and suggestions; and Dr. Nirao Shah and the Lomvardas lab for critical reading of the manuscript. Also, we are grateful to Dr. Allan Basbaum for making the Shidduch between S.L. and C.A.L. E.J.C. and E.C.M.-P. are supported by fellowships from the National Science Foundation (NSF GRFP). This project was funded by the Roadmap for Epigenomics grant 5R01DA030320-02 and the McKnight Endowment for Neurosciences. National Center for X-Ray Tomography is funded by grants from the National Center for Research Resources (5P41RR019664-08) and the National Institute of General Medical Sciences (8 P41 GM103445-08) from the National Institutes of Health and US Department of Energy, Office of Biological and Environmental Research (DE-AC02-05CH11231). G.B. is a Pew scholar and is supported, in part, by NIH grant 5R01MH086920.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clowney EJ, 2011, GENOME RES, V21, P1249, DOI 10.1101/gr.120162.110; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Eskiw CH, 2010, COLD SH Q B, V75, P501, DOI 10.1101/sqb.2010.75.046; Fleischmann A, 2008, NEURON, V60, P1068, DOI 10.1016/j.neuron.2008.10.046; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fuss SH, 2009, MOL CELL NEUROSCI, V41, P101, DOI 10.1016/j.mcn.2009.02.014; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; GOLDOWITZ D, 1982, DEV BIOL, V89, P261, DOI 10.1016/0012-1606(82)90313-X; Hoffmann K, 2002, NAT GENET, V31, P410, DOI 10.1038/ng925; Imai T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001776; Khan M, 2011, CELL, V147, P907, DOI 10.1016/j.cell.2011.09.049; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; McDermott G, 2009, TRENDS CELL BIOL, V19, P587, DOI 10.1016/j.tcb.2009.08.005; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Nguyen MQ, 2007, CELL, V131, P1009, DOI 10.1016/j.cell.2007.10.050; Okada Y, 2005, EMBO REP, V6, P452, DOI 10.1038/sj.embor.7400406; Olins AL, 2009, EUR J CELL BIOL, V88, P203, DOI 10.1016/j.ejcb.2008.10.001; Peric-Hupkes D, 2010, COLD SH Q B, V75, P517, DOI 10.1101/sqb.2010.75.014; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pyrpasopoulou A, 1996, EMBO J, V15, P7108, DOI 10.1002/j.1460-2075.1996.tb01102.x; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Uchida M, 2009, P NATL ACAD SCI USA, V106, P19375, DOI 10.1073/pnas.0906145106; ZACHARIAS H, 1995, GENETICS, V141, P7; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	35	220	222	0	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					724	737		10.1016/j.cell.2012.09.043	http://dx.doi.org/10.1016/j.cell.2012.09.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141535	Bronze, Green Accepted			2022-12-28	WOS:000310921200006
J	Cooke, J; Sullivan, M; Gal-Yam, A; Barton, EJ; Carlberg, RG; Ryan-Weber, EV; Horst, C; Omori, Y; Diaz, CG				Cooke, Jeff; Sullivan, Mark; Gal-Yam, Avishay; Barton, Elizabeth J.; Carlberg, Raymond G.; Ryan-Weber, Emma V.; Horst, Chuck; Omori, Yuuki; Diaz, C. Gonzalo			Superluminous supernovae at redshifts of 2.05 and 3.90	NATURE			English	Article							LYMAN-BREAK GALAXIES; POPULATION-III; IC SUPERNOVAE; DISCOVERY; EVOLUTION; EXPLOSIONS; STARS; GAS	A rare class of 'superluminous' supernovae that are about ten or more times more luminous at their peaks than other types of luminous supernova has recently been found at low to intermediate redshifts(1,2). A small subset of these events have luminosities that evolve slowly and result in radiated energies of up to about 10(51) ergs. Therefore, they are probably examples of 'pair-instability' or 'pulsational pair-instability' supernovae with estimated progenitor masses of 100 to 250 times that of the Sun(3-5). These events are exceedingly rare at low redshift, but are expected to be more common at high redshift because the mass distribution of the earliest stars was probably skewed to high values(6,7). Here we report the detection of two superluminous supernovae, at redshifts of 2.05 and 3.90, that have slowly evolving light curves. We estimate the rate of events at redshifts of 2 and 4 to be approximately ten times higher than the rate at low redshift. The extreme luminosities of superluminous supernovae extend the redshift limit for supernova detection using present technology, previously 2.36 (ref. 8), and provide a way of investigating the deaths of the first generation of stars to form after the Big Bang.	[Cooke, Jeff; Ryan-Weber, Emma V.; Diaz, C. Gonzalo] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; [Sullivan, Mark] Univ Oxford, Dept Phys, Oxford OX1 3RH, England; [Gal-Yam, Avishay] Weizmann Inst Sci, Benoziyo Ctr Astrophys, IL-76100 Rehovot, Israel; [Barton, Elizabeth J.] Univ Calif Irvine, Dept Phys & Astron, Ctr Cosmol, Irvine, CA 92697 USA; [Carlberg, Raymond G.] Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Horst, Chuck] San Diego State Univ, Dept Astron, San Diego, CA 92182 USA; [Omori, Yuuki] McGill Univ, Dept Phys, Montreal, PQ H2A 2T8, Canada	Swinburne University of Technology; University of Oxford; Weizmann Institute of Science; University of California System; University of California Irvine; University of Toronto; California State University System; San Diego State University; McGill University	Cooke, J (corresponding author), Swinburne Univ Technol, Ctr Astrophys & Supercomp, POB 218,H30, Hawthorn, Vic 3122, Australia.	jcooke@astro.swin.edu.au		Diaz, C. Gonzalo/0000-0001-5146-1358; Sullivan, Mark/0000-0001-9053-4820	ARC; NSERC; Royal Society; ISF; GIF; Minerva grants; ARCHES award; Lord Seiff of Brimpton Fund; ANSTO AMRFP; Commonwealth of Australia; W. M. Keck Foundation	ARC(Australian Research Council); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Royal Society(Royal Society of London); ISF(Israel Science Foundation); GIF(German-Israeli Foundation for Scientific Research and Development); Minerva grants; ARCHES award; Lord Seiff of Brimpton Fund; ANSTO AMRFP; Commonwealth of Australia(Australian Government); W. M. Keck Foundation(W.M. Keck Foundation)	We acknowledge support from ARC, NSERC and the Royal Society. A.G.-Y. acknowledges support from ISF, GIF, Minerva grants, an ARCHES award and the Lord Seiff of Brimpton Fund. This work was supported in part by a grant from the ANSTO AMRFP. The Access to Major Research Facilities Program is supported by the Commonwealth of Australia under the International Science Linkages program. The results presented here are based on observations obtained with MegaPrime/MegaCam, a joint project of the Canada-France-Hawaii Telescope (CFHT) and CEA-Irfu, at the CFHT, which is operated by the National Research Council (NRC) of Canada, the Institut National des Sciences de l'Univers of the Centre National de la Recherche Scientifique (CNRS) of France, and the University of Hawaii. This work is based in part on data products produced at TERAPIX and the Canadian Astronomy Data Centre as part of the CFHT Legacy Survey, a collaborative project of the NRC and CNRS. We used data products from the Canadian Astronomy Data Centre as part of the CFHT Legacy Survey. The spectroscopic data presented here were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California and the National Aeronautics and Space Administration. The observatory was made possible by the generous financial support of the W. M. Keck Foundation. The CFHT and the W. M. Keck Observatory are located near the summit of Mauna Kea, Hawaii.	Barbary K, 2009, ASTROPHYS J, V690, P1358, DOI 10.1088/0004-637X/690/2/1358; BARKAT Z, 1967, PHYS REV LETT, V18, P379, DOI 10.1103/PhysRevLett.18.379; Bromm V, 1999, ASTROPHYS J, V527, pL5, DOI 10.1086/312385; Chomiuk L, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/114; Cooke J, 2008, ASTROPHYS J, V677, P137, DOI 10.1086/526490; Cooke J, 2009, NATURE, V460, P237, DOI 10.1038/nature08082; Fukugita M, 1996, ASTRON J, V111, P1748, DOI 10.1086/117915; Fumagalli M, 2011, SCIENCE, V334, P1245, DOI 10.1126/science.1213581; Gal-Yam A, 2009, NATURE, V462, P624, DOI 10.1038/nature08579; Gal-Yam A, 2012, SCIENCE, V337, P927, DOI 10.1126/science.1203601; Gezari S, 2009, ASTROPHYS J, V690, P1313, DOI 10.1088/0004-637X/690/2/1313; Heger A, 2002, ASTROPHYS J, V567, P532, DOI 10.1086/338487; Kann DA, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/2/96; Kasen D, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/2/102; Larson RB, 1998, MON NOT R ASTRON SOC, V301, P569, DOI 10.1046/j.1365-8711.1998.02045.x; OKE JB, 1974, ASTROPHYS J SUPPL S, V27, P21, DOI 10.1086/190287; Pastorello A, 2010, ASTROPHYS J LETT, V724, pL16, DOI 10.1088/2041-8205/724/1/L16; Quimby RM, 2011, NATURE, V474, P487, DOI 10.1038/nature10095; RAKAVY G, 1967, ASTROPHYS J, V148, P803, DOI 10.1086/149204; Scannapieco E, 2005, ASTROPHYS J, V633, P1031, DOI 10.1086/444450; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Smith N, 2007, ASTROPHYS J, V666, P1116, DOI 10.1086/519949; Smith N, 2010, ASTROPHYS J, V709, P856, DOI 10.1088/0004-637X/709/2/856; Steidel CC, 1999, ASTROPHYS J, V519, P1, DOI 10.1086/307363; Steidel CC, 2003, ASTROPHYS J, V592, P728, DOI 10.1086/375772; Steidel CC, 2004, ASTROPHYS J, V604, P534, DOI 10.1086/381960; Tornatore L, 2007, MON NOT R ASTRON SOC, V382, P945, DOI 10.1111/j.1365-2966.2007.12215.x; Trenti M, 2009, ASTROPHYS J, V700, P1672, DOI 10.1088/0004-637X/700/2/1672; Young DR, 2010, ASTRON ASTROPHYS, V512, DOI 10.1051/0004-6361/200913004	29	130	130	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					228	231		10.1038/nature11521	http://dx.doi.org/10.1038/nature11521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23123848	Green Submitted, Green Accepted			2022-12-28	WOS:000310774300038
J	Gotzsche, PC; Ioannidis, JPA				Gotzsche, Peter C.; Ioannidis, John P. A.			Content area experts as authors: helpful or harmful for systematic reviews and meta-analyses?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; TRIALS; RECOMMENDATIONS; ASSOCIATION		[Gotzsche, Peter C.] Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA	Rigshospitalet; University of Copenhagen; Stanford University	Gotzsche, PC (corresponding author), Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark.	pcg@cochrane.dk	Ioannidis, John P. A./G-9836-2011					Agency for Health Research and Policy Evidence-Practice Centers, REP DEV; ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; Bjelakovic G, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007176.pub2, 10.1590/1516-3180.20151332T1]; Bryson B., 2003, SHORT HIST NEARLY EV; Eddy DM, 1992, METAANALYSIS CONFIDE, V3; Fowler FJ, 2000, JAMA-J AM MED ASSOC, V283, P3217, DOI 10.1001/jama.283.24.3217; Fugh-Berman A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000425; Fugh-Berman AJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000335; Gotzsche PC, 2012, MAMMOGRAPHY SCREENIN; Gotzsche PC, 2010, COCHRANE DB SYST REV, V7; Gotzsche PC, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-249; Hammarquist C, 1998, COCHRANE DB SYST REV, V3; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Ioannidis JPA, 2001, ANN INTERN MED, V135, P782, DOI 10.7326/0003-4819-135-9-200111060-00008; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; Krogsboll LT, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009009.pub2; *NAT I HLTH CLIN E, 2009, NICE CLIN GUID DEV O; OXMAN AD, 1993, ANN NY ACAD SCI, V703, P125, DOI 10.1111/j.1749-6632.1993.tb26342.x; Panagiotou OA, 2012, J CLIN EPIDEMIOL, V65, P740, DOI 10.1016/j.jclinepi.2012.01.008; Siontis GCM, 2009, AM HEART J, V157, P695, DOI 10.1016/j.ahj.2008.11.023; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Tatsioni A, 2010, J GEN INTERN MED, V25, P914, DOI 10.1007/s11606-010-1360-7; U.S. Institute of Medicine National Academy of Sciences, 2011, FIND WHAT WORKS HLTH; Wang AT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1344; Yank V, 2007, BMJ-BRIT MED J, V335, P1202, DOI 10.1136/bmj.39376.447211.BE	27	43	44	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2012	345								e7031	10.1136/bmj.e7031	http://dx.doi.org/10.1136/bmj.e7031			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033FG	23118303				2022-12-28	WOS:000310779000003
J	Geoerger, B; Blockus, H				Geoerger, Birgit; Blockus, Heike			Everolimus for astrocytomas in tuberous sclerosis complex	LANCET			English	Editorial Material							MAMMALIAN TARGET; THERAPY		[Geoerger, Birgit] Inst Gustave Roussy, CNRS, UMR8203, F-94805 Villejuif, France; [Blockus, Heike] INSERM, U968, Inst Vis, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Geoerger, B (corresponding author), Inst Gustave Roussy, CNRS, UMR8203, Rue Camille Desmoulins, F-94805 Villejuif, France.	geoerger@igr.fr		Blockus, Heike/0000-0001-5274-2805				Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Carew JS, 2011, TARGET ONCOL, V6, P17, DOI 10.1007/s11523-011-0167-8; Dabora SL, 2001, AM J HUM GENET, V68, P64, DOI 10.1086/316951; Das F, 2012, J BIOL CHEM, V287, P3808, DOI 10.1074/jbc.M111.246397; Davies DM, 2008, NEW ENGL J MED, V358, P200, DOI 10.1056/NEJMc072500; Ehninger D, 2012, NEUROPHARMACOLOGY; Franz D.N., 2012, LANCET; Franz DN, 2006, ANN NEUROL, V59, P490, DOI 10.1002/ana.20784; Haidinger M, 2011, TRANSPLANT REV-ORLAN, V25, P145, DOI 10.1016/j.trre.2010.11.001; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Leung Alexander K C, 2007, J Pediatr Health Care, V21, P108, DOI 10.1016/j.pedhc.2006.05.004; Moavero R, 2011, CHILD NERV SYST, V27, P1203, DOI 10.1007/s00381-011-1406-0; Tischmeyer W, 2003, EUR J NEUROSCI, V18, P942, DOI 10.1046/j.1460-9568.2003.02820.x; Turner SG, 2011, EXPERT OPIN PHARMACO, V12, P2265, DOI 10.1517/14656566.2011.601742; van Eeghen AM, 2012, EUR J HUM GENET, V20, P510, DOI 10.1038/ejhg.2011.241	15	2	2	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 12	2013	381	9861					95	96		10.1016/S0140-6736(12)61221-5	http://dx.doi.org/10.1016/S0140-6736(12)61221-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069FO	23158521				2022-12-28	WOS:000313420900006
J	Dong, CH; Fiore, V; Kuzyk, MC; Wang, HL				Dong, Chunhua; Fiore, Victor; Kuzyk, Mark C.; Wang, Hailin			Optomechanical Dark Mode	SCIENCE			English	Article							QUANTUM GROUND-STATE; CAVITY OPTOMECHANICS; MECHANICAL RESONATOR; INDUCED TRANSPARENCY; SIDE-BAND; SPIN; OSCILLATOR; MOTION; QUBIT; FIELD	Thermal mechanical motion hinders the use of a mechanical system in applications such as quantum information processing. Whereas the thermal motion can be overcome by cooling a mechanical oscillator to its motional ground state, an alternative approach is to exploit the use of a mechanically dark mode that can protect the system from mechanical dissipation. We have realized such a dark mode by coupling two optical modes in a silica resonator to one of its mechanical breathing modes in the regime of weak optomechanical coupling. The dark mode, which is a superposition of the two optical modes and is decoupled from the mechanical oscillator, can still mediate an effective optomechanical coupling between the two optical modes. We show that the formation of the dark mode enables the transfer of optical fields between the two optical modes. Optomechanical dark mode opens the possibility of using mechanically mediated coupling in quantum applications without cooling the mechanical oscillator to its motional ground state.	[Wang, Hailin] Univ Oregon, Dept Phys, Eugene, OR 97403 USA; Univ Oregon, Oregon Ctr Opt, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Wang, HL (corresponding author), Univ Oregon, Dept Phys, Eugene, OR 97403 USA.	hailin@uoregon.edu	Dong, Chunhua/G-1883-2010; Wang, Hailin/A-2362-2011		Defense Advanced Research Projects Agency ORCHID (Optical Radiation Cooling and Heating in Integrated Devices) program; Air Force Office for Scientific Research; NSF	Defense Advanced Research Projects Agency ORCHID (Optical Radiation Cooling and Heating in Integrated Devices) program; Air Force Office for Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF))	This work is supported by the Defense Advanced Research Projects Agency ORCHID (Optical Radiation Cooling and Heating in Integrated Devices) program through a grant from Air Force Office for Scientific Research and by NSF.	Anetsberger G, 2009, NAT PHYS, V5, P909, DOI 10.1038/NPHYS1425; Arimondo E, 1996, PROG OPTICS, V35, P257, DOI 10.1016/S0079-6638(08)70531-6; Aspelmeyer M, 2012, PHYS TODAY, V65, P29, DOI 10.1063/PT.3.1640; Chan J, 2011, NATURE, V478, P89, DOI 10.1038/nature10461; Chang DE, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/023003; Fiore V, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.133601; Groblacher S, 2009, NATURE, V460, P724, DOI 10.1038/nature08171; Hill JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2201; Kippenberg TJ, 2008, SCIENCE, V321, P1172, DOI 10.1126/science.1156032; Kolkowitz S, 2012, SCIENCE, V335, P1603, DOI 10.1126/science.1216821; Lukin MD, 2003, REV MOD PHYS, V75, P457, DOI 10.1103/RevModPhys.75.457; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Park YS, 2009, NAT PHYS, V5, P489, DOI 10.1038/NPHYS1303; Rabl P, 2010, NAT PHYS, V6, P602, DOI 10.1038/NPHYS1679; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Safavi-Naeini AH, 2011, NATURE, V472, P69, DOI 10.1038/nature09933; Safavi-Naeini AH, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/013017; Santori C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.247401; Stannigel K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.220501; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Teufel JD, 2011, NATURE, V471, P204, DOI 10.1038/nature09898; Thompson JD, 2008, NATURE, V452, P72, DOI 10.1038/nature06715; Tian L, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.053806; Tian L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.153604; Togan E, 2011, NATURE, V478, P497, DOI 10.1038/nature10528; Treutlein P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.140403; Verhagen E, 2012, NATURE, V482, P63, DOI 10.1038/nature10787; Wang YD, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/10/105010; Wang YD, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.153603; Weis S, 2010, SCIENCE, V330, P1520, DOI 10.1126/science.1195596; Xu XD, 2008, NAT PHYS, V4, P692, DOI 10.1038/nphys1054	32	310	316	4	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1609	1613		10.1126/science.1228370	http://dx.doi.org/10.1126/science.1228370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23160956				2022-12-28	WOS:000312533100050
J	Gil-Moreno, A; Perez-Benavente, A				Gil-Moreno, Antonio; Perez-Benavente, Assumpcio			Anaphylaxis Associated with Blue Dye	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gil-Moreno, Antonio; Perez-Benavente, Assumpcio] Hosp Valle De Hebron, Barcelona, Spain	Hospital Universitari Vall d'Hebron	Gil-Moreno, A (corresponding author), Hosp Valle De Hebron, Barcelona, Spain.		BENAVENTE, ASUNCION PEREZ/C-5116-2014; Gil-Moreno, Antonio/C-1122-2016; PEREZ BENAVENTE, ASUNCION/J-8272-2016	Gil-Moreno, Antonio/0000-0003-1106-5590; PEREZ BENAVENTE, ASUNCION/0000-0003-1872-9003					0	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2012	367	21					2026	2026		10.1056/NEJMicm1112719	http://dx.doi.org/10.1056/NEJMicm1112719			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040RI	23171099				2022-12-28	WOS:000311340200010
J	Gilliam, JC; Chang, JT; Sandoval, IM; Zhang, YW; Li, TS; Pittler, SJ; Chiu, W; Wensel, TG				Gilliam, Jared C.; Chang, Juan T.; Sandoval, Ivette M.; Zhang, Youwen; Li, Tiansen; Pittler, Steven J.; Chiu, Wah; Wensel, Theodore G.			Three-Dimensional Architecture of the Rod Sensory Cilium and Its Disruption in Retinal Neurodegeneration	CELL			English	Article							INTRAFLAGELLAR TRANSPORT PROTEIN; BARDET-BIEDL-SYNDROME; CGMP-GATED CHANNEL; ACID-RICH PROTEINS; CRYOELECTRON TOMOGRAPHY; CILIARY ROOTLET; BETA-SUBUNIT; BASAL BODY; DISK MORPHOGENESIS; OUTER SEGMENTS	Defects in primary cilia lead to devastating disease because of their roles in sensation and developmental signaling but much is unknown about ciliary structure and mechanisms of their formation and maintenance. We used cryo-electron tomography to obtain 3D maps of the connecting cilium and adjacent cellular structures of a modified primary cilium, the rod outer segment, from wild-type and genetically defective mice. The results reveal the molecular architecture of the cilium and provide insights into protein functions. They suggest that the ciliary rootlet is involved in cellular transport and stabilizes the axoneme. A defect in the BBSome membrane coat caused defects in vesicle targeting near the base of the cilium. Loss of the proteins encoded by the Cngb1 gene disrupted links between the disk and plasma membranes. The structures of the outer segment membranes support a model for disk morphogenesis in which basal disks are enveloped by the plasma membrane.	[Gilliam, Jared C.; Chang, Juan T.; Sandoval, Ivette M.; Chiu, Wah; Wensel, Theodore G.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Chang, Juan T.; Chiu, Wah] Baylor Coll Med, Natl Ctr Macromol Imaging, Houston, TX 77030 USA; [Zhang, Youwen; Pittler, Steven J.] Univ Alabama Birmingham, Dept Vis Sci, Birmingham, AL 35924 USA; [Li, Tiansen] NEI, Neurobiol Neurodegenerat & Repair Lab, Bethesda, MD 20892 USA	Baylor College of Medicine; Baylor College of Medicine; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Wensel, TG (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	twensel@bcm.edu	Pittler, Steven/J-7091-2013	Pittler, Steven/0000-0002-8464-9303; Wensel, Theodore/0000-0003-3518-9352	NIH [EY011900, EY07981, P41RR002250, EY018143, EY10309, EY10581, EY011731, T32EY007001, EY002520]; Robert Welch Foundation [Q-0035, Q1242]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009, P41RR002250] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007001, R01EY010309, P30EY003039, R01EY011731, P30EY002520, R29EY010581, R01EY007981, R01EY018143, R01EY010581, ZIAEY000490, R01EY011900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103832, R25GM056929] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Welch Foundation(The Welch Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the NIH (EY011900 and EY07981 to T.G.W., P41RR002250 to W. C., EY018143 to S.J.P., EY10309 and EY10581 to T.L., support for I.M.S. by EY011731, an NIH NRSA trainee appointment on grant T32EY007001 to J.C.G., and Vision Research Core Grant EY002520) and by the Robert Welch Foundation (Q-0035 to T.G.W. and Q1242 to W.C.). We thank Mr. Ralph Nichols for help with electron microscopy of fixed samples, Dr. Vera Moiseenkova-Bell for help in the early stages of the project, and Dr. Alecia Gross for helpful suggestions and pilot experiments.	Abd-El-Barr MM, 2007, VISION RES, V47, P3394, DOI 10.1016/j.visres.2007.09.016; Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams NA, 2007, OPHTHALMIC GENET, V28, P113, DOI 10.1080/13816810701537424; ANDERSON RG, 1972, J CELL BIOL, V54, P246, DOI 10.1083/jcb.54.2.246; Ardell MD, 2000, GENE, V245, P311, DOI 10.1016/S0378-1119(00)00023-8; Batra-Safferling R, 2006, J BIOL CHEM, V281, P1449, DOI 10.1074/jbc.M505012200; Calvert PD, 2010, J GEN PHYSIOL, V135, P173, DOI 10.1085/jgp.200910322; Chaitin M H, 1989, Prog Clin Biol Res, V314, P265; CHAITIN MH, 1984, J CELL BIOL, V99, P239, DOI 10.1083/jcb.99.1.239; CHAITIN MH, 1986, INVEST OPHTH VIS SCI, V27, P1764; CHAITIN MH, 1992, EXP EYE RES, V54, P261, DOI 10.1016/S0014-4835(05)80216-7; Chuang JZ, 2007, CELL, V130, P535, DOI 10.1016/j.cell.2007.06.030; Clarke R.D., 1946, J I ACTUARIES, V72, P481, DOI [DOI 10.1017/S0020268100035435, 10.1017/S0020268100035435]; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; DELPRIORE LV, 1987, INVEST OPHTH VIS SCI, V28, P633; Eichers ER, 2006, HUM GENET, V120, P211, DOI 10.1007/s00439-006-0197-y; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Jin H, 2009, CURR BIOL, V19, pR472, DOI 10.1016/j.cub.2009.04.015; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kobayashi T, 2011, J CELL BIOL, V193, P435, DOI 10.1083/jcb.201101005; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; Koyfman AY, 2011, P NATL ACAD SCI USA, V108, P11105, DOI 10.1073/pnas.1103634108; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Maerker T, 2008, HUM MOL GENET, V17, P71, DOI 10.1093/hmg/ddm285; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mayer U, 2009, PROTEOMICS, V9, P322, DOI 10.1002/pmic.200800149; Moser JJ, 2010, SEMIN CELL DEV BIOL, V21, P148, DOI 10.1016/j.semcdb.2009.06.006; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Nicastro D, 2005, P NATL ACAD SCI USA, V102, P15889, DOI 10.1073/pnas.0508274102; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; Novarino G, 2011, CELL, V147, P70, DOI 10.1016/j.cell.2011.09.014; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Ozanics V., 1982, OCULAR ANATOMY EMBRY, P462; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Poetsch A, 2001, J BIOL CHEM, V276, P48009, DOI 10.1074/jbc.M108941200; RENTHAL R, 1973, EXP EYE RES, V17, P511, DOI 10.1016/0014-4835(73)90081-X; Sedmak T, 2010, J CELL BIOL, V189, P171, DOI 10.1083/jcb.200911095; SPIRA AW, 1979, AM J ANAT, V155, P319, DOI 10.1002/aja.1001550304; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; Swiderski RE, 2007, INVEST OPHTH VIS SCI, V48, P3329, DOI 10.1167/iovs.06-1477; Yahav T, 2011, CURR OPIN STRUC BIOL, V21, P670, DOI 10.1016/j.sbi.2011.07.004; Yang J, 2005, MOL CELL BIOL, V25, P4129, DOI 10.1128/MCB.25.10.4129-4137.2005; Yang J, 2002, J CELL BIOL, V159, P431, DOI 10.1083/jcb.200207153; Yang J, 2005, EXP CELL RES, V309, P379, DOI 10.1016/j.yexcr.2005.05.026; Yang J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000955; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041; Zhang Y, 2009, J CELL SCI, V122, P1192, DOI 10.1242/jcs.042531	53	106	110	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					1029	1041		10.1016/j.cell.2012.10.038	http://dx.doi.org/10.1016/j.cell.2012.10.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178122	Bronze, Green Accepted			2022-12-28	WOS:000311423500016
J	Gitlin, LN; Kales, HC; Lyketsos, CG				Gitlin, Laura N.; Kales, Helen C.; Lyketsos, Constantine G.			Nonpharmacologic Management of Behavioral Symptoms in Dementia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NURSING-HOME PLACEMENT; QUALITY-OF-LIFE; NEUROPSYCHIATRIC-SYMPTOMS; PSYCHOLOGICAL SYMPTOMS; ALZHEIMERS-DISEASE; OLDER-ADULTS; CAREGIVER BURDEN; RANDOMIZED-TRIAL; PRIMARY-CARE; INTERVENTIONS	Behavioral symptoms such as repetitive speech, wandering, and sleep disturbances are a core clinical feature of Alzheimer disease and related dementias. If untreated, these behaviors can accelerate disease progression, worsen functional decline and quality of life, cause significant care giver distress, and result in earlier nursing home placement. Systematic screening for behavioral symptoms in dementia is an important prevention strategy that facilitates early treatment of behavioral symptoms by identifying underlying causes and tailoring a treatment plan. First-line nonpharmacologic treatments are recommended because available pharmacologic treatments are only modestly effective, have notable risks, and do not effectively treat some of the behaviors that family members and caregivers find most distressing. Examples of nonpharmacologic treatments include provision of caregiver education and support, training in problem solving, and targeted therapy directed at the underlying causes for specific behaviors (eg, implementing nighttime routines to address sleep disturbances). Based on an actual case, we characterize common behavioral symptoms and describe a strategy for selecting evidence-based nonpharmacologic dementia treatments. Nonpharmacologic management of behavioral symptoms in dementia can significantly improve quality of life and patient-caregiver satisfaction. JAMA. 2012;308(19):2020-2029 www.jama.com	Johns Hopkins Univ, Sch Nursing, Dept Community Publ Hlth, Dept Psychiat, Baltimore, MD 21205 USA; [Gitlin, Laura N.] Johns Hopkins Univ, Sch Med, Div Geriatr & Gerontol, Baltimore, MD 21205 USA; [Gitlin, Laura N.] Johns Hopkins Univ, Ctr Innovat Care Aging, Baltimore, MD 21205 USA; [Kales, Helen C.] Univ Michigan, Dept Psychiat, Sect Geriatr Psychiat, Ann Arbor, MI 48109 USA; [Kales, Helen C.] Univ Michigan, Program Posit Aging, Ann Arbor, MI 48109 USA; [Kales, Helen C.] VA Ann Arbor Healthcare Syst, VA Ctr Clin Management Res, Ann Arbor, MI USA; [Kales, Helen C.] VA Ann Arbor Healthcare Syst, Geriatr Res Educ & Clin Ctr, Ann Arbor, MI USA; [Lyketsos, Constantine G.] Johns Hopkins Bayview Med Ctr, Dept Psychiat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Johns Hopkins University; Johns Hopkins Medicine	Gitlin, LN (corresponding author), Johns Hopkins Univ, Sch Nursing, Dept Community Publ Hlth, Dept Psychiat, 525 Wolfe St,Ste 316, Baltimore, MD 21205 USA.	lgitlin1@jhu.edu			National Institute of Mental Health (NIMH); National Institute on Aging (NIA); Associated Jewish Federation of Baltimore; Weinberg Foundation; Forest; GlaxoSmithKline; Eisai; Pfizer; AstraZeneca; Lilly; Ortho-McNeil; Bristol-Myers; Novartis; National Football League (NFL); Elan; Functional Neuromodulation Inc; NIA [1R01AG041781-01A]; National Institute on Nursing [RO1 AG22254]; Pennsylvania Department of Health Tobacco Settlement [SAP 100027298]; NIMH [R21 MH069425]; Alzheimer's Association [NPSASA-10-174265]; Johns Hopkins Alzheimer's Disease Research Center [P50-AG005146]; SCAN Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH069425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146, R01AG041781, R01AG022254] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Associated Jewish Federation of Baltimore; Weinberg Foundation; Forest; GlaxoSmithKline(GlaxoSmithKline); Eisai(Eisai Co Ltd); Pfizer(Pfizer); AstraZeneca(AstraZeneca); Lilly(Eli Lilly); Ortho-McNeil; Bristol-Myers(Bristol-Myers Squibb); Novartis(Novartis); National Football League (NFL); Elan; Functional Neuromodulation Inc; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Nursing; Pennsylvania Department of Health Tobacco Settlement; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Alzheimer's Association(Alzheimer's Association); Johns Hopkins Alzheimer's Disease Research Center; SCAN Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Gitlin reports serving as a member on the Fall Advisory Committee for Phillips Lifeline. Dr Lyketsos reports receipt of grant support (research or CME) from the National Institute of Mental Health (NIMH), the National Institute on Aging (NIA), Associated Jewish Federation of Baltimore, Weinberg Foundation, Forest, GlaxoSmithKline, Eisai, Pfizer, AstraZeneca, Lilly, Ortho-McNeil, Bristol-Myers, Novartis, the National Football League (NFL), Elan, and Functional Neuromodulation Inc; serving as consultant/advisor for AstraZeneca, GlaxoSmithKline, Eisai, Novartis, Forest, Supernus, Adlyfe, Takeda, Wyeth, Lundbeck, Merz, Lilly, Pfizer, Genentech, Elan, NFL Players Association, NFL Benefits Office, Avanir, Zinfandel; and receipt of an honorarium or travel support from Pfizer, Forest, GlaxoSmithKline, and Health Monitor. Dr Kales reports no disclosures.; Dr Gitlin has been supported for research reported in this article, in part, by funds from the NIA and the National Institute on Nursing (research grant RO1 AG22254), the NIA (research grant 1R01AG041781-01A), the Pennsylvania Department of Health Tobacco Settlement (SAP 100027298), NIMH (grant R21 MH069425), and the Alzheimer's Association (grant NPSASA-10-174265). Dr Lyketsos was supported by the Johns Hopkins Alzheimer's Disease Research Center (P50-AG005146). The Care of the Aging Patient series is made possible by funding from The SCAN Foundation.	Aalten P, 2005, INT J GERIATR PSYCH, V20, P531, DOI 10.1002/gps.1317; Aalten P, 2005, INT J GERIATR PSYCH, V20, P523, DOI 10.1002/gps.1316; Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; American Academy of Neurology, 2001, DET DIAGN MAN DEM; APA Work Group on Alzheimer's Disease and other Dementias, 2007, Am J Psychiatry, V164, P5; Ballard C, 2009, LANCET NEUROL, V8, P151, DOI 10.1016/S1474-4422(08)70295-3; Beeri MS, 2002, INT J GERIATR PSYCH, V17, P403, DOI 10.1002/gps.490; Belle SH, 2006, ANN INTERN MED, V145, P727, DOI 10.7326/0003-4819-145-10-200611210-00005; Brodaty H, 2012, AM J PSYCHIAT, V169, P946, DOI 10.1176/appi.ajp.2012.11101529; Burns A, 2000, INT PSYCHOGERIATR, V12; Burns A, 2011, DEMENT GERIATR COGN, V31, P158, DOI 10.1159/000324438; Burns R, 2003, GERONTOLOGIST, V43, P547, DOI 10.1093/geront/43.4.547; California Department of Public Health, 2008, CAL WORKGR GUID ALZH; Callahan CM, 2012, J AM GERIATR SOC, V60, P813, DOI 10.1111/j.1532-5415.2012.03905.x; Callahan CM, 2006, JAMA-J AM MED ASSOC, V295, P2148, DOI 10.1001/jama.295.18.2148; Chan DC, 2003, J GERONTOL A-BIOL, V58, P548; Chodosh J, 2007, J AM GERIATR SOC, V55, P1260, DOI 10.1111/j.1532-5415.2007.01249.x; Cohen-Mansfield J, 2001, AM J GERIAT PSYCHIAT, V9, P361, DOI 10.1176/appi.ajgp.9.4.361; Colena CCI, 1995, BEHAV COMPLICATIONS, P3; Cooke ML, 2010, AGING MENT HEALTH, V14, P905, DOI 10.1080/13607861003713190; Czaja SJ, 2009, J AM GERIATR SOC, V57, P1064, DOI 10.1111/j.1532-5415.2009.02260.x; de Medeiros K, 2010, INT PSYCHOGERIATR, V22, P984, DOI 10.1017/S1041610210000876; de Vugt ME, 2004, INT J GERIATR PSYCH, V19, P85, DOI 10.1002/gps.1044; Eustace A, 2002, INT J GERIATR PSYCH, V17, P968, DOI 10.1002/gps.736; Gaugler JE, 2003, INT PSYCHOGERIATR, V15, P37, DOI 10.1017/S1041610203008743; Gilley DW, 2004, PSYCHOL MED, V34, P1129, DOI 10.1017/S0033291703001831; Gitlin LN, 2008, AM J GERIAT PSYCHIAT, V16, P229, DOI 10.1097/JGP.0b013e318160da72; Gitlin LN, 2006, GERONTOLOGIST, V46, P630, DOI 10.1093/geront/46.5.630; Gitlin LN, 2010, JAMA-J AM MED ASSOC, V304, P983, DOI 10.1001/jama.2010.1253; Gitlin LN, 2010, J AM GERIATR SOC, V58, P1465, DOI 10.1111/j.1532-5415.2010.02971.x; Gitlin LN, 2001, GERONTOLOGIST, V41, P4, DOI 10.1093/geront/41.1.4; Gitlin LN, 2003, PSYCHOL AGING, V18, P361, DOI 10.1037/0882-7974.18.3.361; Gitlin LN, 2003, GERONTOLOGIST, V43, P532, DOI 10.1093/geront/43.4.532; Gitlin LN, 2002, DISABIL REHABIL, V24, P59, DOI 10.1080/09638280110066325; Graff MJL, 2008, BMJ-BRIT MED J, V336, P134, DOI 10.1136/bmj.39408.481898.BE; Hodgson N., 2010, ALZ DIS ASSOC DIS, V24, P603; Holtzer R, 2003, J AM GERIATR SOC, V51, P953, DOI 10.1046/j.1365-2389.2003.51308.x; Kales HC, 2005, AM J GERIAT PSYCHIAT, V13, P441, DOI 10.1176/appi.ajgp.13.6.441; Kales HC, 2007, AM J PSYCHIAT, V164, P1568, DOI 10.1176/appi.ajp.2007.06101710; Kales HC, 2011, ARCH GEN PSYCHIAT, V68, P190, DOI 10.1001/archgenpsychiatry.2010.200; Karttunen K, 2011, INT J GERIATR PSYCH, V26, P473, DOI 10.1002/gps.2550; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/appi.neuropsych.12.2.233; Kunik ME, 2010, J CLIN PSYCHIAT, V71, P1145, DOI 10.4088/JCP.08m04703oli; Kverno KS, 2009, INT PSYCHOGERIATR, V21, P825, DOI 10.1017/S1041610209990196; Lyketsos CG, 2001, INT J GERIATR PSYCH, V16, P1043, DOI 10.1002/gps.448; Lyketsos CG, 2007, INT PSYCHOGERIATR, V19, P409, DOI 10.1017/S104161020700484X; Lyketsos Constantine G, 2011, Alzheimers Dement, V7, P532, DOI 10.1016/j.jalz.2011.05.2410; Lyketsos CG, 2006, AM J GERIAT PSYCHIAT, V14, P561, DOI 10.1097/01.JGP.0000221334.65330.55; Magai C, 1995, BEHAV COMPLICATIONS, P223; Marra C, 2007, DEMENT GERIATR COGN, V24, P317, DOI 10.1159/000108115; Mittelman MS, 2006, NEUROLOGY, V67, P1592, DOI 10.1212/01.wnl.0000242727.81172.91; Murman DL, 2002, NEUROLOGY, V59, P1721, DOI 10.1212/01.WNL.0000036904.73393.E4; National Collaborating Centre for Mental Health; Social Care Institute for Excellence, 2011, NICE SCIE SUPP CAR P; Nguyen VT, 2008, GERIATRICS-US, V63, P21; Norton MC, 2009, J GERONTOL B-PSYCHOL, V64, P560, DOI 10.1093/geronb/gbp052; Nyatsanza S, 2003, J NEUROL NEUROSUR PS, V74, P1398, DOI 10.1136/jnnp.74.10.1398; O'Neil M. E., 2011, NONPHARMACOLOGICAL I; Okura T, 2011, J AM GERIATR SOC, V59, P473, DOI 10.1111/j.1532-5415.2011.03314.x; Okura T, 2011, ALZ DIS ASSOC DIS, V25, P116, DOI 10.1097/WAD.0b013e318203f208; Okura T, 2010, J AM GERIATR SOC, V58, P330, DOI 10.1111/j.1532-5415.2009.02680.x; Physician Consortium for Performance Improvement, PERF MEAS SET; Reuben D, 2009, ALZHEIMERS DEMENT, V5, P498, DOI 10.1016/j.jalz.2009.01.024; Ryu SH, 2005, AM J GERIAT PSYCHIAT, V13, P976, DOI 10.1176/appi.ajgp.13.11.976; Salzman C, 2008, J CLIN PSYCHIAT, V69, P889, DOI 10.4088/JCP.v69n0602; Schneider LS, 2006, NEW ENGL J MED, V355, P1525, DOI 10.1056/NEJMoa061240; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; SCHULZ R, 1995, GERONTOLOGIST, V35, P771, DOI 10.1093/geront/35.6.771; Sink KM, 2005, JAMA-J AM MED ASSOC, V293, P596, DOI 10.1001/jama.293.5.596; Sloane PD, 2004, J AM GERIATR SOC, V52, P1795, DOI 10.1111/j.1532-5415.2004.52501.x; Spalletta G, 2010, AM J GERIAT PSYCHIAT, V18, P1026, DOI 10.1097/JGP.0b013e3181d6b68d; Spillman BC, 2009, INQUIRY-J HEALTH CAR, V46, P140, DOI 10.5034/inquiryjrnl_46.02.140; Staekenborg SS, 2010, J NEUROL NEUROSUR PS, V81, P547, DOI 10.1136/jnnp.2009.187500; Steinberg M, 2008, INT J GERIATR PSYCH, V23, P170, DOI 10.1002/gps.1858; Teri L, 2000, NEUROLOGY, V55, P1271, DOI 10.1212/WNL.55.9.1271; Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015; Van Den Wijngaart MAG, 2007, AGING MENT HEALTH, V11, P626, DOI 10.1080/13607860701368463; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR	77	253	261	2	75	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2012	308	19					2020	2029		10.1001/jama.2012.36918	http://dx.doi.org/10.1001/jama.2012.36918			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040AQ	23168825	Green Accepted			2022-12-28	WOS:000311291400026
J	Mehta, S; Burry, L; Cook, D; Fergusson, D; Steinberg, M; Granton, J; Herridge, M; Ferguson, N; Devlin, J; Tanios, M; Dodek, P; Fowler, R; Burns, K; Jacka, M; Olafson, K; Skrobik, Y; Hebert, P; Sabri, E; Meade, M				Mehta, Sangeeta; Burry, Lisa; Cook, Deborah; Fergusson, Dean; Steinberg, Marilyn; Granton, John; Herridge, Margaret; Ferguson, Niall; Devlin, John; Tanios, Maged; Dodek, Peter; Fowler, Robert; Burns, Karen; Jacka, Michael; Olafson, Kendiss; Skrobik, Yoanna; Hebert, Paul; Sabri, Elham; Meade, Maureen		SLEAP Investigators; Canadian Critical Care Trials Grp	Daily Sedation Interruption in Mechanically Ventilated Critically Ill Patients Cared for With a Sedation Protocol A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEUROMUSCULAR BLOCKING-AGENTS; ANALGESICS; INFUSIONS; DELIRIUM; SCALE	Context Protocolized sedation and daily sedation interruption are 2 strategies to minimize sedation and reduce the duration of mechanical ventilation and intensive care unit (ICU) stay. Wehypothesized that combining these strategies would augment the benefits. Objective To compare protocolized sedation with protocolized sedation plus daily sedation interruption in critically ill patients. Design, Setting, and Patients Randomized controlled trial of 430 critically ill, mechanically ventilated adults conducted in 16 tertiary care medical and surgical ICUs in Canada and the United States between January 2008 and July 2011. Intervention Continuous opioid and/or benzodiazepine infusions and random allocation to protocolized sedation (n=209) (control) or to protocolized sedation plus daily sedation interruption (n=214). Using validated scales, nurses titrated infusions to achieve light sedation. For patients receiving daily interruption, nurses resumed infusions, if indicated, at half of previous doses. Patients were assessed for delirium and for readiness for unassisted breathing. Main Outcome Measure Time to successful extubation. Secondary outcomes included duration of stay, doses of sedatives and opioids, unintentional device removal, delirium, and nurse and respiratory therapist clinical workload (on a 10-point visual analog scale [VAS]). Results Median time to successful extubation was 7 days in both the interruption and control groups (median [IQR], 7 [4-13] vs 7 [3-12]; interruption group hazard ratio, 1.08; 95% CI, 0.86-1.35; P=.52). Duration of ICU stay (median [IQR], 10 [5-17] days vs 10 [6-20] days; P=.36) and hospital stay (median [IQR], 20 [10-36] days vs 20 [10-48] days; P=.42) did not differ between the daily interruption and control groups, respectively. Daily interruption was associated with higher mean daily doses of midazolam (102 mg/d vs 82 mg/d; P=.04) and fentanyl (median [IQR], 550 [50-1850] vs 260 [0-1400]; P<.001) and more daily boluses of benzodiazepines (mean, 0.253 vs 0.177; P=.007) and opiates (mean, 2.18 vs 1.79; P<.001). Unintentional endotracheal tube removal occurred in 10 of 214 (4.7%) vs 12 of 207 patients (5.8%) in the interruption and control groups, respectively (relative risk, 0.82; 95% CI, 0.36-1.84; P=.64). Rates of delirium were not significantly different between groups (53.3% vs 54.1%; relative risk, 0.98; 95% CI, 0.82-1.17; P=.83). Nurse workload was greater in the interruption group (VAS score, 4.22 vs 3.80; mean difference, 0.41; 95% CI, 0.17-0.66; P=.001). Conclusion For mechanically ventilated adults managed with protocolized sedation, the addition of daily sedation interruption did not reduce the duration of mechanical ventilation or ICU stay.	[Mehta, Sangeeta] Mt Sinai Hosp, Div Crit Care, Dept Med & Interdept, Toronto, ON M5G 1X5, Canada; [Mehta, Sangeeta; Burry, Lisa] Univ Toronto, Toronto, ON, Canada; [Burry, Lisa] Mt Sinai Hosp, Dept Pharm & Med, Toronto, ON M5G 1X5, Canada; [Cook, Deborah; Meade, Maureen] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Cook, Deborah; Meade, Maureen] McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8S 4L8, Canada; [Cook, Deborah; Meade, Maureen] McMaster Univ, Dept Biostat, Hamilton, ON, Canada; [Cook, Deborah] St Josephs Healthcare, Hamilton, ON, Canada; [Fergusson, Dean] Univ Ottawa, Clin Epidemiol Program, Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Fergusson, Dean] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Granton, John] Univ Toronto, Toronto Gen Hosp, Div Respirol, Interdept Div Crit Care,Fac Med, Toronto, ON M5S 1A1, Canada; [Devlin, John] Univ Toronto, Interdept Div Crit Care Med, Univ Hlth Network, Toronto, ON M5S 1A1, Canada; [Tanios, Maged] Long Beach Mem Med Ctr, Dept Med, Long Beach, CA USA; [Dodek, Peter] St Pauls Hosp, Div Crit Care Med, Vancouver, BC V6Z 1Y6, Canada; [Dodek, Peter] St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V6Z 1Y6, Canada; [Fowler, Robert] Sunnybrook Med Ctr, Dept Med, Toronto, ON, Canada; [Fowler, Robert] Sunnybrook Med Ctr, Dept Crit Care Med, Toronto, ON, Canada; [Fowler, Robert; Burns, Karen] St Michaels Hosp, Interdept Div Crit Care Med, Toronto, ON M5B 1W8, Canada; [Burns, Karen] St Michaels Hosp, Inst Hlth Policy Management & Evaluat, Toronto, ON M5B 1W8, Canada; [Burns, Karen] St Michaels Hosp, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Burns, Karen] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Jacka, Michael] Univ Alberta Hosp, Dept Anesthesiol, Edmonton, AB T6G 2B7, Canada; [Jacka, Michael] Univ Alberta Hosp, Dept Crit Care, Edmonton, AB T6G 2B7, Canada; [Olafson, Kendiss] Univ Manitoba, Fac Med, Sect Crit Care, Dept Med, Winnipeg, MB, Canada; [Skrobik, Yoanna] Univ Montreal, Dept Med, Hop Maison Neuve Rosemont, Montreal, PQ H3C 3J7, Canada; [Hebert, Paul] Univ Ottawa, Dept Crit Care, Ottawa, ON, Canada; [Meade, Maureen] Hamilton Hlth Sci, Dept Crit Care, Hamilton, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; McMaster University; McMaster University; McMaster University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; St. Paul's Hospital; University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Alberta; University of Alberta; University of Manitoba; Universite de Montreal; University of Ottawa; McMaster University	Mehta, S (corresponding author), Mt Sinai Hosp, Div Crit Care, Dept Med & Interdept, 600 Univ Ave,Ste 18-216, Toronto, ON M5G 1X5, Canada.	geeta.mehta@utoronto.ca	Skrobik, Yoanna/K-8165-2014; Sabri, Elham/GXG-8198-2022; Mehta, Sangeeta/C-4623-2015; Burry, Lisa D/C-6546-2017; Ferguson, Niall/D-7619-2019	Skrobik, Yoanna/0000-0002-5315-6020; Burry, Lisa D/0000-0002-6545-3890; Ferguson, Niall/0000-0002-6213-5264; Herridge, Margaret/0000-0002-2903-1631; Fergusson, Dean/0000-0002-3389-2485	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding was provided by the Canadian Institutes of Health Research. Dr Cook is a Canada Research Chair of the Canadian Institutes for Health Research. Dr Burns holds a Clinician Scientist Phase 2 Award of the Canadian Institutes for Health Research. Dr Fowler is a Clinician Scientist of the Heart and Stroke Foundation (Ontario).	Anifantaki S, 2009, J ADV NURS, V65, P1054, DOI 10.1111/j.1365-2648.2009.04967.x; Arroliga AC, 2008, CRIT CARE MED, V36, P1083, DOI 10.1097/CCM.0B013E3181653895; Augustes R, 2011, ANAESTH INTENS CARE, V39, P401, DOI 10.1177/0310057X1103900310; Bergeron N, 2001, INTENS CARE MED, V27, P859, DOI 10.1007/s001340100909; Brook AD, 1999, CRIT CARE MED, V27, P2609, DOI 10.1097/00003246-199912000-00001; Bucknall TK, 2008, CRIT CARE MED, V36, P1444, DOI 10.1097/CCM.0b013e318168f82d; Burry L, 2009, AM J RESP CRIT CARE, V179; Burry L, 2011, INTENS CARE MED, V37, pS83; de Wit M, 2008, CRIT CARE, V12, DOI 10.1186/cc6908; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Kollef MH, 1998, CHEST, V114, P541, DOI 10.1378/chest.114.2.541; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Mehta S, 2006, CRIT CARE MED, V34, P374, DOI 10.1097/01.CCM.0000196830.61965.F1; Mehta S, 2008, CRIT CARE MED, V36, P2092, DOI 10.1097/CCM.0b013e31817bff85; O'Connor M, 2010, AM J CRIT CARE, V19, P285, DOI 10.4037/ajcc2009541; Ouimet S, 2007, INTENS CARE MED, V33, P66, DOI 10.1007/s00134-006-0399-8; Patanwala AE, 2007, ANN PHARMACOTHER, V41, P255, DOI 10.1345/aph.1H421; Patel RP, 2009, CRIT CARE MED, V37, P825, DOI 10.1097/CCM.0b013e31819b8608; Riker RR, 1999, CRIT CARE MED, V27, P1325, DOI 10.1097/00003246-199907000-00022; Roberts RJ, 2010, J CRIT CARE, V25; Ruokonen E, 2009, INTENS CARE MED, V35, P282, DOI 10.1007/s00134-008-1296-0; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Tanios MA, 2009, J CRIT CARE, V24, P66, DOI 10.1016/j.jcrc.2008.03.037; Weisbrodt L, 2011, AM J CRIT CARE, V20, pE90, DOI 10.4037/ajcc2011415; Yilmaz C, 2010, ULUS TRAVMA ACIL CER, V16, P521	26	301	323	4	135	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2012	308	19					1985	1992		10.1001/jama.2012.13872	http://dx.doi.org/10.1001/jama.2012.13872			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040AQ	23180503				2022-12-28	WOS:000311291400022
J	Xu, J; Smale, ST				Xu, Jian; Smale, Stephen T.			Designing an Enhancer Landscape	CELL			English	Editorial Material							CELL; DISTINCT	In this issue and in a recent issue of Cell, Vahedi et al. and Samstein et al. provide new insights into the strategies used to establish an enhancer landscape during development of cell lineages. They report that enhancer landscapes characterizing T cell lineages are pre-established and strongly influenced by environmental stimuli.	[Smale, Stephen T.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Xu, Jian] Harvard Univ, Childrens Hosp Boston, Div Hematol Oncol, Sch Med, Boston, MA 02115 USA	University of California System; University of California Los Angeles; Harvard University; Boston Children's Hospital; Harvard Medical School	Smale, ST (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	smale@mednet.ucla.edu			NATIONAL CANCER INSTITUTE [R01CA127279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR063020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086372] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA127279] Funding Source: Medline; NIAID NIH HHS [R01 AI073868] Funding Source: Medline; NIAMS NIH HHS [P50 AR063020] Funding Source: Medline; NIDDK NIH HHS [R01 DK043726] Funding Source: Medline; NIGMS NIH HHS [R01 GM086372] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Krebs AR, 2011, MOL CELL, V44, P410, DOI 10.1016/j.molcel.2011.08.037; Mercer EM, 2011, IMMUNITY, V35, P413, DOI 10.1016/j.immuni.2011.06.013; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730	10	10	10	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 21	2012	151	5					929	931		10.1016/j.cell.2012.11.007	http://dx.doi.org/10.1016/j.cell.2012.11.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178114	Green Accepted, Bronze			2022-12-28	WOS:000311423500006
J	Yang, YWJ; Baltus, AE; Mathew, RS; Murphy, EA; Evrony, GD; Gonzalez, DM; Wang, EP; Marshall-Walker, CA; Barry, BJ; Murn, J; Tatarakis, A; Mahajan, MA; Samuels, HH; Shi, Y; Golden, JA; Mahajnah, M; Shenhav, R; Walsh, CA				Yang, Yawei J.; Baltus, Andrew E.; Mathew, Rebecca S.; Murphy, Elisabeth A.; Evrony, Gilad D.; Gonzalez, Dilenny M.; Wang, Estee P.; Marshall-Walker, Christine A.; Barry, Brenda J.; Murn, Jernej; Tatarakis, Antonis; Mahajan, Muktar A.; Samuels, Herbert H.; Shi, Yang; Golden, Jeffrey A.; Mahajnah, Muhammad; Shenhav, Ruthie; Walsh, Christopher A.			Microcephaly Gene Links Trithorax and REST/NRSF to Control Neural Stem Cell Proliferation and Differentiation	CELL			English	Article							HISTONE MODIFICATIONS; SELF-RENEWAL; CHROMATIN; NEUROGENESIS; REST; COMPLEX; TRANSCRIPTION; PROTEINS; NEURONS; STATES	Microcephaly is a neurodevelopmental disorder causing significantly reduced cerebral cortex size. Many known microcephaly gene products localize to centrosomes, regulating cell fate and proliferation. Here, we identify and characterize a nuclear zinc finger protein, ZNF335/NIF-1, as a causative gene for severe microcephaly, small somatic size, and neonatal death. Znf335 null mice are embryonically lethal, and conditional knockout leads to severely reduced cortical size. RNA-interference and postmortem human studies show that ZNF335 is essential for neural progenitor self-renewal, neurogenesis, and neuronal differentiation. ZNF335 is a component of a vertebrate-specific, trithorax H3K4-methylation complex, directly regulating REST/NRSF, a master regulator of neural gene expression and cell fate, as well as other essential neural-specific genes. Our results reveal ZNF335 as an essential link between H3K4 complexes and REST/NRSF and provide the first direct genetic evidence that this pathway regulates human neurogenesis and neuronal differentiation.	[Yang, Yawei J.; Baltus, Andrew E.; Murphy, Elisabeth A.; Evrony, Gilad D.; Gonzalez, Dilenny M.; Wang, Estee P.; Marshall-Walker, Christine A.; Barry, Brenda J.; Walsh, Christopher A.] Boston Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Yang, Yawei J.; Baltus, Andrew E.; Murphy, Elisabeth A.; Evrony, Gilad D.; Gonzalez, Dilenny M.; Wang, Estee P.; Marshall-Walker, Christine A.; Barry, Brenda J.; Walsh, Christopher A.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Murn, Jernej; Shi, Yang] Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Yang, Yawei J.; Evrony, Gilad D.; Wang, Estee P.; Walsh, Christopher A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Yang, Yawei J.; Evrony, Gilad D.; Walsh, Christopher A.] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Yang, Yawei J.; Evrony, Gilad D.] Harvard Univ, Sch Med, Harvard MD PhD MSTP Program, Boston, MA 02115 USA; [Mathew, Rebecca S.; Murn, Jernej; Tatarakis, Antonis; Shi, Yang] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Yang, Yawei J.; Baltus, Andrew E.; Mathew, Rebecca S.; Murphy, Elisabeth A.; Evrony, Gilad D.; Gonzalez, Dilenny M.; Wang, Estee P.; Marshall-Walker, Christine A.; Barry, Brenda J.; Tatarakis, Antonis; Walsh, Christopher A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Yang, Yawei J.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Murphy, Elisabeth A.] Northeastern Univ, Dept Neurosci, Boston, MA 02115 USA; [Wang, Estee P.] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Mahajan, Muktar A.; Samuels, Herbert H.] NYU, Sch Med, Dept Pharmacol & Med, New York, NY 10016 USA; [Golden, Jeffrey A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Mahajnah, Muhammad] Hillel Yaffe Med Ctr, IL-38100 Hadera, Israel; [Mahajnah, Muhammad] Technion Israel Inst Technol, IL-32000 Haifa, Israel; [Shenhav, Ruthie] Rabin Med Ctr, Raphael Recanati Genet Inst, IL-49100 Petah Tiqwa, Israel	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Northeastern University; Harvard University; Harvard School of Dental Medicine; New York University; Harvard University; Brigham & Women's Hospital; Technion Israel Institute of Technology; Rabin Medical Center	Walsh, CA (corresponding author), Boston Childrens Hosp, Div Genet, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu	Murn, Jernej/ABD-3624-2020	Gonzalez, Dilenny/0000-0003-0661-5930; Golden, Jeffrey/0000-0001-9933-5502; Evrony, Gilad/0000-0001-7621-2630; Walsh, Christopher/0000-0002-0156-2238; Mahajan, Muktar/0000-0003-1024-6808	Stuart H.Q. and Victoria Quan Fellowship; NIH MSTP [T32GM007753]; NIH [T32 HD007466, GM058012, GM071004, CA118487]; Damon Runyon Cancer Research Foundation [DRG-2042-10]; HHMI Medical Research Fellows Program; NINDS [RO1 NS032457, R01 NS35129]; Manton Center for Orphan Disease Research;  [RO1 DK16636]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007466] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA118487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK016636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071004, R01GM058012, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035129, R01NS032457] Funding Source: NIH RePORTER	Stuart H.Q. and Victoria Quan Fellowship; NIH MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; HHMI Medical Research Fellows Program; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Manton Center for Orphan Disease Research; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Moazed, M.E. Hatten, B. Ren, D.M. Ferrero, and members of the Walsh laboratory for helpful discussions; L. Shechtman for tissue; N. Dwyer for early mapping; G. Mandel for DN-REST construct; E.E. Govek for help with cerebellar slices; K. S. Krishnamoorthy for control MRIs; and D.J. Tischfield, L.B. Hills, K.D. Atabay, P.P. Wang, J. Wortzel, D.G. Tierney, and J.M. Felie for technical assistance. This work was supported by a Stuart H.Q. and Victoria Quan Fellowship (Y.J.Y.); a NIH MSTP grant T32GM007753 (Y.J.Y. and G.D.E.); a NIH T32 HD007466 (A.E.B.); The Damon Runyon Cancer Research Foundation DRG-2042-10 (R.S.M.); HHMI Medical Research Fellows Program (E.P.W.); RO1 DK16636 (H.H.S.); NIH grants (GM058012, GM071004, and CA118487) (Y.S.); grants from the NINDS (RO1 NS032457 and R01 NS35129); and the Manton Center for Orphan Disease Research (C.A.W.). C.A.W. is an Investigator of the Howard Hughes Medical Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NINDS or the NIH.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; BARKOVICH A, 2007, DIAGNOSTIC IMAGING P; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Dredge BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021585; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fisher CL, 2011, CURR OPIN GENET DEV, V21, P140, DOI 10.1016/j.gde.2011.01.015; Garapaty S, 2009, J BIOL CHEM, V284, P7542, DOI 10.1074/jbc.M805872200; Glaser S, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-5; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hoyer J, 2012, AM J HUM GENET, V90, P565, DOI 10.1016/j.ajhg.2012.02.007; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Lehtinen MK, 2011, ANNU REV CELL DEV BI, V27, P653, DOI 10.1146/annurev-cellbio-092910-154026; Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Mahmood S, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-39; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Mochida GH, 2009, SEMIN PEDIATR NEUROL, V16, P120, DOI 10.1016/j.spen.2009.07.001; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Omichinski JG, 1997, NAT STRUCT BIOL, V4, P122, DOI 10.1038/nsb0297-122; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Paro R, 1998, CIBA F SYMP, V214, P51; SCHOENHERR CJ, 1995, CURR OPIN NEUROBIOL, V5, P566, DOI 10.1016/0959-4388(95)80060-3; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Zheng JN, 2006, LIFE SCI, V78, P724, DOI 10.1016/j.lfs.2005.05.064	33	113	128	2	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 21	2012	151	5					1097	1112		10.1016/j.cell.2012.10.043	http://dx.doi.org/10.1016/j.cell.2012.10.043			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178126	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000311423500021
J	Meleth, AD; Pinninti, U; Coffee, RE; Carvounis, PE				Meleth, Annal D.; Pinninti, Usha; Coffee, Robert E., III; Carvounis, Petros E.			Acute severe visual loss and a brainstem mass	LANCET			English	Editorial Material							NEURO-BEHCETS-DISEASE		[Meleth, Annal D.; Pinninti, Usha; Coffee, Robert E., III; Carvounis, Petros E.] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA	Baylor College of Medicine	Meleth, AD (corresponding author), Baylor Coll Med, Dept Ophthalmol, 1977 Butler Blvd, Houston, TX 77030 USA.	meleth@bcm.edu		Carvounis, Petros/0000-0002-3879-3486				Al-Araji A, 2009, LANCET NEUROL, V8, P192, DOI 10.1016/S1474-4422(09)70015-8; Ishida S, 2004, CLIN IMAG, V28, P399, DOI 10.1016/S0899-7071(03)00284-5; SILMAN AJ, 1990, LANCET, V335, P1078	3	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 17	2012	380	9855					1790	1790		10.1016/S0140-6736(12)61335-X	http://dx.doi.org/10.1016/S0140-6736(12)61335-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CV	23158253				2022-12-28	WOS:000311153700037
J	Tentolouris, N; Bowling, FL; Jude, EB				Tentolouris, Nicholas; Bowling, Frank L.; Jude, Edward B.			A patient with longstanding type 1 diabetes and a swollen, warm, and red foot	BRITISH MEDICAL JOURNAL			English	Editorial Material							CHARCOT NEURO-OSTEOARTHROPATHY; FEET		[Jude, Edward B.] Tameside Hosp NHS Fdn Trust, Ashton Under Lyne OL6 9RW, England; [Tentolouris, Nicholas] Univ Athens, Sch Med, GR-11527 Athens, Greece; [Bowling, Frank L.] Cent Manchester Univ Hosp, Manchester, Lancs, England; [Bowling, Frank L.; Jude, Edward B.] Univ Manchester, Manchester, Lancs, England	Athens Medical School; National & Kapodistrian University of Athens; University of Manchester	Jude, EB (corresponding author), Tameside Hosp NHS Fdn Trust, Ashton Under Lyne OL6 9RW, England.	Edward.jude@tgh.nhs.uk	TENTOLOURIS, NIKOLAOS/AAH-6231-2019	TENTOLOURIS, NIKOLAOS/0000-0003-0615-2534				Armstrong DG, 1997, DIABETIC MED, V14, P357, DOI 10.1002/(SICI)1096-9136(199705)14:5<357::AID-DIA341>3.3.CO;2-#; Baglioni P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1397; Bem R, 2006, DIABETES CARE, V29, P1392, DOI 10.2337/dc06-0376; CAVANAGH PR, 1994, DIABETES CARE, V17, P201, DOI 10.2337/diacare.17.3.201; Fabrin J, 2000, DIABETES CARE, V23, P796, DOI 10.2337/diacare.23.6.796; Hartemann-Heurtier A, 2002, LANCET, V360, P1776, DOI 10.1016/S0140-6736(02)11671-0; Jeffcoate WJ, 2008, DIABETES-METAB RES, V24, pS62, DOI 10.1002/dmrr.837; Jude EB, 2001, DIABETOLOGIA, V44, P2032, DOI 10.1007/s001250100008; Petrova NL, 2008, DIABETES-METAB RES, V24, pS58, DOI 10.1002/dmrr.846; Rogers LC, 2011, DIABETES CARE, V34, P2123, DOI 10.2337/dc11-0844	10	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 16	2012	345								e7760	10.1136/bmj.e7760	http://dx.doi.org/10.1136/bmj.e7760			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040QI	23160784				2022-12-28	WOS:000311337500010
J	Wodak, A				Wodak, Alex			Drug law reform: when bad policy is good politics	LANCET			English	Editorial Material									St Vincents Hosp, Darlinghurst, NSW 2010, Australia	St Vincents Hospital Sydney	Wodak, A (corresponding author), St Vincents Hosp, Darlinghurst, NSW 2010, Australia.	alex.wodak@gmail.com						Bewley-Taylor D. R., 1999, US INT DRUG CONTROL; Cave D., 2012, NY TIMES; Commission on Narcotic Drugs, 2008, ECN72008CRP17 COMM N; Douglas B., 2012, ALTERNATIVES PROHIBI; Global Commission on Drug Policy, 2012, WAR DRUGS HIV AIDS C; Hughes CE, 2010, BRIT J CRIMINOL, V50, P999, DOI 10.1093/bjc/azq038; Nutt DJ, 2010, LANCET, V376, P1558, DOI 10.1016/S0140-6736(10)61462-6; Rau B, 2006, INT AFF, V82, P285, DOI 10.1111/j.1468-2346.2006.00531.x; Rolles Stephen, 2010, BMJ, V341, pc3360, DOI 10.1136/bmj.c3360; The Global Commission on Drug Policy, 2011, WAR DRUGS; UNODC, 2008, 51 SESS COMM NARC DR; Youngers C., 2012, DRUG LAW REFORM GENI	12	3	3	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2012	380	9854					1624	1626		10.1016/S0140-6736(12)61847-9	http://dx.doi.org/10.1016/S0140-6736(12)61847-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	035MN	23134835				2022-12-28	WOS:000310951400005
J	Macdonald, JB; Nguyen, XH				Macdonald, James B.; Nguyen, Xuan H.			Rhinophyma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Macdonald, James B.] Mayo Clin Arizona, Scottsdale, AZ USA; [Nguyen, Xuan H.] Maricopa Cty Hosp, Phoenix, AZ USA	Mayo Clinic; Mayo Clinic Phoenix	Macdonald, JB (corresponding author), Mayo Clin Arizona, Scottsdale, AZ USA.								0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2012	367	19					1838	1838		10.1056/NEJMicm1208058	http://dx.doi.org/10.1056/NEJMicm1208058			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033DG	23134384				2022-12-28	WOS:000310773200012
J	Burgess, S; Butterworth, A; Malarstig, A; Thompson, SG				Burgess, Stephen; Butterworth, Adam; Malarstig, Anders; Thompson, Simon G.			Use of Mendelian randomisation to assess potential benefit of clinical intervention	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OBESITY; STATINS; TRIALS; RISK; FTO	Mendelian randomisation is a technique for assessing causal associations in observational data. Genetic variants associated with the risk factor of interest are regarded in a similar way to random assignment in a clinical trial. The difference in the risk factor due to the genetic variation, however, is materially distinct from the change due to any proposed therapeutic intervention and so might affect the outcome differently. Consequently, it can be misleading to generalise the magnitude of a Mendelian randomisation estimate to the effect of a potential intervention on the risk factor in practice. Awareness of the limitations of such estimates is important for the use of Mendelian randomisation in target based drug development	[Burgess, Stephen] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cardiovasc Epidemiol Unit, Cambridge CB1 8RN, England; [Malarstig, Anders] Pfizer Global Res & Dev, Cambridge, England	University of Cambridge; Pfizer	Burgess, S (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cardiovasc Epidemiol Unit, Cambridge CB1 8RN, England.	sb452@medschl.cam.ac.uk		Butterworth, Adam/0000-0002-6915-9015; Burgess, Stephen/0000-0001-5365-8760	British Heart Foundation [RG/08/014]	British Heart Foundation(British Heart Foundation)	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: all authors receive support through grant RG/08/014 from the British Heart Foundation; AM is currently on secondment to the University of Cambridge from Pfizer Pharmaceuticals.	Brennan P, 2009, INT J EPIDEMIOL, V38, P971, DOI 10.1093/ije/dyp162; Cheung BMY, 2004, BRIT J CLIN PHARMACO, V57, P640, DOI 10.1111/j.1365-2125.2003.02060.x; Dekkers OM, 2010, INT J EPIDEMIOL, V39, P89, DOI 10.1093/ije/dyp174; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Hirschfield GM, 2005, P NATL ACAD SCI USA, V102, P8309, DOI 10.1073/pnas.0503202102; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Nitsch D, 2006, AM J EPIDEMIOL, V163, P397, DOI 10.1093/aje/kwj062; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2005, BMJ-BRIT MED J, V330, P1076, DOI 10.1136/bmj.330.7499.1076; Tanabe M, 2005, J MED MICROBIOL, V54, P7, DOI 10.1099/jmm.0.45736-0; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548	19	137	137	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2012	345								e7325	10.1136/bmj.e7325	http://dx.doi.org/10.1136/bmj.e7325			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036LE	23131671	Bronze, Green Submitted			2022-12-28	WOS:000311026600009
J	Chertow, GM; Block, GA; Correa-Rotter, R; Drueke, TB; Floege, J; Goodman, WG; Herzog, CA; Kubo, Y; London, GM; Mahaffey, KW; Mix, TCH; Moe, SM; Trotman, ML; Wheeler, DC; Parfrey, PS				Chertow, Glenn M.; Block, Geoffrey A.; Correa-Rotter, Ricardo; Drueeke, Tilman B.; Floege, Juergen; Goodman, William G.; Herzog, Charles A.; Kubo, Yumi; London, Gerard M.; Mahaffey, Kenneth W.; Mix, T. Christian H.; Moe, Sharon M.; Trotman, Marie-Louise; Wheeler, David C.; Parfrey, Patrick S.		EVOLVE Trial Investigators	Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC KIDNEY-DISEASE; CHRONIC HEART-FAILURE; QUALITY-OF-LIFE; SECONDARY HYPERPARATHYROIDISM; PARATHYROID-HORMONE; PERITONEAL-DIALYSIS; RENAL REPLACEMENT; EVENTS EVOLVE; DOUBLE-BLIND; HEMODIALYSIS	BACKGROUND Disorders of mineral metabolism, including secondary hyperparathyroidism, are thought to contribute to extraskeletal (including vascular) calcification among patients with chronic kidney disease. It has been hypothesized that treatment with the calcimimetic agent cinacalcet might reduce the risk of death or nonfatal cardiovascular events in such patients. METHODS In this clinical trial, we randomly assigned 3883 patients with moderate-to-severe secondary hyperparathyroidism (median level of intact parathyroid hormone, 693 pg per milliliter [10th to 90th percentile, 363 to 1694]) who were undergoing hemodialysis to receive either cinacalcet or placebo. All patients were eligible to receive conventional therapy, including phosphate binders, vitamin D sterols, or both. The patients were followed for up to 64 months. The primary composite end point was the time until death, myocardial infarction, hospitalization for unstable angina, heart failure, or a peripheral vascular event. The primary analysis was performed on the basis of the intention-to-treat principle. RESULTS The median duration of study-drug exposure was 21.2 months in the cinacalcet group, versus 17.5 months in the placebo group. The primary composite end point was reached in 938 of 1948 patients (48.2%) in the cinacalcet group and 952 of 1935 patients (49.2%) in the placebo group (relative hazard in the cinacalcet group vs. the placebo group, 0.93; 95% confidence interval, 0.85 to 1.02; P = 0.11). Hypocalcemia and gastrointestinal adverse events were significantly more frequent in patients receiving cinacalcet. CONCLUSIONS In an unadjusted intention-to-treat analysis, cinacalcet did not significantly reduce the risk of death or major cardiovascular events in patients with moderate-to-severe secondary hyperparathyroidism who were undergoing dialysis. (Funded by Amgen; EVOLVE ClinicalTrials.gov number, NCT00345839.)	[Chertow, Glenn M.] Stanford Univ, Sch Med, Palo Alto, CA 93034 USA; [Block, Geoffrey A.] Denver Nephrol, Denver, CO USA; [Correa-Rotter, Ricardo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Drueeke, Tilman B.] Univ Picardie, Sch Med & Pharm, Amiens, France; [Floege, Juergen] Rhein Westfal TH Aachen Univ Hosp, Aachen, Germany; [Goodman, William G.; Kubo, Yumi; Mix, T. Christian H.; Trotman, Marie-Louise] Amgen Inc, Thousand Oaks, CA USA; [Herzog, Charles A.] Univ Minnesota, Minneapolis, MN USA; [London, Gerard M.] Hop Manhes, Paris, France; [Mahaffey, Kenneth W.] Duke Clin Res Inst, Durham, NC USA; [Moe, Sharon M.] Indiana Univ Sch Med, Roudebush Vet Affairs Med Ctr, Indianapolis, IN USA; [Wheeler, David C.] UCL, London, England; [Parfrey, Patrick S.] Hlth Sci Ctr, St John, NF, Canada	Stanford University; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Picardie Universites; Universite de Picardie Jules Verne (UPJV); RWTH Aachen University; RWTH Aachen University Hospital; Amgen; University of Minnesota System; University of Minnesota Twin Cities; Duke University; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; University of London; University College London; Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba	Chertow, GM (corresponding author), Stanford Univ, Sch Med, 780 Welch Rd,Suite 106, Palo Alto, CA 93034 USA.	gchertow@stanford.edu	Block, Geoffrey/AAV-8070-2021; Combe, Christian/N-3726-2015; Gesualdo, Loreto/K-7751-2016; P, Evenepoel/D-9597-2018; Fassett, Robert G/F-1752-2010; Healy, Helen/G-2686-2010; Cozzolino, Mario/AAB-9965-2022; Moyses, Rosa M A/F-8268-2012; Cappelli, Gianni/N-8812-2019; JORGETTI, VANDA/C-9470-2012; Goldsmith, David J.A./H-8500-2013; Frazão, João/J-9811-2013; Salgado Filho, Natalino/P-2276-2014; DRUEKE, Tilman B./B-4958-2010; Rozhinskaya, Liudmila/B-6618-2017	Block, Geoffrey/0000-0002-4646-7074; Combe, Christian/0000-0002-0360-573X; Gesualdo, Loreto/0000-0002-4861-0911; P, Evenepoel/0000-0002-2846-2026; Fassett, Robert G/0000-0002-5318-6940; Healy, Helen/0000-0003-4342-5300; Cozzolino, Mario/0000-0002-8494-6252; Moyses, Rosa M A/0000-0002-7902-2127; Cappelli, Gianni/0000-0003-2304-5001; JORGETTI, VANDA/0000-0002-4824-8879; Frazão, João/0000-0002-8081-5474; DRUEKE, Tilman B./0000-0002-0700-7681; James, Martin/0000-0001-6065-6018; Brown, Wendy/0000-0002-0137-2688; Hutchison, Alastair/0000-0003-3268-8324; Lok, Charmaine/0000-0001-5365-0064; MacRae, Jennifer/0000-0002-4711-1440; MOYSES NETO, MIGUEL/0000-0003-1351-4775; Capasso, Giovambattista/0000-0003-3469-8614; Chertow, Glenn/0000-0002-7599-0534; Shilo, Valeriy/0000-0001-9025-8061; Galicia Basart, Maria/0000-0002-8125-5974; plumb, Troy/0000-0002-8517-0070; Olgaard, Klaus/0000-0002-4063-1283; Mount, Peter/0000-0001-7637-3661; Rozhinskaya, Liudmila/0000-0001-7041-0732; Rizk, Dana/0000-0002-6877-2811; Tomson, Charles/0000-0002-0224-8726	Amgen	Amgen(Amgen)	Supported by Amgen.	Avram MM, 2001, AM J KIDNEY DIS, V38, P1351, DOI 10.1053/ajkd.2001.29254; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Block GA, 2004, NEW ENGL J MED, V350, P1516, DOI 10.1056/NEJMoa031633; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Briet M, 2012, CLIN SCI, V123, P399, DOI 10.1042/CS20120074; Chertow GM, 2007, CLIN J AM SOC NEPHRO, V2, P898, DOI 10.2215/CJN.04381206; Chertow GM, 2012, NEPHROL DIAL TRANSPL, V27, P2872, DOI 10.1093/ndt/gfr777; Chiu YW, 2009, CLIN J AM SOC NEPHRO, V4, P1089, DOI 10.2215/CJN.00290109; Cunningham J, 2005, KIDNEY INT, V68, P1793, DOI 10.1111/j.1523-1755.2005.00596.x; Drechsler C, 2009, NEPHROL DIAL TRANSPL, V24, P3151, DOI 10.1093/ndt/gfp260; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Fellstrom BC, 2010, NEW ENGL J MED, V362, P1450; Fishbane Steven, 2008, Heart Fail Clin, V4, P401, DOI 10.1016/j.hfc.2008.03.005; Floege J, 2011, NEPHROL DIAL TRANSPL, V26, P1948, DOI 10.1093/ndt/gfq219; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Himmelfarb J, 2009, SEMIN DIALYSIS, V22, P636, DOI 10.1111/j.1525-139X.2009.00659.x; Jourde-Chiche N, 2011, SEMIN DIALYSIS, V24, P327, DOI 10.1111/j.1525-139X.2011.00925.x; Kalantar-Zadeh K, 2006, KIDNEY INT, V70, P771, DOI 10.1038/sj.ki.5001514; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Lindberg JS, 2005, J AM SOC NEPHROL, V16, P800, DOI 10.1681/ASN.2004060512; London GM, 2005, CURR OPIN NEPHROL HY, V14, P525, DOI 10.1097/01.mnh.0000168336.67499.c0; Mallamaci F, 2005, KIDNEY INT, V67, P2330, DOI 10.1111/j.1523-1755.2005.00338.x; Melamed ML, 2006, KIDNEY INT, V70, P351, DOI 10.1038/sj.ki.5001542; Mezzano D, 1996, THROMB HAEMOSTASIS, V76, P312; Nakamura H, 2009, ATHEROSCLEROSIS, V206, P512, DOI 10.1016/j.atherosclerosis.2009.03.031; Nusair MB, 2012, CARDIORENAL MED, V2, P117, DOI 10.1159/000337082; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Quarles LD, 2003, J AM SOC NEPHROL, V14, P575, DOI 10.1097/01.ASN.0000050224.03126.AD; Raggi P, 2011, NEPHROL DIAL TRANSPL, V26, P1327, DOI 10.1093/ndt/gfq725; Rubinger D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036943; Suzuki T, 2004, BLOOD PURIFICAT, V22, P293, DOI 10.1159/000078700; Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8; Tonelli M, 2004, CIRCULATION, V110, P1557, DOI 10.1161/01.CIR.0000143892.84582.60; United States Renal Data System, 2011, USRDS 2011 ANN DAT R; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545	39	616	639	6	111	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2012	367	26					2482	2494		10.1056/NEJMoa1205624	http://dx.doi.org/10.1056/NEJMoa1205624			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	059OG	23121374	Green Published			2022-12-28	WOS:000312714200006
J	Brighton, TA; Eikelboom, JW; Mann, K; Biostat, M; Mister, R; Gallus, A; Ockelford, P; Gibbs, H; Hague, W; Xavier, D; Diaz, R; Kirby, A; Simes, J				Brighton, Timothy A.; Eikelboom, John W.; Mann, Kristy; Biostat, M.; Mister, Rebecca; Gallus, Alexander; Ockelford, Paul; Gibbs, Harry; Hague, Wendy; Xavier, Denis; Diaz, Rafael; Kirby, Adrienne; Simes, John		ASPIRE Investigators	Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL ANTICOAGULANT-THERAPY; PULMONARY-EMBOLISM; 1ST EPISODE; THROMBOSIS; EVENTS	BACKGROUND Patients who have had a first episode of unprovoked venous thromboembolism have a high risk of recurrence after anticoagulants are discontinued. Aspirin may be effective in preventing a recurrence of venous thromboembolism. METHODS We randomly assigned 822 patients who had completed initial anticoagulant therapy after a first episode of unprovoked venous thromboembolism to receive aspirin, at a dose of 100 mg daily, or placebo for up to 4 years. The primary outcome was a recurrence of venous thromboembolism. RESULTS During a median follow-up period of 37.2 months, venous thromboembolism re-curred in 73 of 411 patients assigned to placebo and in 57 of 411 assigned to aspirin (a rate of 6.5% per year vs. 4.8% per year; hazard ratio with aspirin, 0.74; 95% confidence interval [CI], 0.52 to 1.05; P = 0.09). Aspirin reduced the rate of the two prespecified secondary composite outcomes: the rate of venous thromboembolism, myocardial infarction, stroke, or cardiovascular death was reduced by 34% (a rate of 8.0% per year with placebo vs. 5.2% per year with aspirin; hazard ratio with aspirin, 0.66; 95% CI, 0.48 to 0.92; P = 0.01), and the rate of venous thromboembolism, myocardial infarction, stroke, major bleeding, or death from any cause was reduced by 33% (hazard ratio, 0.67; 95% CI, 0.49 to 0.91; P = 0.01). There was no significant between-group difference in the rates of major or clinically relevant nonmajor bleeding episodes (rate of 0.6% per year with placebo vs. 1.1% per year with aspirin, P = 0.22) or serious adverse events. CONCLUSIONS In this study, aspirin, as compared with placebo, did not significantly reduce the rate of recurrence of venous thromboembolism but resulted in a significant reduction in the rate of major vascular events, with improved net clinical benefit. These results substantiate earlier evidence of a therapeutic benefit of aspirin when it is given to patients after initial anticoagulant therapy for a first episode of unprovoked venous thromboembolism. (Funded by National Health and Medical Research Council [Australia] and others; Australian New Zealand Clinical Trials Registry number, ACTRN12605000004662.)	[Brighton, Timothy A.] Prince Wales Hosp, SEALS, Dept Haematol, Sydney, NSW, Australia; [Mann, Kristy; Mister, Rebecca; Hague, Wendy; Kirby, Adrienne; Simes, John] Univ Sydney, Natl Hlth & Med Res Council, Clin Trials Ctr, Sydney, NSW 2006, Australia; [Gallus, Alexander] SA Pathol Flinders Med Ctr, Dept Haematol, Adelaide, SA, Australia; [Gibbs, Harry] Alfred Hosp, Gen Med Unit, Melbourne, Vic, Australia; [Eikelboom, John W.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Ockelford, Paul] Auckland City Hosp, Thrombosis Unit, Auckland, New Zealand; [Xavier, Denis] St Johns Med Coll & Res Inst, Bangalore, Karnataka, India; [Diaz, Rafael] Estudios Clin Latinoamer ECLA Int, Rosario, Argentina	University of Sydney; Flinders Medical Centre; SA Pathology; Florey Institute of Neuroscience & Mental Health; McMaster University; Population Health Research Institute; Auckland City Hospital; St. John's National Academy of Health Sciences; St. John's Medical College	Brighton, TA (corresponding author), Prince Wales Hosp, SEALS, Dept Haematol, Sydney, NSW, Australia.	aspire@ctc.usyd.edu.au	Colquhoun, David M/F-9078-2013; Simes, Robert John/P-1497-2014; Eikelboom, John/AAG-6117-2019	Eikelboom, John/0000-0003-4126-1285; van Holst Pellekaan, Caitlin/0000-0002-4841-972X; Tiley, Campbell/0000-0002-4314-0877; Gallus, Alexander/0000-0001-7347-9989; Robledo, Kristy/0000-0003-0213-7652; Nandurkar, Harshal/0000-0002-8767-116X	National Health and Medical Research Council [Australia]; National Health and Medical Research Council (Australia); Health Research Council (New Zealand); Austral-asian Society of Thrombosis and Hemostasis; National Heart Foundation of Australia; Bayer HealthCare; Boehringer Ingelheim; Daiichi-Sankyo; Pfizer; Amgen Australia; GlaxoSmithKline; Bayer; Bristol-Myers Squibb; Corgenix; Eisai; Eli Lilly; McNeil; Sanofi-Aventis; Haemoscope; Daichii-Sankyo; CSL Australia; Covidien; AstraZeneca; Cadila Pharmaceuticals	National Health and Medical Research Council [Australia](National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Health Research Council (New Zealand)(Health Research Council of New Zealand); Austral-asian Society of Thrombosis and Hemostasis; National Heart Foundation of Australia(National Heart Foundation of Australia); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); Boehringer Ingelheim(Boehringer Ingelheim); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Pfizer(Pfizer); Amgen Australia(Amgen); GlaxoSmithKline(GlaxoSmithKline); Bayer(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Corgenix; Eisai(Eisai Co Ltd); Eli Lilly(Eli Lilly); McNeil; Sanofi-Aventis(Sanofi-Aventis); Haemoscope; Daichii-Sankyo(Daiichi Sankyo Company Limited); CSL Australia; Covidien; AstraZeneca(AstraZeneca); Cadila Pharmaceuticals	Funded by National Health and Medical Research Council [Australia] and others; Australian New Zealand Clinical Trials Registry number, ACTRN12605000004662.r Supported by National Health and Medical Research Council (Australia), Health Research Council (New Zealand), Austral-asian Society of Thrombosis and Hemostasis, National Heart Foundation of Australia, and Bayer HealthCare. Dr. Brighton reports receiving consulting fees from Bayer HealthCare, Boehringer Ingelheim, Daiichi-Sankyo, Pfizer, Amgen Australia, and GlaxoSmithKline; Dr. Eikelboom, receiving consulting and lecture fees from Bayer, Boehringer Ingelheim, and Bristol-Myers Squibb and consulting fees from Corgenix, Daiichi-Sankyo, Eisai, Eli Lilly, McNeil, GlaxoSmithKline, Sanofi-Aventis, and Haemoscope; Dr. Gallus, serving on an advisory board for Bristol-Myers Squibb, Pfizer, Boehringer Ingelheim, and Bayer and receiving consulting fees from Bristol-Myers Squibb, Pfizer, Daichii-Sankyo, and CSL Australia; Dr. Gibbs, receiving consulting and lecture fees from Boehringer Ingelheim and Bayer HealthCare and lecture fees from Covidien; and Dr. Xavier, receiving grant support from AstraZeneca, Boehringer Ingelheim, Cadila Pharmaceuticals, GlaxoSmithKline, Sanofi-Aventis, Pfizer, and Bristol-Myers Squibb. No other potential conflict of interest relevant to this article was reported.	Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; [Anonymous], 1994, BMJ, V308, P235; Antithrombotic Trialists' Collaboration, 2002, BMJ-BRIT MED J, V324, P141, DOI DOI 10.1136/BMJ.324.7330.141; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Becattini C, 2010, J THROMB HAEMOST, V8, P891, DOI 10.1111/j.1538-7836.2010.03777.x; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; Carrier M, 2010, ANN INTERN MED, V152, P578, DOI 10.7326/0003-4819-152-9-201005040-00008; Couturaud F, 2000, CURR OPIN HEMATOL, V7, P302, DOI 10.1097/00062752-200009000-00008; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; Egger M, 2001, SYSTEMATIC REV HLTH; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Kahn SR, 2008, ANN INTERN MED, V149, P698, DOI 10.7326/0003-4819-149-10-200811180-00004; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Linkins LA, 2003, ANN INTERN MED, V139, P893, DOI 10.7326/0003-4819-139-11-200312020-00007; Mohr DN, 2000, MAYO CLIN PROC, V75, P1249, DOI 10.4065/75.12.1249; O'Brien J, 2000, LANCET, V355, P1295; Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Rodger M, 2010, BLOOD REV, V24, P171, DOI 10.1016/j.blre.2010.06.001; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; Simes J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008580	23	382	401	1	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2012	367	21					1979	1987		10.1056/NEJMoa1210384	http://dx.doi.org/10.1056/NEJMoa1210384			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040RI	23121403	Green Published, Bronze			2022-12-28	WOS:000311340200005
J	Palen, TE; Ross, C; Powers, JD; Xu, S				Palen, Ted E.; Ross, Colleen; Powers, J. David; Xu, Stanley			Association of Online Patient Access to Clinicians and Medical Records With Use of Clinical Services	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							KAISER PERMANENTE; E-MAIL; HEALTH; CARE; COMMUNICATION; PHYSICIANS; RECOMMENDATIONS; QUALITY	Context Prior studies suggest that providing patients with online access to health records and e-mail communication with physicians may substitute for traditional health care services. Objective To assess health care utilization by both users and nonusers of online access to health records before and after initiation of MyHealthManager (MHM), a patient online access system. Design, Setting, and Participants Retrospective cohort study of the use of health care services by members (>= 18 years old) who were continuously enrolled for at least 24 months during the study period March 2005 through June 2010 in Kaiser Permanente Colorado, a group model, integrated health care delivery system. Propensity scores (using age, sex, utilization frequencies, and chronic illnesses) were used for cohort matching. Unadjusted utilization rates were calculated for both MHM users and nonusers and were the basis for difference-of-differences analyses. We also used generalized estimating equations to compare the adjusted rates of utilization of health care services before and after online access. Main Outcome Measures Rates of office visits, telephone encounters, after-hours clinic visits, emergency department encounters, and hospitalizations between members with and without online access. Results Comparing the unadjusted rates for use of clinical services before and after the index date between the matched cohorts, there was a significant increase in the per-member rates of office visits (0.7 per member per year; 95% CI, 0.6-0.7; P<.001) and telephone encounters (0.3 per member per year; 95% CI, 0.2-0.3; P<.001). There was also a significant increase in per-1000-member rates of after-hours clinic visits (18.7 per 1000members per year; 95% CI, 12.8-24.3; P<.001), emergency department encounters (11.2 per 1000 members per year; 95% CI, 2.6-19.7; P=.01), and hospitalizations (19.9 per 1000 members per year; 95% CI, 14.6-25.3; P<.001) for MHM users vs nonusers. Conclusion Having online access to medical records and clinicians was associated with increased use of clinical services compared with group members who did not have online access. JAMA. 2012;308(19):2012-2019 www.jama.com	[Palen, Ted E.; Ross, Colleen; Powers, J. David; Xu, Stanley] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO 80231 USA	Kaiser Permanente	Palen, TE (corresponding author), Kaiser Permanente Colorado, Inst Hlth Res, 10065 E Harvard Ave,Ste 300, Denver, CO 80231 USA.	ted.e.palen@kp.org			Kaiser Permanente Colorado Regional Initiative Committee Fund	Kaiser Permanente Colorado Regional Initiative Committee Fund	This study was supported by the Kaiser Permanente Colorado Regional Initiative Committee Fund.	[Anonymous], COMM PAT EL VIA TEL; Baer D, 2011, J ONCOL PRACT, V7, P230, DOI 10.1200/JOP.2011.000323; Barr J L, 1998, Healthc Inf Manage, V12, P71; Bergmo TS, 2005, INT J MED INFORM, V74, P705, DOI 10.1016/j.ijmedinf.2005.06.002; BERGSTRALH EJ, 1995, 56 MAY FDN; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Bryne JM, 2009, J AM MED INFORM ASSN, V16, P267, DOI 10.1197/jamia.M2835; Chen C, 2009, HEALTH AFFAIR, V28, P323, DOI 10.1377/hlthaff.28.2.323; Coile R C Jr, 1999, Russ Coiles Health Trends, V11, P2; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Emont S., MEASURING IMPACT PAT; Garrido T, 2005, BMJ-BRIT MED J, V330, P581, DOI 10.1136/bmj.330.7491.581; Harris LT, 2009, DIABETES CARE, V32, P1182, DOI 10.2337/dc08-1771; Hogan TP, 2011, J GEN INTERN MED, V26, pS628, DOI 10.1007/s11606-011-1765-y; Horner Kathryn, 2011, Issue Brief (Commonw Fund), V23, P1; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW; Katz SJ, 2004, AM J MANAG CARE, V10, P593; Kilo CM, 2005, HEALTH AFFAIR, V24, P1296, DOI 10.1377/hlthaff.24.5.1296; Kummervold PE, 2006, PATIENT PHYS INTERAC; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Liederman Eric M, 2005, J Healthc Inf Manag, V19, P81; McGeady D, 2008, INT J MED INFORM, V77, P17, DOI 10.1016/j.ijmedinf.2006.11.004; Osborn CY, 2010, CURR DIABETES REP, V10, P422, DOI 10.1007/s11892-010-0151-1; Rainie L., INFORM SEARCH SOLVE; Schuh W., 2012, CARLE SELECTED PAPER, V55, P46; Stone JH, 2007, NEW ENGL J MED, V356, P2451, DOI 10.1056/NEJMp068198; Takahashi PY, 2012, ARCH INTERN MED, V172, P773, DOI 10.1001/archinternmed.2012.256; Umefjord G, 2006, FAM PRACT, V23, P159, DOI 10.1093/fampra/cmi117; Umefjord Goran, 2004, Inform Prim Care, V12, P85; *US DEP HHS, HLTH PEOPL 2010; VICKERY DM, 1983, JAMA-J AM MED ASSOC, V250, P2952, DOI 10.1001/jama.250.21.2952; Whitten P, 2007, DIS MANAG HEALTH OUT, V15, P207, DOI 10.2165/00115677-200715040-00002; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhou Yi Y, 2007, Am J Manag Care, V13, P418; Zhou YY, 2010, HEALTH AFFAIR, V29, P1370, DOI 10.1377/hlthaff.2010.0048	35	125	126	2	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2012	308	19					2012	2019		10.1001/jama.2012.14126	http://dx.doi.org/10.1001/jama.2012.14126			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040AQ	23168824				2022-12-28	WOS:000311291400025
J	Shell, KM				Shell, Karen M.			Constraining Cloud Feedbacks	SCIENCE			English	Editorial Material							CLIMATE FEEDBACKS		Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Oregon State University	Shell, KM (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	kshell@coas.oregonstate.edu	Shell, Karen/C-5161-2009	Shell, Karen/0000-0002-9059-6842				Andrews T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051607; Chung ES, 2012, SURV GEOPHYS, V33, P733, DOI 10.1007/s10712-012-9187-x; Dessler AE, 2010, SCIENCE, V330, P1523, DOI 10.1126/science.1192546; Fasullo JT, 2012, SCIENCE, V338, P792, DOI 10.1126/science.1227465; Gettelman A, 2012, J CLIMATE, V25, P1453, DOI 10.1175/JCLI-D-11-00197.1; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Soden BJ, 2008, J CLIMATE, V21, P3504, DOI 10.1175/2007JCLI2110.1	8	1	1	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2012	338	6108					755	756		10.1126/science.1231083	http://dx.doi.org/10.1126/science.1231083			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139323				2022-12-28	WOS:000310839500032
J	Wilkins, JT; Ning, HY; Berry, J; Zhao, LH; Dyer, AR; Lloyd-Jones, DM				Wilkins, John T.; Ning, Hongyan; Berry, Jarett; Zhao, Lihui; Dyer, Alan R.; Lloyd-Jones, Donald M.			Lifetime Risk and Years Lived Free of Total Cardiovascular Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FACTOR BURDEN; CORONARY; DEATH; PREDICTION; TERM; MEN	Context Estimates of lifetime risk for total cardiovascular disease (CVD) may provide projections of the future population burden of CVD and may assist in clinician-patient risk communication. To date, no lifetime risk estimates of total CVD have been reported. Objectives To calculate lifetime risk estimates of total CVD by index age (45, 55, 65, 75 years) and risk factor strata and to estimate years lived free of CVD across risk factor strata. Design, Setting, and Participants Pooled survival analysis of as many as 905 115 person-years of data from 1964 through 2008 from 5 National Heart, Lung, and Blood Institute-funded community-based cohorts: Framingham Heart Study, Framingham Offspring Study, Atherosclerosis Risk in Communities Study, Chicago Heart Association Detection Project in Industry Study, and Cardiovascular Health Study. All participants were free of CVD at baseline with risk factor data (blood pressure [BP], total cholesterol [TC], diabetes, and smoking status) and total CVD outcome data. Main Outcome Measures Any total CVD event (including fatal and nonfatal coronary heart disease, all forms of stroke, congestive heart failure, and other CVD deaths). Results At an index age of 45 years, overall lifetime risk for total CVD was 60.3%(95% CI, 59.3%-61.2%) for men and 55.6% (95% CI, 54.5%-56.7%) for women. Men had higher lifetime risk estimates than women across all index ages. At index ages 55 and 65 years, men and women with at least 1 elevated risk factor (BP, 140-149/90-99 mm Hg; or TC, 200-239 mg/dL; but no diabetes or smoking), 1 major risk factor, or at least 2 major risk factors (BP, >= 160/100 mm Hg or receiving treatment; TC, >= 240 mg/dL or receiving treatment; diabetes mellitus; or current smoking) had lifetime risk estimates to age 95 years that exceeded 50%. Despite an optimal risk factor profile (BP, <120/80 mm Hg; TC, <180 mg/dL; and no smoking or diabetes), men and women at the index age of 55 years had lifetime risks (through 85 years of age) for total CVD of greater than 40% and 30%, respectively. Compared with participants with at least 2 major risk factors, those with an optimal risk factor profile lived up to 14 years longer free of total CVD. Conclusions Lifetime risk estimates for total CVD were high (>30%) for all individuals, even those with optimal risk factors in middle age. However, maintenance of optimal risk factor levels in middle age was associated with substantially longer morbidity-free survival. JAMA. 2012;308(17):1795-1801	[Wilkins, John T.; Ning, Hongyan; Zhao, Lihui; Dyer, Alan R.; Lloyd-Jones, Donald M.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Wilkins, John T.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Cardiol, Chicago, IL 60611 USA; [Berry, Jarett] Univ Texas SW Med Ctr Dallas, Div Cardiovasc Dis, Dallas, TX 75390 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wilkins, JT (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lakeshore Dr,Suite 1400, Chicago, IL 60611 USA.	j-wilkins@fsm.northwestern.edu		Lloyd-Jones, Donald/0000-0003-0847-6110	National Heart, Lung, and Blood Institute (NHLBI) [R21 HL085375, K23 HL092229, HHSN268201200036C, N01-HC-85239, N01-HC-85079, N01-HC-85086, N01-HC-35129, N01-HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, HL080295]; Dedman Family Scholar in Clinical Care endowment at UT Southwestern Medical Center; American Heart Association [10BG1A4280091]; National Institute of Neurological Disorders and Stroke; National Institute on Aging [AG-023629, AG-15928, AG-20098, AG-027058]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085080, N01HC015103, N01HC085083, N01HC085081, N01HC035129, N01HC075150, N01HC085085, N01HC045133, N01HC055222, N01HC085084, N01HC085082, N01HC085086, N01HC085079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, K23HL092229, R01HL080295, R21HL085375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG020098, R56AG023629, R01AG020098, R01AG027058, R01AG015928, R01AG023629] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Dedman Family Scholar in Clinical Care endowment at UT Southwestern Medical Center; American Heart Association(American Heart Association); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Lloyd-Jones and this work were supported in part by grant R21 HL085375 from the National Heart, Lung, and Blood Institute (NHLBI). Dr Berry reports receipt of funding from: the Dedman Family Scholar in Clinical Care endowment at UT Southwestern Medical Center; the NHLBI (grant K23 HL092229); and the American Heart Association (grant 10BG1A4280091). The data reported from Cardiovascular Health Study in this article were supported by contracts from the NHLBI (grants HHSN268201200036C, N01-HC-85239, N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01-HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, and HL080295), with an additional contribution from the National Institute of Neurological Disorders and Stroke. Additional support was provided from the National Institute on Aging (grants AG-023629, AG-15928, AG-20098, and AG-027058).	Berry JD, 2007, CIRCULATION, V116, P832; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Berry JD, 2009, CIRCULATION, V119, P382, DOI 10.1161/CIRCULATIONAHA.108.800235; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; IRWIN JO, 1949, J HYG-CAMBRIDGE, V47, P188, DOI 10.1017/S0022172400014443; Kannell WB, 1999, ARCH INTERN MED, V159, P1197, DOI 10.1001/archinte.159.11.1197; Karrison TG, 1997, CONTROL CLIN TRIALS, V18, P151, DOI 10.1016/S0197-2456(96)00089-X; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Lloyd-Jones DM, 2007, AM J CARDIOL, V99, P535, DOI 10.1016/j.amjcard.2006.09.099; National Heart Lung and Blood Institute., 1989, CLIN GUID ID EV TREA; PROBSTFIELD JL, 1991, JAMA-J AM MED ASSOC, V265, P3255; STAMLER J, 1993, CARDIOLOGY, V82, P191, DOI 10.1159/000175868; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	22	182	185	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1795	1801		10.1001/jama.2012.14312	http://dx.doi.org/10.1001/jama.2012.14312			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117780	Bronze, Green Accepted			2022-12-28	WOS:000310726500026
J	Baudisch, A; Vaupel, JW				Baudisch, Annette; Vaupel, James W.			Getting to the Root of Aging	SCIENCE			English	Editorial Material							SENESCENCE		[Baudisch, Annette] Max Planck Res Grp Modeling Evolut Aging, Rostock, Germany; [Baudisch, Annette; Vaupel, James W.] Max Planck Inst Demog Res, Rostock, Germany; [Vaupel, James W.] Univ So Denmark, Odense, Denmark; [Vaupel, James W.] Duke Univ, Durham, NC 27705 USA	Max Planck Society; University of Southern Denmark; Duke University	Baudisch, A (corresponding author), Max Planck Res Grp Modeling Evolut Aging, Rostock, Germany.	baudisch@demogr.mpg.de	Baudisch, Annette/ABA-2290-2020	Baudisch, Annette/0000-0002-4202-089X; Vaupel, James/0000-0003-0783-3905	NATIONAL INSTITUTE ON AGING [P01AG031719] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG031719, AG-031719] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baudisch A, 2008, INEVITABLE SENESCENC; Baudisch A, 2012, GERONTOLOGY, V58, P481, DOI 10.1159/000341861; Baudisch A, 2011, METHODS ECOL EVOL, V2, P375, DOI 10.1111/j.2041-210X.2010.00087.x; Burger O, 2012, P NATL ACAD SCI USA, V109, P18210, DOI 10.1073/pnas.1215627109; Colchero F, 2012, METHODS ECOL EVOL, V3, P466, DOI 10.1111/j.2041-210X.2012.00186.x; Danko MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034146; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Jones OR, 2008, ECOL LETT, V11, P664, DOI 10.1111/j.1461-0248.2008.01187.x; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Martinez DE, 1998, EXP GERONTOL, V33, P217, DOI 10.1016/S0531-5565(97)00113-7; Medawar P. B., 1952, UNIQUENESS INDIVIDUA, P44; PARTRIDGE L, 1991, PHILOS T R SOC B, V332, P3, DOI 10.1098/rstb.1991.0027; Salguero-Gomez R, 2010, J ECOL, V98, P312, DOI 10.1111/j.1365-2745.2009.01616.x; Stearns S.C., 1992, pi; Turner F.B., 1987, 87RD81 SO CAL ED CO; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Vaupel JW, 2004, THEOR POPUL BIOL, V65, P339, DOI 10.1016/j.tpb.2003.12.003; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	18	66	66	2	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107					618	619		10.1126/science.1226467	http://dx.doi.org/10.1126/science.1226467			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	029SM	23118175	Green Accepted			2022-12-28	WOS:000310516000036
J	Diehl, MR				Diehl, Michael R.			Templating a Molecular Tug-of-War	SCIENCE			English	Editorial Material							INTRACELLULAR-TRANSPORT; MECHANISM; KINESINS		[Diehl, Michael R.] Rice Univ, Dept Chem, Houston, TX 77030 USA; [Diehl, Michael R.] Rice Univ, Dept Bioengn, Houston, TX 77030 USA	Rice University; Rice University	Diehl, MR (corresponding author), Rice Univ, Dept Chem, Houston, TX 77030 USA.	diehl@rice.edu						Derr ND, 2012, SCIENCE, V338, P662, DOI 10.1126/science.1226734; Diehl MR, 2006, SCIENCE, V311, P1468, DOI 10.1126/science.1122125; Driver JW, 2011, BIOPHYS J, V101, P386, DOI 10.1016/j.bpj.2011.05.067; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Jamison DK, 2012, J BIOL CHEM, V287, P3357, DOI 10.1074/jbc.M111.296582; Jamison DK, 2010, BIOPHYS J, V99, P2967, DOI 10.1016/j.bpj.2010.08.025; Jolly AL, 2011, BIOCHEM SOC T, V39, P1126, DOI 10.1042/BST0391126; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; T Valentine M, 2007, CURR OPIN CELL BIOL, V19, P75, DOI 10.1016/j.ceb.2006.12.011; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Xu J, 2012, TRAFFIC, V13, P1198, DOI 10.1111/j.1600-0854.2012.01385.x; Zalatan JG, 2012, SCIENCE, V337, P1218, DOI 10.1126/science.1220683	15	4	4	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107					626	627		10.1126/science.1230818	http://dx.doi.org/10.1126/science.1230818			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118181				2022-12-28	WOS:000310516000042
J	Stocker, R				Stocker, Roman			Marine Microbes See a Sea of Gradients	SCIENCE			English	Review							MICROSCALE NUTRIENT PATCHES; EXTRACELLULAR PRODUCTS; CHEMOTACTIC RESPONSE; NATURAL ASSEMBLAGES; FOOD-WEB; BACTERIA; MOTILITY; BEHAVIOR; WATER; BACTERIOPLANKTON	Marine bacteria influence Earth's environmental dynamics in fundamental ways by controlling the biogeochemistry and productivity of the oceans. These large-scale consequences result from the combined effect of countless interactions occurring at the level of the individual cells. At these small scales, the ocean is surprisingly heterogeneous, and microbes experience an environment of pervasive and dynamic chemical and physical gradients. Many species actively exploit this heterogeneity, while others rely on gradient-independent adaptations. This is an exciting time to explore this frontier of oceanography, but understanding microbial behavior and competition in the context of the water column's microarchitecture calls for new ecological frameworks, such as a microbial optimal foraging theory, to determine the relevant trade-offs and global consequences of microbial life in a sea of gradients.	MIT, Ralph M Parsons Lab, Dept Civil & Environm Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Stocker, R (corresponding author), MIT, Ralph M Parsons Lab, Dept Civil & Environm Engn, 49-213,77 Massachusetts Ave, Cambridge, MA 02139 USA.	romans@mit.edu	Stocker, Roman/T-9456-2017; Stocker, Roman/N-8987-2019	Stocker, Roman/0000-0002-3199-0508; 	NSF [OCE-0744641-CAREER, CBET-0966000]; NIH [1R01GM100473]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100473] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I thank E. F. DeLong, W. M. Durham, V. Fernandez, M. S. Garren, M. Gatto, D. L. Kirchman, F. M. Lauro, F. Malfatti, J. G. Mitchell, M. F. Polz, J. R. Seymour, S. Smriga, and B. Ward for insightful discussions and comments on the manuscript, and J. R. Taylor for the figure on turbulence. I am grateful for support by NSF through grants OCE-0744641-CAREER and CBET-0966000, and by NIH through grant 1R01GM100473.	ALLDREDGE AL, 1987, SCIENCE, V235, P689, DOI 10.1126/science.235.4789.689; Ayo B, 2001, MAR BIOL, V138, P1071, DOI 10.1007/s002270000518; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Azam F, 1984, MARINE PHYTOPLANKTON; AZAM F, 1991, NATO ASI SERIES G, V27, P213; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Barbara GM, 2003, FEMS MICROBIOL ECOL, V44, P79, DOI 10.1111/j.1574-6941.2003.tb01092.x; BATCHELOR GK, 1959, J FLUID MECH, V5, P113, DOI 10.1017/S002211205900009X; BELL W, 1972, BIOL BULL, V143, P265, DOI 10.2307/1540052; Blackburn N, 1997, LIMNOL OCEANOGR, V42, P613, DOI 10.4319/lo.1997.42.4.0613; Blackburn N, 1998, SCIENCE, V282, P2254, DOI 10.1126/science.282.5397.2254; Brentnall SJ, 2003, J PLANKTON RES, V25, P121, DOI 10.1093/plankt/25.2.121; Campbell BJ, 2011, P NATL ACAD SCI USA, V108, P12776, DOI 10.1073/pnas.1101405108; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; Ducklow H., 2000, MICROBIAL ECOLOGY OC, P85, DOI DOI 10.1002/9780470281840; Dusenbery D. B., 2009, LIVING MICROSCALE; Fenchel T, 2002, SCIENCE, V296, P1068, DOI 10.1126/science.1070118; Fenchel T, 2001, AQUAT MICROB ECOL, V24, P197, DOI 10.3354/ame024197; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Gardes A, 2011, ISME J, V5, P436, DOI 10.1038/ismej.2010.145; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Grossart HP, 2007, FEMS MICROBIOL LETT, V266, P194, DOI 10.1111/j.1574-6968.2006.00520.x; Grossart HP, 2001, AQUAT MICROB ECOL, V25, P247, DOI 10.3354/ame025247; Guasto JS, 2012, ANNU REV FLUID MECH, V44, P373, DOI 10.1146/annurev-fluid-120710-101156; Hutz A, 2011, APPL ENVIRON MICROB, V77, P4412, DOI 10.1128/AEM.00490-11; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Johansen JE, 2002, AQUAT MICROB ECOL, V28, P229, DOI 10.3354/ame028229; Kalisky T, 2011, NAT METHODS, V8, P311, DOI 10.1038/nmeth0411-311; KEIL RG, 1994, MAR CHEM, V45, P187, DOI 10.1016/0304-4203(94)90002-7; Kindler K, 2010, P NATL ACAD SCI USA, V107, P22163, DOI 10.1073/pnas.1012319108; Kiorboe T, 2001, LIMNOL OCEANOGR, V46, P1309, DOI 10.4319/lo.2001.46.6.1309; Kirchman D.L., 2008, MICROBIAL ECOLOGY OC, Vsecond; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Malfatti F, 2009, AQUAT MICROB ECOL, V58, P1, DOI 10.3354/ame01355; MCCARTHY JJ, 1979, SCIENCE, V203, P670, DOI 10.1126/science.203.4381.670; Miller TR, 2006, ENVIRON MICROBIOL, V8, P1648, DOI 10.1111/j.1462-2920.2006.01071.x; MITCHELL JG, 1995, APPL ENVIRON MICROB, V61, P877, DOI 10.1128/AEM.61.3.877-882.1995; Musat N, 2008, P NATL ACAD SCI USA, V105, P17861, DOI 10.1073/pnas.0809329105; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000; Seymour JR, 2010, AQUAT MICROB ECOL, V59, P161, DOI 10.3354/ame01400; Seymour JR, 2008, LIMNOL OCEANOGR-METH, V6, P477, DOI 10.4319/lom.2008.6.477; Seymour JR, 2000, AQUAT MICROB ECOL, V22, P143, DOI 10.3354/ame022143; Seymour JR, 2010, SCIENCE, V329, P342, DOI 10.1126/science.1188418; SMITH DC, 1992, NATURE, V359, P139, DOI 10.1038/359139a0; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Taylor JR, 2012, SCIENCE, V338, P675, DOI 10.1126/science.1219417; Wagner M, 2009, ANNU REV MICROBIOL, V63, P411, DOI 10.1146/annurev.micro.091208.073233; Xie L, 2011, P NATL ACAD SCI USA, V108, P2246, DOI 10.1073/pnas.1011953108; Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530	54	352	360	9	300	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107					628	633		10.1126/science.1208929	http://dx.doi.org/10.1126/science.1208929			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118182				2022-12-28	WOS:000310516000043
J	Marx, V				Marx, Vivien			READING THE SECOND GENOMIC CODE	NATURE			English	Editorial Material							CHROMATIN; CANCER; DNA											Byrum SD, 2012, CELL REP, V2, P198, DOI 10.1016/j.celrep.2012.06.019; Cipriany BR, 2012, P NATL ACAD SCI USA, V109, P8477, DOI 10.1073/pnas.1117549109; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ecker JR, 2012, NATURE, V489, P52, DOI 10.1038/489052a; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232	9	17	19	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2012	491	7422					143	146		10.1038/491143a	http://dx.doi.org/10.1038/491143a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	028PM	23128234	Bronze			2022-12-28	WOS:000310434500047
J	Pieters, CM; Ammannito, E; Blewett, DT; Denevi, BW; De Sanctis, MC; Gaffey, MJ; Le Corre, L; Li, JY; Marchi, S; McCord, TB; McFadden, LA; Mittlefehldt, DW; Nathues, A; Palmer, E; Reddy, V; Raymond, CA; Russell, CT				Pieters, C. M.; Ammannito, E.; Blewett, D. T.; Denevi, B. W.; De Sanctis, M. C.; Gaffey, M. J.; Le Corre, L.; Li, J. -Y.; Marchi, S.; McCord, T. B.; McFadden, L. A.; Mittlefehldt, D. W.; Nathues, A.; Palmer, E.; Reddy, V.; Raymond, C. A.; Russell, C. T.			Distinctive space weathering on Vesta from regolith mixing processes	NATURE			English	Article							ITOKAWA DUST PARTICLES; ASTEROID 4 VESTA; ORDINARY CHONDRITES; IRRADIATION; MORPHOLOGY; MINERALOGY; SURFACE; ALBEDO; BELT; DAWN	The surface of the asteroid Vesta has prominent near-infrared absorption bands characteristic of a range of pyroxenes, confirming a direct link to the basaltic howardite-eucrite-diogenite class of meteorites(1,2,3). Processes active in the space environment produce 'space weathering' products that substantially weaken or mask such diagnostic absorption on airless bodies observed elsewhere(4,5), and it has long been a mystery why Vesta's absorption bands are so strong. Analyses of soil samples from both the Moon(6) and the asteroid Itokawa(7) determined that nanophase metallic particles (commonly nanophase iron) accumulate on the rims of regolith grains with time, accounting for an observed optical degradation. These nanophase particles, believed to be related to solar wind and micrometeoroid bombardment processes, leave unique spectroscopic signatures that can be measured remotely(8-10) but require sufficient spatial resolution to discern the geologic context and history of the surface, which has not been achieved for Vesta until now. Here we report that Vesta shows its own form of space weathering, which is quite different from that of other airless bodies visited. No evidence is detected on Vesta for accumulation of lunar-like nanophase iron on regolith particles, even though distinct material exposed at several fresh craters becomes gradually masked and fades into the background as the craters age. Instead, spectroscopic data reveal that on Vesta a locally homogenized upper regolith is generated with time through small-scale mixing of diverse surface components.	[Pieters, C. M.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Ammannito, E.; De Sanctis, M. C.] ARTOV, INAF, Ist Astrofis & Planetol Spaziali, I-00133 Rome, Italy; [Blewett, D. T.; Denevi, B. W.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Gaffey, M. J.] Univ N Dakota, Dept Space Studies, Grand Forks, ND 58202 USA; [Le Corre, L.; Nathues, A.; Reddy, V.] Max Planck Inst Solar Syst Res, D-37191 Katlenburg Lindau, Germany; [Li, J. -Y.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Marchi, S.] NASA, Lunar Sci Inst, Boulder, CO 80302 USA; [McCord, T. B.] Bear Fight Inst, Winthrop, WA 98862 USA; [McFadden, L. A.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Mittlefehldt, D. W.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Palmer, E.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Raymond, C. A.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Russell, C. T.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA	Brown University; Istituto Nazionale Astrofisica (INAF); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of North Dakota Grand Forks; Max Planck Society; University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Los Angeles	Pieters, CM (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	carle_pieters@brown.edu	De Sanctis, Maria Cristina/G-5232-2013; McFadden, Lucy-Ann/I-4902-2013; Russell, Christopher T/E-7745-2012; Nathues, Andreas/AAW-4340-2020; Denevi, Brett W./I-6502-2012; Blewett, David T/I-4904-2012	De Sanctis, Maria Cristina/0000-0002-3463-4437; McFadden, Lucy-Ann/0000-0002-0537-9975; Russell, Christopher T/0000-0003-1639-8298; Denevi, Brett W./0000-0001-7837-6663; Blewett, David T/0000-0002-9241-6358; Reddy, Vishnu/0000-0002-7743-3491; Le Corre, Lucille/0000-0003-0349-7932; Li, Jian-Yang/0000-0003-3841-9977	NASA [NNM05AA86C]; NASA Dawn participating scientist programme	NASA(National Aeronautics & Space Administration (NASA)); NASA Dawn participating scientist programme	We acknowledge the Dawn Instrument, Flight and Operations teams for the successful development, cruise, orbital insertion and operations of the Dawn spacecraft at Vesta. US team members are supported by the NASA Discovery Program through contract NNM05AA86C to the University of California, Los Angeles and by the NASA Dawn participating scientist programme.	ADAMS JB, 1971, SCIENCE, V171, P567, DOI 10.1126/science.171.3971.567; Binzel RP, 2001, METEORIT PLANET SCI, V36, P1167, DOI 10.1111/j.1945-5100.2001.tb01950.x; BOTTKE WF, 1994, ICARUS, V107, P255, DOI 10.1006/icar.1994.1021; BRITT DT, 1994, GEOCHIM COSMOCHIM AC, V58, P3905, DOI 10.1016/0016-7037(94)90370-0; Chapman CR, 2004, ANNU REV EARTH PL SC, V32, P539, DOI 10.1146/annurev.earth.32.101802.120453; Clark BE, 2001, METEORIT PLANET SCI, V36, P1617, DOI 10.1111/j.1945-5100.2001.tb01853.x; Clark BE, 2002, ASTEROIDS, P585, DOI DOI 10.1016/0273-1177(91)90551-T; De Sanctis MC, 2012, SCIENCE, V336, P697, DOI 10.1126/science.1219270; Hapke B, 2001, J GEOPHYS RES-PLANET, V106, P10039, DOI 10.1029/2000JE001338; HIROI T, 1994, METEORITICS, V29, P394, DOI 10.1111/j.1945-5100.1994.tb00603.x; Hiroi T, 2006, NATURE, V443, P56, DOI 10.1038/nature05073; Jaumann R, 2012, SCIENCE, V336, P687, DOI 10.1126/science.1219122; Keller LP, 1997, GEOCHIM COSMOCHIM AC, V61, P2331, DOI 10.1016/S0016-7037(97)00085-9; Li J.-Y., 2012, P LUNAR PLANET SCI C, V43; Marchi S, 2005, ASTRON ASTROPHYS, V443, P769, DOI 10.1051/0004-6361:20053525; Marchi S, 2012, SCIENCE, V336, P690, DOI 10.1126/science.1218757; Matson D.L., 1977, P LUNAR PLANET SCI C, V8, P625; McCord T., NATURE; MCCORD TB, 1970, SCIENCE, V168, P1445, DOI 10.1126/science.168.3938.1445; Nakamura T, 2011, SCIENCE, V333, P1113, DOI 10.1126/science.1207758; Noble SK, 2007, ICARUS, V192, P629, DOI 10.1016/j.icarus.2007.07.021; Noble SK, 2010, METEORIT PLANET SCI, V45, P2007, DOI 10.1111/j.1945-5100.2010.01151.x; Noguchi T, 2011, SCIENCE, V333, P1121, DOI 10.1126/science.1207794; Pieters C. M., 2006, ASTEROIDS COMETS MET, P273; Pieters CM, 2009, CURR SCI INDIA, V96, P500; Pieters CM, 2000, METEORIT PLANET SCI, V35, P1101, DOI 10.1111/j.1945-5100.2000.tb01496.x; Reddy V, 2012, SCIENCE, V336, P700, DOI 10.1126/science.1219088; Russell CT, 2012, SCIENCE, V336, P684, DOI 10.1126/science.1219381; Sasaki S, 2001, NATURE, V410, P555, DOI 10.1038/35069013; Schenk P, 2012, SCIENCE, V336, P694, DOI 10.1126/science.1223272; Trombka JI, 2000, SCIENCE, V289, P2101, DOI 10.1126/science.289.5487.2101	31	102	103	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					79	82		10.1038/nature11534	http://dx.doi.org/10.1038/nature11534			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23128227				2022-12-28	WOS:000310434500033
J	Tulloch, J; David, B; Newman, RD; Meek, S				Tulloch, Jim; David, Benedict; Newman, Robert D.; Meek, Sylvia			Artemisinin-resistant malaria in the Asia-Pacific region	LANCET			English	Editorial Material									[Tulloch, Jim] Artemisinin Resistance Assessment Team, Adelaide, SA, Australia; [David, Benedict] Australian Agcy Int Dev, Canberra, ACT 2601, Australia; [Newman, Robert D.] WHO, Global Malaria Programme, CH-1211 Geneva, Switzerland; [Meek, Sylvia] Malaria Consortium, London, England	World Health Organization	David, B (corresponding author), Australian Agcy Int Dev, Canberra, ACT 2601, Australia.	benedict.david@ausaid.gov.au						[Anonymous], 2011, GLOB PLAN ART RES CO; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Faulde M, 2006, INT J MED MICROBIOL, V296, P225, DOI 10.1016/j.ijmm.2006.01.008; Malaria Consortium National Malaria Centre Ministry of Health Cambodia WHO, 2011, MOV MAL EL TOOLS STR; Meek S, 2011, JOINT ASSESSMENT RES; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; Roll Back Malaria, 2011, PROGR IMP SER, V7; Trape JF, 1998, CR ACAD SCI III-VIE, V321, P689, DOI 10.1016/S0764-4469(98)80009-7; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO - World Health Organization, 2012, UPD ART RES APR 2012; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601	11	14	14	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 1	2013	381	9881					E16	E17		10.1016/S0140-6736(12)61820-0	http://dx.doi.org/10.1016/S0140-6736(12)61820-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163EV	23122219				2022-12-28	WOS:000320319500001
J	Cohen, JA; Coles, AJ; Arnold, DL; Confavreux, C; Fox, EJ; Hartung, HP; Havrdova, E; Selmaj, KW; Weiner, HL; Fisher, E; Brinar, VV; Giovannoni, G; Stojanovic, M; Ertik, BI; Lake, SL; Margolin, DH; Panzara, MA; Compston, DAS				Cohen, Jeffrey A.; Coles, Alasdair J.; Arnold, Douglas L.; Confavreux, Christian; Fox, Edward J.; Hartung, Hans-Peter; Havrdova, Eva; Selmaj, Krzysztof W.; Weiner, Howard L.; Fisher, Elizabeth; Brinar, Vesna V.; Giovannoni, Gavin; Stojanovic, Miroslav; Ertik, Bella I.; Lake, Stephen L.; Margolin, David H.; Panzara, Michael A.; Compston, D. Alastair S.		CARE-MS I Investigators	Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial	LANCET			English	Article							THERAPEUTIC LYMPHOCYTE DEPLETION; INTRAMUSCULAR INTERFERON; FUNCTIONAL COMPOSITE; GLATIRAMER ACETATE; THYROID-NODULES; FOLLOW-UP; MS; MULTICENTER; DISABILITY; ANTIBODY	Background The anti-CD52 monoclonal antibody alemtuzumab reduced disease activity in a phase 2 trial of previously untreated patients with relapsing-remitting multiple sclerosis. We aimed to assess efficacy and safety of first-line alemtuzumab compared with interferon beta 1a in a phase 3 trial. Methods In our 2 year, rater-masked, randomised controlled phase 3 trial, we enrolled adults aged 18-50 years with previously untreated relapsing-remitting multiple sclerosis. Eligible participants were randomly allocated in a 2: 1 ratio by an interactive voice response system, stratified by site, to receive intravenous alemtuzumab 12 mg per day or subcutaneous interferon beta 1a 44 mu g. Interferon beta 1a was given three-times per week and alemtuzumab was given once per day for 5 days at baseline and once per day for 3 days at 12 months. Coprimary endpoints were relapse rate and time to 6 month sustained accumulation of disability in all patients who received at least one dose of study drug. This study is registered with ClinicalTrials.gov, number NCT00530348. Findings 187 (96%) of 195 patients randomly allocated interferon beta 1a and 376 (97%) of 386 patients randomly allocated alemtuzumab were included in the primary analyses. 75 (40%) patients in the interferon beta 1a group relapsed (122 events) compared with 82 (22%) patients in the alemtuzumab group (119 events; rate ratio 0.45 [95% CI 0.32-0.63]; p<0.0001), corresponding to a 54.9% improvement with alemtuzumab. Based on Kaplan-Meier estimates, 59% of patients in the interferon beta 1a group were relapse-free at 2 years compared with 78% of patients in the alemtuzumab group (p<0.0001). 20 (11%) of patients in the interferon beta 1a group had sustained accumulation of disability compared with 30 (8%) in the alemtuzumab group (hazard ratio 0.70 [ 95% CI 0.40-1.23]; p=0.22). 338 (90%) of patients in the alemtuzumab group had infusion-associated reactions; 12 (3%) of which were regarded as serious. Infections, predominantly of mild or moderate severity, occurred in 253 (67%) patients treated with alemtuzumab versus 85 (45%) patients treated with interferon beta 1a. 62 (16%) patients treated with alemtuzumab had herpes infections (predominantly cutaneous) compared with three (2%) patients treated with interferon beta 1a. By 24 months, 68 (18%) patients in the alemtuzumab group had thyroid-associated adverse events compared with 12 (6%) in the interferon beta 1a group, and three (1%) had immune thrombocytopenia compared with none in the interferon beta 1a group. Two patients in the alemtuzumab group developed thyroid papillary carcinoma. Interpretation Alemtuzumab's consistent safety profi le and benefit in terms of reductions of relapse support its use for patients with previously untreated relapsing-remitting multiple sclerosis; however, benefit in terms of disability endpoints noted in previous trials was not observed here.	[Cohen, Jeffrey A.] Cleveland Clin, Mellen Ctr, Cleveland, OH 44195 USA; [Fisher, Elizabeth] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Coles, Alasdair J.; Compston, D. Alastair S.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Arnold, Douglas L.] McGill Univ, Montreal Neurol Inst, NeuroRx Res, Montreal, PQ, Canada; [Arnold, Douglas L.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Confavreux, Christian] Univ Lyon 1, Hosp Civils Lyon, Serv Neurol A, F-69365 Lyon, France; [Fox, Edward J.] Cent Texas Neurol Consultants, MS Clin Cent Texas, Round Rock, TX USA; [Hartung, Hans-Peter] Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, Germany; [Havrdova, Eva] Charles Univ Prague, Sch Med 1, Dept Neurol, Prague, Czech Republic; [Selmaj, Krzysztof W.] Med Univ Lodz, Dept Neurol, Lodz, Poland; [Weiner, Howard L.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Brinar, Vesna V.] Zagreb Med Sch, Zagreb, Croatia; [Brinar, Vesna V.] Univ Hosp Ctr, Zagreb, Croatia; [Giovannoni, Gavin] Queen Mary Univ London, Blizard Inst, London, England; [Giovannoni, Gavin] London Sch Med & Dent, London, England; [Stojanovic, Miroslav] Clin Ctr Kragujevac, Neurol Clin, Kragujevac, Serbia; [Ertik, Bella I.; Lake, Stephen L.; Margolin, David H.; Panzara, Michael A.] Genzyme, Cambridge, MA USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Cambridge; McGill University; McGill University; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Heinrich Heine University Dusseldorf; Charles University Prague; Medical University Lodz; Harvard University; Brigham & Women's Hospital; University of Zagreb; University of Zagreb; University of London; Queen Mary University London; University of London; Queen Mary University London; Sanofi-Aventis; Genzyme Corporation	Cohen, JA (corresponding author), Cleveland Clin, Neurol Inst, Mellen Ctr U 10, 9500 Euclid Ave, Cleveland, OH 44195 USA.	cohenj@ccf.org	Havrdova, Eva Kubala/P-4892-2017; Goodman, Andrew D/N-3974-2018; McCombe, Pamela/C-9692-2010; Calabrese, Massimiliano/I-6195-2012; Orzheshkovskyi, Vasyl/G-7283-2012; Macedo, Ana/L-9912-2018; Kovarova, Ivana/P-5201-2017; Snydman, David R/O-3889-2014; Nehrych, Tetyana I/L-7555-2016	Havrdova, Eva Kubala/0000-0002-9543-4359; McCombe, Pamela/0000-0003-2704-8517; Orzheshkovskyi, Vasyl/0000-0002-9033-0753; Macedo, Ana/0000-0002-6978-8989; Kovarova, Ivana/0000-0002-1568-5749; Snydman, David R/0000-0003-0119-3978; Nehrych, Tetyana I/0000-0003-0170-511X; Arnold, Douglas/0000-0003-4266-0106; Selmaj, Krzysztof/0000-0003-1213-7218; antel, jack/0000-0002-5148-0636; Reddel, Stephen/0000-0002-0169-3350; Lycke, Jan/0000-0002-7891-8466; Panzara, Michael/0000-0003-2810-4832; Coles, Alasdair/0000-0003-4738-0760; Vucic, Steve/0000-0002-8323-873X	Genzyme (Sanofi); Bayer Schering Pharma; Biogen Idec; Elan; Five Prime Therapeutics; Lilly; Novartis; Teva; Vaccinex; Waterfront Media; Genzyme; Merck Serono; Bayer; Coronado Biosciences; Consortium of Multiple Sclerosis Centers; Eli Lilly; EMD Serono; Genentech; GlaxoSmithKline; MS Forum; NeuroRx Research; Opexa Therapeutics; Roche; SA Serono Symposia International Foundation; Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Sanofi-Aventis; UCB; Bayer-Schering; Octopharma; Ono; National Institute for Health Research [NF-SI-0508-10335] Funding Source: researchfish	Genzyme (Sanofi)(Sanofi-AventisGenzyme Corporation); Bayer Schering Pharma(Bayer AG); Biogen Idec(Biogen); Elan; Five Prime Therapeutics; Lilly(Eli Lilly); Novartis(Novartis); Teva(Teva Pharmaceutical Industries); Vaccinex; Waterfront Media; Genzyme(Sanofi-AventisGenzyme Corporation); Merck Serono(Merck & Company); Bayer(Bayer AG); Coronado Biosciences; Consortium of Multiple Sclerosis Centers; Eli Lilly(Eli Lilly); EMD Serono; Genentech(Roche HoldingGenentech); GlaxoSmithKline(GlaxoSmithKline); MS Forum; NeuroRx Research; Opexa Therapeutics; Roche(Roche Holding); SA Serono Symposia International Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada; Sanofi-Aventis(Sanofi-Aventis); UCB(UCB Pharma SA); Bayer-Schering(Bayer AG); Octopharma; Ono; National Institute for Health Research(National Institute for Health Research (NIHR))	Genzyme (Sanofi) and Bayer Schering Pharma.; JAC reports receiving consulting fees from Biogen Idec, Elan, Five Prime Therapeutics, Lilly, Novartis, Teva, and Vaccinex; lecture fees from Novartis and Waterfront Media; and research support paid to his institution from Biogen Idec, Genzyme, Novartis, and Teva. AJC reports receiving consulting fees from Genzyme, lecture fees from Merck Serono, and research support paid to his institution from Genzyme. DLA reports having served on advisory boards, received speaker honoraria, served as a consultant, or received research support from Bayer, Biogen Idec, Coronado Biosciences, Consortium of Multiple Sclerosis Centers, Eli Lilly, EMD Serono, Genentech, GlaxoSmithKline, MS Forum, NeuroRx Research, Novartis, Opexa Therapeutics, Roche, Merck Serono, SA Serono Symposia International Foundation, Teva, the Canadian Institutes of Health Research, and the Multiple Sclerosis Society of Canada; and holds stock in NeuroRx Research. CC reports receiving consulting fees from Biogen Idec, Gemacbio, Genzyme, Novartis, Sanofi-Aventis, Teva, and UCB; lecture fees from Bayer-Schering, Biogen Idec, Genzyme, Merck Serono, Novartis, Octopharma, Sanofi-Aventis, and Teva; and research support paid to his institution from Bayer Schering, Biogen Idec, Merck Serono, Novartis, Sanofi-Aventis, and Teva. EJF reports receiving consulting fees, honoraria, travel, or research support from Acorda, Bayer, Biogen Idec, Eli Lilly, EMD Serono, Genzyme, GlaxoSmithKline, Novartis, Ono, Opexa Therapeutics, Pfizer, Roche, Sanofi, and Teva. H-PH reports receiving honoraria for consulting and speaking, with approval by the Rector of Heinrich-Heine University, from Bayer, Biogen Idec, Genzyme, Merck Serono, Novartis, Sanofi-Aventis, and Teva. EH reports receiving consulting fees, honoraria, travel, and research support from Bayer, Biogen Idec, Genzyme, GSK, Merck Serono, Novartis, Roche, and Teva. KWS reports receiving consulting fees from Biogen Idec, Genzyme, Novartis, and Roche; lecture fees from Bayer, Biogen Idec, Merck Serono, and Novartis; and financial compensation including travel from Genzyme for presentation at ECTRIMS in 2010. HLW reports receiving consulting fees from Biogen Idec, EMD Serono, Nasvax, Novartis, and Teva and research support paid to his institution from Biogen Idec and EMD Serono. EF reports receiving consulting fees from Biogen Idec, Genzyme, Pfizer, and Wyeth; lecture fees from Biogen Idec and Teva; and research support paid to her institution from Biogen Idec, Genzyme, and Wyeth. VVB reports no conflicts of interest. GG reports receiving compensation for participating in advisory boards, trial steering committees, and trial data and safety monitoring boards from Bayer Schering Healthcare, Biogen Idec, Eisai, Elan, Fiveprime, Genzyme, Genentech, GSK, GW Pharma, Ironwood, Merck Serono, Novartis, Pfizer, Roche, Sanofi-Aventis, Synthon BV, Teva, UCB Pharma, and Vertex Pharmaceuticals and research grant support from Bayer-Schering Healthcare, Biogen Idec, GW Pharma, Merck Serono, Merz, Novartis, Teva, and Sanofi -Aventis. MS reports no conflicts of interest. BIE, SLL, DHM, and MAP receive personal compensation as employees of Genzyme (a Sanofi company). DASC reports receiving consulting fees, lecture fees, and grant support from Genzyme, and lecture fees from Bayer Schering Pharma, on behalf of the University of Cambridge (Cambridge, UK).	Anil C, 2010, THYROID, V20, P601, DOI 10.1089/thy.2009.0450; Berker D, 2011, ENDOCRINE, V39, P13, DOI 10.1007/s12020-010-9405-6; Clanet M, 2002, NEUROLOGY, V59, P1507, DOI 10.1212/01.WNL.0000032256.35561.D6; Clark RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003008; Cohen JA, 2001, ARCH NEUROL-CHICAGO, V58, P961, DOI 10.1001/archneur.58.6.961; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Coles AJ, 2012, NEUROLOGY, V78, P1069, DOI 10.1212/WNL.0b013e31824e8ee7; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; Coles AJ, 2006, J NEUROL, V253, P98, DOI 10.1007/s00415-005-0934-5; Coles AJ, 2012, LANCET; Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670; Comi G, 2011, ANN NEUROL, V69, P75, DOI 10.1002/ana.22316; Cox AL, 2005, EUR J IMMUNOL, V35, P3332, DOI 10.1002/eji.200535075; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Hochberg Y., 1987, MULTIPLE COMP PROCED; Hu YP, 2009, IMMUNOLOGY, V128, P260, DOI 10.1111/j.1365-2567.2009.03115.x; *INT C HARM, ICH HARM TRIP GUID G; Jones JL, 2009, J CLIN INVEST, V119, P2052, DOI 10.1172/JCI37878; Kappos L, 2007, LANCET, V370, P389, DOI 10.1016/S0140-6736(07)61194-5; Kawade Y, 2003, J IMMUNOL METHODS, V278, P127, DOI 10.1016/S0022-1759(03)00203-5; Kim WB, 2004, CLIN ENDOCRINOL, V60, P719, DOI 10.1111/j.1365-2265.2004.02043.x; Kinkel RP, 2012, ARCH NEUROL-CHICAGO, V69, P183, DOI 10.1001/archneurol.2011.1426; Kraimps JL, 2000, BRIT J SURG, V87, P1111, DOI 10.1046/j.1365-2168.2000.01504.x; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LACHIN JM, 1992, STAT MED, V11, P1151, DOI 10.1002/sim.4780110903; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lin DY, 2000, J ROY STAT SOC B, V62, P711, DOI 10.1111/1467-9868.00259; Mikol DD, 2008, LANCET NEUROL, V7, P903, DOI 10.1016/S1474-4422(08)70200-X; MOREAU T, 1994, LANCET, V344, P298, DOI 10.1016/S0140-6736(94)91339-0; O'Connor P, 2009, LANCET NEUROL, V8, P889, DOI 10.1016/S1474-4422(09)70226-1; Panitch H, 2002, NEUROLOGY, V59, P1496, DOI 10.1212/01.WNL.0000034080.43681.DA; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Thompson SAJ, 2010, J CLIN IMMUNOL, V30, P99, DOI 10.1007/s10875-009-9327-3; Wang YC, 2009, J NEUROL SCI, V285, P206, DOI 10.1016/j.jns.2009.07.017; WEI LJ, 1984, J AM STAT ASSOC, V79, P653, DOI 10.2307/2288413; World Medical Association, DECL HELS ETH PRINC	37	791	808	2	91	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2012	380	9856					1819	1828		10.1016/S0140-6736(12)61769-3	http://dx.doi.org/10.1016/S0140-6736(12)61769-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	041XK	23122652				2022-12-28	WOS:000311435000027
J	Dietrich, MO; Horvath, TL				Dietrich, Marcelo O.; Horvath, Tamas L.			Phosphoribosomes for Fingerprinting Neurons	CELL			English	Editorial Material							TOOLBOX	The mammalian brain comprises a diverse variety of cell types. Fine characterization of specific subpopulations of neurons, however, has been a technical challenge. Here, Knight et al. describe an elegant technique for high throughput of molecular profiling of activated hypothalamic neurons.	[Dietrich, Marcelo O.; Horvath, Tamas L.] Yale Univ, Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, Comparat Med Sect, New Haven, CT 06520 USA; [Dietrich, Marcelo O.] Univ Fed Rio Grande do Sul, Dept Biochem, BR-90035 Porto Alegre, RS, Brazil	Yale University; Universidade Federal do Rio Grande do Sul	Horvath, TL (corresponding author), Yale Univ, Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, Comparat Med Sect, 333 Cedar St, New Haven, CT 06520 USA.	tamas.horvath@yale.edu	Dietrich, Marcelo/A-9928-2009	Dietrich, Marcelo/0000-0001-9781-2221	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP1DK098058] Funding Source: NIH RePORTER; NIDDK NIH HHS [DP1 DK098058] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Fuente-Martin E, 2012, J CLIN INVEST, V122, P3900, DOI 10.1172/JCI64102; Geffers L, 2012, MAMM GENOME, V23, P525, DOI 10.1007/s00335-012-9413-3; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Horvath TL, 2010, P NATL ACAD SCI USA, V107, P14875, DOI 10.1073/pnas.1004282107; Knight ZA, 2012, CELL, V151, P1126, DOI 10.1016/j.cell.2012.10.039; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	10	1	1	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 21	2012	151	5					934	936		10.1016/j.cell.2012.11.006	http://dx.doi.org/10.1016/j.cell.2012.11.006			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178116	Bronze			2022-12-28	WOS:000311423500008
J	Vahedi, G; Takahashi, H; Nakayamada, S; Sun, HW; Sartorelli, V; Kanno, Y; O'Shea, JJ				Vahedi, Golnaz; Takahashi, Hayato; Nakayamada, Shingo; Sun, Hong-wei; Sartorelli, Vittorio; Kanno, Yuka; O'Shea, John J.			STATs Shape the Active Enhancer Landscape of T Cell Populations	CELL			English	Article							CHIP-SEQ DATA; TRANSCRIPTION FACTOR; GENE-EXPRESSION; REGULATORY ELEMENTS; LINEAGE COMMITMENT; RNA-SEQ; BET; DIFFERENTIATION; IDENTIFICATION; ACCESSIBILITY	Signaling pathways are intimately involved in cellular differentiation, allowing cells to respond to their environment by regulating gene expression. Although enhancers are recognized as key elements that regulate selective gene expression, the interplay between signaling pathways and actively used enhancer elements is not clear. Here, we use CD4(+) T cells as a model of differentiation, mapping the activity of cell-type-specific enhancer elements in T helper 1 (Th1) and Th2 cells. Our data establish that STAT proteins have a major impact on the activation of lineage-specific enhancers and the suppression of enhancers associated with alternative cell fates. Transcriptome analysis further supports a functional role for enhancers regulated by STATs. Importantly, expression of lineage-defining master regulators in STAT-deficient cells fails to fully recover the chromatin signature of STAT-dependent enhancers. Thus, these findings point to a critical role of STATs as environmental sensors in dynamically molding the specialized enhancer architecture of differentiating cells.	[Vahedi, Golnaz; Takahashi, Hayato; Nakayamada, Shingo; Kanno, Yuka; O'Shea, John J.] NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Sun, Hong-wei] NIAMSD, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA; [Sartorelli, Vittorio] NIAMSD, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Kanno, Y (corresponding author), NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	kannoy@mail.nih.gov	Takahashi, Hayato/AAV-7707-2021; Kanno, Yuka/B-5802-2013	Takahashi, Hayato/0000-0001-6768-8821; Kanno, Yuka/0000-0001-5668-9319; Sartorelli, Vittorio/0000-0002-9284-3675	Intramural Research Programs of NIAMS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041164, ZIAAR041159, ZIHAR041173, Z01AR041159] Funding Source: NIH RePORTER	Intramural Research Programs of NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Drs. K. Zhao, A. Poholek, and K. Ghoreschi for critically reading this manuscript. We also thank G. Gutierrez-Cruz (Biodata Mining Core Facility, NIAMS), J. Simone, and J. Lay (Flow Cytometry Section, NIAMS) for their excellent technical support. This study utilized the high-performance computational capabilities of the Biowulf Linux cluster at the NIH. This work was supported by the Intramural Research Programs of NIAMS.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Balasubramani A, 2010, IMMUNITY, V33, P35, DOI 10.1016/j.immuni.2010.07.004; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Chong MMW, 2010, GENE DEV, V24, P659, DOI 10.1101/gad.1901610; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Kashiwada M, 2011, EMBO J, V30, P2071, DOI 10.1038/emboj.2011.111; Krebs AR, 2011, MOL CELL, V44, P410, DOI 10.1016/j.molcel.2011.08.037; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nicolas CS, 2012, NEURON, V73, P374, DOI 10.1016/j.neuron.2011.11.024; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Smale ST, 2010, IMMUNITY, V32, P296, DOI 10.1016/j.immuni.2010.03.011; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Watson CJ, 2008, SEMIN CELL DEV BIOL, V19, P401, DOI 10.1016/j.semcdb.2008.07.021; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	41	251	254	1	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 21	2012	151	5					981	993		10.1016/j.cell.2012.09.044	http://dx.doi.org/10.1016/j.cell.2012.09.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178119	Bronze, Green Accepted			2022-12-28	WOS:000311423500012
J	Kepros, J				Kepros, John			An 8-factor prognostic model predicted early death in patients with traumatic bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Michigan State Univ, Sparrow Hosp, Lansing, MI 48824 USA	Michigan State University	Kepros, J (corresponding author), Michigan State Univ, Sparrow Hosp, Lansing, MI 48824 USA.							Fueglistaler P, 2010, AM J SURG, V200, P204, DOI 10.1016/j.amjsurg.2009.08.035; Rehn M, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-17; Rogers FB, 2012, J TRAUMA ACUTE CARE, V73, P326, DOI 10.1097/TA.0b013e31825a7758; Sasser Scott M., 2009, Morbidity and Mortality Weekly Report, V58, P1	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10							JC5-13	10.7326/0003-4819-157-10-201211200-02013	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043VZ	23165689				2022-12-28	WOS:000311580000012
J	Hoy, RR				Hoy, Ronald R.			Convergent Evolution of Hearing	SCIENCE			English	Editorial Material									Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Cornell University	Hoy, RR (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	rrh3@cornell.edu			NIDCD NIH HHS [R01 DC000103] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000103] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BALL E, 1974, Z ZELLFORSCH MIK ANA, V147, P313, DOI 10.1007/BF00307467; Fay R. R., 2004, EVOLUTION VERTEBRATE; Gwynne Darryl T., 1995, Journal of Orthoptera Research, V4, P203; Michelsen A., 1998, HDB AUDITORY RES COM; Montealegre-Z F, 2012, SCIENCE, V338, P968, DOI 10.1126/science.1225271; OLDFIELD BP, 1982, J COMP PHYSIOL, V147, P461, DOI 10.1007/BF00612011; Pickles JO, 2012, INTRO PHYSL HEARING; vonBekesy G., 1960, EXPT HEARING; Yost W A., 2006, FUNDAMENTALS HEARING	9	3	4	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					894	895		10.1126/science.1231169	http://dx.doi.org/10.1126/science.1231169			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161985				2022-12-28	WOS:000311083600029
J	Kalager, M; Tamimi, RM; Bretthauer, M; Adami, HO				Kalager, Mette; Tamimi, Rulla M.; Bretthauer, Michael; Adami, Hans-Olov			Prognosis in women with interval breast cancer: population based observational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SCREENING-PROGRAM; TRUE INTERVAL; SURVIVAL; MAMMOGRAPHY; COMPLETENESS; FEATURES; REGISTRY; 10-YEAR; NORWAY; TIME	Objective To compare the prognosis in women with interval breast cancer (cancer detected after a normal screening mammogram and before the next scheduled mammogram) with breast cancer detected among women not yet invited to mammography screening (non-screened). Design Population based observational study. Setting Norwegian breast cancer screening programme, implemented in different counties from 1996 to 2005. Participants 7116 women with a diagnosis of breast cancer at age 50 to 72 years; 1816 had interval breast cancer and 5300 had a diagnosis of breast cancer but had not yet been invited to screening. Main outcome measures Characteristics of the breast tumours, and survival of the women using Kaplan Meier curves and multivariable Cox proportional hazard models. Results Although interval cancers on average were slightly larger than the cancers in women not invited to screening, the histological type or status of axilliary lymph nodes did not differ noticeably between the two groups. Among interval cancers, there were no appreciable trends in size, nodal status, grade, or hormone receptor positivity associated with time since the last normal mammogram as a marker of growth rate. After 10 years of follow-up, the survival rates were 79.1% (95% confidence interval 75.4% to 82.3%) among women with interval cancers and 76.8% (75.3% to 78.2%) among women in the non-screened cancer group (hazard ratio 0.98, 95% confidence interval 0.84 to 1.15; P=0.53). Analyses stratified by time since last normal mammogram, age at diagnosis, or screening round showed similar results. Conclusion The prognosis of women with interval breast cancers was the same as that of women with breast cancers diagnosed without mammography screening.	[Kalager, Mette; Tamimi, Rulla M.; Adami, Hans-Olov] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kalager, Mette; Bretthauer, Michael] Univ Oslo, Fac Med, Inst Hlth & Soc, Oslo, Norway; [Kalager, Mette] Telemark Hosp, Dept Clin Res, Skien, Norway; [Tamimi, Rulla M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab,Dept Med, Boston, MA 02115 USA; [Bretthauer, Michael] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Organ Transplantat, N-0027 Oslo, Norway; [Adami, Hans-Olov] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Harvard University; Harvard T.H. Chan School of Public Health; University of Oslo; Telemark Hospital Trust; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Oslo; National Hospital Norway; Karolinska Institutet	Kalager, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	mkalager@hsph.harvard.edu			Norwegian Research Council and Frontier Science	Norwegian Research Council and Frontier Science	This study was funded by research grants from the Norwegian Research Council and Frontier Science. The funders had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; and the preparation, review, or approval of the manuscript.	ANDERSSON I, 1988, BRIT MED J, V297, P943, DOI 10.1136/bmj.297.6654.943; Bordas P, 2007, BREAST, V16, P47, DOI 10.1016/j.breast.2006.05.006; BREKELMANS CT, 1995, EUR J CANCER, V31A, P1830, DOI 10.1016/0959-8049(95)00324-C; Collett K, 2005, CANCER EPIDEM BIOMAR, V14, P1108, DOI 10.1158/1055-9965.EPI-04-0394; Collins S, 1998, BRIT MED J, V316, P832, DOI 10.1136/bmj.316.7134.832; Cowan WK, 2000, J CLIN PATHOL, V53, P140, DOI 10.1136/jcp.53.2.140; DEGROOTE R, 1983, SURGERY, V94, P543; Domingo L, 2010, CANCER CAUSE CONTROL, V21, P1155, DOI 10.1007/s10552-010-9541-6; Edge SB, 2010, AJCC CANC STAGING MA; ERZAAS A, 2003, QUALITY ASSURANCE MA; FEINSTEIN AR, 1985, NEW ENGL J MED, V312, P1604, DOI 10.1056/NEJM198506203122504; FRISELL J, 1992, BREAST CANCER RES TR, V24, P11, DOI 10.1007/BF01832353; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Gilliland FD, 2000, J NATL CANCER I, V92, P743, DOI 10.1093/jnci/92.9.743; Hofvind S, 2008, ACTA RADIOL, V49, P975, DOI 10.1080/02841850802403730; Hofvind S, 2005, RADIOLOGY, V237, P437, DOI 10.1148/radiol.2372041174; HOLMBERG LH, 1986, LANCET, V2, P27; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Kalager M, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2331; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; Lawrence G, 2009, J MED SCREEN, V16, P186, DOI 10.1258/jms.2009.009040; PERRY NM, 1996, EUROPEAN GUIDELINES; Porter GJR, 2006, J MED SCREEN, V13, P115, DOI 10.1258/096914106778440572; Rayson D, 2011, CLIN BREAST CANCER, V11, P27, DOI 10.3816/CBC.2011.n.005; Schroen AA, 1996, J SURG ONCOL, V63, P141, DOI 10.1002/(SICI)1096-9098(199611)63:3<141::AID-JSO2>3.0.CO;2-D; SHAPIRO S, 1982, JNCI-J NATL CANCER I, V69, P349; Sihto H, 2008, CLIN CANCER RES, V14, P4103, DOI 10.1158/1078-0432.CCR-07-5003; Tingulstad S, 2002, INT J CANCER, V98, P907, DOI 10.1002/ijc.10254; Vitak B, 1999, EUR RADIOL, V9, P460, DOI 10.1007/s003300050693; Vitak B, 1997, EUR J CANCER, V33, P1453, DOI 10.1016/S0959-8049(97)00185-8; Vitak B, 1998, EUR RADIOL, V8, P639, DOI 10.1007/s003300050452; Wang H, 2001, CANCER CAUSE CONTROL, V12, P39, DOI 10.1023/A:1008999403069; Wang HG, 2001, INT J CANCER, V94, P594, DOI 10.1002/ijc.1511; Zackrisson S, 2007, J MED SCREEN, V14, P138, DOI 10.1258/096914107782066239	34	27	28	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 16	2012	345								e7536	10.1136/bmj.e7536	http://dx.doi.org/10.1136/bmj.e7536			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040QI	23160783	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000311337500001
J	Delamothe, T				Delamothe, Tony			ON THE CONTRARY Let us now praise famous men and women	BRITISH MEDICAL JOURNAL			English	Editorial Material							SMOKING					tdelamothe@bmj.com						Delamothe T, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2029; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; Hawkes N, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1428; HILL AB, 1951, BRIT MED J, V2, P1157, DOI 10.1136/bmj.2.4740.1157-c; Keating C., 2009, SMOKING KILLS REVOLU; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Sakata R, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7093	7	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 13	2012	345								e7605	10.1136/bmj.e7605	http://dx.doi.org/10.1136/bmj.e7605			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040PU	23150474				2022-12-28	WOS:000311335800014
J	Schlipalius, DI; Valmas, N; Tuck, AG; Jagadeesan, R; Ma, L; Kaur, R; Goldinger, A; Anderson, C; Kuang, JJ; Zuryn, S; Mau, YS; Cheng, Q; Collins, PJ; Nayak, MK; Schirra, HJ; Hilliard, MA; Ebert, PR				Schlipalius, David I.; Valmas, Nicholas; Tuck, Andrew G.; Jagadeesan, Rajeswaran; Ma, Li; Kaur, Ramandeep; Goldinger, Anita; Anderson, Cameron; Kuang, Jujiao; Zuryn, Steven; Mau, Yosep S.; Cheng, Qiang; Collins, Patrick J.; Nayak, Manoj K.; Schirra, Horst Joachim; Hilliard, Massimo A.; Ebert, Paul R.			A Core Metabolic Enzyme Mediates Resistance to Phosphine Gas	SCIENCE			English	Article							DOMINICA F COLEOPTERA; LESSER GRAIN BORER; RHYZOPERTHA-DOMINICA; CAENORHABDITIS-ELEGANS; COMPARATIVE TOXICITY; DEHYDROGENASE; BOSTRYCHIDAE; STRAINS	Phosphine is a small redox-active gas that is used to protect global grain reserves, which are threatened by the emergence of phosphine resistance in pest insects. We find that polymorphisms responsible for genetic resistance cluster around the redox-active catalytic disulfide or the dimerization interface of dihydrolipoamide dehydrogenase (DLD) in insects (Rhyzopertha dominica and Tribolium castaneum) and nematodes (Caenorhabditis elegans). DLD is a core metabolic enzyme representing a new class of resistance factor for a redox-active metabolic toxin. It participates in four key steps of core metabolism, and metabolite profiles indicate that phosphine exposure in mutant and wild-type animals affects these steps differently. Mutation of DLD in C. elegans increases arsenite sensitivity. This specific vulnerability may be exploited to control phosphine-resistant insects and safeguard food security.	[Valmas, Nicholas; Hilliard, Massimo A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Schlipalius, David I.; Tuck, Andrew G.; Kuang, Jujiao; Collins, Patrick J.; Nayak, Manoj K.] Agri Sci Queensland, Dept Agr Fisheries & Forestry, Ecosci Precinct, Brisbane, Qld 4001, Australia; [Schlipalius, David I.; Tuck, Andrew G.; Jagadeesan, Rajeswaran; Ma, Li; Kaur, Ramandeep; Ebert, Paul R.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Schlipalius, David I.; Tuck, Andrew G.; Collins, Patrick J.; Nayak, Manoj K.] Cooperat Res Ctr Natl Plant Biosecur, Bruce, ACT 2617, Australia; [Valmas, Nicholas; Goldinger, Anita; Anderson, Cameron; Zuryn, Steven; Mau, Yosep S.; Cheng, Qiang; Schirra, Horst Joachim; Ebert, Paul R.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Mau, Yosep S.] Univ Nusa Cendana, Fac Agr, Kupang 85001, NTT, Indonesia; [Schirra, Horst Joachim] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia	University of Queensland; Queensland Department of Agriculture & Fisheries; University of Queensland; University of Queensland; Nippon Telegraph & Telephone Corporation; Universitas Nusa Cendana; University of Queensland	Hilliard, MA (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	m.hilliard@uq.edu.au; p.ebert@uq.edu.au	Schlipalius, David/B-8155-2011; Jagadeesan, Rajeswaran/K-8804-2019; Mau, Yosep Seran/GNP-4795-2022; Schirra, Horst Joachim/B-4210-2009; Mau, Yosep Seran/AAC-4003-2021; Zuryn, Steven/C-7967-2018; Goldinger, Anita/K-9171-2018	Schlipalius, David/0000-0002-8102-7031; Mau, Yosep Seran/0000-0001-6654-5407; Schirra, Horst Joachim/0000-0002-7541-246X; Zuryn, Steven/0000-0002-3551-6790; Goldinger, Anita/0000-0002-7688-1823; Ebert, Paul/0000-0002-4435-0737; Jagadeesan, Rajeswaran/0000-0002-9890-5953; Valmas, Nicholas/0000-0002-6925-9673; Hilliard, Massimo A/0000-0001-7458-5812; Kuang, Jujiao/0000-0002-1366-0089	Cooperative Research Centre for National Plant Biosecurity [CRC20080, CRC50150]; Australian Research Council (ARC) [DP0558507]; Grains Research and Development Corporation [UQ00010]; National Institutes of Health [R01NS060129]; National Health and Medical Research Council [569500]; ARC Future Fellowship; Queensland Smart State Fellowship; Australian Postgraduate Award scholarships; University of Queensland Research Scholarship; AusAid scholarship; NIH National Center for Research Resources; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060129] Funding Source: NIH RePORTER	Cooperative Research Centre for National Plant Biosecurity(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Research Council (ARC)(Australian Research Council); Grains Research and Development Corporation(Grains R&D Corp); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC Future Fellowship(Australian Research Council); Queensland Smart State Fellowship; Australian Postgraduate Award scholarships; University of Queensland Research Scholarship(University of Queensland); AusAid scholarship; NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Cooperative Research Centre for National Plant Biosecurity (CRC20080 and CRC50150) (D.I.S.); Australian Research Council (ARC) (DP0558507) and Grains Research and Development Corporation (UQ00010) (P.R.E.); National Institutes of Health (R01NS060129), National Health and Medical Research Council (PG# 569500), and ARC Future Fellowship (M.A.H.); Queensland Smart State Fellowship (H.J.S.); Australian Postgraduate Award scholarships (N.V., S.Z., and J.K.); University of Queensland Research Scholarship (Q.C., R.J., and R.K.); and AusAid scholarship (Y.S.M.). Sequence accession numbers (JX434596 to JX434608). We thank R. Tweedale, P. Bazzicalupo, and R. Tellam for comments and R. Barrero, H. Pavic, L. Bond, L. Kirszenblat, P. Mugno-Ramirez, A. Johnston, N. Mathew, and M. Mathew for technical assistance. Nematode strains provided by the Caenorhabditis Genetics Center, funded by the NIH National Center for Research Resources. NMR data acquired at the Queensland NMR Network and University of Queensland-Institute of Molecular Bioscience NMR facilities. Author contribution statement: N.V., L.M., A.G.T., S.Z, J.K., Q.C., M.A.H., and P.R.E. provided data and analysis for C. elegans. R.J., R.K., A.G.T., and D.I.S. provided data and analysis for R. dominica and T. castaneum. H.J.S., A.G., and C.A. provided metabolomics data and analysis. H.J.S. performed homology modeling. P.J.C. and M.K.N. provided insect strains and phenotype data. D.I.S., N.V., H.J.S., M.A.H., and P.R.E. drafted the manuscript.	Benhalima H, 2004, J STORED PROD RES, V40, P241, DOI 10.1016/S0022-474X(03)00012-2; Bergquist ER, 2009, J ORGANOMET CHEM, V694, P973, DOI 10.1016/j.jorganchem.2008.12.028; Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; CHAUDHRY MQ, 1991, COMP BIOCHEM PHYS C, V99, P41, DOI 10.1016/0742-8413(91)90072-2; Chen WH, 2010, PLANT PHYSIOL, V153, P1385, DOI 10.1104/pp.110.153452; Cheng Q, 2003, TOXICOL SCI, V73, P60, DOI 10.1093/toxsci/kfg049; Collins PJ, 2005, J STORED PROD RES, V41, P373, DOI 10.1016/j.jspr.2004.05.002; Collins PJ, 2002, J ECON ENTOMOL, V95, P862, DOI 10.1603/0022-0493-95.4.862; Jagadeesan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031582; Lorini I, 2007, PEST MANAG SCI, V63, P358, DOI 10.1002/ps.1344; Mau YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034027; Mau YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031541; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; ROBINSON JR, 1970, J STORED PROD RES, V6, P133, DOI 10.1016/0022-474X(70)90002-0; Schlipalius DI, 2008, HEREDITY, V100, P506, DOI 10.1038/hdy.2008.4; Valmas N, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000130; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Zuryn S, 2008, TOXICOL SCI, V102, P179, DOI 10.1093/toxsci/kfm278	18	102	110	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					807	810		10.1126/science.1224951	http://dx.doi.org/10.1126/science.1224951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139334				2022-12-28	WOS:000310839500047
J	Nielsen, SF; Nordestgaard, BG; Bojesen, SE				Nielsen, Sune F.; Nordestgaard, Borge G.; Bojesen, Stig E.			Statin Use and Reduced Cancer-Related Mortality	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HMG-COA REDUCTASE; BREAST-CANCER; MEVALONATE PATHWAY; PROSPECTIVE COHORT; CELL-GROWTH; RISK; CHOLESTEROL; RECURRENCE; INHIBITORS; DRUGS	BACKGROUND A reduction in the availability of cholesterol may limit the cellular proliferation required for cancer growth and metastasis. We tested the hypothesis that statin use begun before a cancer diagnosis is associated with reduced cancer-related mortality. METHODS We assessed mortality among patients from the entire Danish population who had received a diagnosis of cancer between 1995 and 2007, with follow-up until December 31, 2009. Among patients 40 years of age or older, 18,721 had used statins regularly before the cancer diagnosis and 277,204 had never used statins. RESULTS Multivariable-adjusted hazard ratios for statin users, as compared with patients who had never used statins, were 0.85 (95% confidence interval [CI], 0.83 to 0.87) for death from any cause and 0.85 (95% CI, 0.82 to 0.87) for death from cancer. Adjusted hazard ratios for death from any cause according to the defined daily statin dose (the assumed average maintenance dose per day) were 0.82 (95% CI, 0.81 to 0.85) for a dose of 0.01 to 0.75 defined daily dose per day, 0.87 (95% CI, 0.83 to 0.89) for 0.76 to 1.50 defined daily dose per day, and 0.87 (95% CI, 0.81 to 0.91) for higher than 1.50 defined daily dose per day; the corresponding hazard ratios for death from cancer were 0.83 (95% CI, 0.81 to 0.86), 0.87 (95% CI, 0.83 to 0.91), and 0.87 (95% CI, 0.81 to 0.92). The reduced cancer-related mortality among statin users as compared with those who had never used statins was observed for each of 13 cancer types. CONCLUSIONS Statin use in patients with cancer is associated with reduced cancer-related mortality. This suggests a need for trials of statins in patients with cancer.	[Bojesen, Stig E.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Bojesen, SE (corresponding author), Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, 54M1,Herlev Ringvej 75, DK-2730 Herlev, Denmark.	stig.egil.bojesen@regionh.dk	Nordestgaard, Borge Gronne/ABF-1310-2020	Nordestgaard, Borge/0000-0002-1954-7220; Bojesen, Stig/0000-0002-4061-4133				Ahern TP, 2011, JNCI-J NATL CANCER I, V103, P1461, DOI 10.1093/jnci/djr291; Andersen TF, 1999, DAN MED BULL, V46, P263; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; BASERGA R, 1986, INT J RADIAT BIOL, V49, P219, DOI 10.1080/09553008514552511; Benn M, 2011, JNCI-J NATL CANCER I, V103, P508, DOI 10.1093/jnci/djr008; Boudreau DM, 2010, EXPERT OPIN DRUG SAF, V9, P603, DOI 10.1517/14740331003662620; Chan KKW, 2003, CLIN CANCER RES, V9, P10; Cholesterol Treatment Trialists' (CTT) Collaborators, 2012, LANCET; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Denoyelle C, 2001, CARCINOGENESIS, V22, P1139, DOI 10.1093/carcin/22.8.1139; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Emberson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029849; FENTON RG, 1992, J CELL BIOL, V117, P347, DOI 10.1083/jcb.117.2.347; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fiorenza AM, 2000, INT J CLIN LAB RES, V30, P141, DOI 10.1007/s005990070013; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Fritz G, 2005, INT J ONCOL, V27, P1401; Fritz G, 2009, CURR CANCER DRUG TAR, V9, P626, DOI 10.2174/156800909789057033; Garcia MJ, 2003, METHOD FIND EXP CLIN, V25, P457; Gauthaman K, 2009, J CELL BIOCHEM, V106, P975, DOI 10.1002/jcb.22092; Hamilton RJ, 2010, CANCER-AM CANCER SOC, V116, P3389, DOI 10.1002/cncr.25308; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; HEROLD G, 1995, DIGESTION, V56, P57, DOI 10.1159/000201223; Jakobisiak M, 2003, INT J ONCOL, V23, P1055; Kawata S, 2001, BRIT J CANCER, V84, P886, DOI 10.1054/bjoc.2000.1716; Kusama T, 2001, CANCER RES, V61, P4885; Kwan ML, 2008, BREAST CANCER RES TR, V109, P573, DOI 10.1007/s10549-007-9683-8; LAMB E, 2009, PHARM TIMES     0515; Lamond AI, 2002, NATURE, V417, P383, DOI 10.1038/417383a; Mannello F, 2009, CANCER INVEST, V27, P466, DOI 10.1080/07357900802491444; Nielsen SF, 2012, CAN MED ASSOC J, V184, pE57, DOI 10.1503/cmaj.110167; Nielsen SF, 2011, BLOOD, V118, P4062, DOI 10.1182/blood-2011-02-337170; Pedersen CB, 2006, DAN MED BULL, V53, P441; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Platz EA, 2006, JNCI-J NATL CANCER I, V98, P1819, DOI 10.1093/jnci/djj499; Sobin L, 2009, TNM CLASSIFICATION M; Solomon KR, 2008, TRENDS ENDOCRIN MET, V19, P113, DOI 10.1016/j.tem.2007.12.004; Storm HH, 1997, DAN MED BULL, V44, P535; Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476	40	681	694	1	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2012	367	19					1792	1802		10.1056/NEJMoa1201735	http://dx.doi.org/10.1056/NEJMoa1201735			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033DG	23134381				2022-12-28	WOS:000310773200006
J	Glaser, G				Glaser, Gisbert			Base sustainable development goals on science	NATURE			English	Editorial Material									Int Council Sci, Paris, France		Glaser, G (corresponding author), Int Council Sci, Paris, France.	gisbert.glaser@icsu.org						HAK TB, 2007, SCOPE SERIES, V67; Sachs JD, 2012, LANCET, V379, P2206, DOI 10.1016/S0140-6736(12)60685-0; UN Univ. Int. Hum. Dimens. Program. Glob. Change/UN Environ. Program, 2012, INCL WEALTH REP 2012; UNGA, 2012, FUTURE WE WANT; United Nations Department of Economic and Social Affairs (UN DESA), 2007, IND SUST DEV GUID ME	5	45	46	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					35	35		10.1038/491035a	http://dx.doi.org/10.1038/491035a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	028PM	23128211	Bronze			2022-12-28	WOS:000310434500015
J	Yamanaka, S; Mehta, S; Reyes-Turcu, FE; Zhuang, FL; Fuchs, RT; Rong, YK; Robb, GB; Grewal, SIS				Yamanaka, Soichiro; Mehta, Sameet; Reyes-Turcu, Francisca E.; Zhuang, Fanglei; Fuchs, Ryan T.; Rong, Yikang; Robb, Gregory B.; Grewal, Shiv I. S.			RNAi triggered by specialized machinery silences developmental genes and retrotransposons	NATURE			English	Article							MEIOTIC MESSENGER-RNAS; FISSION YEAST; ELIMINATION; PROMOTES; COMPLEX; TRANSCRIPTOME; SURVEILLANCE; MAINTENANCE; METHYLATION; NUCLEATION	RNA interference (RNAi) is a conserved mechanism in which small interfering RNAs (siRNAs) guide the degradation of cognate RNAs, but also promote heterochromatin assembly at repetitive DNA elements such as centromeric repeats(1,2). However, the full extent of RNAi functions and its endogenous targets have not been explored. Here we show that, in the fission yeast Schizosaccharomyces pombe, RNAi and heterochromatin factors cooperate to silence diverse loci, including sexual differentiation genes, genes encoding transmembrane proteins, and retrotransposons that are also targeted by the exosome RNA degradation machinery. In the absence of the exosome, transcripts are processed preferentially by the RNAi machinery, revealing siRNA clusters and a corresponding increase in heterochromatin modifications across large domains containing genes and retrotransposons. We show that the generation of siRNAs and heterochromatin assembly by RNAi is triggered by a mechanism involving the canonical poly(A) polymerase Pla1 and an associated RNA surveillance factor Red1, which also activate the exosome. Notably, siRNA production and heterochromatin modifications at these target loci are regulated by environmental growth conditions, and by developmental signals that induce gene expression during sexual differentiation. Our analyses uncover an interaction between RNAi and the exosome that is conserved in Drosophila, and show that differentiation signals modulate RNAi silencing to regulate developmental genes.	[Yamanaka, Soichiro; Mehta, Sameet; Reyes-Turcu, Francisca E.; Rong, Yikang; Grewal, Shiv I. S.] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Zhuang, Fanglei; Fuchs, Ryan T.; Robb, Gregory B.] New England Biolabs Inc, Ipswich, MA 01938 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New England Biolabs	Grewal, SIS (corresponding author), NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov	Mehta, Sameet/A-1936-2011	Mehta, Sameet/0000-0002-3029-3217; Grewal, Shiv/0000-0002-4552-9261; Robb, Gregory Brett/0000-0002-2382-2256	National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011208, ZIABC010523, ZIABC010446] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Zofall and K. Zhang for contributions, J. Barrowman for editing the manuscript, M. Yamamoto for the pla1-37 strain, E. Lei for the Drosophila rrp6 mutant, B. Walker and M. Pineda for their help in sequencing, and Grewal laboratory members for discussions. This study used the Helix Systems and the Biowulf Linux cluster at the National Institutes of Health. This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute.	Anderson HE, 2009, MOL CELL BIOL, V29, P5158, DOI 10.1128/MCB.00698-09; Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Bitton DA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.90; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cam HP, 2008, NATURE, V451, P431, DOI 10.1038/nature06499; Djupedal I, 2009, EMBO J, V28, P3832, DOI 10.1038/emboj.2009.351; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; Hiriart E, 2012, EMBO J, V31, P2296, DOI 10.1038/emboj.2012.105; Lemay JF, 2010, MOL CELL, V37, P34, DOI 10.1016/j.molcel.2009.12.019; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Munafo DB, 2010, RNA, V16, P2537, DOI 10.1261/rna.2242610; Murakami H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000317; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Reyes-Turcu FE, 2012, CURR OPIN GENET DEV, V22, P156, DOI 10.1016/j.gde.2011.12.004; Reyes-Turcu FE, 2011, NAT STRUCT MOL BIOL, V18, P1132, DOI 10.1038/nsmb.2122; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Sugiyama T, 2011, EMBO J, V30, P1027, DOI 10.1038/emboj.2011.32; Tarailo-Graovac M., 2009, CURR PROTOC BIOINFOR, V25, p4.10.11, DOI 10.1002/0471250953.bi0410s25; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Woolcock KJ, 2011, NAT STRUCT MOL BIOL, V18, P94, DOI 10.1038/nsmb.1935; Yamanaka S, 2010, EMBO J, V29, P2173, DOI 10.1038/emboj.2010.108; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zhang K, 2011, SCIENCE, V331, P1624, DOI 10.1126/science.1198712; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	32	101	105	0	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2013	493	7433					557	+		10.1038/nature11716	http://dx.doi.org/10.1038/nature11716			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23151475	Green Accepted			2022-12-28	WOS:000313871400043
J	Guerreiro, R; Wojtas, A; Bras, J; Carrasquillo, M; Rogaeva, E; Majounie, E; Cruchaga, C; Sassi, C; Kauwe, JSK; Lupton, MK; Ryten, M; Brown, K; Lowe, J; Ridge, PG; Hammer, MB; Wakutani, Y; Proitsi, P; Newhouse, S; Lohmann, E; Erginel-Unaltuna, N; Medway, C; Hanagasi, H; Troakes, C; Gurvit, H; Bilgic, B; Al-Sarraj, S; Benitez, B; Cooper, B; Carrell, D; Emre, M; Zou, FG; Ma, L; Murray, ME; Dickson, DW; Younkin, S; Hazrati, L; Petersen, RC; Corcoran, CD; Cai, YF; Oliveira, C; Ribeiro, MH; Santana, I; Tschanz, JT; Gibbs, JR; Norton, MC; Kloszewska, I; Mecocci, P; Soininen, H; Tsolaki, M; Vellas, B; Munger, RG; Mann, DMA; Pickering-Brown, S; Lovestone, S; Beck, J; Mead, S; Collinge, J; Parsons, L; Pocock, J; Morris, JC; Revesz, T; Lashley, T; Fox, NC; Rossor, MN; Grenier-Boley, B; Bellenguez, C; Moskvina, V; Sims, R; Harold, D; Williams, J; Lambert, JC; Amouyel, P; Graff-Radford, N; Goate, A; Rademakers, R; Morgan, K; Powell, J; St George-Hyslop, P; Singleton, A; Hardy, J				Guerreiro, Rita; Wojtas, Aleksandra; Bras, Jose; Carrasquillo, Minerva; Rogaeva, Ekaterina; Majounie, Elisa; Cruchaga, Carlos; Sassi, Celeste; Kauwe, John S. K.; Lupton, Michelle K.; Ryten, Mina; Brown, Kristelle; Lowe, James; Ridge, Perry G.; Hammer, Monia B.; Wakutani, Yosuke; Proitsi, Petroula; Newhouse, Stephen; Lohmann, Ebba; Erginel-Unaltuna, Nihan; Medway, Christopher; Hanagasi, Hasmet; Troakes, Claire; Gurvit, Hakan; Bilgic, Basar; Al-Sarraj, Safa; Benitez, Bruno; Cooper, Breanna; Carrell, David; Emre, Murat; Zou, Fanggeng; Ma, Li; Murray, Melissa E.; Dickson, Dennis W.; Younkin, Steven; Hazrati, Lilinaz; Petersen, Ronald C.; Corcoran, Christopher D.; Cai, Yefei; Oliveira, Catarina; Ribeiro, Maria Helena; Santana, Isabel; Tschanz, JoAnn T.; Gibbs, J. Raphael; Norton, Maria C.; Kloszewska, Iwona; Mecocci, Patrizia; Soininen, Hilkka; Tsolaki, Magda; Vellas, Bruno; Munger, Ronald G.; Mann, David M. A.; Pickering-Brown, Stuart; Lovestone, Simon; Beck, Jonathan; Mead, Simon; Collinge, John; Parsons, Linda; Pocock, Jennifer; Morris, John C.; Revesz, Tamas; Lashley, Tammaryn; Fox, Nick C.; Rossor, Martin N.; Grenier-Boley, Benjamin; Bellenguez, Celine; Moskvina, Valentina; Sims, Rebecca; Harold, Denise; Williams, Julie; Lambert, Jean-Charles; Amouyel, Philippe; Graff-Radford, Neill; Goate, Alison; Rademakers, Rosa; Morgan, Kevin; Powell, John; St George-Hyslop, Peter; Singleton, Andrew; Hardy, John		EADI Consortium; GERAD Consortium; UKBE Consortium; Alzheimer Genetic Anal Grp	TREM2 Variants in Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; MISSENSE MUTATIONS; COMMON VARIANTS; GENE; MICROGLIA; FRAMEWORK; CD2AP; EPHA1; CD33	BACKGROUND Homozygous loss-of-function mutations in TREM2, encoding the triggering receptor expressed on myeloid cells 2 protein, have previously been associated with an autosomal recessive form of early-onset dementia. METHODS We used genome, exome, and Sanger sequencing to analyze the genetic variability in TREM2 in a series of 1092 patients with Alzheimer's disease and 1107 controls (the discovery set). We then performed a meta-analysis on imputed data for the TREM2 variant rs75932628 (predicted to cause a R47H substitution) from three genomewide association studies of Alzheimer's disease and tested for the association of the variant with disease. We genotyped the R47H variant in an additional 1887 cases and 4061 controls. We then assayed the expression of TREM2 across different regions of the human brain and identified genes that are differentially expressed in a mouse model of Alzheimer's disease and in control mice. RESULTS We found significantly more variants in exon 2 of TREM2 in patients with Alzheimer's disease than in controls in the discovery set (P = 0.02). There were 22 variant alleles in 1092 patients with Alzheimer's disease and 5 variant alleles in 1107 controls (P<0.001). The most commonly associated variant, rs75932628 (encoding R47H), showed highly significant association with Alzheimer's disease (P<0.001). Meta-analysis of rs75932628 genotypes imputed from genomewide association studies confirmed this association (P = 0.002), as did direct genotyping of an additional series of 1887 patients with Alzheimer's disease and 4061 controls (P<0.001). Trem2 expression differed between control mice and a mouse model of Alzheimer's disease. CONCLUSIONS Heterozygous rare variants in TREM2 are associated with a significant increase in the risk of Alzheimer's disease. (Funded by Alzheimer's Research UK and others.)	[Guerreiro, Rita; Sassi, Celeste; Ryten, Mina; Gibbs, J. Raphael; Beck, Jonathan; Mead, Simon; Collinge, John; Parsons, Linda; Pocock, Jennifer; Revesz, Tamas; Lashley, Tammaryn; Fox, Nick C.; Rossor, Martin N.; Hardy, John] UCL, Inst Neurol, London WC1E 6BT, England; [Guerreiro, Rita; Sassi, Celeste; Hammer, Monia B.; Gibbs, J. Raphael; Singleton, Andrew] NIA, NIH, Bethesda, MD 20892 USA; [Wojtas, Aleksandra; Carrasquillo, Minerva; Majounie, Elisa; Zou, Fanggeng; Ma, Li; Murray, Melissa E.; Dickson, Dennis W.; Younkin, Steven; Graff-Radford, Neill; Rademakers, Rosa] Mayo Clin, Jacksonville, FL 32224 USA; [Rogaeva, Ekaterina; Wakutani, Yosuke; Hazrati, Lilinaz; St George-Hyslop, Peter] Univ Toronto, Tanz Ctr, Toronto, ON, Canada; [Cruchaga, Carlos; Benitez, Bruno; Cooper, Breanna; Carrell, David; Cai, Yefei; Morris, John C.; Goate, Alison] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Kauwe, John S. K.; Ridge, Perry G.] Brigham Young Univ, Provo, UT 84602 USA; [Beck, Jonathan; Mead, Simon; Collinge, John] MRC Prion Unit, London, England; [Sims, Rebecca; Harold, Denise; Williams, Julie] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales; [Grenier-Boley, Benjamin; Bellenguez, Celine; Lambert, Jean-Charles; Amouyel, Philippe] CHRU Lille, Inst Pasteur Lille, INSERM, U744, Lille, France; [Grenier-Boley, Benjamin; Bellenguez, Celine; Lambert, Jean-Charles; Amouyel, Philippe] Univ Lille Nord France, Lille, France; [Morgan, Kevin] Univ Nottingham, Sch Mol Med Sci, Nottingham NG7 2RD, England; [Lupton, Michelle K.; Proitsi, Petroula; Newhouse, Stephen; Troakes, Claire; Al-Sarraj, Safa; Lovestone, Simon; Powell, John] Kings Coll London, Inst Psychiat, London, England; [St George-Hyslop, Peter] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Hardy, John] UCL Inst Neurol, Reta Lila Weston Res Labs, London WC1N 3BG, England; [Brown, Kristelle; Lowe, James; Medway, Christopher] Univ Nottingham, Nottingham NG7 2RD, England; [Ridge, Perry G.] ARUP Inst, Salt Lake City, UT USA; [Lohmann, Ebba; Hanagasi, Hasmet; Gurvit, Hakan; Bilgic, Basar; Emre, Murat] Istanbul Univ, Fac Med, Istanbul, Turkey; [Erginel-Unaltuna, Nihan] Istanbul Univ, Expt Med Res Inst, Istanbul, Turkey; [Al-Sarraj, Safa] Kings Coll Hosp London, London, England; [Petersen, Ronald C.] Mayo Clin, Rochester, MN USA; [Corcoran, Christopher D.; Tschanz, JoAnn T.; Norton, Maria C.; Munger, Ronald G.] Utah State Univ, Logan, UT 84322 USA; [Oliveira, Catarina; Ribeiro, Maria Helena; Santana, Isabel] Univ Coimbra, Coimbra, Portugal; [Kloszewska, Iwona] Med Univ Lodz, Lodz, Poland; [Mecocci, Patrizia] Univ Perugia, I-06100 Perugia, Italy; [Soininen, Hilkka] Univ Eastern Finland, Kuopio, Finland; [Soininen, Hilkka] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Tsolaki, Magda] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece; [Vellas, Bruno] Hop Toulouse, INSERM, UMR 1027, Toulouse, France; [Mann, David M. A.; Pickering-Brown, Stuart] Univ Manchester, Manchester, Lancs, England; [Moskvina, Valentina] Cardiff Univ, Sch Med, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales	University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Mayo Clinic; University of Toronto; Washington University (WUSTL); Brigham Young University; University of London; University College London; Cardiff University; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; University of Nottingham; University of London; King's College London; University of Cambridge; University of London; University College London; University of Nottingham; Utah System of Higher Education; University of Utah; ARUP Laboratories; Istanbul University; Istanbul University; King's College Hospital NHS Foundation Trust; King's College Hospital; Mayo Clinic; Utah System of Higher Education; Utah State University; Universidade de Coimbra; Medical University Lodz; University of Perugia; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Aristotle University of Thessaloniki; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Manchester; Cardiff University	Hardy, J (corresponding author), UCL Inst Neurol, Reta Lila Weston Res Labs, London WC1N 3BG, England.	j.hardy@ucl.ac.uk	Revesz, Tamas/A-8732-2010; Epelbaum, Jacques/B-2263-2013; Gw, Safwan/ABG-4675-2020; Ryten, Mina/Q-8419-2016; Kornhuber, Johannes/B-9613-2014; Murray, Melissa E/C-2763-2015; Trabzuni, Daniah M/C-4034-2012; Mecocci, Patrizia/W-2116-2019; Bilgic, Basar/E-4821-2012; Erginel-Unaltuna, Nihan/A-4885-2018; Hanagasi, Hasmet A./AAT-9501-2020; Gibbs, J. Raphael/A-3984-2010; Gurvit, Hakan/A-7646-2019; Tschanz, JoAnn T./E-5986-2010; Guerreiro, Rita J L/A-1327-2011; Belllenguez, Céline/Y-3183-2018; Ramirez, Alfredo/S-5126-2019; Cruchaga, Carlos/ABF-4065-2020; Bras, Jose MT/A-1428-2011; Rossor, Martin/C-1598-2008; Lashley, Tammaryn/D-2583-2009; Frölich, Lutz/AAA-6940-2019; Lambert, jean-charles/A-9553-2014; LICEND, CEMND/F-1296-2015; Kauwe, John/AAC-6646-2021; Benitez, Bruno A./E-7116-2014; Weale, Michael E/F-2587-2010; Powell, John F/G-4412-2011; lambert, jean-charles/F-8787-2013; Troakes, Claire/K-4346-2015; Deloukas, Panos/B-2922-2013; Hardy, John/C-2451-2009; , beccie/AAM-3770-2021; hazrati, lili-naz/AAE-7785-2020; McQuillin, Andrew/C-1623-2008; Singleton, Andrew B/C-3010-2009; Trabzuni, Daniah/AAI-2037-2021; Bellenguez, Céline/X-4004-2019; berr, Claudine/D-5238-2014; Kehoe, Patrick/P-8760-2018	Revesz, Tamas/0000-0003-2501-0259; Gw, Safwan/0000-0001-6764-1038; Kornhuber, Johannes/0000-0002-8096-3987; Murray, Melissa E/0000-0001-7379-2545; Trabzuni, Daniah M/0000-0003-4826-9570; Mecocci, Patrizia/0000-0003-0729-5246; Bilgic, Basar/0000-0001-6032-0856; Erginel-Unaltuna, Nihan/0000-0003-0562-0455; Gibbs, J. Raphael/0000-0002-6985-0658; Gurvit, Hakan/0000-0003-2908-8475; Belllenguez, Céline/0000-0002-1240-7874; Ramirez, Alfredo/0000-0003-4991-763X; Cruchaga, Carlos/0000-0002-0276-2899; Frölich, Lutz/0000-0003-1494-0813; Lambert, jean-charles/0000-0003-0829-7817; Kauwe, John/0000-0001-8641-2468; Benitez, Bruno A./0000-0002-2699-3878; Weale, Michael E/0000-0003-4593-1186; Powell, John F/0000-0001-6124-439X; lambert, jean-charles/0000-0003-0829-7817; Deloukas, Panos/0000-0001-9251-070X; Hardy, John/0000-0002-3122-0423; , beccie/0000-0002-3885-1199; hazrati, lili-naz/0000-0003-2715-1485; McQuillin, Andrew/0000-0003-1567-2240; Trabzuni, Daniah/0000-0003-4826-9570; Bellenguez, Céline/0000-0002-1240-7874; berr, Claudine/0000-0001-5254-7655; Hampel, Harald/0000-0003-0894-8982; Bras, Jose/0000-0001-8186-0333; Oliveira, Catarina/0000-0001-6942-4328; Lovestone, Simon/0000-0003-0473-4565; Morgan, Kevin/0000-0002-8217-2396; Kehoe, Patrick/0000-0002-7542-1139; Guerreiro, Rita/0000-0001-5879-3486; Nothen, Markus/0000-0002-8770-2464; Pickering-Brown, Stuart/0000-0003-1561-6054; Rossor, Martin/0000-0001-8215-3120; Dichgans, Martin/0000-0002-0654-387X; Lupton, Michelle/0000-0002-7274-7299; Santana, Isabel/0000-0002-8114-9434; Mead, Simon/0000-0002-4326-1468; Goate, Alison/0000-0002-0576-2472; Lashley, Tammaryn/0000-0001-7389-0348; Troakes, Claire/0000-0002-1790-7376; St George-Hyslop, Peter/0000-0003-0796-7209; Williams, Julie/0000-0002-4069-0259; Brayne, Carol/0000-0001-5307-663X; Amouyel, Philippe/0000-0001-9088-234X	Alzheimer's Research UK; Medical Research Council (MRC); Wellcome Trust; Wellcome Trust/MRC Joint Call in Neurodegeneration Award [WT089698]; Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program (which support the Mayo Alzheimer's Disease Research Center) [P50 AG016574, U01 AG006786, R01 AG18023]; Washington University School of Medicine Alzheimer's Disease Research Center [2P50 AG005681-27, 5P30 NS069329-02, NIRG-11-200110, 1R01 AG041797-01]; National Institute for Health Research Biomedical Research Unit in Dementia at University College London Hospitals, University College London; Ontario Research Fund; Canadian Institutes of Health Research; National Institutes of Health Research; Wellcome Trust Medical Research Council; an anonymous charitable foundation; Fondation pour la Recherche sur Alzheimer; Alzheimer Society of Ontario; Big Lottery; Intramural Research Programs of the National Institute on Aging; National Institute of Neurological Disease and Stroke; National Institutes of Health (Department of Health and Human Services) [ZO1 AG000950-10]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681, Z01AG000950, R01AG018023, R01AG041797, R01AG042611, P50AG008702, U01AG006786, P50AG016574, U24AG021886] Funding Source: NIH RePORTER; MRC [G0701441, G0300429, G0802462, G0902227, MC_U123160651, MC_U123192748, MC_G1000735, G0701075, MR/K013041/1, G1100695] Funding Source: UKRI; Alzheimers Research UK [ART-BIG2009-1, ARUK-PG2014-1, ARUK-NCG2012B-1, ART-PPG2011A-14, ARUK-TRFUS2012-3, ART-SB2010A-1, ART-NCG2008A-1, ARUK-TRFUS2012-1, ART-PG2010-1, ART-RF2007-3] Funding Source: researchfish; Medical Research Council [G0802462, MC_U123160651, G0701075, MC_G1000735, MR/K013041/1, MC_U123192748, G0801418B, G0701441, G0300429, G1100695, G0902227] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10033] Funding Source: researchfish	Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust/MRC Joint Call in Neurodegeneration Award(Wellcome TrustUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program (which support the Mayo Alzheimer's Disease Research Center); Washington University School of Medicine Alzheimer's Disease Research Center; National Institute for Health Research Biomedical Research Unit in Dementia at University College London Hospitals, University College London; Ontario Research Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Wellcome Trust); an anonymous charitable foundation; Fondation pour la Recherche sur Alzheimer; Alzheimer Society of Ontario; Big Lottery; Intramural Research Programs of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health (Department of Health and Human Services)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by the Alzheimer's Research UK, the Medical Research Council (MRC), the Wellcome Trust, the Wellcome Trust/MRC Joint Call in Neurodegeneration Award (WT089698) to the UK Parkinson's Disease Consortium (whose members are from the University College London Institute of Neurology, the University of Sheffield, and the MRC Protein Phosphorylation Unit at the University of Dundee), grants (P50 AG016574, U01 AG006786, and R01 AG18023) from the Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program (which support the Mayo Alzheimer's Disease Research Center), grants (2P50 AG005681-27, 5P30 NS069329-02, NIRG-11-200110, and 1R01 AG041797-01) from the Washington University School of Medicine Alzheimer's Disease Research Center, the National Institute for Health Research Biomedical Research Unit in Dementia at University College London Hospitals, University College London; grants from the Ontario Research Fund, Canadian Institutes of Health Research (to Drs. Rogaeva and Hyslop); grants from the National Institutes of Health Research, the Wellcome Trust Medical Research Council, an anonymous charitable foundation, the Fondation pour la Recherche sur Alzheimer, and the Alzheimer Society of Ontario (to Dr. Hyslop); the Big Lottery (to Dr. Morgan); a fellowship from Alzheimer's Research UK (to Dr. Guerreiro); and the Intramural Research Programs of the National Institute on Aging and the National Institute of Neurological Disease and Stroke, National Institutes of Health (Department of Health and Human Services Project number, ZO1 AG000950-10). Additional funders of individual investigators and institutions are provided in the Supplementary Appendix.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Breitner JCS, 2000, NEUROLOGY, V55, P161; Butler AW, 2009, NEUROBIOL AGING, V30, P1037, DOI 10.1016/j.neurobiolaging.2009.03.013; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Crehan H, 2012, INT J ALZHEIMERS DIS, V2012; Crehan H, 2012, IMMUNOBIOLOGY, V217, P244, DOI 10.1016/j.imbio.2011.07.017; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Frank S, 2008, GLIA, V56, P1438, DOI 10.1002/glia.20710; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Guerreiro RJ, 2012, ARCH NEUROL; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hazrati LN, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.07.001; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Majounie E, 2012, NEW ENGL J MED, V366, P283, DOI 10.1056/NEJMc1113592; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Melchior B, 2006, NEUROCHEM INT, V49, P145, DOI 10.1016/j.neuint.2006.04.002; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Neumann H, 2007, J NEUROIMMUNOL, V184, P92, DOI 10.1016/j.jneuroim.2006.11.032; Paloneva, 2003, AM J HUM GENET, V72, P225; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Piccio L, 2007, EUR J IMMUNOL, V37, P1290, DOI 10.1002/eji.200636837; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Singleton AB, 2010, TRENDS GENET, V26, P438, DOI 10.1016/j.tig.2010.07.004; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	33	1772	1809	22	366	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2013	368	2					117	127		10.1056/NEJMoa1211851	http://dx.doi.org/10.1056/NEJMoa1211851			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066RO	23150934	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000313238100002
J	Lariviere, L; Plaschka, C; Seizl, M; Wenzeck, L; Kurth, F; Cramer, P				Lariviere, Laurent; Plaschka, Clemens; Seizl, Martin; Wenzeck, Larissa; Kurth, Fabian; Cramer, Patrick			Structure of the Mediator head module	NATURE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION INITIATION; PREINITIATION COMPLEX; MAXIMUM-LIKELIHOOD; YEAST; RECRUITMENT; PROTEIN; CTD; ARCHITECTURE; HOLOENZYME	Gene transcription by RNA polymerase (Pol) II requires the coactivator complex Mediator. Mediator connects transcriptional regulators and Pol II, and is linked to human disease(1-4). Mediator from the yeast Saccharomyces cerevisiae has a molecular mass of 1.4 megadaltons and comprises 25 subunits that form the head, middle, tail and kinase modules(5-7). The head module constitutes one-half of the essential Mediator core(8), and comprises the conserved(9) subunits Med6, Med8, Med11, Med17, Med18, Med20 and Med22. Recent X-ray analysis of the S. cerevisiae head module at 4.3 angstrom resolution led to a partial architectural model with three submodules called neck, fixed jaw and moveable jaw(10). Here we determine de novo the crystal structure of the head module from the fission yeast Schizosaccharomyces pombe at 3.4 angstrom resolution. Structure solution was enabled by new structures of Med6 and the fixed jaw, and previous structures of the moveable jaw(11) and part of the neck(12), and required deletion of Med20. The S. pombe head module resembles the head of a crocodile with eight distinct elements, of which at least four are mobile. The fixed jaw comprises tooth and nose domains, whereas the neck submodule contains a helical spine and one limb, with shoulder, arm and finger elements. The arm and the essential shoulder contact other parts of Mediator. The jaws and a central joint are implicated in interactions with Pol II and its carboxy-terminal domain, and the joint is required for transcription in vitro. The S. pombe head module structure leads to a revised model of the S. cerevisiae module, reveals a high conservation and flexibility, explains knownmutations, and provides the basis for unravelling a central mechanism of gene regulation.	[Lariviere, Laurent; Plaschka, Clemens; Seizl, Martin; Wenzeck, Larissa; Kurth, Fabian; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Lariviere, Laurent; Plaschka, Clemens; Seizl, Martin; Wenzeck, Larissa; Kurth, Fabian; Cramer, Patrick] Univ Munich, CIPSM, Dept Biochem, D-81377 Munich, Germany	University of Munich; University of Munich	Lariviere, L (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	larivier@genzentrum.lmu.de; cramer@genzentrum.lmu.de		Plaschka, Clemens/0000-0002-6020-9514	Boehringer Ingelheim fellowship; Elite Network of Bavaria; Deutsche Forschungsgemeinschaft [SFB646, TR5, GraKo1721, SFB960]; CIPSM; NIM; European Research Council; LMU innovativ project Bioimaging Network; Vallee Foundation; Jung-Stiftung	Boehringer Ingelheim fellowship(Boehringer Ingelheim); Elite Network of Bavaria; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CIPSM; NIM; European Research Council(European Research Council (ERC)European Commission); LMU innovativ project Bioimaging Network; Vallee Foundation; Jung-Stiftung	We thank S. Baumli, A. C. Cheung, A. Imhof and C. Schmidt for help. We acknowledge the crystallization facility at the Max Planck Institute of Biochemistry, Martinsried. Diffraction data were collected at the Swiss Light Source, Villigen, Switzerland. M.S. was supported by a Boehringer Ingelheim fellowship and the Elite Network of Bavaria. P.C. was supported by the Deutsche Forschungsgemeinschaft, SFB646, TR5, GraKo1721, SFB960, CIPSM, NIM, an Advanced Grant of the European Research Council, the LMU innovativ project Bioimaging Network, the Vallee Foundation, and the Jung-Stiftung.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Baek HJ, 2006, J BIOL CHEM, V281, P15172, DOI 10.1074/jbc.M601983200; Baumli S, 2005, J BIOL CHEM, V280, P18171, DOI 10.1074/jbc.M413466200; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen W., 2011, SEMIN CELL DEV BIOL; Conaway RC, 2011, SEMIN CELL DEV BIOL, V22, P729, DOI 10.1016/j.semcdb.2011.07.021; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; Girard E, 2003, ACTA CRYSTALLOGR D, V59, P1914, DOI 10.1107/S0907444903020511; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang JS, 2001, J BIOL CHEM, V276, P42003, DOI 10.1074/jbc.M105961200; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kaufmann R, 2010, AM J HUM GENET, V87, P667, DOI 10.1016/j.ajhg.2010.09.016; Knablein J, 1997, J MOL BIOL, V270, P1, DOI 10.1006/jmbi.1997.1074; KOLESKE AJ, 1992, CELL, V69, P883, DOI 10.1016/0092-8674(92)90298-Q; Lariviere L., 2012, CURR OPIN CELL BIOL; Lariviere L, 2008, GENE DEV, V22, P872, DOI 10.1101/gad.465108; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Lee TI, 1998, MOL CELL BIOL, V18, P4455, DOI 10.1128/MCB.18.8.4455; Lee YC, 1998, MOL CELL BIOL, V18, P5364, DOI 10.1128/MCB.18.9.5364; Liu Y, 2001, J BIOL CHEM, V276, P7169, DOI 10.1074/jbc.M009586200; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; NONET ML, 1989, GENETICS, V123, P715; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; SCHNEIDER G, 1994, ACTA CRYSTALLOGR D, V50, P186, DOI 10.1107/S0907444993009679; Seizl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027595; Seizl M, 2011, NUCLEIC ACIDS RES, V39, P6291, DOI 10.1093/nar/gkr229; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Soutourina J, 2011, SCIENCE, V331, P1451, DOI 10.1126/science.1200188; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; Tan Q, 2000, GENE DEV, V14, P339; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]	48	76	78	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					448	+		10.1038/nature11670	http://dx.doi.org/10.1038/nature11670			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23123849	Green Published			2022-12-28	WOS:000312488200060
J	Mian-McCarthy, S; Agnandji, ST; Lell, B; Fernandes, JF; Abossolo, BP; Methogo, BGNO; Kabwende, AL; Adegnika, AA; Mordmuller, B; Issifou, S; Kremsner, PG; Sacarlal, J; Aide, P; Lanaspa, M; Aponte, JJ; Machevo, S; Acacio, S; Bulo, H; Sigauque, B; Macete, E; Alonso, P; Abdulla, S; Salim, N; Minja, R; Mpina, M; Ahmed, S; Ali, AM; Mtoro, AT; Hamad, AS; Mutani, P; Tanner, M; Tinto, H; D'Alessandro, U; Sorgho, H; Valea, I; Bihoun, B; Guiraud, I; Kabore, B; Sombie, O; Guiguemde, RT; Ouedraogo, JB; Hamel, MJ; Kariuki, S; Oneko, M; Odero, C; Otieno, K; Awino, N; McMorrow, M; Muturi-Kioi, V; Laserson, KF; Slutsker, L; Otieno, W; Otieno, L; Otsyula, N; Gondi, S; Otieno, A; Owira, V; Oguk, E; Odongo, G; Ben Woods, J; Ogutu, B; Njuguna, P; Chilengi, R; Akoo, P; Kerubo, C; Maingi, C; Lang, T; Olotu, A; Bejon, P; Marsh, K; Mwanbingu, G; Owusu-Agyei, S; Asante, KP; Osei-Kwakye, K; Boahen, O; Dosoo, D; Asante, I; Adjei, G; Kwara, E; Chandramohan, D; Greenwood, B; Lusingu, J; Gesase, S; Malabeja, A; Abdul, O; Mahende, C; Liheluka, E; Malle, L; Lemnge, M; Theander, TG; Drakeley, C; Ansong, D; Agbenyega, T; Adjei, S; Boateng, HO; Rettig, T; Bawa, J; Sylverken, J; Sambian, D; Sarfo, A; Agyekum, A; Martinson, F; Hoffman, I; Mvalo, T; Kamthunzi, P; Nkomo, R; Tembo, T; Tegha, G; Tsidya, M; Kilembe, J; Chawinga, C; Ballou, WR; Cohen, J; Guerra, Y; Jongert, E; Lapierre, D; Leach, A; Lievens, M; Ofori-Anyinam, O; Olivier, A; Vekemans, J; Carter, T; Kaslow, D; Leboulleux, D; Loucq, C; Radford, A; Savarese, B; Schellenberg, D; Sillman, M; Vansadia, P				Mian-McCarthy, Sara; Agnandji, Selidji Todagbe; Lell, Bertrand; Fernandes, Jose Francisco; Abossolo, Beatrice Peggy; Methogo, Barbara Gaelle Nfono Ondo; Kabwende, Anita Lumeka; Adegnika, Ayola Akim; Mordmueller, Benjamin; Issifou, Saadou; Kremsner, Peter Gottfried; Sacarlal, Jahit; Aide, Pedro; Lanaspa, Miguel; Aponte, John J.; Machevo, Sonia; Acacio, Sozinho; Bulo, Helder; Sigauque, Betuel; Macete, Eusebio; Alonso, Pedro; Abdulla, Salim; Salim, Nahya; Minja, Rose; Mpina, Maxmillian; Ahmed, Saumu; Ali, Ali Mohammed; Mtoro, Ali Takadir; Hamad, Ali Said; Mutani, Paul; Tanner, Marcel; Tinto, Halidou; D'Alessandro, Umberto; Sorgho, Hermann; Valea, Innocent; Bihoun, Biebo; Guiraud, Issa; Kabore, Berenger; Sombie, Olivier; Guiguemde, Robert Tinga; Ouedraogo, Jean Bosco; Hamel, Mary J.; Kariuki, Simon; Oneko, Martina; Odero, Chris; Otieno, Kephas; Awino, Norbert; McMorrow, Meredith; Muturi-Kioi, Vincent; Laserson, Kayla F.; Slutsker, Laurence; Otieno, Walter; Otieno, Lucas; Otsyula, Nekoye; Gondi, Stacey; Otieno, Allan; Owira, Victorine; Oguk, Esther; Odongo, George; Ben Woods, Jon; Ogutu, Bernhards; Njuguna, Patricia; Chilengi, Roma; Akoo, Pauline; Kerubo, Christine; Maingi, Charity; Lang, Trudie; Olotu, Ally; Bejon, Philip; Marsh, Kevin; Mwanbingu, Gabriel; Owusu-Agyei, Seth; Asante, Kwaku Poku; Osei-Kwakye, Kingsley; Boahen, Owusu; Dosoo, David; Asante, Isaac; Adjei, George; Kwara, Evans; Chandramohan, Daniel; Greenwood, Brian; Lusingu, John; Gesase, Samwel; Malabeja, Anangisye; Abdul, Omari; Mahende, Coline; Liheluka, Edwin; Malle, Lincoln; Lemnge, Martha; Theander, Thor G.; Drakeley, Chris; Ansong, Daniel; Agbenyega, Tsiri; Adjei, Samuel; Boateng, Harry Owusu; Rettig, Theresa; Bawa, John; Sylverken, Justice; Sambian, David; Sarfo, Anima; Agyekum, Alex; Martinson, Francis; Hoffman, Irving; Mvalo, Tisungane; Kamthunzi, Portia; Nkomo, Rutendo; Tembo, Tapiwa; Tegha, Gerald; Tsidya, Mercy; Kilembe, Jane; Chawinga, Chimwemwe; Ballou, W. Ripley; Cohen, Joe; Guerra, Yolanda; Jongert, Erik; Lapierre, Didier; Leach, Amanda; Lievens, Marc; Ofori-Anyinam, Opokua; Olivier, Aurelie; Vekemans, Johan; Carter, Terrell; Kaslow, David; Leboulleux, Didier; Loucq, Christian; Radford, Afiya; Savarese, Barbara; Schellenberg, David; Sillman, Marla; Vansadia, Preeti		RTS S Clin Trials Partnership	A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							III MULTICENTER TRIAL; CANDIDATE VACCINE; CASE-DEFINITION; FALCIPARUM-MALARIA; DATA-COLLECTION; DOUBLE-BLIND; SAFETY; IMMUNOGENICITY; EFFICACY; IMMUNIZATION	BACKGROUND The candidate malaria vaccine RTS,S/AS01 reduced episodes of both clinical and severe malaria in children 5 to 17 months of age by approximately 50% in an ongoing phase 3 trial. We studied infants 6 to 12 weeks of age recruited for the same trial. METHODS We administered RTS,S/AS01 or a comparator vaccine to 6537 infants who were 6 to 12 weeks of age at the time of the first vaccination in conjunction with Expanded Program on Immunization (EPI) vaccines in a three-dose monthly schedule. Vaccine efficacy against the first or only episode of clinical malaria during the 12 months after vaccination, a coprimary end point, was analyzed with the use of Cox regression. Vaccine efficacy against all malaria episodes, vaccine efficacy against severe malaria, safety, and immunogenicity were also assessed. RESULTS The incidence of the first or only episode of clinical malaria in the intention-to-treat population during the 14 months after the first dose of vaccine was 0.31 per person-year in the RTS,S/AS01 group and 0.40 per person-year in the control group, for a vaccine efficacy of 30.1% (95% confidence interval [ CI], 23.6 to 36.1). Vaccine efficacy in the per-protocol population was 31.3% (97.5% CI, 23.6 to 38.3). Vaccine efficacy against severe malaria was 26.0% (95% CI, -7.4 to 48.6) in the intention-to-treat population and 36.6% (95% CI, 4.6 to 57.7) in the per-protocol population. Serious adverse events occurred with a similar frequency in the two study groups. One month after administration of the third dose of RTS,S/AS01, 99.7% of children were positive for anti-circumsporozoite antibodies, with a geometric mean titer of 209 EU per milliliter (95% CI, 197 to 222). CONCLUSIONS The RTS,S/AS01 vaccine coadministered with EPI vaccines provided modest protection against both clinical and severe malaria in young infants. (Funded by GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative; RTS,S ClinicalTrials.gov number, NCT00866619.)	[Agnandji, Selidji Todagbe; Lell, Bertrand; Fernandes, Jose Francisco; Abossolo, Beatrice Peggy; Methogo, Barbara Gaelle Nfono Ondo; Kabwende, Anita Lumeka; Adegnika, Ayola Akim; Mordmueller, Benjamin; Issifou, Saadou; Kremsner, Peter Gottfried] Albert Schweitzer Hosp, Lambarene, Gabon; [Agnandji, Selidji Todagbe; Lell, Bertrand; Fernandes, Jose Francisco; Abossolo, Beatrice Peggy; Methogo, Barbara Gaelle Nfono Ondo; Kabwende, Anita Lumeka; Adegnika, Ayola Akim; Mordmueller, Benjamin; Issifou, Saadou; Kremsner, Peter Gottfried] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Sacarlal, Jahit; Aide, Pedro; Lanaspa, Miguel; Aponte, John J.; Machevo, Sonia; Acacio, Sozinho; Bulo, Helder; Sigauque, Betuel; Macete, Eusebio; Alonso, Pedro] Ctr Invest Saude Manhica, Manhica, Mozambique; [Sacarlal, Jahit; Aide, Pedro; Lanaspa, Miguel; Aponte, John J.; Machevo, Sonia; Acacio, Sozinho; Bulo, Helder; Sigauque, Betuel; Macete, Eusebio; Alonso, Pedro] Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, Barcelona, Spain; [Abdulla, Salim; Salim, Nahya; Minja, Rose; Mpina, Maxmillian; Ahmed, Saumu; Ali, Ali Mohammed; Mtoro, Ali Takadir; Hamad, Ali Said; Mutani, Paul; Tanner, Marcel] Ifakara Hlth Inst, Bagamoyo, Tanzania; [Abdulla, Salim; Salim, Nahya; Minja, Rose; Mpina, Maxmillian; Ahmed, Saumu; Ali, Ali Mohammed; Mtoro, Ali Takadir; Hamad, Ali Said; Mutani, Paul; Tanner, Marcel] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Tinto, Halidou; D'Alessandro, Umberto; Sorgho, Hermann; Valea, Innocent; Bihoun, Biebo; Guiraud, Issa; Kabore, Berenger; Sombie, Olivier; Guiguemde, Robert Tinga; Ouedraogo, Jean Bosco] Inst Rech Sci Sante, Nanoro, Burkina Faso; [Tinto, Halidou; D'Alessandro, Umberto; Sorgho, Hermann; Valea, Innocent; Bihoun, Biebo; Guiraud, Issa; Kabore, Berenger; Sombie, Olivier; Guiguemde, Robert Tinga; Ouedraogo, Jean Bosco] Inst Trop Med, B-2000 Antwerp, Belgium; [Hamel, Mary J.; Kariuki, Simon; Oneko, Martina; Odero, Chris; Otieno, Kephas; Awino, Norbert; McMorrow, Meredith; Muturi-Kioi, Vincent; Laserson, Kayla F.; Slutsker, Laurence] KEMRI CDC Res & Publ Hlth Collaborat, Kisumu, Kenya; [Otieno, Walter; Otieno, Lucas; Otsyula, Nekoye; Gondi, Stacey; Otieno, Allan; Owira, Victorine; Oguk, Esther; Odongo, George; Ben Woods, Jon; Ogutu, Bernhards] KEMRI Walter Reed Project, Kombewa, Kenya; [Njuguna, Patricia; Chilengi, Roma; Akoo, Pauline; Kerubo, Christine; Maingi, Charity; Lang, Trudie; Olotu, Ally; Bejon, Philip; Marsh, Kevin; Mwanbingu, Gabriel] KEMRI Wellcome Trust Res Program, Kilifi, Kenya; [Owusu-Agyei, Seth; Asante, Kwaku Poku; Osei-Kwakye, Kingsley; Boahen, Owusu; Dosoo, David; Asante, Isaac; Adjei, George; Kwara, Evans; Chandramohan, Daniel; Greenwood, Brian] Kintampo Hlth Res Ctr, Kintampo, Ghana; [Owusu-Agyei, Seth; Asante, Kwaku Poku; Osei-Kwakye, Kingsley; Boahen, Owusu; Dosoo, David; Asante, Isaac; Adjei, George; Kwara, Evans; Chandramohan, Daniel; Greenwood, Brian; Lusingu, John; Gesase, Samwel; Malabeja, Anangisye; Abdul, Omari; Mahende, Coline; Liheluka, Edwin; Malle, Lincoln; Lemnge, Martha; Theander, Thor G.; Drakeley, Chris] London Sch Hyg & Trop Med, London, England; [Lusingu, John; Gesase, Samwel; Malabeja, Anangisye; Abdul, Omari; Mahende, Coline; Liheluka, Edwin; Malle, Lincoln; Lemnge, Martha; Theander, Thor G.; Drakeley, Chris] Natl Inst Med Res, Korogwe, Tanzania; [Lusingu, John; Gesase, Samwel; Malabeja, Anangisye; Abdul, Omari; Mahende, Coline; Lemnge, Martha; Theander, Thor G.; Drakeley, Chris] Univ Copenhagen, Copenhagen, Denmark; [Ansong, Daniel; Agbenyega, Tsiri; Adjei, Samuel; Boateng, Harry Owusu; Rettig, Theresa; Bawa, John; Sylverken, Justice; Sambian, David; Sarfo, Anima; Agyekum, Alex] Sch Med Sci, Kumasi, Ghana; [Martinson, Francis; Hoffman, Irving; Mvalo, Tisungane; Kamthunzi, Portia; Nkomo, Rutendo; Tembo, Tapiwa; Tegha, Gerald; Tsidya, Mercy; Kilembe, Jane; Chawinga, Chimwemwe] Univ N Carolina Project, Lilongwe, Malawi; [Ballou, W. Ripley; Cohen, Joe; Guerra, Yolanda; Jongert, Erik; Lapierre, Didier; Leach, Amanda; Lievens, Marc; Ofori-Anyinam, Opokua; Olivier, Aurelie; Vekemans, Johan] GlaxoSmithKline Vaccines, Wavre, Belgium; [Mian-McCarthy, Sara] PATH Malaria Vaccine Initiat, Commun & Advocacy Unit, Washington, DC 20001 USA	Eberhard Karls University of Tubingen; Centro de Investigacao em Saude de Manhica; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute; Institute of Tropical Medicine (ITM); Kintampo Health Research Centre; University of London; London School of Hygiene & Tropical Medicine; University of Copenhagen; GlaxoSmithKline	Mian-McCarthy, S (corresponding author), PATH Malaria Vaccine Initiat, Commun & Advocacy Unit, 455 Massachusetts Ave NW,Suite 1000, Washington, DC 20001 USA.	smian-mccarthy@path.org	Valea, Innocent/ABE-6694-2020; Odero, Christopher/AAW-2752-2020; Theander, Thor/F-6714-2015; Kaboré, Bérenger/J-2773-2017; McMorrow, Meredith/M-1274-2019; Alonso, Pedro L/AAZ-3645-2020; Mordmüller, Benjamin/A-5749-2010; D'Alessandro, Umberto/D-3457-2015; Kariuki, Simon/AFT-6596-2022; Lusingu, John P. A./GSJ-3228-2022; Leach, Amanda/AAS-1120-2020; ADEGNIKA, Ayola Akim/AAK-7307-2020; Sacarlal, Jahit/R-3172-2016; Lanaspa, Miguel/AAO-4971-2020; Aide, Pedro/D-8771-2018; Issa, GUIRAUD/AGU-8073-2022	Odero, Christopher/0000-0003-2317-9405; Theander, Thor/0000-0002-3509-7514; Kaboré, Bérenger/0000-0002-3719-7033; Alonso, Pedro L/0000-0003-3292-3443; Mordmüller, Benjamin/0000-0001-9101-2768; D'Alessandro, Umberto/0000-0001-6341-5009; Leach, Amanda/0000-0002-7114-9967; Sacarlal, Jahit/0000-0003-1059-217X; Schellenberg, David/0000-0001-8222-0186; ANSONG, Daniel/0000-0003-1328-9117; Muturi-Kioi, Vincent/0000-0003-1620-3999; McMorrow, Meredith/0000-0001-6363-4033; Lang, Trudie/0000-0003-2273-5975; ABDUL, OMARI/0000-0002-7728-0149; Lusingu, John P. A./0000-0002-9407-0602; Valea, Innocent/0000-0002-3085-0490; Ouedraogo, Jean Bosco/0000-0003-0412-8733; Liheluka, Edwin/0000-0001-9043-7529; masoud, nahya salim/0000-0002-3784-6478; Lanaspa, Miguel/0000-0002-9310-177X; Owusu-Agyei, Seth/0000-0002-0807-1781; Tinto, Halidou/0000-0002-0472-3586	GlaxoSmithKline Biologicals (GSK); PATH Malaria Vaccine Initiative; Bill and Melinda Gates Foundation; GlaxoSmithKline; Sigma-Tau Pharmaceuticals; Novartis; UBS Optimus Foundation	GlaxoSmithKline Biologicals (GSK)(GlaxoSmithKline); PATH Malaria Vaccine Initiative; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); GlaxoSmithKline(GlaxoSmithKline); Sigma-Tau Pharmaceuticals; Novartis(Novartis); UBS Optimus Foundation	Supported by GlaxoSmithKline Biologicals (GSK) and the PATH Malaria Vaccine Initiative, which received a grant from the Bill and Melinda Gates Foundation.; Drs. Aide, Greenwood, and Woods report receiving grant support from GlaxoSmithKline through their institutions. Drs. Aponte and Sacarlal report receiving consulting fees from GlaxoSmithKline through their institutions. Drs. Jongert and Olivier report being employees of GlaxoSmithKline, and Drs. Ballou, Guerra, Lapierre, Leach, Ofori-Anyinam, and Vekemans and Mr. Lievens report being employees of and holding stock in GlaxoSmithKline. Dr. Rettig reports receiving travel support from the PATH Malaria Vaccine Initiative, and Mr. Bawa reports receiving travel support from the PATH Malaria Vaccine Initiative through his institution. Drs. Bejon, Mwambingu, and Olotu report receiving grant support from the PATH Malaria Vaccine Initiative through their institutions. Dr. Cohen reports receiving consulting fees from and holding stock in GlaxoSmithKline, being a former employee of GlaxoSmithKline, and being a named inventor on several patents and patent applications related to malaria-vaccine development, the rights to which have been assigned to GlaxoSmithKline. Dr. D'Alessandro reports receiving consulting fees and lecture fees from Sigma-Tau Pharmaceuticals through his institution and lecture fees from Novartis through his institution. Dr. Kaslow reports holding stock and stock options in Merck. Dr. Loucq reports holding stock in GlaxoSmithKline. Dr. Lusingu reports receiving grant support, payment for the development of education presentations, and travel support from the PATH Malaria Vaccine Initiative through his institution and grant support from GlaxoSmithKline through his institution. Dr. Marsh reports receiving travel support and payment for board membership from Novartis. Dr. Njuguna reports receiving consulting fees from GlaxoSmithKline and grant support from the PATH Malaria Vaccine Initiative through her institution. Dr. Schellenberg reports receiving consulting fees from the PATH Malaria Vaccine Initiative. Dr. Tanner reports receiving payment for board membership from the UBS Optimus Foundation, payment for board membership from Novartis through his institution, grant support and travel support from the PATH Malaria Vaccine Initiative through his institution, and travel support from Sanaria through his institution. No other potential conflict of interest relevant to this article was reported.	Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Agnandji S, 2011, J INFECT DIS, V203, P1344, DOI 10.1093/infdis/jir016; Agnandji ST, 2010, J INFECT DIS, V202, P1076, DOI 10.1086/656190; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; [Anonymous], 2004, IMM PRACT MOD 2 EPI, P26; [Anonymous], 1996, INT C HARM TECHN REQ, P30; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Asante KP, 2011, LANCET INFECT DIS, V11, P727; Beigel J, 2007, VACCINE, V25, P5697, DOI 10.1016/j.vaccine.2007.02.066; Bejon P, 2007, PLOS MED, V4, P1333, DOI 10.1371/journal.pmed.0040251; Bonhoeffer J, 2004, VACCINE, V22, P557, DOI 10.1016/j.vaccine.2003.09.008; Brabin B., 1990, Tropical Diseases Bulletin, V87, pR1; Clement F, MALAR J IN PRESS; Dagan R, 2010, VACCINE, V28, P5513, DOI 10.1016/j.vaccine.2010.06.026; Halloran ME., 2010, DESIGN ANAL VACCINE; Hodgins DC, 2012, VACCINE, V30, P1541, DOI 10.1016/j.vaccine.2011.12.047; INSEL RA, 1995, ANN NY ACAD SCI, V754, P35, DOI 10.1111/j.1749-6632.1995.tb44436.x; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Leach A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-224; Lell B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007611; Lievens M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-222; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Prymula R, 2008, EXPERT OPIN BIOL TH, V8, P503, DOI [10.1517/14712598.8.4.503, 10.1517/14712598.8.4.503 ]; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6; Steketee RW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-299; Swysen C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-223; Therneau TM, 2000, MODELING SURVIVAL DA; Vekemans J, 2011, HUM VACCINES, V7, P1309, DOI 10.4161/hv.7.12.18046; Vekemans J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-221; White MT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-82; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, MAL VACC RAINB TABL; World Health Organization, 2007, VERB AUT STAND ASC A	33	490	504	2	139	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24					2284	2295		10.1056/NEJMoa1208394	http://dx.doi.org/10.1056/NEJMoa1208394			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HF	23136909	Green Accepted			2022-12-28	WOS:000312187700002
J	Davies, SC; Fowler, T; McKee, M				Davies, Sally C.; Fowler, Tom; McKee, Martin			On the state of public health in England	LANCET			English	Editorial Material									[McKee, Martin] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England; [Davies, Sally C.; Fowler, Tom] Off Chief Med Officer, Dept Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine	McKee, M (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England.	martin.mckee@lshtm.ac.uk	Fowler, Tom/AGT-1933-2022; Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011	Fowler, Tom/0000-0002-7258-2279; Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X				[Anonymous], 1996, GLOBAL BURDEN DIS CO; Davies S., 2012, ANN REPORT CHIEF MED; Department of Health, 2012, NEW PUBL HLTH ROL LO; DOLL R, 1954, BMJ-BRIT MED J, V1, P1451, DOI 10.1136/bmj.1.4877.1451; Ingleby D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1079; Jakubowski E, 2010, CLIN MED, V10, P560, DOI 10.7861/clinmedicine.10-6-560; Leon DA, 2006, LANCET, V367, P52, DOI 10.1016/S0140-6736(06)67924-5; Lim SS, 2012, LANCET IN PRESS; McKee M, 1999, BMJ-BRIT MED J, V318, P1300, DOI 10.1136/bmj.318.7194.1300; Mulholland H., 2005, GUARDIAN; Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X; Royal College of Physicians, 1962, SMOK HLTH REP ROYAL; Sheard S, 2006, NATIONS DOCTOR ROLE; Tennant R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-63	14	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 24	2012	380	9856					1793	1795		10.1016/S0140-6736(12)61955-2	http://dx.doi.org/10.1016/S0140-6736(12)61955-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	041XK	23176801				2022-12-28	WOS:000311435000005
J	Bleyer, A; Welch, HG				Bleyer, Archie; Welch, H. Gilbert			Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MORTALITY; THERAPY	Background To reduce mortality, screening must detect life-threatening disease at an earlier, more curable stage. Effective cancer-screening programs therefore both increase the incidence of cancer detected at an early stage and decrease the incidence of cancer presenting at a late stage. Methods We used Surveillance, Epidemiology, and End Results data to examine trends from 1976 through 2008 in the incidence of early-stage breast cancer (ductal carcinoma in situ and localized disease) and late-stage breast cancer (regional and distant disease) among women 40 years of age or older. Results The introduction of screening mammography in the United States has been associated with a doubling in the number of cases of early-stage breast cancer that are detected each year, from 112 to 234 cases per 100,000 women - an absolute increase of 122 cases per 100,000 women. Concomitantly, the rate at which women present with late-stage cancer has decreased by 8%, from 102 to 94 cases per 100,000 women - an absolute decrease of 8 cases per 100,000 women. With the assumption of a constant underlying disease burden, only 8 of the 122 additional early-stage cancers diagnosed were expected to progress to advanced disease. After excluding the transient excess incidence associated with hormone-replacement therapy and adjusting for trends in the incidence of breast cancer among women younger than 40 years of age, we estimated that breast cancer was overdiagnosed (i.e., tumors were detected on screening that would never have led to clinical symptoms) in 1.3 million U.S. women in the past 30 years. We estimated that in 2008, breast cancer was overdiagnosed in more than 70,000 women; this accounted for 31% of all breast cancers diagnosed. Conclusions Despite substantial increases in the number of cases of early-stage breast cancer detected, screening mammography has only marginally reduced the rate at which women present with advanced cancer. Although it is not certain which women have been affected, the imbalance suggests that there is substantial overdiagnosis, accounting for nearly a third of all newly diagnosed breast cancers, and that screening is having, at best, only a small effect on the rate of death from breast cancer.	[Bleyer, Archie] St Charles Hlth Syst, Qual Dept, Cent Oregon, OR USA; [Bleyer, Archie] Oregon Hlth & Sci Univ, Dept Radiat Med, Portland, OR 97201 USA; [Bleyer, Archie] Univ Texas Med Sch Houston, Houston, TX USA; [Welch, H. Gilbert] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA	Oregon Health & Science University; University of Texas System; University of Texas Health Science Center Houston; Dartmouth College	Bleyer, A (corresponding author), 2500 NE Neff Rd, Bend, OR 97701 USA.	ableyer@gmail.com	wang, edwin/G-5372-2010	Welch, H. Gilbert/0000-0002-3448-1207				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; [Anonymous], 2005, SEER DAT 1973 2009 I; Autier P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4411; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Breen N, 2007, CANCER DETECT PREV, V31, P220, DOI 10.1016/j.cdp.2007.04.006; CHU KC, 1991, JNCI-J NATL CANCER I, V83, P1636, DOI 10.1093/jnci/83.22.1636; De P, 2010, JNCI-J NATL CANCER I, V102, P1489, DOI 10.1093/jnci/djq345; Ernster VL, 1996, JAMA-J AM MED ASSOC, V275, P913, DOI 10.1001/jama.275.12.913; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Gager J.G., 1992, BATTLEFIELDS KNOWLED, P3; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Kopans DB, 2011, RADIOLOGY, V260, P616, DOI 10.1148/radiol.11110716; Ries LAG, 2007, SEER SURVIVAL MONOGR, P105; Surveillance Epidemiology and End Results (SEER) Program, 2010, SEER STAT DAT BAS IN; United States Census Bureau, POP EST; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Welch HG, 2006, BRIT MED J, V332, P727, DOI 10.1136/bmj.332.7543.727; Welch HG, 1997, J GEN INTERN MED, V12, P118, DOI 10.1046/j.1525-1497.1997.00017.x; Welch HG, 2011, OVERDIAGNOSED MAKING, P84; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C; Zahl PH, 2008, ARCH INTERN MED, V168, P2311, DOI 10.1001/archinte.168.21.2311	21	892	912	0	94	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2012	367	21					1998	2005		10.1056/NEJMoa1206809	http://dx.doi.org/10.1056/NEJMoa1206809			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040RI	23171096	Bronze			2022-12-28	WOS:000311340200007
J	Firth, P; Ttendo, S				Firth, Paul; Ttendo, Stephen			Intensive Care in Low-Income Countries - A Critical Need	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							AFRICA		[Firth, Paul] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Ttendo, Stephen] Mbarara Reg Referral Hosp, Dept Anaesthesia & Crit Care, Mbarara, Uganda	Harvard University; Massachusetts General Hospital	Firth, P (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA.			Firth, Paul/0000-0003-1909-5225				[Anonymous], 2011, BMJ-BRIT MED J, DOI DOI 10.1136/bmj.d7031; Central Intelligence Agency, WORLD FACTB; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Riviello ED, 2011, CRIT CARE MED, V39, P860, DOI 10.1097/CCM.0b013e318206d6d5; Towey RM, 2008, AFR HEALTH SCI, V8, P61	5	47	47	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2012	367	21					1974	1976		10.1056/NEJMp1204957	http://dx.doi.org/10.1056/NEJMp1204957			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040RI	23171093				2022-12-28	WOS:000311340200003
J	Fleming, M; Burnham, EL; Huskins, WC				Fleming, Michael; Burnham, Ellen L.; Huskins, W. Charles			Mentoring Translational Science Investigators	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fleming, Michael] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Fleming, Michael] Northwestern Univ, Feinberg Sch Med, Dept Family & Community Med, Chicago, IL 60611 USA; [Burnham, Ellen L.] Univ Colorado, Dept Med, Div Pulm Sci & Crit Care Med, Denver, CO USA; [Huskins, W. Charles] Mayo Clin, Div Pediat Infect Dis, Rochester, MN USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Mayo Clinic	Fleming, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, 710 N Lakeshore Dr, Chicago, IL 60611 USA.	m-fleming@northwestern.edu		Huskins, W. Charles/0000-0002-9989-175X	NIAAA NIH HHS [K24 AA015390] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K24AA015390] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Abedin Z, 2012, CTS-CLIN TRANSL SCI, V5, P273, DOI 10.1111/j.1752-8062.2011.00366.x; Anderson L, 2012, CTS-CLIN TRANSL SCI, V5, P71, DOI 10.1111/j.1752-8062.2011.00361.x; Burnham EL, 2011, CTS-CLIN TRANSL SCI, V4, P199, DOI 10.1111/j.1752-8062.2011.00286.x; Burnham EL, 2011, CTS-CLIN TRANSL SCI, V4, P87, DOI 10.1111/j.1752-8062.2011.00273.x; Feldman MD, 2009, CTS-CLIN TRANSL SCI, V2, P216, DOI 10.1111/j.1752-8062.2009.00120.x; Huskins WC, 2011, CTS-CLIN TRANSL SCI, V4, P439, DOI 10.1111/j.1752-8062.2011.00356.x; Meagher E, 2011, CTS-CLIN TRANSL SCI, V4, P353, DOI 10.1111/j.1752-8062.2011.00317.x; Meyers FJ, 2012, CTS-CLIN TRANSL SCI, V5, P132, DOI 10.1111/j.1752-8062.2011.00392.x; Silet KA, 2010, CTS-CLIN TRANSL SCI, V3, P299, DOI 10.1111/j.1752-8062.2010.00237.x	9	34	35	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2012	308	19					1981	1982		10.1001/jama.2012.14367	http://dx.doi.org/10.1001/jama.2012.14367			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040AQ	23168821	Green Accepted			2022-12-28	WOS:000311291400020
J	Brouwer, MC; Thwaites, GE; Tunkel, AR; van de Beek, D				Brouwer, Matthijs C.; Thwaites, Guy E.; Tunkel, Allan R.; van de Beek, Diederik			Dilemmas in the diagnosis of acute community-acquired bacterial meningitis	LANCET			English	Article							CEREBROSPINAL-FLUID PLEOCYTOSIS; CLINICAL-PREDICTION RULE; SUB-SAHARAN AFRICA; DIFFERENTIAL-DIAGNOSIS; ASEPTIC-MENINGITIS; TUBERCULOUS MENINGITIS; VIRAL MENINGITIS; HAEMOPHILUS-INFLUENZAE; MENINGOCOCCAL-DISEASE; DISTINGUISH BACTERIAL	Rapid diagnosis and treatment of acute community-acquired bacterial meningitis reduces mortality and neurological sequelae, but can be delayed by atypical presentation, assessment of lumbar puncture safety, and poor sensitivity of standard diagnostic microbiology. Thus, diagnostic dilemmas are common in patients with suspected acute community-acquired bacterial meningitis. History and physical examination alone are sometimes not sufficient to confirm or exclude the diagnosis. Lumbar puncture is an essential investigation, but can be delayed by brain imaging. Results of cerebrospinal fluid (CSF) examination should be interpreted carefully, because CSF abnormalities vary according to the cause, patient's age and immune status, and previous treatment. Diagnostic prediction models that use a combination of clinical findings, with or without test results, can help to distinguish acute bacterial meningitis from other causes, but these models are not infallible. We review the dilemmas in the diagnosis of acute community-acquired bacterial meningitis, and focus on the roles of clinical assessment and CSF examination.	[Brouwer, Matthijs C.; van de Beek, Diederik] Univ Amsterdam, Acad Med Ctr, Dept Neurol, Ctr Infect & Immun Amsterdam CINIMA, NL-1100 DD Amsterdam, Netherlands; [Thwaites, Guy E.] Kings Coll London, Dept Infect Dis, Ctr Clin Infect & Diagnost Res, London WC2R 2LS, England; [Thwaites, Guy E.] Guys & St Thomas NHS Fdn Trust, London, England; [Tunkel, Allan R.] Monmouth Med Ctr, Dept Med, Long Branch, NJ USA	University of Amsterdam; Academic Medical Center Amsterdam; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	van de Beek, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurol, Ctr Infect & Immun Amsterdam CINIMA, POB 22660, NL-1100 DD Amsterdam, Netherlands.	d.vandebeek@amc.uva.nl	Thwaites, Guy E/R-4993-2019; van de Beek, Diederik/Y-2713-2019	Thwaites, Guy E/0000-0002-2858-2087; van de Beek, Diederik/0000-0002-4571-044X				Aronin SI, 1998, ANN INTERN MED, V129, P862, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00004; Baty V, 2000, EUR J CLIN MICROBIOL, V19, P422, DOI 10.1007/s100960000287; Bonsu BK, 2004, PEDIATR INFECT DIS J, V23, P511, DOI 10.1097/01.inf.0000129689.58211.9e; Boving MK, 2009, J CLIN MICROBIOL, V47, P908, DOI 10.1128/JCM.01966-08; Bronska E, 2006, CLIN MICROBIOL INFEC, V12, P137, DOI 10.1111/j.1469-0691.2005.01327.x; Brouwer MC, 2010, NEUROLOGY, V75, P1533, DOI 10.1212/WNL.0b013e3181f96297; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Brouwer MC, 2009, SCAND J INFECT DIS, V41, P375, DOI 10.1080/00365540902744766; Chavanet P, 2007, J INFECTION, V54, P328, DOI 10.1016/j.jinf.2006.06.009; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Cubells CL, 1997, ACTA PAEDIATR, V86, P26, DOI 10.1111/j.1651-2227.1997.tb08826.x; Curtis S, 2010, PEDIATRICS, V126, P952, DOI 10.1542/peds.2010-0277; De Cauwer HG, 2007, EUR J EMERG MED, V14, P343, DOI 10.1097/MEJ.0b013e328270366b; Determann RM, 2006, INTENS CARE MED, V32, P1243, DOI 10.1007/s00134-006-0240-4; du Chatelet IP, 2005, CLIN INFECT DIS, V40, P17, DOI 10.1086/426436; Dubos F, 2006, ARCH DIS CHILD, V91, P647, DOI 10.1136/adc.2005.085704; Dubos F, 2008, ARCH PEDIAT ADOL MED, V162, P1157, DOI 10.1001/archpedi.162.12.1157; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; Elmore JG, 1996, AM J MED, V100, P78, DOI 10.1016/S0002-9343(96)90015-7; Fitch MT, 2007, LANCET INFECT DIS, V7, P191, DOI 10.1016/S1473-3099(07)70050-6; Franco-Paredes C, 2008, INT J INFECT DIS, V12, P380, DOI 10.1016/j.ijid.2007.09.012; Hasbun R, 2001, NEW ENGL J MED, V345, P1727, DOI 10.1056/NEJMoa010399; Heckenberg SGB, 2008, MEDICINE, V87, P185, DOI 10.1097/MD.0b013e318180a6b4; HOEN B, 1995, EUR J CLIN MICROBIOL, V14, P267, DOI 10.1007/BF02116518; Holub M, 2007, CRIT CARE, V11, DOI 10.1186/cc5729; Hsieh CC, 2009, CHILD NERV SYST, V25, P461, DOI 10.1007/s00381-008-0715-4; Huy NT, 2010, CRIT CARE, V14, DOI 10.1186/cc9268; Ihekwaba UK, 2008, CLIN INFECT DIS, V47, P783, DOI 10.1086/591129; Jarvis JN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-67; Jim KK, 2012, J INFECTION, V64, P236, DOI 10.1016/j.jinf.2011.11.011; Kasanmoentalib ES, 2010, NEUROLOGY, V75, P918, DOI 10.1212/WNL.0b013e3181f11e10; Kumar R, 1999, ARCH DIS CHILD, V81, P221, DOI 10.1136/adc.81.3.221; Leblebicioglu H, 1996, EUR J CLIN MICROBIOL, V15, P252, DOI 10.1007/BF01591365; Linder A, 2011, CRIT CARE MED, V39, P812, DOI 10.1097/CCM.0b013e318206c396; Mai NTH, 2007, NEW ENGL J MED, V357, P2431, DOI 10.1056/NEJMoa070852; MCKINNEY WP, 1994, J GEN INTERN MED, V9, P8, DOI 10.1007/BF02599135; Michael B, 2010, EMERG MED J, V27, P433, DOI 10.1136/emj.2009.075598; Moghtaderi A, 2009, SCAND J INFECT DIS, V41, P188, DOI 10.1080/00365540902721384; Molyneux EM, 2003, ARCH DIS CHILD, V88, P1112, DOI 10.1136/adc.88.12.1112; Molyneux EM, 2002, LANCET, V360, P211, DOI 10.1016/S0140-6736(02)09458-8; Nigrovic LE, 2002, PEDIATRICS, V110, P712, DOI 10.1542/peds.110.4.712; Nigrovic LE, 2007, JAMA-J AM MED ASSOC, V297, P52, DOI 10.1001/jama.297.1.52; Nigrovic LE, 2008, PEDIATRICS, V122, P726, DOI 10.1542/peds.2007-3275; Oliver WJ, 2003, PEDIATRICS, V112, pE174, DOI 10.1542/peds.112.3.e174; Oostenbrink R, 2002, ARCH PEDIAT ADOL MED, V156, P1189, DOI 10.1001/archpedi.156.12.1189; Oostenbrink R, 2004, EUR J EPIDEMIOL, V19, P109, DOI 10.1023/B:EJEP.0000017828.13995.76; Oostenbrink R, 2001, ACTA PAEDIATR, V90, P611, DOI 10.1080/080352501750258649; Pandit L, 2005, J MED MICROBIOL, V54, P539, DOI 10.1099/jmm.0.45599-0; Pelkonen T, 2009, CLIN INFECT DIS, V48, P1107, DOI 10.1086/597463; Proulx N, 2005, QJM-INT J MED, V98, P291, DOI 10.1093/qjmed/hci047; Sacchi CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020675; Saez-Llorens X, 2003, LANCET, V361, P2139, DOI 10.1016/S0140-6736(03)13693-8; Saha SK, 2005, PEDIATR INFECT DIS J, V24, P1093, DOI 10.1097/01.inf.0000190030.75892.78; Sakushima K, 2011, J INFECTION, V62, P255, DOI 10.1016/j.jinf.2011.02.010; Scarborough M, 2008, LANCET NEUROL, V7, P637, DOI 10.1016/S1474-4422(08)70139-X; Scarborough M, 2007, NEW ENGL J MED, V357, P2441, DOI 10.1056/NEJMoa065711; Schut ES, 2012, NEUROCRIT CARE, V16, P421, DOI 10.1007/s12028-011-9634-4; Sharp C G, 1987, Pediatr Emerg Care, V3, P39, DOI 10.1097/00006565-198703000-00012; Sigurdardottir B, 1997, ARCH INTERN MED, V157, P425, DOI 10.1001/archinte.157.4.425; Sormunen P, 1999, J PEDIATR-US, V134, P725, DOI 10.1016/S0022-3476(99)70288-X; SPANOS A, 1989, JAMA-J AM MED ASSOC, V262, P2700, DOI 10.1001/jama.262.19.2700; Stahel PF, 1997, LANCET, V349, P1886, DOI 10.1016/S0140-6736(05)63877-9; Tang RB, 2001, CHILD NERV SYST, V17, P453, DOI 10.1007/s003810000422; Thomas KE, 2002, CLIN INFECT DIS, V35, P46, DOI 10.1086/340979; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4; Thwaites GE, 2005, LANCET NEUROL, V4, P160, DOI 10.1016/S1474-4422(05)01013-6; Thwaites GE, 2002, LANCET, V360, P1287, DOI 10.1016/S0140-6736(02)11318-3; Tzanakaki G, 2005, CLIN MICROBIOL INFEC, V11, P386, DOI 10.1111/j.1469-0691.2005.01109.x; UCHIHARA T, 1991, HEADACHE, V31, P167, DOI 10.1111/j.1526-4610.1991.hed3103167.x; van Crevel H, 2002, J NEUROL, V249, P129, DOI 10.1007/PL00007855; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573; Waghdhare S, 2010, CLIN NEUROL NEUROSUR, V112, P752, DOI 10.1016/j.clineuro.2010.06.003; Werno AM, 2008, CLIN INFECT DIS, V46, P926, DOI 10.1086/528798; Wylie PAL, 1997, BRIT MED J, V315, P774, DOI 10.1136/bmj.315.7111.774; Youssef FG, 2006, DIAGN MICR INFEC DIS, V55, P275, DOI 10.1016/j.diagmicrobio.2006.01.027	77	143	148	2	35	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2012	380	9854					1684	1692		10.1016/S0140-6736(12)61185-4	http://dx.doi.org/10.1016/S0140-6736(12)61185-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035MN	23141617				2022-12-28	WOS:000310951400031
J	van de Beek, D				van de Beek, Diederik			Progress and challenges in bacterial meningitis	LANCET			English	Editorial Material							DEXAMETHASONE; DISEASE; ADULTS		Univ Amsterdam, Dept Neurol, Ctr Infect & Immun Amsterdam CINIMA, Acad Med Ctr, NL-1100 DD Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	van de Beek, D (corresponding author), Univ Amsterdam, Dept Neurol, Ctr Infect & Immun Amsterdam CINIMA, Acad Med Ctr, NL-1100 DD Amsterdam, Netherlands.	d.vandebeek@amc.uva.nl	van de Beek, Diederik/Y-2713-2019	van de Beek, Diederik/0000-0002-4571-044X				Brouwer MC, 2010, NEUROLOGY, V75, P1533, DOI 10.1212/WNL.0b013e3181f96297; Brouwer MC, 2012, LANCET, V380, P1684, DOI 10.1016/S0140-6736(12)61185-4; Brouwer MC, 2010, LANCET INFECT DIS, V10, P262, DOI 10.1016/S1473-3099(10)70045-1; Brouwer MC, 2009, LANCET INFECT DIS, V9, P31, DOI 10.1016/S1473-3099(08)70261-5; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; McIntyre PB, 2012, LANCET, V380, P1703, DOI 10.1016/S0140-6736(12)61187-8; Mook-Kanamori BB, 2011, CLIN MICROBIOL REV, V24, P557, DOI 10.1128/CMR.00008-11; Novak RT, 2012, LANCET INFECT DIS, V12, P757, DOI 10.1016/S1473-3099(12)70168-8; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van de Beek D, 2012, LANCET, V380, P1693, DOI 10.1016/S0140-6736(12)61186-6; van de Beek D, 2010, LANCET NEUROL, V9, P254, DOI 10.1016/S1474-4422(10)70023-5; Woehrl B, 2011, J CLIN INVEST, V121, P3943, DOI 10.1172/JCI57522	15	61	63	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2012	380	9854					1623	1624		10.1016/S0140-6736(12)61808-X	http://dx.doi.org/10.1016/S0140-6736(12)61808-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035MN	23141602				2022-12-28	WOS:000310951400004
J	Bintu, L; Ishibashi, T; Dangkulwanich, M; Wu, YY; Lubkowska, L; Kashlev, M; Bustamante, C				Bintu, Lacramioara; Ishibashi, Toyotaka; Dangkulwanich, Manchuta; Wu, Yueh-Yi; Lubkowska, Lucyna; Kashlev, Mikhail; Bustamante, Carlos			Nucleosomal Elements that Control the Topography of the Barrier to Transcription	CELL			English	Article							RNA-POLYMERASE-II; HISTONE TAIL DOMAINS; DNA TRANSLOCATION; KINETIC-MODEL; ELONGATION; CHROMATIN; ACETYLATION; STABILITY; DYNAMICS; ARREST	The nucleosome represents a mechanical barrier to transcription that operates as a general regulator of gene expression. We investigate how each nucleosomal component-the histone tails, the specific histone-DNA contacts, and the DNA sequence-contributes to the strength of the barrier. Removal of the tails favors progression of RNA polymerase II into the entry region of the nucleosome by locally increasing the wrapping-unwrapping rates of the DNA around histones. In contrast, point mutations that affect histone-DNA contacts at the dyad abolish the barrier to transcription in the central region by decreasing the local wrapping rate. Moreover, we show that the nucleosome amplifies sequence-dependent transcriptional pausing, an effect mediated through the structure of the nascent RNA. Each of these nucleosomal elements controls transcription elongation by affecting distinctly the density and duration of polymerase pauses, thus providing multiple and alternative mechanisms for control of gene expression by chromatin remodeling and transcription factors.	[Bintu, Lacramioara; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Bintu, Lacramioara; Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Ishibashi, Toyotaka; Bustamante, Carlos] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Dangkulwanich, Manchuta; Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Wu, Yueh-Yi; Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Lubkowska, Lucyna; Kashlev, Mikhail] NCI Ctr Canc Res, Frederick, MD 21702 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bustamante, C (corresponding author), Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu	Ishibashi, Toyotaka/AAW-2687-2020	Ishibashi, Toyotaka/0000-0001-8015-2319; Dangkulwanich, Manchuta/0000-0001-8927-0952; Bustamante, Carlos/0000-0002-2970-0073	NIH [R01-GM032543-31]; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-AC02-05CH11231]; JSPS; NATIONAL CANCER INSTITUTE [ZIABC010795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Hodges, S. Kassube, S. Sternberg, B. Zamft, and members of the Bustamante laboratory for assistance and discussions. T. I. is supported by a fellowship from JSPS. This work was supported by NIH grant R01-GM032543-31 (C. B.) and by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under Contract No. DE-AC02-05CH11231 (C.B.).	Anderson JD, 2001, J MOL BIOL, V307, P977, DOI 10.1006/jmbi.2001.4528; Andrecka J, 2008, P NATL ACAD SCI USA, V105, P135, DOI 10.1073/pnas.0703815105; Angelov D, 2001, P NATL ACAD SCI USA, V98, P6599, DOI 10.1073/pnas.121171498; Bai L, 2004, J MOL BIOL, V344, P335, DOI 10.1016/j.jmb.2004.08.107; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Brower-Toland B, 2005, J MOL BIOL, V346, P135, DOI 10.1016/j.jmb.2004.11.056; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; Greive SJ, 2011, BIOPHYS J, V101, P1155, DOI 10.1016/j.bpj.2011.07.042; Greive SJ, 2011, BIOPHYS J, V101, P1166, DOI 10.1016/j.bpj.2011.07.043; Hawryluk PJ, 2004, NUCLEIC ACIDS RES, V32, P1904, DOI 10.1093/nar/gkh505; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Hsieh FK, 2010, EMBO REP, V11, P705, DOI 10.1038/embor.2010.113; Keene RG, 1999, NUCLEIC ACIDS RES, V27, P3173, DOI 10.1093/nar/27.15.3173; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kireeva ML, 2003, METHOD ENZYMOL, V370, P138; Koopmans WJA, 2009, BIOPHYS J, V97, P195, DOI 10.1016/j.bpj.2009.04.030; KRUGER W, 1995, GENE DEV, V9, P2770, DOI 10.1101/gad.9.22.2770; Kulaeva OI, 2010, P NATL ACAD SCI USA, V107, P11325, DOI 10.1073/pnas.1001148107; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Mihardja S, 2006, P NATL ACAD SCI USA, V103, P15871, DOI 10.1073/pnas.0607526103; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Muthurajan UM, 2004, EMBO J, V23, P260, DOI 10.1038/sj.emboj.7600046; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Protacio RU, 2000, MOL CELL BIOL, V20, P8866, DOI 10.1128/MCB.20.23.8866-8878.2000; Samkurashvili I, 1996, J BIOL CHEM, V271, P23495, DOI 10.1074/jbc.271.38.23495; SIMPSON RT, 1978, CELL, V13, P691, DOI 10.1016/0092-8674(78)90219-2; Tadigotla VR, 2006, P NATL ACAD SCI USA, V103, P4439, DOI 10.1073/pnas.0600508103; Thastrom A, 2004, METHODS, V33, P33, DOI 10.1016/j.ymeth.2003.10.018; Ujvari A, 2008, J BIOL CHEM, V283, P32236, DOI 10.1074/jbc.M806636200; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; Widlund HR, 2000, BIOCHEMISTRY-US, V39, P3835, DOI 10.1021/bi991957l; Wittmeyer J, 2004, METHOD ENZYMOL, V377, P322; Xayaphoummine A, 2005, NUCLEIC ACIDS RES, V33, pW605, DOI 10.1093/nar/gki447; Xu F, 2010, NUCLEIC ACIDS RES, V38, P6872, DOI 10.1093/nar/gkq506; YAGER TD, 1991, BIOCHEMISTRY-US, V30, P1097, DOI 10.1021/bi00218a032; Zamft B, 2012, P NATL ACAD SCI USA, V109, P8948, DOI 10.1073/pnas.1205063109; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025	41	124	130	1	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					738	749		10.1016/j.cell.2012.10.009	http://dx.doi.org/10.1016/j.cell.2012.10.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141536	Green Accepted, Bronze			2022-12-28	WOS:000310921200007
J	Gire, SK; Stremlau, M; Andersen, KG; Schaffner, SF; Bjornson, Z; Rubins, K; Hensley, L; McCormick, JB; Lander, ES; Garry, RF; Happi, C; Sabeti, PC				Gire, Stephen K.; Stremlau, Matthew; Andersen, Kristian G.; Schaffner, Stephen F.; Bjornson, Zach; Rubins, Kathleen; Hensley, Lisa; McCormick, Joseph B.; Lander, Eric. S.; Garry, Robert F.; Happi, Christian; Sabeti, Pardis C.			Emerging Disease or Diagnosis?	SCIENCE			English	Editorial Material							LASSA FEVER; EBOLA-VIRUS; NIGERIA					sgire@oeb.harvard.edu; psabeti@oeb.harvard.edu	Schaffner, Stephen F/D-1189-2011; Sabeti, Pardis/GQH-8610-2022; Andersen, Kristian/D-5006-2009	Andersen, Kristian/0000-0001-6431-5982; Happi, Christian/0000-0002-3056-6705; Garry, Robert/0000-0002-5683-3250; McCormick, Joseph/0000-0002-5844-8102; Schaffner, Stephen/0000-0001-6699-3568; Hensley, Lisa/0000-0003-1188-4342	NIAID NIH HHS [AI2008031, AI2009061] Funding Source: Medline; NIH HHS [DP2 OD006514, 1DP2OD006514-01] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006514] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Andersen KG, 2012, PHILOS T R SOC B, V367, P868, DOI 10.1098/rstb.2011.0299; Asogun DA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001839; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Bausch DG, 2001, VECTOR-BORNE ZOONOT, V1, P269, DOI 10.1089/15303660160025903; Becquart P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009126; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; Ehichioya DU, 2011, J CLIN MICROBIOL, V49, P1157, DOI 10.1128/JCM.01891-10; Fichet-Calvet E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000388; FISHERHOCH SP, 1995, BRIT MED J, V311, P857, DOI 10.1136/bmj.311.7009.857; Khan SH, 2008, ANTIVIR RES, V78, P103, DOI 10.1016/j.antiviral.2007.11.003; Lederberg J., 1992, I MED US COMMITTEE; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2004, J INFECT DIS, V190, P1895, DOI 10.1086/425421; McCormick JB, 2002, CURR TOP MICROBIOL, V262, P75; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Suzuki Y, 1997, MOL BIOL EVOL, V14, P800, DOI 10.1093/oxfordjournals.molbev.a025820; Walsh PD, 2005, PLOS BIOL, V3, P1946, DOI 10.1371/journal.pbio.0030371	17	23	24	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					750	752		10.1126/science.1225893	http://dx.doi.org/10.1126/science.1225893			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	033ZI	23139320				2022-12-28	WOS:000310839500029
J	Rafelski, SM; Viana, MP; Zhang, Y; Chan, YHM; Thorn, KS; Yam, P; Fung, JC; Li, H; Costa, LD; Marshall, WF				Rafelski, Susanne M.; Viana, Matheus P.; Zhang, Yi; Chan, Yee-Hung M.; Thorn, Kurt S.; Yam, Phoebe; Fung, Jennifer C.; Li, Hao; Costa, Luciano da F.; Marshall, Wallace F.			Mitochondrial Network Size Scaling in Budding Yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; INHERITANCE; DAUGHTER; DIVISION; GROWTH	Mitochondria must grow with the growing cell to ensure proper cellular physiology and inheritance upon division. We measured the physical size of mitochondrial networks in budding yeast and found that mitochondrial network size increased with increasing cell size and that this scaling relation occurred primarily in the bud. The mitochondria-to-cell size ratio continually decreased in aging mothers over successive generations. However, regardless of the mother's age or mitochondrial content, all buds attained the same average ratio. Thus, yeast populations achieve a stable scaling relation between mitochondrial content and cell size despite asymmetry in inheritance.	[Rafelski, Susanne M.; Zhang, Yi; Chan, Yee-Hung M.; Thorn, Kurt S.; Li, Hao; Marshall, Wallace F.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Rafelski, Susanne M.; Chan, Yee-Hung M.; Li, Hao; Marshall, Wallace F.] Univ Calif San Francisco, Ctr Syst & Synthet Biol, San Francisco, CA 94143 USA; [Viana, Matheus P.; Costa, Luciano da F.] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Zhang, Yi] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China; [Zhang, Yi] Peking Univ, Sch Phys, Beijing 100871, Peoples R China; [Yam, Phoebe; Fung, Jennifer C.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universidade de Sao Paulo; Peking University; Peking University; University of California System; University of California San Francisco	Rafelski, SM (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Ctr Complex Biol Syst, Irvine, CA 92717 USA.	susanner@uci.edu; wallace.marshall@ucsf.edu	da F. Costa, Luciano/H-5475-2011; Viana, Matheus/A-7137-2012	da F. Costa, Luciano/0000-0001-5203-4366; Viana, Matheus/0000-0001-9288-2108; Zhang, Yi/0000-0001-6609-8635; Thorn, Kurt/0000-0001-9310-288X	Sandler Postdoctoral Fellowship; Herbert Boyer Junior Faculty Endowed Chair Award; NIH [R01GM097017, R01GM070808, R01GM026259, P50Gm081879, 5RO1GM097213-02]; NIH National Research Service Award fellowship; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [05/00587-5, 07/50882-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [301303/06-1]; Packard Fellowship; China Scholarship Council (CSC) scholarship; Boyer Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026259, R01GM070808, P50GM081879, R01GM097017, R01GM097213] Funding Source: NIH RePORTER	Sandler Postdoctoral Fellowship; Herbert Boyer Junior Faculty Endowed Chair Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Packard Fellowship(The David & Lucile Packard Foundation); China Scholarship Council (CSC) scholarship(China Scholarship Council); Boyer Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Nunnari, J. Shaw, and A. Lewandowska for plasmids, strains, and discussions; G. Pesce for sharing unpublished results and discussions; and A. Caudy, E. Hong, K. C. Huang, A. Rosebrock, and the Marshall laboratory for reading the manuscript. Microscopy was performed at the UCSF Nikon Imaging Center. This work was supported by Sandler and Boyer Postdoctoral Fellowships (S. M. R.); the Herbert Boyer Junior Faculty Endowed Chair Award and NIH grant R01GM097017 (W. F. M.); an NIH National Research Service Award fellowship (Y.-H.M.C.); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (05/00587-5, 07/50882-9) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (301303/06-1) grants (L.d.F.C. and M. P. V.); NIH grants R01GM070808, R01GM026259, P50Gm081879, and a Packard Fellowship (Y.Z. and H. L.); a China Scholarship Council (CSC) scholarship (Y.Z.); and NIH grant 5RO1GM097213-02 (P.Y. and J. C. F.). Image analysis algorithms are described in detail in methods (6). The data are included in the main and supplementary figures.	Devin A, 2004, TOXICOL MECH METHOD, V14, P271, DOI 10.1080/15376520490479620; Frederick RL, 2008, GENETICS, V178, P825, DOI 10.1534/genetics.107.083055; Huxley J. S., 1936, Nature London, V137, P780, DOI 10.1038/137780b0; Itoh T, 2002, MOL CELL BIOL, V22, P7744, DOI 10.1128/MCB.22.22.7744-7757.2002; McFaline-Figueroa JR, 2011, AGING CELL, V10, P885, DOI 10.1111/j.1474-9726.2011.00731.x; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; POSAKONY JW, 1977, J CELL BIOL, V74, P468, DOI 10.1083/jcb.74.2.468; TANAKA K, 1985, J CELL SCI, V73, P207; Turner JJ, 2012, CURR BIOL, V22, pR350, DOI 10.1016/j.cub.2012.02.041; Uchida M, 2011, YEAST, V28, P227, DOI 10.1002/yea.1834; WOLDRINGH CL, 1993, J BACTERIOL, V175, P3174, DOI 10.1128/JB.175.10.3174-3181.1993	11	112	114	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					822	824		10.1126/science.1225720	http://dx.doi.org/10.1126/science.1225720			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139336	Green Accepted			2022-12-28	WOS:000310839500051
J	Schubeler, D				Schuebeler, Dirk			Epigenetic Islands in a Genetic Ocean	SCIENCE			English	Editorial Material							EMBRYONIC STEM-CELLS; DNA METHYLATION; BASE-RESOLUTION; IN-VIVO; TRANSCRIPTION; 5-HYDROXYMETHYLCYTOSINE; REGIONS; BINDING; STATES		Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Schubeler, D (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	dirk@fmi.ch						Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Perini G, 2005, P NATL ACAD SCI USA, V102, P12117, DOI 10.1073/pnas.0409097102; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Satterlee JS, 2010, NAT BIOTECHNOL, V28, P1039, DOI 10.1038/nbt1010-1039; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Velasco G, 2010, P NATL ACAD SCI USA, V107, P9281, DOI 10.1073/pnas.1000473107; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Xu J, 2007, P NATL ACAD SCI USA, V104, P12377, DOI 10.1073/pnas.0704579104; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	25	38	40	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					756	757		10.1126/science.1227243	http://dx.doi.org/10.1126/science.1227243			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139324				2022-12-28	WOS:000310839500033
J	Harper, J; Humphrey, N; Pfeffer, WT; Brown, J; Fettweis, X				Harper, J.; Humphrey, N.; Pfeffer, W. T.; Brown, J.; Fettweis, X.			Greenland ice-sheet contribution to sea-level rise buffered by meltwater storage in firn	NATURE			English	Article							MASS-BALANCE; ACCUMULATION; MODEL; PARAMETERIZATIONS; RETENTION; RUNOFF; MELT	Surface melt on the Greenland ice sheet has shown increasing trends in areal extent and duration since the beginning of the satellite era(1-3). Records for melt were broken in 2005(4), 2007(5), 2010(6) and 2012(7). Much of the increased surface melt is occurring in the percolation zone, a region of the accumulation area that is perennially covered by snow and firn (partly compacted snow). The fate of melt water in the percolation zone is poorly constrained: some may travel away from its point of origin and eventually influence the ice sheet's flow dynamics and mass balance and the global sea level, whereas some may simply infiltrate into cold snow or firn and refreeze with none of these effects. Here we quantify the existing water storage capacity of the percolation zone of the Greenland ice sheet and show the potential for hundreds of gigatonnes of meltwater storage. We collected in situ observations of firn structure and meltwater retention along a roughly 85-kilometre-long transect of the melting accumulation area. Our data show that repeated infiltration events in which melt water penetrates deeply(more than 10 metres) eventually fill all pore space with water. As future surface melt intensifies under Arctic warming, a fraction of melt water that would otherwise contribute to sea-level rise will fill existing pore space of the percolation zone. We estimate the lower and upper bounds of this storage sink to be 322 +/- 44 gigatonnes and 1,289(-252)(+388) gigatonnes, respectively. Furthermore, we find that decades are required to fill this pore space under a range of plausible future climate conditions. Hence, routing of surface melt water into filling the pore space of the firn column will delay expansion of the area contributing to sea-level rise, although once the pore space is filled it cannot quickly be regenerated.	[Harper, J.; Brown, J.] Univ Montana, Missoula, MT 59812 USA; [Humphrey, N.] Univ Wyoming, Laramie, WY 82071 USA; [Pfeffer, W. T.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Fettweis, X.] Univ Liege, B-114000 Liege, Belgium	University of Montana System; University of Montana; University of Wyoming; University of Colorado System; University of Colorado Boulder; University of Liege	Harper, J (corresponding author), Univ Montana, Missoula, MT 59812 USA.	joel@mso.umt.edu		humphrey, neil/0000-0002-5175-2080; Harper, Joel/0000-0002-2151-8509; Brown, Joel/0000-0001-5823-3083; Fettweis, Xavier/0000-0002-4140-3813	US National Science Foundation Office of Polar Programs, Arctic Natural Sciences [0612506, 0612374, 0612351]	US National Science Foundation Office of Polar Programs, Arctic Natural Sciences	This work was funded by the US National Science Foundation Office of Polar Programs, Arctic Natural Sciences with grants to J.H. (0612506), N.H. (0612374) and W.T.P. (0612351).	Abdalati W, 2001, J GEOPHYS RES-ATMOS, V106, P33983, DOI 10.1029/2001JD900181; Alley RB, 2005, SCIENCE, V310, P456, DOI 10.1126/science.1114613; Bales RC, 2001, J GEOPHYS RES-ATMOS, V106, P33813, DOI 10.1029/2001JD900153; Box J. E., 2011, STATE CLIMATE 2010, P156; Box JE, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004451; BRAITHWAITE RJ, 1994, J GLACIOL, V40, P477, DOI 10.3189/S002214300001234X; Brown J, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002089; Brown J, 2011, ANN GLACIOL, V52, P35, DOI 10.3189/172756411799096286; Burgess EW, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001293; Fettweis X, 2011, CRYOSPHERE, V5, P359, DOI 10.5194/tc-5-359-2011; Fettweis X, 2011, CLIMATE CHANGE - GEOPHYSICAL FOUNDATIONS AND ECOLOGICAL EFFECTS, P503; FISCHER H, 1995, J GLACIOL, V41, P515, DOI 10.3189/S0022143000034857; Hanna E, 2008, J CLIMATE, V21, P331, DOI 10.1175/2007JCLI1964.1; Harper J., 2011, 60 INSTAAR; HERRON MM, 1980, J GLACIOL, V25, P373, DOI 10.3189/S0022143000015239; Humphrey NF, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002083; Huybrechts P, 2011, SURV GEOPHYS, V32, P397, DOI 10.1007/s10712-011-9131-5; Janssens I, 2000, ANN GLACIOL-SER, V31, P133, DOI 10.3189/172756400781819941; MARSH P, 1984, WATER RESOUR RES, V20, P1853, DOI 10.1029/WR020i012p01853; McConnell JR, 2000, J GEOPHYS RES-ATMOS, V105, P4039, DOI 10.1029/1999JD901049; Mote TL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031976; Muller F., 1962, J GLACIOL, V4, P302, DOI [10.3189/s0022143000027623, DOI 10.3189/S0022143000027623, 10.3189/S0022143000027623]; PFEFFER WT, 1991, J GEOPHYS RES-OCEANS, V96, P22117, DOI 10.1029/91JC02502; Reijmer CH, 2012, CRYOSPHERE, V6, P743, DOI 10.5194/tc-6-743-2012; Tedesco M., 2007, EOS, V88, P383, DOI DOI 10.1029/2007EO390003; Tedesco M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028466; van den Broeke M, 2009, SCIENCE, V326, P984, DOI 10.1126/science.1178176; Vizcaino M, 2010, CLIM DYNAM, V34, P301, DOI 10.1007/s00382-009-0591-y	28	135	135	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					240	243		10.1038/nature11566	http://dx.doi.org/10.1038/nature11566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23135470				2022-12-28	WOS:000310774300041
J	Svanstrom, H; Pasternak, B; Hviid, A				Svanstrom, Henrik; Pasternak, Bjorn; Hviid, Anders			Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; PREDICTIVE-VALUE; BUPROPION; STROKE; DIAGNOSES; REGISTER; VALIDITY; DISEASE; SMOKERS; SAFETY	Objective To investigate whether varenicline is associated with an increased risk of serious cardiovascular events compared with another drug used for smoking cessation, bupropion. Design Nationwide historical cohort study. Setting Denmark, 2007-10. Participants New users of varenicline (n=17 926) and bupropion (n=17 926). Main outcome measures Individual level data on dispensed drug prescriptions, cardiovascular events, and potential confounders were linked between registries. Cox regression was used to estimate hazard ratios of cardiovascular events in analyses matched for propensity score. The primary outcomes at six months after start of treatment were acute coronary syndrome, ischaemic stroke, and cardiovascular death analysed individually and as a composite of any major event. Results There were 57 major cardiovascular events among varenicline users (6.9 cases per 1000 person years) compared with 60 events among bupropion users (7.1 cases per 1000 person years); the hazard ratio for any major event was 0.96 (95% confidence interval 0.67 to 1.39). Varenicline use was not associated with an increased risk of acute coronary syndrome (1.20, 0.75 to 1.91), ischaemic stroke (0.77, 0.40 to 1.48), and cardiovascular death (0.51, 0.13 to 2.02). In subgroup analyses, the risk of any major cardiovascular event was not significantly different between patients with and without a history of cardiovascular disease (1.24 (0.72 to 2.12) and 0.83 (0.51 to 1.36), respectively; P=0.29). Conclusions This cohort study found no increased risk of major cardiovascular events associated with use of varenicline compared with bupropion for smoking cessation. On the basis of the upper confidence limit, the data allowed the exclusion of a 40% increased risk of the composite outcome of any major cardiovascular event. While the estimates were less precise for specific outcomes, any differences would be small in absolute terms.	[Svanstrom, Henrik; Pasternak, Bjorn; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark	Statens Serum Institut	Svanstrom, H (corresponding author), Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.	htr@ssi.dk	Pasternak, Bjorn/H-5739-2012; Hviid, Anders/AAH-4319-2020	Pasternak, Bjorn/0000-0002-2097-8466; Hviid, Anders/0000-0002-7509-9127				Alper BS, 2011, CAN MED ASSOC J, V183, P1405, DOI 10.1503/cmaj.111-2071; Beyens MN, 2008, DRUG SAFETY, V31, P1017, DOI 10.2165/00002018-200831110-00006; Brophy JM, 2011, ANN INTERN MED, V155, DOI 10.7326/0003-4819-155-8-201110180-02005; Cahill K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006103.pub2; European Medicines Agency, EUR MED AG CONF POS; FDA, FDA DRUG SAF COMM CH; Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Harrison-Woolrych M, 2012, DRUG SAFETY, V35, P33, DOI 10.2165/11597690-000000000-00000; Harrison-Woolrych M, 2010, PHARMACOEPIDEM DR S, V19, P949, DOI 10.1002/pds.2003; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Hubbard R, 2005, TOB CONTROL, V14, P416, DOI 10.1136/tc.2005.011387; Johnsen SP, 2002, J CLIN EPIDEMIOL, V55, P602, DOI 10.1016/S0895-4356(02)00391-8; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Leonard CE, 2011, PHARMACOEPIDEM DR S, V20, P903, DOI 10.1002/pds.2181; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Parsons LS, 2001, SAS SUGI, P214; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Planer D, 2011, ARCH INTERN MED, V171, P1055, DOI 10.1001/archinternmed.2011.72; Prochaska JJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2856; Rea TD, 2002, ANN INTERN MED, V137, P494, DOI 10.7326/0003-4819-137-6-200209170-00009; Rigotti NA, 2006, AM J MED, V119, P1080, DOI 10.1016/j.amjmed.2006.04.024; Rigotti NA, 2010, CIRCULATION, V121, P221, DOI 10.1161/CIRCULATIONAHA.109.869008; ROSENBERG L, 1990, NEW ENGL J MED, V322, P213, DOI 10.1056/NEJM199001253220401; Samuels L, 2011, CAN MED ASSOC J, V183, DOI 10.1503/cmaj.111-2073; Schneeweiss S, 2011, CLIN PHARMACOL THER, V90, P777, DOI 10.1038/clpt.2011.235; Schneeweiss S, 2010, PHARMACOEPIDEM DR S, V19, P858, DOI 10.1002/pds.1926; Singh S, 2011, CAN MED ASSOC J, V183, P1359, DOI 10.1503/cmaj.110218; Squire EN, 2011, CAN MED ASSOC J, V183, P1404, DOI 10.1503/cmaj.111-2070; Sturmer T, 2011, EPIDEMIOLOGY, V22, P298, DOI 10.1097/EDE.0b013e318212640c; Takagi H, 2011, CAN MED ASSOC J, V183, P1404, DOI 10.1503/cmaj.111-2063; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Tonstad S, 2003, EUR HEART J, V24, P946, DOI 10.1016/S0195-668X(03)00003-4; US Food and Drug Administration, INF HEALTHC PROF VAR; World Health Organization, 2009, WHO REP GLOB TOB EP	38	39	39	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 8	2012	345								e7176	10.1136/bmj.e7176	http://dx.doi.org/10.1136/bmj.e7176			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036LM	23138033	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000311027400003
J	Connelly, JN; Bizzarro, M; Krot, AN; Nordlund, A; Wielandt, D; Ivanova, MA				Connelly, James N.; Bizzarro, Martin; Krot, Alexander N.; Nordlund, Ake; Wielandt, Daniel; Ivanova, Marina A.			The Absolute Chronology and Thermal Processing of Solids in the Solar Protoplanetary Disk	SCIENCE			English	Article							ISOTOPE HETEROGENEITY; CHONDRULES; ACCRETION; EVOLUTION; ORIGIN; SYSTEM; CM-247	Transient heating events that formed calcium-aluminum-rich inclusions (CAIs) and chondrules are fundamental processes in the evolution of the solar protoplanetary disk, but their chronology is not understood. Using U-corrected Pb-Pb dating, we determined absolute ages of individual CAIs and chondrules from primitive meteorites. CAIs define a brief formation interval corresponding to an age of 4567.30 +/- 0.16 million years (My), whereas chondrule ages range from 4567.32 +/- 0.42 to 4564.71 +/- 0.30 My. These data refute the long-held view of an age gap between CAIs and chondrules and, instead, indicate that chondrule formation started contemporaneously with CAIs and lasted similar to 3 My. This time scale is similar to disk lifetimes inferred from astronomical observations, suggesting that the formation of CAIs and chondrules reflects a process intrinsically linked to the secular evolution of accretionary disks.	[Connelly, James N.; Bizzarro, Martin; Krot, Alexander N.; Wielandt, Daniel] Univ Copenhagen, Ctr Star & Planet Format, DK-1350 Copenhagen, Denmark; [Connelly, James N.; Bizzarro, Martin; Krot, Alexander N.; Wielandt, Daniel] Univ Copenhagen, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark; [Krot, Alexander N.] Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; [Nordlund, Ake] Univ Copenhagen, Ctr Star & Planet Format, DK-2100 Copenhagen, Denmark; [Nordlund, Ake] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Ivanova, Marina A.] Vernadsky Inst Geochem & Analyt Chem, Moscow 119991, Russia	University of Copenhagen; University of Copenhagen; University of Hawaii System; University of Hawaii Manoa; University of Copenhagen; University of Copenhagen; Niels Bohr Institute; Russian Academy of Sciences; Vernadsky Institute of Geochemistry & Analytical Chemistry	Connelly, JN (corresponding author), Univ Copenhagen, Ctr Star & Planet Format, DK-1350 Copenhagen, Denmark.	connelly@snm.ku.dk; bizzarro@snm.ku.dk	Connelly, James/O-7996-2015; Bizzarro, Martin/I-8701-2012; Bizzarro, Martin/M-7474-2019	Bizzarro, Martin/0000-0001-9966-2124; Bizzarro, Martin/0000-0001-9966-2124	Danish National Research Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond)	All the data reported in this paper are presented in the supplementary materials. The Centre for Star and Planet Formation is financed by the Danish National Research Foundation. We thank C. Paton for help in the mass spectrometer laboratory and J. K. Jorgensen for discussion.	Alexander CMO, 2008, SCIENCE, V320, P1617, DOI 10.1126/science.1156561; Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; Amelin Y, 2010, EARTH PLANET SC LETT, V300, P343, DOI 10.1016/j.epsl.2010.10.015; Asphaug E, 2011, EARTH PLANET SC LETT, V308, P369, DOI 10.1016/j.epsl.2011.06.007; Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Bizzarro M, 2004, NATURE, V431, P275, DOI 10.1038/nature02882; BLAKE JB, 1973, NATURE-PHYS SCI, V243, P138, DOI 10.1038/physci243138a0; Blichert-Toft J, 2010, EARTH PLANET SC LETT, V300, P152, DOI 10.1016/j.epsl.2010.10.001; Boss AP, 2005, ASTROPHYS J, V621, pL137, DOI 10.1086/429160; BOSS AP, 1993, ICARUS, V106, P168, DOI 10.1006/icar.1993.1164; Brennecka GA, 2010, SCIENCE, V327, P449, DOI 10.1126/science.1180871; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Connelly JN, 2008, GEOCHIM COSMOCHIM AC, V72, P4813, DOI 10.1016/j.gca.2008.06.007; D'Alessio P., 2005, CHONDRITES PROTOPLAN, P353; Evans NJ, 2009, ASTROPHYS J SUPPL S, V181, P321, DOI 10.1088/0067-0049/181/2/321; Galy A, 2000, SCIENCE, V290, P1751, DOI 10.1126/science.290.5497.1751; GOPEL C, 1991, METEORITICS, V26, P338; JONES RH, 2005, CHONDRITES PROTOPLAN, V341, P251; Joung M. K. Ryan, 2004, ASTROPHYS J, V606, P532; Krot AN, 2009, GEOCHIM COSMOCHIM AC, V73, P4963, DOI 10.1016/j.gca.2008.09.039; KROT AN, 1995, GEOCHIM COSMOCHIM AC, V59, P4951, DOI 10.1016/0016-7037(95)00337-1; Larsen KK, 2011, ASTROPHYS J LETT, V735, DOI 10.1088/2041-8205/735/2/L37; LEE T, 1977, ASTROPHYS J, V211, pL107, DOI 10.1086/182351; Libourel G, 2007, EARTH PLANET SC LETT, V254, P1, DOI 10.1016/j.epsl.2006.11.013; MacPherson GJ, 2005, TREATISE GEOCHEM, V1, P201; Palme H, 2005, TREATISE GEOCHEM, V1, P41; Salmeron R, 2012, EARTH PLANET SC LETT, V327, P61, DOI 10.1016/j.epsl.2012.01.033; Scott ERD, 2007, ANNU REV EARTH PL SC, V35, P577, DOI 10.1146/annurev.earth.35.031306.140100; Stirling CH, 2005, GEOCHIM COSMOCHIM AC, V69, P1059, DOI 10.1016/j.gca.2004.06.034; Trinquier A, 2007, ASTROPHYS J, V655, P1179, DOI 10.1086/510360; Trinquier A, 2009, SCIENCE, V324, P374, DOI 10.1126/science.1168221; Trinquier A, 2008, J ANAL ATOM SPECTROM, V23, P1565, DOI 10.1039/b809755k; Vorobyov EI, 2010, ASTROPHYS J, V719, P1896, DOI 10.1088/0004-637X/719/2/1896; Weidenschilling SJ, 1998, SCIENCE, V279, P681, DOI 10.1126/science.279.5351.681; Zanni C, 2007, ASTRON ASTROPHYS, V469, P811, DOI 10.1051/0004-6361:20066400	39	582	583	3	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107					651	655		10.1126/science.1226919	http://dx.doi.org/10.1126/science.1226919			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118187				2022-12-28	WOS:000310516000049
J	Creutz, SE; Lotito, KJ; Fu, GC; Peters, JC				Creutz, Sidney E.; Lotito, Kenneth J.; Fu, Gregory C.; Peters, Jonas C.			Photoinduced Ullmann C-N Coupling: Demonstrating the Viability of a Radical Pathway	SCIENCE			English	Article							ARYL HALIDES; COPPER; COMPLEXES; SELECTIVITIES; CHEMISTRY	Carbon-nitrogen (C-N) bond-forming reactions of amines with aryl halides to generate arylamines (anilines), mediated by a stoichiometric copper reagent at elevated temperature (>180 degrees C), were first described by Ullmann in 1903. In the intervening century, this and related C-N bond-forming processes have emerged as powerful tools for organic synthesis. Here, we report that Ullmann C-N coupling can be photoinduced by using a stoichiometric or a catalytic amount of copper, which enables the reaction to proceed under unusually mild conditions (room temperature or even -40 degrees C). An array of data are consistent with a single-electron transfer mechanism, representing the most substantial experimental support to date for the viability of this pathway for Ullmann C-N couplings.	[Creutz, Sidney E.; Lotito, Kenneth J.; Fu, Gregory C.; Peters, Jonas C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Fu, Gregory C.] MIT, Dept Chem, Cambridge, MA 02139 USA	California Institute of Technology; Massachusetts Institute of Technology (MIT)	Fu, GC (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	gcfu@caltech.edu; jpeters@caltech.edu			National Science Foundation; Gordon and Betty Moore Foundation	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This work was supported by the National Science Foundation (graduate research fellowships for S. E. C. and K.J.L.) and by the Gordon and Betty Moore Foundation. Metrical parameters for the structure of copper complex 1 are available free of charge from the Cambridge Crystallographic Data Centre under reference CCDC-896019.	Annunziata A, 2001, EUR J ORG CHEM, V2001, P1323; Beletskaya IP, 2004, COORDIN CHEM REV, V248, P2337, DOI 10.1016/j.ccr.2004.09.014; DANNLEY RL, 1954, J AM CHEM SOC, V76, P445, DOI 10.1021/ja01631a035; Deaton JC, 2010, J AM CHEM SOC, V132, P9499, DOI 10.1021/ja1004575; Enemrke R. J., 2001, J CHEM SOC P2, V9, P1620; Evano G, 2008, CHEM REV, V108, P3054, DOI 10.1021/cr8002505; Giri R, 2010, J AM CHEM SOC, V132, P15860, DOI 10.1021/ja105695s; Goldberg I, 1906, BER DTSCH CHEM GES, V39, P1691, DOI 10.1002/cber.19060390298; Grundy S., 2007, ATORVASTATIN MANAGEM; Harkins SB, 2005, J AM CHEM SOC, V127, P2030, DOI 10.1021/ja043092r; Hartwig J.F., 2007, CHEM ANILINES, P455; Hay M, 1996, P NATL ACAD SCI USA, V93, P461, DOI 10.1073/pnas.93.1.461; Jiang L., 2004, METAL CATALYZED CROS, V2, P699, DOI DOI 10.1002/9783527619535.CH13; Jones GO, 2010, J AM CHEM SOC, V132, P6205, DOI 10.1021/ja100739h; Keller CL, 2008, J ORG CHEM, V73, P3616, DOI 10.1021/jo7026905; Ley SV, 2003, ANGEW CHEM INT EDIT, V42, P5400, DOI 10.1002/anie.200300594; Lotito KJ, 2010, CHEM COMMUN, V46, P3690, DOI 10.1039/c000818d; Mankad NP, 2009, J AM CHEM SOC, V131, P3878, DOI 10.1021/ja809834k; Monnier F, 2009, ANGEW CHEM INT EDIT, V48, P6954, DOI 10.1002/anie.200804497; Narayanam JMR, 2011, CHEM SOC REV, V40, P102, DOI 10.1039/b913880n; Natarajan S, 2006, J PHYS CHEM B, V110, P8047, DOI 10.1021/jp0604239; Natarajan S, 2006, CHEM COMMUN, P729, DOI 10.1039/b515087f; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; ROSSI RA, 1982, ACCOUNTS CHEM RES, V15, P164, DOI 10.1021/ar00078a001; Solomon EI, 2006, INORG CHEM, V45, P8012, DOI 10.1021/ic060450d; Sperotto E, 2010, DALTON T, V39, P10338, DOI 10.1039/c0dt00674b; Travis A.S., 2007, CHEM ANILINES, V2, P715; Travis A.S., 2007, CHEM ANILINES, V1, P1; Tye JW, 2008, J AM CHEM SOC, V130, P9971, DOI 10.1021/ja076668w; Ullmann F, 1903, BER DTSCH CHEM GES, V36, P2382, DOI 10.1002/cber.190303602174; Xi ZX, 2008, TETRAHEDRON, V64, P4254, DOI 10.1016/j.tet.2008.02.082; Yu HZ, 2010, J AM CHEM SOC, V132, P18078, DOI 10.1021/ja104264v	32	343	345	17	327	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107					647	651		10.1126/science.1226458	http://dx.doi.org/10.1126/science.1226458			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118186				2022-12-28	WOS:000310516000048
J	Konstam, MA				Konstam, Marvin A.			RELAX-AHF: rising from the doldrums in acute heart failure	LANCET			English	Editorial Material							RANDOMIZED-TRIAL; NESIRITIDE; CAPTOPRIL; MORTALITY; SURVIVAL; LOSARTAN; ELITE		[Konstam, Marvin A.] Tufts Med Ctr, Ctr Cardiovasc, Boston, MA 02111 USA; [Konstam, Marvin A.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Konstam, MA (corresponding author), Tufts Med Ctr, Ctr Cardiovasc, Boston, MA 02111 USA.	mkonstam@tuftsmedicalcenter.org						Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; McMurray JJV, 2007, JAMA-J AM MED ASSOC, V298, P2009, DOI 10.1001/jama.298.17.2009; O'Connor CM, 2011, NEW ENGL J MED, V365, P32, DOI 10.1056/NEJMoa1100171; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Pitt B, 1997, LANCET, V349, P747, DOI 10.1016/S0140-6736(97)01187-2; Sackner-Bernstein JD, 2005, CIRCULATION, V111, P1487, DOI 10.1161/01.CIR.0000159340.93220.E4; Teerlink JR, 2012, LANCET; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531, DOI 10.1001/jama.287.12.1531; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	12	11	11	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 5	2013	381	9860					5	6		10.1016/S0140-6736(12)61896-0	http://dx.doi.org/10.1016/S0140-6736(12)61896-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064AW	23141815				2022-12-28	WOS:000313044300005
J	Coles, AJ; Twyman, CL; Arnold, DL; Cohen, JA; Confavreux, C; Fox, EJ; Hartung, HP; Havrdova, E; Selmaj, KW; Weiner, HL; Miller, T; Fisher, E; Sandbrink, R; Lake, SL; Margolin, DH; Oyuela, P; Panzara, MA; Compston, DAS				Coles, Alasdair J.; Twyman, Cary L.; Arnold, Douglas L.; Cohen, Jeffrey A.; Confavreux, Christian; Fox, Edward J.; Hartung, Hans-Peter; Havrdova, Eva; Selmaj, Krzysztof W.; Weiner, Howard L.; Miller, Tamara; Fisher, Elizabeth; Sandbrink, Rupert; Lake, Stephen L.; Margolin, David H.; Oyuela, Pedro; Panzara, Michael A.; Compston, D. Alastair S.		CARE-MS II Investigators	Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial	LANCET			English	Article							MONOCLONAL-ANTIBODY TREATMENT; LYMPHOCYTE DEPLETION; INTERFERON-BETA; CLINICAL-TRIAL; FUNCTIONAL COMPOSITE; OUTCOME MEASURE; RECONSTITUTION; CAMPATH-1H; TESTS	Background The anti-CD52 monoclonal antibody alemtuzumab reduces disease activity in previously untreated patients with relapsing-remitting multiple sclerosis. We aimed to assess efficacy and safety of alemtuzumab compared with interferon beta 1a in patients who have relapsed despite first-line treatment. Methods In our 2 year, rater-masked, randomised controlled phase 3 trial, we enrolled adults aged 18-55 years with relapsing-remitting multiple sclerosis and at least one relapse on interferon beta or glatiramer. Eligible participants were randomly allocated in a 1: 2: 2 ratio by an interactive voice response system, stratified by site, to receive subcutaneous interferon beta 1a 44 mu g, intravenous alemtuzumab 12 mg per day, or intravenous alemtuzumab 24 mg per day. Interferon beta 1a was given three-times per week and alemtuzumab was given once per day for 5 days at baseline and for 3 days at 12 months. The 24 mg per day group was discontinued to aid recruitment, but data are included for safety assessments. Coprimary endpoints were relapse rate and time to 6 month sustained accumulation of disability, comparing alemtuzumab 12 mg and interferon beta 1a in all patients who received at least one dose of study drug. This study is registered with ClinicalTrials.gov, number NCT00548405. Findings 202 (87%) of 231 patients randomly allocated interferon beta 1a and 426 (98%) of 436 patients randomly allocated alemtuzumab 12 mg were included in the primary analyses. 104 (51%) patients in the interferon beta 1a group relapsed (201 events) compared with 147 (35%) patients in the alemtuzumab group (236 events; rate ratio 0.51 [95% CI 0.39-0.65]; p<0.0001), corresponding to a 49.4% improvement with alemtuzumab. 94 (47%) patients in the interferon beta 1a group were relapse-free at 2 years compared with 278 (65%) patients in the alemtuzumab group (p<0.0001). 40 (20%) patients in the interferon beta 1a group had sustained accumulation of disability compared with 54 (13%) in the alemtuzumab group (hazard ratio 0.58 [95% CI 0.38-0.87]; p=0.008), corresponding to a 42% improvement in the alemtuzumab group. For 435 patients allocated alemtuzumab 12 mg, 393 (90%) had infusion-associated reactions, 334 (77%) had infections (compared with 134 [66%] of 202 patients in the interferon beta 1a group) that were mostly mild-moderate with none fatal, 69 (16%) had thyroid disorders, and three (1%) had immune thrombocytopenia. Interpretation For patients with first-line treatment-refractory relapsing-remitting multiple sclerosis, alemtuzumab could be used to reduce relapse rates and sustained accumulation of disability. Suitable risk management strategies allow for early identification of alemtuzumab's main adverse effect of secondary autoimmunity.	[Coles, Alasdair J.; Compston, D. Alastair S.] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 0QQ, England; [Arnold, Douglas L.] McGill Univ, Montreal Neurol Inst, NeuroRx Res, Montreal, PQ, Canada; [Arnold, Douglas L.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Cohen, Jeffrey A.] Cleveland Clin, Mellen Ctr, Cleveland, OH 44106 USA; [Fisher, Elizabeth] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [Twyman, Cary L.] Associates Neurol, Lexington, KY USA; [Confavreux, Christian] Univ Lyon 1, Hosp Civils Lyon, Serv Neurol A, F-69365 Lyon, France; [Fox, Edward J.] Cent Texas Neurol Consultants, MS Clin Cent Texas, Round Rock, TX USA; [Hartung, Hans-Peter; Sandbrink, Rupert] Univ Dusseldorf, Dept Neurol, Dusseldorf, Germany; [Havrdova, Eva] Charles Univ Prague, Sch Med 1, Dept Neurol, Prague, Czech Republic; [Selmaj, Krzysztof W.] Med Univ Lodz, Dept Neurol, Lodz, Poland; [Weiner, Howard L.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Miller, Tamara] Adv Neurol Colorado, Ft Collins, CO USA; [Sandbrink, Rupert] Bayer HealthCare, Berlin, Germany; [Lake, Stephen L.; Margolin, David H.; Oyuela, Pedro; Panzara, Michael A.] Genzyme, Cambridge, MA USA	University of Cambridge; McGill University; McGill University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Heinrich Heine University Dusseldorf; Charles University Prague; Medical University Lodz; Harvard University; Brigham & Women's Hospital; Bayer AG; Bayer Healthcare Pharmaceuticals; Sanofi-Aventis; Genzyme Corporation	Coles, AJ (corresponding author), Univ Cambridge, Dept Clin Neurosci, Addenbrookes Hosp, Box 165, Cambridge CB2 0QQ, England.	ajc1020@medschl.cam.ac.uk	Macedo, Ana/L-9912-2018; Havrdova, Eva Kubala/P-4892-2017; Kremenchutzky, Marcelo/B-6413-2015; Skoromets, Alexander/I-7569-2013; Goodman, Andrew D/N-3974-2018; Nehrych, Tetyana I/L-7555-2016; McCombe, Pamela/C-9692-2010; LICEND, CEMND/F-1296-2015; Montalban, Xavier/J-5938-2016; Snydman, David R/O-3889-2014; Kovarova, Ivana/P-5201-2017; Bertolotto, Antonio/K-8346-2015; De Seze, Jerome/M-8316-2016; Dubois, Benedicte/A-4338-2019	Macedo, Ana/0000-0002-6978-8989; Havrdova, Eva Kubala/0000-0002-9543-4359; Nehrych, Tetyana I/0000-0003-0170-511X; McCombe, Pamela/0000-0003-2704-8517; Montalban, Xavier/0000-0002-0098-9918; Snydman, David R/0000-0003-0119-3978; Kovarova, Ivana/0000-0002-1568-5749; Bertolotto, Antonio/0000-0002-7052-1907; De Seze, Jerome/0000-0002-7197-7578; Pozzilli, Carlo/0000-0002-6360-4798; Dubois, Benedicte/0000-0003-0604-8702; Dunn, Jeffrey/0000-0002-1721-6081; Vucic, Steve/0000-0002-8323-873X; Karni, Arnonk/0000-0002-5625-7900; Reddel, Stephen/0000-0002-0169-3350; Lycke, Jan/0000-0002-7891-8466; Hunter, Samuel/0000-0002-0542-1176; Coles, Alasdair/0000-0003-4738-0760; Arnold, Douglas/0000-0003-4266-0106; Selmaj, Krzysztof/0000-0003-1213-7218; Panzara, Michael/0000-0003-2810-4832; antel, jack/0000-0002-5148-0636	Genzyme; Merck Serono; Sanofi company; Bayer Schering Pharma; Czech Ministry of Education, Research program [MSM 0021620849]; Cambridge National Institute for Health Research Biomedical Research Centre; Acorda; Bayer; Biogen Idec; Eli Lilly; EMD Serono; GlaxoSmithKline; Novartis; Ono; Opexa; Pfizer; Roche; Sanofi; Teva; GSK; Nasvax; Sanofi-Aventis; Roche/Genentech; National Institute for Health Research [NF-SI-0508-10335] Funding Source: researchfish	Genzyme(Sanofi-AventisGenzyme Corporation); Merck Serono(Merck & Company); Sanofi company; Bayer Schering Pharma(Bayer AG); Czech Ministry of Education, Research program; Cambridge National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Acorda; Bayer(Bayer AG); Biogen Idec(Biogen); Eli Lilly(Eli Lilly); EMD Serono; GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Ono; Opexa; Pfizer(Pfizer); Roche(Roche Holding); Sanofi; Teva(Teva Pharmaceutical Industries); GSK(GlaxoSmithKline); Nasvax; Sanofi-Aventis(Sanofi-Aventis); Roche/Genentech(Roche HoldingGenentech); National Institute for Health Research(National Institute for Health Research (NIHR))	AJC reports receiving consulting fees from Genzyme, lecture fees from Merck Serono, and research support paid to his institution from Genzyme. CLT reports receiving compensation from clinical trials with Genzyme, Sanofi-Aventis, Eli Lilly, Opexa Therapeutics, Biogen Idec, Teva, Roche, Novartis, Xenoport, Acorda, and Pfizer Pharmaceuticals and compensation for speaker activities and consultation activities from Acorda, Biogen Idec, Novartis, Forrest, and Teva. DLA served on advisory boards, received speaker honoraria, and served as a consultant or received research support from Bayer, Biogen Idec, Coronado Biosciences, Consortium of Multiple Sclerosis Centers, Eli Lilly, EMD Serono, Genentech, Genzyme, GlaxoSmithKline, MS Forum, NeuroRx Research, Novartis, Opexa Therapeutics, Roche, Merck Serono, SA Serono Symposia International Foundation, Teva, the Canadian Institutes of Health Research, and the Multiple Sclerosis Society of Canada; and holds stock in NeuroRx Research. JAC reports receiving consulting fees from Biogen Idec, Elan, Five Prime Therapeutics, Eli Lilly, Novartis, Teva, Vaccinex, lecture fees from Novartis and Waterfront Media, and research support paid to his institution from Biogen Idec, Genzyme, Novartis, and Teva. CC reports receiving consulting fees from Biogen Idec, Gemacbio, Genzyme, Novartis, Sanofi-Aventis, Teva, UCB; lecture fees from Bayer-Schering, Biogen Idec, Genzyme, Merck-Serono, Novartis, Octopharma, Sanofi-Aventis, Teva; research support paid to his institution from Bayer-Schering, Biogen Idec, Merck-Serono, Novartis, Sanofi-Aventis, Teva. EJF reports receiving consulting fees, honoraria, travel, and research support from Acorda, Bayer, Biogen Idec, Eli Lilly, EMD Serono, Genzyme, GlaxoSmithKline, Novartis, Ono, Opexa, Pfizer, Roche, Sanofi, and Teva. H-PH reports receiving honoraria for consulting and speaking, with approval by the rector of Heinrich-Heine-University from Bayer, Biogen Idec, Genzyme, Merck Serono, Novartis, Sanofi, and Teva. EH reports receiving consulting fees, honoraria, travel, and research support from Bayer, Biogen Idec, Genzyme, GSK, Merck Serono, Novartis, Roche, and Teva. KJ reports receiving consulting fees from Genzyme, Novartis, Biogen Idec, and Roche; he has received lecture fees from Novartis, Merck-Serono, Biogen Idec, and Bayer; and received financial compensation including travel from Genzyme for presentation at ECTRIMS 2010. HLW reports receiving consulting fees from Biogen Idec, EMD Serono, Nasvax, Novartis, Teva, and research support paid to his institution from Biogen Idec and EMD Serono. TM has received compensation for speaker activities for Acorda, Allergan, Bayer, Biogen Idec, Eli Lilly, Forest, Novartis, Pfizer, Questcor, Teva and National MS Society; until clinical trial closure, TM was an independent contractor for Allergan, Biogen Idec, Genzyme, Elan, Teva, Ono, Pfizer, Novartis, Sanofi-Aventis, EMD Serono, and Roche/Genentech. EF reports receiving consulting fees from Biogen Idec, Genzyme, Pfizer, and Wyeth, lecture fees from Biogen Idec and Teva, and research support paid to her institution from Biogen Idec, Genzyme, and Wyeth. RS receives personal compensation as an employee of Bayer HealthCare, Berlin, Germany. ASC reports receiving consulting fees, lecture fees and grant support from Genzyme and lecture fees from Bayer Schering Pharma, on behalf of the University of Cambridge. DHM, SLL, PO, and MP receive personal compensation as employees of Genzyme (a Sanofi company).; This trial was supported by Genzyme, a Sanofi company, and Bayer Schering Pharma. EH has been supported by Czech Ministry of Education, Research program MSM 0021620849. AJC and DASC are supported by the Cambridge National Institute for Health Research Biomedical Research Centre. Shelton Smith (Genzyme) provided editorial assistance.	Clark RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003008; Cohen JA, 2001, ARCH NEUROL-CHICAGO, V58, P961, DOI 10.1001/archneur.58.6.961; Cohen JA, 2012, LANCET; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Coles AJ, 2012, NEUROLOGY, V78, P1069, DOI 10.1212/WNL.0b013e31824e8ee7; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; Coles AJ, 2006, J NEUROL, V253, P98, DOI 10.1007/s00415-005-0934-5; Coles AJ, 1999, LANCET, V354, P1691, DOI 10.1016/S0140-6736(99)02429-0; Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670; Cox AL, 2005, EUR J IMMUNOL, V35, P3332, DOI 10.1002/eji.200535075; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Fox EJ, 2012, EUR J NEUROL, V19, P307, DOI 10.1111/j.1468-1331.2011.03507.x; Halpern R, 2011, ADV THER, V28, P761, DOI 10.1007/s12325-011-0054-9; Hill-Cawthorne GA, 2012, J NEUROL NEUROSUR PS, V83, P298, DOI 10.1136/jnnp-2011-300826; Hochberg Y., 1987, MULTIPLE COMP PROCED; Jones JL, 2009, J CLIN INVEST, V119, P2052, DOI 10.1172/JCI37878; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LACHIN JM, 1992, STAT MED, V11, P1151, DOI 10.1002/sim.4780110903; Limmroth V, 2007, J NEUROL, V254, P67, DOI 10.1007/s00415-006-0281-1; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lin DY, 2000, J ROY STAT SOC B, V62, P711, DOI 10.1111/1467-9868.00259; Moreau T, 1996, BRAIN, V119, P225, DOI 10.1093/brain/119.1.225; MOREAU T, 1994, LANCET, V344, P298, DOI 10.1016/S0140-6736(94)91339-0; Panitch H, 2002, NEUROLOGY, V59, P1496, DOI 10.1212/01.WNL.0000034080.43681.DA; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Prosperini L, 2009, EUR J NEUROL, V16, P1202, DOI 10.1111/j.1468-1331.2009.02708.x; Rio J, 2006, ANN NEUROL, V59, P344, DOI 10.1002/ana.20740; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Rudick RA, 2004, ANN NEUROL, V56, P548, DOI 10.1002/ana.20224; Rudick RA, 2009, LANCET NEUROL, V8, P545, DOI 10.1016/S1474-4422(09)70082-1; Thompson SAJ, 2010, J CLIN IMMUNOL, V30, P99, DOI 10.1007/s10875-009-9327-3; WEI LJ, 1984, J AM STAT ASSOC, V79, P653, DOI 10.2307/2288413	32	781	801	1	70	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 24	2012	380	9856					1829	1839		10.1016/S0140-6736(12)61768-1	http://dx.doi.org/10.1016/S0140-6736(12)61768-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	041XK	23122650				2022-12-28	WOS:000311435000028
J	Chistol, G; Liu, SX; Hetherington, CL; Moffitt, JR; Grimes, S; Jardine, PJ; Bustamante, C				Chistol, Gheorghe; Liu, Shixin; Hetherington, Craig L.; Moffitt, Jeffrey R.; Grimes, Shelley; Jardine, Paul J.; Bustamante, Carlos			High Degree of Coordination and Division of Labor among Subunits in a Homomeric Ring ATPase	CELL			English	Article							HEXAMERIC HELICASE; DNA TRANSLOCATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MECHANISM; HYDROLYSIS; MOTOR; TRANSPORT; MCM2-7; MODEL	Ring NTPases of the ASCE superfamily perform a variety of cellular functions. An important question about the operation of these molecular machines is how the ring subunits coordinate their chemical and mechanical transitions. Here, we present a comprehensive mechanochemical characterization of a homomeric ring ATPase-the bacteriophage phi 29 packaging motor-a homopentamer that translocates double-stranded DNA in cycles composed of alternating dwells and bursts. We use high-resolution optical tweezers to determine the effect of nucleotide analogs on the cycle. We find that ATP hydrolysis occurs sequentially during the burst and that ADP release is interlaced with ATP binding during the dwell, revealing a high degree of coordination among ring subunits. Moreover, we show that the motor displays an unexpected division of labor: although all subunits of the homopentamer bind and hydrolyze ATP during each cycle, only four participate in translocation, whereas the remaining subunit plays an ATP-dependent regulatory role.	[Chistol, Gheorghe; Liu, Shixin; Hetherington, Craig L.; Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Chistol, Gheorghe; Liu, Shixin; Hetherington, Craig L.; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Liu, Shixin; Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Moffitt, Jeffrey R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Grimes, Shelley; Jardine, Paul J.] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [Grimes, Shelley; Jardine, Paul J.] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Harvard University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu		Bustamante, Carlos/0000-0002-2970-0073; Jardine, Paul/0000-0002-1090-0550; Chistol, Gheorghe/0000-0003-4868-3667	National Institutes of Health [GM071552, GM059604, DE003606]; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE003606, R37DE003606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059604, R01GM071552] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Dangkulwanich, T. Ishibashi, C. Kaiser, N. Liu, R. Maillard, M. Morais, and M. Sen for critical discussions. This work was supported in part by grants from the National Institutes of Health (GM071552 to C.B., GM059604 and DE003606 to S.G.) and the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under Contract No. DE-AC02-05CH11231 (single molecule force measurement) to C.B.	Aathavan K, 2009, NATURE, V461, P669, DOI 10.1038/nature08443; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Adelman JL, 2006, MOL CELL, V22, P611, DOI 10.1016/j.molcel.2006.04.022; Baird CL, 1999, P NATL ACAD SCI USA, V96, P13685, DOI 10.1073/pnas.96.24.13685; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Burroughs A. M., 2007, V3, P48, DOI 10.1159/000107603; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Bustamante C., 2008, SINGLE MOL TECHNIQUE, P297; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; GOODNO CC, 1982, METHOD ENZYMOL, V85, P116; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; Hetherington CL, 2011, COMPREHENSIVE BIOPHYSICS, VOL 4: MOLECULAR MOTORS AND MOTILITY, P420, DOI 10.1016/B978-0-12-374920-8.00431-8; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Itsathitphaisarn O, 2012, CELL, V151, P267, DOI 10.1016/j.cell.2012.09.014; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Johnson A, 2003, J BIOL CHEM, V278, P14406, DOI 10.1074/jbc.M212708200; Kainov DE, 2008, J BIOL CHEM, V283, P3607, DOI 10.1074/jbc.M706366200; Kalafut B, 2008, COMPUT PHYS COMMUN, V179, P716, DOI 10.1016/j.cpc.2008.06.008; Lyubimov AY, 2011, CURR OPIN STRUC BIOL, V21, P240, DOI 10.1016/j.sbi.2011.01.002; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Moffitt JR, 2010, METHOD ENZYMOL, V475, P221, DOI 10.1016/S0076-6879(10)75010-2; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Morais MC, 2008, STRUCTURE, V16, P1267, DOI 10.1016/j.str.2008.05.010; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; Segel IH, 1975, ENZYME KINETICS BEHA; Sharma S, 2000, J BACTERIOL, V182, P6570, DOI 10.1128/JB.182.23.6570-6576.2000; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; Yang Q, 2004, BIOCHEMISTRY-US, V43, P289, DOI 10.1021/bi035532h; Yu J, 2010, J MOL BIOL, V400, P186, DOI 10.1016/j.jmb.2010.05.002	46	80	80	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					1017	1028		10.1016/j.cell.2012.10.031	http://dx.doi.org/10.1016/j.cell.2012.10.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178121	Green Accepted, Bronze			2022-12-28	WOS:000311423500015
J	Miyamoto, T; Slone, J; Song, XY; Amrein, H				Miyamoto, Tetsuya; Slone, Jesse; Song, Xiangyu; Amrein, Hubert			A Fructose Receptor Functions as a Nutrient Sensor in the Drosophila Brain	CELL			English	Article							BITTER TASTE RECEPTORS; NEUROPEPTIDE Y-LIKE; EXPRESSION; SUGAR; GLUCOSE; FOOD; GENE; GUSTDUCIN; BEHAVIOR; NEURONS	Internal nutrient sensors play important roles in feeding behavior, yet their molecular structure and mechanism of action are poorly understood. Using Ca2+ imaging and behavioral assays, we show that the gustatory receptor 43a (Gr43a) functions as a narrowly tuned fructose receptor in taste neurons. Remarkably, Gr43a also functions as a fructose receptor in the brain. Interestingly, hemolymph fructose levels are tightly linked to feeding status: after nutritious carbohydrate consumption, fructose levels rise several fold and reach a concentration sufficient to activate Gr43a in the brain. By using different feeding paradigms and artificial activation of Gr43a-expressing brain neurons, we show that Gr43a is both necessary and sufficient to sense hemolymph fructose and promote feeding in hungry flies but suppress feeding in satiated flies. Thus, our studies indicate that the Gr43a-expressing brain neurons function as a nutrient sensor for hemolymph fructose and assign opposing valence to feeding experiences in a satiation-dependent manner.	[Miyamoto, Tetsuya; Slone, Jesse; Song, Xiangyu; Amrein, Hubert] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77845 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Amrein, H (corresponding author), Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77845 USA.	amrein@tamhsc.edu	Amrein, Hubert/AAG-9480-2021	Amrein, Hubert/0000-0001-8799-7250; Slone, Jesse/0000-0002-2478-3295	National Institute of Health [RO1-DC009014, RO1-DC005606]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005606, R01DC009014] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank Drs. S. Fujii and Y. Chen for stimulating discussions while conducting these studies, and Drs. S. Waddell, R. Sitcheran, and two anonymous reviewers for comments and suggestions on the manuscript. We thank Drs. L. Looger, T. Lee, T. Kitamoto, and J. Carlson for Drosophila strains G-CaMP3.0, lexAop-rCD2GFP, Cha<SUP>7.4kb</SUP>-GAL80, and Delta Gr61a, respectively, and Dr. L.B. Vosshall for a LexA plasmid. This work was supported by grants from the National Institute of Health, RO1-DC009014 and RO1-DC005606, to H.A. T.M. conducted all experiments, except the PER analysis. J.S. and X.S. performed the PER analysis, and J.S. generated the Gr64f<SUP>GAL4</SUP> knock-in strain. T.M. and H.A. conceived the experiments and wrote the paper.	Bharucha KN, 2008, J EXP BIOL, V211, P3103, DOI 10.1242/jeb.016451; Buch S, 2008, CELL METAB, V7, P321, DOI 10.1016/j.cmet.2008.02.012; Burke CJ, 2011, CURR BIOL, V21, P746, DOI 10.1016/j.cub.2011.03.032; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; Dethier V. G., 1976, HUNGRY FLY PHYSL STU; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Dus M, 2011, P NATL ACAD SCI USA, V108, P11644, DOI 10.1073/pnas.1017096108; Dyer J, 2005, BIOCHEM SOC T, V33, P302, DOI 10.1042/BST0330302; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Hasemeyer M, 2009, NEURON, V61, P511, DOI 10.1016/j.neuron.2009.01.009; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Harvey RA., 2011, BIOCHEMISTRY-US; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Jiao Y, 2007, P NATL ACAD SCI USA, V104, P14110, DOI 10.1073/pnas.0702421104; Karnani M, 2011, AM J PHYSIOL-REG I, V300, pR47, DOI 10.1152/ajpregu.00527.2010; Kohyama-Koganeya A, 2008, P NATL ACAD SCI USA, V105, P15328, DOI 10.1073/pnas.0807833105; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kubli E, 2008, CURR BIOL, V18, pR210, DOI 10.1016/j.cub.2007.12.047; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Marty N, 2007, PHYSIOLOGY, V22, P241, DOI 10.1152/physiol.00010.2007; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Nunes RD, 2008, J VECTOR ECOL, V33, P225, DOI 10.3376/1081-1710-33.2.225; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Rozengurt E, 2006, AM J PHYSIOL-GASTR L, V291, pG171, DOI 10.1152/ajpgi.00073.2006; Sakai T, 2009, GENES BRAIN BEHAV, V8, P546, DOI 10.1111/j.1601-183X.2009.00503.x; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; Singh N, 2011, BIOCHEM BIOPH RES CO, V406, P146, DOI 10.1016/j.bbrc.2011.02.016; Slone J, 2007, CURR BIOL, V17, P1809, DOI 10.1016/j.cub.2007.09.027; Suster ML, 2004, GENESIS, V39, P240, DOI 10.1002/gene.20051; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Thompson SN, 2003, ADV INSECT PHYSIOL, V31, P205, DOI 10.1016/S0065-2806(03)31004-5; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tomchik SM, 2009, NEURON, V64, P510, DOI 10.1016/j.neuron.2009.09.029; Valassi E, 2008, NUTR METAB CARDIOVAS, V18, P158, DOI 10.1016/j.numecd.2007.06.004; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wanner KW, 2008, INSECT MOL BIOL, V17, P621, DOI 10.1111/j.1365-2583.2008.00836.x; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483	58	275	282	6	99	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					1113	1125		10.1016/j.cell.2012.10.024	http://dx.doi.org/10.1016/j.cell.2012.10.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178127	Green Accepted, Bronze			2022-12-28	WOS:000311423500022
J	Whalen, F				Whalen, Francis			Review: Femoral and subclavian or internal jugular venous catheters do not differ for bloodstream infections	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Whalen, F (corresponding author), Mayo Clin, Rochester, MN 55905 USA.							O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003; Parienti JJ, 2008, JAMA-J AM MED ASSOC, V299, P2413, DOI 10.1001/jama.299.20.2413; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10							JC5-8	10.7326/0003-4819-157-10-201211200-02008	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043VZ	23165684				2022-12-28	WOS:000311580000007
J	Lima, MD; Li, N; de Andrade, MJ; Fang, SL; Oh, J; Spinks, GM; Kozlov, ME; Haines, CS; Suh, D; Foroughi, J; Kim, SJ; Chen, YS; Ware, T; Shin, MK; Machado, LD; Fonseca, AF; Madden, JDW; Voit, WE; Galvao, DS; Baughman, RH				Lima, Marcio D.; Li, Na; de Andrade, Monica Jung; Fang, Shaoli; Oh, Jiyoung; Spinks, Geoffrey M.; Kozlov, Mikhail E.; Haines, Carter S.; Suh, Dongseok; Foroughi, Javad; Kim, Seon Jeong; Chen, Yongsheng; Ware, Taylor; Shin, Min Kyoon; Machado, Leonardo D.; Fonseca, Alexandre F.; Madden, John D. W.; Voit, Walter E.; Galvao, Douglas S.; Baughman, Ray H.			Electrically, Chemically, and Photonically Powered Torsional and Tensile Actuation of Hybrid Carbon Nanotube Yarn Muscles	SCIENCE			English	Article							ARRAYS; DYNAMICS; SHEETS; FIBERS; SPUN	Artificial muscles are of practical interest, but few types have been commercially exploited. Typical problems include slow response, low strain and force generation, short cycle life, use of electrolytes, and low energy efficiency. We have designed guest-filled, twist-spun carbon nanotube yarns as electrolyte-free muscles that provide fast, high-force, large-stroke torsional and tensile actuation. More than a million torsional and tensile actuation cycles are demonstrated, wherein a muscle spins a rotor at an average 11,500 revolutions/minute or delivers 3% tensile contraction at 1200 cycles/minute. Electrical, chemical, or photonic excitation of hybrid yarns changes guest dimensions and generates torsional rotation and contraction of the yarn host. Demonstrations include torsional motors, contractile muscles, and sensors that capture the energy of the sensing process to mechanically actuate.	[Lima, Marcio D.; Li, Na; de Andrade, Monica Jung; Fang, Shaoli; Oh, Jiyoung; Kozlov, Mikhail E.; Haines, Carter S.; Suh, Dongseok; Ware, Taylor; Voit, Walter E.; Baughman, Ray H.] Univ Texas Dallas, Alan G MacDiarmid NanoTech Inst, Richardson, TX 75083 USA; [Li, Na; Chen, Yongsheng] Nankai Univ, Coll Chem, Inst Polymer Chem, Ctr Nanoscale Sci & Technol, Tianjin 300071, Peoples R China; [Spinks, Geoffrey M.; Foroughi, Javad] Univ Wollongong, Intelligent Polymer Res Inst, Australian Res Council Ctr Excellence Electromat, Wollongong, NSW 2522, Australia; [Kim, Seon Jeong; Shin, Min Kyoon] Hanyang Univ, Ctr Bioartificial Muscle, Seoul 133791, South Korea; [Kim, Seon Jeong; Shin, Min Kyoon] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea; [Machado, Leonardo D.; Galvao, Douglas S.] Univ Estadual Campinas, Dept Appl Phys, BR-13081970 Campinas, SP, Brazil; [Fonseca, Alexandre F.] Univ Estadual Paulista, Fac Ciencias, BR-17033360 Bauru, SP, Brazil; [Madden, John D. W.] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V6T 1Z4, Canada	University of Texas System; University of Texas Dallas; Nankai University; University of Wollongong; Hanyang University; Hanyang University; Universidade Estadual de Campinas; Universidade Estadual Paulista; University of British Columbia	Baughman, RH (corresponding author), Univ Texas Dallas, Alan G MacDiarmid NanoTech Inst, Richardson, TX 75083 USA.	ray.baughman@utdallas.edu	Machado, Leonardo D/E-2081-2017; de Andrade, Monica Jung/N-3963-2019; Spinks, Geoffrey/E-5612-2011; Li, Na/M-9852-2015; Lima, Marcio/G-4634-2012; Suh, Dongseok/A-5447-2013; Ware, Taylor/I-2812-2013; Fonseca, Alexandre/H-3105-2011; Madden, John DW/B-8948-2009; Foroughi, Javad/A-1439-2012; Spinks, Geoffrey/T-6363-2019; Fonseca, Alexandre F./K-5477-2019; Chen, Yongsheng/D-3256-2011; Kim, Seon Jeong/AAR-8127-2021; Voit, Walter/D-1185-2010; Baughman, Ray/A-8628-2018; Galvao, Douglas/J-6017-2013; Ware, Taylor/A-7130-2017	Machado, Leonardo D/0000-0003-1221-4228; de Andrade, Monica Jung/0000-0003-0411-4008; Spinks, Geoffrey/0000-0003-4656-9473; Li, Na/0000-0002-1909-6378; Fonseca, Alexandre/0000-0001-8413-9744; Madden, John DW/0000-0002-0014-4712; Foroughi, Javad/0000-0003-1979-5213; Spinks, Geoffrey/0000-0003-4656-9473; Chen, Yongsheng/0000-0003-1448-8177; Kim, Seon Jeong/0000-0002-2867-6737; Voit, Walter/0000-0003-0135-0531; Baughman, Ray/0000-0001-5845-5137; Suh, Dongseok/0000-0002-0392-3391; Galvao, Douglas/0000-0003-0145-8358; Ware, Taylor/0000-0001-7996-7393	Air Force Office of Scientific Research [FA9550-09-1-0537, FA9550-12-1-0211]; Office of Naval Research MURI [N00014-08-1-0654]; Robert A. Welch Foundation [AT-0029]; Creative Research Initiative Center for Bio-Artificial Muscle; Korea-U.S. Air Force Cooperation Program (Korea) [2012-00074]; Australian Research Council; MoST [2012CB933401]; National Natural Science Foundation of China [50933003]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Office of Naval Research MURI(MURIOffice of Naval Research); Robert A. Welch Foundation(The Welch Foundation); Creative Research Initiative Center for Bio-Artificial Muscle; Korea-U.S. Air Force Cooperation Program (Korea); Australian Research Council(Australian Research Council); MoST; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank X. Lepro for scanning electron micrograph (SEM) images of yarn cross sections; B. J. Swedlove, D. B. Hagenasr, J. M. Cruciger, C. Mozayan, and S. Rudraraju for assistance with sample preparation and measurements; and F. Goktepe and O. Goktepe for valuable discussions. Support is largely from Air Force Office of Scientific Research grants FA9550-09-1-0537 and FA9550-12-1-0211, with additional support from Office of Naval Research MURI grant N00014-08-1-0654, Robert A. Welch Foundation grant AT-0029, the Creative Research Initiative Center for Bio-Artificial Muscle and the Korea-U.S. Air Force Cooperation Program grant-2012-00074 (Korea), and the Centre of Excellence funding from the Australian Research Council. N.L. and Y.C. acknowledge financial support from MoST (grant 2012CB933401) and National Natural Science Foundation of China (grant 50933003). D. S. G., L. D. M., and A. F. F. are research fellows of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo of Brazil. A provisional patent application on the topic of this manuscript has been filed by N. Li et al., "Coiled and non-coiled nanofiber yarn torsional and tensile actuators," U.S. Provisional Patent 61678340 (1 August 2012).	Carlen ET, 2002, J MICROELECTROMECH S, V11, P165, DOI 10.1109/JMEMS.2002.1007394; Chen LZ, 2011, ACS NANO, V5, P1588, DOI 10.1021/nn102251a; da Fonseca AF, 2006, J APPL PHYS, V99, DOI 10.1063/1.2194309; Foroughi J, 2011, SCIENCE, V334, P494, DOI 10.1126/science.1211220; FULLER FB, 1971, P NATL ACAD SCI USA, V68, P815, DOI 10.1073/pnas.68.4.815; Goriely A, 1997, PHYSICA D, V105, P20, DOI 10.1016/S0167-2789(96)00290-4; Hu Y, 2010, ACS NANO, V4, P3498, DOI 10.1021/nn1006013; Huber JE, 1997, P ROY SOC A-MATH PHY, V453, P2185, DOI 10.1098/rspa.1997.0117; Jakubinek MB, 2012, CARBON, V50, P244, DOI 10.1016/j.carbon.2011.08.041; JOSEPHSON RK, 1993, ANNU REV PHYSIOL, V55, P527, DOI 10.1146/annurev.ph.55.030193.002523; Li QW, 2006, ADV MATER, V18, P3160, DOI 10.1002/adma.200601344; Lima MD, 2011, SCIENCE, V331, P51, DOI 10.1126/science.1195912; Miaudet P, 2007, SCIENCE, V318, P1294, DOI 10.1126/science.1145593; Mirfakhrai T, 2007, SMART MATER STRUCT, V16, pS243, DOI 10.1088/0964-1726/16/2/S07; Mizumoto M, 2009, J ALLOY COMPD, V482, P416, DOI 10.1016/j.jallcom.2009.04.041; Peng HS, 2009, NAT NANOTECHNOL, V4, P738, DOI [10.1038/nnano.2009.264, 10.1038/NNANO.2009.264]; Peterson D. R., 2008, BIOMECHANICS PRINCIP; Potschke P, 2008, MACROMOL RAPID COMM, V29, P244, DOI 10.1002/marc.200700637; Sellinger AT, 2010, ADV MATER, V22, P3430, DOI 10.1002/adma.200904107; Shang YY, 2012, ADV MATER, V24, P2896, DOI 10.1002/adma.201200576; Xiao L, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2909593; Zhang M, 2005, SCIENCE, V309, P1215, DOI 10.1126/science.1115311; Zhang M, 2004, SCIENCE, V306, P1358, DOI 10.1126/science.1104276; Zhang XB, 2006, ADV MATER, V18, P1505, DOI 10.1002/adma.200502528; Zhang XF, 2007, SMALL, V3, P244, DOI 10.1002/smll.200600368; Zhou RF, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/34/345701	26	466	488	53	848	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2012	338	6109					928	932		10.1126/science.1226762	http://dx.doi.org/10.1126/science.1226762			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161994				2022-12-28	WOS:000311083600038
J	McGourty, K; Thurston, TL; Matthews, SA; Pinaud, L; Mota, LJ; Holden, DW				McGourty, Kieran; Thurston, Teresa L.; Matthews, Sophie A.; Pinaud, Laurie; Mota, Luis Jaime; Holden, David W.			Salmonella Inhibits Retrograde Trafficking of Mannose-6-Phosphate Receptors and Lysosome Function	SCIENCE			English	Article							TRANS-GOLGI; VIRULENCE PROTEIN; TYPHIMURIUM; ENDOSOMES; SIFA; PHAGOSOMES; MECHANISM	Salmonella enterica is an intracellular bacterial pathogen that replicates within membrane-bound vacuoles through the action of effector proteins translocated into host cells. Salmonella vacuoles have characteristics of lysosomes but are reduced in hydrolytic enzymes transported by mannose-6-phosphate receptors (MPRs). We found that the effector SifA subverted Rab9-dependent retrograde trafficking of MPRs, thereby attenuating lysosome function. This required binding of SifA to its host cell target SKIP/PLEKHM2. Furthermore, SKIP regulated retrograde trafficking of MPRs in noninfected cells. Translocated SifA formed a stable complex with SKIP and Rab9 in infected cells. Sequestration of Rab9 by SifA-SKIP accounted for the effect of SifA on MPR transport and lysosome function. Growth of Salmonella increased in cells with reduced lysosomal activity and decreased in cells with higher lysosomal activity. These results suggest that Salmonella vacuoles undergo fusion with lysosomes whose potency has been reduced by SifA.	[McGourty, Kieran; Thurston, Teresa L.; Matthews, Sophie A.; Pinaud, Laurie; Mota, Luis Jaime; Holden, David W.] Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	Imperial College London	Holden, DW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, Ctr Mol Microbiol & Infect, Armstrong Rd, London SW7 2AZ, England.	d.holden@imperial.ac.uk	Thurston, Teresa/AAZ-9938-2020; Mota, Luis/B-9497-2008	Thurston, Teresa/0000-0001-6139-3723; Mota, Luis/0000-0002-5592-8397	Wellcome Trust; Medical Research Council; Medical Research Council [G0800148] Funding Source: researchfish; MRC [G0800148] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Tang and members of the Holden laboratory for comments on the manuscript, S. Meresse for providing MEFs, S. Meresse and F. Randow for plasmids, and the European Conditional Mouse Mutagenesis Program Consortium for SkipPlekhm2<SUP>-/-</SUP> mice. We thank I. Dikic and D. McEwan for advice and discussions. This research was supported by a Wellcome Trust funded studentship to K. M. and grants to D. W. H. from the Medical Research Council and Wellcome Trust. The data are included in the main and the supplementary figures.	Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Beuzon CR, 2002, MICROBIOL-SGM, V148, P2705, DOI 10.1099/00221287-148-9-2705; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Deiwick J, 1998, J BACTERIOL, V180, P4775, DOI 10.1128/JB.180.18.4775-4780.1998; Diacovich L, 2009, J BIOL CHEM, V284, P33151, DOI 10.1074/jbc.M109.034975; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Figueira R, 2012, MICROBIOL-SGM, V158, P1147, DOI 10.1099/mic.0.058115-0; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; GARCIADELPORTILLO F, 1995, J CELL BIOL, V129, P81, DOI 10.1083/jcb.129.1.81; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Hang HC, 2006, ACS CHEM BIOL, V1, P713, DOI 10.1021/cb600431a; Ikeda K, 2008, BIOCHEM BIOPH RES CO, V377, P268, DOI 10.1016/j.bbrc.2008.09.121; Jackson LK, 2008, P NATL ACAD SCI USA, V105, P14141, DOI 10.1073/pnas.0801872105; Meresse S, 1999, EMBO J, V18, P4394, DOI 10.1093/emboj/18.16.4394; Metcalf DJ, 2008, TRAFFIC, V9, P1905, DOI 10.1111/j.1600-0854.2008.00807.x; Rathman M, 1996, INFECT IMMUN, V64, P2765, DOI 10.1128/IAI.64.7.2765-2773.1996; Rathman M, 1997, INFECT IMMUN, V65, P1475, DOI 10.1128/IAI.65.4.1475-1485.1997; Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Schroeder N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001002; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; SHAPIRO AD, 1993, J BIOL CHEM, V268, P6925	24	120	123	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					963	967		10.1126/science.1227037	http://dx.doi.org/10.1126/science.1227037			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23162002	Green Accepted			2022-12-28	WOS:000311083600048
J	Cohn, A				Cohn, Anthony			PERSONAL VIEW Junior doctors take heart: you do everything as well as we did	BRITISH MEDICAL JOURNAL			English	Editorial Material									Watford Dist Gen Hosp, Dept Paediat, Watford WD18 0HB, Herts, England	Watford General Hospital	Cohn, A (corresponding author), Watford Dist Gen Hosp, Dept Paediat, Watford WD18 0HB, Herts, England.	anthony.cohn@whht.nhs.uk							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 12	2012	345								e7646	10.1136/bmj.e7646	http://dx.doi.org/10.1136/bmj.e7646			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040PM	23148331				2022-12-28	WOS:000311334900005
J	McIntyre, PB; O'Brien, KL; Greenwood, B; van de Beek, D				McIntyre, Peter B.; O'Brien, Katherine L.; Greenwood, Brian; van de Beek, Diederik			Effect of vaccines on bacterial meningitis worldwide	LANCET			English	Article							INFLUENZAE-TYPE-B; PNEUMOCOCCAL CONJUGATE VACCINE; INVASIVE HAEMOPHILUS-INFLUENZAE; UNITED-STATES; MENINGOCOCCAL DISEASE; SEROTYPE REPLACEMENT; CHILDREN YOUNGER; HIB DISEASE; STREPTOCOCCUS-PNEUMONIAE; NEISSERIA-MENINGITIDIS	Three bacteria-Haemophilus influenzae, Streptococcus pneumoniae, and Neisseria meningitidis-account for most acute bacterial meningitis. Measurement of the effect of protein-polysaccharide conjugate vaccines is most reliable for H influenzae meningitis because one serotype and one age group account for more than 90% of cases and the incidence has been best measured in high-income countries where these vaccines have been used longest. Pneumococcal and meningococcal meningitis are caused by diverse serotypes and have a wide age distribution; measurement of their incidence is complicated by epidemics and scarcity of surveillance, especially in low-income countries. Near elimination of H influenzae meningitis has been documented after vaccine introduction. Despite greater than 90% reductions in disease attributable to vaccine serotypes, all-age pneumococcal meningitis has decreased by around 25%, with little data from low-income settings. Near elimination of serogroup C meningococcal meningitis has been documented in several high-income countries, boding well for the effect of a new serogroup A meningococcal conjugate vaccine in the African meningitis belt.	[McIntyre, Peter B.] Childrens Hosp Westmead, Natl Ctr Immunisat Res & Surveillance Vaccine Pre, Sydney, NSW 2145, Australia; [McIntyre, Peter B.] Univ Sydney, Sydney, NSW 2006, Australia; [O'Brien, Katherine L.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr IVAC, Baltimore, MD USA; [O'Brien, Katherine L.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Amer Indian Hlth CAIH, Baltimore, MD USA; [Greenwood, Brian] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England; [van de Beek, Diederik] Univ Amsterdam, Acad Med Ctr, Dept Neurol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands	University of Sydney; University of Sydney; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; University of Amsterdam; Academic Medical Center Amsterdam	McIntyre, PB (corresponding author), Childrens Hosp Westmead, Natl Ctr Immunisat Res & Surveillance Vaccine Pre, Locked Bag 4001, Sydney, NSW 2145, Australia.	peter.mcintyre@health.nsw.gov.au	McIntyre, Peter/GNM-5277-2022; van de Beek, Diederik/Y-2713-2019	McIntyre, Peter/0000-0001-5808-7450; van de Beek, Diederik/0000-0002-4571-044X; O'Brien, Katherine/0000-0002-0164-4030	Pfizer	Pfizer(Pfizer)	KLO'B has received research grant support from Pfizer and has served on pneumcooccal vaccine expert advisory boards for Pfizer, GlaxoSmithKline, Sanofi Pasteur, and Merck. The other authors declare that they have no conflicts of interest.	Adam HJ, 2010, VACCINE, V28, P4073, DOI 10.1016/j.vaccine.2010.03.075; Adamkiewicz TV, 2003, J PEDIATR-US, V143, P438, DOI 10.1067/S0022-3476(03)00331-7; Adegbola RA, 1996, ANN TROP PAEDIATR, V16, P103, DOI 10.1080/02724936.1996.11747812; Adegbola RA, 2005, LANCET, V366, P144, DOI 10.1016/S0140-6736(05)66788-8; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P1; [Anonymous], 2008, GLOB BURD DIS EST; Bender JM, 2010, CLIN INFECT DIS, V50, pE41, DOI 10.1086/651165; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Brouwer MC, 2009, LANCET INFECT DIS, V9, P31, DOI 10.1016/S1473-3099(08)70261-5; Bruce MG, 2008, EMERG INFECT DIS, V14, P48, DOI 10.3201/eid1401.070822; CADOZ M, 1981, B WORLD HEALTH ORGAN, V59, P575; Campagne G, 1999, B WORLD HEALTH ORGAN, V77, P499; Campbell H, 2009, VACCINE, V27, pB20, DOI 10.1016/j.vaccine.2009.04.067; Capeding MRZ, 1998, VACCINE, V16, P1004, DOI 10.1016/S0264-410X(97)00276-4; Chandran A, 2005, EXPERT REV VACCINES, V4, P819, DOI 10.1586/14760584.4.6.819; COULEHAN JL, 1984, PUBLIC HEALTH REP, V99, P404; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; du Chatelet IP, 2005, CLIN INFECT DIS, V40, P17, DOI 10.1086/426436; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Santolaya ME, 2012, LANCET, V379, P617, DOI 10.1016/S0140-6736(11)61713-3; ESKOLA J, 1990, NEW ENGL J MED, V323, P1381, DOI 10.1056/NEJM199011153232004; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Foster RA, 2010, CLIN VACCINE IMMUNOL, V17, P1104, DOI 10.1128/CVI.00481-09; Galloway Y, 2009, INT J EPIDEMIOL, V38, P413, DOI 10.1093/ije/dyn228; Gessner BD, 2005, LANCET, V365, P43, DOI 10.1016/S0140-6736(04)17664-2; Gessner BD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-22; Gessner BD, 2009, EXPERT REV VACCINES, V8, P91, DOI 10.1586/14760584.8.1.91; Ginsburg AS, 2012, EXPERT REV VACCINES, V11, P279, DOI [10.1586/ERV.12.5, 10.1586/erv.12.5]; Goldblatt D, 2011, CLIN VACCINE IMMUNOL, V18, P1728, DOI 10.1128/CVI.05252-11; Gossger N, 2012, JAMA-J AM MED ASSOC, V307, P573, DOI 10.1001/jama.2012.85; Greenwood B, 2006, TROP MED INT HEALTH, V11, P773, DOI 10.1111/j.1365-3156.2006.01639.x; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032; Harboe ZB, 2010, CLIN INFECT DIS, V50, P329, DOI 10.1086/649872; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Howie SRC, 2007, VACCINE, V25, P6305, DOI 10.1016/j.vaccine.2007.06.023; Jefferson T, 2006, LANCET INFECT DIS, V6, P405, DOI 10.1016/S1473-3099(06)70520-5; Kaaijk P, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-35; Kaeyhty Helena, 2008, P227; Kelly DF, 2004, IMMUNOLOGY, V113, P163, DOI 10.1111/j.1365-2567.2004.01971.x; Khatami A, 2011, CLIN VACCINE IMMUNOL, V18, P2038, DOI 10.1128/CVI.05354-11; Khatami A, 2010, EXPERT REV VACCINES, V9, P285, DOI 10.1586/ERV.10.3; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Kyaw MH, 2002, SCAND J INFECT DIS, V34, P289, DOI 10.1080/00365540110080403; Ladhani S, 2008, ARCH DIS CHILD, V93, P665, DOI 10.1136/adc.2007.126888; Ladhani S, 2008, LANCET INFECT DIS, V8, P275, DOI 10.1016/S1473-3099(08)70078-1; Ladhani S, 2011, VACCINE, V29, P9137, DOI 10.1016/j.vaccine.2011.09.107; Lennon D, 2009, CLIN INFECT DIS, V49, P597, DOI 10.1086/603552; LETSON GW, 1992, AM J DIS CHILD, V146, P560; Lo H, 2009, LANCET INFECT DIS, V9, P418, DOI 10.1016/S1473-3099(09)70132-X; McVernon J, 2008, ARCH DIS CHILD, V93, P670, DOI 10.1136/adc.2006.097501; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Moberley SA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub2; Molyneux EM, 2003, ARCH DIS CHILD, V88, P1112, DOI 10.1136/adc.88.12.1112; Morris SK, 2008, LANCET INFECT DIS, V8, P435, DOI 10.1016/S1473-3099(08)70152-X; Mudhune S, 2009, CLIN INFECT DIS, V48, pS147, DOI 10.1086/596494; Novak RT, 2012, LANCET INFECT DIS, V12, P757, DOI 10.1016/S1473-3099(12)70168-8; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; Park SY, 2010, J PEDIATR-US, V156, P478, DOI 10.1016/j.jpeds.2009.10.008; Patel M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001093.pub2; Pavia M, 2009, PEDIATRICS, V123, pE1103, DOI 10.1542/peds.2008-3422; Perdue DG, 2000, JAMA-J AM MED ASSOC, V283, P3089, DOI 10.1001/jama.283.23.3089; Ribeiro GS, 2007, VACCINE, V25, P4420, DOI 10.1016/j.vaccine.2007.03.024; SALWEN KM, 1987, SCAND J INFECT DIS, V19, P1, DOI 10.3109/00365548709032371; SANTOSHAM M, 1991, NEW ENGL J MED, V324, P1767, DOI 10.1056/NEJM199106203242503; Scarborough M, 2008, LANCET NEUROL, V7, P637, DOI 10.1016/S1474-4422(08)70139-X; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Scott JAG, 2011, CLIN INFECT DIS, V53, P663, DOI 10.1093/cid/cir444; Scott P, 2011, VACCINE, V29, P9711, DOI 10.1016/j.vaccine.2011.07.042; Seigrist CA., 2008, VACCINES; Singleton R, 2006, PEDIATRICS, V118, pE421, DOI 10.1542/peds.2006-0287; Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056/NEJMoa1003812; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; von Gottberg A, 2012, VACCINE, V30, P565, DOI 10.1016/j.vaccine.2011.11.066; WARD J, 1990, NEW ENGL J MED, V323, P1393, DOI 10.1056/NEJM199011153232006; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; WENGER JD, 1991, LANCET, V338, P395; WENGER JD, 1990, J INFECT DIS, V162, P1316, DOI 10.1093/infdis/162.6.1316; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763	84	190	201	1	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2012	380	9854					1703	1711		10.1016/S0140-6736(12)61187-8	http://dx.doi.org/10.1016/S0140-6736(12)61187-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035MN	23141619				2022-12-28	WOS:000310951400033
J	Basu, A				Basu, Anna			Visual agnosia	BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Victoria Infirm, Sir James Spence Inst, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK	Basu, A (corresponding author), Royal Victoria Infirm, Sir James Spence Inst, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	anna.basu@ncl.ac.uk	Basu, Anna/C-1458-2009	Basu, Anna/0000-0002-1356-3027	National Institute for Health Research [CL-2009-01-001] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))			0	0	0	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 9	2012	345								e7342	10.1136/bmj.e7342	http://dx.doi.org/10.1136/bmj.e7342			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036LZ	23144207	Green Submitted, Bronze			2022-12-28	WOS:000311029100011
J	Sando, R; Gounko, N; Pieraut, S; Liao, LJ; Yates, J; Maximov, A				Sando, Richard, III; Gounko, Natalia; Pieraut, Simon; Liao, Lujian; Yates, John, III; Maximov, Anton			HDAC4 Governs a Transcriptional Program Essential for Synaptic Plasticity and Memory	CELL			English	Article							II HISTONE DEACETYLASES; NEURONAL-ACTIVITY; GENE-EXPRESSION; MECP2 PHOSPHORYLATION; NERVOUS-SYSTEM; NUCLEAR EXPORT; NMDA RECEPTOR; CELL-DEATH; CORTEX; GROWTH	Neuronal activity influences genes involved in circuit development and information processing. However, the molecular basis of this process remains poorly understood. We found that HDAC4, a histone deacetylase that shuttles between the nucleus and cytoplasm, controls a transcriptional program essential for synaptic plasticity and memory. The nuclear import of HDAC4 and its association with chromatin is negatively regulated by NMDA receptors. In the nucleus, HDAC4 represses genes encoding constituents of central synapses, thereby affecting synaptic architecture and strength. Furthermore, we show that a truncated form of HDAC4 encoded by an allele associated with mental retardation is a gain-of-function nuclear repressor that abolishes transcription and synaptic transmission despite the loss of the deacetylase domain. Accordingly, mice carrying a mutant that mimics this allele exhibit deficits in neurotransmission, spatial learning, and memory. These studies elucidate a mechanism of experience-dependent plasticity and define the biological role of HDAC4 in the brain.	[Sando, Richard, III; Gounko, Natalia; Pieraut, Simon; Maximov, Anton] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Liao, Lujian; Yates, John, III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Sando, Richard, III; Gounko, Natalia; Pieraut, Simon; Maximov, Anton] Scripps Res Inst, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Sando, Richard, III] Scripps Res Inst, Kellogg Sch Sci & Technol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Maximov, A (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	amaximov@scripps.edu	Karakhanov, Edward/P-1660-2015; Gounko, Natalia/N-4102-2019	Gounko, Natalia/0000-0003-0791-9477	NIH [MH085776, MH067880-09, RR011823, NS057096]; Novartis Advanced Discovery Institute; Baxter Foundation; Helen Dorris Postdoctoral Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880, R01MH085776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Advanced Discovery Institute; Baxter Foundation; Helen Dorris Postdoctoral Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Hollis Cline, Ulrich Mueller, Ardem Patapoutian, Franck Polleux, Mark Mayford, and Kristin Baldwin for advice and critical comments; Drs. Thomas Sudhof and Martyn Goulding for mouse strains and antibodies; members of the Cline, Mueller, Polleux, Baldwin, Feeney, and McHeyzer-Williams labs for help with experiments; and Nina Torabi-Rander, TSRI DNA array, mouse transgenic, and behavioral cores for expert technical assistance. This study was supported, in part, by the NIH grants MH085776 (A. M.), MH067880-09 (J.Y.), RR011823 (J.Y.), and NS057096 (J.Y.); Novartis Advanced Discovery Institute (A. M.); The Baxter Foundation (A. M.); and Helen Dorris Postdoctoral Fellowship (S.P.).	Akhtar MW, 2009, J NEUROSCI, V29, P8288, DOI 10.1523/JNEUROSCI.0097-09.2009; Backs J, 2011, J CELL BIOL, V195, P403, DOI 10.1083/jcb.201105063; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Cao P, 2011, CELL, V145, P300, DOI 10.1016/j.cell.2011.03.034; Ch'ng TH, 2011, CURR OPIN NEUROBIOL, V21, P345, DOI 10.1016/j.conb.2011.01.011; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chao HT, 2009, P NATL ACAD SCI USA, V106, P4577, DOI 10.1073/pnas.0901518106; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Darcy MJ, 2010, J COMP NEUROL, V518, P722, DOI 10.1002/cne.22241; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Kerschensteiner D, 2009, NATURE, V460, P1016, DOI 10.1038/nature08236; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Lai KO, 2008, P NATL ACAD SCI USA, V105, P17175, DOI 10.1073/pnas.0803906105; Leslie JH, 2011, PROG NEUROBIOL, V94, P223, DOI 10.1016/j.pneurobio.2011.05.002; Li JL, 2012, NAT MED, V18, P783, DOI 10.1038/nm.2709; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Majdzadeh N, 2008, DEV NEUROBIOL, V68, P1076, DOI 10.1002/dneu.20637; Mandel G, 2011, P NATL ACAD SCI USA, V108, P16789, DOI 10.1073/pnas.1113486108; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Platel JC, 2010, NEURON, V65, P859, DOI 10.1016/j.neuron.2010.03.009; Qiu Z, 2008, NEURON, V60, P775, DOI 10.1016/j.neuron.2008.09.040; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Seabrooke S, 2008, DEV NEUROBIOL, V68, P379, DOI 10.1002/dneu.20595; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Williams SR, 2010, AM J HUM GENET, V87, P219, DOI 10.1016/j.ajhg.2010.07.011; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027; Zito K, 2002, NEURON, V35, P1015, DOI 10.1016/S0896-6273(02)00903-0	57	184	191	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 9	2012	151	4					821	834		10.1016/j.cell.2012.09.037	http://dx.doi.org/10.1016/j.cell.2012.09.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141539	Green Accepted, Bronze			2022-12-28	WOS:000310921200013
J	Thomas, JM				Thomas, John Meurig			The birth of X-ray crystallography	NATURE			English	Editorial Material											Thomas, JM (corresponding author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 3QZ, England.	jmt2@cam.ac.uk						Armstrong HE, 1927, NATURE, V120, P478, DOI 10.1038/120478b0; Bragg WH, 1913, P R SOC LOND A-CONTA, V89, P277, DOI 10.1098/rspa.1913.0084; Bragg WL, 1913, P R SOC LOND A-CONTA, V89, P248, DOI 10.1098/rspa.1913.0083; BRAGG WL, 1912, NATURE, V90, P410, DOI DOI 10.1038/090410B0; Bragg WL, 1962, 50 YEARS XRAY DIFFRA, P531; Bragg WL, 1913, P CAMBRIDGE PHILOS S, V17, P43; Rubinstenn G, 1998, NAT STRUCT BIOL, V5, P568, DOI 10.1038/823; Spence JCH, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/10/102601; Thomas JM, 1990, SELECTIONS REFLECTIO; von Laue M., 1912, INTERFERENZ ERSCHEIN, p303?322	10	16	16	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					186	187		10.1038/491186a	http://dx.doi.org/10.1038/491186a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23135450	Bronze			2022-12-28	WOS:000310774300015
J	Fickler, R; Lapkiewicz, R; Plick, WN; Krenn, M; Schaeff, C; Ramelow, S; Zeilinger, A				Fickler, Robert; Lapkiewicz, Radek; Plick, William N.; Krenn, Mario; Schaeff, Christoph; Ramelow, Sven; Zeilinger, Anton			Quantum Entanglement of High Angular Momenta	SCIENCE			English	Article							GENERATION; PHOTONS; BEAMS	Single photons with helical phase structures may carry a quantized amount of orbital angular momentum (OAM), and their entanglement is important for quantum information science and fundamental tests of quantum theory. Because there is no theoretical upper limit on how many quanta of OAM a single photon can carry, it is possible to create entanglement between two particles with an arbitrarily high difference in quantum number. By transferring polarization entanglement to OAM with an interferometric scheme, we generate and verify entanglement between two photons differing by 600 in quantum number. The only restrictive factors toward higher numbers are current technical limitations. We also experimentally demonstrate that the entanglement of very high OAM can improve the sensitivity of angular resolution in remote sensing.	[Fickler, Robert; Zeilinger, Anton] Univ Vienna, Fac Phys, Vienna Ctr Quantum Sci & Technol, A-1090 Vienna, Austria; [Fickler, Robert; Lapkiewicz, Radek; Plick, William N.; Krenn, Mario; Schaeff, Christoph; Ramelow, Sven; Zeilinger, Anton] Austrian Acad Sci, Inst Quantum Opt & Quantum Informat, A-1090 Vienna, Austria	University of Vienna; Austrian Academy of Sciences	Fickler, R (corresponding author), Univ Vienna, Fac Phys, Vienna Ctr Quantum Sci & Technol, Waehringer Guertel 18, A-1090 Vienna, Austria.	robert.fickler@univie.ac.at; anton.zeilinger@univie.ac.at	Lapkiewicz, Radek/B-5786-2015; Ramelow, Sven/H-6798-2012; Zeilinger, Anton/A-1170-2011; Krenn, Mario/A-2799-2013	Ramelow, Sven/0000-0002-7801-4440; Krenn, Mario/0000-0003-1620-9207; Lapkiewicz, Radek/0000-0002-7026-7275; Fickler, Robert/0000-0001-6251-753X	European Research Council [QIT4QAD, 227844]; Austrian Science Fund (FWF) within the Special Research Programs (SFB) F40 (Foundations and Applications of Quantum Science; FoQuS); Vienna Doctoral Program on Complex Quantum Systems; CoQuS [W1210-2]	European Research Council(European Research Council (ERC)European Commission); Austrian Science Fund (FWF) within the Special Research Programs (SFB) F40 (Foundations and Applications of Quantum Science; FoQuS)(Austrian Science Fund (FWF)); Vienna Doctoral Program on Complex Quantum Systems; CoQuS	Supported by the European Research Council (advanced grant QIT4QAD, 227844) and the Austrian Science Fund (FWF) within the Special Research Programs (SFB) F40 (Foundations and Applications of Quantum Science; FoQuS) and W1210-2 (Vienna Doctoral Program on Complex Quantum Systems; CoQuS). R. F. participated in the design and building of the experimental apparatus, collected and analyzed the data, and wrote the manuscript. R. L., C. S., and S. R. participated in the design and building of the experiment and assisted on the experimental side. W.N.P., S. R., and M. K. assisted on the theoretical side. A.Z. initiated the work and supervised the experiment. All authors contributed to conceiving the experiment, discussing the results, and contributing to the final text of the manuscript.	ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; Aspelmeyer M, 2012, PHYS TODAY, V65, P29, DOI 10.1063/PT.3.1640; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Bentley JB, 2006, OPT LETT, V31, P649, DOI 10.1364/OL.31.000649; Campbell G, 2012, APPL OPTICS, V51, P873, DOI 10.1364/AO.51.000873; Chavez-Cerda S, 2002, J OPT B-QUANTUM S O, V4, pS52, DOI 10.1088/1464-4266/4/2/368; Dada AC, 2011, NAT PHYS, V7, P677, DOI [10.1038/nphys1996, 10.1038/NPHYS1996]; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Fedrizzi A, 2007, OPT EXPRESS, V15, P15377, DOI 10.1364/OE.15.015377; FREEDMAN SJ, 1972, PHYS REV LETT, V28, P938, DOI 10.1103/PhysRevLett.28.938; Galvez E. J., 2011, INT C QUANT INF OTT; Guhne O, 2009, PHYS REP, V474, P1, DOI 10.1016/j.physrep.2009.02.004; Howell JC, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.210403; Jesacher A, 2006, OPT EXPRESS, V14, P6342, DOI 10.1364/OE.14.006342; Jha AK, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.053829; Kim T, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.012316; KWIAT PG, 1993, PHYS REV A, V47, pR2472, DOI 10.1103/PhysRevA.47.R2472; Langford NK, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.053601; Leach J, 2010, SCIENCE, V329, P662, DOI 10.1126/science.1190523; Leggett AJ, 2002, J PHYS-CONDENS MAT, V14, pR415, DOI 10.1088/0953-8984/14/15/201; Mair A, 2001, NATURE, V412, P313, DOI 10.1038/35085529; Nagali E, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.013601; Pires HD, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.020505; Pors BJ, 2011, J OPTICS-UK, V13, DOI 10.1088/2040-8978/13/6/064008; Ramelow S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.253601; Siviloglou GA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.213901; Vaziri A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.240401; ZUKOWSKI M, 1988, PHYS LETT A, V127, P1, DOI 10.1016/0375-9601(88)90954-1	28	503	517	16	213	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					640	643		10.1126/science.1227193	http://dx.doi.org/10.1126/science.1227193			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118185	Green Submitted			2022-12-28	WOS:000310516000046
J	Shah, AK; Mullainathan, S; Shafir, E				Shah, Anuj K.; Mullainathan, Sendhil; Shafir, Eldar			Some Consequences of Having Too Little	SCIENCE			English	Article							POVERTY; PERFORMANCE; TIME	Poor individuals often engage in behaviors, such as excessive borrowing, that reinforce the conditions of poverty. Some explanations for these behaviors focus on personality traits of the poor. Others emphasize environmental factors such as housing or financial access. We instead consider how certain behaviors stem simply from having less. We suggest that scarcity changes how people allocate attention: It leads them to engage more deeply in some problems while neglecting others. Across several experiments, we show that scarcity leads to attentional shifts that can help to explain behaviors such as overborrowing. We discuss how this mechanism might also explain other puzzles of poverty.	[Shah, Anuj K.] Univ Chicago, Booth Sch Business, Chicago, IL 60637 USA; [Mullainathan, Sendhil] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Shafir, Eldar] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Shafir, Eldar] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	University of Chicago; Harvard University; Princeton University; Princeton University	Shah, AK (corresponding author), Univ Chicago, Booth Sch Business, Chicago, IL 60637 USA.	anuj.shah@chicagobooth.edu	Shafir, Eldar/H-9957-2014		NSF [0933497]; Canadian Institute for Advanced Research	NSF(National Science Foundation (NSF)); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR))	Supported by NSF award 0933497 and by the Canadian Institute for Advanced Research. Data are available at http://theslab.uchicago.edu/browse/scidata.	Aarts H, 2001, BRIT J PSYCHOL, V92, P631, DOI 10.1348/000712601162383; Acquaye L, 2011, COMMUNITY DEV, V42, P16, DOI 10.1080/15575330.2010.491154; Allard Scott W., 2004, METROPOLITAN POLICY; [Anonymous], 2004, HIGH COST BEING POOR; [Anonymous], 2010, 16205 NBER; ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; Bair S., 2005, LOW COST PAYDAY LOAN; Banerjee A., 2011, POOR EC; Barr M. S., 2012, NO SLACK; Bernheim BD, 2001, J PUBLIC ECON, V80, P435, DOI 10.1016/S0047-2727(00)00120-1; Bertrand M, 2004, AM ECON REV, V94, P419, DOI 10.1257/0002828041302019; Binkley JK, 2003, J RETAILING, V79, P27, DOI 10.1016/S0022-4359(03)00005-8; Chen P., 2004, U ILLINOIS LAW REV, V2004, P723; Cleaver F, 2005, WORLD DEV, V33, P893, DOI 10.1016/j.worlddev.2004.09.015; Clotfelter C.T., 1991, SELLING HOPE STATE L; Collins D., 2009, INSUFFICIENT FUNDS; DARLEY JM, 1973, J PERS SOC PSYCHOL, V27, P100, DOI 10.1037/h0034449; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Goldin J., SMOKE GETS YOUR EYES; Haisley E, 2008, J RISK UNCERTAINTY, V37, P57, DOI 10.1007/s11166-008-9041-1; Johnson R. W., 2007, 0707 URB I; KANE TJ, 1987, SOC SERV REV, V61, P405, DOI 10.1086/644459; KARAU SJ, 1992, J EXP SOC PSYCHOL, V28, P542, DOI 10.1016/0022-1031(92)90045-L; Lewis O, 1969, UNDERSTANDING POVERT, P187; Ludwig J, 2001, Q J ECON, V116, P655, DOI 10.1162/00335530151144122; Mendel D., 2005, ADVOCASEY, V7, P4; Milgram S., 1963, J ABNORM SOC PSYCHOL, V67, P371, DOI [10.1037/h0040525, DOI 10.1037/H0040525]; Perlow LA, 1999, ADMIN SCI QUART, V44, P57, DOI 10.2307/2667031; Radel R, 2012, PSYCHOL SCI, V23, P232, DOI 10.1177/0956797611427920; SALLING M, 1981, ENVIRON BEHAV, V13, P131, DOI 10.1177/0013916581132001; Schmeichel BJ, 2003, J PERS SOC PSYCHOL, V85, P33, DOI 10.1037/0022-3514.85.1.33; Shurtleff D. S., 2009, IMPROVING SAVINGS IN; SPILERMAN S, 1971, SOC PROBL, V18, P358, DOI 10.1525/sp.1971.18.3.03a00060	33	602	620	20	285	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107					682	685		10.1126/science.1222426	http://dx.doi.org/10.1126/science.1222426			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	029SM	23118192				2022-12-28	WOS:000310516000057
J	Taylor, JR; Stocker, R				Taylor, John R.; Stocker, Roman			Trade-Offs of Chemotactic Foraging in Turbulent Water	SCIENCE			English	Article							MICROSCALE NUTRIENT PATCHES; MICROBIAL FOOD-WEB; MARINE-BACTERIA; SIMULATION; MOTILITY; BEHAVIOR; FLUID; SEA	Bacteria play an indispensable role in marine biogeochemistry by recycling dissolved organic matter. Motile species can exploit small, ephemeral solute patches through chemotaxis and thereby gain a fitness advantage over nonmotile competitors. This competition occurs in a turbulent environment, yet turbulence is generally considered inconsequential for bacterial uptake. In contrast, we show that turbulence affects uptake by stirring nutrient patches into networks of thin filaments that motile bacteria can readily exploit. We find that chemotactic motility is subject to a trade-off between the uptake benefit due to chemotaxis and the cost of locomotion, resulting in an optimal swimming speed. A second trade-off results from the competing effects of stirring and mixing and leads to the prediction that chemotaxis is optimally favored at intermediate turbulence intensities.	[Stocker, Roman] MIT, Dept Civil & Environm Engn, Ralph M Parsons Lab, Cambridge, MA 02139 USA; [Taylor, John R.] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England	Massachusetts Institute of Technology (MIT); University of Cambridge	Stocker, R (corresponding author), MIT, Dept Civil & Environm Engn, Ralph M Parsons Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	romans@mit.edu	Stocker, Roman/N-8987-2019; Stocker, Roman/T-9456-2017	Stocker, Roman/0000-0002-3199-0508	NSF Mathematical Sciences Postdoctoral Research Fellowship; NSF [OCE-0744641-CAREER, CBET-1066566]	NSF Mathematical Sciences Postdoctoral Research Fellowship(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	We thank W. M. Durham, R. Ferrari, M. Follows, M. Garren, F. Menolascina, S. Merrifield, T. Pedley, S. Smriga, and R. Watteaux for helpful comments and suggestions. The calculation of the resistive force coefficient for a bacterium was performed by Marcos. J.R.T. was supported by an NSF Mathematical Sciences Postdoctoral Research Fellowship. R. S. acknowledges NSF grants OCE-0744641-CAREER and CBET-1066566.	Ahmed T, 2008, BIOPHYS J, V95, P4481, DOI 10.1529/biophysj.108.134510; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; BATCHELOR GK, 1959, J FLUID MECH, V5, P113, DOI 10.1017/S002211205900009X; Blackburn N, 1998, SCIENCE, V282, P2254, DOI 10.1126/science.282.5397.2254; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Donzis DA, 2010, FLOW TURBUL COMBUST, V85, P549, DOI 10.1007/s10494-010-9271-6; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Durham WM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.238102; Fenchel T, 2002, SCIENCE, V296, P1068, DOI 10.1126/science.1070118; Gregg MC, 1996, DYNAM ATMOS OCEANS, V24, P1, DOI 10.1016/0377-0265(95)00406-8; Grossart HP, 2001, AQUAT MICROB ECOL, V25, P247, DOI 10.3354/ame025247; Grunbaum D, 2002, HYDROBIOLOGIA, V480, P175, DOI 10.1023/A:1021296103358; Hutz A, 2011, APPL ENVIRON MICROB, V77, P4412, DOI 10.1128/AEM.00490-11; KarpBoss L, 1996, OCEANOGR MAR BIOL, V34, P71; Kiorboe T, 2001, LIMNOL OCEANOGR, V46, P1309, DOI 10.4319/lo.2001.46.6.1309; LAZIER JRN, 1989, DEEP-SEA RES, V36, P1721, DOI 10.1016/0198-0149(89)90068-X; Marshall JS, 2010, CHEM ENG SCI, V65, P3865, DOI 10.1016/j.ces.2010.03.036; Matz C, 2005, APPL ENVIRON MICROB, V71, P921, DOI 10.1128/AEM.71.2.921-929.2005; Mitchell JG, 1996, APPL ENVIRON MICROB, V62, P3716, DOI 10.1128/AEM.62.10.3716-3721.1996; Moin P, 1998, ANNU REV FLUID MECH, V30, P539, DOI 10.1146/annurev.fluid.30.1.539; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Munoz-Garcia J, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/103043; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Seymour JR, 2009, AM NAT, V173, pE15, DOI 10.1086/593004; Seymour JR, 2010, SCIENCE, V329, P342, DOI 10.1126/science.1188418; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Williams P.J.I.B., 2000, MICROBIAL ECOLOGY OC, P153; Xie L, 2011, P NATL ACAD SCI USA, V108, P2246, DOI 10.1073/pnas.1011953108	28	111	115	3	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					675	679		10.1126/science.1219417	http://dx.doi.org/10.1126/science.1219417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118190				2022-12-28	WOS:000310516000055
J	Tran, V; Lim, C; Xie, J; Chen, X				Vuong Tran; Lim, Cindy; Xie, Jing; Chen, Xin			Asymmetric Division of Drosophila Male Germline Stem Cell Shows Asymmetric Histone Distribution	SCIENCE			English	Article							SELF-RENEWAL; EPIGENETIC REGULATION; CHROMATIN; CENTROSOME; MEMORY; DNA; MECHANISMS; DEPOSITION; POLYCOMB	Stem cells can self-renew and generate differentiating daughter cells. It is not known whether these cells maintain their epigenetic information during asymmetric division. Using a dual-color method to differentially label "old" versus "new" histones in Drosophila male germline stem cells (GSCs), we show that preexisting canonical H3, but not variant H3.3, histones are selectively segregated to the GSC, whereas newly synthesized histones incorporated during DNA replication are enriched in the differentiating daughter cell. The asymmetric histone distribution occurs in GSCs but not in symmetrically dividing progenitor cells. Furthermore, if GSCs are genetically manipulated to divide symmetrically, this asymmetric mode is lost. This work suggests that stem cells retain preexisting canonical histones during asymmetric cell divisions, probably as a mechanism to maintain their unique molecular properties.	[Vuong Tran; Lim, Cindy; Xie, Jing; Chen, Xin] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University	Chen, X (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	xchen32@jhu.edu	, jxie10@live.johnshopkins.edu/B-5028-2015	, jxie10@live.johnshopkins.edu/0000-0001-9715-3369	NICHD/NIH [R21HD065089, R01HD065816]; David & Lucile Packard Foundation; American Federation of Aging Research; JHU; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065816] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007231] Funding Source: NIH RePORTER	NICHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); David & Lucile Packard Foundation(The David & Lucile Packard Foundation); American Federation of Aging Research; JHU; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Prado for discussions to develop a controlled gene expression system and the FRT-MCS-SV40 Poly A-FRT plasmid; A. Talaga, A. Chin, A. Kim, and B. Weber for experimental assistance; K. Ahmad for plasmids containing H3, H2B, and H3.3 sequences; A. Nakamura for the UAS-mKO-vasa strain; S. DiNardo for the UAS-upd strain; Y. Yamashita for GSC cell cycle information and insightful suggestions; and R. Kuruvilla, K. Zhao, Y. Zheng, H. Zhao, M. Van Doren, D. Drummond-Barbosa, A. Hoyt, and Chen lab members for critical reading. Supported by NICHD/NIH grants R21HD065089 and R01HD065816, the David & Lucile Packard Foundation, American Federation of Aging Research, and JHU start-up (X.C.).	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ANNUNZIATO AT, 1982, J BIOL CHEM, V257, P8507; Buszczak M, 2006, CELL, V125, P233, DOI 10.1016/j.cell.2006.04.004; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Eun SH, 2010, CURR OPIN CELL BIOL, V22, P737, DOI 10.1016/j.ceb.2010.09.004; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; JACKSON V, 1981, CELL, V23, P121, DOI 10.1016/0092-8674(81)90277-4; JACKSON V, 1981, J BIOL CHEM, V256, P5095; Jacobs JJL, 2002, BBA-REV CANCER, V1602, P151, DOI 10.1016/S0304-419X(02)00052-5; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Losick VP, 2011, DEV CELL, V21, P159, DOI 10.1016/j.devcel.2011.06.018; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; RUSSEV G, 1981, NUCLEIC ACIDS RES, V9, P4129, DOI 10.1093/nar/9.16.4129; Sheng XR, 2011, DEVELOPMENT, V138, P3367, DOI 10.1242/dev.065797; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Xu M, 2010, SCIENCE, V328, P94, DOI 10.1126/science.1178994; Yadlapalli S, 2011, J CELL SCI, V124, P933, DOI 10.1242/jcs.079798; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910	25	112	117	7	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					679	682		10.1126/science.1226028	http://dx.doi.org/10.1126/science.1226028			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118191	Green Accepted			2022-12-28	WOS:000310516000056
J	Sainsbury, S; Niesser, J; Cramer, P				Sainsbury, Sarah; Niesser, Juergen; Cramer, Patrick			Structure and function of the initially transcribing RNA polymerase II-TFIIB complex	NATURE			English	Article							TRANSCRIPTION FACTOR IIB; SACCHAROMYCES-CEREVISIAE; PREINITIATION COMPLEX; ANGSTROM RESOLUTION; PROMOTER CLEARANCE; IN-VIVO; INITIATION; MECHANISM; DNA; ARCHITECTURE	The general transcription factor (TF) IIB is required for RNA polymerase (Pol) II initiation and extends with its B-reader element into the Pol II active centre cleft. Low-resolution structures of the Pol II-TFIIB complex(1,2) indicated how TFIIB functions in DNA recruitment, but they lacked nucleic acids and half of the B-reader, leaving other TFIIB functions(3,4) enigmatic. Here we report crystal structures of the Pol II-TFIIB complex from the yeast Saccharomyces cerevisiae at 3.4 angstrom resolution and of an initially transcribing complex that additionally contains the DNA template and a 6-nucleotide RNA product. The structures reveal the entire B-reader and protein-nucleic acid interactions, and together with functional data lead to a more complete understanding of transcription initiation. TFIIB partially closes the polymerase cleft to position DNA and assist in its opening. The B-reader does not reach the active site but binds the DNA template strand upstream to assist in the recognition of the initiator sequence and in positioning the transcription start site. TFIIB rearranges active-site residues, induces binding of the catalytic metal ion B, and stimulates initial RNA synthesis allosterically. TFIIB then prevents the emerging DNA-RNA hybrid duplex from tilting, which would impair RNA synthesis. When the RNA grows beyond 6 nucleotides, it is separated from DNA and is directed to its exit tunnel by the B-reader loop. Once the RNA grows to 12-13 nucleotides, it clashes with TFIIB, triggering TFIIB displacement and elongation complex formation. Similar mechanisms may underlie all cellular transcription because all eukaryotic and archaeal RNA polymerases use TFIIB-like factors(5), and the bacterial initiation factor sigma has TFIIB-like topology(1,2) and contains the loop region 3.2 that resembles the B-reader loop in location, charge and function(6-8). TFIIB and its counterparts may thus account for the two fundamental properties that distinguish RNA from DNA polymerases: primer-independent chain initiation and product separation from the template.	[Sainsbury, Sarah; Niesser, Juergen; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Sainsbury, Sarah; Niesser, Juergen; Cramer, Patrick] Univ Munich, Dept Biochem, Ctr Integrated Prot Sci CIPSM, D-81377 Munich, Germany	University of Munich; University of Munich	Cramer, P (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@lmb.uni-muenchen.de			Alexander-von-Humboldt Foundation; Deutsche Forschungsgemeinschaft [SFB646, TR5, GraKo1721, SFB960]; CIPSM; NIM; European Research Council; LMUinnovativ project Bioimaging Network; Jung-Stiftung; Vallee Foundation	Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CIPSM; NIM; European Research Council(European Research Council (ERC)European Commission); LMUinnovativ project Bioimaging Network; Jung-Stiftung; Vallee Foundation	We thank C. Bajen, A. Cheung, S. Etzold, F. Hog, D. Kostrewa, N. Pirkl and other members of the Cramer laboratory. Part of this work was performed at the Swiss Light Source (SLS) at the Paul Scherrer Institut, Villigen, Switzerland. S. S. was supported by a postdoctoral fellowship from the Alexander-von-Humboldt Foundation. P. C. was supported by the Deutsche Forschungsgemeinschaft, SFB646, TR5, GraKo1721, SFB960, CIPSM, NIM, an Advanced Grant of the European Research Council, the LMUinnovativ project Bioimaging Network, the Jung-Stiftung, and the Vallee Foundation.	Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Bangur CS, 1997, MOL CELL BIOL, V17, P6784, DOI 10.1128/MCB.17.12.6784; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Cabart P, 2011, P NATL ACAD SCI USA, V108, P15786, DOI 10.1073/pnas.1104591108; Chen BS, 2004, MOL CELL BIOL, V24, P3983, DOI 10.1128/MCB.24.9.3983-3991.2004; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cheung ACM, 2011, EMBO J, V30, P4755, DOI 10.1038/emboj.2011.396; Cho EJ, 1999, J BIOL CHEM, V274, P25807, DOI 10.1074/jbc.274.36.25807; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Fishburn J, 2012, MOL CELL BIOL, V32, P12, DOI 10.1128/MCB.06242-11; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; Hawkes NA, 1999, J BIOL CHEM, V274, P14337, DOI 10.1074/jbc.274.20.14337; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kuehner JN, 2006, J BIOL CHEM, V281, P14119, DOI 10.1074/jbc.M601937200; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Naji S, 2008, NUCLEIC ACIDS RES, V36, P676, DOI 10.1093/nar/gkm1086; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Seizl M, 2011, NUCLEIC ACIDS RES, V39, P6291, DOI 10.1093/nar/gkr229; SIKORSKI RS, 1989, GENETICS, V122, P19; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; STEITZ TA, 1994, SCIENCE, V266, P2022, DOI 10.1126/science.7528445; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Tran K, 2008, J BIOL CHEM, V283, P15665, DOI 10.1074/jbc.M801439200; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Werner F, 2005, MOL CELL BIOL, V25, P8344, DOI 10.1128/MCB.25.18.8344-8355.2005; Yang C, 2012, NUCLEIC ACIDS RES, V40, P6495, DOI 10.1093/nar/gks323; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583	34	130	132	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2013	493	7432					437	U191		10.1038/nature11715	http://dx.doi.org/10.1038/nature11715			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23151482	Green Published			2022-12-28	WOS:000313615900059
J	Taniguchi, H; Lu, JT; Huang, ZJ				Taniguchi, Hiroki; Lu, Jiangteng; Huang, Z. Josh			The Spatial and Temporal Origin of Chandelier Cells in Mouse Neocortex	SCIENCE			English	Article							CEREBRAL-CORTEX; NEURONS; INTERNEURON; SPECIFICATION; GENERATION	Diverse gamma-aminobutyric acid-releasing interneurons regulate the functional organization of cortical circuits and derive from multiple embryonic sources. It remains unclear to what extent embryonic origin influences interneuron specification and cortical integration because of difficulties in tracking defined cell types. Here, we followed the developmental trajectory of chandelier cells (ChCs), the most distinct interneurons that innervate the axon initial segment of pyramidal neurons and control action potential initiation. ChCs mainly derive from the ventral germinal zone of the lateral ventricle during late gestation and require the homeodomain protein Nkx2.1 for their specification. They migrate with stereotyped routes and schedule and achieve specific laminar distribution in the cortex. The developmental specification of this bona fide interneuron type likely contributes to the assembly of a cortical circuit motif.	[Taniguchi, Hiroki; Lu, Jiangteng; Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Huang, ZJ (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	huangj@cshl.edu		Huang, Z. Josh/0000-0003-0592-028X	NIH [R01 MH094705]; Japan Science and Technology Agency; Brain and Behavior Research Foundation (NARSAD); Patterson Foundation; Simons Foundation; NARSAD; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094705] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Brain and Behavior Research Foundation (NARSAD)(NARSAD); Patterson Foundation; Simons Foundation; NARSAD(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank G. Miyoshi for technical advice of fate-mapping experiments and helpful discussion. Support by NIH R01 MH094705. H.T. is a Precursory Research for Embryonic Science and Technology investigator supported by Japan Science and Technology Agency and was supported by a Brain and Behavior Research Foundation (NARSAD) Postdoctoral Fellowship. J.L. is in part supported by a Patterson Foundation Postdoctoral Fellowship. Z.J.H. is supported by the Simons Foundation and a NARSAD Distinguished Investigator award.	ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; FAIREN A, 1986, J COMP NEUROL, V251, P67, DOI 10.1002/cne.902510105; Gelman DM, 2010, EUR J NEUROSCI, V31, P2136, DOI 10.1111/j.1460-9568.2010.07267.x; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Inan M, 2012, CEREB CORTEX, V22, P820, DOI 10.1093/cercor/bhr148; Inda MC, 2006, P NATL ACAD SCI USA, V103, P2920, DOI 10.1073/pnas.0511197103; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Lewis DA, 2011, DEV NEUROBIOL, V71, P118, DOI 10.1002/dneu.20825; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MILLER MW, 1985, DEV BRAIN RES, V23, P187, DOI 10.1016/0165-3806(85)90040-9; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; SOMOGYI P, 1977, BRAIN RES, V136, P345, DOI 10.1016/0006-8993(77)90808-3; Sussel L, 1999, DEVELOPMENT, V126, P3359; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Szentagothai J, 1974, Neurosci Res Program Bull, V12, P305; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Woodruff A, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.015.2009	20	172	174	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					70	74		10.1126/science.1227622	http://dx.doi.org/10.1126/science.1227622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23180771	Green Accepted			2022-12-28	WOS:000312985800053
J	Wang, R; Dearing, JA; Langdon, PG; Zhang, EL; Yang, XD; Dakos, V; Scheffer, M				Wang, Rong; Dearing, John A.; Langdon, Peter G.; Zhang, Enlou; Yang, Xiangdong; Dakos, Vasilis; Scheffer, Marten			Flickering gives early warning signals of a critical transition to a eutrophic lake state	NATURE			English	Article							ECOSYSTEM SERVICES; REGIME SHIFTS; CLIMATE-CHANGE; TIPPING POINT; RESILIENCE; SYSTEMS; SCIENCE; TIME	There is a recognized need to anticipate tipping points, or critical transitions, in social-ecological systems(1,2). Studies of mathematical(3-5) and experimental(6-9) systems have shown that systems may 'wobble' before a critical transition. Such early warning signals(10) may be due to the phenomenon of critical slowing down, which causes a system to recover slowly from small impacts, or to a flickering phenomenon, which causes a system to switch back and forth between alternative states in response to relatively large impacts. Such signals for transitions in social-ecological systems have rarely been observed(11), not the least because high-resolution time series are normally required. Here we combine empirical data from a lake-catchment system with a mathematical model and show that flickering can be detected from sparse data. We show how rising variance coupled to decreasing autocorrelation and skewness started 10-30 years before the transition to eutrophic lake conditions in both the empirical records and the model output, a finding that is consistent with flickering rather than critical slowing down(4,12). Our results suggest that if environmental regimes are sufficiently affected by large external impacts that flickering is induced, then early warning signals of transitions in modern social-ecological systems may be stronger, and hence easier to identify, than previously thought.	[Wang, Rong; Dearing, John A.; Langdon, Peter G.] Univ Southampton, Palaeoecol Lab, Southampton SO17 1BJ, Hants, England; [Wang, Rong; Zhang, Enlou; Yang, Xiangdong] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing 210008, Jiangsu, Peoples R China; [Dakos, Vasilis; Scheffer, Marten] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 AA Wageningen, Netherlands; [Dakos, Vasilis] CSIC, Estn Biol Donana, Integrat Ecol Grp, E-41092 Seville, Spain	University of Southampton; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Wageningen University & Research; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Dearing, JA (corresponding author), Univ Southampton, Palaeoecol Lab, Southampton SO17 1BJ, Hants, England.	j.dearing@soton.ac.uk	Langdon, Peter G/B-4682-2013; Dearing, John/E-4206-2010; Scheffer, Marten/C-1852-2012	Dearing, John/0000-0002-1466-9640; Dakos, Vasilis/0000-0001-8862-718X; Langdon, Peter/0000-0003-2724-2643; Zhang, Enlou/0000-0002-8057-7760	UK Overseas Research Students Awards; Great Britain-China Educational Trust; University of Southampton; National Basic Research Program of China (973 program) [2012CB956104]; NWO-Rubicon; EU Marie Curie fellowship; Spinoza (NWO) Award; European Research Council	UK Overseas Research Students Awards; Great Britain-China Educational Trust; University of Southampton; National Basic Research Program of China (973 program)(National Basic Research Program of China); NWO-Rubicon(Netherlands Organization for Scientific Research (NWO)); EU Marie Curie fellowship(European Commission); Spinoza (NWO) Award; European Research Council(European Research Council (ERC)European Commission)	A studentship to R.W. was funded through the UK Overseas Research Students Awards Scheme, the Great Britain-China Educational Trust and the University of Southampton. Laboratory analyses and fieldwork were supported by the National Basic Research Program of China (973 program, 2012CB956104). We are grateful to J. Shen and X. Chen for data collection, Y. L. Li for diatomanalysis (core EH2), W. L. Xia for radionuclide measurements and Y. X. Zhu for geochemical analyses. V. D. is supported by an NWO-Rubicon and an EU Marie Curie fellowship. M. S. is funded by a Spinoza (NWO) Award and by a European Research Council Advanced Grant. We thank J. Dash and J. Noble for discussions about ARIMA models. This is a Sustainability Science at Southampton publication.	Beddington J, 2010, PHILOS T R SOC B, V365, P61, DOI 10.1098/rstb.2009.0201; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Brock WA, 2010, ECOL MONOGR, V80, P353, DOI 10.1890/09-1824.1; Brock WA, 2006, ECOL SOC, V11; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter SR, 1999, ECOL APPL, V9, P751, DOI 10.1890/1051-0761(1999)009[0751:MOEFLS]2.0.CO;2; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Dai L, 2012, SCIENCE, V336, P1175, DOI 10.1126/science.1219805; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dearing JA, 2012, P NATL ACAD SCI USA, V109, pE1111, DOI 10.1073/pnas.1118263109; Dearing JA, 2010, ECOL SOC, V15; Ditlevsen PD, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044486; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; International Council for Science, 2011, ICSU STRAT PLAN 2 20; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Little JL, 2000, CAN J FISH AQUAT SCI, V57, P333, DOI 10.1139/cjfas-57-2-333; Livina VN, 2010, CLIM PAST, V6, P77, DOI 10.5194/cp-6-77-2010; Nicholson E, 2009, J APPL ECOL, V46, P1139, DOI 10.1111/j.1365-2664.2009.01716.x; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Scheffer M., 2020, CRITICAL TRANSITIONS, V16, DOI 10.2307/j.ctv173f1g1; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; TAYLOR KC, 1993, NATURE, V361, P432, DOI 10.1038/361432a0; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723	27	305	339	16	491	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					419	422		10.1038/nature11655	http://dx.doi.org/10.1038/nature11655			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23160492				2022-12-28	WOS:000312488200054
J	Moss, AJ; Schuger, C; Beck, CA; Brown, MW; Cannom, DS; Daubert, JP; Estes, NAM; Greenberg, H; Hall, WJ; Huang, DT; Kautzner, J; Klein, H; McNitt, S; Olshansky, B; Shoda, M; Wilber, D; Zareba, W				Moss, Arthur J.; Schuger, Claudio; Beck, Christopher A.; Brown, Mary W.; Cannom, David S.; Daubert, James P.; Estes, N. A. Mark, III; Greenberg, Henry; Hall, W. Jackson; Huang, David T.; Kautzner, Josef; Klein, Helmut; McNitt, Scott; Olshansky, Brian; Shoda, Morio; Wilber, David; Zareba, Wojciech		MADIT-RIT Trial Investigators	Reduction in Inappropriate Therapy and Mortality through ICD Programming	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; PROPHYLACTIC IMPLANTATION; HEART-FAILURE; SHOCKS; TRIAL; PREVENTION; GUIDELINES; RATIONALE	BACKGROUND The implantable cardioverter-defibrillator (ICD) is highly effective in reducing mortality among patients at risk for fatal arrhythmias, but inappropriate ICD activations are frequent, with potential adverse effects. METHODS We randomly assigned 1500 patients with a primary-prevention indication to receive an ICD with one of three programming configurations. The primary objective was to determine whether programmed high-rate therapy (with a 2.5-second delay before the initiation of therapy at a heart rate of >= 200 beats per minute) or delayed therapy (with a 60-second delay at 170 to 199 beats per minute, a 12-second delay at 200 to 249 beats per minute, and a 2.5-second delay at >= 250 beats per minute) was associated with a decrease in the number of patients with a first occurrence of inappropriate antitachycardia pacing or shocks, as compared with conventional programming (with a 2.5-second delay at 170 to 199 beats per minute and a 1.0-second delay at >= 200 beats per minute). RESULTS During an average follow-up of 1.4 years, high-rate therapy and delayed ICD therapy, as compared with conventional device programming, were associated with reductions in a first occurrence of inappropriate therapy (hazard ratio with high-rate therapy vs. conventional therapy, 0.21; 95% confidence interval [CI], 0.13 to 0.34; P < 0.001; hazard ratio with delayed therapy vs. conventional therapy, 0.24; 95% CI, 0.15 to 0.40; P < 0.001) and reductions in all-cause mortality (hazard ratio with high-rate therapy vs. conventional therapy, 0.45; 95% CI, 0.24 to 0.85; P = 0.01; hazard ratio with delayed therapy vs. conventional therapy, 0.56; 95% CI, 0.30 to 1.02; P = 0.06). There were no significant differences in procedure-related adverse events among the three treatment groups. CONCLUSIONS Programming of ICD therapies for tachyarrhythmias of 200 beats per minute or higher or with a prolonged delay in therapy at 170 beats per minute or higher, as compared with conventional programming, was associated with reductions in inappropriate therapy and all-cause mortality during long-term follow-up. (Funded by Boston Scientific; MADIT-RIT ClinicalTrials.gov number, NCT00947310.)	[Moss, Arthur J.] Univ Rochester, Med Ctr, Heart Res Follow Up Program, Dept Med, Rochester, NY 14642 USA; [Beck, Christopher A.; Hall, W. Jackson] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Schuger, Claudio] Henry Ford Hosp, Div Cardiol, Detroit, MI 48202 USA; [Cannom, David S.] Hosp Good Samaritan, Div Cardiol, Los Angeles, CA 90017 USA; [Daubert, James P.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Estes, N. A. Mark, III] Tufts Univ New England Med Ctr, New England Cardiac Arrhythmia Ctr, Boston, MA USA; [Greenberg, Henry] Columbia Univ, St Lukes Hosp, Dept Med, New York, NY USA; [Greenberg, Henry] Columbia Univ, Dept Med, Roosevelt Hosp, New York, NY USA; [Greenberg, Henry] Columbia Univ, Dept Epidemiol, Roosevelt Hosp, New York, NY USA; [Greenberg, Henry] Columbia Univ, St Lukes Hosp, Dept Epidemiol, New York, NY USA; [Kautzner, Josef] Inst Clin & Expt Med, Dept Cardiol, Prague, Czech Republic; [Olshansky, Brian] Univ Iowa Hlth Care, Dept Med, Iowa City, IA USA; [Shoda, Morio] Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan; [Wilber, David] Loyola Univ, Med Ctr, Cardiovasc Inst, Chicago, IL 60611 USA	University of Rochester; University of Rochester; Henry Ford Health System; Henry Ford Hospital; Duke University; Tufts Medical Center; Columbia University; Mount Sinai St. Luke's; Columbia University; Mount Sinai West; Columbia University; Mount Sinai West; Columbia University; Mount Sinai St. Luke's; Institute for Clinical & Experimental Medicine (IKEM); University of Iowa; Tokyo Women's Medical University; Loyola University Chicago	Moss, AJ (corresponding author), Univ Rochester, Med Ctr, Heart Res Follow Up Program, Dept Med, 265 Crittenden Blvd,CU 420653, Rochester, NY 14642 USA.	heartajm@heart.rochester.edu	Kaab, Stefan/H-3915-2012; Daubert, James P./ABC-1476-2021; Olshansky, Brian/S-3671-2016	Olshansky, Brian/0000-0002-6044-045X	Boston Scientific; University of Rochester; Guidant; Lundbeck; Gilead; Zoll; Medtronic; Sanofi-Aventis; Premier; Biotronik; Cameron Health; Executive Health Resources; Boehringer Ingelheim; Amarin; BioControl; Network for Continuing Medical Education; St. Jude Medical	Boston Scientific(Boston Scientific); University of Rochester; Guidant; Lundbeck(Lundbeck Corporation); Gilead(Gilead Sciences); Zoll; Medtronic(Medtronic); Sanofi-Aventis(Sanofi-Aventis); Premier; Biotronik; Cameron Health; Executive Health Resources; Boehringer Ingelheim(Boehringer Ingelheim); Amarin; BioControl; Network for Continuing Medical Education; St. Jude Medical(St. Jude Medical)	Supported by a research grant from Boston Scientific to the University of Rochester, with funds distributed to the coordination and data center, enrolling centers, core laboratories, committees, and boards under subcontract from the University of Rochester.; Drs. Moss and Zareba report receiving grant support from Boston Scientific through their institutions. Dr. Beck reports receiving grant support from Guidant and Lundbeck through his institution. Ms. Brown reports receiving grant support and travel support from Boston Scientific through her institution, grant support and travel support from Gilead through her institution, and grant support from Zoll through her institution. Dr. Cannom reports receiving lecture fees from Boston Scientific, Medtronic, and Sanofi-Aventis. Dr. Daubert reports receiving consulting fees from Premier; receiving consulting fees and lecture fees, as well as grant support through his institution, from Boston Scientific; receiving lecture fees, as well as grant support through his institution, from Medtronic; receiving lecture fees from Biotronik, St. Jude Medical, and Sorin; holding stock in and receiving grant support through his institution from Biosense Webster; and receiving grant support from Gilead through his institution. Dr. Estes reports receiving consulting fees from Boston Scientific and Medtronic. Dr. Huang reports receiving consulting fees, as well as grant support through his institution, from St. Jude Medical; lecture fees, as well as grant support through his institution, from Biotronik; and grant support from Medtronic, Boston Scientific, and Gilead through his institution. Dr. Kautzner reports receiving payment for board membership and lecture fees from Boston Scientific; payment for board membership and lecture fees from St. Jude Medical; lecture fees, as well as grant support through his institution, from Biotronik; and lecture fees, as well as grant support through his institution, from Medtronic. Dr. Klein reports receiving lecture fees from Boston Scientific, Cameron Health, and Zoll. Dr. Olshansky reports receiving consulting fees, lecture fees, and grant support from Boston Scientific, receiving consulting fees and lecture fees from Medtronic, receiving consulting fees from Executive Health Resources, Boehringer Ingelheim, Sanofi-Aventis, Amarin, and BioControl, receiving lecture fees from the Network for Continuing Medical Education, and serving as an expert witness in a case regarding a patient's coronary bypass operation. Dr. Wilber reports receiving lecture fees from Boston Scientific, Medtronic, Biotronik, and St. Jude Medical. No other potential conflict of interest relevant to this article was reported.	Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; BARKERVOELZ MA, 1983, J ELECTROCARDIOL, V16, P167, DOI 10.1016/S0022-0736(83)80021-1; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; COX DR, 1972, J R STAT SOC B, V34, P187; Curtis AB, 2009, CIRCULATION, V120, P921, DOI 10.1161/CIRCULATIONAHA.109.890335; Daubert JP, 2008, J AM COLL CARDIOL, V51, P1357, DOI 10.1016/j.jacc.2007.09.073; Epstein AE, 1998, CIRCULATION, V98, P1517, DOI 10.1161/01.CIR.98.15.1517; Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742; Goldenberg I, 2006, CIRCULATION, V113, P2810, DOI 10.1161/CIRCULATIONAHA.105.577262; HEALY B, 1989, NEW ENGL J MED, V320, P949, DOI 10.1056/NEJM198904063201432; HINKLE LE, 1982, CIRCULATION, V65, P457, DOI 10.1161/01.CIR.65.3.457; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Pacifico A, 1999, NEW ENGL J MED, V340, P1855, DOI 10.1056/NEJM199906173402402; Poole JE, 2008, NEW ENGL J MED, V359, P1009, DOI 10.1056/NEJMoa071098; Saeed M, 2011, EUROPACE, V13, P1648, DOI 10.1093/europace/eur195; Schuger C, 2012, ANN NONINVAS ELECTRO, V17, P176, DOI 10.1111/j.1542-474X.2012.00531.x; Tereshchenko LG, 2009, J AM COLL CARDIOL, V54, P822, DOI 10.1016/j.jacc.2009.06.004; van Rees JB, 2011, J AM COLL CARDIOL, V57, P556, DOI 10.1016/j.jacc.2010.06.059; Wathen MS, 2004, CIRCULATION, V110, P2591, DOI 10.1161/01.CIR.0000145610.64014.E4; Wilkoff BL, 2008, J AM COLL CARDIOL, V52, P541, DOI 10.1016/j.jacc.2008.05.011; Xie JL, 1997, CIRCULATION, V96, P683	23	880	892	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24					2275	2283		10.1056/NEJMoa1211107	http://dx.doi.org/10.1056/NEJMoa1211107			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HF	23131066	Bronze			2022-12-28	WOS:000312187700001
J	Barish, B				Barish, Barry			Let US physics commit to collaboration	NATURE			English	Editorial Material									[Barish, Barry] CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Barish, B (corresponding author), CALTECH, Pasadena, CA 91125 USA.	barish@ligo.caltech.edu							0	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					522	522		10.1038/491522a	http://dx.doi.org/10.1038/491522a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040RE	23172199				2022-12-28	WOS:000311339800025
J	Cheng, JK				Cheng, Jennifer K.			Confronting the Social Determinants of Health - Obesity, Neglect, and Inequity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA USA	Harvard University; Boston Children's Hospital	Cheng, JK (corresponding author), Boston Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA USA.							Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Murtagh L, 2011, JAMA-J AM MED ASSOC, V306, P206, DOI 10.1001/jama.2011.903; Waldfogel J, 1998, ARCH PEDIAT ADOLESC, V8, P104; Wilkinson RG, 2003, SOCIAL DETERMINANTS	4	21	21	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2012	367	21					1976	1977		10.1056/NEJMp1209420	http://dx.doi.org/10.1056/NEJMp1209420			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040RI	23171094	Bronze			2022-12-28	WOS:000311340200004
J	Chou, R; Selph, S; Dana, T; Bougatsos, C; Zakher, B; Blazina, I; Korthuis, PT				Chou, Roger; Selph, Shelley; Dana, Tracy; Bougatsos, Christina; Zakher, Bernadette; Blazina, Ian; Korthuis, P. Todd			Screening for HIV: Systematic Review to Update the 2005 US Preventive Services Task Force Recommendation	ANNALS OF INTERNAL MEDICINE			English	Review							ACTIVE ANTIRETROVIRAL THERAPY; CD4 CELL COUNT; IMMUNODEFICIENCY-VIRUS-INFECTION; MYOCARDIAL-INFARCTION; UNITED-STATES; HIV-1-INFECTED PATIENTS; SERODISCORDANT COUPLES; COLLABORATIVE ANALYSIS; CLINICAL-OUTCOMES; BASE-LINE	Background: A 2005 U.S. Preventive Services Task Force (USPSTF) review found good evidence that HIV screening is accurate and that antiretroviral therapy (ART) for immunologically advanced disease is associated with substantial clinical benefits, but insufficient evidence to determine the effects on transmission or in less immunologically advanced disease. Purpose: To update the 2005 USPSTF review on benefits and harms of HIV screening in adolescents and adults, focusing on research gaps identified in the prior review. Data Sources: MEDLINE (2004 to June 2012) and the Cochrane Library (through the second quarter of 2012). Study Selection: Randomized trials and observational studies that compared HIV screening strategies and reported clinical outcomes, evaluated the effects of starting ART at different CD4 cell count thresholds and long-term harms, or reported the effects of interventions on transmission risk. Data Extraction: 2 authors abstracted and checked study details and quality using predefined criteria. Data Synthesis: No study directly evaluated the effects on clinical outcomes of screening versus no screening for HIV infection. A randomized trial and a subgroup analysis from a randomized trial found that ART initiation at CD4 counts less than 0.250 x 10(9) cells/L was associated with a higher risk for death or AIDS-defining events than initiation at CD4 counts greater than 0.350 x 10(9) cells/L (hazard ratios, 1.7 [95% CI, 1.1 to 2.5] and 5.3 [CI, 1.3 to 9.6]). Large, fair-quality cohort studies also consistently found that ART initiation at CD4 counts of 0.350 to 0.500 x 10(9) cells/L was associated with lower risk for death or AIDS-defining events than delayed initiation. New evidence from good-quality cohorts with longer-term follow-up confirms a previously observed small increased risk for cardiovascular events associated with certain antiretrovirals. Strong evidence from 1 good-quality randomized trial and 7 observational studies found that ART was associated with a 10- to 20-fold reduction in risk for sexual transmission of HIV. Limitations: Only English-language articles were included. Observational studies were included. Studies done in resource-poor or high-prevalence settings were included but might have limited applicability to general screening in the United States. Conclusion: Previous studies have shown that HIV screening is accurate, targeted screening misses a substantial proportion of cases, and treatments are effective in patients with advanced immunodeficiency. New evidence indicates that ART reduces risk for AIDS-defining events and death in persons with less advanced immunodeficiency and reduces sexual transmission of HIV. Primary Funding Source: Agency for Healthcare Research and Quality.	[Chou, Roger] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; Oregon Evidence Based Practice Ctr, Portland, OR USA	Oregon Health & Science University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	chour@ohsu.edu		Blazina, Ian/0000-0003-0164-6674; Chou, Roger/0000-0001-9889-8610; Korthuis, Philip/0000-0001-5556-3597	Agency for Healthcare Research and Quality [HHSA 290-2007-10057-I]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Support: By contract HHSA 290-2007-10057-I, task order 8, from the Agency for Healthcare Research and Quality.	Ahdieh-Grant L, 2003, AM J EPIDEMIOL, V157, P738, DOI 10.1093/aje/kwg036; Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; Anglemyer A., 2011, COCHRANE DATABASE SY; Bedimo R, 2012, AIDS, V26, P825, DOI 10.1097/QAD.0b013e32835192ae; Bedimo RJ, 2011, CLIN INFECT DIS, V53, P84, DOI 10.1093/cid/cir269; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Buchacz K, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/869841; Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Campsmith ML, 2010, JAIDS-J ACQ IMM DEF, V53, P619, DOI 10.1097/QAI.0b013e3181bf1c45; Centers for Disease Control and Prevention, 2011, HIV US GLANC; Centers for Disease Control and Prevention, 2008, EST NEW HIV INF US; Chou R, 2005, ANN INTERN MED, V143, P55, DOI 10.7326/0003-4819-143-1-200507050-00010; Chou R, SCREENING HIV SYSTEM; Chou R, 2005, SCREENING HUMAN IMMU; CHOU R, 2007, AHRQ PUBLICATION; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; El-Bassel N, 2010, ARCH INTERN MED, V170, P1594, DOI 10.1001/archinternmed.2010.261; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Funk MJ, 2011, ARCH INTERN MED, V171, P1560, DOI 10.1001/archinternmed.2011.401; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hernando V, 2009, SEX TRANSM DIS, V36, P621, DOI 10.1097/OLQ.0b013e3181aac222; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Kaplan JE, 2003, CLIN INFECT DIS, V37, P951, DOI 10.1086/377606; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Lanoy E, 2009, AIDS, V23, P2199, DOI 10.1097/QAD.0b013e3283305a00; Lepri AC, 2001, AIDS, V15, P983, DOI 10.1097/00002030-200105250-00006; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; Melo MG, 2008, SEX TRANSM DIS, V35, P912, DOI 10.1097/OLQ.0b013e31817e2491; Metsch LR, 2012, AM J PUBLIC HEALTH, V102, P1160, DOI 10.2105/AJPH.2011.300460; Moore DM, 2009, JAIDS-J ACQ IMM DEF, V52, P357, DOI 10.1097/QAI.0b013e3181b62933; MUSICCO M, 1994, ARCH INTERN MED, V154, P1971, DOI 10.1001/archinte.154.17.1971; Neaton JD, STRATEGIC TIMING ANT; Obel N, 2010, HIV MED, V11, P130, DOI 10.1111/j.1468-1293.2009.00751.x; Opravil M, 2002, AIDS, V16, P1371, DOI 10.1097/00002030-200207050-00009; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Peterman TA, 1996, J ACQ IMMUN DEF SYND, V12, P69, DOI 10.1097/00042560-199605010-00010; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Ribaudo HJ, 2011, CLIN INFECT DIS, V52, P929, DOI 10.1093/cid/ciq244; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Sterling TR, 2003, CLIN INFECT DIS, V36, P812, DOI 10.1086/367934; Sterling TR, 2001, AIDS, V15, P2251, DOI 10.1097/00002030-200111230-00006; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; SULLIVAN P, 2009, 16 C RETR OPP INF MO; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; U.S. Preventive Services Task Force, 2007, SCREEN HIV REC STAT; US Preventive Serv Task Force, 2005, ANN INTERN MED, V143, P32, DOI 10.7326/0003-4819-143-1-200507050-00008; Wang L, 2010, JAIDS-J ACQ IMM DEF, V55, P232, DOI 10.1097/QAI.0b013e3181e9b6b7; Waters L, 2007, INT J CLIN PRACT, V61, P999, DOI 10.1111/j.1742-1241.2007.01385.x; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897	65	29	29	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10					706	+		10.7326/0003-4819-157-10-201211200-00007	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-00007			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043VZ	23165662				2022-12-28	WOS:000311580000016
J	Strano, MS				Strano, Michael S.			Functional DNA Origami Devices	SCIENCE			English	Editorial Material									MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Strano, MS (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	strano@mit.edu						Acuna GP, 2012, SCIENCE, V338, P506, DOI 10.1126/science.1228638; Bates FS, 2012, SCIENCE, V336, P434, DOI 10.1126/science.1215368; Kowalczyk SW, 2011, TRENDS BIOTECHNOL, V29, P607, DOI 10.1016/j.tibtech.2011.07.006; Langecker M, 2012, SCIENCE, V338, P932, DOI 10.1126/science.1225624; Lee CY, 2010, SCIENCE, V329, P1320, DOI 10.1126/science.1193383; Nangreave J, 2010, CURR OPIN CHEM BIOL, V14, P608, DOI 10.1016/j.cbpa.2010.06.182; Palma CA, 2012, CHEM SOC REV, V41, P3713, DOI 10.1039/c2cs15302e; Torring T, 2011, CHEM SOC REV, V40, P5636, DOI 10.1039/c1cs15057j	8	11	11	6	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2012	338	6109					890	891		10.1126/science.1231024	http://dx.doi.org/10.1126/science.1231024			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161982				2022-12-28	WOS:000311083600026
J	Gao, WB; Fallahi, P; Togan, E; Miguel-Sanchez, J; Imamoglu, A				Gao, W. B.; Fallahi, P.; Togan, E.; Miguel-Sanchez, J.; Imamoglu, A.			Observation of entanglement between a quantum dot spin and a single photon	NATURE			English	Article							COMPUTATION; ATOM	Entanglement has a central role in fundamental tests of quantum mechanics(1) as well as in the burgeoning field of quantum information processing. Particularly in the context of quantum networks and communication, a main challenge is the efficient generation of entanglement between stationary (spin) and propagating (photon) quantum bits(2). Here we report the observation of quantum entanglement between a semiconductor quantum dot spin and the colour of a propagating optical photon. The demonstration of entanglement relies on the use of fast, single-photon detection, which allows us to project the photon into a superposition of red and blue frequency components. Our results extend the previous demonstrations of single-spin/single-photon entanglement in trapped ions(3), neutral atoms(4,5) and nitrogen-vacancy centres(6) to the domain of artificial atoms in semiconductor nanostructures that allow for on-chip integration of electronic and photonic elements(7,8). As a result of its fast optical transitions and favourable selection rules, the scheme we implement could in principle generate nearly deterministic entangled spin-photon pairs at a rate determined ultimately by the high spontaneous emission rate. Our observation constitutes a first step towards implementation of a quantum network with nodes(9) consisting of semiconductor spin quantum bits(10-12).	[Gao, W. B.; Fallahi, P.; Togan, E.; Miguel-Sanchez, J.; Imamoglu, A.] Swiss Fed Inst Technol, Inst Quantum Elect, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Gao, WB (corresponding author), Swiss Fed Inst Technol, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	weibo@phys.ethz.ch; imamoglu@phys.ethz.ch	gao, WEIBO/F-9408-2017	gao, WEIBO/0000-0003-3971-621X	NCCR Quantum Science and Technology; Swiss National Science Foundation; Swiss NSF [200021-140818]; ERC; Marie Curie International Incoming Fellowship within FP7	NCCR Quantum Science and Technology; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss NSF(Swiss National Science Foundation (SNSF)); ERC(European Research Council (ERC)European Commission); Marie Curie International Incoming Fellowship within FP7	We acknowledge discussions with W. Chin, M. Kroner, A. Srivastava, J. Elzerman, A. Reinhard, T. Volz, P. Maletinsky and D. Gershoni. This work is supported by NCCR Quantum Science and Technology, a research instrument of the Swiss National Science Foundation; the Swiss NSF (grant no. 200021-140818); an ERC Advanced Investigator Grant (A.I.); and a Marie Curie International Incoming Fellowship within FP7 (W.B.G.).	ASPECT A, 1982, PHYS REV LETT, V49, P91, DOI 10.1103/PhysRevLett.49.91; Blinov BB, 2004, NATURE, V428, P153, DOI 10.1038/nature02377; Cirac JI, 1999, PHYS REV A, V59, P4249, DOI 10.1103/PhysRevA.59.4249; Claudon J, 2010, NAT PHOTONICS, V4, P174, DOI 10.1038/nphoton.2009.287x; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; Dousse A, 2010, NATURE, V466, P217, DOI 10.1038/nature09148; Faraon A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.033604; Flagg EB, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.137401; Gol'tsman GN, 2001, APPL PHYS LETT, V79, P705, DOI 10.1063/1.1388868; Greilich A, 2009, NAT PHYS, V5, P262, DOI 10.1038/NPHYS1226; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Hennessy K, 2007, NATURE, V445, P896, DOI 10.1038/nature05586; Imamoglu A, 1999, PHYS REV LETT, V83, P4204, DOI 10.1103/PhysRevLett.83.4204; Kim D, 2011, NAT PHYS, V7, P223, DOI [10.1038/nphys1863, 10.1038/NPHYS1863]; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Moehring DL, 2007, NATURE, V449, P68, DOI 10.1038/nature06118; Muller A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.187402; Patel RB, 2010, NAT PHOTONICS, V4, P632, DOI [10.1038/NPHOTON.2010.161, 10.1038/nphoton.2010.161]; Poem E, 2010, NAT PHYS, V6, P993, DOI [10.1038/nphys1812, 10.1038/NPHYS1812]; Press D, 2008, NATURE, V456, P218, DOI 10.1038/nature07530; Press D, 2010, NAT PHOTONICS, V4, P367, DOI 10.1038/NPHOTON.2010.83; Shulman MD, 2012, SCIENCE, V336, P202, DOI 10.1126/science.1217692; Togan E, 2010, NATURE, V466, P730, DOI 10.1038/nature09256; Vamivakas AN, 2009, NAT PHYS, V5, P925, DOI 10.1038/nphys1459; Volz J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030404; Wilk T, 2007, SCIENCE, V317, P488, DOI 10.1126/science.1143835; Xu XD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.097401; Xu XD, 2009, NATURE, V459, P1105, DOI 10.1038/nature08120; Yilmaz ST, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.033601; Yuan ZS, 2008, NATURE, V454, P1098, DOI 10.1038/nature07241	30	309	315	5	182	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					426	430		10.1038/nature11573	http://dx.doi.org/10.1038/nature11573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23151586				2022-12-28	WOS:000311031600042
J	Killu, AM; Lanzino, G				Killu, Ammar M.; Lanzino, Giuseppe			Giant Basilar-Artery Aneurysm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Killu, Ammar M.; Lanzino, Giuseppe] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Killu, AM (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	killu.ammar@mayo.edu							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2012	367	19								10.1056/NEJMicm1207982	http://dx.doi.org/10.1056/NEJMicm1207982			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033DG	23134405				2022-12-28	WOS:000310773200013
J	Watts, G				Watts, Geoff			Profile Marleen Temmerman: a polymath in reproductive health	LANCET			English	Biographical-Item																			0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 3	2012	380	9853					1549	1549		10.1016/S0140-6736(12)61869-8	http://dx.doi.org/10.1016/S0140-6736(12)61869-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030VR	23122238				2022-12-28	WOS:000310598700016
J	McCord, TB; Li, JY; Combe, JP; McSween, HY; Jaumann, R; Reddy, V; Tosi, F; Williams, DA; Blewett, DT; Turrini, D; Palomba, E; Pieters, CM; De Sanctis, MC; Ammannito, E; Capria, MT; Le Corre, L; Longobardo, A; Nathues, A; Mittlefehldt, DW; Schroder, SE; Hiesinger, H; Beck, AW; Capaccioni, F; Carsenty, U; Keller, HU; Denevi, BW; Sunshine, JM; Raymond, CA; Russell, CT				McCord, T. B.; Li, J. -Y.; Combe, J. -P.; McSween, H. Y.; Jaumann, R.; Reddy, V.; Tosi, F.; Williams, D. A.; Blewett, D. T.; Turrini, D.; Palomba, E.; Pieters, C. M.; De Sanctis, M. C.; Ammannito, E.; Capria, M. T.; Le Corre, L.; Longobardo, A.; Nathues, A.; Mittlefehldt, D. W.; Schroeder, S. E.; Hiesinger, H.; Beck, A. W.; Capaccioni, F.; Carsenty, U.; Keller, H. U.; Denevi, B. W.; Sunshine, J. M.; Raymond, C. A.; Russell, C. T.			Dark material on Vesta from the infall of carbonaceous volatile-rich material	NATURE			English	Article							DAWN; HETEROGENEITY; MINERALOGY; SURFACE; ALBEDO; COLOR	Localized dark and bright materials, often with extremely different albedos, were recently found on Vesta's surface(1,2). The range of albedos is among the largest observed on Solar System rocky bodies. These dark materials, often associated with craters, appear in ejecta and crater walls, and their pyroxene absorption strengths are correlated with material brightness. It was tentatively suggested that the dark material on Vesta could be either exogenic, from carbon-rich, low-velocity impactors, or endogenic, from freshly exposed mafic material or impact melt, created or exposed by impacts. Here we report Vesta spectra and images and use them to derive and interpret the properties of the 'pure' dark and bright materials. We argue that the dark material is mainly from infall of hydrated carbonaceous material (like that found in a major class of meteorites and some comet surfaces(3-5)), whereas the bright material is the uncontaminated indigenous Vesta basaltic soil. Dark material from low-albedo impactors is diffused over time through the Vestan regolith by impact mixing, creating broader, diffuse darker regions and finally Vesta's background surface material. This is consistent with howardite-eucrite-diogenite meteorites coming from Vesta.	[McCord, T. B.; Combe, J. -P.] Bear Fight Inst, Winthrop, WA 98862 USA; [Li, J. -Y.] Planetary Sci Inst, Tucson, AZ 85719 USA; [McSween, H. Y.] Univ Tennessee, Knoxville, TN 37996 USA; [Jaumann, R.; Carsenty, U.] Inst Planetary Res, DLR, D-80302 Berlin, Germany; [Reddy, V.; Le Corre, L.; Nathues, A.; Schroeder, S. E.] Max Planck Inst Solar Syst Res, D-37191 Katlenburg, Germany; [Reddy, V.] Univ N Dakota, Grand Forks, ND 58202 USA; [Tosi, F.; Turrini, D.; Palomba, E.; De Sanctis, M. C.; Ammannito, E.; Capria, M. T.; Longobardo, A.; Capaccioni, F.] Ist Nazl Astrofis IASF, I-00133 Rome, Italy; [Williams, D. A.] Arizona State Univ, Tempe, AZ 85287 USA; [Blewett, D. T.; Denevi, B. W.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Pieters, C. M.] Brown Univ, Providence, RI 02912 USA; [Mittlefehldt, D. W.] NASA, Lyndon B Johnson Space Ctr, Astromat Res Off, Houston, TX 77058 USA; [Hiesinger, H.] Univ Munster, Inst Planetol, D-48149 Munster, Germany; [Beck, A. W.] Smithsonian Natl Museum Nat Hist, Dept Mineral Sci, Washington, DC 20024 USA; [Keller, H. U.] Inst Geophys & Extraterr Phys, D-38106 Braunschweig, Germany; [Sunshine, J. M.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Raymond, C. A.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Russell, C. T.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA	University of Tennessee System; University of Tennessee Knoxville; Helmholtz Association; German Aerospace Centre (DLR); Max Planck Society; University of North Dakota Grand Forks; Istituto Nazionale Astrofisica (INAF); Arizona State University; Arizona State University-Tempe; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Brown University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Munster; Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Maryland; University of Maryland College Park; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Los Angeles	McCord, TB (corresponding author), Bear Fight Inst, 22 Fiddlers Rd,Box 667, Winthrop, WA 98862 USA.	tmccord@bearfightinstitute.com; jean-philippe_combe@bearfightinstitutute.com	De Sanctis, Maria Cristina/G-5232-2013; Blewett, David T/I-4904-2012; Jaumann, Ralf/N-1001-2018; Denevi, Brett W./I-6502-2012; Beck, Andrew W/J-7215-2015; Tosi, Federico/F-2321-2018; Russell, Christopher T/E-7745-2012; Schröder, Stefan/D-9709-2013; Nathues, Andreas/AAW-4340-2020; Palomba, Ernesto/E-8287-2017	De Sanctis, Maria Cristina/0000-0002-3463-4437; Blewett, David T/0000-0002-9241-6358; Jaumann, Ralf/0000-0002-9759-6597; Denevi, Brett W./0000-0001-7837-6663; Beck, Andrew W/0000-0003-4455-2299; Tosi, Federico/0000-0003-4002-2434; Russell, Christopher T/0000-0003-1639-8298; Schröder, Stefan/0000-0003-0323-8324; Palomba, Ernesto/0000-0002-9101-6774; Turrini, Diego/0000-0002-1923-7740; Sunshine, Jessica/0000-0002-9413-8785; Reddy, Vishnu/0000-0002-7743-3491; Longobardo, Andrea/0000-0002-1797-2741; Le Corre, Lucille/0000-0003-0349-7932; Capaccioni, Fabrizio/0000-0003-1631-4314; capria, maria teresa/0000-0002-9814-9588; Li, Jian-Yang/0000-0003-3841-9977	NASA Dawn Project under UCLA; NASA Dawn at Vesta Participating Scientist program; Italian Space Agency; Max Planck Institute for Solar System Research; Germany Aerospace Agency (DLR)	NASA Dawn Project under UCLA; NASA Dawn at Vesta Participating Scientist program; Italian Space Agency(Agenzia Spaziale Italiana (ASI)); Max Planck Institute for Solar System Research; Germany Aerospace Agency (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR))	This research was supported by the NASA Dawn Project under contract from UCLA, by the NASA Dawn at Vesta Participating Scientist program, the Italian Space Agency, the Max Planck Institute for Solar System Research, and the Germany Aerospace Agency (DLR). We acknowledge the support of the Dawn Science, Instrument and Operations Teams.	Beck AW, 2012, METEORIT PLANET SCI, V47, P947, DOI 10.1111/j.1945-5100.2012.01360.x; CLARK RN, 1983, J GEOPHYS RES, V88, P635, DOI 10.1029/JB088iB12p10635; Combe JP, 2008, PLANET SPACE SCI, V56, P951, DOI 10.1016/j.pss.2007.12.007; Combe J.-Ph., 2012, LUNAR PLANET SCI C, V431, P2463; Coradini A, 2011, SPACE SCI REV, V163, P25, DOI 10.1007/s11214-011-9792-x; De Sanctis MC, 2012, ASTROPHYS J LETT, V758, DOI 10.1088/2041-8205/758/2/L36; De Sanctis MC, 2012, SCIENCE, V336, P697, DOI 10.1126/science.1219270; DEGEWIJ J, 1979, ICARUS, V40, P364, DOI 10.1016/0019-1035(79)90029-0; Gibb EL, 2007, ICARUS, V188, P224, DOI 10.1016/j.icarus.2006.11.009; Jaumann R, 2012, SCIENCE, V336, P687, DOI 10.1126/science.1219122; McCord TB, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003711; MCCORD TB, 1970, SCIENCE, V168, P1445, DOI 10.1126/science.168.3938.1445; McCord Thomas B., 2006, EOS T AM GEOPHYS UN, V87, P105, DOI DOI 10.1029/2006E0100002; McSween Harry Y.  Jr., 2011, Space Science Reviews, V163, P141, DOI 10.1007/s11214-010-9637-z; Pieters CM, 2009, SCIENCE, V326, P568, DOI 10.1126/science.1178658; Prettyman TH, 2012, SCIENCE, V338, P242, DOI 10.1126/science.1225354; Reddy V, 2012, SCIENCE, V336, P700, DOI 10.1126/science.1219088; Russell CT, 2012, SCIENCE, V336, P684, DOI 10.1126/science.1219381; Russell CT, 2011, SPACE SCI REV, V163, P3, DOI 10.1007/s11214-011-9836-2; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Sunshine JM, 2006, SCIENCE, V311, P1453, DOI 10.1126/science.1123632; Zellner BH, 1997, ICARUS, V128, P83, DOI 10.1006/icar.1997.5735; Zolensky ME, 1996, METEORIT PLANET SCI, V31, P518, DOI 10.1111/j.1945-5100.1996.tb02093.x	23	134	135	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2012	491	7422					83	U93		10.1038/nature11561	http://dx.doi.org/10.1038/nature11561			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23128228				2022-12-28	WOS:000310434500034
J	Raal, FJ				Raal, Frederick J.			Lomitapide for homozygous familial hypercholesterolaemia	LANCET			English	Editorial Material							RANDOMIZED-TRIALS; LOWERING THERAPY; LDL CHOLESTEROL; PARTICIPANTS; METAANALYSIS; EFFICACY; SAFETY		Univ Witwatersrand, Fac Hlth Sci, Dept Med, Div Endocrinol & Metab, ZA-2193 Johannesburg, South Africa	University of Witwatersrand	Raal, FJ (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Med, Div Endocrinol & Metab, ZA-2193 Johannesburg, South Africa.	frederick.raal@wits.ac.za	Raal, FJ/ABD-5111-2021	Raal, FJ/0000-0002-9170-7938				Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Cuchel M, 2012, LANCET; Di Leo E, 2005, ATHEROSCLEROSIS, V180, P311, DOI 10.1016/j.athersclerosis.2004.12.004; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; Grundy SM, 2008, CIRCULATION, V117, P569, DOI 10.1161/CIRCULATIONAHA.107.720300; Raal FJ, 2012, ATHEROSCLEROSIS, V223, P262, DOI 10.1016/j.atherosclerosis.2012.02.019; Raal FJ, 2011, CIRCULATION, V124, P2202, DOI 10.1161/CIRCULATIONAHA.111.042523; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Wetterau JR, 1997, BBA-LIPID LIPID MET, V1345, P136, DOI 10.1016/S0005-2760(96)00168-3	12	22	23	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 5	2013	381	9860					7	8		10.1016/S0140-6736(12)61845-5	http://dx.doi.org/10.1016/S0140-6736(12)61845-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064AW	23122767				2022-12-28	WOS:000313044300006
J	Tonkin, AM; Watts, GF				Tonkin, Andrew M.; Watts, Gerald F.			Into the future: diversifying lipid management	LANCET			English	Editorial Material							DENSITY-LIPOPROTEIN CHOLESTEROL; FAMILIAL HYPERCHOLESTEROLEMIA; MONOCLONAL-ANTIBODY; CONTROLLED-TRIAL; LDL CHOLESTEROL; DOUBLE-BLIND; PCSK9; THERAPY; EZETIMIBE; MUTATIONS		[Tonkin, Andrew M.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Watts, Gerald F.] Univ W Australia, Sch Med & Pharmacol, Perth, WA, Australia	Monash University; University of Western Australia	Tonkin, AM (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.	andrew.tonkin@monash.edu		Watts, Gerald/0000-0003-2276-1524				Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Dias CS, 2012, J AM COLL CARDIOL, V60, P1888, DOI 10.1016/j.jacc.2012.08.986; Giugliano RP, 2012, LANCET; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Konrad RJ, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-38; Koren MJ, 2012, LANCET; McKenney JM, 2012, J AM COLL CARDIOL, V59, P2344, DOI 10.1016/j.jacc.2012.03.007; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Samaha FF, 2008, NAT CLIN PRACT CARD, V5, P497, DOI 10.1038/ncpcardio1250; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	15	3	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 8	2012	380	9858					1971	1974		10.1016/S0140-6736(12)61888-1	http://dx.doi.org/10.1016/S0140-6736(12)61888-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051KI	23141810				2022-12-28	WOS:000312124900006
J	Su, CY; Menuz, K; Reisert, J; Carlson, JR				Su, Chih-Ying; Menuz, Karen; Reisert, Johannes; Carlson, John R.			Non-synaptic inhibition between grouped neurons in an olfactory circuit	NATURE			English	Article							RECEPTOR NEURONS; DROSOPHILA-MELANOGASTER; CHEMOSENSORY RECEPTORS; BEHAVIORAL-RESPONSES; MOLECULAR-BASIS; PHEROMONE; SENSILLA; ORGANIZATION; MOTH; PERCEPTION	Diverse sensory organs, including mammalian taste buds and insect chemosensory sensilla, show a marked compartmentalization of receptor cells; however, the functional impact of this organization remains unclear. Here we show that compartmentalized Drosophila olfactory receptor neurons (ORNs) communicate with each other directly. The sustained response of one ORN is inhibited by the transient activation of a neighbouring ORN. Mechanistically, such lateral inhibition does not depend on synapses and is probably mediated by ephaptic coupling. Moreover, lateral inhibition in the periphery can modulate olfactory behaviour. Together, the results show that integration of olfactory information can occur via lateral interactions between ORNs. Inhibition of a sustained response by a transient response may provide a means of encoding salience. Finally, a CO2-sensitive ORN in the malaria mosquito Anopheles can also be inhibited by excitation of an adjacent ORN, suggesting a broad occurrence of lateral inhibition in insects and possible applications in insect control.	[Su, Chih-Ying; Menuz, Karen; Carlson, John R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Reisert, Johannes] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Yale University; Monell Chemical Senses Center	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	john.carlson@yale.edu		Menuz, Karen/0000-0001-8163-0941	National Institutes of Health (NIH) [NIH DC009613]; Foundation for the NIH through the Grand Challenges in Global Health Initiative (GCGH) [121]; NRSA [NIH F32DC011242]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009613, R01DC011697, F32DC011242, R01DC004729] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the NIH through the Grand Challenges in Global Health Initiative (GCGH); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank J. Cardin for help with establishing the optogenetics system; Y. Zhao and E. Fikrig for providing mosquitoes; A. Tzingounis and G. Lowe for suggestions; Z. Berman and P. Graham for technical assistance; T. Koh for suggestions and for sharing reagents; and G. Thomas, F. Marion-Poll, R. Wyman and D. McCormick for comments on the manuscript. This work was funded by National Institutes of Health (NIH) grants to J. R. C. and by a grant from the Foundation for the NIH through the Grand Challenges in Global Health Initiative (GCGH no. 121); an NRSA postdoctoral fellowship to K. M. (NIH F32DC011242); and an NIH grant to J. R. (NIH DC009613).	Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; AKERS RP, 1988, J COMP PHYSIOL A, V163, P641, DOI 10.1007/BF00603848; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; BERG BG, 1995, J COMP PHYSIOL A, V177, P683, DOI 10.1007/BF00187627; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Brito Sanchez MG, 2005, EUR J NEUROSCI, V22, P3161, DOI 10.1111/j.1460-9568.2005.04516.x; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DETHIER VG, 1989, PHYSIOL ENTOMOL, V14, P127, DOI 10.1111/j.1365-3032.1989.tb00944.x; FABER DS, 1989, PHYSIOL REV, V69, P821, DOI 10.1152/physrev.1989.69.3.821; Gaffin DD, 2002, MICROSC RES TECHNIQ, V58, P325, DOI 10.1002/jemt.10140; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Jorgensen K, 2007, CHEM SENSES, V32, P863, DOI 10.1093/chemse/bjm057; Kaissling KE, 1996, CHEM SENSES, V21, P257, DOI 10.1093/chemse/21.2.257; KAISSLING KE, 1986, ANNU REV NEUROSCI, V9, P121, DOI 10.1146/annurev.ne.09.030186.001005; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; KEIL TA, 1984, ZOOMORPHOLOGY, V104, P147, DOI 10.1007/BF00312133; Keller A, 2002, J NEUROBIOL, V50, P221, DOI 10.1002/neu.10029; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Martin JP, 2011, PROG NEUROBIOL, V95, P427, DOI 10.1016/j.pneurobio.2011.09.007; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; MITCHELL BK, 1987, J CHEM ECOL, V13, P2009, DOI 10.1007/BF01041728; Nagel KI, 2011, NAT NEUROSCI, V14, P208, DOI 10.1038/nn.2725; Nikonov AA, 2002, J CHEM ECOL, V28, P1075, DOI 10.1023/A:1015274104626; OCONNELL RJ, 1985, J COMP PHYSIOL A, V156, P747, DOI 10.1007/BF00610828; Pellegrino Maurizio, 2010, J Vis Exp, P1, DOI 10.3791/1725; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; Schoonhoven LM, 2002, ACTA ZOOL ACAD SCI H, V48, P215; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Shanbhag SR, 2000, ARTHROPOD STRUCT DEV, V29, P211, DOI 10.1016/S1467-8039(00)00028-1; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Su CY, 2011, P NATL ACAD SCI USA, V108, P5075, DOI 10.1073/pnas.1100369108; Su CY, 2009, CELL, V139, P45, DOI 10.1016/j.cell.2009.09.015; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Takanashi T, 2006, J EXP BIOL, V209, P4946, DOI 10.1242/jeb.02587; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vermeulen A, 2004, EUR BIOPHYS J BIOPHY, V33, P633, DOI 10.1007/s00249-004-0405-4; Yaksi E, 2010, NEURON, V67, P1034, DOI 10.1016/j.neuron.2010.08.041; Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793	50	141	147	1	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					66	+		10.1038/nature11712	http://dx.doi.org/10.1038/nature11712			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23172146	Green Accepted, Green Submitted			2022-12-28	WOS:000311893400046
J	Leone, M				Leone, Marc			Prevention of CAUTI: simple is beautiful	LANCET			English	Editorial Material							URINARY-TRACT-INFECTIONS; HOSPITALIZED-PATIENTS; CATHETER; DRAINAGE; SYSTEMS		Aix Marseille Univ, Assistance Publ Hop Marseille, Hop Nord, Serv Anesthesie & Reanimat, F-13915 Marseille 20, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Leone, M (corresponding author), Aix Marseille Univ, Assistance Publ Hop Marseille, Hop Nord, Serv Anesthesie & Reanimat, F-13915 Marseille 20, France.	marc.leone@ap-hm.fr	Leone, Marc/P-4835-2016	Leone, Marc/0000-0002-3097-758X				Audard V, 2003, INTENS CARE MED, V29, P1376, DOI 10.1007/s00134-003-1865-1; Chant C, 2011, CRIT CARE MED, V39, P1167, DOI 10.1097/CCM.0b013e31820a8581; Foley FEB, 1937, J UROLOGY, V38, P140, DOI 10.1016/S0022-5347(17)71936-2; Hong T, 2005, CLIN INFECT DIS, V40, pE84, DOI 10.1086/429822; Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482; Johnson JR, 2006, ANN INTERN MED, V144, P116, DOI 10.7326/0003-4819-144-2-200601170-00009; KUNIN CM, 1966, NEW ENGL J MED, V274, P1155, DOI 10.1056/NEJM196605262742101; Lebovici L, 2009, INFECT DIS CLIN N AM, V23, P181, DOI 10.1016/j.idc.2009.01.002; Leone M, 2003, INTENS CARE MED, V29, P410, DOI 10.1007/s00134-003-1644-z; Meddings J, 2010, CLIN INFECT DIS, V51, P550, DOI 10.1086/655133; Pickard R, 2012, LANCET; Schumm K, 2008, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD004013.pub1, DOI 10.1002/14651858.CD004013.PUB1]; Umscheid CA, 2011, INFECT CONT HOSP EP, V32, P101, DOI 10.1086/657912	13	5	5	1	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2012	380	9857					1891	1892		10.1016/S0140-6736(12)61515-3	http://dx.doi.org/10.1016/S0140-6736(12)61515-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	046IK	23134836				2022-12-28	WOS:000311758500008
J	Ackermann, M; Ajello, M; Allafort, A; Schady, P; Baldini, L; Ballet, J; Barbiellini, G; Bastieri, D; Bellazzini, R; Blandford, RD; Bloom, ED; Borgland, AW; Bottacini, E; Bouvier, A; Bregeon, J; Brigida, M; Bruel, P; Buehler, R; Buson, S; Caliandro, GA; Cameron, RA; Caraveo, PA; Cavazzuti, E; Cecchi, C; Charles, E; Chaves, RCG; Chekhtman, A; Cheung, CC; Chiang, J; Chiaro, G; Ciprini, S; Claus, R; Cohen-Tanugi, J; Conrad, J; Cutini, S; D'Ammando, F; de Palma, F; Dermer, CD; Digel, SW; Silva, EDE; Domnguez, A; Drell, PS; Drlica-Wagner, A; Favuzzi, C; Fegan, SJ; Focke, WB; Franckowiak, A; Fukazawa, Y; Funk, S; Fusco, P; Gargano, F; Gasparrini, D; Gehrels, N; Germani, S; Giglietto, N; Giordano, F; Giroletti, M; Glanzman, T; Godfrey, G; Grenier, IA; Grove, JE; Guiriec, S; Gustafsson, M; Hadasch, D; Hayashida, M; Hays, E; Jackson, MS; Jogler, T; Kataoka, J; Knodlseder, J; Kuss, M; Lande, J; Larsson, S; Latronico, L; Longo, F; Loparco, F; Lovellette, MN; Lubrano, P; Mazziotta, MN; McEnery, JE; Mehault, J; Michelson, PF; Mizuno, T; Monte, C; Monzani, ME; Morselli, A; Moskalenko, IV; Murgia, S; Tramacere, A; Nuss, E; Greiner, J; Ohno, M; Ohsugi, T; Omodei, N; Orienti, M; Orlando, E; Ormes, JF; Paneque, D; Perkins, JS; Pesce-Rollins, M; Piron, F; Pivato, G; Porter, TA; Raino, S; Rando, R; Razzano, M; Razzaque, S; Reimer, A; Reimer, O; Reyes, LC; Ritz, S; Rau, A; Romoli, C; Roth, M; Sanchez-Conde, M; Sanchez, DA; Scargle, JD; Sgro, C; Siskind, EJ; Spandre, G; Spinelli, P; Stawarz, L; Suson, DJ; Takahashi, H; Tanaka, T; Thayer, JG; Thompson, DJ; Tibaldo, L; Tinivella, M; Torres, DF; Tosti, G; Troja, E; Usher, TL; Vandenbroucke, J; Vasileiou, V; Vianello, G; Vitale, V; Waite, AP; Winer, BL; Wood, KS; Wood, M				Ackermann, M.; Ajello, M.; Allafort, A.; Schady, P.; Baldini, L.; Ballet, J.; Barbiellini, G.; Bastieri, D.; Bellazzini, R.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Bottacini, E.; Bouvier, A.; Bregeon, J.; Brigida, M.; Bruel, P.; Buehler, R.; Buson, S.; Caliandro, G. A.; Cameron, R. A.; Caraveo, P. A.; Cavazzuti, E.; Cecchi, C.; Charles, E.; Chaves, R. C. G.; Chekhtman, A.; Cheung, C. C.; Chiang, J.; Chiaro, G.; Ciprini, S.; Claus, R.; Cohen-Tanugi, J.; Conrad, J.; Cutini, S.; D'Ammando, F.; de Palma, F.; Dermer, C. D.; Digel, S. W.; do Couto e Silva, E.; Domnguez, A.; Drell, P. S.; Drlica-Wagner, A.; Favuzzi, C.; Fegan, S. J.; Focke, W. B.; Franckowiak, A.; Fukazawa, Y.; Funk, S.; Fusco, P.; Gargano, F.; Gasparrini, D.; Gehrels, N.; Germani, S.; Giglietto, N.; Giordano, F.; Giroletti, M.; Glanzman, T.; Godfrey, G.; Grenier, I. A.; Grove, J. E.; Guiriec, S.; Gustafsson, M.; Hadasch, D.; Hayashida, M.; Hays, E.; Jackson, M. S.; Jogler, T.; Kataoka, J.; Knoedlseder, J.; Kuss, M.; Lande, J.; Larsson, S.; Latronico, L.; Longo, F.; Loparco, F.; Lovellette, M. N.; Lubrano, P.; Mazziotta, M. N.; McEnery, J. E.; Mehault, J.; Michelson, P. F.; Mizuno, T.; Monte, C.; Monzani, M. E.; Morselli, A.; Moskalenko, I. V.; Murgia, S.; Tramacere, A.; Nuss, E.; Greiner, J.; Ohno, M.; Ohsugi, T.; Omodei, N.; Orienti, M.; Orlando, E.; Ormes, J. F.; Paneque, D.; Perkins, J. S.; Pesce-Rollins, M.; Piron, F.; Pivato, G.; Porter, T. A.; Raino, S.; Rando, R.; Razzano, M.; Razzaque, S.; Reimer, A.; Reimer, O.; Reyes, L. C.; Ritz, S.; Rau, A.; Romoli, C.; Roth, M.; Sanchez-Conde, M.; Sanchez, D. A.; Scargle, J. D.; Sgro, C.; Siskind, E. J.; Spandre, G.; Spinelli, P.; Stawarz, Lukasz; Suson, D. J.; Takahashi, H.; Tanaka, T.; Thayer, J. G.; Thompson, D. J.; Tibaldo, L.; Tinivella, M.; Torres, D. F.; Tosti, G.; Troja, E.; Usher, T. L.; Vandenbroucke, J.; Vasileiou, V.; Vianello, G.; Vitale, V.; Waite, A. P.; Winer, B. L.; Wood, K. S.; Wood, M.			The Imprint of the Extragalactic Background Light in the Gamma-Ray Spectra of Blazars	SCIENCE			English	Article							1ST STARS; RADIATIVE-TRANSFER; UNIVERSE; REDSHIFT; REIONIZATION; ABSORPTION; EVOLUTION; FEEDBACK; CATALOG; OPACITY	The light emitted by stars and accreting compact objects through the history of the universe is encoded in the intensity of the extragalactic background light (EBL). Knowledge of the EBL is important to understand the nature of star formation and galaxy evolution, but direct measurements of the EBL are limited by galactic and other foreground emissions. Here, we report an absorption feature seen in the combined spectra of a sample of gamma-ray blazars out to a redshift of z similar to 1.6. This feature is caused by attenuation of gamma rays by the EBL at optical to ultraviolet frequencies and allowed us to measure the EBL flux density in this frequency band.	[Ajello, M.; Allafort, A.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Bottacini, E.; Buehler, R.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Drlica-Wagner, A.; Focke, W. B.; Franckowiak, A.; Funk, S.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Jogler, T.; Lande, J.; Michelson, P. F.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Omodei, N.; Orlando, E.; Paneque, D.; Porter, T. A.; Reimer, A.; Reimer, O.; Sanchez-Conde, M.; Tanaka, T.; Thayer, J. G.; Usher, T. L.; Vandenbroucke, J.; Vianello, G.; Waite, A. P.; Wood, M.] Stanford Univ, Dept Phys, Kavli Inst Particle Astrophys & Cosmol, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA; [Ajello, M.; Allafort, A.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Bottacini, E.; Buehler, R.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Drlica-Wagner, A.; Focke, W. B.; Franckowiak, A.; Funk, S.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Jogler, T.; Lande, J.; Michelson, P. F.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Omodei, N.; Orlando, E.; Paneque, D.; Porter, T. A.; Reimer, A.; Reimer, O.; Sanchez-Conde, M.; Tanaka, T.; Thayer, J. G.; Usher, T. L.; Vandenbroucke, J.; Vianello, G.; Waite, A. P.; Wood, M.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Ackermann, M.] Deutsch Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany; [Ajello, M.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Schady, P.; Greiner, J.; Rau, A.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Baldini, L.] Univ Pisa, I-56127 Pisa, Italy; [Baldini, L.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Ballet, J.; Chaves, R. C. G.; Grenier, I. A.] Univ Paris Diderot, CNRS, CEA IRFU, Lab AIM,Serv Astrophys,CEA Saclay, F-91191 Gif Sur Yvette, France; [Barbiellini, G.; Longo, F.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Barbiellini, G.; Longo, F.] Univ Trieste, Dipartmento Fis, I-34127 Trieste, Italy; [Bastieri, D.; Buson, S.; Gustafsson, M.; Rando, R.; Tibaldo, L.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Bastieri, D.; Buson, S.; Pivato, G.; Rando, R.; Romoli, C.; Tibaldo, L.] Univ Padua, Dipartimento Fis & Astron G Galilei, I-35131 Padua, Italy; [Bellazzini, R.; Bregeon, J.; Kuss, M.; Pesce-Rollins, M.; Razzano, M.; Sgro, C.; Spandre, G.; Tinivella, M.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Bouvier, A.; Domnguez, A.; Porter, T. A.; Razzano, M.; Ritz, S.] Univ Calif Santa Cruz, Dept Phys, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Bouvier, A.; Domnguez, A.; Porter, T. A.; Razzano, M.; Ritz, S.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Univ Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Politecn Bari, I-70126 Bari, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Gargano, F.; Giglietto, N.; Giordano, F.; Loparco, F.; Mazziotta, M. N.; Monte, C.; Raino, S.; Spinelli, P.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Bruel, P.; Fegan, S. J.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Caliandro, G. A.; Hadasch, D.; Torres, D. F.] CSIC, IEEE, Inst Ciencies Espai, Barcelona 08193, Spain; [Caraveo, P. A.] INAF Ist Astrofis Spaziale & Fis Cosm, I-20133 Milan, Italy; [Cavazzuti, E.; Cutini, S.; Gasparrini, D.] Agenzia Spaziale Italiana ASI Sci Data Ctr, I-00044 Rome, Italy; [Cecchi, C.; D'Ammando, F.; Germani, S.; Lubrano, P.; Tosti, G.] Ist Nazl Fis Nucl, Sez Perugia, I-06123 Perugia, Italy; [Cecchi, C.; Ciprini, S.; Germani, S.; Lubrano, P.; Tosti, G.] Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy; [Chekhtman, A.; Razzaque, S.] George Mason Univ, Coll Sci, Ctr Earth Observing & Space Res, Fairfax, VA 22030 USA; [Cheung, C. C.] Natl Acad Sci, Natl Res Council, Washington, DC 20001 USA; [Chiaro, G.] Univ Padua, Ist Nazl Fis Nucl, I-35131 Padua, Italy; [Chiaro, G.] Univ Padua, Dipartimento Fis & Astron G Galilei, I-35131 Padua, Italy; [Ciprini, S.] ASI Sci Data Ctr, I-00044 Rome, Italy; [Cohen-Tanugi, J.; Mehault, J.; Nuss, E.; Piron, F.; Vasileiou, V.] Univ Montpellier 2, CNRS, IN2P3, Lab Universe & Particules Montpellier, Montpellier, France; [Conrad, J.; Larsson, S.] Stockholm Univ, Dept Phys, AlbaNova, SE-10691 Stockholm, Sweden; [Conrad, J.; Jackson, M. S.; Larsson, S.] Oskar Klein Ctr Cosmoparticle Phys, AlbaNova, SE-10691 Stockholm, Sweden; [Conrad, J.] Royal Swedish Acad Sci Res, SE-10691 Stockholm, Sweden; [D'Ammando, F.] IASF Palermo, I-90146 Palermo, Italy; [D'Ammando, F.] INAF Ist Astrofis Spaziale & Fis Cosm, I-00133 Rome, Italy; [Dermer, C. D.; Grove, J. E.; Lovellette, M. N.; Wood, K. S.] USN, Res Lab, Div Space Sci, Washington, DC 20375 USA; [Fukazawa, Y.; Takahashi, H.] Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan; [Gehrels, N.; Guiriec, S.; Hays, E.; McEnery, J. E.; Perkins, J. S.; Thompson, D. J.; Troja, E.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Giroletti, M.; Orienti, M.] INAF Ist Radioastron, I-40129 Bologna, Italy; [Hayashida, M.] Kyoto Univ, Grad Sch Sci, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Jackson, M. S.] Royal Inst Technol KTH, Dept Phys, AlbaNova, SE-10691 Stockholm, Sweden; [Kataoka, J.] Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Knoedlseder, J.] IRAP, CNRS, F-31028 Toulouse 4, France; [Knoedlseder, J.] Univ Toulouse, UPS OMP, IRAP, GAHEC, Toulouse, France; [Larsson, S.] Stockholm Univ, Dept Astron, SE-10691 Stockholm, Sweden; [Latronico, L.] Ist Nazl Fis Nucl, Sez Torino, I-10125 Turin, Italy; [McEnery, J. E.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [McEnery, J. E.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Mizuno, T.; Ohsugi, T.] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan; [Morselli, A.; Vitale, V.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Tramacere, A.] INTEGRAL Sci Data Ctr, CH-1290 Versoix, Switzerland; [Ohno, M.; Stawarz, Lukasz] JAXA, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Ormes, J. F.] Univ Denver, Dept Phys & Astron, Denver, CO 80208 USA; [Paneque, D.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; [Perkins, J. S.] Univ Maryland Baltimore Cty, Dept Phys, Baltimore, MD 21250 USA; [Perkins, J. S.] Univ Maryland Baltimore Cty, Ctr Space Sci & Technol, Baltimore, MD 21250 USA; [Perkins, J. S.] CRESST, Greenbelt, MD 20771 USA; [Perkins, J. S.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Perkins, J. S.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Astro & Teilchenphys, A-6020 Innsbruck, Austria; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Reyes, L. C.] Calif Polytech State Univ San Luis Obispo, Dept Phys, San Luis Obispo, CA 93401 USA; [Roth, M.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Sanchez, D. A.] Max Planck Inst Kernphys, D-69029 Heidelberg, Germany; [Scargle, J. D.] NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; [Siskind, E. J.] NYCB Real Time Comp Inc, Lattingtown, NY 11560 USA; [Stawarz, Lukasz] Jagiellonian Univ, Astron Observ, PL-30244 Krakow, Poland; [Suson, D. J.] Purdue Univ Calumet, Dept Chem & Phys, Hammond, IN 46323 USA; [Torres, D. F.] ICREA, Barcelona, Spain; [Vianello, G.] CIFS, I-10133 Turin, Italy; [Vitale, V.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Winer, B. L.] Ohio State Univ, Dept Phys, Ctr Cosmol & Astroparticle Phys, Columbus, OH 43210 USA	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of California System; University of California Berkeley; Max Planck Society; University of Pisa; Istituto Nazionale di Fisica Nucleare (INFN); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Universita degli Studi di Bari Aldo Moro; Politecnico di Bari; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Istituto Nazionale Astrofisica (INAF); Agenzia Spaziale Italiana (ASI); Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; George Mason University; National Academies of Sciences, Engineering & Medicine; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; University of Padua; Agenzia Spaziale Italiana (ASI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; Stockholm University; Oskar Klein Centre; Royal Swedish Academy of Sciences; Istituto Nazionale Astrofisica (INAF); United States Department of Defense; United States Navy; Naval Research Laboratory; Hiroshima University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Istituto Nazionale Astrofisica (INAF); Kyoto University; Royal Institute of Technology; Waseda University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Stockholm University; Istituto Nazionale di Fisica Nucleare (INFN); University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Hiroshima University; Istituto Nazionale di Fisica Nucleare (INFN); University of Geneva; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of Denver; Max Planck Society; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Innsbruck; University of Innsbruck; California State University System; California Polytechnic State University San Luis Obispo; University of Washington; University of Washington Seattle; Max Planck Society; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Jagiellonian University; Purdue University System; Purdue University; ICREA; University of Rome Tor Vergata; University System of Ohio; Ohio State University	Ajello, M (corresponding author), Stanford Univ, Dept Phys, Kavli Inst Particle Astrophys & Cosmol, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA.	majello@slac.stanford.edu; buehler@stanford.edu; anita.reimer@uibk.ac.at	Gasparrini, Dario/X-6699-2019; Reimer, Olaf/A-3117-2013; Gargano, Fabio/O-8934-2015; Sgrò, Carmelo/K-3395-2016; Torres, Diego F./O-9422-2016; Fukazawa, Yasushi/G-2081-2017; Rando, Riccardo/M-7179-2013; Caraveo, Patrizia/AAL-5708-2020; Rando, Riccardo/O-1302-2019; Morselli, Aldo/G-6769-2011; Gargano, Fabio/AAD-5121-2021; Tosti, Gino/E-9976-2013; cohen-tanugi, Johann/ABB-1481-2021; Loparco, Francesco/O-8847-2015; Troja, Eleonora/AAB-3604-2020; Giglietto, Nicola/Y-2425-2019; Bastieri, Denis/AAC-5917-2020; Funk, Stefan/B-7629-2015; tramacere, andrea/B-9424-2012; Mazziotta, Mario N/O-8867-2015; giglietto, nicola/I-8951-2012; Torres, Diego F/ABD-7940-2020; Reimer, Anita/K-5822-2015; Cutini, Sara/ABB-1787-2020; Takahashi, Hiromitsu H/T-2713-2017; Dominguez, Alberto/J-4429-2016; Torres, Diego F./AAF-7931-2019; Funk, Stefan/AAI-1568-2021; Hays, Elizabeth/D-3257-2012; Moskalenko, Igor V/A-1301-2007; Troja, Eleonora/I-5282-2017; Orlando, Elena/R-5594-2016; Hadasch, Daniela/N-7819-2016	Gasparrini, Dario/0000-0002-5064-9495; Reimer, Olaf/0000-0001-6953-1385; Gargano, Fabio/0000-0002-5055-6395; Torres, Diego F./0000-0002-1522-9065; Fukazawa, Yasushi/0000-0002-0921-8837; Caraveo, Patrizia/0000-0003-2478-8018; Rando, Riccardo/0000-0001-6992-818X; Morselli, Aldo/0000-0002-7704-9553; Gargano, Fabio/0000-0002-5055-6395; cohen-tanugi, Johann/0000-0001-9022-4232; Loparco, Francesco/0000-0002-1173-5673; Troja, Eleonora/0000-0002-1869-7817; Giglietto, Nicola/0000-0002-9021-2888; Bastieri, Denis/0000-0002-6954-8862; Funk, Stefan/0000-0002-2012-0080; tramacere, andrea/0000-0002-8186-3793; Mazziotta, Mario N/0000-0001-9325-4672; giglietto, nicola/0000-0002-9021-2888; Reimer, Anita/0000-0001-8604-7077; Cutini, Sara/0000-0002-1271-2924; Takahashi, Hiromitsu H/0000-0001-6314-5897; Dominguez, Alberto/0000-0002-3433-4610; Torres, Diego F./0000-0002-1522-9065; Funk, Stefan/0000-0002-2012-0080; Moskalenko, Igor V/0000-0001-6141-458X; Troja, Eleonora/0000-0002-1869-7817; Orlando, Elena/0000-0001-6406-9910; Hadasch, Daniela/0000-0001-8663-6461; Sgro', Carmelo/0000-0001-5676-6214; Monzani, Maria Elena/0000-0002-8254-5308; Fusco, Piergiorgio/0000-0002-9383-2425; Baldini, Luca/0000-0002-9785-7726; Porter, Troy/0000-0002-2621-4440; Ciprini, Stefano/0000-0002-0712-2479; Buson, Sara/0000-0002-3308-324X; Sanchez-Conde, Miguel/0000-0002-3849-9164; SANCHEZ, David/0000-0002-7210-4496; Buehler, Rolf/0000-0003-4425-6641; Charles, Eric/0000-0002-3925-7802; Vianello, Giacomo/0000-0002-2553-0839; Larsson, Stefan/0000-0003-0716-107X; de Palma, Francesco/0000-0001-5898-2834; Omodei, Nicola/0000-0002-5448-7577; Grenier, Isabelle/0000-0003-3274-674X; Spandre, Gloria/0000-0003-0802-3453; Tibaldo, Luigi/0000-0001-7523-570X; Ackermann, Markus/0000-0001-8952-588X; Pesce-Rollins, Melissa/0000-0003-1790-8018; Tanaka, Takaaki/0000-0002-4383-0368; Romoli, Carlo/0000-0003-2541-4499; Raino', Silvia/0000-0002-9181-0345; SPINELLI, Paolo/0000-0001-6688-8864; orienti, monica/0000-0003-4470-7094; Cameron, Robert/0000-0003-0942-2747; Cavazzuti, Elisabetta/0000-0001-7150-9638; Razzaque, Soebur/0000-0002-0130-2460; Ajello, Marco/0000-0002-6584-1703; Cheung, Chi (Teddy)/0000-0002-4377-0174; D'Ammando, Filippo/0000-0001-7618-7527; Cecchi, Claudia/0000-0002-2192-8233; RAZZANO, MASSIMILIANO/0000-0003-4825-1629; Giroletti, Marcello/0000-0002-8657-8852; Tosti, Gino/0000-0002-0839-4126; Murgia, Simona/0000-0003-0516-9422; Schady, Patricia/0000-0002-1214-770X	K. A. Wallenberg Foundation; Fermi guest investigator program [31117, 51258]; ICREA Funding Source: Custom	K. A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Fermi guest investigator program; ICREA(ICREA)	M. A. acknowledges generous support from the Fermi guest investigator program (proposals ID 31117 and 51258) and the Swift and the Gamma-Ray Burst Optical/Near-Infrared Detector (GROND) teams for observing similar to 100 Fermi blazars in an effort to constrain their redshifts. The Fermi LAT Collaboration acknowledges generous ongoing support from a number of agencies and institutes that have supported both the development and the operation of the LAT as well as scientific data analysis. These include the National Aeronautics and Space Administration and the Department of Energy in the United States; the Commissariat a l'Energie Atomique and the Centre National de la Recherche Scientifique/Institut National de Physique Nucleaire et de Physique des Particules in France; the Agenzia Spaziale Italiana and the Istituto Nazionale di Fisica Nucleare in Italy; the Ministry of Education, Culture, Sports, Science and Technology (MEXT), High Energy Accelerator Research Organization (KEK), and Japan Aerospace Exploration Agency (JAXA) in Japan; and the K. A. Wallenberg Foundation, the Swedish Research Council, and the Swedish National Space Board in Sweden. Additional support for science analysis during the operations phase is gratefully acknowledged from the Istituto Nazionale di Astrofisica in Italy and the Centre National d'Etudes Spatiales in France. J. Conrad is funded by a grant from the K. A. Wallenberg Foundation. E. Troja is a NASA Postdoctoral Program Fellow.	Abdo AA, 2010, ASTROPHYS J, V723, P1082, DOI 10.1088/0004-637X/723/2/1082; Ackermann M, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/171; Aharonian F, 2006, NATURE, V440, P1018, DOI 10.1038/nature04680; Albert J, 2008, SCIENCE, V320, P1752, DOI 10.1126/science.1157087; BOWYER S, 1991, ANNU REV ASTRON ASTR, V29, P59; Bromm V, 2004, ANNU REV ASTRON ASTR, V42, P79, DOI 10.1146/annurev.astro.42.053102.134034; Bromm V, 2002, ASTROPHYS J, V575, P111, DOI 10.1086/341189; Dominguez A, 2011, MON NOT R ASTRON SOC, V410, P2556, DOI 10.1111/j.1365-2966.2010.17631.x; Fan XH, 2006, ASTRON J, V132, P117, DOI 10.1086/504836; FAZIO GG, 1970, NATURE, V226, P135, DOI 10.1038/226135a0; Finke JD, 2010, ASTROPHYS J, V712, P238, DOI 10.1088/0004-637X/712/1/238; Franceschini A, 2008, ASTRON ASTROPHYS, V487, P837, DOI 10.1051/0004-6361:200809691; Gardner JP, 2000, ASTROPHYS J, V542, pL79, DOI 10.1086/312930; Ghisellini G, 1998, MON NOT R ASTRON SOC, V301, P451, DOI 10.1046/j.1365-8711.1998.02032.x; Ghisellini G, 2009, MON NOT R ASTRON SOC, V396, pL105, DOI 10.1111/j.1745-3933.2009.00673.x; Gilmore R. C., 2011, ARXIV11090592; Gilmore RC, 2012, MON NOT R ASTRON SOC, V422, P3189, DOI 10.1111/j.1365-2966.2012.20841.x; Gilmore RC, 2009, MON NOT R ASTRON SOC, V399, P1694, DOI 10.1111/j.1365-2966.2009.15392.x; GOULD RJ, 1966, PHYS REV LETT, V16, P252, DOI 10.1103/PhysRevLett.16.252; Greif TH, 2007, ASTROPHYS J, V670, P1, DOI 10.1086/522028; Haardt F, 1996, ASTROPHYS J, V461, P20, DOI 10.1086/177035; Hartmann DH, 2007, AIP CONF PROC, V921, P24; Inoue S, 2010, MON NOT R ASTRON SOC, V404, P1938, DOI 10.1111/j.1365-2966.2010.16414.x; Kashlinsky A, 2007, AIP CONF PROC, V921, P243; Kneiske TM, 2010, ASTRON ASTROPHYS, V515, DOI 10.1051/0004-6361/200912000; Kneiske TM, 2004, ASTRON ASTROPHYS, V413, P807, DOI 10.1051/0004-6361:20031542; Mannheim K, 1996, ASTRON ASTROPHYS, V315, P77; Mazin D, 2007, ASTRON ASTROPHYS, V471, P439, DOI 10.1051/0004-6361:20077158; Meyer ET, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/98; Nolan P., 2011, ARXIV11081435; Ostriker JP, 1996, ASTROPHYS J, V472, pL63, DOI 10.1086/310375; Rau A, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201118159; Raue M, 2010, ASTRON ASTROPHYS, V520, DOI 10.1051/0004-6361/201014915; Raue M, 2009, ASTRON ASTROPHYS, V498, P25, DOI 10.1051/0004-6361/200810396; Reimer A, 2007, ASTROPHYS J, V665, P1023, DOI 10.1086/519766; Santos MR, 2002, MON NOT R ASTRON SOC, V336, P1082, DOI 10.1046/j.1365-8711.2002.05895.x; Scott J, 2000, ASTROPHYS J SUPPL S, V130, P67, DOI 10.1086/317340; Stecker FW, 2007, AIP CONF PROC, V921, P237; Stecker FW, 2006, ASTROPHYS J, V648, P774, DOI 10.1086/506188; Stecker F. W., 2012, ARXIV12055168; STECKER FW, 1992, ASTROPHYS J, V390, pL49, DOI 10.1086/186369; Tornatore L, 2007, MON NOT R ASTRON SOC, V382, P945, DOI 10.1111/j.1365-2966.2007.12215.x; Wise JH, 2008, ASTROPHYS J, V685, P40, DOI 10.1086/590417	45	187	190	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1190	1192		10.1126/science.1227160	http://dx.doi.org/10.1126/science.1227160			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23118013	Green Submitted			2022-12-28	WOS:000311666200040
J	Qaseem, A; Fihn, SD; Dallas, P; Williams, S; Owens, DK; Shekelle, P				Qaseem, Amir; Fihn, Stephan D.; Dallas, Paul; Williams, Sankey; Owens, Douglas K.; Shekelle, Paul		Amer Coll Phys	Management of Stable Ischemic Heart Disease: Summary of a Clinical Practice Guideline From the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; LEFT-VENTRICULAR DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; LONG-TERM SURVIVAL; OPTIMAL MEDICAL THERAPY; IN-HOSPITAL MORTALITY; INDIVIDUAL ANTIRETROVIRAL DRUGS; CONVERTING-ENZYME-INHIBITORS; SUSTAINED-RELEASE BUPROPION; RECEPTOR PARTIAL AGONIST	Description: The American College of Physicians (ACP) developed this guideline with the American College of Cardiology Foundation (ACCF), American Heart Association (AHA), American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, and Society of Thoracic Surgeons to present the available evidence on the management of stable known or suspected ischemic heart disease. Methods: Literature on this topic published before November 2011 was identified by using MEDLINE, Embase, Cochrane CENTRAL, PsychINFO, AMED, and SCOPUS. Searches were limited to human studies published in English. This guideline grades the evidence and recommendations according to a translation of the ACCF/AHA grading system into ACP's clinical practice guidelines grading system. Recommendations: The guideline includes 48 specific recommendations that address the following issues: patient education, management of proven risk factors (dyslipidemia, hypertension, diabetes, physical activity body weight, and smoking), risk factor reduction strategies of unproven benefit, medical therapy to prevent myocardial infarction and death and to relieve symptoms, alternative therapy, revascularization to improve survival and symptoms, and patient follow-up. Ann Intern Med. 2012;157:735-743.	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Univ Penn, Philadelphia, PA 19104 USA; Dept Vet Affairs, Seattle, WA USA; Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA USA; Stanford Univ, Stanford, CA 94305 USA; Virginia Tech Caril Sch Med, Roanoke, VA USA; W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA	American College of Physicians; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org	Fihn, Stephan/ABA-1040-2020		ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Abrams J, 2003, ORGANIC NITRATES NIT; ALDERMAN EL, 1983, CIRCULATION, V68, P785, DOI 10.1161/01.CIR.68.4.785; ALDERMAN EL, 1993, J AM COLL CARDIOL, V22, P1141, DOI 10.1016/0735-1097(93)90429-5; Alter DA, 2004, JAMA-J AM MED ASSOC, V291, P1100, DOI 10.1001/jama.291.9.1100; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; American Academy of Family Physicians (AAFP), 2000, AM FAM PHYSICIAN, V62, P1712; Anand SS, 2003, J AM COLL CARDIOL, V41, p62S, DOI 10.1016/S0735-1097(02)02776-6; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 2004, N S W Public Health Bull, V15, P107; [Anonymous], 1982, NEW ENGL J MED, V307, P976; [Anonymous], 2005, Wkly Epidemiol Rec, V80, P277; [Anonymous], 1984, HYPERTENSION, V6, pI198; Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Aubry MC, 2007, J RHEUMATOL, V34, P937; Avendano M, 2006, HEART, V92, P461, DOI 10.1136/hrt.2005.065532; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; BALL SG, 1993, LANCET, V342, P821; BALSANO F, 1990, CIRCULATION, V82, P17, DOI 10.1161/01.CIR.82.1.17; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Berman DS, 2006, J NUCL CARDIOL, V13, P191, DOI 10.1016/j.nuclcard.2006.01.020; Bernheim AM, 2011, AM HEART J, V161, P740, DOI 10.1016/j.ahj.2010.12.017; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Boekholdt SM, 2001, CIRCULATION, V104, P3063, DOI 10.1161/hc5001.100793; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; BOMAN K, 1995, EUR J CLIN PHARMACOL, V49, P27; Bosworth HB, 2007, CONTEMP CLIN TRIALS, V28, P33, DOI 10.1016/j.cct.2006.08.006; Bottcher M, 2002, AM J CARDIOL, V89, P1019, DOI 10.1016/S0002-9149(02)02268-3; Bouzas-Mosquera A, 2010, EUR J CLIN INVEST, V40, P1122, DOI 10.1111/j.1365-2362.2010.02365.x; Bozzette SA, 2003, NEW ENGL J MED, V348, P702, DOI 10.1056/NEJMoa022048; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Bravata DM, 2007, ANN INTERN MED, V147, P703, DOI 10.7326/0003-4819-147-10-200711200-00185; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brogden RN, 1996, DRUGS, V51, P792, DOI 10.2165/00003495-199651050-00007; Brosius FC, 2006, CIRCULATION, V114, P1083, DOI 10.1161/CIRCULATIONAHA.106.177321; Bugiardini R, 2005, JAMA-J AM MED ASSOC, V293, P477, DOI 10.1001/jama.293.4.477; Buse JB, 2007, DIABETES CARE, V30, P162, DOI 10.2337/dc07-9917; Buszman PE, 2008, J AM COLL CARDIOL, V51, P538, DOI 10.1016/j.jacc.2007.09.054; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cecil WT, 2008, AM J MANAG CARE, V14, P521; Centers for Medicare & Medicaid Services, 2008, MED MED STAT SUPPL; Chae C, 1999, BETABLOCKERS; Chaitman BR, 2004, J AM COLL CARDIOL, V43, P1375, DOI 10.1016/j.jacc.2003.11.045; Chaitman BR, 2004, JAMA-J AM MED ASSOC, V291, P309, DOI 10.1001/jama.291.3.309; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clark AM, 2009, NAT REV CARDIOL, V6, P712, DOI 10.1038/nrcardio.2009.163; Clayton TC, 2005, BMJ-BRIT MED J, V331, P869, DOI 10.1136/bmj.38603.656076.63; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Collins R, 1994, ANTIHYPERTENSIVE DRU; Critchley J, 2003, COCHRANE DB SYST REV; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; Cui YD, 2001, ARCH INTERN MED, V161, P1413, DOI 10.1001/archinte.161.11.1413; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Daly C, 2003, EUR HEART J, V24, P534, DOI 10.1016/S0195-668X(02)00820-5; Daly CA, 2006, BMJ-BRIT MED J, V332, P262, DOI 10.1136/bmj.38695.605440.AE; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Dargie HJ, 2002, LANCET, V359, P1269, DOI 10.1016/s0140-6736(02)08265-x; Davis AM, 2007, MED CARE RES REV, V64, p29S, DOI 10.1177/1077558707305416; Davis MM, 2006, J AM COLL CARDIOL, V48, P1498, DOI 10.1016/j.jacc.2006.09.004; DEBUSK RF, 1994, ANN INTERN MED, V120, P721, DOI 10.7326/0003-4819-120-9-199405010-00001; Dey S, 2009, HEART, V95, P20, DOI 10.1136/hrt.2007.138537; Di Carli MF, 1998, J THORAC CARDIOV SUR, V116, P997, DOI 10.1016/S0022-5223(98)70052-2; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; DICARLI MF, 1995, CIRCULATION, V92, P3436, DOI 10.1161/01.CIR.92.12.3436; DIGENIO AG, 1991, S AFR MED J, V79, P188; Dluhy RG, 2008, NEW ENGL J MED, V358, P2630, DOI 10.1056/NEJMe0804182; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; Durrington PN, 2001, HEART, V85, P544, DOI 10.1136/heart.85.5.544; Durstine J Larry, 2002, J Cardiopulm Rehabil, V22, P385, DOI 10.1097/00008483-200211000-00002; Durstine JL, 2001, SPORTS MED, V31, P1033, DOI 10.2165/00007256-200131150-00002; Duvall WL, 2006, J NUCL CARDIOL, V13, P202, DOI 10.1016/j.nuclcard.2006.01.003; Dzavik V, 2001, AM HEART J, V142, P119, DOI 10.1067/mhj.2001.116072; Edwards FH, 1998, ANN THORAC SURG, V66, P125, DOI 10.1016/S0003-4975(98)00358-0; Emanuelsson H, 1999, AM HEART J, V137, P854, DOI 10.1016/S0002-8703(99)70409-6; EVERY NR, 1992, J AM COLL CARDIOL, V19, P1435, DOI 10.1016/0735-1097(92)90599-I; EZEKOWITZ MD, 1995, AM HEART J, V129, P527, DOI 10.1016/0002-8703(95)90281-3; FARNETT L, 1991, JAMA-J AM MED ASSOC, V265, P489, DOI 10.1001/jama.265.4.489; Feit F, 2000, CIRCULATION, V101, P2795, DOI 10.1161/01.CIR.101.24.2795; Feldman DN, 2006, AM J CARDIOL, V98, P1334, DOI 10.1016/j.amjcard.2006.06.026; Fihn SD, 2012, J AM COLL C IN PRESS; Fleischmann KE, 1998, JAMA-J AM MED ASSOC, V280, P913, DOI 10.1001/jama.280.10.913; Food and Drug Administration, 2008, INF HEALTHC PROF VAR; Food and Drug Administration, 2008, IMP INF CHANT VAR; Fox KM, 2003, LANCET, V362, P782; Franklin BA, 1998, CHEST, V114, P902, DOI 10.1378/chest.114.3.902; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; FRISHMAN WH, 1991, AM J CARDIOL, V67, P665, DOI 10.1016/0002-9149(91)90518-P; FROELICHER V, 1984, JAMA-J AM MED ASSOC, V252, P1291, DOI 10.1001/jama.252.10.1291; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI [DOI 10.1056/NEJMOA0805796, 10.1056/NEJMoa0805796]; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; GIANROSSI R, 1989, CIRCULATION, V80, P87, DOI 10.1161/01.CIR.80.1.87; Ginsberg HN, 1998, ARTERIOSCL THROM VAS, V18, P441, DOI 10.1161/01.ATV.18.3.441; Goel K, 2011, AM HEART J, V161, P590, DOI 10.1016/j.ahj.2010.12.012; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Gorin SS, 2004, CANCER EPIDEM BIOMAR, V13, P2012; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; Goyal D, 2009, CARDIOVASC THER, V27, P10, DOI 10.1111/j.1755-5922.2008.00067.x; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Gulati M, 2009, ARCH INTERN MED, V169, P843, DOI 10.1001/archinternmed.2009.50; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Hachamovitch R, 2003, J AM COLL CARDIOL, V41, P1329, DOI 10.1016/S0735-1097(03)00125-6; Haffner SM, 2000, NEW ENGL J MED, V342, P1040, DOI 10.1056/NEJM200004063421408; Hambrecht R, 2004, CIRCULATION, V109, P1371, DOI 10.1161/01.CIR.0000121360.31954.1F; Hambrecht R, 1993, J AM COLL CARDIOL, V22, P468, DOI 10.1016/0735-1097(93)90051-2; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; HASKELL WL, 1994, CIRCULATION, V89, P975, DOI 10.1161/01.CIR.89.3.975; HaufZachariou U, 1997, EUR J CLIN PHARMACOL, V52, P95, DOI 10.1007/s002280050256; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; HEBERT PR, 1993, ARCH INTERN MED, V153, P578, DOI 10.1001/archinte.153.5.578; Heidenreich PA, 1999, JAMA-J AM MED ASSOC, V281, P1927, DOI 10.1001/jama.281.20.1927; Henderson RA, 2003, J AM COLL CARDIOL, V42, P1161, DOI 10.1016/S0735-1097(03)00951-3; HIRSH J, 1995, CHEST, V108, pS247, DOI 10.1378/chest.108.4_Supplement.247S; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; HOLMES DR, 1989, J AM COLL CARDIOL, V13, P524, DOI 10.1016/0735-1097(89)90587-1; Holubkov R, 2002, AM HEART J, V144, P826, DOI 10.1067/mhj.2002.125505; HSIEH SD, 1995, INT J OBESITY, V19, P585; Hughes J., 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000031.PUB2; Hughes JR, 2003, J GEN INTERN MED, V18, P1053, DOI 10.1111/j.1525-1497.2003.20640.x; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hypertension Detection and Follow-up Program Cooperative Group, 1979, JAMA-J AM MED ASSOC, V242, P2562, DOI DOI 10.1001/JAMA.242.23.2562; Innocenti F, 2011, INT J CARDIOVAS IMAG, V27, P65, DOI 10.1007/s10554-010-9655-7; Jagathesan R, 2006, J CARDIOVASC PHARM, V48, P110, DOI 10.1097/01.fjc.0000245404.20922.9f; Jeger RV, 2004, CHEST, V125, P1124, DOI 10.1378/chest.125.3.1124; Joint Commission, 2007, Jt Comm Perspect, V27, P9; Joint Commission on Accreditation of Healthcare Organizations, 2007, Jt Comm Perspect, V27, P9; Jones RH, 1996, J THORAC CARDIOV SUR, V111, P1013, DOI 10.1016/S0022-5223(96)70378-1; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Julius S, 2006, HYPERTENSION, V48, P385, DOI 10.1161/01.HYP.0000236119.96301.f2; KANNEL WB, 1972, AM J CARDIOL, V29, P154, DOI 10.1016/0002-9149(72)90624-8; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; Kardas P, 2007, VASC HEALTH RISK MAN, V3, P235, DOI 10.2147/vhrm.2007.3.2.235; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; KERN MJ, 1995, J AM COLL CARDIOL, V25, P178, DOI 10.1016/0735-1097(94)00328-N; Kernis SJ, 2004, J AM COLL CARDIOL, V43, P1773, DOI 10.1016/j.jacc.2003.09.071; Khunnawat C, 2008, AM J CARDIOL, V102, P635, DOI 10.1016/j.amjcard.2008.04.035; King SB, 1997, AM J CARDIOL, V79, P1453, DOI 10.1016/S0002-9149(97)00170-7; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; KREPP HP, 1991, CARDIOLOGY, V79, P14, DOI 10.1159/000174919; KROLEWSKI AS, 1987, AM J CARDIOL, V59, P750, DOI 10.1016/0002-9149(87)91086-1; Kwok JMF, 2002, J AM COLL CARDIOL, V39, P1475, DOI 10.1016/S0735-1097(02)01769-2; LACOSTE LL, 1994, AM J CARDIOL, V73, P1058; Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6; LANCASTER T, 2005, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001292.PUB3, 10.1002/14651858.CD001292.pub3]; Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lavi S, 2007, CATHETER CARDIO INTE, V70, P525, DOI 10.1002/ccd.21154; LECHAT P, 1994, CIRCULATION, V90, P1765, DOI 10.1161/01.CIR.90.4.1765; Leizorovicz A, 2002, AM HEART J, V143, P301, DOI 10.1067/mhj.2002.120768; Leon AS, 2001, MED SCI SPORT EXER, V33, pS502, DOI 10.1097/00005768-200106001-00021; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Lichtenstein A, 2006, CIRCULATION, V114, pE629, DOI 10.1161/CIRCULATIONAHA.106.180281; MACGREGOR GA, 1989, LANCET, V2, P1244, DOI 10.1016/S0140-6736(89)91852-7; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mannucci PM, 2003, CIRCULATION, V107, P1117, DOI 10.1161/01.CIR.0000051465.94572.D0; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; Martini CH, 2005, J THROMB HAEMOST, V3, P177, DOI 10.1111/j.1538-7836.2004.01080.x; Matetzky S, 2003, ARCH INTERN MED, V163, P457, DOI 10.1001/archinte.163.4.457; Matzkies FK, 2001, NEPHRON, V89, P10, DOI 10.1159/000046036; MAY GA, 1984, PHYS THER, V64, P1361, DOI 10.1093/ptj/64.9.1361; McGillion M, 2007, CAN J NURS RES, V39, P48; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McNulty PH, 2002, CATHETER CARDIO INTE, V56, P174, DOI 10.1002/ccd.10186; MEADE TW, 1992, BMJ-BRIT MED J, V304, P405; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Mehta NJ, 2003, ANGIOLOGY, V54, P269, DOI 10.1177/000331970305400302; Mensah GA, 2007, HEALTH AFFAIR, V26, P38, DOI 10.1377/hlthaff.26.1.38; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Miller NH, 1995, MONOGRAPH HUMAN KINE, V2; Morrow D, 2005, CHRONIC CORONARY ART; Morrow DA, 2007, JAMA-J AM MED ASSOC, V297, P1775, DOI 10.1001/jama.297.16.1775; Mosca L, 2007, J AM COLL CARDIOL, V49, P1230, DOI 10.1016/j.jacc.2007.02.020; Moscucci M, 2001, CIRCULATION, V104, P263, DOI 10.1161/01.CIR.104.3.263; Mulvagh SL, 2000, J AM SOC ECHOCARDIOG, V13, P331, DOI 10.1067/mje.2000.105462; Munzel T, 2002, CIRCULATION, V106, P170, DOI 10.1161/01.CIR.0000021663.39699.30; Muszbek N, 2008, INT J CLIN PRACT, V62, P338, DOI 10.1111/j.1742-1241.2007.01683.x; MYERS WO, 1989, J THORAC CARDIOV SUR, V97, P487; NARAHARA KA, 1990, AM J CARDIOL, V65, P577, DOI 10.1016/0002-9149(90)91033-3; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; National Heart Lung and Blood Institute, 2008, CLIN GUID ID EV TREA; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; O'Connor CM, 2002, AM J CARDIOL, V90, P101, DOI 10.1016/S0002-9149(02)02429-3; Oka R, 2008, DIABETES RES CLIN PR, V79, P474, DOI 10.1016/j.diabres.2007.10.016; Okin PM, 2003, CIRCULATION, V108, P684, DOI 10.1161/01.CIR.0000083724.28630.C3; OLDRIDGE NB, 1989, MED SCI SPORT EXER, V21, P308; ORNISH D, 1983, JAMA-J AM MED ASSOC, V249, P54, DOI 10.1001/jama.249.1.54; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Parker JD, 1998, NEW ENGL J MED, V338, P520, DOI 10.1056/NEJM199802193380807; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pazhenkottil AP, 2011, J NUCL MED, V52, P196, DOI 10.2967/jnumed.110.080580; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; PEKKANEN J, 1990, NEW ENGL J MED, V322, P1700, DOI 10.1056/NEJM199006143222403; PEPINE CJ, 1994, CIRCULATION, V90, P762, DOI 10.1161/01.CIR.90.2.762; Pepine CJ, 2004, HOPE PEACE UPDATE RO; Perrone-Filardi P, 2010, J NUCL CARDIOL, V17, P310, DOI 10.1007/s12350-009-9182-x; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pfisterer M, 2003, JAMA-J AM MED ASSOC, V289, P1117, DOI 10.1001/jama.289.9.1117; Phillips HR, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2007.01.026; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Pitt B, 1999, NEW ENGL J MED, V341, P70, DOI 10.1056/NEJM199907083410202; Pitt B, 2001, AM J CARDIOL, V87, P1058, DOI 10.1016/S0002-9149(01)01461-8; Poole-Wilson PA, 2007, EUR HEART J, V28, P1928, DOI 10.1093/eurheartj/ehm198; Qaseem A, 2012, ANN INTERN MED, V157, P729, DOI 10.7326/0003-4819-157-10-201211200-00010; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Qaseern A, 2007, ANN INTERN MED, V147, P417, DOI 10.7326/0003-4819-147-6-200709180-00012; Qureshi MA, 2003, J AM COLL CARDIOL, V42, P1890, DOI 10.1016/j.jacc.2003.06.014; Raftery EB, 1996, EUR HEART J, V17, P30, DOI 10.1093/eurheartj/17.suppl_B.30; Rao SV, 2004, ARCH INTERN MED, V164, P1128, DOI 10.1001/archinte.164.10.1128; Rehnqvist N, 1995, Cardiologia, V40, P301; REICHARD P, 1993, NEW ENGL J MED, V329, P304, DOI 10.1056/NEJM199307293290502; Resnic FS, 2001, AM J CARDIOL, V88, P5, DOI 10.1016/S0002-9149(01)01576-4; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; RIMM EB, 1995, AM J EPIDEMIOL, V141, P1117, DOI 10.1093/oxfordjournals.aje.a117385; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; ROSSOUW JE, 1990, NEW ENGL J MED, V323, P1112, DOI 10.1056/NEJM199010183231606; Ruggenenti P, 1997, LANCET, V349, P1857; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Savonitto S, 1996, J AM COLL CARDIOL, V27, P311, DOI 10.1016/0735-1097(95)00489-0; Sawada S, 2003, J AM COLL CARDIOL, V42, P2099, DOI 10.1016/j.jacc.2003.07.026; SCHAEFER EJ, 1995, ARTERIOSCL THROM VAS, V15, P1079, DOI 10.1161/01.ATV.15.8.1079; Schaefer EJ, 1997, AM J CLIN NUTR, V65, P823, DOI 10.1093/ajcn/65.3.823; SCHULER G, 1992, CIRCULATION, V86, P1, DOI 10.1161/01.CIR.86.1.1; SEBRECHTS CP, 1986, AM HEART J, V112, P1217, DOI 10.1016/0002-8703(86)90351-0; Sedlis SP, 2009, AM J CARDIOL, V104, P1647, DOI 10.1016/j.amjcard.2009.07.043; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Shaw RE, 2002, J AM COLL CARDIOL, V39, P1104, DOI 10.1016/S0735-1097(02)01731-X; Shaw Richard E, 2003, J Invasive Cardiol, V15, P578; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Silagy C., 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD000146.PUB2; Singh M, 2005, AM J CARDIOL, V96, P907, DOI 10.1016/j.amjcard.2005.05.045; Singh M, 2002, J AM COLL CARDIOL, V40, P387, DOI 10.1016/S0735-1097(02)01980-0; Singh M, 2008, J AM COLL CARDIOL, V51, P2313, DOI 10.1016/j.jacc.2008.01.066; Slomka PJ, 2007, J NUCL CARDIOL, V14, P44, DOI 10.1016/j.nuclcard.2006.10.021; Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026; Snow V, 2005, ANN INTERN MED, V142, P525, DOI 10.7326/0003-4819-142-7-200504050-00011; Sorajja P, 2005, CIRCULATION, V112, pI311, DOI 10.1161/CIRCULATIONAHA.104.525022; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; Stead LF, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001007.PUB2; Stead LF, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002850; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007; STEVENS VJ, 1993, ARCH INTERN MED, V153, P849, DOI 10.1001/archinte.153.7.849; Stone PH, 2006, J AM COLL CARDIOL, V48, P566, DOI 10.1016/j.jacc.2006.05.044; SULLIVAN AK, 1994, BRIT MED J, V308, P883, DOI 10.1136/bmj.308.6933.883; Tabib A, 2000, CORONARY ARTERY DIS, V11, P41, DOI 10.1097/00019501-200002000-00008; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Tarakji KG, 2006, CIRCULATION, V113, P230, DOI 10.1161/CIRCULATIONAHA.105.541664; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Tepper David, 1999, Congest Heart Fail, V5, P184; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Thompson PD, 2007, CIRCULATION, V115, P2358, DOI 10.1161/CIRCULATIONAHA.107.181485; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; TODD IC, 1992, BRIT HEART J, V68, P560; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; TRESCH DD, 1985, AM HEART J, V110, P1139, DOI 10.1016/0002-8703(85)90003-1; Trikalinos TA, 2009, LANCET, V373, P911, DOI 10.1016/S0140-6736(09)60319-6; TSUYA T, 1990, AM J CARDIOL, V66, P275, DOI 10.1016/0002-9149(90)90835-O; Tsuyuki RT, 2006, CAN MED ASSOC J, V175, P361, DOI 10.1503/cmaj.060108; Turnbull F, 2003, LANCET, V362, P1527; Turnbull F., 2007, J HYPERTENS, V25, P951, DOI [DOI 10.1097/HJH.0B013E3280BAD9B4, 10.1097/HJH.0b013-3280bad9b4]; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Ussher M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002295.pub2; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Vaccarino V, 2002, CIRCULATION, V105, P1176, DOI 10.1161/hc1002.105133; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; VANCAMP SP, 1986, JAMA-J AM MED ASSOC, V256, P1160, DOI 10.1001/jama.256.9.1160; VARNAUSKAS E, 1988, NEW ENGL J MED, V319, P332, DOI 10.1056/NEJM198808113190603; Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356; Verma S, 2007, J AM SOC HYPERTENS, V1, P286, DOI 10.1016/j.jash.2007.05.003; VONARNIM T, 1995, J AM COLL CARDIOL, V25, P231, DOI 10.1016/0735-1097(94)00345-Q; Vongvanich P, 1996, AM J CARDIOL, V77, P1383, DOI 10.1016/S0002-9149(96)00215-9; WAYSBORT J, 1991, CARDIOLOGY, V79, P19, DOI 10.1159/000174920; Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839; Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657; Whelton SP, 2004, AM J CARDIOL, V93, P1119, DOI 10.1016/j.amjcard.2004.01.038; Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006; WILLETT WC, 1987, NEW ENGL J MED, V317, P1303, DOI 10.1056/NEJM198711193172102; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wilt TJ, 2004, ARCH INTERN MED, V164, P1427, DOI 10.1001/archinte.164.13.1427; WONG ND, 1991, ANN INTERN MED, V115, P687, DOI 10.7326/0003-4819-115-9-687; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Wright JT, 2002, ARCH INTERN MED, V162, P1636, DOI 10.1001/archinte.162.14.1636; Wu CT, 2006, J AM COLL CARDIOL, V47, P654, DOI 10.1016/j.jacc.2005.09.071; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424; Yu-Poth S, 1999, AM J CLIN NUTR, V69, P632; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	317	46	51	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10					735	+		10.7326/0003-4819-157-10-201211200-00011	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-00011			31	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043VZ	23165665				2022-12-28	WOS:000311580000019
J	Bates, CM; Seshimo, T; Maher, MJ; Durand, WJ; Cushen, JD; Dean, LM; Blachut, G; Ellison, CJ; Willson, CG				Bates, Christopher M.; Seshimo, Takehiro; Maher, Michael J.; Durand, William J.; Cushen, Julia D.; Dean, Leon M.; Blachut, Gregory; Ellison, Christopher J.; Willson, C. Grant			Polarity-Switching Top Coats Enable Orientation of Sub-10-nm Block Copolymer Domains	SCIENCE			English	Article							ORDER-DISORDER TRANSITION; THIN-FILMS; DIBLOCK COPOLYMERS; DIFFUSION; SYSTEMS; BLENDS; MODEL	Block copolymers (BCPs) must necessarily have high interaction parameters (chi), a fundamental measure of block incompatibility, to self-assemble into sub-10-nanometer features. Unfortunately, a high chi often results from blocks that have disparate interfacial energies, which makes the formation of useful thin-film domain orientations challenging. To mitigate interfacial forces, polymers composed of maleic anhydride and two other components have been designed as top coats that can be spin-coated from basic aqueous solution in the ring-opened, acid salt form. When baked, the anhydride reforms and switches polarity to create a neutral layer enabling BCP feature alignment not possible by thermal annealing alone. Top coats were applied to the lamella-forming block copolymers poly(styrene-block-trimethylsilylstyrene-block-styrene) and poly(trimethylsilylstyrene-block-lactide), which were thermally annealed to produce perpendicular features with linewidths of 15 and 9 nanometers, respectively.	[Bates, Christopher M.; Seshimo, Takehiro; Maher, Michael J.; Willson, C. Grant] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA; [Durand, William J.; Cushen, Julia D.; Dean, Leon M.; Blachut, Gregory; Ellison, Christopher J.; Willson, C. Grant] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Willson, CG (corresponding author), Univ Texas Austin, Dept Chem, 1 Univ Stn A5300, Austin, TX 78712 USA.	willson@che.utexas.edu		Ellison, Christopher/0000-0002-0393-2941; Dean, Leon/0000-0003-1001-9111	Nissan Chemical Company; Rashid Engineering Regents Chair; NSF Scalable Nanomanufacturing Program [1120823]; Welch Foundation [F-1709]; Tokyo Ohka Kogyo Co.; Virginia, Jr. Fellowship in Engineering; Ernest Cockrell, Jr. Fellowship in Engineering; NSF; National Merit Scholarship; Arrington Endowed Scholarship; Paul D. Meek Endowed Graduate Fellowship in Engineering	Nissan Chemical Company; Rashid Engineering Regents Chair; NSF Scalable Nanomanufacturing Program; Welch Foundation(The Welch Foundation); Tokyo Ohka Kogyo Co.; Virginia, Jr. Fellowship in Engineering; Ernest Cockrell, Jr. Fellowship in Engineering; NSF(National Science Foundation (NSF)); National Merit Scholarship; Arrington Endowed Scholarship; Paul D. Meek Endowed Graduate Fellowship in Engineering	The authors gratefully thank Nissan Chemical Company and the Rashid Engineering Regents Chair for financial support. This material is based on work supported by the NSF Scalable Nanomanufacturing Program under grant no. 1120823. C.J.E. thanks the Welch Foundation (grant F-1709) for partial financial support. T. S. thanks Tokyo Ohka Kogyo Co. for financial support. W.J.D. thanks the Virginia and Ernest Cockrell, Jr. Fellowships in Engineering for partial support. J.D.C. thanks NSF for a Graduate Research Fellowship. L.M.D. thanks the National Merit Scholarship and the Arrington Endowed Scholarship for support. G.B. thanks the Paul D. Meek Endowed Graduate Fellowship in Engineering for support. The authors also thank D. Romanovicz for SEM assistance. The University of Texas has submitted a provisional patent application covering aspects of the work described in this paper to the U.S. Patent Office.	Albert JNL, 2010, MATER TODAY, V13, P24, DOI 10.1016/S1369-7021(10)70106-1; [Anonymous], SPECTROMETRIC IDENTI; Bates CM, 2011, LANGMUIR, V27, P2000, DOI 10.1021/la1042958; Bates FS, 2012, SCIENCE, V336, P434, DOI 10.1126/science.1215368; BATES FS, 1990, ANNU REV PHYS CHEM, V41, P525, DOI 10.1146/annurev.pc.41.100190.002521; Bates FS, 1999, PHYS TODAY, V52, P32, DOI 10.1063/1.882522; Cushen JD, 2012, MACROMOLECULES, V45, P8722, DOI 10.1021/ma301238j; Cushen JD, 2012, ACS NANO, V6, P3424, DOI 10.1021/nn300459r; DUDA JL, 1985, PURE APPL CHEM, V57, P1681, DOI 10.1351/pac198557111681; GILMORE PT, 1980, MACROMOLECULES, V13, P880, DOI 10.1021/ma60076a022; Hardy CM, 2002, MACROMOLECULES, V35, P3189, DOI 10.1021/ma0115489; HELFAND E, 1976, MACROMOLECULES, V9, P879, DOI 10.1021/ma60054a001; Herr DJC, 2011, J MATER RES, V26, P122, DOI 10.1557/jmr.2010.74; HIGUCHI T, 1967, J AM CHEM SOC, V89, P3001, DOI 10.1021/ja00988a036; Hillmyer MA, 2005, ADV POLYM SCI, V190, P137, DOI 10.1007/12_002; Houlihan FM, 1997, MACROMOLECULES, V30, P6517, DOI 10.1021/ma970771w; Huang E, 1998, MACROMOLECULES, V31, P7641, DOI 10.1021/ma980705+; Ji SX, 2010, ACS NANO, V4, P599, DOI 10.1021/nn901342j; Ji S, 2008, MACROMOLECULES, V41, P9098, DOI 10.1021/ma801861h; Jung YS, 2010, NANO LETT, V10, P1000, DOI 10.1021/nl904141r; Kim HC, 2010, CHEM REV, V110, P146, DOI 10.1021/cr900159v; Kim S, 2012, ACS MACRO LETT, V1, P11, DOI 10.1021/mz2000169; Liu GL, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.065502; Mansky P, 1997, PHYS REV LETT, V79, P237, DOI 10.1103/PhysRevLett.79.237; Mansky P, 1997, SCIENCE, V275, P1458, DOI 10.1126/science.275.5305.1458; Matsen MW, 2010, MACROMOLECULES, V43, P1671, DOI 10.1021/ma902173w; Nyquist RA, 2001, INTERPRETING INFRARE, V1; Paik MY, 2010, MACROMOLECULES, V43, P4253, DOI 10.1021/ma902646t; Panasonic, 2011, Patent JP, Patent No. [2011-78978, 201178978]; Ross CA, 2008, J VAC SCI TECHNOL B, V26, P2489, DOI 10.1116/1.2981079; Ryu DY, 2005, SCIENCE, V308, P236, DOI 10.1126/science.1106604; Segalman RA, 2009, MACROMOLECULES, V42, P9205, DOI 10.1021/ma901350w; Seshimo T, 2012, J PHOTOPOLYM SCI TEC, V25, P125, DOI 10.2494/photopolymer.25.125; Son JG, 2008, ADV MATER, V20, P3643, DOI 10.1002/adma.200800670; Stein GE, 2010, MACROMOLECULES, V43, P433, DOI 10.1021/ma901914b; Suh HS, 2010, MACROMOLECULES, V43, P461, DOI 10.1021/ma901987q; Vu T, 2011, MACROMOLECULES, V44, P6121, DOI 10.1021/ma2009222; TURNER MS, 1992, PHYS REV LETT, V69, P1788, DOI 10.1103/PhysRevLett.69.1788; WALTON DG, 1994, MACROMOLECULES, V27, P6225, DOI 10.1021/ma00099a045; Wan L, 2009, LANGMUIR, V25, P12408, DOI 10.1021/la901648y; Welander AM, 2008, MACROMOLECULES, V41, P2759, DOI 10.1021/ma800056s; Yokoyama H, 1998, MACROMOLECULES, V31, P7871, DOI 10.1021/ma9805250; Zhao Y, 2008, MACROMOLECULES, V41, P9948, DOI 10.1021/ma8013004	43	327	359	12	319	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					775	779		10.1126/science.1226046	http://dx.doi.org/10.1126/science.1226046			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139327				2022-12-28	WOS:000310839500037
J	Bristol, JB				Bristol, James B.			Let's keep clinical breast examination until the breast service is reconfigured	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									Cheltenham Gen Hosp, Cheltenham GL53 7AN, Glos, England	Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital	Bristol, JB (corresponding author), Cheltenham Gen Hosp, Cheltenham GL53 7AN, Glos, England.	bristols@gmail.com						Spence D, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6789	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 7	2012	345								e7422	10.1136/bmj.e7422	http://dx.doi.org/10.1136/bmj.e7422			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036LI	23135223				2022-12-28	WOS:000311027000014
J	Roumie, CL; Hung, AM; Greevy, RA; Grijalva, CG; Liu, XL; Murff, HJ; Elasy, TA; Griffin, MR				Roumie, Christianne L.; Hung, Adriana M.; Greevy, Robert A.; Grijalva, Carlos G.; Liu, Xulei; Murff, Harvey J.; Elasy, Tom A.; Griffin, Marie R.			Comparative Effectiveness of Sulfonylurea and Metformin Monotherapy on Cardiovascular Events in Type 2 Diabetes Mellitus A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							STROKE STATISTICS-2012 UPDATE; ACUTE MYOCARDIAL-INFARCTION; POSITIVE PREDICTIVE-VALUE; ALL-CAUSE MORTALITY; UNMEASURED CONFOUNDERS; CLINICAL-TRIALS; HEART-DISEASE; ANTIDIABETIC DRUGS; RISK; UGDP	Background: The effects of sulfonylureas and metformin on outcomes of cardiovascular disease (CVD) in type 2 diabetes are not well-characterized. Objective: To compare the effects of sulfonylureas and metformin on CVD outcomes (acute myocardial infarction and stroke) or death. Design: Retrospective cohort study. Setting: National Veterans Health Administration databases linked to Medicare files. Patients: Veterans who initiated metformin or sulfonylurea therapy for diabetes. Patients with chronic kidney disease or serious medical illness were excluded. Measurements: Composite outcome of hospitalization for acute myocardial infarction or stroke, or death, adjusted for baseline demographic characteristics; medications; cholesterol, hemoglobin A(1c), and serum creatinine levels; blood pressure; body mass index; health care utilization; and comorbid conditions. Results: Among 253 690 patients initiating treatment (98 665 with sulfonylurea therapy and 155 025 with metformin therapy), crude rates of the composite outcome were 18.2 per 1000 person-years in sulfonylurea users and 10.4 per 1000 person-years in metformin users (adjusted incidence rate difference, 2.2 [95% CI, 1.4 to 3.0] more CVD events with sulfonylureas per 1000 person-years; adjusted hazard ratio [aHR], 1.21 [CI, 1.13 to 1.30]). Results were consistent for both glyburide (aHR, 1.26 [CI, 1.16 to 1.37]) and glipizide (aHR, 1.15 [CI, 1.06 to 1.26]) in subgroups by CVD history, age, body mass index, and albuminuria; in a propensity score-matched cohort analysis; and in sensitivity analyses. Limitation: Most of the veterans in the study population were white men; data on women and minority groups were limited but reflective of the Veterans Health Administration population. Conclusion: Use of sulfonylureas compared with metformin for initial treatment of diabetes was associated with an increased hazard of CVD events or death.	Tennessee Valley Healthcare Syst Geriatr Res Educ, Hlth Serv Res & Dev Ctr, Nashville, TN USA; Vanderbilt Univ, Nashville, TN USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Roumie, CL (corresponding author), Geriatr Res Educ Clin Ctr 4A120, Nashville Vet Affairs Med Ctr, 1310 24th Ave S, Nashville, TN USA.	christianne.roumie@vanderbilt.edu		Grijalva, Carlos/0000-0002-2329-7797	Agency for Healthcare Research and Quality [290-05-0042]; U.S. Department of Health and Human Services; Veterans Affairs Career Development Awards [04-342-2, 2-031-09S]; Vanderbilt Clinical Translational Scientist Award from National Center for Research Resources/National Institutes of Health [UL1 RR024975-01]; Veterans Affairs Information Resource Center [SDR 02-237, 98-004]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975, TL1RR024978, KL2RR024977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092986] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); U.S. Department of Health and Human Services; Veterans Affairs Career Development Awards; Vanderbilt Clinical Translational Scientist Award from National Center for Research Resources/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Information Resource Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was funded under contract 290-05-0042 from the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, as part of the Developing Evidence to Inform Decisions about Effectiveness program. Drs. Roumie (04-342-2) and Hung (2-031-09S) were supported by Veterans Affairs Career Development Awards. Dr. Roumie was also supported in part by the Vanderbilt Clinical Translational Scientist Award UL1 RR024975-01 from the National Center for Research Resources/National Institutes of Health. Support for Veterans Affairs/Centers for Medicare & Medicaid Services data provided by the Department of Veterans Affairs, Veterans Affairs Health Services Research and Development Service, Veterans Affairs Information Resource Center (project numbers SDR 02-237 and 98-004).	Alexander GC, 2008, ARCH INTERN MED, V168, P2088, DOI 10.1001/archinte.168.19.2088; American Diabetes Association, 2011, Diabetes Care, V34 Suppl 1, pS4, DOI 10.2337/dc11-S004; Arnold N, 2006, 1 VIREC; Arnold N, 2006, 2 VIREC; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Bennett WL, 2011, ANN INTERN MED, V154, P602, DOI 10.7326/0003-4819-154-9-201105030-00336; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; BRADLEY RF, 1975, JAMA-J AM MED ASSOC, V232, P813, DOI 10.1001/jama.232.8.813; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Choma NN, 2009, PHARMACOEPIDEM DR S, V18, P1064, DOI 10.1002/pds.1821; Corrao G, 2011, EUR J CLIN PHARMACOL, V67, P289, DOI 10.1007/s00228-010-0939-6; Cryer DR, 2005, DIABETES CARE, V28, P539, DOI 10.2337/diacare.28.3.539; D'Agostino RB, 2000, J AM STAT ASSOC, V95, P749, DOI 10.2307/2669455; GOLDNER MG, 1971, J AMER MED ASSOC, V218, P1400, DOI 10.1001/jama.218.9.1400; Grymonpre R, 2006, MED CARE, V44, P471, DOI 10.1097/01.mlr.0000207817.32496.cb; Huizinga MM, 2010, PHARMACOEPIDEM DR S, V19, P1108, DOI 10.1002/pds.2035; Huizinga Mary Margaret, 2007, Diabetes Care, V30, pe85, DOI 10.2337/dc07-0650; Hung AM, 2012, KIDNEY INT, V81, P698, DOI 10.1038/ki.2011.444; Hynes DM, 2007, MED CARE, V45, P214, DOI 10.1097/01.mlr.0000244657.90074.b7; Kahler KH, 2007, DIABETES CARE, V30, P1689, DOI 10.2337/dc06-2272; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Knatterud G L, 1979, Diabetes Care, V2, P247; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; McAfee AT, 2007, PHARMACOEPIDEM DR S, V16, P711, DOI 10.1002/pds.1443; National Center for Health Statistics, 1988, INT CLASS DIS 9 REV; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nissen SE, 2010, ARCH INTERN MED, V170, P1191, DOI 10.1001/archinternmed.2010.207; Pantalone KM, 2010, DIABETES CARE, V33, P1224, DOI 10.2337/dc10-0017; Parsons LS, 2001, SAS SUGI, P214; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Phung OJ, 2010, JAMA-J AM MED ASSOC, V303, P1410, DOI 10.1001/jama.2010.405; PROUT TE, 1972, DIABETES, V21, P1035; Psaty BM, 1999, J AM GERIATR SOC, V47, P749, DOI 10.1111/j.1532-5415.1999.tb01603.x; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rosamond WD, 2004, AM J EPIDEMIOL, V160, P1137, DOI 10.1093/aje/kwh341; Roumie CL, 2012, PHARMACOEPIDEM DR S, V21, P515, DOI 10.1002/pds.3249; Roumie CL, 2011, PHARMACOEPIDEM DR S, V20, P36, DOI 10.1002/pds.2029; Rournie CL, 2008, PHARMACOEPIDEM DR S, V17, P20, DOI 10.1002/pds.1518; Schneeweiss S, 2005, EPIDEMIOLOGY, V16, P17, DOI 10.1097/01.ede.0000147164.11879.b5; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; SCHOR SS, 1973, AM J MED, V55, P727, DOI 10.1016/0002-9343(73)90252-0; SELTZER HS, 1972, DIABETES, V21, P976, DOI 10.2337/diab.21.9.976; Selvin E, 2008, ARCH INTERN MED, V168, P2070, DOI 10.1001/archinte.168.19.2070; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Tzoulaki I, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4731; Yuan Y. C., 2011, MULTIPLE IMPUTATION	51	220	230	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2012	157	9					601	+		10.7326/0003-4819-157-9-201211060-00003	http://dx.doi.org/10.7326/0003-4819-157-9-201211060-00003			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033GX	23128859	Green Accepted			2022-12-28	WOS:000310783300001
J	Schauss, P; Cheneau, M; Endres, M; Fukuhara, T; Hild, S; Omran, A; Pohl, T; Gross, C; Kuhr, S; Bloch, I				Schauss, Peter; Cheneau, Marc; Endres, Manuel; Fukuhara, Takeshi; Hild, Sebastian; Omran, Ahmed; Pohl, Thomas; Gross, Christian; Kuhr, Stefan; Bloch, Immanuel			Observation of spatially ordered structures in a two-dimensional Rydberg gas	NATURE			English	Article							NEUTRAL ATOMS; BLOCKADE	The ability to control and tune interactions in ultracold atomic gases has paved the way for the realization of new phases of matter. So far, experiments have achieved a high degree of control over short-range interactions, but the realization of long-range interactions has become a central focus of research because it would open up a new realm of many-body physics. Rydberg atoms are highly suited to this goal because the van der Waals forces between them are many orders of magnitude larger than those between ground-state atoms(1). Consequently, mere laser excitation of ultracold gases can cause strongly correlated many-body states to emerge directly when atoms are transferred to Rydberg states. A key example is a quantum crystal composed of coherent superpositions of different, spatially ordered configurations of collective excitations(2-5). Here we use high-resolution, in situ Rydberg atom imaging to measure directly strong correlations in a laser-excited, two-dimensional atomic Mott insulator(6). The observations reveal the emergence of spatially ordered excitation patterns with random orientation, but well-defined geometry, in the high-density components of the prepared many-body state. Together with a time-resolved analysis, this supports the description of the system in terms of a correlated quantum state of collective excitations delocalized throughout the gas. Our experiment demonstrates the potential of Rydberg gases to realize exotic phases of matter, thereby laying the basis for quantum simulations of quantum magnets with long-range interactions.	[Schauss, Peter; Cheneau, Marc; Endres, Manuel; Fukuhara, Takeshi; Hild, Sebastian; Omran, Ahmed; Gross, Christian; Kuhr, Stefan; Bloch, Immanuel] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Pohl, Thomas] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Kuhr, Stefan] Univ Strathclyde, Dept Phys, SUPA, Glasgow G4 0NG, Lanark, Scotland; [Bloch, Immanuel] Univ Munich, Fak Phys, D-80799 Munich, Germany	Max Planck Society; Max Planck Society; University of Strathclyde; University of Munich	Schauss, P (corresponding author), Max Planck Inst Quantum Opt, D-85748 Garching, Germany.	peter.schauss@mpq.mpg.de	Bloch, Immanuel/N-9169-2019; Pohl, Thomas/B-5133-2013; Fukuhara, Takeshi/A-6254-2014; Gross, Christian/P-5475-2014; Kuhr, Stefan/F-7296-2011; Bloch, Immanuel/G-3174-2010; Cheneau, Marc/O-9312-2014; Kuhr, Stefan/ABC-8654-2020; Schauss, Peter/AAV-1298-2020; Omran, Ahmed/AHH-4541-2022	Fukuhara, Takeshi/0000-0002-6702-9882; Gross, Christian/0000-0003-2292-5234; Kuhr, Stefan/0000-0001-8386-5357; Bloch, Immanuel/0000-0002-0679-4759; Cheneau, Marc/0000-0001-7261-566X; Kuhr, Stefan/0000-0001-8386-5357; Schauss, Peter/0000-0002-8505-5195; Omran, Ahmed/0000-0002-2253-0278; Pohl, Thomas/0000-0002-4093-3644	MPG; DFG; EU; JSPS	MPG(Max Planck Society); DFG(German Research Foundation (DFG)); EU(European Commission); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank R. Low for discussions. We acknowledge funding by MPG, DFG, EU (NAMEQUAM, AQUTE, Marie Curie Fellowship to M. C.) and JSPS (Postdoctoral Fellowship for Research Abroad to T.F.).	Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Cinti F, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.135301; Dudin YO, 2012, SCIENCE, V336, P887, DOI 10.1126/science.1217901; Dudin Y. O., NATURE PHYS; Endres M, 2011, SCIENCE, V334, P200, DOI [10.1126/science.1209284, 10.1126/science.1210268]; Gaetan A, 2009, NAT PHYS, V5, P115, DOI 10.1038/NPHYS1183; Garttner M., 2012, DYNAMICAL FORMATION; Gunter G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.013002; Henkel N, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.195302; Honer J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.160404; Honing M., 2012, STEADY STATE CRYSTAL; Isenhower L, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.010503; Jaksch D, 2000, PHYS REV LETT, V85, P2208, DOI 10.1103/PhysRevLett.85.2208; Low R, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.033422; Lukin MD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.037901; Muller M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.170502; Olmos B, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.041607; Pohl T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.043002; Pupillo G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.223002; Raitzsch U, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.013002; Reetz-Lamour M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.253001; Robicheaux F, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.063403; Saffman M, 2010, REV MOD PHYS, V82, P2313, DOI 10.1103/RevModPhys.82.2313; Schachenmayer J, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/103044; Schwarzkopf A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.103001; Tong D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.063001; Urban E, 2009, NAT PHYS, V5, P110, DOI 10.1038/NPHYS1178; van Bijnen RMW, 2011, J PHYS B-AT MOL OPT, V44, DOI 10.1088/0953-4075/44/18/184008; Viteau M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.060402; Weimer H, 2010, NAT PHYS, V6, P382, DOI 10.1038/NPHYS1614; Weimer H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.250601; Wilk T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.010502	33	400	402	5	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					87	91		10.1038/nature11596	http://dx.doi.org/10.1038/nature11596			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23128229	Green Accepted, Green Submitted			2022-12-28	WOS:000310434500035
J	van Rooij, WJ; Thijssen, A; Beute, G; Sluzewski, M				van Rooij, Willem Jan; Thijssen, Anthony; Beute, Guus; Sluzewski, Menno			A young woman with a first-time seizure and a huge intracranial vascular structure	LANCET			English	Editorial Material									[van Rooij, Willem Jan; Thijssen, Anthony; Sluzewski, Menno] St Elizabeth Hosp, Dept Radiol, NL-5022 GC Tilburg, Netherlands; [Beute, Guus] St Elizabeth Hosp, Dept Neurosurg, NL-5022 GC Tilburg, Netherlands	Elisabeth-TweeSteden Ziekenhuis (ETZ); Elisabeth-TweeSteden Ziekenhuis (ETZ)	van Rooij, WJ (corresponding author), St Elizabeth Hosp, Dept Radiol, NL-5022 GC Tilburg, Netherlands.	wjjvanrooij@gmail.com		Sluzewski, Menno/0000-0002-3949-5958					0	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 6	2013	381	9873					1223	1223		10.1016/S0140-6736(12)61129-5	http://dx.doi.org/10.1016/S0140-6736(12)61129-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122WU	23122769	Bronze			2022-12-28	WOS:000317350100032
J	Norman, JE; Shennan, AH				Norman, Jane E.; Shennan, Andrew H.			Prevention of preterm birth-why can't we do any better?	LANCET			English	Editorial Material							METAANALYSIS		[Norman, Jane E.] Univ Edinburgh, Tommys Ctr Maternal & Fetal Hlth, London, England; [Shennan, Andrew H.] Kings Coll London, Womens Hlth Acad Ctr, London WC2R 2LS, England	University of Edinburgh; University of London; King's College London	Norman, JE (corresponding author), Univ Edinburgh, Tommys Ctr Maternal & Fetal Hlth, London, England.	jane.norman@ed.ac.uk		Shennan, Andrew/0000-0001-5273-3132; Norman, Jane/0000-0001-6031-6953	MRC [G1002033, G0700452] Funding Source: UKRI; Medical Research Council [G1002033] Funding Source: researchfish; Medical Research Council [G0700452] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Berghella V, 2005, OBSTET GYNECOL, V106, P181, DOI 10.1097/01.AOG.0000168435.17200.53; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Chang HH, 2012, LANCET; Denison FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042926; Fisk NM, 2008, PLOS MED, V5, P22, DOI 10.1371/journal.pmed.0050022; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Kenyon S, 2008, LANCET, V372, P1319, DOI 10.1016/S0140-6736(08)61203-9; Likis FE, 2012, OBSTET GYNECOL, V120, P897, DOI 10.1097/AOG.0b013e3182699a15; Mackay DF, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001175; McLernon DJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6945; Thornton JG, 2004, LANCET, V364, P513, DOI 10.1016/S0140-6736(04)16809-8; Villar J, 2012, AM J OBSTET GYNECOL, V206, P119, DOI 10.1016/j.ajog.2011.10.866	13	46	51	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2013	381	9862					184	185		10.1016/S0140-6736(12)61956-4	http://dx.doi.org/10.1016/S0140-6736(12)61956-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	075LL	23158880				2022-12-28	WOS:000313887600008
J	McKinney, JC; Tchekhovskoy, A; Blandford, RD				McKinney, Jonathan C.; Tchekhovskoy, Alexander; Blandford, Roger D.			Alignment of Magnetized Accretion Disks and Relativistic Jets with Spinning Black Holes	SCIENCE			English	Article							SAGITTARIUS-A-ASTERISK; SIMULATIONS; ENERGY; MODEL; EXTRACTION; EMISSION; M87	Accreting black holes (BHs) produce intense radiation and powerful relativistic jets, which are affected by the BH's spin magnitude and direction. Although thin disks might align with the BH spin axis via the Bardeen-Petterson effect, this does not apply to jet systems with thick disks. We used fully three-dimensional general relativistic magnetohydrodynamical simulations to study accreting BHs with various spin vectors and disk thicknesses and with magnetic flux reaching saturation. Our simulations reveal a "magneto-spin alignment" mechanism that causes magnetized disks and jets to align with the BH spin near BHs and to reorient with the outer disk farther away. This mechanism has implications for the evolution of BH mass and spin, BH feedback on host galaxies, and resolved BH images for the accreting BHs in SgrA* and M87.	[McKinney, Jonathan C.; Blandford, Roger D.] Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94309 USA; [McKinney, Jonathan C.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [McKinney, Jonathan C.] Univ Maryland, Joint Space Sci Inst, College Pk, MD 20742 USA; [Tchekhovskoy, Alexander] Princeton Univ, Ctr Theoret Sci, Princeton, NJ 08544 USA	Stanford University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Princeton University	McKinney, JC (corresponding author), Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94309 USA.	jcm@umd.edu	Tchekhovskoy, Alexander/AAN-6908-2020	Tchekhovskoy, Alexander/0000-0002-9182-2047	NASA Fermi grant [NNX11AO21G]; Princeton Center for Theoretical Science fellowship; NSF by the Texas Advanced Computing Center (Lonestar/Ranch); National Institute for Computational Sciences (Kraken) [TG-PHY120005, TG-AST100040]; NASA Advanced Supercomputing (Pleiades)	NASA Fermi grant; Princeton Center for Theoretical Science fellowship; NSF by the Texas Advanced Computing Center (Lonestar/Ranch); National Institute for Computational Sciences (Kraken); NASA Advanced Supercomputing (Pleiades)	J.C.M. thanks R. Narayan, J. Dexter, and P. C. Fragile for useful discussions, and R. Kaehler at KIPAC (SLAC/Stanford) for the artistic rendering in fig. S1. Supported by NASA Fermi grant NNX11AO21G (J. C. M.), a Princeton Center for Theoretical Science fellowship (A. T.), and NSF Extreme Science and Engineering Discovery Environment resources provided by the Texas Advanced Computing Center (Lonestar/Ranch) and the National Institute for Computational Sciences (Kraken) under awards TG-PHY120005 (J. C. M.) and TG-AST100040 (A. T.) and provided by NASA Advanced Supercomputing (Pleiades) for the Fermi grant. GRMHD simulation data are contained in Table 1 and tables S1 and S2. A. T. is a Princeton Center for Theoretical Science Fellow.	BALBUS SA, 1991, ASTROPHYS J, V376, P214, DOI 10.1086/170270; BARDEEN JM, 1975, ASTROPHYS J, V195, pL65, DOI 10.1086/181711; BEGELMAN MC, 1980, NATURE, V287, P307, DOI 10.1038/287307a0; BEGELMAN MC, 1979, NATURE, V279, P770, DOI 10.1038/279770a0; BLANDFORD RD, 1977, MON NOT R ASTRON SOC, V179, P433, DOI 10.1093/mnras/179.3.433; Bloom JS, 2011, SCIENCE, V333, P203, DOI 10.1126/science.1207150; Bogdanovic T, 2007, ASTROPHYS J, V661, pL147, DOI 10.1086/518769; Di Matteo T, 2005, NATURE, V433, P604, DOI 10.1038/nature03335; Doeleman SS, 2008, NATURE, V455, P78, DOI 10.1038/nature07245; Doeleman SS, 2012, SCIENCE, V338, P355, DOI 10.1126/science.1224768; Fish VL, 2011, ASTROPHYS J LETT, V727, DOI 10.1088/2041-8205/727/2/L36; Fragile PC, 2007, ASTROPHYS J, V668, P417, DOI 10.1086/521092; Gebhardt K, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/119; Hada K, 2011, NATURE, V477, P185, DOI 10.1038/nature10387; HATCHETT SP, 1981, ASTROPHYS J, V247, P677, DOI 10.1086/159079; Kim H, 2003, J COSMOL ASTROPART P; King AR, 2005, AIP CONF PROC, V784, P175, DOI 10.1063/1.2077182; KING AR, 1977, ASTRON ASTROPHYS, V58, P175; Koide S, 2002, SCIENCE, V295, P1688, DOI 10.1126/science.1068240; KUMAR S, 1985, MON NOT R ASTRON SOC, V213, P435, DOI 10.1093/mnras/213.3.435; LOVELACE RVE, 1976, NATURE, V262, P649, DOI 10.1038/262649a0; McKinney JC, 2012, MON NOT R ASTRON SOC, V423, P3083, DOI 10.1111/j.1365-2966.2012.21074.x; NARAYAN R, 1995, NATURE, V374, P623, DOI 10.1038/374623a0; Natarajan P, 1999, MON NOT R ASTRON SOC, V309, P961, DOI 10.1046/j.1365-8711.1999.02917.x; Nelson RP, 2000, MON NOT R ASTRON SOC, V315, P570, DOI 10.1046/j.1365-8711.2000.03478.x; Palenzuela C, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.044045; Perego A, 2009, MON NOT R ASTRON SOC, V399, P2249, DOI 10.1111/j.1365-2966.2009.15427.x; Reis RC, 2012, SCIENCE, V337, P949, DOI 10.1126/science.1223940; Reynolds CS, 2008, ASTROPHYS J, V675, P1048, DOI 10.1086/527344; Semenov V, 2004, SCIENCE, V305, P978, DOI 10.1126/science.1100638; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Stone N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.061302; Tchekhovskoy A, 2012, MON NOT R ASTRON SOC, V423, pL55, DOI 10.1111/j.1745-3933.2012.01256.x; Tchekhovskoy A, 2011, MON NOT R ASTRON SOC, V418, pL79, DOI 10.1111/j.1745-3933.2011.01147.x	34	121	122	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					49	52		10.1126/science.1230811	http://dx.doi.org/10.1126/science.1230811			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23160958	Green Submitted			2022-12-28	WOS:000312985800047
J	Tougher, S; Ye, Y; Amuasi, JH; Kourgueni, IA; Thomson, R; Goodman, C; Mann, AG; Ren, RL; Willey, BA; Adegoke, CA; Amin, A; Ansong, D; Bruxvoort, K; Diallo, DA; Diap, G; Festo, C; Johanes, B; Juma, E; Kalolella, A; Malam, O; Mberu, B; Ndiaye, S; Nguah, SB; Seydou, M; Taylor, M; Rueda, ST; Wamukoya, M; Arnold, F; Hanson, K				Tougher, Sarah; Ye, Yazoume; Amuasi, John H.; Kourgueni, Idrissa A.; Thomson, Rebecca; Goodman, Catherine; Mann, Andrea G.; Ren, Ruilin; Willey, Barbara A.; Adegoke, Catherine A.; Amin, Abdinasir; Ansong, Daniel; Bruxvoort, Katia; Diallo, Diadier A.; Diap, Graciela; Festo, Charles; Johanes, Boniface; Juma, Elizabeth; Kalolella, Admirabilis; Malam, Oumarou; Mberu, Blessing; Ndiaye, Salif; Nguah, Samuel B.; Seydou, Moctar; Taylor, Mark; Rueda, Sergio Torres; Wamukoya, Marilyn; Arnold, Fred; Hanson, Kara		ACTwatch Grp	Effect of the Affordable Medicines Facility-malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data	LANCET			English	Article							GLOBAL SUBSIDY; TANZANIA; ACT	Background Malaria is one of the greatest causes of mortality worldwide. Use of the most effective treatments for malaria remains inadequate for those in need, and there is concern over the emergence of resistance to these treatments. In 2010, the Global Fund launched the Affordable Medicines Facility-malaria (AMFm), a series of national-scale pilot programmes designed to increase the access and use of quality-assured artemisinin based combination therapies (QAACTs) and reduce that of artemisinin monotherapies for treatment of malaria. AMFm involves manufacturer price negotiations, subsidies on the manufacturer price of each treatment purchased, and supporting interventions such as communications campaigns. We present findings on the effect of AMFm on QAACT price, availability, and market share, 6-15 months after the delivery of subsidised ACTs in Ghana, Kenya, Madagascar, Niger, Nigeria, Uganda, and Tanzania (including Zanzibar). Methods We did nationally representative baseline and endpoint surveys of public and private sector outlets that stock antimalarial treatments. QAACTs were identified on the basis of the Global Fund's quality assurance policy. Changes in availability, price, and market share were assessed against specified success benchmarks for 1 year of AMFm implementation. Key informant interviews and document reviews recorded contextual factors and the implementation process. Findings In all pilots except Niger and Madagascar, there were large increases in QAACT availability (25.8-51.9 percentage points), and market share (15.9-40.3 percentage points), driven mainly by changes in the private for-profit sector. Large falls in median price for QAACTs per adult equivalent dose were seen in the private for-profit sector in six pilots, ranging from US$1.28 to $4.82. The market share of oral artemisinin monotherapies decreased in Nigeria and Zanzibar, the two pilots where it was more than 5% at baseline. Interpretation Subsidies combined with supporting interventions can be effective in rapidly improving avail ability, price, and market share of QAACTs, particularly in the private for-profit sector. Decisions about the future of AMFm should also consider the effect on use in vulnerable populations, access to malaria diagnostics, and cost-effectiveness.	[Tougher, Sarah; Thomson, Rebecca; Goodman, Catherine; Mann, Andrea G.; Willey, Barbara A.; Bruxvoort, Katia; Diallo, Diadier A.; Taylor, Mark; Rueda, Sergio Torres; Hanson, Kara] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Amuasi, John H.] Univ Minnesota, Sch Publ Hlth, PhD Program, Div Hlth Policy & Management, Minneapolis, MN USA; [Amuasi, John H.; Ansong, Daniel; Nguah, Samuel B.] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Kourgueni, Idrissa A.] Ctr Int Etud & Rech Populat Africaines, Niamey, Niger; [Kourgueni, Idrissa A.; Malam, Oumarou; Seydou, Moctar] Inst Natl Stat, Niamey, Niger; [Diap, Graciela] Drugs Neglected Dis Initiat, Geneva, Switzerland; [Thomson, Rebecca; Bruxvoort, Katia; Festo, Charles; Johanes, Boniface; Kalolella, Admirabilis; Taylor, Mark] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Ansong, Daniel] Kwame Nkrumah Univ Sci & Technol, Dept Child Hlth, Sch Med Sci, Kumasi, Ghana; [Mberu, Blessing] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Ndiaye, Salif] Ctr Rech Dev Humain, Dakar, Senegal; [Juma, Elizabeth] Ctr Global Hlth Res, Kenya Med Res Inst, Nairobi, Kenya; [Taylor, Mark] Univ Exeter, European Ctr Environm & Human Hlth, Sch Med, Exeter EX4 4QJ, Devon, England	University of London; London School of Hygiene & Tropical Medicine; University of Minnesota System; University of Minnesota Twin Cities; Kwame Nkrumah University Science & Technology; Ifakara Health Institute; Kwame Nkrumah University Science & Technology; African Population & Health Research Centre; Kenya Medical Research Institute; University of Exeter	Tougher, S (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	sarah.tougher@lshtm.ac.uk	Nguah, Samuel/AAQ-9725-2020	Taylor, Mark/0000-0002-7646-7905; ANSONG, Daniel/0000-0003-1328-9117; Bruxvoort, Katia/0000-0001-8277-2431; Goodman, Catherine/0000-0002-2241-3485; Amuasi, John/0000-0002-8640-2662; Wamukoya, Marylene/0000-0002-2900-9178; Tougher, Sarah/0000-0001-7990-4368; Thomson, Rebecca/0000-0001-9683-9457	Global Fund; Tuberculosis and Malaria; Bill & Melinda Gates Foundation; Tuberculosis; Malaria; Bill & Melinda Gates Foundation for ACTwatch Central; ACTwatch surveys [058992]; Bill and Melinda Gates Foundation; European Regional Development Fund; European Social Fund Convergence Programme for Cornwall; Isles of Scilly	Global Fund; Tuberculosis and Malaria; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Tuberculosis; Malaria; Bill & Melinda Gates Foundation for ACTwatch Central; ACTwatch surveys; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); European Regional Development Fund(European Commission); European Social Fund Convergence Programme for Cornwall; Isles of Scilly	The Global Fund to Fight AIDS, Tuberculosis and Malaria, and the Bill & Melinda Gates Foundation.; We thank the large number of people from many different organisations who assisted with data analysis, data processing, and primary data collection. We acknowledge the contributions of Noureddine Abderrahim, Mwenda Gitonga, and David Muturi with data entry programmes; Ronnette Nolasco with project arrangements; Adrienne Keen with support to data analysis and processing, and Barry Dewitt, Dan Hamilton, Zhuzhi Moore, Falgunee Parekh, Yuan Cheng, and Ashley Garley with outlet survey table preparation. We also thank Immo Kleinschmidt, Milly Marston, Neal Alexander, Karim Anaya-Izquierdo and John Bradley for statistical advice; Meghna Ranganathan, Olivia Nuccio, Angela Camilleri, Edna Ogada, Emily Carter, Emily Harris, Tsione Solomon, Yohannes Kinfu, and Iarimalanto Rabary for research assistance; and Ohene Buabeng, Isaac Boakye, Raymond Atiemo Danso and other staff of the Research and Development Unit at Komfo Ankye Teaching Hospital who assisted technically and logistically with the field surveys in Ghana. We thank the following members of the AMFm Secretariat for their advice and support: Melisse Murray, Silas Holland, Fabienne Jourberton, Lloyd Matowe, and Orion Yeandel. Finally, we acknowledge the contribution of all the respondents who participated in the surveys and interviews. The evaluation was funded by the Global Fund to Fight AIDS, Tuberculosis and Malaria, with support from the Bill & Melinda Gates Foundation for ACTwatch Central and ACTwatch surveys in three countries (#058992). Sarah Tougher, Rebecca Thomson, Catherine Goodman, Andrea G Mann, Barbara Willey, Katia Bruxvoort, Sergio Torres Rueda, Kara Hanson, and Benjamin Palafox are members of the LSHTM Malaria Centre. Catherine Goodman, Rebecca Thomson, Katia Bruxvoort, Charles Festo, Boniface Johanes, Admirabilis Kalolella, and Mark Taylor work with the IMPACT2 project, part of the ACT Consortium (http://www.actconsortium.org/) which is funded by the Bill and Melinda Gates Foundation. Mark Taylor now works with the European Centre for Environment and Human Health (part of the University of Exeter Medical School) which is supported by investment from the European Regional Development Fund and the European Social Fund Convergence Programme for Cornwall and the Isles of Scilly.	ACTwatch Group, 2012, ACTWATCH HOUS SURV; ACTwatch Group and Association Beninoise pour le Marketing Social (ABMS)/Benin, 2011, OUTL SURV REP BEN 20; ACTwatch Group and Association Beninoise pour le Marketing Social (ABMS)/Benin, 2009, OUTL SURV REP BEN 20; ACTwatch Group and Population Services International (PSI)/Madagascar, 2009, MAD OUTL SURV 2008 R; ACTwatch Group and Society for Family Health (SFH)/Zambia, 2009, OUTL SURV REP ZAMB 2; ACTwatch Group and Society for Family Health (SFH)/Zambia, 2011, OUTL SURV REP ZAM 20; ACTwatch Group and the Program for Accessible Health CEPU, 2009, UG OUTL SURV 2009 RE; Adeyi O, 2010, LANCET, V376, P1869, DOI 10.1016/S0140-6736(10)61189-0; [Anonymous], AFF MED FAC MAL; [Anonymous], 2012, IND EV PHAS 1 AFF ME; [Anonymous], GLOB FUND QUAL ASS P; Craig P., 2008, DEV EVALUATING COMPL; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Government of India Department of Customs, 2009, IND CHEM IMP EXP DAT; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING; Kamal-Yanni M, 2010, LANCET, V375, P121, DOI 10.1016/S0140-6736(10)60048-7; Kangwana BP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000437; Laxminarayan R, 2009, HEALTH AFFAIR, V28, P949, DOI 10.1377/hlthaff.28.4.949; Measure DHS, 2012, DEM HLTH SURV MAL RW; Measure DHS, 2012, MAL IND SURV ANG KEN; Moon S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000106; O'Connell KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-326; Roll Back Malaria, 2011, UPD ACT PRIC AFF MED; Sabot O, 2009, DISTRIBUTION ARTEMIS; Sabot O, 2011, HEALTH POLICY PLANN, V26, P441, DOI 10.1093/heapol/czr067; Sabot OJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006857; Schaferhoff M, 2010, ESTIMATING BENCHMARK; Shewchuk T, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-325; Talisuna A, 2009, LANCET, V374, P1224, DOI 10.1016/S0140-6736(09)61767-0; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Yadav P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-299; Yamey G, 2012, B WORLD HEALTH ORGAN, V90, P452, DOI 10.2471/BLT.11.091199; Yeung S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-243	33	114	115	2	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 1	2012	380	9857					1916	1926		10.1016/S0140-6736(12)61732-2	http://dx.doi.org/10.1016/S0140-6736(12)61732-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	046IK	23122217				2022-12-28	WOS:000311758500028
J	Manheimer, E				Manheimer, Eric			Seeing in the Dark	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NYU, Sch Med, New York, NY 10012 USA	New York University	Manheimer, E (corresponding author), NYU, Sch Med, New York, NY 10012 USA.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2012	367	22								10.1056/NEJMp1213611	http://dx.doi.org/10.1056/NEJMp1213611			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	044MS	23151282				2022-12-28	WOS:000311624400004
J	Piccione, A; Petruzziello, C; Mazzarelli, P; Bertoli, A				Piccione, Alessandro; Petruzziello, Carmelina; Mazzarelli, Paola; Bertoli, Aldo			Persistent watery diarrhoea and coma in an elderly woman	LANCET			English	Editorial Material									[Piccione, Alessandro; Petruzziello, Carmelina; Bertoli, Aldo] Univ Rome, Dept Internal Med, Rome, Italy; [Mazzarelli, Paola] Univ Rome, Dept Biopathol, Rome, Italy	Sapienza University Rome; Sapienza University Rome	Bertoli, A (corresponding author), Univ Roma Tor Vergata, Dept Internal Med, Via Montpellier 1, I-00133 Rome, Italy.	aldo.bertoli@uniroma2.it		Bertoli, Aldo/0000-0001-8995-2582				Barton SH, 2008, GASTROENTEROL CLIN N, V37, P411, DOI 10.1016/j.gtc.2008.02.001; Francini-Pesenti F, 2009, NUTRITION, V25, P142, DOI 10.1016/j.nut.2008.08.003; Freeman HJ, 2010, WORLD J GASTROENTERO, V16, P296, DOI 10.3748/wjg.v16.i3.296; Rubio-Tapia A, 2010, CLIN GASTROENTEROL H, V8, P344, DOI 10.1016/j.cgh.2009.12.023; Tysk C, 2008, WORLD J GASTROENTERO, V14, P7280, DOI 10.3748/wjg.14.7280	5	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 24	2012	380	9856					1880	1880		10.1016/S0140-6736(12)61412-3	http://dx.doi.org/10.1016/S0140-6736(12)61412-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	041XK	23177701				2022-12-28	WOS:000311435000034
J	Huang, SD; Holzel, M; Knijnenburg, T; Schlicker, A; Roepman, P; McDermott, U; Garnett, M; Grernrum, W; Sun, C; Prahallad, A; Groenendijk, FH; Mittempergher, L; Nijkamp, W; Neefjes, J; Salazar, R; ten Dijke, P; Uramoto, H; Tanaka, F; Beijersbergen, RL; Wessels, LFA; Bernards, R				Huang, Sidong; Hoelzel, Michael; Knijnenburg, Theo; Schlicker, Andreas; Roepman, Paul; McDermott, Ultan; Garnett, Mathew; Grernrum, Wipawadee; Sun, Chong; Prahallad, Anirudh; Groenendijk, Floris H.; Mittempergher, Lorenza; Nijkamp, Wouter; Neefjes, Jacques; Salazar, Ramon; ten Dijke, Peter; Uramoto, Hidetaka; Tanaka, Fumihiro; Beijersbergen, Roderick L.; Wessels, Lodewyk F. A.; Bernards, Rene			MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-beta Receptor Signaling	CELL			English	Article							ANAPLASTIC LYMPHOMA KINASE; CELL LUNG-CANCER; COLORECTAL-CANCER; RESISTANCE; MUTATIONS; SENSITIVITY; INHIBITION; PATHWAY; THERAPY; SCREEN	Inhibitors of the ALK and EGF receptor tyrosine kinases provoke dramatic but short-lived responses in lung cancers harboring EML4-ALK translocations or activating mutations of EGFR, respectively. We used a large-scale RNAi screen to identify MED12, a component of the transcriptional MEDIATOR complex that is mutated in cancers, as a determinant of response to ALK and EGFR inhibitors. MED12 is in part cytoplasmic where it negatively regulates TGF-beta R2 through physical interaction. MED12 suppression therefore results in activation of TGF-beta R signaling, which is both necessary and sufficient for drug resistance. TGF-beta signaling causes MEK/ERK activation, and consequently MED12 suppression also confers resistance to MEK and BRAF inhibitors in other cancers. MED12 loss induces an EMT-like phenotype, which is associated with chemotherapy resistance in colon cancer patients and to gefitinib in lung cancer. Inhibition of TGF-beta R signaling restores drug responsiveness in MED12(KD) cells, suggesting a strategy to treat drug-resistant tumors that have lost MED12.	[Huang, Sidong; Hoelzel, Michael; Knijnenburg, Theo; Schlicker, Andreas; Grernrum, Wipawadee; Sun, Chong; Prahallad, Anirudh; Groenendijk, Floris H.; Mittempergher, Lorenza; Nijkamp, Wouter; Beijersbergen, Roderick L.; Wessels, Lodewyk F. A.; Bernards, Rene] Netherlands Canc Inst, Canc Genom Ctr, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; [Huang, Sidong; Hoelzel, Michael; Knijnenburg, Theo; Schlicker, Andreas; Grernrum, Wipawadee; Sun, Chong; Prahallad, Anirudh; Groenendijk, Floris H.; Mittempergher, Lorenza; Nijkamp, Wouter; Beijersbergen, Roderick L.; Wessels, Lodewyk F. A.; Bernards, Rene] Netherlands Canc Inst, Canc Syst Biol Ctr, NL-1066 CX Amsterdam, Netherlands; [Neefjes, Jacques] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands; [Roepman, Paul; Bernards, Rene] Agendia Inc, Irvine, CA 92618 USA; [Roepman, Paul; Bernards, Rene] Agendia NV, NL-1098 XH Amsterdam, Netherlands; [McDermott, Ultan; Garnett, Mathew] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Salazar, Ramon] Inst Catala Oncol IDIBELL, Lhospitalet De Llobregat 08908, Spain; [ten Dijke, Peter] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; [Uramoto, Hidetaka; Tanaka, Fumihiro] Univ Occupat & Environm Hlth, Dept Surg 2, Sch Med, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Agendia; Agendia; Wellcome Trust Sanger Institute; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Occupational & Environmental Health - Japan	Bernards, R (corresponding author), Netherlands Canc Inst, Canc Genom Ctr, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl	Dijke, Peter ten/AAG-4660-2021; Sun, Chong/AAB-4859-2021; Neefjes, Jacques J.C./H-8780-2017	Dijke, Peter ten/0000-0002-7234-342X; Sun, Chong/0000-0001-9008-2158; Neefjes, Jacques J.C./0000-0001-6763-2211; Bernards, Rene/0000-0001-8677-3423; Mittempergher, Lorenza/0000-0003-3425-3965; Huang, Sidong/0000-0002-2838-4726; Beijersbergen, Roderick/0000-0003-0116-4130; McDermott, Ultan/0000-0001-9032-4700; Schlicker, Andreas/0000-0002-6588-7883	Dutch Cancer Society; European Research Council grant; Cancer Systems Biology Center grant by NWO; Netherlands Genomics Initiative (NGI); Spanish BAE FIS travel grant by Instituto Carlos III	Dutch Cancer Society(KWF Kankerbestrijding); European Research Council grant(European Research Council (ERC)); Cancer Systems Biology Center grant by NWO; Netherlands Genomics Initiative (NGI); Spanish BAE FIS travel grant by Instituto Carlos III	We thank the members of the NKI Genomics Core Facility, Maarten van Dinther, Jelle Wesseling, Ingrid Hofland, Ian Majewski, Kylie Greig, Johan Kuiken, and Erik Voets for technical support and discussion. We are grateful to Cinzia Pochet for support. This work was supported by grants from the Dutch Cancer Society, a European Research Council grant, The Cancer Systems Biology Center grant by NWO, The Netherlands Genomics Initiative (NGI), and a Spanish BAE FIS travel grant by Instituto Carlos III (to R.S.). P.R. and R.B. are employees and shareholders of Agendia Inc.	Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kim YW, 2012, BIOCHEM J, V445, P403, DOI 10.1042/BJ20111923; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Uramoto H, 2011, LUNG CANCER, V73, P361, DOI 10.1016/j.lungcan.2011.01.008; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	31	308	333	0	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					937	950		10.1016/j.cell.2012.10.035	http://dx.doi.org/10.1016/j.cell.2012.10.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178117	Bronze, Green Accepted			2022-12-28	WOS:000311423500009
J	Osmundson, J; Montero-Diez, C; Westblade, LF; Hochschild, A; Darst, SA				Osmundson, Joseph; Montero-Diez, Cristina; Westblade, Lars F.; Hochschild, Ann; Darst, Seth A.			Promoter-Specific Transcription Inhibition in Staphylococcus aureus by a Phage Protein	CELL			English	Article							RNA-POLYMERASE HOLOENZYME; PRIMARY SIGMA-FACTOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ALPHA-SUBUNIT; BACTERIOPHAGE-T7 DNA; RIBOSOME SYNTHESIS; BACTERIAL; RECOGNITION; INITIATION	Phage G1 gp67 is a 23 kDa protein that binds to the Staphylococcus aureus (Sau) RNA polymerase (RNAP) sigma(A) subunit and blocks cell growth by inhibiting transcription. We show that gp67 has little to no effect on transcription from most promoters but is a potent inhibitor of ribosomal RNA transcription. A 2.0-angstrom-resolution crystal structure of the complex between gp67 and Sau sigma(A) domain 4 (sigma(A)(4)) explains how gp67 joins the RNAP promoter complex through sigma(A)(4) without significantly affecting sigma(A)(4) function. Our results indicate that gp67 forms a complex with RNAP at most, if not all, sigma(A)-dependent promoters, but selectively inhibits promoters that depend on an interaction between upstream DNA and the RNAP alpha-subunit C-terminal domain (alpha CTD). Thus, we reveal a promoter-specific transcription inhibition mechanism by which gp67 interacts with the RNAP promoter complex through one subunit (sigma(A)), and selectively affects the function of another subunit (alpha CTD) depending on promoter usage.	[Osmundson, Joseph; Westblade, Lars F.; Darst, Seth A.] Rockefeller Univ, New York, NY 10065 USA; [Montero-Diez, Cristina; Hochschild, Ann] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Rockefeller University; Harvard University; Harvard Medical School	Darst, SA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	darst@rockefeller.edu			Office of Basic Energy Sciences, U.S. Department of Energy; National Center for Research Resources, National Institutes of Health (NIH) [RR-15301]; NIH [RO1 GM044025, RO1 GM053759]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044025, R01GM053759] Funding Source: NIH RePORTER	Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E.A. Campbell, R. Gourse, W. Ross, and P. Deighan for helpful discussions; K.R. Rajashankar and F. Murphy at APS NE-CAT beamline 24ID, and W. Shi at NSLS beamline X3A for support with synchrotron data collection; S. Wigneshweraraj for gifts of plasmids and helpful advice; and C. Zhao and S. Dewell of The Rockefeller University Genomics Resource Center for assistance with RNA-seq. We also thank all members of the Darst and Hochschild laboratories for helpful discussions. This work was based in part on research conducted at the APS and NSLS, supported by the Office of Basic Energy Sciences, U.S. Department of Energy. The NE-CAT beamlines at the APS are supported by award RR-15301 from the National Center for Research Resources, National Institutes of Health (NIH). This work was supported by NIH grants RO1 GM044025 to A. H. and RO1 GM053759 to S. A. D.	Barker MM, 2001, J MOL BIOL, V305, P689, DOI 10.1006/jmbi.2000.4328; BLATTER EE, 1994, CELL, V78, P889, DOI 10.1016/S0092-8674(94)90682-3; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Campbell EA, 2008, CURR OPIN MICROBIOL, V11, P121, DOI 10.1016/j.mib.2008.02.016; Campbell EA, 2007, MOL CELL, V27, P793, DOI 10.1016/j.molcel.2007.07.009; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; Darst SA, 2001, CURR OPIN STRUC BIOL, V11, P155; Datta I, 2005, J BIOCHEM MOL BIOL, V38, P97; Dehbi M, 2009, J BACTERIOL, V191, P3763, DOI 10.1128/JB.00241-09; Deora R, 1996, J BIOL CHEM, V271, P21828, DOI 10.1074/jbc.271.36.21828; Deutscher MP, 2003, J BIOL CHEM, V278, P45041, DOI 10.1074/jbc.R300031200; Dove Simon L, 2004, Methods Mol Biol, V261, P231; Estrem ST, 1999, GENE DEV, V13, P2134, DOI 10.1101/gad.13.16.2134; Estrem ST, 1998, P NATL ACAD SCI USA, V95, P9761, DOI 10.1073/pnas.95.17.9761; Feklistov A, 2006, MOL CELL, V23, P97, DOI 10.1016/j.molcel.2006.06.010; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Fox K R, 1997, Methods Mol Biol, V90, P1; Gourse RL, 2000, MOL MICROBIOL, V37, P687, DOI 10.1046/j.1365-2958.2000.01972.x; Gourse RL, 1996, ANNU REV MICROBIOL, V50, P645, DOI 10.1146/annurev.micro.50.1.645; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; Haugen SP, 2008, P NATL ACAD SCI USA, V105, P3292, DOI [10.1073/pnas.0709513105, 10.1073/pnas.07095l3105]; Hinton DM, 2005, MICROBIOL-SGM, V151, P1729, DOI 10.1099/mic.0.27972-0; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Jain D, 2005, MOL CELL, V19, P259, DOI 10.1016/j.molcel.2005.06.006; Jain D, 2004, MOL CELL, V13, P45, DOI 10.1016/S1097-2765(03)00483-0; KADESCH TR, 1982, J MOL BIOL, V155, P1, DOI 10.1016/0022-2836(82)90489-2; KEILTY S, 1987, J BIOL CHEM, V262, P6389; Krasny L, 2004, EMBO J, V23, P4473, DOI 10.1038/sj.emboj.7600423; Kuznedelov K, 2002, SCIENCE, V295, P855, DOI 10.1126/science.1066303; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; Lambert LJ, 2004, EMBO J, V23, P2952, DOI 10.1038/sj.emboj.7600312; Lemke JJ, 2011, P NATL ACAD SCI USA, V108, P5712, DOI 10.1073/pnas.1019383108; Liu J, 2004, NAT BIOTECHNOL, V22, P185, DOI 10.1038/nbt932; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Nechaev S, 2003, ANNU REV MICROBIOL, V57, P301, DOI 10.1146/annurev.micro.57.030502.090942; Nordmann P, 2007, CURR OPIN MICROBIOL, V10, P436, DOI 10.1016/j.mib.2007.07.004; OZOLINE ON, 1995, NUCLEIC ACIDS RES, V23, P4533, DOI 10.1093/nar/23.22.4533; Patikoglou GA, 2007, J MOL BIOL, V372, P649, DOI 10.1016/j.jmb.2007.06.081; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Ptashne M, 1992, GENETIC SWITCH PHAGE; RAO L, 1995, J BACTERIOL, V177, P2609, DOI 10.1128/jb.177.10.2609-2614.1995; Reyes D, 2011, J BACTERIOL, V193, P6020, DOI 10.1128/JB.05436-11; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROSENBERG S, 1982, J MOL BIOL, V155, P31, DOI 10.1016/0022-2836(82)90490-9; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Shultzaberger RK, 2007, NUCLEIC ACIDS RES, V35, P771, DOI 10.1093/nar/gkl956; STEVENS A, 1977, NUCLEIC ACIDS RES, V4, P877, DOI 10.1093/nar/4.4.877; Tiemann B, 2004, J BACTERIOL, V186, P7262, DOI 10.1128/JB.186.21.7262-7272.2004; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TRAVERS AA, 1984, NUCLEIC ACIDS RES, V12, P2605, DOI 10.1093/nar/12.6.2605; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; WADE HE, 1964, BIOCHEM J, V93, P121, DOI 10.1042/bj0930121; Xu HH, 2010, ANTIMICROB AGENTS CH, V54, P3659, DOI 10.1128/AAC.00308-10; Yano ST, 2011, MOL MICROBIOL, V79, P1325, DOI 10.1111/j.1365-2958.2010.07526.x	64	17	19	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					1005	1016		10.1016/j.cell.2012.10.034	http://dx.doi.org/10.1016/j.cell.2012.10.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178120	Green Accepted, Bronze			2022-12-28	WOS:000311423500014
J	Wu, BR; Zhang, Z; Lui, W; Chen, XJ; Wang, YD; Chamberlain, AA; Moreno-Rodriguez, RA; Markwald, RR; O'Rourke, BP; Sharp, DJ; Zheng, DY; Lenz, J; Baldwin, HS; Chang, CP; Zhou, B				Wu, Bingruo; Zhang, Zheng; Lui, Wendy; Chen, Xiangjian; Wang, Yidong; Chamberlain, Alyssa A.; Moreno-Rodriguez, Ricardo A.; Markwald, Roger R.; O'Rourke, Brian P.; Sharp, David J.; Zheng, Deyou; Lenz, Jack; Baldwin, H. Scott; Chang, Ching-Pin; Zhou, Bin			Endocardial Cells Form the Coronary Arteries by Angiogenesis through Myocardial-Endocardial VEGF Signaling	CELL			English	Article							SMOOTH-MUSCLE-CELLS; CARDIAC MORPHOGENESIS; TRANSCRIPTION FACTOR; VESSEL DEVELOPMENT; ENDOTHELIAL-CELLS; NF-ATC; MOUSE; EXPRESSION; LINEAGE; ORIGIN	The origins and developmental mechanisms of coronary arteries are incompletely understood. We show here by fate mapping, clonal analysis, and immunohistochemistry that endocardial cells generate the endothelium of coronary arteries. Dye tracking, live imaging, and tissue transplantation also revealed that ventricular endocardial cells are not terminally differentiated; instead, they are angiogenic and form coronary endothelial networks. Myocardial Vegf-a or endocardial Vegfr-2 deletion inhibited coronary angiogenesis and arterial formation by ventricular endocardial cells. In contrast, lineage and knockout studies showed that endocardial cells make a small contribution to the coronary veins, the formation of which is independent of myocardialto-endocardial Vegf signaling. Thus, contrary to the current view of a common source for the coronary vessels, our findings indicate that the coronary arteries and veins have distinct origins and are formed by different mechanisms. This information may help develop better cell therapies for coronary artery disease.	[Wu, Bingruo; Zhang, Zheng; Lui, Wendy; Chen, Xiangjian; Wang, Yidong; Chamberlain, Alyssa A.; Lenz, Jack; Zhou, Bin] Yeshiva Univ Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Zhou, Bin] Yeshiva Univ Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA; [Zhou, Bin] Yeshiva Univ Albert Einstein Coll Med, Dept Med Cardiol, Bronx, NY 10461 USA; [Zhou, Bin] Yeshiva Univ Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Bronx, NY 10461 USA; [O'Rourke, Brian P.; Sharp, David J.] Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Zheng, Deyou] Yeshiva Univ Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Wu, Bingruo; Baldwin, H. Scott; Zhou, Bin] Vanderbilt Univ, Dept Pediat, Nashville, TN 37322 USA; [Zhang, Zheng; Wang, Yidong] Sichuan Univ, State Key Lab Biotherapy, W China Med Sch, Chengdu 610041, Sichuan, Peoples R China; [Chen, Xiangjian; Zhou, Bin] Jiangsu Prov Hosp, Dept Cardiol, Nanjing 210029, Jiangsu, Peoples R China; [Moreno-Rodriguez, Ricardo A.; Markwald, Roger R.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29403 USA; [Chang, Ching-Pin] Stanford Univ, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Vanderbilt University; Sichuan University; Nanjing Medical University; Medical University of South Carolina; Stanford University	Zhou, B (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	bin.zhou@einstein.yu.edu	Zhang, Zheng/G-7187-2016; moreno, ricardo/AAS-5868-2021; Moreno-Rodriguez, Ricardo/GPT-4006-2022	Zheng, Deyou/0000-0003-4354-5337; Moreno Rodriguez, Ricardo Alberto/0000-0002-5420-4231	NIH [HL078881, HL100398, HL85345]; AHA [0435128N]; Tuner-Hazinski Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100398, R01HL078881, R01HL085345] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Tuner-Hazinski Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to Napoleone Ferrara, Janet Rossant, Kyunghee Choi, and Gordon Fishell for Vegf-a<SUP>f/f</SUP>, Vegfr-2<SUP>f/f</SUP>, RCE<SUP>fsEGFP</SUP> mice. We thank Drs. Bernice Morrow and Richard Kitsis for critical reading of the manuscript and Tatyana Harris for the illustration. B.Z. was supported by NIH (HL078881), AHA (0435128N) and Tuner-Hazinski Research Award. H.S.B. and C.-P.C. were supported by NIH (HL100398 and HL85345, respectively).	Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Chen JW, 2006, CIRC RES, V98, P923, DOI 10.1161/01.RES.0000218041.41932.e3; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Gustafsson E, 2001, J CELL SCI, V114, P671; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Katz TC, 2012, DEV CELL, V22, P639, DOI 10.1016/j.devcel.2012.01.012; KOMIYAMA M, 1987, ANAT EMBRYOL, V176, P183, DOI 10.1007/BF00310051; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Lavine KJ, 2009, CIRC RES, V104, P159, DOI 10.1161/CIRCRESAHA.108.191239; Luttun A, 2003, CARDIOVASC RES, V58, P378, DOI 10.1016/S0008-6363(03)00258-X; Majesky MW, 2004, CURR TOP DEV BIOL, V62, P225; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; MIKAWA T, 1992, P NATL ACAD SCI USA, V89, P9504, DOI 10.1073/pnas.89.20.9504; MIKAWA T, 1992, DEV DYNAM, V193, P11, DOI 10.1002/aja.1001930104; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Misfeldt AM, 2009, DEV BIOL, V333, P78, DOI 10.1016/j.ydbio.2009.06.033; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Olivey HE, 2010, CIRC RES, V106, P818, DOI 10.1161/CIRCRESAHA.109.209197; Peeters MPFMV, 1999, ANAT EMBRYOL, V199, P367, DOI 10.1007/s004290050235; Perez-Pomares JM, 2002, INT J DEV BIOL, V46, P1005; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Sugi Y, 1996, DEV BIOL, V175, P66, DOI 10.1006/dbio.1996.0096; Tomanek RJ, 2006, CIRC RES, V98, P947, DOI 10.1161/01.RES.0000216974.75994.da; VIRAGH S, 1981, ANAT REC, V201, P157, DOI 10.1002/ar.1092010117; Wada AM, 2003, ARTERIOSCL THROM VAS, V23, P2138, DOI 10.1161/01.ATV.0000098645.38676.CC; Wikenheiser J, 2006, DEV DYNAM, V235, P115, DOI 10.1002/dvdy.20499; Wu BR, 2011, CIRC RES, V109, P183, DOI 10.1161/CIRCRESAHA.111.245035; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhou B, 2005, DEVELOPMENT, V132, P1137, DOI 10.1242/dev.01640; Zhou B, 2002, J BIOL CHEM, V277, P10704, DOI 10.1074/jbc.M107068200; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	45	256	263	0	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					1083	1096		10.1016/j.cell.2012.10.023	http://dx.doi.org/10.1016/j.cell.2012.10.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178125	Green Accepted, Bronze			2022-12-28	WOS:000311423500020
J	Polis, MA				Polis, Michael A.			Preexposure prophylaxis reduced HIV-1 spread in serodiscordant heterosexual couples	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									NIAID, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Polis, MA (corresponding author), NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.							Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; U.S. Food and Drug Administration, 2012, FDA APPR 1 MED RED H	2	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10							JC5-3	10.7326/0003-4819-157-10-201211200-02003	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043VZ	23165679				2022-12-28	WOS:000311580000002
J	Laurie, B; Doctorow, C				Laurie, Ben; Doctorow, Cory			Secure the Internet	NATURE			English	Editorial Material											Laurie, B (corresponding author), Univ Cambridge, Cambridge CB2 1TN, England.	ctnaturepaper@links.org						[Anonymous], 2011, EC TIMES        1220	1	5	5	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					325	326		10.1038/491325a	http://dx.doi.org/10.1038/491325a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	036MY	23151561	Bronze, Green Published			2022-12-28	WOS:000311031600013
J	Koerte, IK; Ertl-Wagner, B; Reiser, M; Zafonte, R; Shenton, ME				Koerte, Inga K.; Ertl-Wagner, Birgit; Reiser, Maximilian; Zafonte, Ross; Shenton, Martha E.			White Matter Integrity in the Brains of Professional Soccer Players Without a Symptomatic Concussion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Koerte, Inga K.] Harvard Univ, Sch Med, Psychiat Neuroimaging Lab, Boston, MA 02115 USA; [Zafonte, Ross] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Ertl-Wagner, Birgit; Reiser, Maximilian] Univ Munich, Inst Clin Radiol, Munich, Germany; [Shenton, Martha E.] VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Munich; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Koerte, IK (corresponding author), Harvard Univ, Sch Med, Psychiat Neuroimaging Lab, Boston, MA 02115 USA.	ikoerte@bwh.harvard.edu	Ertl-Wagner, Birgit/AAD-5708-2020; Koerte, Inga Katharina/AAW-3031-2021	Ertl-Wagner, Birgit/0000-0002-7896-7049	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078337] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS078337] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024	5	163	164	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1859	1861		10.1001/jama.2012.13735	http://dx.doi.org/10.1001/jama.2012.13735			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23150002	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000310952700016
J	Kamerow, D				Kamerow, Douglas			Can suicide be prevented?	BRITISH MEDICAL JOURNAL			English	Editorial Material												dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Centers for Disease Control and Prevention National Center for Health Statistics, DEATHS DEATH RAT 201; *DEP HLTH HUM SERV, 2001, NAT STRAT SUIC PREV; Harvard School of Public Health, MEANS MATT; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Luoma JB, 2002, AM J PSYCHIAT, V159, P909, DOI 10.1176/appi.ajp.159.6.909; Office of the Surgeon General (US) & National Action Alliance for Suicide Prevention (US), 2012, 2012 NAT STRAT SUIC; van der Feltz-Cornelis CM, 2011, CRISIS, V32, P319, DOI 10.1027/0227-5910/a000109	7	2	2	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 7	2012	345								e7557	10.1136/bmj.e7557	http://dx.doi.org/10.1136/bmj.e7557			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	036LI	23135286				2022-12-28	WOS:000311027000012
J	Nissen, SE				Nissen, Steven E.			Cardiovascular Effects of Diabetes Drugs: Emerging From the Dark Ages	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MYOCARDIAL-INFARCTION; DEATH; ROSIGLITAZONE; MELLITUS; RISK		Cleveland Clin, Dept Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Nissen, SE (corresponding author), Cleveland Clin, Dept Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	nissens@ccf.org						Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Diamond GA, 2007, ANN INTERN MED, V147, P578, DOI 10.7326/0003-4819-147-8-200710160-00182; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; GOLDNER MG, 1971, J AMER MED ASSOC, V218, P1400, DOI 10.1001/jama.218.9.1400; Meier JJ, 2004, HEART, V90, P9, DOI 10.1136/heart.90.1.9; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Roumie CL, 2012, ANN INTERN MED, V157, P601, DOI 10.7326/0003-4819-157-9-201211060-00003; Schwartz TB, 2004, PERSPECT BIOL MED, V47, P564, DOI 10.1353/pbm.2004.0071; US Food and Drug Administration, 2008, GUID IND DIAB MELL E	11	20	20	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2012	157	9					671	672		10.7326/0003-4819-157-9-201211060-00016	http://dx.doi.org/10.7326/0003-4819-157-9-201211060-00016			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033GX	23128866				2022-12-28	WOS:000310783300011
J	Boyce, N				Boyce, Niall			The Lancet Technology: November, 2012	LANCET			English	Editorial Material												niall.boyce@lancet.com							0	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 3	2012	380	9853					1547	1547		10.1016/S0140-6736(12)61867-4	http://dx.doi.org/10.1016/S0140-6736(12)61867-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	030VR	23130362				2022-12-28	WOS:000310598700015
J	Elli, L				Elli, Luca			Where's the evidence for gluten sensitivity?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Osped Maggiore Policlin, Ctr Prevent & Diag Coeliac Dis, Fdn IRCCS Ca Granda, I-20122 Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico	Elli, L (corresponding author), Osped Maggiore Policlin, Ctr Prevent & Diag Coeliac Dis, Fdn IRCCS Ca Granda, Via Francesco Sforza 35, I-20122 Milan, Italy.	lucelli@yahoo.com	Elli, Luca/K-6084-2016	Elli, Luca/0000-0002-0873-0759				Elli L, 2003, TOXICOL LETT, V146, P1, DOI 10.1016/j.toxlet.2003.09.004; Enck P, 2010, EUR J GASTROEN HEPAT, V22, P1402, DOI 10.1097/MEG.0b013e3283405a17; Painter K, 2008, US TODAY; Sapone A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-13; Sapone A, 2010, INT ARCH ALLERGY IMM, V152, P75, DOI 10.1159/000260087; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Volta U, 2012, NAT REV GASTRO HEPAT, V9, P295, DOI 10.1038/nrgastro.2012.15	7	8	8	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 2	2012	345								e7360	10.1136/bmj.e7360	http://dx.doi.org/10.1136/bmj.e7360			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033FL	23125126				2022-12-28	WOS:000310779500001
J	Kyritsis, N; Kizil, C; Zocher, S; Kroehne, V; Kaslin, J; Freudenreich, D; Iltzsche, A; Brand, M				Kyritsis, Nikos; Kizil, Caghan; Zocher, Sara; Kroehne, Volker; Kaslin, Jan; Freudenreich, Dorian; Iltzsche, Anne; Brand, Michael			Acute Inflammation Initiates the Regenerative Response in the Adult Zebrafish Brain	SCIENCE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL NEUROGENESIS; IN-VIVO; INJURY; PROLIFERATION; TELENCEPHALON; ANTAGONIST; RECEPTOR-1; CELLS	The zebrafish regenerates its brain after injury and hence is a useful model organism to study the mechanisms enabling regenerative neurogenesis, which is poorly manifested in mammals. Yet the signaling mechanisms initiating such a regenerative response in fish are unknown. Using cerebroventricular microinjection of immunogenic particles and immunosuppression assays, we showed that inflammation is required and sufficient for enhancing the proliferation of neural progenitors and subsequent neurogenesis by activating injury-induced molecular programs that can be observed after traumatic brain injury. We also identified cysteinyl leukotriene signaling as an essential component of inflammation in the regenerative process of the adult zebrafish brain. Thus, our results demonstrate that in zebrafish, in contrast to mammals, inflammation is a positive regulator of neuronal regeneration in the central nervous system.	[Kyritsis, Nikos; Kizil, Caghan; Zocher, Sara; Kroehne, Volker; Kaslin, Jan; Freudenreich, Dorian; Iltzsche, Anne; Brand, Michael] Tech Univ Dresden, Deutsch Forshungsgemeinschaft Ctr Regenerat Thera, D-01307 Dresden, Germany; [Kaslin, Jan] Monash Univ, ARMI, Clayton, Vic 3800, Australia	Technische Universitat Dresden; Australian Regenerative Medicine Institute; Monash University	Brand, M (corresponding author), Tech Univ Dresden, Deutsch Forshungsgemeinschaft Ctr Regenerat Thera, Fetscherstasse 105, D-01307 Dresden, Germany.	michael.brand@biotec.tu-dresden.de	Kizil, Caghan/J-6923-2015; Kyritsis, Nikos/AAD-5187-2021; Kizil, Caghan/AFG-2073-2022; Brand, Michael/A-5509-2010	Kizil, Caghan/0000-0002-8164-9762; Kyritsis, Nikos/0000-0001-7801-5796; Kizil, Caghan/0000-0002-8164-9762; Brand, Michael/0000-0001-5711-6512; Kaslin, Jan/0000-0002-6207-1889; Zocher, Sara/0000-0001-8211-5490; Kroehne, Volker/0000-0002-5610-0866	Deutsche Forschungsgemeinschaft [SFB-655]; European Union (ZF Health, EC) [HEALTH-F4-2010-242048]; Technical University of Dresden	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (ZF Health, EC); Technical University of Dresden	We thank A. Menge for cryosections and paraffin sections, G. Kempermann and C. L. Antos for useful discussions, T. Chavakis for discussions and critical reading on the manuscript, N. Trede for discussion and assistance with the immunosuppression assay, and M. Redd for kindly providing us the L-plastin antibody. This work was supported by research grants from the Deutsche Forschungsgemeinschaft (SFB-655), European Union (ZF Health, EC Grant Agreement HEALTH-F4-2010-242048), and Technical University of Dresden.	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Finsen B, 2011, FEBS LETT, V585, P3806, DOI 10.1016/j.febslet.2011.05.030; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kizil C, 2012, DEV CELL, V23, P1230, DOI 10.1016/j.devcel.2012.10.014; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kizil C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027395; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Lieschke GJ, 2009, CURR BIOL, V19, pR678, DOI 10.1016/j.cub.2009.06.068; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Martin P, 2009, NATURE, V459, P921, DOI 10.1038/459921a; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Redd MJ, 2006, CELL MOTIL CYTOSKEL, V63, P415, DOI 10.1002/cm.20133; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Yu GL, 2005, BRAIN RES, V1053, P116, DOI 10.1016/j.brainres.2005.06.046; Zhang WP, 2002, ACTA PHARMACOL SIN, V23, P871	26	345	352	5	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1353	1356		10.1126/science.1228773	http://dx.doi.org/10.1126/science.1228773			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23138980				2022-12-28	WOS:000311991200070
J	Yan, J; Bloom, M; Bae, SC; Luijten, E; Granick, S				Yan, Jing; Bloom, Moses; Bae, Sung Chul; Luijten, Erik; Granick, Steve			Linking synchronization to self-assembly using magnetic Janus colloids	NATURE			English	Article							OSCILLATORS; SPHERES	Synchronization occurs widely in the natural and technological worlds, from the rhythm of applause and neuron firing(1) to the quantum mechanics of coupled Josephson junctions(2), but has not been used to produce new spatial structures. Our understanding of self-assembly has evolved independently in the fields of chemistry and materials, and with a few notable exceptions(3,4) has focused on equilibrium rather than dynamical systems. Here we combine these two phenomena to create synchronization-selected microtubes of Janus colloids, micron-sized spherical particles with different surface chemistry on their opposing hemispheres, which we study using imaging and computer simulation. A thin nickel film coats one hemisphere of each silica particle to generate a discoid magnetic symmetry, such that in a precessing magnetic field its dynamics retain crucial phase freedom. Synchronizing their motion, these Janus spheres self-organize into micrometre-scale tubes in which the constituent particles rotate and oscillate continuously. In addition, the microtube must be tidally locked to the particles, that is, the particles must maintain their orientation within the rotating microtube. This requirement leads to a synchronization-induced structural transition that offers various applications based on the potential to form, disintegrate and fine-tune self-assembled in-motion structures in situ. Furthermore, it offers a generalizable method of controlling structure using dynamic synchronization criteria rather than static energy minimization, and of designing new field-driven microscale devices in which components do not slavishly follow the external field.	[Bloom, Moses; Luijten, Erik] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Yan, Jing; Bae, Sung Chul; Granick, Steve] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Luijten, Erik] Northwestern Univ, Dept Engn Sci & Appl Math, Evanston, IL 60208 USA; [Granick, Steve] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Granick, Steve] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	Northwestern University; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Luijten, E (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.	luijten@northwestern.edu; sgranick@uiuc.edu	Luijten, Erik/E-3899-2010; Bae, Sung C/A-3423-2008	Luijten, Erik/0000-0003-2364-1866; Bae, Sung C/0000-0002-9765-6801	US Army Research Office [W911NF-10-1-0518]; National Science Foundation [DMR-1006430, CBET-0853737]; US Department of Energy, Division of Materials Science through Frederick Seitz Materials Research Laboratory at the University of Illinois at Urbana-Champaign [DE-FG02-07ER46471]; Direct For Mathematical & Physical Scien [1006430] Funding Source: National Science Foundation; Directorate For Engineering [0853737] Funding Source: National Science Foundation	US Army Research Office; National Science Foundation(National Science Foundation (NSF)); US Department of Energy, Division of Materials Science through Frederick Seitz Materials Research Laboratory at the University of Illinois at Urbana-Champaign(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the US Army Research Office, grant award number W911NF-10-1-0518 (Y.J., S. C. B. and S. G.) and by the National Science Foundation under award number DMR-1006430 (M. B. and E. L.). The methods of Janus particle fabrication were supported by the US Department of Energy, Division of Materials Science, under award number DE-FG02-07ER46471 through the Frederick Seitz Materials Research Laboratory at the University of Illinois at Urbana-Champaign. We acknowledge support from the National Science Foundation, CBET-0853737 for equipment and from the Quest high-performance computing facility at Northwestern University. We thank J. Whitmer for writing the original version of the simulation code.	ADLER R, 1946, P IRE, V34, P351, DOI 10.1109/JRPROC.1946.229930; Albrecht M, 2005, NAT MATER, V4, P203, DOI 10.1038/nmat1324; Chen Q, 2011, SCIENCE, V331, P199, DOI 10.1126/science.1197451; Damasceno PF, 2012, SCIENCE, V337, P453, DOI 10.1126/science.1220869; Duncanson WJ, 2012, LAB CHIP, V12, P2135, DOI 10.1039/c2lc21164e; ERICKSON RO, 1973, SCIENCE, V181, P705, DOI 10.1126/science.181.4101.705; Gerbode SJ, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.078301; Grzybowski BA, 2000, NATURE, V405, P1033, DOI 10.1038/35016528; Jager S, 2011, SOFT MATTER, V7, P6606, DOI 10.1039/c1sm05343d; Kantorovich S, 2011, SOFT MATTER, V7, P5217, DOI 10.1039/c1sm05186e; Kiss IZ, 2002, SCIENCE, V296, P1676, DOI 10.1126/science.1070757; Kotar J, 2010, P NATL ACAD SCI USA, V107, P7669, DOI 10.1073/pnas.0912455107; Lohr MA, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.040401; Martin JE, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021508; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Osterman N, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.228301; Ozyuzer L, 2007, SCIENCE, V318, P1291, DOI 10.1126/science.1149802; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Polin M, 2009, SCIENCE, V325, P487, DOI 10.1126/science.1172667; Riedel IH, 2005, SCIENCE, V309, P300, DOI 10.1126/science.1110329; Sacanna S, 2010, NATURE, V464, P575, DOI 10.1038/nature08906; Sinn I, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3541876; Smoukov SK, 2009, SOFT MATTER, V5, P1285, DOI 10.1039/b814304h; Strogatz S, 2003, SYNC EMERGING SCI SP; Tierno P, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.021501; Vilfan M, 2010, P NATL ACAD SCI USA, V107, P1844, DOI 10.1073/pnas.0906819106; Vissers T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.228303; Yellen BB, 2005, P NATL ACAD SCI USA, V102, P8860, DOI 10.1073/pnas.0500409102; Zerrouki D, 2008, NATURE, V455, P380, DOI 10.1038/nature07237	30	281	289	14	574	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					578	+		10.1038/nature11619	http://dx.doi.org/10.1038/nature11619			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23172215	Green Submitted			2022-12-28	WOS:000311339800048
J	Xiang, YT; Yu, X; Sartorius, N; Ungvari, GS; Chiu, HFK				Xiang, Yu-Tao; Yu, Xin; Sartorius, Norman; Ungvari, Gabor S.; Chiu, Helen F. K.			Mental health in China: challenges and progress	LANCET			English	Editorial Material							SUICIDE		[Xiang, Yu-Tao] Capital Med Univ, Beijing Anding Hosp, Beijing, Peoples R China; [Xiang, Yu-Tao] Univ Maryland, Sch Med, Dept Psychiat, Div Res Serv, Baltimore, MD 21201 USA; [Xiang, Yu-Tao; Chiu, Helen F. K.] Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Yu, Xin] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Sartorius, Norman] Assoc Improvement Mental Hlth Programs, Geneva, Switzerland; [Ungvari, Gabor S.] Univ Notre Dame Australia, Marian Ctr, Perth, WA, Australia	Capital Medical University; University System of Maryland; University of Maryland Baltimore; Chinese University of Hong Kong; Peking University; University of Notre Dame Australia	Xiang, YT (corresponding author), Capital Med Univ, Beijing Anding Hosp, Beijing, Peoples R China.	xyutly@gmail.com						[Anonymous], 2010, LANCET; Cooper JE, 1996, MENTAL DISORDERS CHI; Cyranoski D, 2010, NATURE, V468, P145, DOI 10.1038/468145a; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Ng CH, 2009, ASIA-PAC PSYCHIAT, V1, P90, DOI 10.1111/j.1758-5872.2009.00021.x; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Qian H.P., 2011, BEIJING NEWS    0531, V6, P2011; Wang JR, 1998, CHIN J PSYCHIAT, V5, P75; Wu XM, 2012, REPORT CENTRAL SUBSI; Xiang YT, 2012, LANCET, V379, P780, DOI 10.1016/S0140-6736(11)61704-2; Xiang YT, 2010, LANCET, V376, P1145, DOI 10.1016/S0140-6736(10)61539-5; Zhang J, 2011, SOC SCI CHINA, V5, P97; Zhou S., 2012, PEOPLES DAILY O 1031	14	121	125	1	37	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 17	2012	380	9855					1715	1716		10.1016/S0140-6736(11)60893-3	http://dx.doi.org/10.1016/S0140-6736(11)60893-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	038CV	23158236				2022-12-28	WOS:000311153700005
J	Davies, E				Davies, Edward			States get their say on health: post-election round up	BRITISH MEDICAL JOURNAL			English	Editorial Material												edavies@bmj.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 16	2012	345								e7810	10.1136/bmj.e7810	http://dx.doi.org/10.1136/bmj.e7810			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040QI	23160787				2022-12-28	WOS:000311337500012
J	Beletsky, L; Rich, JD; Walley, AY				Beletsky, Leo; Rich, Josiah D.; Walley, Alexander Y.			Prevention of Fatal Opioid Overdose	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NALOXONE		[Beletsky, Leo] Northeastern Univ, Sch Law, Boston, MA 02115 USA; [Beletsky, Leo] Bouve Coll Hlth Sci, Boston, MA 02115 USA; [Beletsky, Leo] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Rich, Josiah D.] Brown Med Sch, Providence, RI USA; [Rich, Josiah D.] Miriam Hosp, Providence, RI 02906 USA; [Walley, Alexander Y.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Walley, Alexander Y.] Boston Med Ctr, Boston, MA USA	Northeastern University; Northeastern University; University of California System; University of California San Diego; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Boston University; Boston Medical Center	Beletsky, L (corresponding author), Northeastern Univ, Sch Law, 400 Huntington Ave, Boston, MA 02115 USA.	l.beletsky@neu.edu		Walley, Alexander/0000-0002-8158-4882; Beletsky, Leo/0000-0003-0726-0676	NATIONAL INSTITUTE ON DRUG ABUSE [R21DA029201, R37DA019829, K24DA022112, R01DA032082, R25DA013582] Funding Source: NIH RePORTER; NIAAA NIH HHS [U01AA11003] Funding Source: Medline; NIAID NIH HHS [P30 AI042853] Funding Source: Medline; NIDA NIH HHS [1R21DA029201, R25-DA13582, R25 DA013582, R01DA032082, R01 DA032082, R21 DA029201, 5K24DA022112, R37DA019829, R37 DA019829, K24 DA022112] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Albert S, 2011, PAIN MED, V12, pS77, DOI 10.1111/j.1526-4637.2011.01128.x; American Medical Association, AMA AD NEW POL ANN M; Beletsky L, 2007, J URBAN HEALTH, V84, P126, DOI 10.1007/s11524-006-9120-z; Burris S., 2009, DREXEL LAW REV, V1, P273; Doe-Simkins M, 2009, AM J PUBLIC HEALTH, V99, P788, DOI 10.2105/AJPH.2008.146647; Paulozzi Leonard, 2012, Morbidity and Mortality Weekly Report, V61, P10; Wheeler Eliza, 2012, Morbidity and Mortality Weekly Report, V61, P101	7	75	76	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1863	1864		10.1001/jama.2012.14205	http://dx.doi.org/10.1001/jama.2012.14205			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23150005	Green Accepted			2022-12-28	WOS:000310952700019
J	Alzu, A; Bermejo, R; Begnis, M; Lucca, C; Piccini, D; Carotenuto, W; Saponaro, M; Brambati, A; Cocito, A; Foiani, M; Liberi, G				Alzu, Amaya; Bermejo, Rodrigo; Begnis, Martina; Lucca, Chiara; Piccini, Daniele; Carotenuto, Walter; Saponaro, Marco; Brambati, Alessandra; Cocito, Andrea; Foiani, Marco; Liberi, Giordano			Senataxin Associates with Replication Forks to Protect Fork Integrity across RNA-Polymerase-II-Transcribed Genes	CELL			English	Article							ONCOGENE-INDUCED SENESCENCE; OCULOMOTOR APRAXIA TYPE-2; SISTER-CHROMATID COHESION; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; GENOMIC INSTABILITY; MESSENGER-RNA; YEAST SEN1; HOMOLOGOUS RECOMBINATION; RESOLVING CONFLICTS	Transcription hinders replication fork progression and stability. The ATR checkpoint and specialized DNA helicases assist DNA synthesis across transcription units to protect genome integrity. Combining genomic and genetic approaches together with the analysis of replication intermediates, we searched for factors coordinating replication with transcription. We show that the Sen1/Senataxin DNA/RNA helicase associates with forks, promoting their progression across RNA polymerase II (RNAPII)-transcribed genes. sen1 mutants accumulate aberrant DNA structures and DNA-RNA hybrids while forks clash head-on with RNAPII transcription units. These replication defects correlate with hyper-recombination and checkpoint activation in sen1 mutants. The Sen1 function at the forks is separable from its role in RNA processing. Our data, besides unmasking a key role for Senataxin in coordinating replication with transcription, provide a framework for understanding the pathological mechanisms caused by Senataxin deficiencies and leading to the severe neurodegenerative diseases ataxia with oculomotor apraxia type 2 and amyotrophic lateral sclerosis 4.	[Alzu, Amaya; Bermejo, Rodrigo; Begnis, Martina; Lucca, Chiara; Piccini, Daniele; Carotenuto, Walter; Saponaro, Marco; Brambati, Alessandra; Cocito, Andrea; Foiani, Marco; Liberi, Giordano] FIRC Inst Mol Oncol IFOM Fdn, I-20139 Milan, Italy; [Brambati, Alessandra; Liberi, Giordano] CNR, Ist Genet Mol, I-27100 Pavia, Italy; [Foiani, Marco] Univ Milan, DSBB, I-20139 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Milan	Liberi, G (corresponding author), FIRC Inst Mol Oncol IFOM Fdn, Via Adamello 16, I-20139 Milan, Italy.	giordano.liberi@igm.cnr.it	BRAMBATI, Alessandra/AAY-8195-2020; Bermejo, Rodrigo/S-2445-2019; BRAMBATI, Alessandra/Q-1213-2018; Foiani, Marco/M-8234-2014; LIBERI, GIORDANO/AAY-7273-2020; Saponaro, Marco/M-1854-2015; Bermejo, Rodrigo/AAG-7830-2019; Bermejo, Rodrigo/K-6613-2014	BRAMBATI, Alessandra/0000-0002-3816-425X; BRAMBATI, Alessandra/0000-0002-3816-425X; Foiani, Marco/0000-0003-4795-834X; LIBERI, GIORDANO/0000-0003-3160-2242; Saponaro, Marco/0000-0002-9302-2553; Bermejo, Rodrigo/0000-0002-2692-7045	Spanish Ministry of Science and Innovation [RYC-2010-07131, BFU2011-24909]; European Community [293770]; Associazione Italiana per la Ricerca sul Cancro (AIRC); Telethon-Italy [GGP08057]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community(European Commission); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Telethon-Italy(Fondazione Telethon)	We thank Yuki Katou and Katsuhiko Shirahige for assistance with ChIP-chip map construction; Massimo Lopes, Ted Weinert, Michele Giannattasio, and all members of our labs for discussion; and Victor Gonzalez-Huici, Cheng-Fu Kao, Aurora Cerutti, Michael Culbertson, Rosella Visintin, Philip Hieter, and Hannah Klein for reagents, advice, and technical support. We also thank the Microarray Facility at the IFOM-IEO campus. A. B. is a student of the PhD program in Genetics, Molecular, and Cellular Biology of the University of Pavia. R. B. is supported by the Spanish Ministry of Science and Innovation (RYC-2010-07131 and BFU2011-24909) and the European Community's FP7 (under grant agreement 293770). This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC) and Telethon-Italy (GGP08057) to G.L.	Aguilera A, 2005, NAT STRUCT MOL BIOL, V12, P737, DOI 10.1038/nsmb0905-737; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Azvolinsky A, 2006, GENE DEV, V20, P3104, DOI 10.1101/gad.1478906; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bermejo R, 2012, MOL CELL, V45, P710, DOI 10.1016/j.molcel.2012.03.001; Bermejo R, 2011, CELL, V146, P233, DOI 10.1016/j.cell.2011.06.033; Bermejo R, 2009, CELL, V138, P870, DOI 10.1016/j.cell.2009.06.022; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; Clelland BW, 2010, TRANSCR-AUSTIN, V1, P115, DOI 10.4161/trns.1.3.13735; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Conrad NK, 2000, GENETICS, V154, P557; Creamer TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002329; DEMARINI DJ, 1992, MOL CELL BIOL, V12, P2154, DOI 10.1128/MCB.12.5.2154; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dominguez-Sanchez MS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002386; Drolet M, 2006, MOL MICROBIOL, V59, P723, DOI 10.1111/j.1365-2958.2005.05006.x; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Gomez-Gonzalez B, 2011, EMBO J, V30, P3106, DOI 10.1038/emboj.2011.206; Gottipati P, 2008, MOL CELL BIOL, V28, P154, DOI 10.1128/MCB.00816-07; Hampsey M, 2011, ADV ENZYME REGUL, V51, P118, DOI 10.1016/j.advenzreg.2010.10.001; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; Hu ZL, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl142; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Jamonnak N, 2011, RNA, V17, P2011, DOI 10.1261/rna.2840711; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kim HD, 1999, BIOCHEMISTRY-US, V38, P14697, DOI 10.1021/bi991470c; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Koster DA, 2010, CELL, V142, P519, DOI 10.1016/j.cell.2010.08.001; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Liberi G, 2006, METHOD ENZYMOL, V409, P442, DOI 10.1016/S0076-6879(05)09026-9; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; Nudler E, 2012, CELL, V149, P1438, DOI 10.1016/j.cell.2012.06.003; Olavarrieta L, 2002, MOL MICROBIOL, V46, P699, DOI 10.1046/j.1365-2958.2002.03217.x; PAGE BD, 1992, GENE DEV, V6, P1414, DOI 10.1101/gad.6.8.1414; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Rasmussen TP, 1998, MOL CELL BIOL, V18, P6885, DOI 10.1128/MCB.18.12.6885; Rocha EPC, 2008, ANNU REV GENET, V42, P211, DOI 10.1146/annurev.genet.42.110807.091653; Rondon AG, 2009, MOL CELL, V36, P88, DOI 10.1016/j.molcel.2009.07.028; Rudolph CJ, 2007, DNA REPAIR, V6, P981, DOI 10.1016/j.dnarep.2007.02.017; Sabouri N, 2012, GENE DEV, V26, P581, DOI 10.1101/gad.184697.111; SHIRAHIGE K, 1993, MOL CELL BIOL, V13, P5043, DOI 10.1128/MCB.13.8.5043; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; SPENCER F, 1990, GENETICS, V124, P237; Steinacher R, 2012, GENE DEV, V26, P594, DOI 10.1101/gad.184663.111; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Stirling PC, 2012, GENE DEV, V26, P163, DOI 10.1101/gad.179721.111; Suraweera A, 2007, J CELL BIOL, V177, P969, DOI 10.1083/jcb.200701042; Suraweera A, 2009, HUM MOL GENET, V18, P3384, DOI 10.1093/hmg/ddp278; Tuduri S, 2009, NAT CELL BIOL, V11, P1315, DOI 10.1038/ncb1984; Ursic D, 1997, NUCLEIC ACIDS RES, V25, P4778, DOI 10.1093/nar/25.23.4778; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Vizeacoumar FJ, 2010, J CELL BIOL, V188, P69, DOI 10.1083/jcb.200909013; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Wlotzka W, 2011, EMBO J, V30, P1790, DOI 10.1038/emboj.2011.97; Xu H, 2004, MOL CELL BIOL, V24, P7082, DOI 10.1128/MCB.24.16.7082-7090.2004; Yurov YB, 2011, THESCIENTIFICWORLDJO, V11, P2602, DOI 10.1100/2011/625690	79	153	157	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					835	846		10.1016/j.cell.2012.09.041	http://dx.doi.org/10.1016/j.cell.2012.09.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141540	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000310921200014
J	Jackson, PK				Jackson, Peter K.			TTBK2 Kinase: Linking Primary Cilia and Cerebellar Ataxias	CELL			English	Editorial Material							PROTEINS	Mutations disrupting primary cilia cause retinal, renal, and cerebellar defects, and misregulated Sonic hedgehog signaling. A new mouse mutant in the TTBK2 kinase fails to make cilia, and shows neural tube and Sonic hedgehog signaling defects. Ciliary targeting mutations in human TTBK2 are linked to spinocerebellar ataxia, suggesting cilia protect from neurodegeneration.	Genentech Inc, San Francisco, CA 94070 USA	Roche Holding; Genentech	Jackson, PK (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94070 USA.	pjackson@gene.com		Jackson, Peter/0000-0002-1742-2539				Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Goetz SC, 2012, CELL, V151, P847, DOI 10.1016/j.cell.2012.10.010; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Houlden H, 2007, NAT GENET, V39, P1434, DOI 10.1038/ng.2007.43; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Matilla-Duenas A., 2012, CEREBELLUM; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108	10	11	13	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					697	699		10.1016/j.cell.2012.10.027	http://dx.doi.org/10.1016/j.cell.2012.10.027			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141531	Bronze			2022-12-28	WOS:000310921200002
J	Kosuri, P; Alegre-Cebollada, J; Feng, J; Kaplan, A; Ingles-Prieto, A; Badilla, CL; Stockwell, BR; Sanchez-Ruiz, JM; Holmgren, A; Fernandez, JM				Kosuri, Pallav; Alegre-Cebollada, Jorge; Feng, Jason; Kaplan, Anna; Ingles-Prieto, Alvaro; Badilla, Carmen L.; Stockwell, Brent R.; Sanchez-Ruiz, Jose M.; Holmgren, Arne; Fernandez, Julio M.			Protein Folding Drives Disulfide Formation	CELL			English	Article							THIOREDOXIN-LIKE DOMAINS; ACTIVE-SITE CYSTEINE; ENDOPLASMIC-RETICULUM; MOLTEN GLOBULE; SINGLE PROTEIN; NMR-SPECTROSCOPY; LIVING CELLS; ISOMERASE; FORCE; BOND	PDI catalyzes the oxidative folding of disulfide-containing proteins. However, the sequence of reactions leading to a natively folded and oxidized protein remains unknown. Here we demonstrate a technique that enables independent measurements of disulfide formation and protein folding. We find that non-native disulfides are formed early in the folding pathway and can trigger misfolding. In contrast, a PDI domain favors native disulfides by catalyzing oxidation at a late stage of folding. We propose a model for cotranslational oxidative folding wherein PDI acts as a placeholder that is relieved by the pairing of cysteines caused by substrate folding. This general mechanism can explain how PDI catalyzes oxidative folding in a variety of structurally unrelated substrates.	[Kosuri, Pallav] Columbia Univ, Grad Program Biochem & Mol Biophys, New York, NY 10027 USA; [Kosuri, Pallav; Alegre-Cebollada, Jorge; Feng, Jason; Kaplan, Anna; Badilla, Carmen L.; Stockwell, Brent R.; Fernandez, Julio M.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10027 USA; [Ingles-Prieto, Alvaro; Sanchez-Ruiz, Jose M.] Univ Granada, Fac Ciencias, Dept Quim Fis, E-18071 Granada, Spain; [Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, S-17177 Stockholm, Sweden	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; University of Granada; Karolinska Institutet	Kosuri, P (corresponding author), Columbia Univ, Grad Program Biochem & Mol Biophys, New York, NY 10027 USA.	pallav@caa.columbia.edu; jfernandez@columbia.edu	Stockwell, Brent R/AAE-7200-2019; Sanchez-Ruiz, Jose/H-2849-2015; Ingles-Prieto, Alvaro/A-4365-2017; Alegre-Cebollada, Jorge/I-4301-2014; Kosuri, Pallav/J-8279-2012	Stockwell, Brent R/0000-0002-3532-3868; Sanchez-Ruiz, Jose/0000-0002-9056-3928; Ingles-Prieto, Alvaro/0000-0002-5409-8571; Alegre-Cebollada, Jorge/0000-0003-0542-0170; Kosuri, Pallav/0000-0002-7025-3543	NIH [HL066030, HL061228, CA097061, CA161061, GM085081]; HHMI; Arnold and Mabel Beckman Foundation; Spanish Ministry of Education; Spanish Ministry of Science and Innovation [BIO2009-09562, CSD2009-00088]; FEDER; Fundacion Ibercaja; Training Program in Molecular Biophysics [T32GM008281]; Fulbright scholarship; NATIONAL CANCER INSTITUTE [R01CA097061, R01CA161061] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061228, R01HL066030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085081, T32GM008281] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Arnold and Mabel Beckman Foundation; Spanish Ministry of Education(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission); Fundacion Ibercaja; Training Program in Molecular Biophysics; Fulbright scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH (HL066030 and HL061228 to J.M.F.; CA097061, CA161061, and GM085081 to B. R. S.), HHMI (B. R. S.), the Arnold and Mabel Beckman Foundation (B. R. S.), the Spanish Ministry of Education (A. I.-P.), the Spanish Ministry of Science and Innovation (BIO2009-09562 and CSD2009-00088 to J.M.S.-R.), FEDER (J.M.S.-R.), Fundacion Ibercaja (J.A.-C.), and the Training Program in Molecular Biophysics (T32GM008281 to A. K.). P. K. was supported by a Fulbright scholarship. P. K., J.A.-C., and J.M.F. designed the experiments. P. K., J.A.-C., and J.F. performed the experiments and analyzed the data. A. K. and B. R. S. provided PDI A1. A. H. provided TRX. A. I.-P. and J.M.S.-R. provided TRX C35S. P. K., J.A.-C., and J.M.F. wrote the manuscript. We thank the members of the Fernandez lab for their illuminating feedback.	Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Alegre-Cebollada J, 2011, NAT CHEM, V3, P882, DOI [10.1038/NCHEM.1155, 10.1038/nchem.1155]; Baldwin RL, 2010, PROTEINS, V78, P2725, DOI 10.1002/prot.22803; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Berkovich R, 2010, BIOPHYS J, V98, P2692, DOI 10.1016/j.bpj.2010.02.053; Borgia MB, 2011, NATURE, V474, P662, DOI 10.1038/nature10099; Cabrita LD, 2009, P NATL ACAD SCI USA, V106, P22239, DOI 10.1073/pnas.0903750106; CAMACHO CJ, 1995, PROTEINS, V22, P27, DOI 10.1002/prot.340220105; Carvalho AP, 2006, PROG BIOPHYS MOL BIO, V91, P229, DOI 10.1016/j.pbiomolbio.2005.06.012; Chakravarthi Seema, 2009, P81; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P15810, DOI 10.1021/bi971504l; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; Darby NJ, 1995, BIOCHEMISTRY-US, V34, P16770, DOI 10.1021/bi00051a027; Debarbieux L, 2000, J BACTERIOL, V182, P723, DOI 10.1128/JB.182.3.723-727.2000; Di Jeso B, 2005, MOL CELL BIOL, V25, P9793, DOI 10.1128/MCB.25.22.9793-9805.2005; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Eichmann C, 2010, P NATL ACAD SCI USA, V107, P9111, DOI 10.1073/pnas.0914300107; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Garcia-Manyes S, 2009, P NATL ACAD SCI USA, V106, P10534, DOI 10.1073/pnas.0901213106; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Lappi AK, 2011, J MOL BIOL, V409, P238, DOI 10.1016/j.jmb.2011.03.024; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; LUNDSTROM J, 1992, J BIOL CHEM, V267, P9047; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Oberhauser AF, 1999, NAT STRUCT BIOL, V6, P1025; Paxman JJ, 2009, J BIOL CHEM, V284, P17835, DOI 10.1074/jbc.M109.011502; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Walker KW, 1997, J BIOL CHEM, V272, P8845; Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n; WALKER KW, 1995, BIOCHEMISTRY-US, V34, P13642, DOI 10.1021/bi00041a045; WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; Welker E, 2001, BIOCHEMISTRY-US, V40, P9059, DOI 10.1021/bi010409g; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; ZAPUN A, 1992, PROTEINS, V14, P10, DOI 10.1002/prot.340140104	58	125	126	1	95	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					794	806		10.1016/j.cell.2012.09.036	http://dx.doi.org/10.1016/j.cell.2012.09.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141538	Green Accepted, Bronze			2022-12-28	WOS:000310921200011
J	Koga, N; Tatsumi-Koga, R; Liu, GH; Xiao, R; Acton, TB; Montelione, GT; Baker, D				Koga, Nobuyasu; Tatsumi-Koga, Rie; Liu, Gaohua; Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.; Baker, David			Principles for designing ideal protein structures	NATURE			English	Article							DE-NOVO DESIGN; TORSION ANGLE DYNAMICS; COMPUTATIONAL DESIGN; STRUCTURE PREDICTION; NEGATIVE DESIGN; NMR STRUCTURE; LOCAL-STRUCTURE; FOLDING FUNNEL; REDESIGN; REFINEMENT	Unlike random heteropolymers, natural proteins fold into unique ordered structures. Understanding how these are encoded in amino-acid sequences is complicated by energetically unfavourable non-ideal features-for example kinked alpha-helices, bulged beta-strands, strained loops and buried polar groups-that arise in proteins from evolutionary selection for biological function or from neutral drift. Here we describe an approach to designing ideal protein structures stabilized by completely consistent local and non-local interactions. The approach is based on a set of rules relating secondary structure patterns to protein tertiary motifs, which make possible the design of funnel-shaped protein folding energy landscapes leading into the target folded state. Guided by these rules, we designed sequences predicted to fold into ideal protein structures consisting of alpha-helices, beta-strands and minimal loops. Designs for five different topologies were found to be monomeric and very stable and to adopt structures in solution nearly identical to the computational models. These results illuminate how the folding funnels of natural proteins arise and provide the foundation for engineering a new generation of functional proteins free from natural evolution.	[Koga, Nobuyasu; Tatsumi-Koga, Rie; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Koga, Nobuyasu; Tatsumi-Koga, Rie; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Liu, Gaohua; Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, NE Struct Genom Consortium, Piscataway, NJ 08854 USA; [Liu, Gaohua; Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	guy@cabm.rutgers.edu; dabaker@u.washington.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Montelione, Gaetano/0000-0002-9440-3059; Koga, Nobuyasu/0000-0001-8457-0809; Koga, Rie/0000-0002-5068-1049	HHMI; DOE; DARPA; DTRA; National Institutes of General Medical Science Protein Structure Initiative (PSI: Biology) programme [U54 GM094597]; Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships for Research Abroad; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); DOE(United States Department of Energy (DOE)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); DTRA(United States Department of DefenseDefense Threat Reduction Agency); National Institutes of General Medical Science Protein Structure Initiative (PSI: Biology) programme; Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Grishin for suggesting target folds for design, P. Rajagopal for one-dimensional NMR measurements of Folds-I and -II, and J. Siegel for measurements by mass spectrometer. We also thank P.-S. Huang and Y.-E. A. Ban for computational tools; J. L. Gallaher for experimental assistance; J. Castellanos for the help with designing Fold-IV; H.-W. Lee, K. Pederson and J. Prestegard for measurements of residual dipolar couplings; and S. Khare, F. DiMaio, I. Andre, S. Fleishman, J. Mills, S. Takada, S. Fuchigami and G. Chikenji for comments on the manuscript. This work was supported by HHMI, DOE, DARPA, DTRA and the National Institutes of General Medical Science Protein Structure Initiative (PSI: Biology) programme, grant U54 GM094597. N. K. was also supported by Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships for Research Abroad.	Acton TB, 2011, METHOD ENZYMOL, V493, P21, DOI 10.1016/B978-0-12-381274-2.00002-9; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Bonneau R, 2002, PROTEIN SCI, V11, P1937, DOI 10.1110/ps.3790102; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butterfoss GL, 2006, ANNU REV BIOPH BIOM, V35, P49, DOI 10.1146/annurev.biophys.35.040405.102046; Bystroff C, 1998, J MOL BIOL, V281, P565, DOI 10.1006/jmbi.1998.1943; Calhoun JR, 2003, J MOL BIOL, V334, P1101, DOI 10.1016/j.jmb.2003.10.004; Chikenji G, 2006, P NATL ACAD SCI USA, V103, P3141, DOI 10.1073/pnas.0508195103; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Eisenbeis S, 2012, J AM CHEM SOC, V134, P4019, DOI 10.1021/ja211657k; Etchebest C, 2005, PROTEINS, V59, P810, DOI 10.1002/prot.20458; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fleming PJ, 2006, PROTEIN SCI, V15, P1829, DOI 10.1110/ps.062305106; GO N, 1983, ANNU REV BIOPHYS BIO, V12, P183, DOI 10.1146/annurev.bb.12.060183.001151; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; HECHT MH, 1990, SCIENCE, V249, P884, DOI 10.1126/science.2392678; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hill RB, 2000, ACCOUNTS CHEM RES, V33, P745, DOI 10.1021/ar970004h; Hu XZ, 2008, STRUCTURE, V16, P1799, DOI 10.1016/j.str.2008.09.013; Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109; Huang YJ, 2006, PROTEINS, V62, P587, DOI 10.1002/prot.20820; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Huang YPJ, 2005, METHOD ENZYMOL, V394, P111, DOI 10.1016/S0076-6879(05)94005-6; Hunter CG, 2003, PROTEINS, V50, P572, DOI 10.1002/prot.10310; Isogai Y, 2005, J MOL BIOL, V354, P801, DOI 10.1016/j.jmb.2005.10.005; Jansson M, 1996, J BIOMOL NMR, V7, P131; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Jin WZ, 2003, STRUCTURE, V11, P581, DOI 10.1016/S0969-2126(03)00075-3; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; Khare SD, 2012, NAT CHEM BIOL, V8, P294, DOI [10.1038/NCHEMBIO.777, 10.1038/nchembio.777]; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Liu GH, 2005, P NATL ACAD SCI USA, V102, P10487, DOI 10.1073/pnas.0504338102; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; ONUCHIC JN, 1995, P NATL ACAD SCI USA, V92, P3626, DOI 10.1073/pnas.92.8.3626; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Samish I, 2011, ANNU REV PHYS CHEM, V62, P129, DOI 10.1146/annurev-physchem-032210-103509; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Shah PS, 2007, J MOL BIOL, V372, P1, DOI 10.1016/j.jmb.2007.06.032; Sheffler W, 2009, PROTEIN SCI, V18, P229, DOI 10.1002/pro.8; Shen Y, 2005, J AM CHEM SOC, V127, P9085, DOI 10.1021/ja0501870; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Street TO, 2007, PROTEIN SCI, V16, P1720, DOI 10.1110/ps.072898507; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Summa CM, 2002, J MOL BIOL, V321, P923, DOI 10.1016/S0022-2836(02)00589-2; Tjandra N, 1996, J AM CHEM SOC, V118, P6264, DOI 10.1021/ja960106n; Tyka MD, 2011, J MOL BIOL, V405, P607, DOI 10.1016/j.jmb.2010.11.008; Voelz VA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000281; Word JM, 2000, PROTEIN SCI, V9, P2251, DOI 10.1110/ps.9.11.2251	71	355	363	21	387	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2012	491	7423					222	227		10.1038/nature11600	http://dx.doi.org/10.1038/nature11600			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23135467	Green Accepted			2022-12-28	WOS:000310774300037
J	Mulley, AG; Trimble, C; Elwyn, G				Mulley, Albert G.; Trimble, Chris; Elwyn, Glyn			Stop the silent misdiagnosis: patients' preferences matter	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SHARED DECISION-MAKING; OUTCOMES; TRIAL; AID		[Mulley, Albert G.; Trimble, Chris; Elwyn, Glyn] Dartmouth Coll, Dartmouth Ctr Hlth Care Delivery Sci, Hanover, NH 03755 USA	Dartmouth College	Elwyn, G (corresponding author), Dartmouth Coll, Dartmouth Ctr Hlth Care Delivery Sci, Hanover, NH 03755 USA.	elwyng@cardiff.ac.uk	Elwyn, G./L-4292-2015; Elwyn, Glyn/B-4798-2009	Elwyn, Glyn/0000-0002-0917-6286				Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Department of Health, 2010, EQ EXC LIB NHS; Elwyn G, 2012, PATIENT ED COUNS; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Katz J., 1984, SILENT WORLD DOCTOR; Kennedy ADM, 2002, JAMA-J AM MED ASSOC, V288, P2701, DOI 10.1001/jama.288.21.2701; Lee CN, 2010, ANN PLAS SURG, V64, P563, DOI 10.1097/SAP.0b013e3181c01279; Marvel MK, 1999, JAMA-J AM MED ASSOC, V281, P283, DOI 10.1001/jama.281.3.283; Morgan MW, 2000, J GEN INTERN MED, V15, P685, DOI 10.1046/j.1525-1497.2000.91139.x; Mullan RJ, 2009, ARCH INTERN MED, V169, P1560, DOI 10.1001/archinternmed.2009.293; Mulley A. G., 2012, PATIENTS PREFERENCES; NHS Rightcare, NHS ATL VAR; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Rothberg MB, 2010, ANN INTERN MED, V153, P307, DOI 10.7326/0003-4819-153-5-201009070-00005; Volandes AE, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2159; WAGNER EH, 1995, MED CARE, V33, P765, DOI 10.1097/00005650-199508000-00002; Wanless, 2002, SECURING OUR FUTURE; Wennberg DE, 2010, NEW ENGL J MED, V363, P1245, DOI 10.1056/NEJMsa0902321; Wennberg JE, 2010, TRACKING MED RES QUE; Wilson SR, 2010, AM J RESP CRIT CARE, V181, P566, DOI 10.1164/rccm.200906-0907OC	20	376	379	4	37	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 8	2012	345								e6572	10.1136/bmj.e6572	http://dx.doi.org/10.1136/bmj.e6572			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	036LM	23137819				2022-12-28	WOS:000311027400012
J	Callahan, MK; Rampal, R; Harding, JJ; Klimek, VM; Chung, YR; Merghoub, T; Wolchok, JD; Solit, DB; Rosen, N; Abdel-Wahab, O; Levine, RL; Chapman, PB				Callahan, Margaret K.; Rampal, Raajit; Harding, James J.; Klimek, Virginia M.; Chung, Young Rock; Merghoub, Taha; Wolchok, Jedd D.; Solit, David B.; Rosen, Neal; Abdel-Wahab, Omar; Levine, Ross L.; Chapman, Paul B.			Progression of RAS-Mutant Leukemia during RAF Inhibitor Treatment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOMONOCYTIC LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; METASTATIC MELANOMA; PARADOXICAL ACTIVATION; IMPROVED SURVIVAL; MEK INHIBITION; B-RAF; BRAF; MUTATIONS; V600E	Vemurafenib, a selective RAF inhibitor, extends survival among patients with BRAF V600E-mutant melanoma. Vemurafenib inhibits ERK signaling in BRAF V600E-mutant cells but activates ERK signaling in BRAF wild-type cells. This paradoxical activation of ERK signaling is the mechanistic basis for the development of RAS-mutant squamous-cell skin cancers in patients treated with RAF inhibitors. We report the accelerated growth of a previously unsuspected RAS-mutant leukemia in a patient with melanoma who was receiving vemurafenib. Exposure to vemurafenib induced hyperactivation of ERK signaling and proliferation of the leukemic cell population, an effect that was reversed on drug withdrawal.	[Chapman, Paul B.] Mem Sloan Kettering Canc Ctr, Dept Med, Melanoma & Sarcoma Serv, New York, NY 10065 USA; [Chung, Young Rock; Solit, David B.; Abdel-Wahab, Omar; Levine, Ross L.] Ludwig Inst Canc Res, Human Oncol & Pathogenesis Program, New York, NY USA; [Rosen, Neal] Ludwig Inst Canc Res, Mol Pharmacol & Chem Program, New York, NY USA; [Callahan, Margaret K.; Rampal, Raajit; Harding, James J.; Klimek, Virginia M.; Merghoub, Taha; Wolchok, Jedd D.; Solit, David B.; Rosen, Neal; Abdel-Wahab, Omar; Levine, Ross L.; Chapman, Paul B.] Weill Cornell Med Coll, New York, NY USA	Memorial Sloan Kettering Cancer Center; Ludwig Institute for Cancer Research; Ludwig Institute for Cancer Research; Cornell University	Chapman, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Melanoma & Sarcoma Serv, 300 E 66th St,Rm 1007, New York, NY 10065 USA.	chapmanp@mskcc.org	Rosen, Neal/ABF-2677-2020; Merghoub, Taha/ABD-8362-2021; levine, ross/AAE-7658-2019; Solit, David B./AAC-5309-2019	Abdel-Wahab, Omar/0000-0002-3907-6171; Harding, James/0000-0002-7029-4310; Chung, Young Rock/0000-0001-5752-8322	NATIONAL CANCER INSTITUTE [T32CA009207] Funding Source: NIH RePORTER; NCI NIH HHS [R25 CA020449, T32 CA009207] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Callahan M, 2012, J CLIN ONCOL, V30; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Gorden A, 2003, CANCER RES, V63, P3955; Hall-Jackson CA, 1999, CHEM BIOL, V6, P559, DOI 10.1016/S1074-5521(99)80088-X; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; HIRSCHGINSBERG C, 1990, BLOOD, V76, P1214; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Menzies AM, 2012, CLIN CANCER RES, V18, P3242, DOI 10.1158/1078-0432.CCR-12-0052; Muramatsu H, 2012, SEMIN ONCOL, V39, P67, DOI 10.1053/j.seminoncol.2011.11.004; Oberholzer PA, 2012, J CLIN ONCOL, V30, P316, DOI 10.1200/JCO.2011.36.7680; Packer LM, 2011, CANCER CELL, V20, P715, DOI 10.1016/j.ccr.2011.11.004; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Robert C, 2011, CURR OPIN ONCOL, V23, P177, DOI 10.1097/CCO.0b013e3283436e8c; Rubinstein JC, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-67; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Zimmer L, 2012, J CLIN ONCOL, V30, P2375, DOI 10.1200/JCO.2011.41.1660	25	180	182	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24					2316	2321		10.1056/NEJMoa1208958	http://dx.doi.org/10.1056/NEJMoa1208958			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HF	23134356	Green Accepted			2022-12-28	WOS:000312187700005
J	Allen, AS; Sequist, TD				Allen, Adrienne S.; Sequist, Thomas D.			Pharmacy Dispensing of Electronically Discontinued Medications	ANNALS OF INTERNAL MEDICINE			English	Article							ADVERSE DRUG EVENTS; HEALTH INFORMATION-TECHNOLOGY; CARE; PERFORMANCE; SAFETY	Background: Most physician offices do not transmit orders for medication discontinuation to the pharmacy, creating the potential for errors in dispensing of previously prescribed medications. Electronic health records offer the potential to assess this patient safety concern. Objective: To assess the frequency of and potential patient harm associated with pharmacy dispensing of discontinued medications in the ambulatory setting. Design: Retrospective cohort study. Setting: Multispecialty group practice in eastern Massachusetts using an electronic health record. Patients: 30 406 adult patients with an electronic discontinuation order for antihypertensive, antiplatelet, anticoagulant, oral hypoglycemic, and statin medications between November 2008 and October 2009. Measurements: Dispensing of discontinued medications within 12 months and associated potential patient harm. Results: Among 83 902 targeted medications that were electronically discontinued, 1218 (1.5% [95% CI, 1.4% to 1.5%]) were subsequently dispensed by the pharmacy a mean of 1.0 (SD, 0.3) time during the 12-month follow-up. Among the top 10 most frequently electronically discontinued medications, the rate of subsequent dispensing by a pharmacy ranged from 0.9% for metformin to 2.5% for metoprolol. Manual chart review of 416 medication-dispensing events that were predefined as high risk according to an automated algorithm identified potential harm in 50 (12%) cases, including clinical reactions (n = 18), laboratory abnormalities (n = 17), duplicated medication classes dispensed (n = 8), and potential allergic reactions (n = 7). Limitation: Information on pharmacy dispensing was available for only 52% of medication orders. Conclusion: The dispensing of discontinued medications represents an important ambulatory patient safety concern. Electronic health records should be used to facilitate better communication between providers and pharmacies and improve medication safety. Primary Funding Source: National Institutes of Health.	[Allen, Adrienne S.] N Shore Phys Grp, Danvers, MA 01923 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Harvard Vanguard Med Associates, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard Vanguard Medical Associates	Allen, AS (corresponding author), N Shore Phys Grp, 104 Endicott St,Suite 104, Danvers, MA 01923 USA.	aallen0@partners.org			National Institutes of Health [T32HP10251-02]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr. Allen was funded by a National Institutes of Health Institutional National Research Service Award (T32HP10251-02).	Allen AS, 2011, J PATIENT SAF, V7, P122, DOI 10.1097/PTS.0b013e318223cb41; Ammenwerth E, 2008, J AM MED INFORM ASSN, V15, P585, DOI 10.1197/jamia.M2667; Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Kaushal R, 2010, J GEN INTERN MED, V25, P530, DOI 10.1007/s11606-009-1238-8; Metzger J, 2010, HEALTH AFFAIR, V29, P655, DOI 10.1377/hlthaff.2010.0160; Nemeth Lynne S, 2010, J Patient Saf, V6, P238, DOI 10.1097/PTS.0b013e3181fe401f; Sequist TD, 2006, ARCH INTERN MED, V166, P2237, DOI 10.1001/archinte.166.20.2237; Sequist TD, 2011, MED CARE, V49, P126, DOI 10.1097/MLR.0b013e3181d5690f; Sequist TD, 2010, ANN INTERN MED, V152, P40, DOI 10.7326/0003-4819-152-1-201001050-00009	15	27	27	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10					700	+		10.7326/0003-4819-157-10-201211200-00006	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	043VZ	23165661				2022-12-28	WOS:000311580000015
J	Charon, R				Charon, Rita			The Reciprocity of Recognition - What Medicine Exposes about Self and Other	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ, Coll Phys & Surg, Program Narrat Med, New York, NY 10027 USA	Columbia University	Charon, R (corresponding author), Columbia Univ, Coll Phys & Surg, Program Narrat Med, New York, NY 10027 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL108014] Funding Source: NIH RePORTER; NHLBI NIH HHS [R25 HL108014] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Dewey J., 1980, ART EXPERIENCE; Gadamer H.G, 1998, TRUTH METHOD; Heidegger Martin, 2008, BASIC WRITINGS; James H, 1909, GOLDEN BOWL NOVELS T, V23, pxxiv; Merleau-Ponty Maurice, 2005, PHENOMENOLOGY PERCEP	5	11	11	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2012	367	20					1878	1881		10.1056/NEJMp1210787	http://dx.doi.org/10.1056/NEJMp1210787			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	036MB	23150957	Green Accepted			2022-12-28	WOS:000311029300003
J	Houllier, F				Houllier, Francois			Bring more rigour to GM research	NATURE			English	Editorial Material							BT COTTON		INRA, Paris, France	INRAE	Houllier, F (corresponding author), INRA, Paris, France.	francois.houllier@paris.inra.fr						[Anonymous], FRANC OGM; Arnich N, 2011, INT J HYG ENVIR HEAL, V214, P271, DOI 10.1016/j.ijheh.2010.12.002; Joly PB, 2007, NATURE, V450, P174, DOI 10.1038/450174a; Lemaire O, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000551; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; Seralini GE, 2012, FOOD CHEM TOXICOL, V50, P4221, DOI 10.1016/j.fct.2012.08.005; Snell C, 2012, FOOD CHEM TOXICOL, V50, P1134, DOI 10.1016/j.fct.2011.11.048; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050	9	5	9	1	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					327	327		10.1038/491327a	http://dx.doi.org/10.1038/491327a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	036MY	23151562	Bronze			2022-12-28	WOS:000311031600014
J	Schulze, A; Harris, AL				Schulze, Almut; Harris, Adrian L.			How cancer metabolism is tuned for proliferation and vulnerable to disruption	NATURE			English	Review							PYRUVATE-KINASE M2; PROSTATE-CANCER; ONCOMETABOLITE 2-HYDROXYGLUTARATE; GLYCOLYTIC METABOLISM; ALPHA-KETOGLUTARATE; AEROBIC GLYCOLYSIS; TUMOR METABOLISM; OXIDATIVE STRESS; LIPID-METABOLISM; SERINE SYNTHESIS	Cancer metabolism has received a substantial amount of interest over the past decade. The advances in analytical tools have, along with the rapid progress of cancer genomics, generated an increasingly complex understanding of metabolic reprogramming in cancer. As numerous connections between oncogenic signalling pathways and metabolic activities emerge, the importance of metabolic reprogramming in cancer is being increasingly recognized. The identification of metabolic weaknesses of cancer cells has been used to create strategies for treating cancer, but there are still challenges to be faced in bringing the drugs that target cancer metabolism to the clinic.	[Schulze, Almut] Canc Res UK, London Res Inst, Gene Express Anal Lab, London WC2A 3LY, England; [Harris, Adrian L.] Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, Canc Res UK Growth Factor Grp, Oxford OX3 9DS, England	Cancer Research UK; University of Oxford	Schulze, A (corresponding author), Canc Res UK, London Res Inst, Gene Express Anal Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	almut.schulze@cancer.org.uk	Schulze, Almut/AAX-8257-2020; ravegnini, gloria/K-1330-2016; Schulze, Almut/E-1496-2013; Harris, Adrian L/ABA-3343-2020	Schulze, Almut/0000-0002-8199-6422; ravegnini, gloria/0000-0002-7774-402X; Harris, Adrian L/0000-0003-1376-8409	Cancer Research UK; EMBO; Oxford Cancer Imaging Centre; Breast Cancer Research Foundation; Oxford NIHR Biomedical Research Centre; Cancer Research UK [11359] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); EMBO(European Molecular Biology Organization (EMBO)); Oxford Cancer Imaging Centre; Breast Cancer Research Foundation; Oxford NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors thank C. Santos and S. Ros for their critical reading and feedback. A.S. is funded by Cancer Research UK and the EMBO Young Investigator Programme. A.L.H. is funded by Cancer Research UK, the Oxford Cancer Imaging Centre, the Breast Cancer Research Foundation and the Oxford NIHR Biomedical Research Centre.	Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; Altman BJ, 2012, FEBS J, V279, P2598, DOI 10.1111/j.1742-4658.2012.08651.x; Amary MF, 2011, NAT GENET, V43, P1262, DOI 10.1038/ng.994; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Beloueche-Babari M, 2012, CANCER RES, V72, P990, DOI 10.1158/0008-5472.CAN-11-2688; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Cheong JH, 2011, MOL CANCER THER, V10, P2350, DOI 10.1158/1535-7163.MCT-11-0497; Chiche J, 2010, J CELL MOL MED, V14, P771, DOI 10.1111/j.1582-4934.2009.00994.x; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Clendening JW, 2010, P NATL ACAD SCI USA, V107, P15051, DOI 10.1073/pnas.0910258107; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Emberson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029849; Ferber EC, 2012, CELL DEATH DIFFER, V19, P968, DOI 10.1038/cdd.2011.179; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Folger O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.35; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gerlinger M, 2012, J PATHOL, V227, P146, DOI 10.1002/path.4006; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Hamanaka RB, 2009, CURR OPIN CELL BIOL, V21, P894, DOI 10.1016/j.ceb.2009.08.005; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jain RK, 2012, CELL, V149, P1408, DOI 10.1016/j.cell.2012.05.025; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Koukourakis MI, 2006, CANCER RES, V66, P632, DOI 10.1158/0008-5472.CAN-05-3260; Kurhanewicz J, 2008, J NUCL MED, V49, P341, DOI 10.2967/jnumed.107.045112; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Mera P, 2009, BIOCHEM PHARMACOL, V77, P1084, DOI 10.1016/j.bcp.2008.11.020; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Ros S, 2012, CANCER DISCOV, V2, P328, DOI 10.1158/2159-8290.CD-11-0234; Rothbart SB, 2010, CANCER RES, V70, P10299, DOI 10.1158/0008-5472.CAN-10-1873; Rothman DL, 2011, NMR BIOMED, V24, P943, DOI 10.1002/nbm.1772; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Shamma A, 2009, CANCER CELL, V15, P255, DOI 10.1016/j.ccr.2009.03.001; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stein M, 2010, PROSTATE, V70, P1388, DOI 10.1002/pros.21172; Swietach P, 2010, ONCOGENE, V29, P6509, DOI 10.1038/onc.2010.455; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Toustrup K, 2012, RADIOTHER ONCOL, V102, P122, DOI 10.1016/j.radonc.2011.09.010; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Whitaker-Menezes D, 2011, CELL CYCLE, V10, P1772, DOI 10.4161/cc.10.11.15659; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Yuneva MO, 2012, CELL METAB, V15, P157, DOI 10.1016/j.cmet.2011.12.015; Zhang W, 2012, NAT CELL BIOL, V14, P276, DOI 10.1038/ncb2432; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71	99	652	673	9	280	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					364	373		10.1038/nature11706	http://dx.doi.org/10.1038/nature11706			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23151579				2022-12-28	WOS:000311031600033
J	Dorlo, TPC; Ravinetto, RM; Beijnen, JH; Boelaert, M				Dorlo, Thomas P. C.; Ravinetto, Raffaella M.; Beijnen, Jos H.; Boelaert, Marleen			Commentary: Substandard medicines are the priority for neglected tropical diseases	BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOTOXICITY		[Dorlo, Thomas P. C.; Beijnen, Jos H.] Slotervaart Hosp, Netherlands Canc Inst, Dept Pharm & Pharmacol, Amsterdam, Netherlands; [Dorlo, Thomas P. C.; Beijnen, Jos H.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Ravinetto, Raffaella M.] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Netherlands Cancer Institute; Slotervaart Hospital; Utrecht University; Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM)	Dorlo, TPC (corresponding author), Slotervaart Hosp, Netherlands Canc Inst, Dept Pharm & Pharmacol, Amsterdam, Netherlands.	thomas.dorlo@slz.nl	Dorlo, Thomas/F-1339-2011; Boelaert, Marleen/E-2698-2012	Dorlo, Thomas/0000-0003-3076-8435; Boelaert, Marleen/0000-0001-8051-6776				Attaran A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7381; Boelaert M, 2002, TROP MED INT HEALTH, V7, P955, DOI 10.1046/j.1365-3156.2002.00959.x; Caudron JM, 2008, TROP MED INT HEALTH, V13, P1062, DOI 10.1111/j.1365-3156.2008.02106.x; Dorlo TPC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001544; Dorlo TPC, 2012, ANALYST, V137, P1265, DOI 10.1039/c2an15641e; Katsnelson A, 2010, NAT MED, V16, P364, DOI 10.1038/nm0410-364b; Ravinetto RM, 2012, TROP MED INT HEALTH, V17, P1412, DOI 10.1111/j.1365-3156.2012.03076.x; Rijal S, 2003, T ROY SOC TROP MED H, V97, P597, DOI 10.1016/S0035-9203(03)80043-3; Sundar S, 1998, AM J TROP MED HYG, V59, P139, DOI 10.4269/ajtmh.1998.59.139	9	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 14	2012	345								e7518	10.1136/bmj.e7518	http://dx.doi.org/10.1136/bmj.e7518			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040PZ	23152570	Green Accepted			2022-12-28	WOS:000311336400007
J	Arie, S				Arie, Sophie			GLOBAL HEALTH Make or break for the Global Fund?	BRITISH MEDICAL JOURNAL			English	Editorial Material												mail@sophiearie.com						Heilprin J., 2011, NBC NEWS        0123	1	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 12	2012	345								e7561	10.1136/bmj.e7561	http://dx.doi.org/10.1136/bmj.e7561			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040PM	23148333				2022-12-28	WOS:000311334900007
J	Goetz, SC; Liem, KF; Anderson, KV				Goetz, Sarah C.; Liem, Karel F., Jr.; Anderson, Kathryn V.			The Spinocerebellar Ataxia-Associated Gene Tau Tubulin Kinase 2 Controls the Initiation of Ciliogenesis	CELL			English	Article							TAU-TUBULIN KINASE; INTRAFLAGELLAR TRANSPORT PROTEINS; HEDGEHOG SIGNAL-TRANSDUCTION; NEURAL STEM-CELLS; PRIMARY CILIA; REPRESSOR FUNCTIONS; MECKEL SYNDROME; SONIC HEDGEHOG; MOUSE; MEMBRANE	The primary cilium has critical roles in human development and disease, but the mechanisms that regulate ciliogenesis are not understood. Here, we show that Tau tubulin kinase 2 (TTBK2) is a dedicated regulator of the initiation of ciliogenesis in vivo. We identified a null allele of mouse Ttbk2 based on loss of Sonic hedgehog activity, a signaling pathway that requires the primary cilium. Despite a normal basal body template, Ttbk2 mutants lack cilia. TTBK2 acts at the distal end of the basal body, where it promotes the removal of CP110, which caps the mother centriole, and promotes recruitment of IFT proteins, which build the ciliary axoneme. Dominant truncating mutations in human TTBK2 cause spinocerebellar ataxia type 11 (SCA11); these mutant proteins do not promote ciliogenesis and inhibit ciliogenesis in wild-type cells. We propose that cell-cycle regulators target TTBK2 to the basal body, where it modifies specific targets to initiate ciliogenesis.	[Goetz, Sarah C.; Liem, Karel F., Jr.; Anderson, Kathryn V.] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Anderson, KV (corresponding author), Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.	k-anderson@sloankettering.edu		Anderson, Kathryn/0000-0003-1657-2161	NIH [NS044385]; American Cancer Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044385] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to P. Jallepalli and B. Tsou and their laboratories for reagents and advice on retroviral transduction. We thank James Sillibourne and Michel Bornens (Institut Curie), Brian Dynlacht (NYU), and Greg Pazour (University of Massachusetts Medical School) for antibodies. We thank the MSKCC Molecular Cytology Core Facility and the Bio-Imaging Resource Center at Rockefeller University for help with imaging; the MSKCC Electron Microscopy Core Facility for SEM; and Peter Satir and Leslie Gunther at the Analytical Imaging Center of Albert Einstein College of Medicine for assistance with TEM. We thank A. Parrish, H. Bazzi, and F. Bangs for comments on the manuscript. This work was funded by NIH Grant NS044385 to K. V. A. and an American Cancer Society Postdoctoral Fellowship to S.C.G.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Aughsteen AA, 2001, EUR J MORPHOL, V39, P277, DOI 10.1076/ejom.39.5.277.7380; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bauer P, 2010, J NEUROL NEUROSUR PS, V81, P1229, DOI 10.1136/jnnp.2009.202150; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chakravarthy B, 2010, BIOCHEM BIOPH RES CO, V401, P458, DOI 10.1016/j.bbrc.2010.09.081; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Domire JS, 2011, CELL MOL LIFE SCI, V68, P2951, DOI 10.1007/s00018-010-0603-4; Dowdle WE, 2011, AM J HUM GENET, V89, P94, DOI 10.1016/j.ajhg.2011.06.003; Evangelista M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162925; Fan SL, 2011, MOL BIOL CELL, V22, P4539, DOI 10.1091/mbc.E11-03-0267; FONTE VG, 1971, J CELL BIOL, V49, P226, DOI 10.1083/jcb.49.1.226; Garcia-Garcia MJ, 2005, P NATL ACAD SCI USA, V102, P5913, DOI 10.1073/pnas.0501071102; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Green JA, 2010, CELL MOL LIFE SCI, V67, P3287, DOI 10.1007/s00018-010-0425-4; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Houlden H, 2007, NAT GENET, V39, P1434, DOI 10.1038/ng.2007.43; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Ko HW, 2010, DEV CELL, V18, P237, DOI 10.1016/j.devcel.2009.12.014; Kobayashi T, 2011, CELL, V145, P914, DOI 10.1016/j.cell.2011.04.028; Liem KF, 2012, J CELL BIOL, V197, P789, DOI 10.1083/jcb.201110049; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010902; Matilla-Duenas A., 2012, CEREBELLUM; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Ocbina PJR, 2008, DEV DYNAM, V237, P2030, DOI 10.1002/dvdy.21551; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Otto EA, 2008, J AM SOC NEPHROL, V19, P587, DOI 10.1681/ASN.2007040490; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Qi HY, 2009, DEV DYNAM, V238, P3248, DOI 10.1002/dvdy.22150; RIEDER CL, 1979, J ULTRA MOL STRUCT R, V68, P173, DOI 10.1016/S0022-5320(79)90152-7; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; TAKAHASHI M, 1995, FEBS LETT, V372, P59, DOI 10.1016/0014-5793(95)00955-9; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Thiel C, 2011, AM J HUM GENET, V88, P106, DOI 10.1016/j.ajhg.2010.12.004; Tomizawa K, 2001, FEBS LETT, V492, P221, DOI 10.1016/S0014-5793(01)02256-6; Tsang WY, 2008, DEV CELL, V15, P187, DOI 10.1016/j.devcel.2008.07.004; Weatherbee SD, 2009, HUM MOL GENET, V18, P4565, DOI 10.1093/hmg/ddp422; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Wheatley DN, 1996, CELL BIOL INT, V20, P73, DOI 10.1006/cbir.1996.0011; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681	56	155	160	2	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					847	858		10.1016/j.cell.2012.10.010	http://dx.doi.org/10.1016/j.cell.2012.10.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141541	Green Accepted, Bronze			2022-12-28	WOS:000310921200015
J	Gringras, P; Gamble, C; Jones, AP; Wiggs, L; Williamson, PR; Sutcliffe, A; Montgomery, P; Whitehouse, WP; Choonara, I; Allport, T; Edmond, A; Appleton, R				Gringras, P.; Gamble, C.; Jones, A. P.; Wiggs, L.; Williamson, P. R.; Sutcliffe, A.; Montgomery, P.; Whitehouse, W. P.; Choonara, I.; Allport, T.; Edmond, A.; Appleton, R.		MENDS Study Grp	Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial	BRITISH MEDICAL JOURNAL			English	Article							AUTISM SPECTRUM DISORDERS; EXOGENOUS MELATONIN; METAANALYSIS; EFFICACY; SAFETY	Objective To assess the effectiveness and safety of melatonin in treating severe sleep problems in children with neurodevelopmental disorders. Design 12 week double masked randomised placebo controlled phase III trial. Setting 19 hospitals across England and Wales. Participants 146 children aged 3 years to 15 years 8 months were randomised. They had a range of neurological and developmental disorders and a severe sleep problem that had not responded to a standardised sleep behaviour advice booklet provided to parents four to six weeks before randomisation. A sleep problem was defined as the child not falling asleep within one hour of lights out or having less than six hours' continuous sleep. Interventions Immediate release melatonin or matching placebo capsules administered 45 minutes before the child's bedtime for a period of 12 weeks. All children started with a 0.5 mg capsule, which was increased through 2 mg, 6 mg, and 12 mg depending on their response to treatment. Main outcome measures Total sleep time at night after 12 weeks adjusted for baseline recorded in sleep diaries completed by the parent. Secondary outcomes included sleep onset latency, assessments of child behaviour, family functioning, and adverse events. Sleep was measured with diaries and actigraphy. Results Melatonin increased total sleep time by 22.4 minutes (95% confidence interval 0.5 to 44.3 minutes) measured by sleep diaries (n=110) and 13.3 (-15.5 to 42.2) measured by actigraphy (n=59). Melatonin reduced sleep onset latency measured by sleep diaries (-37.5 minutes, -55.3 to -19.7 minutes) and actigraphy (-45.3 minutes, -68.8 to -21.9 minutes) and was most effective for children with the longest sleep latency (P=0.009). Melatonin was associated with earlier waking times than placebo (29.9 minutes, 13.6 to 46.3 minutes). Child behaviour and family functioning outcomes showed some improvement and favoured use of melatonin. Adverse events were mild and similar between the two groups. Conclusions Children gained little additional sleep on melatonin; though they fell asleep significantly faster, waking times became earlier. Child behaviour and family functioning outcomes did not significantly improve. Melatonin was tolerable over this three month period. Comparisons with slow release melatonin preparations or melatonin analogues are required.	[Gringras, P.] Kings Coll London, London SE1 7EH, England; [Gringras, P.] St Thomas Hosp, Evelina Childrens Hosp, London SE1 7EH, England; [Gamble, C.; Jones, A. P.; Williamson, P. R.] Univ Liverpool, Alder Hey Childrens NHS Fdn Trust, Med Children Res Network Clin Trials Unit, Liverpool L12 2AP, Merseyside, England; [Wiggs, L.] Oxford Brookes Univ, Dept Psychol, Oxford OX3 0BP, England; [Sutcliffe, A.] UCL, Inst Child Hlth, GAP Unit, London WC1N 1EH, England; [Montgomery, P.] Univ Oxford, Ctr Evidence Based Intervent, Oxford OX1 2ER, England; [Whitehouse, W. P.] Univ Nottingham, Nottingham NG7 2RD, England; [Whitehouse, W. P.] Nottingham Univ Hosp NHS Trust, Nottingham Childrens Hosp, Nottingham, England; [Choonara, I.] Derbyshire Childrens Hosp, Sch Med, Acad Div Child Hlth, Derby DE22 3DT, England; [Allport, T.; Edmond, A.] Univ Bristol, Ctr Child & Adolescent Hlth, Bristol BS8 2BN, Avon, England; [Appleton, R.] Alder Hey Childrens NHS Fdn Trust, Paediat Neurosci Fdn, Roald Dahl EEG Dept, Liverpool, Merseyside, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Alder Hey Children's NHS Foundation Trust; University of Liverpool; Oxford Brookes University; University of London; University College London; University of Oxford; University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham; University of Bristol; Alder Hey Children's NHS Foundation Trust	Gringras, P (corresponding author), Kings Coll London, London SE1 7EH, England.	Paul.Gringras@gstt.nhs.uk	Whitehouse, William P/F-9065-2017; Choonara, Imti/I-3559-2019; Williamson, Paula R/B-6425-2016; Gamble, Carrol/AAE-9895-2019	Whitehouse, William P/0000-0001-5207-5731; Choonara, Imti/0000-0002-3069-6323; Williamson, Paula R/0000-0001-9802-6636; Gamble, Carrol/0000-0002-3021-1955; Sutcliffe, Alastair/0000-0001-8542-6155; Montgomery, Paul/0000-0001-8008-1370; Allport, Tom/0000-0002-4115-1281	NIHR Health Technology Assessment programme [05/14/02]; National Institute for Health Research [05/14/02] Funding Source: researchfish	NIHR Health Technology Assessment programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the NIHR Health Technology Assessment programme (project number 05/14/02) and will be published in full in Health Technology Assessment journal. See the HTA programme website for further project information. This report presents independent research commissioned by the National Institute for Health Research (NIHR). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NHS, the NIHR, NETSCC, the HTA programme, or the Department of Health.	Aman M.G., 1986, ABERRANT BEHAV CHECK; Aman MG., 2017, ABERRANT BEHAV CHECK, V2; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Braam W, 2010, J INTELL DISABIL RES, V54, P547, DOI 10.1111/j.1365-2788.2010.01283.x; Braam W, 2009, DEV MED CHILD NEUROL, V51, P340, DOI 10.1111/j.1469-8749.2008.03244.x; Buscemi N, 2006, BMJ-BRIT MED J, V332, P385, DOI 10.1136/bmj.38731.532766.F6; Buscemi N, 2005, J GEN INTERN MED, V20, P1151, DOI 10.1111/j.1525-1497.2005.0243.x; Czeisler CA, 1997, J BIOL RHYTHM, V12, P618, DOI 10.1177/074873049701200617; Dwan KM, 2009, OUTCOME REPORTING BI; Evans Scott, 2007, PLoS Clin Trials, V2, pe18, DOI 10.1371/journal.pctr.0020018; Harrison P, 2008, ADAPTIVE BEHAV SYSTE; Hill CM, 2007, ARCH DIS CHILD, V92, P637, DOI 10.1136/adc.2006.096156; Jan JE, 2010, EUR J PAEDIATR NEURO, V14, P380, DOI 10.1016/j.ejpn.2010.05.001; JAN JE, 1994, DEV MED CHILD NEUROL, V36, P97; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Krakowiak P, 2008, J SLEEP RES, V17, P197, DOI 10.1111/j.1365-2869.2008.00650.x; Kunz D, 2004, J CLIN ENDOCR METAB, V89, P128, DOI 10.1210/jc.2002-021057; Lewy AJ, 1997, J BIOL RHYTHM, V12, P588, DOI 10.1177/074873049701200614; Malow B, 2012, J AUTISM DEV DISORD, V42, P1729, DOI 10.1007/s10803-011-1418-3; McArthur AJ, 1998, DEV MED CHILD NEUROL, V40, P186; Meltzer LJ, 2007, J FAM PSYCHOL, V21, P67, DOI 10.1037/0893-3200.21.1.67; Montgomery P, 2004, ARCH DIS CHILD, V89, P125, DOI 10.1136/adc.2002.017202; O'Callaghan FJK, 1999, DEV MED CHILD NEUROL, V41, P123, DOI 10.1017/S0012162299000237; Phillips L, 2004, DEV MED CHILD NEUROL, V46, P771, DOI 10.1017/S001216220400132X; QUINE L, 1991, J MENT DEFIC RES, V35, P269; Quine L., 1992, HELPING PARENTS MANA; RICHMAN N, 1971, J CHILD PSYCHOL PSYC, V12, P5, DOI 10.1111/j.1469-7610.1971.tb01047.x; Rossignol DA, 2011, DEV MED CHILD NEUROL, V53, P783, DOI 10.1111/j.1469-8749.2011.03980.x; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Stone BM, 2000, SLEEP, V23, P663; van Geijlswijk IM, 2010, PSYCHOPHARMACOLOGY, V212, P379, DOI 10.1007/s00213-010-1962-0; Varni James W, 2004, Health Qual Life Outcomes, V2, P55, DOI 10.1186/1477-7525-2-55	33	108	111	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 5	2012	345								e6664	10.1136/bmj.e6664	http://dx.doi.org/10.1136/bmj.e6664			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036KY	23129488	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000311026000001
J	Laxminarayan, R; Arrow, K; Jamison, D; Bloom, BR				Laxminarayan, Ramanan; Arrow, Kenneth; Jamison, Dean; Bloom, Barry R.			From Financing to Fevers: Lessons of an Antimalarial Subsidy Program	SCIENCE			English	Editorial Material							MALARIA		[Bloom, Barry R.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Laxminarayan, Ramanan] Princeton Univ, Washington, DC 20036 USA; [Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC 20036 USA; [Arrow, Kenneth] Stanford Univ, Stanford, CA 94305 USA; [Jamison, Dean] Univ Washington, Seattle, WA 98195 USA	Harvard University; Harvard T.H. Chan School of Public Health; Princeton University; Stanford University; University of Washington; University of Washington Seattle	Bloom, BR (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	bbloom@hsph.harvard.edu	Laxminarayan, Ramanan/ABD-5050-2021					Adeyi O, 2010, LANCET, V376, P1869, DOI 10.1016/S0140-6736(10)61189-0; AMFm Expert Advisory Group, AMFM GLOB FUND AIDS; [Anonymous], IMCI HDB; [Anonymous], 2001, ANT DRUG COMB THER; [Anonymous], 2012, IND EV PHAS 1 AFF ME; Cohen JM, 2012, SCIENCE, V338, P612, DOI 10.1126/science.1229045; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Frost LJ, 2008, ACCESS DO GOOD HLTH; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; WHO, WHO URG REG MEAS STO; Yamey G, 2012, B WORLD HEALTH ORGAN, V90, P452, DOI 10.2471/BLT.11.091199; Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340	14	5	5	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					615	616		10.1126/science.1231010	http://dx.doi.org/10.1126/science.1231010			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	029SM	23118173				2022-12-28	WOS:000310516000034
J	Buse, JB; Nauck, M; Forst, T; Sheu, WHH; Shenouda, SK; Heilmann, CR; Hoogwerf, BJ; Gao, AJ; Boardman, MK; Fineman, M; Porter, L; Schernthaner, G				Buse, John B.; Nauck, Michael; Forst, Thomas; Sheu, Wayne H-H; Shenouda, Sylvia K.; Heilmann, Cory R.; Hoogwerf, Byron J.; Gao, Aijun; Boardman, Marilyn K.; Fineman, Mark; Porter, Lisa; Schernthaner, Guntram			Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study	LANCET			English	Article							GLYCEMIC CONTROL; RECEPTOR AGONISTS; TREATED PATIENTS; PARALLEL-GROUP; METFORMIN; EFFICACY; SAFETY; EXENDIN-4; SITAGLIPTIN; 26-WEEK	Background Glucagon-like peptide-1 receptor agonists exenatide and liraglutide have been shown to improve glycaemic control and reduce bodyweight in patients with type 2 diabetes. We compared the efficacy and safety of exenatide once weekly with liraglutide once daily in patients with type 2 diabetes. Methods We did a 26 week, open-label, randomised, parallel-group study at 105 sites in 19 countries between Jan 11, 2010, and Jan 17, 2011. Patients aged 18 years or older with type 2 diabetes treated with lifestyle modification and oral antihyperglycaemic drugs were randomly assigned (1:1), via a computer-generated randomisation sequence with a voice response system, to receive injections of once-daily liraglutide (1.8 mg) or once-weekly exenatide (2 mg). Participants and investigators were not masked to treatment assignment. The primary endpoint was change in glycated haemoglobin (HbA(1c)) from baseline to week 26. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT01029886. Findings Of 912 randomised patients, 911 were included in the intention-to-treat analysis (450 liraglutide, 461 exenatide). The least-squares mean change in HbA(1c) was greater in patients in the liraglutide group (-1.48%, SE 0.05; n=386) than in those in the exenatide group (-1.28%, 0.05; 390) with the treatment difference (0.21%, 95% CI 0.08-0.33) not meeting predefined non-inferiority criteria (upper limit of CI <0.25%). The most common adverse events were nausea (93 [21%] in the liraglutide group vs 43 [9%] in the exenatide group), diarrhoea (59 [13%] vs 28 [6%]), and vomiting 48 [11%] vs 17 [4%]), which occurred less frequently in the exenatide group and with decreasing incidence over time in both groups. 24 (5%) patients allocated to liraglutide and 12 (3%) allocated to exenatide discontinued participation because of adverse events. Interpretation Both once daily liraglutide and once weekly exenatide led to improvements in glycaemic control, with greater reductions noted with liraglutide. These findings, plus differences in injection frequency and tolerability, could inform therapeutic decisions for treatment of patients with type 2 diabetes.	[Buse, John B.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Nauck, Michael] Diabeteszentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany; [Forst, Thomas] Inst Clin Res & Dev, Mainz, Germany; [Sheu, Wayne H-H] Taichung Vet Gen Hosp, Div Endocrinol & Metab, Dept Internal Med, Taichung, Taiwan; [Sheu, Wayne H-H] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Shenouda, Sylvia K.; Heilmann, Cory R.; Hoogwerf, Byron J.; Boardman, Marilyn K.] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Gao, Aijun] PharmaNet i3, Cincinnati, OH USA; [Fineman, Mark] Elcelyx Therapeut, San Diego, CA USA; [Porter, Lisa] Amylin Pharmaceut, San Diego, CA USA; [Schernthaner, Guntram] Rudolfstiftung Hosp, A-1030 Vienna, Austria	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Eli Lilly; Bristol-Myers Squibb; Amylin Pharmaceuticals, LLC; Rudolfstiftung Hospital	Schernthaner, G (corresponding author), Rudolfstiftung Hosp, A-1030 Vienna, Austria.	guntram.schernthaner@meduniwien.ac.at	Buse, John Bernard/J-9742-2019; Nauck, Michael Albrecht/ABA-9752-2021	Buse, John Bernard/0000-0002-9723-3876; Nauck, Michael Albrecht/0000-0002-5749-6954	Amylin Pharmaceuticals LLC; Andromeda; AstraZeneca; Bayhill Therapeutics; Biodel; Boehringer Ingelheim; Bristol-Myers Squibb; Catabasis; Cebix; Diartis; Elcelyx; Eli Lilly and Company; Exsulin; GI Dynamics; Halozyme; Hoffman-LaRoche; Johnson Johnson; Lexicon; LipoScience; Medtronic MiniMed; Merck; Metabolon; Novan; Novo Nordisk Pharmaceuticals; Osiris Therapeutics; Orexigen; Pfizer; Sanofi; Tolerx; Transition Therapeutics; TransPharma; Verva Pharmaceuticals; Berlin-Chemie AG (Menarini Group); Sharp Dohme; Novartis Pharma AG; GlaxoSmithKline; MetaCure; Roche Pharma AG; Novo Nordisk Pharma GmbH; Bristol-Myers Squibb EMEA; Diartis Pharmaceuticals; F Hoffmann-LaRoche; Intarcia Therapeutics; MannKind Corp; Merck Sharp Dohme GmbH; NovoNordisk A/S; Sanofi-Aventis Pharma; Takeda; Versartis; Wyeth Research; Novo Nordisk; Bayer; Novartis	Amylin Pharmaceuticals LLC(Bristol-Myers Squibb); Andromeda; AstraZeneca(AstraZeneca); Bayhill Therapeutics; Biodel; Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Catabasis; Cebix; Diartis; Elcelyx; Eli Lilly and Company(Eli Lilly); Exsulin; GI Dynamics; Halozyme; Hoffman-LaRoche; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Lexicon; LipoScience; Medtronic MiniMed; Merck(Merck & Company); Metabolon; Novan; Novo Nordisk Pharmaceuticals(Novo Nordisk); Osiris Therapeutics; Orexigen; Pfizer(Pfizer); Sanofi; Tolerx; Transition Therapeutics; TransPharma; Verva Pharmaceuticals; Berlin-Chemie AG (Menarini Group)(Menarini Group); Sharp Dohme; Novartis Pharma AG; GlaxoSmithKline(GlaxoSmithKline); MetaCure; Roche Pharma AG(Roche Holding); Novo Nordisk Pharma GmbH(Novo Nordisk); Bristol-Myers Squibb EMEA(Bristol-Myers Squibb); Diartis Pharmaceuticals; F Hoffmann-LaRoche(Hoffmann-La Roche); Intarcia Therapeutics; MannKind Corp; Merck Sharp Dohme GmbH; NovoNordisk A/S(Novo Nordisk); Sanofi-Aventis Pharma; Takeda(Takeda Pharmaceutical Company Ltd); Versartis; Wyeth Research(Wyeth); Novo Nordisk(Novo Nordisk); Bayer(Bayer AG); Novartis(Novartis)	JBB is an investigator or consultant without direct financial benefit to him through contracts between his employer and the following companies: Amylin Pharmaceuticals LLC, Andromeda, AstraZeneca, Bayhill Therapeutics, Biodel, Boehringer Ingelheim, Bristol-Myers Squibb, Catabasis, Cebix, Diartis, Elcelyx, Eli Lilly and Company, Exsulin, GI Dynamics, Halozyme, Hoffman-LaRoche, Johnson & Johnson, Lexicon, LipoScience, Medtronic MiniMed, Merck, Metabolon, Novan, Novo Nordisk Pharmaceuticals, Osiris Therapeutics, Orexigen, Pfizer, Sanofi, Tolerx, Transition Therapeutics, TransPharma, and Verva Pharmaceuticals. MN is employed by Diabeteszentrum Bad Lauterberg, Germany; has received research grants to his institution from Berlin-Chemie AG (Menarini Group), Eli Lilly and Company, Merck, Sharp & Dohme, Novartis Pharma AG, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, MetaCure, Roche Pharma AG, Novo Nordisk Pharma GmbH, and Tolerx; has received consulting fees or honoraria for membership in advisory boards and honoraria for speaking from Amylin Pharmaceuticals LLC, AstraZeneca, Berlin-Chemie AG (Menarini group), Boehringer Ingelheim, Bristol-Myers Squibb EMEA, Diartis Pharmaceuticals, Eli Lilly and Company, F Hoffmann-LaRoche, GlaxoSmithKline, Intarcia Therapeutics, MannKind Corp, Merck Sharp & Dohme GmbH, Novartis Pharma AG, NovoNordisk A/S, Sanofi-Aventis Pharma, Takeda, Versartis, and Wyeth Research, including reimbursement for travel expenses in connection with the above mentioned activities. JBB owns no stock. TF received speaker and advisory fees from Eli Lilly and Company and Novo Nordisk. WH-HS received speaker fees from Novo Nordisk, Eli Lilly and Company, Merck, Sharp & Dohme, Takeda, Boehringer Ingelheim, Bristol-Myers Squibb, AstraZeneca, Bayer, and Novartis, and advisory fees from Novo Nordisk, and Merck, Sharp & Dohme. SKS, CRH, BJH, and MKB are employees of Eli Lilly and Company or one of its subsidiaries, and are shareholders of Eli Lilly and Company. AG is an employee of PharmaNet/i3, which undertakes services for Eli Lilly and Company. MF is a former employee and shareholder of Amylin Pharmaceuticals LLC. LP is an employee and shareholder of Amylin Pharmaceuticals LLC. GS has been a consultant for and received honoraria from Amgen, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Eli Lilly and Company, Merck, Novartis, Poxel, Roche, Sanofi-Aventis, Novo Nordisk, Servier, and Takeda.	Agerso H, 2002, DIABETOLOGIA, V45, P195, DOI 10.1007/s00125-001-0719-z; Anderson RT, 2009, DIABETES CARE, V32, P51, DOI 10.2337/dc08-0856; [Anonymous], 1997, Cardiovasc Res, V35, P2; Aroda VR, 2012, CLIN THER, V34, P1247, DOI 10.1016/j.clinthera.2012.04.013; Bergenstal RM, 2010, LANCET, V376, P431, DOI 10.1016/S0140-6736(10)60590-9; Blevins T, 2011, J CLIN ENDOCR METAB, V96, P1301, DOI 10.1210/jc.2010-2081; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; DeYoung MB, 2011, DIABETES TECHNOL THE, V13, P1145, DOI 10.1089/dia.2011.0050; Diamant Michaela, 2010, Lancet, V375, P2234, DOI 10.1016/S0140-6736(10)60406-0; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Hegedus L, 2011, J CLIN ENDOCR METAB, V96, P853, DOI 10.1210/jc.2010-2318; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Kim D, 2007, DIABETES CARE, V30, P1487, DOI 10.2337/dc06-2375; Klonoff DC, 2008, CURR MED RES OPIN, V24, P275, DOI 10.1185/030079908X253870; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Marre M, 2009, DIABETIC MED, V26, P268, DOI 10.1111/j.1464-5491.2009.02666.x; Nauck M, 2009, DIABETES CARE, V32, P84, DOI 10.2337/dc08-1355; Nielsen LL, 2004, REGUL PEPTIDES, V117, P77, DOI 10.1016/j.regpep.2003.10.028; Pratley RE, 2010, LANCET, V375, P1447, DOI 10.1016/S0140-6736(10)60307-8; Russell-Jones D, 2009, DIABETOLOGIA, V52, P2046, DOI 10.1007/s00125-009-1472-y; Russell-Jones D, 2012, DIABETES CARE, V35, P252, DOI 10.2337/dc11-1107; Zinman B, 2007, ANN INTERN MED, V146, P477, DOI 10.7326/0003-4819-146-7-200704030-00003; Zinman B, 2009, DIABETES CARE, V32, P1224, DOI 10.2337/dc08-2124	28	377	388	2	60	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2013	381	9861					117	124		10.1016/S0140-6736(12)61267-7	http://dx.doi.org/10.1016/S0140-6736(12)61267-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069FO	23141817				2022-12-28	WOS:000313420900027
J	Yamaguchi, S; Hong, K; Liu, R; Shen, L; Inoue, A; Diep, D; Zhang, K; Zhang, Y				Yamaguchi, Shinpei; Hong, Kwonho; Liu, Rui; Shen, Li; Inoue, Azusa; Diep, Dinh; Zhang, Kun; Zhang, Yi			Tet1 controls meiosis by regulating meiotic gene expression	NATURE			English	Article							PRIMORDIAL GERM-CELLS; DNA METHYLATION; EPIGENETIC EVENTS; MAMMALIAN DNA; MOUSE; MICE; 5-CARBOXYLCYTOSINE; 5-METHYLCYTOSINE; SPECIFICATION; PLURIPOTENCY	Meiosis is a germ-cell-specific cell division process through which haploid gametes are produced for sexual reproduction(1). Before the initiation of meiosis, mouse primordial germ cells undergo a series of epigenetic reprogramming steps(2,3), including the global erasure of DNA methylation at the 5-position of cytosine (5mC) in CpG-rich DNA(4,5). Although several epigenetic regulators, such as Dnmt3l and the histone methyltransferases G9a and Prdm9, have been reported to be crucial for meiosis(6), little is known about how the expression of meiotic genes is regulated and how their expression contributes to normal meiosis. Using a loss-of-function approach in mice, here we show that the 5mC-specific dioxygenase Tet1 has an important role in regulating meiosis in mouse oocytes. Tet1 deficiency significantly reduces female germ-cell numbers and fertility. Univalent chromosomes and unresolved DNA double-strand breaks are also observed in Tet1-deficient oocytes. Tet1 deficiency does not greatly affect the genome-wide demethylation that takes place in primordial germ cells, but leads to defective DNA demethylation and decreased expression of a subset of meiotic genes. Our study thus establishes a function for Tet1 in meiosis and meiotic gene activation in female germ cells.	[Liu, Rui; Diep, Dinh; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Yamaguchi, Shinpei; Hong, Kwonho; Shen, Li; Inoue, Azusa; Zhang, Yi] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Yamaguchi, Shinpei; Hong, Kwonho; Shen, Li; Inoue, Azusa; Zhang, Yi] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Yamaguchi, Shinpei; Hong, Kwonho; Shen, Li; Inoue, Azusa; Zhang, Yi] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhang, Yi] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA	University of California System; University of California San Diego; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Zhang, K (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	kzhang@bioeng.ucsd.edu; yzhang@genetics.med.harvard.edu	Yamaguchi, Shinpei/HCH-5553-2022; Zhang, Kun/ABE-6349-2020	Zhang, Kun/0000-0002-7596-5224; Zhang, Yi/0000-0002-2789-0811; Hong, Kwonho/0000-0001-7479-4091; Yamaguchi, Shinpei/0000-0002-9377-4835	National Institutes of Health [U01DK089565]; CIRM [BRB3-05083];  [R01GM097253]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097253] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Wang and W. Jiang for FACS sorting, A. Adey and J. Shendure for sharing reagents and protocols for Tn5mC-seq, and H.-L. Fung for Illumina sequencing. This work was partially supported by U01DK089565 (National Institutes of Health) (to Y.Z.), R01GM097253 and CIRM BRB3-05083 (to K.Z.). Y.Z. is an Investigator of the Howard Hughes Medical Institute. D.D. is a CIRM-UCSD pre-doctoral fellow.	Adey A, 2012, GENOME RES, V22, P1139, DOI 10.1101/gr.136242.111; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; Diep D, 2012, NAT METHODS, V9, P270, DOI [10.1038/nmeth.1871, 10.1038/NMETH.1871]; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hayashi K, 2009, CELL STEM CELL, V4, P493, DOI 10.1016/j.stem.2009.05.007; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kota SK, 2010, DEV CELL, V19, P675, DOI 10.1016/j.devcel.2010.10.009; Kouznetsova A, 2005, J CELL SCI, V118, P2271, DOI 10.1242/jcs.02362; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Markoulaki S, 2008, METHODS, V45, P101, DOI 10.1016/j.ymeth.2008.04.002; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Soper SFC, 2008, DEV CELL, V15, P285, DOI 10.1016/j.devcel.2008.05.015; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takada Y, 2011, DEVELOPMENT, V138, P4207, DOI 10.1242/dev.064444; Wang H, 2006, J CELL BIOL, V173, P485, DOI 10.1083/jcb.200512077; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934	29	196	207	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					443	+		10.1038/nature11709	http://dx.doi.org/10.1038/nature11709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23151479	Green Submitted, Green Accepted			2022-12-28	WOS:000312488200059
J	Holmes, D				Holmes, David			Lixin Jiang: at the heart of China's evidence base	LANCET			English	Biographical-Item																		JIANG L, PUBLICATION LIST	1	1	4	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 24	2012	380	9856					1809	1809		10.1016/S0140-6736(12)62017-0	http://dx.doi.org/10.1016/S0140-6736(12)62017-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	041XK	23177691				2022-12-28	WOS:000311435000013
J	Algera, C; Lammers, GJ				Algera, Corrie; Lammers, Gert Jan			Restless legs syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lammers, Gert Jan] Leiden Univ, Med Ctr, Dept Neurol, NL-2333 ZA Leiden, Netherlands; [Algera, Corrie] Stichting Restless Legs, NL-1083 KA Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Lammers, GJ (corresponding author), Leiden Univ, Med Ctr, Dept Neurol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	G.J.Lammers@lumc.nl		Lammers, Gert Jan/0000-0003-4755-7060				Allen RP, 2010, SLEEP MED, V11, P31, DOI 10.1016/j.sleep.2009.03.007; Earley CJ, 2010, SLEEP MED, V11, P807, DOI 10.1016/j.sleep.2010.07.007	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 20	2012	345								e7592	10.1136/bmj.e7592	http://dx.doi.org/10.1136/bmj.e7592			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	044GT	23169803	Bronze			2022-12-28	WOS:000311608200006
J	Boyce, N				Boyce, Niall			A secret history	LANCET			English	Editorial Material												niall.boyce@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 17	2012	380	9855					1732	1733		10.1016/S0140-6736(12)61978-3	http://dx.doi.org/10.1016/S0140-6736(12)61978-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	038CV	23166922				2022-12-28	WOS:000311153700016
J	Luk, KC; Kehm, V; Carroll, J; Zhang, B; O'Brien, P; Trojanowski, JQ; Lee, VMY				Luk, Kelvin C.; Kehm, Victoria; Carroll, Jenna; Zhang, Bin; O'Brien, Patrick; Trojanowski, John Q.; Lee, Virginia M. -Y.			Pathological alpha-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice	SCIENCE			English	Article							LEWY BODIES; DISEASE; BRAIN; DEATH	Parkinson's disease is characterized by abundant alpha-synuclein (alpha-Syn) neuronal inclusions, known as Lewy bodies and Lewy neurites, and the massive loss of midbrain dopamine neurons. However, a cause-and-effect relationship between Lewy inclusion formation and neurodegeneration remains unclear. Here, we found that in wild-type nontransgenic mice, a single intrastriatal inoculation of synthetic alpha-Syn fibrils led to the cell-to-cell transmission of pathologic alpha-Syn and Parkinson's-like Lewy pathology in anatomically interconnected regions. Lewy pathology accumulation resulted in progressive loss of dopamine neurons in the substantia nigra pars compacta, but not in the adjacent ventral tegmental area, and was accompanied by reduced dopamine levels culminating in motor deficits. This recapitulation of a neurodegenerative cascade thus establishes a mechanistic link between transmission of pathologic alpha-Syn and the cardinal features of Parkinson's disease.	[Lee, Virginia M. -Y.] Univ Penn, Dept Pathol & Lab Med, Inst Aging, Perelman Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Lee, VMY (corresponding author), Univ Penn, Dept Pathol & Lab Med, Inst Aging, Perelman Sch Med, Philadelphia, PA 19104 USA.	vmylee@upenn.edu	Luk, Kelvin/AAZ-4202-2020	Luk, Kelvin/0000-0002-6591-6269	NIH [NS053488]; JPB Foundation; RJG Foundation; Parkinson Council; Jeff and Anne Keefer Fund; University of Pennsylvania Institute for Translational Medicine and Therapeutics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS053488] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; RJG Foundation; Parkinson Council; Jeff and Anne Keefer Fund; University of Pennsylvania Institute for Translational Medicine and Therapeutics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Byrne, J. Levitan, I. Song, and J. Yeh for technical assistance, and L. Kwong, H. Tran, and K. Brunden for their comments. This work was funded by NIH NS053488, the JPB and RJG Foundations, the Parkinson Council, and the Jeff and Anne Keefer Fund. K. C. L. is supported in part by the University of Pennsylvania Institute for Translational Medicine and Therapeutics. The data reported in this paper are presented in the main text and supplementary materials. Materials and methods are available as supplementary materials on Science Online.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Angot E, 2010, LANCET NEUROL, V9, P1128, DOI 10.1016/S1474-4422(10)70213-1; Baba M, 1998, AM J PATHOL, V152, P879; Bjorklund A, 2010, PROG BRAIN RES, V184, P17, DOI 10.1016/S0079-6123(10)84002-6; Braak H, 2000, J NEUROL, V247, P3; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kordower JH, 2008, MOVEMENT DISORD, V23, P2303, DOI 10.1002/mds.22369; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Pan WXX, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00147; Poulopoulos M, 2012, MOVEMENT DISORD, V27, P831, DOI 10.1002/mds.24962; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033	24	1523	1559	13	273	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					949	953		10.1126/science.1227157	http://dx.doi.org/10.1126/science.1227157			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161999	Green Accepted			2022-12-28	WOS:000311083600044
J	Weiss, BP				Weiss, Benjamin P.			A Vitrage of Asteroid Magnetism	SCIENCE			English	Editorial Material							METEORITES		MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Weiss, BP (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	bpweiss@mit.edu						[Anonymous], MARTIAN SURFACE; Boesenberg JS, 2012, GEOCHIM COSMOCHIM AC, V89, P134, DOI 10.1016/j.gca.2012.04.037; Boisse A., 1847, M MOIRES SOCI T LETT, V7, P1; BRECHER A, 1977, J GEOMAGN GEOELECTR, V29, P379, DOI 10.5636/jgg.29.379; Chladni E. F. F., 1794, URSPRUNG PALLAS GEFU; CISOWSKI CS, 1987, GEOMAGN AERON, V2, P525; FISH RA, 1960, ASTROPHYS J, V132, P243, DOI 10.1086/146918; Fu RR, 2012, SCIENCE, V338, P238, DOI 10.1126/science.1225648; LOVERING JF, 1959, AM J SCI, V257, P271, DOI 10.2475/ajs.257.4.271; Stevenson DJ, 2010, SPACE SCI REV, V152, P651, DOI 10.1007/s11214-009-9572-z; Tarduno JA, 2012, SCIENCE, V338, P939, DOI 10.1126/science.1223932; Weiss BP, 2010, SPACE SCI REV, V152, P341, DOI 10.1007/s11214-009-9580-z; Yang JJ, 2010, GEOCHIM COSMOCHIM AC, V74, P4471, DOI 10.1016/j.gca.2010.04.016	14	0	0	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2012	338	6109					897	898		10.1126/science.1230532	http://dx.doi.org/10.1126/science.1230532			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161987				2022-12-28	WOS:000311083600031
J	Wilkins, J; Schoville, BJ; Brown, KS; Chazan, M				Wilkins, Jayne; Schoville, Benjamin J.; Brown, Kyle S.; Chazan, Michael			Evidence for Early Hafted Hunting Technology	SCIENCE			English	Article							MIDDLE STONE-AGE; SOUTH-AFRICA; PALEOLITHIC SITE; SPEAR POINTS; CAVE; TOOLS	Hafting stone points to spears was an important advance in weaponry for early humans. Multiple lines of evidence indicate that similar to 500,000-year-old stone points from the archaeological site of Kathu Pan 1 (KP1), South Africa, functioned as spear tips. KP1 points exhibit fracture types diagnostic of impact. Modification near the base of some points is consistent with hafting. Experimental and metric data indicate that the points could function well as spear tips. Shape analysis demonstrates that the smaller retouched points are as symmetrical as larger retouched points, which fits expectations for spear tips. The distribution of edge damage is similar to that in an experimental sample of spear tips and is inconsistent with expectations for cutting or scraping tools. Thus, early humans were manufacturing hafted multicomponent tools similar to 200,000 years earlier than previously thought.	[Wilkins, Jayne; Chazan, Michael] Univ Toronto, Dept Anthropol, Toronto, ON M5S 2S2, Canada; [Schoville, Benjamin J.; Brown, Kyle S.] Arizona State Univ, Sch Human Evolut & Social Change, Inst Human Origins, Tempe, AZ 85287 USA; [Brown, Kyle S.] Univ Cape Town, Dept Archaeol, ZA-7701 Rondebosch, South Africa	University of Toronto; Arizona State University; Arizona State University-Tempe; University of Cape Town	Wilkins, J (corresponding author), Univ Toronto, Dept Anthropol, 19 Russell St, Toronto, ON M5S 2S2, Canada.	jayne.wilkins@utoronto.ca	Wilkins, Jayne/ABF-9501-2020	Wilkins, Jayne/0000-0003-2586-107X; Schoville, Benjamin/0000-0002-0124-7959	Social Sciences and Humanities Research Council Joseph-Armand Bombardier Canada Graduate Scholarship; University of Toronto; Social Sciences and Humanities Research Council of Canada; NSF [BCS-0524087, BCS-1138073]; Hyde Family Foundation; Institute of Human Origins at Arizona State University	Social Sciences and Humanities Research Council Joseph-Armand Bombardier Canada Graduate Scholarship; University of Toronto(University of Toronto); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); NSF(National Science Foundation (NSF)); Hyde Family Foundation; Institute of Human Origins at Arizona State University	This research was supported by a Social Sciences and Humanities Research Council Joseph-Armand Bombardier Canada Graduate Scholarship and funding from the University of Toronto to J.W. The McGregor Museum and the South African Heritage Resources Agency permitted temporary export of the points for study. Fieldwork at KP1 was supported by funding from the Social Sciences and Humanities Research Council of Canada to M. C. B.J.S. and K. S. B. were funded by grants from NSF (BCS-0524087 and BCS-1138073) and the Hyde Family Foundation to C. Marean and from the Institute of Human Origins at Arizona State University. We thank D. Morris, N. Porat, L. K. Horwitz, C. Marean, and P. Beaumont. Data are tabulated in the online supplementary materials.	[Anonymous], 1990, GUIDE ARCHAEOLOGICAL; Beaumont P.B., 2004, ARCHAEOLOGY NO CAPE, P50; Boeda E, 1999, ANTIQUITY, V73, P394, DOI 10.1017/S0003598X00088335; Brooks AS, 2006, INTERD CONTRIB ARCH, P233, DOI 10.1007/0-387-24661-4_13; Endicott P, 2010, J HUM EVOL, V59, P87, DOI 10.1016/j.jhevol.2010.04.005; Fischer A., 1984, J DAN ARCHAEOL, V3, P19, DOI [10.1080/0108464X.1984.10589910, DOI 10.1080/0108464X.1984.10589910]; Hardy BL, 2001, P NATL ACAD SCI USA, V98, P10972, DOI 10.1073/pnas.191384498; Iovita R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029029; Lombard M, 2005, S AFR ARCHAEOL BULL, V60, P115; Lombard M, 2004, S AFR J SCI, V100, P159; Lombard M, 2005, J HUM EVOL, V48, P279, DOI 10.1016/j.jhevol.2004.11.006; Lombard M, 2007, S AFR ARCHAEOL BULL, V62, P62, DOI 10.2307/20474947; Mazza PPA, 2006, J ARCHAEOL SCI, V33, P1310, DOI 10.1016/j.jas.2006.01.006; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Milo RG, 1998, J ARCHAEOL SCI, V25, P99, DOI 10.1006/jasc.1997.0233; ODELL GH, 1986, J FIELD ARCHAEOL, V13, P195, DOI 10.1179/009346986791535780; Pargeter J, 2007, S AFR ARCHAEOL BULL, V62, P147, DOI 10.2307/20474970; Pargeter J, 2011, J ARCHAEOL SCI, V38, P2882, DOI 10.1016/j.jas.2011.04.018; Porat N, 2010, J ARCHAEOL SCI, V37, P269, DOI 10.1016/j.jas.2009.09.038; Rabinovich R, 2008, J HUM EVOL, V54, P134, DOI 10.1016/j.jhevol.2007.07.007; Rightmire GP, 2009, P NATL ACAD SCI USA, V106, P16046, DOI 10.1073/pnas.0903930106; Rightmire GP, 2001, QUATERN INT, V75, P77, DOI 10.1016/S1040-6182(00)00079-3; Roberts M. B., 1999, BOXGROVE A MIDDLE PL; Rots V, 2013, J ARCHAEOL SCI, V40, P497, DOI 10.1016/j.jas.2012.06.042; Rots V, 2011, J HUM EVOL, V60, P637, DOI 10.1016/j.jhevol.2011.01.001; Sano K., 2009, QUARTAR, V56, P67; Sano K, 2012, QUATERN INT, V272, P264, DOI 10.1016/j.quaint.2012.02.057; Schoville BJ, 2010, J HUM EVOL, V59, P378, DOI 10.1016/j.jhevol.2010.07.015; Shea J, 2001, J ARCHAEOL SCI, V28, P807, DOI 10.1006/jasc.2000.0590; SHEA JJ, 1988, J FIELD ARCHAEOL, V15, P441, DOI 10.1179/jfa.1988.15.4.441; Sisk M. L., 2011, INT J EVOL BIOL, DOI DOI 10.4061/2011/968012; Stringer C, 2012, EVOL ANTHROPOL, V21, P101, DOI 10.1002/evan.21311; Thieme H, 1997, NATURE, V385, P807, DOI 10.1038/385807a0; Villa P, 2005, J ARCHAEOL SCI, V32, P399, DOI 10.1016/j.jas.2004.11.007; Villa P, 2010, J ARCHAEOL SCI, V37, P630, DOI 10.1016/j.jas.2009.10.028; Villa P., 2006, SOUTH AFR HUMANIT, V18, P89; Villa P, 2009, J ARCHAEOL SCI, V36, P850, DOI 10.1016/j.jas.2008.11.012; Villa P, 2009, J ARCHAEOL SCI, V36, P441, DOI 10.1016/j.jas.2008.09.028; Wilkins J, 2012, J ARCHAEOL SCI, V39, P1883, DOI 10.1016/j.jas.2012.01.031; Yaroshevich A, 2010, J ARCHAEOL SCI, V37, P368, DOI 10.1016/j.jas.2009.09.050	40	223	230	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					942	946		10.1126/science.1227608	http://dx.doi.org/10.1126/science.1227608			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	037DY	23161998				2022-12-28	WOS:000311083600042
J	Evans, LJ				Evans, Laura Jane			Thoracolumbar Fracture with Preservation of Neurologic Function	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									James Cook Univ Hosp, Middlesbrough, Cleveland, England	James Cook University Hospital	Evans, LJ (corresponding author), James Cook Univ Hosp, Middlesbrough, Cleveland, England.								0	5	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2012	367	20					1939	1939		10.1056/NEJMicm1101495	http://dx.doi.org/10.1056/NEJMicm1101495			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036MB	23150961				2022-12-28	WOS:000311029300010
J	De Rango, P; Pagliuca, V				De Rango, Paola; Pagliuca, Valentino			A Right Wrist Lump	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[De Rango, Paola] Hosp SM Misericordia, Unit Vasc & Endovasc Surg, I-06129 Perugia, Italy; [Pagliuca, Valentino] Poliambulatorio Euromed, Belluno, Italy		De Rango, P (corresponding author), Hosp SM Misericordia, Unit Vasc & Endovasc Surg, I-06129 Perugia, Italy.	plderango@gmail.com						Ernemann U, 2010, EUR J RADIOL, V75, P2, DOI 10.1016/j.ejrad.2010.04.009; Niu ZB, 2011, PEDIATR EMERG CARE, V27, P788, DOI 10.1097/PEC.0b013e318227cafa; Perkins JA, 2010, OTOLARYNG HEAD NECK, V142, P795, DOI 10.1016/j.otohns.2010.02.026	3	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1914	1915		10.1001/jama.2012.12914	http://dx.doi.org/10.1001/jama.2012.12914			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23150010				2022-12-28	WOS:000310952700028
J	Murray, B				Murray, Barbara			Liverpool care pathway: doctors have always aimed to ease distress in dying	BRITISH MEDICAL JOURNAL			English	Editorial Material									Manor Med Practice, Stockport SK1 3PZ, Lancs, England		Murray, B (corresponding author), Manor Med Practice, Stockport SK1 3PZ, Lancs, England.	barby@doctors.org.uk						European Federation of National Associations of Orthopaedics and Traumatology, 2012, CONSENSUS STATEMENT; General Medical Council, 2010, TREATM CAR END LIFE; Marie Curie Palliative Care Institute Liverpool, 2010, WHAT IS LIV CAR PATH; Morrow A., 2009, WHAT IS HOSPICE COMF; National Institute for Health and Clinical Excellence, 2010, PALL CAR NEEDS	5	1	1	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 14	2012	345								e7606	10.1136/bmj.e7606	http://dx.doi.org/10.1136/bmj.e7606			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040PZ	23152571				2022-12-28	WOS:000311336400008
J	Fox, BD; Kahn, SR; Langleben, D; Eisenberg, MJ; Shimony, A				Fox, Benjamin D.; Kahn, Susan R.; Langleben, David; Eisenberg, Mark J.; Shimony, Avi			Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DEEP-VEIN THROMBOSIS; XA INHIBITOR RIVAROXABAN; DABIGATRAN; WARFARIN; THERAPY; NONINFERIORITY; XIMELAGATRAN; PREVENTION; APIXABAN	Objective To critically review the effectiveness of the novel oral anticoagulants (rivaroxaban, dabigatran, ximelagatran, and apixaban) in the treatment of acute venous thromboembolism. Design Systematic review and random effects meta-analysis. Data were extracted independently by two investigators. An adjusted indirect comparison was performed to compare between novel oral anticoagulants. Data sources Medline, Embase, and Cochrane Library (from inception to April 2012). Hand searching of relevant scientific works and contact with experts. Study selection Randomised controlled trials of novel oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism. Selected outcomes were recurrent events, major bleeding, and all cause mortality. Results Nine studies met our inclusion criteria, involving 16 701 patients evaluated for efficacy and 16 611 for safety. Data were stratified according to different novel oral anticoagulants. For recurrent acute venous thromboembolism, there were no significant differences in events rates between any of the anticoagulants and conventional treatment (rivaroxaban (four studies): relative risk 0.85, 95% confidence interval 0.55 to 1.31; dabigatran (two studies): 1.09, 0.76 to 1.57; ximelagatran (two studies): 1.06, 0.62 to 1.80; and apixaban (one study): 0.98, 0.20 to 4.79). Rivaroxaban reduced the risk of major bleeding compared with conventional treatment (0.57, 0.39 to 0.84), whereas other novel oral anticoagulants did not (0.76 (0.49 to 1.18) for dabigatran; 0.54 (0.28 to 1.03) for ximelagatran; 2.95 (0.12 to 71.82) for apixaban). For all cause mortality there were no significant differences between the novel oral anticoagulants and conventional treatment (0.96 (0.72 to 1.27) for rivaroxaban; 1.00 (0.67 to 1.50) for dabigatran; 0.67 (0.42 to 1.08) for ximelagatran; 6.89 (0.36 to 132.06) for apixaban). The adjusted indirect comparison between rivaroxaban and dabigatran did not show superiority of either drug over the others for major bleeding (0.75, 0.41 to 1.34) or the other endpoints. Conclusions Compared with vitamin K antagonists, the novel oral anticoagulants had a similar risk of recurrence of acute venous thromboembolism and all cause mortality, though rivaroxaban was associated with a reduced risk of bleeding.	[Fox, Benjamin D.; Langleben, David; Eisenberg, Mark J.; Shimony, Avi] McGill Univ, Jewish Gen Hosp, Ctr Pulm Vasc Dis, Montreal, PQ H3T 1E2, Canada; [Fox, Benjamin D.; Langleben, David; Eisenberg, Mark J.; Shimony, Avi] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Div Cardiol, Montreal, PQ H3T 1E2, Canada; [Kahn, Susan R.; Eisenberg, Mark J.; Shimony, Avi] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol & Community Studies, Div Internal Med,Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Kahn, Susan R.; Eisenberg, Mark J.; Shimony, Avi] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol & Community Studies, Dept Med,Lady Davis Inst, Montreal, PQ H3T 1E2, Canada	McGill University; Lady Davis Institute; McGill University; Lady Davis Institute; McGill University; Lady Davis Institute; McGill University	Fox, BD (corresponding author), McGill Univ, Jewish Gen Hosp, Ctr Pulm Vasc Dis, Montreal, PQ H3T 1E2, Canada.	benjamin.fox@mcgill.ca	Langleben, David/AAJ-9152-2020	Fox, Benjamin/0000-0001-6199-668X	William Pencer Family Foundation; Azrieli Foundation; Susan Raymer cardiology fellowship grant; Fonds de la recherche en sante du Quebec (FRSQ); Bank of Montreal Center for the Study of Heart Disease in Women; Dimitrious Banousis Foundation	William Pencer Family Foundation; Azrieli Foundation; Susan Raymer cardiology fellowship grant; Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Bank of Montreal Center for the Study of Heart Disease in Women; Dimitrious Banousis Foundation	BDF is supported in part by the William Pencer Family Foundation. AS is supported by the Azrieli Foundation and a Susan Raymer cardiology fellowship grant. SRK and MJE are supported by a national investigator award of the Fonds de la recherche en sante du Quebec (FRSQ). DL receives support from the Bank of Montreal Center for the Study of Heart Disease in Women, and the Dimitrious Banousis Foundation.	Ageno W, 2012, CHEST, V141, pE44S, DOI 10.1378/chest.11-2292; Agnelli G, 2007, CIRCULATION, V116, P180, DOI 10.1161/CIRCULATIONAHA.106.668020; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Buller H, 2008, J THROMB HAEMOST, V6, P1313, DOI 10.1111/j.1538-7836.2008.03054.x; Buller HR, 2008, J THROMB HAEMOST, V6, P227, DOI 10.1111/j.1538-7836.2007.02848.x; Buller HR, 2008, BLOOD, V112, P2242, DOI 10.1182/blood-2008-05-160143; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eriksson H, 2003, J THROMB HAEMOST, V1, P41, DOI 10.1046/j.1538-7836.2003.00034.x; Fiessinger JN, 2005, JAMA-J AM MED ASSOC, V293, P681, DOI 10.1001/jama.293.6.681; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Gotzsche PC, 2006, JAMA-J AM MED ASSOC, V295, P1172, DOI 10.1001/jama.295.10.1172; Januel JM, 2012, JAMA-J AM MED ASSOC, V307, P294, DOI 10.1001/jama.2011.2029; Kearon Clive, 2012, Chest, V141, pe419S, DOI 10.1378/chest.11-2301; Loke YK, 2011, J CLIN PHARM THER, V36, P111, DOI 10.1111/j.1365-2710.2010.01162.x; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Miller CS, 2012, AM J CARDIOL, V110, P453, DOI 10.1016/j.amjcard.2012.03.049; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; R Development Core Team, 2009, R LANG ENV STAT COMP; Schulman S, 2011, BLOOD, V118, P95, DOI 10.1182/blood.V118.21.205.205; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Schwarzer G, 2012, METAMETAANALYSIS R 2; Uchino K, 2012, ARCH INTERN MED, V172, P397, DOI 10.1001/archinternmed.2011.1666; Weitz JI, 2012, AM J HEMATOL, V87, pS133, DOI 10.1002/ajh.23139; Weitz JI, 2012, CHEST, V141, pE120S, DOI 10.1378/chest.11-2294	26	108	114	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 13	2012	345								e7498	10.1136/bmj.e7498	http://dx.doi.org/10.1136/bmj.e7498			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040PU	23150473	Green Published, hybrid			2022-12-28	WOS:000311335800001
J	Zhang, F; Wang, J; Xu, J; Zhang, Z; Koppetsch, BS; Schultz, N; Vreven, T; Meignin, C; Davis, I; Zamore, PD; Weng, ZP; Theurkauf, WE				Zhang, Fan; Wang, Jie; Xu, Jia; Zhang, Zhao; Koppetsch, Birgit S.; Schultz, Nadine; Vreven, Thom; Meignin, Carine; Davis, Ilan; Zamore, Phillip D.; Weng, Zhiping; Theurkauf, William E.			UAP56 Couples piRNA Clusters to the Perinuclear Transposon Silencing Machinery	CELL			English	Article							MESSENGER-RNA EXPORT; DROSOPHILA-MELANOGASTER; MAGO NASHI; AXIS SPECIFICATION; CRYSTAL-STRUCTURE; NUCLEAR EXPORT; VASA PROTEIN; GERM PLASM; LOCALIZATION; HELICASE	piRNAs silence transposons during germline development. In Drosophila, transcripts from heterochromatic clusters are processed into primary piRNAs in the perinuclear nuage. The nuclear DEAD box protein UAP56 has been previously implicated in mRNA splicing and export, whereas the DEAD box protein Vasa has an established role in piRNA production and localizes to nuage with the piRNA binding PIWI proteins Ago3 and Aub. We show that UAP56 colocalizes with the cluster-associated HP1 variant Rhino, that nuage granules containing Vasa localize directly across the nuclear envelope from cluster foci containing UAP56 and Rhino, and that cluster transcripts immunoprecipitate with both Vasa and UAP56. Significantly, a charge-substitution mutation that alters a conserved surface residue in UAP56 disrupts colocalization with Rhino, germline piRNA production, transposon silencing, and perinuclear localization of Vasa. We therefore propose that UAP56 and Vasa function in a piRNA-processing compartment that spans the nuclear envelope.	[Wang, Jie; Xu, Jia; Vreven, Thom; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA; [Zhang, Fan; Zhang, Zhao; Koppetsch, Birgit S.; Schultz, Nadine; Theurkauf, William E.] Univ Massachusetts, Sch Med, Program Cell & Dev Dynam, Worcester, MA 01655 USA; [Zhang, Fan; Zhang, Zhao; Koppetsch, Birgit S.; Schultz, Nadine; Theurkauf, William E.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA; [Meignin, Carine] Univ Strasbourg, Inst Biol Mol & Cellulaire, Unite Propre Rech 9022, CNRS, F-67084 Strasbourg, France; [Davis, Ilan] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA; [Zamore, Phillip D.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Oxford; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Weng, ZP (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA.	zhiping.weng@umassmed.edu; william.theurkauf@umassmed.edu	Xu, Jia/F-7750-2012; Zamore, Phillip D/A-8941-2013	Xu, Jia/0000-0003-3921-018X; Theurkauf, William/0000-0001-7342-1912; Meignin, Carine/0000-0002-6588-9045; Davis, Ilan/0000-0002-5385-3053; Zamore, Phillip/0000-0002-4505-9618	NIH [HD049116]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049116] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Thanks to members of the Theurkauf and Weng labs for critical discussions and constructive criticisms, to Dr. Paul Lasko for antibodies, and to the Bloomington Drosophila Stock Center for strains. Special thanks to Melissa Moore for sharing her insights into DEAD box proteins. This work was supported by NIH grant HD049116.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Bergman CM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r112; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Britten RJ, 2010, P NATL ACAD SCI USA, V107, P19945, DOI 10.1073/pnas.1014330107; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Eberl DF, 1997, GENETICS, V146, P951; EDDY EM, 1974, ANAT REC, V178, P731, DOI 10.1002/ar.1091780406; EDDY EM, 1975, INT REV CYTOL, V43, P229; Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Harris AN, 2001, DEVELOPMENT, V128, P2823; HAY B, 1990, DEVELOPMENT, V109, P425; Hedges DJ, 2011, ADV GENET, V73, P219, DOI 10.1016/B978-0-12-380860-8.00006-9; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Jang JK, 2003, J CELL SCI, V116, P3069, DOI 10.1242/jcs.00614; Johnstone O, 2004, DEVELOPMENT, V131, P4167, DOI 10.1242/dev.01286; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Ma HH, 2012, MOL CELL PROTEOMICS, V11, P501, DOI 10.1074/mcp.O111.016246; MacMorris M, 2003, RNA, V9, P847, DOI 10.1261/rna.5480803; Madigan JP, 2002, NUCLEIC ACIDS RES, V30, P3698, DOI 10.1093/nar/gkf496; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Meignin C, 2008, DEV BIOL, V315, P89, DOI 10.1016/j.ydbio.2007.12.004; Mevel-Ninio M, 2007, GENETICS, V175, P1615, DOI 10.1534/genetics.106.068106; Micklem DR, 1997, CURR BIOL, V7, P468, DOI 10.1016/S0960-9822(06)00218-1; Mohr SE, 2001, GENE DEV, V15, P2886; Montpetit B, 2011, NATURE, V472, P238, DOI 10.1038/nature09862; NEWMARK PA, 1994, DEVELOPMENT, V120, P1303; Newmark PA, 1997, DEVELOPMENT, V124, P3197; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Shen HH, 2009, BMB REP, V42, P185, DOI 10.5483/BMBRep.2009.42.4.185; Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101; Siomi MC, 2010, SEMIN CELL DEV BIOL, V21, P754, DOI 10.1016/j.semcdb.2010.01.011; Updike DL, 2011, J CELL BIOL, V192, P939, DOI 10.1083/jcb.201010104; Zhao R, 2004, STRUCTURE, V12, P1373, DOI 10.1016/j.str.2004.06.006	49	158	165	2	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					871	884		10.1016/j.cell.2012.09.040	http://dx.doi.org/10.1016/j.cell.2012.09.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141543	Bronze, Green Accepted			2022-12-28	WOS:000310921200017
J	Daviglus, ML; Talavera, GA; Aviles-Santa, ML; Allison, M; Cai, J; Criqui, MH; Gellman, M; Giachello, AL; Gouskova, N; Kaplan, RC; LaVange, L; Penedo, F; Perreira, K; Pirzada, A; Schneiderman, N; Wassertheil-Smoller, S; Sorlie, PD; Stamler, J				Daviglus, Martha L.; Talavera, Gregory A.; Aviles-Santa, M. Larissa; Allison, Matthew; Cai, Jianwen; Criqui, Michael H.; Gellman, Marc; Giachello, Aida L.; Gouskova, Natalia; Kaplan, Robert C.; LaVange, Lisa; Penedo, Frank; Perreira, Krista; Pirzada, Amber; Schneiderman, Neil; Wassertheil-Smoller, Sylvia; Sorlie, Paul D.; Stamler, Jeremiah			Prevalence of Major Cardiovascular Risk Factors and Cardiovascular Diseases Among Hispanic/Latino Individuals of Diverse Backgrounds in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY HEART-DISEASE; MEXICAN-AMERICANS; MYOCARDIAL-INFARCTION; NATIONAL-HEALTH; PUERTO-RICANS; ACCULTURATION; HYPERTENSION; MORTALITY; ADULTS; INTERHEART	Context Major cardiovascular diseases (CVDs) are leading causes of mortality among US Hispanic and Latino individuals. Comprehensive data are limited regarding the prevalence of CVD risk factors in this population and relations of these traits to socioeconomic status (SES) and acculturation. Objectives To describe prevalence of major CVD risk factors and CVD (coronary heart disease [CHD] and stroke) among US Hispanic/Latino individuals of different backgrounds, examine relationships of SES and acculturation with CVD risk profiles and CVD, and assess cross-sectional associations of CVD risk factors with CVD. Design, Setting, and Participants Multicenter, prospective, population-based Hispanic Community Health Study/Study of Latinos including individuals of Cuban(n=2201), Dominican (n=1400), Mexican (n=6232), Puerto Rican (n=2590), Central American (n=1634), and South American backgrounds(n=1022) aged 18 to 74 years. Analyses involved 15 079 participants with complete data enrolled between March 2008 and June 2011. Main Outcome Measures Adverse CVD risk factors defined using national guidelines for hypercholesterolemia, hypertension, obesity, diabetes, and smoking. Prevalence of CHD and stroke were ascertained from self-reported data. Results Age-standardized prevalence of CVD risk factors varied by Hispanic/Latino background; obesity and current smoking rates were highest among Puerto Rican participants (for men, 40.9% and 34.7%; for women, 51.4% and 31.7%, respectively); hypercholesterolemia prevalence was highest among Central American men (54.9%) and Puerto Rican women (41.0%). Large proportions of participants (80% of men, 71% of women) had at least 1 risk factor. Age-and sex-adjusted prevalence of 3 or more risk factors was highest in Puerto Rican participants (25.0%) and significantly higher (P<.001) among participants with less education (16.1%), those who were US-born (18.5%), those who had lived in the United States 10 years or longer (15.7%), and those who preferred English (17.9%). Overall, self-reported CHD and stroke prevalence were low (4.2% and 2.0% in men; 2.4% and 1.2% in women, respectively). In multivariate-adjusted models, hypertension and smoking were directly associated with CHD in both sexes as were hypercholesterolemia and obesity in women and diabetes in men (odds ratios [ORs], 1.5-2.2). For stroke, associations were positive with hypertension in both sexes, diabetes in men, and smoking in women (ORs, 1.7-2.6). Conclusion Among US Hispanic/Latino adults of diverse backgrounds, a sizeable proportion of men and women had adverse major risk factors; prevalence of adverse CVD risk profiles was higher among participants with Puerto Rican background, lower SES, and higher levels of acculturation.	[Daviglus, Martha L.] Univ Illinois, Inst Minor Hlth Res, Dept Med, Gen Internal Med Sect, Chicago, IL 60612 USA; [Talavera, Gregory A.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Aviles-Santa, M. Larissa; Sorlie, Paul D.] NHLBI, Div Cardiovasc Sci, NIH, Bethesda, MD 20892 USA; [Allison, Matthew; Criqui, Michael H.] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Cai, Jianwen; Gouskova, Natalia; LaVange, Lisa; Perreira, Krista] Univ N Carolina, Collaborat Studies Coordinating Ctr, Chapel Hill, NC USA; [Gellman, Marc; Schneiderman, Neil] Univ Miami, Dept Psychol, Behav Med Res Ctr, Miami, FL USA; [Daviglus, Martha L.; Giachello, Aida L.; Pirzada, Amber; Stamler, Jeremiah] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Penedo, Frank] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA; [Kaplan, Robert C.; Wassertheil-Smoller, Sylvia] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; California State University System; San Diego State University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill; University of Miami; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Yeshiva University; Albert Einstein College of Medicine	Daviglus, ML (corresponding author), Univ Illinois, Inst Minor Hlth Res, Dept Med, Gen Internal Med Sect, 1819 W Polk St,Ste 246, Chicago, IL 60612 USA.	daviglus@uic.edu	Pirzada, Amber/ABG-6028-2021	Pirzada, Amber/0000-0003-0526-3611; Aviles-Santa, M Larissa/0000-0002-8130-0026; Allison, Matthew/0000-0003-0777-8272; Gouskova, Natalia/0000-0001-7488-5014	National Heart, Lung, and Blood Institute (NHLBI) [N01-HC65233, N01-HC65234, N01-HC65235, N01-HC65236, N01-HC65237]; National Center on Minority Health and Health Disparities; National Institute on Deafness and Other Communications Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Neurological Disorders and Stroke; Office of Dietary Supplements; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC065233] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL065233, R01HL065234] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL060081] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Deafness and Other Communications Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CLINICAL CENTER	The Hispanic Community Health Study/Study of Latinos was carried out as a collaborative study supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (N01-HC65233), University of Miami (N01-HC65234), Albert Einstein College of Medicine (N01-HC65235), Northwestern University (N01-HC65236), and San Diego State University (N01-HC65237). The following institutes, centers, or offices contribute to the HCHS/SOL through a transfer of funds to the NHLBI: National Center on Minority Health and Health Disparities, the National Institute on Deafness and Other Communications Disorders, the National Institute of Dental and Craniofacial Research, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Neurological Disorders and Stroke, and the Office of Dietary Supplements.	Allison MA, 2008, AM J EPIDEMIOL, V167, P962, DOI 10.1093/aje/kwm402; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Bethel JW, 2005, AM J PREV MED, V29, P143, DOI 10.1016/j.amepre.2005.04.014; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Crespo CJ, 1996, PUBLIC HEALTH REP, V111, P7; Crimmins EM, 2007, AM J PUBLIC HEALTH, V97, P1305, DOI 10.2105/AJPH.2006.091892; Derby CA, 2010, ETHNIC DIS, V20, P396; Ennis S, 2010, 2010 CENSUS BRIEFS H; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; FLEGAL KM, 1991, DIABETES CARE, V14, P628, DOI 10.2337/diacare.14.7.628; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Hunt KJ, 2003, AM J EPIDEMIOL, V158, P1048, DOI 10.1093/aje/kwg249; Kandula NR, 2008, DIABETES CARE, V31, P1621, DOI 10.2337/dc07-2182; Keenan Nora L., 2011, Morbidity and Mortality Weekly Report, V60, P94; Lanas F, 2007, CIRCULATION, V115, P1067, DOI 10.1161/CIRCULATIONAHA.106.633552; Lavange LM, 2010, ANN EPIDEMIOL, V20, P642, DOI 10.1016/j.annepidem.2010.05.006; Liu K, 2012, CIRCULATION, V125, P996, DOI 10.1161/CIRCULATIONAHA.111.060681; Mainous AG, 2006, PUBLIC HEALTH REP, V121, P60, DOI 10.1177/003335490612100112; MARMOT MG, 1976, AM J EPIDEMIOL, V104, P225, DOI 10.1093/oxfordjournals.aje.a112296; MITCHELL BD, 1990, AM J EPIDEMIOL, V131, P423, DOI 10.1093/oxfordjournals.aje.a115517; Mooteri SN, 2004, AM J CARDIOL, V93, P359, DOI 10.1016/j.amjcard.2003.09.044; Morales LS, 2011, J IMMIGR MINOR HEALT, V13, P61, DOI 10.1007/s10903-009-9262-7; *NIH, NIH PUBL; Pabon-Nau LP, 2010, J GEN INTERN MED, V25, P847, DOI 10.1007/s11606-010-1335-8; REED D, 1982, AM J EPIDEMIOL, V115, P894, DOI 10.1093/oxfordjournals.aje.a113377; Rewers Marian, 1993, Ethnicity and Disease, V3, P44; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Roux AVD, 2005, CIRCULATION, V112, P1557, DOI 10.1161/CIRCULATIONAHA.104.530147; Schargrodsky H, 2008, AM J MED, V121, P58, DOI 10.1016/j.amjmed.2007.08.038; Sorlie PD, 2010, ANN EPIDEMIOL, V20, P629, DOI 10.1016/j.annepidem.2010.03.015; STERN MP, 1984, AM J EPIDEMIOL, V120, P834, DOI 10.1093/oxfordjournals.aje.a113956; Sundquist J, 1999, AM J PUBLIC HEALTH, V89, P723, DOI 10.2105/AJPH.89.5.723; Swenson CJ, 2002, AM J EPIDEMIOL, V156, P919, DOI 10.1093/aje/kwf140; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	35	591	599	2	56	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1775	1784		10.1001/jama.2012.14517	http://dx.doi.org/10.1001/jama.2012.14517			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117778	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000310726500024
J	Singer, T				Singer, Thea			NUTRITION The vitamin D complex	NATURE			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; D DEFICIENCY; COPD											Banerjee A, 2012, CURR OPIN PHARMACOL, V12, P266, DOI 10.1016/j.coph.2012.01.014; Gold DR, 2012, ANN INTERN MED, V156, P156, DOI 10.7326/0003-4819-156-2-201201170-00013; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Janssens W, 2011, VITAM HORM, V86, P379, DOI 10.1016/B978-0-12-386960-9.00017-4; Janssens W, 2010, THORAX, V65, P215, DOI 10.1136/thx.2009.120659; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; Merlino LA, 2004, ARTHRITIS RHEUM-US, V50, P72, DOI 10.1002/art.11434; Persson LJ, 2012, AM J RESP CRIT CARE, V185, pA3889; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	9	6	6	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S10	S11		10.1038/489S10a	http://dx.doi.org/10.1038/489S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013708	Bronze			2022-12-28	WOS:000309167100006
J	Hughes, V				Hughes, Virginia			Genomics: A complex code	NATURE			English	Editorial Material																			0	8	8	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					S3	S3		10.1038/nature11105	http://dx.doi.org/10.1038/nature11105			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22509504	Bronze			2022-12-28	WOS:000303149900045
J	Deweerdt, S				Deweerdt, Sarah			COMPARATIVE BIOLOGY Looking for a master switch	NATURE			English	Editorial Material							FIBROBLASTS; RESISTANT											Austad SN, 2010, J COMP PATHOL, V141, pS10, DOI 10.1016/j.jcpa.2009.10.024; Edrey YH, 2012, AGING CELL, V11, P213, DOI 10.1111/j.1474-9726.2011.00772.x; Harper JM, 2007, AGING CELL, V6, P1, DOI 10.1111/j.1474-9726.2006.00255.x; Harper JM, 2011, J EXP BIOL, V214, P1902, DOI 10.1242/jeb.054643; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Soltow QA, 2010, INTEGR COMP BIOL, V50, P844, DOI 10.1093/icb/icq094	6	18	19	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					S10	S11		10.1038/492S10a	http://dx.doi.org/10.1038/492S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23222666	Bronze			2022-12-28	WOS:000311893400006
